{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [],
   "source": [
    "import re\n",
    "import json\n",
    "import pickle\n",
    "import pandas as pd\n",
    "from collections import defaultdict\n",
    "from indra.databases.hgnc_client import get_hgnc_name"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "with open('text2grounding.pkl', 'rb') as f:\n",
    "    text2grounding = pickle.load(f)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "with open('entrez_all_pmids.json', 'r') as f:\n",
    "    pmids = json.load(f)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['24015703',\n",
       " '12433946',\n",
       " '20931182',\n",
       " '10575216',\n",
       " '23229553',\n",
       " '15695101',\n",
       " '11907168',\n",
       " '22020285',\n",
       " '18678320',\n",
       " '20049674',\n",
       " '24035804',\n",
       " '23807092',\n",
       " '12437930',\n",
       " '11803450',\n",
       " '26794006',\n",
       " '16420525',\n",
       " '15197476',\n",
       " '25951834',\n",
       " '12198146',\n",
       " '16382106',\n",
       " '20012522',\n",
       " '10748056',\n",
       " '23831603',\n",
       " '20301658',\n",
       " '12003807',\n",
       " '18824070',\n",
       " '11886861',\n",
       " '21838752',\n",
       " '17945357',\n",
       " '24374141',\n",
       " '10321245',\n",
       " '9721223',\n",
       " '21710317',\n",
       " '19657056',\n",
       " '18375952',\n",
       " '25655935',\n",
       " '21540350',\n",
       " '21357689',\n",
       " '15099524',\n",
       " '12477932',\n",
       " '22178873',\n",
       " '23772394',\n",
       " '22893713',\n",
       " '23164059',\n",
       " '12837685',\n",
       " '11256078',\n",
       " '19188660',\n",
       " '26912814',\n",
       " '16574908',\n",
       " '26743085',\n",
       " '25420509',\n",
       " '11680614',\n",
       " '21362619',\n",
       " '9312005',\n",
       " '15099514',\n",
       " '23305490',\n",
       " '23883380',\n",
       " '24743596',\n",
       " '24932805',\n",
       " '27453251']"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pmids['KCNK3']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 62,
   "metadata": {},
   "outputs": [],
   "source": [
    "two_letter = defaultdict(lambda: defaultdict(set))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "bad = []\n",
    "for stmt_id, _, text, hgnc_id, reader in text2grounding:\n",
    "    name = get_hgnc_name(hgnc_id)\n",
    "    if name:\n",
    "        hgnc_texts[name][text].add((stmt_id, reader))\n",
    "    else:\n",
    "        bad.append(hgnc_id)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "with open('hgnc_groundings.pkl', 'wb') as f:\n",
    "    pickle.dump(dict(hgnc_texts), f)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "metadata": {},
   "outputs": [],
   "source": [
    "two_letterSF = [x for x in text2grounding if re.match(r'^[A-Z][A-Z]$', x[2])]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 63,
   "metadata": {},
   "outputs": [],
   "source": [
    "bad = []\n",
    "for stmt_id, _, text, hgnc_id, reader in two_letterSF:\n",
    "    name = get_hgnc_name(hgnc_id)\n",
    "    if name:\n",
    "        two_letter[name][text].add((stmt_id, reader))\n",
    "    else:\n",
    "        bad.append(hgnc_id)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 67,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "86275"
      ]
     },
     "execution_count": 67,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(two_letter['ESR1']['ER'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 56,
   "metadata": {},
   "outputs": [],
   "source": [
    "SF2 = defaultdict(set)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 57,
   "metadata": {},
   "outputs": [],
   "source": [
    "for _, _, shortform, gene_id, _ in two_letterSF:\n",
    "    SF2[get_hgnc_name(gene_id)].add(shortform)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 58,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "defaultdict(set,\n",
       "            {'TFF2': {'SP', 'WU'},\n",
       "             'CFH': {'HF'},\n",
       "             'PRH1': {'PA'},\n",
       "             'GLS2': {'GA'},\n",
       "             'CD74': {'II'},\n",
       "             'GH1': {'GH'},\n",
       "             'ESR1': {'ER'},\n",
       "             'HMOX1': {'HO'},\n",
       "             'PODXL': {'PC'},\n",
       "             'GK': {'GK'},\n",
       "             'SNCG': {'SR'},\n",
       "             'CLEC3B': {'TN'},\n",
       "             'MTR': {'MS'},\n",
       "             'TYMS': {'TS'},\n",
       "             'PGR': {'PR'},\n",
       "             'PSMD4': {'AF'},\n",
       "             'FUT2': {'SE'},\n",
       "             'FDFT1': {'SS'},\n",
       "             'KLK8': {'NP'},\n",
       "             'QPCT': {'EC', 'OD', 'QC'},\n",
       "             'OXT': {'OT'},\n",
       "             'CHN1': {'NC'},\n",
       "             'GC': {'GC'},\n",
       "             'LEP': {'OB'},\n",
       "             'SI': {'SI'},\n",
       "             'CA9': {'MN'},\n",
       "             'TG': {'TG'},\n",
       "             'HGF': {'SF'},\n",
       "             'ERMAP': {'SC'},\n",
       "             'LTF': {'LF'},\n",
       "             'OCM': {'OM'},\n",
       "             'AR': {'AR', 'KD'},\n",
       "             'FMN1': {'LD'},\n",
       "             'VCL': {'MV'},\n",
       "             'FH': {'FH'},\n",
       "             'NTS': {'NN', 'NT'},\n",
       "             'MFSD11': {'ET'},\n",
       "             'AVP': {'VP'},\n",
       "             'HR': {'HR'},\n",
       "             'GSR': {'GR'},\n",
       "             'MB': {'MB'},\n",
       "             'HTN3': {'PB'},\n",
       "             'NR3C2': {'MR'},\n",
       "             'CP': {'CP'},\n",
       "             'RANGAP1': {'SD'},\n",
       "             'ERVK-10': {'IN', 'RT'},\n",
       "             'DSP': {'DP'},\n",
       "             'INSR': {'IR'},\n",
       "             'DBI': {'EP'},\n",
       "             'ASAH1': {'AC'},\n",
       "             'TCN1': {'HC'},\n",
       "             'DHPS': {'DS'},\n",
       "             'SDHB': {'IP'},\n",
       "             'HTT': {'HD'},\n",
       "             'XK': {'XK'},\n",
       "             'TH': {'TH'},\n",
       "             'TFRC': {'TR'},\n",
       "             'KL': {'KL'},\n",
       "             'SPARC': {'ON'},\n",
       "             'KDM5D': {'HY'},\n",
       "             'TOR1A': {'TA'},\n",
       "             'MMP12': {'ME'},\n",
       "             'CMPK1': {'CK'},\n",
       "             'GLUL': {'GS'},\n",
       "             'PREP': {'PE'},\n",
       "             'DCT': {'DT'},\n",
       "             'ERVK-18': {'SU', 'TM'},\n",
       "             'LIPC': {'HL'},\n",
       "             'TF': {'TF'},\n",
       "             'TYMP': {'TP'},\n",
       "             'SCG2': {'SN'},\n",
       "             'CHKA': {'CK', 'EK'},\n",
       "             'RB1': {'RB'},\n",
       "             'ADM': {'AM'},\n",
       "             'HP': {'BP', 'HP'},\n",
       "             'TNXB': {'XB'},\n",
       "             'NELFE': {'RD'},\n",
       "             'PPY': {'PH', 'PP'},\n",
       "             'MCAT': {'MT'},\n",
       "             'FMOD': {'FM'},\n",
       "             'NRGN': {'NG'},\n",
       "             'GNL3': {'NS'},\n",
       "             'FABP6': {'GT'},\n",
       "             'TBCEL': {'EL'},\n",
       "             'CFD': {'DF'},\n",
       "             'HPS6': {'RU'},\n",
       "             'BTN1A1': {'BT'},\n",
       "             'FUT3': {'LE'},\n",
       "             'ID1': {'ID'},\n",
       "             'FN1': {'FN'},\n",
       "             'FST': {'FS'},\n",
       "             'BLMH': {'BH'},\n",
       "             'SERPINA1': {'PI'},\n",
       "             'F11R': {'JA'},\n",
       "             'NPPA': {'NF'},\n",
       "             'NR3C1': {'GR'},\n",
       "             'EMILIN1': {'EM'},\n",
       "             'LIAS': {'LS'},\n",
       "             'ELANE': {'NE'},\n",
       "             'CBLIF': {'IF'},\n",
       "             'DMAC2L': {'FB'},\n",
       "             'CTSG': {'CG'},\n",
       "             'DKK1': {'SK'},\n",
       "             'ATP1A1': {'NA'},\n",
       "             'GBA': {'GC'},\n",
       "             'BLOC1S5': {'MU'},\n",
       "             'PAEP': {'GD'},\n",
       "             'MT-RNR2': {'HN'},\n",
       "             'CS': {'CS'},\n",
       "             'SEPSECS': {'LP'},\n",
       "             'RGN': {'RC'},\n",
       "             'LIPF': {'GL'},\n",
       "             'UPP1': {'UP'},\n",
       "             'DCXR': {'XR'},\n",
       "             'CD55': {'CR', 'TC'},\n",
       "             'SDHA': {'FP'},\n",
       "             'CFB': {'BF'},\n",
       "             'CSH1': {'PL'},\n",
       "             'MDK': {'MK'},\n",
       "             'EDAR': {'DL'},\n",
       "             'HCRT': {'OX'},\n",
       "             'THPO': {'ML'},\n",
       "             'TKT': {'TK'},\n",
       "             'XDH': {'XD', 'XO'},\n",
       "             'LEPR': {'DB'},\n",
       "             'EEA1': {'EE'},\n",
       "             'HJV': {'JH'},\n",
       "             'SLC4A1': {'DI', 'WR'},\n",
       "             'CACNA1A': {'BI'},\n",
       "             'MASTL': {'GW'},\n",
       "             'CREBZF': {'ZF'},\n",
       "             'BLVRB': {'FR'},\n",
       "             'POSTN': {'PN'},\n",
       "             'AKAP4': {'HI'},\n",
       "             'RAX': {'RX'},\n",
       "             'KY': {'KY'},\n",
       "             'SERPINB1': {'EI'},\n",
       "             'ART4': {'DO'},\n",
       "             'EPO': {'EP'},\n",
       "             'THBD': {'TM'},\n",
       "             'AOX1': {'AO'},\n",
       "             'GZMA': {'HF'},\n",
       "             'TMSB4X': {'FX'},\n",
       "             'XG': {'XG'},\n",
       "             'IK': {'IK'},\n",
       "             'VTN': {'VN'},\n",
       "             'RAC2': {'GX'},\n",
       "             'ADK': {'AK'},\n",
       "             'AWAT2': {'WS'},\n",
       "             'TXNRD1': {'TR'},\n",
       "             'F2R': {'TR'},\n",
       "             'PSMA1': {'NU'},\n",
       "             'CALB2': {'CR'},\n",
       "             'NME2': {'NM'},\n",
       "             'ICAM4': {'LW'},\n",
       "             'BCAM': {'LU'},\n",
       "             'RPL10': {'QM'},\n",
       "             'GRK1': {'RK'},\n",
       "             'MT-ATP6': {'RP'},\n",
       "             'SLC14A1': {'JK'},\n",
       "             'MSTN': {'MH'},\n",
       "             'CR1': {'KN'},\n",
       "             'BLM': {'BS'},\n",
       "             'CALR': {'RO'},\n",
       "             'APOH': {'BG'},\n",
       "             'STK36': {'FU'},\n",
       "             'ACKR1': {'FY'},\n",
       "             'GYPA': {'MN'},\n",
       "             'OC90': {'OC'},\n",
       "             'CASP4': {'TX'},\n",
       "             'DST': {'DT'},\n",
       "             'ERMN': {'JN'},\n",
       "             'TNXA': {'XA'},\n",
       "             'TNC': {'JI', 'TN'},\n",
       "             'PPP1R3A': {'GM'},\n",
       "             'PRB1': {'PM'},\n",
       "             'ALOX5': {'LO'},\n",
       "             'LOX': {'LO'},\n",
       "             'MVK': {'MK'},\n",
       "             'CSN2': {'BC'},\n",
       "             'VIPR1': {'II'},\n",
       "             'RAPGEF5': {'CV'},\n",
       "             'UBB': {'UB'},\n",
       "             'DCX': {'DC'},\n",
       "             'FANCA': {'FA'},\n",
       "             'PPOX': {'QO'},\n",
       "             'BGLAP': {'OC'},\n",
       "             'DCN': {'DC'},\n",
       "             'IFI27': {'SJ'},\n",
       "             'FCN3': {'OZ'},\n",
       "             'BTK': {'AT'},\n",
       "             'MID1': {'OS'},\n",
       "             'NBL1': {'NB'},\n",
       "             'NT5E': {'NT'},\n",
       "             'SOCS3': {'WT'}})"
      ]
     },
     "execution_count": 58,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "SF2 = "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(16939, 0, 'SP', '11756', 'REACH')"
      ]
     },
     "execution_count": 42,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "two_letterSF[0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'SP': 'TFF2',\n",
       " 'HF': 'CFH',\n",
       " 'PA': 'PRH1',\n",
       " 'GA': 'GLS2',\n",
       " 'II': 'CD74',\n",
       " 'GH': 'GH1',\n",
       " 'ER': 'ESR1',\n",
       " 'HO': 'HMOX1',\n",
       " 'PC': 'PODXL',\n",
       " 'GK': 'GK',\n",
       " 'SR': 'SNCG',\n",
       " 'TN': 'CLEC3B',\n",
       " 'MS': 'MTR',\n",
       " 'TS': 'TYMS',\n",
       " 'PR': 'PGR',\n",
       " 'AF': 'PSMD4',\n",
       " 'SE': 'FUT2',\n",
       " 'SS': 'FDFT1',\n",
       " 'NP': 'KLK8',\n",
       " 'EC': 'QPCT',\n",
       " 'OT': 'OXT',\n",
       " 'NC': 'CHN1',\n",
       " 'GC': 'GC',\n",
       " 'OB': 'LEP',\n",
       " 'SI': 'SI',\n",
       " 'MN': 'CA9',\n",
       " 'TG': 'TG',\n",
       " 'SF': 'HGF',\n",
       " 'SC': 'ERMAP',\n",
       " 'LF': 'LTF',\n",
       " 'OM': 'OCM',\n",
       " 'AR': 'AR',\n",
       " 'LD': 'FMN1',\n",
       " 'MV': 'VCL',\n",
       " 'FH': 'FH',\n",
       " 'NT': 'NTS',\n",
       " 'ET': 'MFSD11',\n",
       " 'VP': 'AVP',\n",
       " 'HR': 'HR',\n",
       " 'GR': 'GSR',\n",
       " 'MB': 'MB',\n",
       " 'PB': 'HTN3',\n",
       " 'MR': 'NR3C2',\n",
       " 'CP': 'CP',\n",
       " 'SD': 'RANGAP1',\n",
       " 'RT': 'ERVK-10',\n",
       " 'DP': 'DSP',\n",
       " 'IR': 'INSR',\n",
       " 'EP': 'DBI',\n",
       " 'AC': 'ASAH1',\n",
       " 'HC': 'TCN1',\n",
       " 'DS': 'DHPS',\n",
       " 'IP': 'SDHB',\n",
       " 'HD': 'HTT',\n",
       " 'XK': 'XK',\n",
       " 'TH': 'TH',\n",
       " 'TR': 'TFRC',\n",
       " 'KL': 'KL',\n",
       " 'ON': 'SPARC',\n",
       " 'HY': 'KDM5D',\n",
       " 'TA': 'TOR1A',\n",
       " 'ME': 'MMP12',\n",
       " 'CK': 'CMPK1',\n",
       " 'GS': 'GLUL',\n",
       " 'PE': 'PREP',\n",
       " 'DT': 'DCT',\n",
       " 'TM': 'ERVK-18',\n",
       " 'HL': 'LIPC',\n",
       " 'TF': 'TF',\n",
       " 'TP': 'TYMP',\n",
       " 'SN': 'SCG2',\n",
       " 'EK': 'CHKA',\n",
       " 'RB': 'RB1',\n",
       " 'AM': 'ADM',\n",
       " 'HP': 'HP',\n",
       " 'XB': 'TNXB',\n",
       " 'RD': 'NELFE',\n",
       " 'PH': 'PPY',\n",
       " 'MT': 'MCAT',\n",
       " 'FM': 'FMOD',\n",
       " 'NG': 'NRGN',\n",
       " 'NS': 'GNL3',\n",
       " 'GT': 'FABP6',\n",
       " 'EL': 'TBCEL',\n",
       " 'DF': 'CFD',\n",
       " 'RU': 'HPS6',\n",
       " 'BT': 'BTN1A1',\n",
       " 'LE': 'FUT3',\n",
       " 'ID': 'ID1',\n",
       " 'FN': 'FN1',\n",
       " 'FS': 'FST',\n",
       " 'BH': 'BLMH',\n",
       " 'PI': 'SERPINA1',\n",
       " 'JA': 'F11R',\n",
       " 'IN': 'ERVK-10',\n",
       " 'NF': 'NPPA',\n",
       " 'PP': 'PPY',\n",
       " 'EM': 'EMILIN1',\n",
       " 'LS': 'LIAS',\n",
       " 'KD': 'AR',\n",
       " 'NE': 'ELANE',\n",
       " 'IF': 'CBLIF',\n",
       " 'FB': 'DMAC2L',\n",
       " 'CG': 'CTSG',\n",
       " 'SK': 'DKK1',\n",
       " 'NA': 'ATP1A1',\n",
       " 'MU': 'BLOC1S5',\n",
       " 'GD': 'PAEP',\n",
       " 'HN': 'MT-RNR2',\n",
       " 'CS': 'CS',\n",
       " 'LP': 'SEPSECS',\n",
       " 'RC': 'RGN',\n",
       " 'GL': 'LIPF',\n",
       " 'UP': 'UPP1',\n",
       " 'XR': 'DCXR',\n",
       " 'CR': 'CD55',\n",
       " 'FP': 'SDHA',\n",
       " 'BF': 'CFB',\n",
       " 'PL': 'CSH1',\n",
       " 'MK': 'MDK',\n",
       " 'DL': 'EDAR',\n",
       " 'OX': 'HCRT',\n",
       " 'ML': 'THPO',\n",
       " 'TK': 'TKT',\n",
       " 'XO': 'XDH',\n",
       " 'DB': 'LEPR',\n",
       " 'EE': 'EEA1',\n",
       " 'JH': 'HJV',\n",
       " 'DI': 'SLC4A1',\n",
       " 'BI': 'CACNA1A',\n",
       " 'GW': 'MASTL',\n",
       " 'ZF': 'CREBZF',\n",
       " 'FR': 'BLVRB',\n",
       " 'PN': 'POSTN',\n",
       " 'HI': 'AKAP4',\n",
       " 'RX': 'RAX',\n",
       " 'SU': 'ERVK-18',\n",
       " 'KY': 'KY',\n",
       " 'EI': 'SERPINB1',\n",
       " 'DO': 'ART4',\n",
       " 'AO': 'AOX1',\n",
       " 'FX': 'TMSB4X',\n",
       " 'XG': 'XG',\n",
       " 'IK': 'IK',\n",
       " 'VN': 'VTN',\n",
       " 'GX': 'RAC2',\n",
       " 'AK': 'ADK',\n",
       " 'WS': 'AWAT2',\n",
       " 'QC': 'QPCT',\n",
       " 'NU': 'PSMA1',\n",
       " 'XD': 'XDH',\n",
       " 'NM': 'NME2',\n",
       " 'LW': 'ICAM4',\n",
       " 'LU': 'BCAM',\n",
       " 'QM': 'RPL10',\n",
       " 'NN': 'NTS',\n",
       " 'RK': 'GRK1',\n",
       " 'WR': 'SLC4A1',\n",
       " 'BP': 'HP',\n",
       " 'RP': 'MT-ATP6',\n",
       " 'JK': 'SLC14A1',\n",
       " 'MH': 'MSTN',\n",
       " 'KN': 'CR1',\n",
       " 'BS': 'BLM',\n",
       " 'RO': 'CALR',\n",
       " 'BG': 'APOH',\n",
       " 'FU': 'STK36',\n",
       " 'FY': 'ACKR1',\n",
       " 'OC': 'OC90',\n",
       " 'TX': 'CASP4',\n",
       " 'JN': 'ERMN',\n",
       " 'XA': 'TNXA',\n",
       " 'GM': 'PPP1R3A',\n",
       " 'PM': 'PRB1',\n",
       " 'LO': 'ALOX5',\n",
       " 'BC': 'CSN2',\n",
       " 'CV': 'RAPGEF5',\n",
       " 'JI': 'TNC',\n",
       " 'UB': 'UBB',\n",
       " 'DC': 'DCN',\n",
       " 'FA': 'FANCA',\n",
       " 'OD': 'QPCT',\n",
       " 'QO': 'PPOX',\n",
       " 'SJ': 'IFI27',\n",
       " 'OZ': 'FCN3',\n",
       " 'AT': 'BTK',\n",
       " 'TC': 'CD55',\n",
       " 'OS': 'MID1',\n",
       " 'WU': 'TFF2',\n",
       " 'NB': 'NBL1',\n",
       " 'WT': 'SOCS3'}"
      ]
     },
     "execution_count": 40,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "SF2"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "dict_keys(['GK', 'GC', 'SI', 'TG', 'AR', 'IK', 'CP', 'FH', 'TH', 'HR', 'MB', 'HP', 'XK', 'KL', 'TF', 'PC', 'CS', 'KY', 'XG'])"
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "two_letterSF.keys()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [],
   "source": [
    "a = [x for x in text2grounding if x[2] == 'ER']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(17223, 0, 'ER', '3467', 'REACH')"
      ]
     },
     "execution_count": 34,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "a[0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<re.Match object; span=(0, 2), match='SF'>"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "re.match(r'^[A-Z][A-Z]$', 'SF')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 55,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "32.606"
      ]
     },
     "execution_count": 55,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "16303/500"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [],
   "source": [
    "ion_channels = pd.read_csv('ion_channels.tsv', sep='\\t')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [],
   "source": [
    "ic_symbols = set(ion_channels['Approved symbol'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "328"
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(ic_symbols)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [],
   "source": [
    "channel_texts = {key: value for key, value in hgnc_texts.items() if key in ic_symbols}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "metadata": {},
   "outputs": [],
   "source": [
    "with open('ion_channel_groundings.pkl', 'wb') as f:\n",
    "    pickle.dump(channel_texts, f)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "We have no info in the database at all for the following 6 genes"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "dict_items([('task', {(12385504, 'REACH'), (13058055, 'REACH'), (25575431, 'REACH'), (1052728, 'REACH'), (27922488, 'REACH'), (4325494, 'REACH'), (209779, 'REACH'), (18483456, 'REACH'), (13754059, 'REACH'), (3269989, 'REACH'), (17815062, 'REACH'), (20403734, 'REACH'), (21262867, 'REACH'), (25777686, 'REACH'), (27478337, 'REACH'), (28730725, 'REACH'), (19348640, 'REACH'), (3244172, 'REACH'), (18263177, 'REACH'), (12361274, 'REACH'), (3638684, 'SPARSER'), (1103654, 'REACH'), (27547430, 'REACH'), (12231892, 'REACH'), (13051092, 'REACH'), (18992898, 'REACH'), (3584783, 'REACH'), (294064, 'REACH'), (3650319, 'REACH'), (12385456, 'REACH'), (21866094, 'REACH'), (3230538, 'REACH'), (24922954, 'REACH'), (28539479, 'REACH'), (24435507, 'REACH'), (15668242, 'REACH'), (9201088, 'REACH'), (8159867, 'REACH'), (9485123, 'REACH'), (24456692, 'REACH'), (1850609, 'REACH'), (21609713, 'REACH'), (11682269, 'REACH'), (9869369, 'REACH'), (8673091, 'SPARSER'), (1298469, 'REACH'), (24081875, 'REACH'), (18483457, 'REACH'), (2620082, 'REACH'), (27482185, 'REACH'), (30136393, 'REACH'), (17113991, 'REACH'), (30151976, 'REACH'), (4325501, 'REACH'), (1759577, 'REACH'), (26839562, 'REACH'), (26170903, 'REACH'), (618227, 'REACH'), (17329907, 'REACH'), (11873185, 'REACH'), (10632146, 'REACH'), (12361275, 'REACH'), (18638805, 'REACH'), (23867385, 'REACH'), (22306615, 'REACH'), (29122359, 'REACH'), (14854550, 'REACH'), (27141152, 'REACH'), (24178526, 'REACH'), (16542965, 'REACH'), (25513044, 'REACH'), (27538063, 'REACH'), (27550768, 'REACH'), (12385564, 'REACH'), (26105976, 'REACH'), (27259646, 'REACH'), (13081900, 'REACH'), (11944233, 'REACH'), (10914522, 'REACH'), (15668117, 'REACH'), (12061638, 'REACH'), (12815302, 'REACH'), (24971377, 'REACH'), (20953634, 'REACH'), (15246672, 'REACH'), (17557003, 'REACH'), (10204138, 'REACH'), (11744234, 'REACH'), (18741810, 'REACH'), (19650147, 'REACH'), (15667988, 'REACH'), (9459522, 'REACH'), (13522754, 'REACH'), (20213327, 'REACH'), (2569433, 'REACH'), (21623191, 'REACH'), (24932759, 'REACH'), (26795894, 'REACH'), (26520612, 'REACH'), (24178527, 'REACH'), (16481293, 'REACH'), (8342971, 'REACH'), (12638260, 'REACH'), (12872976, 'REACH'), (20573456, 'REACH'), (274126, 'REACH'), (16110680, 'REACH'), (13153791, 'REACH'), (4207323, 'REACH'), (25263464, 'REACH'), (26994608, 'REACH'), (26637035, 'REACH'), (17401175, 'REACH'), (18982092, 'SPARSER'), (288986, 'SPARSER'), (3904481, 'REACH'), (1303314, 'REACH'), (375327, 'REACH'), (8348434, 'REACH'), (13640876, 'REACH'), (18752684, 'REACH'), (21699349, 'REACH'), (23020099, 'REACH'), (1939700, 'REACH'), (25219021, 'SPARSER'), (25786763, 'REACH'), (863036, 'REACH'), (23931091, 'REACH'), (28420307, 'REACH'), (741377, 'REACH'), (2836717, 'REACH'), (19870773, 'REACH'), (20959718, 'REACH'), (13441684, 'REACH'), (29330378, 'REACH'), (13754050, 'REACH'), (10768744, 'SPARSER'), (21198756, 'REACH'), (10983135, 'REACH'), (13316992, 'REACH'), (8835367, 'REACH'), (16105416, 'REACH'), (12666374, 'REACH'), (538548, 'REACH'), (20391932, 'REACH'), (24538666, 'REACH'), (26446391, 'REACH'), (11403224, 'REACH'), (24189925, 'REACH'), (24335556, 'REACH'), (2027457, 'REACH'), (27366176, 'REACH'), (9141480, 'REACH'), (28977981, 'REACH'), (12121546, 'REACH'), (23595666, 'REACH'), (25410975, 'REACH'), (16124749, 'REACH'), (17632077, 'REACH'), (24519724, 'REACH'), (25723528, 'REACH'), (24588998, 'REACH'), (29009347, 'REACH'), (27729967, 'REACH'), (11884624, 'REACH'), (1036381, 'REACH'), (27959343, 'REACH'), (30136400, 'REACH'), (24571626, 'REACH'), (24735466, 'REACH'), (27343190, 'REACH'), (19656577, 'REACH'), (19587355, 'REACH'), (1608616, 'REACH'), (25037736, 'REACH'), (13203814, 'REACH'), (11437411, 'REACH'), (24541542, 'REACH'), (25606069, 'REACH'), (21358333, 'REACH'), (18161802, 'REACH'), (26648714, 'REACH'), (21892641, 'REACH'), (11771474, 'REACH'), (17547871, 'REACH'), (2780396, 'REACH'), (24878490, 'REACH'), (11485000, 'REACH'), (11767171, 'REACH'), (1103668, 'REACH'), (2098402, 'REACH'), (624078, 'REACH'), (537803, 'REACH'), (12737184, 'REACH'), (9979358, 'REACH'), (27723880, 'REACH'), (30136401, 'REACH'), (18227530, 'REACH'), (18456906, 'REACH'), (28909898, 'REACH'), (20021988, 'REACH'), (23796672, 'REACH'), (21096830, 'REACH'), (12268460, 'REACH'), (13841324, 'REACH'), (13203815, 'REACH'), (8582677, 'REACH'), (26834453, 'REACH'), (26356655, 'REACH'), (24258702, 'REACH'), (1655556, 'REACH'), (18691841, 'REACH'), (11686066, 'REACH'), (24835053, 'REACH'), (29319323, 'REACH'), (15073077, 'REACH'), (8820966, 'REACH'), (18770127, 'REACH'), (23830538, 'REACH'), (24846346, 'REACH'), (28685952, 'REACH'), (2445965, 'REACH'), (66622, 'REACH'), (29013632, 'REACH'), (9350649, 'REACH'), (24456697, 'REACH'), (23295894, 'REACH'), (11744147, 'REACH'), (11611076, 'REACH'), (2808352, 'REACH'), (13884333, 'REACH'), (9054555, 'REACH'), (597946, 'REACH'), (3743674, 'REACH'), (2376437, 'REACH'), (13443238, 'REACH'), (29115125, 'REACH'), (2362498, 'REACH'), (26414210, 'REACH'), (28340367, 'REACH'), (11475740, 'REACH'), (10408525, 'REACH'), (517929, 'REACH'), (17639642, 'REACH'), (28647655, 'REACH'), (22983061, 'REACH'), (24262851, 'REACH'), (25591668, 'REACH'), (25868483, 'REACH'), (1030178, 'REACH'), (26880815, 'REACH'), (15126542, 'REACH'), (14965177, 'REACH'), (21518777, 'REACH'), (24932773, 'REACH'), (10531441, 'SPARSER'), (9669252, 'REACH'), (26816204, 'REACH'), (23488168, 'REACH'), (18302031, 'REACH'), (1233625, 'REACH'), (22270681, 'REACH'), (27579097, 'REACH'), (2832696, 'REACH'), (11878085, 'REACH'), (22682998, 'REACH'), (23779666, 'REACH'), (13864287, 'REACH'), (29313979, 'REACH'), (14955651, 'REACH'), (1909297, 'REACH'), (28680753, 'REACH'), (17400592, 'REACH'), (25385501, 'REACH'), (25513166, 'REACH'), (18274940, 'REACH'), (16389045, 'SPARSER'), (11096664, 'REACH'), (15088403, 'REACH'), (25625030, 'SPARSER'), (25457663, 'REACH'), (1121676, 'REACH'), (20179770, 'REACH'), (18791623, 'REACH'), (23248071, 'REACH'), (24636021, 'REACH'), (15942481, 'REACH'), (18468879, 'REACH'), (20099950, 'REACH'), (26188444, 'REACH'), (17323417, 'REACH'), (16605238, 'REACH'), (12889572, 'REACH'), (30136387, 'REACH'), (23209716, 'REACH'), (28939577, 'REACH'), (26246657, 'REACH'), (8572863, 'REACH'), (27129581, 'REACH'), (11865246, 'REACH'), (22017612, 'REACH'), (20826106, 'REACH'), (12197245, 'REACH'), (28816988, 'REACH'), (10408537, 'REACH'), (23460373, 'SPARSER'), (26275236, 'REACH'), (1254561, 'REACH'), (25435533, 'REACH'), (2412350, 'REACH'), (18934587, 'REACH'), (20179771, 'REACH'), (29515779, 'REACH'), (22673250, 'REACH'), (9624989, 'REACH'), (17700089, 'REACH'), (27579864, 'REACH'), (29971928, 'REACH'), (12558998, 'REACH'), (15809171, 'REACH'), (24007364, 'REACH'), (13447456, 'REACH'), (29213357, 'REACH'), (23371020, 'REACH'), (10218170, 'REACH'), (26349045, 'REACH'), (27692533, 'REACH'), (2718371, 'REACH'), (12745379, 'REACH'), (1228497, 'REACH'), (2810754, 'REACH'), (1427773, 'REACH'), (15223101, 'REACH'), (10223897, 'REACH'), (18514201, 'REACH'), (22034788, 'REACH'), (18358247, 'REACH'), (16116885, 'REACH'), (9462723, 'REACH'), (25051127, 'REACH'), (17932696, 'REACH'), (22411429, 'REACH'), (10104193, 'REACH'), (11447681, 'REACH'), (13675905, 'REACH'), (10209146, 'REACH'), (18142645, 'REACH'), (11248483, 'REACH'), (9464852, 'REACH'), (22983057, 'REACH'), (2198571, 'REACH'), (17522153, 'REACH'), (21599130, 'REACH'), (11578023, 'REACH'), (21113941, 'REACH'), (9931280, 'REACH'), (4158155, 'REACH'), (2723754, 'REACH'), (19246007, 'REACH'), (22034789, 'REACH'), (12511766, 'REACH'), (22091283, 'REACH'), (8911615, 'REACH'), (27428052, 'SPARSER'), (19807789, 'REACH'), (21315721, 'REACH'), (2578191, 'REACH'), (22559342, 'REACH'), (24932764, 'REACH'), (8126712, 'REACH'), (14950195, 'REACH'), (15349988, 'REACH'), (22853860, 'REACH'), (23804132, 'REACH'), (23915745, 'REACH'), (20646093, 'REACH'), (23830536, 'REACH'), (25321122, 'REACH'), (20963588, 'REACH'), (13348097, 'REACH'), (15609089, 'REACH'), (28031679, 'REACH'), (1356538, 'REACH'), (13092743, 'REACH'), (17074472, 'REACH'), (18155816, 'REACH'), (13108966, 'REACH'), (23199682, 'REACH'), (30152005, 'REACH'), (12007998, 'REACH'), (26697065, 'REACH'), (1509576, 'REACH'), (16554161, 'REACH'), (13030800, 'REACH'), (10888014, 'REACH'), (16160800, 'SPARSER'), (9268630, 'REACH'), (1626515, 'REACH'), (1636943, 'SPARSER'), (22028740, 'REACH'), (1421741, 'REACH'), (29942622, 'REACH'), (22680391, 'REACH'), (10660482, 'REACH'), (18773647, 'REACH'), (1030192, 'REACH'), (238653, 'REACH'), (1862126, 'REACH'), (13199854, 'REACH'), (9269532, 'REACH'), (18117461, 'SPARSER'), (334295, 'REACH'), (21353142, 'REACH'), (17674540, 'REACH'), (16147753, 'REACH'), (28089716, 'REACH'), (11263522, 'REACH'), (12279330, 'REACH'), (16372853, 'SPARSER'), (1356374, 'REACH'), (28255571, 'REACH'), (24371332, 'REACH'), (8967297, 'REACH'), (24902266, 'REACH'), (20645032, 'REACH'), (13538449, 'REACH'), (27929410, 'REACH'), (11526735, 'REACH'), (27485614, 'REACH'), (19639516, 'REACH'), (26959045, 'REACH'), (12948342, 'REACH'), (9902881, 'REACH'), (10176338, 'REACH'), (25413458, 'REACH'), (26349036, 'REACH'), (13812969, 'REACH'), (10660483, 'REACH'), (138292, 'REACH'), (1030193, 'REACH'), (10185199, 'REACH'), (18514192, 'REACH'), (18999791, 'REACH'), (22323918, 'REACH'), (11225977, 'REACH'), (30137002, 'REACH'), (13546774, 'REACH'), (23218500, 'REACH'), (227393, 'REACH'), (26212417, 'REACH'), (2148863, 'REACH'), (27674948, 'REACH'), (22271707, 'REACH'), (21782645, 'REACH'), (21979253, 'REACH'), (10103298, 'REACH'), (12361231, 'REACH'), (19013135, 'REACH'), (20765829, 'REACH'), (12279327, 'REACH'), (11656830, 'REACH'), (4275989, 'REACH'), (21601524, 'REACH'), (13640879, 'REACH'), (17788732, 'REACH'), (28892164, 'REACH'), (8606721, 'REACH'), (29152257, 'REACH'), (2430816, 'REACH'), (27618380, 'REACH'), (2828105, 'REACH'), (29459496, 'REACH'), (29224419, 'REACH'), (15668241, 'REACH'), (24012078, 'REACH'), (13241436, 'REACH'), (20548700, 'REACH'), (11812106, 'REACH'), (29199452, 'REACH'), (25036291, 'REACH'), (15813556, 'REACH'), (22030667, 'REACH'), (3935799, 'REACH'), (2007013, 'REACH'), (24068246, 'REACH'), (11266234, 'REACH'), (30330439, 'REACH'), (28204884, 'REACH'), (19684561, 'REACH'), (21895554, 'REACH'), (10461028, 'REACH'), (1054561, 'REACH'), (2568607, 'REACH'), (22983071, 'REACH'), (18602435, 'REACH'), (1979682, 'REACH'), (24716010, 'REACH'), (13303287, 'REACH'), (20348407, 'REACH'), (8396453, 'REACH'), (27193240, 'REACH'), (27618387, 'REACH'), (16342681, 'SPARSER'), (17818907, 'REACH'), (16822184, 'REACH'), (11783093, 'REACH'), (24653736, 'REACH'), (9931284, 'REACH'), (21315735, 'REACH'), (8270392, 'REACH'), (24068247, 'REACH'), (13877793, 'REACH'), (23397983, 'REACH'), (17638144, 'REACH'), (2167194, 'REACH'), (1985332, 'REACH'), (24561680, 'REACH'), (18721207, 'REACH'), (17527640, 'REACH'), (889087, 'REACH'), (23400703, 'REACH'), (334302, 'REACH'), (21772940, 'REACH'), (17342200, 'SPARSER'), (2647764, 'REACH'), (2660029, 'REACH'), (1677212, 'REACH'), (25040796, 'REACH'), (19020887, 'REACH'), (29509942, 'REACH'), (26892575, 'REACH'), (9674688, 'REACH'), (22271693, 'REACH'), (20442494, 'REACH'), (16822185, 'REACH'), (24653737, 'REACH'), (114023, 'REACH'), (9931285, 'REACH'), (18418197, 'REACH'), (21509282, 'REACH'), (2023376, 'REACH'), (25732235, 'REACH'), (18257468, 'REACH'), (22010648, 'REACH'), (9226789, 'REACH'), (13752511, 'REACH'), (17547872, 'REACH'), (26928519, 'REACH'), (2558832, 'REACH'), (4274813, 'REACH'), (28731415, 'REACH'), (2176440, 'REACH'), (21083576, 'REACH'), (334303, 'REACH'), (29463339, 'SPARSER'), (21163720, 'REACH'), (17474399, 'SPARSER'), (2264175, 'REACH'), (29756527, 'REACH'), (21322062, 'REACH'), (29509943, 'REACH'), (796389, 'REACH'), (11922326, 'REACH'), (12400531, 'REACH'), (25636804, 'REACH'), (25765605, 'REACH'), (30523762, 'REACH'), (18684031, 'REACH'), (12279328, 'REACH'), (18009435, 'REACH'), (16969225, 'REACH'), (15263316, 'REACH'), (29288401, 'REACH'), (4325506, 'REACH'), (27531896, 'REACH'), (13797985, 'REACH'), (1473938, 'REACH'), (9414464, 'REACH'), (9807680, 'REACH'), (12658683, 'REACH'), (8576812, 'REACH'), (13030805, 'REACH'), (28759445, 'REACH'), (3603651, 'REACH'), (25414257, 'REACH'), (28428913, 'REACH'), (10972975, 'REACH'), (10257245, 'REACH'), (20579165, 'REACH'), (26440718, 'REACH'), (11447786, 'REACH'), (28683754, 'REACH'), (21772952, 'REACH'), (25912147, 'REACH'), (9252484, 'REACH'), (1364090, 'REACH'), (24400135, 'REACH'), (2718376, 'REACH'), (13284628, 'REACH'), (23595665, 'REACH'), (23468111, 'REACH'), (8132313, 'REACH'), (15668106, 'REACH'), (17787799, 'REACH'), (29176517, 'REACH'), (2448722, 'REACH'), (22043986, 'REACH'), (25169851, 'REACH'), (20363605, 'REACH'), (12658819, 'REACH'), (22221771, 'REACH'), (628906, 'REACH'), (11560513, 'REACH'), (1785635, 'REACH'), (17057458, 'SPARSER'), (11169003, 'REACH'), (9251225, 'REACH'), (11020119, 'REACH'), (1356480, 'REACH'), (10192333, 'REACH'), (25473728, 'REACH'), (28553920, 'REACH'), (28008108, 'REACH'), (17498793, 'REACH'), (28082857, 'REACH'), (1979669, 'REACH'), (17018182, 'REACH'), (2258282, 'REACH'), (17331562, 'REACH'), (9519640, 'REACH'), (26932586, 'REACH'), (3949267, 'REACH'), (15432196, 'REACH'), (15328046, 'SPARSER'), (28187642, 'REACH'), (26431623, 'REACH'), (17624035, 'REACH'), (18199057, 'REACH'), (25905346, 'REACH'), (8873584, 'REACH'), (9135895, 'REACH'), (17622807, 'REACH'), (23400694, 'REACH'), (13249523, 'REACH'), (17665851, 'REACH'), (23975529, 'REACH'), (17553434, 'REACH'), (27416169, 'REACH'), (19932163, 'REACH'), (14856011, 'REACH'), (2378807, 'REACH'), (13396440, 'REACH'), (20472946, 'REACH'), (10778495, 'REACH'), (1463584, 'REACH'), (11200173, 'REACH'), (23424698, 'REACH'), (26865338, 'REACH'), (15830333, 'REACH'), (9418478, 'REACH'), (12563563, 'REACH'), (29033848, 'REACH'), (11556193, 'REACH'), (23691167, 'REACH'), (2575693, 'REACH'), (25537734, 'REACH'), (16119153, 'REACH'), (17556015, 'REACH'), (28231064, 'REACH'), (11135571, 'REACH'), (1505740, 'REACH'), (12057036, 'REACH'), (28383239, 'REACH'), (21439912, 'REACH'), (889085, 'REACH'), (8425725, 'REACH'), (20774955, 'REACH'), (23400701, 'REACH'), (29261867, 'REACH'), (19487370, 'REACH'), (12658744, 'REACH'), (15849590, 'REACH'), (2182003, 'REACH'), (86098, 'REACH'), (18793150, 'REACH'), (1586481, 'REACH'), (23848674, 'REACH'), (18808559, 'REACH'), (667152, 'REACH'), (24084207, 'REACH'), (12914044, 'REACH'), (10437753, 'REACH'), (18943356, 'REACH'), (2841957, 'REACH'), (24024644, 'REACH'), (1959922, 'REACH'), (27062829, 'REACH'), (13482124, 'REACH'), (10963560, 'REACH'), (28812835, 'REACH'), (1038315, 'REACH'), (1172298, 'REACH'), (29033861, 'REACH'), (2370578, 'REACH'), (25513165, 'REACH'), (12776876, 'REACH'), (1168195, 'REACH'), (13390498, 'REACH'), (10735896, 'REACH'), (20959512, 'REACH'), (8531185, 'SPARSER'), (26699813, 'REACH'), (29006550, 'REACH'), (29984004, 'REACH'), (20755949, 'REACH'), (15223710, 'REACH'), (11557606, 'REACH'), (24206054, 'REACH'), (15668162, 'REACH'), (18033359, 'REACH'), (22221762, 'REACH'), (27175631, 'REACH'), (20708910, 'REACH'), (25203059, 'REACH'), (9939108, 'REACH'), (18229412, 'REACH'), (27080251, 'REACH'), (25640730, 'REACH'), (24009905, 'REACH'), (24897936, 'REACH'), (18684061, 'REACH'), (2096938, 'REACH'), (21067575, 'REACH'), (10248598, 'REACH'), (1263044, 'REACH'), (30156638, 'REACH'), (4306759, 'REACH'), (19642183, 'REACH'), (740377, 'REACH'), (10505241, 'REACH'), (11169912, 'REACH'), (25522296, 'REACH'), (19887798, 'REACH'), (20444854, 'REACH'), (13726797, 'REACH'), (22443308, 'REACH'), (10762537, 'REACH'), (25783599, 'REACH'), (30004315, 'SPARSER'), (12339726, 'REACH'), (8229426, 'REACH'), (909677, 'REACH'), (2425371, 'REACH'), (9363660, 'REACH'), (22221769, 'REACH'), (11315345, 'REACH'), (11020528, 'REACH'), (24226032, 'REACH'), (9836974, 'REACH'), (22839083, 'REACH'), (29843233, 'REACH'), (22354770, 'REACH'), (30156639, 'REACH'), (13251597, 'REACH'), (9201083, 'REACH'), (11215340, 'REACH'), (18923162, 'REACH'), (3738696, 'REACH'), (20548680, 'REACH'), (23906133, 'REACH'), (18493059, 'REACH'), (19031758, 'REACH'), (9080697, 'REACH'), (27807044, 'REACH'), (25765598, 'REACH'), (28858055, 'REACH'), (19445096, 'REACH'), (19510632, 'REACH'), (25429329, 'REACH'), (11316590, 'REACH'), (11447662, 'REACH'), (20765852, 'REACH'), (26979694, 'REACH'), (17586739, 'REACH'), (1533853, 'SPARSER'), (9916959, 'REACH'), (30217634, 'SPARSER'), (3603628, 'REACH'), (1866504, 'REACH'), (10484488, 'REACH'), (82758, 'REACH'), (2333251, 'REACH'), (23053126, 'REACH'), (24574728, 'REACH'), (27257841, 'REACH'), (21256367, 'REACH'), (18485049, 'REACH'), (21729081, 'REACH'), (24932763, 'REACH'), (26828876, 'REACH'), (19758727, 'REACH'), (19830824, 'REACH'), (1197354, 'SPARSER'), (2378805, 'REACH'), (13175270, 'REACH'), (28387345, 'REACH'), (13186754, 'REACH'), (12409192, 'SPARSER'), (25321121, 'REACH'), (491014, 'REACH'), (26246662, 'REACH'), (29413300, 'REACH'), (18666863, 'REACH'), (9215901, 'REACH'), (23326027, 'REACH'), (22102583, 'REACH'), (10478742, 'REACH'), (30041238, 'REACH'), (26324154, 'REACH'), (17630630, 'REACH'), (20765859, 'REACH'), (20749869, 'SPARSER'), (27139458, 'REACH'), (20105008, 'REACH'), (1555320, 'REACH'), (13240755, 'REACH'), (28871091, 'REACH'), (24368543, 'REACH'), (11335727, 'REACH'), (3926109, 'REACH'), (1152352, 'SPARSER'), (17213162, 'REACH'), (9597270, 'REACH'), (12928897, 'REACH'), (27641729, 'REACH'), (26706239, 'REACH'), (29262143, 'REACH'), (23370106, 'REACH'), (26246663, 'REACH'), (26697059, 'REACH'), (10696258, 'REACH'), (25475033, 'REACH'), (28702858, 'REACH'), (11570980, 'REACH'), (28696333, 'REACH'), (20207002, 'REACH'), (8832167, 'REACH'), (12744520, 'REACH'), (13431174, 'REACH'), (24902265, 'REACH'), (13462967, 'REACH'), (1016854, 'REACH'), (29345811, 'REACH'), (648690, 'REACH'), (9054253, 'REACH'), (12658733, 'REACH'), (21838548, 'REACH'), (16389046, 'SPARSER'), (13288706, 'REACH'), (26919183, 'REACH'), (28838589, 'REACH'), (25360714, 'REACH'), (11215608, 'REACH'), (17998584, 'REACH'), (9931059, 'REACH'), (23591652, 'REACH'), (12066079, 'REACH'), (9425856, 'REACH'), (22752172, 'REACH'), (26028972, 'REACH'), (13885582, 'REACH'), (24163261, 'SPARSER'), (15042144, 'REACH'), (24685549, 'REACH'), (8403099, 'REACH'), (21290967, 'SPARSER'), (24033435, 'REACH'), (21117319, 'REACH'), (3282741, 'REACH'), (21860113, 'REACH'), (22941457, 'REACH'), (25779837, 'REACH'), (22025643, 'REACH'), (25908900, 'REACH'), (21518753, 'REACH'), (12177024, 'REACH'), (518797, 'REACH'), (27781773, 'REACH'), (27579674, 'REACH'), (20016167, 'REACH'), (29807898, 'REACH'), (11697621, 'REACH'), (4325487, 'REACH'), (8179600, 'REACH'), (19949049, 'REACH'), (27323703, 'REACH'), (25381779, 'REACH'), (3278194, 'REACH'), (10820958, 'REACH'), (12684195, 'REACH'), (2212994, 'REACH'), (28837437, 'REACH'), (13686123, 'REACH'), (10527257, 'REACH'), (78807, 'REACH'), (17998597, 'REACH'), (15576673, 'REACH'), (22983058, 'REACH'), (16009470, 'REACH'), (21711102, 'REACH'), (1446700, 'REACH'), (2793257, 'REACH'), (8863962, 'REACH'), (10176349, 'REACH'), (14914823, 'REACH'), (19578536, 'REACH'), (9823331, 'REACH'), (88573, 'REACH'), (2808317, 'REACH'), (18259886, 'REACH'), (20011517, 'REACH'), (12618457, 'REACH'), (18773701, 'REACH'), (1791350, 'REACH'), (13686134, 'REACH'), (27186550, 'REACH'), (20132365, 'REACH'), (2524279, 'SPARSER'), (21745644, 'REACH'), (20765850, 'REACH'), (21953877, 'REACH'), (20473038, 'REACH'), (19011531, 'REACH'), (25410976, 'REACH'), (1446701, 'REACH'), (21578974, 'REACH'), (15901301, 'REACH'), (1960404, 'REACH'), (224258, 'REACH'), (10316802, 'REACH'), (10099133, 'REACH'), (10461419, 'REACH'), (13462937, 'REACH'), (2588746, 'REACH'), (21841951, 'REACH'), (25614797, 'REACH'), (16730238, 'REACH'), (19661691, 'REACH'), (26940076, 'REACH'), (13128807, 'REACH'), (18132898, 'REACH'), (26839402, 'REACH'), (22820983, 'REACH'), (29066776, 'REACH'), (13461203, 'REACH'), (397037, 'REACH'), (24485787, 'REACH'), (3706444, 'REACH'), (25071180, 'REACH'), (9409671, 'REACH'), (20568038, 'REACH'), (2124994, 'REACH'), (8988623, 'REACH'), (13298882, 'REACH'), (24098173, 'REACH'), (29040197, 'REACH'), (27383030, 'REACH'), (23755937, 'REACH'), (12373202, 'REACH'), (12609342, 'REACH'), (22381371, 'REACH'), (17619994, 'REACH'), (10366408, 'REACH'), (19650563, 'REACH'), (27864930, 'REACH'), (26853431, 'REACH'), (29224408, 'REACH'), (13554149, 'REACH'), (2718358, 'REACH'), (17230112, 'REACH'), (22462297, 'SPARSER'), (29692244, 'REACH'), (11744143, 'REACH'), (1277232, 'REACH'), (11739453, 'REACH'), (12385584, 'REACH'), (16730219, 'REACH'), (19791152, 'REACH'), (22661870, 'REACH'), (8354519, 'REACH'), (24440755, 'REACH'), (10418297, 'SPARSER'), (29673001, 'REACH'), (18684040, 'REACH'), (23289460, 'REACH'), (28290850, 'REACH'), (9350739, 'REACH'), (30262728, 'SPARSER'), (20881179, 'REACH'), (21437447, 'REACH'), (8898961, 'REACH'), (18532753, 'REACH'), (23111152, 'REACH'), (13153753, 'REACH'), (13229174, 'REACH'), (18182003, 'REACH'), (25615478, 'REACH'), (26013555, 'REACH'), (124160, 'REACH'), (18081024, 'REACH'), (25115372, 'REACH'), (20505685, 'REACH'), (12610868, 'REACH'), (2276637, 'REACH'), (25674108, 'REACH'), (11948389, 'REACH'), (667155, 'REACH'), (16115872, 'REACH'), (11449310, 'REACH'), (30061534, 'REACH'), (18684041, 'REACH'), (19647034, 'REACH'), (29084218, 'REACH'), (3562019, 'REACH'), (17947171, 'REACH'), (20875440, 'REACH'), (2828106, 'REACH'), (30156618, 'REACH'), (11753720, 'REACH'), (21259062, 'REACH'), (1103667, 'REACH'), (19453747, 'REACH'), (2098401, 'REACH'), (29544676, 'REACH'), (13554112, 'REACH'), (759816, 'REACH'), (28383240, 'REACH'), (25594097, 'REACH'), (11641299, 'REACH'), (26335492, 'REACH'), (124161, 'REACH'), (24794802, 'REACH'), (27633307, 'REACH'), (18986057, 'REACH'), (11944232, 'REACH'), (21964049, 'REACH'), (3614064, 'REACH'), (10659184, 'REACH'), (12104238, 'REACH'), (12844157, 'REACH'), (13788682, 'REACH'), (11862551, 'REACH'), (22559475, 'REACH'), (19180708, 'REACH'), (8152993, 'REACH'), (16783314, 'REACH'), (18013151, 'REACH'), (20472960, 'REACH'), (1493563, 'REACH'), (13246664, 'REACH'), (10638293, 'REACH'), (11070864, 'REACH'), (22819626, 'REACH'), (1530308, 'REACH'), (18649281, 'REACH'), (21246591, 'REACH'), (14862594, 'SPARSER'), (12658700, 'REACH'), (23830537, 'REACH'), (28387340, 'REACH'), (13817940, 'REACH'), (25235921, 'REACH'), (26034818, 'REACH'), (26341007, 'REACH'), (30136404, 'REACH'), (18379627, 'REACH'), (18155804, 'REACH'), (18647324, 'REACH'), (12563576, 'REACH'), (15807608, 'REACH'), (16079109, 'REACH'), (20698803, 'REACH'), (21039798, 'REACH'), (28035372, 'REACH'), (9364593, 'REACH'), (11166833, 'REACH'), (8901131, 'REACH'), (21360549, 'REACH'), (2741810, 'REACH'), (24042926, 'REACH'), (21443371, 'REACH'), (11859141, 'REACH'), (28758504, 'SPARSER'), (19129836, 'REACH'), (10941082, 'REACH'), (27161242, 'REACH'), (24821832, 'REACH'), (26526339, 'REACH'), (9818161, 'REACH'), (1417711, 'REACH'), (21616912, 'REACH'), (8354510, 'REACH'), (8271307, 'REACH'), (9075406, 'REACH'), (28469372, 'REACH'), (30024569, 'REACH'), (9830488, 'REACH'), (26706244, 'REACH'), (18780225, 'REACH'), (13656575, 'REACH'), (11450682, 'REACH'), (17381690, 'REACH'), (23779665, 'REACH'), (21784118, 'REACH'), (21483489, 'REACH'), (21126930, 'REACH'), (26586304, 'REACH'), (11083331, 'REACH'), (13543822, 'REACH'), (19007017, 'SPARSER'), (23012153, 'REACH'), (26013546, 'REACH'), (27080485, 'REACH'), (11816406, 'REACH'), (11666643, 'REACH'), (10316801, 'REACH'), (13640941, 'REACH'), (2504091, 'REACH'), (17120296, 'REACH'), (21183528, 'REACH'), (21740584, 'REACH'), (10192355, 'REACH'), (15332618, 'REACH'), (15668293, 'REACH'), (3950067, 'REACH'), (3154852, 'REACH'), (13018020, 'REACH'), (18666145, 'REACH'), (26757842, 'REACH'), (16765837, 'REACH'), (24007565, 'REACH'), (21574150, 'REACH'), (22289329, 'REACH'), (24718296, 'REACH'), (9451670, 'REACH'), (12040342, 'REACH'), (13435076, 'REACH'), (9054591, 'REACH'), (17547870, 'REACH'), (21629160, 'REACH'), (25150453, 'REACH'), (29468477, 'REACH'), (18169720, 'REACH'), (20811187, 'REACH'), (22673252, 'REACH'), (12666366, 'REACH'), (23601813, 'REACH'), (13210051, 'REACH'), (23460980, 'REACH'), (2837794, 'REACH'), (19439437, 'SPARSER'), (11940944, 'REACH'), (23371019, 'REACH'), (13838232, 'REACH'), (24426149, 'REACH'), (10851670, 'REACH'), (26674259, 'REACH'), (24756100, 'REACH'), (25995977, 'REACH'), (8281466, 'REACH'), (28187632, 'REACH'), (13849341, 'REACH'), (17557678, 'REACH'), (23145433, 'REACH'), (19458616, 'REACH'), (25389624, 'REACH'), (18248310, 'REACH'), (22037284, 'REACH'), (23599649, 'REACH'), (27531809, 'REACH'), (2768479, 'REACH'), (28400384, 'REACH'), (8997865, 'REACH'), (11903573, 'REACH'), (19150214, 'REACH'), (17824131, 'REACH'), (21017990, 'REACH'), (10719458, 'REACH'), (12058640, 'REACH'), (1030166, 'REACH'), (18967597, 'REACH'), (19081691, 'REACH'), (2445964, 'REACH'), (860615, 'REACH'), (23503142, 'REACH'), (2768596, 'REACH'), (13582036, 'REACH'), (21530116, 'SPARSER'), (29017848, 'REACH'), (24648417, 'REACH'), (12666386, 'REACH'), (2821837, 'REACH'), (27215230, 'REACH'), (22998956, 'REACH'), (26273705, 'REACH'), (26800044, 'REACH'), (21912134, 'REACH'), (18435234, 'REACH'), (28232866, 'REACH'), (16783312, 'REACH'), (19458617, 'REACH'), (20021866, 'REACH'), (20954884, 'REACH'), (26525444, 'REACH'), (13725887, 'REACH'), (18247871, 'REACH'), (12333037, 'REACH'), (19509229, 'REACH'), (24587061, 'REACH'), (18137873, 'REACH'), (21975897, 'REACH'), (12578232, 'REACH'), (19964406, 'REACH'), (11698816, 'REACH'), (15208077, 'REACH'), (2480236, 'REACH'), (23597929, 'REACH'), (26650906, 'REACH'), (16120067, 'REACH'), (702562, 'REACH'), (18471581, 'REACH'), (21912221, 'REACH'), (26843641, 'REACH'), (10084908, 'SPARSER'), (8322789, 'REACH'), (9490323, 'REACH'), (17381293, 'REACH'), (667148, 'REACH'), (271881, 'REACH'), (27353270, 'REACH'), (20086372, 'REACH'), (28560638, 'REACH'), (28607706, 'REACH'), (30153959, 'REACH'), (3619208, 'REACH'), (19203887, 'REACH'), (11485008, 'REACH'), (11537422, 'REACH'), (10192362, 'REACH'), (12172115, 'REACH'), (12782878, 'REACH'), (10938631, 'REACH'), (11555496, 'REACH'), (12314887, 'REACH'), (702563, 'REACH'), (16862136, 'SPARSER'), (22820963, 'REACH'), (1953871, 'REACH'), (29115120, 'REACH'), (17674539, 'REACH'), (2468746, 'REACH'), (27039032, 'REACH'), (20204229, 'REACH'), (28939576, 'REACH'), (4207954, 'REACH'), (22221758, 'REACH'), (2574267, 'REACH'), (18736039, 'REACH'), (12052614, 'REACH'), (10696316, 'REACH'), (2805930, 'REACH'), (21111574, 'REACH'), (18736964, 'REACH'), (8880509, 'SPARSER'), (21001458, 'REACH'), (20427168, 'REACH'), (13239515, 'REACH'), (1103651, 'REACH'), (29515778, 'REACH'), (4343019, 'REACH'), (8615580, 'REACH'), (13140377, 'REACH'), (21634903, 'REACH'), (19158520, 'REACH'), (21353093, 'REACH'), (10046590, 'REACH'), (24530046, 'REACH'), (12883628, 'REACH'), (13846631, 'REACH'), (23954758, 'REACH'), (17298095, 'REACH'), (23083731, 'REACH'), (29115117, 'REACH'), (3562024, 'REACH'), (21526328, 'SPARSER'), (25535459, 'REACH'), (15886865, 'REACH'), (22628733, 'REACH'), (22082314, 'REACH'), (20472819, 'REACH'), (29553199, 'SPARSER'), (13675904, 'REACH'), (9485118, 'REACH'), (27513934, 'SPARSER'), (2363418, 'REACH'), (3916232, 'REACH'), (28269571, 'REACH'), (15038900, 'REACH'), (788893, 'REACH'), (985501, 'REACH'), (26121294, 'REACH'), (13410776, 'REACH'), (24125078, 'REACH'), (464531, 'REACH'), (242113, 'REACH'), (11547073, 'REACH'), (9263198, 'REACH'), (13241435, 'REACH'), (18025563, 'REACH'), (8242247, 'REACH'), (19429877, 'REACH'), (24242897, 'REACH'), (14866319, 'REACH'), (21833021, 'REACH'), (118510, 'REACH'), (20546076, 'REACH'), (23862999, 'REACH'), (9916933, 'REACH'), (19793846, 'REACH'), (19807788, 'REACH'), (11447665, 'REACH'), (13656866, 'REACH'), (28701451, 'REACH'), (21708985, 'REACH'), (16120042, 'REACH'), (24035513, 'REACH'), (29466008, 'REACH'), (27388758, 'REACH'), (13030788, 'REACH'), (22782770, 'REACH'), (18530925, 'REACH'), (13541406, 'REACH'), (17838087, 'REACH'), (12279208, 'REACH'), (18765482, 'SPARSER'), (1461649, 'REACH'), (18119503, 'REACH'), (9226493, 'REACH'), (972462, 'REACH'), (10192348, 'REACH'), (3525081, 'REACH'), (26853432, 'REACH'), (2810739, 'REACH'), (28304243, 'REACH'), (26883167, 'REACH'), (9266556, 'REACH'), (29201765, 'REACH'), (451091, 'REACH'), (19458605, 'REACH'), (13686133, 'REACH'), (26324144, 'REACH'), (21734589, 'REACH'), (13407854, 'REACH'), (24126653, 'REACH'), (15019420, 'REACH'), (20765849, 'REACH'), (15528917, 'SPARSER'), (25996700, 'REACH'), (27314216, 'SPARSER'), (26425119, 'REACH'), (21983867, 'REACH'), (17010522, 'REACH'), (20376769, 'SPARSER'), (17481135, 'REACH'), (2095210, 'REACH'), (28957956, 'REACH'), (12709357, 'REACH'), (8922014, 'REACH'), (2718363, 'REACH'), (13116318, 'REACH'), (11439866, 'REACH'), (19369722, 'REACH'), (14975285, 'REACH'), (23950054, 'REACH'), (16922992, 'REACH'), (22034800, 'REACH'), (2741806, 'REACH'), (2509145, 'REACH'), (25905497, 'REACH'), (26872169, 'REACH'), (17884360, 'REACH'), (25206964, 'REACH'), (12361314, 'REACH'), (18579856, 'REACH'), (18083068, 'REACH'), (11570999, 'REACH'), (19417304, 'REACH'), (21729079, 'REACH'), (16084397, 'REACH'), (2403340, 'REACH'), (29621332, 'REACH'), (12919439, 'REACH'), (17437744, 'REACH'), (28957957, 'REACH'), (986806, 'REACH'), (22355044, 'REACH'), (16605855, 'REACH'), (9913237, 'REACH'), (523206, 'REACH'), (13789891, 'REACH'), (20005781, 'REACH'), (21833007, 'REACH'), (18797303, 'REACH'), (12628120, 'REACH'), (27684438, 'REACH'), (10121103, 'SPARSER'), (10168882, 'REACH'), (3219007, 'REACH'), (8794946, 'SPARSER'), (22034797, 'REACH'), (29768045, 'REACH'), (3262051, 'REACH'), (21315729, 'REACH'), (177963, 'REACH'), (559301, 'REACH'), (26500132, 'REACH'), (14930770, 'REACH'), (28643774, 'REACH'), (12321191, 'REACH'), (20472904, 'REACH'), (802645, 'REACH'), (22373448, 'REACH'), (13633155, 'REACH'), (88546, 'REACH'), (12560249, 'REACH'), (13838201, 'REACH'), (27958373, 'REACH'), (15843606, 'REACH'), (10934176, 'REACH'), (11707099, 'REACH'), (22291163, 'REACH'), (11670409, 'REACH'), (28091099, 'REACH'), (24184322, 'REACH'), (1345433, 'REACH'), (28247961, 'REACH'), (18221189, 'REACH'), (19003958, 'REACH'), (23032371, 'REACH'), (25823870, 'REACH'), (28340393, 'REACH'), (13607514, 'REACH'), (10451782, 'REACH'), (28196801, 'SPARSER'), (2214132, 'REACH'), (15008753, 'REACH'), (21518754, 'REACH'), (26860752, 'REACH'), (11447694, 'REACH'), (12496270, 'REACH'), (15609880, 'REACH'), (27689430, 'REACH'), (25581779, 'REACH'), (18874369, 'REACH'), (1816813, 'REACH'), (22001901, 'REACH'), (22251931, 'REACH'), (28051102, 'REACH'), (15528777, 'REACH'), (13675002, 'REACH'), (28588269, 'REACH'), (28701513, 'REACH'), (14787637, 'REACH'), (24283796, 'REACH'), (15533063, 'SPARSER'), (18230361, 'REACH'), (28330250, 'REACH'), (2276631, 'REACH'), (10173719, 'REACH'), (12159045, 'REACH'), (9388392, 'SPARSER'), (23796211, 'REACH'), (2463629, 'REACH'), (2446700, 'REACH'), (13030764, 'REACH'), (2268698, 'REACH'), (2858709, 'REACH'), (28406275, 'REACH'), (28892714, 'REACH'), (8048975, 'SPARSER'), (16932801, 'REACH'), (24249540, 'REACH'), (29590304, 'REACH'), (15042142, 'REACH'), (3171514, 'REACH'), (10389713, 'REACH'), (11447695, 'REACH'), (8134448, 'REACH'), (22002903, 'REACH'), (185937, 'SPARSER'), (2289055, 'REACH'), (88574, 'REACH'), (29354471, 'REACH'), (21049460, 'REACH'), (20524302, 'REACH'), (22882646, 'REACH'), (30136403, 'REACH'), (2203521, 'REACH'), (10797165, 'REACH'), (12518942, 'REACH'), (21315693, 'REACH'), (27738221, 'REACH'), (20491977, 'REACH'), (555944, 'REACH'), (8162995, 'SPARSER'), (21585451, 'REACH'), (26316938, 'REACH'), (20528279, 'REACH'), (16805432, 'REACH'), (12008993, 'REACH'), (10030674, 'REACH'), (10508478, 'REACH'), (2319547, 'REACH'), (2778299, 'REACH'), (8428780, 'REACH'), (20538555, 'REACH'), (20395234, 'REACH'), (24932778, 'REACH'), (12395959, 'REACH'), (30577509, 'REACH'), (28753394, 'REACH'), (20851967, 'REACH'), (21039776, 'REACH'), (27003552, 'REACH'), (26335881, 'REACH'), (4387701, 'REACH'), (12346662, 'REACH'), (9303075, 'REACH'), (27718517, 'REACH'), (20768704, 'SPARSER'), (24429468, 'REACH'), (9902745, 'REACH'), (16503114, 'REACH'), (10236644, 'REACH'), (1979679, 'REACH'), (12062843, 'REACH'), (18736044, 'REACH'), (13794217, 'REACH'), (26706243, 'REACH'), (16805433, 'REACH'), (17344037, 'REACH'), (25779808, 'REACH'), (1827821, 'REACH'), (13680460, 'REACH'), (24915765, 'REACH'), (11008404, 'REACH'), (25552752, 'REACH'), (8970680, 'REACH'), (487237, 'REACH'), (19801590, 'REACH'), (23424676, 'REACH'), (9867681, 'REACH'), (29687092, 'SPARSER'), (10934121, 'REACH'), (25105877, 'REACH'), (1509264, 'REACH'), (1690699, 'REACH'), (13356107, 'REACH'), (11832001, 'REACH'), (8142194, 'REACH'), (9463111, 'REACH'), (26043719, 'REACH'), (19165941, 'REACH'), (27062868, 'REACH'), (11369602, 'REACH'), (26377346, 'REACH'), (17386032, 'REACH'), (25611036, 'REACH'), (25688601, 'REACH'), (8186839, 'REACH'), (26286853, 'REACH'), (15518098, 'REACH'), (16828793, 'SPARSER'), (23892987, 'REACH'), (1103657, 'REACH'), (2431194, 'REACH'), (2658535, 'REACH'), (2401905, 'REACH'), (25141085, 'REACH'), (26220184, 'REACH'), (1024421, 'REACH'), (23175589, 'REACH'), (140929, 'REACH'), (19248191, 'REACH'), (11223326, 'REACH'), (22102302, 'REACH'), (13098700, 'REACH'), (13754060, 'REACH'), (20969907, 'SPARSER'), (3562020, 'REACH'), (24184320, 'REACH'), (1189868, 'REACH'), (19148747, 'REACH'), (26806908, 'REACH'), (17622806, 'REACH'), (24070295, 'SPARSER'), (17441236, 'REACH'), (10462210, 'REACH'), (13287439, 'REACH'), (26031364, 'SPARSER'), (11547069, 'REACH'), (2810734, 'REACH'), (27482186, 'REACH'), (30136394, 'REACH'), (15149560, 'REACH'), (16176773, 'REACH'), (157747, 'REACH'), (15003328, 'REACH'), (11768269, 'REACH'), (4325502, 'REACH'), (30179454, 'REACH'), (399450, 'REACH'), (12010382, 'REACH'), (21872152, 'REACH'), (23503141, 'REACH'), (13582035, 'REACH'), (27052978, 'REACH'), (25519853, 'REACH'), (2160634, 'REACH'), (23358993, 'REACH'), (24923517, 'REACH'), (15597358, 'REACH'), (18563673, 'REACH'), (1455882, 'REACH'), (13102326, 'REACH'), (12658675, 'REACH'), (21622006, 'REACH'), (15191847, 'REACH'), (10763700, 'REACH'), (25749346, 'REACH'), (2810735, 'REACH'), (13831581, 'REACH'), (18484637, 'REACH'), (3294457, 'REACH'), (9869367, 'REACH'), (28263896, 'REACH'), (30190227, 'REACH'), (23329886, 'REACH'), (30136391, 'REACH'), (28769781, 'REACH'), (21093286, 'REACH'), (28835317, 'REACH'), (23330923, 'REACH'), (910282, 'REACH'), (17297784, 'REACH'), (19164736, 'REACH'), (25231358, 'REACH'), (913964, 'REACH'), (20164744, 'REACH'), (13738353, 'REACH'), (24405794, 'REACH'), (19807791, 'REACH'), (26306338, 'REACH'), (27043421, 'REACH'), (1455883, 'REACH'), (2012939, 'REACH'), (29736170, 'REACH'), (9819596, 'REACH'), (1557705, 'REACH'), (10212812, 'REACH'), (24499660, 'REACH'), (11791969, 'SPARSER'), (2378818, 'REACH'), (24706895, 'REACH'), (28560637, 'REACH'), (654379, 'REACH'), (334300, 'REACH'), (2718359, 'REACH'), (18395034, 'SPARSER'), (11318390, 'REACH'), (30518354, 'REACH'), (19671135, 'REACH'), (23552699, 'REACH'), (11670403, 'REACH'), (10898776, 'REACH'), (29066771, 'REACH'), (15080769, 'REACH'), (29629761, 'REACH'), (9483404, 'REACH'), (21509260, 'REACH'), (25465379, 'REACH'), (11834114, 'REACH'), (16290562, 'REACH'), (28250882, 'REACH'), (11984097, 'REACH'), (8296466, 'REACH'), (22014400, 'REACH'), (22330347, 'SPARSER'), (1057196, 'REACH'), (19394309, 'SPARSER'), (16092995, 'REACH'), (10168784, 'REACH'), (23400708, 'REACH'), (16529126, 'REACH'), (22153108, 'REACH'), (12385553, 'REACH'), (12877073, 'REACH'), (21866191, 'REACH'), (22752171, 'REACH'), (25734059, 'REACH'), (10079577, 'REACH'), (12704279, 'REACH'), (23954757, 'REACH'), (24711923, 'REACH'), (29646753, 'REACH'), (10796160, 'REACH'), (20528256, 'REACH'), (19458622, 'REACH'), (29354778, 'REACH'), (9497557, 'REACH'), (23222022, 'REACH'), (12388529, 'REACH'), (28103266, 'REACH'), (17322830, 'REACH'), (606795, 'REACH'), (3745985, 'REACH'), (2775922, 'REACH'), (17689215, 'REACH'), (26355905, 'REACH'), (16015372, 'REACH'), (25920327, 'REACH'), (13723696, 'REACH'), (1030169, 'REACH'), (13336266, 'REACH'), (26773975, 'REACH'), (856325, 'REACH'), (23400709, 'REACH'), (28820150, 'REACH'), (22290732, 'REACH'), (13582042, 'REACH'), (762454, 'REACH'), (11903574, 'REACH'), (13509206, 'REACH'), (26223190, 'REACH'), (16805426, 'REACH'), (28791359, 'REACH'), (26697069, 'REACH'), (26860748, 'REACH'), (24868008, 'REACH'), (19626595, 'REACH'), (9146959, 'REACH'), (437035, 'REACH'), (1878827, 'REACH'), (2566955, 'REACH'), (9841451, 'REACH'), (15907033, 'REACH'), (25595704, 'REACH'), (30117061, 'REACH'), (301683, 'REACH'), (16015373, 'REACH'), (18142654, 'REACH'), (8255560, 'REACH'), (13015683, 'REACH'), (2809314, 'REACH'), (28365518, 'REACH'), (27074684, 'REACH'), (27523961, 'REACH'), (21246053, 'REACH'), (2680086, 'REACH'), (13952278, 'REACH'), (23509316, 'REACH'), (12658753, 'REACH'), (16529138, 'REACH'), (14866313, 'REACH'), (20314478, 'REACH'), (18496409, 'REACH'), (23692874, 'REACH'), (17799160, 'REACH'), (29693944, 'REACH'), (27967030, 'REACH'), (21372877, 'REACH'), (27439483, 'REACH'), (27058791, 'REACH'), (20548852, 'REACH'), (25479153, 'REACH'), (29286943, 'SPARSER'), (18239269, 'REACH'), (12965311, 'REACH'), (20940640, 'REACH'), (18471582, 'REACH'), (29276213, 'REACH'), (23880386, 'REACH'), (27091650, 'REACH'), (1437808, 'REACH'), (11169904, 'REACH'), (12640345, 'REACH'), (26287603, 'REACH'), (23554721, 'REACH'), (24648415, 'REACH'), (25547290, 'REACH'), (19133955, 'REACH'), (1006946, 'REACH'), (13254199, 'REACH'), (9867237, 'REACH'), (24310721, 'REACH'), (23541362, 'REACH'), (29927003, 'REACH'), (2814374, 'REACH'), (10412577, 'SPARSER'), (24932774, 'REACH'), (25513169, 'REACH'), (13519234, 'REACH'), (21882475, 'REACH'), (18886871, 'REACH'), (25367557, 'REACH'), (736914, 'REACH'), (21892160, 'REACH'), (2718357, 'REACH'), (21363349, 'REACH'), (608707, 'REACH'), (10045891, 'REACH'), (24129015, 'REACH'), (21258136, 'REACH'), (15027877, 'REACH'), (2674341, 'REACH'), (24456695, 'REACH'), (28433491, 'REACH'), (25617714, 'REACH'), (12385599, 'REACH'), (25926283, 'SPARSER'), (25385502, 'REACH'), (1446443, 'REACH'), (20948352, 'SPARSER'), (28103818, 'REACH'), (523205, 'REACH'), (783967, 'REACH'), (16290560, 'REACH'), (8969406, 'REACH'), (13393086, 'REACH'), (19509484, 'REACH'), (27132314, 'REACH'), (28539477, 'REACH'), (28160387, 'REACH'), (9485108, 'REACH'), (3534641, 'REACH'), (17283730, 'SPARSER'), (22043063, 'REACH'), (15668033, 'REACH'), (28033279, 'REACH'), (29311231, 'REACH'), (1984990, 'REACH'), (17689228, 'REACH'), (23140213, 'REACH'), (12457684, 'REACH'), (28593233, 'REACH'), (19083522, 'REACH'), (23039664, 'REACH'), (2228715, 'REACH'), (29018012, 'REACH'), (27618391, 'REACH'), (11450678, 'REACH'), (23979315, 'REACH'), (27870925, 'REACH'), (20353606, 'REACH'), (1049923, 'REACH'), (23856451, 'REACH'), (20270833, 'REACH'), (13640866, 'REACH'), (26247087, 'REACH'), (20765838, 'REACH'), (10792311, 'REACH'), (226754, 'SPARSER'), (19031454, 'REACH'), (21259061, 'REACH'), (27523952, 'REACH'), (18311805, 'REACH'), (23765668, 'REACH'), (19541458, 'REACH'), (17844703, 'REACH'), (23539154, 'REACH'), (2115213, 'REACH'), (28145885, 'SPARSER'), (20910188, 'REACH'), (14920553, 'REACH'), (2621722, 'REACH'), (3921959, 'REACH'), (23039665, 'REACH'), (10056349, 'REACH'), (23273525, 'SPARSER'), (16476888, 'REACH'), (29220410, 'SPARSER'), (29511597, 'REACH'), (2390343, 'REACH'), (16783313, 'REACH'), (12029488, 'REACH'), (29127229, 'REACH'), (28646937, 'REACH'), (20738007, 'REACH'), (13784896, 'REACH'), (2463174, 'REACH'), (28304244, 'REACH'), (13263886, 'REACH'), (20472846, 'REACH'), (20598880, 'SPARSER'), (25781262, 'REACH'), (16995155, 'REACH'), (13436991, 'REACH'), (11173344, 'REACH'), (18024511, 'REACH'), (22266119, 'REACH'), (27600148, 'REACH'), (11827857, 'REACH'), (20675217, 'REACH'), (15014807, 'REACH'), (21999731, 'REACH'), (29175923, 'REACH'), (11381481, 'REACH'), (18496423, 'REACH'), (23692872, 'REACH'), (22882645, 'REACH'), (17687092, 'REACH'), (9892046, 'REACH'), (25227470, 'REACH'), (1334885, 'REACH'), (24024641, 'REACH'), (29642541, 'REACH'), (12255628, 'REACH'), (19701365, 'REACH'), (29767682, 'REACH'), (10478607, 'REACH'), (21921054, 'SPARSER'), (11324920, 'REACH'), (9916900, 'REACH'), (1344543, 'REACH'), (23978688, 'REACH'), (11220429, 'REACH'), (13586092, 'REACH'), (18520994, 'REACH'), (21596847, 'REACH'), (26714599, 'SPARSER'), (10762553, 'REACH'), (24012069, 'REACH'), (748036, 'REACH'), (25128882, 'REACH'), (23166304, 'REACH'), (12512585, 'REACH'), (78799, 'REACH'), (1984683, 'REACH'), (837209, 'REACH'), (9258585, 'REACH'), (26249994, 'REACH'), (20634611, 'REACH'), (24150413, 'REACH'), (1738297, 'SPARSER'), (15669704, 'REACH'), (2172783, 'REACH'), (13812125, 'REACH'), (26459191, 'REACH'), (28347877, 'REACH'), (27584383, 'REACH'), (12623546, 'REACH'), (25104104, 'REACH'), (14962004, 'REACH'), (12906383, 'REACH'), (19070269, 'REACH'), (17540846, 'REACH'), (27108459, 'REACH'), (1979673, 'REACH'), (22271703, 'REACH'), (21850629, 'REACH'), (22043571, 'REACH'), (28782495, 'REACH'), (20444158, 'REACH'), (20771838, 'REACH'), (11874857, 'REACH'), (550874, 'REACH'), (23352124, 'SPARSER'), (19868563, 'SPARSER'), (26613699, 'REACH'), (13709546, 'REACH'), (19509482, 'REACH'), (3601215, 'REACH'), (19921517, 'REACH'), (17553438, 'REACH'), (25611035, 'REACH'), (24110766, 'SPARSER'), (22673251, 'REACH'), (18157588, 'REACH'), (10223869, 'REACH'), (18647690, 'REACH'), (9869368, 'REACH'), (1882995, 'REACH'), (141581, 'REACH'), (22030011, 'REACH'), (1491433, 'REACH'), (17121769, 'REACH'), (10403495, 'REACH'), (11739464, 'REACH'), (86101, 'REACH'), (9489286, 'REACH'), (13454214, 'REACH'), (13864293, 'REACH'), (17763685, 'REACH'), (74285, 'REACH'), (1909293, 'REACH'), (17786843, 'REACH'), (12658828, 'REACH'), (28680749, 'REACH'), (23830471, 'REACH'), (19921512, 'REACH'), (8362418, 'SPARSER'), (10648765, 'REACH'), (24098181, 'REACH'), (527808, 'REACH'), (2854336, 'REACH'), (11680973, 'REACH'), (13635008, 'REACH'), (26806907, 'REACH'), (477018, 'REACH'), (10176346, 'REACH'), (23890791, 'REACH'), (22853653, 'REACH'), (21849329, 'REACH'), (18576815, 'REACH'), (29224400, 'REACH'), (27467833, 'REACH'), (23579511, 'REACH'), (26757846, 'REACH'), (1442482, 'REACH'), (14942898, 'REACH'), (17731680, 'REACH'), (10626541, 'REACH'), (2012185, 'SPARSER'), (28933022, 'REACH'), (26552652, 'REACH'), (12658813, 'REACH'), (16805422, 'REACH'), (23791964, 'REACH'), (12996834, 'SPARSER'), (11374549, 'REACH'), (13897685, 'REACH'), (11484931, 'REACH'), (2160633, 'REACH'), (16807929, 'REACH'), (22607077, 'REACH'), (25591666, 'REACH'), (19033727, 'REACH'), (28167200, 'REACH'), (14919085, 'REACH'), (20649822, 'REACH'), (3155783, 'REACH'), (11427458, 'REACH'), (25747074, 'REACH'), (20548656, 'REACH'), (25779842, 'REACH'), (21062940, 'REACH'), (1162265, 'REACH'), (2487396, 'REACH'), (25202785, 'REACH'), (29750372, 'REACH'), (28850847, 'REACH'), (30098115, 'REACH'), (11574575, 'REACH'), (13081903, 'REACH'), (667147, 'REACH'), (15903059, 'REACH'), (63039, 'REACH'), (15111136, 'REACH'), (18052671, 'REACH'), (19903003, 'REACH'), (18684049, 'REACH'), (28871086, 'REACH'), (1840780, 'SPARSER'), (10208056, 'REACH'), (12140741, 'REACH'), (23053112, 'REACH'), (1216289, 'REACH'), (8244050, 'REACH'), (13554156, 'REACH'), (9337255, 'REACH'), (2440264, 'REACH'), (8255317, 'REACH'), (29146184, 'REACH'), (29815266, 'REACH'), (12361199, 'REACH'), (22271694, 'REACH'), (3702649, 'REACH'), (21691480, 'REACH'), (22117464, 'REACH'), (29621336, 'REACH'), (29750373, 'REACH'), (13855809, 'REACH'), (16444481, 'REACH'), (20474945, 'REACH'), (118688, 'REACH'), (22661874, 'REACH'), (2468745, 'REACH'), (2861961, 'REACH'), (11822440, 'REACH'), (27977064, 'REACH'), (24208340, 'REACH'), (22951249, 'REACH'), (24653744, 'REACH'), (22221757, 'REACH'), (24747374, 'REACH'), (8186872, 'REACH'), (10826294, 'REACH'), (21007122, 'REACH'), (13877791, 'REACH'), (16564767, 'REACH'), (22277292, 'REACH'), (1595994, 'REACH'), (2513498, 'REACH'), (20634609, 'REACH'), (12853643, 'REACH'), (19018359, 'REACH'), (8348453, 'REACH'), (19263699, 'REACH'), (11556865, 'REACH'), (26632698, 'REACH'), (1995235, 'REACH'), (29815267, 'REACH'), (27587696, 'REACH'), (15439531, 'REACH'), (22794332, 'REACH'), (15048970, 'REACH'), (28911314, 'REACH'), (15237177, 'SPARSER'), (11246907, 'REACH'), (23144766, 'REACH'), (27108457, 'REACH'), (19922868, 'REACH'), (21198769, 'REACH'), (29738351, 'REACH'), (21509264, 'REACH'), (22989083, 'SPARSER'), (23835792, 'REACH'), (15177258, 'REACH'), (10498615, 'REACH'), (12104247, 'REACH'), (25159640, 'REACH'), (3603652, 'REACH'), (27998145, 'REACH'), (29308865, 'REACH'), (2513499, 'REACH'), (17869577, 'REACH'), (12917946, 'REACH'), (23472905, 'REACH'), (11990438, 'REACH'), (25912148, 'REACH'), (21067568, 'REACH'), (27172298, 'REACH'), (19661668, 'REACH'), (27631680, 'REACH'), (1168205, 'REACH'), (29597760, 'REACH'), (25403643, 'REACH'), (13855788, 'REACH'), (21097516, 'REACH'), (10101223, 'REACH'), (13290947, 'REACH'), (16754804, 'REACH'), (27381187, 'REACH'), (30053052, 'REACH'), (23159287, 'REACH'), (11539352, 'REACH'), (8323749, 'REACH'), (19001427, 'REACH'), (3206020, 'REACH'), (8124722, 'REACH'), (24237204, 'SPARSER'), (9526814, 'REACH'), (11077321, 'REACH'), (2193392, 'REACH'), (9074672, 'REACH'), (10503342, 'REACH'), (15603243, 'REACH'), (17018486, 'REACH'), (12318241, 'REACH'), (18302546, 'REACH'), (18691840, 'REACH'), (14913293, 'REACH'), (10743998, 'REACH'), (17991066, 'REACH'), (865447, 'REACH'), (30156616, 'REACH'), (21586310, 'REACH'), (9196931, 'REACH'), (15073076, 'REACH'), (11584751, 'REACH'), (17220847, 'REACH'), (26860747, 'REACH'), (28752764, 'REACH'), (29354410, 'REACH'), (2451288, 'REACH'), (12609368, 'REACH'), (20637528, 'REACH'), (24945047, 'SPARSER'), (28394606, 'REACH'), (8166300, 'REACH'), (10985559, 'REACH'), (20488279, 'REACH'), (3206021, 'REACH'), (13511396, 'REACH'), (18199058, 'REACH'), (16730235, 'REACH'), (19850450, 'SPARSER'), (24258699, 'REACH'), (25305411, 'SPARSER'), (19226838, 'REACH'), (19217363, 'REACH'), (21592242, 'REACH'), (3294458, 'REACH'), (24122595, 'REACH'), (28257261, 'SPARSER'), (12658698, 'REACH'), (15834135, 'REACH'), (13641541, 'REACH'), (30156613, 'REACH'), (21645729, 'REACH'), (20315776, 'REACH'), (21699213, 'REACH'), (2378814, 'REACH'), (11781179, 'REACH'), (23966828, 'REACH'), (25480254, 'REACH'), (21890330, 'REACH'), (15096871, 'REACH'), (30178944, 'REACH'), (16494037, 'REACH'), (10938630, 'REACH'), (13472866, 'REACH'), (24661326, 'REACH'), (25283918, 'REACH'), (29707598, 'REACH'), (21847351, 'REACH'), (18496403, 'REACH'), (18736045, 'REACH'), (20476251, 'REACH'), (2574266, 'REACH'), (1984678, 'REACH'), (28933027, 'REACH'), (223828, 'REACH'), (11135572, 'REACH'), (14955650, 'REACH'), (8966681, 'REACH'), (20665093, 'REACH'), (22346934, 'REACH'), (24247478, 'REACH'), (25206963, 'REACH'), (12361313, 'REACH'), (21586322, 'REACH'), (25665715, 'REACH'), (27929408, 'REACH'), (28289856, 'REACH'), (22821118, 'REACH'), (24488955, 'REACH'), (27244798, 'REACH'), (13012777, 'REACH'), (17625306, 'REACH'), (18486664, 'REACH'), (25394801, 'REACH'), (13560656, 'REACH'), (886866, 'SPARSER'), (16955229, 'REACH'), (27392014, 'REACH'), (25389303, 'REACH'), (11737509, 'REACH'), (9836371, 'REACH'), (2378815, 'REACH'), (11186656, 'REACH'), (25480255, 'REACH'), (30140085, 'REACH'), (12658790, 'REACH'), (8149268, 'REACH'), (736913, 'REACH'), (11574594, 'REACH'), (15080770, 'REACH'), (17927467, 'REACH'), (24485783, 'REACH'), (26689848, 'REACH'), (2336453, 'REACH'), (29942098, 'REACH'), (26246656, 'REACH'), (24735465, 'REACH'), (17976474, 'REACH'), (27782889, 'REACH'), (20765827, 'REACH'), (26270851, 'REACH'), (27321908, 'REACH'), (9921053, 'REACH'), (18637341, 'REACH'), (29712925, 'REACH'), (29334104, 'REACH'), (29597462, 'REACH'), (518721, 'REACH'), (19458625, 'REACH'), (29157953, 'REACH'), (2289056, 'REACH'), (9268640, 'REACH'), (1524105, 'REACH'), (24982330, 'REACH'), (17384647, 'REACH'), (16489320, 'REACH'), (22771727, 'REACH'), (13668587, 'REACH'), (26644715, 'REACH'), (3525463, 'REACH'), (8991201, 'REACH'), (17443090, 'REACH'), (1030175, 'REACH'), (23081441, 'REACH'), (18221517, 'REACH'), (1504123, 'REACH'), (16511302, 'REACH'), (17485556, 'REACH'), (30625524, 'REACH'), (18112418, 'REACH'), (22202684, 'REACH'), (10927853, 'REACH'), (21353013, 'REACH'), (14851266, 'REACH'), (15607165, 'REACH'), (1103662, 'REACH'), (27341042, 'SPARSER'), (25611031, 'REACH'), (10636869, 'REACH'), (3249572, 'REACH'), (9256146, 'REACH'), (19245932, 'REACH'), (21497639, 'REACH'), (26937347, 'REACH'), (12965300, 'REACH'), (28916591, 'REACH'), (21353104, 'REACH'), (23568462, 'REACH'), (24289358, 'REACH'), (16730226, 'REACH'), (11688224, 'REACH'), (16090380, 'REACH'), (24716008, 'REACH'), (24499701, 'REACH'), (26321807, 'REACH'), (12947773, 'REACH'), (22820971, 'REACH'), (27311050, 'REACH'), (29264248, 'REACH'), (9597261, 'REACH'), (19458604, 'REACH'), (2124739, 'REACH'), (384802, 'REACH'), (26514991, 'REACH'), (22913806, 'REACH'), (546026, 'REACH'), (23906134, 'REACH'), (13030785, 'REACH'), (13686145, 'REACH'), (10279136, 'REACH'), (9080698, 'REACH'), (26117990, 'REACH'), (12728721, 'REACH'), (972032, 'REACH'), (26520845, 'REACH'), (17757886, 'REACH'), (15069863, 'REACH'), (1533898, 'SPARSER'), (18423092, 'REACH'), (27433265, 'REACH'), (29115119, 'REACH'), (21352976, 'REACH'), (162507, 'REACH'), (8354507, 'REACH'), (12333436, 'REACH'), (16730233, 'REACH'), (24421720, 'REACH'), (18881092, 'REACH'), (11215615, 'REACH'), (17998591, 'REACH'), (26469342, 'REACH'), (2272396, 'REACH'), (13486217, 'REACH'), (22198842, 'REACH'), (15668167, 'REACH'), (10681960, 'REACH'), (27820405, 'REACH'), (11743421, 'REACH'), (23070873, 'REACH'), (23595397, 'REACH'), (12304612, 'REACH'), (1237791, 'REACH'), (8348447, 'REACH'), (24932777, 'REACH'), (21101402, 'REACH'), (24005108, 'REACH'), (29116916, 'REACH'), (23986640, 'REACH'), (23145949, 'REACH'), (10034830, 'REACH'), (21632651, 'REACH'), (28003040, 'SPARSER'), (20472889, 'REACH'), (27600152, 'REACH'), (23424726, 'REACH'), (19191041, 'REACH'), (1253278, 'REACH'), (2760606, 'REACH'), (9825612, 'REACH'), (28348295, 'REACH'), (20270822, 'REACH'), (17556014, 'REACH'), (21042698, 'REACH'), (16329459, 'REACH'), (20765860, 'REACH'), (18696146, 'REACH'), (14924347, 'REACH'), (2573673, 'REACH'), (26887529, 'REACH'), (17812302, 'REACH'), (27413326, 'REACH'), (8348458, 'REACH'), (12647223, 'REACH'), (17726263, 'REACH'), (13912293, 'REACH'), (25676005, 'REACH'), (19646916, 'REACH'), (13181567, 'REACH'), (11086686, 'REACH'), (18918238, 'REACH'), (28383244, 'REACH'), (2674342, 'REACH'), (1180113, 'REACH'), (27619970, 'REACH'), (26558512, 'REACH'), (3547607, 'REACH'), (13472865, 'REACH'), (25321119, 'REACH'), (10286810, 'REACH'), (20270823, 'REACH'), (1713524, 'REACH'), (26191220, 'REACH'), (29942096, 'REACH'), (16766301, 'REACH'), (28539478, 'REACH'), (22481028, 'REACH'), (10651186, 'REACH'), (11699998, 'REACH'), (25671195, 'REACH'), (18126028, 'REACH'), (15170311, 'REACH'), (10300584, 'REACH'), (18228405, 'REACH'), (20532838, 'REACH'), (21126932, 'REACH'), (26868077, 'SPARSER'), (21466542, 'REACH'), (16104310, 'REACH'), (2239327, 'REACH'), (11086687, 'REACH'), (28383245, 'REACH'), (23783867, 'REACH'), (12919450, 'REACH'), (13148826, 'REACH'), (26193992, 'REACH'), (3525461, 'REACH'), (24922965, 'REACH'), (2276630, 'REACH'), (19656434, 'REACH'), (19328905, 'REACH'), (21772999, 'REACH'), (20257059, 'REACH'), (27385579, 'REACH'), (2286725, 'REACH'), (12889651, 'REACH'), (20225216, 'REACH'), (20633549, 'REACH'), (17662124, 'REACH'), (12361306, 'REACH'), (23328582, 'REACH'), (1281603, 'REACH'), (9315572, 'REACH'), (15848249, 'REACH'), (24808510, 'SPARSER'), (22238839, 'REACH'), (18461907, 'REACH'), (20890034, 'REACH'), (24432063, 'REACH'), (18441627, 'REACH'), (27723888, 'REACH'), (12163965, 'REACH'), (26549117, 'REACH'), (21498539, 'REACH'), (30022525, 'REACH'), (15341657, 'REACH'), (13149450, 'REACH'), (12137144, 'REACH'), (17998582, 'REACH'), (8354514, 'REACH'), (9796306, 'REACH'), (2203520, 'REACH'), (12010381, 'REACH'), (17746458, 'REACH'), (26757845, 'REACH'), (2724171, 'REACH'), (27136331, 'REACH'), (20705476, 'REACH'), (13244799, 'REACH'), (17662125, 'REACH'), (12301895, 'REACH'), (22853864, 'REACH'), (12252149, 'REACH'), (22014374, 'REACH'), (17113251, 'REACH'), (23098357, 'REACH'), (26959467, 'REACH'), (274296, 'REACH'), (20065285, 'REACH'), (238656, 'REACH'), (407038, 'REACH'), (8171923, 'SPARSER'), (17558644, 'REACH'), (25401614, 'REACH'), (28612284, 'REACH'), (20699833, 'REACH'), (1677208, 'REACH'), (17601670, 'SPARSER'), (18627890, 'REACH'), (11777343, 'REACH'), (26131762, 'REACH'), (17111753, 'REACH'), (11588287, 'SPARSER'), (25514516, 'REACH'), (849231, 'REACH'), (12556462, 'REACH'), (15576671, 'REACH'), (10211515, 'REACH'), (18567355, 'REACH'), (17917318, 'REACH'), (2351566, 'REACH'), (19009739, 'REACH'), (334299, 'REACH'), (30134330, 'REACH'), (2709995, 'REACH'), (24271339, 'REACH'), (29585124, 'REACH'), (16812769, 'REACH'), (19182974, 'REACH'), (1317210, 'REACH'), (10474005, 'REACH'), (26331718, 'REACH'), (17540849, 'REACH'), (3603618, 'REACH'), (21116847, 'REACH'), (23755938, 'REACH'), (24807376, 'REACH'), (12711054, 'REACH'), (11622969, 'REACH'), (26690328, 'REACH'), (26145317, 'REACH'), (16290561, 'REACH'), (23486655, 'REACH'), (10914636, 'REACH'), (1103656, 'REACH'), (1062292, 'REACH'), (24564592, 'REACH'), (17582940, 'REACH'), (17886218, 'REACH'), (23448993, 'REACH'), (16730220, 'REACH'), (19661673, 'REACH'), (12441882, 'REACH'), (18536136, 'REACH'), (23145734, 'REACH'), (12563567, 'REACH'), (1018361, 'REACH'), (858410, 'REACH'), (19306436, 'REACH'), (812737, 'REACH'), (26613700, 'REACH'), (29267908, 'REACH'), (22043578, 'REACH'), (30134599, 'REACH'), (14892963, 'REACH'), (15839185, 'REACH'), (19458621, 'REACH'), (29157949, 'REACH'), (8762570, 'REACH'), (19009718, 'REACH'), (8832179, 'REACH'), (10408545, 'REACH'), (3723259, 'REACH'), (11429676, 'REACH'), (17911803, 'REACH'), (21516283, 'REACH'), (23848131, 'REACH'), (9224856, 'REACH'), (86102, 'REACH'), (17492819, 'REACH'), (29742724, 'REACH'), (2558829, 'REACH'), (23295003, 'REACH'), (18320076, 'REACH'), (8323752, 'REACH'), (23698101, 'REACH'), (10938467, 'REACH'), (25362511, 'REACH'), (1592829, 'REACH'), (24007575, 'REACH'), (8354501, 'REACH'), (28998341, 'REACH'), (11494738, 'REACH'), (9054559, 'REACH'), (4223980, 'REACH'), (28317830, 'REACH'), (16805425, 'REACH'), (17662122, 'REACH'), (23379967, 'REACH'), (10544941, 'REACH'), (11429677, 'REACH'), (28034441, 'REACH'), (18462522, 'REACH'), (18790202, 'REACH'), (25581767, 'REACH'), (837411, 'REACH'), (28810708, 'REACH'), (888834, 'REACH'), (12029373, 'REACH'), (10911598, 'REACH'), (27633308, 'REACH'), (24932761, 'REACH'), (18986058, 'REACH'), (12387832, 'REACH'), (8922163, 'REACH'), (3493325, 'REACH'), (23000154, 'REACH'), (702567, 'REACH'), (22820967, 'REACH'), (29291610, 'REACH'), (10679622, 'REACH'), (10928884, 'REACH'), (29115124, 'REACH'), (11834077, 'REACH'), (8643467, 'REACH'), (28603893, 'SPARSER'), (9931288, 'REACH'), (2727205, 'REACH'), (23200260, 'REACH'), (26747803, 'REACH'), (10408524, 'REACH'), (13944137, 'REACH'), (13050874, 'REACH'), (18684039, 'REACH'), (29283299, 'REACH'), (20765844, 'REACH'), (25221649, 'REACH'), (23655004, 'REACH'), (29323868, 'REACH'), (20800266, 'REACH'), (9932567, 'REACH'), (29137251, 'SPARSER'), (1859745, 'REACH'), (29735309, 'REACH'), (21968699, 'REACH'), (24358764, 'REACH'), (25669484, 'REACH'), (8863770, 'REACH'), (18563098, 'REACH'), (25779817, 'REACH'), (26959465, 'REACH'), (28383238, 'REACH'), (29249093, 'SPARSER'), (16769457, 'REACH'), (24476061, 'REACH'), (26854478, 'REACH'), (19102204, 'REACH'), (3624834, 'REACH'), (870287, 'REACH'), (27215759, 'REACH'), (25777469, 'REACH'), (2129646, 'REACH'), (19345948, 'REACH'), (18140441, 'REACH'), (26889943, 'REACH'), (23200261, 'REACH'), (13760438, 'REACH'), (13145011, 'REACH'), (24646579, 'REACH'), (10119071, 'REACH'), (21761160, 'REACH'), (18465396, 'REACH'), (10034545, 'REACH'), (2189871, 'REACH'), (19458607, 'REACH'), (11413262, 'REACH'), (15786763, 'REACH'), (20800267, 'REACH'), (23993174, 'REACH'), (10408531, 'REACH'), (18744708, 'REACH'), (11984096, 'REACH'), (30024570, 'REACH'), (23736757, 'REACH'), (12658708, 'REACH'), (30136386, 'REACH'), (12658731, 'REACH'), (26251136, 'SPARSER'), (29763627, 'REACH'), (8613944, 'REACH'), (28144538, 'SPARSER'), (15668083, 'REACH'), (11401544, 'REACH'), (19949653, 'REACH'), (1039665, 'REACH'), (8871217, 'REACH'), (14998833, 'REACH'), (21632528, 'REACH'), (13030780, 'REACH'), (22752170, 'REACH'), (25514515, 'REACH'), (12361284, 'REACH'), (15779583, 'REACH'), (17628730, 'REACH'), (19432821, 'REACH'), (27080486, 'REACH'), (23790804, 'REACH'), (623185, 'REACH'), (12649041, 'REACH'), (19443458, 'REACH'), (21954539, 'REACH'), (27089495, 'REACH'), (23088376, 'REACH'), (21629153, 'REACH'), (1401467, 'REACH'), (516967, 'REACH'), (21783399, 'REACH'), (2322453, 'REACH'), (21466612, 'REACH'), (26349044, 'REACH'), (2718370, 'REACH'), (10582690, 'REACH'), (27717039, 'REACH'), (584331, 'REACH'), (17689227, 'REACH'), (27448787, 'REACH'), (11229874, 'REACH'), (17522157, 'REACH'), (12036763, 'REACH'), (1769210, 'REACH'), (25595619, 'REACH'), (24887286, 'REACH'), (18992883, 'REACH'), (20270835, 'REACH'), (28842962, 'REACH'), (249823, 'REACH'), (15912927, 'REACH'), (20765837, 'REACH'), (11107899, 'REACH'), (25034299, 'REACH'), (19844348, 'SPARSER'), (13009670, 'REACH'), (9268453, 'REACH'), (27381188, 'REACH'), (19736191, 'REACH'), (8178933, 'REACH'), (18208238, 'REACH'), (11446986, 'REACH'), (1099072, 'REACH'), (9673805, 'REACH'), (13849342, 'REACH'), (25429328, 'REACH'), (10013021, 'REACH'), (24777706, 'REACH'), (28377847, 'REACH'), (28574455, 'REACH'), (3731066, 'SPARSER'), (12361302, 'REACH'), (16715327, 'REACH'), (18299849, 'REACH'), (27311049, 'REACH'), (2629800, 'REACH'), (2635957, 'REACH'), (28516520, 'REACH'), (20199011, 'REACH'), (18117494, 'SPARSER'), (24464975, 'REACH'), (18506749, 'REACH'), (3249369, 'REACH'), (21850604, 'REACH'), (29911532, 'REACH'), (1697434, 'REACH'), (2784902, 'REACH'), (19758726, 'REACH'), (10934137, 'REACH'), (14866297, 'REACH'), (22029994, 'REACH'), (13139219, 'REACH'), (15598657, 'REACH'), (11789042, 'REACH'), (19522290, 'REACH'), (24371954, 'REACH'), (1650398, 'REACH'), (16178467, 'REACH'), (1668610, 'REACH'), (10408522, 'REACH'), (11494743, 'REACH'), (19458614, 'REACH'), (18583524, 'REACH'), (26284004, 'REACH'), (203295, 'REACH'), (10028204, 'REACH'), (13443241, 'REACH'), (20800264, 'REACH'), (16743189, 'REACH'), (26769652, 'REACH'), (25513168, 'REACH'), (10914620, 'REACH'), (27887827, 'REACH'), (29995009, 'REACH'), (17527648, 'REACH'), (18262092, 'REACH'), (1172297, 'REACH'), (26843642, 'REACH'), (28411527, 'REACH'), (11236147, 'SPARSER'), (28553702, 'REACH'), (12679828, 'REACH'), (29081282, 'REACH'), (20473948, 'REACH'), (18863800, 'REACH'), (10934180, 'REACH'), (13289121, 'REACH'), (1933630, 'REACH'), (783675, 'REACH'), (26706238, 'REACH'), (17674535, 'REACH'), (13770696, 'REACH'), (3508578, 'REACH'), (27133853, 'REACH'), (9525838, 'REACH'), (27154169, 'REACH'), (1232426, 'REACH'), (8474154, 'REACH'), (15846954, 'REACH'), (16972773, 'REACH'), (19458615, 'REACH'), (24628778, 'REACH'), (25389623, 'REACH'), (13432414, 'REACH'), (15753993, 'REACH'), (20800265, 'REACH'), (8183183, 'REACH'), (12385518, 'REACH'), (20066332, 'REACH'), (12441034, 'REACH'), (13462966, 'REACH'), (16018870, 'REACH'), (26005939, 'REACH'), (26843639, 'REACH'), (18555780, 'REACH'), (17674546, 'REACH'), (3213631, 'REACH'), (27756492, 'REACH'), (15024506, 'REACH'), (19474012, 'SPARSER'), (25674106, 'REACH'), (1232427, 'REACH'), (3716060, 'REACH'), (8303580, 'REACH'), (9641528, 'REACH'), (1103652, 'REACH'), (11110590, 'REACH'), (1297644, 'REACH'), (9235843, 'REACH'), (18462516, 'REACH'), (25197535, 'SPARSER'), (15668240, 'REACH'), (18930756, 'REACH'), (2115212, 'REACH'), (887433, 'REACH'), (11814540, 'REACH'), (30496199, 'REACH'), (12872962, 'REACH'), (13859504, 'REACH'), (10755182, 'REACH'), (27440028, 'REACH'), (838392, 'REACH'), (18238200, 'REACH'), (24771520, 'REACH'), (21645694, 'REACH'), (4325499, 'REACH'), (17994668, 'REACH'), (3244171, 'REACH'), (29152211, 'REACH'), (17998596, 'REACH'), (27224872, 'REACH'), (12902197, 'REACH'), (9153763, 'REACH'), (14854548, 'REACH'), (24730050, 'REACH'), (13588336, 'REACH'), (26050570, 'REACH'), (16118807, 'REACH'), (22876600, 'REACH'), (23294999, 'REACH'), (19420662, 'REACH'), (23607762, 'REACH'), (2135079, 'REACH'), (13098676, 'REACH'), (18283185, 'REACH'), (16730223, 'REACH'), (11354139, 'SPARSER'), (26130320, 'REACH'), (9463118, 'REACH'), (16813561, 'REACH'), (24614199, 'REACH'), (2148056, 'REACH'), (28939575, 'REACH'), (13944158, 'REACH'), (23791963, 'REACH'), (27101705, 'REACH'), (12440903, 'REACH'), (12722933, 'REACH'), (15564966, 'REACH'), (18874534, 'REACH'), (24726510, 'REACH'), (16505011, 'REACH'), (2744932, 'REACH'), (27058788, 'REACH'), (30236015, 'SPARSER'), (21783360, 'REACH'), (889086, 'REACH'), (11600891, 'REACH'), (11447688, 'REACH'), (30518664, 'REACH'), (25243475, 'REACH'), (12741252, 'REACH'), (13361661, 'REACH'), (12658606, 'REACH'), (14962396, 'REACH'), (8467161, 'REACH'), (14866327, 'REACH'), (19557491, 'REACH'), (12385569, 'REACH'), (10369362, 'REACH'), (19248640, 'REACH'), (11494741, 'REACH'), (8348432, 'REACH'), (10590107, 'SPARSER'), (9033494, 'REACH'), (9902867, 'REACH'), (20749075, 'REACH'), (3580481, 'REACH'), (25291588, 'REACH'), (14904542, 'REACH'), (18946441, 'REACH'), (27599697, 'REACH'), (19359152, 'REACH'), (15668078, 'REACH'), (2718364, 'REACH'), (88568, 'REACH'), (15058565, 'REACH'), (26853430, 'REACH'), (28347876, 'REACH'), (8536338, 'REACH'), (8155167, 'REACH'), (22117479, 'REACH'), (12388678, 'REACH'), (21627196, 'REACH'), (26706236, 'REACH'), (12693203, 'REACH'), (20491987, 'REACH'), (23590883, 'REACH'), (17604113, 'REACH'), (29368944, 'REACH'), (3931517, 'REACH'), (19142236, 'REACH'), (10118922, 'REACH'), (4158648, 'REACH'), (23692869, 'REACH'), (24249925, 'REACH'), (12064755, 'REACH'), (10028193, 'REACH'), (14904543, 'REACH'), (2155372, 'REACH'), (20472858, 'REACH'), (999207, 'REACH'), (8470531, 'REACH'), (9268660, 'REACH'), (15668079, 'REACH'), (23595664, 'REACH'), (825422, 'REACH'), (22779982, 'REACH'), (27751673, 'REACH'), (22229700, 'REACH'), (4325490, 'REACH'), (10648844, 'REACH'), (13351252, 'REACH'), (23144765, 'REACH'), (27678236, 'REACH'), (22221770, 'REACH'), (10934195, 'REACH'), (1446241, 'REACH'), (13013345, 'REACH'), (74284, 'REACH'), (1909292, 'REACH'), (28680748, 'REACH'), (22201283, 'REACH'), (18847522, 'REACH'), (9350703, 'REACH'), (28548688, 'REACH'), (4158649, 'REACH'), (8778937, 'REACH'), (8389016, 'REACH'), (18208933, 'REACH'), (802646, 'REACH'), (11485014, 'REACH'), (29491608, 'REACH'), (1103666, 'REACH'), (19453746, 'REACH'), (2094701, 'REACH'), (12994192, 'SPARSER'), (10192332, 'REACH'), (25929594, 'REACH'), (29566842, 'REACH'), (21053864, 'REACH'), (29898165, 'REACH'), (16703334, 'REACH'), (18931558, 'REACH'), (27169169, 'REACH'), (2415278, 'REACH'), (2812971, 'REACH'), (20472950, 'REACH'), (15899730, 'REACH'), (19522284, 'REACH'), (12664297, 'REACH'), (28402412, 'REACH'), (25594535, 'REACH'), (3578607, 'REACH'), (15886864, 'REACH'), (15571301, 'REACH'), (29241542, 'SPARSER'), (10935039, 'REACH'), (11744219, 'REACH'), (21181403, 'REACH'), (19650152, 'REACH'), (3525414, 'REACH'), (8053691, 'SPARSER'), (12121067, 'REACH'), (28107141, 'REACH'), (29818675, 'REACH'), (20505670, 'REACH'), (11484995, 'REACH'), (27550790, 'REACH'), (9852558, 'REACH'), (10213006, 'REACH'), (17018507, 'REACH'), (15408185, 'REACH'), (18536078, 'REACH'), (22965354, 'REACH'), (12385560, 'REACH'), (27585642, 'REACH'), (30025788, 'REACH'), (25956845, 'REACH'), (11834106, 'REACH'), (8132303, 'REACH'), (29115123, 'REACH'), (1116780, 'REACH'), (15154537, 'REACH'), (25081012, 'REACH'), (12104267, 'REACH'), (889084, 'REACH'), (23400700, 'REACH'), (26022140, 'REACH'), (11621175, 'REACH'), (27155242, 'REACH'), (30178520, 'REACH'), (21581206, 'REACH'), (2182002, 'REACH'), (12367904, 'REACH'), (20222381, 'REACH'), (26284461, 'REACH'), (18468876, 'REACH'), (2369545, 'REACH'), (28701511, 'REACH'), (30190056, 'REACH'), (27993766, 'REACH'), (24932771, 'REACH'), (29876308, 'REACH'), (66621, 'REACH'), (22890990, 'REACH'), (2249557, 'SPARSER'), (25360855, 'REACH'), (10764549, 'REACH'), (29464896, 'REACH'), (22941996, 'REACH'), (2861960, 'REACH'), (2027462, 'REACH'), (9243761, 'REACH'), (12008994, 'REACH'), (28035375, 'REACH'), (26236430, 'REACH'), (25429331, 'REACH'), (13090948, 'REACH'), (12563585, 'REACH'), (22269132, 'REACH'), (25513164, 'REACH'), (25722825, 'REACH'), (24247477, 'REACH'), (19526801, 'REACH'), (13916971, 'REACH'), (27155243, 'REACH'), (27825559, 'REACH'), (24081270, 'REACH'), (434212, 'REACH'), (9807698, 'REACH'), (24477893, 'SPARSER'), (12965287, 'REACH'), (27599701, 'REACH'), (3177524, 'REACH'), (26004962, 'REACH'), (30016206, 'REACH'), (897299, 'REACH'), (30648050, 'REACH'), (15915936, 'REACH'), (11655469, 'REACH'), (20164134, 'REACH'), (29847843, 'REACH'), (13197649, 'REACH'), (16124418, 'REACH'), (11901872, 'REACH'), (22289328, 'REACH'), (23780617, 'SPARSER'), (18684060, 'REACH'), (22440857, 'REACH'), (16805430, 'REACH'), (17578909, 'SPARSER'), (27341044, 'SPARSER'), (27341040, 'SPARSER'), (10409562, 'REACH'), (26150664, 'REACH'), (29597461, 'REACH'), (24192579, 'REACH'), (1121675, 'REACH'), (12066187, 'REACH'), (10677049, 'REACH'), (10934122, 'REACH'), (20179769, 'REACH'), (22159939, 'SPARSER'), (28947457, 'REACH'), (22673248, 'REACH'), (22666651, 'REACH'), (17783431, 'REACH'), (26004963, 'REACH'), (18904081, 'REACH'), (21317071, 'REACH'), (27618396, 'REACH'), (11574538, 'REACH'), (15843607, 'REACH'), (20454666, 'REACH'), (19771930, 'SPARSER'), (26349043, 'REACH'), (30103916, 'REACH'), (11112553, 'REACH'), (2425370, 'REACH'), (996647, 'REACH'), (12062825, 'REACH'), (22221768, 'REACH'), (21620227, 'REACH'), (25323011, 'REACH'), (26028980, 'REACH'), (26356660, 'REACH'), (26577227, 'REACH'), (21871612, 'REACH'), (16805431, 'REACH'), (20704823, 'REACH'), (29152216, 'REACH'), (1915027, 'REACH'), (24964427, 'SPARSER'), (26150665, 'REACH'), (9488570, 'REACH'), (1024422, 'REACH'), (3569827, 'REACH'), (8190338, 'REACH'), (2412349, 'REACH'), (1337802, 'REACH'), (17818038, 'REACH'), (22673249, 'REACH'), (25849490, 'REACH'), (24047102, 'REACH'), (11574523, 'REACH'), (11869435, 'REACH'), (16176838, 'REACH'), (18536134, 'REACH'), (820271, 'REACH'), (12354282, 'REACH'), (25513043, 'REACH'), (27620461, 'REACH'), (22034787, 'REACH'), (15133204, 'REACH'), (1281359, 'REACH'), (23165693, 'REACH'), (11452971, 'REACH'), (23020075, 'REACH'), (11732106, 'REACH'), (2039959, 'REACH'), (3281464, 'REACH'), (20933573, 'REACH'), (13769334, 'REACH'), (30239459, 'SPARSER'), (74273, 'REACH'), (9987508, 'SPARSER'), (19989248, 'REACH'), (24932762, 'REACH'), (29876391, 'REACH'), (2867658, 'SPARSER'), (3573369, 'REACH'), (9800119, 'REACH'), (15668243, 'REACH'), (25321120, 'REACH'), (13120557, 'REACH'), (21380177, 'REACH'), (1716715, 'REACH'), (26480281, 'REACH'), (15848755, 'REACH'), (11634404, 'REACH'), (26904292, 'REACH'), (23199680, 'REACH'), (13743821, 'REACH'), (24923518, 'REACH'), (18940486, 'REACH'), (20391924, 'REACH'), (24653743, 'REACH'), (1261520, 'REACH'), (12379101, 'REACH'), (23655602, 'REACH'), (13411148, 'REACH'), (21044454, 'REACH'), (29826278, 'REACH'), (19958991, 'REACH'), (19572129, 'REACH'), (30190208, 'REACH'), (29521549, 'REACH'), (4325484, 'REACH'), (17592602, 'REACH'), (11180501, 'REACH'), (19547398, 'REACH'), (18787216, 'REACH'), (86314, 'REACH'), (24432938, 'REACH'), (15813526, 'REACH'), (12008992, 'REACH'), (20692909, 'REACH'), (17473134, 'SPARSER'), (18199482, 'REACH'), (18957478, 'REACH'), (28495854, 'REACH'), (13504025, 'REACH'), (14904522, 'REACH'), (15081431, 'REACH'), (10476946, 'REACH'), (10696269, 'REACH'), (1512702, 'REACH'), (13916969, 'REACH'), (11076839, 'REACH'), (19150229, 'REACH'), (1807220, 'REACH'), (19796852, 'REACH'), (24914545, 'REACH'), (29942621, 'REACH'), (13390862, 'REACH'), (12677131, 'REACH'), (22947260, 'REACH'), (3294455, 'REACH'), (30190209, 'REACH'), (138290, 'REACH'), (21896242, 'REACH'), (29082477, 'REACH'), (16730434, 'REACH'), (25667069, 'REACH'), (27491246, 'REACH'), (27806615, 'REACH'), (8568120, 'REACH'), (8876406, 'REACH'), (10547574, 'REACH'), (11774464, 'REACH'), (24685548, 'REACH'), (28158887, 'REACH'), (25835080, 'REACH'), (3217749, 'REACH'), (24287573, 'REACH'), (25535458, 'REACH'), (21358352, 'REACH'), (22003229, 'REACH'), (24887673, 'REACH'), (620714, 'REACH'), (16178963, 'REACH'), (18995199, 'REACH'), (8306477, 'REACH'), (1981833, 'REACH'), (9936675, 'REACH'), (18142676, 'REACH'), (23455569, 'REACH'), (12658690, 'REACH'), (18633743, 'REACH'), (10099120, 'REACH'), (3483314, 'SPARSER'), (1297643, 'REACH'), (21495452, 'REACH'), (3278679, 'REACH'), (28769784, 'REACH'), (138291, 'REACH'), (10512080, 'REACH'), (18496395, 'REACH'), (28207417, 'REACH'), (13686122, 'REACH'), (78806, 'REACH'), (28914646, 'REACH'), (29275094, 'REACH'), (27870143, 'REACH'), (24702304, 'REACH'), (12610285, 'REACH'), (20146764, 'REACH'), (11846446, 'SPARSER'), (4219432, 'REACH'), (22110760, 'REACH'), (12121062, 'REACH'), (13674690, 'REACH'), (15893294, 'REACH'), (20349742, 'REACH'), (23361707, 'REACH'), (24004375, 'REACH'), (22331812, 'REACH'), (21888, 'REACH'), (13030784, 'REACH'), (13686144, 'REACH'), (13317737, 'REACH'), (1030170, 'REACH'), (22460442, 'REACH'), (13175240, 'REACH'), (4407509, 'REACH'), (17403536, 'REACH'), (30612558, 'REACH'), (13191417, 'REACH'), (14866303, 'REACH'), (406816, 'REACH'), (13612320, 'REACH'), (13874464, 'REACH'), (27680862, 'REACH'), (13640969, 'REACH'), (29959433, 'REACH'), (19168596, 'REACH'), (12584834, 'REACH'), (14923835, 'SPARSER'), (16979914, 'REACH'), (23147873, 'REACH'), (29646751, 'REACH'), (408315, 'REACH'), (13220603, 'REACH'), (27289132, 'REACH'), (19716058, 'REACH'), (13640840, 'REACH'), (24068245, 'REACH'), (3166800, 'REACH'), (10408528, 'REACH'), (13240505, 'REACH'), (18882794, 'REACH'), (15545335, 'REACH'), (11730085, 'REACH'), (2489509, 'REACH'), (1997989, 'REACH'), (1946454, 'REACH'), (2509395, 'REACH'), (2457985, 'REACH'), (3603621, 'REACH'), (24122592, 'REACH'), (12806765, 'REACH'), (28236236, 'REACH'), (30562764, 'REACH'), (2784122, 'REACH'), (27523962, 'REACH'), (17630632, 'REACH'), (28199349, 'REACH'), (22820982, 'REACH'), (18356257, 'REACH'), (12472648, 'REACH'), (19087445, 'REACH'), (22271691, 'REACH'), (27485098, 'REACH'), (9597272, 'REACH'), (28765718, 'REACH'), (26706241, 'REACH'), (10441888, 'REACH'), (19716059, 'REACH'), (18684044, 'REACH'), (661050, 'REACH'), (22764917, 'REACH'), (21986516, 'REACH'), (11094799, 'REACH'), (25326167, 'REACH'), (15528755, 'REACH'), (18980068, 'REACH'), (20225252, 'REACH'), (12574495, 'REACH'), (4274811, 'REACH'), (24489385, 'REACH'), (28064615, 'REACH'), (19932168, 'REACH'), (22013973, 'REACH'), (23111156, 'REACH'), (334301, 'REACH'), (19917884, 'REACH'), (28856377, 'REACH'), (27523959, 'REACH'), (22136869, 'REACH'), (8354518, 'REACH'), (16603468, 'REACH'), (21322060, 'REACH'), (24134000, 'REACH'), (18684029, 'REACH'), (29409648, 'REACH'), (27127319, 'REACH'), (28903588, 'REACH'), (20796370, 'REACH'), (4325504, 'REACH'), (12711053, 'REACH'), (30613054, 'REACH'), (14904520, 'REACH'), (4409166, 'REACH'), (18175563, 'REACH'), (10678488, 'REACH'), (19182995, 'REACH'), (18182002, 'REACH'), (10026016, 'REACH'), (18142637, 'REACH'), (20940638, 'REACH'), (11824137, 'REACH'), (17886217, 'REACH'), (27799329, 'SPARSER'), (11990435, 'REACH'), (26349038, 'REACH'), (8773483, 'REACH'), (20780316, 'REACH'), (15937565, 'SPARSER'), (9121314, 'SPARSER'), (26947106, 'SPARSER'), (9607465, 'REACH'), (19905255, 'REACH'), (19328904, 'REACH'), (1215381, 'REACH'), (4325489, 'REACH'), (11476491, 'REACH'), (22565817, 'REACH'), (23495812, 'REACH'), (477313, 'REACH'), (980372, 'SPARSER'), (1962782, 'REACH'), (2164881, 'REACH'), (826365, 'REACH'), (29957117, 'REACH'), (30108055, 'REACH'), (24765476, 'REACH'), (11484961, 'REACH'), (26117983, 'REACH'), (1591296, 'REACH'), (9427177, 'REACH'), (9232866, 'REACH'), (1281519, 'REACH'), (25398767, 'REACH'), (26349039, 'REACH'), (11857785, 'REACH'), (12921944, 'REACH'), (29255958, 'REACH'), (13546771, 'REACH'), (22555972, 'REACH'), (11324927, 'REACH'), (1277229, 'REACH'), (30034651, 'REACH'), (22321036, 'REACH'), (20825021, 'REACH'), (1909302, 'REACH'), (21654497, 'REACH'), (10700992, 'REACH'), (25905344, 'REACH'), (23911596, 'REACH'), (24829100, 'REACH'), (22950132, 'REACH'), (2089591, 'REACH'), (17553432, 'REACH'), (16290597, 'REACH'), (20209875, 'REACH'), (17684927, 'REACH'), (24118027, 'SPARSER'), (12889758, 'REACH'), (8288296, 'REACH'), (19672117, 'REACH'), (29354470, 'REACH'), (16606320, 'REACH'), (17799470, 'REACH'), (16774233, 'REACH'), (26865336, 'REACH'), (10399813, 'REACH'), (22271698, 'REACH'), (16527071, 'REACH'), (21089152, 'REACH'), (12599181, 'REACH'), (21604647, 'REACH'), (27979338, 'SPARSER'), (15432195, 'REACH'), (28323764, 'REACH'), (20824418, 'REACH'), (1909303, 'REACH'), (2081942, 'REACH'), (16082881, 'REACH'), (9475304, 'REACH'), (29005032, 'REACH'), (11162452, 'REACH'), (24137937, 'REACH'), (19922306, 'REACH'), (23053117, 'REACH'), (25500536, 'REACH'), (28383237, 'REACH'), (1712786, 'REACH'), (17040157, 'SPARSER'), (25900447, 'REACH'), (889083, 'REACH'), (15096876, 'REACH'), (29261865, 'REACH'), (26335880, 'REACH'), (25901323, 'REACH'), (11555158, 'REACH'), (385107, 'REACH'), (15980171, 'SPARSER'), (28298782, 'REACH'), (28921374, 'REACH'), (25786746, 'REACH'), (28836776, 'REACH'), (27127316, 'REACH'), (28472494, 'REACH'), (23463467, 'REACH'), (2081943, 'REACH'), (2027461, 'REACH'), (19701366, 'REACH'), (10383140, 'REACH'), (17300063, 'REACH'), (13640940, 'REACH'), (25384937, 'REACH'), (140455, 'REACH'), (12428455, 'REACH'), (414086, 'REACH'), (9059554, 'REACH'), (12574493, 'REACH'), (16694734, 'REACH'), (12147321, 'REACH'), (24221528, 'REACH'), (28387347, 'REACH'), (15668292, 'REACH'), (17154697, 'REACH'), (18465417, 'REACH'), (770152, 'REACH'), (10797160, 'REACH'), (27987238, 'REACH'), (26721315, 'REACH'), (13640962, 'REACH'), (12354296, 'REACH'), (9280389, 'REACH'), (26208563, 'REACH'), (13153216, 'REACH'), (11526526, 'REACH'), (27127317, 'REACH'), (24249926, 'REACH'), (20634612, 'REACH'), (19129263, 'REACH'), (12658653, 'REACH'), (21315726, 'REACH'), (25673870, 'REACH'), (10244471, 'REACH'), (8911620, 'REACH'), (2240257, 'REACH'), (12576946, 'REACH'), (19443457, 'REACH'), (24209822, 'REACH'), (1317019, 'REACH'), (2332233, 'REACH'), (25592616, 'REACH'), (22912046, 'REACH'), (18163548, 'REACH'), (30156636, 'REACH'), (13784901, 'REACH'), (23088630, 'REACH'), (8573394, 'REACH'), (21352914, 'REACH'), (13155390, 'REACH'), (21871678, 'REACH'), (3702633, 'REACH'), (26575560, 'REACH'), (23697670, 'REACH'), (13640963, 'REACH'), (18392323, 'REACH'), (24206053, 'REACH'), (28916863, 'REACH'), (25263454, 'REACH'), (23970313, 'REACH'), (12772453, 'SPARSER'), (8997864, 'REACH'), (22411430, 'REACH'), (1827822, 'REACH'), (8271211, 'REACH'), (22537198, 'REACH'), (2425369, 'REACH'), (27550702, 'REACH'), (12354309, 'REACH'), (26324150, 'REACH'), (21256804, 'REACH'), (18262175, 'REACH'), (1989627, 'REACH'), (10099142, 'REACH'), (9350769, 'REACH'), (26226289, 'REACH'), (20430488, 'REACH'), (25413459, 'REACH'), (13381249, 'REACH'), (26939442, 'REACH'), (17022015, 'REACH'), (9232864, 'REACH'), (24961504, 'REACH'), (13461196, 'REACH'), (24605959, 'REACH'), (16078950, 'REACH'), (29621327, 'REACH'), (19922862, 'REACH'), (23028399, 'SPARSER'), (16699730, 'REACH'), (18787840, 'REACH'), (12333036, 'REACH'), (30592935, 'REACH'), (24010069, 'REACH'), (25746773, 'REACH'), (15604496, 'REACH'), (24639435, 'REACH'), (4313724, 'REACH'), (11376823, 'REACH'), (21348965, 'REACH'), (23053124, 'REACH'), (26859558, 'REACH'), (22596052, 'REACH'), (26298836, 'REACH'), (30603709, 'REACH'), (27695881, 'SPARSER'), (9232865, 'REACH'), (11739462, 'REACH'), (11615988, 'REACH'), (11484847, 'REACH'), (1604304, 'REACH'), (8354512, 'REACH'), (12843324, 'REACH'), (3143638, 'REACH'), (20255666, 'REACH'), (29814509, 'REACH'), (10186316, 'REACH'), (27342822, 'REACH'), (16158691, 'REACH'), (9349268, 'REACH'), (18667025, 'REACH'), (28018639, 'REACH'), (3603627, 'REACH'), (11807928, 'REACH'), (20765857, 'REACH'), (25917223, 'REACH'), (16747976, 'REACH'), (24499708, 'REACH'), (12872953, 'REACH'), (654378, 'REACH'), (19963959, 'REACH'), (28857852, 'REACH'), (24490469, 'REACH'), (16470675, 'REACH'), (1186477, 'REACH'), (3926107, 'REACH'), (22014043, 'REACH'), (21717690, 'REACH'), (10094069, 'REACH'), (18736038, 'REACH'), (22271697, 'REACH'), (9280386, 'REACH'), (1039664, 'REACH'), (21627197, 'REACH'), (26050877, 'REACH'), (12658795, 'REACH'), (3894812, 'REACH'), (21753372, 'REACH'), (26706237, 'REACH'), (30189675, 'REACH'), (26246661, 'REACH'), (29413299, 'REACH'), (18684050, 'REACH'), (24024640, 'REACH'), (11739469, 'REACH'), (26124621, 'REACH'), (13098747, 'REACH'), (9607724, 'REACH'), (28909901, 'REACH'), (555144, 'REACH'), (8160405, 'REACH'), (12482696, 'REACH'), (13468821, 'REACH'), (18717635, 'REACH'), (27919509, 'REACH'), (26324153, 'REACH'), (22916469, 'SPARSER'), (16807927, 'REACH'), (13667923, 'REACH'), (15059998, 'REACH'), (25329756, 'SPARSER'), (12578229, 'REACH'), (13907010, 'REACH'), (17700093, 'REACH'), (11641308, 'REACH'), (9424755, 'REACH'), (357458, 'REACH'), (23418184, 'REACH'), (13749556, 'REACH'), (9931057, 'REACH'), (28998370, 'REACH'), (11574557, 'REACH'), (12263804, 'REACH'), (21471612, 'REACH'), (21705061, 'REACH'), (576068, 'REACH'), (30292166, 'SPARSER'), (777202, 'REACH'), (16290559, 'REACH'), (21172991, 'REACH'), (21879794, 'REACH'), (19917787, 'REACH'), (28702857, 'REACH'), (8348454, 'REACH'), (16988707, 'REACH'), (29385510, 'REACH'), (24779522, 'REACH'), (19966955, 'REACH'), (28847083, 'REACH'), (19871897, 'REACH'), (24033433, 'REACH'), (3193080, 'REACH'), (15448312, 'REACH'), (20619282, 'REACH'), (217887, 'REACH'), (242112, 'REACH'), (1993562, 'REACH'), (16771930, 'REACH'), (23886324, 'REACH'), (20474097, 'REACH'), (11892386, 'REACH'), (9936349, 'REACH'), (27108458, 'REACH'), (60453, 'REACH'), (25114290, 'REACH'), (19081709, 'REACH'), (11784094, 'REACH'), (22043980, 'REACH'), (18774755, 'REACH'), (24947775, 'SPARSER'), (21300497, 'REACH'), (23594257, 'REACH'), (29308866, 'REACH'), (28444016, 'REACH'), (23925294, 'REACH'), (15668139, 'REACH'), (10934200, 'REACH'), (23596196, 'REACH'), (11990377, 'REACH'), (1909287, 'REACH'), (28680743, 'REACH'), (78805, 'REACH'), (2513506, 'REACH'), (1461648, 'REACH'), (3177294, 'REACH'), (12511819, 'REACH'), (28035324, 'REACH'), (12647417, 'REACH'), (28657916, 'REACH'), (29157963, 'REACH'), (21360833, 'REACH'), (2810738, 'REACH'), (28864705, 'REACH'), (8155168, 'REACH'), (22092638, 'REACH'), (24030650, 'REACH'), (24175080, 'REACH'), (14918274, 'REACH'), (3926300, 'REACH'), (24426757, 'REACH'), (19183283, 'REACH'), (25867955, 'REACH'), (1016929, 'REACH'), (88571, 'REACH'), (22363879, 'REACH'), (13030772, 'REACH'), (24134769, 'REACH'), (24762962, 'SPARSER'), (8282044, 'REACH'), (10934201, 'REACH'), (20765848, 'REACH'), (11992403, 'REACH'), (683398, 'SPARSER'), (21097601, 'REACH'), (26425118, 'REACH'), (4265141, 'REACH'), (27058787, 'REACH'), (233236, 'REACH'), (9153776, 'REACH'), (3609387, 'REACH'), (13030794, 'REACH'), (26815895, 'REACH'), (29906744, 'REACH'), (30022495, 'REACH'), (23055360, 'REACH'), (21044457, 'REACH'), (22936405, 'REACH'), (10399793, 'REACH'), (23520738, 'REACH'), (12658717, 'REACH'), (18130973, 'REACH'), (14947787, 'REACH'), (16730236, 'REACH'), (2160741, 'REACH'), (25972443, 'REACH'), (29338311, 'REACH'), (22288340, 'REACH'), (25671183, 'REACH'), (331338, 'REACH'), (11978701, 'REACH'), (9398887, 'REACH'), (2271046, 'REACH'), (10376436, 'REACH'), (12395938, 'REACH'), (3603631, 'REACH'), (11547058, 'REACH'), (12431794, 'REACH'), (22353307, 'REACH'), (18318412, 'REACH'), (26674252, 'REACH'), (26853429, 'REACH'), (29224422, 'REACH'), (23379246, 'REACH'), (22756011, 'REACH'), (28398326, 'REACH'), (23111155, 'REACH'), (19007024, 'SPARSER'), (26706235, 'REACH'), (16730217, 'REACH'), (27406700, 'REACH'), (8354517, 'REACH'), (24371961, 'REACH'), (20617770, 'REACH'), (18684054, 'REACH'), (28290848, 'REACH'), (10367756, 'REACH'), (29529940, 'REACH'), (13873538, 'REACH'), (25581783, 'REACH'), (2203512, 'REACH'), (29415639, 'REACH'), (13462963, 'REACH'), (11982692, 'REACH'), (8402539, 'SPARSER'), (3286526, 'REACH'), (14942869, 'REACH'), (27618397, 'REACH'), (26213643, 'REACH'), (1428153, 'REACH'), (24206058, 'REACH'), (21042679, 'REACH'), (22153112, 'REACH'), (565124, 'REACH'), (25586994, 'REACH'), (25783602, 'REACH'), (29560544, 'REACH'), (20548717, 'REACH'), (2276635, 'REACH'), (1444553, 'REACH'), (13372105, 'REACH'), (14866321, 'REACH'), (19458626, 'REACH'), (20617771, 'REACH'), (249820, 'REACH'), (18684055, 'REACH'), (19142807, 'REACH'), (26063629, 'REACH'), (28588268, 'REACH'), (28847081, 'REACH'), (26164696, 'SPARSER'), (1103665, 'REACH'), (1962781, 'REACH'), (11105053, 'REACH'), (10305739, 'REACH'), (29999307, 'REACH'), (25779833, 'REACH'), (9485121, 'REACH'), (20191730, 'REACH'), (18483455, 'REACH'), (23796210, 'REACH'), (29445165, 'REACH'), (10060070, 'REACH'), (972464, 'REACH'), (9521262, 'REACH'), (16730222, 'REACH'), (11093657, 'REACH'), (22398617, 'REACH'), (21176197, 'REACH'), (26689846, 'REACH'), (20999475, 'REACH'), (24927972, 'REACH'), (25586995, 'REACH'), (10934208, 'REACH'), (27232602, 'REACH'), (17987536, 'REACH'), (25643577, 'REACH'), (10211519, 'REACH'), (29577407, 'REACH'), (15779624, 'REACH'), (3640117, 'REACH'), (22645557, 'REACH'), (16715822, 'REACH'), (22820972, 'REACH'), (21492585, 'REACH'), (21432008, 'REACH'), (13044404, 'REACH'), (1057903, 'REACH'), (9872495, 'REACH'), (15121053, 'REACH'), (18736016, 'REACH'), (27024914, 'SPARSER'), (8569143, 'REACH'), (10236632, 'REACH'), (22786776, 'REACH'), (17668466, 'REACH'), (29313978, 'REACH'), (393543, 'REACH'), (13533511, 'REACH'), (10985205, 'REACH'), (25821511, 'REACH'), (21706882, 'REACH'), (29944975, 'REACH'), (84331, 'REACH'), (12666393, 'REACH'), (25081011, 'REACH'), (13931922, 'REACH'), (11119775, 'REACH'), (22597197, 'REACH'), (3473403, 'REACH'), (26351404, 'REACH'), (35973, 'SPARSER'), (12451047, 'REACH'), (18465393, 'REACH'), (28608608, 'SPARSER'), (2330021, 'REACH'), (11814532, 'REACH'), (9884722, 'REACH'), (30134335, 'REACH'), (12322272, 'REACH'), (27523949, 'REACH'), (28801901, 'REACH'), (11740187, 'REACH'), (8354508, 'REACH'), (16730234, 'REACH'), (28035335, 'REACH'), (29985461, 'REACH'), (26706242, 'REACH'), (11120719, 'REACH'), (23310415, 'REACH'), (24968701, 'REACH'), (15668142, 'REACH'), (9933099, 'REACH'), (24063104, 'SPARSER'), (26639869, 'REACH'), (10062730, 'REACH'), (27426301, 'REACH'), (22850245, 'REACH'), (62185, 'REACH'), (24236186, 'REACH'), (16699733, 'REACH'), (28571521, 'SPARSER'), (19458612, 'REACH'), (21745647, 'REACH'), (8230429, 'REACH'), (12818638, 'REACH'), (1939068, 'REACH'), (8919417, 'REACH'), (17668473, 'REACH'), (22976124, 'REACH'), (781912, 'REACH'), (22373989, 'REACH'), (23938997, 'SPARSER'), (653075, 'REACH'), (13846340, 'REACH'), (27684440, 'REACH'), (26351405, 'REACH'), (11265243, 'REACH'), (19777141, 'REACH'), (25787430, 'REACH'), (27080483, 'REACH'), (11128276, 'REACH'), (19715740, 'REACH'), (11231641, 'REACH'), (10200138, 'REACH'), (12395594, 'REACH'), (13383160, 'REACH'), (17869855, 'REACH'), (15668291, 'REACH'), (11555503, 'REACH'), (15408848, 'REACH'), (12906382, 'REACH'), (9556875, 'REACH'), (11608377, 'REACH'), (2067749, 'REACH'), (15830309, 'REACH'), (1028612, 'REACH'), (23796671, 'REACH'), (29663981, 'REACH'), (12127022, 'SPARSER'), (23892986, 'REACH'), (27576455, 'REACH'), (19416629, 'REACH'), (12504212, 'REACH'), (13849354, 'REACH'), (12327332, 'REACH'), (9807675, 'REACH'), (12265275, 'REACH'), (20347093, 'REACH'), (28490755, 'REACH'), (15183727, 'REACH'), (19210489, 'REACH'), (15602113, 'REACH'), (22820958, 'REACH'), (15887451, 'REACH'), (27618395, 'REACH'), (22030010, 'REACH'), (11445319, 'REACH'), (88565, 'REACH'), (16495956, 'REACH'), (20952404, 'REACH'), (26757841, 'REACH'), (26130319, 'REACH'), (30001873, 'REACH'), (29712924, 'REACH'), (2276633, 'REACH'), (30113495, 'REACH'), (20765842, 'REACH'), (29957118, 'REACH'), (9243623, 'REACH'), (3525462, 'REACH'), (30288988, 'SPARSER'), (23838120, 'REACH'), (1611796, 'REACH'), (11447697, 'REACH'), (26019906, 'REACH'), (16151178, 'REACH'), (25588362, 'REACH'), (27467832, 'REACH'), (860613, 'REACH'), (17551478, 'REACH'), (29946506, 'REACH'), (9162785, 'REACH'), (3559693, 'REACH'), (19590859, 'REACH'), (16696700, 'REACH'), (14900138, 'REACH'), (13694309, 'REACH'), (19015190, 'REACH'), (12062276, 'REACH'), (3604466, 'REACH'), (19507143, 'REACH'), (24098165, 'REACH'), (12104273, 'REACH'), (13831580, 'REACH'), (17159125, 'SPARSER'), (20749130, 'REACH'), (22607076, 'REACH'), (2365215, 'REACH'), (13062779, 'REACH'), (23494132, 'REACH'), (28835316, 'REACH'), (10192339, 'REACH'), (28622084, 'REACH'), (12171360, 'REACH'), (21581293, 'REACH'), (2724172, 'REACH'), (12658761, 'REACH'), (27136332, 'REACH'), (11744135, 'REACH'), (24012072, 'REACH'), (20525046, 'REACH'), (12558500, 'REACH'), (28933025, 'REACH'), (9459262, 'REACH'), (17662132, 'REACH'), (22410417, 'REACH'), (13722000, 'REACH'), (27529373, 'REACH'), (24706894, 'REACH'), (25100281, 'REACH'), (9148202, 'REACH'), (29826277, 'REACH'), (26392982, 'REACH'), (27618707, 'REACH'), (10105888, 'REACH'), (30038875, 'REACH'), (28838924, 'REACH'), (845288, 'REACH'), (28630100, 'REACH'), (23324290, 'REACH'), (12782876, 'REACH'), (11562678, 'REACH'), (29723315, 'REACH'), (10762337, 'REACH'), (8536735, 'REACH'), (29521216, 'REACH'), (9931853, 'REACH'), (21934448, 'SPARSER'), (2714924, 'REACH'), (86313, 'REACH'), (20311340, 'REACH'), (23218722, 'REACH'), (22221756, 'REACH'), (3502419, 'REACH'), (25181316, 'REACH'), (25849607, 'REACH'), (1626280, 'REACH'), (22913812, 'REACH'), (28726269, 'REACH'), (1421742, 'REACH'), (17787704, 'REACH'), (18084286, 'REACH'), (23884222, 'REACH'), (8242248, 'REACH'), (24530044, 'REACH'), (28036220, 'REACH'), (11712945, 'SPARSER'), (17834262, 'REACH'), (13305156, 'REACH'), (13141503, 'REACH'), (3301086, 'REACH'), (19235547, 'REACH'), (17927459, 'REACH'), (25323010, 'REACH'), (22756285, 'REACH'), (1032939, 'REACH'), (22266603, 'REACH'), (29115115, 'REACH'), (606794, 'REACH'), (18666839, 'REACH'), (24650721, 'REACH'), (8604191, 'REACH'), (9805179, 'REACH'), (10034555, 'REACH'), (27715103, 'SPARSER'), (29605072, 'REACH'), (2017675, 'REACH'), (25410364, 'REACH'), (3557177, 'REACH'), (2491242, 'REACH'), (19992600, 'REACH'), (17017637, 'REACH'), (1168201, 'REACH'), (1018362, 'REACH'), (18069987, 'REACH'), (23609361, 'REACH'), (23764080, 'REACH'), (17674542, 'REACH'), (21513912, 'REACH'), (9496645, 'REACH'), (30113809, 'SPARSER'), (30468165, 'REACH'), (18773665, 'REACH'), (12002619, 'REACH'), (12883462, 'REACH'), (21825460, 'REACH'), (14891362, 'REACH'), (22034786, 'REACH'), (11447679, 'REACH'), (15348909, 'REACH'), (18658477, 'REACH'), (20440670, 'REACH'), (24098178, 'REACH'), (19369359, 'REACH'), (15668274, 'SPARSER'), (2780398, 'REACH'), (11169006, 'REACH'), (16542958, 'REACH'), (25410365, 'REACH'), (26454884, 'REACH'), (24126305, 'REACH'), (3660434, 'REACH'), (26037663, 'REACH'), (24619072, 'REACH'), (28916222, 'REACH'), (26429691, 'REACH'), (13746466, 'REACH'), (9269515, 'REACH'), (22606091, 'REACH'), (17616569, 'REACH'), (20364184, 'REACH'), (24007556, 'REACH'), (11215584, 'REACH'), (11870317, 'REACH'), (21042695, 'REACH'), (18099778, 'REACH'), (2390351, 'REACH'), (25182192, 'REACH'), (27308658, 'SPARSER'), (29718863, 'REACH'), (12009003, 'REACH'), (19807787, 'REACH'), (20472796, 'REACH'), (13215685, 'REACH'), (18145651, 'REACH'), (27696047, 'SPARSER'), (9371392, 'REACH'), (11447706, 'REACH'), (27257222, 'REACH'), (26880817, 'REACH'), (2780399, 'REACH'), (19498000, 'REACH'), (13612829, 'REACH'), (26425117, 'REACH'), (18580683, 'REACH'), (22733692, 'REACH'), (10490489, 'REACH'), (23919363, 'SPARSER'), (11484993, 'REACH'), (18079789, 'REACH'), (23122805, 'REACH'), (18275586, 'REACH'), (1811133, 'REACH'), (27796380, 'REACH'), (2718361, 'REACH'), (9803039, 'REACH'), (24689022, 'REACH'), (11169915, 'REACH'), (29276542, 'REACH'), (14900137, 'REACH'), (26658325, 'REACH'), (21495366, 'REACH'), (28355313, 'REACH'), (1859746, 'REACH'), (18496431, 'REACH'), (1634443, 'REACH'), (28340363, 'REACH'), (11587129, 'REACH'), (13330807, 'REACH'), (988351, 'REACH'), (13475660, 'REACH'), (21044451, 'REACH'), (9884718, 'REACH'), (20319659, 'REACH'), (22573066, 'REACH'), (13706263, 'REACH'), (22889059, 'SPARSER'), (23720353, 'REACH'), (24932769, 'REACH'), (18142687, 'REACH'), (13633152, 'REACH'), (27821696, 'REACH'), (24706156, 'REACH'), (29656103, 'REACH'), (23039668, 'REACH'), (507549, 'REACH'), (18923165, 'REACH'), (15563716, 'REACH'), (22781298, 'REACH'), (23147870, 'REACH'), (238092, 'REACH'), (9520455, 'REACH'), (10408532, 'REACH'), (15813591, 'REACH'), (22346501, 'REACH'), (28283712, 'REACH'), (1509571, 'REACH'), (10389699, 'REACH'), (13240515, 'REACH'), (2403339, 'REACH'), (13180755, 'REACH'), (27285984, 'REACH'), (2226203, 'REACH'), (8288283, 'REACH'), (18562764, 'REACH'), (19492103, 'REACH'), (24426152, 'REACH'), (10842214, 'REACH'), (27979878, 'REACH'), (8536340, 'REACH'), (24692464, 'REACH'), (9474557, 'REACH'), (24542940, 'REACH'), (10756825, 'REACH'), (27271897, 'REACH'), (28091097, 'REACH'), (28298949, 'REACH'), (11447670, 'REACH'), (17771894, 'REACH'), (15936175, 'SPARSER'), (22949238, 'REACH'), (18377042, 'REACH'), (24000233, 'REACH'), (23495811, 'REACH'), (8142201, 'REACH'), (8403557, 'REACH'), (24004374, 'REACH'), (13032670, 'REACH'), (11447692, 'REACH'), (30460707, 'REACH'), (12290742, 'SPARSER'), (8426928, 'REACH'), (19862960, 'REACH'), (28588267, 'REACH'), (17527639, 'REACH'), (2639923, 'REACH'), (88545, 'REACH'), (8834752, 'REACH'), (1695870, 'REACH'), (30132488, 'REACH'), (8536341, 'REACH'), (2718022, 'REACH'), (23796209, 'REACH'), (18159279, 'REACH'), (22321035, 'REACH'), (9856313, 'REACH'), (12263786, 'REACH'), (12628087, 'REACH'), (25669751, 'REACH'), (29418809, 'REACH'), (28544513, 'REACH'), (20225983, 'REACH'), (22464076, 'REACH'), (3168250, 'REACH'), (11556858, 'REACH'), (19148774, 'REACH'), (24068244, 'REACH'), (15340144, 'REACH'), (10696261, 'REACH'), (9747876, 'REACH'), (2457984, 'REACH'), (21648236, 'REACH'), (13230697, 'REACH'), (27923482, 'REACH'), (28290855, 'REACH'), (113877, 'REACH'), (236980, 'REACH'), (18226612, 'REACH'), (21297808, 'REACH'), (18532430, 'REACH'), (26966071, 'REACH'), (13666963, 'REACH'), (9459137, 'REACH'), (18372033, 'REACH'), (25907885, 'REACH'), (994572, 'REACH'), (26520844, 'REACH'), (21485885, 'REACH'), (28402414, 'REACH'), (27054361, 'REACH'), (24036298, 'REACH'), (15024481, 'REACH'), (29635523, 'REACH'), (28276340, 'REACH'), (3640912, 'REACH'), (23300443, 'SPARSER'), (23382798, 'REACH'), (22712311, 'REACH'), (23766637, 'REACH'), (13640905, 'REACH'), (10934138, 'REACH'), (14866298, 'REACH'), (2814376, 'REACH'), (24932776, 'REACH'), (19353446, 'REACH'), (27050385, 'REACH'), (27016688, 'REACH'), (28683517, 'REACH'), (28375516, 'REACH'), (20550774, 'REACH'), (13404019, 'REACH'), (20548690, 'REACH'), (18621338, 'REACH'), (2718375, 'REACH'), (14866310, 'REACH'), (21833012, 'REACH'), (12618479, 'REACH'), (11465193, 'SPARSER'), (9153880, 'REACH'), (28975684, 'REACH'), (13798957, 'REACH'), (26316937, 'REACH'), (18235962, 'REACH'), (913955, 'REACH'), (4229332, 'REACH'), (22034001, 'REACH'), (25397460, 'REACH'), (26970734, 'REACH'), (17613212, 'REACH'), (11841111, 'REACH'), (23908741, 'REACH'), (13643571, 'REACH'), (18716877, 'REACH'), (25323390, 'REACH'), (13833851, 'REACH'), (22976123, 'REACH'), (10099113, 'REACH'), (18160041, 'REACH'), (11097158, 'REACH'), (22113954, 'REACH'), (23424674, 'REACH'), (21989840, 'REACH'), (14866295, 'REACH'), (12448004, 'REACH'), (17382496, 'REACH'), (23870560, 'REACH'), (27083245, 'REACH'), (14866311, 'REACH'), (28382950, 'REACH'), (24774351, 'REACH'), (25037739, 'REACH'), (27947763, 'REACH'), (21914788, 'REACH'), (19369938, 'REACH'), (9215104, 'REACH'), (13814334, 'REACH'), (19024446, 'REACH'), (162412, 'REACH'), (25611034, 'REACH'), (2827444, 'REACH'), (14885910, 'SPARSER'), (17437689, 'REACH'), (18988438, 'REACH'), (8610195, 'REACH'), (11231635, 'REACH'), (20790678, 'REACH'), (11254642, 'REACH'), (3590783, 'REACH'), (9386068, 'SPARSER'), (28916594, 'REACH'), (25575436, 'REACH'), (12608327, 'REACH'), (86100, 'REACH'), (24050158, 'REACH'), (8929564, 'REACH'), (10706634, 'REACH'), (13396439, 'REACH'), (17330437, 'REACH'), (1427776, 'REACH'), (16795968, 'REACH'), (22811269, 'SPARSER'), (27319176, 'REACH'), (18063302, 'REACH'), (23367363, 'REACH'), (23830470, 'REACH'), (19922033, 'REACH'), (11450671, 'REACH'), (17107280, 'REACH'), (23218699, 'REACH'), (15243196, 'REACH'), (8351673, 'REACH'), (15415930, 'SPARSER'), (10907780, 'REACH'), (22474884, 'REACH'), (24170034, 'REACH'), (24454273, 'REACH'), (9526811, 'REACH'), (21609676, 'REACH'), (19181513, 'REACH'), (26324149, 'REACH'), (9485122, 'REACH'), (2431193, 'REACH'), (27760857, 'REACH'), (25259832, 'REACH'), (29610020, 'REACH'), (22265869, 'REACH'), (9916859, 'REACH'), (17630631, 'REACH'), (30136392, 'REACH'), (24102961, 'REACH'), (3493323, 'REACH'), (4325500, 'REACH'), (19192697, 'REACH'), (11250346, 'REACH'), (23265404, 'REACH'), (17184649, 'REACH'), (24248476, 'SPARSER'), (11878760, 'REACH'), (13299829, 'REACH'), (15024488, 'REACH'), (25018728, 'REACH'), (667151, 'REACH'), (15014809, 'REACH'), (16807928, 'REACH'), (19311749, 'REACH'), (12361270, 'REACH'), (12535592, 'SPARSER'), (29201971, 'REACH'), (11379904, 'REACH'), (755884, 'REACH'), (16156844, 'REACH'), (233237, 'REACH'), (18589681, 'REACH'), (8795311, 'REACH'), (10859695, 'REACH'), (2007438, 'REACH'), (28000060, 'REACH'), (11656823, 'REACH'), (20255768, 'REACH'), (28290853, 'REACH'), (9884712, 'REACH'), (24126950, 'REACH'), (30098114, 'REACH'), (18764530, 'SPARSER'), (17298091, 'REACH'), (16599798, 'REACH'), (19070451, 'REACH'), (21846948, 'REACH'), (17556178, 'REACH'), (9403103, 'REACH'), (22346463, 'REACH'), (22947712, 'REACH'), (18199066, 'REACH'), (26522138, 'REACH'), (230344, 'REACH'), (28318644, 'REACH'), (15668145, 'REACH'), (10907792, 'REACH'), (17002640, 'REACH'), (17368, 'REACH'), (21394173, 'SPARSER'), (24405792, 'REACH'), (9176667, 'REACH'), (21585479, 'REACH'), (18099571, 'SPARSER'), (12398420, 'REACH'), (23406978, 'REACH'), (2836075, 'REACH'), (3262059, 'REACH'), (13837340, 'REACH'), (20913810, 'REACH'), (10486175, 'REACH'), (334298, 'REACH'), (10099162, 'REACH'), (19716757, 'REACH'), (12563572, 'REACH'), (15172898, 'REACH'), (27571247, 'REACH'), (22457424, 'REACH'), (24592654, 'REACH'), (1370983, 'SPARSER'), (14866308, 'REACH'), (2036609, 'REACH'), (12377407, 'REACH'), (17620287, 'REACH'), (9823341, 'REACH'), (26057653, 'REACH'), (29740390, 'REACH'), (13550553, 'REACH'), (1722600, 'SPARSER'), (430625, 'REACH'), (27058770, 'REACH'), (12496262, 'REACH'), (16063284, 'REACH'), (12476655, 'REACH'), (20224203, 'REACH'), (25967031, 'REACH'), (11646821, 'REACH'), (1188315, 'REACH'), (11073236, 'REACH'), (8425730, 'REACH'), (2440463, 'REACH'), (8810160, 'REACH'), (1697469, 'REACH'), (18571374, 'REACH'), (18968240, 'REACH'), (19031741, 'REACH'), (24444850, 'SPARSER'), (19352663, 'REACH'), (28649759, 'REACH'), (2027456, 'REACH'), (9829758, 'REACH'), (29740391, 'REACH'), (21914947, 'REACH'), (15963423, 'SPARSER'), (19836880, 'REACH'), (12522461, 'REACH'), (24296042, 'REACH'), (13831543, 'REACH'), (10754597, 'REACH'), (14948901, 'REACH'), (19551048, 'SPARSER'), (24779521, 'REACH'), (10408544, 'REACH'), (1168204, 'REACH'), (606793, 'REACH'), (23053109, 'REACH'), (3919078, 'REACH'), (21082339, 'REACH'), (25218104, 'SPARSER'), (28179663, 'REACH'), (2105771, 'REACH'), (1993561, 'REACH'), (22506329, 'REACH'), (17987607, 'REACH'), (25920325, 'REACH'), (88566, 'REACH'), (18473775, 'SPARSER'), (24284009, 'REACH'), (30575465, 'REACH'), (1030183, 'REACH'), (24376582, 'REACH'), (23400707, 'REACH'), (27188335, 'REACH'), (8783378, 'SPARSER'), (19902969, 'REACH'), (23763255, 'REACH'), (22523424, 'REACH'), (24653741, 'REACH'), (20392286, 'REACH'), (204123, 'REACH'), (16805424, 'REACH'), (12440125, 'REACH'), (27983854, 'REACH'), (482506, 'REACH'), (15944883, 'REACH'), (2513505, 'REACH'), (18462528, 'REACH'), (18576838, 'REACH'), (10900924, 'REACH'), (22470112, 'REACH'), (20067430, 'REACH'), (23627028, 'REACH'), (3660433, 'REACH'), (9615682, 'REACH'), (26355791, 'REACH'), (29005309, 'REACH'), (21866201, 'REACH'), (18736010, 'REACH'), (1756685, 'REACH'), (21227080, 'REACH'), (13440784, 'REACH'), (16800534, 'REACH'), (22941459, 'REACH'), (1315038, 'REACH'), (9277662, 'REACH'), (13263244, 'REACH'), (30007495, 'REACH'), (8127956, 'REACH'), (28383234, 'REACH'), (22561807, 'REACH'), (28871088, 'REACH'), (26051710, 'REACH'), (23781243, 'REACH'), (17370179, 'REACH'), (28933026, 'REACH'), (22271696, 'REACH'), (760541, 'REACH'), (13838222, 'REACH'), (23861981, 'REACH'), (23123260, 'REACH'), (17799481, 'REACH'), (13944170, 'REACH'), (24648413, 'REACH'), (15127064, 'REACH'), (13153215, 'REACH'), (9525836, 'REACH'), (12664373, 'REACH'), (22221775, 'REACH'), (10696304, 'REACH'), (21116528, 'REACH'), (13612823, 'REACH'), (28801208, 'REACH'), (16124485, 'REACH'), (28412485, 'REACH'), (24932772, 'REACH'), (12300724, 'REACH'), (28871089, 'REACH'), (736912, 'REACH'), (19860558, 'REACH'), (20548686, 'REACH'), (18404145, 'SPARSER'), (29013654, 'REACH'), (12062814, 'REACH'), (10153704, 'REACH'), (17329896, 'REACH'), (4205908, 'REACH'), (9271170, 'REACH'), (10805406, 'SPARSER'), (22679455, 'REACH'), (9386091, 'SPARSER'), (11654142, 'REACH'), (19655419, 'REACH'), (11169941, 'REACH'), (12745506, 'REACH'), (27570735, 'REACH'), (13009488, 'REACH'), (13015645, 'REACH'), (24091229, 'REACH'), (27818404, 'SPARSER'), (30294880, 'SPARSER'), (10326250, 'REACH'), (9843073, 'REACH'), (13873537, 'REACH'), (12899135, 'REACH'), (2098400, 'REACH'), (24435506, 'REACH'), (1030174, 'REACH'), (17017627, 'REACH'), (13252809, 'REACH'), (516966, 'REACH'), (11982691, 'REACH'), (2322452, 'REACH'), (11989012, 'REACH'), (11146063, 'REACH'), (16325491, 'REACH'), (20230400, 'REACH'), (1024489, 'REACH'), (13533512, 'REACH'), (13285684, 'REACH'), (25038477, 'SPARSER'), (25726703, 'REACH'), (4180253, 'REACH'), (17159289, 'REACH'), (15668138, 'REACH'), (4162720, 'REACH'), (22446637, 'REACH'), (249822, 'REACH'), (9193435, 'REACH'), (19254645, 'REACH'), (24405226, 'SPARSER'), (19478051, 'REACH'), (21473873, 'REACH'), (24122521, 'REACH'), (24548505, 'REACH'), (26407754, 'REACH'), (27784010, 'REACH'), (333189, 'REACH'), (24778117, 'REACH'), (10744033, 'REACH'), (19015514, 'REACH'), (24811541, 'REACH'), (30468166, 'REACH'), (28910242, 'REACH'), (18142639, 'REACH'), (26432943, 'REACH'), (29500066, 'REACH'), (4270967, 'REACH'), (27831159, 'REACH'), (1030181, 'REACH'), (12466213, 'REACH'), (23039679, 'REACH'), (23419806, 'REACH'), (24821833, 'REACH'), (16606146, 'REACH'), (277199, 'REACH'), (8474158, 'REACH'), (26601820, 'REACH'), (29942105, 'REACH'), (21847575, 'REACH'), (10813210, 'SPARSER'), (29030725, 'REACH'), (10302369, 'REACH'), (11744161, 'REACH'), (17982605, 'REACH'), (27550861, 'REACH'), (1609498, 'REACH'), (12008999, 'REACH'), (2635956, 'REACH'), (10696290, 'REACH'), (20199010, 'REACH'), (23676491, 'REACH'), (13640956, 'REACH'), (3295031, 'REACH'), (21623190, 'REACH'), (2270611, 'REACH'), (24932758, 'REACH'), (13862317, 'REACH'), (70491, 'REACH'), (15541875, 'SPARSER'), (1970027, 'REACH'), (966776, 'REACH'), (25040133, 'REACH'), (25129057, 'REACH'), (13383163, 'REACH'), (12601641, 'REACH'), (15668166, 'REACH'), (25669745, 'REACH'), (74274, 'REACH'), (1277231, 'REACH'), (14950946, 'REACH'), (17947150, 'REACH'), (23673834, 'REACH'), (13511415, 'REACH'), (10946134, 'REACH'), (2159748, 'REACH'), (23436098, 'SPARSER'), (24371998, 'REACH'), (1446427, 'REACH'), (910281, 'REACH'), (1984680, 'REACH'), (523028, 'REACH'), (22771857, 'REACH'), (12566338, 'REACH'), (21002480, 'REACH'), (16011051, 'REACH'), (12333276, 'REACH'), (27767004, 'REACH'), (8389002, 'REACH'), (29416665, 'REACH'), (23012152, 'REACH'), (29767680, 'REACH'), (9800126, 'REACH'), (8189371, 'REACH'), (18576827, 'REACH'), (26167529, 'REACH'), (17612419, 'REACH'), (25911348, 'REACH'), (18574385, 'REACH'), (24876304, 'REACH'), (25166972, 'REACH'), (18931577, 'REACH'), (27053738, 'REACH'), (11082006, 'REACH'), (2378817, 'REACH'), (3607433, 'REACH'), (13133511, 'REACH'), (26109219, 'REACH'), (10135817, 'SPARSER'), (3281462, 'REACH'), (19458611, 'REACH'), (30037988, 'REACH'), (20347072, 'REACH'), (78797, 'REACH'), (28398971, 'REACH'), (9456812, 'REACH'), (1984681, 'REACH'), (16389047, 'SPARSER'), (2311783, 'REACH'), (22980783, 'REACH'), (893927, 'SPARSER'), (15528764, 'REACH'), (28841973, 'SPARSER'), (20451959, 'REACH'), (30137194, 'REACH'), (29767681, 'REACH'), (13462962, 'REACH'), (18221503, 'REACH'), (25790911, 'REACH'), (25321118, 'REACH'), (2671003, 'REACH'), (17613211, 'REACH'), (27807367, 'REACH'), (157736, 'REACH'), (20667445, 'REACH'), (14942868, 'REACH'), (13911746, 'REACH'), (8940795, 'SPARSER'), (29152368, 'REACH'), (28035374, 'REACH'), (3518556, 'REACH'), (10223882, 'REACH'), (18496384, 'REACH'), (19938176, 'REACH'), (17664318, 'REACH'), (19201339, 'REACH'), (25461865, 'REACH'), (25671194, 'REACH'), (4249895, 'REACH'), (11324934, 'REACH'), (28782493, 'REACH'), (13098745, 'REACH'), (3281463, 'REACH'), (14783031, 'REACH'), (2182291, 'REACH'), (22559520, 'REACH'), (13892794, 'REACH'), (1528391, 'REACH'), (9192680, 'REACH'), (303093, 'REACH'), (368629, 'REACH'), (22368839, 'REACH'), (12971394, 'REACH'), (27223439, 'REACH'), (1103664, 'REACH'), (2487101, 'REACH'), (13640942, 'REACH'), (25611033, 'REACH'), (10799109, 'REACH'), (21518771, 'REACH'), (516964, 'REACH'), (28832541, 'SPARSER'), (2228711, 'REACH'), (20185575, 'REACH'), (27723892, 'REACH'), (10985552, 'REACH'), (86099, 'REACH'), (11225988, 'REACH'), (22346464, 'REACH'), (21573580, 'REACH'), (11794606, 'SPARSER'), (25546247, 'REACH'), (11744168, 'REACH'), (12428462, 'REACH'), (23830469, 'REACH'), (29710707, 'REACH'), (9936676, 'REACH'), (1465941, 'REACH'), (4351638, 'SPARSER'), (27731183, 'REACH'), (306638, 'REACH'), (16891083, 'REACH'), (10062693, 'REACH'), (21124118, 'REACH'), (8536736, 'REACH'), (1030189, 'REACH'), (288985, 'SPARSER'), (25588361, 'REACH'), (25669736, 'REACH'), (2182005, 'REACH'), (26757844, 'REACH'), (10985553, 'REACH'), (26182320, 'REACH'), (10911831, 'REACH'), (13929188, 'REACH'), (12171981, 'REACH'), (1817516, 'REACH'), (10696262, 'REACH'), (29115121, 'REACH'), (4225596, 'REACH'), (25779818, 'REACH'), (8175991, 'REACH'), (2469656, 'REACH'), (15024503, 'REACH'), (1097942, 'REACH'), (21470163, 'REACH'), (3210221, 'REACH'), (23251099, 'REACH'), (1769702, 'REACH'), (2785510, 'REACH'), (23441615, 'REACH'), (14961710, 'REACH'), (20649820, 'REACH'), (17395545, 'REACH'), (11151777, 'REACH'), (13309036, 'REACH'), (20550764, 'REACH'), (21849370, 'REACH'), (9452583, 'REACH'), (17120295, 'REACH'), (11832789, 'REACH'), (29312692, 'REACH'), (29750370, 'REACH'), (12062831, 'REACH'), (28246889, 'SPARSER'), (408316, 'REACH'), (21833002, 'REACH'), (13877792, 'REACH'), (16564768, 'REACH'), (27149229, 'REACH'), (29007175, 'REACH'), (12424322, 'REACH'), (1270320, 'REACH'), (15685181, 'REACH'), (17556016, 'REACH'), (2065180, 'REACH'), (3608778, 'REACH'), (17007575, 'REACH'), (22462298, 'SPARSER'), (1317023, 'REACH'), (22386847, 'REACH'), (13707495, 'REACH'), (25779825, 'REACH'), (26725200, 'REACH'), (20649821, 'REACH'), (22847929, 'REACH'), (9337253, 'REACH'), (11427457, 'REACH'), (23794144, 'REACH'), (2363419, 'REACH'), (22271692, 'REACH'), (28779783, 'REACH'), (28976391, 'REACH'), (18810982, 'REACH'), (27723878, 'REACH'), (11548948, 'REACH'), (16660756, 'REACH'), (20913809, 'REACH'), (27618383, 'REACH'), (11774461, 'REACH'), (22998958, 'REACH'), (2714923, 'REACH'), (12315947, 'REACH'), (485258, 'REACH'), (25034647, 'REACH'), (22221755, 'REACH'), (19218343, 'REACH'), (2663558, 'REACH'), (12666420, 'REACH'), (19416628, 'REACH'), (9640943, 'REACH'), (18465404, 'REACH'), (16116906, 'REACH'), (22544150, 'REACH'), (11782721, 'REACH'), (11146042, 'REACH'), (13846566, 'REACH'), (27413329, 'REACH'), (10704911, 'REACH'), (13831600, 'REACH'), (8858045, 'REACH'), (12018332, 'REACH'), (23794145, 'REACH'), (24545554, 'REACH'), (18609908, 'SPARSER'), (18804642, 'SPARSER'), (1284222, 'REACH'), (1842615, 'SPARSER'), (8835398, 'REACH'), (13098717, 'REACH'), (12200252, 'REACH'), (13081913, 'REACH'), (11859903, 'REACH'), (2663559, 'REACH'), (2430504, 'REACH'), (28698598, 'REACH'), (557027, 'REACH'), (25414256, 'REACH'), (29033853, 'REACH'), (24964267, 'REACH'), (28539481, 'REACH'), (15679475, 'REACH'), (25051123, 'REACH'), (1117345, 'REACH'), (13769938, 'REACH'), (562399, 'REACH'), (17013970, 'REACH'), (23462457, 'SPARSER'), (11539259, 'REACH'), (20747067, 'REACH'), (10974421, 'REACH'), (10462214, 'REACH'), (3702626, 'REACH'), (27892591, 'REACH'), (25362510, 'REACH'), (23764217, 'REACH'), (2812970, 'REACH'), (22618597, 'REACH'), (8354500, 'REACH'), (27163332, 'REACH'), (13374558, 'REACH'), (21251793, 'REACH'), (3607426, 'REACH'), (22119311, 'REACH'), (10262635, 'REACH'), (11886108, 'REACH'), (30480491, 'REACH'), (9425846, 'REACH'), (19747766, 'REACH'), (702817, 'REACH'), (2164882, 'REACH'), (22034785, 'REACH'), (22382144, 'REACH'), (22156841, 'REACH'), (12658824, 'REACH'), (25588885, 'REACH'), (25779805, 'REACH'), (27729081, 'REACH'), (21509354, 'REACH'), (20865189, 'REACH'), (24422230, 'REACH'), (16449107, 'REACH'), (28616534, 'REACH'), (30156630, 'REACH'), (15073074, 'REACH'), (29818674, 'REACH'), (4202093, 'REACH'), (22441755, 'REACH'), (3207034, 'REACH'), (26454883, 'REACH'), (20505666, 'REACH'), (25584706, 'REACH'), (10192345, 'REACH'), (18493066, 'REACH'), (27933752, 'REACH'), (16564083, 'REACH'), (11574564, 'REACH'), (20242152, 'SPARSER'), (448190, 'REACH'), (22271678, 'REACH'), (29771080, 'REACH'), (11215599, 'REACH'), (9886411, 'REACH'), (790908, 'REACH'), (23799929, 'REACH'), (19989247, 'REACH'), (25700489, 'REACH'), (11999802, 'REACH'), (30605550, 'SPARSER'), (16290598, 'REACH'), (20209876, 'REACH'), (24243793, 'REACH'), (21096837, 'REACH'), (22037279, 'REACH'), (22466765, 'REACH'), (3616379, 'REACH'), (28498348, 'REACH'), (10627080, 'REACH'), (29355078, 'REACH'), (3135729, 'REACH'), (24866679, 'REACH'), (26889942, 'REACH'), (3533060, 'REACH'), (12694785, 'REACH'), (29590036, 'SPARSER'), (12385589, 'REACH'), (27410990, 'REACH'), (2428252, 'REACH'), (22935050, 'REACH'), (2574264, 'REACH'), (15014902, 'REACH'), (28187638, 'REACH'), (17987725, 'REACH'), (13739369, 'REACH'), (23515687, 'REACH'), (3305222, 'REACH'), (13849347, 'REACH'), (12844212, 'REACH'), (22658561, 'SPARSER'), (17910941, 'REACH'), (12036942, 'REACH'), (17976477, 'REACH'), (30582915, 'SPARSER'), (27825558, 'REACH'), (26396296, 'SPARSER'), (23912641, 'REACH'), (12227442, 'REACH'), (8870146, 'SPARSER'), (24175057, 'REACH'), (2378813, 'REACH'), (17904110, 'REACH'), (3533061, 'REACH'), (3516516, 'REACH'), (29750369, 'REACH'), (13660050, 'REACH'), (22271706, 'REACH'), (2336451, 'REACH'), (29033844, 'REACH'), (21691918, 'REACH'), (2574265, 'REACH'), (3624088, 'REACH'), (27089494, 'REACH'), (20765825, 'REACH'), (2193376, 'REACH'), (16443166, 'REACH'), (21042715, 'REACH'), (10974412, 'REACH'), (17921454, 'SPARSER'), (1401466, 'REACH'), (24405790, 'REACH'), (27756489, 'REACH'), (29638565, 'SPARSER'), (1168194, 'REACH'), (28201794, 'REACH'), (1085437, 'REACH'), (23891965, 'REACH'), (13452075, 'REACH'), (15611100, 'REACH'), (17544412, 'REACH'), (28241326, 'REACH'), (28870026, 'REACH'), (19671893, 'REACH'), (17783430, 'REACH'), (381571, 'REACH'), (25068596, 'REACH'), (26335878, 'REACH'), (17553437, 'REACH'), (16337614, 'REACH'), (11427905, 'REACH'), (17485554, 'REACH'), (18992882, 'REACH'), (21623295, 'REACH'), (11657517, 'REACH'), (30625522, 'REACH'), (28384140, 'REACH'), (24070300, 'SPARSER'), (13203816, 'REACH'), (24541544, 'REACH'), (12613158, 'REACH'), (28750338, 'REACH'), (13788687, 'REACH'), (11779819, 'REACH'), (13778667, 'REACH'), (10241157, 'REACH'), (1347123, 'REACH'), (12553779, 'REACH'), (19966948, 'REACH'), (2401918, 'REACH'), (12913833, 'REACH'), (26324143, 'REACH'), (17544413, 'REACH'), (20317579, 'REACH'), (24982329, 'REACH'), (26403844, 'REACH'), (17855677, 'SPARSER'), (23699890, 'REACH'), (29279738, 'REACH'), (23240166, 'REACH'), (12315950, 'REACH'), (20311342, 'REACH'), (20999470, 'REACH'), (20546826, 'REACH'), (23274565, 'REACH'), (153075, 'REACH'), (29500065, 'REACH'), (12575084, 'REACH'), (23509097, 'REACH'), (20278787, 'REACH'), (26356657, 'REACH'), (26219874, 'REACH'), (18506748, 'REACH'), (27550716, 'REACH'), (24622647, 'REACH'), (1108929, 'REACH'), (24374209, 'REACH'), (25786751, 'REACH'), (25568012, 'REACH'), (12963593, 'REACH'), (4239546, 'REACH'), (2332231, 'REACH'), (26880816, 'REACH'), (1816814, 'REACH'), (28588270, 'REACH'), (15598656, 'REACH'), (29005310, 'REACH'), (27807368, 'REACH'), (13689283, 'REACH'), (1277809, 'REACH'), (16178466, 'REACH'), (25484578, 'REACH'), (25591665, 'REACH'), (15169806, 'REACH'), (994571, 'REACH'), (11494742, 'REACH'), (22910035, 'REACH'), (18714500, 'REACH'), (30151999, 'REACH'), (15127070, 'REACH'), (8354505, 'REACH'), (573959, 'REACH'), (1099665, 'REACH'), (2333250, 'REACH'), (22198840, 'REACH'), (15668165, 'REACH'), (9525842, 'REACH'), (12062303, 'REACH'), (12344297, 'REACH'), (24337385, 'REACH'), (30217345, 'SPARSER'), (28588271, 'REACH'), (13193232, 'REACH'), (28467068, 'REACH'), (10545985, 'REACH'), (17135871, 'REACH'), (24961502, 'REACH'), (10399802, 'REACH'), (17674534, 'REACH'), (22360358, 'REACH'), (18483458, 'REACH'), (20522071, 'REACH'), (18714501, 'REACH'), (11574579, 'REACH'), (23406120, 'SPARSER'), (16771809, 'REACH'), (28122419, 'REACH'), (13754061, 'REACH'), (26449591, 'SPARSER'), (23836585, 'REACH'), (20370200, 'SPARSER'), (3842262, 'SPARSER'), (20765858, 'REACH'), (26633947, 'SPARSER'), (19246045, 'REACH'), (2272395, 'REACH'), (27042584, 'REACH'), (1626661, 'REACH'), (24911026, 'REACH'), (9748461, 'REACH'), (19939309, 'REACH'), (25182189, 'REACH'), (24967753, 'REACH'), (14932218, 'REACH'), (27080488, 'REACH'), (11076838, 'REACH'), (21992852, 'REACH'), (1081390, 'REACH'), (26299402, 'REACH'), (27881974, 'REACH'), (19774116, 'REACH'), (25996705, 'REACH'), (3917266, 'REACH'), (9232863, 'REACH'), (9618898, 'REACH'), (24961503, 'REACH'), (27795085, 'REACH'), (16245609, 'REACH'), (12009941, 'REACH'), (21861487, 'REACH'), (17820153, 'REACH'), (4289068, 'SPARSER'), (9232275, 'REACH'), (4325503, 'REACH'), (12620875, 'SPARSER'), (12666400, 'REACH'), (22955552, 'REACH'), (28170329, 'SPARSER'), (11168934, 'REACH'), (12853155, 'REACH'), (8261204, 'REACH'), (12658818, 'REACH'), (23382589, 'REACH'), (12064750, 'REACH'), (22034795, 'REACH'), (2089592, 'REACH'), (13168822, 'REACH'), (13640883, 'REACH'), (22127795, 'REACH'), (18635935, 'REACH'), (20765855, 'REACH'), (13598285, 'REACH'), (12868862, 'REACH'), (8348457, 'REACH'), (1019334, 'REACH'), (12455366, 'REACH'), (27882097, 'REACH'), (13937501, 'REACH'), (3258379, 'REACH'), (12578236, 'REACH'), (17778787, 'REACH'), (23903508, 'REACH'), (27843269, 'REACH'), (2430500, 'REACH'), (22681124, 'REACH'), (11569503, 'REACH'), (26104320, 'REACH'), (21492647, 'REACH'), (30523733, 'REACH'), (30636166, 'REACH'), (24170033, 'REACH'), (25182191, 'REACH'), (13223548, 'REACH'), (19777148, 'REACH'), (26324151, 'REACH'), (13213272, 'REACH'), (13407845, 'REACH'), (13288690, 'REACH'), (10998731, 'SPARSER'), (17647405, 'REACH'), (11286727, 'REACH'), (21097510, 'REACH'), (28217169, 'REACH'), (24928110, 'REACH'), (11751833, 'REACH'), (12571033, 'REACH'), (29234250, 'REACH'), (18220083, 'REACH'), (29419180, 'REACH'), (13640968, 'REACH'), (1791302, 'REACH'), (11543284, 'REACH'), (17998580, 'REACH'), (24499697, 'REACH'), (2278063, 'REACH'), (28472029, 'REACH'), (24485774, 'REACH'), (18873637, 'REACH'), (1989590, 'REACH'), (26757843, 'REACH'), (8550913, 'REACH'), (15340896, 'REACH'), (26900021, 'REACH'), (8919421, 'REACH'), (25682091, 'REACH'), (24125017, 'REACH'), (1970028, 'REACH'), (25300844, 'REACH'), (630810, 'REACH'), (16982042, 'REACH'), (17430534, 'REACH'), (20890033, 'REACH'), (12395598, 'REACH'), (88572, 'REACH'), (889081, 'REACH'), (23400697, 'REACH'), (23424662, 'REACH'), (19557490, 'REACH'), (2202715, 'REACH'), (18946316, 'REACH'), (28316743, 'REACH'), (11494740, 'REACH'), (8354513, 'REACH'), (9075409, 'REACH'), (13838223, 'REACH'), (24556861, 'REACH'), (28826731, 'REACH'), (30007242, 'REACH'), (19735908, 'REACH'), (19348833, 'REACH'), (17680287, 'REACH'), (10205760, 'REACH'), (783693, 'REACH'), (849229, 'REACH'), (18465531, 'REACH'), (25333292, 'REACH'), (27608991, 'REACH'), (27520136, 'REACH'), (27062211, 'REACH'), (9525840, 'REACH'), (10408541, 'REACH'), (11296091, 'SPARSER'), (13157131, 'REACH'), (26167530, 'REACH'), (29784918, 'REACH'), (16118578, 'REACH'), (21492530, 'REACH'), (29684530, 'REACH'), (25825901, 'REACH'), (8348443, 'REACH'), (18694604, 'REACH'), (23356187, 'REACH'), (30055056, 'SPARSER'), (13565959, 'REACH'), (24351157, 'REACH'), (29834086, 'REACH'), (3258434, 'REACH'), (29419182, 'REACH'), (23234603, 'REACH'), (17585628, 'REACH'), (334297, 'REACH'), (24499676, 'REACH'), (9279127, 'REACH'), (13193272, 'REACH'), (29132843, 'REACH'), (4405992, 'SPARSER'), (27379968, 'REACH'), (19559865, 'SPARSER'), (397036, 'REACH'), (24485786, 'REACH'), (11978702, 'REACH'), (10934199, 'REACH'), (22455653, 'REACH'), (17057457, 'SPARSER'), (28737092, 'REACH'), (28188635, 'REACH'), (27288788, 'REACH'), (12856568, 'REACH'), (11447685, 'REACH'), (1103670, 'REACH'), (402660, 'REACH'), (17052134, 'SPARSER'), (21902206, 'REACH'), (1275305, 'REACH'), (24603656, 'REACH'), (2659388, 'REACH'), (16730218, 'REACH'), (22610646, 'REACH'), (10759428, 'REACH'), (12372225, 'REACH'), (16533761, 'REACH'), (14691860, 'SPARSER'), (3926112, 'REACH'), (22030015, 'REACH'), (28033356, 'REACH'), (29417210, 'REACH'), (20665640, 'REACH'), (16748853, 'REACH'), (23418152, 'REACH'), (29115110, 'REACH'), (24007572, 'REACH'), (24545553, 'REACH'), (15200975, 'REACH'), (21315709, 'REACH'), (22479196, 'REACH'), (477312, 'REACH'), (2094700, 'REACH'), (8348422, 'REACH'), (20279476, 'REACH'), (18228401, 'REACH'), (20060376, 'REACH'), (16738710, 'REACH'), (29994436, 'REACH'), (27747521, 'REACH'), (30106656, 'REACH'), (25880686, 'SPARSER'), (30007111, 'REACH'), (29606566, 'REACH'), (14787632, 'REACH'), (2276636, 'REACH'), (4229834, 'REACH'), (28263895, 'REACH'), (1928292, 'REACH'), (3926113, 'REACH'), (15610527, 'REACH'), (29115111, 'REACH'), (23251910, 'REACH'), (8354499, 'REACH'), (29710708, 'REACH'), (16730225, 'REACH'), (11434530, 'REACH'), (2483536, 'REACH'), (22043577, 'REACH'), (15004650, 'REACH'), (8348407, 'REACH'), (16118762, 'REACH'), (1938341, 'REACH'), (11637669, 'REACH'), (3596627, 'REACH'), (29942099, 'REACH'), (19164735, 'REACH'), (18070302, 'REACH'), (29801246, 'REACH'), (15001804, 'REACH'), (26844105, 'REACH'), (30515814, 'REACH'), (13652756, 'REACH'), (29053073, 'REACH'), (9350735, 'REACH'), (21117322, 'REACH'), (22796485, 'REACH'), (8359936, 'REACH'), (23510029, 'REACH'), (15524286, 'REACH'), (24645051, 'REACH'), (1553480, 'REACH'), (23058051, 'REACH'), (29742723, 'REACH'), (9071074, 'REACH'), (20524304, 'REACH'), (13139068, 'REACH'), (10499961, 'REACH'), (1928293, 'REACH'), (19091734, 'REACH'), (2356548, 'REACH'), (29115122, 'REACH'), (15295789, 'REACH'), (25005790, 'REACH'), (29560542, 'REACH'), (2342796, 'REACH'), (19021708, 'REACH'), (15154536, 'REACH'), (4205905, 'REACH'), (27864401, 'REACH'), (13539855, 'REACH'), (13944151, 'REACH'), (18105687, 'REACH'), (28317829, 'REACH'), (22913810, 'REACH'), (24697470, 'REACH'), (13192571, 'REACH'), (15066284, 'REACH'), (17662121, 'REACH'), (29323866, 'REACH'), (12361319, 'REACH'), (22299400, 'REACH'), (18940483, 'REACH'), (3609585, 'REACH'), (24417265, 'REACH'), (20179772, 'REACH'), (26163001, 'REACH'), (11364563, 'REACH'), (28383236, 'REACH'), (28774401, 'REACH'), (82761, 'REACH'), (29261864, 'REACH'), (9071075, 'REACH'), (20539875, 'REACH'), (13672911, 'REACH'), (23822153, 'SPARSER'), (1093291, 'REACH'), (30136389, 'REACH'), (17213174, 'REACH'), (4270579, 'REACH'), (21651154, 'REACH'), (22271711, 'REACH'), (13838221, 'REACH'), (21331912, 'REACH'), (25822726, 'REACH'), (2228739, 'REACH'), (2425347, 'REACH'), (9667075, 'REACH'), (10211249, 'REACH'), (23200259, 'REACH'), (8858768, 'REACH'), (25264643, 'REACH'), (29413297, 'REACH'), (13097957, 'REACH'), (13425637, 'REACH'), (12496833, 'REACH'), (12927602, 'REACH'), (11975912, 'REACH'), (22870005, 'REACH'), (2330022, 'REACH'), (9159843, 'REACH'), (8875824, 'REACH'), (21581015, 'REACH'), (773558, 'REACH'), (25254756, 'REACH'), (2640530, 'REACH'), (20472876, 'REACH'), (27968136, 'REACH'), (15799153, 'REACH'), (18997295, 'REACH'), (21585967, 'REACH'), (18263786, 'REACH'), (9902757, 'REACH'), (11874177, 'REACH'), (21615328, 'REACH'), (8605805, 'REACH'), (15071157, 'REACH'), (22034790, 'REACH'), (22493542, 'REACH'), (26552655, 'REACH'), (11107896, 'REACH'), (3561413, 'REACH'), (13537651, 'REACH'), (10762020, 'REACH'), (8769057, 'REACH'), (1465938, 'REACH'), (17550881, 'REACH'), (2240256, 'REACH'), (19443456, 'REACH'), (24555264, 'REACH'), (12367035, 'REACH'), (24489196, 'REACH'), (25779794, 'REACH'), (29157566, 'REACH'), (29989254, 'REACH'), (3282740, 'REACH'), (24435505, 'REACH'), (9192674, 'REACH'), (26952930, 'REACH'), (24405789, 'REACH'), (26932427, 'REACH'), (516965, 'REACH'), (2322451, 'REACH'), (27471681, 'REACH'), (26349042, 'REACH'), (17689225, 'REACH'), (19196553, 'REACH'), (402132, 'REACH'), (235601, 'REACH'), (29115108, 'REACH'), (25595617, 'REACH'), (22034791, 'REACH'), (23476583, 'REACH'), (25671189, 'REACH'), (25684488, 'REACH'), (24603567, 'REACH'), (249821, 'REACH'), (12052622, 'REACH'), (17628729, 'REACH'), (78803, 'REACH'), (19989252, 'REACH'), (429900, 'REACH'), (1810823, 'REACH'), (2761095, 'REACH'), (1031989, 'REACH'), (19736189, 'REACH'), (21866109, 'REACH'), (30156633, 'REACH'), (1040394, 'REACH'), (9524247, 'REACH'), (21124119, 'REACH'), (22147512, 'REACH'), (10192351, 'REACH'), (12928062, 'REACH'), (2276634, 'REACH'), (12658799, 'REACH'), (12201629, 'REACH'), (21001527, 'REACH'), (29115109, 'REACH'), (26601819, 'REACH'), (13101577, 'REACH'), (20537274, 'REACH'), (1586503, 'REACH'), (26337210, 'REACH'), (9456770, 'REACH'), (10246704, 'REACH'), (19966958, 'REACH'), (19269973, 'SPARSER'), (8778934, 'REACH'), (10696289, 'REACH'), (29741215, 'REACH'), (23053120, 'REACH'), (24615724, 'REACH'), (24932757, 'REACH'), (13433027, 'REACH'), (10469236, 'REACH'), (9394765, 'SPARSER'), (29915170, 'REACH'), (19753450, 'REACH'), (11149559, 'REACH'), (4187800, 'REACH'), (13726806, 'REACH'), (26013549, 'REACH'), (24547614, 'REACH'), (18725321, 'REACH'), (20548707, 'REACH'), (28825233, 'REACH'), (1818506, 'REACH'), (25779574, 'REACH'), (16178465, 'REACH'), (21042688, 'REACH'), (22037658, 'REACH'), (1528392, 'REACH'), (13944149, 'REACH'), (2159747, 'REACH'), (19807796, 'REACH'), (1303089, 'REACH'), (2789346, 'REACH'), (21672338, 'SPARSER'), (16105419, 'REACH'), (17113271, 'REACH'), (9292612, 'REACH'), (12373214, 'REACH'), (28406638, 'REACH'), (10589593, 'REACH'), (1220882, 'REACH'), (17135880, 'REACH'), (24005105, 'REACH'), (16013218, 'REACH'), (13092747, 'REACH'), (17674533, 'REACH'), (22360357, 'REACH'), (22429185, 'REACH'), (27211501, 'REACH'), (28247963, 'REACH'), (19458613, 'REACH'), (10935677, 'REACH'), (587356, 'REACH'), (3138327, 'REACH'), (10248983, 'REACH'), (16742387, 'REACH'), (22870003, 'REACH'), (863035, 'REACH'), (18142664, 'REACH'), (14904533, 'REACH'), (25688142, 'REACH'), (19191033, 'REACH'), (16098346, 'REACH'), (24827129, 'REACH'), (23036747, 'SPARSER'), (8848045, 'REACH'), (29482252, 'REACH'), (10223881, 'REACH'), (20425402, 'REACH'), (12658759, 'REACH'), (26028966, 'REACH'), (16562851, 'REACH'), (18496399, 'REACH'), (28608829, 'REACH'), (348267, 'REACH'), (2226532, 'REACH'), (28933023, 'REACH'), (19908347, 'REACH'), (28205031, 'REACH'), (2162824, 'REACH'), (9240712, 'REACH'), (9677973, 'REACH'), (16414498, 'REACH'), (587357, 'REACH'), (1297642, 'REACH'), (27820023, 'REACH'), (22755493, 'REACH'), (964402, 'REACH'), (11571007, 'REACH'), (22009453, 'REACH'), (11842590, 'REACH'), (11699995, 'REACH'), (20420021, 'REACH'), (13431185, 'REACH'), (28257776, 'REACH'), (26006981, 'REACH'), (18081037, 'REACH'), (29684411, 'REACH'), (1032940, 'REACH'), (29115116, 'REACH'), (13134933, 'REACH'), (27618389, 'REACH'), (22848387, 'REACH'), (17674545, 'REACH'), (22628732, 'REACH'), (4325497, 'REACH'), (16285817, 'REACH'), (27319640, 'REACH'), (20708909, 'REACH'), (13550732, 'REACH'), (8268743, 'REACH'), (12069831, 'REACH'), (29109030, 'REACH'), (28195028, 'REACH'), (10691330, 'REACH'), (22983068, 'REACH'), (11013962, 'REACH'), (25779799, 'REACH'), (24932780, 'REACH'), (10405735, 'REACH'), (21124117, 'REACH'), (15671107, 'REACH'), (28263901, 'REACH'), (25459769, 'REACH'), (11113509, 'REACH'), (15668261, 'REACH'), (2171140, 'REACH'), (25787071, 'REACH'), (10908141, 'REACH'), (17479582, 'REACH'), (26154293, 'REACH'), (2836198, 'REACH'), (27444966, 'REACH'), (14866324, 'REACH'), (30250538, 'SPARSER'), (11316592, 'REACH'), (11447664, 'REACH'), (27319641, 'REACH'), (29895191, 'REACH'), (18470052, 'REACH'), (19637215, 'REACH'), (24530048, 'REACH'), (8616510, 'REACH'), (12612155, 'REACH'), (22462296, 'SPARSER'), (1807760, 'REACH'), (10810929, 'SPARSER'), (11447702, 'REACH'), (10660722, 'REACH'), (12818464, 'REACH'), (27324845, 'REACH'), (24126302, 'REACH'), (23347445, 'REACH'), (21930623, 'SPARSER'), (23674964, 'REACH'), (29047249, 'REACH'), (12417899, 'REACH'), (2171141, 'REACH'), (9830500, 'REACH'), (18230369, 'REACH'), (11073183, 'REACH'), (21721388, 'REACH'), (19744487, 'REACH'), (10934165, 'REACH'), (14866325, 'REACH'), (17682374, 'REACH'), (22044020, 'REACH'), (19557489, 'REACH'), (3743673, 'REACH'), (23654998, 'REACH'), (11494739, 'REACH'), (12722308, 'REACH'), (25326166, 'REACH'), (4210226, 'REACH'), (19807794, 'REACH'), (11316589, 'REACH'), (29843230, 'REACH'), (2809801, 'REACH'), (20701129, 'REACH'), (28250887, 'REACH'), (21093557, 'REACH'), (2311782, 'REACH'), (26691174, 'REACH'), (14919086, 'REACH'), (10642878, 'REACH'), (2718362, 'REACH'), (17689219, 'REACH'), (28257762, 'REACH'), (8155165, 'REACH'), (8286332, 'REACH'), (29216439, 'REACH'), (15299862, 'REACH'), (18118065, 'SPARSER'), (18496416, 'REACH'), (24034208, 'REACH'), (28091102, 'REACH'), (9810828, 'REACH'), (12268428, 'REACH'), (19883913, 'REACH'), (26706234, 'REACH'), (10788981, 'REACH'), (17014901, 'REACH'), (23415295, 'SPARSER'), (17744209, 'REACH'), (27491248, 'REACH'), (1759575, 'REACH'), (23746903, 'REACH'), (16948767, 'REACH'), (1056382, 'REACH'), (21346476, 'REACH'), (10696282, 'REACH'), (24489378, 'REACH'), (20473007, 'REACH'), (13246672, 'REACH'), (14904541, 'REACH'), (9268445, 'REACH'), (12276110, 'REACH'), (12571022, 'REACH'), (1985337, 'REACH'), (25996706, 'REACH'), (27140304, 'REACH'), (26021101, 'REACH'), (10238599, 'REACH'), (12452598, 'SPARSER'), (8421488, 'REACH'), (21964078, 'REACH'), (1088581, 'REACH'), (2718369, 'REACH'), (15667922, 'REACH'), (25302912, 'REACH'), (22034796, 'REACH'), (4219418, 'REACH'), (30147285, 'REACH'), (20596227, 'REACH'), (826364, 'REACH'), (28187644, 'REACH'), (1909290, 'REACH'), (28680746, 'REACH'), (78808, 'REACH'), (28773113, 'REACH'), (17727638, 'REACH'), (29957116, 'REACH'), (559300, 'REACH'), (1509572, 'REACH'), (2427076, 'REACH'), (11129215, 'REACH'), (18462893, 'REACH'), (25070456, 'SPARSER'), (18489172, 'REACH'), (17767633, 'REACH'), (20349744, 'REACH'), (26050775, 'REACH'), (24932767, 'REACH'), (21781568, 'REACH'), (15006971, 'REACH'), (1030188, 'REACH'), (20232236, 'REACH'), (18221530, 'REACH'), (17497575, 'REACH'), (9364596, 'REACH'), (30053049, 'REACH'), (21113939, 'REACH'), (30518355, 'REACH'), (1586482, 'REACH'), (22271712, 'REACH'), (26236640, 'REACH'), (13640987, 'REACH'), (29566330, 'REACH'), (16497159, 'REACH'), (27229542, 'REACH'), (8198499, 'REACH'), (21109091, 'REACH'), (11260482, 'REACH'), (1909291, 'REACH'), (28680747, 'REACH'), (26312855, 'REACH'), (23251909, 'REACH'), (25589992, 'SPARSER'), (1866509, 'REACH'), (27840922, 'REACH'), (15528776, 'REACH'), (28701512, 'REACH'), (25487327, 'SPARSER'), (15073073, 'REACH'), (27950897, 'REACH'), (26948440, 'REACH'), (2582373, 'REACH'), (9830422, 'REACH'), (25121023, 'REACH'), (25809151, 'REACH'), (9212973, 'REACH'), (9916891, 'REACH'), (18633179, 'REACH'), (17018505, 'REACH'), (11651130, 'REACH'), (18958394, 'REACH'), (21363340, 'REACH'), (27580451, 'REACH'), (20573455, 'REACH'), (448189, 'REACH'), (22271677, 'REACH'), (22942187, 'REACH'), (25006571, 'REACH'), (22455626, 'REACH'), (29621335, 'REACH'), (10914102, 'REACH'), (24469440, 'REACH'), (11447678, 'REACH'), (29025403, 'REACH'), (1892934, 'REACH'), (13333666, 'REACH'), (13733807, 'REACH'), (9609168, 'REACH'), (15798191, 'REACH'), (26415023, 'REACH'), (15685180, 'REACH'), (18372156, 'REACH'), (18705002, 'REACH'), (19327594, 'REACH'), (20749080, 'REACH'), (28371562, 'REACH'), (21545800, 'SPARSER'), (1038317, 'REACH'), (889082, 'REACH'), (8425722, 'REACH'), (23400698, 'REACH'), (9489812, 'REACH'), (14904527, 'REACH'), (16734254, 'REACH'), (25654712, 'REACH'), (10337746, 'REACH'), (13640966, 'REACH'), (24232605, 'REACH'), (2543691, 'REACH'), (17674538, 'REACH'), (4187877, 'REACH'), (24911553, 'REACH'), (27547775, 'REACH'), (2268704, 'REACH'), (26549323, 'SPARSER'), (12889609, 'REACH'), (16005221, 'SPARSER'), (22221754, 'REACH'), (12068436, 'REACH'), (21955133, 'REACH'), (4387179, 'REACH'), (27127321, 'REACH'), (3603635, 'REACH'), (2761096, 'REACH'), (4387700, 'REACH'), (27718516, 'REACH'), (25413456, 'REACH'), (19248142, 'REACH'), (2718360, 'REACH'), (27599699, 'REACH'), (17550816, 'REACH'), (2581606, 'REACH'), (20472934, 'REACH'), (2028820, 'REACH'), (13490255, 'REACH'), (30136399, 'REACH'), (2382766, 'REACH'), (21518635, 'REACH'), (17848025, 'REACH'), (9556874, 'REACH'), (22271705, 'REACH'), (11574584, 'REACH'), (15561413, 'REACH'), (29907605, 'SPARSER'), (21315699, 'REACH'), (22523428, 'REACH'), (15024479, 'REACH'), (23796670, 'REACH'), (27528172, 'REACH'), (20101865, 'REACH'), (24885993, 'REACH'), (1608615, 'REACH'), (2332232, 'REACH'), (24024648, 'REACH'), (19855343, 'REACH'), (20840654, 'REACH'), (20473015, 'REACH'), (9907813, 'REACH'), (25611030, 'REACH'), (487236, 'REACH'), (8239103, 'REACH'), (23449996, 'REACH'), (10719431, 'REACH'), (1005416, 'REACH'), (25413457, 'REACH'), (11644139, 'REACH'), (1598518, 'REACH'), (22019123, 'REACH'), (24169953, 'REACH'), (26973215, 'REACH'), (27035897, 'SPARSER'), (19415721, 'REACH'), (23839401, 'REACH'), (27618394, 'REACH'), (15299861, 'REACH'), (1862982, 'REACH'), (28908276, 'REACH'), (396785, 'REACH'), (26349041, 'REACH'), (10033839, 'REACH'), (2425368, 'REACH'), (406821, 'REACH'), (988118, 'REACH'), (13538262, 'REACH'), (22381267, 'REACH'), (26458628, 'REACH'), (22661869, 'REACH'), (12320926, 'REACH'), (26528493, 'REACH'), (16805429, 'REACH'), (22113845, 'REACH'), (20804756, 'REACH'), (10389698, 'REACH'), (13945042, 'REACH'), (12276109, 'REACH'), (11273022, 'REACH'), (28934974, 'REACH'), (26341008, 'REACH'), (20548663, 'REACH'), (22359427, 'SPARSER'), (8789477, 'REACH'), (22027749, 'REACH'), (17874579, 'REACH'), (18464403, 'REACH'), (25114495, 'REACH'), (21315678, 'REACH'), (20959500, 'REACH'), (26586810, 'REACH'), (18951239, 'REACH'), (26108405, 'REACH'), (13950292, 'REACH'), (22043988, 'REACH'), (19883906, 'REACH'), (11082032, 'REACH'), (713813, 'SPARSER'), (2647767, 'REACH'), (16696696, 'REACH'), (14891525, 'REACH'), (25904504, 'REACH'), (10820964, 'REACH'), (17982610, 'REACH'), (8208287, 'REACH'), (1645307, 'REACH'), (1754668, 'REACH'), (4245036, 'REACH'), (11452969, 'REACH'), (906215, 'REACH'), (25475034, 'REACH'), (28787241, 'REACH'), (14904518, 'REACH'), (26045638, 'REACH'), (1909295, 'REACH'), (10203728, 'REACH'), (20351581, 'REACH'), (24453679, 'REACH'), (28680751, 'REACH'), (29526621, 'REACH'), (16716791, 'REACH'), (17437687, 'REACH'), (17991064, 'REACH'), (20765861, 'REACH'), (29430775, 'REACH'), (9560449, 'REACH'), (20658636, 'REACH'), (27843450, 'REACH'), (18245032, 'REACH'), (19835317, 'REACH'), (21648230, 'REACH'), (23983505, 'REACH'), (1417712, 'REACH'), (13310602, 'REACH'), (30218124, 'SPARSER'), (25618885, 'REACH'), (8288289, 'REACH'), (28425311, 'REACH'), (10942733, 'REACH'), (29265575, 'REACH'), (4174152, 'REACH'), (29667656, 'REACH'), (27319174, 'REACH'), (26492655, 'REACH'), (16660765, 'REACH'), (4159628, 'REACH'), (1945543, 'REACH'), (19214279, 'REACH'), (13035043, 'REACH'), (515284, 'REACH'), (13788707, 'REACH'), (21882403, 'REACH'), (25883824, 'REACH'), (17943741, 'REACH'), (17111019, 'REACH'), (18576796, 'REACH'), (24540572, 'REACH'), (3294456, 'REACH'), (17974661, 'REACH'), (12263649, 'REACH'), (18681037, 'REACH'), (13396862, 'REACH'), (24537982, 'REACH'), (2340268, 'REACH'), (30136390, 'REACH'), (15799107, 'REACH'), (12387828, 'REACH'), (26940066, 'REACH'), (2378812, 'REACH'), (4325482, 'REACH'), (9830506, 'REACH'), (27103512, 'REACH'), (8924627, 'REACH'), (9612755, 'REACH'), (1696001, 'REACH'), (19541459, 'REACH'), (20679582, 'REACH'), (20843422, 'REACH'), (26635228, 'SPARSER'), (27319175, 'REACH'), (27987240, 'REACH'), (25765603, 'REACH'), (11870576, 'REACH'), (12664366, 'REACH'), (19807790, 'REACH'), (23200266, 'REACH'), (11744184, 'REACH'), (22870006, 'REACH'), (23619748, 'REACH'), (78802, 'REACH'), (24883933, 'SPARSER'), (21782656, 'REACH'), (26484693, 'REACH'), (12806767, 'REACH'), (23234553, 'REACH'), (18462519, 'REACH'), (11076837, 'REACH'), (21093569, 'REACH'), (30178943, 'REACH'), (2340269, 'REACH'), (17808849, 'REACH'), (1016932, 'REACH'), (445087, 'REACH'), (29903519, 'REACH'), (18560077, 'REACH'), (206331, 'REACH'), (19262357, 'REACH'), (18571377, 'REACH'), (18418190, 'REACH'), (28259257, 'REACH'), (20472964, 'REACH'), (217886, 'REACH'), (8208923, 'REACH'), (13849374, 'REACH'), (18498075, 'REACH'), (21685839, 'REACH'), (999211, 'REACH'), (8306475, 'REACH'), (9363676, 'REACH'), (27593945, 'REACH'), (26339167, 'REACH'), (26440717, 'REACH'), (20167102, 'REACH'), (3236332, 'REACH'), (28588265, 'REACH'), (12733512, 'REACH'), (9279110, 'REACH'), (16674532, 'SPARSER'), (15705806, 'REACH'), (21866190, 'REACH'), (12563580, 'REACH'), (10403498, 'REACH'), (1016933, 'REACH'), (29011455, 'REACH'), (21847341, 'REACH'), (26565933, 'REACH'), (1909286, 'REACH'), (28680742, 'REACH'), (78804, 'REACH'), (11744212, 'REACH'), (28831234, 'REACH'), (1474480, 'REACH'), (1773465, 'REACH'), (11276831, 'REACH'), (30026330, 'REACH'), (15479573, 'REACH'), (13030798, 'REACH'), (2165610, 'REACH'), (10095466, 'REACH'), (1030168, 'REACH'), (14944726, 'REACH'), (18418134, 'REACH'), (12963844, 'REACH'), (26274656, 'REACH'), (1982087, 'REACH'), (25971174, 'REACH'), (23642595, 'REACH'), (13841044, 'REACH'), (29608422, 'REACH'), (15130716, 'REACH'), (3240202, 'REACH'), (20756178, 'REACH'), (25474770, 'REACH'), (12664326, 'REACH'), (21872134, 'REACH'), (22153137, 'REACH'), (12263778, 'REACH'), (18992889, 'REACH'), (11412630, 'REACH'), (24159382, 'REACH'), (28523667, 'REACH'), (13933170, 'REACH'), (19918430, 'REACH'), (2146887, 'REACH'), (11269352, 'REACH'), (29777948, 'SPARSER'), (28122275, 'REACH'), (23441617, 'REACH'), (24562283, 'REACH'), (29224394, 'REACH'), (27523960, 'REACH'), (12027318, 'REACH'), (15668068, 'REACH'), (14942866, 'REACH'), (4167071, 'REACH'), (8557983, 'REACH'), (975693, 'REACH'), (21709310, 'REACH'), (28762957, 'REACH'), (10206252, 'REACH'), (11090568, 'REACH'), (17821333, 'REACH'), (18378389, 'REACH'), (26989464, 'SPARSER'), (3546527, 'SPARSER'), (1030191, 'REACH'), (21772335, 'REACH'), (13030670, 'REACH'), (21660073, 'SPARSER'), (11212473, 'REACH'), (11769529, 'REACH'), (1454583, 'REACH'), (19902967, 'REACH'), (16771808, 'REACH'), (23001371, 'REACH'), (13475171, 'REACH'), (20878225, 'REACH'), (12124495, 'REACH'), (24059645, 'REACH'), (21030443, 'REACH'), (16094776, 'REACH'), (26312310, 'REACH'), (1345907, 'REACH'), (10589594, 'REACH'), (13389397, 'REACH'), (9843078, 'REACH'), (11800372, 'REACH'), (25595700, 'REACH'), (11537424, 'REACH'), (18226638, 'REACH'), (3259001, 'REACH'), (1571242, 'REACH'), (16956025, 'REACH'), (2783064, 'REACH'), (1918785, 'REACH'), (23111154, 'REACH'), (15610528, 'REACH'), (157741, 'REACH'), (21982266, 'REACH'), (19328455, 'REACH'), (8354516, 'REACH'), (29380689, 'REACH'), (21627151, 'REACH'), (17298096, 'REACH'), (10807305, 'SPARSER'), (19245980, 'REACH'), (26239641, 'REACH'), (26043128, 'REACH'), (28323126, 'REACH'), (19905252, 'REACH'), (18564833, 'REACH'), (11862546, 'REACH'), (15832000, 'REACH'), (22221760, 'REACH'), (18684027, 'REACH'), (13686106, 'REACH'), (1319432, 'REACH'), (11560518, 'REACH'), (21727555, 'REACH'), (27280303, 'REACH'), (19458620, 'REACH'), (661049, 'REACH'), (1183338, 'REACH'), (16094777, 'REACH'), (18257465, 'REACH'), (28874297, 'REACH'), (10620673, 'REACH'), (28011501, 'REACH'), (20936859, 'REACH'), (20993274, 'REACH'), (1103669, 'REACH'), (402659, 'REACH'), (11390737, 'REACH'), (97261, 'SPARSER'), (12701552, 'REACH'), (12361341, 'REACH'), (11009070, 'REACH'), (19353456, 'REACH'), (22218588, 'REACH'), (178186, 'REACH'), (28871096, 'REACH'), (16985590, 'REACH'), (26240243, 'REACH'), (489734, 'REACH'), (19887796, 'REACH'), (23777119, 'SPARSER'), (11574606, 'REACH'), (17853180, 'REACH'), (1215379, 'REACH'), (10230911, 'REACH'), (13147263, 'REACH'), (21473804, 'REACH'), (23517350, 'REACH'), (11893332, 'REACH'), (1047505, 'REACH'), (23495810, 'REACH'), (10340495, 'REACH'), (12798095, 'REACH'), (12948016, 'REACH'), (26049489, 'REACH'), (24371973, 'REACH'), (13431186, 'REACH'), (24623936, 'REACH'), (18483454, 'REACH'), (28868826, 'REACH'), (22218589, 'REACH'), (9916857, 'REACH'), (1024490, 'REACH'), (27618390, 'REACH'), (27969228, 'REACH'), (1791239, 'REACH'), (702566, 'REACH'), (11614310, 'REACH'), (26843645, 'REACH'), (29006333, 'REACH'), (24983237, 'REACH'), (25662838, 'REACH'), (13241856, 'REACH'), (16740877, 'REACH'), (18870797, 'REACH'), (20910060, 'REACH'), (11615977, 'REACH'), (28089498, 'REACH'), (23637927, 'REACH'), (24653735, 'REACH'), (29364204, 'REACH'), (2632835, 'REACH'), (26900020, 'REACH'), (8234190, 'REACH'), (22927307, 'REACH'), (20765866, 'REACH'), (17672792, 'REACH'), (13619987, 'REACH'), (13652755, 'REACH'), (13849363, 'REACH'), (1533899, 'SPARSER'), (3511495, 'REACH'), (9213127, 'REACH'), (9677672, 'REACH'), (1030182, 'REACH'), (28879720, 'REACH'), (26557872, 'REACH'), (13273966, 'REACH'), (11447705, 'REACH'), (20098457, 'REACH'), (22512853, 'SPARSER'), (24821834, 'REACH'), (10626532, 'REACH'), (18720228, 'REACH'), (25346529, 'REACH'), (11180493, 'REACH'), (23009741, 'REACH'), (24154376, 'REACH'), (29255957, 'REACH'), (18284870, 'REACH'), (11902708, 'REACH'), (26739185, 'REACH'), (24435408, 'REACH'), (25005789, 'REACH'), (2342795, 'REACH'), (25319740, 'REACH'), (84330, 'REACH'), (13650282, 'REACH'), (13655556, 'REACH'), (2860991, 'REACH'), (17845836, 'REACH'), (3473402, 'REACH'), (8967303, 'REACH'), (1909301, 'REACH'), (28248212, 'REACH'), (8926737, 'REACH'), (11286033, 'REACH'), (12496066, 'REACH'), (26940662, 'REACH'), (3204516, 'REACH'), (28228769, 'REACH'), (2098399, 'REACH'), (18073984, 'REACH'), (11092795, 'REACH'), (23053115, 'REACH'), (1103655, 'REACH'), (28383235, 'REACH'), (11219022, 'REACH'), (30465066, 'REACH'), (26105970, 'REACH'), (21358069, 'REACH'), (24036262, 'REACH'), (16699732, 'REACH'), (28096209, 'REACH'), (21623695, 'REACH'), (27934000, 'REACH'), (4230090, 'REACH'), (11373514, 'REACH'), (15571320, 'REACH'), (12377605, 'REACH'), (17668472, 'REACH'), (10563507, 'REACH'), (23370104, 'REACH'), (16771425, 'REACH'), (23662948, 'REACH'), (24195999, 'REACH'), (12150782, 'REACH'), (30041237, 'REACH'), (9054577, 'REACH'), (2381815, 'REACH'), (21518744, 'REACH'), (18345555, 'REACH'), (17939916, 'REACH'), (23781242, 'REACH'), (21322759, 'REACH'), (24633210, 'REACH'), (20472852, 'REACH'), (10717585, 'REACH'), (15668290, 'REACH'), (24081881, 'REACH'), (21609741, 'REACH'), (12793160, 'REACH'), (21898325, 'REACH'), (78798, 'REACH'), (26105977, 'REACH'), (9519638, 'REACH'), (21611030, 'REACH'), (27127315, 'REACH'), (27878721, 'REACH'), (30283974, 'SPARSER'), (19617325, 'REACH'), (23294942, 'REACH'), (27341038, 'SPARSER'), (17518965, 'REACH'), (19779957, 'REACH'), (14948899, 'REACH'), (10244308, 'REACH'), (1465937, 'REACH'), (20230766, 'REACH'), (12609354, 'REACH'), (22996810, 'REACH'), (10459384, 'REACH'), (26952929, 'REACH'), (18592543, 'REACH'), (22216909, 'REACH'), (3207038, 'REACH'), (29257598, 'REACH'), (28432195, 'REACH'), (88564, 'REACH'), (28557372, 'REACH'), (25461866, 'REACH'), (25887850, 'REACH'), (13336278, 'REACH'), (1356479, 'REACH'), (12018784, 'REACH'), (12137151, 'REACH'), (20472928, 'REACH'), (28782494, 'REACH'), (28177481, 'REACH'), (21061511, 'REACH'), (21627176, 'REACH'), (28323125, 'REACH'), (11983587, 'REACH'), (28678082, 'REACH'), (26816207, 'REACH'), (20931952, 'REACH'), (2126382, 'REACH'), (24180057, 'REACH'), (19015178, 'REACH'), (9454103, 'REACH'), (9519639, 'REACH'), (9825605, 'REACH'), (19692275, 'REACH'), (19989251, 'REACH'), (12844189, 'REACH'), (28269561, 'REACH'), (15528746, 'REACH'), (1985335, 'REACH'), (23955885, 'REACH'), (29329837, 'REACH'), (18163547, 'REACH'), (13831610, 'REACH'), (17829306, 'REACH'), (19501104, 'REACH'), (8207421, 'REACH'), (29930347, 'REACH'), (22111946, 'REACH'), (28723894, 'REACH'), (11769523, 'REACH'), (12658765, 'REACH'), (26582759, 'REACH'), (21742472, 'REACH'), (25208157, 'REACH'), (26979854, 'REACH'), (19148778, 'REACH'), (2448723, 'REACH'), (19142788, 'REACH'), (23500574, 'REACH'), (10118348, 'REACH'), (13062778, 'REACH'), (13901414, 'REACH'), (27214435, 'REACH'), (23053122, 'REACH'), (21017994, 'REACH'), (28183959, 'REACH'), (21968696, 'REACH'), (26809121, 'REACH'), (21986537, 'REACH'), (10226310, 'REACH'), (13387234, 'REACH'), (24004066, 'REACH'), (21315672, 'REACH'), (17443091, 'REACH'), (26388755, 'REACH'), (27644832, 'REACH'), (1444551, 'REACH'), (18320071, 'REACH'), (21957319, 'REACH'), (2226132, 'REACH'), (29956433, 'REACH'), (17405455, 'REACH'), (13496043, 'REACH'), (19807795, 'REACH'), (20339684, 'REACH'), (10901023, 'REACH'), (8988621, 'REACH'), (25669482, 'REACH'), (26638117, 'REACH'), (20405695, 'REACH'), (25648575, 'REACH'), (20837787, 'REACH'), (25640777, 'REACH'), (19767349, 'REACH'), (26037734, 'REACH'), (18007523, 'REACH'), (29781009, 'REACH'), (19130457, 'REACH'), (20296970, 'REACH'), (22014041, 'REACH'), (23783513, 'REACH'), (26948874, 'REACH'), (581947, 'REACH'), (19671145, 'REACH'), (13682018, 'REACH'), (18684048, 'REACH'), (235086, 'REACH'), (29115129, 'REACH'), (23796673, 'REACH'), (3247904, 'REACH'), (15038886, 'REACH'), (9450360, 'SPARSER'), (22851747, 'REACH'), (15168721, 'REACH'), (11652124, 'REACH'), (642483, 'REACH'), (30156621, 'REACH'), (11740201, 'REACH'), (11343335, 'REACH'), (20959683, 'REACH'), (21847307, 'REACH'), (1697468, 'REACH'), (1992380, 'REACH'), (22362858, 'REACH'), (28910970, 'SPARSER'), (15945010, 'REACH'), (1099071, 'REACH'), (9486878, 'REACH'), (2759963, 'REACH'), (1419176, 'REACH'), (11813813, 'REACH'), (12658600, 'REACH'), (29865318, 'REACH'), (28414717, 'REACH'), (26041482, 'REACH'), (10898803, 'REACH'), (3562017, 'REACH'), (11602514, 'REACH'), (18123346, 'REACH'), (24779520, 'REACH'), (11100347, 'REACH'), (8984812, 'REACH'), (29276547, 'REACH'), (22489327, 'REACH'), (13287440, 'REACH'), (17552157, 'REACH'), (24226031, 'REACH'), (15344055, 'REACH'), (3504150, 'REACH'), (2370579, 'REACH'), (11086867, 'REACH'), (24078404, 'REACH'), (12133593, 'SPARSER'), (28886665, 'REACH'), (27108456, 'REACH'), (24426754, 'REACH'), (23039677, 'REACH'), (22043978, 'REACH'), (30039163, 'REACH'), (24653740, 'REACH'), (1419177, 'REACH'), (9398618, 'REACH'), (26601818, 'REACH'), (19470918, 'REACH'), (19467587, 'REACH'), (24887284, 'REACH'), (10319601, 'REACH'), (15194064, 'REACH'), (24991451, 'SPARSER'), (20765835, 'REACH'), (338489, 'REACH'), (13619992, 'REACH'), (30035358, 'REACH'), (29157961, 'REACH'), (25795975, 'REACH'), (22459842, 'REACH'), (17900612, 'SPARSER'), (26467826, 'SPARSER'), (10862357, 'SPARSER'), (17935800, 'REACH'), (13445796, 'REACH'), (23794143, 'REACH'), (26034816, 'REACH'), (20074125, 'REACH'), (88569, 'REACH'), (8228755, 'REACH'), (13215684, 'REACH'), (1669490, 'REACH'), (25669759, 'REACH'), (13013342, 'REACH'), (1492315, 'REACH'), (24700425, 'REACH'), (19246010, 'REACH'), (20765862, 'REACH'), (16449108, 'REACH'), (8616509, 'REACH'), (26425116, 'REACH'), (9250329, 'REACH'), (19658540, 'REACH'), (11849875, 'SPARSER'), (24919494, 'REACH'), (29368945, 'REACH'), (22351524, 'SPARSER'), (20948050, 'SPARSER'), (23322044, 'REACH'), (18142649, 'REACH'), (13288938, 'REACH'), (11869431, 'REACH'), (27185816, 'REACH'), (27041878, 'REACH'), (26034817, 'REACH'), (21443634, 'REACH'), (27469946, 'REACH'), (26940072, 'REACH'), (26995381, 'REACH'), (18780239, 'REACH'), (19783165, 'REACH'), (12440888, 'REACH'), (26208630, 'REACH'), (25671795, 'REACH'), (22611492, 'REACH'), (13301074, 'REACH'), (22034783, 'REACH'), (29914450, 'REACH'), (26334142, 'REACH'), (23398331, 'REACH'), (19807793, 'REACH'), (3262053, 'REACH'), (8146943, 'REACH'), (21745663, 'REACH'), (4388653, 'REACH'), (24932768, 'REACH'), (29192608, 'REACH'), (2708873, 'REACH'), (3207016, 'REACH'), (21555704, 'SPARSER'), (8924628, 'REACH'), (19541460, 'REACH'), (23682493, 'REACH'), (13812121, 'REACH'), (17613209, 'REACH'), (10819064, 'REACH'), (24050148, 'REACH'), (23520737, 'REACH'), (28206561, 'REACH'), (18226637, 'REACH'), (21171326, 'REACH'), (1791240, 'REACH'), (12309768, 'REACH'), (13849332, 'REACH'), (16008689, 'REACH'), (28091101, 'REACH'), (26706233, 'REACH'), (29720889, 'REACH'), (2560516, 'REACH'), (11266561, 'REACH'), (28494095, 'SPARSER'), (19626943, 'REACH'), (17624038, 'REACH'), (21556198, 'REACH'), (9677972, 'REACH'), (20701378, 'REACH'), (27048911, 'REACH'), (18452651, 'REACH'), (27201707, 'REACH'), (21126935, 'REACH'), (15448287, 'REACH'), (9268608, 'REACH'), (15894331, 'REACH'), (27224871, 'REACH'), (23517397, 'REACH'), (12658694, 'REACH'), (29415637, 'REACH'), (12413206, 'SPARSER'), (17130338, 'REACH'), (9324363, 'REACH'), (18208229, 'REACH'), (12050070, 'REACH'), (29449878, 'REACH'), (21623233, 'REACH'), (19844349, 'SPARSER'), (17674544, 'REACH'), (8208924, 'REACH'), (13877788, 'REACH'), (13098711, 'REACH'), (21347704, 'REACH'), (30313640, 'SPARSER'), (11818340, 'REACH'), (19458624, 'REACH'), (1356539, 'REACH'), (20708908, 'REACH'), (249818, 'REACH'), (26041480, 'REACH'), (18684053, 'REACH'), (9674691, 'REACH'), (24400500, 'REACH'), (30010737, 'REACH'), (3621469, 'REACH'), (10256569, 'REACH'), (17662137, 'REACH'), (22853866, 'REACH'), (15850904, 'REACH'), (28588266, 'REACH'), (11086678, 'REACH'), (30577829, 'REACH'), (24778116, 'REACH'), (153985, 'REACH'), (22889057, 'SPARSER'), (28565347, 'REACH'), (8288276, 'REACH'), (13831569, 'REACH'), (27561361, 'REACH'), (23796208, 'REACH'), (18483453, 'REACH'), (1030187, 'REACH'), (18007516, 'REACH'), (28263900, 'REACH'), (28869061, 'REACH'), (27244800, 'REACH'), (30060464, 'SPARSER'), (19089897, 'REACH'), (25957322, 'SPARSER'), (565123, 'REACH'), (12126168, 'SPARSER'), (18720124, 'REACH'), (18496426, 'REACH'), (249819, 'REACH'), (13065353, 'REACH'), (20765833, 'REACH'), (12279331, 'REACH'), (17514242, 'REACH'), (20800271, 'REACH'), (21261488, 'REACH'), (20473021, 'REACH'), (24395522, 'REACH'), (24428290, 'REACH'), (13462940, 'REACH'), (24940523, 'REACH'), (28208304, 'REACH'), (25029207, 'REACH'), (3295030, 'REACH'), (120036, 'REACH'), (22947241, 'REACH'), (18658151, 'REACH'), (1174769, 'REACH'), (12798009, 'REACH'), (11574532, 'REACH'), (21652382, 'REACH'), (27873018, 'REACH'), (10568161, 'SPARSER'), (13098723, 'REACH'), (21344381, 'REACH'), (26514990, 'REACH'), (27232601, 'REACH'), (24726456, 'REACH'), (29313976, 'REACH'), (10985203, 'REACH'), (23044063, 'REACH'), (9899579, 'REACH'), (28563226, 'REACH'), (13640904, 'REACH'), (743381, 'REACH'), (28250886, 'REACH'), (2282673, 'REACH'), (27050384, 'REACH'), (19287627, 'REACH'), (1855287, 'REACH'), (30166607, 'SPARSER'), (11941503, 'REACH'), (14875732, 'SPARSER'), (27923488, 'REACH'), (25141086, 'REACH'), (29491642, 'REACH'), (29703252, 'REACH'), (824785, 'REACH'), (20420049, 'REACH'), (22914542, 'REACH'), (162506, 'REACH'), (8354506, 'REACH'), (11220439, 'REACH'), (16730232, 'REACH'), (9260726, 'REACH'), (26995379, 'REACH'), (27576440, 'REACH'), (28925028, 'REACH'), (20436288, 'REACH'), (27618381, 'REACH'), (28769787, 'REACH'), (9456940, 'REACH'), (17674537, 'REACH'), (1345908, 'REACH'), (25671793, 'REACH'), (16118716, 'REACH'), (29313977, 'REACH'), (24036261, 'REACH'), (16699731, 'REACH'), (19458610, 'REACH'), (28466751, 'REACH'), (12384621, 'REACH'), (18716876, 'REACH'), (22976122, 'REACH'), (13107988, 'REACH'), (80092, 'REACH'), (13613276, 'REACH'), (18164106, 'REACH'), (11706775, 'REACH'), (1985336, 'REACH'), (12525975, 'REACH'), (1103649, 'REACH'), (2840353, 'REACH'), (19474013, 'SPARSER'), (21097485, 'REACH'), (29013658, 'REACH'), (23445927, 'REACH'), (3702613, 'REACH'), (21240290, 'REACH'), (2729455, 'REACH'), (23111151, 'REACH'), (21310493, 'REACH'), (13098702, 'REACH'), (1337803, 'REACH'), (18514198, 'REACH'), (15668289, 'REACH'), (8319730, 'REACH'), (21063167, 'REACH'), (19469613, 'REACH'), (25476830, 'REACH'), (30151981, 'REACH'), (25947427, 'REACH'), (23796669, 'REACH'), (29663979, 'REACH'), (13262820, 'REACH'), (2752704, 'REACH'), (15948749, 'REACH'), (28701448, 'REACH'), (25611029, 'REACH'), (10099106, 'REACH'), (1187024, 'REACH'), (421262, 'REACH'), (8843288, 'REACH'), (9898789, 'REACH'), (12009942, 'REACH'), (16980179, 'REACH'), (25030680, 'REACH'), (25280982, 'REACH'), (2176434, 'REACH'), (21645723, 'REACH'), (19627120, 'REACH'), (29257597, 'REACH'), (22941998, 'REACH'), (18705497, 'REACH'), (27618393, 'REACH'), (22030008, 'REACH'), (88563, 'REACH'), (21309348, 'REACH'), (19289761, 'REACH'), (23547602, 'REACH'), (12961503, 'REACH'), (14866317, 'REACH'), (16503102, 'REACH'), (8835390, 'REACH'), (10934157, 'REACH'), (26329383, 'REACH'), (30519811, 'REACH'), (2486232, 'REACH'), (26636248, 'REACH'), (29654166, 'REACH'), (9674689, 'REACH'), (11170418, 'REACH'), (13837498, 'REACH'), (19495495, 'REACH'), (24967751, 'REACH'), (21509283, 'REACH'), (3525460, 'REACH'), (24922964, 'REACH'), (9268623, 'REACH'), (24752921, 'REACH'), (30178519, 'REACH'), (13273956, 'REACH'), (13343230, 'REACH'), (633083, 'REACH'), (26843646, 'REACH'), (29006334, 'REACH'), (30190055, 'REACH'), (881288, 'REACH'), (21226182, 'REACH'), (25787068, 'REACH'), (21225194, 'REACH'), (27385578, 'REACH'), (8874326, 'REACH'), (16771414, 'REACH'), (29464895, 'REACH'), (4325485, 'REACH'), (22955550, 'REACH'), (20633548, 'REACH'), (518069, 'REACH'), (19527011, 'REACH'), (12232212, 'REACH'), (12700561, 'REACH'), (17767979, 'REACH'), (2486233, 'REACH'), (26636249, 'REACH'), (3243159, 'REACH'), (15024499, 'REACH'), (25674099, 'REACH'), (1791757, 'REACH'), (13424397, 'REACH'), (16718014, 'REACH'), (23664830, 'REACH'), (19148777, 'REACH'), (27704695, 'SPARSER'), (867495, 'REACH'), (19774631, 'REACH'), (26819751, 'REACH'), (10914609, 'REACH'), (13497570, 'REACH'), (22711089, 'REACH'), (24474850, 'REACH'), (23500573, 'REACH'), (8287694, 'REACH'), (25283823, 'REACH'), (9201079, 'REACH'), (20619283, 'REACH'), (9628740, 'REACH'), (28825228, 'REACH'), (18532433, 'REACH'), (21616911, 'REACH'), (13085806, 'REACH'), (18492907, 'REACH'), (28683755, 'REACH'), (21914934, 'REACH'), (14975283, 'REACH'), (15332639, 'REACH'), (8919422, 'REACH'), (20429737, 'REACH'), (29206887, 'REACH'), (29370727, 'REACH'), (23098356, 'REACH'), (3262058, 'REACH'), (8866167, 'REACH'), (10013047, 'REACH'), (9175218, 'REACH'), (17662130, 'REACH'), (24552429, 'REACH'), (28086427, 'REACH'), (24768309, 'REACH'), (8381421, 'SPARSER'), (2172784, 'REACH'), (415357, 'REACH'), (3593853, 'REACH'), (10932234, 'REACH'), (1016855, 'REACH'), (12963850, 'REACH'), (19248607, 'REACH'), (2378811, 'REACH'), (18093929, 'REACH'), (18113575, 'REACH'), (22113972, 'REACH'), (29723313, 'REACH'), (870288, 'REACH'), (1099664, 'REACH'), (849230, 'REACH'), (2714922, 'REACH'), (11625783, 'REACH'), (22271704, 'REACH'), (13838230, 'REACH'), (20662977, 'REACH'), (1638924, 'REACH'), (18684425, 'REACH'), (23495180, 'REACH'), (12100935, 'REACH'), (12104276, 'REACH'), (78801, 'REACH'), (27386244, 'SPARSER'), (11447659, 'REACH'), (21315743, 'REACH'), (27500798, 'REACH'), (24105979, 'REACH'), (12146906, 'REACH'), (458120, 'REACH'), (24078531, 'REACH'), (28838923, 'REACH'), (24271338, 'REACH'), (23400695, 'REACH'), (12925408, 'REACH'), (17553435, 'REACH'), (24530042, 'REACH'), (10637414, 'REACH'), (18212162, 'REACH'), (18560079, 'REACH'), (10269995, 'REACH'), (13697753, 'REACH'), (22381273, 'REACH'), (13838231, 'REACH'), (1653875, 'REACH'), (19494846, 'REACH'), (1895988, 'REACH'), (2846260, 'REACH'), (524258, 'REACH'), (762863, 'REACH'), (16805428, 'REACH'), (17746461, 'REACH'), (21353009, 'REACH'), (18193785, 'REACH'), (10637495, 'REACH'), (9542245, 'REACH'), (12104257, 'REACH'), (22025632, 'REACH'), (18615692, 'REACH'), (20472834, 'REACH'), (15115118, 'REACH'), (20685678, 'REACH'), (28231065, 'REACH'), (13882199, 'REACH'), (9574179, 'SPARSER'), (26023557, 'REACH'), (12658739, 'REACH'), (12925409, 'REACH'), (1855949, 'REACH'), (25051262, 'REACH'), (28898743, 'SPARSER'), (21518426, 'REACH'), (20548711, 'REACH'), (21255924, 'REACH'), (17745826, 'REACH'), (9329214, 'SPARSER'), (1212115, 'REACH'), (27229907, 'REACH'), (3476402, 'REACH'), (18317247, 'REACH'), (702816, 'REACH'), (2467565, 'REACH'), (22034784, 'REACH'), (16492108, 'REACH'), (12138490, 'REACH'), (28892712, 'REACH'), (9820725, 'REACH'), (593894, 'REACH'), (667153, 'REACH'), (8217794, 'REACH'), (25358960, 'REACH'), (27594109, 'REACH'), (21620723, 'REACH'), (4191258, 'REACH'), (18904090, 'REACH'), (741379, 'REACH'), (8146947, 'REACH'), (21591473, 'REACH'), (25647760, 'REACH'), (26037661, 'REACH'), (3240201, 'REACH'), (29115118, 'REACH'), (25116779, 'REACH'), (10127445, 'SPARSER'), (21042693, 'REACH'), (30464950, 'REACH'), (15901025, 'REACH'), (9350720, 'REACH'), (13272026, 'REACH'), (462739, 'SPARSER'), (23713990, 'REACH'), (15668163, 'REACH'), (22221763, 'REACH'), (20708911, 'REACH'), (9933208, 'REACH'), (13612827, 'REACH'), (19969031, 'REACH'), (1528232, 'REACH'), (27663856, 'REACH'), (29560061, 'REACH'), (19028444, 'REACH'), (2619018, 'REACH'), (15809175, 'REACH'), (28588695, 'REACH'), (27618386, 'REACH'), (3205215, 'REACH'), (21220841, 'REACH'), (1979677, 'REACH'), (13589431, 'REACH'), (22043575, 'REACH'), (18098533, 'REACH'), (29829477, 'REACH'), (12273171, 'REACH'), (12649028, 'REACH'), (30464951, 'REACH'), (1859744, 'REACH'), (12711052, 'REACH'), (1626659, 'REACH'), (21352995, 'REACH'), (13849346, 'REACH'), (21044449, 'REACH'), (17553426, 'REACH'), (25611039, 'REACH'), (23689421, 'REACH'), (29063373, 'REACH'), (593928, 'REACH'), (26002453, 'REACH'), (12308291, 'REACH'), (23056195, 'REACH'), (642722, 'REACH'), (19758731, 'REACH'), (846905, 'REACH'), (18574393, 'REACH'), (29846846, 'SPARSER'), (23039666, 'REACH'), (29265586, 'REACH'), (849228, 'REACH'), (22340346, 'REACH'), (19993315, 'REACH'), (19458606, 'REACH'), (2584530, 'REACH'), (23843807, 'REACH'), (9841434, 'REACH'), (13252808, 'REACH'), (18003101, 'REACH'), (23311517, 'REACH'), (27593944, 'REACH'), (23830540, 'REACH'), (178185, 'REACH'), (21510153, 'REACH'), (82759, 'REACH'), (22950133, 'REACH'), (2659389, 'REACH'), (986232, 'REACH'), (9604787, 'REACH'), (23039667, 'REACH'), (22355041, 'REACH'), (18167698, 'REACH'), (23345042, 'REACH'), (17719373, 'REACH'), (17540862, 'REACH'), (572296, 'REACH'), (23199686, 'REACH'), (19254644, 'REACH'), (12523823, 'REACH'), (27133861, 'REACH'), (20914144, 'REACH'), (25567042, 'SPARSER'), (14958107, 'REACH'), (20225228, 'REACH'), (11374537, 'REACH'), (17220848, 'REACH'), (16742397, 'REACH'), (12965294, 'REACH'), (3926827, 'REACH'), (11447690, 'REACH'), (19661686, 'REACH'), (11600896, 'REACH'), (23830541, 'REACH'), (26936320, 'REACH'), (332494, 'REACH'), (29430478, 'REACH'), (556727, 'REACH'), (27979877, 'REACH'), (8536339, 'REACH'), (15432191, 'REACH'), (11442057, 'REACH'), (13408137, 'REACH'), (15844039, 'REACH'), (17384135, 'REACH'), (27082278, 'REACH'), (10682659, 'REACH'), (842242, 'REACH'), (26028976, 'REACH'), (22034798, 'REACH'), (22412854, 'REACH'), (15045604, 'REACH'), (13885389, 'REACH'), (815483, 'REACH'), (10696259, 'REACH'), (12463499, 'REACH'), (17524586, 'REACH'), (27682666, 'REACH'), (16118808, 'REACH'), (19133464, 'REACH'), (15842515, 'REACH'), (21645746, 'REACH'), (29215154, 'REACH'), (26188446, 'REACH'), (17689223, 'REACH'), (10105896, 'REACH'), (21902376, 'REACH'), (17744913, 'REACH'), (19879375, 'REACH'), (24040911, 'REACH'), (13073500, 'REACH'), (22117468, 'REACH'), (27103511, 'REACH'), (23448645, 'REACH'), (18496420, 'REACH'), (17384146, 'REACH'), (11983583, 'REACH'), (11077504, 'REACH'), (23926078, 'REACH'), (12476521, 'REACH'), (24023578, 'REACH'), (10056405, 'REACH'), (13415939, 'REACH'), (15024495, 'REACH'), (2838672, 'REACH'), (22597198, 'REACH'), (20691705, 'REACH'), (11107895, 'REACH'), (21592260, 'REACH'), (11744193, 'REACH'), (17557677, 'REACH'), (8389007, 'REACH'), (4267837, 'REACH'), (12959982, 'REACH'), (13529303, 'REACH'), (20348562, 'REACH'), (2378816, 'REACH'), (25480256, 'REACH'), (769534, 'REACH'), (20200085, 'REACH'), (18221507, 'REACH'), (15900348, 'REACH'), (13849322, 'REACH'), (21484266, 'REACH'), (29945335, 'REACH'), (888485, 'REACH'), (17308755, 'REACH'), (24070292, 'SPARSER'), (2705120, 'REACH'), (15779552, 'REACH'), (22037613, 'REACH'), (25684487, 'REACH'), (30525795, 'REACH'), (20757012, 'REACH'), (29819458, 'REACH'), (11744240, 'REACH'), (24458224, 'REACH'), (17662126, 'REACH'), (43638, 'REACH'), (29567606, 'REACH'), (28882527, 'REACH'), (17613210, 'REACH'), (26374531, 'REACH'), (628345, 'REACH'), (18142634, 'REACH'), (10099127, 'REACH'), (23172729, 'REACH'), (29597764, 'REACH'), (1168193, 'REACH'), (23424672, 'REACH'), (10551771, 'REACH'), (27609123, 'REACH'), (22271700, 'REACH'), (30166776, 'SPARSER'), (10678530, 'REACH'), (12448002, 'REACH'), (30152010, 'REACH'), (20973261, 'REACH'), (21555705, 'SPARSER'), (22928766, 'REACH'), (24184525, 'REACH'), (11260486, 'REACH'), (22368838, 'REACH'), (10712029, 'REACH'), (10230926, 'REACH'), (18355339, 'REACH'), (11094808, 'REACH'), (25611032, 'REACH'), (23591681, 'REACH'), (2720946, 'REACH'), (22008987, 'REACH'), (13009146, 'REACH'), (20790676, 'REACH'), (26860751, 'REACH'), (23234606, 'REACH'), (17553431, 'REACH'), (16605860, 'REACH'), (11857362, 'REACH'), (27541563, 'REACH'), (781161, 'REACH'), (13670439, 'REACH'), (13098696, 'REACH'), (11219042, 'REACH'), (13810799, 'REACH'), (22051127, 'REACH'), (28269462, 'REACH'), (23830468, 'REACH'), (21705074, 'REACH'), (477311, 'REACH'), (16730239, 'REACH'), (13640847, 'REACH'), (10669616, 'REACH'), (2412316, 'REACH'), (16506393, 'REACH'), (16703001, 'REACH'), (21609674, 'REACH'), (13098757, 'REACH'), (26324147, 'REACH'), (9533028, 'REACH'), (11570988, 'REACH'), (13012780, 'REACH'), (17601669, 'SPARSER'), (4166024, 'REACH'), (12441030, 'REACH'), (18142662, 'REACH'), (21097506, 'REACH'), (8134447, 'REACH'), (13635001, 'REACH'), (13831609, 'REACH'), (17337785, 'REACH'), (12395941, 'REACH'), (25747076, 'REACH'), (20793407, 'REACH'), (15668077, 'REACH'), (8389918, 'REACH'), (18789068, 'REACH'), (21581257, 'REACH'), (4325498, 'REACH'), (28639354, 'REACH'), (10402449, 'REACH'), (26974530, 'REACH'), (3922839, 'REACH'), (12639127, 'REACH'), (21985792, 'REACH'), (667149, 'REACH'), (9842189, 'REACH'), (3210220, 'REACH'), (12610281, 'REACH'), (19744922, 'REACH'), (555943, 'REACH'), (22718163, 'SPARSER'), (1909300, 'REACH'), (18257457, 'REACH'), (25375714, 'REACH'), (25882236, 'REACH'), (1970553, 'REACH'), (755882, 'REACH'), (15671108, 'REACH'), (1339614, 'REACH'), (28270197, 'REACH'), (15668262, 'REACH'), (28290851, 'REACH'), (30598612, 'REACH'), (24221527, 'REACH'), (21859832, 'REACH'), (21596805, 'REACH'), (9884726, 'REACH'), (18169723, 'REACH'), (15069865, 'REACH'), (2202714, 'REACH'), (770151, 'REACH'), (1687655, 'REACH'), (2680085, 'REACH'), (10797159, 'REACH'), (11718588, 'SPARSER'), (13855811, 'REACH'), (13303281, 'REACH'), (13952277, 'REACH'), (19492104, 'REACH'), (27025883, 'SPARSER'), (12620867, 'SPARSER'), (18199064, 'REACH'), (2302465, 'REACH'), (22221759, 'REACH'), (27450661, 'SPARSER'), (2162823, 'REACH'), (12361269, 'REACH'), (25224340, 'REACH'), (24158589, 'REACH'), (3593006, 'REACH'), (16156843, 'REACH'), (755883, 'REACH'), (11621166, 'REACH'), (21727403, 'REACH'), (23382794, 'REACH'), (3922104, 'REACH'), (29157957, 'REACH'), (11452662, 'REACH'), (8370735, 'SPARSER'), (26998994, 'REACH'), (10744031, 'REACH'), (13382462, 'REACH'), (10934124, 'REACH'), (3262057, 'REACH'), (26532296, 'REACH'), (28901789, 'REACH'), (27618382, 'REACH'), (334296, 'REACH'), (52709, 'REACH'), (18221505, 'REACH'), (9876745, 'REACH'), (29774325, 'REACH'), (15744934, 'REACH'), (1281364, 'REACH'), (12673745, 'REACH'), (27419345, 'REACH'), (20472939, 'REACH'), (18638794, 'REACH'), (15149573, 'REACH'), (28318643, 'REACH'), (21253476, 'REACH'), (13944161, 'REACH'), (11224039, 'REACH'), (25015432, 'REACH'), (11526736, 'REACH'), (16891068, 'REACH'), (11505086, 'SPARSER'), (1420676, 'REACH'), (27612584, 'REACH'), (1262438, 'REACH'), (1786726, 'REACH'), (23024112, 'REACH'), (10764541, 'REACH'), (17411758, 'REACH'), (25980971, 'REACH'), (18096601, 'REACH'), (22071180, 'SPARSER'), (30242193, 'SPARSER'), (27523955, 'REACH'), (889088, 'REACH'), (24930573, 'REACH'), (1356478, 'REACH'), (1697467, 'REACH'), (10934147, 'REACH'), (14866307, 'REACH'), (19656431, 'REACH'), (12563577, 'REACH'), (20824408, 'REACH'), (12664342, 'REACH'), (24599059, 'REACH'), (15243250, 'REACH'), (12739744, 'REACH'), (17556013, 'REACH'), (12822491, 'REACH'), (24392841, 'REACH'), (13690426, 'REACH'), (20941393, 'REACH'), (13640880, 'REACH'), (13837488, 'REACH'), (28765806, 'REACH'), (17483755, 'REACH'), (8234396, 'REACH'), (20029238, 'REACH'), (3198400, 'REACH'), (27485612, 'REACH'), (3504149, 'REACH'), (27820706, 'REACH'), (19020860, 'REACH'), (13178917, 'REACH'), (19830821, 'REACH'), (24376580, 'REACH'), (8425729, 'REACH'), (23400705, 'REACH'), (21295771, 'REACH'), (25457307, 'REACH'), (23684858, 'REACH'), (27380454, 'REACH'), (20959505, 'REACH'), (24653739, 'REACH'), (2410844, 'REACH'), (16925017, 'REACH'), (12054298, 'REACH'), (29821702, 'REACH'), (1956463, 'REACH'), (12803611, 'SPARSER'), (23668299, 'REACH'), (25695264, 'SPARSER'), (2209785, 'REACH'), (12138489, 'REACH'), (23869433, 'REACH'), (28290858, 'REACH'), (23268545, 'REACH'), (22101874, 'REACH'), (27485613, 'REACH'), (29189959, 'REACH'), (12664296, 'REACH'), (24373309, 'REACH'), (10757404, 'REACH'), (21964060, 'REACH'), (29883417, 'REACH'), (13349988, 'REACH'), (21509220, 'REACH'), (2718367, 'REACH'), (566349, 'REACH'), (20522061, 'REACH'), (21042683, 'REACH'), (29005307, 'REACH'), (18074343, 'REACH'), (20208533, 'REACH'), (13459828, 'REACH'), (25682292, 'REACH'), (9887023, 'REACH'), (14998831, 'REACH'), (23040349, 'REACH'), (12007950, 'REACH'), (18736057, 'REACH'), (21424467, 'REACH'), (25663617, 'REACH'), (2245170, 'REACH'), (21381918, 'REACH'), (24036297, 'REACH'), (17684047, 'REACH'), (28290859, 'REACH'), (28315868, 'REACH'), (12494710, 'REACH'), (10564644, 'REACH'), (25775905, 'REACH'), (25895949, 'REACH'), (12361347, 'REACH'), (8991202, 'REACH'), (1039855, 'REACH'), (15234320, 'REACH'), (20472861, 'REACH'), (23627027, 'REACH'), (25658643, 'REACH'), (21940166, 'SPARSER'), (10329599, 'REACH'), (12361215, 'REACH'), (22271710, 'REACH'), (13838220, 'REACH'), (10176199, 'REACH'), (22455656, 'REACH'), (16437798, 'REACH'), (23515686, 'REACH'), (849233, 'REACH'), (28164623, 'REACH'), (19376306, 'SPARSER'), (3132572, 'REACH'), (18435228, 'REACH'), (26466890, 'REACH'), (18172690, 'REACH'), (23284498, 'REACH'), (26542718, 'REACH'), (24098171, 'REACH'), (11183719, 'REACH'), (28701510, 'REACH'), (11452660, 'REACH'), (25697265, 'REACH'), (24932770, 'REACH'), (4291343, 'SPARSER'), (3610625, 'REACH'), (18454529, 'REACH'), (24880390, 'SPARSER'), (20667232, 'REACH'), (12730014, 'REACH'), (18923166, 'REACH'), (18493063, 'REACH'), (30129205, 'REACH'), (17553425, 'REACH'), (11740866, 'REACH'), (20817602, 'REACH'), (21113295, 'REACH'), (28911298, 'REACH'), (30075198, 'REACH'), (16566787, 'REACH'), (30016879, 'REACH'), (22679453, 'REACH'), (23891964, 'REACH'), (20472805, 'REACH'), (21517462, 'REACH'), (9640736, 'REACH'), (10955949, 'REACH'), (2661982, 'REACH'), (17768030, 'REACH'), (26324141, 'REACH'), (8969402, 'REACH'), (15073269, 'REACH'), (17714339, 'REACH'), (17910947, 'REACH'), (21504209, 'REACH'), (25413007, 'REACH'), (964400, 'REACH'), (29931312, 'REACH'), (10704924, 'REACH'), (17553436, 'REACH'), (21435607, 'REACH'), (10627077, 'REACH'), (18576822, 'REACH'), (22934966, 'REACH'), (26166116, 'REACH'), (30137185, 'REACH'), (10023570, 'REACH'), (11427904, 'REACH'), (17689224, 'REACH'), (2854339, 'REACH'), (12029379, 'REACH'), (25198672, 'REACH'), (2267229, 'REACH'), (30563779, 'SPARSER'), (18117489, 'SPARSER'), (2160513, 'REACH'), (22628730, 'REACH'), (20393479, 'REACH'), (15668136, 'REACH'), (2741803, 'REACH'), (2806935, 'REACH'), (23199685, 'REACH'), (10946130, 'REACH'), (8906568, 'REACH'), (2761094, 'REACH'), (10753411, 'REACH'), (20543507, 'REACH'), (18007515, 'REACH'), (28263899, 'REACH'), (1039654, 'REACH'), (25198673, 'REACH'), (4174095, 'REACH'), (27100270, 'REACH'), (21093276, 'REACH'), (11246902, 'REACH'), (12782879, 'REACH'), (13517760, 'REACH'), (989901, 'REACH'), (15408044, 'REACH'), (15668137, 'REACH'), (20179956, 'REACH'), (1767586, 'REACH'), (3569826, 'REACH'), (11744175, 'REACH'), (2065977, 'REACH'), (11765305, 'REACH'), (9932568, 'REACH'), (12664357, 'REACH'), (16149695, 'REACH'), (22558304, 'REACH'), (24754590, 'REACH'), (4236873, 'REACH'), (15668008, 'REACH'), (13431188, 'REACH'), (11215314, 'REACH'), (17550815, 'REACH'), (21646815, 'REACH'), (2218637, 'REACH'), (2493502, 'REACH'), (20548670, 'REACH'), (11105388, 'REACH'), (27915372, 'REACH'), (29224405, 'REACH'), (18961506, 'REACH'), (2166094, 'REACH'), (24499705, 'REACH'), (23301173, 'SPARSER'), (18423095, 'REACH'), (9424600, 'REACH'), (19196645, 'REACH'), (15668164, 'REACH'), (590529, 'REACH'), (20087489, 'REACH'), (24530047, 'REACH'), (29215871, 'REACH'), (24337384, 'REACH'), (24020331, 'REACH'), (20836554, 'REACH'), (25617367, 'REACH'), (27512440, 'REACH'), (16290565, 'REACH'), (28172467, 'REACH'), (18701921, 'REACH'), (13030792, 'REACH'), (25946566, 'REACH'), (1976567, 'REACH'), (25828438, 'REACH'), (29417522, 'REACH'), (2493503, 'REACH'), (13743820, 'REACH'), (8488199, 'REACH'), (19955345, 'REACH'), (20348561, 'REACH'), (24010050, 'REACH'), (29511598, 'REACH'), (26050872, 'REACH'), (1337029, 'REACH'), (16106870, 'REACH'), (11293220, 'REACH'), (19939308, 'REACH'), (9534024, 'REACH'), (19495496, 'REACH'), (19987329, 'SPARSER'), (23495814, 'REACH'), (24967752, 'REACH'), (28974211, 'REACH'), (9222114, 'REACH'), (13318114, 'REACH'), (19544034, 'REACH'), (29489736, 'REACH'), (13030777, 'REACH'), (22959481, 'REACH'), (414309, 'REACH'), (25723667, 'REACH'), (21473857, 'REACH'), (15893293, 'REACH'), (11410393, 'SPARSER'), (12255625, 'REACH'), (12658726, 'REACH'), (10248995, 'REACH'), (12811768, 'SPARSER'), (21437442, 'REACH'), (27523950, 'REACH'), (27807365, 'REACH'), (21290966, 'SPARSER'), (12853154, 'REACH'), (18718626, 'REACH'), (23039663, 'REACH'), (26757840, 'REACH'), (24034190, 'REACH'), (19328907, 'REACH'), (12385593, 'REACH'), (20953450, 'REACH'), (22034794, 'REACH'), (20198936, 'REACH'), (17774885, 'REACH'), (2623446, 'REACH'), (22271699, 'REACH'), (12273153, 'REACH'), (28493313, 'REACH'), (21509278, 'REACH'), (23495815, 'REACH'), (3281461, 'REACH'), (12948021, 'REACH'), (15857812, 'REACH'), (22043842, 'REACH'), (16783311, 'REACH'), (27647170, 'REACH'), (19994414, 'REACH'), (1595993, 'REACH'), (2513497, 'REACH'), (23858954, 'REACH'), (3294454, 'REACH'), (20268278, 'REACH'), (25085174, 'REACH'), (26373281, 'REACH'), (3601211, 'REACH'), (15528763, 'REACH'), (15779623, 'REACH'), (28241329, 'REACH'), (12607330, 'REACH'), (27523951, 'REACH'), (11744075, 'REACH'), (29566460, 'REACH'), (10362677, 'SPARSER'), (17345174, 'REACH'), (18930372, 'REACH'), (2668635, 'REACH'), (18149447, 'REACH'), (20607516, 'SPARSER'), (1086965, 'REACH'), (20311344, 'REACH'), (17910041, 'REACH'), (22628633, 'REACH'), (4233569, 'REACH'), (9875789, 'REACH'), (15239304, 'REACH'), (3286608, 'REACH'), (20800270, 'REACH'), (14913291, 'REACH'), (23858955, 'REACH'), (24371982, 'REACH'), (985496, 'REACH'), (1465939, 'REACH'), (2761092, 'REACH'), (595329, 'REACH'), (23781170, 'REACH'), (4183871, 'REACH'), (13784895, 'REACH'), (482505, 'REACH'), (10176358, 'REACH'), (11008401, 'REACH'), (27874800, 'REACH'), (10941079, 'REACH'), (10546209, 'REACH'), (794719, 'REACH'), (11867392, 'REACH'), (10644749, 'REACH'), (13463932, 'REACH'), (18647161, 'REACH'), (18347946, 'REACH'), (28808513, 'REACH'), (30152001, 'REACH'), (12781101, 'REACH'), (25672667, 'REACH'), (30523765, 'REACH'), (24474406, 'REACH'), (17002685, 'REACH'), (20105011, 'REACH'), (24474849, 'REACH'), (9970463, 'REACH'), (25469727, 'REACH'), (1683661, 'REACH'), (22769511, 'REACH'), (22415010, 'REACH'), (21509226, 'REACH'), (26655781, 'REACH'), (26331396, 'REACH'), (29312690, 'REACH'), (23552703, 'REACH'), (29646750, 'REACH'), (21062729, 'REACH'), (17674536, 'REACH'), (1039669, 'REACH'), (19668687, 'REACH'), (13030768, 'REACH'), (1909294, 'REACH'), (28680750, 'REACH'), (12658616, 'REACH'), (9900652, 'REACH'), (24020329, 'REACH'), (18801434, 'REACH'), (25825900, 'REACH'), (27386650, 'REACH'), (30511724, 'REACH'), (18992902, 'REACH'), (17662129, 'REACH'), (17632078, 'REACH'), (15546955, 'REACH'), (11897849, 'REACH'), (25200869, 'REACH'), (266831, 'SPARSER'), (27703725, 'REACH'), (20649819, 'REACH'), (12123578, 'REACH'), (8903075, 'REACH'), (18532436, 'REACH'), (21518755, 'REACH'), (11248491, 'REACH'), (26331397, 'REACH'), (13777590, 'REACH'), (29312691, 'REACH'), (27723876, 'REACH'), (28856210, 'REACH'), (13573791, 'REACH'), (12058944, 'REACH'), (26050880, 'REACH'), (26706240, 'REACH'), (11774459, 'REACH'), (27482189, 'REACH'), (2714921, 'REACH'), (11529513, 'REACH'), (16529114, 'REACH'), (30136397, 'REACH'), (12518946, 'REACH'), (23200267, 'REACH'), (27873015, 'REACH'), (25824595, 'REACH'), (480621, 'REACH'), (2446701, 'REACH'), (13686125, 'REACH'), (18642459, 'REACH'), (27612525, 'REACH'), (16114869, 'REACH'), (15208038, 'REACH'), (20844134, 'REACH'), (29597460, 'REACH'), (27983088, 'REACH'), (17454962, 'SPARSER'), (20473226, 'REACH'), (11412677, 'REACH'), (27523958, 'REACH'), (27740196, 'REACH'), (25658145, 'REACH'), (9595743, 'REACH'), (2854334, 'REACH'), (27923948, 'REACH'), (26239642, 'REACH'), (23838119, 'REACH'), (1030173, 'REACH'), (12690090, 'REACH'), (2502744, 'REACH'), (12005700, 'REACH'), (22653242, 'REACH'), (8354503, 'REACH'), (21518696, 'REACH'), (21485859, 'REACH'), (2560514, 'REACH'), (21054991, 'REACH'), (12290747, 'SPARSER'), (20087127, 'REACH'), (21272273, 'SPARSER'), (1895987, 'REACH'), (16805427, 'REACH'), (27330079, 'REACH'), (21866875, 'REACH'), (24305242, 'REACH'), (19921511, 'REACH'), (25182193, 'REACH'), (13854091, 'REACH'), (22374181, 'REACH'), (22767688, 'SPARSER'), (2854335, 'REACH'), (13667775, 'REACH'), (15171424, 'REACH'), (17436095, 'REACH'), (206330, 'REACH'), (15192117, 'REACH'), (22410723, 'REACH'), (23272465, 'REACH'), (13400770, 'REACH'), (25947599, 'REACH'), (16730224, 'REACH'), (20991278, 'REACH'), (9962565, 'REACH'), (1938340, 'REACH'), (10431806, 'REACH'), (1319430, 'REACH'), (23344052, 'REACH'), (3476401, 'REACH'), (19527010, 'REACH'), (22034799, 'REACH'), (28259252, 'REACH'), (4178940, 'REACH'), (19458602, 'REACH'), (23649240, 'REACH'), (11118742, 'REACH'), (23441604, 'REACH'), (8543835, 'REACH'), (28946185, 'REACH'), (3912693, 'REACH'), (22711088, 'REACH'), (12361323, 'REACH'), (9464837, 'REACH'), (28871094, 'REACH'), (2582372, 'REACH'), (15171425, 'REACH'), (19588160, 'REACH'), (13554138, 'REACH'), (28225160, 'REACH'), (18931569, 'REACH'), (2800733, 'REACH'), (22271676, 'REACH'), (13944150, 'REACH'), (20446514, 'REACH'), (1792713, 'REACH'), (1319431, 'REACH'), (27977062, 'REACH'), (28730726, 'REACH'), (11735572, 'REACH'), (22292086, 'SPARSER'), (19989245, 'REACH'), (21256366, 'REACH'), (19458603, 'REACH'), (2464312, 'REACH'), (13941737, 'REACH'), (24427497, 'REACH'), (11096661, 'REACH'), (19669454, 'REACH'), (24137931, 'REACH'), (20852581, 'REACH'), (30136388, 'REACH'), (28944882, 'REACH'), (14932223, 'REACH'), (17578908, 'SPARSER'), (19501350, 'REACH'), (27988262, 'REACH'), (27763793, 'REACH'), (11528450, 'REACH'), (20296975, 'REACH'), (3489766, 'SPARSER'), (15613645, 'REACH'), (19371945, 'REACH'), (1759578, 'REACH'), (12313959, 'REACH'), (21849447, 'REACH'), (791061, 'REACH'), (3609109, 'REACH'), (16124486, 'REACH'), (20318790, 'REACH'), (27977063, 'REACH'), (19348642, 'REACH'), (28730727, 'REACH'), (28511371, 'REACH'), (11107900, 'REACH'), (22150716, 'REACH'), (24183576, 'REACH'), (11874853, 'REACH'), (23646977, 'REACH'), (3603634, 'REACH'), (18358253, 'REACH'), (9829790, 'REACH'), (23579468, 'REACH'), (14899785, 'REACH'), (26466889, 'REACH'), (24435509, 'REACH'), (28453091, 'REACH'), (19920276, 'REACH'), (25021942, 'SPARSER'), (13493698, 'REACH'), (29468899, 'REACH'), (28498347, 'REACH'), (28912650, 'REACH'), (25028851, 'REACH'), (24159698, 'REACH'), (25601490, 'REACH'), (26654779, 'REACH'), (19669461, 'REACH'), (18514254, 'REACH'), (11884619, 'REACH'), (24100604, 'REACH'), (27482187, 'REACH'), (30136395, 'REACH'), (8835383, 'REACH'), (24695340, 'SPARSER'), (18294465, 'REACH'), (18655602, 'REACH'), (23126143, 'REACH'), (8201760, 'REACH'), (12501342, 'REACH'), (13631464, 'REACH'), (9456806, 'REACH'), (18345556, 'REACH'), (11628497, 'REACH'), (20449410, 'REACH'), (28501552, 'REACH'), (3288896, 'REACH'), (27014362, 'REACH'), (16325492, 'REACH'), (17100624, 'REACH'), (22889051, 'SPARSER'), (11140110, 'REACH'), (13211659, 'REACH'), (28383243, 'REACH'), (26875524, 'REACH'), (12385566, 'REACH'), (21777100, 'REACH'), (10192329, 'REACH'), (26105978, 'REACH'), (19671139, 'REACH'), (11574548, 'REACH'), (28544509, 'REACH'), (15819694, 'REACH'), (15132787, 'REACH'), (23045458, 'REACH'), (16771423, 'REACH'), (23521631, 'REACH'), (28255570, 'REACH'), (734188, 'REACH'), (29115113, 'REACH'), (219270, 'REACH'), (13523078, 'REACH'), (19966946, 'REACH'), (28551374, 'REACH'), (16505803, 'REACH'), (26322556, 'REACH'), (29953207, 'REACH'), (15667990, 'REACH'), (19154707, 'REACH'), (12474180, 'REACH'), (13784900, 'REACH'), (21509339, 'REACH'), (28870025, 'REACH'), (16718023, 'REACH'), (15911974, 'REACH'), (8969684, 'REACH'), (22983065, 'REACH'), (28177482, 'REACH'), (29279736, 'REACH'), (2802309, 'REACH'), (21982262, 'REACH'), (13810719, 'REACH'), (26588657, 'REACH'), (11784925, 'REACH'), (1379322, 'SPARSER'), (13482966, 'REACH'), (10627795, 'REACH'), (8897028, 'REACH'), (16770994, 'REACH'), (11611071, 'REACH'), (2032969, 'REACH'), (15045603, 'REACH'), (26226288, 'REACH'), (19556772, 'REACH'), (9493888, 'REACH'), (19330875, 'REACH'), (15668066, 'REACH'), (3716939, 'REACH'), (651513, 'REACH'), (19870775, 'REACH'), (13554136, 'REACH'), (10192357, 'REACH'), (8472399, 'SPARSER'), (16178464, 'REACH'), (8287303, 'REACH'), (13944148, 'REACH'), (1152895, 'SPARSER'), (18714498, 'REACH'), (13541680, 'REACH'), (30151997, 'REACH'), (18071278, 'REACH'), (10959979, 'REACH'), (17382507, 'REACH'), (26492654, 'REACH'), (2834378, 'REACH'), (11439831, 'REACH'), (24328118, 'REACH'), (8770483, 'REACH'), (19747763, 'REACH'), (11999808, 'REACH'), (13422531, 'REACH'), (18013553, 'REACH'), (20265552, 'REACH'), (26813195, 'REACH'), (1596407, 'REACH'), (25025527, 'REACH'), (10749093, 'REACH'), (16798514, 'REACH'), (28289855, 'REACH'), (17002697, 'REACH'), (17621882, 'REACH'), (18735994, 'REACH'), (29915609, 'REACH'), (18511511, 'REACH'), (11547077, 'REACH'), (13849459, 'REACH'), (20357153, 'REACH'), (30136402, 'REACH'), (29516895, 'REACH'), (29014505, 'REACH'), (12658773, 'REACH'), (18714499, 'REACH'), (13081905, 'REACH'), (9228002, 'REACH'), (10771099, 'SPARSER'), (12658638, 'REACH'), (26834454, 'REACH'), (28764481, 'REACH'), (25710578, 'REACH'), (12664378, 'REACH'), (20543431, 'REACH'), (23446901, 'REACH'), (26638118, 'REACH'), (12403924, 'REACH'), (29508820, 'REACH'), (86799, 'REACH'), (30320644, 'SPARSER'), (3262062, 'REACH'), (9248156, 'REACH'), (13831557, 'REACH'), (2098404, 'REACH'), (11076836, 'REACH'), (23704594, 'REACH'), (21772962, 'REACH'), (24961501, 'REACH'), (20621963, 'REACH'), (26654777, 'REACH'), (12658794, 'REACH'), (9407748, 'REACH'), (11479297, 'REACH'), (29018208, 'REACH'), (22913356, 'REACH'), (29012884, 'REACH'), (23796674, 'REACH'), (15573117, 'REACH'), (27074685, 'REACH'), (29942108, 'REACH'), (12613143, 'REACH'), (11439859, 'REACH'), (12147666, 'REACH'), (22034793, 'REACH'), (20166183, 'REACH'), (11390562, 'REACH'), (17712321, 'REACH'), (25229170, 'REACH'), (30288980, 'SPARSER'), (9874267, 'REACH'), (11086683, 'REACH'), (13680455, 'REACH'), (23765670, 'REACH'), (2616404, 'REACH'), (27618388, 'REACH'), (2759964, 'REACH'), (11472133, 'REACH'), (2776141, 'REACH'), (16290558, 'REACH'), (177045, 'REACH'), (12868291, 'REACH'), (16754801, 'REACH'), (30151983, 'REACH'), (1811388, 'REACH'), (29115127, 'REACH'), (1465942, 'REACH'), (19139716, 'REACH'), (9902878, 'REACH'), (25979419, 'REACH'), (15479572, 'REACH'), (10544939, 'REACH'), (15349957, 'REACH'), (19367713, 'REACH'), (2631322, 'REACH'), (2814375, 'REACH'), (24932775, 'REACH'), (12398421, 'REACH'), (19512966, 'REACH'), (10237571, 'REACH'), (17380995, 'REACH'), (25243477, 'REACH'), (28316744, 'REACH'), (29013635, 'REACH'), (23009739, 'REACH'), (30039164, 'REACH'), (29291608, 'REACH'), (10173715, 'REACH'), (1070404, 'REACH'), (27579099, 'REACH'), (11889190, 'REACH'), (26274342, 'REACH'), (1281361, 'REACH'), (19793840, 'REACH'), (22153136, 'REACH'), (11380055, 'REACH'), (1909299, 'REACH'), (28680755, 'REACH'), (11744225, 'REACH'), (3562015, 'REACH'), (3502272, 'REACH'), (27525637, 'SPARSER'), (15088405, 'REACH'), (9473232, 'REACH'), (12066190, 'REACH'), (25435534, 'REACH'), (24564586, 'REACH'), (12395954, 'REACH'), (24476059, 'REACH'), (9496652, 'REACH'), (88570, 'REACH'), (27760, 'REACH'), (29265579, 'REACH'), (19671132, 'REACH'), (25901322, 'REACH'), (898783, 'REACH'), (11654016, 'REACH'), (28826729, 'REACH'), (2575898, 'REACH'), (14929434, 'REACH'), (26889941, 'REACH'), (16770566, 'REACH'), (22308358, 'REACH'), (10563505, 'REACH'), (22497634, 'REACH'), (22889060, 'SPARSER'), (29018013, 'REACH'), (24186410, 'REACH'), (24427493, 'REACH'), (18592544, 'REACH'), (12301918, 'REACH'), (10408539, 'REACH'), (21044456, 'REACH'), (12336366, 'REACH'), (3138329, 'REACH'), (24371993, 'REACH'), (21375634, 'REACH'), (1120507, 'REACH'), (16012762, 'REACH'), (1677799, 'REACH'), (12229095, 'REACH'), (19800712, 'REACH'), (11574542, 'REACH'), (23502094, 'REACH'), (25104106, 'REACH'), (88567, 'REACH'), (2718373, 'REACH'), (23746902, 'REACH'), (18532435, 'REACH'), (1427775, 'REACH'), (27963501, 'REACH'), (22308359, 'REACH'), (15571302, 'REACH'), (2168340, 'REACH'), (21206548, 'REACH'), (21745648, 'REACH'), (3603630, 'REACH'), (22384171, 'REACH'), (16118748, 'REACH'), (16806876, 'REACH'), (23044057, 'REACH'), (18988626, 'REACH'), (10620672, 'REACH'), (2187241, 'REACH'), (13090202, 'REACH'), (30007112, 'REACH'), (20857701, 'REACH'), (26166117, 'REACH'), (2718368, 'REACH'), (22818861, 'REACH'), (24503774, 'REACH'), (24086156, 'REACH'), (2561082, 'REACH'), (2463175, 'REACH'), (12658792, 'REACH'), (18735989, 'REACH'), (20190266, 'REACH'), (30151974, 'REACH'), (22610644, 'REACH'), (2567426, 'REACH'), (1356477, 'REACH'), (10961226, 'REACH'), (18736005, 'REACH'), (29585121, 'REACH'), (24848914, 'REACH'), (26334124, 'REACH'), (26028969, 'REACH'), (204122, 'REACH'), (10820954, 'REACH'), (15571303, 'REACH'), (12062278, 'REACH'), (16092742, 'REACH'), (26049488, 'REACH'), (24737386, 'REACH'), (2027934, 'REACH'), (24932766, 'REACH'), (17017640, 'REACH'), (28650280, 'REACH'), (22853862, 'REACH'), (23804134, 'REACH'), (16738708, 'REACH'), (19076881, 'REACH'), (10105879, 'REACH'), (24503775, 'REACH'), (27553076, 'SPARSER'), (30103168, 'REACH'), (238654, 'REACH'), (19020859, 'REACH'), (9618901, 'REACH'), (23986438, 'REACH'), (9484977, 'REACH'), (24377232, 'REACH'), (1039658, 'REACH'), (25777463, 'REACH'), (11215589, 'REACH'), (13400769, 'REACH'), (25787073, 'REACH'), (30010738, 'REACH'), (10681261, 'REACH'), (27491245, 'REACH'), (30152007, 'REACH'), (12121064, 'REACH'), (8348405, 'REACH'), (10378603, 'REACH'), (27916690, 'REACH'), (25809150, 'REACH'), (12571029, 'REACH'), (11989006, 'REACH'), (23510027, 'REACH'), (11791975, 'SPARSER'), (15339941, 'REACH'), (238655, 'REACH'), (12395583, 'REACH'), (21315686, 'REACH'), (20472911, 'REACH'), (9791406, 'REACH'), (25005788, 'REACH'), (18356119, 'REACH'), (13098693, 'REACH'), (26197366, 'REACH'), (22448676, 'REACH'), (306527, 'REACH'), (1038316, 'REACH'), (22009836, 'REACH'), (13640858, 'REACH'), (10934183, 'REACH'), (2563636, 'REACH'), (2245169, 'REACH'), (22913808, 'REACH'), (21581177, 'REACH'), (2752695, 'REACH'), (17662135, 'REACH'), (23655000, 'REACH'), (23953591, 'REACH'), (16716799, 'REACH'), (28808191, 'REACH'), (30465223, 'REACH'), (25195368, 'REACH'), (4229355, 'REACH'), (26843640, 'REACH'), (21220836, 'REACH'), (18514194, 'REACH'), (8925215, 'REACH'), (15562819, 'REACH'), (22271709, 'REACH'), (13838219, 'REACH'), (9236842, 'REACH'), (23686680, 'REACH'), (23424723, 'REACH'), (18496434, 'REACH'), (16771424, 'REACH'), (3656245, 'REACH'), (19003634, 'SPARSER'), (20473003, 'REACH'), (23655001, 'REACH'), (15429438, 'REACH'), (16251952, 'SPARSER'), (15115116, 'REACH'), (22459848, 'REACH'), (21322758, 'REACH'), (28892166, 'REACH'), (22947249, 'REACH'), (27482190, 'REACH'), (30136398, 'REACH'), (27852284, 'REACH'), (28769788, 'REACH'), (18958391, 'REACH'), (21315698, 'REACH'), (21643378, 'REACH'), (18230366, 'REACH'), (12062811, 'REACH'), (20101864, 'REACH'), (22362856, 'REACH'), (24456693, 'REACH'), (29825699, 'REACH'), (30075197, 'REACH'), (143467, 'REACH'), (21042716, 'REACH'), (23037445, 'REACH'), (24184325, 'REACH'), (17209267, 'REACH'), (15915935, 'REACH'), (20225600, 'REACH'), (23961152, 'REACH'), (26552653, 'REACH'), (25333289, 'REACH'), (19777140, 'REACH'), (1103650, 'REACH'), (16805423, 'REACH'), (3659357, 'REACH'), (16554149, 'REACH'), (3938098, 'REACH'), (3494112, 'REACH'), (21116525, 'REACH'), (24405787, 'REACH'), (21325690, 'REACH'), (26166115, 'REACH'), (26349040, 'REACH'), (15674411, 'REACH'), (10927577, 'REACH'), (19870776, 'REACH'), (20993907, 'REACH'), (13874468, 'REACH'), (15341663, 'REACH'), (29663980, 'REACH'), (17497577, 'REACH'), (19070280, 'REACH'), (25513045, 'REACH'), (29115106, 'REACH'), (18788266, 'REACH'), (16993207, 'REACH'), (18631607, 'REACH'), (24653738, 'REACH'), (22284822, 'REACH'), (24726455, 'REACH'), (1128143, 'SPARSER'), (24779519, 'REACH'), (22379486, 'REACH'), (20144265, 'REACH'), (3642984, 'REACH'), (19989250, 'REACH'), (15562511, 'REACH'), (23105712, 'REACH'), (10204139, 'REACH'), (25727388, 'REACH'), (2761093, 'REACH'), (1985334, 'REACH'), (11078881, 'REACH'), (23681472, 'REACH'), (25114494, 'REACH'), (25698053, 'SPARSER'), (26800986, 'REACH'), (24002568, 'REACH'), (14955541, 'REACH'), (29730663, 'REACH'), (10099152, 'REACH'), (18378379, 'REACH'), (13920316, 'REACH'), (8183102, 'SPARSER'), (22014012, 'REACH'), (26209931, 'REACH'), (2276632, 'REACH'), (29212338, 'REACH'), (2329696, 'REACH'), (9916909, 'REACH'), (13390317, 'REACH'), (796390, 'REACH'), (29115107, 'REACH'), (20573457, 'REACH'), (9674690, 'REACH'), (10835663, 'REACH'), (13260495, 'REACH'), (2606205, 'REACH'), (13831536, 'REACH'), (22271695, 'REACH'), (23992878, 'REACH'), (19951114, 'REACH'), (10616760, 'REACH'), (16716790, 'REACH'), (29430774, 'REACH'), (118689, 'REACH'), (16797601, 'REACH'), (23841319, 'REACH'), (11118792, 'REACH'), (27214434, 'REACH'), (10696303, 'REACH'), (1934206, 'SPARSER'), (13831574, 'REACH'), (17042716, 'SPARSER'), (12314278, 'REACH'), (12421614, 'REACH'), (17994012, 'REACH'), (19590858, 'REACH'), (28635830, 'REACH'), (29212339, 'REACH'), (16474212, 'REACH'), (8824722, 'REACH'), (28235423, 'REACH'), (3674189, 'REACH'), (8389929, 'REACH'), (8138458, 'REACH'), (1945542, 'REACH'), (29212020, 'REACH'), (18155823, 'REACH'), (29956432, 'REACH'), (21581149, 'REACH'), (24431965, 'REACH'), (10616761, 'REACH'), (13893561, 'REACH'), (2081944, 'REACH'), (13550744, 'REACH'), (25408625, 'SPARSER'), (13682003, 'REACH'), (2563634, 'REACH'), (2834377, 'REACH'), (2618119, 'REACH'), (19165959, 'REACH'), (28701447, 'REACH'), (21509265, 'REACH'), (1100610, 'REACH'), (29721167, 'REACH'), (13862318, 'REACH'), (21562798, 'REACH'), (24239498, 'REACH'), (15073080, 'REACH'), (1335332, 'REACH'), (19348257, 'REACH'), (22559521, 'REACH'), (25457664, 'REACH'), (8839611, 'REACH'), (313987, 'REACH'), (23465442, 'REACH'), (2718378, 'REACH'), (21782629, 'REACH'), (13365523, 'REACH'), (17985811, 'REACH'), (12354270, 'REACH'), (30113909, 'REACH'), (26484692, 'REACH'), (20994204, 'REACH'), (20645880, 'REACH'), (8879237, 'REACH'), (4236851, 'REACH'), (10518047, 'REACH'), (24818880, 'REACH'), (20315774, 'REACH'), (2711931, 'REACH'), (30178942, 'REACH'), (13690435, 'REACH'), (2193393, 'REACH'), (17758193, 'REACH'), (22216912, 'REACH'), (25775325, 'REACH'), (30650766, 'REACH'), (11086649, 'REACH'), (21736249, 'REACH'), (189464, 'REACH'), (18142678, 'REACH'), (24499670, 'REACH'), (293892, 'REACH'), (1587040, 'REACH'), (2780397, 'REACH'), (445086, 'REACH'), (16542957, 'REACH'), (24878491, 'REACH'), (27539296, 'REACH'), (10066567, 'REACH'), (23586869, 'REACH'), (26181268, 'REACH'), (23704593, 'REACH'), (24515266, 'REACH'), (17368527, 'REACH'), (2763868, 'REACH'), (24173834, 'REACH'), (18111222, 'REACH'), (26028964, 'REACH'), (2153121, 'REACH'), (24959649, 'REACH'), (26024413, 'SPARSER'), (18496397, 'REACH'), (1099070, 'REACH'), (28182843, 'REACH'), (22279463, 'REACH'), (21717717, 'REACH'), (4387183, 'REACH'), (12889655, 'REACH'), (13538264, 'REACH'), (10308190, 'REACH'), (28179665, 'REACH'), (30650767, 'REACH'), (22635312, 'REACH'), (1587041, 'REACH'), (8404032, 'REACH'), (2725932, 'REACH'), (22255660, 'REACH'), (11781167, 'REACH'), (29621328, 'REACH'), (29115114, 'REACH'), (10034679, 'REACH'), (11872132, 'REACH'), (23966829, 'REACH'), (332489, 'REACH'), (23270089, 'REACH'), (22044006, 'REACH'), (26697062, 'REACH'), (17792913, 'REACH'), (806223, 'REACH'), (17002670, 'REACH'), (22794808, 'REACH'), (17017636, 'REACH'), (1655552, 'REACH'), (19612416, 'REACH'), (10389691, 'REACH'), (9249004, 'REACH'), (1168200, 'REACH'), (18999893, 'REACH'), (2761091, 'REACH'), (22932118, 'SPARSER'), (25466627, 'SPARSER'), (10657440, 'REACH'), (13573792, 'REACH'), (2218636, 'REACH'), (12750473, 'REACH'), (12658746, 'REACH'), (29993415, 'REACH'), (1030179, 'REACH'), (17479715, 'REACH'), (25607856, 'REACH'), (13743805, 'REACH'), (24447445, 'SPARSER'), (18992888, 'REACH'), (27707108, 'REACH'), (667154, 'REACH'), (13831550, 'REACH'), (18347948, 'REACH'), (21113365, 'REACH'), (1294918, 'REACH'), (23020102, 'REACH'), (27738694, 'REACH'), (12566257, 'REACH'), (22998959, 'REACH'), (11403216, 'REACH'), (23415950, 'REACH'), (10696252, 'REACH'), (21353017, 'REACH'), (20433514, 'REACH'), (26274341, 'REACH'), (9921120, 'REACH'), (8557982, 'REACH'), (10749083, 'REACH'), (13177417, 'REACH'), (28290856, 'REACH'), (1868003, 'REACH'), (11447700, 'REACH'), (22970595, 'REACH'), (25513167, 'REACH'), (13675376, 'REACH'), (24697469, 'REACH'), (1030190, 'REACH'), (24932779, 'REACH'), (24552284, 'REACH'), (15680522, 'REACH'), (3204513, 'REACH'), (26568097, 'REACH'), (28810706, 'REACH'), (16674530, 'SPARSER'), (18378811, 'REACH'), (10797164, 'REACH'), (13092903, 'REACH'), (28367317, 'REACH'), (25607857, 'REACH'), (29718862, 'REACH'), (27948796, 'REACH'), (1599799, 'REACH'), (2317016, 'REACH'), (28207415, 'REACH'), (10062742, 'REACH'), (10934163, 'REACH'), (14866323, 'REACH'), (18185921, 'REACH'), (29583671, 'REACH'), (24674221, 'REACH'), (22034782, 'REACH'), (17788251, 'REACH'), (15109641, 'REACH'), (21739496, 'REACH'), (20486051, 'REACH'), (19807792, 'REACH'), (23968376, 'REACH'), (1560325, 'REACH'), (17852598, 'REACH'), (18992901, 'REACH'), (29157558, 'REACH'), (24288041, 'REACH'), (11289831, 'REACH'), (18662631, 'REACH'), (26952935, 'REACH'), (2172752, 'REACH'), (30156624, 'REACH'), (1979678, 'REACH'), (17002618, 'REACH'), (3270141, 'REACH'), (11599160, 'REACH'), (15901023, 'REACH'), (8302523, 'REACH'), (18705388, 'REACH'), (9263445, 'REACH'), (3281460, 'REACH'), (23640234, 'REACH'), (14950622, 'REACH'), (12373211, 'REACH'), (26627291, 'REACH'), (1016870, 'REACH'), (384803, 'REACH'), (25105876, 'REACH'), (2172753, 'REACH'), (9414481, 'REACH'), (15668239, 'REACH'), (28878673, 'REACH'), (30156625, 'REACH'), (13588334, 'REACH'), (11078891, 'REACH'), (10415390, 'SPARSER'), (14957189, 'REACH'), (25055528, 'SPARSER'), (22282724, 'REACH'), (2180370, 'REACH'), (12702400, 'REACH'), (22434942, 'REACH'), (29840661, 'REACH'), (13815110, 'REACH'), (1502705, 'REACH'), (23751389, 'REACH'), (19856267, 'REACH'), (28758503, 'SPARSER'), (30151973, 'REACH'), (30536662, 'REACH'), (29497860, 'REACH'), (21704032, 'REACH'), (30190156, 'REACH'), (1909288, 'REACH'), (28680744, 'REACH'), (20697469, 'REACH'), (10381916, 'REACH'), (22284055, 'REACH'), (29071941, 'REACH'), (25071622, 'REACH'), (18072579, 'REACH'), (24932765, 'REACH'), (2776142, 'REACH'), (1030186, 'REACH'), (22460458, 'REACH'), (26773976, 'REACH'), (10034835, 'REACH'), (794718, 'REACH'), (20488286, 'REACH'), (24569879, 'SPARSER'), (23039674, 'REACH'), (25321123, 'REACH'), (16850815, 'SPARSER'), (28368783, 'REACH'), (8124720, 'REACH'), (16808240, 'REACH'), (25232009, 'SPARSER'), (22008939, 'REACH'), (28703024, 'REACH'), (13640985, 'REACH'), (29413302, 'REACH'), (22973363, 'REACH'), (19907730, 'REACH'), (15541876, 'SPARSER'), (18512635, 'REACH'), (1909289, 'REACH'), (9803738, 'REACH'), (28680745, 'REACH'), (2818197, 'REACH'), (21894513, 'REACH'), (26324156, 'REACH'), (30260670, 'SPARSER'), (23888241, 'SPARSER'), (999809, 'REACH'), (8268397, 'REACH'), (15088411, 'REACH'), (10099148, 'REACH'), (11868620, 'REACH'), (11254650, 'REACH'), (24484300, 'REACH'), (28386127, 'REACH'), (9916889, 'REACH'), (13554137, 'REACH'), (18633177, 'REACH'), (26374226, 'REACH'), (1235213, 'REACH'), (22271675, 'REACH'), (11642604, 'REACH'), (19572460, 'REACH'), (11012404, 'REACH'), (13885390, 'REACH'), (2764310, 'REACH'), (22556182, 'REACH'), (12301892, 'REACH'), (19939649, 'REACH'), (28323350, 'REACH'), (19398868, 'SPARSER'), (29417215, 'REACH'), (11706334, 'REACH'), (24954403, 'REACH'), (113876, 'REACH'), (26586301, 'REACH'), (19855339, 'REACH'), (18973514, 'REACH'), (1356375, 'REACH'), (12104279, 'REACH'), (24109096, 'SPARSER'), (14904525, 'REACH'), (18643579, 'REACH'), (8426924, 'REACH'), (9268649, 'REACH'), (27485615, 'REACH'), (28810704, 'REACH'), (1052729, 'REACH'), (12836970, 'REACH'), (26087481, 'REACH'), (17592600, 'REACH'), (23234597, 'REACH'), (28818295, 'REACH'), (25923027, 'REACH'), (13640964, 'REACH'), (25273604, 'REACH'), (13098687, 'REACH'), (23199840, 'REACH'), (12559003, 'REACH'), (12919451, 'REACH'), (17027145, 'REACH'), (23501132, 'REACH'), (572295, 'REACH'), (14827571, 'SPARSER'), (18496391, 'REACH'), (28514636, 'REACH'), (641940, 'REACH'), (1196095, 'SPARSER'), (15813524, 'REACH'), (26757839, 'REACH'), (10329646, 'REACH'), (22221752, 'REACH'), (988114, 'REACH'), (15668178, 'REACH'), (19324478, 'REACH'), (3305219, 'REACH'), (294065, 'REACH'), (19826274, 'REACH'), (2334506, 'REACH'), (18886872, 'REACH'), (21115096, 'REACH'), (29491606, 'REACH'), (21978751, 'REACH'), (8928288, 'REACH'), (2718374, 'REACH'), (20651473, 'REACH'), (11816578, 'REACH'), (23595663, 'REACH'), (9869373, 'REACH'), (9825305, 'REACH'), (24257226, 'REACH'), (13640965, 'REACH'), (17620288, 'REACH'), (641941, 'REACH'), (17518964, 'REACH'), (913954, 'REACH'), (20078091, 'REACH'), (23796668, 'REACH'), (22221753, 'REACH'), (18684056, 'REACH'), (12684197, 'REACH'), (2212996, 'REACH'), (12104242, 'REACH'), (20145727, 'REACH'), (30552626, 'REACH'), (22216908, 'REACH'), (25611028, 'REACH'), (11013954, 'REACH'), (14904537, 'REACH'), (20705477, 'REACH'), (29781619, 'REACH'), (12172114, 'REACH'), (26167135, 'REACH'), (29905933, 'REACH'), (25013320, 'REACH'), (10399796, 'REACH'), (29058320, 'REACH'), (9245725, 'REACH'), (9916875, 'REACH'), (27840971, 'REACH'), (667513, 'REACH'), (27618392, 'REACH'), (20472933, 'REACH'), (23489860, 'REACH'), (15246673, 'REACH'), (13296182, 'REACH'), (27484726, 'REACH'), (8972260, 'REACH'), (9902856, 'REACH'), (29725461, 'REACH'), (18113350, 'REACH'), (20855363, 'REACH'), (18563293, 'REACH'), (27214045, 'REACH'), (19196374, 'REACH'), (8128513, 'REACH'), (10242912, 'REACH'), (15597805, 'REACH'), (1030184, 'REACH'), (10710069, 'REACH'), (11217382, 'REACH'), (16552596, 'REACH'), (24561681, 'REACH'), (29364884, 'REACH'), (1614960, 'REACH'), (14866301, 'REACH'), (24192112, 'REACH'), (13254748, 'REACH'), (16750290, 'REACH'), (27520735, 'REACH'), (22074338, 'SPARSER'), (27330074, 'REACH'), (26458627, 'REACH'), (24440756, 'REACH'), (18612578, 'REACH'), (29673002, 'REACH'), (18023574, 'REACH'), (27919510, 'REACH'), (24098175, 'REACH'), (25015679, 'REACH'), (806074, 'REACH'), (10850513, 'REACH'), (28676305, 'REACH'), (16800537, 'REACH'), (3493322, 'REACH'), (2782052, 'REACH'), (18576799, 'REACH'), (10473536, 'REACH'), (24877172, 'REACH'), (29431855, 'REACH'), (20296974, 'REACH'), (10985555, 'REACH'), (27387777, 'REACH'), (1840779, 'SPARSER'), (9521261, 'REACH'), (16730221, 'REACH'), (12361223, 'REACH'), (15408647, 'REACH'), (667156, 'REACH'), (12186513, 'REACH'), (28323348, 'REACH'), (29942095, 'REACH'), (15348910, 'REACH'), (4245035, 'REACH'), (19068472, 'REACH'), (19511903, 'REACH'), (20757087, 'REACH'), (22910792, 'REACH'), (18296405, 'REACH'), (19590964, 'REACH'), (3276002, 'REACH'), (3142895, 'REACH'), (12839804, 'REACH'), (17835030, 'REACH'), (17606465, 'REACH'), (13153755, 'REACH'), (17096332, 'REACH'), (28554715, 'REACH'), (2378810, 'REACH'), (25787427, 'REACH'), (26278947, 'REACH'), (18081026, 'REACH'), (17260815, 'REACH'), (86103, 'REACH'), (13455447, 'REACH'), (19258245, 'REACH'), (27319173, 'REACH'), (29115128, 'REACH'), (24815329, 'REACH'), (25765601, 'REACH'), (736543, 'REACH'), (23200264, 'REACH'), (667157, 'REACH'), (28323349, 'REACH'), (125251, 'REACH'), (28187636, 'REACH'), (78800, 'REACH'), (1493564, 'REACH'), (26900025, 'REACH'), (22544152, 'REACH'), (18256086, 'REACH'), (26486962, 'REACH'), (20994203, 'REACH'), (17684041, 'REACH'), (2098403, 'REACH'), (9916866, 'REACH'), (30178941, 'REACH'), (2340267, 'REACH'), (26384394, 'REACH'), (13323287, 'REACH'), (28383242, 'REACH'), (18290501, 'REACH'), (26349046, 'REACH'), (12238303, 'REACH'), (10226317, 'REACH'), (9368635, 'REACH'), (21417264, 'SPARSER'), (17384136, 'REACH'), (28810709, 'REACH'), (16079110, 'REACH'), (26335494, 'REACH'), (1016930, 'REACH'), (30113496, 'REACH'), (24648421, 'REACH'), (2733192, 'SPARSER'), (15668141, 'REACH'), (28926299, 'REACH'), (29942107, 'REACH'), (23200265, 'REACH'), (27339683, 'REACH'), (13195860, 'REACH'), (9525844, 'REACH'), (19900559, 'REACH'), (30208560, 'REACH'), (17552156, 'REACH'), (9519641, 'REACH'), (9806026, 'REACH'), (13226967, 'REACH'), (10468984, 'REACH'), (1655557, 'REACH'), (22859361, 'REACH'), (17112059, 'REACH'), (13483817, 'REACH'), (9363674, 'REACH'), (18413799, 'REACH'), (27543957, 'REACH'), (10934132, 'REACH'), (24787388, 'REACH'), (22839786, 'REACH'), (28593238, 'REACH'), (13928275, 'REACH'), (2802308, 'REACH'), (18465412, 'REACH'), (28649758, 'REACH'), (13295643, 'REACH'), (10711497, 'REACH'), (1016931, 'REACH'), (22032017, 'REACH'), (19467586, 'REACH'), (20692910, 'REACH'), (21745559, 'REACH'), (27570488, 'REACH'), (25575972, 'REACH'), (18317246, 'REACH'), (25690046, 'REACH'), (8876012, 'REACH'), (11574613, 'REACH'), (12658658, 'REACH'), (28256226, 'REACH'), (29580048, 'REACH'), (17302734, 'REACH'), (12454488, 'REACH'), (14910053, 'REACH'), (9363675, 'REACH'), (13030796, 'REACH'), (8614281, 'REACH'), (20167101, 'REACH'), (24787389, 'REACH'), (22442652, 'REACH'), (18615705, 'REACH'), (25457308, 'REACH'), (19902968, 'REACH'), (19512965, 'REACH'), (30330931, 'REACH'), (27525026, 'SPARSER'), (22262444, 'REACH'), (18441897, 'REACH'), (24576090, 'REACH'), (9054570, 'REACH'), (1615384, 'REACH'), (13456306, 'REACH'), (18263789, 'REACH'), (160073, 'REACH'), (1512977, 'REACH'), (8230417, 'REACH'), (21042705, 'REACH'), (21632529, 'REACH'), (22091281, 'REACH'), (26531197, 'REACH'), (12926123, 'REACH'), (19918428, 'REACH'), (12582666, 'REACH'), (15088407, 'REACH'), (27080487, 'REACH'), (17302741, 'REACH'), (17430531, 'REACH'), (14942864, 'REACH'), (21585975, 'REACH'), (29364883, 'REACH'), (22820978, 'REACH'), (21486253, 'REACH'), (1598558, 'REACH'), (1516454, 'REACH'), (11555491, 'REACH'), (24171171, 'REACH'), (16667535, 'REACH'), (28274313, 'SPARSER'), (8186826, 'REACH'), (19600287, 'REACH'), (27547200, 'REACH'), (29942093, 'REACH'), (8341502, 'REACH'), (13770491, 'REACH'), (23145434, 'REACH'), (26425480, 'REACH'), (2081941, 'REACH'), (22249670, 'REACH'), (2722161, 'REACH'), (9341297, 'REACH'), (24185201, 'REACH'), (18542173, 'REACH'), (19918429, 'REACH'), (25030237, 'REACH'), (16418026, 'REACH'), (11570994, 'REACH'), (8297932, 'REACH'), (16710056, 'REACH'), (19839843, 'REACH'), (23259537, 'REACH'), (26470801, 'REACH'), (869419, 'REACH'), (19758730, 'REACH'), (2378808, 'REACH'), (11815992, 'REACH'), (12844150, 'REACH'), (19188792, 'REACH'), (27381189, 'REACH'), (2104353, 'REACH'), (26248448, 'REACH'), (16605863, 'REACH'), (30152008, 'REACH'), (13123462, 'REACH'), (24756102, 'REACH'), (20906512, 'REACH'), (22221774, 'REACH'), (11215382, 'REACH'), (8428684, 'REACH'), (10230924, 'REACH'), (19458618, 'REACH'), (29929684, 'REACH'), (10935042, 'REACH'), (8186859, 'REACH'), (25786757, 'REACH'), (13083873, 'REACH'), (24504748, 'REACH'), (8610217, 'REACH'), (17333318, 'REACH'), (22489329, 'REACH'), (28794333, 'REACH'), (20780312, 'REACH'), (22679454, 'REACH'), (18935700, 'REACH'), (13062702, 'REACH'), (18208089, 'REACH'), (9635338, 'REACH'), (19011512, 'REACH'), (1526948, 'REACH'), (28232868, 'REACH'), (19458619, 'REACH'), (21883451, 'REACH'), (9302997, 'REACH'), (19096323, 'REACH'), (2440185, 'REACH'), (10670890, 'REACH'), (13849386, 'REACH'), (27784408, 'REACH'), (29698871, 'REACH'), (42390, 'REACH'), (9070995, 'REACH'), (13182358, 'REACH'), (10399776, 'REACH'), (26012077, 'REACH'), (10799116, 'REACH'), (24758284, 'REACH'), (1024488, 'REACH'), (26769653, 'REACH'), (25861181, 'REACH'), (15668075, 'REACH'), (20719900, 'REACH'), (8901752, 'REACH'), (16389032, 'SPARSER'), (19887795, 'REACH'), (17792914, 'REACH'), (15519391, 'REACH'), (18992894, 'REACH'), (26843643, 'REACH'), (13186755, 'REACH'), (18126196, 'REACH'), (11944239, 'REACH'), (29364202, 'REACH'), (25116407, 'REACH'), (12007999, 'REACH'), (20765864, 'REACH'), (12506293, 'REACH'), (1244774, 'REACH'), (26082918, 'REACH'), (25119889, 'REACH'), (17574253, 'SPARSER'), (13925806, 'REACH'), (30637486, 'REACH'), (1639644, 'REACH'), (25106232, 'REACH'), (1030180, 'REACH'), (22460452, 'REACH'), (1654206, 'REACH'), (10192364, 'REACH'), (17689222, 'REACH'), (989902, 'REACH'), (18372043, 'REACH'), (29896608, 'SPARSER'), (11555498, 'REACH'), (10399809, 'REACH'), (17674541, 'REACH'), (9446382, 'SPARSER'), (24485769, 'REACH'), (2425346, 'REACH'), (23200258, 'REACH'), (24805890, 'REACH'), (20270827, 'REACH'), (3180086, 'REACH'), (10696223, 'REACH'), (28018637, 'REACH'), (8919419, 'REACH'), (17668475, 'REACH'), (20765865, 'REACH'), (10002184, 'REACH'), (1639645, 'REACH'), (21992843, 'REACH'), (23053113, 'REACH'), (247415, 'REACH'), (1103653, 'REACH'), (12231891, 'REACH'), (21623218, 'REACH'), (24178528, 'REACH'), (18662637, 'REACH'), (1530920, 'REACH'), (12889574, 'REACH'), (28794319, 'REACH'), (1277230, 'REACH'), (13209472, 'REACH'), (21044542, 'REACH'), (16511340, 'REACH'), (27723881, 'REACH'), (20429338, 'REACH'), (8966662, 'REACH'), (26246659, 'REACH'), (20298673, 'REACH'), (9965837, 'SPARSER'), (18282640, 'REACH'), (11632971, 'REACH'), (28832544, 'SPARSER'), (15813592, 'REACH'), (20263085, 'REACH'), (28701452, 'REACH'), (24192583, 'REACH'), (13707496, 'REACH'), (21623170, 'REACH'), (21645711, 'REACH'), (27760855, 'REACH'), (28269573, 'REACH'), (15075743, 'REACH'), (15668288, 'REACH'), (30209511, 'REACH'), (11547075, 'REACH'), (16533774, 'REACH'), (26184377, 'REACH'), (3578602, 'REACH'), (21109482, 'REACH'), (12002623, 'REACH'), (23613152, 'REACH'), (11744204, 'REACH'), (23662947, 'REACH'), (9454100, 'REACH'), (9519636, 'REACH'), (27259645, 'REACH'), (12671531, 'REACH'), (16714296, 'REACH'), (10172961, 'REACH'), (12511826, 'REACH'), (27818406, 'SPARSER'), (23591680, 'REACH'), (21645722, 'REACH'), (29868629, 'REACH'), (25594095, 'REACH'), (21443357, 'REACH'), (11768270, 'REACH'), (12279210, 'REACH'), (8159671, 'REACH'), (13065642, 'REACH'), (17553430, 'REACH'), (18925636, 'REACH'), (25588364, 'REACH'), (26853434, 'REACH'), (18931573, 'REACH'), (17129172, 'REACH'), (21964047, 'REACH'), (274125, 'REACH'), (2509146, 'REACH'), (13650266, 'REACH'), (20092263, 'REACH'), (9519637, 'REACH'), (22497626, 'REACH'), (23489859, 'REACH'), (25717922, 'REACH'), (27469743, 'REACH'), (27994031, 'REACH'), (10619449, 'REACH'), (13869674, 'REACH'), (13030775, 'REACH'), (13686135, 'REACH'), (16714297, 'REACH'), (19989249, 'REACH'), (11119794, 'REACH'), (25268415, 'REACH'), (3952621, 'REACH'), (25996702, 'REACH'), (1985333, 'REACH'), (18995427, 'REACH'), (1303313, 'REACH'), (11264785, 'REACH'), (23323855, 'REACH'), (30318686, 'SPARSER'), (12029368, 'REACH'), (17337784, 'REACH'), (1939699, 'REACH'), (12061348, 'REACH'), (18142674, 'REACH'), (25351634, 'REACH'), (19496999, 'REACH'), (21037095, 'REACH'), (29261863, 'REACH'), (24450737, 'REACH'), (2718365, 'REACH'), (24496203, 'REACH'), (26050871, 'REACH'), (13660051, 'REACH'), (29710706, 'REACH'), (12062847, 'REACH'), (1610320, 'SPARSER'), (19148776, 'REACH'), (26819750, 'REACH'), (1465940, 'REACH'), (2809809, 'REACH'), (29515729, 'REACH'), (8858767, 'REACH'), (13195837, 'REACH'), (2066795, 'REACH'), (17662134, 'REACH'), (23953590, 'REACH'), (18279583, 'REACH'), (3706445, 'REACH'), (8261197, 'REACH'), (12062285, 'REACH'), (1103660, 'REACH'), (2182004, 'REACH'), (2673524, 'REACH'), (20951643, 'SPARSER'), (4271118, 'REACH'), (12290750, 'SPARSER'), (12385527, 'REACH'), (28376311, 'REACH'), (24576086, 'REACH'), (16770075, 'REACH'), (13103784, 'REACH'), (1559221, 'REACH'), (20528230, 'REACH'), (28723893, 'REACH'), (11043190, 'SPARSER'), (19522288, 'REACH'), (1888555, 'REACH'), (9403100, 'REACH'), (805238, 'REACH'), (22628726, 'REACH'), (24552428, 'REACH'), (20648277, 'REACH'), (16091270, 'REACH'), (16285827, 'REACH'), (20698748, 'REACH'), (4249977, 'REACH'), (9350744, 'REACH'), (16997953, 'REACH'), (1103661, 'REACH'), (9459501, 'REACH'), (12270630, 'REACH'), (22902563, 'REACH'), (26655782, 'REACH'), (29130754, 'REACH'), (4271119, 'REACH'), (26415536, 'REACH'), (29680875, 'REACH'), (12853657, 'REACH'), (13680471, 'REACH'), (158959, 'SPARSER'), (15227364, 'REACH'), (24004065, 'REACH'), (2718377, 'REACH'), (10236660, 'REACH'), (23111153, 'REACH'), (2757295, 'REACH'), (29155024, 'REACH'), (13647164, 'REACH'), (28990163, 'REACH'), (4200370, 'REACH'), (19522285, 'REACH'), (18684062, 'REACH'), (606796, 'REACH'), (10371660, 'REACH'), (20051273, 'REACH'), (26198604, 'REACH'), (19331624, 'REACH'), (29439269, 'SPARSER'), (3640468, 'REACH'), (11834122, 'REACH'), (9223959, 'REACH'), (15667978, 'REACH'), (12104261, 'REACH'), (21380887, 'REACH'), (24923520, 'REACH'), (23223102, 'REACH'), (27726257, 'REACH'), (26166114, 'REACH'), (2828107, 'REACH'), (11774460, 'REACH'), (22720196, 'REACH'), (20959681, 'REACH'), (1653874, 'REACH'), (17927456, 'REACH'), (28008109, 'REACH'), (24930572, 'REACH'), (1697466, 'REACH'), (13330342, 'REACH'), (21456806, 'REACH'), (63375, 'REACH'), (22942000, 'REACH'), (1099069, 'REACH'), (2475325, 'REACH'), (22965355, 'REACH'), (12385561, 'REACH'), (17606582, 'REACH'), (22039104, 'REACH'), (11263532, 'REACH'), (19331625, 'REACH'), (15857813, 'REACH'), (18807117, 'SPARSER'), (11834123, 'REACH'), (18518795, 'REACH'), (10698136, 'REACH'), (13090200, 'REACH'), (10062678, 'REACH'), (8189316, 'REACH'), (11990404, 'REACH'), (23614330, 'REACH'), (30300325, 'SPARSER'), (13781862, 'REACH'), (17553428, 'REACH'), (12024304, 'REACH'), (358062, 'REACH'), (22255659, 'REACH'), (16605240, 'REACH'), (20711506, 'REACH'), (23039675, 'REACH'), (9348775, 'REACH'), (10485635, 'REACH'), (13541684, 'REACH'), (29053213, 'REACH'), (16771416, 'REACH'), (30533142, 'REACH'), (25182194, 'REACH'), (882431, 'REACH'), (3935392, 'REACH'), (21919487, 'REACH'), (25857184, 'REACH'), (27078619, 'REACH'), (2453050, 'REACH'), (16805434, 'REACH'), (12008995, 'REACH'), (16565007, 'REACH'), (10696302, 'REACH'), (13837330, 'REACH'), (13634988, 'REACH'), (17630633, 'REACH'), (9396245, 'REACH'), (19755078, 'REACH'), (24165876, 'REACH'), (10489325, 'REACH'), (25398765, 'REACH'), (26349037, 'REACH'), (20205900, 'REACH'), (15667942, 'REACH'), (16814205, 'REACH'), (23040348, 'REACH'), (9398617, 'REACH'), (24118028, 'SPARSER'), (19246008, 'REACH'), (25821509, 'REACH'), (26706245, 'REACH'), (20865188, 'REACH'), (16805435, 'REACH'), (9414403, 'REACH'), (9350731, 'REACH'), (18951755, 'REACH'), (11485177, 'REACH'), (1103658, 'REACH'), (24915767, 'REACH'), (25444345, 'REACH'), (13634989, 'REACH'), (18874206, 'REACH'), (30291202, 'SPARSER'), (26299404, 'REACH'), (17100615, 'REACH'), (10626536, 'REACH'), (20380917, 'REACH'), (23111144, 'REACH'), (13462947, 'REACH'), (140930, 'REACH'), (10934123, 'REACH'), (13588331, 'REACH'), (25105879, 'REACH'), (23799928, 'REACH'), (21560581, 'REACH'), (28540165, 'REACH'), (17513572, 'REACH'), (13356109, 'REACH'), (19989246, 'REACH'), (21957315, 'REACH'), (11343985, 'REACH'), (849232, 'REACH'), (22034781, 'REACH'), (28164622, 'REACH'), (28685835, 'REACH'), (26028985, 'REACH'), (12062294, 'REACH'), (9875795, 'REACH'), (25611038, 'REACH'), (22373987, 'REACH'), (12429122, 'REACH'), (17606466, 'REACH'), (18411950, 'REACH'), (1103659, 'REACH'), (1313162, 'REACH'), (26184074, 'REACH'), (12513142, 'REACH'), (157748, 'REACH'), (14955569, 'REACH'), (23698103, 'REACH'), (24398764, 'SPARSER'), (21526167, 'SPARSER'), (17521190, 'REACH'), (18349393, 'REACH'), (1049966, 'REACH'), (17839260, 'REACH'), (13838233, 'REACH'), (234839, 'REACH'), (20673528, 'REACH'), (3281459, 'REACH'), (1306215, 'REACH'), (1135171, 'REACH'), (23602161, 'REACH'), (26409788, 'REACH'), (20420670, 'SPARSER'), (20948040, 'SPARSER'), (27502596, 'REACH'), (11547071, 'REACH'), (27482188, 'REACH'), (24974153, 'REACH'), (30136396, 'REACH'), (21637780, 'REACH'), (23031490, 'REACH'), (27193026, 'REACH'), (21191792, 'REACH'), (9490301, 'REACH'), (24930570, 'REACH'), (30137623, 'REACH'), (12658757, 'REACH'), (28323538, 'REACH'), (1500475, 'REACH'), (11625787, 'REACH'), (28773481, 'REACH'), (2560515, 'REACH'), (11316591, 'REACH'), (13845835, 'REACH'), (13565482, 'REACH'), (20708906, 'REACH'), (249816, 'REACH'), (9399269, 'REACH'), (17624037, 'REACH'), (2478857, 'REACH'), (21912135, 'REACH'), (20645877, 'REACH'), (8858452, 'REACH'), (15667993, 'REACH'), (29416663, 'REACH'), (15625060, 'REACH'), (19196772, 'REACH'), (19917668, 'REACH'), (1030185, 'REACH'), (9618906, 'REACH'), (9979354, 'REACH'), (18007514, 'REACH'), (28263898, 'REACH'), (29833257, 'REACH'), (25490883, 'REACH'), (15749236, 'REACH'), (12658768, 'REACH'), (2765067, 'REACH'), (17484118, 'REACH'), (11139155, 'REACH'), (4276097, 'REACH'), (13236543, 'REACH'), (21782637, 'REACH'), (10678555, 'REACH'), (19362170, 'REACH'), (28854197, 'REACH'), (20643824, 'REACH'), (20708907, 'REACH'), (249817, 'REACH'), (23179402, 'REACH'), (3935800, 'REACH'), (28513910, 'REACH'), (18296402, 'REACH'), (25245453, 'REACH'), (13462938, 'REACH'), (18302549, 'REACH'), (10364724, 'REACH'), (18142670, 'REACH'), (19879374, 'REACH'), (19973323, 'REACH'), (11162233, 'REACH'), (12571257, 'REACH'), (23208828, 'REACH'), (22150977, 'REACH'), (22871873, 'REACH'), (21581055, 'REACH'), (27959341, 'REACH'), (13531785, 'REACH'), (9962554, 'REACH'), (15668085, 'REACH'), (8317616, 'REACH'), (23552701, 'REACH'), (2264174, 'REACH'), (26349035, 'REACH'), (12870556, 'REACH'), (18736028, 'REACH'), (20363929, 'REACH'), (9799767, 'REACH'), (27783498, 'REACH'), (2495365, 'REACH'), (57651, 'REACH'), (581939, 'REACH'), (10079578, 'REACH'), (29066773, 'REACH'), (27491247, 'REACH'), (11611088, 'REACH'), (21866871, 'REACH'), (16290564, 'REACH'), (1990834, 'REACH'), (21946782, 'REACH'), (12480667, 'REACH'), (15609082, 'REACH'), (19362183, 'REACH'), (24288040, 'REACH'), (25546549, 'REACH'), (18221506, 'REACH'), (26360015, 'REACH'), (13348874, 'REACH'), (11013957, 'REACH'), (20654374, 'SPARSER'), (29798817, 'REACH'), (16956524, 'REACH'), (8354504, 'REACH'), (25459018, 'SPARSER'), (3240198, 'REACH'), (1734767, 'REACH'), (2160751, 'REACH'), (18574411, 'REACH'), (28875825, 'SPARSER'), (22044018, 'REACH'), (22752173, 'REACH'), (28340390, 'REACH'), (30610004, 'REACH'), (15668177, 'REACH'), (27713085, 'REACH'), (628344, 'REACH'), (1075602, 'REACH'), (22374802, 'REACH'), (1168192, 'REACH'), (2761293, 'REACH'), (24897938, 'REACH'), (20952059, 'REACH'), (26470802, 'REACH'), (23394089, 'REACH'), (16015374, 'REACH'), (17886219, 'REACH'), (29249980, 'REACH'), (2799256, 'REACH'), (20376771, 'SPARSER'), (1311345, 'SPARSER'), (29996696, 'REACH'), (28547716, 'REACH'), (334304, 'REACH'), (10099168, 'REACH'), (17635808, 'REACH'), (1030171, 'REACH'), (22511308, 'REACH'), (29759968, 'REACH'), (23145735, 'REACH'), (27709949, 'REACH'), (25476828, 'REACH'), (25947425, 'REACH'), (25329757, 'SPARSER'), (2205184, 'REACH'), (10934206, 'REACH'), (23796667, 'REACH'), (10441882, 'REACH'), (20665685, 'REACH'), (30552625, 'REACH'), (24548112, 'REACH'), (26860750, 'REACH'), (30134219, 'REACH'), (10301623, 'REACH'), (22284054, 'REACH'), (11094803, 'REACH'), (23284499, 'REACH'), (27133718, 'REACH'), (29361942, 'REACH'), (4178943, 'REACH'), (26184073, 'REACH'), (16245608, 'REACH'), (29385576, 'REACH'), (15668049, 'REACH'), (20399106, 'REACH'), (16015375, 'REACH'), (30057881, 'REACH'), (1946455, 'REACH'), (30158902, 'REACH'), (27767058, 'REACH'), (13541407, 'REACH'), (27692736, 'REACH'), (2668634, 'REACH'), (1928295, 'REACH'), (21037333, 'REACH'), (18691828, 'REACH'), (26761713, 'REACH'), (972463, 'REACH'), (27936477, 'REACH'), (11546582, 'REACH'), (24603570, 'REACH'), (8198496, 'REACH'), (21109088, 'REACH'), (12009000, 'REACH'), (17727636, 'REACH'), (25726481, 'REACH'), (9609167, 'REACH'), (8363008, 'SPARSER'), (9475243, 'REACH'), (19068485, 'REACH'), (11666642, 'REACH'), (999808, 'REACH'), (15668076, 'REACH'), (15245929, 'REACH'), (13869673, 'REACH'), (12385493, 'REACH'), (19661679, 'REACH'), (12889596, 'REACH'), (26654775, 'REACH'), (11003352, 'REACH'), (10941078, 'REACH'), (26767474, 'REACH'), (17994413, 'REACH'), (10644748, 'REACH'), (12872972, 'REACH'), (24354293, 'REACH'), (8874324, 'REACH'), (12440880, 'REACH'), (22786775, 'REACH'), (26131382, 'REACH'), (10570356, 'SPARSER'), (25250719, 'REACH'), (1759565, 'REACH'), (19832830, 'REACH'), (12009001, 'REACH'), (25617370, 'REACH'), (17559527, 'REACH'), (13317748, 'REACH'), (21116532, 'REACH'), (26041903, 'REACH'), (17845840, 'REACH'), (21876304, 'REACH'), (17632014, 'REACH'), (17911799, 'REACH'), (24932760, 'REACH'), (18591574, 'REACH'), (15263315, 'REACH'), (2782051, 'REACH'), (15139217, 'REACH'), (13855810, 'REACH'), (24496814, 'REACH'), (19962519, 'REACH'), (8922168, 'REACH'), (24943255, 'REACH'), (2705267, 'REACH'), (8234276, 'REACH'), (26756979, 'REACH'), (20727903, 'REACH'), (13098686, 'REACH'), (3146427, 'REACH'), (17018184, 'REACH'), (29621333, 'REACH'), (14975281, 'REACH'), (22661871, 'REACH'), (25221648, 'REACH'), (19345897, 'SPARSER'), (20694176, 'SPARSER'), (8919420, 'REACH'), (1364089, 'REACH'), (18784170, 'REACH'), (26131383, 'REACH'), (25266533, 'REACH'), (18627905, 'REACH'), (12121074, 'REACH'), (805237, 'REACH'), (11880821, 'REACH'), (12104227, 'REACH'), (17005350, 'REACH'), (21836323, 'REACH'), (17662128, 'REACH'), (13867197, 'REACH'), (10308206, 'REACH'), (16718013, 'REACH'), (10092956, 'REACH'), (22684651, 'REACH'), (24552427, 'REACH'), (23400696, 'REACH'), (19730821, 'REACH'), (9485110, 'REACH'), (19590963, 'REACH'), (22460434, 'REACH'), (13392077, 'REACH'), (17684685, 'REACH'), (20535501, 'REACH'), (20698747, 'REACH'), (23772430, 'SPARSER'), (1110024, 'REACH'), (15668294, 'REACH'), (29774324, 'REACH'), (9967069, 'REACH'), (2115214, 'REACH'), (26121693, 'REACH'), (9869372, 'REACH'), (2378809, 'REACH'), (16964714, 'REACH'), (15033381, 'REACH'), (13014742, 'REACH'), (24765477, 'REACH'), (30260669, 'SPARSER'), (21692909, 'REACH'), (27608990, 'REACH'), (15619404, 'REACH'), (21097545, 'REACH'), (22910855, 'REACH'), (26236646, 'REACH'), (13838228, 'REACH'), (11574545, 'REACH'), (29973781, 'SPARSER'), (15577016, 'REACH'), (20787955, 'REACH'), (26017697, 'REACH'), (21745618, 'REACH'), (20414605, 'REACH'), (17904953, 'SPARSER'), (28033276, 'REACH'), (29152249, 'REACH'), (23053111, 'REACH'), (10244325, 'REACH'), (29544677, 'REACH'), (11547076, 'REACH'), (16135238, 'SPARSER'), (27523954, 'REACH'), (810843, 'REACH'), (11370508, 'REACH'), (759817, 'REACH'), (18874380, 'REACH'), (28383241, 'REACH'), (30630307, 'REACH'), (26298833, 'REACH'), (23234608, 'REACH'), (17553433, 'REACH'), (26279009, 'REACH'), (27709947, 'REACH'), (13838229, 'REACH'), (13446690, 'REACH'), (2279760, 'REACH'), (2604381, 'REACH'), (12273166, 'REACH'), (8302521, 'REACH'), (16393329, 'SPARSER'), (816467, 'REACH'), (20472961, 'REACH'), (1382804, 'SPARSER'), (11215623, 'REACH'), (18916103, 'REACH'), (23975526, 'REACH'), (25732241, 'REACH'), (10203727, 'REACH'), (2381821, 'REACH'), (11275658, 'REACH'), (11087672, 'REACH'), (27157366, 'REACH'), (17709683, 'REACH'), (20472832, 'REACH'), (26473918, 'REACH'), (17522156, 'REACH'), (26151578, 'REACH'), (25500537, 'REACH'), (2279725, 'REACH'), (28035373, 'REACH'), (18744204, 'REACH'), (511956, 'REACH'), (28929551, 'REACH'), (3476400, 'REACH'), (3922841, 'REACH'), (4236874, 'REACH'), (12495191, 'REACH'), (2209784, 'REACH'), (16860378, 'SPARSER'), (20392279, 'REACH'), (21097605, 'REACH'), (12252132, 'REACH'), (24730521, 'REACH'), (27161572, 'REACH'), (22523423, 'REACH'), (28256225, 'REACH'), (20021863, 'REACH'), (29590035, 'SPARSER'), (24024643, 'REACH'), (9153780, 'REACH'), (13545680, 'REACH'), (8469725, 'REACH'), (18886864, 'REACH'), (13831563, 'REACH'), (28263894, 'REACH'), (9546162, 'REACH'), (30156640, 'REACH'), (2718366, 'REACH'), (9501342, 'REACH'), (12745374, 'REACH'), (18021022, 'REACH'), (11324922, 'REACH'), (27792424, 'REACH'), (12638261, 'REACH'), (15849525, 'REACH'), (18700341, 'REACH'), (22468661, 'REACH'), (590530, 'REACH'), (23528317, 'REACH'), (3169372, 'REACH'), (17992970, 'REACH'), (20364787, 'REACH'), (28046654, 'REACH'), (10797161, 'REACH'), (18989161, 'REACH'), (15105378, 'REACH'), (13574511, 'REACH'), (25360715, 'REACH'), (28908281, 'REACH'), (26402359, 'REACH'), (10585048, 'REACH'), (19148773, 'REACH'), (11526527, 'REACH'), (28362925, 'REACH'), (11083335, 'REACH'), (20225607, 'REACH'), (17395540, 'REACH'), (3534033, 'REACH'), (14904529, 'REACH'), (13270845, 'REACH'), (16770076, 'REACH'), (20395896, 'REACH'), (24389473, 'REACH'), (11485005, 'REACH'), (25107966, 'REACH'), (20712935, 'REACH'), (13441685, 'REACH'), (13723505, 'REACH'), (15254818, 'REACH'), (27618384, 'REACH'), (549981, 'REACH'), (12018781, 'REACH'), (16744718, 'REACH'), (1811129, 'REACH'), (13849473, 'REACH'), (3548896, 'REACH'), (15813580, 'REACH'), (26575561, 'REACH'), (30133196, 'REACH'), (1523624, 'REACH'), (22043573, 'REACH'), (13831526, 'REACH'), (23773096, 'REACH'), (19567600, 'REACH'), (20329003, 'REACH'), (17682977, 'REACH'), (28442492, 'SPARSER'), (82760, 'REACH'), (29891157, 'REACH'), (24435508, 'REACH'), (17553424, 'REACH'), (24070299, 'SPARSER'), (21113294, 'REACH'), (17684683, 'REACH'), (12494716, 'REACH'), (25611037, 'REACH'), (2340266, 'REACH'), (24246711, 'REACH'), (20579160, 'REACH'), (22673253, 'REACH'), (26002451, 'REACH'), (22721345, 'REACH'), (2543264, 'REACH'), (11641901, 'REACH'), (15027872, 'REACH'), (15519392, 'REACH'), (26077662, 'REACH'), (9869370, 'REACH'), (27269575, 'REACH'), (30022087, 'REACH'), (11024245, 'REACH'), (27618385, 'REACH'), (11870318, 'REACH'), (1024491, 'REACH'), (25731182, 'REACH'), (20474143, 'REACH'), (12696958, 'REACH'), (18216059, 'REACH'), (28926298, 'REACH'), (29942106, 'REACH'), (11794646, 'SPARSER'), (12711051, 'REACH'), (19626602, 'REACH'), (10005272, 'REACH'), (3562021, 'REACH'), (12373206, 'REACH'), (19585793, 'REACH'), (20850669, 'REACH'), (21699345, 'REACH'), (2854338, 'REACH'), (29605071, 'REACH'), (157742, 'REACH'), (1030167, 'REACH'), (9618872, 'REACH'), (8167483, 'REACH'), (22596053, 'REACH'), (25713552, 'REACH'), (26552654, 'REACH'), (17719371, 'REACH'), (28406265, 'REACH'), (11944234, 'REACH'), (23031489, 'REACH'), (25203058, 'REACH'), (12658815, 'REACH'), (22113824, 'REACH'), (22998957, 'REACH'), (16771422, 'REACH'), (17557004, 'REACH'), (9467046, 'REACH'), (20018342, 'REACH'), (19829309, 'REACH'), (25182190, 'REACH'), (15024491, 'REACH'), (1337976, 'REACH'), (26525445, 'REACH'), (17574255, 'SPARSER'), (1215890, 'REACH'), (30178522, 'REACH'), (16160828, 'SPARSER'), (19661684, 'REACH'), (1414992, 'REACH'), (24549200, 'REACH'), (23830539, 'REACH'), (17497578, 'REACH'), (17630629, 'REACH'), (29001125, 'REACH'), (12361184, 'REACH'), (28406637, 'REACH'), (17818910, 'REACH'), (10195660, 'REACH'), (23335628, 'REACH'), (12061352, 'REACH'), (2180372, 'REACH'), (9869969, 'REACH'), (4254638, 'REACH'), (29278665, 'SPARSER'), (28634424, 'REACH'), (17384133, 'REACH'), (12263798, 'REACH'), (12008996, 'REACH'), (1273170, 'REACH'), (11118746, 'REACH'), (24562005, 'REACH'), (8356404, 'REACH'), (11622160, 'REACH'), (749085, 'REACH'), (24565520, 'REACH'), (20148601, 'REACH'), (9214742, 'REACH'), (10696257, 'REACH'), (3494110, 'REACH'), (12385499, 'REACH'), (19419358, 'REACH'), (1879433, 'REACH'), (28778298, 'REACH'), (30178523, 'REACH'), (19650562, 'REACH'), (17778542, 'REACH'), (13512348, 'REACH'), (19870774, 'REACH'), (1995236, 'REACH'), (29815268, 'REACH'), (26575552, 'REACH'), (10900941, 'REACH'), (2212990, 'REACH'), (8810156, 'REACH'), (29621338, 'REACH'), (13655537, 'REACH'), (23997103, 'REACH'), (15034254, 'REACH'), (13043050, 'REACH'), (15807607, 'REACH'), (29066602, 'REACH'), (19236133, 'REACH'), (27222998, 'REACH'), (1475073, 'REACH'), (21916571, 'REACH'), (19517992, 'REACH'), (16564753, 'REACH'), (4163309, 'SPARSER'), (21148918, 'SPARSER'), (2513500, 'REACH'), (1915064, 'REACH'), (27140342, 'REACH'), (23690227, 'REACH'), (3494111, 'REACH'), (17545068, 'REACH'), (30456264, 'REACH'), (12620874, 'SPARSER'), (23349681, 'REACH'), (24016489, 'SPARSER'), (3193081, 'REACH'), (18573354, 'REACH'), (11794904, 'REACH'), (25618881, 'REACH'), (29619314, 'REACH'), (2793740, 'REACH'), (16553225, 'REACH'), (1449277, 'REACH'), (11246909, 'REACH'), (11932210, 'SPARSER'), (13686136, 'REACH'), (24345523, 'REACH'), (26584417, 'REACH'), (22043981, 'REACH'), (20602250, 'SPARSER'), (8141602, 'REACH'), (30208559, 'REACH'), (9851114, 'REACH'), (12914052, 'REACH'), (13831556, 'REACH'), (19023072, 'REACH'), (26952928, 'REACH'), (19822793, 'REACH'), (13040053, 'REACH'), (2561891, 'REACH'), (28463951, 'REACH'), (14459133, 'REACH'), (19205806, 'REACH'), (23039662, 'REACH'), (29265582, 'REACH'), (12036746, 'REACH'), (20621962, 'REACH'), (23906337, 'REACH'), (28330253, 'REACH'), (1993606, 'REACH'), (118511, 'REACH'), (11161327, 'REACH'), (17485551, 'REACH'), (21432011, 'REACH'), (11447653, 'REACH'), (20757011, 'REACH'), (23020077, 'REACH'), (20058078, 'REACH'), (23269342, 'REACH'), (2836620, 'REACH'), (9409673, 'REACH'), (29888478, 'REACH'), (14904532, 'REACH'), (2296749, 'SPARSER'), (12658667, 'REACH'), (11752601, 'REACH'), (762455, 'REACH'), (13030789, 'REACH'), (15073078, 'REACH'), (20401380, 'REACH'), (26860749, 'REACH'), (9677671, 'REACH'), (13937511, 'REACH'), (17553429, 'REACH'), (12658758, 'REACH'), (20420015, 'REACH'), (17612857, 'REACH'), (26853433, 'REACH'), (13629477, 'REACH'), (1075926, 'REACH'), (21766834, 'REACH'), (1039656, 'REACH'), (9362728, 'REACH'), (11787560, 'REACH'), (27767057, 'REACH'), (8354511, 'REACH'), (28244687, 'REACH'), (16730237, 'REACH'), (2723755, 'REACH'), (29790579, 'REACH'), (10369349, 'REACH'), (20645878, 'REACH'), (27080484, 'REACH'), (19544031, 'REACH'), (10667579, 'REACH'), (3763959, 'SPARSER'), (26959048, 'REACH'), (13098755, 'REACH'), (26540212, 'REACH'), (26324145, 'REACH'), (20313698, 'REACH'), (12434031, 'REACH'), (19330894, 'REACH'), (30023538, 'REACH'), (2720780, 'REACH'), (10474580, 'REACH'), (9490283, 'REACH'), (23270090, 'REACH'), (16254801, 'SPARSER'), (18952289, 'REACH'), (1233626, 'REACH'), (17002609, 'REACH'), (26767473, 'REACH'), (13539854, 'REACH'), (16010763, 'REACH'), (18631612, 'REACH'), (1909298, 'REACH'), (4170290, 'REACH'), (11744224, 'REACH'), (28680754, 'REACH'), (23081164, 'REACH'), (21575825, 'REACH'), (23560002, 'REACH'), (28588272, 'REACH'), (11570987, 'REACH'), (10437002, 'REACH'), (21518743, 'REACH'), (20209861, 'REACH'), (23289459, 'REACH'), (11113508, 'REACH'), (28290849, 'REACH'), (11529042, 'REACH'), (27539295, 'REACH'), (27866555, 'REACH'), (1706217, 'REACH'), (25200873, 'REACH'), (2464167, 'REACH'), (601137, 'REACH'), (27016687, 'REACH'), (18740942, 'REACH'), (2203513, 'REACH'), (28635831, 'REACH'), (20225348, 'REACH'), (12610861, 'REACH'), (28939578, 'REACH'), (30151994, 'REACH'), (29413296, 'REACH'), (13281843, 'REACH'), (26762209, 'REACH'), (9147771, 'REACH'), (755881, 'REACH'), (19458627, 'REACH'), (29157955, 'REACH'), (29122361, 'REACH'), (17519223, 'REACH'), (19509485, 'REACH'), (2334366, 'REACH'), (17400219, 'REACH'), (138293, 'REACH'), (16332459, 'REACH'), (27975352, 'REACH'), (13098719, 'REACH'), (1427774, 'REACH'), (16795966, 'REACH'), (29724012, 'REACH'), (27116649, 'REACH'), (11082023, 'REACH'), (16607176, 'REACH'), (29462022, 'REACH'), (18945969, 'REACH'), (621899, 'REACH'), (11369803, 'REACH'), (13303115, 'REACH'), (29349825, 'REACH'), (24636018, 'REACH'), (25068776, 'REACH'), (10104194, 'REACH'), (11447682, 'REACH'), (21312317, 'REACH'), (1030172, 'REACH'), (4208668, 'REACH'), (21366789, 'REACH'), (9936346, 'REACH'), (10111624, 'REACH'), (8354502, 'REACH'), (16730228, 'REACH'), (2358129, 'REACH'), (27523953, 'REACH'), (24930571, 'REACH'), (1767146, 'REACH'), (11744152, 'REACH'), (12919461, 'REACH'), (14866305, 'REACH'), (1816685, 'REACH'), (13449325, 'REACH'), (2035207, 'REACH'), (9335720, 'REACH'), (22382146, 'REACH'), (23692866, 'REACH'), (2017418, 'REACH'), (27576458, 'REACH'), (27747896, 'REACH'), (25580711, 'REACH'), (26189620, 'REACH'), (11570973, 'REACH'), (22403964, 'REACH'), (10288567, 'REACH'), (3278680, 'REACH'), (13781861, 'REACH'), (17553427, 'REACH'), (18392319, 'REACH'), (4326048, 'REACH'), (26474541, 'REACH'), (16002526, 'REACH'), (17837534, 'REACH'), (30216912, 'SPARSER'), (20377704, 'REACH'), (19129835, 'REACH'), (3578163, 'REACH'), (17340723, 'REACH'), (22663698, 'REACH'), (25947423, 'REACH'), (8354509, 'REACH'), (9791611, 'REACH'), (25018727, 'REACH'), (11886101, 'REACH'), (24118026, 'SPARSER'), (11134521, 'REACH'), (25231574, 'REACH'), (21871597, 'REACH'), (24034285, 'REACH'), (24474408, 'REACH'), (3661585, 'REACH'), (21360847, 'REACH'), (17553244, 'REACH'), (10799114, 'REACH'), (25934871, 'REACH'), (28130806, 'REACH'), (1180114, 'REACH'), (12361344, 'REACH'), (20472891, 'REACH'), (13128812, 'REACH'), (21718075, 'REACH'), (13640986, 'REACH'), (13349986, 'REACH'), (24270493, 'REACH'), (10200139, 'REACH'), (23552705, 'REACH'), (2272383, 'REACH'), (22043975, 'REACH'), (23551303, 'REACH'), (29545602, 'REACH'), (1909296, 'REACH'), (28680752, 'REACH'), (17367, 'REACH'), (11224023, 'REACH'), (21973824, 'REACH'), (284926, 'REACH'), (28290857, 'REACH'), (22380578, 'REACH'), (3609391, 'REACH'), (16519983, 'REACH'), (22508010, 'REACH'), (12188758, 'REACH'), (12361345, 'REACH'), (24125057, 'REACH'), (20472954, 'REACH'), (26665308, 'SPARSER'), (29025402, 'REACH'), (21225200, 'REACH'), (12103598, 'REACH'), (24653742, 'REACH'), (22271708, 'REACH'), (13838218, 'REACH'), (12124498, 'REACH'), (8351678, 'REACH'), (8371909, 'SPARSER'), (21654682, 'REACH'), (14899784, 'REACH'), (28715644, 'SPARSER'), (20634607, 'REACH'), (18711069, 'REACH'), (12560331, 'REACH'), (16495993, 'REACH'), (11678309, 'REACH'), (10248979, 'REACH'), (13713650, 'REACH'), (28187647, 'REACH'), (29957119, 'REACH'), (13709547, 'REACH'), (19509483, 'REACH'), (13410808, 'REACH'), (17018501, 'REACH'), (15353910, 'REACH'), (28320248, 'REACH'), (8573409, 'REACH'), (17553439, 'REACH'), (29677599, 'REACH'), (2457506, 'REACH'), (27175632, 'REACH'), (27893469, 'REACH'), (21042712, 'REACH'), (20756179, 'REACH'), (12273169, 'REACH'), (19184834, 'REACH'), (11158909, 'REACH'), (16696701, 'REACH'), (19330862, 'REACH'), (26324139, 'REACH'), (29849390, 'REACH'), (29711544, 'REACH'), (10939973, 'REACH'), (18462526, 'REACH'), (18232533, 'REACH'), (27502595, 'REACH'), (23386991, 'REACH'), (12868857, 'REACH'), (3522008, 'REACH'), (2425491, 'REACH'), (21838532, 'REACH'), (2854337, 'REACH'), (11365890, 'SPARSER'), (29115112, 'REACH'), (3489825, 'SPARSER'), (12010383, 'REACH'), (21863964, 'REACH'), (26650905, 'REACH'), (19024599, 'REACH'), (15445509, 'REACH'), (22221750, 'REACH'), (10469299, 'REACH'), (28598628, 'REACH'), (29329964, 'REACH'), (2741801, 'REACH'), (27579945, 'REACH'), (12658663, 'REACH'), (18003093, 'REACH'), (20705478, 'REACH'), (12486040, 'SPARSER'), (20836550, 'REACH'), (12150775, 'REACH'), (24766872, 'REACH'), (30108056, 'REACH'), (15420038, 'SPARSER'), (27893173, 'REACH'), (22080355, 'REACH'), (12395586, 'REACH'), (13153776, 'REACH'), (2835929, 'REACH'), (28263897, 'REACH'), (17558646, 'REACH'), (20951441, 'SPARSER'), (25591667, 'REACH'), (2660030, 'REACH'), (16771810, 'REACH'), (11789039, 'REACH'), (17927453, 'REACH'), (18076028, 'REACH'), (15132793, 'REACH'), (20697468, 'REACH'), (22221751, 'REACH'), (1762861, 'REACH'), (24471085, 'REACH'), (16534668, 'REACH'), (19570900, 'REACH'), (3474030, 'REACH'), (304727, 'REACH'), (22053663, 'REACH'), (25658143, 'REACH'), (30146430, 'REACH'), (23728553, 'REACH'), (4187810, 'REACH'), (18647471, 'REACH'), (17550813, 'REACH'), (21220829, 'REACH'), (24052793, 'REACH'), (274295, 'REACH'), (2677229, 'REACH'), (30325264, 'SPARSER'), (11932216, 'SPARSER'), (16771811, 'REACH'), (21752547, 'REACH'), (22446638, 'REACH'), (1997988, 'REACH'), (19337767, 'REACH'), (16290563, 'REACH'), (28250883, 'REACH'), (18873967, 'REACH'), (17113281, 'REACH'), (26034815, 'REACH'), (20748717, 'REACH'), (13348873, 'REACH'), (22942184, 'REACH'), (22489333, 'REACH'), (736911, 'REACH'), (22030003, 'REACH'), (10938468, 'REACH'), (25372339, 'REACH'), (9482130, 'REACH'), (28565824, 'REACH'), (29792107, 'SPARSER'), (1018363, 'REACH'), (9463330, 'REACH'), (17674543, 'REACH'), (20885239, 'REACH'), (14892965, 'REACH'), (20070309, 'REACH'), (1273171, 'REACH'), (23534721, 'REACH'), (19458623, 'REACH'), (29157951, 'REACH'), (4269854, 'REACH'), (20403739, 'REACH'), (12526515, 'SPARSER'), (17616040, 'REACH'), (21578933, 'REACH'), (23813360, 'REACH'), (28872921, 'REACH'), (28034442, 'REACH'), (21303923, 'REACH'), (8348449, 'REACH'), (13656865, 'REACH'), (28871099, 'REACH'), (12636232, 'REACH'), (650069, 'REACH'), (28175189, 'REACH'), (27214900, 'REACH'), (18142690, 'REACH'), (17498794, 'REACH'), (19887799, 'REACH'), (7508056, 'REACH'), (29597761, 'REACH'), (22520109, 'REACH'), (20953448, 'REACH'), (22034792, 'REACH'), (20166182, 'REACH'), (27887572, 'REACH'), (19030960, 'REACH'), (1998571, 'REACH'), (23495813, 'REACH'), (26900022, 'REACH'), (17624036, 'REACH'), (22002880, 'REACH'), (17616041, 'REACH'), (18099779, 'REACH'), (22523459, 'REACH'), (2007025, 'REACH'), (28420304, 'REACH'), (10974839, 'REACH'), (10379104, 'REACH'), (15698626, 'SPARSER'), (21116141, 'REACH'), (25723527, 'REACH'), (10399797, 'REACH'), (24499683, 'REACH'), (28706452, 'REACH'), (21199889, 'REACH'), (12658800, 'REACH'), (9255805, 'REACH'), (20505669, 'REACH'), (443126, 'REACH'), (10032627, 'REACH'), (21042675, 'REACH'), (16605857, 'REACH'), (24437409, 'REACH'), (29115126, 'REACH'), (11920269, 'REACH'), (2095209, 'REACH'), (21756009, 'REACH'), (11574567, 'REACH'), (23200262, 'REACH'), (15668148, 'REACH'), (24646580, 'REACH'), (13686114, 'REACH'), (2815543, 'REACH'), (23295543, 'REACH'), (26900023, 'REACH'), (16707186, 'REACH'), (17113261, 'REACH'), (15786764, 'REACH'), (20800268, 'REACH'), (801167, 'REACH'), (29354422, 'REACH'), (19330893, 'REACH'), (13812987, 'REACH'), (20774956, 'REACH'), (1733673, 'REACH'), (29261868, 'REACH'), (19590411, 'REACH'), (22689688, 'REACH'), (8311891, 'REACH'), (1039666, 'REACH'), (19627117, 'REACH'), (23200263, 'REACH'), (22221749, 'REACH'), (3142164, 'REACH'), (22153105, 'REACH'), (21763407, 'REACH'), (10689907, 'REACH'), (11390559, 'REACH'), (20800269, 'REACH'), (8548539, 'REACH'), (25028844, 'REACH'), (24476058, 'REACH'), (1984679, 'REACH'), (13239686, 'REACH'), (29951366, 'REACH'), (18413807, 'REACH'), (2002553, 'REACH'), (11547063, 'REACH'), (10518735, 'SPARSER'), (27244799, 'REACH'), (22900794, 'REACH'), (29847846, 'REACH'), (21632271, 'REACH'), (22890160, 'REACH'), (13098685, 'REACH'), (15533065, 'SPARSER'), (16737367, 'REACH'), (20505687, 'REACH'), (1039667, 'REACH'), (11439844, 'REACH'), (1512978, 'REACH'), (21042706, 'REACH'), (13030782, 'REACH'), (20409467, 'REACH'), (25619014, 'REACH'), (29157958, 'REACH'), (29256262, 'REACH'), (28122274, 'REACH'), (24570845, 'REACH'), (3138328, 'REACH'), (13656856, 'REACH'), (18992900, 'REACH'), (524479, 'REACH'), (27241056, 'REACH'), (458733, 'REACH'), (19671884, 'REACH'), (23394088, 'REACH'), (9485109, 'REACH'), (25200867, 'REACH'), (13030804, 'REACH'), (18379632, 'REACH'), (11537418, 'REACH'), (24640325, 'REACH'), (19902966, 'REACH'), (2718372, 'REACH'), (3177124, 'REACH'), (10192338, 'REACH'), (10582692, 'REACH'), (23817003, 'SPARSER'), (17096333, 'REACH'), (9869371, 'REACH'), (23001370, 'REACH'), (10399783, 'REACH'), (26331395, 'REACH'), (9341026, 'REACH'), (29942094, 'REACH'), (23699196, 'REACH'), (24485779, 'REACH'), (47044, 'REACH'), (12620879, 'SPARSER'), (25051263, 'REACH'), (23919362, 'SPARSER'), (2187240, 'REACH'), (18992885, 'REACH'), (10955942, 'REACH'), (29646755, 'REACH'), (30625525, 'REACH'), (511953, 'REACH'), (875663, 'REACH'), (20765839, 'REACH'), (1038318, 'REACH'), (22017797, 'REACH'), (12062308, 'REACH'), (17778066, 'REACH'), (26184072, 'REACH'), (27381190, 'REACH'), (15572632, 'SPARSER'), (27523956, 'REACH'), (1103663, 'REACH'), (22607492, 'REACH'), (19645490, 'REACH'), (23702381, 'REACH'), (9278491, 'REACH'), (9201097, 'REACH'), (26917127, 'REACH'), (23765672, 'REACH'), (13777589, 'REACH'), (1928294, 'REACH'), (10153062, 'REACH'), (27723875, 'REACH'), (21635151, 'REACH'), (23751388, 'REACH'), (13204362, 'REACH'), (19856266, 'REACH'), (21623703, 'REACH'), (21895877, 'REACH'), (16730227, 'REACH'), (24773970, 'REACH'), (2410847, 'REACH'), (12831071, 'REACH'), (574989, 'REACH'), (19188063, 'REACH'), (25429330, 'REACH'), (24716009, 'REACH'), (11622964, 'REACH'), (21954543, 'REACH'), (12603152, 'REACH'), (12945785, 'REACH'), (13240697, 'REACH'), (1465944, 'REACH'), (19650149, 'REACH'), (10665832, 'REACH'), (18904693, 'REACH'), (10337748, 'REACH'), (22097341, 'REACH'), (9933209, 'REACH'), (2378806, 'REACH'), (27214899, 'REACH'), (26998241, 'REACH'), (20573458, 'REACH'), (20576960, 'REACH'), (9235917, 'REACH'), (25787072, 'REACH'), (24237947, 'REACH'), (18081032, 'REACH'), (30152006, 'REACH'), (26043124, 'REACH'), (17817486, 'REACH'), (18744203, 'REACH'), (21044182, 'REACH'), (13686112, 'REACH'), (26282142, 'REACH'), (11858508, 'REACH'), (10798074, 'REACH'), (26425479, 'REACH'), (19458600, 'REACH'), (10696245, 'REACH'), (3243156, 'REACH'), (30133199, 'REACH'), (1465945, 'REACH'), (23047959, 'REACH'), (9485095, 'REACH'), (28871092, 'REACH'), (12477518, 'REACH'), (20505678, 'REACH'), (22484811, 'REACH'), (26843644, 'REACH'), (27959338, 'REACH'), (29006332, 'REACH'), (22390419, 'REACH'), (25157316, 'REACH'), (20036896, 'REACH'), (19089909, 'REACH'), (29116917, 'REACH'), (15246676, 'REACH'), (10679613, 'REACH'), (2059545, 'REACH'), (9039129, 'REACH'), (14875733, 'SPARSER'), (21372874, 'REACH'), (1319429, 'REACH'), (24864100, 'REACH'), (11173217, 'REACH'), (23166305, 'REACH'), (28730724, 'REACH'), (17473136, 'SPARSER'), (1232428, 'REACH'), (19458601, 'REACH'), (2272392, 'REACH'), (19827247, 'REACH'), (25200874, 'REACH'), (11447704, 'REACH')}), ('Task', {(462048, 'REACH'), (18502253, 'REACH'), (29047244, 'REACH'), (2330024, 'REACH'), (9611284, 'REACH'), (11640852, 'REACH'), (29189521, 'REACH'), (20843343, 'REACH'), (25468590, 'REACH'), (10626524, 'REACH'), (24502745, 'REACH'), (3645496, 'REACH'), (11604421, 'REACH'), (17529285, 'REACH'), (28406643, 'REACH'), (26124580, 'REACH'), (1030177, 'REACH'), (13821023, 'REACH'), (13713664, 'REACH'), (21113534, 'REACH'), (17913531, 'REACH'), (4187884, 'REACH'), (24009193, 'REACH'), (21866151, 'REACH'), (22030664, 'REACH'), (15341653, 'REACH'), (27344551, 'REACH'), (30602118, 'REACH'), (11940148, 'REACH'), (8860977, 'REACH'), (16748852, 'REACH'), (22464226, 'REACH'), (2842909, 'REACH'), (25852189, 'REACH'), (3495627, 'REACH'), (20270460, 'REACH'), (30039161, 'REACH'), (27127318, 'REACH'), (26050881, 'REACH'), (17911794, 'REACH'), (26308929, 'REACH'), (28102642, 'REACH'), (8227373, 'REACH'), (29566112, 'REACH'), (2150363, 'REACH'), (9399866, 'REACH'), (11107898, 'REACH'), (4258408, 'REACH'), (27482055, 'REACH'), (13755939, 'REACH'), (9284177, 'REACH'), (26277634, 'REACH'), (1733391, 'REACH'), (23356175, 'REACH'), (20334190, 'REACH'), (2330012, 'REACH'), (17235356, 'REACH'), (1168202, 'REACH'), (17519191, 'REACH'), (19678361, 'REACH'), (20825241, 'REACH'), (13012790, 'REACH'), (23041177, 'REACH'), (25949002, 'REACH'), (3135713, 'REACH'), (27855690, 'REACH'), (29323863, 'REACH'), (20272576, 'REACH'), (29635812, 'REACH'), (21353083, 'REACH'), (2330028, 'REACH'), (2330025, 'REACH'), (22466630, 'REACH'), (26587971, 'REACH'), (26182306, 'REACH'), (2330031, 'REACH'), (18576848, 'REACH'), (27550347, 'REACH'), (13218876, 'REACH'), (3645497, 'REACH'), (18576851, 'REACH'), (13461761, 'REACH'), (23787199, 'REACH'), (19107851, 'SPARSER'), (1281517, 'REACH'), (26917531, 'REACH'), (8767820, 'REACH'), (19109961, 'REACH'), (2392967, 'REACH'), (2861959, 'REACH'), (11940149, 'REACH'), (17229096, 'REACH'), (26050869, 'REACH'), (30602119, 'REACH'), (41679, 'REACH'), (20754800, 'REACH'), (21500029, 'REACH'), (26875438, 'REACH'), (2410411, 'REACH'), (15024473, 'REACH'), (12976405, 'SPARSER'), (13877770, 'REACH'), (17095001, 'REACH'), (22245898, 'REACH'), (20346870, 'REACH'), (29241950, 'SPARSER'), (20537508, 'REACH'), (8428685, 'REACH'), (9399867, 'REACH'), (30496315, 'REACH'), (2619753, 'REACH'), (25018729, 'REACH'), (25988890, 'REACH'), (2150357, 'REACH'), (10918662, 'REACH'), (29417429, 'REACH'), (2632881, 'REACH'), (10695279, 'REACH'), (1317021, 'REACH'), (21500061, 'REACH'), (21989533, 'REACH'), (22597195, 'REACH'), (20346873, 'REACH'), (632618, 'REACH'), (27782990, 'REACH'), (11168997, 'REACH'), (10136113, 'SPARSER'), (29635813, 'REACH'), (2330029, 'REACH'), (15172620, 'REACH'), (18273292, 'REACH'), (781557, 'REACH'), (11169013, 'REACH'), (1965475, 'REACH'), (760916, 'REACH'), (2330019, 'REACH'), (17550581, 'REACH'), (25490516, 'REACH'), (138288, 'REACH'), (18081853, 'REACH'), (24276843, 'REACH'), (13697738, 'REACH'), (562647, 'REACH'), (8875479, 'REACH'), (10626519, 'REACH'), (1500260, 'REACH'), (11179085, 'REACH'), (25848176, 'SPARSER'), (1277228, 'REACH'), (11169068, 'REACH'), (20101863, 'REACH'), (11162307, 'REACH'), (20662979, 'REACH'), (18009424, 'REACH'), (15024477, 'REACH'), (13605390, 'REACH'), (17019836, 'REACH'), (20537496, 'REACH'), (26927256, 'REACH'), (1336452, 'REACH'), (2107521, 'REACH'), (2612356, 'REACH'), (3281458, 'REACH'), (16094783, 'REACH'), (13672987, 'REACH'), (30646023, 'REACH'), (23490370, 'REACH'), (23957934, 'REACH'), (16511196, 'REACH'), (27289797, 'REACH'), (29305029, 'REACH'), (413299, 'REACH'), (3138596, 'REACH'), (20334195, 'REACH'), (30132086, 'REACH'), (28187661, 'REACH'), (8320443, 'REACH'), (2380268, 'REACH'), (27251180, 'REACH'), (22918341, 'SPARSER'), (1323431, 'REACH'), (21053863, 'REACH'), (22983079, 'REACH'), (24537511, 'REACH'), (419459, 'REACH'), (26853428, 'REACH'), (138289, 'REACH'), (24009186, 'REACH'), (24910897, 'REACH'), (2440464, 'REACH'), (8352797, 'REACH'), (29047243, 'REACH'), (25403257, 'REACH'), (1500261, 'REACH'), (21592342, 'REACH'), (11169043, 'REACH'), (18009412, 'REACH'), (20282433, 'REACH'), (19665650, 'REACH'), (9797536, 'REACH'), (17024928, 'REACH'), (23751387, 'REACH'), (22830791, 'REACH'), (21896552, 'REACH'), (11156597, 'REACH'), (13227125, 'REACH'), (17558645, 'REACH'), (27548963, 'REACH'), (13569361, 'REACH'), (17019837, 'REACH'), (17558520, 'REACH'), (288986, 'SPARSER'), (12121057, 'REACH'), (22221773, 'REACH'), (11553406, 'REACH'), (12957051, 'REACH'), (1471660, 'REACH'), (9914537, 'REACH'), (11529831, 'REACH'), (11383560, 'REACH'), (15024904, 'REACH'), (1168198, 'REACH'), (28250888, 'REACH'), (28318705, 'REACH'), (22983074, 'REACH'), (2003119, 'REACH'), (29876399, 'REACH'), (19284796, 'REACH'), (13012793, 'REACH'), (23877656, 'REACH'), (10918693, 'REACH'), (334294, 'REACH'), (2265558, 'REACH'), (18131749, 'REACH'), (29385509, 'REACH'), (2092466, 'REACH'), (2330034, 'REACH'), (8320434, 'REACH'), (24777568, 'REACH'), (27647646, 'REACH'), (9368058, 'REACH'), (20011494, 'REACH'), (24009190, 'REACH'), (23379650, 'REACH'), (29047247, 'REACH'), (11940142, 'REACH'), (24359004, 'REACH'), (21592330, 'REACH'), (9922232, 'REACH'), (25695967, 'REACH'), (26050878, 'REACH'), (19006828, 'REACH'), (11156585, 'REACH'), (19199944, 'REACH'), (22271701, 'REACH'), (2329931, 'REACH'), (8918347, 'REACH'), (26205945, 'REACH'), (2150360, 'REACH'), (12121061, 'REACH'), (19471510, 'REACH'), (20456598, 'REACH'), (20738008, 'REACH'), (29347259, 'REACH'), (29417432, 'REACH'), (642828, 'REACH'), (23365388, 'REACH'), (28250889, 'REACH'), (17773731, 'REACH'), (29566115, 'REACH'), (25581777, 'REACH'), (26148239, 'REACH'), (1333276, 'REACH'), (10918681, 'REACH'), (10168325, 'REACH'), (12029366, 'REACH'), (20269061, 'REACH'), (29347254, 'REACH'), (2330015, 'REACH'), (13213087, 'REACH'), (23448991, 'REACH'), (30136384, 'REACH'), (19960059, 'REACH'), (9601065, 'REACH'), (10626522, 'REACH'), (29565415, 'REACH'), (27550344, 'REACH'), (20662982, 'REACH'), (12191171, 'REACH'), (28406641, 'REACH'), (30072912, 'REACH'), (21890318, 'REACH'), (18514187, 'REACH'), (1356476, 'REACH'), (27079356, 'REACH'), (29721870, 'REACH'), (4236184, 'REACH'), (648088, 'REACH'), (26182309, 'REACH'), (4171649, 'REACH'), (8912769, 'REACH'), (1058689, 'REACH'), (9904447, 'REACH'), (8972397, 'REACH'), (11940146, 'REACH'), (26050879, 'REACH'), (3495625, 'REACH'), (21433863, 'REACH'), (11169123, 'REACH'), (28730723, 'REACH'), (2863439, 'REACH'), (21682560, 'SPARSER'), (12121052, 'REACH'), (2150361, 'REACH'), (19471511, 'REACH'), (26613701, 'REACH'), (20754803, 'REACH'), (21721459, 'REACH'), (13755937, 'REACH'), (23880891, 'REACH'), (11168994, 'REACH'), (11726063, 'REACH'), (2380668, 'REACH'), (11207289, 'REACH'), (8244663, 'REACH'), (21125989, 'REACH'), (13855766, 'REACH'), (29377604, 'REACH'), (1281522, 'REACH'), (10116351, 'REACH'), (12666354, 'REACH'), (13681312, 'REACH'), (288985, 'SPARSER'), (10051038, 'REACH'), (10626523, 'REACH'), (27550345, 'REACH'), (2731066, 'REACH'), (10626503, 'REACH'), (17229094, 'REACH'), (2346019, 'REACH'), (30072913, 'REACH'), (8852738, 'REACH'), (11169026, 'REACH'), (1281515, 'REACH'), (16815004, 'REACH'), (19415705, 'REACH'), (27543882, 'REACH'), (29519339, 'REACH'), (10918648, 'REACH'), (20210998, 'REACH'), (16748851, 'REACH'), (379620, 'REACH'), (13308644, 'REACH'), (22464225, 'REACH'), (23950052, 'REACH'), (25139507, 'REACH'), (25695969, 'REACH'), (11278718, 'REACH'), (26768694, 'REACH'), (27437996, 'REACH'), (13213018, 'REACH'), (18684424, 'REACH'), (8767811, 'REACH'), (26308931, 'REACH'), (11727601, 'REACH'), (19586000, 'REACH'), (20893661, 'REACH'), (428604, 'REACH'), (11107897, 'REACH'), (23136024, 'REACH'), (3175973, 'REACH'), (17311958, 'REACH'), (25146917, 'REACH'), (26520324, 'REACH'), (28250884, 'REACH'), (2003122, 'REACH'), (12135357, 'SPARSER'), (29409048, 'REACH'), (29909406, 'REACH'), (10393420, 'REACH'), (1703497, 'REACH'), (18131752, 'REACH'), (27494630, 'REACH'), (11618708, 'REACH'), (1220369, 'REACH'), (24340093, 'REACH'), (24910894, 'REACH'), (2330027, 'REACH'), (8320427, 'REACH'), (18085721, 'REACH'), (18085724, 'REACH'), (20269066, 'REACH'), (20430681, 'REACH'), (24852313, 'REACH'), (25931179, 'REACH'), (24537505, 'REACH'), (97588, 'SPARSER'), (12598751, 'REACH'), (20786816, 'REACH'), (2731067, 'REACH'), (29228501, 'REACH'), (24287494, 'REACH'), (11169027, 'REACH'), (27241731, 'REACH'), (8972399, 'REACH'), (13298428, 'REACH'), (19665660, 'REACH'), (24616247, 'REACH'), (26768695, 'REACH'), (12610277, 'REACH'), (27200229, 'REACH'), (12595744, 'REACH'), (13672992, 'REACH'), (18207661, 'REACH'), (17095003, 'REACH'), (12104204, 'REACH'), (13605388, 'REACH'), (13877772, 'REACH'), (27437997, 'REACH'), (28164620, 'REACH'), (18489940, 'REACH'), (11156610, 'REACH'), (15480975, 'REACH'), (19458608, 'REACH'), (28394859, 'REACH'), (13877785, 'REACH'), (2732234, 'REACH'), (28250885, 'REACH'), (2003123, 'REACH'), (17860787, 'REACH'), (13616737, 'REACH'), (22006372, 'REACH'), (13925184, 'REACH'), (557310, 'REACH'), (70444, 'REACH'), (632617, 'REACH'), (4202714, 'REACH'), (27494631, 'REACH'), (2329992, 'REACH'), (26810822, 'REACH'), (28035267, 'REACH'), (413297, 'REACH'), (18456177, 'REACH'), (70447, 'REACH'), (10918703, 'REACH'), (24601165, 'SPARSER'), (25949008, 'REACH'), (15868939, 'REACH'), (18273291, 'REACH'), (28187659, 'REACH'), (29798237, 'REACH'), (181912, 'REACH'), (13098648, 'REACH'), (23324289, 'REACH'), (26853426, 'REACH'), (21066208, 'REACH'), (733641, 'REACH'), (30039162, 'REACH'), (26844423, 'REACH'), (10409640, 'REACH'), (27344552, 'REACH'), (1210470, 'REACH'), (1500259, 'REACH'), (4278374, 'REACH'), (19886182, 'REACH'), (20192578, 'REACH'), (25677122, 'REACH'), (4187888, 'REACH'), (28695631, 'REACH'), (2410414, 'REACH'), (8808366, 'REACH'), (10934190, 'REACH'), (18388910, 'REACH'), (19756938, 'REACH'), (25231242, 'REACH'), (11940152, 'REACH'), (22830789, 'REACH'), (13284726, 'REACH'), (8238195, 'REACH'), (26411737, 'REACH'), (1701153, 'REACH'), (29870809, 'REACH'), (29957494, 'REACH'), (13605389, 'REACH'), (2027454, 'REACH'), (28164621, 'REACH'), (20326380, 'REACH'), (19199911, 'REACH'), (18009429, 'REACH'), (28974717, 'REACH'), (1336451, 'REACH'), (17980547, 'REACH'), (3281457, 'REACH'), (19458609, 'REACH'), (18672623, 'REACH'), (25094705, 'REACH'), (10695292, 'REACH'), (3476650, 'REACH'), (17519192, 'REACH'), (22006373, 'REACH'), (24268566, 'REACH'), (23356179, 'REACH'), (1168196, 'REACH'), (1964868, 'REACH'), (19960050, 'REACH'), (20093170, 'REACH'), (2330016, 'REACH'), (70445, 'REACH'), (462046, 'REACH'), (4202715, 'REACH'), (20270476, 'REACH'), (10918714, 'REACH'), (9601062, 'REACH'), (22817617, 'REACH'), (28267345, 'REACH'), (2330032, 'REACH'), (12116846, 'REACH'), (15548651, 'REACH'), (26917532, 'REACH'), (2545049, 'REACH'), (9368056, 'REACH'), (20050424, 'REACH'), (26853427, 'REACH'), (17731264, 'REACH'), (29047245, 'REACH'), (30579149, 'REACH'), (164524, 'REACH'), (24711852, 'REACH'), (24858714, 'REACH'), (1500263, 'REACH'), (8238183, 'REACH'), (10030183, 'REACH'), (9904454, 'REACH'), (28820140, 'REACH'), (8320756, 'REACH'), (10985204, 'REACH'), (20011505, 'REACH'), (19887791, 'REACH'), (13175504, 'REACH'), (25695965, 'REACH'), (29070032, 'REACH'), (18493323, 'REACH'), (11940156, 'REACH'), (20211001, 'REACH'), (2619754, 'REACH'), (20899959, 'REACH'), (25018730, 'REACH'), (13465893, 'REACH'), (2150358, 'REACH'), (25528636, 'REACH'), (25851603, 'REACH'), (26050876, 'REACH'), (22674354, 'REACH'), (2027455, 'REACH'), (22497632, 'REACH'), (26124581, 'REACH'), (22597196, 'REACH'), (8767817, 'REACH'), (12424327, 'REACH'), (24867975, 'REACH'), (29673000, 'REACH'), (12027878, 'REACH'), (20724536, 'SPARSER'), (27916436, 'REACH'), (22654927, 'REACH'), (1471659, 'REACH'), (3476651, 'REACH'), (14924984, 'REACH'), (1004790, 'REACH'), (8178934, 'REACH'), (2330020, 'REACH'), (17886369, 'REACH'), (21747699, 'REACH'), (462047, 'REACH'), (16542943, 'REACH'), (12524396, 'REACH'), (4258409, 'REACH'), (10837018, 'REACH'), (2092465, 'REACH'), (2330033, 'REACH'), (11982690, 'REACH'), (3660432, 'REACH'), (2330013, 'REACH'), (9934926, 'REACH'), (1168203, 'REACH'), (20843339, 'REACH'), (28406639, 'REACH'), (562648, 'REACH'), (3596773, 'REACH'), (10626520, 'REACH'), (13827544, 'REACH'), (17654468, 'REACH'), (29565413, 'REACH'), (875614, 'REACH'), (24359003, 'REACH'), (27079354, 'REACH'), (22466631, 'REACH'), (22797032, 'REACH'), (18774691, 'REACH'), (26182307, 'REACH'), (12709585, 'REACH'), (2036610, 'REACH'), (17013634, 'REACH'), (28529968, 'REACH'), (1210475, 'REACH'), (12572953, 'REACH'), (12069834, 'REACH'), (24414935, 'REACH'), (29870807, 'REACH'), (22702003, 'REACH'), (11133284, 'REACH'), (22497633, 'REACH'), (10948941, 'REACH'), (17397499, 'REACH'), (22689767, 'REACH'), (19471509, 'REACH'), (22396053, 'REACH'), (12618691, 'REACH'), (20754801, 'REACH'), (10055458, 'REACH'), (26875439, 'REACH'), (13616733, 'REACH'), (642827, 'REACH'), (16511164, 'REACH'), (23365387, 'REACH'), (30531992, 'REACH'), (16511141, 'REACH'), (28852389, 'REACH'), (13928836, 'REACH'), (20270465, 'REACH'), (10837022, 'REACH'), (25988891, 'REACH'), (11804108, 'REACH'), (16694732, 'REACH'), (10836999, 'REACH'), (1323432, 'REACH'), (21084584, 'REACH'), (12868628, 'REACH'), (21959746, 'REACH'), (1281520, 'REACH'), (8852733, 'REACH'), (24502748, 'REACH'), (10626521, 'REACH'), (13803146, 'REACH'), (16694725, 'REACH'), (28695634, 'REACH'), (27983967, 'REACH'), (1356475, 'REACH'), (27079355, 'REACH'), (10051049, 'REACH'), (11169096, 'REACH'), (15246664, 'REACH'), (2150278, 'REACH'), (23141251, 'REACH'), (1043764, 'REACH'), (11169076, 'REACH'), (11244258, 'REACH'), (11578095, 'REACH'), (12610274, 'REACH'), (988445, 'REACH'), (13877776, 'REACH'), (11162315, 'REACH'), (17576316, 'REACH'), (19262414, 'REACH'), (8808362, 'REACH'), (230327, 'REACH'), (13821866, 'REACH'), (1904997, 'REACH'), (8835606, 'REACH'), (21998936, 'REACH'), (30217895, 'SPARSER'), (18007361, 'REACH'), (18775026, 'REACH'), (26875437, 'REACH'), (16767966, 'REACH'), (9466843, 'REACH'), (8918156, 'REACH'), (10894476, 'REACH'), (16767963, 'REACH'), (18164282, 'REACH'), (17436264, 'REACH'), (192885, 'REACH'), (18131750, 'REACH'), (24867980, 'REACH'), (29178823, 'REACH'), (1655554, 'REACH'), (2003120, 'REACH'), (11207278, 'REACH'), (20634603, 'REACH'), (372964, 'REACH'), (12107794, 'REACH'), (15001805, 'REACH'), (28974715, 'REACH'), (26509740, 'REACH'), (1323433, 'REACH'), (4217926, 'REACH'), (12725318, 'REACH'), (20050420, 'REACH'), (26750022, 'REACH'), (29047248, 'REACH'), (10626525, 'REACH'), (12498574, 'REACH'), (29400715, 'REACH'), (27127320, 'REACH'), (12790890, 'REACH'), (8352805, 'REACH'), (22271702, 'REACH'), (28073686, 'REACH'), (9922226, 'REACH'), (21113535, 'REACH'), (2380269, 'REACH'), (20011501, 'REACH'), (24485790, 'REACH'), (8918348, 'REACH'), (2329932, 'REACH'), (12725321, 'REACH'), (13284684, 'REACH'), (16767738, 'REACH'), (1043765, 'REACH'), (379619, 'REACH'), (11244259, 'REACH'), (2440465, 'REACH'), (21840611, 'REACH'), (25825218, 'REACH'), (27570734, 'REACH'), (29050808, 'REACH'), (24485793, 'REACH'), (1221599, 'REACH'), (27665375, 'REACH'), (3917965, 'REACH'), (16511176, 'REACH'), (17187016, 'REACH'), (30646022, 'REACH'), (1655555, 'REACH'), (10918659, 'REACH'), (13298435, 'REACH'), (15024899, 'REACH'), (26520323, 'REACH'), (27819188, 'REACH'), (29876401, 'REACH'), (20843342, 'REACH'), (20093180, 'REACH'), (70442, 'REACH'), (1004330, 'REACH'), (8901848, 'REACH'), (12899114, 'REACH'), (19419365, 'REACH'), (17529284, 'REACH'), (27095922, 'REACH'), (28406642, 'REACH'), (1030176, 'REACH'), (10168329, 'REACH'), (1168199, 'REACH'), (3596776, 'REACH'), (13713653, 'REACH'), (10278566, 'REACH'), (21066216, 'REACH'), (24537507, 'REACH'), (27854932, 'REACH'), (28868239, 'REACH'), (13218877, 'REACH'), (24760626, 'SPARSER'), (25852188, 'REACH'), (23877657, 'REACH'), (3495626, 'REACH'), (20650455, 'REACH'), (18514181, 'REACH'), (22081797, 'REACH'), (24549476, 'REACH'), (13821025, 'REACH'), (8542098, 'REACH'), (19756946, 'REACH'), (27647647, 'REACH'), (11940140, 'REACH'), (19085612, 'REACH'), (20347180, 'REACH'), (13755938, 'REACH'), (11940143, 'REACH'), (19511599, 'REACH'), (667150, 'REACH'), (11103758, 'REACH'), (29050809, 'REACH'), (19471512, 'REACH'), (18706341, 'REACH'), (23041176, 'REACH'), (10317139, 'REACH'), (16967218, 'REACH'), (11169133, 'REACH'), (13422537, 'REACH'), (19199945, 'REACH'), (11727623, 'REACH'), (14924981, 'REACH'), (17550950, 'REACH'), (2163857, 'REACH'), (12555074, 'REACH'), (21744450, 'REACH'), (25848173, 'SPARSER'), (10168317, 'REACH'), (2330030, 'REACH'), (70443, 'REACH'), (462044, 'REACH'), (22947246, 'REACH'), (2329994, 'REACH'), (9611277, 'REACH'), (1281516, 'REACH'), (11271401, 'REACH'), (23764201, 'REACH'), (2330023, 'REACH'), (13911463, 'REACH'), (26917530, 'REACH'), (26853425, 'REACH'), (10626507, 'REACH'), (20272587, 'REACH'), (13253290, 'REACH'), (8974424, 'REACH'), (26308932, 'REACH'), (29939777, 'REACH'), (30136385, 'REACH'), (17386400, 'REACH'), (28933024, 'REACH'), (21960411, 'REACH'), (21592378, 'REACH'), (18250439, 'REACH'), (26050874, 'REACH'), (28708981, 'REACH'), (13465891, 'REACH'), (2150356, 'REACH'), (26124579, 'REACH'), (1317020, 'REACH'), (27904921, 'REACH'), (21721431, 'REACH'), (26451960, 'REACH'), (22654925, 'REACH'), (28974718, 'REACH'), (17576315, 'REACH'), (13616730, 'REACH'), (10055445, 'REACH'), (24268565, 'REACH'), (25859861, 'REACH'), (17550580, 'REACH'), (29409045, 'REACH'), (2330018, 'REACH'), (660655, 'REACH'), (462045, 'REACH'), (11618702, 'REACH'), (4281975, 'REACH'), (29228502, 'REACH'), (28187649, 'REACH'), (23764205, 'REACH'), (10728071, 'REACH'), (2812968, 'REACH'), (8352808, 'REACH'), (21155548, 'SPARSER'), (12598755, 'REACH'), (13098644, 'REACH'), (27550343, 'REACH'), (19196610, 'REACH'), (22658560, 'SPARSER'), (8974425, 'REACH'), (11169034, 'REACH'), (24858713, 'REACH'), (24912568, 'REACH'), (27079352, 'REACH'), (11727606, 'REACH'), (1281523, 'REACH'), (12666355, 'REACH'), (1058688, 'REACH'), (25044864, 'REACH'), (11169086, 'REACH'), (11940155, 'REACH'), (25528635, 'REACH'), (24601166, 'SPARSER'), (26050875, 'REACH'), (848390, 'REACH'), (12002658, 'REACH'), (20638063, 'REACH'), (15484187, 'SPARSER'), (28730722, 'REACH'), (2762318, 'REACH'), (8767819, 'REACH'), (17972814, 'REACH'), (12610297, 'REACH'), (19665657, 'REACH'), (21840633, 'REACH'), (19723224, 'REACH'), (24760625, 'SPARSER'), (27916438, 'REACH'), (413298, 'REACH'), (16511162, 'REACH'), (19419368, 'REACH'), (21592296, 'REACH'), (1323430, 'REACH'), (28588264, 'REACH'), (26535741, 'REACH'), (9220334, 'REACH'), (8352796, 'REACH'), (10478620, 'REACH'), (8912760, 'REACH'), (16719736, 'REACH'), (25403256, 'REACH'), (28187653, 'REACH'), (11982689, 'REACH'), (17546898, 'REACH'), (2748831, 'REACH'), (15071647, 'REACH'), (21959744, 'REACH'), (2812969, 'REACH'), (8352809, 'REACH'), (24502746, 'REACH'), (21036680, 'REACH'), (21318293, 'REACH'), (22830790, 'REACH'), (26810819, 'REACH'), (13227124, 'REACH'), (16719729, 'REACH'), (21372020, 'REACH'), (28695632, 'REACH'), (875613, 'REACH'), (18291979, 'REACH'), (29721867, 'REACH'), (27079353, 'REACH'), (9434615, 'REACH'), (25848172, 'SPARSER'), (4217939, 'REACH'), (760915, 'REACH'), (29621331, 'REACH'), (20192575, 'REACH'), (12790893, 'REACH'), (22221772, 'REACH'), (9419465, 'REACH'), (18972026, 'REACH'), (1217031, 'REACH'), (10934184, 'REACH'), (11223989, 'REACH'), (13821864, 'REACH'), (18684423, 'REACH'), (25764812, 'REACH'), (8542097, 'REACH'), (30532966, 'REACH'), (15246671, 'REACH'), (2150364, 'REACH'), (4236249, 'REACH'), (13878233, 'REACH'), (19314839, 'REACH'), (19723225, 'REACH'), (20893660, 'REACH'), (27916439, 'REACH'), (27570721, 'REACH'), (8403538, 'REACH'), (9284178, 'REACH'), (11727616, 'REACH'), (13616735, 'REACH'), (20634601, 'REACH'), (864643, 'REACH'), (964401, 'REACH'), (21381917, 'REACH'), (29047246, 'REACH'), (2330026, 'REACH'), (16087896, 'REACH'), (10837011, 'REACH'), (12999154, 'REACH'), (9408767, 'REACH'), (20050418, 'REACH'), (24502747, 'REACH'), (12498569, 'REACH'), (13803145, 'REACH'), (1500264, 'REACH'), (18843348, 'REACH'), (28695633, 'REACH'), (26586813, 'REACH'), (16372745, 'SPARSER'), (24009195, 'REACH'), (181913, 'REACH'), (2329930, 'REACH'), (8320760, 'REACH'), (17397496, 'REACH'), (11940150, 'REACH'), (13679923, 'REACH'), (24608484, 'REACH'), (25309158, 'SPARSER'), (26050870, 'REACH'), (26205944, 'REACH'), (16082880, 'REACH'), (18411213, 'REACH'), (2410412, 'REACH'), (13801388, 'REACH'), (30532967, 'REACH'), (8918339, 'REACH'), (17886370, 'REACH'), (30486480, 'REACH'), (26942429, 'REACH'), (8428686, 'REACH'), (11156619, 'REACH'), (10880743, 'SPARSER'), (16094780, 'REACH'), (24760617, 'SPARSER'), (24867979, 'REACH'), (1004312, 'REACH'), (24867982, 'REACH'), (27665373, 'REACH'), (2150355, 'REACH'), (2330014, 'REACH'), (13713658, 'REACH'), (2329991, 'REACH'), (84195, 'REACH'), (27095920, 'REACH'), (28406640, 'REACH'), (23957931, 'REACH'), (15868938, 'REACH'), (9611287, 'REACH'), (8244664, 'REACH'), (1168197, 'REACH'), (20050422, 'REACH'), (28910966, 'SPARSER'), (26182308, 'REACH'), (2330017, 'REACH'), (10626514, 'REACH'), (29400717, 'REACH'), (9869374, 'REACH'), (12648510, 'REACH'), (30136382, 'REACH'), (1714215, 'REACH'), (9606856, 'REACH'), (334293, 'REACH'), (22830792, 'REACH'), (2863438, 'REACH'), (19085646, 'REACH'), (11940138, 'REACH'), (20347191, 'REACH'), (18911875, 'SPARSER'), (18263781, 'REACH'), (10984342, 'REACH'), (19756947, 'REACH'), (13422532, 'REACH'), (24414936, 'REACH'), (20754802, 'REACH'), (2410413, 'REACH'), (13801389, 'REACH'), (19006811, 'REACH'), (11103753, 'REACH'), (10168296, 'REACH'), (18706339, 'REACH'), (30486481, 'REACH'), (26875440, 'REACH'), (428605, 'REACH'), (17911790, 'REACH'), (13125995, 'REACH'), (25018731, 'REACH'), (13755929, 'REACH'), (2150359, 'REACH'), (2150149, 'REACH'), (17860790, 'REACH'), (25848175, 'SPARSER'), (4385951, 'REACH'), (2762317, 'REACH'), (10153178, 'REACH'), (18759320, 'SPARSER'), (28406644, 'REACH'), (9611275, 'REACH'), (18007530, 'REACH'), (781559, 'REACH'), (13925203, 'REACH'), (419460, 'REACH'), (19671891, 'REACH'), (30136383, 'REACH'), (988446, 'REACH'), (13920519, 'REACH'), (1500262, 'REACH'), (20347202, 'REACH'), (9934927, 'REACH'), (11578096, 'REACH'), (15341647, 'REACH'), (25848178, 'SPARSER'), (26050882, 'REACH'), (26308930, 'REACH'), (21960409, 'REACH'), (25695961, 'REACH'), (648087, 'REACH'), (17654469, 'REACH'), (10317138, 'REACH'), (9368064, 'REACH'), (2323981, 'REACH'), (14900158, 'REACH'), (18672620, 'REACH'), (21996524, 'REACH'), (29244396, 'REACH'), (1703496, 'REACH'), (17972808, 'REACH'), (13935156, 'REACH'), (21155551, 'SPARSER'), (20326383, 'REACH'), (17888797, 'REACH'), (19524555, 'REACH'), (28974716, 'REACH'), (8178930, 'REACH'), (13369760, 'REACH'), (29155744, 'REACH'), (10153179, 'REACH'), (29069708, 'REACH'), (2329993, 'REACH'), (20270473, 'REACH'), (24616762, 'REACH'), (8875476, 'REACH'), (10168322, 'REACH'), (4406287, 'REACH'), (10837007, 'REACH'), (27470256, 'REACH'), (30531993, 'REACH'), (11179082, 'REACH'), (1827894, 'REACH'), (20011492, 'REACH'), (11804109, 'REACH'), (16694733, 'REACH'), (10011063, 'SPARSER'), (13253289, 'REACH'), (19887788, 'REACH'), (4278375, 'REACH'), (21500007, 'REACH'), (8918342, 'REACH'), (12610292, 'REACH'), (1281521, 'REACH'), (19756942, 'REACH'), (11940153, 'REACH'), (26050873, 'REACH'), (28394858, 'REACH'), (12104216, 'REACH'), (11169061, 'REACH'), (13877784, 'REACH'), (28242643, 'REACH'), (13877764, 'REACH'), (9368065, 'REACH'), (17429856, 'REACH'), (1317022, 'REACH'), (2329929, 'REACH'), (12430330, 'REACH'), (21155553, 'SPARSER'), (12121059, 'REACH'), (22926484, 'REACH'), (28035266, 'REACH'), (19585999, 'REACH'), (413296, 'REACH'), (18456176, 'REACH'), (70446, 'REACH'), (13624110, 'REACH'), (18983293, 'REACH'), (11160330, 'REACH'), (19665674, 'REACH'), (20976394, 'REACH'), (27024913, 'SPARSER'), (12430323, 'REACH'), (11808978, 'REACH'), (16511186, 'REACH'), (10136107, 'SPARSER'), (12571021, 'REACH'), (29069709, 'REACH'), (13293594, 'REACH'), (18131751, 'REACH'), (733640, 'REACH'), (10836995, 'REACH'), (27470257, 'REACH'), (21125986, 'REACH'), (10534731, 'REACH'), (13713657, 'REACH'), (1827895, 'REACH'), (8922167, 'REACH'), (18007525, 'REACH'), (20650456, 'REACH'), (17546899, 'REACH'), (12844146, 'REACH'), (25044863, 'REACH'), (1701152, 'REACH'), (25468589, 'REACH'), (17731258, 'REACH'), (26750023, 'REACH'), (18263784, 'REACH'), (30302067, 'SPARSER'), (9797542, 'REACH'), (10562257, 'REACH'), (13175505, 'REACH'), (19511600, 'REACH'), (10136114, 'SPARSER'), (20347184, 'REACH'), (848389, 'REACH'), (22674355, 'REACH'), (1043809, 'REACH'), (3624082, 'REACH'), (21535334, 'SPARSER'), (2329933, 'REACH'), (21998925, 'REACH'), (2150362, 'REACH'), (29417434, 'REACH'), (27916437, 'REACH'), (25825219, 'REACH'), (24642463, 'SPARSER'), (10918690, 'REACH'), (13624098, 'REACH'), (13935151, 'REACH'), (18489936, 'REACH'), (20976395, 'REACH'), (23880892, 'REACH'), (30294880, 'SPARSER'), (17558519, 'REACH'), (14787749, 'REACH'), (19137366, 'REACH'), (11278721, 'REACH')}), ('TASK1', {(15523099, 'REACH'), (13411335, 'REACH'), (12911528, 'REACH'), (12911541, 'REACH'), (18562984, 'REACH'), (22898695, 'REACH'), (12911505, 'REACH'), (13026925, 'SPARSER'), (20749942, 'SPARSER'), (29730990, 'REACH'), (12911580, 'REACH'), (13866122, 'REACH'), (12911557, 'REACH'), (28268065, 'REACH'), (29577249, 'REACH'), (12911514, 'REACH'), (11224369, 'REACH'), (20734769, 'REACH'), (457744, 'REACH'), (15523101, 'REACH'), (19734913, 'REACH'), (19734908, 'REACH'), (18562986, 'REACH'), (25477047, 'REACH'), (22403393, 'REACH'), (28992616, 'REACH'), (8869552, 'REACH'), (28340259, 'SPARSER'), (17858513, 'SPARSER'), (20734751, 'REACH'), (12911529, 'REACH'), (17276686, 'SPARSER'), (22898696, 'REACH'), (9895494, 'REACH'), (21973827, 'REACH'), (22898676, 'REACH'), (23924035, 'REACH'), (12911535, 'REACH'), (636473, 'REACH'), (19734903, 'REACH'), (28268069, 'REACH'), (8869554, 'REACH'), (16764095, 'REACH'), (12911518, 'REACH'), (8649272, 'SPARSER'), (9383992, 'SPARSER'), (12911554, 'REACH'), (11224189, 'REACH'), (12911531, 'REACH'), (22898698, 'REACH'), (725786, 'SPARSER'), (10119670, 'REACH'), (22013253, 'REACH'), (13866148, 'REACH'), (22898678, 'REACH'), (27121998, 'SPARSER'), (20940570, 'REACH'), (29428073, 'REACH'), (12911573, 'REACH'), (19654101, 'REACH'), (8869556, 'REACH'), (8869553, 'REACH'), (10386589, 'REACH'), (9383968, 'SPARSER'), (22898700, 'REACH'), (22898697, 'REACH'), (12911592, 'REACH'), (13026936, 'SPARSER'), (27103651, 'REACH'), (12911569, 'REACH'), (10386575, 'REACH'), (9895485, 'REACH'), (20153737, 'SPARSER'), (29384043, 'REACH'), (11224364, 'REACH'), (13026949, 'SPARSER'), (1812422, 'REACH'), (29577250, 'REACH'), (10907439, 'REACH'), (11032740, 'SPARSER'), (457742, 'REACH'), (13026912, 'SPARSER'), (11224485, 'REACH'), (18562981, 'REACH'), (12911584, 'REACH'), (503070, 'REACH'), (457755, 'REACH'), (15523102, 'REACH'), (12911534, 'REACH'), (11224261, 'REACH'), (20734753, 'REACH'), (25853279, 'REACH'), (457741, 'REACH'), (22898701, 'REACH'), (20749943, 'SPARSER'), (13866138, 'REACH'), (12911527, 'REACH'), (9245315, 'REACH'), (1812427, 'REACH'), (179633, 'SPARSER'), (9895489, 'REACH'), (17732922, 'REACH'), (29577254, 'REACH'), (20734755, 'REACH'), (22898690, 'REACH'), (660495, 'REACH'), (12911536, 'REACH'), (1262977, 'REACH'), (1209710, 'REACH'), (20538734, 'REACH'), (12911588, 'REACH'), (457759, 'REACH'), (28268063, 'REACH'), (15523093, 'REACH'), (9895491, 'REACH'), (20538786, 'REACH'), (29384042, 'REACH'), (29428074, 'REACH'), (115493, 'REACH'), (12911538, 'REACH'), (10958271, 'REACH'), (27103679, 'REACH'), (13866132, 'REACH'), (22898705, 'REACH'), (22898675, 'REACH'), (25840036, 'REACH'), (11224274, 'REACH'), (13699968, 'REACH'), (22403390, 'REACH'), (29384044, 'REACH'), (457754, 'REACH'), (24118928, 'REACH'), (13026921, 'SPARSER'), (12911576, 'REACH'), (18530966, 'REACH'), (20734752, 'REACH'), (8869549, 'REACH'), (25918297, 'SPARSER'), (9383981, 'SPARSER'), (9384000, 'SPARSER'), (457756, 'REACH'), (9384007, 'SPARSER'), (15523097, 'REACH'), (12911542, 'REACH'), (12911539, 'REACH'), (15140705, 'REACH'), (9895488, 'REACH'), (20734754, 'REACH'), (11355270, 'SPARSER')}), ('TASK', {(13550701, 'REACH'), (8560158, 'REACH'), (12649161, 'REACH'), (18434938, 'REACH'), (18943689, 'REACH'), (23807866, 'REACH'), (18434918, 'REACH'), (19196771, 'REACH'), (21130424, 'SPARSER'), (21653058, 'REACH'), (8560302, 'REACH'), (25906398, 'SPARSER'), (13550730, 'REACH'), (25768074, 'REACH'), (28420726, 'REACH'), (23807859, 'REACH'), (20734756, 'REACH'), (8953722, 'SPARSER'), (13159773, 'SPARSER'), (12928607, 'REACH'), (15905313, 'REACH'), (17677919, 'REACH'), (21272019, 'SPARSER'), (27546058, 'SPARSER'), (21191919, 'REACH'), (22898704, 'REACH'), (8560413, 'REACH'), (21074300, 'REACH'), (12062329, 'REACH'), (29386154, 'REACH'), (24817509, 'REACH'), (8389654, 'REACH'), (15905299, 'REACH'), (28779030, 'REACH'), (11842034, 'REACH'), (13612530, 'REACH'), (15308500, 'SPARSER'), (8977883, 'REACH'), (10507227, 'REACH'), (20077708, 'REACH'), (4226618, 'REACH'), (25369737, 'REACH'), (25369740, 'REACH'), (25768076, 'REACH'), (1480097, 'SPARSER'), (13347622, 'REACH'), (1973460, 'REACH'), (10255060, 'REACH'), (19699793, 'REACH'), (21191951, 'REACH'), (28268067, 'REACH'), (9383945, 'SPARSER'), (820846, 'REACH'), (18727836, 'REACH'), (25165934, 'REACH'), (1280842, 'REACH'), (4313557, 'SPARSER'), (4347128, 'REACH'), (10211415, 'REACH'), (414006, 'REACH'), (27546060, 'SPARSER'), (9383919, 'SPARSER'), (26130207, 'REACH'), (13794509, 'REACH'), (28503757, 'REACH'), (9245307, 'REACH'), (29626491, 'REACH'), (8977885, 'REACH'), (25768078, 'REACH'), (13550731, 'REACH'), (8560234, 'REACH'), (19024598, 'REACH'), (16371727, 'SPARSER'), (16371732, 'SPARSER'), (11877472, 'REACH'), (4226541, 'REACH'), (11842029, 'REACH'), (16371723, 'SPARSER'), (16371728, 'SPARSER'), (16371737, 'SPARSER'), (18434892, 'REACH'), (22089407, 'REACH'), (1379896, 'SPARSER'), (15284116, 'REACH'), (446966, 'SPARSER'), (1190850, 'REACH'), (8854801, 'REACH'), (16104340, 'REACH'), (9383922, 'SPARSER'), (29626493, 'REACH'), (4203356, 'REACH'), (2655242, 'REACH'), (21011466, 'REACH'), (24449861, 'REACH'), (12911606, 'REACH'), (21191923, 'REACH'), (21090783, 'REACH'), (9789568, 'REACH'), (13866125, 'REACH'), (17276715, 'SPARSER'), (15905339, 'REACH'), (12062316, 'REACH'), (13159758, 'SPARSER'), (25165932, 'REACH'), (10507221, 'REACH'), (16371734, 'SPARSER'), (15214690, 'REACH'), (16371725, 'SPARSER'), (16371739, 'SPARSER'), (16371730, 'SPARSER'), (18434894, 'REACH'), (23228238, 'REACH'), (28312316, 'REACH'), (8953726, 'SPARSER'), (9273143, 'REACH'), (1973464, 'REACH'), (9383980, 'SPARSER'), (21191909, 'REACH'), (24253007, 'SPARSER'), (22761665, 'REACH'), (23570113, 'REACH'), (29463632, 'SPARSER'), (10273902, 'SPARSER'), (9273159, 'REACH'), (10078184, 'REACH'), (11842024, 'REACH'), (21191925, 'REACH'), (15284131, 'REACH'), (19024803, 'REACH'), (13550722, 'REACH'), (24817515, 'REACH'), (18862407, 'SPARSER'), (18862421, 'SPARSER'), (13159761, 'SPARSER'), (21030579, 'REACH'), (28420708, 'REACH'), (2071915, 'SPARSER'), (12397310, 'REACH'), (1973466, 'REACH'), (13101799, 'REACH'), (15284117, 'REACH'), (23060618, 'SPARSER'), (22764916, 'REACH'), (27171441, 'REACH'), (4226594, 'REACH'), (8272930, 'REACH'), (17035428, 'SPARSER'), (19196752, 'REACH'), (10507196, 'REACH'), (23314364, 'REACH'), (29428156, 'REACH'), (8560280, 'REACH'), (13550721, 'REACH'), (9414207, 'REACH'), (15905343, 'REACH'), (18884382, 'REACH'), (10599255, 'SPARSER'), (11492044, 'REACH'), (19024841, 'REACH'), (15214694, 'REACH'), (17677923, 'REACH'), (21191956, 'REACH'), (20077713, 'REACH'), (8953723, 'SPARSER'), (1973468, 'REACH'), (1973465, 'REACH'), (19024778, 'REACH'), (22390981, 'REACH'), (18434934, 'REACH'), (21074294, 'REACH'), (27103678, 'REACH'), (21090807, 'REACH'), (22106604, 'REACH'), (23314363, 'REACH'), (4226612, 'REACH'), (21090799, 'REACH'), (15214680, 'REACH'), (11224339, 'REACH'), (28774666, 'REACH'), (4313556, 'SPARSER'), (4313561, 'SPARSER'), (1973467, 'REACH'), (13167838, 'REACH'), (27546064, 'SPARSER'), (10329448, 'REACH'), (9273169, 'REACH'), (9273198, 'REACH'), (18434926, 'REACH'), (23807854, 'REACH'), (29733532, 'REACH'), (22976586, 'REACH'), (4226611, 'REACH'), (13159720, 'SPARSER'), (13430464, 'REACH'), (20589005, 'REACH'), (12062334, 'REACH'), (19024556, 'REACH'), (16371726, 'SPARSER'), (20994729, 'REACH'), (28541031, 'REACH'), (16371731, 'SPARSER'), (25728838, 'REACH'), (16371736, 'SPARSER'), (4313558, 'SPARSER'), (15284130, 'REACH'), (18972578, 'REACH'), (1973469, 'REACH'), (13167837, 'REACH'), (27546066, 'SPARSER'), (19024697, 'REACH'), (24817514, 'REACH'), (28731705, 'REACH'), (9370136, 'REACH'), (28899820, 'SPARSER'), (1973459, 'REACH'), (26152207, 'SPARSER'), (27503026, 'REACH'), (21090541, 'REACH'), (19699788, 'REACH'), (18434889, 'REACH'), (4226554, 'REACH'), (4226600, 'REACH'), (4226613, 'REACH'), (10507235, 'REACH'), (27171440, 'REACH'), (18462510, 'REACH'), (8560217, 'REACH'), (16371733, 'SPARSER'), (16371724, 'SPARSER'), (16392542, 'SPARSER'), (21191959, 'REACH'), (21191926, 'REACH'), (13612531, 'REACH'), (24578117, 'REACH'), (9909921, 'REACH'), (1973458, 'REACH'), (28581110, 'REACH'), (1379897, 'SPARSER'), (8649273, 'SPARSER'), (25208635, 'REACH'), (15214697, 'REACH'), (28420713, 'REACH'), (1973461, 'REACH'), (19024597, 'REACH'), (10164739, 'REACH'), (27503028, 'REACH'), (29859761, 'REACH'), (26152205, 'SPARSER'), (26090128, 'REACH'), (29014672, 'REACH'), (27566697, 'SPARSER'), (13159712, 'SPARSER'), (22898679, 'REACH'), (21191929, 'REACH'), (15905322, 'REACH'), (8560275, 'REACH'), (12116627, 'REACH'), (12062322, 'REACH'), (27171442, 'REACH'), (26130208, 'REACH'), (27225376, 'REACH'), (1420359, 'REACH'), (8303175, 'REACH'), (19024616, 'REACH'), (26206791, 'REACH'), (8953727, 'SPARSER'), (20734768, 'REACH'), (3175662, 'REACH'), (12397294, 'REACH'), (15214699, 'REACH'), (1973463, 'REACH'), (19024819, 'REACH'), (17132388, 'REACH'), (27503027, 'REACH'), (26090130, 'REACH'), (8560192, 'REACH'), (13209152, 'REACH'), (3652347, 'REACH'), (2695991, 'SPARSER'), (8560169, 'REACH'), (15905321, 'REACH'), (28312315, 'REACH'), (10450056, 'REACH'), (8560067, 'REACH'), (15214708, 'REACH'), (13347618, 'REACH'), (4226607, 'REACH'), (13159771, 'SPARSER'), (24889391, 'REACH'), (28774667, 'REACH'), (2071916, 'SPARSER'), (19734936, 'REACH'), (9684645, 'REACH'), (27573554, 'REACH')}), ('TASK-1', {(9303776, 'REACH'), (19811552, 'REACH'), (12993168, 'SPARSER'), (12993189, 'SPARSER'), (20236666, 'REACH'), (12993208, 'SPARSER'), (10408980, 'REACH'), (17592852, 'REACH'), (16532034, 'REACH'), (30521167, 'REACH'), (16282096, 'REACH'), (25300654, 'REACH'), (27676846, 'REACH'), (12417429, 'SPARSER'), (11150999, 'REACH'), (12417434, 'SPARSER'), (9971830, 'REACH'), (12417425, 'SPARSER'), (19024755, 'REACH'), (12417446, 'SPARSER'), (22728484, 'REACH'), (30561398, 'REACH'), (12417451, 'SPARSER'), (23817058, 'SPARSER'), (2865851, 'REACH'), (28049798, 'REACH'), (12886915, 'REACH'), (11302038, 'SPARSER'), (12993165, 'SPARSER'), (12993179, 'SPARSER'), (12993170, 'SPARSER'), (11602894, 'REACH'), (19844256, 'SPARSER'), (12993205, 'SPARSER'), (12993196, 'SPARSER'), (29077431, 'REACH'), (3200022, 'REACH'), (10408979, 'REACH'), (10090191, 'SPARSER'), (12886849, 'REACH'), (12993149, 'SPARSER'), (23703873, 'REACH'), (29421780, 'SPARSER'), (27889118, 'REACH'), (8315867, 'REACH'), (29807579, 'REACH'), (29807582, 'REACH'), (12417436, 'SPARSER'), (15214696, 'REACH'), (29346759, 'REACH'), (1704742, 'REACH'), (25929474, 'REACH'), (23803069, 'REACH'), (29556925, 'REACH'), (12887019, 'REACH'), (27952597, 'SPARSER'), (13008471, 'REACH'), (1502968, 'REACH'), (19119569, 'SPARSER'), (10932964, 'REACH'), (17592850, 'REACH'), (10605556, 'SPARSER'), (23622674, 'REACH'), (22390989, 'REACH'), (28855166, 'REACH'), (20958478, 'SPARSER'), (13159690, 'SPARSER'), (19873034, 'SPARSER'), (28399535, 'REACH'), (29346768, 'REACH'), (18098141, 'REACH'), (13159721, 'SPARSER'), (17968446, 'SPARSER'), (13159669, 'SPARSER'), (17860471, 'REACH'), (22030393, 'REACH'), (23298003, 'REACH'), (10734852, 'REACH'), (29346771, 'REACH'), (19380761, 'SPARSER'), (27820876, 'REACH'), (9521914, 'REACH'), (18066396, 'SPARSER'), (18553893, 'SPARSER'), (23489061, 'SPARSER'), (28576660, 'REACH'), (19869122, 'REACH'), (17730928, 'REACH'), (24889390, 'REACH'), (27820869, 'REACH'), (28742134, 'REACH'), (9521907, 'REACH'), (8198049, 'REACH'), (16610770, 'REACH'), (29807583, 'REACH'), (1141547, 'SPARSER'), (17968441, 'SPARSER'), (8478779, 'REACH'), (18434921, 'REACH'), (12886810, 'REACH'), (12886997, 'REACH'), (21642709, 'REACH'), (23298005, 'REACH'), (29556335, 'REACH'), (9579040, 'SPARSER'), (16532043, 'REACH'), (19024636, 'REACH'), (25647609, 'REACH'), (23360044, 'SPARSER'), (917123, 'SPARSER'), (2882963, 'REACH'), (8430671, 'SPARSER'), (10760595, 'REACH'), (22981716, 'SPARSER'), (18098208, 'REACH'), (23906142, 'REACH'), (10408972, 'REACH'), (27820871, 'REACH'), (11602920, 'REACH'), (12886947, 'REACH'), (12272593, 'REACH'), (22036269, 'SPARSER'), (12143086, 'REACH'), (17968448, 'SPARSER'), (12272599, 'REACH'), (16437880, 'REACH'), (19699832, 'REACH'), (21642711, 'REACH'), (12417448, 'SPARSER'), (12842163, 'REACH'), (19729075, 'REACH'), (21783160, 'REACH'), (11151007, 'REACH'), (18434880, 'REACH'), (8953721, 'SPARSER'), (13347628, 'REACH'), (429865, 'REACH'), (25814746, 'REACH'), (12886920, 'REACH'), (12993162, 'SPARSER'), (12272582, 'REACH'), (8835779, 'REACH'), (12993183, 'SPARSER'), (28576661, 'REACH'), (30521168, 'REACH'), (10408974, 'REACH'), (443403, 'REACH'), (12993193, 'SPARSER'), (4226538, 'REACH'), (18098154, 'REACH'), (15329393, 'SPARSER'), (12417875, 'REACH'), (30580628, 'SPARSER'), (12417433, 'SPARSER'), (3410775, 'SPARSER'), (13159772, 'SPARSER'), (12541875, 'SPARSER'), (1063605, 'REACH'), (3734630, 'REACH'), (9812661, 'REACH'), (11596390, 'REACH'), (12417450, 'SPARSER'), (16437859, 'REACH'), (30581839, 'REACH'), (19811568, 'REACH'), (12887037, 'REACH'), (28399534, 'REACH'), (8379520, 'SPARSER'), (9303772, 'REACH'), (12993152, 'SPARSER'), (12993159, 'SPARSER'), (28576663, 'REACH'), (1973445, 'REACH'), (12993178, 'SPARSER'), (12993199, 'SPARSER'), (30521170, 'REACH'), (8278367, 'REACH'), (12993204, 'SPARSER'), (18098176, 'REACH'), (18098156, 'REACH'), (4146382, 'SPARSER'), (19024538, 'REACH'), (25046508, 'REACH'), (29556969, 'REACH'), (10933077, 'REACH'), (12417430, 'SPARSER'), (26394594, 'REACH'), (12417426, 'SPARSER'), (12417440, 'SPARSER'), (12417447, 'SPARSER'), (29877664, 'SPARSER'), (16501349, 'REACH'), (8854806, 'REACH'), (27820868, 'REACH'), (12367090, 'REACH'), (917122, 'SPARSER'), (20890508, 'REACH'), (9428361, 'REACH'), (27820858, 'REACH'), (17897962, 'SPARSER'), (23298004, 'REACH'), (4146389, 'SPARSER'), (8278359, 'REACH'), (25647608, 'REACH'), (12417437, 'SPARSER'), (10408991, 'REACH'), (12272589, 'REACH'), (29143996, 'SPARSER'), (22222613, 'REACH'), (27820870, 'REACH'), (9540632, 'SPARSER'), (23489060, 'SPARSER'), (1634525, 'REACH'), (19119570, 'SPARSER'), (20890510, 'REACH'), (12886844, 'REACH'), (17897978, 'SPARSER'), (21424421, 'REACH'), (26839510, 'REACH'), (20736447, 'REACH'), (21630816, 'REACH'), (12993218, 'SPARSER'), (9549102, 'SPARSER'), (12886857, 'REACH'), (25647610, 'REACH'), (26266419, 'SPARSER'), (1141546, 'SPARSER'), (2878762, 'SPARSER'), (29631201, 'SPARSER'), (10408977, 'REACH'), (19763663, 'REACH'), (11224445, 'REACH'), (19024476, 'REACH'), (13159774, 'SPARSER'), (8854794, 'REACH'), (4226629, 'REACH'), (13739254, 'REACH'), (16371729, 'SPARSER'), (27750417, 'SPARSER'), (8835745, 'REACH'), (20890509, 'REACH'), (30293474, 'SPARSER'), (27820859, 'REACH'), (8430666, 'SPARSER'), (20302081, 'SPARSER'), (20974493, 'REACH'), (2311499, 'REACH'), (10011132, 'REACH'), (1141548, 'SPARSER'), (10409015, 'REACH'), (17968433, 'SPARSER'), (22680260, 'REACH'), (13159750, 'SPARSER'), (9971826, 'REACH'), (28855167, 'REACH'), (19024475, 'REACH'), (8854793, 'REACH'), (2372794, 'REACH'), (13159781, 'SPARSER'), (19024570, 'REACH'), (2071914, 'SPARSER'), (12417876, 'REACH'), (20678996, 'REACH'), (17510799, 'REACH'), (12886845, 'REACH'), (22036718, 'REACH'), (17623147, 'REACH'), (417877, 'SPARSER'), (8430668, 'SPARSER'), (11188826, 'SPARSER'), (3630006, 'REACH'), (12887045, 'REACH'), (28645999, 'SPARSER'), (19810918, 'SPARSER'), (10036639, 'REACH'), (15329396, 'SPARSER'), (27820877, 'REACH'), (15329392, 'SPARSER'), (10332201, 'REACH'), (12272602, 'REACH'), (17968444, 'SPARSER'), (21642714, 'REACH'), (12417432, 'SPARSER'), (12417439, 'SPARSER'), (12842172, 'REACH'), (2372793, 'REACH'), (21651129, 'REACH'), (21651132, 'REACH'), (20974488, 'REACH'), (10164819, 'REACH'), (29631110, 'SPARSER'), (2842418, 'REACH'), (12886847, 'REACH')}), ('TASK-1 and TASK-3', {(472186, 'SPARSER'), (11971608, 'SPARSER'), (17897975, 'SPARSER'), (8953724, 'SPARSER')}), ('KCNK3', {(13753696, 'REACH'), (12602654, 'REACH'), (3057751, 'SPARSER'), (3634121, 'REACH'), (3634124, 'REACH'), (12901836, 'REACH'), (1199539, 'SPARSER'), (20794844, 'SPARSER'), (26114439, 'REACH'), (10255892, 'REACH'), (14886125, 'SPARSER'), (3634127, 'REACH'), (11336816, 'REACH'), (10124032, 'SPARSER'), (3726686, 'SPARSER'), (12602647, 'REACH'), (12672056, 'REACH'), (13115973, 'REACH'), (13753669, 'REACH'), (12672033, 'REACH'), (1199540, 'SPARSER'), (12672059, 'REACH'), (10034796, 'REACH'), (18689660, 'SPARSER'), (3634120, 'REACH'), (3634133, 'REACH'), (21560661, 'REACH'), (22646227, 'REACH'), (3726687, 'SPARSER'), (13116084, 'REACH'), (10034786, 'REACH'), (1880175, 'REACH'), (22646229, 'REACH'), (3634126, 'REACH'), (3634123, 'REACH'), (18689662, 'SPARSER'), (27591896, 'REACH'), (16914021, 'REACH'), (18561814, 'REACH'), (23834945, 'REACH'), (20794836, 'SPARSER'), (20794841, 'SPARSER'), (8303989, 'REACH'), (14886122, 'SPARSER'), (23793525, 'REACH'), (18689663, 'SPARSER'), (22646228, 'REACH'), (22646230, 'REACH'), (10124036, 'SPARSER'), (1199538, 'SPARSER'), (1880174, 'REACH'), (10034795, 'REACH'), (12602652, 'REACH'), (3634122, 'REACH'), (3634135, 'REACH'), (16914017, 'REACH'), (29974369, 'REACH'), (8253215, 'REACH'), (3634125, 'REACH'), (23453612, 'REACH'), (13115974, 'REACH'), (12901827, 'REACH'), (1880177, 'REACH'), (18785826, 'REACH'), (16914000, 'REACH'), (3726688, 'SPARSER'), (26114443, 'REACH'), (12671781, 'REACH'), (16914006, 'REACH'), (3634131, 'REACH'), (19531908, 'REACH')}), ('TASK-1 -/-', {(1634534, 'REACH'), (26206793, 'REACH')}), ('KCNK3-GFP', {(3634128, 'REACH'), (3634129, 'REACH'), (3634130, 'REACH')}), ('<0.01, and task', {(9000794, 'SPARSER')}), ('task and CaN', {(22049163, 'SPARSER'), (9331218, 'SPARSER'), (9331192, 'SPARSER'), (22049166, 'SPARSER')}), ('Kcnk3', {(23271803, 'REACH'), (26416039, 'REACH'), (30476104, 'REACH'), (15024028, 'REACH'), (10392915, 'REACH')}), ('si-KCNK3', {(21090230, 'REACH')}), ('task and CREB', {(22810578, 'SPARSER')}), ('TASK1 and TASK3', {(22959911, 'SPARSER')}), ('TWIK-related acid-sensitive K(+) channel 1', {(23718534, 'REACH')}), ('TaSK1', {(25865581, 'REACH'), (24027370, 'SPARSER'), (25865571, 'REACH'), (23989489, 'REACH'), (23989509, 'REACH'), (25865569, 'REACH')}), ('TASK1, TASK3, TREK1 and TRAAK', {(24656247, 'SPARSER')}), ('Task-1', {(25828025, 'REACH'), (25828026, 'REACH')}), ('TaSK', {(26604624, 'REACH'), (25865589, 'REACH'), (25865555, 'REACH'), (25865529, 'REACH')}), ('Task1', {(27103683, 'REACH'), (27103682, 'REACH'), (27103673, 'REACH'), (27103671, 'REACH'), (27103672, 'REACH'), (27103670, 'REACH'), (27103681, 'REACH')}), ('TASK1, TASK3 and TALK1', {(29799601, 'SPARSER')}), ('task and striatum', {(30280385, 'SPARSER')})])"
      ]
     },
     "execution_count": 48,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "channel_texts['KCNK3'].items()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['task', 'Task', 'TASK1', 'TASK', 'TASK-1', 'KCNK3']"
      ]
     },
     "execution_count": 49,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "[key for key, value in channel_texts['KCNK3'].items() if len(value) > 10]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'AQP12B', 'CATSPERG', 'GJA10', 'GJA6P', 'KCNK7', 'TRPC7'}"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "set(ic_symbols) - set(channel_texts.keys())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [],
   "source": [
    "from indra_db.util.content_scripts import get_text_content_from_stmt_ids, get_text_content_from_pmids"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [],
   "source": [
    "from adeft.modeling.find_anomalies import AdeftAnomalyDetector"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [],
   "source": [
    "task_stmts = list(channel_texts.values())[2]['task']\n",
    "task_stmts = [x[0] for x in task_stmts]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [],
   "source": [
    "_, task_content = get_text_content_from_stmt_ids(task_stmts)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [],
   "source": [
    "_, kcnk3_content = get_text_content_from_pmids(pmids['KCNK3'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [],
   "source": [
    "anomaly_detector = AdeftAnomalyDetector(blacklist=['task', 'task1', 'kcnk3'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [],
   "source": [
    "param_grid = {'nu': [0.1, 0.2, 0.4], 'max_features': [100], 'ngram_range': [(1, 1)]}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['Platelet-activating factor (PAF), an inflammatory phospholipid, induces ventricular arrhythmia via an unknown ionic mechanism. We can now link PAF-mediated cardiac electrophysiological effects to inhibition of a two-pore domain K(+) channel [TWIK-related acid-sensitive K(+) background channel (TASK-1)]. Superfusion of carbamyl-PAF (C-PAF), a stable analog of PAF, over murine ventricular myocytes causes abnormal automaticity, plateau phase arrest of the action potential, and early afterdepolarizations in paced and quiescent cells from wild-type but not PAF receptor knockout mice. C-PAF-dependent currents are insensitive to Cs(+) and are outwardly rectifying with biophysical properties consistent with a K(+)-selective channel. The current is blocked by TASK-1 inhibitors, including protons, Ba(2+), Zn(2+), and methanandamide, a stable analog of the endogenous lipid ligand of cannabinoid receptors. In addition, when TASK-1 is expressed in CHO cells that express an endogenous PAF receptor, superfusion of C-PAF decreases the expressed current. Like C-PAF, methanandamide evoked spontaneous activity in quiescent myocytes. C-PAF- and methanandamide-sensitive currents are blocked by a specific protein kinase C (PKC) inhibitor, implying overlapping signaling pathways. In conclusion, C-PAF blocks TASK-1 or a closely related channel, the effect is PKC dependent, and the inhibition alters the electrical activity of myocytes in ways that would be arrhythmogenic in the intact heart.',\n",
       " '<!DOCTYPE article PUBLIC \"-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN\" \"JATS-archivearticle1.dtd\">\\n<article xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" article-type=\"research-article\"><?properties open_access?><front><journal-meta><journal-id journal-id-type=\"nlm-ta\">Sci Rep</journal-id><journal-id journal-id-type=\"iso-abbrev\">Sci Rep</journal-id><journal-title-group><journal-title>Scientific Reports</journal-title></journal-title-group><issn pub-type=\"epub\">2045-2322</issn><publisher><publisher-name>Nature Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type=\"pmid\">26794006</article-id><article-id pub-id-type=\"pmc\">4726246</article-id><article-id pub-id-type=\"pii\">srep19492</article-id><article-id pub-id-type=\"doi\">10.1038/srep19492</article-id><article-categories><subj-group subj-group-type=\"heading\"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Functional mutagenesis screens reveal the &#x02018;cap structure&#x02019; formation in disulfide-bridge free TASK channels</article-title></title-group><contrib-group><contrib contrib-type=\"author\"><name><surname>Goldstein</surname><given-names>Matthias</given-names></name><xref ref-type=\"aff\" rid=\"a1\">1</xref><xref ref-type=\"author-notes\" rid=\"n1\">*</xref></contrib><contrib contrib-type=\"author\"><name><surname>Rinn&#x000e9;</surname><given-names>Susanne</given-names></name><xref ref-type=\"aff\" rid=\"a1\">1</xref><xref ref-type=\"author-notes\" rid=\"n1\">*</xref></contrib><contrib contrib-type=\"author\"><name><surname>Kiper</surname><given-names>Aytug K.</given-names></name><xref ref-type=\"aff\" rid=\"a1\">1</xref><xref ref-type=\"author-notes\" rid=\"n1\">*</xref></contrib><contrib contrib-type=\"author\"><name><surname>Ram&#x000ed;rez</surname><given-names>David</given-names></name><xref ref-type=\"aff\" rid=\"a2\">2</xref></contrib><contrib contrib-type=\"author\"><name><surname>Netter</surname><given-names>Michael F.</given-names></name><xref ref-type=\"aff\" rid=\"a1\">1</xref></contrib><contrib contrib-type=\"author\"><name><surname>Bustos</surname><given-names>Daniel</given-names></name><xref ref-type=\"aff\" rid=\"a2\">2</xref></contrib><contrib contrib-type=\"author\"><name><surname>Ortiz-Bonnin</surname><given-names>Beatriz</given-names></name><xref ref-type=\"aff\" rid=\"a1\">1</xref></contrib><contrib contrib-type=\"author\"><name><surname>Gonz&#x000e1;lez</surname><given-names>Wendy</given-names></name><xref ref-type=\"aff\" rid=\"a2\">2</xref></contrib><contrib contrib-type=\"author\"><name><surname>Decher</surname><given-names>Niels</given-names></name><xref ref-type=\"corresp\" rid=\"c1\">a</xref><xref ref-type=\"aff\" rid=\"a1\">1</xref></contrib><aff id=\"a1\"><label>1</label><institution>Institute for Physiology and Pathophysiology, University of Marburg</institution>, 35037 Marburg, <country>Germany</country></aff><aff id=\"a2\"><label>2</label><institution>Center for Bioinformatics and Molecular Simulation, University of Talca</institution>, Talca, <country>Chile</country></aff></contrib-group><author-notes><corresp id=\"c1\"><label>a</label><email>decher@staff.uni-marburg.de</email></corresp><fn id=\"n1\"><label>*</label><p>These authors contributed equally to this work.</p></fn></author-notes><pub-date pub-type=\"epub\"><day>22</day><month>01</month><year>2016</year></pub-date><pub-date pub-type=\"collection\"><year>2016</year></pub-date><volume>6</volume><elocation-id>19492</elocation-id><history><date date-type=\"received\"><day>08</day><month>10</month><year>2015</year></date><date date-type=\"accepted\"><day>14</day><month>12</month><year>2015</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2016, Macmillan Publishers Limited</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Macmillan Publishers Limited</copyright-holder><license xmlns:xlink=\"http://www.w3.org/1999/xlink\" license-type=\"open-access\" xlink:href=\"http://creativecommons.org/licenses/by/4.0/\"><!--author-paid--><license-p>This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article&#x02019;s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit <ext-link ext-link-type=\"uri\" xlink:href=\"http://creativecommons.org/licenses/by/4.0/\">http://creativecommons.org/licenses/by/4.0/</ext-link></license-p></license></permissions><abstract><p>Two-pore-domain potassium (K<sub>2P</sub>) channels have a large extracellular cap structure formed by two M1-P1 linkers, containing a cysteine for dimerization. However, this cysteine is not present in the TASK-1/3/5 subfamily. The functional role of the cap is poorly understood and it remained unclear whether K<sub>2P</sub> channels assemble in the domain-swapped orientation or not. Functional alanine-mutagenesis screens of TASK-1 and TRAAK were used to build an <italic>in silico</italic> model of the TASK-1 cap. According to our data the cap structure of disulfide-bridge free TASK channels is similar to that of other K<sub>2P</sub> channels and is most likely assembled in the domain-swapped orientation. As the conserved cysteine is not essential for functional expression of all K<sub>2P</sub> channels tested, we propose that hydrophobic residues at the inner leaflets of the cap domains can interact with each other and that this way of stabilizing the cap is most likely conserved among K<sub>2P</sub> channels.</p></abstract></article-meta></front><body><p>Two-pore domain potassium (K<sub>2P</sub>) channels have four transmembrane domains (M1 to M4) containing two pore loops per subunit<xref ref-type=\"bibr\" rid=\"b1\">1</xref>. The functional channels are formed by an antiparallel dimeric assembly, so that four pore loops form the selectivity filter of the channel<xref ref-type=\"bibr\" rid=\"b2\">2</xref><xref ref-type=\"bibr\" rid=\"b3\">3</xref><xref ref-type=\"bibr\" rid=\"b4\">4</xref>. Crystallization of K<sub>2P</sub> channels revealed a unique cap structure formed by the two large extracellular linkers from the M1 to the pore loop (M1-P1 linker)<xref ref-type=\"bibr\" rid=\"b2\">2</xref><xref ref-type=\"bibr\" rid=\"b3\">3</xref><xref ref-type=\"bibr\" rid=\"b4\">4</xref>. The cap structure forms two tunnel-like side portals which serve as extracellular ion pathway (EIP) after the selectivity filter<xref ref-type=\"bibr\" rid=\"b5\">5</xref>. These side portals also play an important role in regulating the extracellular pH dependence of TASK channels<xref ref-type=\"bibr\" rid=\"b5\">5</xref>. Interestingly, following the initial crystal structure of TRAAK<xref ref-type=\"bibr\" rid=\"b2\">2</xref>, a second structure with higher resolution showed a domain-swapped chain connectivity of the M1-P1 linker at the helical cap which also results in structural rearrangement of two opposing transmembrane helices<xref ref-type=\"bibr\" rid=\"b3\">3</xref>. However, whether most of the TRAAK channels or only a fraction of the functional channels are domain-swapped still remained elusive, although the recently released TREK-1 (PDB ID: 4TWK) and TREK-2&#x02009;<xref ref-type=\"bibr\" rid=\"b6\">6</xref> structures were also crystallized in the domain-swapped orientation. Thus, a study providing information about the function of the cap and experiments providing insights towards the physiological orientation of the assembled channels would be very valuable.</p><p>In 1996 it was suggested by Lesage <italic>et al</italic>., that a K<sub>2P</sub> channel dimer is covalently assembled by a disulfide-bridge and that the extracellular domain as well as the cysteine residues are essential elements for the dimerization process of TWIK-1&#x02009;<xref ref-type=\"bibr\" rid=\"b7\">7</xref>. Crystallization of TWIK-1, TRAAK and TREK-2 confirmed the presence of a disulfide-bridge in homomeric K<sub>2P</sub> channels<xref ref-type=\"bibr\" rid=\"b2\">2</xref><xref ref-type=\"bibr\" rid=\"b4\">4</xref><xref ref-type=\"bibr\" rid=\"b6\">6</xref>. In addition, TASK-2, TASK-4, TALK-1, TREK-1, TRESK, KCNK7 and TWIK-2 share a homologous cysteine residue. However, for some K<sub>2P</sub> channels there is evidence that the disulfide bond is not required for dimerization or the functional expression of homodimers<xref ref-type=\"bibr\" rid=\"b8\">8</xref><xref ref-type=\"bibr\" rid=\"b9\">9</xref><xref ref-type=\"bibr\" rid=\"b10\">10</xref>. Accordingly, other unidentified mechanisms may exist for the functional assembly of K<sub>2P</sub> channels, especially as the TASK-1/3/5 and THIK-1/2 subfamilies do not contain a homologous cysteine residue in the M1-P1 linker. Unfortunately, no &#x02018;disulfide-bridge free&#x02019; K<sub>2P</sub> channel could be crystallized yet. The lack of a cysteine in the M1-P1 linker, together with a very strong computational coiled-coil prediction in this domain of TASK channels, prompted us to study the role of this linker in TASK-1 channels. In the current study, using functional alanine-mutagenesis screens, we have built an experimentally validated model of the disulfide-bridge free cap structure of the TASK-1 channels in the domain-swapped orientation. Combined with a mutagenesis screen in TRAAK our data suggest that the cysteine residues in the cap structure are not relevant for the functional expression of K<sub>2P</sub> channels. Furthermore, our model indicates that the cap structure formation of TASK channels is conserved to that of K<sub>2P</sub> channels containing an extracellular disulfide-bridge.</p><sec disp-level=\"1\"><title>Results</title><sec disp-level=\"2\"><title>Potential coiled-coil domain in the cysteine-free M1-P1 linker of TASK-1 channels</title><p>In 1996 Lesage <italic>et al</italic>. proposed that the extracellular M1-P1 linker of K<sub>2P</sub> channels is essential for the dimerization process and that channel dimers are covalently assembled via a disulfide-bridge within this linker<xref ref-type=\"bibr\" rid=\"b7\">7</xref>. Most K<sub>2P</sub> channels share a homologues cysteine residue, while TASK-1, TASK-3, TASK-5, THIK-1 and THIK-2 do not have a cysteine in the M1-P1 linker (<xref ref-type=\"fig\" rid=\"f1\">Fig. 1a,b</xref>). Before the first K<sub>2P</sub> channels were crystallized, we aimed at understanding the structural differences between the particularly long extracellular M1-P1 linkers of K<sub>2P</sub> channels. Using secondary structure predictions of the M1-P1 linkers, we identified a strong coiled-coil prediction (Expasy, COILS version 2.1&#x02009;<xref ref-type=\"bibr\" rid=\"b11\">11</xref>) which was very prominent in the non disulfide-bridge containing TASK-1 and TASK-3 channels. The coiled-coil domain is a common structural motif, consisting of two to five &#x003b1;-helices mutually wrapped into a left-handed helix forming a supercoil<xref ref-type=\"bibr\" rid=\"b12\">12</xref> (<xref ref-type=\"fig\" rid=\"f1\">Fig. 1c</xref>; <xref ref-type=\"supplementary-material\" rid=\"S1\">Supplementary Fig. S1a</xref>). Interestingly, only for TASK-1 and TASK-3 strong 4-fold heptad repeat predictions were observed (<xref ref-type=\"supplementary-material\" rid=\"S1\">Supplementary Fig. S1b</xref>). <xref ref-type=\"fig\" rid=\"f1\">Figure 1d</xref> illustrates examples of 4-fold heptad repeat coiled-coil predictions for TASK-1 (no cysteine in the M1-P1 linker) and TASK-4 (cysteine containing M1-P1 linker). To functionally probe for a coiled-coil domain, we introduced mutations in TASK-1 affecting all &#x02018;a&#x02019;-sites (R38A/Q45A/Y52A/Y59A) and all &#x02018;d&#x02019;- sites (L41A/L48A/S55A/L62A) which should be relevant for the coiled-coil formation (<xref ref-type=\"fig\" rid=\"f1\">Fig. 1e</xref>; <xref ref-type=\"supplementary-material\" rid=\"S1\">Supplementary Fig. S1b</xref>), or all &#x02018;f&#x02019;-sites which should be not relevant for coiled-coil assembly (L43A/A50V/G57A/R64A) (<xref ref-type=\"fig\" rid=\"f1\">Fig. 1e</xref>; <xref ref-type=\"supplementary-material\" rid=\"S1\">Supplementary Fig. S1b</xref>). Subsequently, we studied the current amplitudes of the four-fold mutations using two-electrode voltage clamp (TEVC) recordings in <italic>Xenopus</italic> oocytes. Consistent with a coiled-coil domain in the extracellular M1-P1 linker of TASK-1, we revealed a strong current reduction for the &#x02018;a&#x02019;-site mutant (93%) as well as for the &#x02018;d&#x02019;-site mutant (93%), whereas the &#x02018;f&#x02019;-site mutant showed only a minor current reduction (20%) (<xref ref-type=\"fig\" rid=\"f1\">Fig. 1e</xref>). These experiments prompted us to alanine-scan the extracellular M1-P1 linker to identify amino acids relevant for the dimerization or functional expression of TASK-1 channels.</p></sec><sec disp-level=\"2\"><title>Functional alanine-scanning of the extracellular M1-P1 linker of TASK-1</title><p>The alanine scan ranged from S31 up to Q77 (<xref ref-type=\"fig\" rid=\"f1\">Figs 1a,b</xref> and <xref ref-type=\"fig\" rid=\"f2\">2</xref>), including the 31 amino acid span of the coiled-coil prediction (<xref ref-type=\"fig\" rid=\"f1\">Figs 1b</xref> and <xref ref-type=\"fig\" rid=\"f2\">2</xref>). Alanine residues were mutated to valine. For all mutants current amplitudes were analyzed after expression in <italic>Xenopus</italic> oocytes. Representative current traces resulting from a voltage step to +40&#x02009;mV are depicted in <xref ref-type=\"fig\" rid=\"f2\">Fig. 2a</xref>. While the alanine-scan revealed only a few mutants with a significant current increase, several mutations with a strong current reduction were observed (<xref ref-type=\"fig\" rid=\"f2\">Fig. 2a,b</xref>). Mutants located in the predicted coiled-coil region exhibiting a very strong current decrease (L48A, Y52A, N53A, L54A, S55A, Y59A and L62A) are highlighted as black bars (<xref ref-type=\"fig\" rid=\"f2\">Fig. 2b</xref>). Interestingly, within this span of the coiled-coil prediction five of these seven residues highly relevant for functional channel expression were located at hydrophobic &#x02018;a&#x02019;- and &#x02018;d&#x02019;-sites (L48, Y52, S55, Y59 and L62) which might be relevant for hydrophobic coiled-coil formation (<xref ref-type=\"fig\" rid=\"f2\">Fig. 2b</xref>; <xref ref-type=\"supplementary-material\" rid=\"S1\">Supplementary Fig. S1b</xref>). However, the residues identified essential for functional channel expression were not strictly following a coiled-coil prediction, as not all &#x02018;a&#x02019;- and &#x02018;d&#x02019;-sites were affected and ionic &#x02018;e&#x02019;- and &#x02018;g&#x02019;-sites remained normal. In addition, N53A and L54A were located at &#x02018;b&#x02019;- and &#x02018;c&#x02019;-sites. Accordingly, mutating all the residues we have identified to alanine (L48A/Y52A/N53A/L54A/S55A/Y59A/L62A) did not destroy the <italic>in silico</italic> coiled-coiled prediction (p&#x02009;=&#x02009;0.999). Thus, despite the initial computational predictions it is not a classical coiled-coil domain stabilizing the extracellular structure of this disulfide-bridge free K<sub>2P</sub> channel. In contrast, alignments with the TWIK, TRAAK and TREK channels<xref ref-type=\"bibr\" rid=\"b2\">2</xref><xref ref-type=\"bibr\" rid=\"b3\">3</xref><xref ref-type=\"bibr\" rid=\"b4\">4</xref><xref ref-type=\"bibr\" rid=\"b6\">6</xref>-crystallized in the progress of this study - suggest that the coiled-coil prediction and the containing loss-of-function mutations in L48, Y52, N53, L54, S55, Y59 and L62, directly fall into the region of the two extracellular cap domains, while the residues following the coiled-coil prediction (starting from amino acid L67) are more likely to be homologous to the previously described EIP<xref ref-type=\"bibr\" rid=\"b5\">5</xref>.</p></sec><sec disp-level=\"2\"><title>Loss-of-function mutations within the cap domains are caused by a decreased surface expression</title><p>To test for surface expression of the different alanine mutants, we performed an ELISA based chemiluminescence assay in <italic>Xenopus</italic> oocytes. TASK-1 and all alanine-mutants of the M1-P1 linker were tagged with an hemagglutinin (HA) epitope near the end of the extracellular P2-M4 linker. The relative surface expression compared to TASK-1 wild-type (WT-HA) is shown in <xref ref-type=\"fig\" rid=\"f2\">Fig. 2c</xref>. Interestingly, the current reduction observed for mutations within the cap (L48A, Y52A, N53A, L54A, S55A, Y59A, L62A) was paralleled by a reduction in surface expression (<xref ref-type=\"fig\" rid=\"f2\">Fig. 2b</xref> versus <xref ref-type=\"fig\" rid=\"f2\">Fig. 2c</xref>), indicating a reduced functional expression at the surface as a mechanism for the strong loss-of-function. To probe for changes in the channel gating, we analyzed the ratio of the current amplitudes (<xref ref-type=\"fig\" rid=\"f2\">Fig. 2b</xref>) to surface expression (<xref ref-type=\"fig\" rid=\"f2\">Fig. 2c</xref>) as a measure for the &#x02018;conductivity&#x02019; of the mutants (<xref ref-type=\"fig\" rid=\"f2\">Fig. 2d</xref>). Note that the changes in &#x02018;conductivity&#x02019; observed here can either result from an altered single-channel conductance or open probability, which was not studied in further detail. These analyses confirmed that L48A, Y52A, N53A, L54A, S55A, Y59A and L62A have a normal &#x02018;conductivity&#x02019; (<xref ref-type=\"fig\" rid=\"f2\">Fig. 2d</xref>), while functional expression at the surface membrane is reduced (<xref ref-type=\"fig\" rid=\"f2\">Fig. 2c</xref>).</p></sec><sec disp-level=\"2\"><title>Loss-of-function mutations in the region following the cap domains (putative EIP) are caused by a decreased &#x02018;conductivity&#x02019;</title><p>Alanine mutations in the region following the putative cap domains, in the range of K70 to Q77, are very prone to induce a loss-of-function (<xref ref-type=\"fig\" rid=\"f2\">Fig. 2b</xref>). This region is likely to form the previously described EIP in TASK channels<xref ref-type=\"bibr\" rid=\"b5\">5</xref>. However, in contrast to the seven mutations within the putative cap domains (<xref ref-type=\"fig\" rid=\"f2\">Fig. 2c,d</xref>), only H72A caused a reduced surface expression while retaining a normal channel gating (<xref ref-type=\"fig\" rid=\"f2\">Fig. 2c,d</xref>). The other loss-of-function mutations in the putative EIP were caused by a combination of a reduced surface expression and a reduced conductivity (A74V, Q77A) (<xref ref-type=\"fig\" rid=\"f2\">Fig. 2c,d</xref>) or by a pure gating defect (K70A, P71A, K73A), as these channels reached the plasma membrane with a normal efficiency but the current amplitudes are strongly reduced (<xref ref-type=\"fig\" rid=\"f2\">Fig. 2c,d</xref>). This loss of &#x02018;conductivity&#x02019; which we have observed in this region by alanine-mutations (<xref ref-type=\"fig\" rid=\"f2\">Fig. 2d</xref>) is in good agreement with the idea that the hydrophilicity in the EIP is important for the conductivity of TASK channels<xref ref-type=\"bibr\" rid=\"b5\">5</xref>. Thus, we propose that the mutations in the EIP change the conductivity of the channel either due to changes in the single-channel conductance or the open probability, while the mutations within the cap might be important for the channel assembly or dimerization.</p></sec><sec disp-level=\"2\"><title>Impaired surface expression of &#x02018;hit&#x02019; mutations in the cap domains is caused by a reduced abundance of dimeric TASK-1 protein</title><p>To probe whether the reduced surface expression of mutations in the cap was caused by an impaired channel dimerization, we performed western blot experiments injecting equal amounts of HA-tagged constructs into oocytes (<xref ref-type=\"fig\" rid=\"f3\">Fig. 3a</xref>). Analyzing the amount of dimeric TASK-1 protein for L48A, Y52A, N53A, L54A, S55A, Y59A and L62A, we found that all these &#x02018;hits&#x02019;, identified in the cap structure, showed a strongly reduced expression of dimeric protein compared to wild-type TASK-1 (<xref ref-type=\"fig\" rid=\"f3\">Fig. 3a,b</xref>). This reduction was not exclusively present for the dimeric protein (<xref ref-type=\"fig\" rid=\"f3\">Fig. 3a,b</xref>; <xref ref-type=\"supplementary-material\" rid=\"S1\">Supplementary Fig. S2</xref>), suggesting that the diminished formation of stable TASK-1 protein is the most likely cause for the impaired functional expression at the cell surface. As a control we used the K70A mutation, as this amino acid exchange is located in the putative EIP and should not interfere with channel dimerization. In contrast to the mutations within the cap domains, the K70A mutation has a normal surface expression (<xref ref-type=\"fig\" rid=\"f2\">Fig. 2c</xref>) and a pure loss-of-function by a reduced &#x02018;conductivity&#x02019; (<xref ref-type=\"fig\" rid=\"f2\">Fig. 2b,d</xref>). Consistently, this mutation had a normal abundance of dimeric and monomeric protein (<xref ref-type=\"fig\" rid=\"f3\">Fig. 3d,e</xref>; <xref ref-type=\"supplementary-material\" rid=\"S1\">Supplementary Fig. S2</xref>).</p><p>TASK-1 channels studied with fluorescence imaging were primarily localized at the ER and only a weak surface expression was detected (<xref ref-type=\"fig\" rid=\"f3\">Fig. 3c</xref>), similar as previously described<xref ref-type=\"bibr\" rid=\"b13\">13</xref>. Notably, for the wild-type TASK-1 surface expression appears as uniform staining of the entire cell, also between the ER<xref ref-type=\"bibr\" rid=\"b13\">13</xref>, which is not present for the mutants (<xref ref-type=\"fig\" rid=\"f3\">Fig. 3c</xref>). Consistent with the reduced functional expression of the mutants at the surface membrane in oocytes (<xref ref-type=\"fig\" rid=\"f2\">Fig. 2b,c</xref>), and an impaired protein stability, we observed a preferential fluorescence of the mutations to an intracellular compartments. As misfolded proteins are known to accumulate in the ER and concomitantly cause ER stress, the TASK-1 mutations with diminished protein stability (<xref ref-type=\"fig\" rid=\"f3\">Fig. 3b</xref>) were primarily located in a compartment most probably reflecting the endoplasmic reticulum (<xref ref-type=\"fig\" rid=\"f3\">Fig. 3c</xref>).</p></sec><sec disp-level=\"2\"><title>The impaired surface expression of N53A and S55A, by a reduced abundance of dimeric TASK-1 channels, is not caused by an altered glycosylation</title><p>The residue N53 resides at the homologues position to the cysteine at the tip of the TWIK-1, TREK-2 and TRAAK cap structure (<xref ref-type=\"fig\" rid=\"f1\">Fig. 1b</xref>). This asparagine is predicted as a weak glycosylation site and S55 is part of the consensus motif for a glycosylation at position N53. In fact, the western blot analyses revealed that the molecular weight of N53A and S55A is reduced by approximately 10&#x02009;kDa (<xref ref-type=\"fig\" rid=\"f3\">Fig. 3a</xref>) which supports that TASK-1 channels might be glycosylated at N53. To show that the loss-of-function by N53A and S55A is caused by interfering with the channel structure or assembly and is not indirectly caused by an altered glycosylation, we next studied the mutation Q56P. The Q56A mutation showed normal current amplitudes and surface expression, thus Q56 is not an essential structural requirement for the assembly of the dimeric cap structure. Introducing a proline after the N-(x)-S motif destroys the glycosylation site<xref ref-type=\"bibr\" rid=\"b14\">14</xref>. Thus, with a Q56P mutation it is possible to destroy the glycosylation site at N53 without interfering with the structural requirements of having an asparagine at position 53 and a serine at position 55. The Q56P mutation had a similar reduction in molecular weight as N53A and S55A (<xref ref-type=\"fig\" rid=\"f3\">Fig. 3d</xref>), indicating the expected loss of glycosylation at position N53. However, unlike for N53A and S55A the abundance of dimeric protein was not reduced (<xref ref-type=\"fig\" rid=\"f3\">Fig. 3d,e</xref>) and the functional expression was not altered (<xref ref-type=\"fig\" rid=\"f3\">Fig. 3f,g</xref>). These data indicate that the reduced abundance of dimeric proteins by N53A and S55A and the resulting loss of functional expression is not caused by an altered glycosylation at position N53. Summarizing, the residues L48A, Y52A, N53A, L54A, S55A, Y59A and L62A might be the major prerequisite for the stability and dimerization of the cap structures in TASK-1 channels.</p></sec><sec disp-level=\"2\"><title>Residues L48A, Y52A, L54A, S55A, Y59A and L62A are involved in intersubunit interactions with the closely related TASK-3 channels</title><p>A sequence alignment of the M1-P1 linkers of TASK-1 and TASK-3 revealed a high conservation of the critical amino acids identified in TASK-1 (<xref ref-type=\"fig\" rid=\"f4\">Fig. 4a</xref>). To elucidate a functional conservation of the cap structures and a role of these residues for hetero dimerization, we expressed wild-type TASK-3 in the absence and presence of the identified TASK-1 mutants (<xref ref-type=\"fig\" rid=\"f4\">Fig. 4b</xref>). In all cases (except for N53A) the co-expression of the TASK-1 mutants reduced the current amplitude of wild-type TASK-3. In contrast, co-expression of TASK-1 wild-type lead to a minor current increase. As the current suppression by the TASK-1 mutants was conferred to the co-expressed wild-type TASK-3 in a dominant-negative manner, the TASK-1 mutations must cause a disturbance in the heteromeric channel complex with TASK-3. Thus, the mutations might perturb intersubunit interactions of these conserved residues which are necessary for a stable heteromeric cap structure. Thus, it is likely that the residues L48A, Y52A, L54A, S55A, Y59A and L62A are also involved in intersubunit (not intrasubunit) interactions for homomeric TASK channel assembly.</p></sec><sec disp-level=\"2\"><title>A domain-swapped TASK-1 cap structure model based on the functional mutagenesis screens</title><p>Next we generated homology models of the cysteine-free cap structure of TASK-1 based on the x-ray structures of TRAAK, domain-swapped TRAAK, TWIK-1 and TREK-2&#x02009;<xref ref-type=\"bibr\" rid=\"b2\">2</xref><xref ref-type=\"bibr\" rid=\"b3\">3</xref><xref ref-type=\"bibr\" rid=\"b4\">4</xref><xref ref-type=\"bibr\" rid=\"b6\">6</xref>. After generating the homology models, we performed MD simulation of 10&#x02009;ns duration analyzing putative intersubunit interactions that might stabilize the cap structure. Here the average distances of the residues, which we identified in the coiled-coil domain as relevant for channel dimerization and functional expression, were quantified over a time period of 10&#x02009;ns (<xref ref-type=\"table\" rid=\"t1\">Table 1</xref>; <xref ref-type=\"supplementary-material\" rid=\"S1\">Supplementary Tables S1&#x02013;3</xref>). Interactions of key residue in the helical cap were evaluated measuring carbon-carbon atom distances (see also Methods). A relative remote cut-off of 6.0&#x02009;&#x000c5; (instead of 4&#x02009;&#x000c5;) was used to probe for interactions, as the predefined C atoms selected for the automatic distance measurements (<xref ref-type=\"supplementary-material\" rid=\"S1\">Supplementary Fig. S3</xref>) do not necessarily reflect the closest C atom for carbon-carbon interactions and in addition the space of the H atoms are not considered. Using the TWIK-1 structure as a template for a homology model of the TASK-1 cap, the distances of the residues which we identified in our alanine mutagenesis screens, were overall too remote to contribute to an intersubunit interaction (<xref ref-type=\"supplementary-material\" rid=\"S1\">Supplementary Table S1</xref>). Analyzing intersubunit distances within the cap structure, the homology model predicted only one putative intersubunit interaction involving our &#x02018;hit&#x02019; residues (Y59 with Y59, <xref ref-type=\"supplementary-material\" rid=\"S1\">Supplementary Table S1</xref>). Using TRAAK as template for the cap structure model, three intersubunit interactions (involving L48, N53, L54 and Y59) were predicted (<xref ref-type=\"supplementary-material\" rid=\"S1\">Supplementary Fig. S4</xref>) and the intersubunit distances of our &#x02018;hit&#x02019; residues were overall smaller, indicating that TRAAK was a more suitable template (<xref ref-type=\"supplementary-material\" rid=\"S1\">Supplementary Table S2</xref>). Using the domain-swapped TRAAK crystal as a template, we identified three putative intersubunit interactions, involving L48, Y52, L54, S55 and L62 (<xref ref-type=\"supplementary-material\" rid=\"S1\">Supplementary Table S3</xref>). However, the homology model which was in perfect agreement with our alanine-scanning mutagenesis was based on the domain-swapped TREK-2 crystal structure. This model had much smaller average distances for the residues relevant for dimerization and it predicted six intersubunit interactions (<xref ref-type=\"table\" rid=\"t1\">Table 1</xref> and <xref ref-type=\"fig\" rid=\"f5\">Fig. 5</xref>), confirming all the residues (L48, Y52, N53, L54, S55, Y59 and L62) we have identified in the alanine mutagenesis screens (<xref ref-type=\"table\" rid=\"t1\">Table 1</xref>; <xref ref-type=\"fig\" rid=\"f2\">Fig. 2</xref>). Subsequently, this homology model, which was in full agreement with our functional data, was probed by additional 90&#x02009;ns of unrestrained MD simulations to generate the final model of a K<sub>2P</sub> channel with a cysteine-free cap structure (<xref ref-type=\"fig\" rid=\"f5\">Fig. 5</xref>). During the entire 100&#x02009;ns of MD simulations the cap structure and the identified interactions (<xref ref-type=\"table\" rid=\"t1\">Table 1</xref>) remained intact (see Methods). In this final model of the TASK-1 cap structure (<xref ref-type=\"fig\" rid=\"f5\">Fig. 5a</xref>), N53, L54 and Y59 interact with the identical residues of the opposing subunit (<xref ref-type=\"fig\" rid=\"f5\">Fig. 5b&#x02013;e</xref>; see the diagonal in <xref ref-type=\"table\" rid=\"t1\">Table 1</xref>). In addition, L48 interacts with L62, Y52 with S55 and L62 with Y59 of the opposing subunit (<xref ref-type=\"fig\" rid=\"f5\">Fig. 5b&#x02013;e</xref>; under the diagonal in <xref ref-type=\"table\" rid=\"t1\">Table 1</xref>). Analyzing the smallest distance between these residues (not the automated measure of preset carbon-carbon atom distances (<xref ref-type=\"supplementary-material\" rid=\"S1\">Supplementary Fig. S3</xref>) as in <xref ref-type=\"table\" rid=\"t1\">Table 1</xref>), all these residues were involved in hydrophobic interactions with a distance of less than 3&#x02009;&#x000c5; (<xref ref-type=\"fig\" rid=\"f5\">Fig. 5b</xref>). Mutating Y59 to alanine, leucine, aspartate, glutamate, lysine, arginine or cysteine resulted in a loss-of-function, while a phenylalanine did not disturb functional expression (<xref ref-type=\"supplementary-material\" rid=\"S1\">Supplementary Fig. S5</xref>), supporting our model that Y59 is involved in a &#x003c0;&#x02013;&#x003c0; interaction with Y59 of the neighboring subunit (<xref ref-type=\"fig\" rid=\"f5\">Fig. 5b,e</xref>). As mentioned above, it still remained an open question whether the cap structure of K<sub>2P</sub> channels predominantly exist in the domain-swapped orientation or not. TRAAK crystallization revealed a domain-swapped and non domain-swapped structure whereas for TREK-2 only a domain-swapped structure has been described so far. Our functional data together with molecular modeling experiments are in perfect agreement with a domain-swapped cap structure of TASK-1 (<xref ref-type=\"fig\" rid=\"f5\">Fig. 5</xref>). Furthermore our data indicate that hydrophobic interactions at the tip of the cap structure stabilize the dimeric channels (<xref ref-type=\"fig\" rid=\"f6\">Fig. 6a,b</xref>), while residues that alter channel conductivity or gating are facing the EIP located above the selectivity filter (<xref ref-type=\"fig\" rid=\"f6\">Fig. 6b</xref>).</p></sec><sec disp-level=\"2\"><title>Functional conservation of hydrophobic interactions in the cap between TRAAK and disulfide-bridge free TASK-1 channels</title><p>To probe for the functional difference in dimerization compared to a K<sub>2P</sub> channel containing a disulfide-bridge, we performed a functional alanine-screen through the extracellular M1-P1 linker of TRAAK. Moreover this channel was crystallized in two cap variants, thus functional data might provide conclusions towards the most likely chain connectivity of the cap (domain-swapped or not). Unexpectedly, the alanine-scan in TRAAK identified only one lipophilic residue (L84) as functional relevant (<xref ref-type=\"fig\" rid=\"f7\">Fig. 7a</xref>), while lipophilic residues were previously thought to form a hydrophobic zipper-like structure in the core of the helical cap domains, including residues L65, F72, L73, L84, L87, I88, V91, A92 and A94&#x02009;<xref ref-type=\"bibr\" rid=\"b2\">2</xref>. The lack of functional relevance of this lipophilic zipper described by Brohwan <italic>et al</italic>., might be attributed to the fact that TRAAK channels are primarily stabilized by a disulfide-bridge between two cysteine residues (C78) at the tip of the cap structure, which are at the site homologous to N53 in TASK-1. Surprisingly, we found that the disulfide-bridge has no major relevance for the functional expression of the channels, as the C78A mutant had a regular functional expression (<xref ref-type=\"fig\" rid=\"f7\">Fig. 7a</xref>). Thus, the TRAAK channels might be stabilized by a concerted action of the disulfide-bridge and a set of hydrophobic interactions. Accordingly, hydrophobic interactions in the C78A mutant might keep the channel functional in the absence of the disulfide-bridge. Therefore, we next mutated the residues F72, H76, V79, S80, L84 and L87, which correspond to the residues L48, Y52, L54, S55, Y59 and L62 we identified in TASK-1, in the presence of the C78A mutation (<xref ref-type=\"fig\" rid=\"f7\">Fig. 7b</xref>). Studying TRAAK channels without cysteine (C78A mutant), we found that with the exception of S80 (corresponding to S55), all the homologous residues, identified in the TASK-1 mutagenesis screen, become highly relevant for functional expression of TRAAK (<xref ref-type=\"fig\" rid=\"f7\">Fig. 7b</xref>). <xref ref-type=\"fig\" rid=\"f7\">Figure 7c</xref> illustrates that the lipophilic residues, homologous to the TASK-1 &#x02018;hits&#x02019;, which stabilize the TRAAK channel are forming a zipper-like structure which resembles the model, we describe for the TASK-1 cap (<xref ref-type=\"fig\" rid=\"f5\">Fig. 5</xref>). This lipophilic zipper was present and stable after 10&#x02009;ns of MD simulations for the domain-swapped crystal structure (<xref ref-type=\"fig\" rid=\"f7\">Fig. 7c</xref>), but also for an <italic>in silico</italic> mutated C78A TRAAK channel (<xref ref-type=\"fig\" rid=\"f7\">Fig. 7d</xref>). These data suggest that the lipophilic zipper is present in the TRAAK cap and is able to stabilize the channel in the absence of the disulfide-bridge. However, Brohawn <italic>et al</italic>., 2012 proposed that the residues L65, L73, P77, I88, V91, A92 and A94 might be relevant for the hydrophobic zipper and the structure of the cap. Therefore, we also studied these mutations in the C78A background (<xref ref-type=\"supplementary-material\" rid=\"S1\">Supplementary Fig. S6</xref>). From these residues only I88 had a major relevance in the absence of the disulfide-bridge (<xref ref-type=\"supplementary-material\" rid=\"S1\">Supplementary Fig. S6</xref>), confirming the predominant relevance of the residues at the sites we also identified in TASK-1. These functional data are unexpected when looking at the first TRAAK structure, as the residues L65, L73, P77, V91, A92 and A94 played no major role (<xref ref-type=\"fig\" rid=\"f7\">Fig. 7a</xref>), even in the absence of the disulfide-bridge (<xref ref-type=\"supplementary-material\" rid=\"S1\">Supplementary Fig. S6</xref>). In contrast and also unexpected, our functional mutagenesis screen revealed that the structures and the positions of the amino acids (with the exception of I88) stabilizing the caps of cysteine and non-cysteine containing K<sub>2P</sub> channels are highly conserved.</p><p>As we have observed that the residues F72, H76, V79, L84, L87 and I88 are relevant for a stable TRAAK expression, we next analyzed whether these residues are more likely to stabilize a domain-swapped or a non domain-swapped cap structure (<xref ref-type=\"supplementary-material\" rid=\"S1\">Supplementary Fig. S7; Supplementary Tables S4&#x02013;5</xref>). Despite some differences at the tip of the cap structure these residues appear in both TRAAK structures to be equally important in terms of forming a hydrophobic interaction domain which stabilizes the cap (<xref ref-type=\"supplementary-material\" rid=\"S1\">Supplementary Fig. S7</xref>). Therefore, our functional data does not favor the physiological predominance of a particular cap structure variant, which is also in agreement with the crystallization of both, the domain-swapped and non domain-swapped, TRAAK channel.</p></sec><sec disp-level=\"2\"><title>Disulfide-bridges in the cap structure are mostly not essential for the functional expression of K<sub>2P</sub> channels</title><p>As expected performing western blot analysis of TASK-1, TASK-3 and TWIK-1 under non-reducing conditions the molecular weight of the major band are corresponding to the dimeric channel protein (<xref ref-type=\"supplementary-material\" rid=\"S1\">Supplementary Fig. S8</xref>). Unexpectedly despite the lack of a cysteine in the M1-P1 linker, DTT treatment resulted for TASK-1 and TASK-3 in an intensive band corresponding to the monomeric channel protein (<xref ref-type=\"supplementary-material\" rid=\"S1\">Supplementary Fig. S8</xref>). For TASK-1 this behavior was observed independent of the tag used (EGFP or HA-epitope) and was similar to the effects observed for the cysteine containing TWIK-1 (<xref ref-type=\"supplementary-material\" rid=\"S1\">Supplementary Fig. S8</xref>). Similar results were obtained using &#x000df;-mercapto-ethanol instead of DTT (data not shown). Thus, biochemically, we did not observe differences between channels containing a cysteine in the cap structure (TWIK-1) or not (TASK-1 and TASK-3). These data suggest that reducing agents like DTT or &#x000df;-mercapto-ethanol in combination with SDS might have denaturing effects that might have led to wrong conclusions about the functional relevance of disulfide-bridges in the cap structure.</p><p>As TWIK-1 channels were reported to dimerize via C69 in the cap structure and mutations at this site were reported to result in a loss of functional expression<xref ref-type=\"bibr\" rid=\"b7\">7</xref>, the western blot experiments were reproduced using the identical expression constructs and antibodies as in the original study by Lesage <italic>et al</italic>. However, the results still resembled the data from TASK-1 and TASK-3 (<xref ref-type=\"supplementary-material\" rid=\"S1\">Supplementary Fig. S8</xref>), questioning the relevance of the disulfide-bridge in TWIK-1. TWIK-1 channels were previously difficult to record due to a small current amplitude<xref ref-type=\"bibr\" rid=\"b7\">7</xref>, however using Rb<sup>+</sup> as a charge carrier, TWIK-1 generates large and stable macroscopic currents<xref ref-type=\"bibr\" rid=\"b15\">15</xref><xref ref-type=\"bibr\" rid=\"b16\">16</xref>. Recording TWIK-1 currents of the C69A mutation under these conditions revealed that the disulfide-bridge has no major relevance for the functional expression of TWIK-1 (<xref ref-type=\"fig\" rid=\"f7\">Fig. 7e,f</xref>), similar as for TRAAK C78A (<xref ref-type=\"fig\" rid=\"f7\">Fig. 7a,f</xref>). Next, we probed the functional relevance of mutating the putative disulfide-bridge of TASK-4 (C68A) and TREK-1 (C108A) and also here preventing the disulfide-bridge by mutagenesis did not alter the functional expression (<xref ref-type=\"fig\" rid=\"f7\">Fig. 7f</xref>). Thus, despite the clear presence of a disulfide-bridge in the crystal structures of TRAAK, TREK-1 and TWIK-1&#x02009;<xref ref-type=\"bibr\" rid=\"b2\">2</xref><xref ref-type=\"bibr\" rid=\"b3\">3</xref><xref ref-type=\"bibr\" rid=\"b4\">4</xref>, this covalent binding seems to be of minor relevance for the functional expression, indicating that the formation of a disulfide-bridge does not play a predominant role in the dimerization or functional expression of many K<sub>2P</sub> channels.</p></sec></sec><sec disp-level=\"1\"><title>Discussion</title><p>The recent crystallization of K<sub>2P</sub> channels revealed that two extracellular M1-P1 linkers of the dimeric channels form a cap which is at the tip stabilized by a disulfide-bridge<xref ref-type=\"bibr\" rid=\"b2\">2</xref><xref ref-type=\"bibr\" rid=\"b3\">3</xref><xref ref-type=\"bibr\" rid=\"b4\">4</xref><xref ref-type=\"bibr\" rid=\"b5\">5</xref><xref ref-type=\"bibr\" rid=\"b6\">6</xref><xref ref-type=\"bibr\" rid=\"b7\">7</xref>. This cysteine in the first extracellular loop is conserved in most K<sub>2P</sub> channels. We aimed at understanding the structural differences between these channels and the K<sub>2P</sub> channels that do not contain a disulfide-bridge in the extracellular cap, like TASK-1 and TASK-3. Functional mutagenesis screens together with the structures of crystallized K<sub>2P</sub> channels as templates, were used to build an experimentally validated model of the disulfide-bridge free cap structure of TASK-1. Moreover, we alanine-screened the TRAAK M1-P1 linker to identify residues relevant for homomerization and additionally investigated the role of cysteine residues in the M1-P1 loop of other K<sub>2P</sub> channels. Our data suggest that the cysteine residues in the cap structure of K<sub>2P</sub> channels are less important for channel assembly than expected. In particular for TASK-1, using a domain-swapped K<sub>2P</sub> channel crystal structure as a template for the modeling, we can show that the cap is stabilized by a defined set of hydrophobic intersubunit interactions which are primarily present near the tip of the cap. Our data indicate that TASK-1 channels might primarily assemble in the domain-swapped orientation, and our functional data obtained with TRAAK could be reconciled with the existence of both channel variants crystallized.</p><p>Comparing our data of the TASK model with the functional data in TRAAK channels which lack the extracellular disulfide-bridge (C78A mutant), revealed that the overall structure and the sites of hydrophobic interactions are conserved between cysteine-containing and cysteine-free cap structures of K<sub>2P</sub> channels. This data is supported by our observation that the cysteine residues also do not play a role for the functional expression of TRAAK, TWIK, TASK-4 and TREK-1. For TRAAK we could specifically show that in the absence of the cysteine, the cap is stabilized by residues which are at sites homologous to that relevant in TASK-1. Thus, we propose that the conserved cysteine residues do not play a major role in the stabilization of the cap structure of homomeric K<sub>2P</sub> channels and that the structures of all K<sub>2P</sub> channels are likely to be stabilized by hydrophobic residues at the inner leaflet of the cap.</p><p>It is noteworthy that previous studies also found evidence that the disulfide-bridges in the cap structure are not required for the homodimerization of TWIK-2&#x02009;<xref ref-type=\"bibr\" rid=\"b9\">9</xref> and TREK-1&#x02009;<xref ref-type=\"bibr\" rid=\"b8\">8</xref> or functional expression of TASK-2&#x02009;<xref ref-type=\"bibr\" rid=\"b10\">10</xref> homodimers. Our data support this evidence for TREK-1 and additionally show that disulfide-bridges within the cap structures are also not relevant for dimerization or function of other K<sub>2P</sub> channels like TWIK-1, TASK-4 and TRAAK. Thus, the question arises why do K<sub>2P</sub> channels harbor a cysteine at the tip of the cap structure, when it is on the other hand not relevant for the stability of the cap and the functional expression of the homomeric channels. Here, one explanation might be that the cysteine is required for hetero dimerization with other K<sub>2P</sub> channels that have &#x02018;non-matching&#x02019; lipophilic residues at the inner leaflets of the cap, enabling also a hetero dimerization with more distantly related K<sub>2P</sub> channels. In fact it has been described that heterodimers might be formed via disulfide-bridges between TWIK-1 and the TREK-1, TREK-2 and TRAAK channels that belong into another K<sub>2P</sub> channel subfamily<xref ref-type=\"bibr\" rid=\"b8\">8</xref>. However, this idea that the cysteine is predominantly important for hetero dimerization with other K<sub>2P</sub> channel subfamilies is also challenged by two studies (1) Plant <italic>et al</italic>. showed the lack of FRET signals for TWIK-1 with TREK-1, which appears to be in direct contradiction to the hetero dimerization postulated by Hwang <italic>et al</italic>. (2) In addition, it was reported that the cysteine containing channel TWIK-1 can assemble with TASK-1 or TASK-3&#x02009;<xref ref-type=\"bibr\" rid=\"b17\">17</xref> which lack a cysteine in the cap structure, thus hetero dimerization with more distantly related K<sub>2P</sub> channels does not necessarily require a cysteine in the cap domain.</p><p>Our study reveals that disulfide-bridges at the tip of the cap structures of K<sub>2P</sub> channels are not essential for channel assembly and functional expression, but rather seem to stabilize the cap in a way that hydrophobic residues at the inner leaflets of the cap can interact with each other. Consistently, our data indicate that the formation of cysteine-free cap structures must be conserved to that of K<sub>2P</sub> channels containing an extracellular disulfide-bridge.</p></sec><sec disp-level=\"1\"><title>Methods</title><sec disp-level=\"2\"><title>Sequence alignment and coiled-coil prediction</title><p>For sequence alignments of the extracellular M1-P1 linkers of different human K<sub>2P</sub> channels the following accession numbers were used: TASK-1, NM_002246; TASK-3, AF212829; TASK-5, NM_022358; TASK-2, NM_003740; TASK-4, NM_031460; TALK-1a, NM_032115; TREK-1b, AF004711; TREK-2c, NM_138317; TRAAK, AF247042; TWIK-1, NM_002245; TWIK-2, NM_004823; THIK-1, NM_022054; THIK-2, NM_022055; TRESK, NM_181840. For coiled-coil predictions in the extracellular M1-P1 linkers the Network Protein Sequence (NPS) Analysis tool was used<xref ref-type=\"bibr\" rid=\"b11\">11</xref>.</p></sec><sec disp-level=\"2\"><title>Site-directed mutagenesis</title><p>Mutations in the human TASK-1 (<italic>KCNK3</italic>, NM_002246), TRAAK (<italic>KCNK4</italic>, AF247042), TWIK-1 (<italic>KCNK1</italic>, U33632), TASK-3 (<italic>KCNK9</italic>, AF212829), TREK-1b (<italic>KCNK2</italic>, AF004711) or TASK-4 (<italic>KCNK17</italic>, AF358910) cDNA were introduced with the QuickChange Site Directed Mutagenesis Kit (Stratagene) according to the instructions of the manufacturer.</p></sec><sec disp-level=\"2\"><title>Oocyte preparation, cRNA synthesis and cRNA injection</title><p>Oocytes were obtained from anesthetized <italic>Xenopus laevis</italic> frogs and incubated in OR2 solution containing in mM: NaCl 82.5, KCl 2, MgCl<sub>2</sub> 1, HEPES 5 (pH 7.5) substituted with 2&#x02009;mg/ml collagenase II (Sigma) to remove residual connective tissue. Subsequently, oocytes were stored at 18&#x02009;&#x000b0;C in ND96 solution containing in mM: NaCl 96, KCl 2, CaCl<sub>2</sub> 1.8, MgCl<sub>2</sub> 1, HEPES 5 (pH 7.5), supplemented with 33.6&#x02009;&#x003bc;M gentamycine, 2.5&#x02009;mM sodium pyruvate and 0.5&#x02009;mM theophylline. All channels were subcloned into an oocyte expression vector. Subsequently, cDNA was linearized and cRNA was synthesized with mMESSAGE mMACHINE-Kit (Ambion). The quality of cRNA was tested using gel electrophoresis. cRNA was quantified using a UV-Vis spectrophotometer (NanoDrop 2000). Oocytes were each injected with 50&#x02009;nl of cRNA. For the functional expression studies and for the chemiluminecence assay of the different TASK-1 and TRAAK constructs 5&#x02009;ng of cRNA were injected per oocyte. For TWIK-1, TREK-1 and TASK-4 recordings 20&#x02009;ng, 1.25&#x02009;ng and 25&#x02009;ng of cRNA were injected, respectively. For co-expression studies 0.025&#x02009;ng TASK-3 was co-injected with 2.5&#x02009;ng of TASK-1 cRNA per oocyte. TASK-3 is known as one of the best expressing K<sub>2P</sub> channel, while TASK-1 is due to binding to p11 primarily retained in the ER<xref ref-type=\"bibr\" rid=\"b13\">13</xref><xref ref-type=\"bibr\" rid=\"b18\">18</xref>. As TASK-3 has in the oocyte expression system a much more pronounced expression than TASK-1&#x02009;<xref ref-type=\"bibr\" rid=\"b18\">18</xref>, we performed TEVC experiments to find the amounts of cRNA that need to be injected to get a similar expression. Here, we found that TASK-1 and TASK-3 generate similar current amplitudes, when the oocytes were injected with 0.025&#x02009;ng of TASK-3 and 2.5&#x02009;ng of TASK-1. Therefore, these concentrations were used for our co-expression studies.</p></sec><sec disp-level=\"2\"><title>TEVC recordings in <italic>Xenopus laevis</italic> oocytes</title><p>All TEVC recordings were performed 48&#x02009;h after cRNA injection at room temperature (20&#x02013;22&#x02009;&#x000b0;C) with a TurboTEC 10CD (npi) amplifier and a Digidata 1200 Series (Axon Instruments) as A/D converter. Micropipettes were made from borosilicate glass capillaries GB 150TF-8P (Science Products) and pulled with a DMZ-Universal Puller (Zeitz). Recording pipettes had a resistance of 0.5&#x02013;1.5&#x02009;M&#x003a9; and were filled with 3&#x02009;M KCl solution. As recording solution ND96 was used. Current was analyzed with voltage steps from a holding potential of &#x02013;80&#x02009;mV. A first test pulse to 0&#x02009;mV of 1&#x02009;s duration was followed by a repolarizing step to &#x02013;80&#x02009;mV for 1&#x02009;s, directly followed by another 1&#x02009;s test pulse to +40&#x02009;mV. The sweep time interval was 10&#x02009;s. Data were acquired with Clampex 10 (Molecular Devices) and analyzed with Clampfit 10 (Molecular Devices) and Origin 7 (OriginLab Corporation).</p></sec><sec disp-level=\"2\"><title>Chemiluminescence assay in <italic>Xenopus</italic> oocytes</title><p>Surface expression of TASK-1 channel constructs was studied using a chemiluminescence based assay. A hemagglutinin (HA)-epitope (YPYDVPDYA), preceded and followed by a proline&#x02013;glycine&#x02013;glycine linker, was inserted in the extracellular P2-M4 loop of human TASK-&#x00394;i20 at amino acid position 214. cRNA of HA-tagged channels was injected into <italic>Xenopus</italic> oocytes and surface expression was analyzed after 48&#x02009;h. First, oocytes were incubated in ND96 plus 1% BSA on ice for 30&#x02009;min to reduce unspecific antibody binding, followed by incubation with primary antibody (rat anti-HA (Roche), 1:100) for 1&#x02009;h, extensive washing and incubation with secondary antibody (goat anti-rat-IgG, HRP-coupled (Dianova), 1:500) for 1&#x02009;h. Oocytes were again extensively washed, before they were individually placed into a vial with 20&#x02009;&#x003bc;l of luminescence substrate (SuperSignal Femto (Thermo Scientific)). Light emission was detected with a GloMax luminometer (Promega).</p></sec><sec disp-level=\"2\"><title>Western blot analysis</title><p>cRNA of HA-tagged wild-type or mutant TASK-1 channels was injected into <italic>Xenopus</italic> oocytes and after 48&#x02009;h whole oocytes were lysed and protein extraction was carried out as described previously<xref ref-type=\"bibr\" rid=\"b19\">19</xref>. Briefly, 20 oocytes were used for each lysis reaction. The oocytes were homogenized in 400&#x02009;&#x003bc;l lysis buffer (NaCl, 150&#x02009;mM; Tris/HCl, 20&#x02009;mM; Triton X-100, 1%; Protease Inhibitor Cocktail (Roche), 10&#x02009;&#x003bc;l; pH 7.5). Insoluble material was separated by centrifugation (13000&#x02009;rpm) for 15&#x02009;min at 4&#x02009;&#x000b0;C. Protein was quantified using Bradford assay. Supernatant containing similar protein amounts were mixed with SDS sample buffer in the presence or absence of 50&#x02009;mM DTT as indicated, heat denatured at 95&#x02009;&#x000b0;C for 5&#x02009;minutes, separated on 10% SDS-polyacrylamide gels and visualized by immunoblotting. Primary anti-HA antibodies (Roche) were used and the binding of the primary antibodies was detected using peroxidase-conjugated anti-rat IgG (Pierce), respectively and a chemiluminescent extended-duration substrate (SuperSignal WEST Dura, Pierce). Uninjected oocytes were used as negative control. Band intensities were analyzed from four to eleven independent western blot experiments with ImageJ software (NIH), background subtracted and normalized to wild-type TASK-1 without DTT. For all western blots Bradford assays were performed to ensure loading of equal amounts of total protein. Ponceau S staining after blotting was used to verify correct protein transfer and ensure equal lane loading.</p><p>HeLa cells were transfected with human TASK-1-&#x00394;i20 pEGFP<xref ref-type=\"bibr\" rid=\"b13\">13</xref>, human TASK-3 pEGFP or human TWIK-1 pRAT, respectively using JetPRIME (Peqlab). After 48&#x02009;h cells were lysed in the lysis buffer. After centrifugation, supernatants were mixed with SDS sample buffer in the presence or absence of 50&#x02009;mM DTT as indicated, heat denatured, separated on 10% SDS-polyacrylamide gels and visualized by immunoblotting. As primary antibodies anti-GFP (ab290, abcam) or anti-TWIK-1 (kindly provided by Florian Lesage) were used and the binding of the primary antibodies was detected using peroxidase-conjugated anti-rabbit antibodies (1:2000) and a chemiluminescent extended-duration substrate (SuperSignal WEST Dura, Pierce).</p></sec><sec disp-level=\"2\"><title>Cell culture and transfection</title><p>HeLa cells were cultivated at 37&#x02009;&#x000b0;C and 5% CO<sub>2</sub> in DMEM medium (Invitrogen) supplemented with 10% FCS and 1% Penicillin/Streptomycin solution (Invitrogen). For imaging experiments cells were grown on glass bottom (WillCo) 35&#x02009;mm petri dishes, respectively. At a confluency of 60&#x02013;70% cells were transfected with FuGENE6 (Promega) or JetPRIME (Peqlab). For fluorescence imaging experiments, a total amount of 1&#x02009;&#x003bc;g of cDNA per 35&#x02009;mm dish was used for transfection.</p></sec><sec disp-level=\"2\"><title>Fluorescence imaging</title><p>Fluorescence microscopy of transfected HeLa cells was performed with an Axio Observer.Z1 microscope (Zeiss), equipped with a Zeiss Plan&#x02010;Apochromat 60&#x02009;&#x000d7;&#x02009;/1.40 Oil DIC objective. During live cell imaging, cells were maintained at 37&#x02009;&#x000b0;C using an objective heater (Bioptechs). A standard Zeiss filter set (38HE) was used. Images were taken with a Zeiss 12bit &#x02018;AxioCam MRm&#x02019; camera, and digital images were processed using Zeiss AxioVision Software.</p></sec><sec disp-level=\"2\"><title>Homology modeling and MD simulations</title><p>Four TASK-1 homology models were built using the following crystal structures as templates: domain-swapped TRAAK -PDB ID 4I9W-<xref ref-type=\"bibr\" rid=\"b3\">3</xref>, non domain-swapped TRAAK -PDB ID 3UM7-<xref ref-type=\"bibr\" rid=\"b2\">2</xref>, TWIK-1 -PDB ID 3UKM-<xref ref-type=\"bibr\" rid=\"b4\">4</xref> and TREK-2 -PDB ID 4BW5-<xref ref-type=\"bibr\" rid=\"b6\">6</xref>. The TASK-1 homology models were made using ICM software<xref ref-type=\"bibr\" rid=\"b20\">20</xref> and according to the multiple alignment reported by Brohawn <italic>et al</italic>. in 2012&#x02009;<xref ref-type=\"bibr\" rid=\"b2\">2</xref>. The domain-swapped and non domain-swapped TRAAK crystal structures (PDB IDs 4I9W and 3UM7 respectively) as well as the four TASK-1 homology models were embedded into a pre-equilibrated phosphatidyl oleoyl phosphatidylcholine (POPC) bilayer in a periodic boundary condition box (15&#x02009;&#x000d7;&#x02009;15&#x02009;&#x000d7;&#x02009;15&#x02009;&#x000c5;<sup>3</sup>) with pre-equilibrated SPC water molecules. Two K<sup>+</sup> ions were associated to the models at positions S2 and S4 of the selectivity filter, and two water molecules at positions S1 and S3. Finally, the systems were neutralized by adding K<sup>+</sup> counter ions to balance the net charge of the systems and KCl at a concentration of 0.096&#x02009;M was added to simulate physiological conditions of the channels. An excluded region for counter ions was set at 5&#x02009;&#x000c5; from the selectivity filter of the models. MD simulations were performed employed OPLS-AA force field<xref ref-type=\"bibr\" rid=\"b21\">21</xref> within Desmond package<xref ref-type=\"bibr\" rid=\"b22\">22</xref> contained in Maestro 9.2 suite. The systems were equilibrated using default relaxation protocol.</p><p>MD simulations were performed during 10&#x02009;ns for all systems. For the TASK-1 homology model based on TREK-2 the model subsequently ran additional 90&#x02009;ns. In all MD simulations the alpha helixes of the channels were energy-restricted with a spring constant of 0.5&#x02009;kcal mol<sup>&#x02212;1</sup> &#x000c5;<sup>&#x02212;2</sup> at constant temperature (300&#x02009;K) and pressure (1.01325 bar) in an isothermal-isobaric ensemble. Data were collected every 4 ps during the trajectory. The stability of the models during the MD simulations was validated by calculating the Root-Mean-Square Deviation (RMSD) (<xref ref-type=\"supplementary-material\" rid=\"S1\">Supplementary Fig. S9</xref>). The values of <xref ref-type=\"table\" rid=\"t1\">Table 1</xref> and the <xref ref-type=\"supplementary-material\" rid=\"S1\">Supplemental Tables S1&#x02013;5</xref> are an average (and its respective standard deviation) of the distances between the residues during the Molecular Dynamics Simulations (MDS). During the MDS the structures were collected each 4 ps. A total of 2500 structures were obtained during each 10&#x02009;ns MDS and the distances between the residues were calculated using an in house written script in tcl language.</p><p>Interactions of key residues of the helical cap were evaluated measuring the carbon-carbon atom distances from predefined carbon atoms. The carbon atoms selected/predefined are shown in ball representation in <xref ref-type=\"supplementary-material\" rid=\"S1\">Supplementary Fig. S3</xref>. They are the carbon atoms before the last ramification of the side chains. The distances were measured using a script in house written in tcl language. A cut-off of 6.0&#x02009;&#x000c5; (instead 4.0&#x02009;&#x000c5;) was used to probe for interactions, as the carbon atoms selected for the automatic distance measurements do not necessarily reflect the closest atom for interactions and the space of the H atoms are not considered.</p></sec><sec disp-level=\"2\"><title>Animal experiments</title><p>All animal experiments were carried out in accordance with EU Directive 2010/63/EU for animal experiments. The work with <italic>Xenopus</italic> at the University of Marburg with all experimental protocols were approved by the Regierungspr&#x000e4;sidium Gie&#x000df;en, Germany (V54-19c 20 15&#x02009;h 02 MR 20/28 Nr.A 4/2013).</p></sec><sec disp-level=\"2\"><title>Statistical analyses</title><p>All values, unless stated otherwise are expressed as Mean&#x02009;&#x000b1;&#x02009;SEM. Significance was assessed using unpaired two tailed Student&#x02019;s T-Test. Asterisks indicate significance: *p&#x02009;&#x0003c;&#x02009;0.05; **p&#x02009;&#x0003c;&#x02009;0.01; ***p&#x02009;&#x0003c;&#x02009;0.001. The number of experiments are included in the Figure.</p></sec></sec><sec disp-level=\"1\"><title>Additional Information</title><p><bold>How to cite this article</bold>: Goldstein, M. <italic>et al</italic>. Functional mutagenesis screens reveal the `cap structure&#x000b4; formation in disulfide-bridge free TASK channels. <italic>Sci. Rep.</italic>\\n<bold>6</bold>, 19492; doi: 10.1038/srep19492 (2016).</p></sec><sec sec-type=\"supplementary-material\" id=\"S1\"><title>Supplementary Material</title><supplementary-material id=\"d33e27\" content-type=\"local-data\"><caption><title>Supplementary Information</title></caption><media xmlns:xlink=\"http://www.w3.org/1999/xlink\" xlink:href=\"srep19492-s1.pdf\"/></supplementary-material></sec></body><back><ack><p>This work was supported by grants of the Deutsche Forschungsgemeinschaft 1482-3/1 and 1482-3/2 to N.D., the Anneliese Pohl Stiftung to S.R. and by the FONDECYT grant 1140624 to W.G. and D.R. We thank Florian Lesage for providing us the TWIK-1 expression construct and antibody and Klaus Liedl for helpful discussions. We are grateful to Oxana Nowak and Kirsten Ramlow for excellent technical support.</p></ack><ref-list><ref id=\"b1\"><mixed-citation publication-type=\"journal\"><name><surname>Goldstein</surname><given-names>S. A.</given-names></name>, <name><surname>Bockenhauer</surname><given-names>D.</given-names></name>, <name><surname>O&#x02019;Kelly</surname><given-names>I.</given-names></name> &#x00026; <name><surname>Zilberberg</surname><given-names>N.</given-names></name>\\n<article-title>Potassium leak channels and the <italic>KCNK</italic> family of two-P-domain subunits</article-title>. <source>Nat. Rev. Neurosci.</source>\\n<volume>2</volume>, <fpage>175</fpage>&#x02013;<lpage>184</lpage> (<year>2001</year>).<pub-id pub-id-type=\"pmid\">11256078</pub-id></mixed-citation></ref><ref id=\"b2\"><mixed-citation publication-type=\"journal\"><name><surname>Brohawn</surname><given-names>S. G.</given-names></name>, <name><surname>del Marmol</surname><given-names>J.</given-names></name> &#x00026; <name><surname>MacKinnon</surname><given-names>R.</given-names></name>\\n<article-title>Crystal structure of the human K<sub>2P</sub> TRAAK, a lipid- and mechano-sensitive K<sup>+</sup> ion channel</article-title>. <source>Science</source>\\n<volume>335</volume>, <fpage>436</fpage>&#x02013;<lpage>441</lpage> (<year>2012</year>).<pub-id pub-id-type=\"pmid\">22282805</pub-id></mixed-citation></ref><ref id=\"b3\"><mixed-citation publication-type=\"journal\"><name><surname>Brohawn</surname><given-names>S. G.</given-names></name>, <name><surname>Campbell</surname><given-names>E. B.</given-names></name> &#x00026; <name><surname>MacKinnon</surname><given-names>R.</given-names></name>\\n<article-title>Domain-swapped chain connectivity and gated membrane access in a Fab-mediated crystal of the human TRAAK K<sup>+</sup> channel</article-title>. <source>Proc. Natl. Acad. Sci. USA</source>\\n<volume>110</volume>, <fpage>2129</fpage>&#x02013;<lpage>2134</lpage> (<year>2013</year>).<pub-id pub-id-type=\"pmid\">23341632</pub-id></mixed-citation></ref><ref id=\"b4\"><mixed-citation publication-type=\"journal\"><name><surname>Miller</surname><given-names>A. N.</given-names></name> &#x00026; <name><surname>Long</surname><given-names>S. B.</given-names></name>\\n<article-title>Crystal structure of the human two-pore domain potassium channel K<sub>2P</sub>1</article-title>. <source>Science</source>\\n<volume>335</volume>, <fpage>432</fpage>&#x02013;<lpage>436</lpage> (<year>2012</year>).<pub-id pub-id-type=\"pmid\">22282804</pub-id></mixed-citation></ref><ref id=\"b5\"><mixed-citation publication-type=\"journal\"><name><surname>Gonzalez</surname><given-names>W.</given-names></name>\\n<etal/>. <article-title>An extracellular ion pathway plays a central role in the cooperative gating of a K<sub>2P</sub> K<sup>+</sup> channel by extracellular pH</article-title>. <source>J. Biol. Chem.</source>\\n<volume>288</volume>, <fpage>5984</fpage>&#x02013;<lpage>5991</lpage> (<year>2013</year>).<pub-id pub-id-type=\"pmid\">23319597</pub-id></mixed-citation></ref><ref id=\"b6\"><mixed-citation publication-type=\"journal\"><name><surname>Dong</surname><given-names>Y. Y.</given-names></name>\\n<etal/>. <article-title>K<sub>2P</sub> channel gating mechanisms revealed by structures of TREK-2 and a complex with Prozac</article-title>. <source>Science</source>\\n<volume>347</volume>, <fpage>1256</fpage>&#x02013;<lpage>1259</lpage> (<year>2015</year>).<pub-id pub-id-type=\"pmid\">25766236</pub-id></mixed-citation></ref><ref id=\"b7\"><mixed-citation publication-type=\"journal\"><name><surname>Lesage</surname><given-names>F.</given-names></name>\\n<etal/>. <article-title>Dimerization of TWIK-1 K<sup>+</sup> channel subunits via a disulfide bridge</article-title>. <source>EMBO J.</source>\\n<volume>15</volume>, <fpage>6400</fpage>&#x02013;<lpage>6407</lpage> (<year>1996</year>).<pub-id pub-id-type=\"pmid\">8978667</pub-id></mixed-citation></ref><ref id=\"b8\"><mixed-citation publication-type=\"journal\"><name><surname>Hwang</surname><given-names>E. M.</given-names></name>\\n<etal/>. <article-title>A disulphide-linked heterodimer of TWIK-1 and TREK-1 mediates passive conductance in astrocytes</article-title>. <source>Nat. Commun.</source>\\n<volume>5</volume>, <fpage>3227</fpage> (<year>2014</year>).<pub-id pub-id-type=\"pmid\">24496152</pub-id></mixed-citation></ref><ref id=\"b9\"><mixed-citation publication-type=\"journal\"><name><surname>Patel</surname><given-names>A. J.</given-names></name>\\n<etal/>. <article-title>TWIK-2, an inactivating 2P domain K<sup>+</sup> channel</article-title>. <source>J. Biol. Chem.</source>\\n<volume>275</volume>, <fpage>28722</fpage>&#x02013;<lpage>28730</lpage> (<year>2000</year>).<pub-id pub-id-type=\"pmid\">10887187</pub-id></mixed-citation></ref><ref id=\"b10\"><mixed-citation publication-type=\"journal\"><name><surname>Niemeyer</surname><given-names>M. I.</given-names></name>, <name><surname>Cid</surname><given-names>L. P.</given-names></name>, <name><surname>Valenzuela</surname><given-names>X.</given-names></name>, <name><surname>Paeile</surname><given-names>V.</given-names></name> &#x00026; <name><surname>Sepulveda</surname><given-names>F. V.</given-names></name>\\n<article-title>Extracellular conserved cysteine forms an intersubunit disulphide bridge in the <italic>KCNK5</italic> (TASK-2) K<sup>+</sup> channel without having an essential effect upon activity</article-title>. <source>Mol. Membr. Biol.</source>\\n<volume>20</volume>, <fpage>185</fpage>&#x02013;<lpage>191</lpage> (<year>2003</year>).<pub-id pub-id-type=\"pmid\">12851074</pub-id></mixed-citation></ref><ref id=\"b11\"><mixed-citation publication-type=\"journal\"><name><surname>Combet</surname><given-names>C.</given-names></name>, <name><surname>Blanchet</surname><given-names>C.</given-names></name>, <name><surname>Geourjon</surname><given-names>C.</given-names></name> &#x00026; <name><surname>Deleage</surname><given-names>G.</given-names></name>\\n<article-title>NPS@: network protein sequence analysis</article-title>. <source>Trends Biochem. Sci.</source>\\n<volume>25</volume>, <fpage>147</fpage>&#x02013;<lpage>150</lpage> (<year>2000</year>).<pub-id pub-id-type=\"pmid\">10694887</pub-id></mixed-citation></ref><ref id=\"b12\"><mixed-citation publication-type=\"journal\"><name><surname>Mason</surname><given-names>J. M.</given-names></name> &#x00026; <name><surname>Arndt</surname><given-names>K. M.</given-names></name>\\n<article-title>Coiled coil domains: stability, specificity, and biological implications</article-title>. <source>Chembiochem.</source>\\n<volume>5</volume>, <fpage>170</fpage>&#x02013;<lpage>176</lpage> (<year>2004</year>).<pub-id pub-id-type=\"pmid\">14760737</pub-id></mixed-citation></ref><ref id=\"b13\"><mixed-citation publication-type=\"journal\"><name><surname>Renigunta</surname><given-names>V.</given-names></name>\\n<etal/>. <article-title>The retention factor p11 confers an endoplasmic reticulum-localization signal to the potassium channel TASK-1</article-title>. <source>Traffic</source>\\n<volume>7</volume>, <fpage>168</fpage>&#x02013;<lpage>181</lpage> (<year>2006</year>).<pub-id pub-id-type=\"pmid\">16420525</pub-id></mixed-citation></ref><ref id=\"b14\"><mixed-citation publication-type=\"journal\"><name><surname>Mellquist</surname><given-names>J. L.</given-names></name>, <name><surname>Kasturi</surname><given-names>L.</given-names></name>, <name><surname>Spitalnik</surname><given-names>S. L.</given-names></name> &#x00026; <name><surname>Shakin-Eshleman</surname><given-names>S. H.</given-names></name>\\n<article-title>The amino acid following an asn-X-Ser/Thr sequon is an important determinant of N-linked core glycosylation efficiency</article-title>. <source>Biochemistry</source>\\n<volume>37</volume>, <fpage>6833</fpage>&#x02013;<lpage>6837</lpage> (<year>1998</year>).<pub-id pub-id-type=\"pmid\">9578569</pub-id></mixed-citation></ref><ref id=\"b15\"><mixed-citation publication-type=\"journal\"><name><surname>Ma</surname><given-names>L.</given-names></name>, <name><surname>Xie</surname><given-names>Y. P.</given-names></name>, <name><surname>Zhou</surname><given-names>M.</given-names></name> &#x00026; <name><surname>Chen</surname><given-names>H.</given-names></name>\\n<article-title>Silent TWIK-1 potassium channels conduct monovalent cation currents</article-title>. <source>Biophys. J.</source>\\n<volume>102</volume>, <fpage>L34</fpage>&#x02013;<lpage>36</lpage> (<year>2012</year>).<pub-id pub-id-type=\"pmid\">22768960</pub-id></mixed-citation></ref><ref id=\"b16\"><mixed-citation publication-type=\"journal\"><name><surname>Ma</surname><given-names>L.</given-names></name>, <name><surname>Zhang</surname><given-names>X.</given-names></name> &#x00026; <name><surname>Chen</surname><given-names>H.</given-names></name>\\n<article-title>TWIK-1 two-pore domain potassium channels change ion selectivity and conduct inward leak sodium currents in hypokalemia</article-title>. <source>Sci. Signal</source>\\n<volume>4</volume>, <fpage>ra37</fpage> (<year>2011</year>).<pub-id pub-id-type=\"pmid\">21653227</pub-id></mixed-citation></ref><ref id=\"b17\"><mixed-citation publication-type=\"journal\"><name><surname>Plant</surname><given-names>L. D.</given-names></name>, <name><surname>Zuniga</surname><given-names>L.</given-names></name>, <name><surname>Araki</surname><given-names>D.</given-names></name>, <name><surname>Marks</surname><given-names>J. D.</given-names></name> &#x00026; <name><surname>Goldstein</surname><given-names>S. A.</given-names></name>\\n<article-title>SUMOylation silences heterodimeric TASK potassium channels containing K2P1 subunits in cerebellar granule neurons</article-title>. <source>Sci. Signal</source>\\n<volume>5</volume>, <fpage>ra84</fpage> (<year>2012</year>).<pub-id pub-id-type=\"pmid\">23169818</pub-id></mixed-citation></ref><ref id=\"b18\"><mixed-citation publication-type=\"journal\"><name><surname>Rinn&#x000e9;</surname><given-names>S.</given-names></name>\\n<etal/>. <article-title>TASK-1 and TASK-3 may form heterodimers in human atrial cardiomyocytes</article-title>. <source>J. Mol. Cell. Cardiol.</source>\\n<volume>81</volume>, <fpage>71</fpage>&#x02013;<lpage>80</lpage> (<year>2015</year>).<pub-id pub-id-type=\"pmid\">25655935</pub-id></mixed-citation></ref><ref id=\"b19\"><mixed-citation publication-type=\"journal\"><name><surname>Rinn&#x000e9;</surname><given-names>S.</given-names></name>\\n<etal/>. <article-title>A splice variant of the two-pore domain potassium channel TREK-1 with only one pore domain reduces the surface expression of full-length TREK-1 channels</article-title>. <source>Pfl&#x000fc;gers Arch</source>. <volume>466</volume>, <fpage>1559</fpage>&#x02013;<lpage>1570</lpage> (<year>2014</year>).<pub-id pub-id-type=\"pmid\">24196565</pub-id></mixed-citation></ref><ref id=\"b20\"><mixed-citation publication-type=\"journal\"><name><surname>Abagyan</surname><given-names>R.</given-names></name> &#x00026; <name><surname>Totrov</surname><given-names>M.</given-names></name>\\n<article-title>Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins</article-title>. <source>J. Mol. Biol.</source>\\n<volume>235</volume>, <fpage>983</fpage>&#x02013;<lpage>1002</lpage> (<year>1994</year>).<pub-id pub-id-type=\"pmid\">8289329</pub-id></mixed-citation></ref><ref id=\"b21\"><mixed-citation publication-type=\"journal\"><name><surname>Kaminski</surname><given-names>G. A.</given-names></name>, <name><surname>Friesner</surname><given-names>R. A.</given-names></name>, <name><surname>Tirado-Rives</surname><given-names>J.</given-names></name> &#x00026; <name><surname>Jorgensen</surname><given-names>W. L.</given-names></name>\\n<article-title>Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides</article-title>. <source>Journal of Physical Chemistry B.</source>\\n<volume>105</volume>, <fpage>6474</fpage>&#x02013;<lpage>6487</lpage> (<year>2001</year>).</mixed-citation></ref><ref id=\"b22\"><mixed-citation publication-type=\"journal\"><name><surname>Guo</surname><given-names>Z.</given-names></name>\\n<etal/>. <article-title>Probing the alpha-helical structural stability of stapled p53 peptides: molecular dynamics simulations and analysis</article-title>. <source>Chem. Biol. Drug Des.</source>\\n<volume>75</volume>, <fpage>348</fpage>&#x02013;<lpage>359</lpage> (<year>2010</year>).<pub-id pub-id-type=\"pmid\">20331649</pub-id></mixed-citation></ref></ref-list><fn-group><fn><p><bold>Author Contributions</bold> N.D. conceived the study. M.G. performed the majority of the TEVC and chemiluminescence experiments. M.F.N. performed fluorescence microscopy and TEVC experiments. W.G. and D.R. performed and analyzed molecular modeling experiments. S.R. created mutant and HA tagged channel constructs, designed/performed western blot experiments and TEVC recordings. A.K.K. performed TEVC recordings, data analyses of electrophysiological and in silico data. D.B. analyzed molecular modeling experiments. B.O.B. performed TEVC measurements of TASK-1 hits co-expressed with TASK-3. N.D., S.R. and A.K.K. wrote the manuscript.</p></fn></fn-group></back><floats-group><fig id=\"f1\"><label>Figure 1</label><caption><title>A coiled-coil prediction in the M1-P1 linker of TASK-1 channels.</title><p>(<bold>a</bold>) Transmembrane topology of TASK-1. The extracellular region corresponding to the cap structure of other K<sub>2P</sub> channels is indicated. (<bold>b</bold>) Amino acid sequence alignment of different K<sub>2P</sub> channels for the extracellular region indicated in (<bold>a</bold>). The cysteine residues, conserved in most K<sub>2P</sub> channels, are highlighted in bold. Residues of the four heptad repeat coiled-coil predictions in TASK-1 and TASK-3 are indicated in italics and by underlining. (<bold>c</bold>) Coiled-coil structures usually contain a repeated pattern of hydrophobic (h) and charged (c) amino-acid residues. &#x02018;hxxhcxc&#x02019; refers to a heptad repeat re-occuring after every two turns of the helix. The positions within the heptad repeat are commonly labeled as &#x02018;a&#x02013;g&#x02019;, where &#x02018;a&#x02019; (<italic>red</italic>) and &#x02018;d&#x02019; (<italic>gray</italic>) are the hydrophobic core positions, often occupied by the amino acids isoleucine, leucine, or valine, thus stabilizing helix dimerization through hydrophobic and van-der-Waals interactions, whereas &#x02018;e&#x02019; (<italic>orange</italic>) and &#x02018;g&#x02019; (<italic>blue</italic>) are typically solvent-exposed, polar residues (e.g. glutamate or lysine) that give specificity between the two helices through interhelical electrostatic interactions. The remaining three positions (&#x02018;b&#x02019;, &#x02018;c&#x02019;, and &#x02018;f&#x02019;, <italic>white</italic>) must be all hydrophilic, as these will form helical solvent exposed surfaces. (<bold>d</bold>) Coiled-coil prediction tools revealed with a high probability a four-fold coiled-coil repeat in TASK-1 (<italic>top</italic>), whereas for instance in TASK-4 no coiled-coil domain was predicted (<italic>bottom</italic>). AA, amino acid. (<bold>e</bold>) Typical interaction sites of coiled-coil domains were mutated and current amplitudes, analyzed at +40&#x02009;mV, were compared to wild-type TASK-1. &#x02018;a&#x02019;, indicates the four-fold mutation of all a-sites (R38A/Q45A/Y52A/Y59A); &#x02018;f&#x02019;, indicates the four-fold mutation of all f-sites (L43A/A50V/G57A/R64A); &#x02018;d&#x02019;, indicates the four-fold mutation of all d-sites (L41A/L48A/S55A/L62A). **p&#x02009;&#x0003c;&#x02009;0.01; ***p&#x02009;&#x0003c;&#x02009;0.001. Unpaired Student&#x02019;s T-Test. Data are presented as Mean&#x02009;&#x000b1;&#x02009;SEM. The number of experiments are included in the bar graph.</p></caption><graphic xmlns:xlink=\"http://www.w3.org/1999/xlink\" xlink:href=\"srep19492-f1\"/></fig><fig id=\"f2\"><label>Figure 2</label><caption><title>Alanine scan through the extracellular M1-P1 linker of human TASK-1 reveals hydrophobic residues relevant for functional surface expression.</title><p>(<bold>a</bold>) Normalized representative current traces of wild-type and mutant TASK-1 channels recorded in <italic>Xenopus</italic> oocytes by a voltage step to +40&#x02009;mV. (<bold>b</bold>) Relative current amplitudes at +40&#x02009;mV compared to wild-type TASK-1 (WT). Mutants within the predicted coiled-coil domain exhibiting a pronounced current amplitude reduction are highlighted in <italic>black</italic>. (<bold>c</bold>) Relative surface expression analyzed with a chemiluminescence assay of wild-type TASK-1 with an extracellular HA epitope (WT-HA) and TASK-1 mutants introduced into the WT-HA background. Mutants within the predicted coiled-coil domain showing a strong reduction in relative surface expression are highlighted in <italic>black</italic>. (<bold>b</bold>,<bold>c</bold>) **p&#x02009;&#x0003c;&#x02009;0.01; ***p&#x02009;&#x0003c;&#x02009;0.001. Unpaired Student&#x02019;s T-Test. Significance was probed against WT or WT-HA. Data are presented as Mean&#x02009;&#x000b1;&#x02009;SEM. The number of experiments are indicated in parentheses above the construct name. (<bold>d</bold>) The &#x02018;conductivity&#x02019; of TASK-1 mutants was calculated by dividing the relative change in current amplitudes of a mutant by the relative change in surface expression of the respective mutant. Red bars indicate a loss of channel gating, due to a reduced single-channel conductance or open probability (Po). Data are presented as Mean&#x02009;&#x000b1;&#x02009;SEM.</p></caption><graphic xmlns:xlink=\"http://www.w3.org/1999/xlink\" xlink:href=\"srep19492-f2\"/></fig><fig id=\"f3\"><label>Figure 3</label><caption><title>Protein expression of the identified TASK-1 &#x02018;hits&#x02019;.</title><p>(<bold>a</bold>) Western blot analysis of <italic>Xenopus</italic> protein lysates after injection of HA-tagged TASK-1 wild-type (WT) or indicated TASK-1 mutants using anti-HA antibodies. Samples were not treated with a reducing agent as DTT, thus the proteins appear as a dimer. (<bold>b</bold>) Analysis of the pixel intensities of the protein signals corresponding to dimeric TASK-1 from 4 to 11 independent western blots normalized to TASK-1 wild-type without DTT. Image J was used for pixel intensity analysis. RPD: relative pixel density. (<bold>c</bold>) Live cell imaging of TASK-1 mutants in HeLa cells. HeLa cells were transfected with the indicated pEGFP-TASK-1 mutants and fluorescence imaging was performed 48&#x02009;h after transfection. (<bold>d</bold>) Western blot analysis of protein lysates of oocytes 48&#x02009;hours after injection of HA-tagged TASK-1 wild-type (WT) or indicated TASK-1 mutants using anti-HA antibodies. Samples were not treated with a reducing agent as DTT, thus proteins appear as a dimer. (<bold>e</bold>) Analysis of the pixel intensities of the protein signals corresponding to dimeric TASK-1 from 4 to 11 independent western blots normalized to TASK-1 wild-type without DTT. Image J was used for pixel intensity analysis. (<bold>f</bold>) Current traces of TASK-1 WT compared to the Q56P mutant, preventing glycosylation. (<bold>g</bold>) Current amplitudes at +40&#x02009;mV for TASK-1 (WT) and the Q56P mutant normalized to TASK-1 were plotted. (<bold>b</bold>,<bold>e</bold>,<bold>g</bold>) ***p&#x02009;&#x0003c;&#x02009;0.001. Unpaired Student&#x02019;s T-Test. Significance was probed against wild-type TASK-1 (WT). Data are presented as Mean&#x02009;&#x000b1;&#x02009;SEM. The number of experiments are included in the bar graphs.</p></caption><graphic xmlns:xlink=\"http://www.w3.org/1999/xlink\" xlink:href=\"srep19492-f3\"/></fig><fig id=\"f4\"><label>Figure 4</label><caption><title>Co-expression of TASK-1 &#x02018;hits&#x02019; from the alanine scan with TASK-3.</title><p>(<bold>a</bold>) Sequence alignment of the tip of the TASK-1 and TASK-3 cap. TASK-1 &#x02018;hits&#x02019; are highlighted in bold. *conserved residues; <sup>#</sup>conservative amino acids. (<bold>b</bold>) TASK-3 was injected in <italic>Xenopus</italic> oocytes alone (TASK-3 WT), in the presence of TASK-1 WT or in presence of TASK-1 mutants. Changes in current amplitudes compared to TASK-3 WT were analyzed at +40&#x02009;mV. *p&#x02009;&#x0003c;&#x02009;0.05; **p&#x02009;&#x0003c;&#x02009;0.01; ***p&#x02009;&#x0003c;&#x02009;0.001. Unpaired Student&#x02019;s T-Test. Significance was probed against TASK-3 WT. Data are presented as Mean&#x02009;&#x000b1;&#x02009;SEM. The number of experiments are included in the bar graphs.</p></caption><graphic xmlns:xlink=\"http://www.w3.org/1999/xlink\" xlink:href=\"srep19492-f4\"/></fig><fig id=\"f5\"><label>Figure 5</label><caption><title>TASK-1 cap structure model based on domain-swapped TREK-2.</title><p>TASK-1 cap structure illustrated after 100&#x02009;ns of MD simulations. The two different subunits are shown in <italic>gray</italic> and <italic>light gray</italic>. TASK-1 cap model with the residues identified essential for channel expression, which are involved in intersubunit interactions. Pairs of residues that interact with each other are illustrated using the same color code. (<bold>a</bold>) Complete structure of the TASK-1 model. (<bold>b</bold>) Zoom-in to the boxed area of (<bold>a</bold>) illustrating interacting residues and their distances, and (<bold>c</bold>) after 45&#x000b0; rotation or (<bold>d</bold>) after additional tilting of 45&#x000b0; out of the plane. (<bold>e</bold>) Close-up in the cap on specific pairs of amino acids involved in intersubunit interactions.</p></caption><graphic xmlns:xlink=\"http://www.w3.org/1999/xlink\" xlink:href=\"srep19492-f5\"/></fig><fig id=\"f6\"><label>Figure 6</label><caption><title>Hydrophobic interactions stabilize the tip of the TASK-1 cap structure.</title><p>TASK-1 &#x02018;hits&#x02019; identified in the alanine scan are highlighted in the TASK-1 homology model based on the domain-swapped TREK-2, following a 100&#x02009;ns MD simulation. The two different subunits are shown in <italic>gray</italic> and <italic>light gray</italic>. (<bold>a</bold>) Residues stabilizing the tip of the cap structure are shown in space fill mode and a zoom-in is provided at the bottom. (<bold>b</bold>) 90&#x000b0; rotation of the model. Mutations resulting in a loss of &#x02018;conductivity&#x02019; are illustrated in red space fill and a zoom-in showing these residues located in the EIP is provided at the bottom.</p></caption><graphic xmlns:xlink=\"http://www.w3.org/1999/xlink\" xlink:href=\"srep19492-f6\"/></fig><fig id=\"f7\"><label>Figure 7</label><caption><title>Alanine scan through the extracellular M1-P1 linker of human TRAAK.</title><p>(<bold>a</bold>) Relative current amplitudes at +40&#x02009;mV compared to TRAAK wild-type (WT). Mutations in the cap exhibiting a pronounced current amplitude reduction are highlighted in <italic>black</italic>. Note that the C78A mutation at the tip of the cap structure did not affect current amplitudes. (<bold>b</bold>) TRAAK mutations at the sites homologous to the TASK-1 &#x02018;hits&#x02019; were functionally studied in TRAAK alone (as in (<bold>a</bold>)) or in the absence of the cysteine at position 78 (C78A). F72 in TRAAK corresponds to L48 in TASK-1, H76 to Y52, C78 to N53, V79 to L54, S80 to S55, L84 to Y59 and L87 to L62. Pronounced reduction in current amplitudes compared to the C78A mutant alone are illustrated in <italic>black</italic>. (<bold>c</bold>) Domain-swapped TRAAK cap structure after 10&#x02009;ns of MD simulation illustrating the relevant residues identified in (<bold>b</bold>). Upper panel shows the orientation as in Brohawn <italic>et al</italic>., 2012 and the lower panel is rotated by 90&#x000b0;. (<bold>d</bold>) Domain-swapped TRAAK cap structure of the C78A mutation after 10&#x02009;ns of MD simulation, illustrating the relevant residues identified in (<bold>b</bold>). <italic>Upper panel</italic> shows the orientation as in Brohawn <italic>et al</italic>., 2012 and the lower panel is rotated by 90&#x000b0;. (<bold>e</bold>) Representative current traces of TWIK-1 and TWIK-1 C69A recorded in oocytes, using a voltage ramp from &#x02212;120 to +40&#x02009;mV. (<bold>f</bold>) Changes in relative current amplitudes at +40&#x02009;mV, after mutating the conserved cysteine residues in the cap structure of different K<sub>2P</sub> channels. (<bold>a</bold>,<bold>b</bold>,<bold>f</bold>) **p&#x02009;&#x0003c;&#x02009;0.01; ***p&#x02009;&#x0003c;&#x02009;0.001. Significance was probed using unpaired Student&#x02019;s T-Test against the respective wild-type channel, unless for panel (<bold>b</bold>), here significance of the double mutation was probed against the respective single mutation without C78A. Data are presented as Mean&#x02009;&#x000b1;&#x02009;SEM. The number of experiments are given above the construct name or included in the bar graphs.</p></caption><graphic xmlns:xlink=\"http://www.w3.org/1999/xlink\" xlink:href=\"srep19492-f7\"/></fig><table-wrap position=\"float\" id=\"t1\"><label>Table 1</label><caption><title>Intersubunit interactions in a TASK-1 homology model based on domain-swapped TREK-2.</title></caption><graphic xmlns:xlink=\"http://www.w3.org/1999/xlink\" xlink:href=\"srep19492-t1\"/><table-wrap-foot><fn id=\"t1-fn1\"><p>The diagonal line, highlighted in gray, indicates the distance to the same residue in the neighboring subunit of the dimeric protein. Intersubunit distances are listed under the diagonal line and are written black. Intrasubunit interactions which should be less relevant for the dimerization of the channel are listed over the diagonal line and written in a light gray. Distances are measured from a predefined carbon of the amino acid side chain, lacking also the hydrogen atoms, and thus a more remote cut-off of 6&#x02009;&#x000c5; was used (<xref ref-type=\"supplementary-material\" rid=\"S1\">Supplementary Fig. S3</xref> and Methods). Intersubunit distances under 6&#x02009;&#x000c5; are indicated in red. Mean&#x02009;&#x000b1;&#x02009;SDEV.</p></fn></table-wrap-foot></table-wrap></floats-group></article>',\n",
       " \"The interaction of the adaptor protein p11, also denoted S100A10, with the C-terminus of the two-pore-domain K+ channel TASK-1 was studied using yeast two-hybrid analysis, glutathione S-transferase pull-down, and co-immunoprecipitation. We found that p11 interacts with a 40 amino-acid region in the proximal C-terminus of the channel. In heterologous expression systems, deletion of the p11-interacting domain enhanced surface expression of TASK-1. Attachment of the p11-interacting domain to the cytosolic tail of the reporter protein CD8 caused retention/retrieval of the construct in the endoplasmic reticulum (ER). Attachment of the last 36 amino acids of p11 to CD8 also caused ER localization, which was abolished by removal or mutation of a putative retention motif (H/K)xKxxx, at the C-terminal end of p11. Imaging of EGFP-tagged TASK-1 channels in COS cells suggested that wild-type TASK-1 was largely retained in the ER. Knockdown of p11 with siRNA enhanced trafficking of TASK-1 to the surface membrane. Our results suggest that binding of p11 to TASK-1 retards the surface expression of the channel, most likely by virtue of a di-lysine retention signal at the C-terminus of p11. Thus, the cytosolic protein p11 may represent a 'retention factor' that causes localization of the channel to the ER.\",\n",
       " 'Acid-sensitive two-pore domain potassium channels (K2P3.1 and K2P9.1) play key roles in both physiological and pathophysiological mechanisms, the most fundamental of which is control of resting membrane potential of cells in which they are expressed. These background \"leak\" channels are constitutively active once expressed at the plasma membrane, and hence tight control of their targeting and surface expression is fundamental to the regulation of K(+) flux and cell excitability. The chaperone protein, 14-3-3, binds to a critical phosphorylated serine in the channel C termini of K2P3.1 and K2P9.1 (Ser(393) and Ser(373), respectively) and overcomes retention in the endoplasmic reticulum by βCOP. We sought to identify the kinase responsible for phosphorylation of the terminal serine in human and rat variants of K2P3.1 and K2P9.1. Adopting a bioinformatic approach, three candidate protein kinases were identified: cAMP-dependent protein kinase, ribosomal S6 kinase, and protein kinase C. In vitro phosphorylation assays were utilized to determine the ability of the candidate kinases to phosphorylate the channel C termini. Electrophysiological measurements of human K2P3.1 transiently expressed in HEK293 cells and cell surface assays of GFP-tagged K2P3.1 and K2P9.1 enabled the determination of the functional implications of phosphorylation by specific kinases. All of our findings support the conclusion that cAMP-dependent protein kinase is responsible for the phosphorylation of the terminal serine in both K2P3.1 and K2P9.1.',\n",
       " 'Antiarrhythmic management of atrial fibrillation (AF) remains a major clinical challenge. Mechanism-based approaches to AF therapy are sought to increase effectiveness and to provide individualized patient care. K(2P)3.1 (TASK-1 [tandem of P domains in a weak inward-rectifying K+ channel-related acid-sensitive K+ channel-1]) 2-pore-domain K+ (K(2P)) channels have been implicated in action potential regulation in animal models. However, their role in the pathophysiology and treatment of paroxysmal and chronic patients with AF is unknown. Right and left atrial tissue was obtained from patients with paroxysmal or chronic AF and from control subjects in sinus rhythm. Ion channel expression was analyzed by quantitative real-time polymerase chain reaction and Western blot. Membrane currents and action potentials were recorded using voltage- and current-clamp techniques. K(2P)3.1 subunits exhibited predominantly atrial expression, and atrial K(2P)3.1 transcript levels were highest among functional K(2P) channels. K(2P)3.1 mRNA and protein levels were increased in chronic AF. Enhancement of corresponding currents in the right atrium resulted in shortened action potential duration at 90% of repolarization (APD90) compared with patients in sinus rhythm. In contrast, K(2P)3.1 expression was not significantly affected in subjects with paroxysmal AF. Pharmacological K(2P)3.1 inhibition prolonged APD90 in atrial myocytes from patients with chronic AF to values observed among control subjects in sinus rhythm. Enhancement of atrium-selective K(2P)3.1 currents contributes to APD shortening in patients with chronic AF, and K(2P)3.1 channel inhibition reverses AF-related APD shortening. These results highlight the potential of K(2P)3.1 as a novel drug target for mechanism-based AF therapy.',\n",
       " 'Peri-operative atrial fibrillation (peri-op AF) is a common complication following thoracic surgery. This arrhythmia is thought to be triggered by an inflammatory response and can be reproduced in various animal models. Previous work has shown that the lipid inflammatory mediator, platelet-activating factor (PAF), synthesized by activated neutrophils, can induce atrial and ventricular arrhythmias as well as repolarization abnormalities in isolated ventricular myocytes. We have previously shown that carbamylated PAF-induced repolarization abnormalities result from the protein kinase C (PKC) ε-dependent phosphorylation of the two-pore domain potassium channel TASK-1. We now demonstrate that canine peri-op AF is associated with the phosphorylation-dependent loss of TASK-1 current. Further studies identified threonine 383 in the C terminus of human and canine TASK-1 as the phosphorylation site required for PAF-dependent inhibition of the channel. Using a novel phosphorylation site-specific antibody targeting the phosphorylated channel, we have determined that peri-op AF is associated with the loss of TASK-1 current and increased phosphorylation of TASK-1 at this site.',\n",
       " '<!DOCTYPE article PUBLIC \"-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN\" \"JATS-archivearticle1.dtd\">\\n<article xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" article-type=\"research-article\" xml:lang=\"en\"><?properties open_access?><front><journal-meta><journal-id journal-id-type=\"nlm-ta\">Virol J</journal-id><journal-id journal-id-type=\"iso-abbrev\">Virol. J</journal-id><journal-title-group><journal-title>Virology Journal</journal-title></journal-title-group><issn pub-type=\"epub\">1743-422X</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type=\"pmid\">23164059</article-id><article-id pub-id-type=\"pmc\">3547713</article-id><article-id pub-id-type=\"publisher-id\">1743-422X-9-277</article-id><article-id pub-id-type=\"doi\">10.1186/1743-422X-9-277</article-id><article-categories><subj-group subj-group-type=\"heading\"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Human immunodeficiency virus type 1 Vpu and cellular TASK proteins suppress transcription of unintegrated HIV-1 DNA</article-title></title-group><contrib-group><contrib contrib-type=\"author\" id=\"A1\"><name><surname>Emeagwali</surname><given-names>Nkiruka</given-names></name><xref ref-type=\"aff\" rid=\"I1\">1</xref><email>nemeagwali02@email.mmc.edu</email></contrib><contrib contrib-type=\"author\" corresp=\"yes\" id=\"A2\"><name><surname>Hildreth</surname><given-names>James EK</given-names></name><xref ref-type=\"aff\" rid=\"I2\">2</xref><email>jekhildreth@ucdavis.edu</email></contrib></contrib-group><aff id=\"I1\"><label>1</label>Center for AIDS Health Disparities Research, Meharry Medical College, Nashville, TN, 37208, USA</aff><aff id=\"I2\"><label>2</label>Department of Molecular and Cellular Biology, College of Biological Sciences, University of California, Davis, One Shields Ave, Davis, CA, 95616, USA</aff><pub-date pub-type=\"collection\"><year>2012</year></pub-date><pub-date pub-type=\"epub\"><day>19</day><month>11</month><year>2012</year></pub-date><volume>9</volume><fpage>277</fpage><lpage>277</lpage><history><date date-type=\"received\"><day>17</day><month>5</month><year>2012</year></date><date date-type=\"accepted\"><day>31</day><month>10</month><year>2012</year></date></history><permissions><copyright-statement>Copyright &#x000a9;2012 Emeagwali and Hildreth; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2012</copyright-year><copyright-holder>Emeagwali and Hildreth; licensee BioMed Central Ltd.</copyright-holder><license license-type=\"open-access\" xlink:href=\"http://creativecommons.org/licenses/by/2.0\"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type=\"uri\" xlink:href=\"http://creativecommons.org/licenses/by/2.0\">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href=\"http://www.virologyj.com/content/9/1/277\"/><abstract><sec><title>Background</title><p>Unintegrated HIV-1 DNA serves as transcriptionally active templates in HIV-infected cells. Several host factors including NF-&#x003ba;&#x003b2; enhance HIV-1 transcription. HIV-1 induced NF-&#x003ba;&#x003b2; activation can be suppressed by viral protein U (Vpu). Interestingly HIV-1 Vpu shares amino acid homology with cellular Twik-related Acid Sensitive K+ (TASK) channel 1 and the proteins physically interact in cultured cells and AIDS lymphoid tissue. Furthermore, the first transmembrane domain of TASK-1 is functionally interchangeable with Vpu and like Vpu enhances HIV-1 release.</p></sec><sec><title>Results</title><p>Here we further characterize the role of TASK channels and Vpu in HIV-1 replication. We demonstrate that both TASK channels and Vpu can preferentially inhibit transcription of unintegrated HIV-1 DNA. Interestingly, TASK-1 ion channel function is not required and suppression of HIV-1 transcription by TASK-1 and Vpu was reversed by overexpression of RelA (NF-&#x003ba;&#x003b2; p65).</p></sec><sec><title>Conclusion</title><p>TASK proteins and Vpu suppress transcription of unintegrated HIV-1 DNA through an NF-&#x003ba;&#x003b2;-dependent mechanism. Taken together these findings support a possible physiological role for HIV-1 Vpu and TASK proteins as modulators of transcription of unintegrated HIV-1 DNA genomes.</p></sec></abstract><kwd-group><kwd>HIV-1</kwd><kwd>Viral protein U</kwd><kwd>Unintegrated HIV-1 DNA</kwd><kwd>HIV-1 transcription Twik-related Acid Sensitive K+ proteins</kwd></kwd-group></article-meta></front><body><sec><title>Background</title><p>Human immunodeficiency virus type 1 (HIV-1) replication involves a series of highly orchestrated steps that are regulated by both viral and cellular factors. Like other retroviruses, HIV-1&#x02019;s genome is reverse transcribed before the proviral DNA integrates into host cell chromatin. HIV-1 proviral DNA preferentially integrates into open transcriptionally active sites in the host cell chromatin where robust viral gene transcription can occur. Integration of HIV-1 DNA, mediated by viral integrase, allows the viral genome to persist throughout the lifespan of the cell. However, despite the critical role of integration in the lifecycle of all retroviruses, during the course of HIV-1 infection the majority of viral DNA remains unintegrated [<xref ref-type=\"bibr\" rid=\"B1\">1</xref>].</p><p>Unintegrated HIV-1 DNA (uDNA) is generated during virus replication and serves as DNA templates for transcription. The majority of viral uDNA genomes remain linear. Linear HIV-1 DNA, the substrate for integration, is found in both the cytoplasm and nucleus and can be degraded or modified by host factors [<xref ref-type=\"bibr\" rid=\"B1\">1</xref>-<xref ref-type=\"bibr\" rid=\"B3\">3</xref>]. uDNA can circularize by homologous recombination [<xref ref-type=\"bibr\" rid=\"B4\">4</xref>] or ligation of interrupted reverse transcription intermediates [<xref ref-type=\"bibr\" rid=\"B5\">5</xref>] to form 1-LTR circles. uDNA can also circularize by non-homologous end joining DNA repair events to form 2-LTR circles [<xref ref-type=\"bibr\" rid=\"B6\">6</xref>,<xref ref-type=\"bibr\" rid=\"B7\">7</xref>]. In addition, formation of 1-LTR and 2-LTR circles can result from activity of host factors involved in DNA repair. Circular forms of the viral genome are found exclusively in the nucleus. Interestingly, the host restriction factor APOBEC3G has been shown to cause a 2-fold decrease in 2-LTR circle formation in cells infected with &#x00394;vif HIV-1 [<xref ref-type=\"bibr\" rid=\"B8\">8</xref>].</p><p>In HIV-1-infected patients, high levels of uDNA can be found in the blood, lymphoid tissues, and brain [<xref ref-type=\"bibr\" rid=\"B1\">1</xref>,<xref ref-type=\"bibr\" rid=\"B6\">6</xref>,<xref ref-type=\"bibr\" rid=\"B9\">9</xref>-<xref ref-type=\"bibr\" rid=\"B12\">12</xref>]. uDNA also accumulates in non-dividing cells such as macrophages and resting T cells but is lost in dividing cells through dilution during cell division [<xref ref-type=\"bibr\" rid=\"B13\">13</xref>-<xref ref-type=\"bibr\" rid=\"B15\">15</xref>]. Clinically, detection of high levels of uDNA in the brain is associated with development of AIDS dementia and correlates with a decline in CD4+ T cells. In addition, uDNA templates are increased in HIV-infected cells of patients given ART regimens with the integrase inhibitor, Raltegravir. The accumulation of uDNA in patients appears to be independent of viral load [<xref ref-type=\"bibr\" rid=\"B16\">16</xref>,<xref ref-type=\"bibr\" rid=\"B17\">17</xref>].</p><p>Several studies have characterized important roles for uDNA with respect to HIV-1 infection [<xref ref-type=\"bibr\" rid=\"B18\">18</xref>-<xref ref-type=\"bibr\" rid=\"B24\">24</xref>]. Linear uDNA is the form used by HIV-1 integrase to incorporate the viral genome into host cell chromatin. uDNA can contribute to virus genetic diversity by providing templates for viral genome complementation of the integrated HIV-1 genome during virus assembly and production [<xref ref-type=\"bibr\" rid=\"B25\">25</xref>,<xref ref-type=\"bibr\" rid=\"B26\">26</xref>]. Transcriptional activity in uDNA is lower than that of integrated genomes. However, early gene products of HIV-1 infection, Tat and Nef, are transcribed and translated in cells containing only uDNA [<xref ref-type=\"bibr\" rid=\"B20\">20</xref>,<xref ref-type=\"bibr\" rid=\"B24\">24</xref>,<xref ref-type=\"bibr\" rid=\"B27\">27</xref>,<xref ref-type=\"bibr\" rid=\"B28\">28</xref>]. Nef protein production from uDNA is sufficient to promote T cell activation, down regulate CD4 and enhance HIV-1 infection [<xref ref-type=\"bibr\" rid=\"B24\">24</xref>]. Tat, an important viral protein in HIV replication, is initially produced from uDNA. Tat production from uDNA transactivates the HIV-1 LTR of both uDNA and integrated HIV-1 DNA [<xref ref-type=\"bibr\" rid=\"B29\">29</xref>].</p><p>Transcription of uDNA is enhanced by viral protein R (Vpr) a late gene product of HIV-1 infection. Interestingly both virion-associated Vpr and newly synthesized Vpr preferentially increase transcription of nef from uDNA templates [<xref ref-type=\"bibr\" rid=\"B30\">30</xref>]. Another late gene product of HIV-1 infection is viral protein U (Vpu). Vpu promotes the efficient release of virus particles from the cell surface, induces the degradation of CD4 in the ER and suppresses the activation of NF-&#x003ba;&#x003b2; [<xref ref-type=\"bibr\" rid=\"B31\">31</xref>-<xref ref-type=\"bibr\" rid=\"B33\">33</xref>]. Vpu also restricts the function of several host proteins including tetherin and Twik-related Acid Sensitive K+ channel-1 (TASK-1) [<xref ref-type=\"bibr\" rid=\"B34\">34</xref>,<xref ref-type=\"bibr\" rid=\"B35\">35</xref>]. TASK proteins are a part of the family of two-pore domain background potassium (K(2P)) channels.</p><p>TASK channels are widely expressed by many cell types and establish resting membrane potential and cell excitability. They are functional as dimers and have been shown to form homo- and heterodimers <italic>in vivo</italic>[<xref ref-type=\"bibr\" rid=\"B36\">36</xref>]. Hsu et al. demonstrated that HIV-1 Vpu shows a high degree of sequence similarity to the first transmembrane domain of TASK-1 (Ttm1) [<xref ref-type=\"bibr\" rid=\"B34\">34</xref>]. In addition, Vpu can self-assemble into homo-oligomeric complexes and form ion channels in lipid bilayers. Interestingly Vpu&#x02019;s ion channel function is not required to antagonize CD317-mediated restriction of HIV release [<xref ref-type=\"bibr\" rid=\"B37\">37</xref>,<xref ref-type=\"bibr\" rid=\"B38\">38</xref>]. In their study characterizing the homology between Vpu and the first transmembrane domain of TASK-1, Hsu et al. demonstrated that Vpu and Ttm1 were each capable of functional inhibition of the other. Furthermore it was found that cells infected with Vpu-deleted HIV-1, NL4-3 Udel, produced low levels of virus and this was reversed when Ttm1 was expressed in <italic>trans</italic>[<xref ref-type=\"bibr\" rid=\"B34\">34</xref>].</p><p>These observations suggest that some form of molecular piracy may have occurred during the evolution of HIV-1 infection. Here we demonstrate for the first time that TASK proteins and Vpu preferentially suppress transcription of uDNA. Our results have important implications for further understanding host-pathogen interactions that regulate HIV-1 replication and pathogenesis.</p></sec><sec sec-type=\"results\"><title>Results</title><sec><title>Overexpression of TASK-1 suppresses HIV-1 replication</title><p>We sought to extend this finding from a previous study that demonstrated that TASK-1 suppressed HIV replication [<xref ref-type=\"bibr\" rid=\"B34\">34</xref>]. 293T cells were cotransfected with HIV-1 pNL4-3 and TASK-1. After 48 hours, supernatants were collected and HIV-1 was quantified with a capture p24 antigen ELISA. Our results show that virus release was reduced by 82.5% in HIV-1-infected cells overexpressing TASK-1 protein compared to cells transfected with the empty vector control (Figure <xref ref-type=\"fig\" rid=\"F1\">1a</xref>, <xref ref-type=\"fig\" rid=\"F1\">1b</xref>). This result confirms the findings of Hsu and co-workers who demonstrated a decrease in HIV-1 release from HeLa cells co-transfected with pNL4-3 and TASK-1. We obtained similar data when 293T cells were co-transfected with pNL4-3 along with human TASK-3, murine TASK-1 or murine TASK-3. In addition, we also accessed the effect of TASK overexpression on cell viability and observed no decrease in viability resulting from TASK overexpression (data not shown). These results indicate that the effect of TASK-1 on HIV-1 release does not result from cellular toxicity and is shared with other TASK proteins, independent of species.</p><fig id=\"F1\" position=\"float\"><label>Figure 1</label><caption><p><bold>TASK-1 suppresses HIV-1 replication. A</bold>. 293T cells were co-transfected with pNL4-3 and TASK-1 expression vector or empty vector. After 48 hours supernatants were collected and a p24 ELISA was performed. Data are normalized to the empty vector control (EV). <bold>B</bold>. TASK-1 expression in transfected cells. 293T cells were harvested and lysed with buffer containing protease inhibitors. Equal amounts of protein from cell lysates were separated by 4-12% SDS-PAGE and transferred onto nitrocellulose membranes. TASK and &#x003b2;-tubulin proteins were detected by immunoblotting using polyclonal antibodies and visualization by chemilumenescence. <bold>C</bold>. TASK-1 does not decrease HIV-1 Gag virus-like particle release. 293T cells were co-transfected with plasmid encoding Gag driven by CMV promoter and TASK-1 or empty vector. After 48 hours supernatants were collected, and a p24 ELISA was performed. Data are normalized to the empty vector control (EV). <bold>D</bold>. TASK-1 expression in transfected cells from (C). 293T cells from (C.) were harvested and lysed with a detergent buffer containing protease inhibitors. Equal protein amounts of cell lysate were separated by 4-12% SDS-PAGE and transferred to nitrocellulose membranes. TASK and &#x003b2;-tubulin proteins were revealed by immunoblotting using polyclonal antibodies followed by chemilumenescence detection. (* P &#x0003c; .0001; Student T test was used to determine statistical significance).</p></caption><graphic xlink:href=\"1743-422X-9-277-1\"/></fig><p>Assembly and budding of progeny virions from infected cells comprise the late stages of HIV-1 biogenesis and are multi-step events driven by the viral protein Gag. Indeed, transient expression of Gag alone is sufficient for the formation of virus-like particles (VLPs) consistent with the central role of Gag in particle assembly and release. To evaluate the effect of TASK proteins on the late stages of the HIV-1 life cycle, particle release from 293T cells co-expressing Gag driven by a CMV promoter and TASK-1 was evaluated. We observed no difference in Gag-mediated VLP release from cells in the presence or absence of TASK-1 protein (Figure <xref ref-type=\"fig\" rid=\"F1\">1c</xref>, <xref ref-type=\"fig\" rid=\"F1\">1d</xref>). Similarly using provirus HIV-1 SG3 containing a neomycin phosphotransferase (NPT) gene under the transcriptional regulation of SV40 we observed no change in NPT protein levels with TASK protein expression while HIV-1 Gag protein under the control of the LTR promoter was significantly decreased (data not shown). These findings indicate that the effect of TASK proteins on HIV-1 replication is not due to inhibition of Gag assembly and release. Furthermore TASK protein expression preferientally suppresses gene transcription driven by the HIV-LTR but not transcription from CMV or SV40 promoters.</p><p>Since the late stages of virus replication were not affected by TASK protein overexpression we examined the effect of TASK protein expression on the earlier stages of HIV-1 replication. 293T cells were cotransfected with pNL4-3 and TASK-3 or empty vector. After 48 hours intracellular Gag from cell lysates was quantified with a capture p24 antigen ELISA. We found that overexpression of TASK proteins decreased intracellular Gag by over 83% (data not shown).</p></sec><sec><title>TASK-1 protein suppresses HIV-1 transcription</title><p>One possible explanation for the decrease in both extracellular and intracellular Gag expression in cells overexpressing TASK proteins is suppression of HIV-1 gene transcription. To test this possibility, a reporter virus construct derived from pNL4-3 in which the luciferase gene is substituted for nef (pNL4-3Luc), was cotransfected into 293T cells along with TASK-1. After 48 hours, the transfected cells were lysed and a luciferase assay was performed to measure HIV-1 LTR-dependent transcription. Overexpression of TASK-1 significantly inhibited HIV-1 transcription, and this inhibition was dose-dependent (Figure <xref ref-type=\"fig\" rid=\"F2\">2a</xref>, <xref ref-type=\"fig\" rid=\"F2\">2c</xref>). Similar results were obtained when cells were co-transfected with TASK-3 and the reporter virus construct (data not shown). Taken together, these results indicate that TASK protein suppresses HIV-1 replication by inhibition of viral transcription.</p><fig id=\"F2\" position=\"float\"><label>Figure 2</label><caption><p><bold>TASK proteins suppress HIV-1 transcription.</bold><bold>A</bold>. 293T cells were transfected with pNL4-3Luc and TASK-1 expression vector or empty vector (EV). After 48 hours cells were lysed and a luciferase assay was performed to determine the effect of TASK-1 on HIV-1 transcription. Data are normalized to the empty vector control (EV). <bold>B</bold>. Transfected 293T cells were harvested and lysed with a detergent buffer containing protease inhibitors. Equal protein amounts of cell lysate were separated by 4-12% SDS PAGE and transferred to nitrocellulose membranes. TASK and &#x003b2;-tubulin proteins were revealed by immunoblotting with polyclonal antibodies followed by chemilumenescence detection. <bold>C</bold>. 293T cells were transfected with pNL4-3Luc and 0.5ug, 1ug, or 2ug TASK-1 or empty vector. After 48 hours cells were lysed and a luciferase assay was performed. Data are normalized to the empty vector control (EV). D. Transfected 293T cells from (C.) were harvested, lysed and equal amounts of protein from cell lysates were subjected to 4-12% SDS PAGE. After transfer to nitrocellulose membranes, TASK and &#x003b2;-tubulin proteins were revealed by immunoblotting with polyclonal antibodies followed by chemilumenescence detection. (* P &#x0003c; .0001; Student T test was used to determine statistical significance).</p></caption><graphic xlink:href=\"1743-422X-9-277-2\"/></fig></sec><sec><title>TASK channel function is not required for suppression of HIV-1 transcription</title><p>TASK proteins are potassium channels whose ion channel function contributes significantly to maintaining the resting cellular membrane potential. However several ion channels have phenotypes independent of their ion channel activity. One example, the Ether-&#x000e0;-go-go (EAG) K+ channels regulates intracellular signaling pathways by a mechanism that depends on the position of its voltage sensor [<xref ref-type=\"bibr\" rid=\"B39\">39</xref>]. Therefore to examine whether TASK ion channel function was required for suppression of HIV-1 transcription we co-transfected 293T cells with pNL4-3Luc and either a dominant negative TASK-1(Y191F) or TASK-5. TASK-5 is a naturally occurring non-functional TASK protein that is homologous to TASK-1 and TASK-3 [<xref ref-type=\"bibr\" rid=\"B40\">40</xref>]. In addition, we added 5mM BaCl<sub>2</sub> to pharmacologically block TASK function in cells transfected with wild type TASK-1 and a luciferase assay was performed after 48 hours. Our results show that the dominant negative TASK-1 mutant TY191F and the naturally non-functional channel TASK-5 were both able to suppress HIV-1 transcription similar to wildtype TASK proteins (Figure <xref ref-type=\"fig\" rid=\"F3\">3a</xref>). Furthermore, wild type TASK channels in the presence of 5mM BaCl<sub>2</sub> were also able to suppress HIV-1 transcription (Figure <xref ref-type=\"fig\" rid=\"F3\">3b</xref>, <xref ref-type=\"fig\" rid=\"F3\">3c</xref>). Therefore, TASK ion channel function is not required to suppress HIV-1 transcription. In addition, suppression of HIV-1 transcription appears to be specific to TASK protein family members because an inwardly-rectifying K channel (IRK1), from a different K+ channel family, enhanced rather than suppressed HIV-1 transcription (data not shown).</p><fig id=\"F3\" position=\"float\"><label>Figure 3</label><caption><p><bold>TASK channel function is not required for suppression of HIV-1 transcription. A</bold>. 293T cells were transfected with pNL4-3Luc and either wild type TASK-1 or non-functional TASK protein expression vectors as described in the text. After 48 hours a luciferase assay was performed to determine the effect of ion channel function on TASK-1&#x02019;s ability to suppress HIV-1 transcription. Data shown are normalized to empty vector control (EV). <bold>B</bold>. 293T cells were transfected with pNL4-3Luc and wild type TASK-1 in the presence of the ion channel inhibitor 5mM BaCl<sub>2</sub>. After 48 hours a luciferase assay was performed to measure HIV-1 transcription. Data are normalized to the empty vector control (EV). C. Transfected 293T cells were harvested, lysed and equal amounts of cell lysate protein were subjected to 4-12% SDS-PAGE. After transfer to nitrocellulose membranes, TASK and <bold>&#x003b2;</bold>-tubulin proteins were revealed by immunoblotting with polyclonal antibodies followed by chemilumenescence detection. (* P &#x0003c; .001; Statistical analysis was performed on the samples using a student T test).</p></caption><graphic xlink:href=\"1743-422X-9-277-3\"/></fig></sec><sec><title>Both HIV-1 Vpu and TASK protein decrease HIV-1 transcription</title><p>As noted above, the first transmembrane domain of TASK-1 (Ttm1) shares amino acid identity with HIV-1 Vpu and can reverse defects in HIV-1 release when added in <italic>trans</italic> to cells transfected with the &#x02206;vpu HIV-1 provirus pNL4-3-Udel [<xref ref-type=\"bibr\" rid=\"B34\">34</xref>]. In addition, Vpu has been shown to suppress HIV-1 induced NF-&#x003ba;&#x003b2; activation [<xref ref-type=\"bibr\" rid=\"B32\">32</xref>]. To determine if, like TASK proteins, Vpu could also suppress HIV-1 transcription, 293T cells were cotransfected with pNL4-3Luc and a Vpu expression construct in increasing concentrations. After 48 hours, a luciferase assay was performed to measure viral transcription. Like TASK-1, Vpu significantly suppressed HIV-1 transcription in a dose-dependent manner (Figure <xref ref-type=\"fig\" rid=\"F4\">4a</xref>, <xref ref-type=\"fig\" rid=\"F4\">4b</xref>). We also performed a cell viability assay and found no change in cell viability with expression of Vpu (data not shown). Interestingly Vpu suppressed HIV-1 transcription by 90%, a level of suppression even greater than that mediated by TASK-1.</p><fig id=\"F4\" position=\"float\"><label>Figure 4</label><caption><p><bold>Vpu suppresses HIV-1 transcription.</bold><bold>A</bold>. 293T cells were transfected with pNL4-3 and increasing amounts of Vpu expression plasmid. After 48 hours a luciferase assay was performed to determine the effect of Vpu of HIV-1 transcription. Data are normalized to empty vector control (EV). <bold>B</bold>. Transfected 293T cells were harvested, lysed and equal amounts of cell lysate protein were subjected to 4-12% SDS-PAGE. After transfer to nitrocellulose membranes, VPU and &#x003b2;-tubulin proteins were revealed by immunoblotting with polyclonal antibodies followed by chemilumenescence detection. <bold>C</bold>. 293T cells were transfected with an HIV-1 LTR-GFP construct that does not encode Tat along with TASK-3, Vpu or empty vector. After 48 hours, the cells were harvested and subjected to flow cytometry analysis for GFP expression. Data shown are mean fluorescence intensity of transfected cells. Non-transfected cells were used to set the negative gate. (* P &#x0003c; .001; Student T test was used to determine statistical significance).</p></caption><graphic xlink:href=\"1743-422X-9-277-4\"/></fig><p>To determine if the HIV-1 Tat protein was involved in suppression of HIV-1 transcription by TASK and Vpu, we co-transfected 293T cells with an HIV-1-LTR-GFP plasmid along with empty vector, TASK-1 or Vpu cDNA in <italic>trans</italic> and measured expression of HIV-1-LTR-dependent GFP by flow cytometry after 48 hours. The HIV-1-LTR-GFP plasmid does not include the <italic>tat</italic> gene and in the absence of Tat there was a low level of endogenous HIV LTR promoter activity. However as previously seen in Figures <xref ref-type=\"fig\" rid=\"F2\">2</xref> and <xref ref-type=\"fig\" rid=\"F4\">4a</xref> both Vpu and TASK significantly suppressed HIV-1 transcription in the absence of Tat (Figure <xref ref-type=\"fig\" rid=\"F4\">4c</xref>). These results showed that Vpu and TASK-1 suppress HIV-1 transcription in a Tat-independent manner.</p></sec><sec><title>TASK and Vpu proteins preferentially suppress unintegrated HIV-1 DNA</title><p>We have shown that TASK proteins and Vpu suppress viral transcription in cells transfected with HIV-1 proviral DNA. During these transient transfection assays, the HIV-1 provirus remains unintegrated. Therefore we sought to examine the effect of TASK and Vpu proteins on HIV-1 transcription from integrated and unintegrated viral genomes. For this purpose we determined the effect of TASK and Vpu expression on HIV-1 transcription in cells that had contained an integrated and an unintegrated viral genome. We used the JLTRG cell line which is derived from the Jurkat cell line and has been stably transfected with an HIV LTR-GFP construct. The JLTRG cells were transfected with a Tat expression plasmid along with HIV-LTR-DsRed, TASK or Vpu expression vectors or empty vector control. In the absence of HIV-1 infection or HIV-1 Tat expression the cells exhibit no GFP expression. Twenty four hours after transfection we used flow cytometry to assesses the expression of GFP and DsRed as a measure of LTR activity and plotted the respective MFI. As previously observed, both TASK and Vpu proteins significantly suppressed transcription of the unintegrated HIV-LTR-DsRed (Figure <xref ref-type=\"fig\" rid=\"F5\">5b</xref>). Interestingly, both TASK and Vpu had only limited affect on transcription from the integrated HIV LTR-GFP construct (Figure <xref ref-type=\"fig\" rid=\"F5\">5a</xref>). Taken together these results indicate that TASK proteins and Vpu preferentially suppress transcription of uDNA in cells containing both integrated and uDNA.</p><fig id=\"F5\" position=\"float\"><label>Figure 5</label><caption><p><bold>TASK and Vpu proteins preferentially suppress unintegrated HIV-1 DNA.</bold> JLTRG cells, stable transfectants expressing HIV LTR-GFP construct, were co-transfected with tat, HIV-LTR-DsRed and EV, Vpu or TASK-3GFP. Twenty four hours after transfection the cells were fixed, permeabilized and subjected flow cytometry analysis. The mean fluorescence intensities of the double positive DsRed and GFP populations are indicated in the graphs. (*P &#x0003c; .0005; Student T test was used to determine statistical significance).</p></caption><graphic xlink:href=\"1743-422X-9-277-5\"/></fig></sec><sec><title>TASK-1 and Vpu suppress HIV transcription in cells infected with Integrase defective virus</title><p>Unintegrated copies of HIV-1 DNA are enriched in cells infected with integrase-defective viruses. We took advantage of this phenomenon to confirm that Vpu and TASK-1 proteins suppress transcription of uDNA. We transfected Jurkat cells with either TASK-1 or Vpu and then infected the cells with wildtype NL4-3-CFP or integrase-defective NL4-3-D116N-YFP HIV-1. Thirty hours after infection, RNA was isolated and used as template for real-time PCR analysis of nef mRNA. As seen in Figure <xref ref-type=\"fig\" rid=\"F6\">6b</xref>, TASK and Vpu proteins significantly suppressed nef transcription in cells infected with integrase defective HIV-1 and minimally suppressed transcription in cells infected with wildtype HIV-1 (Figure <xref ref-type=\"fig\" rid=\"F6\">6a</xref>). These data confirmed our earlier results and strongly indicated that TASK and Vpu preferentially suppress transcription of uDNA.</p><fig id=\"F6\" position=\"float\"><label>Figure 6</label><caption><p><bold>TASK-1 and Vpu preferentially suppress transcription of cells infected with Integrase defective HIV-1.</bold> Jurkat cells were transfected with empty vector (EV), TASK-1 or Vpu expression plasmids and then infected with wildtype NL4-3-CFP (<bold>A</bold>) or NL4-3D116N-YFP (<bold>B</bold>). Twenty four hours after infection the cells were lysed and total RNA was isolated and used as template for real-time PCR to measure nef mRNA. Data shown are normalized to EV control. (* P = .0002; **P &#x0003c; .0001; Student T test was used to determine statistical significance).</p></caption><graphic xlink:href=\"1743-422X-9-277-6\"/></fig></sec><sec><title>Vpu and TASK-1 suppress unintegrated HIV-1 DNA in an NF&#x003ba;&#x003b2;-dependent manner</title><p>In a previous study, Bour et al. demonstrated that Vpu interferes with NF-&#x003ba;&#x003b2; activation by preventing degradation of I&#x003ba;&#x003b2; [<xref ref-type=\"bibr\" rid=\"B32\">32</xref>]. We explored this phenomenon as a possible mechanism by which Vpu and TASK suppress HIV-1 transcription. We transfected Jurkat cells with empty vector, vectors expressing TASK-1, Vpu, or phosphorylation defective Vpu2/6 along with empty vector or RelA(NF-&#x003ba;&#x003b2;) in trans. Vpu2/6 does not cause degradation of I&#x003ba;&#x003b2; and subsequent NF-&#x003ba;&#x003b2; activation. The cells were then infected with either wildtype or integrase defective HIV-1. Thirty hours after infection we isolated RNA for real-time PCR analysis of nef mRNA. Vpu and TASK minimally suppressed transcription of wild type HIV-1 (Figure <xref ref-type=\"fig\" rid=\"F7\">7a</xref>). However, as previously observed, both proteins suppressed transcription of integrase defective HIV-1 (Figure <xref ref-type=\"fig\" rid=\"F7\">7b</xref>). Interestingly, overexpression of RelA reversed the suppression of transcription by both Vpu and TASK proteins in cells infected with integrase-defective HIV-1 (Figure <xref ref-type=\"fig\" rid=\"F7\">7a</xref>, <xref ref-type=\"fig\" rid=\"F7\">7b</xref>, <xref ref-type=\"fig\" rid=\"F7\">7c</xref>). These results show that both Vpu and TASK suppress HIV-1 transcription through an NF&#x003ba;&#x003b2;-dependent mechanism. Our findings are consistent with the findings of Bour et. al. that Vpu inhibits &#x003b2;TrCP-dependent degradation of I&#x003ba;&#x003b2; since phosphorylation defective Vpu2/6, which does not interfere with I&#x003ba;&#x003b2; degradation and subsequent NF-&#x003ba;&#x003b2; activation, did not suppress HIV-1 transcription. Furthermore overexpression of RelA in the presence of Vpu2/6 did not increase nef mRNA as was observed for overexpression of RelA in wildtype Vpu samples.</p><fig id=\"F7\" position=\"float\"><label>Figure 7</label><caption><p><bold>Suppression of HIV-1 transcription by Vpu and TASK-1 is abrogated by overexpression of RelA.</bold> Jurkat cells were transfected with EV, TASK-1 or Vpu or EV + RelA, TASK-1 + RelA or Vpu + RelA and then infected with wildtype NL4-3CFP (<bold>A</bold>) or NL4-3-D116N-YFP (<bold>B</bold>). Twenty four hours after infection the cells were lysed and total RNA was isolated and used as template for real-time PCR to measure nef mRNA. Data shown are normalized to empty vector control (<bold>C</bold>). Transfected Jurkat cells were harvested, lysed and equal amounts of lysate protein were subjected to 4-12% SDS-PAGE. After transfer to nitrocellulose membranes, Vpu, RelA and &#x003b2;-tubulin proteins were revealed by immunoblotting with polyclonal antibodies and visualized by chemilumenescence detection. (* P &#x0003c; .0001; Student T test was used to determine statistical significance).</p></caption><graphic xlink:href=\"1743-422X-9-277-7\"/></fig></sec></sec><sec sec-type=\"discussion\"><title>Discussion</title><p>Hsu et al. showed that a cellular K+ channel TASK-1 is homologous to HIV-1 Vpu and that the first transmembrane domain of TASK-1 was functionally interchangeable with Vpu [<xref ref-type=\"bibr\" rid=\"B34\">34</xref>]. They also observed that TASK-1 was able to inhibit HIV-1 release and appeared to function as an HIV-1 restriction factor. We wanted to follow up on this observation and examine potential mechanisms by which TASK proteins block HIV-1 replication. Using a combination of transfection experiments and infections by wildtype and integrase-defective virus, we obtained data indicating that Vpu and TASK proteins suppress transcription of HIV-1 genes. This effect was preferentially exerted on uDNA. The mechanism by which TASK and Vpu differentially suppress transcription from uDNA is not clear. We showed that the mechanism likely involves NF-&#x003ba;&#x003b2; and it is not clear why this factor would have a differential effect on integrated versus uDNA. It is possible that other critical proteins required for transcription from uDNA but not integrated genomes are either sequestered or degraded in the presence of Vpu or TASK. Integrated HIV DNA as part of the cellular chromatin structure may require a different set of cellular factors for transcription compared to uDNA.</p><p>HIV-1 Vpu is a late gene product expressed after HIV-1 integration when sufficient levels of Rev is present for the production of unspliced and singly spliced genes [<xref ref-type=\"bibr\" rid=\"B41\">41</xref>]. In addition to antagonizing the host protein tetherin, degrading CD4 and enhancing virus release, Vpu decreases both TNF-&#x003b1; and HIV-1-mediated activation of NF-&#x003ba;&#x003b2; by inhibiting &#x003b2;TrCP-dependent degradation of I&#x003ba;&#x003b2; [<xref ref-type=\"bibr\" rid=\"B32\">32</xref>]. Other viral proteins such as Vpr, Tat, and gp120 have also been shown to directly or indirectly affect NF-&#x003ba;&#x003b2; regulation [<xref ref-type=\"bibr\" rid=\"B42\">42</xref>-<xref ref-type=\"bibr\" rid=\"B46\">46</xref>]. Prior to HIV-1 integration, uDNA produce early gene products: nef, rev and tat. After integration of HIV-1 proviral DNA, when sufficient Rev levels are present, Vpu mRNA is translated and the protein accumulates in infected cells. HIV-1 infection causes constitutive activation of NF-&#x003ba;&#x003b2; [<xref ref-type=\"bibr\" rid=\"B47\">47</xref>-<xref ref-type=\"bibr\" rid=\"B49\">49</xref>], a host transcription activator that resides in the cytoplasm complexed to I&#x003ba;&#x003b2;. &#x003b2;TrCP-mediated degradation of I&#x003ba;&#x003b2; frees NF&#x003ba;&#x003b2; to migrate into the nucleus where it can bind a variety of promoters including the HIV-1 LTR. Using immunoprecipitation studies, Hsu et. al demonstrated an association between Vpu, TASK-1 and &#x003b2;TrCP. They also showed that TASK-1 protein is degraded after infection in primary CD4<sup>+</sup> T lymphocytes [<xref ref-type=\"bibr\" rid=\"B34\">34</xref>]. These findings the led authors to speculate that Vpu may mediate the degradation of TASK-1 through the &#x003b2;TrCP ubiquitin ligase pathway similar to Vpu-mediated degradation of CD4 and I&#x003ba;&#x003b2; [<xref ref-type=\"bibr\" rid=\"B32\">32</xref>,<xref ref-type=\"bibr\" rid=\"B34\">34</xref>]. Our findings with both functional and nonfunctional TASK proteins along with the previously described interaction between TASK-1 and &#x003b2;TrCP indicate that TASK-1 and Vpu may share a common mechanism of suppressing HIV-1 transcription: decreased NF-&#x003ba;&#x003b2; activation by inhibiting &#x003b2;TrCP-dependent I&#x003ba;&#x003b2; degradation.</p><p>Bour et al. showed that overexpression of sub-genomic constructs expressing all HIV-1 proteins except Gag and Pol led to a moderate 3-fold activation of NF-&#x003ba;&#x003b2; in the presence of Vpu and a 14-fold enhancement in the absence of Vpu [<xref ref-type=\"bibr\" rid=\"B32\">32</xref>]. Similar results were obtained when full-length HIV-1 constructs were used. Thus Vpu negatively modulates of NF-&#x003ba;&#x003b2; activation and this would lead to lower levels of HIV-1 transcription in some cell types. This data is consistent with results presented here where we demonstrate that suppression of HIV-1 transcription by Vpu and TASK proteins can be abrogated by overexpression of RelA. Interestingly, our results show that Vpu and TASK proteins exert their negative effect on HIV-1 transcription preferentially on uDNA. Our findings are not in conflict with those of Bour et al. since they used largely transfection-based studies to examine the effect of Vpu on NF-&#x003ba;&#x003b2; activation. In such studies, proviral genomes remain unintegrated.</p><p>We also demonstrated that homologous TASK proteins profoundly suppressed HIV-1 transcription. TASK-1 and TASK-3 proteins are constitutively expressed in primary CD4<sup>+</sup> T cells and contribute 40% of the K<sup>+</sup> efflux needed to mediate Ca<sup>2+</sup>-dependent T cell effector function, namely T cell proliferation and the production of IFN&#x003b3; and IL-2 [<xref ref-type=\"bibr\" rid=\"B50\">50</xref>]. IFN&#x003b3; induces TNF&#x003b1; production leading to NF-&#x003ba;&#x003b2; activation and subsequently HIV-1 LTR mediated transcription. T cell effector function is a Ca<sup>2+</sup> dependent immune response that also leads to the destruction of virally infected cells and the priming of neighboring T cells [<xref ref-type=\"bibr\" rid=\"B50\">50</xref>]. TASK-mediated enhancement of Ca<sup>2+</sup>-dependent transcription of cytokines after HIV-1 infection may be a component of the host cell response to restrict HIV-1 replication. Since TASK proteins can suppress HIV-1 transcription and they play a role in generating critical cytokines needed to combat the virus, TASK proteins can be viewed as HIV-1 host restriction factors. This is consistent with the observation that after HIV-1 infection, Vpu leads to the degradation of TASK proteins [<xref ref-type=\"bibr\" rid=\"B34\">34</xref>]. However, modulation of transcription from uDNA may be essential to efficient replication as this function is present in Vpu and therefore maintained by the virus.</p><p>Our data and model are not in conflict with the earlier studies of Wu and others showing efficient expression of early genes from episomal HIV DNA [<xref ref-type=\"bibr\" rid=\"B20\">20</xref>,<xref ref-type=\"bibr\" rid=\"B24\">24</xref>,<xref ref-type=\"bibr\" rid=\"B30\">30</xref>,<xref ref-type=\"bibr\" rid=\"B41\">41</xref>,<xref ref-type=\"bibr\" rid=\"B51\">51</xref>-<xref ref-type=\"bibr\" rid=\"B54\">54</xref>]. In our model, TASK, as a constitutively expressed cellular protein, would suppress expression of early genes from episomal DNA as part of the cellular response to the virus. TASK may represent the natural silencing mechanism and Vpu, which is able to cause degradation of TASK, may represent the virus&#x02019; mechanism for suppressing the cellular response. It is extremely intriguing, that the virus protein that is able to destroy the restricting protein (TASK) has the same activity itself. Thus, initially Vpu&#x02019;s role may be to suppress TASK and then later it suppresses transcription from uDNA after sufficient early gene products have formed to drive expression from integrated DNA.</p></sec><sec sec-type=\"conclusions\"><title>Conclusion</title><p>Our findings have important implications given the increased use of integrase inhibitors in antiretroviral therapy. In the presence of integrase inhibitors uDNA accumulates because more substrates are available for the non-homologous end joining pathways when integration is blocked [<xref ref-type=\"bibr\" rid=\"B55\">55</xref>,<xref ref-type=\"bibr\" rid=\"B56\">56</xref>]. Although uDNA templates are transcriptionally active and can be suppressed by TASK protein, the presence of uDNA prior to integration has been associated with activation and productive infection in resting T-cells via expression of Tat and Nef from uDNA. When HIV-1 integration is blocked CD4, CCR5 and CXCR4 are down regulated by Nef, leading to a restriction of superinfection events [<xref ref-type=\"bibr\" rid=\"B57\">57</xref>-<xref ref-type=\"bibr\" rid=\"B60\">60</xref>]. In addition, HLA molecules recognized by helper [<xref ref-type=\"bibr\" rid=\"B61\">61</xref>] and cytotoxic T-cells are down regulated by Nef while HLA molecules that are recognized by natural killer cells are not affected by Nef [<xref ref-type=\"bibr\" rid=\"B62\">62</xref>-<xref ref-type=\"bibr\" rid=\"B65\">65</xref>]. Therefore early production of Nef from uDNA may be important for immune evasion by HIV-1 [<xref ref-type=\"bibr\" rid=\"B61\">61</xref>]. In non-dividing cells with slower viral replication kinetics, such as macrophages, uDNA is biologically active and very stable. In these cells there is persistent transcription, primarily of early genes, of the uDNA. In infections with integrase defective lentiviral vectors in animal models, reservoirs of uDNA are relatively long lived [<xref ref-type=\"bibr\" rid=\"B66\">66</xref>,<xref ref-type=\"bibr\" rid=\"B67\">67</xref>].</p><p>The regulation of uDNA is important since replication of integrase-defective viruses can be rescued by superinfection with wild type virus [<xref ref-type=\"bibr\" rid=\"B26\">26</xref>,<xref ref-type=\"bibr\" rid=\"B68\">68</xref>]. Vpr promotes transcription from the uDNA, and after integration when Rev protein is present, transcripts from uDNA can be exported from the nucleus and translated. Therefore proteins encoded by uDNA can participate in virion assembly. Both RNA and protein products from uDNA can be packaged into virions, providing an opportunity for recombination and second round infections [<xref ref-type=\"bibr\" rid=\"B68\">68</xref>]. This phenomenon could contribute meaningfully to the genetic diversity of HIV-1.</p></sec><sec sec-type=\"materials|methods\"><title>Materials and methods</title><sec><title>Reagents, plasmids, and antibodies</title><p>TY191F [<xref ref-type=\"bibr\" rid=\"B69\">69</xref>], rodent TASK-1, rodent TASK-3 and IRK-1 expression plasmids were kind gifts from Dr. Douglas Bayliss (University of Virginia Charlottesville, VA). Human TASK-1, human TASK-3 and RelA-myc expression vectors were obtained from Origene (Rockville, MD). The Vpu-eGFP expression vector was a kind gift from Dr. Vasundhara Varthakavi (National Institutes of Health Bethesda, MD). Expression plasmids for codon-optimized Vpu (pcDNA-Vphu), phosphorylation defective mutant pcDNA-Vphu2/6 and a polyclonal antibody to Vpu were generous gifts from Klaus Strebel (National Institutes of Health, Bethesda, MD) and have been described elsewhere [<xref ref-type=\"bibr\" rid=\"B32\">32</xref>]. A monoclonal antibody against HIV-1 Gag (GagM1) was generated in our laboratory. Commercially available antibodies against HIV-1 Gag KC57-RD1 (Beckman Coulter), TASK-1 (Chemicon) and &#x003b2;-tubulin (Santa Cruz Biotechnology) were used for immunoblotting experiments. Secondary antibodies (horseradish peroxidase-conjugated goat anti-rabbit (HRP-GAM), goat anti-mouse H+L (GAMH+L) and Fc&#x003b3; specific (GAMF<sub>c</sub>) were obtained from Jackson ImmunoResearch Laboratories. Cell viability was measured using the Invitrogen fluorescence based LIVE/DEAD cell assay kit.</p></sec><sec><title>Viruses</title><p>HIV-1 was prepared in 293T cells by transfection of plasmid DNA (pNL4-3-CFP and pNL4-3 D116N-YFP (kind gifts from Dr. David Levi) [<xref ref-type=\"bibr\" rid=\"B26\">26</xref>], and pNL4-3, pNL4-3-Udel (kind gift from Dr. Klaus Strebel)) using Lipofectamine (Invitrogen) per the manufacturer\\'s instructions. The supernatants containing virus particles were harvested after 48hr of culture, filtered through a 0.2 micron filter and pelleted through a 20% sucrose cushion (100,000&#x000d7;g, 1hr). All virus preparations were treated with DNase I to remove plasmid DNA.</p></sec><sec><title>Cells</title><p>The Jurkat T cell line was obtained from the American Type Culture Collection (ATCC) and cultured in complete RPMI (cRPMI) (RPMI, 10 mM HEPES, 2 mM L-glutamine, 10% fetal bovine serum (FBS). The JLTRG cell line was obtained from Dr. Olaf Kutsch through the AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH: JLTRG (Cat #11587). HEK 293T cell line was obtained from the ATCC and cultured in complete Dulbecco modified Eagle medium (cDMEM) DMEM, 10 mM HEPES, 2 mM L-glutamine, 10% fetal bovine serum (FBS). Cell viability was assessed by trypan blue exclusion.</p></sec><sec><title>Infections and transfections</title><p>HEK 293T cells were plated in 60-cm dishes (5 &#x000d7; 10<sup>5</sup> cells/2ml) and co-transfected with pNL4-3-Luc and TASK or Vpu cDNA. After washing and 48 hours of culture as above, the cells were lysed and lysates were analyzed for luciferase activity with the Promega luciferase assay kit as per manufacturer&#x02019;s instructions. Jurkat cells were transfected with Vpu-eGFP or TASK-GFP DNA using the human T cell Nucleofector system (Amaxa, Gaithersburg, MD) per the manufacturer\\'s instructions. After 6 hours cells were infected by spinoculation with 50ng of either wildtype NL4-3-CFP or integrase defective NL4-3D116N-YFP virus. Infection and transfection efficiencies were determined by either western blot analysis or flow cytometry. Briefly, for flow cytometry, cells were fixed with 2% paraformaldehyde, permeabilized using 0.1% saponin, and then stained with the mouse KC57-RD1 (anti-Gag) or an isotype-matched control antibody. Stained cells were analyzed on a Beckman FACS Calibur flow cytometer equipped with Cell Quest software. Viral infection and transfection rates were expressed as percentages of cells staining positively with the anti-p24 antibody or expressing CFP, YFP or GFP as appropriate.</p></sec><sec><title>Virus titer determinations</title><p>Two days after transfection with virus DNA constructs, HIV-1 Gag was measured in the cell culture supernatants and cell lysates using a capture ELISA.</p></sec><sec><title>Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblotting</title><p>Cell lysates were prepared by adding RIPA lysis buffer containing protease inhibitor cocktail (Roche) to cell pellets followed by incubation for 30 min on ice. Protein concentrations of cell lysates were determined using a bicinchoninic acid protein assay kit (Pierce-Rockford, IL). Equal amounts of protein were taken up in gel loading buffer and the samples were heated at 70&#x000b0;C for 10 min before loading onto a 4 - 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis gradient gels (NuPAGE Novex Bis-Tris gels; Invitrogen). Proteins were transferred onto a Hybond-P polyvinylidene difluoride membrane (Amersham Biosciences, NJ) following manufacturers protocol. The membranes were blocked in 5% powdered milk in PBS, 0.1% Tween 20 and then probed with TASK-1 (1:1000), Vpu (1:000) or NF-&#x003ba;&#x003b2; (1:500 dilution) for 60 min at 25&#x000b0;C . The membranes were then incubated for 60 min with horseradish peroxidase-conjugated, anti-mouse (1:10,000) or anti-rabbit (1:10,000) immunoglobulin G secondary antibodies (Promega, San Luis Obispo, CA) and developed using Super Signal chemiluminescence (Pierce). Bands were visualized on Denville Scientific film.</p></sec><sec><title>Real-time PCR</title><p>Total RNA was isolated using a Qiagen total RNA purification kit as per manufacturer&#x02019;s instructions. RNA was treated with Qiagen&#x02019;s DNase I and reverse-transcribed using the Invitrogen Superscript cDNA synthesis kit. The cDNA was treated with RNase H and then subjected to real time PCR with HIV-1 gene-specific primers. Real-time PCR conditions and primers to detect HIV-1 Nef-2 mRNA are described in detail elsewhere [<xref ref-type=\"bibr\" rid=\"B70\">70</xref>].</p></sec><sec><title>Statistical analysis</title><p>All experiments were performed three to six times, and representative experiments are shown. The Student <italic>t</italic> test was used to determine the statistical significance of the results.</p></sec></sec><sec><title>Abbreviations</title><p>TASK: Twik-related acid sensitive K channel; Vpu: Viral protein U; uDNA: unintegrated HIV DNA; IRK: inward rectifying K+ channel; NF-&#x003ba;&#x003b2;: nuclear Factor kappa-light-chain-enhancer of activated B cells; I&#x003ba;&#x003b2;: I kappa beta; RelA: NF-&#x003ba;&#x003b2;(p65); &#x003b2;TrCP: beta-transducin repeat containing protein.</p></sec><sec><title>Competing interests</title><p>The authors of this manuscript have not in the past five years received reimbursements, fees, funding, or salary from an organization that may in any way gain or lose financially from the publication of this manuscript, either now or in the future. They do not hold any stocks or shares in an organization that may in any way gain or lose financially from the publication of this manuscript, either now or in the future. They do not hold or are not currently applying for any patents relating to the content of the manuscript. They have not received reimbursements, fees, funding, or salary from an organization that holds or has applied for patents relating to the content of the manuscript. The authors of this manuscript do not have any other financial competing interests. Lastly, the authors of this manuscript do not have any non-financial competing interests (political, personal, religious, academic, ideological, intellectual, commercial or any other) to declare in relation to this manuscript.</p></sec><sec><title>Authors&#x02019; contributions</title><p>NE carried out the transfections, infections, biochemical assays, immunoassays and drafted the manuscript. JH conceived the study, participated in its design and coordination and edited the manuscript. Both authors read and approved the final manuscript.</p></sec></body><back><sec><title>Acknowledgements</title><p>This work was supported grants from NIH R01 HD40772 JEKH and F31 1F31AI081484-01 NE and NIH NCRR U54RR019192.</p></sec><ref-list><ref id=\"B1\"><mixed-citation publication-type=\"journal\"><name><surname>Chun</surname><given-names>TW</given-names></name><name><surname>Carruth</surname><given-names>L</given-names></name><name><surname>Finzi</surname><given-names>D</given-names></name><name><surname>Shen</surname><given-names>X</given-names></name><name><surname>DiGiuseppe</surname><given-names>JA</given-names></name><name><surname>Taylor</surname><given-names>H</given-names></name><name><surname>Hermankova</surname><given-names>M</given-names></name><name><surname>Chadwick</surname><given-names>K</given-names></name><name><surname>Margolick</surname><given-names>J</given-names></name><name><surname>Quinn</surname><given-names>TC</given-names></name><etal/><article-title>Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection</article-title><source>Nature</source><year>1997</year><volume>387</volume><fpage>183</fpage><lpage>188</lpage><pub-id pub-id-type=\"pmid\">9144289</pub-id></mixed-citation></ref><ref id=\"B2\"><mixed-citation publication-type=\"journal\"><name><surname>Sawyer</surname><given-names>SL</given-names></name><name><surname>Malik</surname><given-names>HS</given-names></name><article-title>Positive selection of yeast nonhomologous end-joining genes and a retrotransposon conflict hypothesis</article-title><source>Proc Natl Acad Sci U S A</source><year>2006</year><volume>103</volume><fpage>17614</fpage><lpage>17619</lpage><pub-id pub-id-type=\"pmid\">17101967</pub-id></mixed-citation></ref><ref id=\"B3\"><mixed-citation publication-type=\"journal\"><name><surname>Demogines</surname><given-names>A</given-names></name><name><surname>East</surname><given-names>AM</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Grossman</surname><given-names>SR</given-names></name><name><surname>Sabeti</surname><given-names>PC</given-names></name><name><surname>Paull</surname><given-names>TT</given-names></name><name><surname>Sawyer</surname><given-names>SL</given-names></name><article-title>Ancient and recent adaptive evolution of primate non-homologous end joining genes</article-title><source>PLoS Genet</source><year>2010</year><volume>6</volume><fpage>e1001169</fpage><pub-id pub-id-type=\"pmid\">20975951</pub-id></mixed-citation></ref><ref id=\"B4\"><mixed-citation publication-type=\"journal\"><name><surname>Farnet</surname><given-names>CM</given-names></name><name><surname>Haseltine</surname><given-names>WA</given-names></name><article-title>Circularization of human immunodeficiency virus type 1 DNA in vitro</article-title><source>J Virol</source><year>1991</year><volume>65</volume><fpage>6942</fpage><lpage>6952</lpage><pub-id pub-id-type=\"pmid\">1834863</pub-id></mixed-citation></ref><ref id=\"B5\"><mixed-citation publication-type=\"journal\"><name><surname>Miller</surname><given-names>MD</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Bushman</surname><given-names>FD</given-names></name><article-title>Human immunodeficiency virus type 1 preintegration complexes containing discontinuous plus strands are competent to integrate in vitro</article-title><source>J Virol</source><year>1995</year><volume>69</volume><fpage>3938</fpage><lpage>3944</lpage><pub-id pub-id-type=\"pmid\">7745750</pub-id></mixed-citation></ref><ref id=\"B6\"><mixed-citation publication-type=\"journal\"><name><surname>Bukrinsky</surname><given-names>MI</given-names></name><name><surname>Stanwick</surname><given-names>TL</given-names></name><name><surname>Dempsey</surname><given-names>MP</given-names></name><name><surname>Stevenson</surname><given-names>M</given-names></name><article-title>Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection</article-title><source>Science</source><year>1991</year><volume>254</volume><fpage>423</fpage><lpage>427</lpage><pub-id pub-id-type=\"pmid\">1925601</pub-id></mixed-citation></ref><ref id=\"B7\"><mixed-citation publication-type=\"journal\"><name><surname>Shoemaker</surname><given-names>C</given-names></name><name><surname>Goff</surname><given-names>S</given-names></name><name><surname>Gilboa</surname><given-names>E</given-names></name><name><surname>Paskind</surname><given-names>M</given-names></name><name><surname>Mitra</surname><given-names>SW</given-names></name><name><surname>Baltimore</surname><given-names>D</given-names></name><article-title>Structure of a cloned circular Moloney murine leukemia virus DNA molecule containing an inverted segment: implications for retrovirus integration</article-title><source>Proc Natl Acad Sci U S A</source><year>1980</year><volume>77</volume><fpage>3932</fpage><lpage>3936</lpage><pub-id pub-id-type=\"pmid\">6449003</pub-id></mixed-citation></ref><ref id=\"B8\"><mixed-citation publication-type=\"journal\"><name><surname>Mbisa</surname><given-names>JL</given-names></name><name><surname>Barr</surname><given-names>R</given-names></name><name><surname>Thomas</surname><given-names>JA</given-names></name><name><surname>Vandegraaff</surname><given-names>N</given-names></name><name><surname>Dorweiler</surname><given-names>IJ</given-names></name><name><surname>Svarovskaia</surname><given-names>ES</given-names></name><name><surname>Brown</surname><given-names>WL</given-names></name><name><surname>Mansky</surname><given-names>LM</given-names></name><name><surname>Gorelick</surname><given-names>RJ</given-names></name><name><surname>Harris</surname><given-names>RS</given-names></name><etal/><article-title>Human immunodeficiency virus type 1 cDNAs produced in the presence of APOBEC3G exhibit defects in plus-strand DNA transfer and integration</article-title><source>J Virol</source><year>2007</year><volume>81</volume><fpage>7099</fpage><lpage>7110</lpage><pub-id pub-id-type=\"pmid\">17428871</pub-id></mixed-citation></ref><ref id=\"B9\"><mixed-citation publication-type=\"journal\"><name><surname>Shaw</surname><given-names>GM</given-names></name><name><surname>Hahn</surname><given-names>BH</given-names></name><name><surname>Arya</surname><given-names>SK</given-names></name><name><surname>Groopman</surname><given-names>JE</given-names></name><name><surname>Gallo</surname><given-names>RC</given-names></name><name><surname>Wong-Staal</surname><given-names>F</given-names></name><article-title>Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome</article-title><source>Science</source><year>1984</year><volume>226</volume><fpage>1165</fpage><lpage>1171</lpage><pub-id pub-id-type=\"pmid\">6095449</pub-id></mixed-citation></ref><ref id=\"B10\"><mixed-citation publication-type=\"journal\"><name><surname>Luzuriaga</surname><given-names>K</given-names></name><name><surname>McManus</surname><given-names>M</given-names></name><name><surname>Catalina</surname><given-names>M</given-names></name><name><surname>Mayack</surname><given-names>S</given-names></name><name><surname>Sharkey</surname><given-names>M</given-names></name><name><surname>Stevenson</surname><given-names>M</given-names></name><name><surname>Sullivan</surname><given-names>JL</given-names></name><article-title>Early therapy of vertical human immunodeficiency virus type 1 (HIV-1) infection: control of viral replication and absence of persistent HIV-1-specific immune responses</article-title><source>J Virol</source><year>2000</year><volume>74</volume><fpage>6984</fpage><lpage>6991</lpage><pub-id pub-id-type=\"pmid\">10888637</pub-id></mixed-citation></ref><ref id=\"B11\"><mixed-citation publication-type=\"journal\"><name><surname>Pang</surname><given-names>S</given-names></name><name><surname>Koyanagi</surname><given-names>Y</given-names></name><name><surname>Miles</surname><given-names>S</given-names></name><name><surname>Wiley</surname><given-names>C</given-names></name><name><surname>Vinters</surname><given-names>HV</given-names></name><name><surname>Chen</surname><given-names>IS</given-names></name><article-title>High levels of unintegrated HIV-1 DNA in brain tissue of AIDS dementia patients</article-title><source>Nature</source><year>1990</year><volume>343</volume><fpage>85</fpage><lpage>89</lpage><pub-id pub-id-type=\"pmid\">2296295</pub-id></mixed-citation></ref><ref id=\"B12\"><mixed-citation publication-type=\"journal\"><name><surname>Teo</surname><given-names>I</given-names></name><name><surname>Veryard</surname><given-names>C</given-names></name><name><surname>Barnes</surname><given-names>H</given-names></name><name><surname>An</surname><given-names>SF</given-names></name><name><surname>Jones</surname><given-names>M</given-names></name><name><surname>Lantos</surname><given-names>PL</given-names></name><name><surname>Luthert</surname><given-names>P</given-names></name><name><surname>Shaunak</surname><given-names>S</given-names></name><article-title>Circular forms of unintegrated human immunodeficiency virus type 1 DNA and high levels of viral protein expression: association with dementia and multinucleated giant cells in the brains of patients with AIDS</article-title><source>J Virol</source><year>1997</year><volume>71</volume><fpage>2928</fpage><lpage>2933</lpage><pub-id pub-id-type=\"pmid\">9060651</pub-id></mixed-citation></ref><ref id=\"B13\"><mixed-citation publication-type=\"journal\"><name><surname>Pierson</surname><given-names>TC</given-names></name><name><surname>Kieffer</surname><given-names>TL</given-names></name><name><surname>Ruff</surname><given-names>CT</given-names></name><name><surname>Buck</surname><given-names>C</given-names></name><name><surname>Gange</surname><given-names>SJ</given-names></name><name><surname>Siliciano</surname><given-names>RF</given-names></name><article-title>Intrinsic stability of episomal circles formed during human immunodeficiency virus type 1 replication</article-title><source>J Virol</source><year>2002</year><volume>76</volume><fpage>4138</fpage><lpage>4144</lpage><pub-id pub-id-type=\"pmid\">11907256</pub-id></mixed-citation></ref><ref id=\"B14\"><mixed-citation publication-type=\"journal\"><name><surname>Butler</surname><given-names>SL</given-names></name><name><surname>Johnson</surname><given-names>EP</given-names></name><name><surname>Bushman</surname><given-names>FD</given-names></name><article-title>Human immunodeficiency virus cDNA metabolism: notable stability of two-long terminal repeat circles</article-title><source>J Virol</source><year>2002</year><volume>76</volume><fpage>3739</fpage><lpage>3747</lpage><pub-id pub-id-type=\"pmid\">11907213</pub-id></mixed-citation></ref><ref id=\"B15\"><mixed-citation publication-type=\"journal\"><name><surname>Brussel</surname><given-names>A</given-names></name><name><surname>Mathez</surname><given-names>D</given-names></name><name><surname>Broche-Pierre</surname><given-names>S</given-names></name><name><surname>Lancar</surname><given-names>R</given-names></name><name><surname>Calvez</surname><given-names>T</given-names></name><name><surname>Sonigo</surname><given-names>P</given-names></name><name><surname>Leibowitch</surname><given-names>J</given-names></name><article-title>Longitudinal monitoring of 2-long terminal repeat circles in peripheral blood mononuclear cells from patients with chronic HIV-1 infection</article-title><source>AIDS</source><year>2003</year><volume>17</volume><fpage>645</fpage><lpage>652</lpage><pub-id pub-id-type=\"pmid\">12646786</pub-id></mixed-citation></ref><ref id=\"B16\"><mixed-citation publication-type=\"journal\"><name><surname>Cara</surname><given-names>A</given-names></name><name><surname>Vargas</surname><given-names>J</given-names><suffix>Jr</suffix></name><name><surname>Keller</surname><given-names>M</given-names></name><name><surname>Jones</surname><given-names>S</given-names></name><name><surname>Mosoian</surname><given-names>A</given-names></name><name><surname>Gurtman</surname><given-names>A</given-names></name><name><surname>Cohen</surname><given-names>A</given-names></name><name><surname>Parkas</surname><given-names>V</given-names></name><name><surname>Wallach</surname><given-names>F</given-names></name><name><surname>Chusid</surname><given-names>E</given-names></name><etal/><article-title>Circular viral DNA and anomalous junction sequence in PBMC of HIV-infected individuals with no detectable plasma HIV RNA</article-title><source>Virology</source><year>2002</year><volume>292</volume><fpage>1</fpage><lpage>5</lpage><pub-id pub-id-type=\"pmid\">11878902</pub-id></mixed-citation></ref><ref id=\"B17\"><mixed-citation publication-type=\"journal\"><name><surname>Carr</surname><given-names>JM</given-names></name><name><surname>Cheney</surname><given-names>KM</given-names></name><name><surname>Coolen</surname><given-names>C</given-names></name><name><surname>Davis</surname><given-names>A</given-names></name><name><surname>Shaw</surname><given-names>D</given-names></name><name><surname>Ferguson</surname><given-names>W</given-names></name><name><surname>Chang</surname><given-names>G</given-names></name><name><surname>Higgins</surname><given-names>G</given-names></name><name><surname>Burrell</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><article-title>Development of methods for coordinate measurement of total cell-associated and integrated human immunodeficiency virus type 1 (HIV-1) DNA forms in routine clinical samples: levels are not associated with clinical parameters, but low levels of integrated HIV-1 DNA may be prognostic for continued successful therapy</article-title><source>J Clin Microbiol</source><year>2007</year><volume>45</volume><fpage>1288</fpage><lpage>1297</lpage><pub-id pub-id-type=\"pmid\">17314225</pub-id></mixed-citation></ref><ref id=\"B18\"><mixed-citation publication-type=\"journal\"><name><surname>Sakai</surname><given-names>H</given-names></name><name><surname>Kawamura</surname><given-names>M</given-names></name><name><surname>Sakuragi</surname><given-names>J</given-names></name><name><surname>Sakuragi</surname><given-names>S</given-names></name><name><surname>Shibata</surname><given-names>R</given-names></name><name><surname>Ishimoto</surname><given-names>A</given-names></name><name><surname>Ono</surname><given-names>N</given-names></name><name><surname>Ueda</surname><given-names>S</given-names></name><name><surname>Adachi</surname><given-names>A</given-names></name><article-title>Integration is essential for efficient gene expression of human immunodeficiency virus type 1</article-title><source>J Virol</source><year>1993</year><volume>67</volume><fpage>1169</fpage><lpage>1174</lpage><pub-id pub-id-type=\"pmid\">8437208</pub-id></mixed-citation></ref><ref id=\"B19\"><mixed-citation publication-type=\"journal\"><name><surname>Stevenson</surname><given-names>M</given-names></name><name><surname>Haggerty</surname><given-names>S</given-names></name><name><surname>Lamonica</surname><given-names>CA</given-names></name><name><surname>Meier</surname><given-names>CM</given-names></name><name><surname>Welch</surname><given-names>SK</given-names></name><name><surname>Wasiak</surname><given-names>AJ</given-names></name><article-title>Integration is not necessary for expression of human immunodeficiency virus type 1 protein products</article-title><source>J Virol</source><year>1990</year><volume>64</volume><fpage>2421</fpage><lpage>2425</lpage><pub-id pub-id-type=\"pmid\">2157898</pub-id></mixed-citation></ref><ref id=\"B20\"><mixed-citation publication-type=\"journal\"><name><surname>Wiskerchen</surname><given-names>M</given-names></name><name><surname>Muesing</surname><given-names>MA</given-names></name><article-title>Human immunodeficiency virus type 1 integrase: effects of mutations on viral ability to integrate, direct viral gene expression from unintegrated viral DNA templates, and sustain viral propagation in primary cells</article-title><source>J Virol</source><year>1995</year><volume>69</volume><fpage>376</fpage><lpage>386</lpage><pub-id pub-id-type=\"pmid\">7983732</pub-id></mixed-citation></ref><ref id=\"B21\"><mixed-citation publication-type=\"journal\"><name><surname>Vandegraaff</surname><given-names>N</given-names></name><name><surname>Kumar</surname><given-names>R</given-names></name><name><surname>Burrell</surname><given-names>CJ</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><article-title>Kinetics of human immunodeficiency virus type 1 (HIV) DNA integration in acutely infected cells as determined using a novel assay for detection of integrated HIV DNA</article-title><source>J Virol</source><year>2001</year><volume>75</volume><fpage>11253</fpage><lpage>11260</lpage><pub-id pub-id-type=\"pmid\">11602768</pub-id></mixed-citation></ref><ref id=\"B22\"><mixed-citation publication-type=\"journal\"><name><surname>Robinson</surname><given-names>HL</given-names></name><name><surname>Zinkus</surname><given-names>DM</given-names></name><article-title>Accumulation of human immunodeficiency virus type 1 DNA in T cells: results of multiple infection events</article-title><source>J Virol</source><year>1990</year><volume>64</volume><fpage>4836</fpage><lpage>4841</lpage><pub-id pub-id-type=\"pmid\">2398529</pub-id></mixed-citation></ref><ref id=\"B23\"><mixed-citation publication-type=\"journal\"><name><surname>Swiggard</surname><given-names>WJ</given-names></name><name><surname>O\\'Doherty</surname><given-names>U</given-names></name><name><surname>McGain</surname><given-names>D</given-names></name><name><surname>Jeyakumar</surname><given-names>D</given-names></name><name><surname>Malim</surname><given-names>MH</given-names></name><article-title>Long HIV type 1 reverse transcripts can accumulate stably within resting CD4+ T cells while short ones are degraded</article-title><source>AIDS Res Hum Retroviruses</source><year>2004</year><volume>20</volume><fpage>285</fpage><lpage>295</lpage><pub-id pub-id-type=\"pmid\">15117452</pub-id></mixed-citation></ref><ref id=\"B24\"><mixed-citation publication-type=\"journal\"><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Marsh</surname><given-names>JW</given-names></name><article-title>Selective transcription and modulation of resting T cell activity by preintegrated HIV DNA</article-title><source>Science</source><year>2001</year><volume>293</volume><fpage>1503</fpage><lpage>1506</lpage><pub-id pub-id-type=\"pmid\">11520990</pub-id></mixed-citation></ref><ref id=\"B25\"><mixed-citation publication-type=\"journal\"><name><surname>Kantor</surname><given-names>B</given-names></name><name><surname>Ma</surname><given-names>H</given-names></name><name><surname>Webster-Cyriaque</surname><given-names>J</given-names></name><name><surname>Monahan</surname><given-names>PE</given-names></name><name><surname>Kafri</surname><given-names>T</given-names></name><article-title>Epigenetic activation of unintegrated HIV-1 genomes by gut-associated short chain fatty acids and its implications for HIV infection</article-title><source>Proc Natl Acad Sci U S A</source><year>2009</year><volume>106</volume><fpage>18786</fpage><lpage>18791</lpage><pub-id pub-id-type=\"pmid\">19843699</pub-id></mixed-citation></ref><ref id=\"B26\"><mixed-citation publication-type=\"journal\"><name><surname>Gelderblom</surname><given-names>HC</given-names></name><name><surname>Vatakis</surname><given-names>DN</given-names></name><name><surname>Burke</surname><given-names>SA</given-names></name><name><surname>Lawrie</surname><given-names>SD</given-names></name><name><surname>Bristol</surname><given-names>GC</given-names></name><name><surname>Levy</surname><given-names>DN</given-names></name><article-title>Viral complementation allows HIV-1 replication without integration</article-title><source>Retrovirology</source><year>2008</year><volume>5</volume><fpage>60</fpage><pub-id pub-id-type=\"pmid\">18613957</pub-id></mixed-citation></ref><ref id=\"B27\"><mixed-citation publication-type=\"journal\"><name><surname>Engelman</surname><given-names>A</given-names></name><name><surname>Englund</surname><given-names>G</given-names></name><name><surname>Orenstein</surname><given-names>JM</given-names></name><name><surname>Martin</surname><given-names>MA</given-names></name><name><surname>Craigie</surname><given-names>R</given-names></name><article-title>Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication</article-title><source>J Virol</source><year>1995</year><volume>69</volume><fpage>2729</fpage><lpage>2736</lpage><pub-id pub-id-type=\"pmid\">7535863</pub-id></mixed-citation></ref><ref id=\"B28\"><mixed-citation publication-type=\"journal\"><name><surname>Kelly</surname><given-names>J</given-names></name><name><surname>Beddall</surname><given-names>MH</given-names></name><name><surname>Yu</surname><given-names>D</given-names></name><name><surname>Iyer</surname><given-names>SR</given-names></name><name><surname>Marsh</surname><given-names>JW</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><article-title>Human macrophages support persistent transcription from unintegrated HIV-1 DNA</article-title><source>Virology</source><year>2008</year><volume>372</volume><fpage>300</fpage><lpage>312</lpage><pub-id pub-id-type=\"pmid\">18054979</pub-id></mixed-citation></ref><ref id=\"B29\"><mixed-citation publication-type=\"journal\"><name><surname>Iyer</surname><given-names>SR</given-names></name><name><surname>Yu</surname><given-names>D</given-names></name><name><surname>Biancotto</surname><given-names>A</given-names></name><name><surname>Margolis</surname><given-names>LB</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><article-title>Measurement of human immunodeficiency virus type 1 preintegration transcription by using Rev-dependent Rev-CEM cells reveals a sizable transcribing DNA population comparable to that from proviral templates</article-title><source>J Virol</source><year>2009</year><volume>83</volume><fpage>8662</fpage><lpage>8673</lpage><pub-id pub-id-type=\"pmid\">19553325</pub-id></mixed-citation></ref><ref id=\"B30\"><mixed-citation publication-type=\"journal\"><name><surname>Poon</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>IS</given-names></name><article-title>Human immunodeficiency virus type 1 (HIV-1) Vpr enhances expression from unintegrated HIV-1 DNA</article-title><source>J Virol</source><year>2003</year><volume>77</volume><fpage>3962</fpage><lpage>3972</lpage><pub-id pub-id-type=\"pmid\">12634356</pub-id></mixed-citation></ref><ref id=\"B31\"><mixed-citation publication-type=\"journal\"><name><surname>Klimkait</surname><given-names>T</given-names></name><name><surname>Strebel</surname><given-names>K</given-names></name><name><surname>Hoggan</surname><given-names>MD</given-names></name><name><surname>Martin</surname><given-names>MA</given-names></name><name><surname>Orenstein</surname><given-names>JM</given-names></name><article-title>The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release</article-title><source>J Virol</source><year>1990</year><volume>64</volume><fpage>621</fpage><lpage>629</lpage><pub-id pub-id-type=\"pmid\">2404139</pub-id></mixed-citation></ref><ref id=\"B32\"><mixed-citation publication-type=\"journal\"><name><surname>Bour</surname><given-names>S</given-names></name><name><surname>Perrin</surname><given-names>C</given-names></name><name><surname>Akari</surname><given-names>H</given-names></name><name><surname>Strebel</surname><given-names>K</given-names></name><article-title>The human immunodeficiency virus type 1 Vpu protein inhibits NF-kappa B activation by interfering with beta TrCP-mediated degradation of Ikappa B</article-title><source>J Biol Chem</source><year>2001</year><volume>276</volume><fpage>15920</fpage><lpage>15928</lpage><pub-id pub-id-type=\"pmid\">11278695</pub-id></mixed-citation></ref><ref id=\"B33\"><mixed-citation publication-type=\"journal\"><name><surname>Strebel</surname><given-names>K</given-names></name><name><surname>Klimkait</surname><given-names>T</given-names></name><name><surname>Maldarelli</surname><given-names>F</given-names></name><name><surname>Martin</surname><given-names>MA</given-names></name><article-title>Molecular and biochemical analyses of human immunodeficiency virus type 1 vpu protein</article-title><source>J Virol</source><year>1989</year><volume>63</volume><fpage>3784</fpage><lpage>3791</lpage><pub-id pub-id-type=\"pmid\">2788224</pub-id></mixed-citation></ref><ref id=\"B34\"><mixed-citation publication-type=\"journal\"><name><surname>Hsu</surname><given-names>K</given-names></name><name><surname>Seharaseyon</surname><given-names>J</given-names></name><name><surname>Dong</surname><given-names>P</given-names></name><name><surname>Bour</surname><given-names>S</given-names></name><name><surname>Marban</surname><given-names>E</given-names></name><article-title>Mutual functional destruction of HIV-1 Vpu and host TASK-1 channel</article-title><source>Mol Cell</source><year>2004</year><volume>14</volume><fpage>259</fpage><lpage>267</lpage><pub-id pub-id-type=\"pmid\">15099524</pub-id></mixed-citation></ref><ref id=\"B35\"><mixed-citation publication-type=\"journal\"><name><surname>Neil</surname><given-names>SJ</given-names></name><name><surname>Zang</surname><given-names>T</given-names></name><name><surname>Bieniasz</surname><given-names>PD</given-names></name><article-title>Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu</article-title><source>Nature</source><year>2008</year><volume>451</volume><fpage>425</fpage><lpage>430</lpage><pub-id pub-id-type=\"pmid\">18200009</pub-id></mixed-citation></ref><ref id=\"B36\"><mixed-citation publication-type=\"journal\"><name><surname>Czirjak</surname><given-names>G</given-names></name><name><surname>Enyedi</surname><given-names>P</given-names></name><article-title>Formation of functional heterodimers between the TASK-1 and TASK-3 two-pore domain potassium channel subunits</article-title><source>J Biol Chem</source><year>2002</year><volume>277</volume><fpage>5426</fpage><lpage>5432</lpage><pub-id pub-id-type=\"pmid\">11733509</pub-id></mixed-citation></ref><ref id=\"B37\"><mixed-citation publication-type=\"journal\"><name><surname>Bolduan</surname><given-names>S</given-names></name><name><surname>Votteler</surname><given-names>J</given-names></name><name><surname>Lodermeyer</surname><given-names>V</given-names></name><name><surname>Greiner</surname><given-names>T</given-names></name><name><surname>Koppensteiner</surname><given-names>H</given-names></name><name><surname>Schindler</surname><given-names>M</given-names></name><name><surname>Thiel</surname><given-names>G</given-names></name><name><surname>Schubert</surname><given-names>U</given-names></name><article-title>Ion channel activity of HIV-1 Vpu is dispensable for counteraction of CD317</article-title><source>Virology</source><year>2011</year><volume>416</volume><fpage>75</fpage><lpage>85</lpage><pub-id pub-id-type=\"pmid\">21601230</pub-id></mixed-citation></ref><ref id=\"B38\"><mixed-citation publication-type=\"journal\"><name><surname>Ewart</surname><given-names>GD</given-names></name><name><surname>Sutherland</surname><given-names>T</given-names></name><name><surname>Gage</surname><given-names>PW</given-names></name><name><surname>Cox</surname><given-names>GB</given-names></name><article-title>The Vpu protein of human immunodeficiency virus type 1 forms cation-selective ion channels</article-title><source>J Virol</source><year>1996</year><volume>70</volume><fpage>7108</fpage><lpage>7115</lpage><pub-id pub-id-type=\"pmid\">8794357</pub-id></mixed-citation></ref><ref id=\"B39\"><mixed-citation publication-type=\"journal\"><name><surname>Hegle</surname><given-names>AP</given-names></name><name><surname>Marble</surname><given-names>DD</given-names></name><name><surname>Wilson</surname><given-names>GF</given-names></name><article-title>A voltage-driven switch for ion-independent signaling by ether-a-go-go K+ channels</article-title><source>Proc Natl Acad Sci U S A</source><year>2006</year><volume>103</volume><fpage>2886</fpage><lpage>2891</lpage><pub-id pub-id-type=\"pmid\">16477030</pub-id></mixed-citation></ref><ref id=\"B40\"><mixed-citation publication-type=\"journal\"><name><surname>Ashmole</surname><given-names>I</given-names></name><name><surname>Goodwin</surname><given-names>PA</given-names></name><name><surname>Stanfield</surname><given-names>PR</given-names></name><article-title>TASK-5, a novel member of the tandem pore K+ channel family</article-title><source>Pflugers Arch</source><year>2001</year><volume>442</volume><fpage>828</fpage><lpage>833</lpage><pub-id pub-id-type=\"pmid\">11680614</pub-id></mixed-citation></ref><ref id=\"B41\"><mixed-citation publication-type=\"journal\"><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Marsh</surname><given-names>JW</given-names></name><article-title>Early transcription from nonintegrated DNA in human immunodeficiency virus infection</article-title><source>J Virol</source><year>2003</year><volume>77</volume><fpage>10376</fpage><lpage>10382</lpage><pub-id pub-id-type=\"pmid\">12970422</pub-id></mixed-citation></ref><ref id=\"B42\"><mixed-citation publication-type=\"journal\"><name><surname>Roux</surname><given-names>P</given-names></name><name><surname>Alfieri</surname><given-names>C</given-names></name><name><surname>Hrimech</surname><given-names>M</given-names></name><name><surname>Cohen</surname><given-names>EA</given-names></name><name><surname>Tanner</surname><given-names>JE</given-names></name><article-title>Activation of transcription factors NF-kappaB and NF-IL-6 by human immunodeficiency virus type 1 protein R (Vpr) induces interleukin-8 expression</article-title><source>J Virol</source><year>2000</year><volume>74</volume><fpage>4658</fpage><lpage>4665</lpage><pub-id pub-id-type=\"pmid\">10775602</pub-id></mixed-citation></ref><ref id=\"B43\"><mixed-citation publication-type=\"journal\"><name><surname>Felzien</surname><given-names>LK</given-names></name><name><surname>Woffendin</surname><given-names>C</given-names></name><name><surname>Hottiger</surname><given-names>MO</given-names></name><name><surname>Subbramanian</surname><given-names>RA</given-names></name><name><surname>Cohen</surname><given-names>EA</given-names></name><name><surname>Nabel</surname><given-names>GJ</given-names></name><article-title>HIV transcriptional activation by the accessory protein, VPR, is mediated by the p300 co-activator</article-title><source>Proc Natl Acad Sci U S A</source><year>1998</year><volume>95</volume><fpage>5281</fpage><lpage>5286</lpage><pub-id pub-id-type=\"pmid\">9560267</pub-id></mixed-citation></ref><ref id=\"B44\"><mixed-citation publication-type=\"journal\"><name><surname>Demarchi</surname><given-names>F</given-names></name><name><surname>Gutierrez</surname><given-names>MI</given-names></name><name><surname>Giacca</surname><given-names>M</given-names></name><article-title>Human immunodeficiency virus type 1 tat protein activates transcription factor NF-kappaB through the cellular interferon-inducible, double-stranded RNA-dependent protein kinase, PKR</article-title><source>J Virol</source><year>1999</year><volume>73</volume><fpage>7080</fpage><lpage>7086</lpage><pub-id pub-id-type=\"pmid\">10400814</pub-id></mixed-citation></ref><ref id=\"B45\"><mixed-citation publication-type=\"journal\"><name><surname>Clouse</surname><given-names>KA</given-names></name><name><surname>Cosentino</surname><given-names>LM</given-names></name><name><surname>Weih</surname><given-names>KA</given-names></name><name><surname>Pyle</surname><given-names>SW</given-names></name><name><surname>Robbins</surname><given-names>PB</given-names></name><name><surname>Hochstein</surname><given-names>HD</given-names></name><name><surname>Natarajan</surname><given-names>V</given-names></name><name><surname>Farrar</surname><given-names>WL</given-names></name><article-title>The HIV-1 gp120 envelope protein has the intrinsic capacity to stimulate monokine secretion</article-title><source>J Immunol</source><year>1991</year><volume>147</volume><fpage>2892</fpage><lpage>2901</lpage><pub-id pub-id-type=\"pmid\">1918997</pub-id></mixed-citation></ref><ref id=\"B46\"><mixed-citation publication-type=\"journal\"><name><surname>Hofman</surname><given-names>FM</given-names></name><name><surname>Wright</surname><given-names>AD</given-names></name><name><surname>Dohadwala</surname><given-names>MM</given-names></name><name><surname>Wong-Staal</surname><given-names>F</given-names></name><name><surname>Walker</surname><given-names>SM</given-names></name><article-title>Exogenous tat protein activates human endothelial cells</article-title><source>Blood</source><year>1993</year><volume>82</volume><fpage>2774</fpage><lpage>2780</lpage><pub-id pub-id-type=\"pmid\">7693046</pub-id></mixed-citation></ref><ref id=\"B47\"><mixed-citation publication-type=\"journal\"><name><surname>DeLuca</surname><given-names>C</given-names></name><name><surname>Roulston</surname><given-names>A</given-names></name><name><surname>Koromilas</surname><given-names>A</given-names></name><name><surname>Wainberg</surname><given-names>MA</given-names></name><name><surname>Hiscott</surname><given-names>J</given-names></name><article-title>Chronic human immunodeficiency virus type 1 infection of myeloid cells disrupts the autoregulatory control of the NF-kappaB/Rel pathway via enhanced IkappaBalpha degradation</article-title><source>J Virol</source><year>1996</year><volume>70</volume><fpage>5183</fpage><lpage>5193</lpage><pub-id pub-id-type=\"pmid\">8764027</pub-id></mixed-citation></ref><ref id=\"B48\"><mixed-citation publication-type=\"journal\"><name><surname>Asin</surname><given-names>S</given-names></name><name><surname>Taylor</surname><given-names>JA</given-names></name><name><surname>Trushin</surname><given-names>S</given-names></name><name><surname>Bren</surname><given-names>G</given-names></name><name><surname>Paya</surname><given-names>CV</given-names></name><article-title>Ikappakappa mediates NF-kappaB activation in human immunodeficiency virus-infected cells</article-title><source>J Virol</source><year>1999</year><volume>73</volume><fpage>3893</fpage><lpage>3903</lpage><pub-id pub-id-type=\"pmid\">10196284</pub-id></mixed-citation></ref><ref id=\"B49\"><mixed-citation publication-type=\"journal\"><name><surname>DeLuca</surname><given-names>C</given-names></name><name><surname>Petropoulos</surname><given-names>L</given-names></name><name><surname>Zmeureanu</surname><given-names>D</given-names></name><name><surname>Hiscott</surname><given-names>J</given-names></name><article-title>Nuclear IkappaBbeta maintains persistent NF-kappaB activation in HIV-1-infected myeloid cells</article-title><source>J Biol Chem</source><year>1999</year><volume>274</volume><fpage>13010</fpage><lpage>13016</lpage><pub-id pub-id-type=\"pmid\">10224051</pub-id></mixed-citation></ref><ref id=\"B50\"><mixed-citation publication-type=\"journal\"><name><surname>Meuth</surname><given-names>SG</given-names></name><name><surname>Bittner</surname><given-names>S</given-names></name><name><surname>Meuth</surname><given-names>P</given-names></name><name><surname>Simon</surname><given-names>OJ</given-names></name><name><surname>Budde</surname><given-names>T</given-names></name><name><surname>Wiendl</surname><given-names>H</given-names></name><article-title>TWIK-related acid-sensitive K+ channel 1 (TASK1) and TASK3 critically influence T lymphocyte effector functions</article-title><source>J Biol Chem</source><year>2008</year><volume>283</volume><fpage>14559</fpage><lpage>14570</lpage><pub-id pub-id-type=\"pmid\">18375952</pub-id></mixed-citation></ref><ref id=\"B51\"><mixed-citation publication-type=\"journal\"><name><surname>Cara</surname><given-names>A</given-names></name><name><surname>Guarnaccia</surname><given-names>F</given-names></name><name><surname>Reitz</surname><given-names>MS</given-names></name><name><surname>Gallo</surname><given-names>RC</given-names></name><name><surname>Lori</surname><given-names>F</given-names></name><article-title>Self-limiting, cell type-dependent replication of an integrase-defective human immunodeficiency virus type 1 in human primary macrophages but not T lymphocytes</article-title><source>Virology</source><year>1995</year><volume>208</volume><fpage>242</fpage><lpage>248</lpage><pub-id pub-id-type=\"pmid\">11831706</pub-id></mixed-citation></ref><ref id=\"B52\"><mixed-citation publication-type=\"journal\"><name><surname>Lu</surname><given-names>R</given-names></name><name><surname>Nakajima</surname><given-names>N</given-names></name><name><surname>Hofmann</surname><given-names>W</given-names></name><name><surname>Benkirane</surname><given-names>M</given-names></name><name><surname>Jeang</surname><given-names>KT</given-names></name><name><surname>Sodroski</surname><given-names>J</given-names></name><name><surname>Engelman</surname><given-names>A</given-names></name><article-title>Simian virus 40-based replication of catalytically inactive human immunodeficiency virus type 1 integrase mutants in nonpermissive T cells and monocyte-derived macrophages</article-title><source>J Virol</source><year>2004</year><volume>78</volume><fpage>658</fpage><lpage>668</lpage><pub-id pub-id-type=\"pmid\">14694097</pub-id></mixed-citation></ref><ref id=\"B53\"><mixed-citation publication-type=\"journal\"><name><surname>Nakajima</surname><given-names>N</given-names></name><name><surname>Lu</surname><given-names>R</given-names></name><name><surname>Engelman</surname><given-names>A</given-names></name><article-title>Human immunodeficiency virus type 1 replication in the absence of integrase-mediated dna recombination: definition of permissive and nonpermissive T-cell lines</article-title><source>J Virol</source><year>2001</year><volume>75</volume><fpage>7944</fpage><lpage>7955</lpage><pub-id pub-id-type=\"pmid\">11483739</pub-id></mixed-citation></ref><ref id=\"B54\"><mixed-citation publication-type=\"journal\"><name><surname>Stevenson</surname><given-names>M</given-names></name><name><surname>Stanwick</surname><given-names>TL</given-names></name><name><surname>Dempsey</surname><given-names>MP</given-names></name><name><surname>Lamonica</surname><given-names>CA</given-names></name><article-title>HIV-1 replication is controlled at the level of T cell activation and proviral integration</article-title><source>EMBO J</source><year>1990</year><volume>9</volume><fpage>1551</fpage><lpage>1560</lpage><pub-id pub-id-type=\"pmid\">2184033</pub-id></mixed-citation></ref><ref id=\"B55\"><mixed-citation publication-type=\"journal\"><name><surname>Kilzer</surname><given-names>JM</given-names></name><name><surname>Stracker</surname><given-names>T</given-names></name><name><surname>Beitzel</surname><given-names>B</given-names></name><name><surname>Meek</surname><given-names>K</given-names></name><name><surname>Weitzman</surname><given-names>M</given-names></name><name><surname>Bushman</surname><given-names>FD</given-names></name><article-title>Roles of host cell factors in circularization of retroviral dna</article-title><source>Virology</source><year>2003</year><volume>314</volume><fpage>460</fpage><lpage>467</lpage><pub-id pub-id-type=\"pmid\">14517098</pub-id></mixed-citation></ref><ref id=\"B56\"><mixed-citation publication-type=\"journal\"><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Ao</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Jayappa</surname><given-names>KD</given-names></name><name><surname>Yao</surname><given-names>X</given-names></name><article-title>Host protein Ku70 binds and protects HIV-1 integrase from proteasomal degradation and is required for HIV replication</article-title><source>J Biol Chem</source><year>2011</year><volume>286</volume><fpage>17722</fpage><lpage>17735</lpage><pub-id pub-id-type=\"pmid\">21454661</pub-id></mixed-citation></ref><ref id=\"B57\"><mixed-citation publication-type=\"journal\"><name><surname>Michel</surname><given-names>N</given-names></name><name><surname>Allespach</surname><given-names>I</given-names></name><name><surname>Venzke</surname><given-names>S</given-names></name><name><surname>Fackler</surname><given-names>OT</given-names></name><name><surname>Keppler</surname><given-names>OT</given-names></name><article-title>The Nef protein of human immunodeficiency virus establishes superinfection immunity by a dual strategy to downregulate cell-surface CCR5 and CD4</article-title><source>Curr Biol</source><year>2005</year><volume>15</volume><fpage>714</fpage><lpage>723</lpage><pub-id pub-id-type=\"pmid\">15854903</pub-id></mixed-citation></ref><ref id=\"B58\"><mixed-citation publication-type=\"journal\"><name><surname>Venzke</surname><given-names>S</given-names></name><name><surname>Michel</surname><given-names>N</given-names></name><name><surname>Allespach</surname><given-names>I</given-names></name><name><surname>Fackler</surname><given-names>OT</given-names></name><name><surname>Keppler</surname><given-names>OT</given-names></name><article-title>Expression of Nef downregulates CXCR4, the major coreceptor of human immunodeficiency virus, from the surfaces of target cells and thereby enhances resistance to superinfection</article-title><source>J Virol</source><year>2006</year><volume>80</volume><fpage>11141</fpage><lpage>11152</lpage><pub-id pub-id-type=\"pmid\">16928758</pub-id></mixed-citation></ref><ref id=\"B59\"><mixed-citation publication-type=\"journal\"><name><surname>Wildum</surname><given-names>S</given-names></name><name><surname>Schindler</surname><given-names>M</given-names></name><name><surname>Munch</surname><given-names>J</given-names></name><name><surname>Kirchhoff</surname><given-names>F</given-names></name><article-title>Contribution of Vpu, Env, and Nef to CD4 down-modulation and resistance of human immunodeficiency virus type 1-infected T cells to superinfection</article-title><source>J Virol</source><year>2006</year><volume>80</volume><fpage>8047</fpage><lpage>8059</lpage><pub-id pub-id-type=\"pmid\">16873261</pub-id></mixed-citation></ref><ref id=\"B60\"><mixed-citation publication-type=\"journal\"><name><surname>Sloan</surname><given-names>RD</given-names></name><name><surname>Donahue</surname><given-names>DA</given-names></name><name><surname>Kuhl</surname><given-names>BD</given-names></name><name><surname>Bar-Magen</surname><given-names>T</given-names></name><name><surname>Wainberg</surname><given-names>MA</given-names></name><article-title>Expression of Nef from unintegrated HIV-1 DNA downregulates cell surface CXCR4 and CCR5 on T-lymphocytes</article-title><source>Retrovirology</source><year>2010</year><volume>7</volume><fpage>44</fpage><pub-id pub-id-type=\"pmid\">20465832</pub-id></mixed-citation></ref><ref id=\"B61\"><mixed-citation publication-type=\"journal\"><name><surname>Sloan</surname><given-names>RD</given-names></name><name><surname>Kuhl</surname><given-names>BD</given-names></name><name><surname>Donahue</surname><given-names>DA</given-names></name><name><surname>Roland</surname><given-names>A</given-names></name><name><surname>Bar-Magen</surname><given-names>T</given-names></name><name><surname>Wainberg</surname><given-names>MA</given-names></name><article-title>Transcription of preintegrated HIV-1 cDNA modulates cell surface expression of major histocompatibility complex class I via Nef</article-title><source>J Virol</source><year>2011</year><volume>85</volume><fpage>2828</fpage><lpage>2836</lpage><pub-id pub-id-type=\"pmid\">21209113</pub-id></mixed-citation></ref><ref id=\"B62\"><mixed-citation publication-type=\"journal\"><name><surname>Cohen</surname><given-names>GB</given-names></name><name><surname>Gandhi</surname><given-names>RT</given-names></name><name><surname>Davis</surname><given-names>DM</given-names></name><name><surname>Mandelboim</surname><given-names>O</given-names></name><name><surname>Chen</surname><given-names>BK</given-names></name><name><surname>Strominger</surname><given-names>JL</given-names></name><name><surname>Baltimore</surname><given-names>D</given-names></name><article-title>The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells</article-title><source>Immunity</source><year>1999</year><volume>10</volume><fpage>661</fpage><lpage>671</lpage><pub-id pub-id-type=\"pmid\">10403641</pub-id></mixed-citation></ref><ref id=\"B63\"><mixed-citation publication-type=\"journal\"><name><surname>Collins</surname><given-names>KL</given-names></name><name><surname>Chen</surname><given-names>BK</given-names></name><name><surname>Kalams</surname><given-names>SA</given-names></name><name><surname>Walker</surname><given-names>BD</given-names></name><name><surname>Baltimore</surname><given-names>D</given-names></name><article-title>HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes</article-title><source>Nature</source><year>1998</year><volume>391</volume><fpage>397</fpage><lpage>401</lpage><pub-id pub-id-type=\"pmid\">9450757</pub-id></mixed-citation></ref><ref id=\"B64\"><mixed-citation publication-type=\"journal\"><name><surname>Cocchi</surname><given-names>F</given-names></name><name><surname>DeVico</surname><given-names>AL</given-names></name><name><surname>Garzino-Demo</surname><given-names>A</given-names></name><name><surname>Arya</surname><given-names>SK</given-names></name><name><surname>Gallo</surname><given-names>RC</given-names></name><name><surname>Lusso</surname><given-names>P</given-names></name><article-title>Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells</article-title><source>Science</source><year>1995</year><volume>270</volume><fpage>1811</fpage><lpage>1815</lpage><pub-id pub-id-type=\"pmid\">8525373</pub-id></mixed-citation></ref><ref id=\"B65\"><mixed-citation publication-type=\"journal\"><name><surname>Schwartz</surname><given-names>O</given-names></name><name><surname>Marechal</surname><given-names>V</given-names></name><name><surname>Le Gall</surname><given-names>S</given-names></name><name><surname>Lemonnier</surname><given-names>F</given-names></name><name><surname>Heard</surname><given-names>JM</given-names></name><article-title>Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein</article-title><source>Nat Med</source><year>1996</year><volume>2</volume><fpage>338</fpage><lpage>342</lpage><pub-id pub-id-type=\"pmid\">8612235</pub-id></mixed-citation></ref><ref id=\"B66\"><mixed-citation publication-type=\"journal\"><name><surname>Yanez-Munoz</surname><given-names>RJ</given-names></name><name><surname>Balaggan</surname><given-names>KS</given-names></name><name><surname>MacNeil</surname><given-names>A</given-names></name><name><surname>Howe</surname><given-names>SJ</given-names></name><name><surname>Schmidt</surname><given-names>M</given-names></name><name><surname>Smith</surname><given-names>AJ</given-names></name><name><surname>Buch</surname><given-names>P</given-names></name><name><surname>MacLaren</surname><given-names>RE</given-names></name><name><surname>Anderson</surname><given-names>PN</given-names></name><name><surname>Barker</surname><given-names>SE</given-names></name><etal/><article-title>Effective gene therapy with nonintegrating lentiviral vectors</article-title><source>Nat Med</source><year>2006</year><volume>12</volume><fpage>348</fpage><lpage>353</lpage><pub-id pub-id-type=\"pmid\">16491086</pub-id></mixed-citation></ref><ref id=\"B67\"><mixed-citation publication-type=\"journal\"><name><surname>Philippe</surname><given-names>S</given-names></name><name><surname>Sarkis</surname><given-names>C</given-names></name><name><surname>Barkats</surname><given-names>M</given-names></name><name><surname>Mammeri</surname><given-names>H</given-names></name><name><surname>Ladroue</surname><given-names>C</given-names></name><name><surname>Petit</surname><given-names>C</given-names></name><name><surname>Mallet</surname><given-names>J</given-names></name><name><surname>Serguera</surname><given-names>C</given-names></name><article-title>Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo</article-title><source>Proc Natl Acad Sci U S A</source><year>2006</year><volume>103</volume><fpage>17684</fpage><lpage>17689</lpage><pub-id pub-id-type=\"pmid\">17095605</pub-id></mixed-citation></ref><ref id=\"B68\"><mixed-citation publication-type=\"journal\"><name><surname>Wu</surname><given-names>Y</given-names></name><article-title>The second chance story of HIV-1 DNA: Unintegrated? Not a problem!</article-title><source>Retrovirology</source><year>2008</year><volume>5</volume><fpage>61</fpage><pub-id pub-id-type=\"pmid\">18613958</pub-id></mixed-citation></ref><ref id=\"B69\"><mixed-citation publication-type=\"journal\"><name><surname>Berg</surname><given-names>AP</given-names></name><name><surname>Talley</surname><given-names>EM</given-names></name><name><surname>Manger</surname><given-names>JP</given-names></name><name><surname>Bayliss</surname><given-names>DA</given-names></name><article-title>Motoneurons express heteromeric TWIK-related acid-sensitive K+ (TASK) channels containing TASK-1 (KCNK3) and TASK-3 (KCNK9) subunits</article-title><source>J Neurosci</source><year>2004</year><volume>24</volume><fpage>6693</fpage><lpage>6702</lpage><pub-id pub-id-type=\"pmid\">15282272</pub-id></mixed-citation></ref><ref id=\"B70\"><mixed-citation publication-type=\"journal\"><name><surname>Dowling</surname><given-names>D</given-names></name><name><surname>Nasr-Esfahani</surname><given-names>S</given-names></name><name><surname>Tan</surname><given-names>CH</given-names></name><name><surname>O\\'Brien</surname><given-names>K</given-names></name><name><surname>Howard</surname><given-names>JL</given-names></name><name><surname>Jans</surname><given-names>DA</given-names></name><name><surname>Purcell</surname><given-names>DF</given-names></name><name><surname>Stoltzfus</surname><given-names>CM</given-names></name><name><surname>Sonza</surname><given-names>S</given-names></name><article-title>HIV-1 infection induces changes in expression of cellular splicing factors that regulate alternative viral splicing and virus production in macrophages</article-title><source>Retrovirology</source><year>2008</year><volume>5</volume><fpage>18</fpage><pub-id pub-id-type=\"pmid\">18241354</pub-id></mixed-citation></ref></ref-list></back></article>',\n",
       " 'Assignment of the 2P domain, acid-sensitive potassium channel OAT1 gene KCNK3 to human chromosome bands 2p24.1-->p23.3 and murine 5B by in situ hybridization.',\n",
       " 'In this work, the distributions of some acid-sensitive two-pore-domain K+ channels (TASK-1, TASK-2 and TASK-3) were investigated in the rat and human cerebellum. Astrocytes situated in rat cerebellar tissue sections were positive for TASK-2 channels. Purkinje cells were strongly stained and granule cells and astrocytes were moderately positive for TASK-3. Astrocytes isolated from the hippocampus, cerebellum and cochlear nucleus expressed TASK channels in a primary tissue culture. Our results suggest that TASK channel expression may be significant in the endoplasmic reticulum of the astrocytes. The human cerebellum showed weak TASK-2 immunolabelling. The pia mater, astrocytes, Purkinje and granule cells demonstrated strong TASK-1 and TASK-3 positivities. The TASK-3 labelling was stronger in general, but it was particularly intense in the Purkinje cells and pia mater.',\n",
       " '<full-text-retrieval-response xmlns=\"http://www.elsevier.com/xml/svapi/article/dtd\" xmlns:bk=\"http://www.elsevier.com/xml/bk/dtd\" xmlns:cals=\"http://www.elsevier.com/xml/common/cals/dtd\" xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns:ja=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" xmlns:tb=\"http://www.elsevier.com/xml/common/table/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:xocs=\"http://www.elsevier.com/xml/xocs/dtd\" xmlns:dc=\"http://purl.org/dc/elements/1.1/\" xmlns:dcterms=\"http://purl.org/dc/terms/\" xmlns:prism=\"http://prismstandard.org/namespaces/basic/2.0/\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\"><coredata><prism:url>https://api.elsevier.com/content/article/pii/S0092867402010401</prism:url><dc:identifier>doi:10.1016/S0092-8674(02)01040-1</dc:identifier><eid>1-s2.0-S0092867402010401</eid><prism:doi>10.1016/S0092-8674(02)01040-1</prism:doi><pii>S0092-8674(02)01040-1</pii><dc:title>Forward Transport 14-3-3 Binding Overcomes Retention in Endoplasmic Reticulum by Dibasic Signals</dc:title><prism:publicationName>Cell</prism:publicationName><prism:aggregationType>Journal</prism:aggregationType><pubType>\\n               Aritcle\\n            </pubType><prism:issn>00928674</prism:issn><prism:volume>111</prism:volume><prism:issueIdentifier>4</prism:issueIdentifier><prism:startingPage>577</prism:startingPage><prism:endingPage>588</prism:endingPage><prism:pageRange>577-588</prism:pageRange><prism:number>4</prism:number><dc:format>text/xml</dc:format><prism:coverDate>2002-11-15</prism:coverDate><prism:coverDisplayDate>15 November 2002</prism:coverDisplayDate><prism:copyright>Copyright © 2002 Cell Press.  All rights reserved.</prism:copyright><prism:publisher>Cell Press.</prism:publisher><dc:creator>O\\'Kelly, Ita</dc:creator><dc:creator>Butler, Margaret H.</dc:creator><dc:creator>Zilberberg, Noam</dc:creator><dc:creator>Goldstein, Steve A.N.</dc:creator><dc:description>\\n               Abstract\\n               \\n                  Proteins with dibasic retention motifs are subject to retrograde transport to endoplasmic reticulum (ER) by COPI-coated vesicles. As forward transport requires escape from ER retention, general release mechanisms have been expected. Here, KCNK3 potassium channels are shown to bear two cytoplasmic trafficking motifs: an N-terminal dibasic site that binds β-COP to hold channels in ER and a C-terminal “release” site that binds the ubiquitous intracellular regulator 14-3-3β on a nonclassical motif in a phosphorylation-dependent fashion to suppress β-COP binding and allow forward transport. The strategy appears to be common. The major histocompatibility antigen class II-associated invariant chain Iip35 exhibits dibasic retention, carries a release motif, and shows mutually exclusive binding of β-COP and 14-3-3β on adjacent N-terminal sites. Other retained proteins are demonstrated to carry functional 14-3-3β release motifs.\\n               \\n            </dc:description><openaccess>1</openaccess><openaccessArticle>true</openaccessArticle><openaccessType>Full</openaccessType><openArchiveArticle>true</openArchiveArticle><openaccessSponsorName/><openaccessSponsorType>ElsevierBranded</openaccessSponsorType><openaccessUserLicense>http://www.elsevier.com/open-access/userlicense/1.0/</openaccessUserLicense><link href=\"https://api.elsevier.com/content/article/pii/S0092867402010401\" rel=\"self\"/><link href=\"https://www.sciencedirect.com/science/article/pii/S0092867402010401\" rel=\"scidir\"/></coredata><objects><object ref=\"si5\" category=\"thumbnail\" type=\"ALTIMG\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"34\" height=\"13\" size=\"264\">https://api.elsevier.com/content/object/eid/1-s2.0-S0092867402010401-si5.gif?httpAccept=%2A%2F%2A</object><object ref=\"si4\" category=\"thumbnail\" type=\"ALTIMG\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"21\" height=\"18\" size=\"201\">https://api.elsevier.com/content/object/eid/1-s2.0-S0092867402010401-si4.gif?httpAccept=%2A%2F%2A</object><object ref=\"si3\" category=\"thumbnail\" type=\"ALTIMG\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"14\" height=\"14\" size=\"149\">https://api.elsevier.com/content/object/eid/1-s2.0-S0092867402010401-si3.gif?httpAccept=%2A%2F%2A</object><object ref=\"si2\" category=\"thumbnail\" type=\"ALTIMG\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"65\" height=\"18\" size=\"425\">https://api.elsevier.com/content/object/eid/1-s2.0-S0092867402010401-si2.gif?httpAccept=%2A%2F%2A</object><object ref=\"si1\" category=\"thumbnail\" type=\"ALTIMG\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"34\" height=\"13\" size=\"264\">https://api.elsevier.com/content/object/eid/1-s2.0-S0092867402010401-si1.gif?httpAccept=%2A%2F%2A</object><object ref=\"gr1\" category=\"standard\" type=\"IMAGE-DOWNSAMPLED\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"451\" height=\"679\" size=\"47360\">https://api.elsevier.com/content/object/eid/1-s2.0-S0092867402010401-gr1.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr1\" category=\"thumbnail\" type=\"IMAGE-THUMBNAIL\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"62\" height=\"93\" size=\"2207\">https://api.elsevier.com/content/object/eid/1-s2.0-S0092867402010401-gr1.sml?httpAccept=%2A%2F%2A</object><object ref=\"gr1\" category=\"high\" type=\"IMAGE-HIGH-RES\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"1219\" height=\"1836\" size=\"237208\">https://api.elsevier.com/content/object/eid/1-s2.0-S0092867402010401-gr1_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr2\" category=\"standard\" type=\"IMAGE-DOWNSAMPLED\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"339\" height=\"355\" size=\"19608\">https://api.elsevier.com/content/object/eid/1-s2.0-S0092867402010401-gr2.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr2\" category=\"thumbnail\" type=\"IMAGE-THUMBNAIL\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"89\" height=\"93\" size=\"1219\">https://api.elsevier.com/content/object/eid/1-s2.0-S0092867402010401-gr2.sml?httpAccept=%2A%2F%2A</object><object ref=\"gr2\" category=\"high\" type=\"IMAGE-HIGH-RES\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"1500\" height=\"1571\" size=\"177676\">https://api.elsevier.com/content/object/eid/1-s2.0-S0092867402010401-gr2_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr3\" category=\"standard\" type=\"IMAGE-DOWNSAMPLED\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"338\" height=\"366\" size=\"20955\">https://api.elsevier.com/content/object/eid/1-s2.0-S0092867402010401-gr3.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr3\" category=\"thumbnail\" type=\"IMAGE-THUMBNAIL\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"86\" height=\"93\" size=\"1356\">https://api.elsevier.com/content/object/eid/1-s2.0-S0092867402010401-gr3.sml?httpAccept=%2A%2F%2A</object><object ref=\"gr3\" category=\"high\" type=\"IMAGE-HIGH-RES\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"1499\" height=\"1624\" size=\"167907\">https://api.elsevier.com/content/object/eid/1-s2.0-S0092867402010401-gr3_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr4\" category=\"standard\" type=\"IMAGE-DOWNSAMPLED\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"602\" height=\"447\" size=\"28291\">https://api.elsevier.com/content/object/eid/1-s2.0-S0092867402010401-gr4.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr4\" category=\"thumbnail\" type=\"IMAGE-THUMBNAIL\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"125\" height=\"93\" size=\"2450\">https://api.elsevier.com/content/object/eid/1-s2.0-S0092867402010401-gr4.sml?httpAccept=%2A%2F%2A</object><object ref=\"gr4\" category=\"high\" type=\"IMAGE-HIGH-RES\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"2667\" height=\"1980\" size=\"188533\">https://api.elsevier.com/content/object/eid/1-s2.0-S0092867402010401-gr4_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr5\" category=\"standard\" type=\"IMAGE-DOWNSAMPLED\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"565\" height=\"467\" size=\"40862\">https://api.elsevier.com/content/object/eid/1-s2.0-S0092867402010401-gr5.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr5\" category=\"thumbnail\" type=\"IMAGE-THUMBNAIL\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"113\" height=\"93\" size=\"1673\">https://api.elsevier.com/content/object/eid/1-s2.0-S0092867402010401-gr5.sml?httpAccept=%2A%2F%2A</object><object ref=\"gr5\" category=\"high\" type=\"IMAGE-HIGH-RES\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"2500\" height=\"2065\" size=\"355170\">https://api.elsevier.com/content/object/eid/1-s2.0-S0092867402010401-gr5_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr6\" category=\"standard\" type=\"IMAGE-DOWNSAMPLED\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"565\" height=\"398\" size=\"40475\">https://api.elsevier.com/content/object/eid/1-s2.0-S0092867402010401-gr6.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr6\" category=\"thumbnail\" type=\"IMAGE-THUMBNAIL\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"125\" height=\"88\" size=\"2167\">https://api.elsevier.com/content/object/eid/1-s2.0-S0092867402010401-gr6.sml?httpAccept=%2A%2F%2A</object><object ref=\"gr6\" category=\"high\" type=\"IMAGE-HIGH-RES\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"2500\" height=\"1761\" size=\"328676\">https://api.elsevier.com/content/object/eid/1-s2.0-S0092867402010401-gr6_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr7\" category=\"standard\" type=\"IMAGE-DOWNSAMPLED\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"565\" height=\"299\" size=\"31182\">https://api.elsevier.com/content/object/eid/1-s2.0-S0092867402010401-gr7.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr7\" category=\"thumbnail\" type=\"IMAGE-THUMBNAIL\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"125\" height=\"66\" size=\"1594\">https://api.elsevier.com/content/object/eid/1-s2.0-S0092867402010401-gr7.sml?httpAccept=%2A%2F%2A</object><object ref=\"gr7\" category=\"high\" type=\"IMAGE-HIGH-RES\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"2500\" height=\"1325\" size=\"263350\">https://api.elsevier.com/content/object/eid/1-s2.0-S0092867402010401-gr7_lrg.jpg?httpAccept=%2A%2F%2A</object></objects><scopus-id>0037112329</scopus-id><scopus-eid>2-s2.0-0037112329</scopus-eid><pubmed-id>12437930</pubmed-id><link href=\"https://api.elsevier.com/content/abstract/scopus_id/0037112329\" rel=\"abstract\"/><originalText><xocs:doc xmlns:xoe=\"http://www.elsevier.com/xml/xoe/dtd\" xsi:schemaLocation=\"http://www.elsevier.com/xml/xocs/dtd http://null/schema/dtds/document/fulltext/xcr/xocs-article.xsd\">\\n   <xocs:meta>\\n      <xocs:content-family>serial</xocs:content-family>\\n      <xocs:content-type>JL</xocs:content-type>\\n      <xocs:cid>272196</xocs:cid>\\n      <xocs:ssids>\\n         <xocs:ssid type=\"alllist\">291210</xocs:ssid>\\n         <xocs:ssid type=\"subj\">291735</xocs:ssid>\\n         <xocs:ssid type=\"subj\">291848</xocs:ssid>\\n         <xocs:ssid type=\"subj\">291852</xocs:ssid>\\n         <xocs:ssid type=\"subj\">291857</xocs:ssid>\\n         <xocs:ssid type=\"subj\">291889</xocs:ssid>\\n         <xocs:ssid type=\"content\">31</xocs:ssid>\\n         <xocs:ssid type=\"oa\">80</xocs:ssid>\\n      </xocs:ssids>\\n      <xocs:srctitle>Cell</xocs:srctitle>\\n      <xocs:normalized-srctitle>CELL</xocs:normalized-srctitle>\\n      <xocs:orig-load-date yyyymmdd=\"20021120\">2002-11-20</xocs:orig-load-date>\\n      <xocs:available-online-date yyyymmdd=\"20021120\">2002-11-20</xocs:available-online-date>\\n      <xocs:ew-transaction-id>2011-01-20T06:38:07</xocs:ew-transaction-id>\\n      <xocs:eid>1-s2.0-S0092867402010401</xocs:eid>\\n      <xocs:pii-formatted>S0092-8674(02)01040-1</xocs:pii-formatted>\\n      <xocs:pii-unformatted>S0092867402010401</xocs:pii-unformatted>\\n      <xocs:doi>10.1016/S0092-8674(02)01040-1</xocs:doi>\\n      <xocs:item-stage>S300</xocs:item-stage>\\n      <xocs:item-version-number>S300.3</xocs:item-version-number>\\n      <xocs:item-weight>FULL-TEXT</xocs:item-weight>\\n      <xocs:hub-eid>1-s2.0-S0092867400X01808</xocs:hub-eid>\\n      <xocs:timestamp yyyymmdd=\"20150514\">2015-05-14T03:33:15.485469-04:00</xocs:timestamp>\\n      <xocs:dco>0</xocs:dco>\\n      <xocs:tomb>0</xocs:tomb>\\n      <xocs:date-search-begin>20021115</xocs:date-search-begin>\\n      <xocs:year-nav>2002</xocs:year-nav>\\n      <xocs:indexeddate epoch=\"1037750400\">2002-11-20T00:00:00Z</xocs:indexeddate>\\n      <xocs:articleinfo>articleinfo crossmark dco dateupdated tomb dateloaded datesearch indexeddate issuelist volumelist yearnav articletitlenorm authfirstinitialnorm authfirstsurnamenorm cid cids contenttype copyright dateloadedtxt docsubtype doctype doi eid ewtransactionid hubeid issfirst issn issnnorm itemstage itemtransactionid itemweight oauserlicense openaccess openarchive pg pgfirst pglast pii piinorm pubdatestart pubdatetxt pubyr sortorder srctitle srctitlenorm srctype subheadings volfirst volissue webpdf webpdfpagecount figure table body acknowledge affil articletitle auth authfirstini authfull authlast primabst pubtype ref alllist content oa subj ssids</xocs:articleinfo>\\n      <xocs:issns>\\n         <xocs:issn-primary-formatted>0092-8674</xocs:issn-primary-formatted>\\n         <xocs:issn-primary-unformatted>00928674</xocs:issn-primary-unformatted>\\n      </xocs:issns>\\n      <xocs:crossmark is-crossmark=\"0\"/>\\n      <xocs:vol-first>111</xocs:vol-first>\\n      <xocs:volume-list>\\n         <xocs:volume>111</xocs:volume>\\n      </xocs:volume-list>\\n      <xocs:iss-first>4</xocs:iss-first>\\n      <xocs:issue-list>\\n         <xocs:issue>4</xocs:issue>\\n      </xocs:issue-list>\\n      <xocs:vol-iss-suppl-text>Volume 111, Issue 4</xocs:vol-iss-suppl-text>\\n      <xocs:sort-order>25</xocs:sort-order>\\n      <xocs:first-fp>577</xocs:first-fp>\\n      <xocs:last-lp>588</xocs:last-lp>\\n      <xocs:pages>\\n         <xocs:first-page>577</xocs:first-page>\\n         <xocs:last-page>588</xocs:last-page>\\n      </xocs:pages>\\n      <xocs:cover-date-orig>\\n         <xocs:start-date>20021115</xocs:start-date>\\n      </xocs:cover-date-orig>\\n      <xocs:cover-date-text>15 November 2002</xocs:cover-date-text>\\n      <xocs:cover-date-start>2002-11-15</xocs:cover-date-start>\\n      <xocs:cover-date-year>2002</xocs:cover-date-year>\\n      <xocs:document-type>converted-article</xocs:document-type>\\n      <xocs:document-subtype>fla</xocs:document-subtype>\\n      <xocs:copyright-line>Copyright © 2002 Cell Press.  All rights reserved.</xocs:copyright-line>\\n      <xocs:normalized-article-title>FORWARDTRANSPORT</xocs:normalized-article-title>\\n      <xocs:normalized-first-auth-surname>OKELLY</xocs:normalized-first-auth-surname>\\n      <xocs:normalized-first-auth-initial>I</xocs:normalized-first-auth-initial>\\n      <xocs:item-toc>\\n         <xocs:item-toc-entry ref-elem=\"ce:sections\">\\n            <xocs:item-toc-section-title>Introduction</xocs:item-toc-section-title>\\n         </xocs:item-toc-entry>\\n         <xocs:item-toc-entry ref-elem=\"ce:sections\">\\n            <xocs:item-toc-section-title>Results</xocs:item-toc-section-title>\\n            <xocs:item-toc-entry ref-elem=\"ce:sections\">\\n               <xocs:item-toc-section-title>KCNK3 Peptide Identifies 14-3-3β</xocs:item-toc-section-title>\\n            </xocs:item-toc-entry>\\n            <xocs:item-toc-entry ref-elem=\"ce:sections\">\\n               <xocs:item-toc-section-title>KCNK3 Binds 14-3-3β in Rat Brain</xocs:item-toc-section-title>\\n            </xocs:item-toc-entry>\\n            <xocs:item-toc-entry ref-elem=\"ce:sections\">\\n               <xocs:item-toc-section-title>The Final Valine Is Required to Bind 14-3-3β</xocs:item-toc-section-title>\\n            </xocs:item-toc-entry>\\n            <xocs:item-toc-entry ref-elem=\"ce:sections\">\\n               <xocs:item-toc-section-title>KCNK3ΔV Channels Do Not Function</xocs:item-toc-section-title>\\n            </xocs:item-toc-entry>\\n            <xocs:item-toc-entry ref-elem=\"ce:sections\">\\n               <xocs:item-toc-section-title>KCNK3ΔV Channels Do Not Reach the Surface</xocs:item-toc-section-title>\\n            </xocs:item-toc-entry>\\n            <xocs:item-toc-entry ref-elem=\"ce:sections\">\\n               <xocs:item-toc-section-title>An N-Terminal Dibasic Motif Holds KCNK3ΔV Channels inside the Cells</xocs:item-toc-section-title>\\n            </xocs:item-toc-entry>\\n            <xocs:item-toc-entry ref-elem=\"ce:sections\">\\n               <xocs:item-toc-section-title>KCNK3 Binds Either β-COP or 14-3-3β</xocs:item-toc-section-title>\\n            </xocs:item-toc-entry>\\n            <xocs:item-toc-entry ref-elem=\"ce:sections\">\\n               <xocs:item-toc-section-title>Release Motifs in KCNK9, α4, and Iip35</xocs:item-toc-section-title>\\n            </xocs:item-toc-entry>\\n            <xocs:item-toc-entry ref-elem=\"ce:sections\">\\n               <xocs:item-toc-section-title>14-3-3β Blocks β-COP Binding to Iip35</xocs:item-toc-section-title>\\n            </xocs:item-toc-entry>\\n            <xocs:item-toc-entry ref-elem=\"ce:sections\">\\n               <xocs:item-toc-section-title>Iip35 Binds Only β-COP or 14-3-3β In Vivo</xocs:item-toc-section-title>\\n            </xocs:item-toc-entry>\\n         </xocs:item-toc-entry>\\n         <xocs:item-toc-entry ref-elem=\"ce:sections\">\\n            <xocs:item-toc-section-title>Discussion</xocs:item-toc-section-title>\\n            <xocs:item-toc-entry ref-elem=\"ce:sections\">\\n               <xocs:item-toc-section-title>Trafficking to the Plasma Membrane</xocs:item-toc-section-title>\\n            </xocs:item-toc-entry>\\n            <xocs:item-toc-entry ref-elem=\"ce:sections\">\\n               <xocs:item-toc-section-title>Iip35 Invariant Chains</xocs:item-toc-section-title>\\n            </xocs:item-toc-entry>\\n            <xocs:item-toc-entry ref-elem=\"ce:sections\">\\n               <xocs:item-toc-section-title>A New Role and a Wealth of Nonclassical Sites for 14-3-3</xocs:item-toc-section-title>\\n            </xocs:item-toc-entry>\\n            <xocs:item-toc-entry ref-elem=\"ce:sections\">\\n               <xocs:item-toc-section-title>Mutually Exclusive Binding and Release from ER Retention</xocs:item-toc-section-title>\\n            </xocs:item-toc-entry>\\n         </xocs:item-toc-entry>\\n         <xocs:item-toc-entry ref-elem=\"ce:sections\">\\n            <xocs:item-toc-section-title>Experimental Procedures</xocs:item-toc-section-title>\\n            <xocs:item-toc-entry ref-elem=\"ce:sections\">\\n               <xocs:item-toc-section-title>Yeast Two-Hybrid Identification of 14-3-3β</xocs:item-toc-section-title>\\n            </xocs:item-toc-entry>\\n            <xocs:item-toc-entry ref-elem=\"ce:sections\">\\n               <xocs:item-toc-section-title>Mutagenesis</xocs:item-toc-section-title>\\n            </xocs:item-toc-entry>\\n            <xocs:item-toc-entry ref-elem=\"ce:sections\">\\n               <xocs:item-toc-section-title>Antibodies</xocs:item-toc-section-title>\\n            </xocs:item-toc-entry>\\n            <xocs:item-toc-entry ref-elem=\"ce:sections\">\\n               <xocs:item-toc-section-title>Peptide Binding Studies</xocs:item-toc-section-title>\\n            </xocs:item-toc-entry>\\n            <xocs:item-toc-entry ref-elem=\"ce:sections\">\\n               <xocs:item-toc-section-title>Immunoprecipitation Protocols</xocs:item-toc-section-title>\\n            </xocs:item-toc-entry>\\n            <xocs:item-toc-entry ref-elem=\"ce:sections\">\\n               <xocs:item-toc-section-title>Production of Recombinant 14-3-3β</xocs:item-toc-section-title>\\n            </xocs:item-toc-entry>\\n            <xocs:item-toc-entry ref-elem=\"ce:sections\">\\n               <xocs:item-toc-section-title>Immunofluorescence</xocs:item-toc-section-title>\\n            </xocs:item-toc-entry>\\n            <xocs:item-toc-entry ref-elem=\"ce:sections\">\\n               <xocs:item-toc-section-title>Electrophysiology</xocs:item-toc-section-title>\\n            </xocs:item-toc-entry>\\n            <xocs:item-toc-entry ref-elem=\"ce:sections\">\\n               <xocs:item-toc-section-title>Surface Binding Assay for KCNK3</xocs:item-toc-section-title>\\n            </xocs:item-toc-entry>\\n         </xocs:item-toc-entry>\\n         <xocs:item-toc-entry ref-elem=\"ce:acknowledgment\">\\n            <xocs:item-toc-section-title>Acknowledgements</xocs:item-toc-section-title>\\n         </xocs:item-toc-entry>\\n         <xocs:item-toc-entry ref-elem=\"ce:bibliography\">\\n            <xocs:item-toc-section-title>References</xocs:item-toc-section-title>\\n         </xocs:item-toc-entry>\\n      </xocs:item-toc>\\n      <xocs:references>\\n         <xocs:ref-info refid=\"BIB1\">\\n            <xocs:ref-normalized-surname>ANDERSON</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1999</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>5435</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>5443</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>H</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB2\">\\n            <xocs:ref-normalized-surname>BOCKENHAUER</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>2001</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>486</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>491</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>D</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB3\">\\n            <xocs:ref-normalized-surname>CAMPBELL</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1997</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>15363</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>15370</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB4\">\\n            <xocs:ref-normalized-surname>CRAPARO</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1997</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>11663</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>11669</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>A</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB5\">\\n            <xocs:ref-normalized-surname>CRESSWELL</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1994</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>259</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>293</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>P</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB6\">\\n            <xocs:ref-normalized-surname>CZIRJAK</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>2000</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>863</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>874</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>G</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB7\">\\n            <xocs:ref-normalized-surname>DRISDEL</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>2000</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>133</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>139</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>R</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB8\">\\n            <xocs:ref-normalized-surname>ELLGAARD</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1999</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>1882</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>1888</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>L</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB9\">\\n            <xocs:ref-normalized-surname>FREED</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1994</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>1713</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>1716</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>E</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB10\">\\n            <xocs:ref-normalized-surname>FU</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>2000</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>617</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>647</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>H</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB11\">\\n            <xocs:ref-normalized-surname>GAYNOR</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1997</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>789</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>802</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>E</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB12\">\\n            <xocs:ref-normalized-surname>GELPERIN</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1995</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>11539</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>11543</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>D</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB13\">\\n            <xocs:ref-normalized-surname>GOLDSTEIN</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1996</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>13256</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>13261</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>S</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB14\">\\n            <xocs:ref-normalized-surname>GOLDSTEIN</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>2001</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>175</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>184</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>S</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB15\">\\n            <xocs:ref-normalized-surname>GOPALAKRISHNAN</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1997</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>524</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>534</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB16\">\\n            <xocs:ref-normalized-surname>ILAN</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>2001</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>241</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>254</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>N</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB17\">\\n            <xocs:ref-normalized-surname>JEANCLOS</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>2001</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>28281</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>28290</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>E</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB18\">\\n            <xocs:ref-normalized-surname>KAGAN</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>2002</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>1889</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>1898</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>A</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB19\">\\n            <xocs:ref-normalized-surname>KELLER</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>2001</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>18384</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>18391</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>S</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB20\">\\n            <xocs:ref-normalized-surname>KETCHUM</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1995</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>690</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>695</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>K</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB21\">\\n            <xocs:ref-normalized-surname>KIM</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1999</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>H1669</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>H1678</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>Y</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB22\">\\n            <xocs:ref-normalized-surname>KIM</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>2000</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>9340</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>9347</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>Y</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB23\">\\n            <xocs:ref-normalized-surname>KINDLER</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1999</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>1092</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>1102</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>C</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB24\">\\n            <xocs:ref-normalized-surname>KLAUSNER</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1990</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>403</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>431</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>R</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB25\">\\n            <xocs:ref-normalized-surname>KUWANA</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1998</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>1056</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>1061</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>T</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB26\">\\n            <xocs:ref-normalized-surname>LESAGE</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>2000</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>F793</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>F801</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>F</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB27\">\\n            <xocs:ref-normalized-surname>LETOURNEUR</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1994</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>1199</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>1207</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>F</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB28\">\\n            <xocs:ref-normalized-surname>LINDSTROM</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1997</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>193</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>222</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB29\">\\n            <xocs:ref-normalized-surname>LOPES</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>2000</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>16969</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>16978</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>C</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB30\">\\n            <xocs:ref-normalized-surname>LOPES</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>2001</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>24449</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>24452</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>C</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB31\">\\n            <xocs:ref-normalized-surname>MCGEHEE</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1999</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>565</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>577</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>D</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB32\">\\n            <xocs:ref-normalized-surname>MELLMAN</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>2000</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>99</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>112</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>I</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB33\">\\n            <xocs:ref-normalized-surname>MUSLIN</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1996</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>889</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>897</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>A</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB34\">\\n            <xocs:ref-normalized-surname>NIGAM</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1989</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>16927</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>16932</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>S</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB35\">\\n            <xocs:ref-normalized-surname>NILSSON</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1989</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>707</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>718</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>T</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB36\">\\n            <xocs:ref-normalized-surname>PALLAS</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1994</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>535</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>537</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>D</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB37\">\\n            <xocs:ref-normalized-surname>PATEL</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1999</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>422</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>426</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>A</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB38\">\\n            <xocs:ref-normalized-surname>PELHAM</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1990</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>483</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>486</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>H</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB39\">\\n            <xocs:ref-normalized-surname>RITTINGER</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1999</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>153</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>166</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>K</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB40\">\\n            <xocs:ref-normalized-surname>ROCHE</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1990</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>615</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>618</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>P</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB41\">\\n            <xocs:ref-normalized-surname>SCHOPPERLE</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1998</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>565</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>573</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>W</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB42\">\\n            <xocs:ref-normalized-surname>SCHRODERKOHNE</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1998</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>3459</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>3470</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>S</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB43\">\\n            <xocs:ref-normalized-surname>SCHUTZE</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1994</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>1696</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>1705</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB44\">\\n            <xocs:ref-normalized-surname>STANDLEY</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>2000</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>887</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>898</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>S</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB45\">\\n            <xocs:ref-normalized-surname>TALLEY</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>2000</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>399</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>410</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>E</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB46\">\\n            <xocs:ref-normalized-surname>TEASDALE</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1996</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>27</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>54</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>R</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB47\">\\n            <xocs:ref-normalized-surname>TEYTON</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1990</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>39</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>44</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>L</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB48\">\\n            <xocs:ref-normalized-surname>THORSON</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1998</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>5229</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>5238</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB49\">\\n            <xocs:ref-normalized-surname>TOKER</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1990</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>421</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>429</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>A</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB50\">\\n            <xocs:ref-normalized-surname>TZIVION</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>2002</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>3061</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>3064</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>G</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB51\">\\n            <xocs:ref-normalized-surname>YAFFE</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1997</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>961</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>971</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB52\">\\n            <xocs:ref-normalized-surname>ZAREI</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>2001</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>16232</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>16239</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB53\">\\n            <xocs:ref-normalized-surname>ZERANGUE</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1999</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>537</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>548</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>N</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB54\">\\n            <xocs:ref-normalized-surname>ZERANGUE</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>2001</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>2431</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>2436</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>N</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB55\">\\n            <xocs:ref-normalized-surname>ZHOU</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1999</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>809</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>818</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>Y</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB56\">\\n            <xocs:ref-normalized-surname>ZILBERBERG</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>2001</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>635</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>648</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>N</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n      </xocs:references>\\n      <xocs:refkeys>\\n         <xocs:refkey3>OKELLYX2002X577</xocs:refkey3>\\n         <xocs:refkey4lp>OKELLYX2002X577X588</xocs:refkey4lp>\\n         <xocs:refkey4ai>OKELLYX2002X577XI</xocs:refkey4ai>\\n         <xocs:refkey5>OKELLYX2002X577X588XI</xocs:refkey5>\\n      </xocs:refkeys>\\n      <xocs:open-access>\\n         <xocs:oa-access-effective-date>2013-07-17T11:36:18Z</xocs:oa-access-effective-date>\\n         <xocs:oa-access-inherited-from winid=\"http://vtw.elsevier.com/content/oaw/GEN_1995_P1Y_ESBranded\" wintype=\"OpenArchive\">OA-Window</xocs:oa-access-inherited-from>\\n         <xocs:oa-user-license>http://www.elsevier.com/open-access/userlicense/1.0/</xocs:oa-user-license>\\n         <xocs:oa-sponsor>\\n            <xocs:oa-sponsor-type>ElsevierBranded</xocs:oa-sponsor-type>\\n         </xocs:oa-sponsor>\\n         <xocs:oa-article-status is-open-access=\"1\" is-open-archive=\"1\">Full</xocs:oa-article-status>\\n      </xocs:open-access>\\n      <xocs:attachment-metadata-doc>\\n         <xocs:attachment-set-type>item</xocs:attachment-set-type>\\n         <xocs:pii-formatted>S0092-8674(02)01040-1</xocs:pii-formatted>\\n         <xocs:pii-unformatted>S0092867402010401</xocs:pii-unformatted>\\n         <xocs:eid>1-s2.0-S0092867402010401</xocs:eid>\\n         <xocs:doi>10.1016/S0092-8674(02)01040-1</xocs:doi>\\n         <xocs:cid>272196</xocs:cid>\\n         <xocs:timestamp>2011-02-03T12:49:59.728634-05:00</xocs:timestamp>\\n         <xocs:cover-date-start>2002-11-15</xocs:cover-date-start>\\n         <xocs:attachments>\\n            <xocs:web-pdf>\\n               <xocs:attachment-eid>1-s2.0-S0092867402010401-main.pdf</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0092867402010401/MAIN/application/pdf/b434e4f924c686e403b75ce57fc241f7/main.pdf</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0092867402010401/MAIN/application/pdf/b434e4f924c686e403b75ce57fc241f7/main.pdf</xocs:ucs-locator>\\n               <xocs:filename>main.pdf</xocs:filename>\\n               <xocs:extension>pdf</xocs:extension>\\n               <xocs:pdf-optimized>true</xocs:pdf-optimized>\\n               <xocs:filesize>425613</xocs:filesize>\\n               <xocs:web-pdf-purpose>MAIN</xocs:web-pdf-purpose>\\n               <xocs:web-pdf-page-count>12</xocs:web-pdf-page-count>\\n               <xocs:web-pdf-images>\\n                  <xocs:web-pdf-image>\\n                     <xocs:attachment-eid>1-s2.0-S0092867402010401-main_1.png</xocs:attachment-eid>\\n                     <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0092867402010401/PREVIEW/image/png/48de06bc678989f2263d4d34553a55e3/main_1.png</xocs:ucs-locator>\\n                     <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0092867402010401/PREVIEW/image/png/48de06bc678989f2263d4d34553a55e3/main_1.png</xocs:ucs-locator>\\n                     <xocs:filename>main_1.png</xocs:filename>\\n                     <xocs:extension>png</xocs:extension>\\n                     <xocs:filesize>96875</xocs:filesize>\\n                     <xocs:pixel-height>849</xocs:pixel-height>\\n                     <xocs:pixel-width>656</xocs:pixel-width>\\n                     <xocs:attachment-type>IMAGE-WEB-PDF</xocs:attachment-type>\\n                     <xocs:pdf-page-num>1</xocs:pdf-page-num>\\n                  </xocs:web-pdf-image>\\n               </xocs:web-pdf-images>\\n            </xocs:web-pdf>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S0092867402010401-si5.gif</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0092867402010401/STRIPIN/image/gif/7fbc14967abce4fe7458640174765188/si5.gif</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0092867402010401/STRIPIN/image/gif/7fbc14967abce4fe7458640174765188/si5.gif</xocs:ucs-locator>\\n               <xocs:file-basename>si5</xocs:file-basename>\\n               <xocs:filename>si5.gif</xocs:filename>\\n               <xocs:extension>gif</xocs:extension>\\n               <xocs:filesize>264</xocs:filesize>\\n               <xocs:pixel-height>13</xocs:pixel-height>\\n               <xocs:pixel-width>34</xocs:pixel-width>\\n               <xocs:attachment-type>ALTIMG</xocs:attachment-type>\\n            </xocs:attachment>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S0092867402010401-si4.gif</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0092867402010401/STRIPIN/image/gif/5814a27ced962dcb5af04250add3d018/si4.gif</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0092867402010401/STRIPIN/image/gif/5814a27ced962dcb5af04250add3d018/si4.gif</xocs:ucs-locator>\\n               <xocs:file-basename>si4</xocs:file-basename>\\n               <xocs:filename>si4.gif</xocs:filename>\\n               <xocs:extension>gif</xocs:extension>\\n               <xocs:filesize>201</xocs:filesize>\\n               <xocs:pixel-height>18</xocs:pixel-height>\\n               <xocs:pixel-width>21</xocs:pixel-width>\\n               <xocs:attachment-type>ALTIMG</xocs:attachment-type>\\n            </xocs:attachment>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S0092867402010401-si3.gif</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0092867402010401/STRIPIN/image/gif/0d0a60cd69cd95a86554dfbad5966d92/si3.gif</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0092867402010401/STRIPIN/image/gif/0d0a60cd69cd95a86554dfbad5966d92/si3.gif</xocs:ucs-locator>\\n               <xocs:file-basename>si3</xocs:file-basename>\\n               <xocs:filename>si3.gif</xocs:filename>\\n               <xocs:extension>gif</xocs:extension>\\n               <xocs:filesize>149</xocs:filesize>\\n               <xocs:pixel-height>14</xocs:pixel-height>\\n               <xocs:pixel-width>14</xocs:pixel-width>\\n               <xocs:attachment-type>ALTIMG</xocs:attachment-type>\\n            </xocs:attachment>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S0092867402010401-si2.gif</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0092867402010401/STRIPIN/image/gif/64ad6156f86b677afa8d15138e99b4fc/si2.gif</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0092867402010401/STRIPIN/image/gif/64ad6156f86b677afa8d15138e99b4fc/si2.gif</xocs:ucs-locator>\\n               <xocs:file-basename>si2</xocs:file-basename>\\n               <xocs:filename>si2.gif</xocs:filename>\\n               <xocs:extension>gif</xocs:extension>\\n               <xocs:filesize>425</xocs:filesize>\\n               <xocs:pixel-height>18</xocs:pixel-height>\\n               <xocs:pixel-width>65</xocs:pixel-width>\\n               <xocs:attachment-type>ALTIMG</xocs:attachment-type>\\n            </xocs:attachment>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S0092867402010401-si1.gif</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0092867402010401/STRIPIN/image/gif/7fbc14967abce4fe7458640174765188/si5.gif</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0092867402010401/STRIPIN/image/gif/7fbc14967abce4fe7458640174765188/si5.gif</xocs:ucs-locator>\\n               <xocs:file-basename>si1</xocs:file-basename>\\n               <xocs:filename>si1.gif</xocs:filename>\\n               <xocs:extension>gif</xocs:extension>\\n               <xocs:filesize>264</xocs:filesize>\\n               <xocs:pixel-height>13</xocs:pixel-height>\\n               <xocs:pixel-width>34</xocs:pixel-width>\\n               <xocs:attachment-type>ALTIMG</xocs:attachment-type>\\n            </xocs:attachment>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S0092867402010401-gr1.jpg</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0092867402010401/gr1/DOWNSAMPLED/image/jpeg/9cc8f33e0c862350e64fd83bdd2e7c9e/gr1.jpg</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0092867402010401/gr1/DOWNSAMPLED/image/jpeg/9cc8f33e0c862350e64fd83bdd2e7c9e/gr1.jpg</xocs:ucs-locator>\\n               <xocs:file-basename>gr1</xocs:file-basename>\\n               <xocs:filename>gr1.jpg</xocs:filename>\\n               <xocs:extension>jpg</xocs:extension>\\n               <xocs:filesize>47360</xocs:filesize>\\n               <xocs:pixel-height>679</xocs:pixel-height>\\n               <xocs:pixel-width>451</xocs:pixel-width>\\n               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>\\n            </xocs:attachment>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S0092867402010401-gr1.sml</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0092867402010401/gr1/THUMBNAIL/image/gif/ca44c67415b8f8819a48f8712416be67/gr1.sml</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0092867402010401/gr1/THUMBNAIL/image/gif/ca44c67415b8f8819a48f8712416be67/gr1.sml</xocs:ucs-locator>\\n               <xocs:file-basename>gr1</xocs:file-basename>\\n               <xocs:filename>gr1.sml</xocs:filename>\\n               <xocs:extension>sml</xocs:extension>\\n               <xocs:filesize>2207</xocs:filesize>\\n               <xocs:pixel-height>93</xocs:pixel-height>\\n               <xocs:pixel-width>62</xocs:pixel-width>\\n               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>\\n            </xocs:attachment>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S0092867402010401-gr1_lrg.jpg</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0092867402010401/gr1/HIGHRES/image/jpeg/848750d7887e452eb67dc6892337433c/gr1_lrg.jpg</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0092867402010401/gr1/HIGHRES/image/jpeg/848750d7887e452eb67dc6892337433c/gr1_lrg.jpg</xocs:ucs-locator>\\n               <xocs:file-basename>gr1</xocs:file-basename>\\n               <xocs:filename>gr1_lrg.jpg</xocs:filename>\\n               <xocs:extension>jpg</xocs:extension>\\n               <xocs:filesize>237208</xocs:filesize>\\n               <xocs:pixel-height>1836</xocs:pixel-height>\\n               <xocs:pixel-width>1219</xocs:pixel-width>\\n               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>\\n            </xocs:attachment>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S0092867402010401-gr2.jpg</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0092867402010401/gr2/DOWNSAMPLED/image/jpeg/ed0a43520fa58d8d5b3b6a50e93397ea/gr2.jpg</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0092867402010401/gr2/DOWNSAMPLED/image/jpeg/ed0a43520fa58d8d5b3b6a50e93397ea/gr2.jpg</xocs:ucs-locator>\\n               <xocs:file-basename>gr2</xocs:file-basename>\\n               <xocs:filename>gr2.jpg</xocs:filename>\\n               <xocs:extension>jpg</xocs:extension>\\n               <xocs:filesize>19608</xocs:filesize>\\n               <xocs:pixel-height>355</xocs:pixel-height>\\n               <xocs:pixel-width>339</xocs:pixel-width>\\n               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>\\n            </xocs:attachment>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S0092867402010401-gr2.sml</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0092867402010401/gr2/THUMBNAIL/image/gif/f3b977c3637dbec26a12090bb2e0293b/gr2.sml</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0092867402010401/gr2/THUMBNAIL/image/gif/f3b977c3637dbec26a12090bb2e0293b/gr2.sml</xocs:ucs-locator>\\n               <xocs:file-basename>gr2</xocs:file-basename>\\n               <xocs:filename>gr2.sml</xocs:filename>\\n               <xocs:extension>sml</xocs:extension>\\n               <xocs:filesize>1219</xocs:filesize>\\n               <xocs:pixel-height>93</xocs:pixel-height>\\n               <xocs:pixel-width>89</xocs:pixel-width>\\n               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>\\n            </xocs:attachment>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S0092867402010401-gr2_lrg.jpg</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0092867402010401/gr2/HIGHRES/image/jpeg/afab7ac2c0b77d6e8ed1891e52b6f5ce/gr2_lrg.jpg</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0092867402010401/gr2/HIGHRES/image/jpeg/afab7ac2c0b77d6e8ed1891e52b6f5ce/gr2_lrg.jpg</xocs:ucs-locator>\\n               <xocs:file-basename>gr2</xocs:file-basename>\\n               <xocs:filename>gr2_lrg.jpg</xocs:filename>\\n               <xocs:extension>jpg</xocs:extension>\\n               <xocs:filesize>177676</xocs:filesize>\\n               <xocs:pixel-height>1571</xocs:pixel-height>\\n               <xocs:pixel-width>1500</xocs:pixel-width>\\n               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>\\n            </xocs:attachment>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S0092867402010401-gr3.jpg</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0092867402010401/gr3/DOWNSAMPLED/image/jpeg/b1d9ebeac1126a7f14c696942a9eb76e/gr3.jpg</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0092867402010401/gr3/DOWNSAMPLED/image/jpeg/b1d9ebeac1126a7f14c696942a9eb76e/gr3.jpg</xocs:ucs-locator>\\n               <xocs:file-basename>gr3</xocs:file-basename>\\n               <xocs:filename>gr3.jpg</xocs:filename>\\n               <xocs:extension>jpg</xocs:extension>\\n               <xocs:filesize>20955</xocs:filesize>\\n               <xocs:pixel-height>366</xocs:pixel-height>\\n               <xocs:pixel-width>338</xocs:pixel-width>\\n               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>\\n            </xocs:attachment>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S0092867402010401-gr3.sml</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0092867402010401/gr3/THUMBNAIL/image/gif/5432ebfa56f96d2c7a1e98b5af54683c/gr3.sml</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0092867402010401/gr3/THUMBNAIL/image/gif/5432ebfa56f96d2c7a1e98b5af54683c/gr3.sml</xocs:ucs-locator>\\n               <xocs:file-basename>gr3</xocs:file-basename>\\n               <xocs:filename>gr3.sml</xocs:filename>\\n               <xocs:extension>sml</xocs:extension>\\n               <xocs:filesize>1356</xocs:filesize>\\n               <xocs:pixel-height>93</xocs:pixel-height>\\n               <xocs:pixel-width>86</xocs:pixel-width>\\n               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>\\n            </xocs:attachment>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S0092867402010401-gr3_lrg.jpg</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0092867402010401/gr3/HIGHRES/image/jpeg/08d7cea7bb71e757741f555742eddf9a/gr3_lrg.jpg</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0092867402010401/gr3/HIGHRES/image/jpeg/08d7cea7bb71e757741f555742eddf9a/gr3_lrg.jpg</xocs:ucs-locator>\\n               <xocs:file-basename>gr3</xocs:file-basename>\\n               <xocs:filename>gr3_lrg.jpg</xocs:filename>\\n               <xocs:extension>jpg</xocs:extension>\\n               <xocs:filesize>167907</xocs:filesize>\\n               <xocs:pixel-height>1624</xocs:pixel-height>\\n               <xocs:pixel-width>1499</xocs:pixel-width>\\n               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>\\n            </xocs:attachment>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S0092867402010401-gr4.jpg</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0092867402010401/gr4/DOWNSAMPLED/image/jpeg/485303070b44024ec67aa4fe611770a2/gr4.jpg</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0092867402010401/gr4/DOWNSAMPLED/image/jpeg/485303070b44024ec67aa4fe611770a2/gr4.jpg</xocs:ucs-locator>\\n               <xocs:file-basename>gr4</xocs:file-basename>\\n               <xocs:filename>gr4.jpg</xocs:filename>\\n               <xocs:extension>jpg</xocs:extension>\\n               <xocs:filesize>28291</xocs:filesize>\\n               <xocs:pixel-height>447</xocs:pixel-height>\\n               <xocs:pixel-width>602</xocs:pixel-width>\\n               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>\\n            </xocs:attachment>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S0092867402010401-gr4.sml</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0092867402010401/gr4/THUMBNAIL/image/gif/2442b0d8aee1f854566750e714ee9c1a/gr4.sml</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0092867402010401/gr4/THUMBNAIL/image/gif/2442b0d8aee1f854566750e714ee9c1a/gr4.sml</xocs:ucs-locator>\\n               <xocs:file-basename>gr4</xocs:file-basename>\\n               <xocs:filename>gr4.sml</xocs:filename>\\n               <xocs:extension>sml</xocs:extension>\\n               <xocs:filesize>2450</xocs:filesize>\\n               <xocs:pixel-height>93</xocs:pixel-height>\\n               <xocs:pixel-width>125</xocs:pixel-width>\\n               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>\\n            </xocs:attachment>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S0092867402010401-gr4_lrg.jpg</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0092867402010401/gr4/HIGHRES/image/jpeg/a34ac196d3915e776046bfe819b9a542/gr4_lrg.jpg</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0092867402010401/gr4/HIGHRES/image/jpeg/a34ac196d3915e776046bfe819b9a542/gr4_lrg.jpg</xocs:ucs-locator>\\n               <xocs:file-basename>gr4</xocs:file-basename>\\n               <xocs:filename>gr4_lrg.jpg</xocs:filename>\\n               <xocs:extension>jpg</xocs:extension>\\n               <xocs:filesize>188533</xocs:filesize>\\n               <xocs:pixel-height>1980</xocs:pixel-height>\\n               <xocs:pixel-width>2667</xocs:pixel-width>\\n               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>\\n            </xocs:attachment>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S0092867402010401-gr5.jpg</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0092867402010401/gr5/DOWNSAMPLED/image/jpeg/3c3c2fccd05f3219d6127fdd78d1bf2c/gr5.jpg</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0092867402010401/gr5/DOWNSAMPLED/image/jpeg/3c3c2fccd05f3219d6127fdd78d1bf2c/gr5.jpg</xocs:ucs-locator>\\n               <xocs:file-basename>gr5</xocs:file-basename>\\n               <xocs:filename>gr5.jpg</xocs:filename>\\n               <xocs:extension>jpg</xocs:extension>\\n               <xocs:filesize>40862</xocs:filesize>\\n               <xocs:pixel-height>467</xocs:pixel-height>\\n               <xocs:pixel-width>565</xocs:pixel-width>\\n               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>\\n            </xocs:attachment>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S0092867402010401-gr5.sml</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0092867402010401/gr5/THUMBNAIL/image/gif/3a79096b6e4cb3d16ba56bb495ba548c/gr5.sml</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0092867402010401/gr5/THUMBNAIL/image/gif/3a79096b6e4cb3d16ba56bb495ba548c/gr5.sml</xocs:ucs-locator>\\n               <xocs:file-basename>gr5</xocs:file-basename>\\n               <xocs:filename>gr5.sml</xocs:filename>\\n               <xocs:extension>sml</xocs:extension>\\n               <xocs:filesize>1673</xocs:filesize>\\n               <xocs:pixel-height>93</xocs:pixel-height>\\n               <xocs:pixel-width>113</xocs:pixel-width>\\n               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>\\n            </xocs:attachment>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S0092867402010401-gr5_lrg.jpg</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0092867402010401/gr5/HIGHRES/image/jpeg/1ffef15471001da00d957ac0618c3b13/gr5_lrg.jpg</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0092867402010401/gr5/HIGHRES/image/jpeg/1ffef15471001da00d957ac0618c3b13/gr5_lrg.jpg</xocs:ucs-locator>\\n               <xocs:file-basename>gr5</xocs:file-basename>\\n               <xocs:filename>gr5_lrg.jpg</xocs:filename>\\n               <xocs:extension>jpg</xocs:extension>\\n               <xocs:filesize>355170</xocs:filesize>\\n               <xocs:pixel-height>2065</xocs:pixel-height>\\n               <xocs:pixel-width>2500</xocs:pixel-width>\\n               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>\\n            </xocs:attachment>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S0092867402010401-gr6.jpg</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0092867402010401/gr6/DOWNSAMPLED/image/jpeg/7a36f2e7f2c079b5dc9b62c161da1af3/gr6.jpg</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0092867402010401/gr6/DOWNSAMPLED/image/jpeg/7a36f2e7f2c079b5dc9b62c161da1af3/gr6.jpg</xocs:ucs-locator>\\n               <xocs:file-basename>gr6</xocs:file-basename>\\n               <xocs:filename>gr6.jpg</xocs:filename>\\n               <xocs:extension>jpg</xocs:extension>\\n               <xocs:filesize>40475</xocs:filesize>\\n               <xocs:pixel-height>398</xocs:pixel-height>\\n               <xocs:pixel-width>565</xocs:pixel-width>\\n               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>\\n            </xocs:attachment>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S0092867402010401-gr6.sml</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0092867402010401/gr6/THUMBNAIL/image/gif/f172352d78825f866c5b24a7d5b60103/gr6.sml</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0092867402010401/gr6/THUMBNAIL/image/gif/f172352d78825f866c5b24a7d5b60103/gr6.sml</xocs:ucs-locator>\\n               <xocs:file-basename>gr6</xocs:file-basename>\\n               <xocs:filename>gr6.sml</xocs:filename>\\n               <xocs:extension>sml</xocs:extension>\\n               <xocs:filesize>2167</xocs:filesize>\\n               <xocs:pixel-height>88</xocs:pixel-height>\\n               <xocs:pixel-width>125</xocs:pixel-width>\\n               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>\\n            </xocs:attachment>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S0092867402010401-gr6_lrg.jpg</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0092867402010401/gr6/HIGHRES/image/jpeg/c4d6792161587ae074eac35c97142a55/gr6_lrg.jpg</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0092867402010401/gr6/HIGHRES/image/jpeg/c4d6792161587ae074eac35c97142a55/gr6_lrg.jpg</xocs:ucs-locator>\\n               <xocs:file-basename>gr6</xocs:file-basename>\\n               <xocs:filename>gr6_lrg.jpg</xocs:filename>\\n               <xocs:extension>jpg</xocs:extension>\\n               <xocs:filesize>328676</xocs:filesize>\\n               <xocs:pixel-height>1761</xocs:pixel-height>\\n               <xocs:pixel-width>2500</xocs:pixel-width>\\n               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>\\n            </xocs:attachment>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S0092867402010401-gr7.jpg</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0092867402010401/gr7/DOWNSAMPLED/image/jpeg/9f1e124860b7d9a718a52a1fc9dedd81/gr7.jpg</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0092867402010401/gr7/DOWNSAMPLED/image/jpeg/9f1e124860b7d9a718a52a1fc9dedd81/gr7.jpg</xocs:ucs-locator>\\n               <xocs:file-basename>gr7</xocs:file-basename>\\n               <xocs:filename>gr7.jpg</xocs:filename>\\n               <xocs:extension>jpg</xocs:extension>\\n               <xocs:filesize>31182</xocs:filesize>\\n               <xocs:pixel-height>299</xocs:pixel-height>\\n               <xocs:pixel-width>565</xocs:pixel-width>\\n               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>\\n            </xocs:attachment>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S0092867402010401-gr7.sml</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0092867402010401/gr7/THUMBNAIL/image/gif/0bdd8e8eeb52b3884508121fa4d785eb/gr7.sml</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0092867402010401/gr7/THUMBNAIL/image/gif/0bdd8e8eeb52b3884508121fa4d785eb/gr7.sml</xocs:ucs-locator>\\n               <xocs:file-basename>gr7</xocs:file-basename>\\n               <xocs:filename>gr7.sml</xocs:filename>\\n               <xocs:extension>sml</xocs:extension>\\n               <xocs:filesize>1594</xocs:filesize>\\n               <xocs:pixel-height>66</xocs:pixel-height>\\n               <xocs:pixel-width>125</xocs:pixel-width>\\n               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>\\n            </xocs:attachment>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S0092867402010401-gr7_lrg.jpg</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0092867402010401/gr7/HIGHRES/image/jpeg/06f2d140dbd2cd93e7cd4b7ac47704df/gr7_lrg.jpg</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0092867402010401/gr7/HIGHRES/image/jpeg/06f2d140dbd2cd93e7cd4b7ac47704df/gr7_lrg.jpg</xocs:ucs-locator>\\n               <xocs:file-basename>gr7</xocs:file-basename>\\n               <xocs:filename>gr7_lrg.jpg</xocs:filename>\\n               <xocs:extension>jpg</xocs:extension>\\n               <xocs:filesize>263350</xocs:filesize>\\n               <xocs:pixel-height>1325</xocs:pixel-height>\\n               <xocs:pixel-width>2500</xocs:pixel-width>\\n               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>\\n            </xocs:attachment>\\n         </xocs:attachments>\\n      </xocs:attachment-metadata-doc>\\n   </xocs:meta>\\n   <xocs:serial-item>\\n      <converted-article xmlns=\"http://www.elsevier.com/xml/ja/dtd\" version=\"4.5.2\" docsubtype=\"fla\" xml:lang=\"en\">\\n         <item-info>\\n            <jid>CELL</jid>\\n            <aid>1080</aid>\\n            <ce:pii>S0092-8674(02)01040-1</ce:pii>\\n            <ce:doi>10.1016/S0092-8674(02)01040-1</ce:doi>\\n            <ce:copyright type=\"society\" year=\"2002\">Cell Press</ce:copyright>\\n         </item-info>\\n         <ce:floats>\\n            <ce:figure id=\"FIG1\">\\n               <ce:label>Figure 1</ce:label>\\n               <ce:caption>\\n                  <ce:simple-para view=\"all\">The KCNK3 C Terminus Is Phosphorylated and Binds 14-3-3β in Rat Brain</ce:simple-para>\\n                  <ce:simple-para view=\"all\">(A) KCNK3 topology; N- and C-terminal residues shown.</ce:simple-para>\\n                  <ce:simple-para view=\"all\">(B) Homogenized and detergent-solubilized rat brain was incubated with immobilized RRSSV peptides, RRSS<ce:sup loc=\"post\">P</ce:sup>V peptides, or peptide-free beads (as indicated). Interacting proteins were eluted, separated by SDS-PAGE, and stained with Coomassie blue. Two major products bound to the phosphorylated peptide (RRSS<ce:sup loc=\"post\">P</ce:sup>V). Markers are kDa.</ce:simple-para>\\n                  <ce:simple-para view=\"all\">(C) MALDI analysis of major bound products from gel in (B) with key peaks labeled by size. Analysis using Sequest algorithms (NCBI) identify the proteins as 14-3-3β and 14-3-3ϵ with a probability close to or equal to 1.</ce:simple-para>\\n                  <ce:simple-para view=\"all\">(D) Isolation of 14-3-3β from rat brain lysate by binding to phosphorylated KCNK3 peptide (RRSS<ce:sup loc=\"post\">P</ce:sup>V) but not nonphosphorylated (RRSSV) peptide. Interacting proteins were eluted and separated by SDS-PAGE and visualized by Western blot analysis using a monoclonal antibody to 14-3-3β and ECL. Rat heart and skeletal muscle yield 14-3-3β by the same strategy (not shown).</ce:simple-para>\\n                  <ce:simple-para view=\"all\">(E) KCNK3 channels were copurified from rat brain when a monoclonal antibody was used to immunoprecipitate (IP) 14-3-3β (top). KCNK3 channels purified in this manner are visualized by antibodies to phosphoserine (bottom). Proteins separated by SDS-PAGE and visualized by Western blot analysis using a polyclonal anti-KCNK3 or anti-phosphoserine (S<ce:sup loc=\"post\">P</ce:sup>) antibody, as indicated, and ECL. Control indicates immunoprecipitation with nonimmune mouse IgG.</ce:simple-para>\\n               </ce:caption>\\n               <ce:link locator=\"gr1\"/>\\n            </ce:figure>\\n            <ce:figure id=\"FIG2\">\\n               <ce:label>Figure 2</ce:label>\\n               <ce:caption>\\n                  <ce:simple-para view=\"all\">KCNK3ΔV Does Not Bind 14-3-3β or Pass Current</ce:simple-para>\\n                  <ce:simple-para view=\"all\">(A) Isolation of 14-3-3β from rat brain was achieved by binding to the phosphorylated KCNK3 (RRSS<ce:sup loc=\"post\">P</ce:sup>V) and Raf1 peptide (RSAS<ce:sup loc=\"post\">P</ce:sup>EP) but not phosphorylated peptide without the final valine (RRSS<ce:sup loc=\"post\">P</ce:sup>) or the nonphosphorylated peptides. Interacting proteins were eluted, separated, and visualized by Western blot analysis using a monoclonal antibody to 14-3-3β and ECL.</ce:simple-para>\\n                  <ce:simple-para view=\"all\">(B) Wild-type and KCNK3-RSAS<ce:sup loc=\"post\">P</ce:sup>EP channels show similar current levels but KCNK3ΔV channels passed no current. Raw two-electrode voltage clamp recordings of oocytes expressing KCNK3 with various C termini as indicated. KCNK3 channels, KCNK3 channels with a Raf1-like C terminus (KCNK3-RSAS<ce:sup loc=\"post\">P</ce:sup>EP), and KCNK3ΔV channels.</ce:simple-para>\\n                  <ce:simple-para view=\"all\">(C) Mean currents (± SEM) evoked in oocytes by step depolarization to +30mV for groups of 6–10 cells in external bath solutions of pH 7.4 and 6.5 as labeled.</ce:simple-para>\\n               </ce:caption>\\n               <ce:link locator=\"gr2\"/>\\n            </ce:figure>\\n            <ce:figure id=\"FIG3\">\\n               <ce:label>Figure 3</ce:label>\\n               <ce:caption>\\n                  <ce:simple-para view=\"all\">KCNK3ΔV Does Not Reach the Surface, whereas NQ-KCNK3ΔV Does</ce:simple-para>\\n                  <ce:simple-para view=\"all\">(A) Surface expression of HA-tagged KCNK3, KCNK3ΔV, and NQ-KCNK3ΔV on single oocytes quantified by antibody labeling and luminometry. Plot is relative light units (RLU) for groups of 6–10 cells less nonspecific background fluorescence (mean ± SEM). HA-tagged, wild-type KCNK3 subunits yielded a strong surface signal, while HA-tagged KCNK3ΔV and untagged wild-type KCNK3 channels showed the same null fluorescence of uninjected oocytes. NQ-KCNK3ΔV showed surface expression not significantly different from HA-tagged wild-type KCNK3.</ce:simple-para>\\n                  <ce:simple-para view=\"all\">(B) SDS-PAGE and Western blot analysis showed similar levels of HA-tagged KCNK3, KCNK3ΔV, and NQ-KCNK3ΔV in total cell lysates.</ce:simple-para>\\n                  <ce:simple-para view=\"all\">(C) Raw currents passed by single cells expressing indicated KCNK3 channels.</ce:simple-para>\\n                  <ce:simple-para view=\"all\">(D) Mean (± SEM) current from groups of 6–10 cells at pH 7.4 and 6.5.</ce:simple-para>\\n               </ce:caption>\\n               <ce:link locator=\"gr3\"/>\\n            </ce:figure>\\n            <ce:figure id=\"FIG4\">\\n               <ce:label>Figure 4</ce:label>\\n               <ce:caption>\\n                  <ce:simple-para view=\"all\">A Dibasic Motif Holds KCNK3 Channels in Endoplasmic Reticulum</ce:simple-para>\\n                  <ce:simple-para view=\"all\">COS-7 cells expressing HA and FLAG-tagged constructs of wild-type KCNK3, KCNK3ΔV, or NQ-KCNK3ΔV were labeled with anti-HA antibodies to stain the surface or anti-FLAG antibodies to visualize intracellular KCNK3ΔV after permeabilization.</ce:simple-para>\\n                  <ce:simple-para view=\"all\">(A) Wild-type KCNK3 channels are observed at the plasma membrane.</ce:simple-para>\\n                  <ce:simple-para view=\"all\">(B) KCNK3ΔV channels are not visualized on the plasma membrane (top), whereas transferrin receptors are visualized on the plasma membrane (middle). Permeabilization with detergent reveals KCNK3ΔV channels accumulate in perinuclear areas (bottom).</ce:simple-para>\\n                  <ce:simple-para view=\"all\">(C) NQ-KCNK3ΔV channels escape ER retention to reach the plasma membrane.</ce:simple-para>\\n               </ce:caption>\\n               <ce:link locator=\"gr4\"/>\\n            </ce:figure>\\n            <ce:figure id=\"FIG5\">\\n               <ce:label>Figure 5</ce:label>\\n               <ce:caption>\\n                  <ce:simple-para view=\"all\">KCNK3 Binds β-COP or 14-3-3β in Mutually Exclusive Fashion</ce:simple-para>\\n                  <ce:simple-para view=\"all\">KCNK3 channels (HA-tagged) were expressed in COS-7 cells and studied by detergent extraction, immunoprecipitation, separation by SDS-PAGE, and visualization by Western blot analysis using antibodies as indicated with ECL.</ce:simple-para>\\n                  <ce:simple-para view=\"all\">(A) KCNK3 channels purified by immunoprecipitation (IP) with anti-HA antibodies and visualized with antibody to HA (top left) led to copurification of native βCOP (top right). Conversely, NQ-KCNK3 channels mutated from KR to NQ in the dibasic motif were isolated (bottom left) in the absence of native βCOP (bottom right). Control indicates immunoprecipitations with nonimmune mouse IgG.</ce:simple-para>\\n                  <ce:simple-para view=\"all\">(B) KCNK3 channels isolated as in (A) copurified native 14-3-3β (top left) that was phosphorylated on serine (top right). S358A KCNK3 channels mutated in the only internal consensus site for serine phosphorylation showed 14-3-3 binding (bottom left) and serine phosphorylation (bottom right) like wild-type. Control indicates immunoprecipitation with nonimmune mouse IgG.</ce:simple-para>\\n                  <ce:simple-para view=\"all\">(C) KCNK3 immunoprecipitates as in (A) were eluted from the beads with HA peptide and subjected to a second round of affinity purification (IP2) with antibody to βCOP or 14-3-3β and visualized with antibody to HA (left), βCOP (middle), and 14-3-3β (right); this revealed two populations of KCNK3 subunits: one with βCOP, another with 14-3-3β; failure to detect βCOP and 14-3-3β indicate levels are at least 90% and 95% less than bound to an equal amount of KCNK3 in IP1 (Experimental Procedures).</ce:simple-para>\\n               </ce:caption>\\n               <ce:link locator=\"gr5\"/>\\n            </ce:figure>\\n            <ce:figure id=\"FIG6\">\\n               <ce:label>Figure 6</ce:label>\\n               <ce:caption>\\n                  <ce:simple-para view=\"all\">Retention and Release Motifs on KCNK9, α4, and Iip35: Phosphorylated Iip35 Binds 14-3-3β, Leading to Blockade of β-COP Association</ce:simple-para>\\n                  <ce:simple-para view=\"all\">Isolation of βCOP and/or 14-3-3β from rat brain lysate using peptide-coupled beads. Interacting proteins were eluted, separated by SDS-PAGE, and visualized by Western blot analysis using monoclonal antibodies as indicated and ECL.</ce:simple-para>\\n                  <ce:simple-para view=\"all\">(A) The peptide analogous to the wild-type N terminus of KCNK9 (and KCNK3) binds β-COP from rat brain, while peptides with the NQ mutation do not (left). The C-terminal residues in KCNK9 subunits (RRKS<ce:sup loc=\"post\">P</ce:sup>V) bind 14-3-3β from rat brain if the penultimate serine is phosphorylated (right). Drawing suggests the membrane topology of a KCNK9 subunit.</ce:simple-para>\\n                  <ce:simple-para view=\"all\">(B) A peptide analogous to a portion of the human neuronal α4 acetylcholine receptor large cytoplasmic loop binds β-COP from rat brain (-RR-, positions 347–348), left. A peptide identical to another portion of the loop binds native 14-3-3β when phosphorylated (-RSLS<ce:sup loc=\"post\">P</ce:sup>V-, positions 464–468; GenBank accession <ce:inter-ref xlink:href=\"genbank:U62433\" xlink:type=\"simple\">U62433</ce:inter-ref>), right. Drawing suggests the membrane topology of an α4 subunit.</ce:simple-para>\\n                  <ce:simple-para view=\"all\">(C) Isolation of native β-COP from rat brain in the presence of native 14-3-3 (top): nonphosphorylated Iip35 (and S<ce:sup loc=\"post\">P</ce:sup> to E) peptides bind β-COP well but the peptide analogous to phosphorylated Iip35 (MHRRRSRS<ce:sup loc=\"post\">P</ce:sup>C) does not. Binding of native 14-3-3β is seen when the Iip35 sequence is phosphorylated (MHRRRSRS<ce:sup loc=\"post\">P</ce:sup>C) but not nonphosphorylated or the S<ce:sup loc=\"post\">P</ce:sup> to E variant (middle). Prebinding of recombinant 14-3-3β ablates β-COP binding to the phosphorylated Iip35 sequence (bottom). Drawing suggests the membrane topology of an Iip35 subunit.</ce:simple-para>\\n               </ce:caption>\\n               <ce:link locator=\"gr6\"/>\\n            </ce:figure>\\n            <ce:figure id=\"FIG7\">\\n               <ce:label>Figure 7</ce:label>\\n               <ce:caption>\\n                  <ce:simple-para view=\"all\">Iip35 In Vivo Binds β-COP or 14-3-3β in Mutually Exclusive Fashion</ce:simple-para>\\n                  <ce:simple-para view=\"all\">COS-7 cells overexpressing Iip35 (FLAG-tagged) were studied by detergent extraction, immunoprecipitation, SDS-PAGE, and Western blot analysis with ECL.</ce:simple-para>\\n                  <ce:simple-para view=\"all\">(A) Iip35 was purified by immunoprecipitation with FLAG antibodies and visualized by antibody to Iip35 (top left); anti-phosphoserine antibodies showed Iip35 to be phosphorylated on serine (bottom left) as expected <ce:cross-ref refid=\"BIB25\">(Kuwana et al., 1998)</ce:cross-ref>. Isolation of Iip35 led to copurification of native βCOP (middle) and native 14-3-3β (right). Control immunoprecipitation with nonimmune IgG.</ce:simple-para>\\n                  <ce:simple-para view=\"all\">(B) When the Iip35 immunoprecipitate was eluted from the beads with FLAG peptide and subjected to a second round of affinity purification with antibody to βCOP (left column) or 14-3-3β (right column) and visualized by antibody to Iip35 (left), βCOP (middle), and 14-3-3β (right), two populations of Iip35 subunits were identified: one with βCOP, another with 14-3-3β.</ce:simple-para>\\n               </ce:caption>\\n               <ce:link locator=\"gr7\"/>\\n            </ce:figure>\\n            <ce:table xmlns=\"http://www.elsevier.com/xml/common/cals/dtd\" id=\"TBL1\" colsep=\"0\" rowsep=\"0\" frame=\"top\">\\n               <ce:label>Table 1</ce:label>\\n               <ce:caption>\\n                  <ce:simple-para view=\"all\">Peptides Used in This Work</ce:simple-para>\\n               </ce:caption>\\n               <tgroup cols=\"3\">\\n                  <colspec colname=\"col1\" colsep=\"0\"/>\\n                  <colspec colname=\"col2\" colsep=\"0\"/>\\n                  <colspec colname=\"col3\" colsep=\"0\"/>\\n                  <thead>\\n                     <row rowsep=\"1\" valign=\"bottom\">\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">Description</entry>\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">Name in Text</entry>\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">Full Product</entry>\\n                     </row>\\n                  </thead>\\n                  <tbody>\\n                     <row valign=\"bottom\">\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">KCNK3 C terminus</entry>\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">-RRSSV</entry>\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">-CHSLSTFRGLMKRRSSV</entry>\\n                     </row>\\n                     <row valign=\"bottom\">\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">KCNK3 C terminus + P</entry>\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">-RRSS<sup loc=\"post\">P</sup>V</entry>\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">-CHSLSTFRGLMKRRSS<sup loc=\"post\">P</sup>V</entry>\\n                     </row>\\n                     <row valign=\"bottom\">\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">KCNK3 with Raf1 site</entry>\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">-RSASEP-</entry>\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">-CSTFRGLMKRSASEP</entry>\\n                     </row>\\n                     <row valign=\"bottom\">\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">KCNK3 with Raf1 site + P</entry>\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">-RSAS<sup loc=\"post\">p</sup>EP</entry>\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">-CSTFRGLMKRSAS<sup loc=\"post\">P</sup>EP</entry>\\n                     </row>\\n                     <row valign=\"bottom\">\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">KCNK3ΔV C terminus</entry>\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">-RSS</entry>\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">-CHSLSTFRGLMKRRSS</entry>\\n                     </row>\\n                     <row valign=\"bottom\">\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">KCNK3ΔV C terminus + P</entry>\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">-RSS<sup loc=\"post\">p</sup>\\n                        </entry>\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">-CHSLSTFRGLMKRRSS<sup loc=\"post\">P</sup>\\n                        </entry>\\n                     </row>\\n                     <row valign=\"bottom\">\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">KCNK3 N terminus</entry>\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">-KR-</entry>\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">MKRQNVAC-</entry>\\n                     </row>\\n                     <row valign=\"bottom\">\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">NQ-KCNK3 N terminus</entry>\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">-NQ-</entry>\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">MNQQNVAC-</entry>\\n                     </row>\\n                     <row valign=\"bottom\">\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">KCNK9 C terminus</entry>\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">-RRKSV</entry>\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">-CFTDHQRLMKRRKSV</entry>\\n                     </row>\\n                     <row valign=\"bottom\">\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">KCNK9 C terminus + P</entry>\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">-RRKS<sup loc=\"post\">p</sup>V</entry>\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">-CFTDHQRLMKRRKS<sup loc=\"post\">P</sup>V</entry>\\n                     </row>\\n                     <row valign=\"bottom\">\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">Human α4 loop</entry>\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">-RSLSV-</entry>\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">-CAPGLAKARSLSVQHMSSPG</entry>\\n                     </row>\\n                     <row valign=\"bottom\">\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">Human α4 loop + P</entry>\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">-RSLS<sup loc=\"post\">p</sup>V-</entry>\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">-CAPGLAKARSLS<sup loc=\"post\">P</sup>VQHMSSPG</entry>\\n                     </row>\\n                     <row valign=\"bottom\">\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">Human α4 loop</entry>\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">-RR-</entry>\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">MPTWVRRVFLDIVPRC-</entry>\\n                     </row>\\n                     <row valign=\"bottom\">\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">Iip35 N terminus</entry>\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">MHRRRSRSC-</entry>\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">MHRRRSRSCREDQKC-</entry>\\n                     </row>\\n                     <row valign=\"bottom\">\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">Iip35 N terminus + P</entry>\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">MHRRRSRS<sup loc=\"post\">p</sup>C-</entry>\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">MHRRRSRS<sup loc=\"post\">P</sup>CREDQKC-</entry>\\n                     </row>\\n                     <row valign=\"bottom\">\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">Iip35 N terminus no S</entry>\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">MHRRRSREC-</entry>\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">MHRRRSRECREDQKC-</entry>\\n                     </row>\\n                     <row valign=\"bottom\">\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">HA peptide</entry>\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">HA peptide</entry>\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">YPYDVPDYA</entry>\\n                     </row>\\n                     <row rowsep=\"1\" valign=\"bottom\">\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">FLAG peptide</entry>\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">FLAG peptide</entry>\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\">DYKDDDDK</entry>\\n                     </row>\\n                     <row>\\n                        <entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" namest=\"col1\" nameend=\"col3\">Peptides were synthesized as described in Experimental Procedures; a dash (-) indicates position of linkage to beads or other residues in the protein.</entry>\\n                     </row>\\n                  </tbody>\\n               </tgroup>\\n            </ce:table>\\n         </ce:floats>\\n         <head>\\n            <ce:dochead>\\n               <ce:textfn>Aritcle</ce:textfn>\\n            </ce:dochead>\\n            <ce:title>Forward Transport</ce:title>\\n            <ce:subtitle>14-3-3 Binding Overcomes Retention in Endoplasmic Reticulum by Dibasic Signals</ce:subtitle>\\n            <ce:author-group>\\n               <ce:author>\\n                  <ce:given-name>Ita</ce:given-name>\\n                  <ce:surname>O\\'Kelly</ce:surname>\\n               </ce:author>\\n               <ce:author>\\n                  <ce:given-name>Margaret H.</ce:given-name>\\n                  <ce:surname>Butler</ce:surname>\\n               </ce:author>\\n               <ce:author>\\n                  <ce:given-name>Noam</ce:given-name>\\n                  <ce:surname>Zilberberg</ce:surname>\\n               </ce:author>\\n               <ce:author>\\n                  <ce:given-name>Steve A.N.</ce:given-name>\\n                  <ce:surname>Goldstein</ce:surname>\\n                  <ce:cross-ref refid=\"CORR1\">*</ce:cross-ref>\\n                  <ce:e-address type=\"email\">steve.goldstein@yale.edu</ce:e-address>\\n               </ce:author>\\n               <ce:affiliation>\\n                  <ce:textfn>Yale University School of Medicine, Department of Pediatrics, Department of Cellular and Molecular Physiology, Boyer Center for Molecular Medicine, New Haven, CT 06536 USA</ce:textfn>\\n               </ce:affiliation>\\n               <ce:correspondence id=\"CORR1\">\\n                  <ce:label>*</ce:label>\\n                  <ce:text>Correspondence: Steve A.N. Goldstein, (203) 737 2214 (phone), (203) 737 2290 (fax)</ce:text>\\n               </ce:correspondence>\\n            </ce:author-group>\\n            <ce:date-received day=\"13\" month=\"3\" year=\"2002\"/>\\n            <ce:date-revised day=\"10\" month=\"9\" year=\"2002\"/>\\n            <ce:abstract class=\"author\">\\n               <ce:section-title>Abstract</ce:section-title>\\n               <ce:abstract-sec>\\n                  <ce:simple-para view=\"all\">Proteins with dibasic retention motifs are subject to retrograde transport to endoplasmic reticulum (ER) by COPI-coated vesicles. As forward transport requires escape from ER retention, general release mechanisms have been expected. Here, KCNK3 potassium channels are shown to bear two cytoplasmic trafficking motifs: an N-terminal dibasic site that binds β-COP to hold channels in ER and a C-terminal “release” site that binds the ubiquitous intracellular regulator 14-3-3β on a nonclassical motif in a phosphorylation-dependent fashion to suppress β-COP binding and allow forward transport. The strategy appears to be common. The major histocompatibility antigen class II-associated invariant chain Iip35 exhibits dibasic retention, carries a release motif, and shows mutually exclusive binding of β-COP and 14-3-3β on adjacent N-terminal sites. Other retained proteins are demonstrated to carry functional 14-3-3β release motifs.</ce:simple-para>\\n               </ce:abstract-sec>\\n            </ce:abstract>\\n         </head>\\n         <body>\\n            <ce:sections>\\n               <ce:section view=\"all\">\\n                  <ce:section-title>Introduction</ce:section-title>\\n                  <ce:para view=\"all\">Newly synthesized proteins destined for membrane expression fold within the endoplasmic reticulum (ER) and travel forward through the <ce:italic>cis</ce:italic>-golgi complex <ce:cross-refs refid=\"BIB8 BIB32\">(Ellgaard et al., 1999; Mellman and Warren, 2000)</ce:cross-refs>. Misfolded or resident proteins that escape the ER are retrieved into COPI-coated vesicles for retrograde transport <ce:cross-refs refid=\"BIB27 BIB11\">(Letourneur et al., 1994; Gaynor and Emr, 1997)</ce:cross-refs>. COPI vesicles operate with notable specificity, recovering proteins through interaction with cytoplasmic dibasic “retrieval” motifs <ce:cross-refs refid=\"BIB35 BIB46 BIB54\">(Nilsson et al., 1989; Teasdale and Jackson, 1996; Zerangue et al., 2001)</ce:cross-refs>. How COPI vesicular machinery (a complex of at least seven proteins) differentiates cargo for retention or forward transport is unknown. A masking strategy has been proposed in cases where expression is limited to fully assembled heteromeric complexes: the retention signal on one subunit hidden through assembly with its nonidentical partner(s) <ce:cross-refs refid=\"BIB24 BIB53 BIB44 BIB52\">(Klausner, 1990; Zerangue et al., 1999; Standley et al., 2000; Zarei et al., 2001)</ce:cross-refs>. Here, the cytoplasmic protein 14-3-3β is shown to act in a phosphorylation-dependent fashion to inhibit association of COPI proteins with dibasic sites and allow forward transport.</ce:para>\\n                  <ce:para view=\"all\">The seven known isoforms of 14-3-3 have been ascribed roles in biological activities as diverse as apoptotic cell death, cell cycle control, cell adhesion, mitogen signaling, and neuronal plasticity <ce:cross-refs refid=\"BIB10 BIB50\">(Fu et al., 2000; Tzivion and Avruch, 2002)</ce:cross-refs>. These ∼30 kDa, soluble, cytoplasmic proteins exert their recognized influences by binding to the consensus motifs -RSXS<ce:sup loc=\"post\">P</ce:sup>XP- and -RXXXS<ce:sup loc=\"post\">P</ce:sup>XP- (hyphen indicates linkage to other residues) present on kinases, phosphatases, and transmembrane receptors after a serine in the motif is phosphorylated (S<ce:sup loc=\"post\">P</ce:sup>) <ce:cross-refs refid=\"BIB49 BIB9 BIB36 BIB33 BIB3 BIB4 BIB48 BIB55\">(Toker et al., 1990; Freed et al., 1994; Pallas et al., 1994; Muslin et al., 1996; Campbell et al., 1997; Craparo et al., 1997; Thorson et al., 1998; Zhou et al., 1999)</ce:cross-refs>. A role for 14-3-3 in intracellular protein trafficking has been inferred from its capacity to rescue yeast cells with clathrin heavy chain mutations <ce:cross-ref refid=\"BIB12\">(Gelperin et al., 1995)</ce:cross-ref>, enhance expression of neuronal acetylcholine receptors <ce:cross-ref refid=\"BIB17\">(Jeanclos et al., 2001)</ce:cross-ref>, and alter levels of immune complexes on cells defective for clathrin-mediated endocytosis <ce:cross-ref refid=\"BIB25\">(Kuwana et al., 1998)</ce:cross-ref>.</ce:para>\\n                  <ce:para view=\"all\">KCNK channels pass background potassium currents that regulate the behavior of nerves and muscles <ce:cross-refs refid=\"BIB26 BIB14\">(Lesage and Lazdunski, 2000; Goldstein et al., 2001)</ce:cross-refs>. Subject to dynamic regulation in current magnitude, KCNK3 channels are homodimeric complexes <ce:cross-ref refid=\"BIB30\">(Lopes et al., 2001)</ce:cross-ref> implicated in responses of the heart and central nervous system to hormones, neurotransmitters, acidosis, hypoxia, and local and volatile anesthetics. In this study, surface expression of KCNK3 is found to be controlled by interplay of two sites: a dibasic site on the N terminus that binds β-COP to retain channels in ER and a C-terminal release site that binds 14-3-3β to a nonclassical motif (-RRSS<ce:sup loc=\"post\">P</ce:sup>V), allowing forward transport. Thus, mutations that abolish 14-3-3β binding suppress trafficking to the plasma membrane while surface expression is restored by ablation of the dibasic site or restitution of 14-3-3β binding on the channel C terminus, for example, by creation of a classical 14-3-3 site as found in Raf1 kinase (-RSAS<ce:sup loc=\"post\">P</ce:sup>EP). A mechanism is suggested by demonstration that (despite separation of retention and release motifs in the KCNK3 primary sequence) the channels bind β-COP or 14-3-3β in mutually exclusive fashion.</ce:para>\\n                  <ce:para view=\"all\">The presence of 14-3-3β binding motifs in other proteins subject to ER retention via dibasic signals suggests that operation of release sites may be common. Functional β-COP and 14-3-3β release motifs are demonstrated in three other membrane proteins. KCNK9 channels are shown to bear an N-terminal retention site identical to that in KCNK3 and a similar C-terminal release site (-RRKS<ce:sup loc=\"post\">P</ce:sup>V). Nicotinic acetylcholine α4 subunits are shown to carry a dibasic motif analogous to a site that retains skeletal muscle α subunits in ER <ce:cross-ref refid=\"BIB19\">(Keller et al., 2001)</ce:cross-ref> and a variant release site (-RSLS<ce:sup loc=\"post\">P</ce:sup>V-), both on a large cytoplasmic loop previously demonstrated to influence surface expression and to bind 14-3-3ϵ <ce:cross-ref refid=\"BIB17\">(Jeanclos et al., 2001)</ce:cross-ref>.</ce:para>\\n                  <ce:para view=\"all\">The cytoplasmic N terminus of the Iip35 major histocompatibility antigen class II-associated invariant chain has a dibasic motif that maintains the subunit in ER <ce:cross-ref refid=\"BIB43\">(Schutze et al., 1994)</ce:cross-ref>. Phosphorylation of the subunit has been shown to regulate forward trafficking of class II complexes <ce:cross-ref refid=\"BIB1\">(Anderson et al., 1999)</ce:cross-ref>, alter release from ER, and lead to 14-3-3 binding <ce:cross-ref refid=\"BIB25\">(Kuwana et al., 1998)</ce:cross-ref>. Inspection reveals that Iip35 carries a retention site (MH<math altimg=\"si1.gif\">\\n                        <unl type=\"bar\" style=\"s\">RRR</unl>\\n                     </math>SRSC-) adjacent to a variant release site (MHRR<math altimg=\"si2.gif\">\\n                        <unl type=\"bar\" style=\"s\">RSRS<sup loc=\"post\">P</sup>C</unl>\\n                     </math>-). Here, we find that like KCNK3, Iip35 binds either β-COP or 14-3-3β in mutually exclusive fashion. When the terminus is not phosphorylated, β-COP binds (even in the presence of 14-3-3β); upon phosphorylation, 14-3-3β binds and β-COP association is suppressed.</ce:para>\\n                  <ce:para view=\"all\">A general mechanism for regulated anterograde trafficking is thus suggested. That 14-3-3β binds to KCNK3 to inhibit association of β-COP leading to release of homodimeric channels from ER retention, and that 14-3-3β binds to Iip35 invariant chains to suppress β-COP binding under conditions that stimulate forward trafficking of heteromeric class II complexes <ce:cross-ref refid=\"BIB1\">(Anderson et al., 1999)</ce:cross-ref> indicates that forward transport of proteins with dibasic retention motifs is favored by phosphorylation-dependent binding of 14-3-3 to the cargo, termination of COPI protein association, and release from ER retention.</ce:para>\\n               </ce:section>\\n               <ce:section view=\"all\">\\n                  <ce:section-title>Results</ce:section-title>\\n                  <ce:section view=\"all\">\\n                     <ce:section-title>KCNK3 Peptide Identifies 14-3-3β</ce:section-title>\\n                     <ce:para view=\"all\">KCNK3 subunits are predicted to have cytoplasmic N and C termini, two pore loops, and four transmembrane segments (<ce:cross-ref refid=\"FIG1\">Figure 1A</ce:cross-ref>\\n                        <ce:float-anchor refid=\"FIG1\"/>; <ce:cross-ref refid=\"BIB14\">Goldstein et al., 2001</ce:cross-ref>). The five carboxy-terminal residues of KCNK3 (residues 390–394, -RRSSV) contain a consensus site for phosphorylation and suggest a potential PDZ-type binding motif. To probe the terminus for protein-protein interactions, a human heart cDNA library was screened by a yeast two-hybrid method using Gal4-based signaling and the last 16 residues of human KCNK3 as bait. Screening produced two independent isolates of the gene for 14-3-3β (GenBank accession number <ce:inter-ref xlink:href=\"genbank:P31946\" xlink:type=\"simple\">P31946</ce:inter-ref>) and the upstream untranslated region of a known protein. This was unexpected, as the bait did not contain either common motif for 14-3-3 binding, -RSXS<ce:sup loc=\"post\">P</ce:sup>XP- or -RXXXS<ce:sup loc=\"post\">P</ce:sup>XP- <ce:cross-ref refid=\"BIB50\">(Tzivion and Avruch, 2002)</ce:cross-ref>.</ce:para>\\n                  </ce:section>\\n                  <ce:section view=\"all\">\\n                     <ce:section-title>KCNK3 Binds 14-3-3β in Rat Brain</ce:section-title>\\n                     <ce:para view=\"all\">Interaction of 14-3-3β and the KCNK3 bait was confirmed at the protein level with two KCNK3 peptides identical to the terminal 16 amino acids of the channel <ce:cross-ref refid=\"TBL1\">(Table 1)</ce:cross-ref>\\n                        <ce:float-anchor refid=\"TBL1\"/>. As 14-3-3 binding to classical motifs requires phosphorylation, the first peptide carried serine at the penultimate position (-RRS<math altimg=\"si3.gif\">\\n                           <unl type=\"bar\" style=\"s\">S</unl>\\n                        </math>V), the second a phosphoserine (-RRS<math altimg=\"si4.gif\">\\n                           <unl type=\"bar\" style=\"s\">S<sup loc=\"post\">P</sup>\\n                           </unl>\\n                        </math>V). The peptides were immobilized on beads and incubated with homogenized, detergent-solubilized rat brain. After washing to remove weakly associated proteins, bound products were eluted with 1% sodium dodecylsulfate (SDS) and separated by polyacrylamide electrophoresis (SDS-PAGE). Coomassie blue staining revealed that two major products bound only to the phosphorylated peptide <ce:cross-ref refid=\"FIG1\">(Figure 1B)</ce:cross-ref>. These products were identified by MALDI-MS analyses to be 14-3-3β and 14-3-3ϵ <ce:cross-ref refid=\"FIG1\">(Figure 1C)</ce:cross-ref>.</ce:para>\\n                     <ce:para view=\"all\">As expected from studies of classical motifs <ce:cross-ref refid=\"BIB33\">(Muslin et al., 1996)</ce:cross-ref>, antibody staining demonstrated that native 14-3-3β from rat brain or heart or skeletal muscle bound only to the phosphorylated KCNK3 peptide <ce:cross-ref refid=\"FIG1\">(Figure 1D)</ce:cross-ref>. Indicating association of native 14-3-3β and KCNK3 channels in vivo, the channels were copurified when a monoclonal antibody was used to immunoprecipitate 14-3-3β from rat brain (<ce:cross-ref refid=\"FIG1\">Figure 1E</ce:cross-ref>, top). The native KCNK3 subunits purified with 14-3-3 were phosphorylated on serine (<ce:cross-ref refid=\"FIG1\">Figure 1E</ce:cross-ref>, bottom); studies of cloned human KCNK3 channels (below) show that serine phosphorylation and 14-3-3 binding occur on the C-terminal motif of the intact channel.</ce:para>\\n                  </ce:section>\\n                  <ce:section view=\"all\">\\n                     <ce:section-title>The Final Valine Is Required to Bind 14-3-3β</ce:section-title>\\n                     <ce:para view=\"all\">The 14-3-3 site in KCNK3 is like classical sites in requiring a phosphoserine but atypical both for lacking proline (P) two positions downstream and in its location at the protein C terminus <ce:cross-refs refid=\"BIB33 BIB51 BIB39\">(Muslin et al., 1996; Yaffe et al., 1997; Rittinger et al., 1999)</ce:cross-refs>. To evaluate these unique attributes, isolation of native 14-3-3β from rat brain was studied with various immobilized peptides. First, the KCNK3 residues -RRSS<ce:sup loc=\"post\">P</ce:sup>V were replaced with a classical binding motif (-RSAS<ce:sup loc=\"post\">P</ce:sup>EP-) that is present in the middle of the canonical 14-3-3 binding protein Raf1 kinase; this showed that, like the atypical site in KCNK3, a classical site could mediate phosphorylation-dependent binding of 14-3-3β when located at a C terminus <ce:cross-ref refid=\"FIG2\">(Figure 2A)</ce:cross-ref>\\n                        <ce:float-anchor refid=\"FIG2\"/>. Next, the KCNK3 site was shown to require its terminal valine since 14-3-3β did not bind to peptides terminating -RRSS or -RRSS<ce:sup loc=\"post\">P</ce:sup> \\n                        <ce:cross-ref refid=\"FIG2\">(Figure 2A)</ce:cross-ref>.</ce:para>\\n                  </ce:section>\\n                  <ce:section view=\"all\">\\n                     <ce:section-title>KCNK3ΔV Channels Do Not Function</ce:section-title>\\n                     <ce:para view=\"all\">To assess the effect of 14-3-3β on KCNK3, function of channels expressed in <ce:italic>Xenopus laevis</ce:italic> oocytes was studied by two-electrode voltage clamp. Wild-type KCNK3 channels were first compared to mutants that terminated like the peptides that bound 14-3-3β via the classical motif found in Raf1 (KCNK3-RSAS<ce:sup loc=\"post\">P</ce:sup>EP). The two channels produced currents that were indistinguishable <ce:cross-ref refid=\"FIG2\">(Figure 2B)</ce:cross-ref>. Thus, cells expressing wild-type KCNK3 or KCNK3-RSAS<ce:sup loc=\"post\">P</ce:sup>EP channels showed currents not seen in control cells and like those observed previously <ce:cross-refs refid=\"BIB29 BIB30\">(Lopes et al., 2000, 2001)</ce:cross-refs>. Currents produced by voltage steps showed a major component that appeared to activate and deactivate instantaneously and a smaller time-dependent component <ce:cross-ref refid=\"FIG2\">(Figure 2B)</ce:cross-ref>. The channels also showed the same selectivity for potassium as judged by reversal potential (shifting 60mV ± 1mV and 60mV ± 2mV with a change in bath potassium from 5 to 100 mM for mutant and wild-type, respectively, n = 6–8 cells). Moreover, in both cases acidification of the external medium from pH 7.4 to 6.5 produced nearly complete blockade <ce:cross-ref refid=\"FIG2\">(Figure 2C)</ce:cross-ref>. In contrast, mutant KCNK3 subunits that terminated like the peptide that could not bind 14-3-3β due to deletion of the final valine residue (KCNK3ΔV) produced no currents in the oocytes <ce:cross-ref refid=\"FIG2\">(Figures 2B and 2C)</ce:cross-ref>. Furthermore, a variant KCNK3 C-terminal peptide with diminished but not absent 14-3-3β binding (-RRS<ce:sup loc=\"post\">P</ce:sup>SV) was associated with mutant KCNK3 channels that showed depressed but not ablated current (KCNK3-RRSAV, KCNK3-RQSSV, and KCNK3-QRSSV, not shown). These findings suggested that 14-3-3 was required either to allow channels to reach the surface or to operate once inserted into the plasma membrane.</ce:para>\\n                  </ce:section>\\n                  <ce:section view=\"all\">\\n                     <ce:section-title>KCNK3ΔV Channels Do Not Reach the Surface</ce:section-title>\\n                     <ce:para view=\"all\">A binding assay demonstrated that KCNK3ΔV subunits fail to reach the plasma membrane. A hemagglutinin (HA) epitope tag was introduced into wild-type KCNK3 and KCNK3ΔV after the second pore domain, a site predicted to be exposed to the external milieu. Each oocyte was first studied by two-electrode voltage clamp, and then channel protein on the surface of intact cells was quantified using anti-HA antibody, a secondary antibody conjugated with horseradish peroxidase, and luminometery, a method developed by others <ce:cross-ref refid=\"BIB53\">(Zerangue et al., 1999)</ce:cross-ref>. Whereas HA-tagged, wild-type KCNK3 subunits yielded a strong surface signal, HA-tagged KCNK3ΔV and untagged wild-type KCNK3 channels showed the same null level of fluorescence as uninjected oocytes <ce:cross-ref refid=\"FIG3\">(Figure 3A)</ce:cross-ref>\\n                        <ce:float-anchor refid=\"FIG3\"/>. Failure to detect KCNK3ΔV channels on the surface was not due to failure to synthesize the protein; study of cells expressing HA-tagged wild-type and KCNK3ΔV channels by homogenization, SDS-PAGE, and Western blot analysis showed that similar levels of the two proteins were produced <ce:cross-ref refid=\"FIG3\">(Figure 3B)</ce:cross-ref>. Since the biophysical attributes of HA-tagged KCNK3 channels were the same as their untagged counterparts, it seemed unlikely the tag further interfered with function of KCNK3ΔV channels <ce:cross-ref refid=\"FIG3\">(Figures 3C and 3D)</ce:cross-ref>.</ce:para>\\n                  </ce:section>\\n                  <ce:section view=\"all\">\\n                     <ce:section-title>An N-Terminal Dibasic Motif Holds KCNK3ΔV Channels inside the Cells</ce:section-title>\\n                     <ce:para view=\"all\">KCNK3 subunits carry a potential ER retention motif, KR, at positions 2–3. To examine whether the motif had a role in failure of KCNK3ΔV subunits to reach the surface, the residues were altered by mutation to NQ <ce:cross-ref refid=\"FIG3\">(Figure 3A)</ce:cross-ref>. The change restored function to KCNK3ΔV channels: NQ-KCNK3ΔV subunits bearing an HA-tag showed strong surface signals <ce:cross-ref refid=\"FIG3\">(Figure 3A)</ce:cross-ref>, and although currents were smaller in magnitude, NQ-KCNK3ΔV channels were like untagged or HA-tagged wild-type KCNK3 channels in their response to voltage steps <ce:cross-ref refid=\"FIG3\">(Figure 3C)</ce:cross-ref>, selectivity for potassium (shifting 58mV ± 2mV with a change in bath potassium from 5 to 100 mM, n = 6 cells), and inhibition by external acidification <ce:cross-ref refid=\"FIG3\">(Figure 3D)</ce:cross-ref>. This supported the conclusions that on its own the ΔV mutation altered surface expression but not capacity to pass current and that 14-3-3 was not required for normal function of the channel once it had achieved surface expression.</ce:para>\\n                     <ce:para view=\"all\">KCNK3 channels expressed in mammalian tissue culture cells (COS-7) behaved like those studied in oocytes. Thus, wild-type channels were transported to the plasma membrane <ce:cross-ref refid=\"FIG4\">(Figure 4A)</ce:cross-ref>\\n                        <ce:float-anchor refid=\"FIG4\"/>; KCNK3ΔV channels did not reach the surface (<ce:cross-ref refid=\"FIG4\">Figure 4B</ce:cross-ref>, top) while surface transferrin receptor was readily apparent (<ce:cross-ref refid=\"FIG4\">Figure 4B</ce:cross-ref>, middle); and finally, N-terminal mutation to form NQ-KCNK3ΔV channels restored transport to the surface <ce:cross-ref refid=\"FIG4\">(Figure 4C)</ce:cross-ref>. Cell permeabilization showed KCNK3ΔV channels to be held in perinuclear areas as expected (<ce:cross-ref refid=\"FIG4\">Figure 4B</ce:cross-ref>, bottom). Immunostain and Western blot analyses revealed native 14-3-3β to be prominent in COS-7 cells (with a diffuse cytoplasmic pattern), suggesting why heterologous expression of recombinant 14-3-3β did not change the trafficking patterns of the three KCNK3 variants (not shown).</ce:para>\\n                  </ce:section>\\n                  <ce:section view=\"all\">\\n                     <ce:section-title>KCNK3 Binds Either β-COP or 14-3-3β</ce:section-title>\\n                     <ce:para view=\"all\">To confirm that ER retention of KCNK3 channels was mediated via the N-terminal dibasic signal and the coatomer retrieval/retention mechanism <ce:cross-refs refid=\"BIB8 BIB32\">(Ellgaard et al., 1999; Mellman and Warren, 2000)</ce:cross-refs>, HA-tagged KCNK3 channels were expressed in COS-7 cells and associated native proteins evaluated by immunoprecipitation. <ce:cross-ref refid=\"FIG5\">Figure 5A</ce:cross-ref>\\n                        <ce:float-anchor refid=\"FIG5\"/> shows that affinity purification with antibodies to HA isolated wild-type KCNK3 (top left) in association with β-COP (top right); conversely, KCNK3 channels altered from KR to NQ in the N-terminal dibasic motif were purified like wild-type (lower left) but were not associated with β-COP (lower right).</ce:para>\\n                     <ce:para view=\"all\">Immunoprecipitation of HA-tagged KCNK3 channels from COS-7 cells also led to isolation of associated native 14-3-3β (<ce:cross-ref refid=\"FIG5\">Figure 5B</ce:cross-ref>, top left). Like KCNK3 channels in rat brain <ce:cross-ref refid=\"FIG1\">(Figure 1E)</ce:cross-ref>, the cloned channels associated with 14-3-3 carried phosphate on serine (<ce:cross-ref refid=\"FIG5\">Figure 5B</ce:cross-ref>, top right). Further evidence that phosphoryation and 14-3-3 binding occurred at the KCNK3 C terminus was offered by mutation of the clone to remove the only serine phosphorylation consensus site external to the C terminus (S358A KCNK3), as this did not interfere with 14-3-3 binding (<ce:cross-ref refid=\"FIG5\">Figure 5B</ce:cross-ref>, bottom left) or phosphoserine staining (<ce:cross-ref refid=\"FIG5\">Figure 5B</ce:cross-ref>, bottom right).</ce:para>\\n                     <ce:para view=\"all\">The HA immunoprecipitates were shown to contain two separable populations of KCNK3 subunits, one associated with β-COP, the other with 14-3-3β, as follows <ce:cross-ref refid=\"FIG5\">(Figure 5C)</ce:cross-ref>: a second immunoprecipitation step (IP2) to reisolate β-COP led to repurification of KCNK3 (left) and β-COP (middle) but not 14-3-3β (right); conversely, IP2 to reisolate 14-3-3β yielded KCNK3 (left) and 14-3-3β (right) but not β-COP (middle). Failure to detect 14-3-3 associated with KCNK3 in the β-COP IP2 indicated its depletion to less than 5% of levels carried by unfractionated KCNK3 in IP1 (Experimental Procedures); depletion of β-COP in the 14-3-3 IP2 was similarly demonstrated to exceed 90%. These findings supported the conclusion that KCNK3 channels were held in ER via the COPI retention pathway and that phosphorylation-dependent binding of 14-3-3 suppressed COPI association to facilitate forward transport.</ce:para>\\n                  </ce:section>\\n                  <ce:section view=\"all\">\\n                     <ce:section-title>Release Motifs in KCNK9, α4, and Iip35</ce:section-title>\\n                     <ce:para view=\"all\">To explore the idea that proteins other than KCNK3 might employ a 14-3-3 release strategy, we studied peptides based on three plasma membrane subunits subject to ER retention by the COPI-dibasic signal pathway where prior studies had implicated phosphorylation and/or 14-3-3 in forward transport. KCNK9 channels are 54% identical to KCNK3 (the first nine residues of the two channels containing the KCNK3 dibasic retention motif are exactly alike) and predicted to have the same membrane topology <ce:cross-ref refid=\"BIB22\">(Kim et al., 2000)</ce:cross-ref>. As expected, peptides matching the wild-type KCNK9/KCNK3 N terminus were found to bind β-COP from rat brain, whereas peptides that disrupted the motif (and allowed NQ-KCNK3ΔV channels to escape ER retention) did not (<ce:cross-ref refid=\"FIG6\">Figure 6A</ce:cross-ref>\\n                        <ce:float-anchor refid=\"FIG6\"/>, left). The C-terminal residues in KCNK9 subunits (-RRKSV) are similar to those in KCNK3 (-RRSSV), and the peptide analogous to the KCNK9 terminus was demonstrated, as anticipated, to bind 14-3-3β from rat brain when the penultimate serine was phosphorylated (<ce:cross-ref refid=\"FIG6\">Figure 6A</ce:cross-ref>, right).</ce:para>\\n                     <ce:para view=\"all\">Neuronal nicotinic acetylcholine receptors (nAChR) are ligand-gated, nonselective cation channels and attain surface expression after homo- or heteropentameric assembly <ce:cross-ref refid=\"BIB31\">(McGehee, 1999)</ce:cross-ref>. Support for the operation of β-COP retention and 14-3-3β release motifs in neuronal α4 subunits was obtained as follows. Skeletal muscle α subunits are confined to ER by a dibasic signal, RK (positions 313–314) <ce:cross-ref refid=\"BIB19\">(Keller et al., 2001)</ce:cross-ref> and released after assembly of α, β, δ, and γ subunits (this appears to mask the α subunit retention signal). We found a similar motif in the large cytoplasmic loop of neuronal α4 subunits (RR, positions 347–348) that bound β-COP from rat brain (<ce:cross-ref refid=\"FIG6\">Figure 6B</ce:cross-ref>, left). Jeanclos and colleagues <ce:cross-ref refid=\"BIB17\">(Jeanclos et al., 2001)</ce:cross-ref> identified a motif in the same loop of α4 subunits (-RSLSVQ-, positions 438–443) that binds 14-3-3η, leading to an increase of homomeric α4 complexes on the surface (a smaller effect was seen on heteromeric α4β2 complexes). Consistent with their potential role as a KCNK3-like release site, these α4 residues were also found to bind 14-3-3β from rat brain when phosphorylated, -RSLS<ce:sup loc=\"post\">P</ce:sup>VQ- (<ce:cross-ref refid=\"FIG6\">Figure 6B</ce:cross-ref>, right).</ce:para>\\n                     <ce:para view=\"all\">Ii chains associate with newly synthesized class II molecules in ER to control their forward trafficking to antigen-processing compartments and prevent unwanted interaction of peptides with the class II binding groove during passage through the secretory pathway <ce:cross-refs refid=\"BIB40 BIB47 BIB5\">(Roche, 1990; Teyton, 1990; Cresswell, 1994)</ce:cross-refs>. The operation of COPI retention and 14-3-3β release sites was strongly suggested by the observations that a dibasic motif retains Iip35 in ER <ce:cross-ref refid=\"BIB43\">(Schutze et al., 1994)</ce:cross-ref> and that phosphorylation regulates forward trafficking of class II complexes <ce:cross-ref refid=\"BIB1\">(Anderson et al., 1999)</ce:cross-ref> in association with 14-3-3 binding <ce:cross-ref refid=\"BIB25\">(Kuwana et al., 1998)</ce:cross-ref>. Kuwana and coworkers <ce:cross-ref refid=\"BIB25\">(Kuwana et al., 1998)</ce:cross-ref> further showed that it is serine 8 of Iip35 that bears phosphate in vivo and that mutation of the site to alanine suppressed 14-3-3 binding.</ce:para>\\n                  </ce:section>\\n                  <ce:section view=\"all\">\\n                     <ce:section-title>14-3-3β Blocks β-COP Binding to Iip35</ce:section-title>\\n                     <ce:para view=\"all\">The Iip35 N terminus carries a basic retention motif, MH<math altimg=\"si5.gif\">\\n                           <unl type=\"bar\" style=\"s\">RRR</unl>\\n                        </math>SRSC-, followed by a suspected 14-3-3 release site. Using rat brain as a source of native β-COP and 14-3-3β, the nonphosphorylated terminus was found to bind a significant level of β-COP in the presence of 14-3-3β but not when the terminus was phosphorylated (MHRRRSRS<ce:sup loc=\"post\">P</ce:sup>C-) (<ce:cross-ref refid=\"FIG6\">Figure 6C</ce:cross-ref>, top). Conversely, 14-3-3β bound only to the phosphorylated form of the N terminus (<ce:cross-ref refid=\"FIG6\">Figure 6C</ce:cross-ref>, middle). We suspected that poor binding of β-COP to the phosphorylated terminus was due to blocking of its binding site by 14-3-3β. To test this idea, β-COP binding was studied again using termini pretreated with recombinant human 14-3-3β synthesized and purified from <ce:italic>E. coli</ce:italic>. As expected, exposure to 14-3-3β did not alter β-COP binding to the nonphosphorylated terminus but ablated binding to the phosphorylated form (<ce:cross-ref refid=\"FIG6\">Figure 6C</ce:cross-ref>, bottom). Supporting the conclusion that phosphorylation per se did not inhibit association of β-COP with its site, mutation of the S<ce:sup loc=\"post\">P</ce:sup> site to a negatively charged glutamic acid (MHRRRSREC-) did not interfere with β-COP binding (<ce:cross-ref refid=\"FIG6\">Figure 6C</ce:cross-ref>, top) nor allow 14-3-3β binding (<ce:cross-ref refid=\"FIG6\">Figure 6C</ce:cross-ref>, middle). The retention and release sites thus operate in exclusive fashion such that 14-3-3β binding precludes β-COP association.</ce:para>\\n                  </ce:section>\\n                  <ce:section view=\"all\">\\n                     <ce:section-title>Iip35 Binds Only β-COP or 14-3-3β In Vivo</ce:section-title>\\n                     <ce:para view=\"all\">The behavior of Iip35 in vivo supported operation of a mechanism for forward transport like that found for KCNK3: ER retention via the COPI-dibasic pathway and phosphorylation-dependent binding of 14-3-3 leading to inhibition of COPI binding and release from ER due to mutually exclusive binding. Thus, immunoprecipitation of Iip35 (bearing a C-terminal FLAG tag) from COS-7 cells with FLAG antibodies yielded Iip35 that was phosphorylated on serine (<ce:cross-ref refid=\"FIG7\">Figure 7A</ce:cross-ref>\\n                        <ce:float-anchor refid=\"FIG7\"/>, left). As with KCNK3, the primary Iip35 immunoprecipitate contained both native βCOP and 14-3-3β (<ce:cross-ref refid=\"FIG7\">Figure 7A</ce:cross-ref>, middle and right), and the two mediators were found to reside in separate populations of Iip35 complexes <ce:cross-ref refid=\"FIG7\">(Figure 7B)</ce:cross-ref>: subjecting the immunoprecipitate to a second affinity purification step (IP2) to reisolate 14-3-3β yielded Iip35 and 14-3-3β (left and right columns) but not β-COP (middle column), while reisolation of β-COP rendered Iip35 and β-COP (left and middle columns) but not 14-3-3β (right column).</ce:para>\\n                     <ce:para view=\"all\">Although KCNK3 has multiple basic residues in its C-terminal 14-3-3 binding site (-KRRSSV), they do not appear to play a direct role in ER retention as do those at the Iip35 N terminus. Thus, wild-type KCNK3 channels bind β-COP (<ce:cross-ref refid=\"FIG5\">Figure 5A</ce:cross-ref>, top) unless the N terminus is mutated (<ce:cross-ref refid=\"FIG5\">Figure 5A</ce:cross-ref>, bottom), suggesting no other β-COP binding site is present. Similarly, N-terminal Iip35 and KCNK3 peptides bind β-COP <ce:cross-ref refid=\"FIG6\">(Figures 6A and 6C)</ce:cross-ref> while C-terminal KCNK3 peptides do not (not shown). Finally, it is the wild-type N terminus that retains KCNK3ΔV channels inside cells <ce:cross-refs refid=\"FIG2 FIG3 FIG4\">(Figures 2, 3, and 4)</ce:cross-refs>, as its mutation to form NQ-KCNK3ΔV channels allows release to the surface <ce:cross-refs refid=\"FIG3 FIG4\">(Figures 3 and 4)</ce:cross-refs>.</ce:para>\\n                  </ce:section>\\n               </ce:section>\\n               <ce:section view=\"all\">\\n                  <ce:section-title>Discussion</ce:section-title>\\n                  <ce:para view=\"all\">Regulated surface expression of plasma membrane receptors is key to normal cellular physiology <ce:cross-refs refid=\"BIB8 BIB32\">(Ellgaard et al., 1999; Mellman and Warren, 2000)</ce:cross-refs>. Membrane trafficking proceeds under tight control to establish steady-state expression levels, respond to acute stimuli, and monitor the quality of secreted multimeric products. One cellular strategy is to maintain proteins in ER through retention and recovery in COPI-coated vesicles via “dibasic” recognition of sites of one, two, or three sequential arginine or lysine residues <ce:cross-refs refid=\"BIB35 BIB46 BIB54\">(Nilsson et al., 1989; Teasdale and Jackson, 1996; Zerangue et al., 2001)</ce:cross-refs>. While masking of retention signals appears to allow some mixed complexes to escape the ER <ce:cross-refs refid=\"BIB53 BIB44 BIB52\">(Zerangue et al., 1999; Standley et al., 2000; Zarei et al., 2001)</ce:cross-refs>, general methods to overcome suppression have been unknown. In this study, we show that surface expression of KCNK3 channels is achieved by phosphorylation-dependent binding of 14-3-3β and release from COPI-mediated ER retention. The mechanistic basis for forward transport of KCNK3 appears to be mutually exclusive binding of β-COP and 14-3-3β. Functional β-COP retention and 14-3-3β release motifs are demonstrated in three other proteins (KCNK9 channels, α4 nicotinic acetylcholine receptors, and Iip35). Retention and release sites on the immune system protein are adjacent and 14-3-3β binding (rather than motif phosphorylation) is demonstrated to suppress β-COP binding. The findings show 14-3-3 to be a generic mediator of release from ER retention, expand recognized binding motifs for 14-3-3, and suggest a mechanism for regulating forward trafficking of homomeric and heteromeric protein complexes.</ce:para>\\n                  <ce:section view=\"all\">\\n                     <ce:section-title>Trafficking to the Plasma Membrane</ce:section-title>\\n                     <ce:para view=\"all\">KCNK channels show widespread tissue expression from at least 17 separate genes <ce:cross-refs refid=\"BIB26 BIB14\">(Lesage and Lazdunski, 2000; Goldstein et al., 2001)</ce:cross-refs>. Subject to regulation in magnitude and character by a panoply of natural and medicinal agents, the channels are notable in both structure and function because they carry two pore-forming P loops on each subunit (K<ce:inf loc=\"post\">2P</ce:inf> channels) and form background potassium channels <ce:cross-refs refid=\"BIB20 BIB13 BIB2 BIB16 BIB56\">(Ketchum et al., 1995; Goldstein et al., 1996; Bockenhauer et al., 2001; Ilan and Goldstein, 2001; Zilberberg et al., 2001)</ce:cross-refs>. Background channels regulate the function of nerves and muscles because increasing potassium leak stabilizes cells at negative resting potentials, thereby diminishing excitability. Slow changes in KCNK3 current magnitude have been implicated in cardiac and nervous tissue responses to hormones, neurotransmitters, and drugs—some of which operate through cAMP-mediated pathways <ce:cross-refs refid=\"BIB21 BIB23 BIB37 BIB6 BIB29 BIB45\">(Kim et al., 1999; Kindler et al., 1999; Patel et al., 1999; Czirjak et al., 2000; Lopes et al., 2000; Talley et al., 2000)</ce:cross-refs>. As the 14-3-3β release site in KCNK3 is a canonical cAMP-dependent protein kinase A (PKA) phosphorylation site, regulated expression of KCNK3 channels may be a pathway for altering leak current magnitude in response to external stimuli. Indeed, activity of potassium channels already in the membrane can also be altered by 14-3-3 in a PKA-dependent fashion in the case of a human cardiac channel <ce:cross-ref refid=\"BIB18\">(Kagan et al., 2002)</ce:cross-ref> and in a calcium/calmodulin kinase II-dependent manner (via a third protein) in <ce:italic>Drosophila</ce:italic> neuromuscular junctions <ce:cross-refs refid=\"BIB41 BIB55\">(Schopperle et al., 1998; Zhou et al., 1999)</ce:cross-refs>.</ce:para>\\n                     <ce:para view=\"all\">Nicotinic receptors are neurotransmitter-gated ion channels implicated in memory, nociception, addiction, epilepsy, and Parkinson\\'s disease <ce:cross-ref refid=\"BIB28\">(Lindstrom, 1997)</ce:cross-ref>. The receptors assemble from 11 subunit isoforms, α2–9 and β2–4 <ce:cross-ref refid=\"BIB7\">(Drisdel, 2000)</ce:cross-ref>, emerging on the surface as α subunit homopentamers or αβ heteropentamers <ce:cross-ref refid=\"BIB31\">(McGehee, 1999)</ce:cross-ref>. Keller and colleagues <ce:cross-ref refid=\"BIB19\">(Keller et al., 2001)</ce:cross-ref> showed that a dibasic motif in the large cytoplasmic loop of skeletal muscle α subunits mediates ER retention, while Jeanclos and coworkers <ce:cross-ref refid=\"BIB17\">(Jeanclos et al., 2001)</ce:cross-ref> implicated a 14-3-3 protein (native isoform undetermined) in forward transport of nicotinic receptors, demonstrating that activation of PKA by forskolin enhanced binding of recombinant 14-3-3η to the α4 loop sequence -RSLS<ce:sup loc=\"post\">P</ce:sup>VQ- and increased surface expression of α4 channels over 5-fold and α4β2 receptors ∼20%; others observed a 2-fold increase in α4β2 receptor surface expression under similar conditions <ce:cross-ref refid=\"BIB15\">(Gopalakrishnan, 1997)</ce:cross-ref>. The findings here that an α4 cytoplasmic loop binds β-COP and shows phosphorylation-dependent interaction with 14-3-3β supports the notion that escape of α4 homomers from ER results from 14-3-3 binding, whereas α4β2 receptors (thought to be the prominent in vivo species) can employ β2 masking and are thus less sensitive to 14-3-3.</ce:para>\\n                  </ce:section>\\n                  <ce:section view=\"all\">\\n                     <ce:section-title>Iip35 Invariant Chains</ce:section-title>\\n                     <ce:para view=\"all\">Invariant chains play a critical role in trafficking of newly synthesized class II complexes to antigen-processing compartments. Iip35 is retained in ER by a dibasic motif <ce:cross-ref refid=\"BIB43\">(Schutze et al., 1994)</ce:cross-ref> and enjoys anterograde transport in a phosphorylation <ce:cross-ref refid=\"BIB1\">(Anderson et al., 1999)</ce:cross-ref> and 14-3-3-dependent fashion <ce:cross-ref refid=\"BIB25\">(Kuwana et al., 1998)</ce:cross-ref>. <ce:cross-ref refid=\"BIB25\">Kuwana and coworkers (1998)</ce:cross-ref> suggested that regulation of 14-3-3 binding (via phosphorylation) could thus serve to control immune signal transduction. These observations can be rationalized by mutually exclusive binding of β-COP and 14-3-3β as observed here: Iip35 binds β-COP and is retained in ER when the N terminus bears no phosphate (MHRRRSRSC-), while phosphorylation of the adjacent release site (MHRRRSRS<ce:sup loc=\"post\">P</ce:sup>C-) leads to 14-3-3 binding, suppression of β-COP association, and forward transport.</ce:para>\\n                  </ce:section>\\n                  <ce:section view=\"all\">\\n                     <ce:section-title>A New Role and a Wealth of Nonclassical Sites for 14-3-3</ce:section-title>\\n                     <ce:para view=\"all\">This study supports the conclusion that release from ER retention should be added to the long list of functions attributed to 14-3-3 variants. Previously implicated in trafficking by studies of endocytosis-deficient yeast cells <ce:cross-ref refid=\"BIB12\">(Gelperin et al., 1995)</ce:cross-ref> and neuronal acetylcholine receptors <ce:cross-ref refid=\"BIB17\">(Jeanclos et al., 2001)</ce:cross-ref>, it was Kuwana and colleagues <ce:cross-ref refid=\"BIB25\">(Kuwana et al., 1998)</ce:cross-ref> who explicitly suggested that 14-3-3 might serve to regulate forward transport of Iip35. How broadly operative this pathway is remains to be assessed. Just as COPI-mediated retention/retrieval motifs are widespread and variable in sequence, so too, the four nonclassical 14-3-3 binding sites identified here are diverse enough to suggest that many serine kinase phosphorylation sites will prove capable of 14-3-3 binding (KCNK3, -RRSSV; KCNK9, -RRKSV; α4, -RSLSV-; and Iip35, -RSRSC-). Further, it is possible that some classical sites mediate release, as altering the KCNK3 C terminus to a classical motif yielded both 14-3-3 binding and surface expression <ce:cross-ref refid=\"FIG2\">(Figure 2)</ce:cross-ref>. It is also unknown whether 14-3-3-mediated release from ER is limited to dibasic sites on membrane proteins, can operate with other retention motifs such as KDEL <ce:cross-ref refid=\"BIB38\">(Pelham, 1990)</ce:cross-ref>, or employs additional proteins to proceed.</ce:para>\\n                  </ce:section>\\n                  <ce:section view=\"all\">\\n                     <ce:section-title>Mutually Exclusive Binding and Release from ER Retention</ce:section-title>\\n                     <ce:para view=\"all\">Regulated release of correctly assembled mixed complexes from ER via masking of retention signals is a recognized strategy to control the type and quality of membrane proteins that reach the surface <ce:cross-refs refid=\"BIB24 BIB53 BIB44 BIB52\">(Klausner, 1990; Zerangue et al., 1999; Standley et al., 2000; Zarei et al., 2001)</ce:cross-refs>. Here, we demonstrate that 14-3-3 can serve as a general mediator for forward transport through inhibition of COPI protein binding, allowing release from ER retention. Evidence for mutually exclusive binding is given in one case where retention and release sites are separate in the primary sequence (KCNK3) and another where they are adjacent (Iip35). While steric interference can rationalize binding of either β-COP or 14-3-3 on adjacent Iip35 sites, it is not known if the regulators interact directly when the sites are separated. Further support for the operation of this pathway in vivo are the presence of 14-3-3 and PKA in ER and golgi <ce:cross-refs refid=\"BIB34 BIB25\">(Nigam, 1989; Kuwana et al., 1998)</ce:cross-refs>, the effects of kinase activators on 14-3-3 binding and forward transport of α4 and α4β2 receptors <ce:cross-refs refid=\"BIB15 BIB17\">(Gopalakrishnan, 1997; Jeanclos et al., 2001)</ce:cross-refs>, and <ce:italic>cis</ce:italic>-acting mutations that leave dibasic signals intact yet act on the separate site to produce forward transport of Emp47p <ce:cross-ref refid=\"BIB42\">(Schroder-Kohne, 1998)</ce:cross-ref>. Evidence that 14-3-3 augments forward transport not only of homomeric KCNK3 channels and α4 receptors but heteromeric complexes (such as α4β2 receptors and class II-invariant chain complexes) where intersubunit retention motif masking has been suspected to be sufficient suggests 14-3-3 may serve a role in normal release from ER in both cases. As many proteins carry both ER retention and 14-3-3 binding motifs, the mechanism described may operate broadly.</ce:para>\\n                  </ce:section>\\n               </ce:section>\\n               <ce:section view=\"all\">\\n                  <ce:section-title>Experimental Procedures</ce:section-title>\\n                  <ce:section view=\"all\">\\n                     <ce:section-title>Yeast Two-Hybrid Identification of 14-3-3β</ce:section-title>\\n                     <ce:para view=\"all\">The Invitrogen ProQuest system, a human heart library, and the pDBLeu vector encoding the last 16 residues in human KCNK3 as bait were employed. One million clones were screened and the inserts in three resultant clones were isolated, sequenced, and identified as described in Results.</ce:para>\\n                  </ce:section>\\n                  <ce:section view=\"all\">\\n                     <ce:section-title>Mutagenesis</ce:section-title>\\n                     <ce:para view=\"all\">hKCNK3 was cloned from a human brain cDNA library (Clontech, Palo Alto, CA) with the primers 5′-CGATGAAGCGGAGAACGTGCGCAC-3′ and 5′-GGGCAGAAGGCAGCAGGGGCAGTC-3′ and subcloned into pRAT <ce:cross-ref refid=\"BIB2\">(Bockenhauer et al., 2001)</ce:cross-ref>. Mutations were made with an XL Quickchange kit (Stratagene, La Jolla, CA) and confirmed by DNA sequencing. FLAG tags (DYKDDDDK) were inserted before the start methionine; HA tags (YPYDVPDYA) were inserted at position 213 in KCNK3.</ce:para>\\n                  </ce:section>\\n                  <ce:section view=\"all\">\\n                     <ce:section-title>Antibodies</ce:section-title>\\n                     <ce:para view=\"all\">Purchased polyclonal (p) and monoclonal (m) antibodies used included: KCNK3 (p, APC024, Alomone Labs, Jerusalem, Israel); 14-3-3β (m, SC1657, Santa Cruz Biotechnology, Santa Cruz, CA); β-COP (m, PC175, Calbiochem, LaJolla, CA); β-COP (p, PA1601, Affinity Bioreagent, Golden, CO); Phosphoserine (p, AB1603, Chemicon International, Temecula, CA); FLAG (m, F3165, Sigma-Aldrich, St. Louis, MO); HA tag (m, 1583816; m, 1867423 and p, 1867423, Roche Molecular Biochemicals, Indianapolis, IN); Transferrin receptor (p, SC9099, Santa Cruz, Santa Cruz, CA); Protein disulfide isomerase (PDI) (p, SPA890, StressGen Biotech., Victoria, Canada); and Iip35 (m, BYA91341, Accurate Chemicals, Westbury, NY).</ce:para>\\n                  </ce:section>\\n                  <ce:section view=\"all\">\\n                     <ce:section-title>Peptide Binding Studies</ce:section-title>\\n                     <ce:para view=\"all\">Peptides and phosphopeptides were synthesized by the W.M. Keck Biotechnology Resource Center (New Haven, CT) with the exceptions of HA (I2149) and FLAG (F3290), which were purchased from Sigma. A cysteine residue was added to the terminus of each peptide that was linked to Sulfolink Coupling Gel (Pierce, Rockford, IL), according to manufacturer\\'s instructions. Rat brain extract was prepared by homogenizing two frozen rat brains in 20 ml of cold Buffer A (10 mM HEPES [pH 7.4], 150 mM NaCl, protease inhibitor cocktail tablets [PI; Roche Molecular Biochemicals Indianapolis, IN]) and centrifuged at 800 × g for 10 min at 4°C. The resulting supernatant was solubilized with 1% Triton X-100 for 1 hr and centrifuged for 1 hr at 100,000 × g at 4°C. The final supernatant was then passed over the various peptides immobilized on Sulfolink Gel (2 mg protein/ml of coupled gel). The gel was washed with 6 bed volumes of phosphate buffered saline (PBS) with 1% Triton X-100 and bound proteins were eluted with SDS-PAGE sample buffer and analyzed by Western blotting and MALDI-MS (Keck Center). Extracts of rat heart and skeletal muscle were prepared similarly. Binding assays with recombinant 14-3-3 proteins were supplemented with 1% bovine serum albumin.</ce:para>\\n                  </ce:section>\\n                  <ce:section view=\"all\">\\n                     <ce:section-title>Immunoprecipitation Protocols</ce:section-title>\\n                     <ce:para view=\"all\">Proteins were extracted from rat brains by homogenization and incubation on ice for 1 hr in cold Buffer B (50 mM Tris [pH 8.0], 1 mM EDTA, 150 mM NaCl, 1% NP-40) plus 0.5% deoxycholate and 0.1% SDS followed by centrifugation at 13,000 × g for 30 min at 4°C. The resulting supernatant (7 mg/ml total protein) was clarified by centrifugation at 50,000 × g for 30 min and dialyzed for 12 hr against Buffer B with 1% Triton X-100 at 4°C. Triton X-100 was added to 1% before extracts were incubated with 5 μg of 14-3-3 monoclonal antibody or control mouse IgG (Sigma) overnight at 4°C. Immune complexes were isolated with 50 μl of Protein G Sepharose (Amersham Pharmacia Biotech, San Francisco, CA), washed with Buffer B with 1% Triton X-100, and eluted with SDS-PAGE sample buffer. SDS-PAGE (12%) and Western blotting were performed by standard methods using ECL (Pierce, Rockford, IL). For protein expression analysis in oocytes, cells were homogenized, subjected to SDS-PAGE, and visualized by Western blot analysis.</ce:para>\\n                     <ce:para view=\"all\">Two-step affinity purification of HA-tagged KCNK3 or FLAG-tagged Iip35 from COS-7 cells was performed 24 hr after transfection using Lipofectamine (Invitrogen, Carlsbad, CA) by incubation for 1 hr in Buffer C (50 mM Tris [pH 8.5], 100 mM NaCl) with 1% Triton X-100 and 0.1% SDS (HA) or 1% CHAPS (FLAG) and centrifugation at 13,000 × g for 20 min at 4°C. Extracts (2.5 mg total protein) were incubated with 5 μg HA or FLAG monoclonal antibody or control mouse IgG overnight at 4°C. Immune complexes were isolated with 50 μl of Protein G Sepharose, washed with Buffer C plus 1% Triton X-100 (HA) or 1% CHAPS (FLAG), and eluted from the beads with 50 μM HA or FLAG peptide. Second-round immunoprecipitations (IP2) were performed on 0.1 mg of recovered protein by incubation with antibodies to β-COP or 14-3-3β, isolation via Protein G, and elution with SDS-PAGE sample buffer. One-fiftieth of the unfractionated extract (∼50 μg) was loaded in the control lysate lane of each gel. To provide a conservative estimate for the minimal detectable level of 14-3-3 or β-COP protein associated with KCNK3 in IP1 (and thereby assess the relative depletion of each in IP2), the amount of KCNK3 in an IP2 was normalized to its level in IP1 by serial dilution using Western blot analysis. The degree of further IP1 dilution that still allowed for specific visualization was more than 1/20 for 14-3-3 and 1/10 for β-COP; this indicated that 5% and 10% of control levels of 14-3-3 and β-COP were readily observed and depletion was greater than 95% and 90%, respectively.</ce:para>\\n                  </ce:section>\\n                  <ce:section view=\"all\">\\n                     <ce:section-title>Production of Recombinant 14-3-3β</ce:section-title>\\n                     <ce:para view=\"all\">The gene encoding human 14-3-3β (P31946) was cloned via the two-hybrid screening of the human heart library and subcloned into pGEX 6P-1; 14-3-3β was released from the glutathione S-transferase (GST) fusion protein with PreScission<ce:sup loc=\"post\">TM</ce:sup> Protease (Amersham Pharamcis Biotech).</ce:para>\\n                  </ce:section>\\n                  <ce:section view=\"all\">\\n                     <ce:section-title>Immunofluorescence</ce:section-title>\\n                     <ce:para view=\"all\">COS-7 cells were seeded on poly-L-lysine-coated coverslips, transfected with HA or Flag-tagged KCNK3 using calcium phosphate, and 48 hr later were fixed in 4% paraformaldehyde for 30 min at 4°C. For surface staining, cells were blocked with 20 mM sodium phosphate (pH 7.4), 10% goat serum, 400 mM NaCl for 1 hr at 4°C, incubated with a rat monoclonal anti-HA antibody for 1 hr, washed, and stained with Oregon Green-conjugated anti-rat antibody (Molecular Probes). Cells were permeabilized by including Triton X-100 (0.3%) in the blocking step, followed by incubation with a mouse monoclonal anti-FLAG antibody and visualized with Oregon Green-conjugated goat anti-mouse antibody. Plasma membrane or ER staining was confirmed by double labeling with polyclonal antibodies to transferrin receptor or PDI, respectively, and Texas-red conjugated goat-anti-rabbit antibodies.</ce:para>\\n                  </ce:section>\\n                  <ce:section view=\"all\">\\n                     <ce:section-title>Electrophysiology</ce:section-title>\\n                     <ce:para view=\"all\">Ooctyes were isolated from <ce:italic>Xenopus laevis</ce:italic> frogs (Nasco, Atkinson, WI) treated with collagenase to ease removal of the follicular layer and injected with 0.1–1 ng of KCNK3 cRNA in 46 nl of sterile water. Currents were measured 48 hr after injection by two-electrode voltage clamp (Warner Instruments Corp., Hamden, CT). Data were filtered at 1 kHz and sampled at 4 kHz. Electrodes of 1.5 mm borosilicate glass tubes (Garner Glass Co., Claremount, CA) contained 3 M KCl and had resistances of 0.3 to 1 mOhm. Recordings were performed at room temperature with perfusion of 0.4–1 ml/min ND96 (in mM) 93 NaCl, 5 KCl, 1 MgCl<ce:inf loc=\"post\">2</ce:inf>, 0.3 CaCl<ce:inf loc=\"post\">2</ce:inf>, 5 HEPES. pH was adjusted to 7.5 or 6.5 where appropriate with NaOH or HCl. Potassium in the bath was altered by isotonic substitution of KCl for NaCl. Holding potential in all cases was −80 mV. Currents were evoked by step depolarization from −135mV to +60mV in 15mV increments. Acid sensitivity was determined by exchanging external bath solutions during repeated step depolarization from holding potential to +30mV at 10 s intervals.</ce:para>\\n                  </ce:section>\\n                  <ce:section view=\"all\">\\n                     <ce:section-title>Surface Binding Assay for KCNK3</ce:section-title>\\n                     <ce:para view=\"all\">\\n                        <ce:italic>Xenopus</ce:italic> oocytes were prepared and injected as described for electrophysiology. The assay was as described by Zerangue and coworkers <ce:cross-ref refid=\"BIB53\">(Zerangue et al., 1999)</ce:cross-ref>. Briefly, oocytes were blocked for 30 min in ND96 with 1% bovine serum albumin (BSA) at 4°C, treated with 5 μg/ml mouse monoclonal anti-HA antibody in 1% BSA for 60 min at 4°C, washed, and incubated with HRP-conjugated secondary antibody (goat anti-mouse IgG) in 1% BSA for 60 min at 4°C. Cells were washed (1% BSA, 4°C, 60 min) and transferred to ND96 without BSA. Individual oocytes were placed in 50 ml SuperSignal ELISA Femto Maximum Sensitivity substrate (Pierce, Rockford, IL) at 22°C for 1 min. Chemiluminescence was quantified with a MultiSkan ELISA plate reader.</ce:para>\\n                  </ce:section>\\n               </ce:section>\\n            </ce:sections>\\n            <ce:acknowledgment>\\n               <ce:section-title>Acknowledgements</ce:section-title>\\n               <ce:para view=\"all\">This work was supported by grants to S.A.N.G. from the NIH. We are grateful to M.J. Caplan, the anonymous reviewers, and the Editor for constructive critical feedback, R. Goldstein for assistance with graphics, and J. Crawford and T. Abbott for excellence in support of peptide synthesis and MALDI analyses.</ce:para>\\n            </ce:acknowledgment>\\n         </body>\\n         <tail>\\n            <ce:bibliography view=\"all\">\\n               <ce:section-title>References</ce:section-title>\\n               <ce:bibliography-sec>\\n                  <ce:bib-reference id=\"BIB1\">\\n                     <ce:label>Anderson et al. 1999</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>H.A.</ce:given-name>\\n                                 <ce:surname>Anderson</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>D.T.</ce:given-name>\\n                                 <ce:surname>Bergstralh</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>T.</ce:given-name>\\n                                 <ce:surname>Kawamura</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>A.</ce:given-name>\\n                                 <ce:surname>Blauvelt</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>P.A.</ce:given-name>\\n                                 <ce:surname>Roche</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Phosphorylation of the invariant chain by protein kinase C regulates MHC class II trafficking to antigen-processing compartments</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>J. Immunol.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>163</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1999</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>5435</sb:first-page>\\n                              <sb:last-page>5443</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB2\">\\n                     <ce:label>Bockenhauer et al. 2001</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>D.</ce:given-name>\\n                                 <ce:surname>Bockenhauer</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>N.</ce:given-name>\\n                                 <ce:surname>Zilberberg</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>S.A.N.</ce:given-name>\\n                                 <ce:surname>Goldstein</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>KCNK2</sb:maintitle>\\n                              <sb:subtitle>reversible conversion of a hippocampal potassium leak into a voltage-dependent channel</sb:subtitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Nat. Neurosci.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>4</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>2001</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>486</sb:first-page>\\n                              <sb:last-page>491</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB3\">\\n                     <ce:label>Campbell et al. 1997</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>J.K.</ce:given-name>\\n                                 <ce:surname>Campbell</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>R.</ce:given-name>\\n                                 <ce:surname>Gurung</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>S.</ce:given-name>\\n                                 <ce:surname>Romero</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>C.J.</ce:given-name>\\n                                 <ce:surname>Speed</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>R.K.</ce:given-name>\\n                                 <ce:surname>Andrews</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>M.C.</ce:given-name>\\n                                 <ce:surname>Berndt</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>C.A.</ce:given-name>\\n                                 <ce:surname>Mitchell</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Activation of the 43 kDa inositol polyphosphate 5-phosphatase by 14-3-3zeta</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Biochemistry</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>36</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1997</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>15363</sb:first-page>\\n                              <sb:last-page>15370</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB4\">\\n                     <ce:label>Craparo et al. 1997</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>A.</ce:given-name>\\n                                 <ce:surname>Craparo</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>R.</ce:given-name>\\n                                 <ce:surname>Freund</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>T.A.</ce:given-name>\\n                                 <ce:surname>Gustafson</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>14-3-3 (epsilon) interacts with the insulin-like growth factor I receptor and insulin receptor substrate I in a phosphoserine-dependent manner</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>J. Biol. Chem.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>272</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1997</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>11663</sb:first-page>\\n                              <sb:last-page>11669</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB5\">\\n                     <ce:label>Cresswell 1994</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>P.</ce:given-name>\\n                                 <ce:surname>Cresswell</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Assembly, transport, and function of MHC class II molecules</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Annu. Rev. Immunol.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>12</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1994</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>259</sb:first-page>\\n                              <sb:last-page>293</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB6\">\\n                     <ce:label>Czirjak et al. 2000</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>G.</ce:given-name>\\n                                 <ce:surname>Czirjak</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>T.</ce:given-name>\\n                                 <ce:surname>Fischer</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>A.</ce:given-name>\\n                                 <ce:surname>Spat</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>F.</ce:given-name>\\n                                 <ce:surname>Lesage</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>P.</ce:given-name>\\n                                 <ce:surname>Enyedi</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>TASK (TWIK-related acid-sensitive K+ channel) is expressed in glomerulosa cells of rat adrenal cortex and inhibited by angiotensin II</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Mol. Endocrinol.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>14</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>2000</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>863</sb:first-page>\\n                              <sb:last-page>874</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB7\">\\n                     <ce:label>Drisdel 2000</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>R.C.</ce:given-name>\\n                                 <ce:surname>Drisdel</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Neuronal alpha-bungarotoxin receptors are alpha7 subunit homomers</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>J. Neurosci.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>20</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>2000</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>133</sb:first-page>\\n                              <sb:last-page>139</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB8\">\\n                     <ce:label>Ellgaard et al. 1999</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>L.</ce:given-name>\\n                                 <ce:surname>Ellgaard</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>M.</ce:given-name>\\n                                 <ce:surname>Molinari</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>A.</ce:given-name>\\n                                 <ce:surname>Helenius</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Setting the standards</sb:maintitle>\\n                              <sb:subtitle>quality control in the secretory pathway</sb:subtitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Science</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>286</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1999</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>1882</sb:first-page>\\n                              <sb:last-page>1888</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB9\">\\n                     <ce:label>Freed et al. 1994</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>E.</ce:given-name>\\n                                 <ce:surname>Freed</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>M.</ce:given-name>\\n                                 <ce:surname>Symons</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>S.G.</ce:given-name>\\n                                 <ce:surname>Macdonald</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>F.</ce:given-name>\\n                                 <ce:surname>McCormick</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>R.</ce:given-name>\\n                                 <ce:surname>Ruggieri</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Binding of 14-3-3 proteins to the protein kinase Raf and effects on its activation</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Science</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>265</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1994</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>1713</sb:first-page>\\n                              <sb:last-page>1716</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB10\">\\n                     <ce:label>Fu et al. 2000</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>H.</ce:given-name>\\n                                 <ce:surname>Fu</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>R.R.</ce:given-name>\\n                                 <ce:surname>Subramanian</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>S.C.</ce:given-name>\\n                                 <ce:surname>Masters</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>14-3-3 proteins</sb:maintitle>\\n                              <sb:subtitle>structure, function, and regulation</sb:subtitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Annu. Rev. Pharmacol. Toxicol.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>40</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>2000</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>617</sb:first-page>\\n                              <sb:last-page>647</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB11\">\\n                     <ce:label>Gaynor and Emr 1997</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>E.C.</ce:given-name>\\n                                 <ce:surname>Gaynor</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>S.D.</ce:given-name>\\n                                 <ce:surname>Emr</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>COPI-independent anterograde transport</sb:maintitle>\\n                              <sb:subtitle>cargo-selective ER to Golgi protein transport in yeast COPI mutants</sb:subtitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>J. Cell Biol.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>136</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1997</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>789</sb:first-page>\\n                              <sb:last-page>802</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB12\">\\n                     <ce:label>Gelperin et al. 1995</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>D.</ce:given-name>\\n                                 <ce:surname>Gelperin</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>J.</ce:given-name>\\n                                 <ce:surname>Weigle</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>K.</ce:given-name>\\n                                 <ce:surname>Nelson</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>P.</ce:given-name>\\n                                 <ce:surname>Roseboom</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>K.</ce:given-name>\\n                                 <ce:surname>Irie</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>K.</ce:given-name>\\n                                 <ce:surname>Matsumoto</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>S.</ce:given-name>\\n                                 <ce:surname>Lemmon</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>14-3-3 proteins</sb:maintitle>\\n                              <sb:subtitle>potential roles in vesicular transport and Ras signaling in <ce:italic>Saccharomyces cerevisiae</ce:italic>\\n                              </sb:subtitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Proc. Natl. Acad. Sci. USA</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>92</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1995</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>11539</sb:first-page>\\n                              <sb:last-page>11543</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB13\">\\n                     <ce:label>Goldstein et al. 1996</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>S.A.N.</ce:given-name>\\n                                 <ce:surname>Goldstein</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>L.A.</ce:given-name>\\n                                 <ce:surname>Price</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>D.N.</ce:given-name>\\n                                 <ce:surname>Rosenthal</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>M.H.</ce:given-name>\\n                                 <ce:surname>Pausch</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>ORK1, a potassium-selective leak channel with two pore domains cloned from <ce:italic>Drosophila melanogaster</ce:italic> by expression in <ce:italic>Saccharomyces cerevisiae</ce:italic>\\n                              </sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Proc. Natl. Acad. Sci. USA</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>93</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1996</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>13256</sb:first-page>\\n                              <sb:last-page>13261</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB14\">\\n                     <ce:label>Goldstein et al. 2001</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>S.A.N.</ce:given-name>\\n                                 <ce:surname>Goldstein</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>D.</ce:given-name>\\n                                 <ce:surname>Bockenhauer</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>I.</ce:given-name>\\n                                 <ce:surname>O\\'Kelly</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>N.</ce:given-name>\\n                                 <ce:surname>Zilberberg</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Potassium leak channels and the KCNK family of two-P-domain subunits</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Nat. Rev. Neurosci.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>2</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>2001</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>175</sb:first-page>\\n                              <sb:last-page>184</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB15\">\\n                     <ce:label>Gopalakrishnan 1997</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>M.</ce:given-name>\\n                                 <ce:surname>Gopalakrishnan</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Regulation of human alpha4beta2 neuronal nicotinic acetylcholine receptors by cholinergic channel ligands and second messenger pathways</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Mol. Pharmacol.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>52</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1997</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>524</sb:first-page>\\n                              <sb:last-page>534</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB16\">\\n                     <ce:label>Ilan and Goldstein 2001</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>N.</ce:given-name>\\n                                 <ce:surname>Ilan</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>S.A.N.</ce:given-name>\\n                                 <ce:surname>Goldstein</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>KCNK0</sb:maintitle>\\n                              <sb:subtitle>single, cloned potassium leak channels are multi-ion pores</sb:subtitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Biophys. J.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>80</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>2001</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>241</sb:first-page>\\n                              <sb:last-page>254</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB17\">\\n                     <ce:label>Jeanclos et al. 2001</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>E.M.</ce:given-name>\\n                                 <ce:surname>Jeanclos</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>L.</ce:given-name>\\n                                 <ce:surname>Lin</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>M.W.</ce:given-name>\\n                                 <ce:surname>Treuil</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>J.</ce:given-name>\\n                                 <ce:surname>Rao</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>M.A.</ce:given-name>\\n                                 <ce:surname>DeCoster</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>R.</ce:given-name>\\n                                 <ce:surname>Anand</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>The chaperone protein 14-3-3eta interacts with the nicotinic acetylcholine receptor alpha 4 subunit. Evidence for a dynamic role in subunit stabilization</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>J. Biol. Chem.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>276</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>2001</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>28281</sb:first-page>\\n                              <sb:last-page>28290</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB18\">\\n                     <ce:label>Kagan et al. 2002</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>A.</ce:given-name>\\n                                 <ce:surname>Kagan</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>Y.</ce:given-name>\\n                                 <ce:surname>Melman</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>A.</ce:given-name>\\n                                 <ce:surname>Krumerman</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>T.V.</ce:given-name>\\n                                 <ce:surname>McDonald</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>14-3-3 amplifies and prolongs adrenergic stimulation of HERG K+ channel activity</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>EMBO J.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>21</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>2002</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>1889</sb:first-page>\\n                              <sb:last-page>1898</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB19\">\\n                     <ce:label>Keller et al. 2001</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>S.H.</ce:given-name>\\n                                 <ce:surname>Keller</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>J.</ce:given-name>\\n                                 <ce:surname>Lindstrom</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>M.</ce:given-name>\\n                                 <ce:surname>Ellisman</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>P.</ce:given-name>\\n                                 <ce:surname>Taylor</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Adjacent basic amino acid residues recognized by the COP I complex and ubiquitination govern endoplasmic reticulum to cell surface trafficking of the nicotinic acetylcholine receptor alpha-subunit</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>J. Biol. Chem.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>276</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>2001</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>18384</sb:first-page>\\n                              <sb:last-page>18391</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB20\">\\n                     <ce:label>Ketchum et al. 1995</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>K.A.</ce:given-name>\\n                                 <ce:surname>Ketchum</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>W.J.</ce:given-name>\\n                                 <ce:surname>Joiner</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>A.J.</ce:given-name>\\n                                 <ce:surname>Sellers</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>L.K.</ce:given-name>\\n                                 <ce:surname>Kaczmarek</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>S.A.N.</ce:given-name>\\n                                 <ce:surname>Goldstein</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>A new family of outwardly-rectifying potassium channel proteins with two pore domains in tandem</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Nature</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>376</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1995</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>690</sb:first-page>\\n                              <sb:last-page>695</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB21\">\\n                     <ce:label>Kim et al. 1999</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>Y.</ce:given-name>\\n                                 <ce:surname>Kim</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>H.</ce:given-name>\\n                                 <ce:surname>Bang</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>D.</ce:given-name>\\n                                 <ce:surname>Kim</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>TBAK-1 and TASK-1, two-pore K(+) channel subunits</sb:maintitle>\\n                              <sb:subtitle>kinetic properties and expression in rat heart</sb:subtitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Am. J. Physiol.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>277</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1999</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>H1669</sb:first-page>\\n                              <sb:last-page>H1678</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB22\">\\n                     <ce:label>Kim et al. 2000</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>Y.</ce:given-name>\\n                                 <ce:surname>Kim</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>H.</ce:given-name>\\n                                 <ce:surname>Bang</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>D.</ce:given-name>\\n                                 <ce:surname>Kim</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>TASK-3, a new member of the tandem pore K(+) channel family</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>J. Biol. Chem.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>275</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>2000</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>9340</sb:first-page>\\n                              <sb:last-page>9347</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB23\">\\n                     <ce:label>Kindler et al. 1999</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>C.H.</ce:given-name>\\n                                 <ce:surname>Kindler</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>C.S.</ce:given-name>\\n                                 <ce:surname>Yost</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>A.T.</ce:given-name>\\n                                 <ce:surname>Gray</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Local anesthetic inhibition of baseline potassium channels with two pore domains in tandem</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Anesthesiology</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>90</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1999</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>1092</sb:first-page>\\n                              <sb:last-page>1102</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB24\">\\n                     <ce:label>Klausner 1990</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>R.D.</ce:given-name>\\n                                 <ce:surname>Klausner</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>The T cell antigen receptor</sb:maintitle>\\n                              <sb:subtitle>insights into organelle biology</sb:subtitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Annu. Rev. Cell Biol.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>6</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1990</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>403</sb:first-page>\\n                              <sb:last-page>431</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB25\">\\n                     <ce:label>Kuwana et al. 1998</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>T.</ce:given-name>\\n                                 <ce:surname>Kuwana</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>P.A.</ce:given-name>\\n                                 <ce:surname>Peterson</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>L.</ce:given-name>\\n                                 <ce:surname>Karlsson</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Exit of major histocompatibility complex class II-invariant chain p35 complexes from the endoplasmic reticulum is modulated by phosphorylation</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Proc. Natl. Acad. Sci. USA</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>95</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1998</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>1056</sb:first-page>\\n                              <sb:last-page>1061</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB26\">\\n                     <ce:label>Lesage and Lazdunski 2000</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>F.</ce:given-name>\\n                                 <ce:surname>Lesage</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>M.</ce:given-name>\\n                                 <ce:surname>Lazdunski</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Molecular and functional properties of two-pore-domain potassium channels</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Am. J. Physiol. Renal Physiol.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>279</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>2000</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>F793</sb:first-page>\\n                              <sb:last-page>F801</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB27\">\\n                     <ce:label>Letourneur et al. 1994</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>F.</ce:given-name>\\n                                 <ce:surname>Letourneur</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>E.C.</ce:given-name>\\n                                 <ce:surname>Gaynor</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>S.</ce:given-name>\\n                                 <ce:surname>Hennecke</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>C.</ce:given-name>\\n                                 <ce:surname>Demolliere</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>R.</ce:given-name>\\n                                 <ce:surname>Duden</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>S.D.</ce:given-name>\\n                                 <ce:surname>Emr</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>H.</ce:given-name>\\n                                 <ce:surname>Riezman</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>P.</ce:given-name>\\n                                 <ce:surname>Cosson</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Coatomer is essential for retrieval of dilysine-tagged proteins to the endoplasmic reticulum</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Cell</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>79</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1994</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>1199</sb:first-page>\\n                              <sb:last-page>1207</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB28\">\\n                     <ce:label>Lindstrom 1997</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>J.</ce:given-name>\\n                                 <ce:surname>Lindstrom</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Nicotinic acetylcholine receptors in health and disease</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Mol. Neurobiol.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>15</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1997</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>193</sb:first-page>\\n                              <sb:last-page>222</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB29\">\\n                     <ce:label>Lopes et al. 2000</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>C.M.B.</ce:given-name>\\n                                 <ce:surname>Lopes</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>P.G.</ce:given-name>\\n                                 <ce:surname>Gallagher</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>M.E.</ce:given-name>\\n                                 <ce:surname>Buck</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>M.H.</ce:given-name>\\n                                 <ce:surname>Butler</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>S.A.N.</ce:given-name>\\n                                 <ce:surname>Goldstein</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Proton block and voltage-gating are potassium-dependent in the cardiac leak channel Kcnk3</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>J. Biol. Chem.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>275</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>2000</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>16969</sb:first-page>\\n                              <sb:last-page>16978</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB30\">\\n                     <ce:label>Lopes et al. 2001</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>C.M.B.</ce:given-name>\\n                                 <ce:surname>Lopes</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>N.</ce:given-name>\\n                                 <ce:surname>Zilberberg</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>S.A.N.</ce:given-name>\\n                                 <ce:surname>Goldstein</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Block of Kcnk3 by protons</sb:maintitle>\\n                              <sb:subtitle>evidence that 2-P-domain potassium channel subunits function as homodimers</sb:subtitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>J. Biol. Chem.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>276</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>2001</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>24449</sb:first-page>\\n                              <sb:last-page>24452</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB31\">\\n                     <ce:label>McGehee 1999</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>D.S.</ce:given-name>\\n                                 <ce:surname>McGehee</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Molecular diversity of neuronal nicotinic acetylcholine receptors</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Ann. N Y Acad. Sci.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>868</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1999</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>565</sb:first-page>\\n                              <sb:last-page>577</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB32\">\\n                     <ce:label>Mellman and Warren 2000</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>I.</ce:given-name>\\n                                 <ce:surname>Mellman</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>G.</ce:given-name>\\n                                 <ce:surname>Warren</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>The road taken</sb:maintitle>\\n                              <sb:subtitle>past and future foundations of membrane traffic</sb:subtitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Cell</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>100</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>2000</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>99</sb:first-page>\\n                              <sb:last-page>112</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB33\">\\n                     <ce:label>Muslin et al. 1996</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>A.J.</ce:given-name>\\n                                 <ce:surname>Muslin</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>J.W.</ce:given-name>\\n                                 <ce:surname>Tanner</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>P.M.</ce:given-name>\\n                                 <ce:surname>Allen</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>A.S.</ce:given-name>\\n                                 <ce:surname>Shaw</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Cell</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>84</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1996</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>889</sb:first-page>\\n                              <sb:last-page>897</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB34\">\\n                     <ce:label>Nigam 1989</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>S.K.</ce:given-name>\\n                                 <ce:surname>Nigam</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Cyclic AMP-dependent protein kinase in canine pancreatic rough endoplasmic reticulum</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>J. Biol. Chem.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>264</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1989</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>16927</sb:first-page>\\n                              <sb:last-page>16932</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB35\">\\n                     <ce:label>Nilsson et al. 1989</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>T.</ce:given-name>\\n                                 <ce:surname>Nilsson</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>M.</ce:given-name>\\n                                 <ce:surname>Jackson</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>P.A.</ce:given-name>\\n                                 <ce:surname>Peterson</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Short cytoplasmic sequences serve as retention signals for transmembrane proteins in the endoplasmic reticulum</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Cell</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>58</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1989</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>707</sb:first-page>\\n                              <sb:last-page>718</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB36\">\\n                     <ce:label>Pallas et al. 1994</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>D.C.</ce:given-name>\\n                                 <ce:surname>Pallas</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>H.</ce:given-name>\\n                                 <ce:surname>Fu</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>L.C.</ce:given-name>\\n                                 <ce:surname>Haehnel</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>W.</ce:given-name>\\n                                 <ce:surname>Weller</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>R.J.</ce:given-name>\\n                                 <ce:surname>Collier</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>T.M.</ce:given-name>\\n                                 <ce:surname>Roberts</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Association of polyomavirus middle tumor antigen with 14-3-3 proteins</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Science</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>265</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1994</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>535</sb:first-page>\\n                              <sb:last-page>537</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB37\">\\n                     <ce:label>Patel et al. 1999</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>A.J.</ce:given-name>\\n                                 <ce:surname>Patel</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>E.</ce:given-name>\\n                                 <ce:surname>Honore</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>F.</ce:given-name>\\n                                 <ce:surname>Lesage</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>M.</ce:given-name>\\n                                 <ce:surname>Fink</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>G.</ce:given-name>\\n                                 <ce:surname>Romey</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>M.</ce:given-name>\\n                                 <ce:surname>Lazdunski</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Inhalational anesthetics activate two-pore-domain background K+ channels</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Nat. Neurosci.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>2</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1999</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>422</sb:first-page>\\n                              <sb:last-page>426</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB38\">\\n                     <ce:label>Pelham 1990</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>H.R.</ce:given-name>\\n                                 <ce:surname>Pelham</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>The retention signal for soluble proteins of the endoplasmic reticulum</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Trends Biochem. Sci.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>15</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1990</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>483</sb:first-page>\\n                              <sb:last-page>486</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB39\">\\n                     <ce:label>Rittinger et al. 1999</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>K.</ce:given-name>\\n                                 <ce:surname>Rittinger</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>J.</ce:given-name>\\n                                 <ce:surname>Budman</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>J.</ce:given-name>\\n                                 <ce:surname>Xu</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>S.</ce:given-name>\\n                                 <ce:surname>Volinia</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>L.C.</ce:given-name>\\n                                 <ce:surname>Cantley</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>S.J.</ce:given-name>\\n                                 <ce:surname>Smerdon</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>S.J.</ce:given-name>\\n                                 <ce:surname>Gamblin</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>M.B.</ce:given-name>\\n                                 <ce:surname>Yaffe</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Structural analysis of 14-3-3 phosphopeptide complexes identifies a dual role for the nuclear export signal of 14–3-3 in ligand binding</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Mol. Cell</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>4</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1999</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>153</sb:first-page>\\n                              <sb:last-page>166</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB40\">\\n                     <ce:label>Roche 1990</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>P.A.</ce:given-name>\\n                                 <ce:surname>Roche</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Nature</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>345</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1990</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>615</sb:first-page>\\n                              <sb:last-page>618</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB41\">\\n                     <ce:label>Schopperle et al. 1998</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>W.M.</ce:given-name>\\n                                 <ce:surname>Schopperle</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>M.H.</ce:given-name>\\n                                 <ce:surname>Holmqvist</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>Y.</ce:given-name>\\n                                 <ce:surname>Zhou</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>J.</ce:given-name>\\n                                 <ce:surname>Wang</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>Z.</ce:given-name>\\n                                 <ce:surname>Wang</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>L.C.</ce:given-name>\\n                                 <ce:surname>Griffith</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>I.</ce:given-name>\\n                                 <ce:surname>Keselman</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>F.</ce:given-name>\\n                                 <ce:surname>Kusinitz</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>D.</ce:given-name>\\n                                 <ce:surname>Dagan</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>I.B.</ce:given-name>\\n                                 <ce:surname>Levitan</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Slob, a novel protein that interacts with the Slowpoke calcium-dependent potassium channel</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Neuron</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>20</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1998</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>565</sb:first-page>\\n                              <sb:last-page>573</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB42\">\\n                     <ce:label>Schroder-Kohne 1998</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>S.</ce:given-name>\\n                                 <ce:surname>Schroder-Kohne</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Alpha-COP can discriminate between distinct, functional di-lysine signals in vitro and regulates access into retrograde transport</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>J. Cell Sci.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>111</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1998</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>3459</sb:first-page>\\n                              <sb:last-page>3470</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB43\">\\n                     <ce:label>Schutze et al. 1994</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>M.P.</ce:given-name>\\n                                 <ce:surname>Schutze</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>P.A.</ce:given-name>\\n                                 <ce:surname>Peterson</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>M.R.</ce:given-name>\\n                                 <ce:surname>Jackson</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>An N-terminal double-arginine motif maintains type II membrane proteins in the endoplasmic reticulum</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>EMBO J.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>13</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1994</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>1696</sb:first-page>\\n                              <sb:last-page>1705</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB44\">\\n                     <ce:label>Standley et al. 2000</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>S.</ce:given-name>\\n                                 <ce:surname>Standley</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>K.W.</ce:given-name>\\n                                 <ce:surname>Roche</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>J.</ce:given-name>\\n                                 <ce:surname>McCallum</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>N.</ce:given-name>\\n                                 <ce:surname>Sans</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>R.J.</ce:given-name>\\n                                 <ce:surname>Wenthold</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>PDZ domain suppression of an ER retention signal in NMDA receptor NR1 splice variants</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Neuron</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>28</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>2000</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>887</sb:first-page>\\n                              <sb:last-page>898</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB45\">\\n                     <ce:label>Talley et al. 2000</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>E.M.</ce:given-name>\\n                                 <ce:surname>Talley</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>Q.B.</ce:given-name>\\n                                 <ce:surname>Lei</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>J.E.</ce:given-name>\\n                                 <ce:surname>Sirois</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>D.A.</ce:given-name>\\n                                 <ce:surname>Bayliss</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>TASK-1, a two-pore domain K+ channel, is modulated by multiple neurotransmitters in motoneurons</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Neuron</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>25</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>2000</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>399</sb:first-page>\\n                              <sb:last-page>410</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB46\">\\n                     <ce:label>Teasdale and Jackson 1996</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>R.D.</ce:given-name>\\n                                 <ce:surname>Teasdale</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>M.R.</ce:given-name>\\n                                 <ce:surname>Jackson</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Signal-mediated sorting of membrane proteins between the endoplasmic reticulum and the golgi apparatus</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Annu. Rev. Cell Dev. Biol.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>12</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1996</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>27</sb:first-page>\\n                              <sb:last-page>54</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB47\">\\n                     <ce:label>Teyton 1990</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>L.</ce:given-name>\\n                                 <ce:surname>Teyton</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Nature</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>348</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1990</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>39</sb:first-page>\\n                              <sb:last-page>44</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB48\">\\n                     <ce:label>Thorson et al. 1998</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>J.A.</ce:given-name>\\n                                 <ce:surname>Thorson</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>L.W.</ce:given-name>\\n                                 <ce:surname>Yu</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>A.L.</ce:given-name>\\n                                 <ce:surname>Hsu</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>N.Y.</ce:given-name>\\n                                 <ce:surname>Shih</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>P.R.</ce:given-name>\\n                                 <ce:surname>Graves</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>J.W.</ce:given-name>\\n                                 <ce:surname>Tanner</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>P.M.</ce:given-name>\\n                                 <ce:surname>Allen</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>H.</ce:given-name>\\n                                 <ce:surname>Piwnica-Worms</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>A.S.</ce:given-name>\\n                                 <ce:surname>Shaw</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>14-3-3 proteins are required for maintenance of Raf-1 phosphorylation and kinase activity</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Mol. Cell. Biol.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>18</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1998</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>5229</sb:first-page>\\n                              <sb:last-page>5238</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB49\">\\n                     <ce:label>Toker et al. 1990</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>A.</ce:given-name>\\n                                 <ce:surname>Toker</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>C.A.</ce:given-name>\\n                                 <ce:surname>Ellis</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>L.A.</ce:given-name>\\n                                 <ce:surname>Sellers</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>A.</ce:given-name>\\n                                 <ce:surname>Aitken</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Protein kinase C inhibitor proteins. Purification from sheep brain and sequence similarity to lipocortins and 14-3-3 protein</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Eur. J. Biochem.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>191</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1990</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>421</sb:first-page>\\n                              <sb:last-page>429</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB50\">\\n                     <ce:label>Tzivion and Avruch 2002</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>G.</ce:given-name>\\n                                 <ce:surname>Tzivion</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>J.</ce:given-name>\\n                                 <ce:surname>Avruch</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>14-3-3 proteins</sb:maintitle>\\n                              <sb:subtitle>active cofactors on cellular regualtion by serine/threonine phosphorylation</sb:subtitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>J. Biol. Chem.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>277</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>2002</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>3061</sb:first-page>\\n                              <sb:last-page>3064</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB51\">\\n                     <ce:label>Yaffe et al. 1997</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>M.B.</ce:given-name>\\n                                 <ce:surname>Yaffe</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>K.</ce:given-name>\\n                                 <ce:surname>Rittinger</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>S.</ce:given-name>\\n                                 <ce:surname>Volinia</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>P.R.</ce:given-name>\\n                                 <ce:surname>Caron</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>A.</ce:given-name>\\n                                 <ce:surname>Aitken</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>H.</ce:given-name>\\n                                 <ce:surname>Leffers</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>S.J.</ce:given-name>\\n                                 <ce:surname>Gamblin</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>S.J.</ce:given-name>\\n                                 <ce:surname>Smerdon</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>L.C.</ce:given-name>\\n                                 <ce:surname>Cantley</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>The structural basis for 14-3-3:phosphopeptide binding specificity</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Cell</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>91</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1997</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>961</sb:first-page>\\n                              <sb:last-page>971</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB52\">\\n                     <ce:label>Zarei et al. 2001</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>M.M.</ce:given-name>\\n                                 <ce:surname>Zarei</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>N.</ce:given-name>\\n                                 <ce:surname>Zhu</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>A.</ce:given-name>\\n                                 <ce:surname>Alioua</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>M.</ce:given-name>\\n                                 <ce:surname>Eghbali</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>E.</ce:given-name>\\n                                 <ce:surname>Stefani</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>L.</ce:given-name>\\n                                 <ce:surname>Toro</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>A novel MaxiK splice variant exhibits dominant-negative properties for surface expression</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>J. Biol. Chem.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>276</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>2001</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>16232</sb:first-page>\\n                              <sb:last-page>16239</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB53\">\\n                     <ce:label>Zerangue et al. 1999</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>N.</ce:given-name>\\n                                 <ce:surname>Zerangue</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>B.</ce:given-name>\\n                                 <ce:surname>Schwappach</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>Y.N.</ce:given-name>\\n                                 <ce:surname>Jan</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>L.Y.</ce:given-name>\\n                                 <ce:surname>Jan</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>A new ER trafficking signal regulates the subunit stoichiometry of plasma membrane K(ATP) channels</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Neuron</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>22</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1999</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>537</sb:first-page>\\n                              <sb:last-page>548</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB54\">\\n                     <ce:label>Zerangue et al. 2001</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>N.</ce:given-name>\\n                                 <ce:surname>Zerangue</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>M.J.</ce:given-name>\\n                                 <ce:surname>Malan</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>S.R.</ce:given-name>\\n                                 <ce:surname>Fried</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>P.F.</ce:given-name>\\n                                 <ce:surname>Dazin</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>Y.N.</ce:given-name>\\n                                 <ce:surname>Jan</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>L.Y.</ce:given-name>\\n                                 <ce:surname>Jan</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>B.</ce:given-name>\\n                                 <ce:surname>Schwappach</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Analysis of endoplasmic reticulum trafficking signals by combinatorial screening in mammalian cells</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Proc. Natl. Acad. Sci. USA</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>98</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>2001</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>2431</sb:first-page>\\n                              <sb:last-page>2436</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB55\">\\n                     <ce:label>Zhou et al. 1999</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>Y.</ce:given-name>\\n                                 <ce:surname>Zhou</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>W.M.</ce:given-name>\\n                                 <ce:surname>Schopperle</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>H.</ce:given-name>\\n                                 <ce:surname>Murrey</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>A.</ce:given-name>\\n                                 <ce:surname>Jaramillo</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>D.</ce:given-name>\\n                                 <ce:surname>Dagan</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>L.C.</ce:given-name>\\n                                 <ce:surname>Griffith</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>I.B.</ce:given-name>\\n                                 <ce:surname>Levitan</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>A dynamically regulated 14-3-3, Slob, and Slowpoke potassium channel complex in <ce:italic>Drosophila</ce:italic> presynaptic nerve terminals</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Neuron</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>22</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1999</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>809</sb:first-page>\\n                              <sb:last-page>818</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB56\">\\n                     <ce:label>Zilberberg et al. 2001</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>N.</ce:given-name>\\n                                 <ce:surname>Zilberberg</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>N.</ce:given-name>\\n                                 <ce:surname>Ilan</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>S.A.</ce:given-name>\\n                                 <ce:surname>Goldstein</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Kcnko</sb:maintitle>\\n                              <sb:subtitle>opening and closing the 2-P-domain potassium leak channel entails “c-type” gating of the outer pore</sb:subtitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Neuron</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>32</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>2001</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>635</sb:first-page>\\n                              <sb:last-page>648</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n               </ce:bibliography-sec>\\n            </ce:bibliography>\\n         </tail>\\n      </converted-article>\\n   </xocs:serial-item>\\n</xocs:doc></originalText></full-text-retrieval-response>',\n",
       " 'In the present study, we analyzed expressions of tandem of P domains in a weak inwardly rectifying K+ channel (TWIK)-related acid-sensitive K+ (TASK) channel-1 and -3 in the hippocampus of patients with temporal lobe epilepsy (TLE) and in rat model. In the control human subjects, TASK-1, and -3 immunoreactivity was observed in pyramidal neurons and dentate granule cells. In TLE patients, TASK-1 and -3 immunoreactivity was rarely observed in neurons. However, TASK-1 immunoreactivity was observed in astrocytes, and TASK-3 immunoreactivity was detected in both astrocytes and microglia. In the rat hippocampus, TASK-1 immunoreactivity was observed in astrocytes within normal and epileptic hippocampus. The alterations in TASK-3 immunoreactivity in the rat hippocampus were similar to those in the human hippocampus. These findings reveal that TASK-1 and -3 are differentially expressed in the normal and epileptic hippocampus, and suggest that TASK channels may contribute to the properties of the epileptic hippocampus.',\n",
       " 'The two-pore-domain potassium channels TASK-1, TASK-3 and TASK-5 possess a conserved C-terminal motif of five amino acids. Truncation of the C-terminus of TASK-1 strongly reduced the currents measured after heterologous expression in Xenopus oocytes or HEK293 cells and decreased surface membrane expression of GFP-tagged channel proteins. Two-hybrid analysis showed that the C-terminal domain of TASK-1, TASK-3 and TASK-5, but not TASK-4, interacts with isoforms of the adapter protein 14-3-3. A pentapeptide motif at the extreme C-terminus of TASK-1, RRx(S/T)x, was found to be sufficient for weak but significant interaction with 14-3-3, whereas the last 40 amino acids of TASK-1 were required for strong binding. Deletion of a single amino acid at the C-terminal end of TASK-1 or TASK-3 abolished binding of 14-3-3 and strongly reduced the macroscopic currents observed in Xenopus oocytes. TASK-1 mutants that failed to interact with 14-3-3 isoforms (V411*, S410A, S410D) also produced only very weak macroscopic currents. In contrast, the mutant TASK-1 S409A, which interacts with 14-3-3-like wild-type channels, displayed normal macroscopic currents. Co-injection of 14-3-3zeta cRNA increased TASK-1 current in Xenopus oocytes by about 70 %. After co-transfection in HEK293 cells, TASK-1 and 14-3-3zeta (but not TASK-1DeltaC5 and 14-3-3zeta) could be co-immunoprecipitated. Furthermore, TASK-1 and 14-3-3 could be co-immunoprecipitated in synaptic membrane extracts and postsynaptic density membranes. Our findings suggest that interaction of 14-3-3 with TASK-1 or TASK-3 may promote the trafficking of the channels to the surface membrane.',\n",
       " '<!DOCTYPE article PUBLIC \"-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN\" \"JATS-archivearticle1.dtd\">\\n<article xmlns:ali=\"http://www.niso.org/schemas/ali/1.0/\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" article-type=\"research-article\"><?properties open_access?><front><journal-meta><journal-id journal-id-type=\"nlm-ta\">J Cell Sci</journal-id><journal-id journal-id-type=\"iso-abbrev\">J. Cell. Sci</journal-id><journal-id journal-id-type=\"publisher-id\">JCS</journal-id><journal-id journal-id-type=\"hwp\">joces</journal-id><journal-title-group><journal-title>Journal of Cell Science</journal-title></journal-title-group><issn pub-type=\"ppub\">0021-9533</issn><issn pub-type=\"epub\">1477-9137</issn><publisher><publisher-name>The Company of Biologists Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type=\"pmid\">26743085</article-id><article-id pub-id-type=\"pmc\">4760375</article-id><article-id pub-id-type=\"doi\">10.1242/jcs.180182</article-id><article-id pub-id-type=\"publisher-id\">JCS180182</article-id><article-categories><subj-group subj-group-type=\"heading\"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>A dual phosphorylation switch controls 14-3-3-dependent cell surface expression of TASK-1</article-title></title-group><contrib-group><contrib contrib-type=\"author\"><name><surname>Kilisch</surname><given-names>Markus</given-names></name><xref ref-type=\"aff\" rid=\"af1\">1</xref><xref ref-type=\"author-notes\" rid=\"AN1\">*</xref></contrib><contrib contrib-type=\"author\"><name><surname>Lytovchenko</surname><given-names>Olga</given-names></name><xref ref-type=\"aff\" rid=\"af1\">1</xref><xref ref-type=\"author-notes\" rid=\"AN1\">*</xref></contrib><contrib contrib-type=\"author\"><name><surname>Arakel</surname><given-names>Eric C.</given-names></name><xref ref-type=\"aff\" rid=\"af1\">1</xref></contrib><contrib contrib-type=\"author\"><name><surname>Bertinetti</surname><given-names>Daniela</given-names></name><xref ref-type=\"aff\" rid=\"af2\">2</xref></contrib><contrib contrib-type=\"author\"><name><surname>Schwappach</surname><given-names>Blanche</given-names></name><xref ref-type=\"aff\" rid=\"af1\">1</xref><xref ref-type=\"aff\" rid=\"af3\">3</xref><xref ref-type=\"corresp\" rid=\"cor1\">&#x02021;</xref></contrib></contrib-group><aff id=\"af1\"><label>1</label><addr-line>Department of Molecular Biology</addr-line>, <institution>Universit&#x000e4;tsmedizin G&#x000f6;ttingen</institution>, <addr-line>Humboldtallee 23, G&#x000f6;ttingen 37073</addr-line>, <country>Germany</country></aff><aff id=\"af2\"><label>2</label><addr-line>Department of Biochemistry</addr-line>, <institution>University of Kassel</institution>, <addr-line>Kassel 34132</addr-line>, <country>Germany</country></aff><aff id=\"af3\"><label>3</label><institution>Max-Planck Institute for Biophysical Chemistry</institution>, <addr-line>G&#x000f6;ttingen 37077</addr-line>, <country>Germany</country></aff><author-notes><fn id=\"AN1\" fn-type=\"equal\"><label>*</label><p>These authors contributed equally to this work</p></fn><corresp id=\"cor1\"><label>&#x02021;</label>Author for correspondence (<email>blanche.schwappach@med.uni-goettingen.de</email>)</corresp></author-notes><pub-date pub-type=\"ppub\"><day>15</day><month>2</month><year>2016</year></pub-date><pub-date pub-type=\"pmc-release\"><day>15</day><month>2</month><year>2016</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the\\n\\t\\t\\t\\t\\t\\t\\t<pub-date pub-type=\"ppub\"/>. --><volume>129</volume><issue>4</issue><fpage>831</fpage><lpage>842</lpage><history><date date-type=\"received\"><day>7</day><month>9</month><year>2015</year></date><date date-type=\"accepted\"><day>29</day><month>12</month><year>2015</year></date></history><permissions><copyright-statement>&#x000a9; 2016. Published by The Company of Biologists Ltd</copyright-statement><copyright-year>2016</copyright-year><license license-type=\"open-access\" xlink:href=\"http://creativecommons.org/licenses/by/3.0\"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<uri xlink:href=\"http://creativecommons.org/licenses/by/3.0\">http://creativecommons.org/licenses/by/3.0</uri>), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.</license-p></license></permissions><self-uri content-type=\"pdf\" xlink:href=\"joces-129-180182.pdf\"/><abstract><title>ABSTRACT</title><p>The transport of the K<sup>+</sup> channels TASK-1 and TASK-3 (also known as KCNK3 and KCNK9, respectively) to the cell surface is controlled by the binding of 14-3-3 proteins to a trafficking control region at the extreme C-terminus of the channels. The current model proposes that phosphorylation-dependent binding of 14-3-3 sterically masks a COPI-binding motif. However, the direct effects of phosphorylation on COPI binding and on the binding parameters of 14-3-3 isoforms are still unknown. We find that phosphorylation of the trafficking control region prevents COPI binding even in the absence of 14-3-3, and we present a quantitative analysis of the binding of all human 14-3-3 isoforms to the trafficking control regions of TASK-1 and TASK-3. Surprisingly, the affinities of 14-3-3 proteins for TASK-1 are two orders of magnitude lower than for TASK-3. Furthermore, we find that phosphorylation of a second serine residue in the C-terminus of TASK-1 inhibits 14-3-3 binding. Thus, phosphorylation of the trafficking control region can stimulate or inhibit transport of TASK-1 to the cell surface depending on the target serine residue. Our findings indicate that control of TASK-1 trafficking by COPI, kinases, phosphatases and 14-3-3 proteins is highly dynamic.</p></abstract><abstract abstract-type=\"precis\"><p><bold>Summary:</bold> Phosphorylation of a previously neglected serine residue in the trafficking control region of TASK-1 interferes with the binding of trafficking machinery and enables complex regulation by physiological stimuli.</p></abstract><kwd-group><title>KEY WORDS</title><kwd>14-3-3 protein</kwd><kwd>Endoplasmic reticulum</kwd><kwd>Golgi</kwd><kwd>Membrane trafficking</kwd><kwd>Phosphorylation</kwd><kwd>Two-pore-domain K<sup>+</sup> channel</kwd><kwd>COPI</kwd><kwd>Protein kinase A</kwd><kwd>TASK-1</kwd></kwd-group><funding-group specific-use=\"FundRef\"><award-group><funding-source><institution-wrap><institution>Deutsche Forschungsgemeinschaft</institution><institution-id>http://dx.doi.org/10.13039/501100001659</institution-id></institution-wrap></funding-source><award-id>FOR1086, TP9</award-id><award-id>SFB1002, B01</award-id></award-group></funding-group><funding-group specific-use=\"FundRef\"><award-group><funding-source><institution-wrap><institution>Seventh Framework Programme</institution><institution-id>http://dx.doi.org/10.13039/501100004963</institution-id></institution-wrap></funding-source><award-id>241481 AFFINOMICS</award-id></award-group></funding-group><funding-group specific-use=\"FundRef\"><award-group><funding-source><institution-wrap><institution>Bundesministerium f&#x000fc;r Bildung und Forschung</institution><institution-id>http://dx.doi.org/10.13039/501100002347</institution-id></institution-wrap></funding-source><award-id>0316177F No Pain</award-id></award-group></funding-group></article-meta></front><body><sec sec-type=\"intro\" id=\"s1\"><title>INTRODUCTION</title><p>Two-pore-domain K<sup>+</sup> (K2P) channels are dimeric membrane proteins that function at the cell surface and contribute to the electrical properties of many different cell types (<xref rid=\"JCS180182C16\" ref-type=\"bibr\">Renigunta et al., 2015</xref>). It is well established that two members of the K2P-channel family &#x02013; i.e. TASK-1 and TASK-3 (also known as KCNK3 and KCNK9, respectively) &#x02013; require phosphorylation-dependent high-affinity binding of 14-3-3 proteins to their distal C-terminus in order to reach the cell surface (<xref rid=\"JCS180182C12\" ref-type=\"bibr\">O\\'Kelly et al., 2002</xref>; <xref rid=\"JCS180182C15\" ref-type=\"bibr\">Rajan et al., 2002</xref>; <xref rid=\"JCS180182C19\" ref-type=\"bibr\">Smith et al., 2011</xref>; <xref rid=\"JCS180182C5\" ref-type=\"bibr\">Kilisch et al., 2015</xref>). 14-3-3 proteins are small adaptor proteins with no specific enzyme activity; they can modulate the function of many &#x02018;client&#x02019; proteins. The distal C-terminus of both channels functions as a trafficking control region; it contains a binding motif for the COPI vesicle coat and an overlapping mode III 14-3-3-binding motif [R-x-x-pS/pT-x-COOH, where &#x02018;p&#x02019; denotes a phosphorylated residue and &#x02018;x&#x02019; any amino acid (<xref rid=\"JCS180182C3\" ref-type=\"bibr\">Coblitz et al., 2005</xref>)]. In the classic model of TASK trafficking, interaction with COPI retains TASK channels in the early secretory pathway until phosphorylation of the distal C-terminus allows binding of 14-3-3, which sterically prevents COPI from accessing the trafficking control region. Consequently, the phosphorylated channel exits the Golgi and is expressed at the cell surface. Based on studies using <italic>in vitro</italic> phosphorylation, on mutagenesis or application of specific inhibitors, protein kinase A (cAMP-dependent protein kinase, PKA) has emerged as the kinase that is most likely to be responsible for phosphorylating TASK C-termini (<xref rid=\"JCS180182C7\" ref-type=\"bibr\">Mant et al., 2011</xref>). However, the direct effect of phosphorylation on COPI binding has not yet been determined, and the protein&#x02013;protein interactions involved in TASK trafficking control have not been assessed quantitatively. Most studies treat the seven 14-3-3 proteins (encoded by seven distinct genes but commonly termed isoforms in the field) as one entity, and little is known about the significance of individual 14-3-3 proteins (denoted with Greek letters as &#x003b2;, &#x003b3;, &#x003b7;, &#x003b5;, &#x003c3;, &#x003c4; and &#x003b6;) in modulating the function of specific 14-3-3 clients.</p><p>The observation that the intracellular trafficking of TASK channels depends on phosphorylation and interaction with 14-3-3 proteins suggests that the surface expression of TASK channels might be regulated by protein kinases and phosphatases. This aspect is poorly understood because studies in heterologous systems have focused on the fundamental prerequisites for cell surface expression rather than on its modulation by signal transduction. However, the cell surface expression of many channels is highly regulated under different physiological conditions. We have recently shown that the COPI-binding motif, which prevents the cell surface expression of ATP-sensitive K<sup>+</sup> channels, can be phosphorylated and thus inactivated upon &#x003b2;-adrenergic stimulation in cardiac myocytes (<xref rid=\"JCS180182C2\" ref-type=\"bibr\">Arakel et al., 2014</xref>). Here, we have used an array of wild-type and mutated TASK distal C-termini, and all seven mammalian 14-3-3 proteins to systematically and quantitatively delineate the molecular events that determine the role of the TASK trafficking control region in regulated cell surface expression.</p></sec><sec sec-type=\"results\" id=\"s2\"><title>RESULTS</title><sec id=\"s2a\"><title>Affinity of 14-3-3 for the TASK-1 C-terminus is substantially lower than that for the TASK-3 C-terminus</title><p>Current insight into COPI and 14-3-3 binding to the trafficking control region of the TASK C-terminus is qualitative (<xref rid=\"JCS180182C12\" ref-type=\"bibr\">O\\'Kelly et al., 2002</xref>; <xref rid=\"JCS180182C15\" ref-type=\"bibr\">Rajan et al., 2002</xref>; <xref rid=\"JCS180182C11\" ref-type=\"bibr\">O\\'Kelly and Goldstein, 2008</xref>; <xref rid=\"JCS180182C22\" ref-type=\"bibr\">Zuzarte et al., 2009</xref>). The equilibrium dissociation constant (<italic>K</italic><sub>d</sub>) for the binding of 14-3-3&#x003c3; to a hexapeptide corresponding to the C-terminus of TASK-3 that included phosphorylated residue S373 has been determined previously (4.1&#x000b1;0.8&#x02005;&#x000b5;M; <xref rid=\"JCS180182C1\" ref-type=\"bibr\">Anders et al., 2013</xref>), but it is not known how the parameters of 14-3-3 binding compare between TASK-1 and TASK-3, or between the different 14-3-3 isoforms. To determine them systematically, we chose fluorescence polarization titration &#x02013; a solution-based method suited to measuring the binding affinity between one 14-3-3 ligand-binding groove and the TASK-derived peptide (<xref ref-type=\"fig\" rid=\"JCS180182F1\">Fig.&#x000a0;1</xref>A,B). The use of synthetic fluorescein-labeled peptides is particularly useful for studying the C-terminus of TASK-1 because the phosphorylation status of the two serine residues (S392 and S393) present in its sequence can be controlled individually. All seven human 14-3-3 isoforms were affinity purified as fusions to the maltose binding protein (MBP). After cleavage of the MBP tag, dimeric 14-3-3 proteins were purified by using size exclusion chromatography (<uri xlink:href=\"http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.180182/-/DC1\">Fig.&#x000a0;S1</uri>).\\n<fig id=\"JCS180182F1\" orientation=\"portrait\" position=\"float\"><label>Fig. 1.</label><caption><p><bold>Peptides and proteins used in this study.</bold> The last 15 amino acids of human TASK-1 and TASK-3 C-termini contain a minimal trafficking control region comprising a COPI recognition motif (green), a PKA target site (red) and a mode III 14-3-3-binding motif (-K-R-R-K/S-pS-V-COOH, where &#x02018;p&#x02019; denotes a phosphorylated residue). Note the presence of a serine residue (S392) preceding the conserved serine residue of the mode III 14-3-3-binding motif in TASK-1 (S393) but not TASK-3 (S373). Fluorescein-labeled peptides comprising the TASK C-termini were used for the determination of equilibrium binding constants by using fluorescence polarization.</p></caption><graphic xlink:href=\"joces-129-180182-g1\"/></fig></p><p>TASK-1 or TASK-3 C-terminal fluorescent peptides (10&#x02005;nM), comprising the last 15 amino acids of the respective C-termini, were titrated with concentrations of the 14-3-3 proteins ranging from 1&#x02005;nM to 120&#x02005;&#x000b5;M (<xref ref-type=\"fig\" rid=\"JCS180182F2\">Fig.&#x000a0;2</xref>), and the equilibrium dissociation constants of 14-3-3 proteins were calculated for TASK-1 phosphorylated at S393 (TASK-1 pS393; the conserved serine residue of the mode III 14-3-3-binding motif) and for TASK-3 phosphorylated at S373 (TASK-3 pS373) (<xref ref-type=\"table\" rid=\"JCS180182TB1\">Table&#x000a0;1</xref>). They ranged from 7.5&#x000b1;0.14&#x02005;&#x000b5;M (mean&#x000b1;s.e.m.; 14-3-3&#x003b2;) to 49.4&#x000b1;2&#x02005;&#x000b5;M (14-3-3&#x003c4;) for TASK-1, whereas dissociation constants for TASK-3 ranged from 110&#x000b1;10&#x02005;nM (14-3-3&#x003b7;) to 3.6&#x000b1;0.44&#x02005;&#x000b5;M (14-3-3&#x003c3;). The latter value matches the result determined previously by <xref rid=\"JCS180182C1\" ref-type=\"bibr\">Anders et al. (2013</xref>) for the TASK-3 C-terminal hexapeptide using isothermal titration calorimetry. The dissociation constants of the seven mammalian 14-3-3 isoforms for the same TASK C-terminal peptide differed up to sevenfold for TASK-1-derived peptides and up to 30-fold for TASK-3-derived peptides. For both TASK C-termini, 14-3-3&#x003b3; and 14-3-3&#x003b7; bound with high affinity, whereas 14-3-3&#x003c3; bound with low affinity. No binding of any 14-3-3 isoform to any TASK C-terminal peptide was observed when the peptides were not phosphorylated.\\n<fig id=\"JCS180182F2\" orientation=\"portrait\" position=\"float\"><label>Fig. 2.</label><caption><p><bold>TASK-1 C-terminus binds to 14-3-3 proteins with 10- to 100-fold lower affinity than the TASK-3 C-terminus.</bold> Fluorescence polarization titration of fluorescein-labeled TASK-1 pS393 (black), TASK-3 pS373 (red) and TASK-3 pS373 &#x00394;V374 (blue) peptide (10&#x02005;nM) with increasing concentrations of the indicated 14-3-3 isoform. Fluorescein was excited at 485&#x02005;nm, and fluorescence polarization was monitored at 535&#x02005;nm. A monophasic fit was used to fit the data (Goodness-of-fit: R<sup>2</sup> from 0.76 to 0.98). Equilibrium constants determined from the fit are listed in <xref ref-type=\"table\" rid=\"JCS180182TB1\">Table&#x000a0;1</xref>. No binding was detectable for the unphosphorylated TASK C-terminal peptides. The assay was repeated at least six times for each data point with two batches of independently purified 14-3-3 proteins. Error bars depict s.e.m. (A) 14-3-3&#x003b2;, (B) 14-3-3&#x003b3;, (C) 14-3-3&#x003b5;, (D) 14-3-3&#x003b6;, (E) 14-3-3&#x003b7; and (F) 14-3-3&#x003c4;.</p></caption><graphic xlink:href=\"joces-129-180182-g2\"/></fig>\\n<table-wrap id=\"JCS180182TB1\" orientation=\"portrait\" position=\"float\"><label>Table&#x000a0;1.</label><caption><p><bold>Binding affinities of 14-3-3 proteins to TASK-1 and TASK-3 C-terminal peptides determined by fluorescence polarization and SPR</bold></p></caption><graphic xlink:href=\"joces-129-180182-i1\"/></table-wrap></p><p>In addition to fluorescence polarization, we used surface plasmon resonance (SPR) as a second, complementary approach to quantify the binding parameters for the TASK-3 C-terminus (<xref ref-type=\"fig\" rid=\"JCS180182F3\">Fig.&#x000a0;3</xref>, <xref ref-type=\"table\" rid=\"JCS180182TB1\">Table&#x000a0;1</xref>). A glutathione S-transferase (GST)-tagged TASK-3 C-terminal 15 residues fusion protein (GST&#x02013;TASK-3) was expressed in and purified from <italic>Escherichia</italic>\\n<italic>coli</italic> (and hence was not phosphorylated). We developed an on-chip phosphorylation protocol (<xref ref-type=\"fig\" rid=\"JCS180182F3\">Fig.&#x000a0;3</xref>A) where we first captured the GST fusion proteins on the chip surface with an antibody against GST (which was crosslinked at a high density to the metal surface) and then phosphorylated GST&#x02013;TASK-3 with recombinantly expressed PKA catalytic subunit (also known as PRKACA; <xref rid=\"JCS180182C6\" ref-type=\"bibr\">Knape et al., 2015</xref>). We verified efficient phosphorylation of the fusion proteins by examining the binding parameters of a phospho-specific antibody that recognizes a phosphorylated PKA target motif to the PKA-treated TASK-3 C-terminus (<xref ref-type=\"fig\" rid=\"JCS180182F3\">Fig.&#x000a0;3</xref>B). We observed high-affinity binding with an equilibrium dissociation constant of 4.5&#x000b1;0.6&#x02005;nM. Consistent with the results of fluorescence polarization titration, no binding of 14-3-3 proteins was observed prior to on-chip phosphorylation, whereas all 14-3-3 isoforms did bind upon phosphorylation of the TASK-3 C-terminus (<xref ref-type=\"fig\" rid=\"JCS180182F3\">Fig.&#x000a0;3</xref>C) with equilibrium dissociation constants (<xref ref-type=\"fig\" rid=\"JCS180182F3\">Fig.&#x000a0;3</xref>D, <xref ref-type=\"table\" rid=\"JCS180182TB1\">Table&#x000a0;1</xref>) between 45&#x000b1;9&#x02005;nM (14-3-3&#x003b3;) to 742&#x000b1;29&#x02005;nM (14-3-3&#x003c3;). Depending on the 14-3-3 isoform, these values were very similar (14-3-3&#x003b7; and 14-3-3&#x003c4;) or differed two- (14-3-3&#x003b2;) to fivefold (14-3-3&#x003b5;, 14-3-3&#x003b6; and 14-3-3&#x003c3;) from the values determined by fluorescence polarization (<xref ref-type=\"fig\" rid=\"JCS180182F2\">Fig.&#x000a0;2</xref>, <xref ref-type=\"table\" rid=\"JCS180182TB1\">Table&#x000a0;1</xref>). Importantly, 14-3-3&#x003b3; and 14-3-3&#x003b7; displayed the same high-affinity binding as that observed in the fluorescence polarization assay. We conclude that the two methods yield comparable parameters for 14-3-3 binding to the TASK-3 pS373 C-terminal peptide. The differences in absolute values might be due to the fact that the presentation of the phosphorylated C-termini is different in the two methods (soluble peptide compared to immobilized GST fusion protein).\\n<fig id=\"JCS180182F3\" orientation=\"portrait\" position=\"float\"><label>Fig. 3.</label><caption><p><bold>Affinities of the seven mammalian 14-3-3 isoforms for the phosphorylated TASK-3 C-terminus obtained by surface plasmon resonance are consistent with values obtained using fluorescence polarization.</bold> (A) Schematic illustration of the surface plasmon resonance (SPR) set-up used to monitor 14-3-3 binding to immobilized TASK-3 C-termini fused to GST and phosphorylated on the carboxymethyldextran sensor chip. (B) An antibody against PKA-phosphorylated substrates was used to confirm on-chip phosphorylation of the TASK-3 C-termini. (C) Representative family of SPR sensograms reflecting the association and dissociation phases of 14-3-3&#x003b2; and 14-3-3&#x003c3; binding to immobilized phosphorylated TASK-3 C-termini. No binding was observed before phosphorylation of the immobilized GST fusion protein. (D) Dose-response curve for the respective pairs of GST&#x02013;TASK-3 C-terminal fusion proteins and the individual 14-3-3 proteins with SPR analysis. Data were analyzed with a sigmoidal dose-response curve fit (Goodness-of-fit: R<sup>2</sup> from 0.96 to 0.99). Equilibrium constants determined from the fit are listed in <xref ref-type=\"table\" rid=\"JCS180182TB1\">Table&#x000a0;1</xref>. The assay was repeated at least six times for each data point with two batches of independently purified 14-3-3 proteins. Error bars depict s.e.m.</p></caption><graphic xlink:href=\"joces-129-180182-g3\"/></fig></p></sec><sec id=\"s2b\"><title>Deletion of the C-terminal valine residue in the TASK-3 C-terminus does not abolish 14-3-3 binding</title><p>Based on yeast two-hybrid and qualitative pull-down assays, it has been proposed that deleting the C-terminal valine residue of the mode III 14-3-3-binding motif abolishes 14-3-3 binding (<xref rid=\"JCS180182C12\" ref-type=\"bibr\">O\\'Kelly et al., 2002</xref>; <xref rid=\"JCS180182C15\" ref-type=\"bibr\">Rajan et al., 2002</xref>). To test this hypothesis, we measured the affinity of all seven 14-3-3 isoforms for the TASK-3 C-terminal peptide containing phosphorylated S373, but lacking the C-terminal valine (V374), by fluorescence polarization titration (<xref ref-type=\"fig\" rid=\"JCS180182F2\">Fig.&#x000a0;2</xref>, <xref ref-type=\"table\" rid=\"JCS180182TB1\">Table&#x000a0;1</xref>). Indeed, the interaction could no longer be measured for 14-3-3&#x003c3;, but the affinities remained in the low micromolar range for 14-3-3&#x003b2;, 14-3-3&#x003b3;, 14-3-3&#x003b6;, 14-3-3&#x003b7; and 14-3-3&#x003c4;. The C-terminal deletion reduced the affinity between three- (14-3-3&#x003b2;) and 23-fold (14-3-3 epsilon), but the absolute values for the equilibrium dissociation constants were lower than those observed for the TASK-1 C-terminus with both pS393 and V394 (<xref ref-type=\"fig\" rid=\"JCS180182F2\">Fig.&#x000a0;2</xref>, <xref ref-type=\"table\" rid=\"JCS180182TB1\">Table&#x000a0;1</xref>). Hence, it appears that the reported lack of surface expression observed in TASK-3 reporter constructs upon deletion of the C-terminal valine (<xref rid=\"JCS180182C12\" ref-type=\"bibr\">O\\'Kelly et al., 2002</xref>; <xref rid=\"JCS180182C15\" ref-type=\"bibr\">Rajan et al., 2002</xref>) cannot be fully explained by reduced 14-3-3 binding.</p><p>To further clarify this point, we studied the phosphorylation of GST fusion proteins of the corresponding C-terminal TASK-3 peptides by using the recombinant PKA catalytic subunit <italic>in vitro</italic> (<xref ref-type=\"fig\" rid=\"JCS180182F4\">Fig.&#x000a0;4</xref>A), and we found that the efficiency of phosphorylation was reduced about threefold for the GST&#x02013;TASK-3 &#x00394;V374 C-terminus compared to that for the wild type (<xref ref-type=\"fig\" rid=\"JCS180182F4\">Fig.&#x000a0;4</xref>B). Analysis of the phosphorylation state of S373 in TASK-3 lacking the terminal valine by transiently transfecting a reporter construct that included the extracellular domain of CD8 (CD8&#x02013;CFP&#x02013;TASK-3 &#x00394;V374) into COS-7 cells and subsequent SDS-PAGE analysis with gels containing a phospho-chelating agent (Phostag) also revealed that the efficiency of S372 phosphorylation was decreased in the absence of the C-terminal valine. The reporter proteins exposing the wild-type TASK-3 C-terminal 15 residues or a mutant, in which the COPI-dependent ER retention&#x02013;retrieval motif (KRR) was disrupted (K369A), migrated slower than the S373A mutant, implying that both the wild-type TASK-3 and the K369A mutant were phosphorylated. Consistent with this interpretation, treatment with phosphatase altered the migratory behavior of the reporter proteins to match that of the S373A mutant. In contrast to the wild type and to the K369A variant, we observed substantial amounts of unphosphorylated CD8&#x02013;CFP&#x02013;TASK-3 &#x00394;V374 reporter protein prior to phosphatase treatment. These findings suggest that truncation of the mode III 14-3-3-binding motif affects the efficiency of phosphorylation by PKA <italic>in vivo</italic> and might also improve access for cellular phosphatases.\\n<fig id=\"JCS180182F4\" orientation=\"portrait\" position=\"float\"><label>Fig. 4.</label><caption><p><bold>Reduced 14-3-3 binding affinity does not explain the lack of cell surface transport of the TASK-3 &#x00394;V mutant.</bold> (A) <italic>In vitro</italic> phosphorylation of recombinant GST&#x02013;TASK-3 (15 C-terminal residues) wild-type (WT), GST&#x02013;TASK-3 &#x00394;V374 and GST&#x02013;TASK-3 S373A fusion proteins with the PKA catalytic subunit. Samples were resolved on an SDS-PAGE gel containing 75&#x02005;&#x000b5;M Phostag reagent and 75&#x02005;&#x000b5;M MnCl<sub>2</sub>, which retards the migration of proteins by chelating phosphorylated amino acid side chains. The Coomassie-stained gel is representative of six independent experiments. TASK-3-P, phosphorylated TASK-3. (B) Bar diagram of the relative amount of phosphorylated TASK-3 trafficking control region constructs shown in A. <italic>n</italic>=6, error bars depict s.e.m. (C) <italic>In vivo</italic> phosphorylation status of the indicated CD8&#x02013;CFP reporter proteins, as reflected by migration in Phostag SDS-PAGE gels. &#x003bb;PPase, &#x003bb; phosphatase. The blot is representative of 11 independent transfections. (D) Flow cytometry assay to determine the effect of the indicated TASK C-termini on the cell surface expression of a CD8&#x02013;CFP reporter protein. Cells were transfected with the same series of constructs in three independent experiments. For each experiment, 10,000 cells per construct were analyzed. The mean of the CD8 signal was expressed as a ratio with the mean of the CFP signal in CFP-positive cells and normalized to that of the wild-type TASK-3 construct. Error bars depict s.e.m. (E) Subcellular localization of CD8&#x02013;CFP&#x02013;TASK-3 &#x00394;V374 is indistinguishable from that of CD8&#x02013;CFP&#x02013;TASK-3 S373A. Constructs were transfected in three independent experiments and ca. 100 cells per transfection were analyzed by indirect immunostaining against the indicated antigens.</p></caption><graphic xlink:href=\"joces-129-180182-g4\"/></fig></p><p>To assess the functional consequences of phosphorylation on cell surface expression of the reporter protein, we employed flow cytometry (<xref ref-type=\"fig\" rid=\"JCS180182F4\">Fig.&#x000a0;4</xref>C). In this assay, transfected cells were identified using the CFP fluorescence signal, and the relative cell surface expression was determined by staining an extracellular epitope of CD8 with a specific antibody. We determined the relative cell surface expression of wild-type CD8&#x02013;CFP&#x02013;TASK-3 as well as that of the &#x00394;V374 and S373A mutants, and we found that the C-terminal truncation variant displayed moderately higher cell surface expression levels than the non-phosphorylatable S373A mutant. We also assessed the steady-state localization of the bulk of the CD8&#x02013;CFP fusion proteins with indirect immunostaining (<xref ref-type=\"fig\" rid=\"JCS180182F4\">Fig.&#x000a0;4</xref>D; <uri xlink:href=\"http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.180182/-/DC1\">Fig.&#x000a0;S2</uri>) and observed a very similar pattern for both, CD8&#x02013;CFP&#x02013;TASK-3 &#x00394;V374 and CD8&#x02013;CFP&#x02013;TASK-3 S373A. As reported previously (<xref rid=\"JCS180182C22\" ref-type=\"bibr\">Zuzarte et al., 2009</xref>), proteins unable to recruit 14-3-3, which is required to counteract the COPI-binding motif present in the C-terminus of TASK proteins, accumulated in a punctate perinuclear COPI-positive structure (<uri xlink:href=\"http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.180182/-/DC1\">Fig.&#x000a0;S2</uri>) in the vicinity of a marker of the Golgi compartment (GM130, also known as GOLGA2; <xref ref-type=\"fig\" rid=\"JCS180182F4\">Fig.&#x000a0;4</xref>D). We conclude that in the mutant TASK-3 &#x00394;V374, less of the CD8&#x02013;CFP reporter fusion protein is phosphorylated and that the phosphorylated form binds to 14-3-3 proteins with lower affinity than wild-type TASK-3 but as strongly as TASK-1 pS393. The simplest interpretation of these findings is that strongly reduced cell surface expression of C-terminally truncated TASK-3 is attributable to the combination of inefficient phosphorylation and a moderately reduced 14-3-3 binding affinity.</p></sec><sec id=\"s2c\"><title>Phosphorylated S392 in the TASK-1 C-terminus inhibits 14-3-3 binding</title><p><xref rid=\"JCS180182C7\" ref-type=\"bibr\">Mant et al. (2011)</xref> report that both serine residues present in the TASK-1 C-terminus can be phosphorylated <italic>in vitro</italic> by the recombinant catalytic subunit of PKA. We confirmed this result (<xref ref-type=\"fig\" rid=\"JCS180182F5\">Fig.&#x000a0;5</xref>A) using GST fusion proteins of the 15 C-terminal residues of TASK-1, in which either one or both of the residues S392 or S393 were phosphorylated. Next, using fluorescence polarization titration, we determined how phosphorylation of S392 affects the affinity of all seven mammalian 14-3-3 proteins for the TASK-1 C-terminus &#x02013; either when phosphorylated alone or in combination with phosphorylation of S393 (<uri xlink:href=\"http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.180182/-/DC1\">Table&#x000a0;S1</uri>). In each case, the presence of phosphorylated S392 significantly reduced the affinity of all 14-3-3 proteins for the TASK-1-derived peptide, which bound to 14-3-3 with dissociation constants in the low micromolar range (<uri xlink:href=\"http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.180182/-/DC1\">Table S1</uri>). In contrast, the <italic>K</italic><sub>d</sub> values obtained for TASK-1 pS392 were &#x0223c;100&#x02005;&#x000b5;M, whereas those for the doubly phosphorylated peptide were in the high micromolar range. The strongly reduced 14-3-3 binding affinity of the doubly phosphorylated peptide was confirmed with a qualitative pull-down assay (<xref ref-type=\"fig\" rid=\"JCS180182F5\">Fig.&#x000a0;5</xref>B) using the GST fusion proteins that exposed the TASK-1 or TASK-3 C-terminal 15 residues. Both constructs were efficiently phosphorylated by recombinant PKA, as demonstrated with Phostag SDS PAGE analysis (lowest panel) or by blotting with an antiserum against phospho-TASK C-termini that had been generated in our laboratory (second panel from top). Although recombinant 14-3-3&#x003b3; was efficiently pulled down using TASK-3 p373 (top panel and Coomassie-stained panels at the bottom), only a very faint band was observed for the doubly phosphorylated TASK-1 C-terminus. This indicates that the <italic>K</italic><sub>d</sub> of &#x0223c;200&#x02005;&#x000b5;M measured for this interaction (<uri xlink:href=\"http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.180182/-/DC1\">Table&#x000a0;S1</uri>) was too high to result in substantial co-purification of 14-3-3&#x003b3; in this assay. Because all <italic>K</italic><sub>d</sub> values determined for TASK-1 pS392 and the doubly phosphorylated protein (at S392 and S393) were substantially higher than those measured for TASK-1 pS393 (<uri xlink:href=\"http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.180182/-/DC1\">Table&#x000a0;S1</uri>), we conclude that phosphorylation of S392 cannot substitute for phosphorylated S393 in creating a high-affinity 14-3-3 binding site. On the contrary, our results are consistent with an inhibitory role for phosphorylation of S392 with respect to 14-3-3-mediated binding.\\n<fig id=\"JCS180182F5\" orientation=\"portrait\" position=\"float\"><label>Fig. 5.</label><caption><p><bold>Phosphorylation of S392 in TASK-1 inhibits 14-3-3 binding.</bold> (A) <italic>In vitro</italic> phosphorylation of recombinant GST&#x02013;TASK-1 wild-type, GST&#x02013;TASK-1 S392A and GST&#x02013;TASK-1 S393A fusion proteins with PKA catalytic subunit. Samples were resolved on an SDS-PAGE gel containing 75&#x02005;&#x000b5;M Phostag reagent and 75&#x02005;&#x000b5;M MnCl<sub>2</sub>. &#x02018;P&#x02019; suffixes denote the number of phosphorylated residues. The gel is representative of three independent experiments. (B) 14-3-3 protein binding to the TASK-1 C-terminal trafficking control region is abolished by double phosphorylation. GST-TASK-1 or GST-TASK-3 C-terminal fusion proteins were <italic>in vitro</italic> phosphorylated using recombinant PKA catalytic subunit and an ATP regeneration system (energy mix; EM). Samples were resolved on SDS-PAGE gels (upper three panels) and on an SDS-PAGE gel containing 100&#x02005;&#x000b5;M Phostag reagent and 100&#x02005;&#x000b5;M MnCl<sub>2</sub> (bottom). The upper two panels show western blots using antibodies against the indicated proteins, and the lower two panels show Coomassie-stained gels. TASK-CT15, the last 15 amino acids of the TASK C-terminus.</p></caption><graphic xlink:href=\"joces-129-180182-g5\"/></fig></p><p>To test this hypothesis, we assessed the effect of mutating S392 on the steady-state phosphorylation and on the cell surface expression of CD8&#x02013;CFP&#x02013;TASK-1 in transfected cells (<xref ref-type=\"fig\" rid=\"JCS180182F6\">Fig.&#x000a0;6</xref>). In line with the results obtained with CD8&#x02013;CFP&#x02013;TASK-3 in <xref ref-type=\"fig\" rid=\"JCS180182F4\">Fig.&#x000a0;4</xref>B, Phostag gel electrophoresis analysis confirmed that the reporter fusion protein displaying the wild-type TASK-1 C-terminus was indeed phosphorylated (<xref ref-type=\"fig\" rid=\"JCS180182F6\">Fig.&#x000a0;6</xref>A). Interestingly, the wild-type, the K389A, the &#x00394;V394 and the S392A constructs migrated in an identical manner, indicating that only one of the serine residues is efficiently phosphorylated or protected from dephosphorylation (<xref ref-type=\"fig\" rid=\"JCS180182F6\">Fig.&#x000a0;6</xref>B). It is generally assumed that binding of 14-3-3 proteins to a phosphorylated 14-3-3 target site acts to protect the phosphorylated side-chain from dephosphorylation by phosphatases (<xref rid=\"JCS180182C4\" ref-type=\"bibr\">Kagan et al., 2002</xref>). Thus, TASK-1 C-termini exposing phosphorylated S392 or phosphorylated S392 and S393 residues will be efficiently dephosphorylated because they bind to 14-3-3 proteins with lower affinity (<uri xlink:href=\"http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.180182/-/DC1\">Table&#x000a0;S1</uri>), whereas phosphorylated S393 should be protected by bound 14-3-3 proteins (<xref ref-type=\"fig\" rid=\"JCS180182F6\">Fig.&#x000a0;6</xref>A). In agreement with this hypothesis, for the S393A mutant, we observed only a minor band reflecting the phosphorylated species. We conclude that S392 can be phosphorylated by the catalytic subunit of PKA (<xref ref-type=\"fig\" rid=\"JCS180182F5\">Fig.&#x000a0;5</xref>), but our results suggest that either phosphorylation is inefficient or that this residue is efficiently dephosphorylated in COS-7 cells.\\n<fig id=\"JCS180182F6\" orientation=\"portrait\" position=\"float\"><label>Fig. 6.</label><caption><p><bold>Phosphorylation of S392 in TASK-1 reduces cell surface expression.</bold> (A) <italic>In vivo</italic> phosphorylation status of the CD8 reporter protein as reflected by migration in Phostag SDS-PAGE gels. The blot is representative of seven independent transfections. TASK-1-P, phosphorylated TASK-1. (B) Flow cytometry assay to determine the effect of replacing either S392 or S393 in the TASK-1 C-terminus on the cell surface expression of the indicated CD8&#x02013;CFP reporter proteins. Cells were transfected with the same series of constructs in three independent experiments. For each experiment, 10,000 cells per construct were analyzed. The mean of the CD8 signal is expressed as a ratio with the mean of the CFP signal in CFP-positive cells and normalized to that for the wild-type TASK-3 construct. Error bars depict s.e.m. (C) Model of the effect of phosphorylation of S392 or S393, or both on 14-3-3 binding and on the access of phosphatases. Note that only the population of TASK-1 reporter proteins phosphorylated on only S393 is expected to be protected from phosphatase action.</p></caption><graphic xlink:href=\"joces-129-180182-g6\"/></fig></p></sec><sec id=\"s2d\"><title>S392 reduces the cell surface expression of CD8&#x02013;CFP&#x02013;TASK-1</title><p>To test the functional consequences of S392 phosphorylation in transfected cells, we determined the relative cell surface expression of CD8&#x02013;CFP&#x02013;TASK-1 S392A using flow cytometry (<xref ref-type=\"fig\" rid=\"JCS180182F6\">Fig.&#x000a0;6</xref>B). Surprisingly, the surface expression of this construct was more than twofold higher than that of &#x02018;wild-type&#x02019; CD8&#x02013;CFP&#x02013;TASK-1. In contrast, CD8&#x02013;CFP&#x02013;TASK-1 S393A did not reach the cell surface, most probably owing to its inability to bind to 14-3-3 proteins. This finding is consistent with the results obtained with the CD8&#x02013;CFP&#x02013;TASK-3 S373A mutant (<xref ref-type=\"fig\" rid=\"JCS180182F4\">Fig.&#x000a0;4</xref>C).</p><p>It has been reported previously that residue K389 in the trafficking control region is a crucial residue of the ER localization motif of TASK-1 (<xref rid=\"JCS180182C22\" ref-type=\"bibr\">Zuzarte et al., 2009</xref>). Mutating the lysine residue to alanine induced the same twofold increase in CD8&#x02013;CFP&#x02013;TASK-1 surface expression as the S392A mutation. These observations are consistent with the notion that transient phosphorylation of S392 is sufficient to reduce the efficacy by which 14-3-3 proteins can remove the cargo protein from the part of the secretory pathway where COPI operates. In the absence of a functional COPI-interaction motif (<xref rid=\"JCS180182C22\" ref-type=\"bibr\">Zuzarte et al., 2009</xref>), 14-3-3 protein binding to the TASK C-terminus is no longer required for cell surface expression. Hence, the corresponding construct K389A reaches the cell surface efficiently. For TASK-3, which displays high-affinity 14-3-3 binding and no second inhibitory serine, the corresponding K369A mutant is expressed at levels at the cell surface that are nearly equal to those of the TASK-3 wild-type construct (<xref ref-type=\"fig\" rid=\"JCS180182F4\">Fig.&#x000a0;4</xref>C). Hence, in the case of TASK-3, 14-3-3 efficiently displaces COPI. The reduced cell surface expression of the TASK-1 wild-type construct with respect to both the TASK-1 K389A and S392A constructs is consistent with the notion that both COPI and 14-3-3 proteins can access the trafficking control region in the steady state.</p></sec><sec id=\"s2e\"><title>Phosphorylation of TASK C-termini abolishes COPI binding</title><p>Although it is well established that phosphorylation of the mode III binding motif is a prerequisite for 14-3-3 binding to TASK C-termini, the effect of phosphorylation on COPI binding is unknown. Functionally, the COPI-binding motif was mapped in the context of TASK &#x00394;V constructs because retention of these constructs from the cell surface reflects COPI activity. Pull-down assays to directly assess the physical interaction were performed with cellular lysates that also contained kinases, phosphatases and 14-3-3 proteins (<xref rid=\"JCS180182C12\" ref-type=\"bibr\">O\\'Kelly et al., 2002</xref>; <xref rid=\"JCS180182C11\" ref-type=\"bibr\">O\\'Kelly and Goldstein, 2008</xref>; <xref rid=\"JCS180182C22\" ref-type=\"bibr\">Zuzarte et al., 2009</xref>). In these experiments, detection of the &#x003b2;-COP (also known as COPB1) subunit served as a proxy for binding of the heptameric COPI coat. To assess the physical interaction with COPI in the absence of additional binding partners (<xref ref-type=\"fig\" rid=\"JCS180182F7\">Fig.&#x000a0;7</xref>), we exploited our previous finding that the ER retention&#x02013;retrieval signal of TASK-3 is also recognized in yeast (<xref rid=\"JCS180182C22\" ref-type=\"bibr\">Zuzarte et al., 2009</xref>). We purified the COPI coat from yeast using tandem-affinity purification (TAP) of tagged &#x003b2;-COP (<xref rid=\"JCS180182C20\" ref-type=\"bibr\">Yip and Walz, 2011</xref>) and tested its interaction with the TASK-1 and TASK-3 trafficking control region (15 C-terminal residues) presented on the cytoplasmic tail of the yeast protein Mst27, which lacked its KKXX signal and had been fused to GST, as described previously (<xref rid=\"JCS180182C17\" ref-type=\"bibr\">Sandmann et al., 2003</xref>). This Mst27 linker increases the accessibility of the C-terminal peptide to the heptameric COPI coat and has been extensively characterized in COPI-binding experiments (<xref rid=\"JCS180182C17\" ref-type=\"bibr\">Sandmann et al., 2003</xref>; <xref rid=\"JCS180182C8\" ref-type=\"bibr\">Michelsen et al., 2007</xref>). We found that both immobilized GST&#x02013;TASK-1 and GST&#x02013;TASK-3 enriched COPI before but not after phosphorylation of the TASK tails (<xref ref-type=\"fig\" rid=\"JCS180182F7\">Fig.&#x000a0;7</xref>A). Quantification of three independent experiments showed that TASK-1 bound to COPI less efficiently than TASK-3 (<xref ref-type=\"fig\" rid=\"JCS180182F7\">Fig.&#x000a0;7</xref>B). We conclude that COPI ceases to interact with the phosphorylated trafficking control region of TASK-1 and TASK-3 channels even in the absence of 14-3-3 proteins. This implies that there is no direct competition between COPI and 14-3-3 binding (<xref ref-type=\"fig\" rid=\"JCS180182F7\">Fig.&#x000a0;7</xref>C). Instead, the respective binding equilibria exist between either the unphosphorylated (COPI) or phosphorylated (14-3-3) forms of the TASK C-terminus and hence are coupled through the action of kinases and phosphatases.\\n<fig id=\"JCS180182F7\" orientation=\"portrait\" position=\"float\"><label>Fig. 7.</label><caption><p><bold>Phosphorylation of TASK C-termini inhibits COPI binding.</bold> (A) GST&#x02013;Mst27&#x02013;TASK-1 or GST&#x02013;Mst27-TASK-3 fusion proteins comprising the last 15 amino acids of the C-termini (CT15) were <italic>in vitro</italic> phosphorylated using recombinant PKA catalytic subunit and an ATP regeneration system (energy mix; EM). Upper panel shows a western blot and detection with an anti-yeast COPI antiserum, lower panel shows a Coomassie-stained gel. (B) Quantification of three independent pull-down experiments similar to that depicted in A. Error bars depict s.e.m. (C) Model of the effect of phosphorylation of S373 in TASK-3 on the binding of COPI, access of phosphatases and 14-3-3 binding. Note that binding of COPI and 14-3-3 proteins is not competitive.</p></caption><graphic xlink:href=\"joces-129-180182-g7\"/></fig></p></sec></sec><sec sec-type=\"discussion\" id=\"s3\"><title>DISCUSSION</title><p>The trafficking control region in the C-termini of the K2P channels TASK-1 and TASK-3 is thought to control the surface expression of the channels through the mutually exclusive binding of either the COPI vesicle coat, which mediates retrieval to the early secretory pathway, or of 14-3-3 proteins, which bind in a phosphorylation-dependent manner and protect the region from COPI binding (<xref rid=\"JCS180182C19\" ref-type=\"bibr\">Smith et al., 2011</xref>). In essence, the trafficking control region is thought to function based on competitive binding events. However, our mechanistic understanding of this trafficking control region is far from complete. A full quantitative model of this competition and its outcome would require insight into the copy numbers of the cargo, COPI and of 14-3-3 proteins as well as the dissociation constants of the pertinent binding events. Furthermore, there are striking differences in the residues that flank the COPI-dependent retention&#x02013;retrieval motif and the mode III 14-3-3-binding motif of TASK-1 and TASK-3; TASK-1 features a second serine that can be phosphorylated (S392) and that precedes the conserved serine residue of the mode III motif (S393). This serine residue is absent in TASK-3, where the corresponding residue immediately following the KRR retention&#x02013;retrieval motif is lysine (K372). Here, we present evidence that this sequence difference between the TASK-1 and TASK-3 C-termini causes biologically relevant differences in COPI and 14-3-3 protein binding that might render TASK-1 more amenable to regulation.</p><p>We determined the binding parameters for all seven mammalian 14-3-3 isoforms to both TASK protein C-termini and to their variants (phosphorylated or non-phosphorylated peptides and mutants thereof). Interestingly, the highest affinity of the TASK-1-derived pS393 peptide to 14-3-3 was approximately two orders of magnitude lower than that of the TASK-3-derived peptide (the <italic>K</italic><sub>d</sub> value was &#x0223c;10&#x02005;&#x000b5;M compared to 100&#x02005;nM; <xref ref-type=\"fig\" rid=\"JCS180182F2\">Fig.&#x000a0;2</xref>, <xref ref-type=\"table\" rid=\"JCS180182TB1\">Table&#x000a0;1</xref>). This illustrates that the numerous pull-down and yeast two-hybrid experiments previously used to assess this interaction (<xref rid=\"JCS180182C12\" ref-type=\"bibr\">O\\'Kelly et al., 2002</xref>; <xref rid=\"JCS180182C15\" ref-type=\"bibr\">Rajan et al., 2002</xref>; <xref rid=\"JCS180182C19\" ref-type=\"bibr\">Smith et al., 2011</xref>) effectively operate down to <italic>K</italic><sub>d</sub> values of 10&#x02005;&#x000b5;M. However, owing to their qualitative nature, the yeast two-hybrid experiments obscure substantial affinity differences. We also showed that pull-down experiments cease to efficiently capture an interaction if the <italic>K</italic><sub>d</sub> is in the order of 200&#x02005;&#x000b5;M (<uri xlink:href=\"http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.180182/-/DC1\">Table&#x000a0;S1</uri>, <xref ref-type=\"fig\" rid=\"JCS180182F5\">Fig.&#x000a0;5</xref>) or higher.</p><p>The marked differences that we found between the affinities of TASK-1 or TASK-3 for 14-3-3 proteins are in excellent agreement with the structure (<xref rid=\"JCS180182C1\" ref-type=\"bibr\">Anders et al., 2013</xref>) of this peptide bound to 14-3-3&#x003c3;; K372 of TASK-3, which is centrally positioned in the trafficking control region and corresponds to a serine residue in TASK-1, forms hydrogen bonds with an aspartate and asparagine residue of the 14-3-3-binding groove. A phosphoserine residue in the position equivalent to K372 of TASK-3 is very likely to destabilize the interaction with 14-3-3 proteins, and this is exactly what we observed for TASK-1 pS392 and the doubly phosphorylated protein (at S392 and S393) (<xref ref-type=\"fig\" rid=\"JCS180182F5\">Fig.&#x000a0;5</xref>, <uri xlink:href=\"http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.180182/-/DC1\">Table&#x000a0;S1</uri>). Because the exact binding site for the trafficking control region on COPI is unknown, we cannot interpret the relevance of K372 in TASK-3 with respect to the higher affinity of its trafficking control region to COPI when compared to that of TASK-1. The consensus of the COPI-binding motif requires basic residues in specific positions (<xref rid=\"JCS180182C22\" ref-type=\"bibr\">Zuzarte et al., 2009</xref>). Hence, we speculate that the additional lysine residue in TASK-3 contributes to the high-affinity binding of COPI to the corresponding trafficking control region.</p><p>The differences between the C-termini of TASK-1 and TASK-3 in the affinities for COPI and 14-3-3 proteins were also found to be relevant in intact cells. We demonstrated that the CD8&#x02013;CFP reporter comprising the exposed TASK-1 wild-type C-terminus reaches the cell surface less efficiently than the corresponding TASK-3 construct (<xref ref-type=\"fig\" rid=\"JCS180182F6\">Fig.&#x000a0;6</xref>). Mutation of S392 to alanine has the same effect as mutating K389 to alanine, which mutates the retention&#x02013;retrieval motif (<xref rid=\"JCS180182C22\" ref-type=\"bibr\">Zuzarte et al., 2009</xref>). We interpret this to be due to an increase in 14-3-3 protein affinity because S392, which results in strongly reduced 14-3-3 binding when phosphorylated, can no longer be phosphorylated (<xref ref-type=\"fig\" rid=\"JCS180182F5\">Fig.&#x000a0;5</xref>, <uri xlink:href=\"http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.180182/-/DC1\">Table&#x000a0;S1</uri>). TASK-1 S392A is expected to recruit 14-3-3 proteins efficiently (<xref ref-type=\"fig\" rid=\"JCS180182F2\">Fig.&#x000a0;2</xref>, <xref ref-type=\"table\" rid=\"JCS180182TB1\">Table&#x000a0;1</xref>) and, indeed, we observed equal cell surface expression of the constructs that comprised the exposed TASK-1 S392A or TASK-3 C-termini (<xref ref-type=\"fig\" rid=\"JCS180182F6\">Fig.&#x000a0;6</xref>).</p><p>We also quantitatively compared the effects on 14-3-3 binding for two commonly and interchangeably used manipulations of the TASK-C-termini &#x02013; mutation of the crucial serine residue in the mode III 14-3-3-binding motif to alanine or deletion of the C-terminal valine. Both variants have been widely used to dissect the role of 14-3-3 in cell surface expression because they have been assumed to impair 14-3-3 binding (<xref rid=\"JCS180182C12\" ref-type=\"bibr\">O\\'Kelly et al., 2002</xref>; <xref rid=\"JCS180182C15\" ref-type=\"bibr\">Rajan et al., 2002</xref>; <xref rid=\"JCS180182C19\" ref-type=\"bibr\">Smith et al., 2011</xref>). Our results clearly indicate that the two manipulations have different effects on 14-3-3 binding &#x02013; the mode III serine in its phosphorylated form is indeed an essential pre-requisite for any detectable 14-3-3 binding because 14-3-3 makes many intricate contacts with the phosphate group of the corresponding phosphoserine (<xref rid=\"JCS180182C1\" ref-type=\"bibr\">Anders et al., 2013</xref>), whereas TASK-3 pS373 &#x00394;V374 bound to 14-3-3 with higher affinity than TASK-1 pS393 (<xref ref-type=\"fig\" rid=\"JCS180182F2\">Fig.&#x000a0;2</xref>, <xref ref-type=\"table\" rid=\"JCS180182TB1\">Table&#x000a0;1</xref>). These observations indicate that in the context of a phosphorylated mode III binding motif, the C-terminal valine does not contribute substantially to the observed binding affinity, in line with the previously reported structure (<xref rid=\"JCS180182C1\" ref-type=\"bibr\">Anders et al., 2013</xref>), which shows one hydrogen bond between the C-terminal carboxy group of TASK-3 and a lysine residue of 14-3-3&#x003c3;. However, we also observed that the biological outcome of the two manipulations is very similar for TASK-3 (<xref ref-type=\"fig\" rid=\"JCS180182F4\">Fig.&#x000a0;4</xref>) because both TASK-3 S373A and TASK-3 &#x00394;V374 failed to reach the cell surface and accumulated in COPI-positive structures (<uri xlink:href=\"http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.180182/-/DC1\">Fig.&#x000a0;S1</uri>) that partially colocalized with markers of the cis-Golgi (GM130; <xref ref-type=\"fig\" rid=\"JCS180182F4\">Fig.&#x000a0;4</xref>). Importantly, when investigating the efficiency by which PKA phosphorylates TASK-3 &#x00394;V374, we found that the recombinant catalytic subunit of PKA modifies this construct less efficiently than TASK-3 wild type and that in transfected cells only a fraction of CD8&#x02013;CFP&#x02013;TASK-3 &#x00394;V374 was phosphorylated, whereas the corresponding wild-type construct was fully phosphorylated (<xref ref-type=\"fig\" rid=\"JCS180182F4\">Fig.&#x000a0;4</xref>). From what is known about the PKA consensus sequence (<xref rid=\"JCS180182C18\" ref-type=\"bibr\">Shabb, 2001</xref>), it is expected that a C-terminal serine would be phosphorylated less efficiently, consistent with our results. In conclusion, effects on phosphorylation efficiency have to be considered in addition to effects on COPI or 14-3-3 binding affinity when comparing the <italic>in vivo</italic> outcome of manipulations in the C-terminal TASK trafficking control region. The lower affinity of COPI (<xref ref-type=\"fig\" rid=\"JCS180182F7\">Fig.&#x000a0;7</xref>) to TASK-1 and of 14-3-3 proteins (<xref ref-type=\"fig\" rid=\"JCS180182F2\">Fig.&#x000a0;2</xref>, <xref ref-type=\"table\" rid=\"JCS180182TB1\">Table&#x000a0;1</xref>) to TASK-1 pS393 (as compared to TASK-3 or TASK-3 pS373) allows for a dynamic steady state where phosphatases, kinases and COPI can probe or modify the trafficking control region more often than is the case for TASK-3 (<xref ref-type=\"fig\" rid=\"JCS180182F6\">Figs&#x000a0;6</xref>B and <xref ref-type=\"fig\" rid=\"JCS180182F7\">7</xref>C).</p><p>Our discovery that the TASK-1 trafficking control region contains a second serine residue that is inhibitory to 14-3-3 binding when phosphorylated (<xref ref-type=\"fig\" rid=\"JCS180182F5\">Fig.&#x000a0;5</xref>, <uri xlink:href=\"http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.180182/-/DC1\">Table&#x000a0;S1</uri>) is reminiscent of a mechanism that has been previously shown to operate on a class of cardiac ATP-sensitive K<sup>+</sup> channels (K<sub>ATP</sub>) comprising Kir6.2 and SUR1 (<xref rid=\"JCS180182C2\" ref-type=\"bibr\">Arakel et al., 2014</xref>). Both subunits of these channels expose arginine-based COPI recognition signals, which can also recruit 14-3-3 proteins when presented in several copies and close vicinity (<xref rid=\"JCS180182C21\" ref-type=\"bibr\">Yuan et al., 2003</xref>). Phosphorylation by PKA uncouples these peptide-sorting motifs from recognition by COPI, thereby rendering the requirement for 14-3-3 binding obsolete and allowing cell surface expression to be regulated by signal transduction. This might be particularly relevant in cardiac myocytes, which have to adapt their electrical excitability to physiological stimuli and therefore might rely on preassembled ion channels that are stored in the Golgi because COPI retains them there (<xref rid=\"JCS180182C2\" ref-type=\"bibr\">Arakel et al., 2014</xref>). Interestingly, cardiac myocytes also express TASK-1 (<xref rid=\"JCS180182C14\" ref-type=\"bibr\">Putzke et al., 2007</xref>). Hence, the TASK-1 trafficking control region might lead to the accumulation of a Golgi-localized TASK-1 population that can be deployed upon &#x003b2;-adrenergic stimulation and concomitant phosphorylation by PKA, similar to the scenario that has been reported for K<sub>ATP</sub>. In this situation, double phosphorylation of the TASK-1 trafficking control region could trigger COPI- and 14-3-3-independent cell surface expression of a previously synthesized and assembled TASK-1 pool.</p><p>In conclusion, our results illustrate how the binding parameters of protein&#x02013;protein interactions with a trafficking control region of a membrane protein can be poised to enable physiological regulation of cell surface expression. They also underscore the need to study not only the kinases but also the phosphatases that have access to cargo membrane proteins in the secretory pathway of different cell types.</p></sec><sec sec-type=\"methods\" id=\"s4\"><title>MATERIALS AND METHODS</title><sec id=\"s4a\"><title>Reagents</title><p>Tables detailing antibodies (<uri xlink:href=\"http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.180182/-/DC1\">Table&#x000a0;S2</uri>), plasmids (<uri xlink:href=\"http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.180182/-/DC1\">Table&#x000a0;S3</uri>) and primers (<uri xlink:href=\"http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.180182/-/DC1\">Table&#x000a0;S4</uri>) used in this study are available as supplementary material.</p></sec><sec id=\"s4b\"><title>Molecular biology</title><p>GST-conjugated C-termini of TASK-1 and TASK-3, and different mutants were created according to <xref rid=\"JCS180182C7\" ref-type=\"bibr\">Mant et al. (2011</xref>). A detailed list of plasmids and primers can be found in <uri xlink:href=\"http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.180182/-/DC1\">Tables&#x000a0;S1 and S2</uri>.</p><p>Reporter constructs containing the extracellular domain of CD8, a fluorophore (eCFP) and the last 15 amino acids of the TASK-1 and TASK-3 C-termini or different mutated C-termini were created by initial sub-cloning of CD8 from constructs that have been previously described by <xref rid=\"JCS180182C22\" ref-type=\"bibr\">Zuzarte et al. (2009</xref>). The PCR product was digested with <italic>Bam</italic>HI and <italic>Eco</italic>RI, and ligated into the multiple cloning site of pcDNA3.1. eCFP was amplified by using PCR from pECFP-N1 (Clontech, Heidelberg, Germany). PCR products were digested with <italic>Eco</italic>RI and <italic>Not</italic>I, and subsequently ligated into the pcDNA3.1 vector, fusing CD8 and CFP. Oligonucleotides encoding the last 15 amino acids of TASK-1, TASK-3 and the different mutants were annealed and ligated into pcDNA3.1 between <italic>Not</italic>I and <italic>Xba</italic>I restriction sites. Open reading frames encoding human 14-3-3 proteins were inserted into the pMAL2Cx vector at <italic>Eco</italic>RI and <italic>Hind</italic>III restriction sites.</p></sec><sec id=\"s4c\"><title>Purification of proteins</title><p>GST proteins fused to the TASK-1 and TASK-3 C-termini were expressed and purified from the <italic>E. coli</italic> strain BL21(pREP4). Protein expression was induced with 1&#x02005;mM IPTG for 3&#x02005;h. Cells were subsequently lysed in GST lysis buffer containing 20&#x02005;mM HEPES pH 6.5, 150&#x02005;mM KOAc, 5&#x02005;mM Mg(OAc)<sub>2</sub>, 1&#x02005;mM EDTA, 1&#x02005;mM DTT and 1&#x02005;mM PMSF. Crude cellular lysates were centrifuged at 100,000 <bold><italic>g</italic></bold> for 30&#x02005;min at 4&#x000b0;C. Cleared lysates were incubated for 90&#x02005;min with equilibrated glutathione Sepharose beads. The bead slurry was transferred to a gravity column and washed with GST lysis buffer. Bound proteins were eluted with GST elution buffer containing 20&#x02005;mM HEPES pH 9.5, 150&#x02005;mM KOAc, 5&#x02005;mM MgOAc, 1&#x02005;mM EDTA, 1&#x02005;mM DTT and 15&#x02005;mM glutathione. Cells expressing MBP-tagged 14-3-3 proteins were lysed in buffer containing 150&#x02005;mM NaCl, 5&#x02005;mM MgCl<sub>2</sub>, 50&#x02005;mM Tris-HCl pH 7.5 (MBP lysis buffer). Further purification steps were executed analogous to the procedure described for GST fusion proteins. Bound proteins were eluted using MBP lysis buffer supplemented with 20&#x02005;mM <sc>d</sc>-maltose. To remove the MBP tag, purified proteins were incubated with Factor Xa for 24&#x02005;h at 4&#x000b0;C. Both GST fusion proteins and processed MBP-tagged proteins were subjected to size exclusion chromatography using an &#x000c4;kta purifier (GE Healthcare, Chalfont St Giles, UK) equipped with a Superdex75 size exclusion column. Recombinant human PKA catalytic subunit was expressed and purified with an IP20 resin, as described previously (<xref rid=\"JCS180182C13\" ref-type=\"bibr\">Olsen and Uhler, 1989</xref>; <xref rid=\"JCS180182C6\" ref-type=\"bibr\">Knape et al., 2015</xref>).</p></sec><sec id=\"s4d\"><title>Fluorescence polarization measurements</title><p>Interactions between 14-3-3 proteins and TASK-1 and TASK-3 C-terminal peptides and variants were investigated using a fluorescence polarization assay (<xref rid=\"JCS180182C9\" ref-type=\"bibr\">Moll et al., 2006</xref>; <xref rid=\"JCS180182C10\" ref-type=\"bibr\">Muda et al., 2014</xref>). Fluorescein-labeled peptides were purchased from Peps4Life Sciences (Heidelberg, Germany). All measurements were performed in buffer containing 20&#x02005;mM MOPS, 150&#x02005;mM NaCl, 0.005% (v/v) CHAPS pH 7.0, using a Fusion&#x02122; &#x003b1;-FP microtiter plate reader at room temperature in a 384-well microtiter plater (Optiplate 384, black; Packard, Meriden, CT). 14-3-3 proteins were serially diluted from 100&#x02005;&#x000b5;M to 1&#x02005;nM and incubated with 10&#x02005;nM of fluorescently labeled peptide. The fluorescence polarization signal was detected for 2&#x02005;s at an excitation wavelength of 485&#x02005;nm with an emission fluorescence polarization filter wavelength of 535&#x02005;nm and a photomultiplier voltage of 1100. Data were analyzed with GraphPad Prism 6.0 (GraphPad Software, San Diego, CA) by plotting the obtained fluorescence polarization signal in millipolarization units (mPol) against the logarithm of the 14-3-3 protein concentration. The data were then fitted using a monophasic fit.</p></sec><sec id=\"s4e\"><title>Surface plasmon resonance measurements</title><p>Binding of 14-3-3 proteins to the C-terminus of TASK-3 was analyzed using surface plasmon resonance. An HC1000m SPR sensor chip was activated with 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide and N-hydroxysuccinimide (EDC&#x02013;NHS) according to the manufacturer\\'s instructions (Xantec Biotechnologies, D&#x000fc;sseldorf, Germany). An antibody against GST (Carl Roth, Karlsruhe, Germany; catalog number 3998.1) was coupled at the N-terminus to the activated chip surface at a flow rate of 15&#x02005;&#x000b5;l/min and a concentration of 30&#x02005;&#x000b5;g/ml to a surface density of 4000&#x02013;8000&#x02005;&#x000b5;RIU (depending on the maximal capacity of each chip and on each batch). The chip surface was subsequently deactivated with a 180-s injection of 1&#x02005;M ethanolamine pH 8.5, at a flow rate of 30&#x02005;&#x000b5;l/min. GST fusion proteins were captured at a flow rate of 30&#x02005;&#x000b5;l/min to a surface density of 200&#x02013;400&#x02005;&#x000b5;RIU onto the ligand and reference channel. Proteins captured on the ligand channel were phosphorylated <italic>in vitro</italic> by injecting a phosphorylation buffer containing 20&#x02005;mM HEPES, 150&#x02005;mM NaCl, 10&#x02005;mM MgCl<sub>2</sub>, 100&#x02005;&#x000b5;M ATP, 200&#x02005;nM PKA catalytic subunit and 0.005% (v/v) Tween 20 pH 7.5 at a flow rate of 15&#x02005;&#x000b5;l/min for 20&#x02005;min. A serial dilution of the analyte [14-3-3 proteins or PKA-phosphorylated-substrate antibody (Cell Signaling Technology, Danvers, MA; clone 100G7E, catalog number 9624) was injected, and association was followed for 4.5&#x02005;min. Dissociation of the analyte from the ligand was monitored for 7&#x02005;min. The surface was regenerated after each experiment with glycine pH 2.2. Data analysis was performed using Scrubber 2.0c. Equilibrium binding isotherms were analyzed using GraphPad Prism 6.0. All binding experiments were performed on a Reichert SR 7500DC biosensor instrument at 20&#x000b0;C and a flow rate of 40&#x02005;&#x000b5;l/min on HC1000m SPR sensor chips (Xantec Bioanalytics, D&#x000fc;sseldorf, Germany) in buffer containing 150&#x02005;mM NaCl, 20&#x02005;mM HEPES, 0.005% (v/v) Tween 20, pH 7.5.</p></sec><sec id=\"s4f\"><title>Cell culture and transfection</title><p>COS-7 cells were obtained from European Collection of Authenticated Cell Cultures via Sigma-Aldrich (Taufkirchen, Germany; catalog number 87021302) and tested for mycoplasma contamination at regular intervals. For western blotting analysis, COS-7 cells were transiently transfected using the calcium phosphate method. 5&#x02005;&#x000b5;g of DNA was mixed with 95&#x02005;&#x000b5;l of 0.25&#x02005;M CaCl<sub>2</sub> and 100&#x02005;&#x000b5;l of BES-buffered saline (BBS; 50&#x02005;mM BES, 273&#x02005;mM NaCl, 2&#x02005;mM Na<sub>2</sub>HPO<sub>4</sub>) and incubated for 30&#x02005;min at room temperature before adding to cells. Cells were incubated for 20&#x02005;h at 37&#x000b0;C under 3% CO<sub>2</sub>, washed twice with 1&#x000d7; PBS and then grown for 48&#x02005;h at 37&#x000b0;C under 5% CO<sub>2</sub>. For indirect immunofluorescence staining, transient transfection was performed on coverslips using FuGENE (Promega, Madison, WI). 150&#x02005;&#x000b5;l of Opti-MEM (Life Technologies, Karlsruhe, Germany) was mixed with 10&#x02005;&#x000b5;l of FuGENE and incubated at room temperature for 5&#x02005;min for equilibration, and added to 5&#x02005;&#x000b5;g of DNA. After incubation for 15&#x02005;min at room temperature, 2&#x02005;ml of Dulbecco\\'s modified Eagle\\'s medium (DMEM; Life Technologies, Karlsruhe, Germany) was added to each tube, and the mixture was transferred to the cells. The cells were incubated with transfection solution for 10&#x02005;h at 37&#x000b0;C under 5% CO<sub>2</sub>, then washed once with 1&#x000d7; PBS, followed by 38&#x02005;h of incubation at 37&#x000b0;C under 5% CO<sub>2</sub>.</p></sec><sec id=\"s4g\"><title><italic>In vitro</italic> phosphorylation assays</title><p>GST fusion proteins of the TASK-1 and TASK-3 C-terminus were <italic>in vitro</italic> phosphorylated using recombinant PKA catalytic subunit in 150&#x02005;mM NaCl, 50&#x02005;mM Tris-HCl pH 7.5, 10&#x02005;mM MgCl<sub>2</sub>, 20&#x02005;nM PKA, 100&#x02005;&#x000b5;M ATP, as described previously by <xref rid=\"JCS180182C7\" ref-type=\"bibr\">Mant et al. (2011</xref>). Proteins were phosphorylated for either 10&#x02005;min at room temperature (<xref ref-type=\"fig\" rid=\"JCS180182F4\">Fig.&#x000a0;4</xref>A,B) or overnight at 4&#x000b0;C. The buffer was supplemented with an ATP regeneration system (<xref rid=\"JCS180182C21\" ref-type=\"bibr\">Yuan et al., 2003</xref>).</p></sec><sec id=\"s4h\"><title><italic>In vivo</italic> phosphorylation assays and western blotting</title><p>1&#x000d7;10<sup>5</sup> COS-7 cells were transiently transfected using calcium phosphate with 5&#x02005;&#x000b5;g of DNA and washed twice with 1&#x000d7; PBS, resuspended in 500&#x02005;&#x000b5;l of membrane preparation buffer [50&#x02005;mM NaCl, 0.32&#x02005;M sucrose, 2&#x02005;mM EDTA, 20&#x02005;mM HEPES, pH 7.4, cOmplete EDTA-free protease inhibitor cocktail (Roche, Mannheim, Germany) and 50&#x02005;&#x000b5;M PKA inhibitor H-89 dihydrochloride hydrate (Sigma-Aldrich)], homogenized using a MICCRA-D-1 homogenizer disperser (ART Prozess- &#x00026; Labortechnik, M&#x000fc;llheim, Germany), followed by 15 strokes with a Dounce homogenizer. After separation of the insoluble fraction with centrifugation for 30&#x02005;min at 100,000&#x02005;<bold><italic>g</italic></bold>, the pellet was solubilized in 250&#x02005;&#x000b5;l of solubilization buffer (1.5% Triton X-100, 0.75% Na-deoxycholate, 0.1% SDS, 50&#x02005;mM Tris-HCl, 100&#x02005;mM NaCl, 5&#x02005;mM EDTA, 2.5&#x02005;mM EGTA, pH 7.5) for 30&#x02005;min on ice, followed by a second centrifugation step. Subsequently, the samples were precipitated with trichloroacetic acid (TCA) and resuspended in &#x003bb; phosphatase buffer (1&#x000d7; PMP buffer, catalog number P0753, New England Biolabs, Frankfurt, Germany). For each construct, one sample was treated with 1600&#x02005;U &#x003bb; phosphatase for 30&#x02005;min at 30&#x000b0;C, supplemented with 5&#x000d7; SDS loading buffer and separated on 12% SDS gels containing 75&#x02005;&#x000b5;M Phostag and 75&#x02005;&#x000b5;M MnCl<sub>2</sub> reagent. Transfer to a membrane was performed at 4&#x000b0;C for 18&#x02005;h at 30&#x02005;V. CD8&#x02013;CFP&#x02013;TASK fusion proteins were detected using a CD8-&#x003b1; antibody (Santa Cruz Biotechnology, Santa Cruz, CA; clone H-160, catalog number SC-7188, lot number E2213). Fluorescently labeled secondary antibodies were detected using an Odyssey LiCOR imaging system (LiCOR, Bad Homburg, Germany).</p></sec><sec id=\"s4i\"><title>Quantification of gels</title><p>To quantitatively compare the intensity of Coomassie-stained protein bands (<xref ref-type=\"fig\" rid=\"JCS180182F4\">Fig.&#x000a0;4</xref>A) or signals obtained by detecting specific proteins with western blotting (<xref ref-type=\"fig\" rid=\"JCS180182F6\">Fig.&#x000a0;6</xref>B), the LiCOR Studio-Lite software was used.</p></sec><sec id=\"s4j\"><title>Flow cytometry</title><p>Flow cytometry was performed with a FACS Calibur&#x02122; flow cytometer and FACS DIVA&#x02122; software (BD Biosciences, Heidelberg, Germany). Cell surface expression of a reporter protein containing the extracellular domain of CD8, an eCFP fluorophore and the last 15 amino acids of the TASK-1 or TASK-3 C-termini, and different mutants was examined using a mouse monoclonal antibody against CD8 (Sigma-Aldrich; catalog number C7423; 5&#x02005;&#x000b5;l/10<sup>6</sup> cells in 500&#x02005;&#x000b5;l PBS) and an Alexa-Fluor-647-coupled secondary antibody (Invitrogen). The ratio between the anti-CD8 antibody staining and the CFP signal was used to determine the relative cell surface expression of constructs bearing different TASK protein C-termini.</p></sec><sec id=\"s4k\"><title>Indirect immunofluorescence staining</title><p>Transiently transfected COS-7 cells were fixed 48&#x02005;h post transfection using a two-step fixation protocol with 2% (w/v) formaldehyde, 0.125&#x02005;M sucrose in 1&#x000d7; PBS for 20&#x02005;min at room temperature following fixation with 1% (w/v) formaldehyde in 1&#x000d7; PBS for 10&#x02005;min. Cells were permeabilized for 10&#x02005;min at room temperature with 0.3% Triton X-100 and 0.05% SDS in 1&#x000d7; PBS, rinsed twice with PBS and blocked for 30&#x02005;min at room temperature with 10% (w/v) FBS in 1&#x000d7; PBS. Primary anti-CD8 antibody (Sigma-Aldrich; catalog number C7423, 1:50 dilution), anti-GM130 antibody (Abcam, Cambridge, UK; catalog number ab52649, 1:100 dilution), CD8-&#x003b1; antibody (Santa Cruz Biotechnology, Santa Cruz, CA; clone H-160, dilution 1:200) and anti-&#x003b2;COP antibody (Sigma-Aldrich; catalog number G6160, dilution 1:2000) were used. Alexa-Fluor-647- or Alexa-Fluor-488-conjugated (Invitrogen) anti-mouse IgG or anti-rabbit IgG secondary antibodies were used at a dilution of 1:500. Coverslips were mounted using Mowiol mounting medium. For <xref ref-type=\"fig\" rid=\"JCS180182F4\">Fig.&#x000a0;4</xref>D, to stain cell surface-exposed CD8, unfixed cells were washed twice with ice-cold PBS, stained on ice for 30&#x02005;min with primary antibodies diluted in 5% FBS in 1&#x000d7; PBS, then washed with PBS; the normal fixation protocol was then followed.</p></sec><sec id=\"s4l\"><title>Light microscopy</title><p>Wide-field microscopy analysis of fixed and stained cells was performed on a Delta Vision microscope system (GE Healthcare) using a 60&#x000d7;UplanSApo objective. Images were acquired using Coolsnap HQ2 CCDcamera (Roper Scientific), SoftWorx software and were processed using ImageJ software.</p></sec><sec id=\"s4m\"><title>COPI and 14-3-3 pull-down experiments</title><p>COPI was purified as described previously (<xref rid=\"JCS180182C20\" ref-type=\"bibr\">Yip and Walz, 2011</xref>). 10&#x02005;&#x000b5;g of purified GST&#x02013;Mst27&#x02013;Task1-C15 or GST&#x02013;Mst27&#x02013;Task3-C15 (<xref rid=\"JCS180182C17\" ref-type=\"bibr\">Sandmann et al., 2003</xref>; <xref rid=\"JCS180182C8\" ref-type=\"bibr\">Michelsen et al., 2007</xref>) was phosphorylated by recombinant PKA (phosphorylation buffer: 20&#x02005;mM HEPES pH 6.8, 2% glycerol, 150&#x02005;mM potassium acetate, 5&#x02005;mM magnesium acetate, 1&#x02005;mM EDTA, 1&#x02005;mM DTT supplemented with an ATP regeneration system comprising 10&#x02005;mM phosphocreatine, 0.5&#x02005;mM ATP, 0.5&#x02005;mM GTP, 50&#x02005;&#x000b5;g/ml creatine phosphokinase). Following phosphorylation, the baits were immobilized on &#x0223c;20&#x02005;&#x000b5;l of glutathione&#x02013;agarose (slurry volume). COPI or purified 14-3-3&#x003b3; was added as indicated and incubated for a minimum period of 60&#x02005;min. The baits were washed four times with phosphorylation buffer and eluted with 1&#x000d7; SDS sample buffer (containing 100&#x02005;mM DTT) and analyzed using SDS-PAGE or Phostag PAGE.</p></sec></sec></body><back><ack><title>Acknowledgements</title><p>We thank F. W. Herberg for generous support and extensive scientific advice, J. Daut for critical discussions and extremely helpful comments on the manuscript, and Anne Spang (Biozentrum Basel, Switzerland) for the gift of the anti-yeast COPI antiserum.</p></ack><fn-group><title>Footnotes</title><fn fn-type=\"conflict\"><p><bold>Competing interests</bold></p><p>The authors declare no competing or financial interests.</p></fn><fn><p><bold>Author contributions</bold></p><p>M.K., E.C.A., D.B. and B.S. designed research; M.K., O.L. and E.C.A. performed research; M.K., O.L., E.C.A., D.B. and B.S. analyzed data; M.K., E.C.A. and B.S. wrote the paper.</p></fn><fn fn-type=\"financial-disclosure\"><p><bold>Funding</bold></p><p>This study was supported by the Deutsche Forschungsgemeinschaft [grant numbers FOR 1086, TP9; SFB 1002, B01] to B. Schwappach; by the European Union FP7 Health Programme 241481 AFFINOMICS; and the Federal Ministry of Education and Research [grant number 0316177F No Pain to D. Bertinetti]. Deposited in PMC for immediate release.</p></fn><fn fn-type=\"supplementary-material\"><p><bold>Supplementary information</bold></p><p>Supplementary information available online at <uri xlink:href=\"http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.180182/-/DC1\">http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.180182/-/DC1</uri></p></fn></fn-group><ref-list><title>References</title><ref id=\"JCS180182C1\"><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Anders</surname><given-names>C.</given-names></name>, <name><surname>Higuchi</surname><given-names>Y.</given-names></name>, <name><surname>Koschinsky</surname><given-names>K.</given-names></name>, <name><surname>Bartel</surname><given-names>M.</given-names></name>, <name><surname>Schumacher</surname><given-names>B.</given-names></name>, <name><surname>Thiel</surname><given-names>P.</given-names></name>, <name><surname>Nitta</surname><given-names>H.</given-names></name>, <name><surname>Preisig-Muller</surname><given-names>R.</given-names></name>, <name><surname>Schlichthorl</surname><given-names>G.</given-names></name>, <name><surname>Renigunta</surname><given-names>V.</given-names></name><etal>et al.</etal></person-group> (<year>2013</year>). <article-title>A semisynthetic fusicoccane stabilizes a protein-protein interaction and enhances the expression of K+ channels at the cell surface</article-title>. <source><italic>Chem. Biol.</italic></source>\\n<volume>20</volume>, <fpage>583</fpage>-<lpage>593</lpage>. <pub-id pub-id-type=\"doi\">10.1016/j.chembiol.2013.03.015</pub-id><pub-id pub-id-type=\"pmid\">23601647</pub-id></mixed-citation></ref><ref id=\"JCS180182C2\"><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Arakel</surname><given-names>E. C.</given-names></name>, <name><surname>Brandenburg</surname><given-names>S.</given-names></name>, <name><surname>Uchida</surname><given-names>K.</given-names></name>, <name><surname>Zhang</surname><given-names>H.</given-names></name>, <name><surname>Lin</surname><given-names>Y.-W.</given-names></name>, <name><surname>Kohl</surname><given-names>T.</given-names></name>, <name><surname>Schrul</surname><given-names>B.</given-names></name>, <name><surname>Sulkin</surname><given-names>M. S.</given-names></name>, <name><surname>Efimov</surname><given-names>I. R.</given-names></name>, <name><surname>Nichols</surname><given-names>C. G.</given-names></name><etal>et al.</etal></person-group> (<year>2014</year>). <article-title>Tuning the electrical properties of the heart by differential trafficking of KATP ion channel complexes</article-title>. <source><italic>J. Cell Sci.</italic></source>\\n<volume>127</volume>, <fpage>2106</fpage>-<lpage>2119</lpage>. <pub-id pub-id-type=\"doi\">10.1242/jcs.141440</pub-id><pub-id pub-id-type=\"pmid\">24569881</pub-id></mixed-citation></ref><ref id=\"JCS180182C3\"><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Coblitz</surname><given-names>B.</given-names></name>, <name><surname>Shikano</surname><given-names>S.</given-names></name>, <name><surname>Wu</surname><given-names>M.</given-names></name>, <name><surname>Gabelli</surname><given-names>S. B.</given-names></name>, <name><surname>Cockrell</surname><given-names>L. M.</given-names></name>, <name><surname>Spieker</surname><given-names>M.</given-names></name>, <name><surname>Hanyu</surname><given-names>Y.</given-names></name>, <name><surname>Fu</surname><given-names>H.</given-names></name>, <name><surname>Amzel</surname><given-names>L. M.</given-names></name> and <name><surname>Li</surname><given-names>M.</given-names></name></person-group> (<year>2005</year>). <article-title>C-terminal recognition by 14-3-3 proteins for surface expression of membrane receptors</article-title>. <source><italic>J. Biol. Chem.</italic></source>\\n<volume>280</volume>, <fpage>36263</fpage>-<lpage>36272</lpage>. <pub-id pub-id-type=\"doi\">10.1074/jbc.M507559200</pub-id><pub-id pub-id-type=\"pmid\">16123035</pub-id></mixed-citation></ref><ref id=\"JCS180182C4\"><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Kagan</surname><given-names>A.</given-names></name>, <name><surname>Melman</surname><given-names>Y. F.</given-names></name>, <name><surname>Krumerman</surname><given-names>A.</given-names></name> and <name><surname>McDonald</surname><given-names>T. V.</given-names></name></person-group> (<year>2002</year>). <article-title>14&#x02013;3&#x02013;3 amplifies and prolongs adrenergic stimulation of HERG K+ channel activity</article-title>. <source><italic>EMBO J.</italic></source>\\n<volume>21</volume>, <fpage>1889</fpage>-<lpage>1898</lpage>. <pub-id pub-id-type=\"doi\">10.1093/emboj/21.8.1889</pub-id><pub-id pub-id-type=\"pmid\">11953308</pub-id></mixed-citation></ref><ref id=\"JCS180182C5\"><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Kilisch</surname><given-names>M.</given-names></name>, <name><surname>Lytovchenko</surname><given-names>O.</given-names></name>, <name><surname>Schwappach</surname><given-names>B.</given-names></name>, <name><surname>Renigunta</surname><given-names>V.</given-names></name> and <name><surname>Daut</surname><given-names>J.</given-names></name></person-group> (<year>2015</year>). <article-title>The role of protein-protein interactions in the intracellular traffic of the potassium channels TASK-1 and TASK-3</article-title>. <source><italic>Pflugers Arch.</italic></source>\\n<volume>467</volume>, <fpage>1105</fpage>-<lpage>1120</lpage>. <pub-id pub-id-type=\"doi\">10.1007/s00424-014-1672-2</pub-id><pub-id pub-id-type=\"pmid\">25559843</pub-id></mixed-citation></ref><ref id=\"JCS180182C6\"><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Knape</surname><given-names>M. J.</given-names></name>, <name><surname>Ahuja</surname><given-names>L. G.</given-names></name>, <name><surname>Bertinetti</surname><given-names>D.</given-names></name>, <name><surname>Burghardt</surname><given-names>N. C. G.</given-names></name>, <name><surname>Zimmermann</surname><given-names>B.</given-names></name>, <name><surname>Taylor</surname><given-names>S. S.</given-names></name> and <name><surname>Herberg</surname><given-names>F. W.</given-names></name></person-group> (<year>2015</year>). <article-title>Divalent metal ions Mg<sup>2+</sup> and Ca<sup>2+</sup> have distinct effects on protein kinase A activity and regulation</article-title>. <source><italic>ACS Chem. Biol.</italic></source>\\n<volume>10</volume>, <fpage>2303</fpage>-<lpage>2315</lpage>. <pub-id pub-id-type=\"doi\">10.1021/acschembio.5b00271</pub-id><pub-id pub-id-type=\"pmid\">26200257</pub-id></mixed-citation></ref><ref id=\"JCS180182C7\"><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Mant</surname><given-names>A.</given-names></name>, <name><surname>Elliott</surname><given-names>D.</given-names></name>, <name><surname>Eyers</surname><given-names>P. A.</given-names></name> and <name><surname>O\\'Kelly</surname><given-names>I. M.</given-names></name></person-group> (<year>2011</year>). <article-title>Protein kinase A is central for forward transport of two-pore domain potassium channels K2P3.1 and K2P9.1</article-title>. <source><italic>J. Biol. Chem.</italic></source>\\n<volume>286</volume>, <fpage>14110</fpage>-<lpage>14119</lpage>. <pub-id pub-id-type=\"doi\">10.1074/jbc.M110.190702</pub-id><pub-id pub-id-type=\"pmid\">21357689</pub-id></mixed-citation></ref><ref id=\"JCS180182C8\"><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Michelsen</surname><given-names>K.</given-names></name>, <name><surname>Schmid</surname><given-names>V.</given-names></name>, <name><surname>Metz</surname><given-names>J.</given-names></name>, <name><surname>Heusser</surname><given-names>K.</given-names></name>, <name><surname>Liebel</surname><given-names>U.</given-names></name>, <name><surname>Schwede</surname><given-names>T.</given-names></name>, <name><surname>Spang</surname><given-names>A.</given-names></name> and <name><surname>Schwappach</surname><given-names>B.</given-names></name></person-group> (<year>2007</year>). <article-title>Novel cargo-binding site in the beta and delta subunits of coatomer</article-title>. <source><italic>J. Cell Biol.</italic></source>\\n<volume>179</volume>, <fpage>209</fpage>-<lpage>217</lpage>. <pub-id pub-id-type=\"doi\">10.1083/jcb.200704142</pub-id><pub-id pub-id-type=\"pmid\">17954604</pub-id></mixed-citation></ref><ref id=\"JCS180182C9\"><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Moll</surname><given-names>D.</given-names></name>, <name><surname>Prinz</surname><given-names>A.</given-names></name>, <name><surname>Gesellchen</surname><given-names>F.</given-names></name>, <name><surname>Drewianka</surname><given-names>S.</given-names></name>, <name><surname>Zimmermann</surname><given-names>B.</given-names></name> and <name><surname>Herberg</surname><given-names>F. W.</given-names></name></person-group> (<year>2006</year>). <article-title>Biomolecular interaction analysis in functional proteomics</article-title>. <source><italic>J. Neural Transmission</italic></source>\\n<volume>113</volume>, <fpage>1015</fpage>-<lpage>1032</lpage>. <pub-id pub-id-type=\"doi\">10.1007/s00702-006-0515-5</pub-id></mixed-citation></ref><ref id=\"JCS180182C10\"><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Muda</surname><given-names>K.</given-names></name>, <name><surname>Bertinetti</surname><given-names>D.</given-names></name>, <name><surname>Gesellchen</surname><given-names>F.</given-names></name>, <name><surname>Hermann</surname><given-names>J. S.</given-names></name>, <name><surname>von Zweydorf</surname><given-names>F.</given-names></name>, <name><surname>Geerlof</surname><given-names>A.</given-names></name>, <name><surname>Jacob</surname><given-names>A.</given-names></name>, <name><surname>Ueffing</surname><given-names>M.</given-names></name>, <name><surname>Gloeckner</surname><given-names>C. J.</given-names></name> and <name><surname>Herberg</surname><given-names>F. W.</given-names></name></person-group> (<year>2014</year>). <article-title>Parkinson-related LRRK2 mutation R1441C/G/H impairs PKA phosphorylation of LRRK2 and disrupts its interaction with 14-3-3</article-title>. <source><italic>Proc. Natl. Acad. Sci. USA</italic></source>\\n<volume>111</volume>, <fpage>E34</fpage>-<lpage>E43</lpage>. <pub-id pub-id-type=\"doi\">10.1073/pnas.1312701111</pub-id><pub-id pub-id-type=\"pmid\">24351927</pub-id></mixed-citation></ref><ref id=\"JCS180182C11\"><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>O\\'Kelly</surname><given-names>I.</given-names></name> and <name><surname>Goldstein</surname><given-names>S. A.</given-names></name></person-group> (<year>2008</year>). <article-title>Forward transport of K 2p 3.1: mediation by 14-3-3 and COPI, modulation by p11</article-title>. <source><italic>Traffic</italic></source>\\n<volume>9</volume>, <fpage>72</fpage>-<lpage>78</lpage>. <pub-id pub-id-type=\"doi\">10.1111/j.1600-0854.2007.00663.x</pub-id><pub-id pub-id-type=\"pmid\">17908283</pub-id></mixed-citation></ref><ref id=\"JCS180182C12\"><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>O\\'Kelly</surname><given-names>I.</given-names></name>, <name><surname>Butler</surname><given-names>M. H.</given-names></name>, <name><surname>Zilberberg</surname><given-names>N.</given-names></name> and <name><surname>Goldstein</surname><given-names>S. A. N.</given-names></name></person-group> (<year>2002</year>). <article-title>Forward transport. 14-3-3 binding overcomes retention in endoplasmic reticulum by dibasic signals</article-title>. <source><italic>Cell</italic></source>\\n<volume>111</volume>, <fpage>577</fpage>-<lpage>588</lpage>. <pub-id pub-id-type=\"doi\">10.1016/S0092-8674(02)01040-1</pub-id><pub-id pub-id-type=\"pmid\">12437930</pub-id></mixed-citation></ref><ref id=\"JCS180182C13\"><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Olsen</surname><given-names>S. R.</given-names></name> and <name><surname>Uhler</surname><given-names>M. D.</given-names></name></person-group> (<year>1989</year>). <article-title>Affinity purification of the C alpha and C beta isoforms of the catalytic subunit of cAMP-dependent protein kinase</article-title>. <source><italic>J. Biol. Chem.</italic></source>\\n<volume>264</volume>, <fpage>18662</fpage>-<lpage>18666</lpage>.<pub-id pub-id-type=\"pmid\">2553718</pub-id></mixed-citation></ref><ref id=\"JCS180182C14\"><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Putzke</surname><given-names>C.</given-names></name>, <name><surname>Wemhoner</surname><given-names>K.</given-names></name>, <name><surname>Sachse</surname><given-names>F. B.</given-names></name>, <name><surname>Rinne</surname><given-names>S.</given-names></name>, <name><surname>Schlichthorl</surname><given-names>G.</given-names></name>, <name><surname>Li</surname><given-names>X. T.</given-names></name>, <name><surname>Jae</surname><given-names>L.</given-names></name>, <name><surname>Eckhardt</surname><given-names>I.</given-names></name>, <name><surname>Wischmeyer</surname><given-names>E.</given-names></name>, <name><surname>Wulf</surname><given-names>H.</given-names></name><etal>et al.</etal></person-group> (<year>2007</year>). <article-title>The acid-sensitive potassium channel TASK-1 in rat cardiac muscle</article-title>. <source><italic>Cardiovasc. Res.</italic></source>\\n<volume>75</volume>, <fpage>59</fpage>-<lpage>68</lpage>. <pub-id pub-id-type=\"doi\">10.1016/j.cardiores.2007.02.025</pub-id><pub-id pub-id-type=\"pmid\">17389142</pub-id></mixed-citation></ref><ref id=\"JCS180182C15\"><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Rajan</surname><given-names>S.</given-names></name>, <name><surname>Preisig-Muller</surname><given-names>R.</given-names></name>, <name><surname>Wischmeyer</surname><given-names>E.</given-names></name>, <name><surname>Nehring</surname><given-names>R.</given-names></name>, <name><surname>Hanley</surname><given-names>P. J.</given-names></name>, <name><surname>Renigunta</surname><given-names>V.</given-names></name>, <name><surname>Musset</surname><given-names>B.</given-names></name>, <name><surname>Schlichthorl</surname><given-names>G.</given-names></name>, <name><surname>Derst</surname><given-names>C.</given-names></name>, <name><surname>Karschin</surname><given-names>A.</given-names></name><etal>et al.</etal></person-group> (<year>2002</year>). <article-title>Interaction with 14-3-3 proteins promotes functional expression of the potassium channels TASK-1 and TASK-3</article-title>. <source><italic>J. Physiol.</italic></source>\\n<volume>545</volume>, <fpage>13</fpage>-<lpage>26</lpage>. <pub-id pub-id-type=\"doi\">10.1113/jphysiol.2002.027052</pub-id><pub-id pub-id-type=\"pmid\">12433946</pub-id></mixed-citation></ref><ref id=\"JCS180182C16\"><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Renigunta</surname><given-names>V.</given-names></name>, <name><surname>Schlichthorl</surname><given-names>G.</given-names></name> and <name><surname>Daut</surname><given-names>J.</given-names></name></person-group> (<year>2015</year>). <article-title>Much more than a leak: structure and function of K(2)p-channels</article-title>. <source><italic>Pflugers Arch.</italic></source>\\n<volume>467</volume>, <fpage>867</fpage>-<lpage>894</lpage>. <pub-id pub-id-type=\"doi\">10.1007/s00424-015-1703-7</pub-id><pub-id pub-id-type=\"pmid\">25791628</pub-id></mixed-citation></ref><ref id=\"JCS180182C17\"><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Sandmann</surname><given-names>T.</given-names></name>, <name><surname>Herrmann</surname><given-names>J. M.</given-names></name>, <name><surname>Dengjel</surname><given-names>J.</given-names></name>, <name><surname>Schwarz</surname><given-names>H.</given-names></name> and <name><surname>Spang</surname><given-names>A.</given-names></name></person-group> (<year>2003</year>). <article-title>Suppression of coatomer mutants by a new protein family with COPI and COPII binding motifs in Saccharomyces cerevisiae</article-title>. <source><italic>Mol. Biol. Cell</italic></source>\\n<volume>14</volume>, <fpage>3097</fpage>-<lpage>3113</lpage>. <pub-id pub-id-type=\"doi\">10.1091/mbc.E02-11-0736</pub-id><pub-id pub-id-type=\"pmid\">12925749</pub-id></mixed-citation></ref><ref id=\"JCS180182C18\"><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Shabb</surname><given-names>J. B.</given-names></name></person-group> (<year>2001</year>). <article-title>Physiological substrates of cAMP-dependent protein kinase</article-title>. <source><italic>Chem. Rev.</italic></source>\\n<volume>101</volume>, <fpage>2381</fpage>-<lpage>2412</lpage>. <pub-id pub-id-type=\"doi\">10.1021/cr000236l</pub-id><pub-id pub-id-type=\"pmid\">11749379</pub-id></mixed-citation></ref><ref id=\"JCS180182C19\"><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Smith</surname><given-names>A. J.</given-names></name>, <name><surname>Daut</surname><given-names>J.</given-names></name> and <name><surname>Schwappach</surname><given-names>B.</given-names></name></person-group> (<year>2011</year>). <article-title>Membrane proteins as 14-3-3 clients in functional regulation and intracellular transport</article-title>. <source><italic>Physiology</italic></source>\\n<volume>26</volume>, <fpage>181</fpage>-<lpage>191</lpage>. <pub-id pub-id-type=\"doi\">10.1152/physiol.00042.2010</pub-id><pub-id pub-id-type=\"pmid\">21670164</pub-id></mixed-citation></ref><ref id=\"JCS180182C20\"><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Yip</surname><given-names>C. K.</given-names></name> and <name><surname>Walz</surname><given-names>T.</given-names></name></person-group> (<year>2011</year>). <article-title>Molecular structure and flexibility of the yeast coatomer as revealed by electron microscopy</article-title>. <source><italic>J. Mol. Biol.</italic></source>\\n<volume>408</volume>, <fpage>825</fpage>-<lpage>831</lpage>. <pub-id pub-id-type=\"doi\">10.1016/j.jmb.2011.03.029</pub-id><pub-id pub-id-type=\"pmid\">21435344</pub-id></mixed-citation></ref><ref id=\"JCS180182C21\"><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Yuan</surname><given-names>H.</given-names></name>, <name><surname>Michelsen</surname><given-names>K.</given-names></name> and <name><surname>Schwappach</surname><given-names>B.</given-names></name></person-group> (<year>2003</year>). <article-title>14-3-3 dimers probe the assembly status of multimeric membrane proteins</article-title>. <source><italic>Curr. Biol.</italic></source>\\n<volume>13</volume>, <fpage>638</fpage>-<lpage>646</lpage>. <pub-id pub-id-type=\"doi\">10.1016/S0960-9822(03)00208-2</pub-id><pub-id pub-id-type=\"pmid\">12699619</pub-id></mixed-citation></ref><ref id=\"JCS180182C22\"><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Zuzarte</surname><given-names>M.</given-names></name>, <name><surname>Heusser</surname><given-names>K.</given-names></name>, <name><surname>Renigunta</surname><given-names>V.</given-names></name>, <name><surname>Schlichthorl</surname><given-names>G.</given-names></name>, <name><surname>Rinne</surname><given-names>S.</given-names></name>, <name><surname>Wischmeyer</surname><given-names>E.</given-names></name>, <name><surname>Daut</surname><given-names>J.</given-names></name>, <name><surname>Schwappach</surname><given-names>B.</given-names></name> and <name><surname>Preisig-Muller</surname><given-names>R.</given-names></name></person-group> (<year>2009</year>). <article-title>Intracellular traffic of the K+ channels TASK-1 and TASK-3: role of N- and C-terminal sorting signals and interaction with 14-3-3 proteins</article-title>. <source><italic>J. Physiol.</italic></source>\\n<volume>587</volume>, <fpage>929</fpage>-<lpage>952</lpage>. <pub-id pub-id-type=\"doi\">10.1113/jphysiol.2008.164756</pub-id><pub-id pub-id-type=\"pmid\">19139046</pub-id></mixed-citation></ref></ref-list></back></article>',\n",
       " '<!DOCTYPE article PUBLIC \"-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN\" \"JATS-archivearticle1.dtd\">\\n<article xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" article-type=\"research-article\">\\n  <?properties open_access?>\\n  <?properties manuscript?>\\n  <front>\\n    <journal-meta>\\n      <journal-id journal-id-type=\"nlm-journal-id\">0410462</journal-id>\\n      <journal-id journal-id-type=\"pubmed-jr-id\">6011</journal-id>\\n      <journal-id journal-id-type=\"nlm-ta\">Nature</journal-id>\\n      <journal-id journal-id-type=\"iso-abbrev\">Nature</journal-id>\\n      <journal-title-group>\\n        <journal-title>Nature</journal-title>\\n      </journal-title-group>\\n      <issn pub-type=\"ppub\">0028-0836</issn>\\n      <issn pub-type=\"epub\">1476-4687</issn>\\n    </journal-meta>\\n    <article-meta>\\n      <article-id pub-id-type=\"pmid\">22020285</article-id>\\n      <article-id pub-id-type=\"pmc\">3229641</article-id>\\n      <article-id pub-id-type=\"doi\">10.1038/nature10546</article-id>\\n      <article-id pub-id-type=\"manuscript\">NIHMS323367</article-id>\\n      <article-categories>\\n        <subj-group subj-group-type=\"heading\">\\n          <subject>Article</subject>\\n        </subj-group>\\n      </article-categories>\\n      <title-group>\\n        <article-title>Image-Based Genome-Wide siRNA Screen Identifies Selective Autophagy Factors</article-title>\\n      </title-group>\\n      <contrib-group>\\n        <contrib contrib-type=\"author\">\\n          <name>\\n            <surname>Orvedahl</surname>\\n            <given-names>Anthony</given-names>\\n          </name>\\n          <xref ref-type=\"aff\" rid=\"A1\">1</xref>\\n          <xref ref-type=\"aff\" rid=\"A2\">2</xref>\\n          <xref ref-type=\"author-notes\" rid=\"FN1\">*</xref>\\n        </contrib>\\n        <contrib contrib-type=\"author\">\\n          <name>\\n            <surname>Sumpter</surname>\\n            <given-names>Rhea</given-names>\\n            <suffix>Jr.</suffix>\\n          </name>\\n          <xref ref-type=\"aff\" rid=\"A1\">1</xref>\\n          <xref ref-type=\"aff\" rid=\"A3\">3</xref>\\n          <xref ref-type=\"author-notes\" rid=\"FN1\">*</xref>\\n        </contrib>\\n        <contrib contrib-type=\"author\">\\n          <name>\\n            <surname>Xiao</surname>\\n            <given-names>Guanghua</given-names>\\n          </name>\\n          <xref ref-type=\"aff\" rid=\"A4\">4</xref>\\n          <xref ref-type=\"author-notes\" rid=\"FN2\">**</xref>\\n        </contrib>\\n        <contrib contrib-type=\"author\">\\n          <name>\\n            <surname>Ng</surname>\\n            <given-names>Aylwin</given-names>\\n          </name>\\n          <xref ref-type=\"aff\" rid=\"A5\">5</xref>\\n          <xref ref-type=\"aff\" rid=\"A6\">6</xref>\\n          <xref ref-type=\"aff\" rid=\"A7\">7</xref>\\n          <xref ref-type=\"author-notes\" rid=\"FN2\">**</xref>\\n        </contrib>\\n        <contrib contrib-type=\"author\">\\n          <name>\\n            <surname>Zou</surname>\\n            <given-names>Zhongju</given-names>\\n          </name>\\n          <xref ref-type=\"aff\" rid=\"A1\">1</xref>\\n          <xref ref-type=\"aff\" rid=\"A3\">3</xref>\\n          <xref ref-type=\"aff\" rid=\"A8\">8</xref>\\n        </contrib>\\n        <contrib contrib-type=\"author\">\\n          <name>\\n            <surname>Tang</surname>\\n            <given-names>Yi</given-names>\\n          </name>\\n          <xref ref-type=\"aff\" rid=\"A9\">9</xref>\\n        </contrib>\\n        <contrib contrib-type=\"author\">\\n          <name>\\n            <surname>Narimatsu</surname>\\n            <given-names>Masahiro</given-names>\\n          </name>\\n          <xref ref-type=\"aff\" rid=\"A10\">10</xref>\\n        </contrib>\\n        <contrib contrib-type=\"author\">\\n          <name>\\n            <surname>Gilpin</surname>\\n            <given-names>Christopher</given-names>\\n          </name>\\n          <xref ref-type=\"aff\" rid=\"A11\">11</xref>\\n        </contrib>\\n        <contrib contrib-type=\"author\">\\n          <name>\\n            <surname>Sun</surname>\\n            <given-names>Qihua</given-names>\\n          </name>\\n          <xref ref-type=\"aff\" rid=\"A1\">1</xref>\\n          <xref ref-type=\"aff\" rid=\"A3\">3</xref>\\n        </contrib>\\n        <contrib contrib-type=\"author\">\\n          <name>\\n            <surname>Roth</surname>\\n            <given-names>Michael</given-names>\\n          </name>\\n          <xref ref-type=\"aff\" rid=\"A12\">12</xref>\\n          <xref ref-type=\"aff\" rid=\"A13\">13</xref>\\n        </contrib>\\n        <contrib contrib-type=\"author\">\\n          <name>\\n            <surname>Forst</surname>\\n            <given-names>Christian V.</given-names>\\n          </name>\\n          <xref ref-type=\"aff\" rid=\"A4\">4</xref>\\n        </contrib>\\n        <contrib contrib-type=\"author\">\\n          <name>\\n            <surname>Wrana</surname>\\n            <given-names>Jeffrey L.</given-names>\\n          </name>\\n          <xref ref-type=\"aff\" rid=\"A10\">10</xref>\\n          <xref ref-type=\"aff\" rid=\"A14\">14</xref>\\n        </contrib>\\n        <contrib contrib-type=\"author\">\\n          <name>\\n            <surname>Zhang</surname>\\n            <given-names>Ying E.</given-names>\\n          </name>\\n          <xref ref-type=\"aff\" rid=\"A9\">9</xref>\\n        </contrib>\\n        <contrib contrib-type=\"author\">\\n          <name>\\n            <surname>Luby-Phelps</surname>\\n            <given-names>Katherine</given-names>\\n          </name>\\n          <xref ref-type=\"aff\" rid=\"A11\">11</xref>\\n        </contrib>\\n        <contrib contrib-type=\"author\">\\n          <name>\\n            <surname>Xavier</surname>\\n            <given-names>Ramnik</given-names>\\n          </name>\\n          <xref ref-type=\"aff\" rid=\"A5\">5</xref>\\n          <xref ref-type=\"aff\" rid=\"A6\">6</xref>\\n          <xref ref-type=\"aff\" rid=\"A7\">7</xref>\\n        </contrib>\\n        <contrib contrib-type=\"author\">\\n          <name>\\n            <surname>Xie</surname>\\n            <given-names>Yang</given-names>\\n          </name>\\n          <xref ref-type=\"aff\" rid=\"A4\">4</xref>\\n          <xref ref-type=\"aff\" rid=\"A13\">13</xref>\\n        </contrib>\\n        <contrib contrib-type=\"author\">\\n          <name>\\n            <surname>Levine</surname>\\n            <given-names>Beth</given-names>\\n          </name>\\n          <xref ref-type=\"aff\" rid=\"A1\">1</xref>\\n          <xref ref-type=\"aff\" rid=\"A2\">2</xref>\\n          <xref ref-type=\"aff\" rid=\"A3\">3</xref>\\n          <xref ref-type=\"aff\" rid=\"A8\">8</xref>\\n          <xref ref-type=\"aff\" rid=\"A13\">13</xref>\\n          <xref ref-type=\"corresp\" rid=\"cor1\">#</xref>\\n        </contrib>\\n      </contrib-group>\\n      <aff id=\"A1\"><label>1</label>Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390-9113 USA</aff>\\n      <aff id=\"A2\"><label>2</label>Department of Microbiology, University of Texas Southwestern Medical Center, Dallas, TX 75390-9113 USA</aff>\\n      <aff id=\"A3\"><label>3</label>Center for Autophagy Research, University of Texas Southwestern Medical Center, Dallas, TX 75390-9113 USA</aff>\\n      <aff id=\"A4\"><label>4</label>Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX 75390-9113 USA</aff>\\n      <aff id=\"A5\"><label>5</label>Center for Computational and Integrative Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114 USA</aff>\\n      <aff id=\"A6\"><label>6</label>Gastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114 USA</aff>\\n      <aff id=\"A7\"><label>7</label>Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA 02142 USA</aff>\\n      <aff id=\"A8\"><label>8</label>Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, TX 75390-9113 USA</aff>\\n      <aff id=\"A9\"><label>9</label>Laboratory of Cellular and Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892</aff>\\n      <aff id=\"A10\"><label>10</label>Center for Systems Biology, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, ON, Canada M5G 1X5</aff>\\n      <aff id=\"A11\"><label>11</label>Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390-9113 USA</aff>\\n      <aff id=\"A12\"><label>12</label>Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX 75390-9113 USA</aff>\\n      <aff id=\"A13\"><label>13</label>Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390-9113 USA</aff>\\n      <aff id=\"A14\"><label>14</label>Department of Molecular Genetics, University of Toronto, Toronto, ON, Candada M5S 3E1</aff>\\n      <author-notes>\\n        <corresp id=\"cor1\"><label>#</label>To whom correspondence should be addressed: <email>beth.levine@utsouthwestern.edu</email></corresp>\\n        <fn id=\"FN1\" fn-type=\"equal\">\\n          <label>*</label>\\n          <p id=\"P1\">These two authors contributed equally to this work</p>\\n        </fn>\\n        <fn id=\"FN2\" fn-type=\"equal\">\\n          <label>**</label>\\n          <p id=\"P2\">These two authors contributed equally to this work</p>\\n        </fn>\\n      </author-notes>\\n      <pub-date pub-type=\"nihms-submitted\">\\n        <day>8</day>\\n        <month>9</month>\\n        <year>2011</year>\\n      </pub-date>\\n      <pub-date pub-type=\"ppub\">\\n        <day>1</day>\\n        <month>12</month>\\n        <year>2011</year>\\n      </pub-date>\\n      <pub-date pub-type=\"pmc-release\">\\n        <day>01</day>\\n        <month>6</month>\\n        <year>2012</year>\\n      </pub-date>\\n      <volume>480</volume>\\n      <issue>7375</issue>\\n      <fpage>113</fpage>\\n      <lpage>117</lpage>\\n      <permissions>\\n        <license>\\n          <license-p>This file is available for text mining. It may also be used consistent with the principles of fair use under the copyright law.</license-p>\\n        </license>\\n      </permissions>\\n      <abstract>\\n        <p id=\"P3\">Selective autophagy involves the recognition and targeting of specific cargo, such as damaged organelles, misfolded proteins, or invading pathogens for lysosomal destruction<sup><xref rid=\"R1\" ref-type=\"bibr\">1</xref>–<xref rid=\"R4\" ref-type=\"bibr\">4</xref></sup>. Yeast genetic screens have identified proteins required for different forms of selective autophagy, including cytoplasm-to-vacuole targeting, pexophagy, and mitophagy, and mammalian genetic screens have identified proteins required for autophagy regulation<sup><xref rid=\"R5\" ref-type=\"bibr\">5</xref></sup>. However, there have been no systematic approaches to identify molecular determinants of selective autophagy in mammalian cells. To identify mammalian genes required for selective autophagy, we performed a high-content, image-based, genome-wide siRNA screen to detect genes required for the colocalization of Sindbis virus capsid protein with autophagolysosomes. We identified 141 candidate genes required for viral autophagy, which were enriched for cellular pathways related to mRNA processing, interferon signaling, vesicle trafficking, cytoskeletal motor function, and metabolism. Ninety-six of these genes were also required for Parkin-mediated mitophagy, indicating that common molecular determinants may be involved in autophagic targeting of viral nucleocapsids and autophagic targeting of damaged mitochondria. Murine embryonic fibroblasts lacking one of these gene products, the C2-domain containing protein, Smurf1, are deficient in the autophagosomal targeting of Sindbis and herpes simplex viruses and in the clearance of damaged mitochondria. Moreover, Smurf1-deficient mice display an accumulation of damaged mitochondria in heart, brain, and liver. Thus, our study identifies candidate determinants of selective autophagy, and defines Smurf1 as a newly recognized mediator of both viral autophagy and mitophagy.</p>\\n      </abstract>\\n    </article-meta>\\n  </front>\\n  <body>\\n    <p id=\"P4\">To identify novel genes required for selective autophagy, we performed a genome-wide siRNA screen to detect changes in the colocalization of a red-labeled Sindbis virus (SIN) capsid protein with a green-labeled marker of autophagosomes, GFP-LC3 (<xref ref-type=\"supplementary-material\" rid=\"SD2\">Supplementary Fig. 1a</xref>) in SIN-infected HeLa/GFP-LC3<sup><xref rid=\"R6\" ref-type=\"bibr\">6</xref></sup> cells. Using correlative light and electron microscopy (EM), we confirmed that colocalized red and green puncta represented autophagic structures (primarily autolysosomes) containing numerous viral nucleocapsids (<xref ref-type=\"fig\" rid=\"F1\">Fig. 1a</xref>). The predominance of viral nucleocapsids concentrated in these structures (relative to within the cytoplasm) is consistent with selective autophagic targeting of viral nucleocapsids (herein referred to as virophagy).</p>\\n    <p id=\"P5\">Screening of a human siGenome library containing 21,215 siRNA pools revealed that knockdown of 195 and 13 genes resulted in decreased or increased colocalization, respectively, (<xref ref-type=\"fig\" rid=\"F1\">Fig. 1b</xref>, <xref ref-type=\"supplementary-material\" rid=\"SD6\">Supplementary Table 1</xref>, <xref ref-type=\"supplementary-material\" rid=\"SD2\">Supplementary Fig. 1b</xref>). Genes were re-screened with sets of 4 individual siRNAs (<xref ref-type=\"supplementary-material\" rid=\"SD7\">Supplementary Table 2</xref>; see column “J” of <xref ref-type=\"supplementary-material\" rid=\"SD8\">Supplementary Table 3</xref> for siRNA sequences) to confirm our primary screen and rule out potential off-target effects of individual siRNAs; knockdown with two or more siRNAs resulted in decreased colocalization for 141 (72%) genes. (<xref ref-type=\"fig\" rid=\"F2\">Fig. 2</xref>, <xref ref-type=\"supplementary-material\" rid=\"SD2\">Supplementary Fig. 1b and 2a</xref>). None of these 141 gene knockdowns decreased numbers of green puncta in uninfected cells (data not shown), indicating these genes function in virophagy but not in regulation of autophagy. There was no enrichment of siRNAs containing miRNA seed sequences among these genes (<italic>P</italic>=0.95) (<xref ref-type=\"supplementary-material\" rid=\"SD8\">Supplementary Tables 3</xref> and <xref ref-type=\"supplementary-material\" rid=\"SD9\">4</xref>), suggesting that bias due to miRNA-like off-target effects was unlikely. There was a low confirmation rate for siRNAs that increased colocalization (2 of 13 genes); therefore, we subsequently focused only on siRNAs that decreased colocalization.</p>\\n    <p id=\"P6\">Bioinformatic analyses of the 141 confirmed hits required for SIN capsid/GFP-LC3 colocalization revealed enrichment for gene sets associated with biological processes and molecular functions including RNA splicing/processing, protein phosphorylation, transport, calcium-binding and the cytoskeleton (<xref ref-type=\"supplementary-material\" rid=\"SD10\">Supplementary Table 5</xref>, <xref ref-type=\"supplementary-material\" rid=\"SD2\">Supplementary Fig. 3a</xref>). Examination of our hits within a framework of functional cellular pathways revealed strongly enriched network modules associated with RNA processing, interferon (IFN)α and γ signaling, SNARE vesicular transport, cytoskeletal-associated components, and several metabolic pathways (<xref ref-type=\"supplementary-material\" rid=\"SD2\">Supplementary Fig. 3b</xref>, <xref ref-type=\"fig\" rid=\"F1\">Fig. 1c</xref>). This is consistent with IFNγ’s function in selective microbial autophagy<sup><xref rid=\"R1\" ref-type=\"bibr\">1</xref></sup> and the described role of the actin cytoskeleton in selective autophagy in yeast<sup><xref rid=\"R7\" ref-type=\"bibr\">7</xref></sup> and mammalian<sup><xref rid=\"R8\" ref-type=\"bibr\">8</xref></sup> cells. The enrichment of SNARE proteins suggests that in addition to a function in autophagosome formation and maturation<sup><xref rid=\"R9\" ref-type=\"bibr\">9</xref>, <xref rid=\"R10\" ref-type=\"bibr\">10</xref></sup>, these proteins may be involved in the trafficking of selective cargo to the autophagosome. Twelve colocalization hits form primary interactions with core autophagy machinery and associated components<sup><xref rid=\"R11\" ref-type=\"bibr\">11</xref></sup> (<xref ref-type=\"fig\" rid=\"F1\">Fig. 1d</xref>). One colocalization screen hit, clathrin interaction 1 (CLINT) interacts with ATG8 components (GABARAPL1, MAP1LC3A, MAP1LC3B), which are crucial in the recognition of cargo during selective autophagy<sup><xref rid=\"R2\" ref-type=\"bibr\">2</xref></sup>. Another hit, ATG13, is a member of the core autophagy network, suggesting that it may have an as yet undefined function in selective autophagy, in addition to its role in the Atg1/ULK1 autophagy induction complex<sup><xref rid=\"R12\" ref-type=\"bibr\">12</xref></sup>. Five colocalization hits, SMURF1, NEFM, KCNAB2, SFRS4, and UBA52, interact with p62/SQSTM1, a known adaptor in diverse forms of selective autophagy<sup><xref rid=\"R2\" ref-type=\"bibr\">2</xref></sup>, including SIN capsid targeting to autophagosomes<sup><xref rid=\"R6\" ref-type=\"bibr\">6</xref></sup>.</p>\\n    <p id=\"P7\">Selective SIN autophagy (virophagy) promotes the survival of SIN-infected cells<sup><xref rid=\"R6\" ref-type=\"bibr\">6</xref></sup>. To determine if our identified candidate virophagy genes have a similar function, we screened our confirmation siRNA library for genes that decreased cell survival after SIN infection. Two or more siRNAs targeting 98 of the genes decreased cell survival after SIN infection (<xref ref-type=\"fig\" rid=\"F2\">Fig. 2</xref>, <xref ref-type=\"supplementary-material\" rid=\"SD8\">Supplementary Tables 3</xref> and <xref ref-type=\"supplementary-material\" rid=\"SD11\">6</xref>, <xref ref-type=\"supplementary-material\" rid=\"SD2\">Supplementary Figs. 1b, 2a</xref>); colocalization and cell survival effects of individual siRNAs were significantly correlated (<xref ref-type=\"supplementary-material\" rid=\"SD2\">Supplementary Fig. 2b</xref>) (<italic>P</italic>=3.8E-08, Spearman correlation). This is consistent with a pro-survival function of autophagic targeting of SIN capsid in virally-infected cells<sup><xref rid=\"R6\" ref-type=\"bibr\">6</xref></sup>.</p>\\n    <p id=\"P8\">To investigate whether the identified candidate virophagy genes also function in other forms of selective autophagy, we performed a secondary screen for autophagy of damaged mitochondria (mitophagy). We used HeLa cells that express an mCherry fusion of Parkin, a cytosolic E3 ubiquitin ligase that translocates to depolarized mitochondria to induce mitophagy after treatment with uncoupling agents (such as CCCP: carbonyl cyanide m-chlorphenylhydrazaone) <sup><xref rid=\"R13\" ref-type=\"bibr\">13</xref></sup>. Of the 141 confirmed colocalization hits, 2 or more siRNAs targeting 96 (68%) genes decreased mitophagy (<xref ref-type=\"fig\" rid=\"F2\">Fig. 2</xref>, <xref ref-type=\"supplementary-material\" rid=\"SD8\">Supplementary Tables 3</xref> and <xref ref-type=\"supplementary-material\" rid=\"SD12\">7</xref>, <xref ref-type=\"supplementary-material\" rid=\"SD2\">Supplementary Figs. 1b, 2a, 2b</xref>). Host factors involved in involved in viral autophagy and mitophagy overlapped significantly (<italic>P</italic>=0.019, Spearman correlation). The minority of genes that only scored positive in either the virophagy confirmation or the mitophagy secondary screen may have a role in targeting some, but not other cargoes, for selective autophagy; however, the lack of overlap may also reflect different sensitivities of the two screens. Mitophagy hits consisted of several mitochondria-associated components<sup><xref rid=\"R14\" ref-type=\"bibr\">14</xref></sup> (NME2, MDH1, NTHL1, PDK1, COX8A, MRPS2, MRPS10, NDUFB9 and BLOC1S) and interactors of mitochondria-associated components (<xref ref-type=\"supplementary-material\" rid=\"SD2\">Supplementary Fig. 4</xref>).</p>\\n    <p id=\"P9\">We focused further on one gene, <italic>SMURF1 (Smad-Ubiquitin Regulatory Factor 1)</italic>, encoding a HECT-domain ubiquitin ligase that targets several cytoplasmic proteins for degradation<sup><xref rid=\"R15\" ref-type=\"bibr\">15</xref></sup>. <italic>SMURF1</italic> was a confirmed hit in all three confirmation or secondary screening assays (see <xref ref-type=\"supplementary-material\" rid=\"SD2\">Supplementary Fig. 5</xref> for representative raw data from colocalization confirmation screen); is present in two of the enriched networks (mRNA processing and actin cytoskeleton) (<xref ref-type=\"fig\" rid=\"F1\">Fig. 1c</xref>); and is a predicted interacting partner of the autophagy adaptor, p62/SQSTM1<sup><xref rid=\"R2\" ref-type=\"bibr\">2</xref>, <xref rid=\"R4\" ref-type=\"bibr\">4</xref></sup> (<xref ref-type=\"fig\" rid=\"F1\">Fig. 1d</xref>).</p>\\n    <p id=\"P10\">We confirmed that SMURF1 is not required for general autophagy, but is a bona fide mediator of selective autophagy, including virophagy and mitophagy. siRNA knockdown of SMURF1 in HeLa cells, unlike knockdown of the essential autophagy protein, ATG7, did not alter general starvation-induced autophagy (<xref ref-type=\"supplementary-material\" rid=\"SD2\">Supplementary Fig. 6a</xref>). Furthermore, <italic>Smurf1</italic><sup>−/−</sup> murine embryonic fibroblasts (MEFs) displayed normal levels of starvation-induced LC3-II conversion, p62 degradation, and ultrastructural evidence of autophagosome and autolysosome accumulation (<xref ref-type=\"fig\" rid=\"F3\">Fig. 3a, b</xref>).</p>\\n    <p id=\"P11\">However, a significant decrease in mCherry.capsid/GFP-LC3 colocalization was observed in SIN-infected <italic>Smurf1</italic><sup>−/−</sup> MEFs (<xref ref-type=\"fig\" rid=\"F3\">Fig. 3c, d</xref>). Similar to p62<sup><xref rid=\"R6\" ref-type=\"bibr\">6</xref></sup>, Smurf1 and SIN capsid protein co-immunoprecipitate in SIN-infected MEFs and HeLa cells (<xref ref-type=\"supplementary-material\" rid=\"SD2\">Supplementary Fig. 7a, b</xref>). Smurf1 is not required for the interaction between p62 and SIN capsid (<xref ref-type=\"supplementary-material\" rid=\"SD2\">Supplementary Fig. 7c</xref>). The interaction between Smurf1 and SIN capsid may be relevant for targeting SIN capsid for autophagosomal degradation, as levels of SIN capsid were increased in <italic>Smurf1</italic><sup>−/−</sup> MEFs and SMURF1 siRNA-treated HeLa cells. (<xref ref-type=\"supplementary-material\" rid=\"SD2\">Supplementary Fig. 7d–f</xref>). Increased SIN capsid levels in <italic>Smurf1</italic>-deficient cells cannot be explained by increased capsid production since viral growth was similar in <italic>Smurf1</italic><sup>−/−</sup> and WT MEFs (<xref ref-type=\"supplementary-material\" rid=\"SD2\">Supplementary Fig. 7g, h</xref>), or by changes in proteasomal degradation since SIN capsid levels were not altered by treatment with the proteasome inhibitor MG132 (<xref ref-type=\"supplementary-material\" rid=\"SD2\">Supplementary Fig. 7d</xref>), and SIN capsid ubiquitination was not detected (data not shown). SIN-infected <italic>Smurf1</italic><sup>−/−</sup> MEFs had accelerated cell death (despite similar viral titers) as compared to WT controls (<xref ref-type=\"fig\" rid=\"F3\">Fig. 3g</xref>). Thus, Smurf1 interacts with SIN capsid; Smurf1 is required for SIN capsid targeting to autophagosomes and degradation through a proteasome-independent pathway; and Smurf1-dependent degradation of SIN capsid promotes cell survival.</p>\\n    <p id=\"P12\">To determine whether Smurf1 is required for the autophagic targeting of other viruses, we performed EM of WT and <italic>Smurf1<sup>−/−</sup></italic> MEFs infected with a mutant strain of herpes simplex virus type 1 harboring a deletion of ICP34.5, a potent inhibitor of viral autophagy<sup><xref rid=\"R16\" ref-type=\"bibr\">16</xref>–<xref rid=\"R18\" ref-type=\"bibr\">18</xref></sup> (<xref ref-type=\"fig\" rid=\"F3\">Fig. 3e</xref>). As reported<sup><xref rid=\"R17\" ref-type=\"bibr\">17</xref></sup>, the majority of cytoplasmic HSV-1 virions in WT MEFs were inside autolysosomal structures and appeared partially degraded. In contrast, in <italic>Smurf1</italic><sup>−/−</sup> MEFs, the majority of cytoplasmic HSV-1 virions were inside single-membraned vesicles involved in HSV-1 cytoplasmic egress and displayed intact structure. This lack of autophagic targeting of HSV-1 in <italic>Smurf1</italic><sup>−/−</sup> MEFs was not due to a general defect in autophagy, since HSV-1 infection induced autophagy similarly in <italic>Smurf1</italic><sup>−/−</sup> and WT MEFs (<xref ref-type=\"supplementary-material\" rid=\"SD2\">Supplementary Fig. 6b</xref>). Thus, Smurf1 is required for the autophagic targeting of both a positive-strand RNA (Sindbis) and a double-stranded DNA (herpes simplex) virus.</p>\\n    <p id=\"P13\">Next, we examined the role of SMURF1 in mitophagy. In HeLa cells, all four SMURF1 siRNAs decreased SMURF1 protein expression expression (<xref ref-type=\"supplementary-material\" rid=\"SD2\">Supplementary Fig. 8a</xref>) and inhibited Parkin-mediated CCCP-induced mitophagy as effectively as an siRNA targeting p62, a mediator of mitophagy in some previous reports<sup><xref rid=\"R19\" ref-type=\"bibr\">19</xref>, <xref rid=\"R20\" ref-type=\"bibr\">20</xref></sup>, and siRNA targeted against the essential autophagy protein, Atg7 (<xref ref-type=\"supplementary-material\" rid=\"SD2\">Supplementary Fig. 8b, c</xref>). The magnitude of each individual siRNA’s effect on SMURF1 protein expression knockdown correlated with the magnitude of inhibition of Parkin-mediated autophagy. Therefore, in the mitophagy confirmation screen, two of the SMURF1 siRNAs were likely false negatives; indeed, the number of Parkin-expressing cells in wells treated with these siRNAs was low (data not shown), precluding meaningful statistical analyses. A similar finding was true in the viral colocalization screen.</p>\\n    <p id=\"P14\">We further examined the role of Smurf1 in mitophagy by assessing mitochondrial clearance in CCCP-treated <italic>Smurf1</italic><sup>−/−</sup> MEFs. Unlike in HeLa cells, Parkin overexpression did not promote mitophagy in MEFs of either genotype (data not shown). However, 25–30% of MEFs treated with 10 µm CCCP showed changes in mitochondrial morphology. In WT MEFs with damaged mitochondria (swollen or fragmented appearance), partial mitochondrial clearance occurred with compaction of the remaining mitochondria around the nucleus (<xref ref-type=\"fig\" rid=\"F4\">Fig. 4a</xref>). In contrast, in <italic>Smurf1</italic><sup>−/−</sup> cells with damaged mitochondria, virtually no mitochondrial clearance occurred and there was diffuse accumulation of fragmented mitochondria throughout the cytoplasm (<xref ref-type=\"fig\" rid=\"F4\">Fig. 4a</xref>, arrows). This phenotypic difference was confirmed using two independent methods of quantitation, including assessment of the total percentage of CCCP-treated cells that displayed diffuse accumulation of abnormal mitochondria (<xref ref-type=\"fig\" rid=\"F4\">Fig. 4b</xref>) and the measurement of fractional mitochondrial surface area per cell (<xref ref-type=\"fig\" rid=\"F4\">Fig. 4c</xref>).</p>\\n    <p id=\"P15\">To evaluate the mechanism of action of Smurf1, we compared the effects of WT and mutant Smurf1 expression plasmids on rescue of selective autophagy in <italic>Smurf1<sup>−/−</sup></italic> MEFs (<xref ref-type=\"fig\" rid=\"F4\">Fig. 4a–c</xref>). We focused on mitophagy rather than SIN capsid virophagy due to the resistance of MEFs to SIN infection after plasmid transfection. The defect in mitophagy in <italic>Smurf1</italic><sup>−/−</sup> MEFs was partially rescued by WT Smurf1 transfection. Smurf1ΔHECT<sup><xref rid=\"R21\" ref-type=\"bibr\">21</xref></sup>, lacking the HECT domain that catalyzes ubiquitin ligation onto target proteins, or Smurf1 C699A<sup><xref rid=\"R21\" ref-type=\"bibr\">21</xref></sup>, a catalytically inactive point mutant, rescued the mitochondrial clearance defect as efficiently as WT Smurf1. Thus, in addition to its known role in targeting proteins for proteasomal degradation via ubiquitination, Smurf1 has a ubiquitin ligase activity-independent function in mediating the selective degradation of damaged mitochondria.</p>\\n    <p id=\"P16\">In contrast, a Smurf1 mutant lacking the C2 domain, Smurf1ΔC2, was completely defective in mitophagy rescue in CCCP-treated <italic>Smurf1</italic><sup>−/−</sup> MEFs (<xref ref-type=\"fig\" rid=\"F4\">Fig. 4a–c</xref>), despite similar levels of expression as transfected WT Smurf1 (<xref ref-type=\"supplementary-material\" rid=\"SD2\">Supplementary Fig. 9a</xref>). The C2 domain of Smurf1 was not required for Smurf1 co-immunoprecipitation with p62 (<xref ref-type=\"supplementary-material\" rid=\"SD2\">Supplementary Fig. 9b</xref>), suggesting that Smurf1 does not function in selective autophagy by recruiting p62. C2 domains (including those of protein kinase C and Smurf1) bind membrane phospholipids and function in protein targeting to the plasma membrane and/or membrane subcellular compartments<sup><xref rid=\"R22\" ref-type=\"bibr\">22</xref>, <xref rid=\"R23\" ref-type=\"bibr\">23</xref></sup>. This raised the possibility that Smurf1 might function in the targeting of selective autophagy cargo through interaction with the nascent autophagosome membrane.</p>\\n    <p id=\"P17\">To investigate this possibility, we examined the subcellular localization of WT Smurf1 and Smurf1ΔC2 with damaged mitochondria and autophagosomes (<xref ref-type=\"fig\" rid=\"F4\">Fig. 4d</xref>). In <italic>Smurf1</italic><sup>−/−</sup> MEFs transfected with WT YFP-Smurf1, CCCP treatment induced the colocalization of YFP-Smurf1 with damaged mitochondria. In <italic>Smurf1</italic><sup>−/−</sup> MEFs transfected with YFP-Smurf1ΔC2, increased numbers of fragmented and swollen mitochondria were observed in basal conditions and these increased further upon CCCP treatment. These abnormal mitochondria colocalized with YFP-Smurf1ΔC2 whereas normal reticular-appearing mitochondria rarely colocalized with YFP-Smurf1ΔC2. YFP-Smurf1 C699A, displayed the same subcellular staining pattern as WT YFP Smurf1 (data not shown). Thus, Smurf1 colocalizes with damaged mitochondria in a C2 domain-independent manner.</p>\\n    <p id=\"P18\">We next determined whether the C2 domain of Smurf1 was required for the colocalization of damaged mitochondria with autophagosomes (<xref ref-type=\"fig\" rid=\"F4\">Fig. 4e</xref>, <xref ref-type=\"supplementary-material\" rid=\"SD2\">Supplementary Fig. 10–11</xref>). In cells expressing WT mCherry-Smurf1, mitochondria were mostly compacted around the nucleus, and numerous autophagosomes were observed surrounding structures that labeled positive for both mCherry-Smurf1 and the mitochondrial marker, Tom20. In constrast, in cells expressing mCherry-Smurf1ΔC2, mCherry-Smurf1ΔC2- and Tom20-postive mitochondria were rarely found inside autophagosomes. In many regions, GFP-LC3-positive linear or cup-shaped structures were observed near mCherry-Smurf1ΔC2-positive mitochondria, but complete autophagosomes surrounding these mitochondria could not be detected. Thus, the C2 domain of Smurf1 is not required for its targeting to damaged mitochondria, but is required for damaged mitochondria to be normally engulfed by autophagosomes. It is not yet known whether this requirement reflects a direct role for the C2 domain in binding to autophagosomal membrane phospholipids or is a more indirect consequence of other, as-yet-undescribed, effects of the C2 domain in mitophagy.</p>\\n    <p id=\"P19\">To investigate whether Smurf1 may function in selective autophagy <italic>in vivo</italic>, we performed EM analyses of cerebellum, liver, and hearts of 10 month-old WT and <italic>Smurf1</italic><sup>−/−</sup> mice<sup><xref rid=\"R21\" ref-type=\"bibr\">21</xref></sup>. In all three organs, <italic>Smurf1</italic><sup>−/−</sup> mice exhibited an accumulation of abnormal mitochondria that were either swollen, fragmented, and/or contained abnormal cristae (<xref ref-type=\"fig\" rid=\"F4\">Fig. 4f</xref>). This phenotype is consistent with a defect in mitophagy and mitochondrial quality control; however, we cannot rule out unknown triggers of mitochondrial damage in these animals. In the livers of <italic>Smurf1</italic><sup>−/−</sup> mice, mitochondria were spatially disorganized and surrounded by networks of dilated endoplasmic reticulum (ER), perhaps reflecting a defect in mitochondrial targeting by isolation membranes (which are believed to originate from the ER<sup><xref rid=\"R1\" ref-type=\"bibr\">1</xref></sup>) and/or a defect in selective autophagy of the ER. There was a marked accumulation of lipid droplets in the livers of <italic>Smurf1</italic><sup>−/−</sup> mice (<xref ref-type=\"supplementary-material\" rid=\"SD2\">Supplementary Fig. 12a</xref>), which may be consistent with selective degradation of lipid droplets by autophagy (lipophagy) in hepatocytes<sup><xref rid=\"R24\" ref-type=\"bibr\">24</xref></sup>. Furthermore, the granule cell layer of the cerebellum and cardiomyocytes of <italic>Smurf1</italic><sup>−/−</sup> mice had increased numbers of p62/SQSTM1 aggregates (<xref ref-type=\"supplementary-material\" rid=\"SD2\">Supplementary Fig. 12b</xref>). Unlike findings in brains and hearts of mice lacking core autophagy genes<sup><xref rid=\"R25\" ref-type=\"bibr\">25</xref></sup>, p62 aggregate accumulation in these tissues was not associated with ubiquitin accumulation. This is consistent with a role for Smurf1 in selective autophagy but not in the form of basal autophagy that is involved in protein quality control<sup><xref rid=\"R25\" ref-type=\"bibr\">25</xref></sup>.</p>\\n    <p id=\"P20\">Together, our data in <italic>Smurf1</italic><sup>−/−</sup> MEFs and in <italic>Smurf1</italic><sup>−/−</sup> mice suggest a crucial function for Smurf1 in selective autophagy, including in the autophagic targeting of genetically distinct viruses, in the autophagic targeting of mitochondria, and, more speculatively, in the potential autophagic targeting of other cellular targets such as hepatic lipid droplets and ER. The mechanism by which Smurf1 functions in selective autophagy is independent of its E3 ubiquitin ligase activity, but rather involves its C2 membrane-targeting domain. We propose that the C2 domain of Smurf1 may participate in the delivery of selective autophagic substrates to the nascent autophagosome. Thus, Smurf1 has parallel functions in two distinct cellular degradation pathways, targeting specific proteins for degradation by the ubiquitin-proteasomal pathway<sup><xref rid=\"R15\" ref-type=\"bibr\">15</xref></sup> (via its E3 ubiquitin ligase activity) and targeting selective cargo for degradation by the autophagy pathway (via its C2 domain).</p>\\n    <p id=\"P21\">Our findings in <italic>Smurf1</italic><sup>−/−</sup> MEFs and mice illustrate that our high-content imaged based genome-wide screen successfully reveals novel candidate determinants of selective autophagy. More broadly, the identification of a set of 96 genes that may dually function in viral autophagy and mitophagy (but not in basal autophagy) suggests the existence of a common molecular network for targeting diverse unwanted cytoplasmic cargo to the lysosome. This network identification provides a basis for a more global understanding of the mechanisms involved in selective autophagy.</p>\\n    <sec sec-type=\"methods\" id=\"S1\">\\n      <title>METHODS SUMMARY</title>\\n      <sec id=\"S2\">\\n        <title>High-content image-based genome wide siRNA screen</title>\\n        <p id=\"P22\">A genome-wide siRNA library (Dharmacon) containing 21,125 SMART pools was used for reverse transfection of HeLa/GFP-LC3 cells, followed by infection with SIN/mCherry.capsid virus, high content imaging using a Pathway855 automated microscope (BD Biosciences), quantitative image analysis, statistical analysis, and bioinformatic analysis as described in <xref ref-type=\"supplementary-material\" rid=\"SD2\">Supplementary Information</xref>. Primary hits were evaluated in three confirmation/secondary screens using the 4 individual siRNAs from each pool, including a screen for viral capsid/autophagsosome colocalization, cell survival during SIN infection, and Parkin-induced mitophagy.</p>\\n      </sec>\\n      <sec id=\"S3\">\\n        <title>Functional analyses of Smurf1</title>\\n        <p id=\"P23\">See <xref ref-type=\"supplementary-material\" rid=\"SD2\">Supplementary Information</xref>.</p>\\n        <p id=\"P24\"><bold>Full Methods</bold> and any associated references are available in the <xref ref-type=\"supplementary-material\" rid=\"SD2\">Supplementary Information</xref>.</p>\\n      </sec>\\n    </sec>\\n    <sec sec-type=\"supplementary-material\" id=\"SM\">\\n      <title>Supplementary Material</title>\\n      <supplementary-material content-type=\"local-data\" id=\"SD1\">\\n        <label>1</label>\\n        <media xlink:href=\"NIHMS323367-supplement-1.doc\" mimetype=\"application\" mime-subtype=\"msword\" orientation=\"portrait\" xlink:type=\"simple\" id=\"d37e859\" position=\"anchor\"/>\\n      </supplementary-material>\\n      <supplementary-material content-type=\"local-data\" id=\"SD10\">\\n        <label>6</label>\\n        <media xlink:href=\"NIHMS323367-supplement-6.xls\" mimetype=\"application\" mime-subtype=\"vnd.ms-excel\" orientation=\"portrait\" xlink:type=\"simple\" id=\"d37e863\" position=\"anchor\"/>\\n      </supplementary-material>\\n      <supplementary-material content-type=\"local-data\" id=\"SD11\">\\n        <label>7</label>\\n        <media xlink:href=\"NIHMS323367-supplement-7.xls\" mimetype=\"application\" mime-subtype=\"vnd.ms-excel\" orientation=\"portrait\" xlink:type=\"simple\" id=\"d37e867\" position=\"anchor\"/>\\n      </supplementary-material>\\n      <supplementary-material content-type=\"local-data\" id=\"SD12\">\\n        <label>8</label>\\n        <media xlink:href=\"NIHMS323367-supplement-8.xls\" mimetype=\"application\" mime-subtype=\"vnd.ms-excel\" orientation=\"portrait\" xlink:type=\"simple\" id=\"d37e871\" position=\"anchor\"/>\\n      </supplementary-material>\\n      <supplementary-material content-type=\"local-data\" id=\"SD13\">\\n        <label>9</label>\\n        <media xlink:href=\"NIHMS323367-supplement-9.xls\" mimetype=\"application\" mime-subtype=\"vnd.ms-excel\" orientation=\"portrait\" xlink:type=\"simple\" id=\"d37e875\" position=\"anchor\"/>\\n      </supplementary-material>\\n      <supplementary-material content-type=\"local-data\" id=\"SD2\">\\n        <label>10</label>\\n        <media xlink:href=\"NIHMS323367-supplement-10.xls\" mimetype=\"application\" mime-subtype=\"vnd.ms-excel\" orientation=\"portrait\" xlink:type=\"simple\" id=\"d37e879\" position=\"anchor\"/>\\n      </supplementary-material>\\n      <supplementary-material content-type=\"local-data\" id=\"SD3\">\\n        <label>11</label>\\n        <media xlink:href=\"NIHMS323367-supplement-11.xls\" mimetype=\"application\" mime-subtype=\"vnd.ms-excel\" orientation=\"portrait\" xlink:type=\"simple\" id=\"d37e883\" position=\"anchor\"/>\\n      </supplementary-material>\\n      <supplementary-material content-type=\"local-data\" id=\"SD4\">\\n        <label>12</label>\\n        <media xlink:href=\"NIHMS323367-supplement-12.xls\" mimetype=\"application\" mime-subtype=\"vnd.ms-excel\" orientation=\"portrait\" xlink:type=\"simple\" id=\"d37e887\" position=\"anchor\"/>\\n      </supplementary-material>\\n      <supplementary-material content-type=\"local-data\" id=\"SD5\">\\n        <label>13</label>\\n        <media xlink:href=\"NIHMS323367-supplement-13.xls\" mimetype=\"application\" mime-subtype=\"vnd.ms-excel\" orientation=\"portrait\" xlink:type=\"simple\" id=\"d37e891\" position=\"anchor\"/>\\n      </supplementary-material>\\n      <supplementary-material content-type=\"local-data\" id=\"SD6\">\\n        <label>2</label>\\n        <media xlink:href=\"NIHMS323367-supplement-2.pdf\" mimetype=\"application\" mime-subtype=\"pdf\" orientation=\"portrait\" xlink:type=\"simple\" id=\"d37e895\" position=\"anchor\"/>\\n      </supplementary-material>\\n      <supplementary-material content-type=\"local-data\" id=\"SD7\">\\n        <label>3</label>\\n        <media xlink:href=\"NIHMS323367-supplement-3.pdf\" mimetype=\"application\" mime-subtype=\"pdf\" orientation=\"portrait\" xlink:type=\"simple\" id=\"d37e900\" position=\"anchor\"/>\\n      </supplementary-material>\\n      <supplementary-material content-type=\"local-data\" id=\"SD8\">\\n        <label>4</label>\\n        <media xlink:href=\"NIHMS323367-supplement-4.pdf\" mimetype=\"application\" mime-subtype=\"pdf\" orientation=\"portrait\" xlink:type=\"simple\" id=\"d37e904\" position=\"anchor\"/>\\n      </supplementary-material>\\n      <supplementary-material content-type=\"local-data\" id=\"SD9\">\\n        <label>5</label>\\n        <media xlink:href=\"NIHMS323367-supplement-5.xls\" mimetype=\"application\" mime-subtype=\"vnd.ms-excel\" orientation=\"portrait\" xlink:type=\"simple\" id=\"d37e908\" position=\"anchor\"/>\\n      </supplementary-material>\\n    </sec>\\n  </body>\\n  <back>\\n    <ack id=\"S4\">\\n      <title>Acknowledgements</title>\\n      <p id=\"P25\">We thank Mridula Vishwanath, Shuguang Wei and Bruce Posner for assistance with high-throughput siRNA screening; William Sun for information technology support; Kurt Scudder for assistance with image analysis algorithms; Angela Diehl for expert medical illustration; Victor Stollar, Margaret McDonald, Richard Kuhn and Richard Youle for helpful discussions and providing reagents; Abhijit Bugde for assistance in the UTSW Live Cell Imaging Facility; and Laurie Mueller and Tom Januszewski for assistance with electron microscopy. This work was supported by NIH grants AI109617 (B.L.), UL1 RR024982 (G.X., Y.X.), AI062773 (R.J.X.), DK83756 (R.J.X.), DK086502 (R.J.X.) and DK043351 (R.J.X. and A.N.); NSF grant DMS-0907562 (G.X.); and the Center for Cancer Research, National Cancer Institute Intramural Research Program (Y.E.Z.).</p>\\n    </ack>\\n    <fn-group>\\n      <fn id=\"FN3\" fn-type=\"con\">\\n        <p id=\"P26\">\\n          <bold>Author Contributions</bold>\\n        </p>\\n        <p id=\"P27\">A.O., R.S., M.N., M.R., J.W., Y.Z., K.L.-P., and B.L. designed the experiments. A.O., R.S., Z.Z., and Q.S. performed the experiments. G.X., A.N., C.F., R.X., and Y.X. performed statistical and bioinformatic analyses. A.O., R.S., and B.L. wrote the manuscript.</p>\\n      </fn>\\n      <fn id=\"FN4\">\\n        <p id=\"P28\">\\n          <bold>Author Information</bold>\\n        </p>\\n        <p id=\"P29\">Reprints and permissions information is available at <ext-link ext-link-type=\"uri\" xlink:href=\"http://www.nature.com/reprints\">www.nature.com/reprints</ext-link>. The authors declare no competing financial interests. Readers are welcome to comment on the online version of this article at <ext-link ext-link-type=\"uri\" xlink:href=\"http://www.nature.com/nature\">www.nature.com/nature</ext-link>.</p>\\n      </fn>\\n    </fn-group>\\n    <ref-list>\\n      <title>REFERENCES</title>\\n      <ref id=\"R1\">\\n        <label>1</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Levine</surname>\\n              <given-names>B</given-names>\\n            </name>\\n            <name>\\n              <surname>Mizushima</surname>\\n              <given-names>N</given-names>\\n            </name>\\n            <name>\\n              <surname>Virgin</surname>\\n              <given-names>HW</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Autophagy in immunity and inflammation</article-title>\\n          <source>Nature</source>\\n          <year>2011</year>\\n          <volume>469</volume>\\n          <fpage>323</fpage>\\n          <lpage>335</lpage>\\n          <pub-id pub-id-type=\"pmid\">21248839</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R2\">\\n        <label>2</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Noda</surname>\\n              <given-names>NN</given-names>\\n            </name>\\n            <name>\\n              <surname>Ohsumi</surname>\\n              <given-names>Y</given-names>\\n            </name>\\n            <name>\\n              <surname>Inagaki</surname>\\n              <given-names>F</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Atg8-family interacting motif crucial for selective autophagy</article-title>\\n          <source>FEBS Lett</source>\\n          <year>2010</year>\\n          <volume>584</volume>\\n          <fpage>1379</fpage>\\n          <lpage>1385</lpage>\\n          <pub-id pub-id-type=\"pmid\">20083108</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R3\">\\n        <label>3</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Wild</surname>\\n              <given-names>P</given-names>\\n            </name>\\n            <etal/>\\n          </person-group>\\n          <article-title>Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth</article-title>\\n          <source>Science</source>\\n          <year>2011</year>\\n          <volume>333</volume>\\n          <fpage>228</fpage>\\n          <lpage>233</lpage>\\n          <pub-id pub-id-type=\"pmid\">21617041</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R4\">\\n        <label>4</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Komatsu</surname>\\n              <given-names>M</given-names>\\n            </name>\\n            <name>\\n              <surname>Ichimura</surname>\\n              <given-names>Y</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Selective autophagy regulates various cellular functions</article-title>\\n          <source>Genes Cells</source>\\n          <year>2010</year>\\n          <volume>15</volume>\\n          <fpage>923</fpage>\\n          <lpage>933</lpage>\\n          <pub-id pub-id-type=\"pmid\">20670274</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R5\">\\n        <label>5</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Lipinski</surname>\\n              <given-names>MM</given-names>\\n            </name>\\n            <etal/>\\n          </person-group>\\n          <article-title>A genome-wide siRNA screen reveals multiple mTORC1 independent signaling pathways regulating autophagy under normal nutritional conditions</article-title>\\n          <source>Dev Cell</source>\\n          <year>2010</year>\\n          <volume>18</volume>\\n          <fpage>1041</fpage>\\n          <lpage>1052</lpage>\\n          <pub-id pub-id-type=\"pmid\">20627085</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R6\">\\n        <label>6</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Orvedahl</surname>\\n              <given-names>AO</given-names>\\n            </name>\\n            <etal/>\\n          </person-group>\\n          <article-title>Autophagy protects against Sindbis virus infection of the central nervous system</article-title>\\n          <source>Cell Host &amp; Microbe</source>\\n          <year>2010</year>\\n          <volume>7</volume>\\n          <fpage>115</fpage>\\n          <lpage>127</lpage>\\n          <pub-id pub-id-type=\"pmid\">20159618</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R7\">\\n        <label>7</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Monastyrska</surname>\\n              <given-names>I</given-names>\\n            </name>\\n            <name>\\n              <surname>Rieter</surname>\\n              <given-names>E</given-names>\\n            </name>\\n            <name>\\n              <surname>Klionsky</surname>\\n              <given-names>DJ</given-names>\\n            </name>\\n            <name>\\n              <surname>Reggiori</surname>\\n              <given-names>F</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Multiple roles of the cytoskeleton in autophagy</article-title>\\n          <source>Biol Rev Camb Philos Soc</source>\\n          <year>2009</year>\\n          <volume>84</volume>\\n          <fpage>431</fpage>\\n          <lpage>448</lpage>\\n          <pub-id pub-id-type=\"pmid\">19659885</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R8\">\\n        <label>8</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Lee</surname>\\n              <given-names>JY</given-names>\\n            </name>\\n            <etal/>\\n          </person-group>\\n          <article-title>HDAC6 controls autophagosome maturation essential for ubiquitin-selective quality-control autophagy</article-title>\\n          <source>Embo J</source>\\n          <year>2010</year>\\n          <volume>29</volume>\\n          <fpage>969</fpage>\\n          <lpage>980</lpage>\\n          <pub-id pub-id-type=\"pmid\">20075865</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R9\">\\n        <label>9</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Longatti</surname>\\n              <given-names>A</given-names>\\n            </name>\\n            <name>\\n              <surname>Tooze</surname>\\n              <given-names>SA</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Vesicular trafficking and autophagosome formation</article-title>\\n          <source>Cell Death Differ</source>\\n          <year>2009</year>\\n          <volume>16</volume>\\n          <fpage>956</fpage>\\n          <lpage>965</lpage>\\n          <pub-id pub-id-type=\"pmid\">19373247</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R10\">\\n        <label>10</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Nair</surname>\\n              <given-names>U</given-names>\\n            </name>\\n            <etal/>\\n          </person-group>\\n          <article-title>SNARE proteins are required for macroautophagy</article-title>\\n          <source>Cell</source>\\n          <year>2011</year>\\n          <volume>146</volume>\\n          <fpage>290</fpage>\\n          <lpage>302</lpage>\\n          <pub-id pub-id-type=\"pmid\">21784249</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R11\">\\n        <label>11</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Behrends</surname>\\n              <given-names>C</given-names>\\n            </name>\\n            <name>\\n              <surname>Sowa</surname>\\n              <given-names>ME</given-names>\\n            </name>\\n            <name>\\n              <surname>Gygi</surname>\\n              <given-names>SP</given-names>\\n            </name>\\n            <name>\\n              <surname>Harper</surname>\\n              <given-names>JW</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Network organization of the human autophagy system</article-title>\\n          <source>Nature</source>\\n          <year>2010</year>\\n          <volume>466</volume>\\n          <fpage>68</fpage>\\n          <lpage>76</lpage>\\n          <pub-id pub-id-type=\"pmid\">20562859</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R12\">\\n        <label>12</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Mizushima</surname>\\n              <given-names>N</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>The role of the Atg1/ULK1 complex in autophagy regulation</article-title>\\n          <source>Curr Opin Cell Biol</source>\\n          <year>2010</year>\\n          <volume>22</volume>\\n          <fpage>132</fpage>\\n          <lpage>139</lpage>\\n          <pub-id pub-id-type=\"pmid\">20056399</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R13\">\\n        <label>13</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Narendra</surname>\\n              <given-names>D</given-names>\\n            </name>\\n            <name>\\n              <surname>Tanaka</surname>\\n              <given-names>A</given-names>\\n            </name>\\n            <name>\\n              <surname>Suen</surname>\\n              <given-names>DF</given-names>\\n            </name>\\n            <name>\\n              <surname>Youle</surname>\\n              <given-names>RJ</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Parkin is recruited selectively to impaired mitochondria and promotes their autophagy</article-title>\\n          <source>J Cell Biol</source>\\n          <year>2008</year>\\n          <volume>183</volume>\\n          <fpage>795</fpage>\\n          <lpage>803</lpage>\\n          <pub-id pub-id-type=\"pmid\">19029340</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R14\">\\n        <label>14</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Pagliarini</surname>\\n              <given-names>DJ</given-names>\\n            </name>\\n            <etal/>\\n          </person-group>\\n          <article-title>A mitochondrial protein compendium elucidates complex I disease biology</article-title>\\n          <source>Cell</source>\\n          <year>2008</year>\\n          <volume>134</volume>\\n          <fpage>112</fpage>\\n          <lpage>123</lpage>\\n          <pub-id pub-id-type=\"pmid\">18614015</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R15\">\\n        <label>15</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Xing</surname>\\n              <given-names>L</given-names>\\n            </name>\\n            <name>\\n              <surname>Zhang</surname>\\n              <given-names>M</given-names>\\n            </name>\\n            <name>\\n              <surname>Chen</surname>\\n              <given-names>D</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Smurf control in bone cells</article-title>\\n          <source>J Cell Biochem</source>\\n          <year>2010</year>\\n          <volume>110</volume>\\n          <fpage>554</fpage>\\n          <lpage>563</lpage>\\n          <pub-id pub-id-type=\"pmid\">20512916</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R16\">\\n        <label>16</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Talloczy</surname>\\n              <given-names>Z</given-names>\\n            </name>\\n            <etal/>\\n          </person-group>\\n          <article-title>Regulation of starvation- and virus-induced autophagy by the eIF2alpha kinase signaling pathway</article-title>\\n          <source>Proc Natl Acad Sci U S A</source>\\n          <year>2002</year>\\n          <volume>99</volume>\\n          <fpage>190</fpage>\\n          <lpage>195</lpage>\\n          <pub-id pub-id-type=\"pmid\">11756670</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R17\">\\n        <label>17</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Talloczy</surname>\\n              <given-names>Z</given-names>\\n            </name>\\n            <name>\\n              <surname>Virgin</surname>\\n              <given-names>HW</given-names>\\n              <suffix>IV</suffix>\\n            </name>\\n            <name>\\n              <surname>Levine</surname>\\n              <given-names>B</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>PKR-fependent autophagic degradation of herpes simplex virus type 1</article-title>\\n          <source>Autophagy</source>\\n          <year>2006</year>\\n          <volume>2</volume>\\n          <fpage>24</fpage>\\n          <lpage>29</lpage>\\n          <pub-id pub-id-type=\"pmid\">16874088</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R18\">\\n        <label>18</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Orvedahl</surname>\\n              <given-names>A</given-names>\\n            </name>\\n            <etal/>\\n          </person-group>\\n          <article-title>HSV-1 ICP34.5 confers neurovirulence by targeting the Beclin 1 autophagy protein</article-title>\\n          <source>Cell Host Microbe</source>\\n          <year>2007</year>\\n          <volume>1</volume>\\n          <fpage>23</fpage>\\n          <lpage>35</lpage>\\n          <pub-id pub-id-type=\"pmid\">18005679</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R19\">\\n        <label>19</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Geisler</surname>\\n              <given-names>S</given-names>\\n            </name>\\n            <etal/>\\n          </person-group>\\n          <article-title>PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1</article-title>\\n          <source>Nat Cell Biol</source>\\n          <year>2010</year>\\n          <volume>12</volume>\\n          <fpage>119</fpage>\\n          <lpage>131</lpage>\\n          <pub-id pub-id-type=\"pmid\">20098416</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R20\">\\n        <label>20</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Narendra</surname>\\n              <given-names>D</given-names>\\n            </name>\\n            <name>\\n              <surname>Kane</surname>\\n              <given-names>LA</given-names>\\n            </name>\\n            <name>\\n              <surname>Hauser</surname>\\n              <given-names>DN</given-names>\\n            </name>\\n            <name>\\n              <surname>Fearnley</surname>\\n              <given-names>IM</given-names>\\n            </name>\\n            <name>\\n              <surname>Youle</surname>\\n              <given-names>RJ</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>p62/SQSTM1 is required for Parkin-induced mitochondrial clustering but not mitophagy; VDAC1 is dispensable for both</article-title>\\n          <source>Autophagy</source>\\n          <year>2010</year>\\n          <volume>6</volume>\\n          <fpage>1090</fpage>\\n          <lpage>1106</lpage>\\n          <pub-id pub-id-type=\"pmid\">20890124</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R21\">\\n        <label>21</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Yamashita</surname>\\n              <given-names>M</given-names>\\n            </name>\\n            <etal/>\\n          </person-group>\\n          <article-title>Ubiquitin ligase Smurf1 controls osteoblast activity and bone homeostasis by targeting MEKK2 for degradation</article-title>\\n          <source>Cell</source>\\n          <year>2005</year>\\n          <volume>121</volume>\\n          <fpage>101</fpage>\\n          <lpage>113</lpage>\\n          <pub-id pub-id-type=\"pmid\">15820682</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R22\">\\n        <label>22</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Cho</surname>\\n              <given-names>W</given-names>\\n            </name>\\n            <name>\\n              <surname>Stahelin</surname>\\n              <given-names>RV</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Membrane binding and subcellular targeting of C2 domains</article-title>\\n          <source>Biochim Biophys Acta</source>\\n          <year>2006</year>\\n          <volume>1761</volume>\\n          <fpage>838</fpage>\\n          <lpage>849</lpage>\\n          <pub-id pub-id-type=\"pmid\">16945584</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R23\">\\n        <label>23</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Lu</surname>\\n              <given-names>K</given-names>\\n            </name>\\n            <etal/>\\n          </person-group>\\n          <article-title>Pivotal role of the C2 domain of the Smurf1 ubiquitin ligase in substrate selection</article-title>\\n          <source>J Biol Chem</source>\\n          <year>2011</year>\\n          <volume>286</volume>\\n          <fpage>16861</fpage>\\n          <lpage>16870</lpage>\\n          <pub-id pub-id-type=\"pmid\">21402695</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R24\">\\n        <label>24</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Singh</surname>\\n              <given-names>R</given-names>\\n            </name>\\n            <etal/>\\n          </person-group>\\n          <article-title>Autophagy regulates lipid metabolism</article-title>\\n          <source>Nature</source>\\n          <year>2009</year>\\n          <volume>458</volume>\\n          <fpage>1131</fpage>\\n          <lpage>1135</lpage>\\n          <pub-id pub-id-type=\"pmid\">19339967</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R25\">\\n        <label>25</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Mizushima</surname>\\n              <given-names>N</given-names>\\n            </name>\\n            <name>\\n              <surname>Levine</surname>\\n              <given-names>B</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Autophagy in mammalian development and differentiation</article-title>\\n          <source>Nat Cell Biol</source>\\n          <year>2010</year>\\n          <volume>12</volume>\\n          <fpage>823</fpage>\\n          <lpage>830</lpage>\\n          <pub-id pub-id-type=\"pmid\">20811354</pub-id>\\n        </element-citation>\\n      </ref>\\n    </ref-list>\\n  </back>\\n  <floats-group>\\n    <fig id=\"F1\" orientation=\"portrait\" position=\"float\">\\n      <label>Figure 1</label>\\n      <caption>\\n        <title>Genome-wide screen to identify cellular factors required for Sindbis virus capsid colocalization with autophagosomes</title>\\n        <p id=\"P30\"><bold>a,</bold> Correlative light and electron microscopy (EM) of HeLa-GFP-LC3 cell infected with SIN/mCherry.capsid virus. Top left, deconvolved image of red and green fluorescence channels; middle, 3-D surface reconstruction of red and green channels; right, yellow (red + green) colocalization channel. Arrows denote yellow puncta that correspond to “1” and “2” in EMs below. Bottom left, EM of identical cell; middle and right, high magnification images of insets “1” and “2”. Scale bars, left = 10 µm, middle and right = 200 nm. <bold>b</bold>, Ranked distribution of median z-scores for each siRNA pool in primary colocalization (virophagy) screen. Red, decreased colocalization; green, increased colocalization; blue, insufficient numbers of green or red puncta per cell or total number of cells per well for analysis. <bold>c,</bold> Maps of protein interactions in enriched network modules (see <xref ref-type=\"supplementary-material\" rid=\"SD2\">Supplementary Fig. 3b</xref>). <bold>d</bold>, Association of siRNA hits with autophagy network.</p>\\n      </caption>\\n      <graphic xlink:href=\"nihms323367f1\"/>\\n    </fig>\\n    <fig id=\"F2\" orientation=\"portrait\" position=\"float\">\\n      <label>Figure 2</label>\\n      <caption>\\n        <title>Gene list for viral capsid/autophagosome colocalization (C) confirmation screen and secondary screens for survival of virus-infected cells (S) and Parkin-mediated mitophagy (M)</title>\\n        <p id=\"P31\">Shown are the number of individual siRNAs from a pool of 4 targeting each gene that scored positive in each screen. Red, genes with 2 or more positive siRNAs (confirmed hits); Green, genes with &lt;2 positive siRNAs. See <xref ref-type=\"supplementary-material\" rid=\"SD7\">Supplementary Tables 2</xref>–<xref ref-type=\"supplementary-material\" rid=\"SD13\">8</xref> for further details.</p>\\n      </caption>\\n      <graphic xlink:href=\"nihms323367f2\"/>\\n    </fig>\\n    <fig id=\"F3\" orientation=\"portrait\" position=\"float\">\\n      <label>Figure 3</label>\\n      <caption>\\n        <title>Smurf1 functions in virophagy but not in starvation-induced autophagy</title>\\n        <p id=\"P32\"><bold>a,</bold> EM analysis of WT and <italic>Smurf1</italic><sup>−/−</sup> MEFs cultured in normal media or EBSS (starvation) for 4 hrs. Arrowheads, representative autophagosomes; arrows, representative autolysosomes. Scale bars, 500 nm. <bold>b</bold>, Western blot analyses of LC3-I/II and p62 levels in MEFs of indicated genotype. <bold>c,</bold> Quantitation of colocalization of SIN mCherry.capsid and GFP-LC3 in indicated MEFs 16 hrs after SIN-mCherry.capsid/GFP-LC3 infection. Data shown represent mean ± s.e.m. number of colocalized red and green puncta per cell for 50 cells per well in triplicate samples. *, <italic>P</italic>&lt;0.001 vs. WT, t-test. <bold>d,</bold> Representative confocal micrographs of images used for quantitation in (<bold>c</bold>). Arrows, colocalized red and green puncta. Scale bar, 15 mm. <bold>e</bold>, Representative EMs of indicated MEFs infected with HSV-1 (strain 17termA). White arrows, partially degraded viral nucleocapsids inside autolysosomes; black arrows, intact viral nucleocapsids inside viral vesicles. Scale bar, 0.5 µm. For <bold>a–e</bold>, similar results were obtained in 3–5 independent experiments.</p>\\n      </caption>\\n      <graphic xlink:href=\"nihms323367f3\"/>\\n    </fig>\\n    <fig id=\"F4\" orientation=\"portrait\" position=\"float\">\\n      <label>Figure 4</label>\\n      <caption>\\n        <title>Smurf1 functions in mitophagy</title>\\n        <p id=\"P33\"><bold>a,</bold> Representative mitochondrial morphology in <italic>Smurf1</italic><sup>+/+</sup> (WT) and <italic>Smurf1</italic><sup>+/+</sup> (KO) MEFs transfected with indicated construct and treated with DMSO or 10 µM CCCP for 24 hrs. <bold>b,</bold> Quantitation of percentage of total cells with a diffuse accumulation of abnormal fragmented mitochondria and lack of mitochondrial clearance. Results shown represent combined data from 3–5 experiments per condition with triplicate wells (of at least 100 cells per well) analyzed for each condition per experiment. Shown are mean ± s.e.m. for average values from each experiment. Similar results were observed in each independent experiment. *, <italic>P</italic>&lt; 0.001, Student t-test. <bold>c</bold>, Measurement of mitochondrial fractional area (% of total cellular area) in MEFs treated as in (<bold>a</bold>). Results shown represent mean ± s.e.m. for 50 cells per condition. <bold>d,</bold> Representative confocal micrographs of KO MEFs transfected with YFP-Smurf1 wild-type (WT) or YFP-Smurf1ΔC2 (ΔC2) and treated for 4 hrs with DMSO or CCCP. <bold>e,</bold> Representative confocal micrographs of KO MEFs transfected with GFP-LC3 and mCherry-Smurf1 wild-type (WT) or mCherry-Smurf1ΔC2 (ΔC2) and treated for 4 hrs with CCCP. Inset, upper right, formation of completed autophagosome around a damaged mitochondrion associated with WT Smurf1; insets, lower right, incomplete autophagosomes or absence of LC3 signal around mitochondria associated with Smurf1ΔC2. See also <xref ref-type=\"supplementary-material\" rid=\"SD2\">Supplementary Fig. 10–11</xref> for enlarged images. <bold>f</bold>, Representative EMs of indicated tissues from 10 month-old WT (<italic>Smurf1</italic><sup>+/+</sup>) or KO (<italic>Smurf1</italic><sup>−/−</sup>) mice. Arrows, representative abnormal mitochondria. Scale bars, 1 µm. Similar abnormalities were observed throughout entire EM tissue section for each mouse and in tissue samples from 3 different mice for each genotype.</p>\\n      </caption>\\n      <graphic xlink:href=\"nihms323367f4\"/>\\n    </fig>\\n  </floats-group>\\n</article>\\n',\n",
       " 'Recent advances in genetics have led to the discovery of new genes associated with pulmonary arterial hypertension, such as TBX4 and KCNK3. The phenotype and prognosis associated with these new genes have been scarcely described and their role in the Spanish population is unknown. The aim of this study was to characterize the genetics of a Spanish cohort of patients with idiopathic and hereditary pulmonary arterial hypertension and to describe the phenotype and prognostic factors associated with BMPR2 and the new genes (KCNK3 and TBX4). A total of 165 adult patients were screened for BMPR2, KCNK3, and TBX4 mutations, 143 with idiopathic pulmonary arterial hypertension and 22 with hereditary pulmonary arterial hypertension. Baseline characteristics and survival were compared among the different subgroups and predictors of poor outcomes were analyzed. We also performed family screening. The genetic study identified a possibly associated mutation in 11.10% of the idiopathic cases (n = 16) and in 68.18% of the hereditary cases (n = 15). There were 19 mutations in BMPR2, 4 in TBX4, and 3 in KCNK3. The forms associated with TBX4 showed the highest survival rate (P < .01). Advanced functional class at diagnosis was the only factor associated with poor outcomes in the hereditary forms. In the family screening, 37.5% of relatives tested positive. The genetics of pulmonary arterial hypertension in the Spanish population may differ from other populations, with a lower proportion of BMPR2 causative mutations. In our cohort, TBX4-related forms of pulmonary arterial hypertension showed a more benign course and late diagnosis was the only predictor of adverse outcomes in the hereditary forms of the disease.',\n",
       " '<!DOCTYPE article PUBLIC \"-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN\" \"JATS-archivearticle1.dtd\">\\n<article xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" article-type=\"research-article\"><?properties open_access?><front><journal-meta><journal-id journal-id-type=\"nlm-ta\">J Cell Mol Med</journal-id><journal-id journal-id-type=\"iso-abbrev\">J. Cell. Mol. Med</journal-id><journal-id journal-id-type=\"publisher-id\">jcmm</journal-id><journal-title-group><journal-title>Journal of Cellular and Molecular Medicine</journal-title></journal-title-group><issn pub-type=\"ppub\">1582-1838</issn><issn pub-type=\"epub\">1582-4934</issn><publisher><publisher-name>Blackwell Publishing Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type=\"pmid\">23305490</article-id><article-id pub-id-type=\"pmc\">3823143</article-id><article-id pub-id-type=\"doi\">10.1111/j.1582-4934.2012.01656.x</article-id><article-categories><subj-group subj-group-type=\"heading\"><subject>Original Articles</subject></subj-group></article-categories><title-group><article-title>A role for two-pore potassium (K2P) channels in endometrial epithelial function</article-title></title-group><contrib-group><contrib contrib-type=\"author\"><name><surname>Patel</surname><given-names>Suraj K</given-names></name><xref ref-type=\"aff\" rid=\"au1\">a</xref></contrib><contrib contrib-type=\"author\"><name><surname>Jackson</surname><given-names>Leigh</given-names></name><xref ref-type=\"aff\" rid=\"au1\">a</xref></contrib><contrib contrib-type=\"author\"><name><surname>Warren</surname><given-names>Averil Y</given-names></name><xref ref-type=\"aff\" rid=\"au1\">a</xref></contrib><contrib contrib-type=\"author\"><name><surname>Arya</surname><given-names>Pratibha</given-names></name><xref ref-type=\"aff\" rid=\"au2\">b</xref></contrib><contrib contrib-type=\"author\"><name><surname>Shaw</surname><given-names>Robert W</given-names></name><xref ref-type=\"aff\" rid=\"au1\">a</xref></contrib><contrib contrib-type=\"author\"><name><surname>Khan</surname><given-names>Raheela N</given-names></name><xref ref-type=\"aff\" rid=\"au1\">a</xref><xref ref-type=\"corresp\" rid=\"cor1\">*</xref></contrib><aff id=\"au1\"><label>a</label><institution>Academic Division of Obstetrics &#x00026; Gynaecology, University of Nottingham</institution><addr-line>Derby, UK</addr-line></aff><aff id=\"au2\"><label>b</label><institution>Department of Obstetrics &#x00026; Gynaecology, Royal Derby Hospital</institution><addr-line>Derby, UK</addr-line></aff></contrib-group><author-notes><corresp id=\"cor1\">*Correspondence to: Raheela N. KHAN, Academic Division of Obstetrics &#x00026; Gynaecology, University of Nottingham, The Medical School, Royal Derby Hospital, Uttoxeter Road, Derby DE22 3DT, UK. Tel.: +44-1332-724664 Fax: +44-1332-724697 E-mail: <email>raheela.khan@nottingham.ac.uk</email></corresp></author-notes><pub-date pub-type=\"ppub\"><month>1</month><year>2013</year></pub-date><pub-date pub-type=\"epub\"><day>11</day><month>1</month><year>2013</year></pub-date><volume>17</volume><issue>1</issue><fpage>134</fpage><lpage>146</lpage><history><date date-type=\"received\"><day>12</day><month>7</month><year>2012</year></date><date date-type=\"accepted\"><day>15</day><month>10</month><year>2012</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2013 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd.</copyright-statement><copyright-year>2013</copyright-year><license license-type=\"open-access\" xlink:href=\"http://creativecommons.org/licenses/by/2.5/\"><license-p>Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation.</license-p></license></permissions><abstract><p>The human endometrial epithelium is pivotal to menstrual cycle progression, implantation and early pregnancy. Endometrial function is directly regulated by local factors that include pH, oxygen tension and ion concentrations to generate an environment conducive to fertilization. A superfamily of potassium channels characterized by two-pore domains (K2P) and encoded by <italic>KCNK</italic> genes is implicated in the control of the cell resting membrane potential through the generation of leak currents and modulation by various physicochemical stimuli. The aims of the study were to determine the expression and function of K2P channel subtypes in proliferative and secretory phase endometrium obtained from normo-ovulatory women and in an endometrial cancer cell line. Using immunochemical methods, real-time qRT-PCR proliferation assays and electrophysiology. Our results demonstrate mRNA for several K2P channel subtypes in human endometrium with molecular expression of TREK-1 shown to be higher in proliferative than secretory phase endometrium (<italic>P</italic> &#x0003c; 0.001). The K2P channel blockers methanandamide, lidocaine, zinc and curcumin had antiproliferative effects (<italic>P</italic> &#x0003c; 0.01) in an endometrial epithelial cancer cell line indicating a role for TASK and TREK-1 channels in proliferation. Tetraethylammonium- and 4-aminopyridine-insensitive outwards currents were inhibited at all voltages by reducing extracellular pH from 7.4 to 6.6. Higher expression of TREK-1 expression in proliferative phase endometrium may, in part, underlie linked to increased cell division. The effects of pH and a lack of effect of non-specific channel blockers of voltage-gated potassium channels imply a role for K2P channels in the regulation of human endometrial function.</p></abstract><kwd-group><kwd>endometrium</kwd><kwd>potassium</kwd><kwd>channel</kwd><kwd>pH</kwd><kwd>proliferation</kwd><kwd>menstrual cycle</kwd></kwd-group></article-meta></front><body><sec><title>Introduction</title><p>The adult human endometrium is central to reproductive success undergoing monthly cyclical renewal in preparation for implantation. During the proliferative phase, regeneration of the endometrium involving increased proliferation of both stromal and epithelial cells occurs principally in response to oestradiol 17&#x003b2;. Following ovulation, progesterone converts the epithelium to a secretory phenotype, endometrial proliferation ceases and a transient receptive state, &#x02018;the window of implantation&#x02019;, is induced. During this brief period, electrolyte balance of the intrauterine fluid is crucial in ensuring apposition and attachment of the blastocyst to the luminal epithelium. Indeed, fluid shifts and oedema occur in the endometrium throughout the perimplantation period [<xref ref-type=\"bibr\" rid=\"b1\">1</xref>], yet comparatively little is known or understood regarding the mechanisms generating ionic gradients across the endometrium.</p><p>The ionic composition of intrauterine fluid differs from normal serum in having a higher potassium (K<sup>+</sup>) concentration [<xref ref-type=\"bibr\" rid=\"b2\">2</xref>] and is supported by evidence from <italic>in vitro</italic> ion measurements in supernatants from cultured human endometrial epithelium [<xref ref-type=\"bibr\" rid=\"b3\">3</xref>]. Interestingly, a K<sup>+</sup>-rich intrauterine environment has been shown to promote both sperm fertilizing capacity and blastocyst cleavage [<xref ref-type=\"bibr\" rid=\"b4\">4</xref>]. Thus, critical aspects of fertilization, implantation and early pregnancy are dependent on an appropriate ionic microenvironment which is in part determined by ion channel activity.</p><p>Ion channels provide a specialized conduit for the rapid transfer of ions across the lipid bilayer. Their specific roles in endometrial epithelia, in common with those in epithelia of other organs, <italic>e.g</italic>. kidney, airways, gastrointestinal tract, include electrolyte homeostasis, fluid/nutrient secretion and setting of the resting membrane potential [<xref ref-type=\"bibr\" rid=\"b5\">5</xref>]. A limited amount of information on ion channels within the human endometrium indicates the presence of an amiloride-sensitive sodium channel (ENaC) that mediates epithelial sodium absorption [<xref ref-type=\"bibr\" rid=\"b3\">3</xref>] as well as a cystic fibrosis transmembrane regulator (CFTR) involved in anion flux [<xref ref-type=\"bibr\" rid=\"b6\">6</xref>]. Gene profiling by microarray analysis has also identified trends in endometrial channel expression with specific phases of the menstrual cycle. For example, Kao <italic>et al.,</italic> [<xref ref-type=\"bibr\" rid=\"b7\">7</xref>] demonstrated a marked up-regulation of cDNA for the sulfonylurea receptor (a key accessory protein of the ATP-sensitive K<sup>+</sup> channel) and the L-type calcium channel during the window of implantation. The gene <italic>KCNJ2</italic> (encoding an inwardly rectifying K<sup>+</sup> channel, KIR2.1) has been shown to be highly expressed in proliferative phase endometrium along with <italic>KCNG1</italic> (encoding Kv6.1) and the epithelial sodium channel, <italic>SCNN1A</italic> gene for ENaC [<xref ref-type=\"bibr\" rid=\"b8\">8</xref>].</p><p>In recent years, the K2P channel superfamily, distinguished from the classical voltage- and receptor-gated K<sup>+</sup> channel families by the presence of two pores arranged in tandem between four transmembrane domains, has achieved prominence. Channels belonging to the mammalian K2P family, first reported following the discovery of TWIK-1 [<xref ref-type=\"bibr\" rid=\"b9\">9</xref>], are gated by a range of physicochemical stimuli that include pH, oxygen tension and stretch [<xref ref-type=\"bibr\" rid=\"b10\">10</xref>, <xref ref-type=\"bibr\" rid=\"b11\">11</xref>]. The channels include TWIK-1 [<xref ref-type=\"bibr\" rid=\"b9\">9</xref>], TWIK-2 [<xref ref-type=\"bibr\" rid=\"b12\">12</xref>], TREK (TWIK related) [<xref ref-type=\"bibr\" rid=\"b13\">13</xref>], TRAAK [<xref ref-type=\"bibr\" rid=\"b14\">14</xref>] and TASK [<xref ref-type=\"bibr\" rid=\"b15\">15</xref>] where TWIK-1 is a weak, inwardly rectifying channel, TRAAK channels are activated by arachidonic acid whereas TASK channels are acid sensitive [<xref ref-type=\"bibr\" rid=\"b15\">15</xref>].</p><p>Given the emerging significance of K2P channels in maintaining resting membrane potential and their coupling to cellular function, we propose that K2P channels in the human endometrium may be of crucial significance where slight perturbations locally in lipid regulation, ion transport, pH or oxygen tension could jeopardize the ambient conditions necessary for successful fertilization and implantation. The objectives of our study were therefore to determine the major K2P channel subtypes expressed in the human endometrium, their relationship to the menstrual cycle and their roles in endometrial physiology.</p></sec><sec sec-type=\"materials|methods\"><title>Material and methods</title><sec><title>Patient inclusion criteria and tissue collection</title><p>Ethical approval for this study was granted by the Lincolnshire Research Ethics Committee (study no. 03/2/39). Endometrial tissue biopsies were collected from fully informed patients who provided written consent prior to clinical procedures being undertaken. The research described was undertaken in accordance with the World Medical Association Declaration of Helsinki. Criteria for recruitment were non-pregnant women aged between 18 and 40 years (mean 32.2 &#x000b1; 4.7; <italic>n</italic> = 49), admitted for gynaecological investigation (pelvic pain, menorrhagia) or laparoscopic sterilization and with regular (28&#x02013;34 days) monthly cycles. Endometrial samples collected from days 5&#x02013;11 were assigned to the proliferative phase (<italic>n</italic> = 31) whereas secretory phase endometrium was designated as such based on a luteal phase progesterone level of &#x0003e;13 nmol/l (<italic>n</italic> = 11). In cases where progesterone levels were not available (for example, laparoscopic sterilizations), the secretory stage was defined as post-day 16 of the cycle, determined from the date of the last menstrual period (<italic>n</italic> = 7). Women diagnosed with diabetes, endometriosis, fibroids, polycystic ovarian syndrome, cancer or amenorrhea were excluded from the study as were those who had been on any form of hormonal contraception up to 1 month before recruitment to the study.</p><p>Endometrial biopsies obtained by pipelle sampling were placed immediately in Dulbecco\\'s modified Eagle\\'s Medium (DMEM, Invitrogen, Paisley, UK) and supplemented with 1% penicillin/streptomycin. Samples were washed in ice-cold sterile phosphate-buffered saline and dispersed no longer than 24 hrs after collection or snap frozen within 10 min. for downstream analyses of molecular and protein channel expression.</p><p>Cell line: The Ishikawa endometrial cell line (99040201), derived from an endometrial adenocarcinoma of a 39-year-old woman, was obtained from the European Collection of Cell Culture (Sigma-Aldrich, Dorset, UK).</p></sec><sec><title>Primary endometrial cell culture</title><p>Fresh endometrial biopsies (50&#x02013;500 mg) were finely chopped and enzymatically digested with collagenase (1 mg/ml; Sigma-Aldrich) in calcium/magnesium-free Hanks Balanced Salt solution (HBSS) in a 37&#x000b0;C water bath for a maximum of 45 min. If the tissue sample contained obvious amounts of blood (particularly early and late menstrual stage samples), then the preparation was carefully layered onto a 60% Percoll (Invitrogen, Paisley, Scotland) solution and centrifuged at 800 r.p.m. for 30 min. at 4&#x000b0;C to remove erythrocytes.</p><p>Following centrifugation, cells were transferred to a fresh tube containing HBSS then passed through a 40 &#x003bc;m nylon cell strainer (BD Falcon, Oxford, UK) to separate stromal and epithelial cells. The former, owing to their smaller size, passed through the strainer whereas the larger glandular cells were retained. Both cell fractions were separately passed through the cell strainer a second time to further enrich the two cell preparations, washed again in HBSS then centrifuged at 50 <italic>g</italic> for 7 min. The final step involved resuspending the cells in DMEM supplemented with 10% heat-inactivated foetal bovine serum (Sigma-Aldrich) followed by incubation at 37&#x000b0;C in a humidified incubator containing 5% CO<sub>2</sub> in air. Media was changed every 2&#x02013;3 days for a maximum of 14 days or two passages.</p></sec><sec><title>RNA extraction and cDNA synthesis</title><p>Total RNA was extracted from either snap-frozen endometrial biopsies (50&#x02013;200 mg) or &#x0223c;5&#x02013;9 &#x000d7; 10<sup>6</sup> cells of the cultured Ishikawa cell line, using TriZol reagent according to the manufacturer\\'s instructions. Only RNA that resulted in an A260/280 ratio of 1.8&#x02013;2.0, and displayed clearly distinguishable 18s and 28s rRNA bands in an agarose gel was reverse transcribed to generate cDNA. Synthesis of cDNA was carried out with SuperScript II RNase Reverse Transcriptase (200 units/&#x003bc;l, Invitrogen) and Oligo (dT)<sub>12-18</sub> primers (Invitrogen) at 42&#x000b0;C with 1 &#x003bc;g of total RNA as template, in a final volume of 20 &#x003bc;l. Negative controls for the reverse-transcription reaction were prepared by omitting the RT enzyme.</p><p>For conventional end-point PCR, 100 ng of cDNA was amplified following addition to a 25 &#x003bc;L mastermix containing dNTPs, Platinum&#x000ae; Taq DNA polymerase (Invitrogen) enzyme and appropriate forward and reverse primers for the desired K2P target gene. Amplicons were visualized under UV light following separation through a 2% agarose gel containing ethidium bromide.</p></sec><sec><title>qRT-PCR</title><p>Quantitation of TWIK-2 and TREK-1 mRNA was carried out by real-time PCR (qPCR) using SYBR I green chemistry on an MJ Chromo 4 thermal cycler (Opticon Monitor 3.1.32 software, BioRad, Hemel Hempstead, UK). Approximately 1 ng/&#x003bc;l of endometrial cDNA was added to Platinum&#x000ae; SYBR&#x000ae; Green qPCR Supermix-UDG (Invitrogen) and primers (maximum concentration 250 nmol) in a 25 &#x003bc;l reaction. The PCR protocol comprised the following steps: 50&#x000b0;C for 2 min., 95&#x000b0;C for 10 min., followed by 40 cycles of 95&#x000b0;C for 15 sec. and 60&#x000b0;C for 60 sec. for annealing and extension. The cycle terminated with melt-curve analysis of the amplicon in 1&#x000b0;C increments (65&#x02013;96&#x000b0;C) to exclude contamination from primer dimers and to confirm amplification of a single, specific transcript. All conditions and methods for TREK-1 qPCR were as for TWIK-2, with the exception of an annealing temperature of 62&#x000b0;C for TREK-1. Standard curves were generated from serially diluted endometrial cDNA and the target transcripts quantitated by normalizing expression relative to an endogenous reference gene, in this case, hypoxanthine-guanine phosphoribosyltransferase (HPRT). Efficiency, calculated from standard curves, varied from 90% to 104% for endometrial cDNA over a threefold dilution series. Exon-spanning primer pairs used for conventional RT-PCR and qRT-PCR are shown in <xref ref-type=\"table\" rid=\"tbl1\">Table 1</xref>. The same TWIK-2 and TREK-1 primers were used in conventional and qRT-PCR.</p><table-wrap id=\"tbl1\" position=\"float\"><label>Table 1</label><caption><p>Primers used for RT-PCR and qRT-PCR for K2P channels in human endometrium</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\" rowspan=\"1\" colspan=\"1\">Gene</th><th align=\"left\" rowspan=\"1\" colspan=\"1\">Protein</th><th align=\"left\" rowspan=\"1\" colspan=\"1\">Sequence 5-3&#x02032;</th><th align=\"left\" rowspan=\"1\" colspan=\"1\">Accession number</th></tr></thead><tbody><tr><td align=\"left\" rowspan=\"1\" colspan=\"1\"><italic>KCNK2</italic></td><td align=\"left\" rowspan=\"1\" colspan=\"1\">TREK-1</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">TCAGCAAATAGTGGCAGCAA AGTGCCAGCAAAGAAGAAGG</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">NM_001017424</td></tr><tr><td align=\"left\" rowspan=\"1\" colspan=\"1\"><italic>KCNK10</italic></td><td align=\"left\" rowspan=\"1\" colspan=\"1\">TREK-2</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">GAGAAGCGCTCTGTCTTTGC TCTTTGGTGTCCGTGGGTAT</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">NM_138317.1</td></tr><tr><td align=\"left\" rowspan=\"1\" colspan=\"1\"><italic>KCNK4</italic></td><td align=\"left\" rowspan=\"1\" colspan=\"1\">TRAAK</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">GGAGAAGGAGCAGCCACTG GCTCTGCGTATCCGAGGACT</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">NM_03310.2</td></tr><tr><td align=\"left\" rowspan=\"1\" colspan=\"1\"><italic>KCNK1</italic></td><td align=\"left\" rowspan=\"1\" colspan=\"1\">TWIK-1</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">GCGCAGTGGTCTTCTCCTC GAAGTCCCAGTTCCAGTTGC</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">NM_002245</td></tr><tr><td align=\"left\" rowspan=\"1\" colspan=\"1\"><italic>KCNK6</italic></td><td align=\"left\" rowspan=\"1\" colspan=\"1\">TWIK-2</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">CAAGGTGCTGGTCACAGTCT ATGGAAGCGTAGTCGGTGTG</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">NM_004823</td></tr><tr><td align=\"left\" rowspan=\"1\" colspan=\"1\"><italic>KCNK3</italic></td><td align=\"left\" rowspan=\"1\" colspan=\"1\">TASK-1</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">AACGCCGAGGACGAGAAG CTCTTGTACCACAGGCACGA</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">NM_002246</td></tr><tr><td align=\"left\" rowspan=\"1\" colspan=\"1\"><italic>KCNK5</italic></td><td align=\"left\" rowspan=\"1\" colspan=\"1\">TASK-2</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">GGAAGAAGGCCATGAAGACA AGTGCTGGTGAAGGTGGACT</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">NM_003740</td></tr><tr><td align=\"left\" rowspan=\"1\" colspan=\"1\"><italic>KCNK9</italic></td><td align=\"left\" rowspan=\"1\" colspan=\"1\">TASK-3</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">TCGTCCTCAGGTTCTTGACC CCCAGGAGAGATGGAGCTAA</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">NM_016601</td></tr><tr><td align=\"left\" rowspan=\"1\" colspan=\"1\"><italic>KCNK17</italic></td><td align=\"left\" rowspan=\"1\" colspan=\"1\">TASK-4/TALK-2</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">CTCGCCTACCTGGCTTACCT CGGTCCAGACACGTGAAGTT</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">NM_031460</td></tr><tr><td align=\"left\" rowspan=\"1\" colspan=\"1\"><italic>KCNK16</italic></td><td align=\"left\" rowspan=\"1\" colspan=\"1\">TALK-1</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">GCTGGCCTATGTCTGCTACC ACTGGTCCAGGCAGGTGTAG</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">NM_032115</td></tr><tr><td align=\"left\" rowspan=\"1\" colspan=\"1\"><italic>KCNK13</italic></td><td align=\"left\" rowspan=\"1\" colspan=\"1\">THIK-1</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">TGGATCCTGAGGAAAATGGA TTGGCCATCTCAGACAGTTG</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">NM_022054</td></tr><tr><td align=\"left\" rowspan=\"4\" colspan=\"1\">HPRT1</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">HPRT</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">TGACCTTGATTTATTTTGCATACC TGAGGAATAAACACCCTTTCCA</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">NM_000194</td></tr><tr><td align=\"left\" rowspan=\"1\" colspan=\"1\">&#x003b2;-actin</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">CATGTACGTTGCTATCCAGGC CTCCTTAATGTCACGCACGAT</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">NM_001101</td></tr><tr><td align=\"left\" rowspan=\"1\" colspan=\"1\">GAPDH</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">CATGAGAAGTATGACAACAGCCT AGTCCTTCCACGATACCAAAGT</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">NM_002046</td></tr><tr><td align=\"left\" rowspan=\"1\" colspan=\"1\">&#x003b2;<sub>2</sub>M</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">GCTATCCAGCGTACTCCAAA GAAAGACCAGTCCTTGCTGA</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">NM_004048</td></tr></tbody></table></table-wrap></sec><sec><title>Immunohistochemistry</title><p>Endometrial biopsies were cleared of mucus or clots, snap-frozen and embedded in OCT medium. Approximately 5 &#x003bc;m thick frozen serial sections were mounted on aminopropyltriethoxysilane (APES)-coated slides and air dried. Endogenous peroxidize activity was blocked with 3% (w/v) aqueous hydrogen peroxide and slides washed with water. Sections were then stained for 1 hr with a primary antibody raised to E-cadherin (BD Biosciences, Oxford, UK) and washed thereafter. After incubation with a biotinylated secondary antibody (DAKO Labs Ely, Cambs, UK) and further washing, sections were exposed for 8 min. to the avidin&#x02013;biotin complex (ABC; Vector Laboratories, Peterborough, UK) followed by 3&#x02032;3-diaminobenzidine for detection of bound antibody. Thereafter, slides were rinsed and counterstained with Harris\\'s haematoxylin before viewing under light microscopy (Zeiss Axiovert, Carl Zeiss, Jena, Germany).</p></sec><sec><title>Immunofluorescence</title><p>Cells cultured to a maximum of two passages were processed as previously described [<xref ref-type=\"bibr\" rid=\"b16\">16</xref>]. Briefly, endometrial cells on glass coverslips were fixed in 4% paraformaldehyde for 10 min. followed by permeabilization with 0.1 M Igepal in PBS. Following block of non-specific sites with 5% goat serum, cells were incubated with anti-TWIK-2 (1 in 50) or anti-TREK-1 (1 in 50) antibody following exposure to FITC-conjugated secondary antibody. Cells were subsequently viewed using either an epifluorescence (Zeiss Axiovert) microscope or a Zeiss Axiovert 100 microscope with an LSM 510 confocal scan head (Carl Zeiss, Jena, Germany) and a plan-Apochromat &#x000d7;63 oil immersion objective lens. For control wells, cells were incubated with control IgG at the same dilution instead of the primary antibody.</p></sec><sec><title>Western blotting of channel proteins</title><p>Individual, unpooled snap-frozen endometrial samples (&#x0223c;200 mg) were processed in homogenization buffer (300 mM sucrose, 25 mM Tris-base, 10 mM monothioglycerol, 1 mM EDTA, 1% Igepal) and protease/phosphatase inhibitor cocktail. Following centrifugation of the tissue preparation at 1000 g for 10 min. at 4&#x000b0;C, the supernatant was removed and centrifuged again at 14,000 &#x000d7; <italic>g</italic> for 60 min. Solubilization of the pellet was carried out overnight at 4&#x000b0;C in solubilization buffer (20 mM, Tris-base pH 7.5, 10 mM, EDTA 120 mM NaCl, 50 mM KCl, 2 mM dithiotreitol, Igepal 2.5% and a cocktail of protease/phosphatase inhibitors). The protein concentration of all samples was determined using the bicinchoninic acid (BCA) assay. Samples were added to sample buffer (1 mM Tris-HCl, 10% SDS, 0.05% bromophenol blue and &#x003b2;-mercaptoethanol) and boiled at 95&#x000b0;C for 5 min. after which 40 &#x003bc;g protein per lane was loaded and resolved by SDS-PAGE on 10% gels. Following electrophoretic transfer of proteins onto nitrocellulose membranes, blocking of non-specific sites was performed for 2 hrs with 5% Marvel in TBS-T followed by washing in TBS-T. Membranes were subsequently incubated overnight at 4&#x000b0;C in anti-TREK-1 (1 in 500) or anti-TWIK-2 antibody (1:2500 dilution) prepared in TBS-T containing 3% Marvel. After washing the blots, alkaline-phosphatase-conjugated secondary antibody (goat antimouse, 1:800 dilution) was applied for 2 hrs. Immunolabelled protein bands were visualized after washing with TBS and exposure to chemiluminescent substrate (ImmunStar, BioRad, Herts, UK) and protein densities quantified after deducting non-specific background. Molecular weights of target proteins were determined by running Precision Plus molecular weight markers (BioRad) alongside. Channel antibodies were purchased from Caltag-Medsystems Ltd (Buckinghamshire, UK).</p><p>Equal loading of proteins was assessed by stripping blots of bound antibody using ReBlot Plus (Chemicon Internationals, Millipore, Livingstone, UK) for 15 min. (TWIK-2) or 20 min. (TREK-1) at room temperature with gentle agitation. After incubation the stripping solution was removed, blots washed with TBST followed by blocking with 5% Marvel in TBS for 1 hr 30 min. and membranes reprobed with anti-&#x003b2;-actin primary antibody. Protein expression for each sample was normalized relative to the corresponding &#x003b2;-actin signal. For pre-adsorption experiments, anti-TWIK-2 antibody was pre-incubated with the antigenic peptide provided with the antibody at fivefold excess before addition to the membrane blots. The effects of progesterone on TREK-1 protein were studied by incubating Ishikawa cells overnight in the presence of a range of progesterone concentrations (10<sup>&#x02212;11</sup>&#x02013;10<sup>&#x02212;5</sup> M) and harvesting cells as described above for Western blotting.</p></sec><sec><title>Cell proliferation assay</title><p>The effects of K2P channel blockers on cell proliferation were determined using 2500 Ishikawa cells per well of a 96-well microtitre plate, following a 24 hrs serum starvation period. Cells were cultured in DMEM containing 10% stripped serum. Channel blockers, tested in triplicate, were added to the media on day 2 and growth assessed thereafter over a 4-day period. Media and drugs were replaced with fresh substitutes midway through the experimental period. Cell proliferation was monitored daily using the MTS [(3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazoilum, inner salt)] assay (Promega, Southampton, UK) at 490 nm. Results from treated cells were compared with control wells to which no test drug had been added. Stock solutions of methanandamide and curcumin were made in 100% ethanol, whereas lidocaine, iberiotoxin, zinc, L-methionine and L-methioninol were dissolved in culture medium. Effects of vehicle alone were tested at concentrations commensurate with those used in the experiment. All experiments were carried out at least twice and samples run in triplicate for each assay.</p></sec><sec><title>Electrophysiology</title><p>Freshly dispersed endometrial epithelial cells or cells of the Ishikawa cell line were prepared as described above and allowed to settle for 30 min. on a glass coverslip. Whole-cell voltage-clamp recordings were initiated following formation of a gigaohm (&#x0003e;2 G&#x003a9;) seal and capacitance cancellation using filled electrodes with a resistance 4&#x02013;6 M&#x003a9;. Individual cell resting membrane potential was determined under current clamp. Ion currents were elicited thereafter under voltage clamp in response to 10 mV step depolarizations from &#x02212;60 to +50 mV and current&#x02013;voltage plots produced. Protocols were delivered through the Axopatch Multiclamp B amplifier with pClamp 9 for acquisition and analysis. The external bath solution consisted of (in mM) 135 NaCl, 5 KCl, 1 CaCl<sub>2</sub>, 1 MgCl<sub>2</sub>, 10 HEPES (pH 7.4), whereas the electrode intracellular solution comprised of (in mM): 140 KCl, 1 KEGTA, 10 HEPES (pH 7.2). Voltage-gated potassium currents were minimized by the addition of 10 mM tetraethylammonium (TEA) and 5 mM 4-aminopyridine (4-AP) to the bath solution. The effects of pH on K<sup>+</sup> currents were evaluated following acidification of the external bathing solution to the required pH by addition of 0.5 M hydrochloric acid and perfusion of the recording chamber with this modified solution. TEA and 4-AP were purchased from Sigma (Dorset, UK).</p></sec><sec><title>Statistical analysis</title><p>Statistical analysis was carried out with GraphPad Prism (V5) software. Data are expressed as mean &#x000b1; SEM. Results were analysed using non-parametric tests (for qPCR, Western blotting) and Student\\'s unpaired two-tailed <italic>t</italic>-test for electrophysiology. Multiple comparisons of drug treatments for proliferation assays were analysed by <sc>anova</sc> with post hoc analysis using the Dunnet\\'s test and assigning untreated cells as the control group.</p></sec></sec><sec sec-type=\"results\"><title>Results</title><p>Immunohistochemistry of endometrial tissue sections obtained at various stages of the menstrual cycle expressed the epithelial cell marker E-cadherin in glands of both proliferative (<italic>n</italic> = 8) and secretory phase (<italic>n</italic> = 6) endometrium with respective representative images presented in <xref ref-type=\"fig\" rid=\"fig01\">Figure 1</xref>A and <xref ref-type=\"fig\" rid=\"fig01\">1</xref>B. Immunostaining was absent from the stroma. Anti-E-cadherin immunofluorescence was also present in primary epithelial endometrial cells cultured for up to 2 weeks and was localized at cell&#x02013;cell boundaries (<xref ref-type=\"fig\" rid=\"fig01\">Fig. 1</xref>C; <italic>n</italic> = 8) as was E-cadherin immunostaining in cells of the Ishikawa cell line (<xref ref-type=\"fig\" rid=\"fig01\">Fig. 1</xref>D; <italic>n</italic> = 3).</p><fig id=\"fig01\" position=\"float\"><label>Fig. 1</label><caption><p>Expression of epithelial cell markers in human endometrium. Freshly collected endometrial samples were formalin fixed for immunohistochemistry or incubated for 1 hr in collagenase to obtain a single cell suspension. For cell culture, epithelial cells were separated from stromal cells by double filtration, plated onto glass coverslips, fixed with paraformaldehyde and then incubated with anti-E-cadherin antibody (AbCam, Cambridge, UK) (<bold>A</bold>) Representative immunohistochemical staining of an early proliferative phase endometrial biopsy. Epithelial endometrial cells express E-cadherin in endometrial glands. E-cadherin immunoreactivity is absent from the stroma and lumen. Scale bar: 100 &#x003bc;m. (<bold>B</bold>) Late secretory phase endometrium. Glands are tortuous in outline and still exhibit E-cadherin staining which is absent from stroma. Scale bar: 100 &#x003bc;m. (<bold>C</bold>) Ishikawa cells at day 8 <italic>in vitro</italic> express E-cadherin at cell&#x02013;cell boundaries. Scale bar: 10 &#x003bc;m. (<bold>D</bold>) Primary culture of human epithelial cells prepared from a proliferative phase biopsy. E-cadherin immunopositivity is observed at cell&#x02013;cell boundaries. Scale bar: 5 &#x003bc;m.</p></caption><graphic xlink:href=\"jcmm0017-0134-f1\"/></fig><p>A variety of K2P channel subtypes was expressed in both Ishikawa cells (<xref ref-type=\"fig\" rid=\"fig02\">Fig. 2</xref>) and tissue biopsies of human endometrium obtained throughout the proliferative (<italic>n</italic> = 9) and secretory phases (<italic>n</italic> = 7) of the menstrual cycle (<xref ref-type=\"fig\" rid=\"fig03\">Fig. 3</xref>). Data from conventional end-point RT-PCR demonstrated mRNA expression of the K2P channel subtypes TWIK-1, TWIK-2, TREK-1, TREK-2, TASK-1, TASK-2, TASK-3, TRAAK, TALK-1, TALK-2 in both Ishikawa cells (<xref ref-type=\"fig\" rid=\"fig02\">Fig. 2</xref>) and human endometrium (<xref ref-type=\"fig\" rid=\"fig03\">Fig. 3</xref>) producing amplicons of the expected size. Omitting RT enzyme during reverse transcription in the synthesis of cDNA confirmed a lack of non-specific amplification. Comparing K2P expression between cultured Ishikawa cells with endometrial biopsies identified an absence of TASK-1 channel mRNA in the former (<xref ref-type=\"fig\" rid=\"fig02\">Fig. 2</xref>) with only low expression apparent in tissue biopsies procured from across the menstrual cycle (<xref ref-type=\"fig\" rid=\"fig03\">Fig. 3</xref>). mRNA for TRAAK channels was present in endometrial biopsies, but barely visible in cultured Ishikawa cells (<xref ref-type=\"fig\" rid=\"fig03\">Fig. 3</xref>). The reference gene &#x003b2;<sub>2</sub>microglobulin (&#x003b2;<sub>2</sub>M) was expressed in all samples tested (<xref ref-type=\"fig\" rid=\"fig02\">Figs 2</xref> and <xref ref-type=\"fig\" rid=\"fig03\">3</xref>).</p><fig id=\"fig02\" position=\"float\"><label>Fig. 2</label><caption><p>Two-pore Potassium channel expression in the Ishikawa cell line. Conventional end-point RT-PCR was carried out using total RNA extracted from Ishikawa cells (<italic>n</italic> = 3&#x02013;5) using TriZol. One &#x003bc;g of total RNA was reverse transcribed to produce cDNA. For first strand negative controls, RT enzyme was omitted to check for non-specific amplification. RT-PCR for each individual K2P channel was then performed with relevant primer pairs. The bottom row of the figure shows amplification of the reference gene &#x003b2;<sub>2</sub>M. Ishikawa cells expressed TWIK-1, TWIK-2, TREK-1, TREK-2, TASK-2, TASK-3, TALK-1 and TALK-2. mRNA for TRAAK and TASK-1 channels was low or absent, respectively, whereas the transcripts for TWIK-2 and TASK-2 qualitatively were of low abundance. Lane 1 (L to R) 100 bp ladder. Lanes 2&#x02013;7 show PCR products from individual preparations of cultured Ishikawa cells. Lane 8 is the no RT control showing an absence of amplification.</p></caption><graphic xlink:href=\"jcmm0017-0134-f2\"/></fig><fig id=\"fig03\" position=\"float\"><label>Fig. 3</label><caption><p>Two-pore Potassium channel expression in human endometrial samples throughout the menstrual cycle. Total RNA was TriZol extracted from 200 mg of snap-frozen endometrium obtained by pipelle biopsy and reverse transcribed into cDNA. Day of cycle of when biopsy was taken is shown above the corresponding lane with days 5&#x02013;11 considered to be proliferative phase and 16&#x02013;30 secretory phase endometrium. Expression of TWIK-1, TWIK-2, TREK-1, TREK-2, TRAAK, TASK-2, TASK-3, TALK-1, TALK-2 and THIK was seen in all samples across the menstrual cycle except for TASK-1. Lane 1: 100 bp ladder. The last lane on the RHS depicts either a signal from cDNA for day 27 endometrium (where a band is present) or where no band is present, served as a no added template (NAT) control.</p></caption><graphic xlink:href=\"jcmm0017-0134-f3\"/></fig><p>Based on the above observations, we elected to quantitate TWIK-2 mRNA expression given the qualitatively distinct sample-dependent changes observed throughout the menstrual cycle (<xref ref-type=\"fig\" rid=\"fig03\">Fig. 3</xref>). TREK-1 was also chosen for further investigation on the basis of its apparent constitutive expression (<xref ref-type=\"fig\" rid=\"fig03\">Fig. 3</xref>) and multimodal regulation by stretch, lipid, oxygen and pH [<xref ref-type=\"bibr\" rid=\"b10\">10</xref>]; factors known to regulate endometrial function. For qRT-PCR experiments, mRNA extracted from whole endometrial biopsies served as template to determine any differential expression of channels with either proliferative or secretory phase endometrium. Expression of four reference genes [&#x003b2;-actin, glyceraldehyde 3-phosphate dehydrogenase (GAPDH), hypoxanthine-guanine phosphoribosyltransferase (HPRT), &#x003b2;<sub>2</sub>M] was examined with no significant difference (<italic>P</italic> &#x0003e; 0.05) amongst them detected across the menstrual cycle. Therefore, HPRT was selected as the reference gene of choice based on its C<sub>t</sub> values that were closest to those of the target genes being studied. Reactions where reverse transcriptase or cDNA (no added template) was omitted showed no signal amplification. qRT-PCR experiments identified significantly greater (<italic>P</italic> &#x0003c; 0.01) expression of TREK-1 mRNA in endometrial samples harvested from the proliferative (<italic>n</italic> = 8) compared with the secretory phase (<italic>n</italic> = 6) of the menstrual cycle (<xref ref-type=\"fig\" rid=\"fig04\">Fig. 4</xref>). The C<sub>t</sub> values for TREK-1 lay between 28 and 34 with a median of 32 and a median of 26 for TWIK-2 (<xref ref-type=\"fig\" rid=\"fig05\">Fig. 5</xref>). TWIK-2 standard curves gave good representative amplification and melt curves (<xref ref-type=\"fig\" rid=\"fig05\">Fig. 5</xref>), although levels between proliferative and secretory phase endometrium were not significantly different (<italic>P</italic> &#x0003e; 0.05; <xref ref-type=\"fig\" rid=\"fig05\">Fig. 5</xref>).</p><fig id=\"fig04\" position=\"float\"><label>Fig. 4</label><caption><p>qRT-PCR of TREK-1 mRNA expression across the menstrual cycle in human endometrial biopsies from normal, cycling women (<italic>n</italic> = 14). TREK-1 expression is significantly greater in proliferative (Prolif) <italic>versus</italic> secretory (Sec) phase endometrium (<italic>P</italic> &#x0003c; 0.001). Expression was quantified relative to the reference gene HPRT. Inset shows melt-curve analysis and production of a single, specific transcript from multiple endometrial samples.</p></caption><graphic xlink:href=\"jcmm0017-0134-f4\"/></fig><fig id=\"fig05\" position=\"float\"><label>Fig. 5</label><caption><p>qRT-PCR of TWIK-2 mRNA expression across the menstrual cycle in human endometrial biopsies from normal women (<italic>n</italic> = 14). Expression was quantified relative to the reference gene HPRT. No significant difference (<italic>P</italic> &#x0003e; 0.05) was detected between proliferative (Prolif) and secretory phase (Sec) samples. Inset shows melt-curve analysis of a single, specific transcript from multiple endometrial samples.</p></caption><graphic xlink:href=\"jcmm0017-0134-f5\"/></fig><p>Translation of mRNA to protein for TREK-1 was verified by Western blotting in both Ishikawa cells (<xref ref-type=\"fig\" rid=\"fig06\">Fig. 6</xref>A) and endometrial biopsies (<xref ref-type=\"fig\" rid=\"fig06\">Fig. 6</xref>B; <italic>n</italic> = 9) where a 47&#x02013;50 kD band corresponding to the monomer of TREK-1 was observed. Owing to the similarities in size of TREK-1 and &#x003b2;-actin, gels were also run separately for each protein without blots being stripped and reprobed. A higher molecular weight &#x0223c;100 kD band, likely to be the dimeric form of the channel, was also frequently present (data not shown). The low levels of TREK-1 in proliferative phase endometrium, led us to examine whether progesterone might be driving TREK-1 down-regulation given its critical role in secretory endometrium. Confirmation of oestrogen (ERa and ERb) and progesterone receptor expression in Ishikawa cells was shown by Western blotting (data not shown). Overnight incubation of Ishikawa cells in 10<sup>&#x02212;12</sup>&#x02013;10<sup>&#x02212;6</sup> M progesterone, corresponding to high circulating levels of the steroid during the late phase of the menstrual cycle, was not associated with a significant down-regulation of TREK-1 protein (<xref ref-type=\"fig\" rid=\"fig06\">Fig. 6</xref>C). Expression of TWIK-2 protein was observed as a 37 kD band (<italic>n</italic> = 8), likely to be the TWIK-2 monomer (<xref ref-type=\"fig\" rid=\"fig06\">Fig. 6</xref>D). This protein band was absent when the immunoblot was incubated with pre-adsorbed anti-TWIK-2 antibody (<italic>n</italic> = 3; <xref ref-type=\"fig\" rid=\"fig06\">Fig. 6</xref>D).</p><fig id=\"fig06\" position=\"float\"><label>Fig. 6</label><caption><p>Protein expression of TREK-1 and TWIK-2 in human endometrium. Snap-frozen endometrium and freshly harvested Ishikawa cells were prepared for electrophoresis by homogenization or cell lysis respectively. Proteins were separated by SDS-PAGE using 10% gels followed by electroblotting and incubation overnight with the relevant TWIK-2 or TREK-1 primary antibody prior to chemiluminescent detection. (<bold>A</bold>) Ishikawa cells express TREK-1 seen as a 47 kD band. The lower trace is also a 47 kD band for &#x003b2;-actin that was visualized following stripping and reblotting of the membrane. (<bold>B</bold>) TREK-1 expression in snap-frozen human endometrial biopsies. (<bold>C</bold>) Ishikawa cells incubated at 10<sup>&#x02212;12</sup>&#x02013;10<sup>&#x02212;6</sup> M progesterone overnight produced no change in signal intensity for TREK-1 compared with control samples. &#x003b2;-actin in the lower trace was used as a positive control. (<bold>D</bold>) TWIK-2 protein was present in human endometrial biopsies. In peptide block experiments where the TWIK-2 antibody was blocked with a fivefold excess of peptide antigen, TWIK-2 signal was abolished (<italic>n</italic> = 3).</p></caption><graphic xlink:href=\"jcmm0017-0134-f6\"/></fig><p>Confocal immunofluorescence demonstrated TREK-1 localization to the cell membrane, cytosol and nuclei of both Ishikawa cells (<xref ref-type=\"fig\" rid=\"fig07\">Fig. 7</xref>A) and primary cultured epithelial cells (<xref ref-type=\"fig\" rid=\"fig07\">Fig. 7</xref>B). <xref ref-type=\"fig\" rid=\"fig07\">Figure 7</xref>A also shows the fine, filamentous, intracellular staining present in endometrial cells. Punctate TWIK-2 expression in Ishikawa epithelial cells was membrane-associated in the cell line (<xref ref-type=\"fig\" rid=\"fig07\">Fig. 7</xref>C) and primary cultures (<xref ref-type=\"fig\" rid=\"fig07\">Fig. 7</xref>D). Interestingly, TWIK-2 immunofluorescence localized to discrete areas located away from cell&#x02013;cell contacts implying a possible apical location <italic>in vivo</italic>.</p><fig id=\"fig07\" position=\"float\"><label>Fig. 7</label><caption><p>Confocal immunofluorescence of TWIK-2 and TREK-1 in cultured human endometrial cells and Ishikawa cells. Fixation was performed with paraformaldehyde followed by permeabilization then incubation in the relevant primary antibody. Immunofluorescence was localized using FITC-conjugated secondary antibody. Scale bar: 10 &#x003bc;M in (<bold>A</bold>), (<bold>B</bold>) and (<bold>C</bold>), but 20 &#x003bc;M for (<bold>D</bold>). (A) Localization of TREK-1 to intracellular filaments, nuclei and cytosol is clearly evident in cultured endometrium. (B) Ishikawa cells express TREK-1 within nuclei and cytosol. (C) TWIK-2 immunostaining was punctate and membrane bound using Ishikawa cells. Inset shows a bright-filed image of cells sampled. (D) Primary cultures prepared from human endometrium express TWIK-2 on membranes but not nuclei. In some cases, TWIK-2 immunofluorescence was localized to membrane areas not in contact with other cells (white arrows).</p></caption><graphic xlink:href=\"jcmm0017-0134-f7\"/></fig><p>Higher potassium channel activation has been implicated in the control of cell proliferation, a key function underlying the endometrial regeneration during the proliferative phase of the cycle when epithelial and stromal cell division is maximal. A panel of drugs shown to inhibit various K2P channels was employed to ascertain effects on cell proliferation. Compared with control, untreated cells, methanandamide (<xref ref-type=\"fig\" rid=\"fig08\">Fig. 8</xref>A) and lidoocaine (<xref ref-type=\"fig\" rid=\"fig08\">Fig. 8</xref>B) inhibited proliferation, respectively, by 82% and 91% inhibition at 120 hrs <italic>in vitro</italic> in a concentration-dependent fashion. Antiproliferative effects of zinc were apparent at 96 hrs with maximal inhibition of 60% seen at 120 hrs (<xref ref-type=\"fig\" rid=\"fig08\">Fig. 8</xref>C). The TREK-1 blocker curcumin reduced proliferation by 44% at 120 hrs at the highest concentration tested (<xref ref-type=\"fig\" rid=\"fig08\">Fig. 8</xref>D), whereas L-methionine (<xref ref-type=\"fig\" rid=\"fig09\">Fig. 9</xref>A) and L-methioninol, blockers of stretch-dependent channels thought to be TREK-1, showed no effect (<italic>P</italic> &#x0003e; 0.05) on proliferation. As a role for BK<sub>Ca</sub> channels in proliferation has been reported and given significant single BK<sub>Ca</sub> channel activity in both Ishikawa and endometrial cells (data not shown), the effects of the BK<sub>Ca</sub> channel antagonist iberiotoxin (IbTX) were tested demonstrating a small yet significant (&#x0003c;20%; <italic>P</italic> &#x0003c; 0.05) antiproliferative effect observable at 72 and 120 hrs (<xref ref-type=\"fig\" rid=\"fig09\">Fig. 9</xref>B).</p><fig id=\"fig08\" position=\"float\"><label>Fig. 8</label><caption><p>Two-pore Potassium channel blockers inhibited cell proliferation of the Ishikawa cell line. For cell proliferation assays, 2500 cells were incubated in a 96-well plate. Following a serum-starvation period of 24 hrs, drugs were added on the following day and cell proliferation measured as cell viability using the MTS assay, assessed daily at the same time over 5 days. Background absorbance was deducted from all wells and a change in proliferation at various concentrations of drug plotted against absorbance. (<bold>A</bold>) Methanandamide significantly inhibited cell proliferation at 120 hrs by 82%. (<bold>B</bold>) Lidocaine had antiproliferative effects that were observed as early as 72 hrs in 1 and 3 mM. (<bold>C</bold>) Zinc caused dose-dependent inhibition of proliferation by a maximum of 60% at 120 hrs compared with control. (<bold>D</bold>) Curcumin had concentration-dependent inhibitory effects on endometrial proliferation, achieving 44% at 120 hrs.</p></caption><graphic xlink:href=\"jcmm0017-0134-f8\"/></fig><fig id=\"fig09\" position=\"float\"><label>Fig. 9</label><caption><p>Proliferation and electrophysiology of K2P currents in endometrial epithelia. (<bold>A</bold>) The stretch-dependent channel inhibitor L-methionine had no effect on Ishikawa cell proliferation. (<bold>B</bold>) The maxiK blocker IbTX had only a minimal effect on endometrial cell proliferation. Patch-clamp recordings were made from freshly dispersed and cultured endometrial cells. (<bold>C</bold>) Whole-cell recordings were made in PSS containing 10 mM TEA and 5 mM 4-AP added to the bath to block voltage-gated K<sup>+</sup> channels to record from K2P channels. Outward currents were apparent for all voltages from &#x02212;60 to +50 mV. Currents had a rapid onset and were sustained for the duration of the test pulse. Two representative current families are shown from the Ishikawa cells (top) and freshly dispersed endometrial epithelia. (<bold>D</bold>) Reducing pH of the extracellular bathing solution (PSS) from 7.4 to 6.6 produced a reduction at all voltages of outward current in the presence of TEA and 4-AP (<italic>n</italic> = 4). (<bold>E</bold>) Outside-out patches formed after WCR recording typically expressed two types of single channels; a small conductance channel that was constitutively active and characterized by a conductance of 30 pS (<italic>n</italic> = 5) along with a larger channel with a unitary conductance of &#x0223c;80 pS (<italic>n</italic> = 4). Both types are present in this representative patch held at a voltage of +50 mV in a quasi-physiological gradient.</p></caption><graphic xlink:href=\"jcmm0017-0134-f9\"/></fig><p>Whole-cell current-clamp electrophysiological investigations demonstrated that freshly dispersed endometrial epithelial cells were characterized by a mean resting membrane potential of &#x02212;42.5 &#x000b1; 5.7 mV (<italic>n</italic> = 9), a value not significantly different (<italic>P</italic> &#x0003e; 0.05) from the &#x02212;39.3 &#x000b1; 4.2 mV (<italic>n</italic> = 7) recorded from Ishikawa cells.</p><p>Because of the lack of potent and specific blockers of K2P channels, and given the reported insensitivity of several K2P channels to TEA and 4-AP, K2P current was isolated by carrying out whole-cell voltage-clamp experiments in the presence of TEA and 4-AP. The predominant current profiles observed on changing the holding voltage from &#x02212;60 to +50 mV, consisted of a rapidly activating sustained outward current (<xref ref-type=\"fig\" rid=\"fig09\">Fig. 9</xref>C) similar to Ishikawa cells (<xref ref-type=\"fig\" rid=\"fig09\">Fig. 9</xref>D) producing a current&#x02013;voltage relationship exhibiting little rectification. For freshly isolated endometrial cells, when the pH of the extracellular bathing solution was reduced from a pH of 7.4 (control) to 6.6, a significant decrease in whole-cell current amplitude was evident at steady-state at voltages above &#x02212;10 mV. However, the small sample size meant it was not possible to correlate whole-cell current profiles with cycle-dependent characteristics. Stable outside-out patches were obtained on cessation of whole-cell recording with the majority of patches predominantly silent owing to the presence of TEA and 4-AP in the bathing solution. However, intermittent channel activity characterized by two distinct channel types of 15&#x02013;25 pS and &#x0223c;80 pS was apparent but not characterized further although the smaller conductance channel appeared to be constitutively active.</p></sec><sec sec-type=\"discussion\"><title>Discussion</title><p>We report the presence of a variety of K2P channels in human endometrial tissue samples obtained from women of reproductive age and in the Ishikawa endometrial cancer cell line. Our findings demonstrate mRNA expression for the main K2P channel subtypes TWIK, TREK, TASK, THIK and TALK in normal, cycling human endometrium. This finding is consistent with molecular expression of K2P channels in epithelia of taste buds [<xref ref-type=\"bibr\" rid=\"b17\">17</xref>], airways [<xref ref-type=\"bibr\" rid=\"b18\">18</xref>&#x02013;<xref ref-type=\"bibr\" rid=\"b20\">20</xref>], gastrointestinal mucosa [<xref ref-type=\"bibr\" rid=\"b21\">21</xref>] and human nephron [<xref ref-type=\"bibr\" rid=\"b22\">22</xref>]. In relation to reproductive physiology, various K2P channels have been reported in sperm [<xref ref-type=\"bibr\" rid=\"b23\">23</xref>] and blastocysts [<xref ref-type=\"bibr\" rid=\"b24\">24</xref>] where culturing mouse zygotes in media supplemented with K2P blockers or using siRNA to knockdown KCNK expression significantly inhibited mouse blastocyst formation [<xref ref-type=\"bibr\" rid=\"b24\">24</xref>]. Virtually undetectable levels of TRAAK expression in the cell line mirror low expression in peripheral organs compared with the brain where TRAAK is highly expressed [<xref ref-type=\"bibr\" rid=\"b14\">14</xref>, <xref ref-type=\"bibr\" rid=\"b25\">25</xref>]. In contrast, the presence of TRAAK mRNA in endometrial biopsies was higher than in Ishikawa cells possibly related to TRAAK channels as targets of arachidonic acid in the endometrium where it is a substrate for prostaglandin biosynthesis in bringing about menstruation. Evidence for THIK (halothane-sensitive) channel mRNA is consistent with high copy number of the gene encoding THIK, <italic>KCNK13</italic>, in proliferative phase endometrium [<xref ref-type=\"bibr\" rid=\"b8\">8</xref>], but further studies are needed to ascertain its function. The presence of TALK mRNA hints at a potential mechanism whereby the endometrium is able to detect and regulate alkalinity of the reproductive tract. Given that bicarbonate levels are high in uterine fluid and essential for sperm capacitation [<xref ref-type=\"bibr\" rid=\"b26\">26</xref>], a combination of TALK and TASK channels will enable the endometrium to respond appropriately to fluctuating pH.</p><p>The endometrium is a type of secretory epithelium that undergoes significant changes to both form and function as it progresses through the menstrual cycle suggesting temporal expression of K2P channels. We therefore sought to quantitate TWIK-2 and TREK-1 mRNA levels as the former is expressed in the periphery whereas TREK-1 appears to be modulated by many factors that change throughout the menstrual cycle. The low transcript levels observed for TREK-1 in human endometrial biopsies were not associated with a decrease in TREK-1 protein implying that TREK-1 protein turnover is low as has been noted previously for this channel in odontoblasts [<xref ref-type=\"bibr\" rid=\"b27\">27</xref>]. Moreover, TREK-1 expression, evidently abundant in the CNS, is relatively low in peripheral tissues [<xref ref-type=\"bibr\" rid=\"b25\">25</xref>]. As endometrial biopsies are heterogenous in composition, consisting of a highly vascularized stroma as well as leucocytes, it is difficult to identify with certainty the nature of the cells expressing TREK-1. It should be noted that progesterone regulation of TREK-1 channels was assessed in the Ishikawa cell line and although it may be a suitable experimental model in which to study epithelial function, this cell line does not replicate characteristics of normal, cycling endometrium and is therefore of limited value.</p><p>Endometrial TREK-1 protein was identified as a 47 kD monomer consistent with its predicted band size from earlier observations [<xref ref-type=\"bibr\" rid=\"b28\">28</xref>&#x02013;<xref ref-type=\"bibr\" rid=\"b30\">30</xref>], but is at variance with reports of a 90 and 60 kD TREK-1 protein in reproductive tissues [<xref ref-type=\"bibr\" rid=\"b31\">31</xref>, <xref ref-type=\"bibr\" rid=\"b32\">32</xref>]. In common with its localization in myometrium [<xref ref-type=\"bibr\" rid=\"b31\">31</xref>], placental cytotrophoblasts [<xref ref-type=\"bibr\" rid=\"b32\">32</xref>], endothelium [<xref ref-type=\"bibr\" rid=\"b33\">33</xref>] keratinocytes [<xref ref-type=\"bibr\" rid=\"b34\">34</xref>] and prostate cancer cells [<xref ref-type=\"bibr\" rid=\"b35\">35</xref>], immunofluorescence for endometrial TREK-1 was observed in the cell membrane, cytoplasm and nuclei. This could be because of the lack of commercial antibodies with high specificity for the TREK-1 epitope although TREK-1 staining has been linked with axonal transport and protein trafficking [<xref ref-type=\"bibr\" rid=\"b28\">28</xref>]. Voloshyna <italic>et al.,</italic> propose that the nuclear localization observed when TREK-1 is overexpressed in prostate cancer influences cell proliferation [<xref ref-type=\"bibr\" rid=\"b35\">35</xref>]. Our finding that progesterone did not lead to reduced TREK-1 expression implies additional regulatory mechanisms governing molecular expression of this channel. Recently, a truncated TREK1 splice variant, TREK1&#x00394;Ex4, has been shown to interfere with the trafficking of wild-type TREK-1 to the membrane, thus causing a functional down-regulation manifest as a decrease in TREK-1 current [<xref ref-type=\"bibr\" rid=\"b36\">36</xref>]. Although determined in the brain, this mechanism of alternative translation initiation adds to other postulated mechanisms that use K<sup>+</sup> channel binding partners to regulate trafficking and surface expression of K2P channel subunits and requires investigation in non-excitable cells.</p><p>No evidence from our study was found to support differential TWIK-2 mRNA expression between the proliferative and secretory phases. Davis and Cowley [<xref ref-type=\"bibr\" rid=\"b18\">18</xref>] have shown apical TWIK-2 channel expression in human airway Calu-3 cells where the channel facilitates anion secretion. The cellular localization of TWIK-2 to the apical surface has also recently been confirmed in normal human bronchial epithelium where blockade of TWIK-2 channels with either bupivacaine or quinidine inhibited sodium absorption through ENaC and forskolin-induced anion secretion [<xref ref-type=\"bibr\" rid=\"b20\">20</xref>]. Although the culture model used in our study did not maintain epithelial cell polarity, culturing cells directly on a substrate that faithfully replicates 3D structure, in parallel with studies of short-circuit current flow, would aid in clarifying the role of TWIK-2 in relation to electrolyte transport across apical and basolateral aspects of endometrial epithelia.</p><p>Opening of K<sup>+</sup> channels underlies cell volume changes accompanying proliferation by mediating the progression of various cell types from the G1 to the S phase of the cell cycle enabling cellular hyperpolarization through K<sup>+</sup> efflux [<xref ref-type=\"bibr\" rid=\"b37\">37</xref>, <xref ref-type=\"bibr\" rid=\"b38\">38</xref>]. Despite the presence of a multitude of mammalian voltage- and ligand-gated K<sup>+</sup> channels, only TASK-3 [<xref ref-type=\"bibr\" rid=\"b39\">39</xref>] and TREK-1 [<xref ref-type=\"bibr\" rid=\"b35\">35</xref>, <xref ref-type=\"bibr\" rid=\"b40\">40</xref>] of the K2P channels have definitively been linked to cell proliferation. The inhibition of endometrial epithelial cell proliferation by the K2P channel blockers lidocaine [<xref ref-type=\"bibr\" rid=\"b41\">41</xref>], methanadamide [<xref ref-type=\"bibr\" rid=\"b42\">42</xref>] and zinc [<xref ref-type=\"bibr\" rid=\"b43\">43</xref>] point to the involvement of TASK channels in the proliferative process given their oncogenic potential [<xref ref-type=\"bibr\" rid=\"b39\">39</xref>, <xref ref-type=\"bibr\" rid=\"b44\">44</xref>]. The inhibitory effects of methanandamide through TASK blockade do not exclude antiproliferative effects <italic>via</italic> endometrial cannabinoid receptor blockade [<xref ref-type=\"bibr\" rid=\"b45\">45</xref>], although no change in CB1 or CB2 receptor density with the menstrual cycle has been noted [<xref ref-type=\"bibr\" rid=\"b45\">45</xref>]. Nor is there any evidence to date to support cannabinoid receptor involvement in endometrial proliferation. Zinc has dual effects, blocking TASK-2, TASK-3 and TWIK-2 channels yet also activates TREK-1 and TREK-2 [<xref ref-type=\"bibr\" rid=\"b43\">43</xref>]; with these opposing effects, it is difficult to discern the precise target of action of this divalent cation. The action of lidocaine would likely be through TASK-2 channels that are categorized as alkaline sensitive and exhibit properties similar to TALK channels.</p><p>Endometrial cell proliferation was also reduced by curcumin which inhibits bovine TREK-1 channels resulting in cortisol secretion from the adrenal gland [<xref ref-type=\"bibr\" rid=\"b46\">46</xref>]. Curcumin has an antiproliferative effect in prostate cell lines [<xref ref-type=\"bibr\" rid=\"b47\">47</xref>] with possible links to prostate cancer [<xref ref-type=\"bibr\" rid=\"b35\">35</xref>]. Thus, we propose that it is likely that TASK channels, but possibly also TREK-1, have a role to play in endometrial epithelial cell proliferation. An anti-apoptotic role for TREK-1 [<xref ref-type=\"bibr\" rid=\"b48\">48</xref>] which would favour a proliferative phenotype, consistent with the process of endometrial regeneration following menstruation, has been postulated. Indeed, apoptosis increases in the endometrium during the late secretory phase [<xref ref-type=\"bibr\" rid=\"b49\">49</xref>] where we also determined mRNA levels for TREK-1 to be at their lowest. Hyperpolarization in several cell types is associated with mitogenic effects mediated <italic>via</italic> G1/S cell-cycle progression [<xref ref-type=\"bibr\" rid=\"b37\">37</xref>] and is a potential function of K2P channels, recognized for their role in the generation of a background, leak current. Linking membrane potential through K2P channels with proliferation and/or apoptosis is complex and influenced by many factors that likely include intracellular calcium and chloride concentrations, cell-cycle stage and checkpoint proteins (<italic>e.g</italic>. cyclins). The nuclear localization of TREK-1 that we and others [<xref ref-type=\"bibr\" rid=\"b35\">35</xref>] have reported is intriguing and does not exclude indirect TREK-1 modulation of molecular mechanisms, notably gene transcription with subsequent downstream effects on cell proliferation.</p><p>Two-pore potassium channels are notoriously difficult to study in native cells given the lack of pharmacological agents that lack the specificity to dissect channel function but also the possibility of redundancy whereby leak channels may be able to compensate for others owing to their shared functions.</p><p>A recent report has implicated BK<sub>Ca</sub> channels in endometrial receptivity and embryo implantation based on reduced rates of implantation, and down-regulation of factors such as nuclear factor-&#x003ba;B, induced by knockdown of the BK<sub>Ca</sub> channel [<xref ref-type=\"bibr\" rid=\"b50\">50</xref>]. We observed only a small but significant role for BK<sub>Ca</sub> in cell proliferation, although our single-channel recordings have shown the BK<sub>Ca</sub> to be one of the most active channels in endometrial epithelium (RN Khan, unpublished observations).</p><p>The regulation of endometrial whole-cell currents by extracellular pH is an interesting phenomenon. In the female reproductive tract, pH of human uterine fluid, produced by endometrial epithelia fluctuates between 6.6 and 7.6 and is stage-dependent, tending towards acidic around the time of ovulation [<xref ref-type=\"bibr\" rid=\"b51\">51</xref>]. Following coitus, uterine fluid is rendered alkaline which is conducive to maintaining sperm motility while a low pH is hostile to sperm activation and therefore conception. In our experiments, acidic pH reduced the whole-cell outward K<sup>+</sup> conductance at all voltages which would tend to depolarize the cell. As our protocol blocked voltage-gated channels and only TASK channels of the K2P superfamily are responsive to extracellular acidic pH, we postulate that TASK channels are putative sensors linking pH with membrane potential in the endometrium. Gardener <italic>et al.,</italic> [<xref ref-type=\"bibr\" rid=\"b33\">33</xref>] working with rat mesenteric and pulmonary arteries argue in favour of TASK-1 channels mediating the membrane potential response to pH. The conductance of the channel we observed is within the range of values reported for K2P channels [<xref ref-type=\"bibr\" rid=\"b10\">10</xref>] although further electrophysiological characterization of these channels is necessary before they can be identified definitively as belonging to the K2P family. Although these data are preliminary, the fact that endometrial epithelial cells generate outward currents that have a sustained activation, display sensitivity to pH and are not blocked by TEA or 4-AP suggests that these currents are carried by K2P channels and may have an important physiological function in the setting of endometrial cell membrane potential.</p><p>The endometrium is unique in terms of the sheer magnitude and frequency of proliferation it undergoes through a woman\\'s reproductive life solely in anticipation of supporting pregnancy. Although we exercised great care in only including patients with a clear menstrual history that met our criteria, future, detailed investigations of ion channel expression and regulation will require sampling of endometrial biopsies with greater rigour. For example, we assigned samples to either proliferative or secretory phase. In reality, these stages are further divisible into early, mid and late stages based on histological dating of endometrial biopsies. Analysis in this sequential fashion will allow us to determine more robustly the role of K2P channels in cellular and molecular mechanisms linked to reproductive events and their potential utility in the management of fertility.</p><p>In terms of the clinical relevance of our findings, endometrial thickness, measured by ultrasound, is arguably, one of the most reliable indicators, to date, of successful pregnancy outcome following IVF [<xref ref-type=\"bibr\" rid=\"b52\">52</xref>]. Our data indicating that blockade of TASK and TREK channels inhibits proliferation may underlie some cases of female infertility where an inadequate (thin) endometrial lining may arise <italic>via</italic> dysfunction or aberrant expression of K<sup>+</sup> channels such that cell division and endometrial remodelling is suboptimal consequently proving detrimental to implantation. Moreover, altered membrane potential responses induced by acidification in normal endometrium reported here and, considering the impact of pH and ionic gradients in the female reproductive tract on fertilization rate [<xref ref-type=\"bibr\" rid=\"b4\">4</xref>], we suggest that the acid-base balance of the female reproductive tract is an important determinant of pregnancy rates. To our knowledge, with the exception of fertility treatments where embryo quality is optimized through tight control of pH and culture conditions, investigations of pH shift with the menstrual cycle, and correlation with reproductive outcome have not been performed yet constitute relatively simple measures to explore unexplained infertility. As a longer term clinical goal, our findings highlight the prospect of endometrial ion channels as potential non-steroidal contraceptive drug targets. In summary, our data provide new evidence for TREK-1 and TASK channel expression and their roles in endometrial epithelial cell proliferation. Evidence in favour of a contribution of TREK-1 in proliferative phase endometrium is corroborated by its higher expression during this period and our finding that the TREK-1 modulators curcumin and zinc modify cell proliferation. Lidocaine, zinc and methanandamide as inhibitors of TASK channels is further proof of K2P channel involvement in proliferation. Direct pH regulation of K<sup>+</sup> currents in endometrial epithelia implies that either TASK-1 and/or TASK-3 channels mediate this response. The control of fertility remains an important goal in reproductive medicine. Despite celebrated advances in reproductive technologies, our meagre understanding of the human endometrium and the fact that idiopathic infertility accounts for over one third of infertility will benefit from detailed analysis of endometrial K2P channels and their clinical application as potential targets through which to modify fertility and reproductive outcome.</p></sec></body><back><ack><p>We are grateful to the theatre staff at the Royal Derby Hospital for facilitating collection of endometrial biopsies. This study was funded by the University of Nottingham.</p></ack><sec><title>Conflict of interest</title><p>The authors confirm that there are no conflicts of interest.</p></sec><ref-list><title>References</title><ref id=\"b1\"><label>1</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Richard</surname><given-names>C</given-names></name><name><surname>Gao</surname><given-names>J</given-names></name><name><surname>Brown</surname><given-names>N</given-names></name><etal/></person-group><article-title>Aquaporin water channel genes are differentially expressed and regulated by ovarian steroids during the periimplantation period in the mouse</article-title><source>Endocrinology</source><year>2003</year><volume>144</volume><fpage>1533</fpage><lpage>41</lpage><pub-id pub-id-type=\"pmid\">12639938</pub-id></element-citation></ref><ref id=\"b2\"><label>2</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Casslen</surname><given-names>B</given-names></name><name><surname>Nilsson</surname><given-names>B</given-names></name></person-group><article-title>Human uterine fluid, examined in undiluted samples for osmolarity and the concentrations of inorganic ions, albumin, glucose, and urea</article-title><source>Am J Obstet Gynecol</source><year>1984</year><volume>150</volume><fpage>877</fpage><lpage>81</lpage><pub-id pub-id-type=\"pmid\">6507514</pub-id></element-citation></ref><ref id=\"b3\"><label>3</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Matthews</surname><given-names>CJ</given-names></name><name><surname>Thomas</surname><given-names>EJ</given-names></name><name><surname>Redfern</surname><given-names>CP</given-names></name><etal/></person-group><article-title>Ion transport by human endometrial epithelia <italic>in vitro</italic></article-title><source>Hum Reprod</source><year>1993</year><volume>8</volume><fpage>1570</fpage><lpage>5</lpage><pub-id pub-id-type=\"pmid\">8300809</pub-id></element-citation></ref><ref id=\"b4\"><label>4</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Roblero</surname><given-names>LS</given-names></name><name><surname>Guadarrama</surname><given-names>A</given-names></name><name><surname>Ortiz</surname><given-names>ME</given-names></name><etal/></person-group><article-title>High potassium concentration and the cumulus corona oocyte complex stimulate the fertilizing capacity of human spermatozoa</article-title><source>Fertil Steril</source><year>1990</year><volume>54</volume><fpage>328</fpage><lpage>32</lpage><pub-id pub-id-type=\"pmid\">2379632</pub-id></element-citation></ref><ref id=\"b5\"><label>5</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Warth</surname><given-names>R</given-names></name></person-group><article-title>Potassium channels in epithelial transport</article-title><source>Pflugers Arch</source><year>2003</year><volume>446</volume><fpage>505</fpage><lpage>13</lpage><pub-id pub-id-type=\"pmid\">12707775</pub-id></element-citation></ref><ref id=\"b6\"><label>6</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Zheng</surname><given-names>XY</given-names></name><name><surname>Chen</surname><given-names>GA</given-names></name><name><surname>Wang</surname><given-names>HY</given-names></name></person-group><article-title>Expression of cystic fibrosis transmembrane conductance regulator in human endometrium</article-title><source>Hum Reprod</source><year>2004</year><volume>19</volume><fpage>2933</fpage><lpage>41</lpage></element-citation></ref><ref id=\"b7\"><label>7</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Kao</surname><given-names>LC</given-names></name><name><surname>Tulac</surname><given-names>S</given-names></name><name><surname>Lobo</surname><given-names>S</given-names></name><etal/></person-group><article-title>Global gene profiling in human endometrium during the window of implantation</article-title><source>Endocrinology</source><year>2002</year><volume>143</volume><fpage>2119</fpage><lpage>38</lpage><pub-id pub-id-type=\"pmid\">12021176</pub-id></element-citation></ref><ref id=\"b8\"><label>8</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Talbi</surname><given-names>S</given-names></name><name><surname>Hamilton</surname><given-names>AE</given-names></name><name><surname>Vo</surname><given-names>KC</given-names></name><etal/></person-group><article-title>Molecular phenotyping of human endometrium distinguishes menstrual cycle phases and underlying biological processes in normo-ovulatory women</article-title><source>Endocrinology</source><year>2006</year><volume>147</volume><fpage>1097</fpage><lpage>121</lpage><pub-id pub-id-type=\"pmid\">16306079</pub-id></element-citation></ref><ref id=\"b9\"><label>9</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Lesage</surname><given-names>F</given-names></name><name><surname>Guillemare</surname><given-names>E</given-names></name><name><surname>Fink</surname><given-names>M</given-names></name><etal/></person-group><article-title>TWIK-1, a ubiquitous human weakly inward rectifying K<sup>+</sup> channel with a novel structure</article-title><source>EMBO J</source><year>1996</year><volume>15</volume><fpage>1004</fpage><lpage>11</lpage><pub-id pub-id-type=\"pmid\">8605869</pub-id></element-citation></ref><ref id=\"b10\"><label>10</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Lesage</surname><given-names>F</given-names></name><name><surname>Lazdunski</surname><given-names>M</given-names></name></person-group><article-title>Molecular and functional properties of two-pore-domain potassium channels</article-title><source>Am J Physiol Renal Physiol</source><year>2000</year><volume>279</volume><fpage>F793</fpage><lpage>801</lpage><pub-id pub-id-type=\"pmid\">11053038</pub-id></element-citation></ref><ref id=\"b11\"><label>11</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Bayliss</surname><given-names>DA</given-names></name><name><surname>Barrett</surname><given-names>PQ</given-names></name></person-group><article-title>Emerging roles for two-pore-domain potassium channels and their potential therapeutic impact</article-title><source>Trends Pharmacol Sci</source><year>2008</year><volume>29</volume><fpage>566</fpage><lpage>75</lpage><pub-id pub-id-type=\"pmid\">18823665</pub-id></element-citation></ref><ref id=\"b12\"><label>12</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Chavez</surname><given-names>RA</given-names></name><name><surname>Gray</surname><given-names>AT</given-names></name><name><surname>Zhao</surname><given-names>BB</given-names></name><etal/></person-group><article-title>TWIK-2, a new weak inward rectifying member of the tandem pore domain potassium channel family</article-title><source>J Biol Chem</source><year>1999</year><volume>274</volume><fpage>7887</fpage><lpage>92</lpage><pub-id pub-id-type=\"pmid\">10075682</pub-id></element-citation></ref><ref id=\"b13\"><label>13</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Meadows</surname><given-names>HJ</given-names></name><name><surname>Benham</surname><given-names>CD</given-names></name><name><surname>Cairns</surname><given-names>W</given-names></name><etal/></person-group><article-title>Cloning, localisation and functional expression of the human orthologue of the TREK-1 potassium channel</article-title><source>Pflugers Arch</source><year>2000</year><volume>439</volume><fpage>714</fpage><lpage>22</lpage><pub-id pub-id-type=\"pmid\">10784345</pub-id></element-citation></ref><ref id=\"b14\"><label>14</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Lesage</surname><given-names>F</given-names></name><name><surname>Maingret</surname><given-names>F</given-names></name><name><surname>Lazdunski</surname><given-names>M</given-names></name></person-group><article-title>Cloning and expression of human TRAAK, a polyunsaturated fatty acids-activated and mechano-sensitive K<sup>+</sup> channel</article-title><source>FEBS Lett</source><year>2000</year><volume>471</volume><fpage>137</fpage><lpage>40</lpage></element-citation></ref><ref id=\"b15\"><label>15</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Duprat</surname><given-names>F</given-names></name><name><surname>Lesage</surname><given-names>F</given-names></name><name><surname>Fink</surname><given-names>M</given-names></name><etal/></person-group><article-title>TASK, a human background K<sup>+</sup> channel to sense external pH variations near physiological pH</article-title><source>EMBO J</source><year>1997</year><volume>16</volume><fpage>5464</fpage><lpage>71</lpage><pub-id pub-id-type=\"pmid\">9312005</pub-id></element-citation></ref><ref id=\"b16\"><label>16</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Chanrachakul</surname><given-names>B</given-names></name><name><surname>Pipkin</surname><given-names>FB</given-names></name><name><surname>Khan</surname><given-names>RN</given-names></name></person-group><article-title>Contribution of coupling between human myometrial beta2-adrenoreceptor and the BK<sub>Ca</sub> channel to uterine quiescence</article-title><source>Am J Physiol Cell Physiol</source><year>2004</year><volume>287</volume><fpage>C1747</fpage><lpage>52</lpage><pub-id pub-id-type=\"pmid\">15329337</pub-id></element-citation></ref><ref id=\"b17\"><label>17</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Richter</surname><given-names>TA</given-names></name><name><surname>Dvoryanchikov</surname><given-names>GA</given-names></name><name><surname>Chaudhari</surname><given-names>N</given-names></name><etal/></person-group><article-title>Acid-sensitive two-pore domain potassium (K2P) channels in mouse taste buds</article-title><source>J Neurophysiol</source><year>2004</year><volume>92</volume><fpage>1928</fpage><lpage>36</lpage><pub-id pub-id-type=\"pmid\">15140906</pub-id></element-citation></ref><ref id=\"b18\"><label>18</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Davis</surname><given-names>KA</given-names></name><name><surname>Cowley</surname><given-names>EA</given-names></name></person-group><article-title>Two-pore-domain potassium channels support anion secretion from human airway Calu-3 epithelial cells</article-title><source>Pflugers Arch</source><year>2006</year><volume>451</volume><fpage>631</fpage><lpage>41</lpage><pub-id pub-id-type=\"pmid\">16311719</pub-id></element-citation></ref><ref id=\"b19\"><label>19</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Inglis</surname><given-names>SK</given-names></name><name><surname>Brown</surname><given-names>SG</given-names></name><name><surname>Constable</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>A Ba<sup>2+</sup>-resistant, acid-sensitive K<sup>+</sup> conductance in Na<sup>+</sup>-absorbing H441 human airway epithelial cells</article-title><source>Am J Physiol Lung Cell Mol Physiol</source><year>2007</year><volume>292</volume><fpage>L1304</fpage><lpage>12</lpage><pub-id pub-id-type=\"pmid\">17277046</pub-id></element-citation></ref><ref id=\"b20\"><label>20</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Zhao</surname><given-names>KQ</given-names></name><name><surname>Xiong</surname><given-names>G</given-names></name><name><surname>Wilber</surname><given-names>M</given-names></name><etal/></person-group><article-title>A role for two-pore K<sup>+</sup> channels in modulating Na<sup>+</sup> absorption and Cl<sup>&#x02212;</sup> secretion in normal human bronchial epithelial cells</article-title><source>Am J Physiol Lung Cell Mol Physiol</source><year>2012</year><volume>302</volume><fpage>L4</fpage><lpage>12</lpage><pub-id pub-id-type=\"pmid\">21964404</pub-id></element-citation></ref><ref id=\"b21\"><label>21</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Kovacs</surname><given-names>I</given-names></name><name><surname>Pocsai</surname><given-names>K</given-names></name><name><surname>Czifra</surname><given-names>G</given-names></name><etal/></person-group><article-title>TASK-3 immunoreactivity shows differential distribution in the human gastrointestinal tract</article-title><source>Virchows Arch</source><year>2005</year><volume>446</volume><fpage>402</fpage><lpage>10</lpage><pub-id pub-id-type=\"pmid\">15789217</pub-id></element-citation></ref><ref id=\"b22\"><label>22</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Levy</surname><given-names>DI</given-names></name><name><surname>Velazquez</surname><given-names>H</given-names></name><name><surname>Goldstein</surname><given-names>SA</given-names></name><etal/></person-group><article-title>Segment-specific expression of 2P domain potassium channel genes in human nephron</article-title><source>Kidney Int</source><year>2004</year><volume>65</volume><fpage>918</fpage><lpage>26</lpage><pub-id pub-id-type=\"pmid\">14871411</pub-id></element-citation></ref><ref id=\"b23\"><label>23</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Chow</surname><given-names>GE</given-names></name><name><surname>Muller</surname><given-names>CH</given-names></name><name><surname>Curnow</surname><given-names>EC</given-names></name><etal/></person-group><article-title>Expression of two-pore domain potassium channels in nonhuman primate sperm</article-title><source>Fertil Steril</source><year>2007</year><volume>87</volume><fpage>397</fpage><lpage>404</lpage><pub-id pub-id-type=\"pmid\">17067589</pub-id></element-citation></ref><ref id=\"b24\"><label>24</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Hur</surname><given-names>CG</given-names></name><name><surname>Kim</surname><given-names>EJ</given-names></name><name><surname>Cho</surname><given-names>SK</given-names></name><etal/></person-group><article-title>K<sup>+</sup> efflux through two-pore domain K<sup>+</sup> channels is required for mouse embryonic development</article-title><source>Reproduction</source><year>2012</year><volume>143</volume><fpage>625</fpage><lpage>36</lpage><pub-id pub-id-type=\"pmid\">22419831</pub-id></element-citation></ref><ref id=\"b25\"><label>25</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Medhurst</surname><given-names>AD</given-names></name><name><surname>Rennie</surname><given-names>G</given-names></name><name><surname>Chapman</surname><given-names>CG</given-names></name><etal/></person-group><article-title>Distribution analysis of human two pore domain potassium channels in tissues of the central nervous system and periphery</article-title><source>Brain Res Mol Brain Res</source><year>2001</year><volume>86</volume><fpage>101</fpage><lpage>14</lpage><pub-id pub-id-type=\"pmid\">11165377</pub-id></element-citation></ref><ref id=\"b26\"><label>26</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Harrison</surname><given-names>RA</given-names></name><name><surname>Gadella</surname><given-names>BM</given-names></name></person-group><article-title>Bicarbonate-induced membrane processing in sperm capacitation</article-title><source>Theriogenology</source><year>2005</year><volume>63</volume><fpage>342</fpage><lpage>51</lpage><pub-id pub-id-type=\"pmid\">15626403</pub-id></element-citation></ref><ref id=\"b27\"><label>27</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Magloire</surname><given-names>H</given-names></name><name><surname>Lesage</surname><given-names>F</given-names></name><name><surname>Couble</surname><given-names>ML</given-names></name><etal/></person-group><article-title>Expression and localization of TREK-1 K<sup>+</sup> channels in human odontoblasts</article-title><source>J Dent Res</source><year>2003</year><volume>82</volume><fpage>542</fpage><lpage>5</lpage><pub-id pub-id-type=\"pmid\">12821716</pub-id></element-citation></ref><ref id=\"b28\"><label>28</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Bearzatto</surname><given-names>B</given-names></name><name><surname>Lesage</surname><given-names>F</given-names></name><name><surname>Reyes</surname><given-names>R</given-names></name><etal/></person-group><article-title>Axonal transport of TREK and TRAAK potassium channels in rat sciatic nerves</article-title><source>NeuroReport</source><year>2000</year><volume>11</volume><fpage>927</fpage><lpage>30</lpage><pub-id pub-id-type=\"pmid\">10790857</pub-id></element-citation></ref><ref id=\"b29\"><label>29</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Blondeau</surname><given-names>N</given-names></name><name><surname>Petrault</surname><given-names>O</given-names></name><name><surname>Manta</surname><given-names>S</given-names></name><etal/></person-group><article-title>Polyunsaturated fatty acids are cerebral vasodilators <italic>via</italic> the TREK-1 potassium channel</article-title><source>Circ Res</source><year>2007</year><volume>101</volume><fpage>176</fpage><lpage>84</lpage><pub-id pub-id-type=\"pmid\">17556656</pub-id></element-citation></ref><ref id=\"b30\"><label>30</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Terrenoire</surname><given-names>C</given-names></name><name><surname>Lauritzen</surname><given-names>I</given-names></name><name><surname>Lesage</surname><given-names>F</given-names></name><etal/></person-group><article-title>A TREK-1-like potassium channel in atrial cells inhibited by beta-adrenergic stimulation and activated by volatile anesthetics</article-title><source>Circ Res</source><year>2001</year><volume>89</volume><fpage>336</fpage><lpage>42</lpage></element-citation></ref><ref id=\"b31\"><label>31</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Bai</surname><given-names>X</given-names></name><name><surname>Bugg</surname><given-names>GJ</given-names></name><name><surname>Greenwood</surname><given-names>SL</given-names></name><etal/></person-group><article-title>Expression of TASK and TREK, two-pore domain K<sup>+</sup> channels, in human myometrium</article-title><source>Reproduction</source><year>2005</year><volume>129</volume><fpage>525</fpage><lpage>30</lpage><pub-id pub-id-type=\"pmid\">15798028</pub-id></element-citation></ref><ref id=\"b32\"><label>32</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Bai</surname><given-names>X</given-names></name><name><surname>Greenwood</surname><given-names>SL</given-names></name><name><surname>Glazier</surname><given-names>JD</given-names></name><etal/></person-group><article-title>Localization of TASK and TREK, two-pore domain K<sup>+</sup> channels, in human cytotrophoblast cells</article-title><source>J Soc Gynecol Investig</source><year>2005</year><volume>12</volume><fpage>77</fpage><lpage>83</lpage></element-citation></ref><ref id=\"b33\"><label>33</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Gardener</surname><given-names>MJ</given-names></name><name><surname>Johnson</surname><given-names>IT</given-names></name><name><surname>Burnham</surname><given-names>MP</given-names></name><etal/></person-group><article-title>Functional evidence of a role for two-pore domain potassium channels in rat mesenteric and pulmonary arteries</article-title><source>Br J Pharmacol</source><year>2004</year><volume>142</volume><fpage>192</fpage><lpage>202</lpage><pub-id pub-id-type=\"pmid\">15066906</pub-id></element-citation></ref><ref id=\"b34\"><label>34</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Kang</surname><given-names>D</given-names></name><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Hwang</surname><given-names>EM</given-names></name><etal/></person-group><article-title>Expression of thermosensitive two-pore domain K<sup>+</sup> channels in human keratinocytes cell line HaCaT cells</article-title><source>Experimental Dermatol</source><year>2007</year><volume>16</volume><fpage>1016</fpage><lpage>22</lpage></element-citation></ref><ref id=\"b35\"><label>35</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Voloshyna</surname><given-names>I</given-names></name><name><surname>Besana</surname><given-names>A</given-names></name><name><surname>Castillo</surname><given-names>M</given-names></name><etal/></person-group><article-title>TREK-1 is a novel molecular target in prostate cancer</article-title><source>Cancer Res</source><year>2008</year><volume>68</volume><fpage>1197</fpage><lpage>203</lpage><pub-id pub-id-type=\"pmid\">18281496</pub-id></element-citation></ref><ref id=\"b36\"><label>36</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Veale</surname><given-names>EL</given-names></name><name><surname>Rees</surname><given-names>KA</given-names></name><name><surname>Mathie</surname><given-names>A</given-names></name><etal/></person-group><article-title>Dominant negative effects of a non-conducting TREK1 splice variant expressed in brain</article-title><source>J Biol Chem</source><year>2010</year><volume>285</volume><fpage>29295</fpage><lpage>304</lpage><pub-id pub-id-type=\"pmid\">20605797</pub-id></element-citation></ref><ref id=\"b37\"><label>37</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Wonderlin</surname><given-names>WF</given-names></name><name><surname>Strobl</surname><given-names>JS</given-names></name></person-group><article-title>Potassium channels, proliferation and G1 progression</article-title><source>J Membr Biol</source><year>1996</year><volume>154</volume><fpage>91</fpage><lpage>107</lpage><pub-id pub-id-type=\"pmid\">8929284</pub-id></element-citation></ref><ref id=\"b38\"><label>38</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Lang</surname><given-names>F</given-names></name><name><surname>Ritter</surname><given-names>M</given-names></name><name><surname>Gamper</surname><given-names>N</given-names></name><etal/></person-group><article-title>Cell volume in the regulation of cell proliferation and apoptotic cell death</article-title><source>Cell PhysiolBiochem</source><year>2000</year><volume>10</volume><fpage>417</fpage><lpage>28</lpage></element-citation></ref><ref id=\"b39\"><label>39</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Mu</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><etal/></person-group><article-title>Genomic amplification and oncogenic properties of the KCNK9 potassium channel gene</article-title><source>Cancer Cell</source><year>2003</year><volume>3</volume><fpage>297</fpage><lpage>302</lpage><pub-id pub-id-type=\"pmid\">12676587</pub-id></element-citation></ref><ref id=\"b40\"><label>40</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Schwingshackl</surname><given-names>A</given-names></name><name><surname>Teng</surname><given-names>B</given-names></name><name><surname>Ghosh</surname><given-names>M</given-names></name><etal/></person-group><article-title>Regulation and function of the two-pore-domain (K2P) potassium channel TREK-1 in alveolar epithelial cells</article-title><source>Am J Physiol Lung Cell Mol Physiol</source><year>2012</year><volume>302</volume><fpage>L93</fpage><lpage>102</lpage><pub-id pub-id-type=\"pmid\">21949155</pub-id></element-citation></ref><ref id=\"b41\"><label>41</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Kindler</surname><given-names>CH</given-names></name><name><surname>Paul</surname><given-names>M</given-names></name><name><surname>Zou</surname><given-names>H</given-names></name><etal/></person-group><article-title>Amide local anesthetics potently inhibit the human tandem pore domain background K<sup>+</sup> channel TASK-2 <italic>(KCNK5)</italic></article-title><source>J Pharmacol Exp Ther</source><year>2003</year><volume>306</volume><fpage>84</fpage><lpage>92</lpage><pub-id pub-id-type=\"pmid\">12660311</pub-id></element-citation></ref><ref id=\"b42\"><label>42</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Veale</surname><given-names>EL</given-names></name><name><surname>Buswell</surname><given-names>R</given-names></name><name><surname>Clarke</surname><given-names>CE</given-names></name><etal/></person-group><article-title>Identification of a region in the TASK3 two pore domain potassium channel that is critical for its blockade by methanandamide</article-title><source>Br J Pharmacol</source><year>2007</year><volume>152</volume><fpage>778</fpage><lpage>86</lpage><pub-id pub-id-type=\"pmid\">17828294</pub-id></element-citation></ref><ref id=\"b43\"><label>43</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Gruss</surname><given-names>M</given-names></name><name><surname>Mathie</surname><given-names>A</given-names></name><name><surname>Lieb</surname><given-names>WR</given-names></name><etal/></person-group><article-title>The two-pore-domain K<sup>+</sup> channels TREK-1 and TASK-3 are differentially modulated by copper and zinc</article-title><source>Mol Pharmacol</source><year>2004</year><volume>66</volume><fpage>530</fpage><lpage>7</lpage><pub-id pub-id-type=\"pmid\">15322244</pub-id></element-citation></ref><ref id=\"b44\"><label>44</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Pei</surname><given-names>L</given-names></name><name><surname>Wiser</surname><given-names>O</given-names></name><name><surname>Slavin</surname><given-names>A</given-names></name><etal/></person-group><article-title>Oncogenic potential of TASK3 <italic>(KCNK9)</italic> depends on K<sup>+</sup> channel function</article-title><source>Proc Natl Acad Sci USA</source><year>2003</year><volume>100</volume><fpage>7803</fpage><lpage>7</lpage><pub-id pub-id-type=\"pmid\">12782791</pub-id></element-citation></ref><ref id=\"b45\"><label>45</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Taylor</surname><given-names>AH</given-names></name><name><surname>Abbas</surname><given-names>MS</given-names></name><name><surname>Habiba</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Histomorphometric evaluation of cannabinoid receptor and anandamide modulating enzyme expression in the human endometrium through the menstrual cycle</article-title><source>Histochem Cell Biol</source><year>2010</year><volume>133</volume><fpage>557</fpage><lpage>65</lpage><pub-id pub-id-type=\"pmid\">20369362</pub-id></element-citation></ref><ref id=\"b46\"><label>46</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Enyeart</surname><given-names>JA</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Enyeart</surname><given-names>JJ</given-names></name></person-group><article-title>Curcumin inhibits bTREK-1 K<sup>+</sup> channels and stimulates cortisol secretion from adrenocortical cells</article-title><source>Biochem Biophys Res Commun</source><year>2008</year><volume>370</volume><fpage>623</fpage><lpage>8</lpage><pub-id pub-id-type=\"pmid\">18406348</pub-id></element-citation></ref><ref id=\"b47\"><label>47</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Mukhopadhyay</surname><given-names>A</given-names></name><name><surname>Bueso-Ramos</surname><given-names>C</given-names></name><name><surname>Chatterjee</surname><given-names>D</given-names></name><etal/></person-group><article-title>Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines</article-title><source>Oncogene</source><year>2001</year><volume>20</volume><fpage>7597</fpage><lpage>609</lpage></element-citation></ref><ref id=\"b48\"><label>48</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Lang-Lazdunski</surname><given-names>L</given-names></name><name><surname>Heurteaux</surname><given-names>C</given-names></name><name><surname>Mignon</surname><given-names>A</given-names></name><etal/></person-group><article-title>Ischemic spinal cord injury induced by aortic cross-clamping: prevention by riluzole</article-title><source>Eur J Cardio Thorac Surg</source><year>2000</year><volume>18</volume><fpage>174</fpage><lpage>81</lpage></element-citation></ref><ref id=\"b49\"><label>49</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Harada</surname><given-names>T</given-names></name><name><surname>Kaponis</surname><given-names>A</given-names></name><name><surname>Iwabe</surname><given-names>T</given-names></name><etal/></person-group><article-title>Apoptosis in human endometrium and endometriosis</article-title><source>Human Reprod Update</source><year>2004</year><volume>10</volume><fpage>29</fpage><lpage>38</lpage></element-citation></ref><ref id=\"b50\"><label>50</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Zhang</surname><given-names>RJ</given-names></name><name><surname>Zou</surname><given-names>LB</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name><etal/></person-group><article-title>Functional expression of large-conductance calcium-activated potassium channels in human endometrium: a novel mechanism involved in endometrial receptivity and embryo implantation</article-title><source>J Clin Endocrinol Metab</source><year>2012</year><volume>97</volume><fpage>543</fpage><lpage>53</lpage><pub-id pub-id-type=\"pmid\">22170720</pub-id></element-citation></ref><ref id=\"b51\"><label>51</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Feo</surname><given-names>LG</given-names></name></person-group><article-title>The pH of the human uterine cavity, <italic>in situ</italic></article-title><source>Am J Obstet Gynecol</source><year>1955</year><volume>70</volume><fpage>60</fpage><lpage>4</lpage><pub-id pub-id-type=\"pmid\">14388063</pub-id></element-citation></ref><ref id=\"b52\"><label>52</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Richter</surname><given-names>KS</given-names></name><name><surname>Bugge</surname><given-names>KR</given-names></name><name><surname>Bromer</surname><given-names>JG</given-names></name><etal/></person-group><article-title>Relationship between endometrial thickness and embryo implantation, based on 1,294 cycles of <italic>in vitro</italic> fertilization with transfer of two blastocyst-stage embryos</article-title><source>Fertil Steril</source><year>2007</year><volume>87</volume><fpage>53</fpage><lpage>9</lpage><pub-id pub-id-type=\"pmid\">17081537</pub-id></element-citation></ref></ref-list></back></article>',\n",
       " '<full-text-retrieval-response xmlns=\"http://www.elsevier.com/xml/svapi/article/dtd\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\" xmlns:prism=\"http://prismstandard.org/namespaces/basic/2.0/\" xmlns:dcterms=\"http://purl.org/dc/terms/\" xmlns:dc=\"http://purl.org/dc/elements/1.1/\" xmlns:xocs=\"http://www.elsevier.com/xml/xocs/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:tb=\"http://www.elsevier.com/xml/common/table/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" xmlns:ja=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns:cals=\"http://www.elsevier.com/xml/common/cals/dtd\" xmlns:bk=\"http://www.elsevier.com/xml/bk/dtd\"><coredata><prism:url>https://api.elsevier.com/content/article/pii/S0005273613002964</prism:url><dc:identifier>doi:10.1016/j.bbamem.2013.08.017</dc:identifier><eid>1-s2.0-S0005273613002964</eid><prism:doi>10.1016/j.bbamem.2013.08.017</prism:doi><pii>S0005-2736(13)00296-4</pii><dc:title>Viral channel proteins in intracellular protein–protein communication: Vpu of HIV-1, E5 of HPV16 and p7 of HCV </dc:title><prism:publicationName>Biochimica et Biophysica Acta (BBA) - Biomembranes</prism:publicationName><prism:aggregationType>Journal</prism:aggregationType><pubType>Review</pubType><prism:issn>00052736</prism:issn><prism:volume>1838</prism:volume><prism:issueIdentifier>4</prism:issueIdentifier><prism:startingPage>1113</prism:startingPage><prism:endingPage>1121</prism:endingPage><prism:pageRange>1113-1121</prism:pageRange><prism:number>4</prism:number><dc:format>text/xml</dc:format><prism:coverDate>2014-04-30</prism:coverDate><prism:coverDisplayDate>April 2014</prism:coverDisplayDate><prism:copyright>Copyright © 2013 Elsevier B.V. All rights reserved.</prism:copyright><prism:publisher>Elsevier B.V.</prism:publisher><prism:issueName>Viral Membrane Proteins - Channels for Cellular Networking</prism:issueName><dc:creator>Fischer, Wolfgang B.</dc:creator><dc:creator>Li, Li-Hua</dc:creator><dc:creator>Mahato, Dhani Ram</dc:creator><dc:creator>Wang, Yi-Ting</dc:creator><dc:creator>Chen, Chin-Pei</dc:creator><dc:description>AbstractViral channel forming proteins are known for their capability to make the lipid membrane of the host cell and its subcellular compartments permeable to ions and small compounds. There is increasing evidence that some of the representatives of this class of proteins are also strongly interacting with host proteins and the effectiveness of this interaction seems to be high. Interaction of viral channel proteins with host factors has been proposed by bioinformatics approaches and has also been identified experimentally. An overview of the interactions with host proteins is given for Vpu from HIV-1, E5 from HPV-16 and p7 from HCV. This article is part of a Special Issue entitled: Viral Membrane Proteins — Channels for Cellular Networking.</dc:description><openaccess>1</openaccess><openaccessArticle>true</openaccessArticle><openaccessType>Full</openaccessType><openArchiveArticle>true</openArchiveArticle><openaccessSponsorName/><openaccessSponsorType>ElsevierBranded</openaccessSponsorType><openaccessUserLicense>http://www.elsevier.com/open-access/userlicense/1.0/</openaccessUserLicense><dcterms:subject>Viral-host protein–protein interaction</dcterms:subject><dcterms:subject>Viral channel proteins</dcterms:subject><dcterms:subject>Vpu of HIV-1</dcterms:subject><dcterms:subject>E5 of HPV16</dcterms:subject><dcterms:subject>p7 of HCV</dcterms:subject><link rel=\"self\" href=\"https://api.elsevier.com/content/article/pii/S0005273613002964\"/><link rel=\"scidir\" href=\"http://www.sciencedirect.com/science/article/pii/S0005273613002964\"/></coredata><objects><object ref=\"gr2\" category=\"high\" type=\"IMAGE-HIGH-RES\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"2274\" height=\"2872\" size=\"628542\">https://api.elsevier.com/content/object/eid/1-s2.0-S0005273613002964-gr2_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr1\" category=\"high\" type=\"IMAGE-HIGH-RES\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"1368\" height=\"2459\" size=\"632761\">https://api.elsevier.com/content/object/eid/1-s2.0-S0005273613002964-gr1_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref=\"fx1\" category=\"high\" type=\"IMAGE-HIGH-RES\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"1400\" height=\"886\" size=\"231050\">https://api.elsevier.com/content/object/eid/1-s2.0-S0005273613002964-fx1_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr2\" category=\"standard\" type=\"IMAGE-DOWNSAMPLED\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"513\" height=\"648\" size=\"68632\">https://api.elsevier.com/content/object/eid/1-s2.0-S0005273613002964-gr2.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr1\" category=\"standard\" type=\"IMAGE-DOWNSAMPLED\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"515\" height=\"926\" size=\"134541\">https://api.elsevier.com/content/object/eid/1-s2.0-S0005273613002964-gr1.jpg?httpAccept=%2A%2F%2A</object><object ref=\"fx1\" category=\"standard\" type=\"IMAGE-DOWNSAMPLED\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"316\" height=\"200\" size=\"28251\">https://api.elsevier.com/content/object/eid/1-s2.0-S0005273613002964-fx1.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr2\" category=\"thumbnail\" type=\"IMAGE-THUMBNAIL\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"130\" height=\"164\" size=\"4614\">https://api.elsevier.com/content/object/eid/1-s2.0-S0005273613002964-gr2.sml?httpAccept=%2A%2F%2A</object><object ref=\"gr1\" category=\"thumbnail\" type=\"IMAGE-THUMBNAIL\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"91\" height=\"164\" size=\"5667\">https://api.elsevier.com/content/object/eid/1-s2.0-S0005273613002964-gr1.sml?httpAccept=%2A%2F%2A</object><object ref=\"fx1\" category=\"thumbnail\" type=\"IMAGE-THUMBNAIL\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"219\" height=\"139\" size=\"7051\">https://api.elsevier.com/content/object/eid/1-s2.0-S0005273613002964-fx1.sml?httpAccept=%2A%2F%2A</object></objects><scopus-id>84895553393</scopus-id><scopus-eid>2-s2.0-84895553393</scopus-eid><pubmed-id>24035804</pubmed-id><link rel=\"abstract\" href=\"https://api.elsevier.com/content/abstract/scopus_id/84895553393\"/><originalText><xocs:doc xmlns:xoe=\"http://www.elsevier.com/xml/xoe/dtd\" xsi:schemaLocation=\"http://www.elsevier.com/xml/xocs/dtd http://be-prod3a/schema/dtds/document/fulltext/xcr/xocs-article.xsd\"><xocs:meta><xocs:content-family>serial</xocs:content-family><xocs:content-type>JL</xocs:content-type><xocs:cid>271033</xocs:cid><xocs:ssids><xocs:ssid type=\"alllist\">291210</xocs:ssid><xocs:ssid type=\"subj\">291847</xocs:ssid><xocs:ssid type=\"subj\">291849</xocs:ssid><xocs:ssid type=\"subj\">291852</xocs:ssid><xocs:ssid type=\"content\">31</xocs:ssid></xocs:ssids><xocs:srctitle>Biochimica et Biophysica Acta (BBA) - Biomembranes</xocs:srctitle><xocs:normalized-srctitle>BIOCHIMICAETBIOPHYSICAACTABBABIOMEMBRANES</xocs:normalized-srctitle><xocs:orig-load-date yyyymmdd=\"20130912\">2013-09-12</xocs:orig-load-date><xocs:available-online-date yyyymmdd=\"20130912\">2013-09-12</xocs:available-online-date><xocs:ew-transaction-id>2014-04-11T16:56:30</xocs:ew-transaction-id><xocs:eid>1-s2.0-S0005273613002964</xocs:eid><xocs:pii-formatted>S0005-2736(13)00296-4</xocs:pii-formatted><xocs:pii-unformatted>S0005273613002964</xocs:pii-unformatted><xocs:doi>10.1016/j.bbamem.2013.08.017</xocs:doi><xocs:item-stage>S300</xocs:item-stage><xocs:item-version-number>S300.2</xocs:item-version-number><xocs:item-weight>FULL-TEXT</xocs:item-weight><xocs:hub-eid>1-s2.0-S0005273614X00027</xocs:hub-eid><xocs:timestamp yyyymmdd=\"20150513\">2015-05-13T23:34:30.267603-04:00</xocs:timestamp><xocs:dco>0</xocs:dco><xocs:tomb>0</xocs:tomb><xocs:date-search-begin>20140401</xocs:date-search-begin><xocs:date-search-end>20140430</xocs:date-search-end><xocs:year-nav>2014</xocs:year-nav><xocs:indexeddate epoch=\"1378944000\">2013-09-12T00:00:00Z</xocs:indexeddate><xocs:articleinfo>articleinfo crossmark dco dateupdated tomb dateloaded datesearch indexeddate issuelist volumelist yearnav absattachment articletitlenorm authfirstinitialnorm authfirstsurnamenorm cid cids confeditor contenttype copyright dateloadedtxt docsubtype doctype doi eid ewtransactionid hubeid issfirst issn issnnorm itemstage itemtransactionid itemweight openaccess openarchive pg pgfirst pglast pii piinorm pubdateend pubdatestart pubdatetxt pubyr sectiontitle sortorder srctitle srctitlenorm srctype subheadings vol volfirst volissue webpdf webpdfpagecount figure table body acknowledge affil articletitle auth authfirstini authfull authkeywords authlast highlightsabst primabst pubtype ref specialabst alllist content subj ssids</xocs:articleinfo><xocs:issns><xocs:issn-primary-formatted>0005-2736</xocs:issn-primary-formatted><xocs:issn-primary-unformatted>00052736</xocs:issn-primary-unformatted></xocs:issns><xocs:crossmark is-crossmark=\"1\">true</xocs:crossmark><xocs:vol-first>1838</xocs:vol-first><xocs:volume-list><xocs:volume>1838</xocs:volume></xocs:volume-list><xocs:iss-first>4</xocs:iss-first><xocs:issue-list><xocs:issue>4</xocs:issue></xocs:issue-list><xocs:vol-iss-suppl-text>Volume 1838, Issue 4</xocs:vol-iss-suppl-text><xocs:sort-order>10</xocs:sort-order><xocs:first-fp>1113</xocs:first-fp><xocs:last-lp>1121</xocs:last-lp><xocs:pages><xocs:first-page>1113</xocs:first-page><xocs:last-page>1121</xocs:last-page></xocs:pages><xocs:cover-date-orig><xocs:start-date>201404</xocs:start-date></xocs:cover-date-orig><xocs:cover-date-text>April 2014</xocs:cover-date-text><xocs:cover-date-start>2014-04-01</xocs:cover-date-start><xocs:cover-date-end>2014-04-30</xocs:cover-date-end><xocs:cover-date-year>2014</xocs:cover-date-year><xocs:title-editors-groups><xocs:title-editors-group><ce:title>Viral Membrane Proteins - Channels for Cellular Networking</ce:title><ce:editors><ce:author-group><ce:author><ce:degrees>Prof.</ce:degrees><ce:given-name>Wolfgang B.</ce:given-name><ce:surname>Fischer</ce:surname><ce:degrees>PhD</ce:degrees></ce:author><ce:affiliation><ce:textfn>National Yang-Ming University</ce:textfn></ce:affiliation></ce:author-group></ce:editors></xocs:title-editors-group></xocs:title-editors-groups><xocs:hub-sec><xocs:hub-sec-title>Interactions</xocs:hub-sec-title></xocs:hub-sec><xocs:document-type>article</xocs:document-type><xocs:document-subtype>rev</xocs:document-subtype><xocs:copyright-line>Copyright © 2013 Elsevier B.V. All rights reserved.</xocs:copyright-line><xocs:normalized-article-title>VIRALCHANNELPROTEINSININTRACELLULARPROTEINPROTEINCOMMUNICATIONVPUHIV1E5HPV16P7HCV</xocs:normalized-article-title><xocs:normalized-first-auth-surname>FISCHER</xocs:normalized-first-auth-surname><xocs:normalized-first-auth-initial>W</xocs:normalized-first-auth-initial><xocs:item-toc><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>1</xocs:item-toc-label><xocs:item-toc-section-title>Introduction</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>2</xocs:item-toc-label><xocs:item-toc-section-title>Vpu of human immunodeficiency virus type 1</xocs:item-toc-section-title><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>2.1</xocs:item-toc-label><xocs:item-toc-section-title>Interaction with CD4</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>2.2</xocs:item-toc-label><xocs:item-toc-section-title>Interaction with TASK</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>2.3</xocs:item-toc-label><xocs:item-toc-section-title>Interaction with BST-2</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>2.4</xocs:item-toc-label><xocs:item-toc-section-title>Interaction with NTB-A</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>2.5</xocs:item-toc-label><xocs:item-toc-section-title>Interaction with CD74</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>2.6</xocs:item-toc-label><xocs:item-toc-section-title>Interaction with TPR</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>2.7</xocs:item-toc-label><xocs:item-toc-section-title>Motifs for protein–protein interaction in Vpu</xocs:item-toc-section-title></xocs:item-toc-entry></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>3</xocs:item-toc-label><xocs:item-toc-section-title>E5 of human papillomavirus 16</xocs:item-toc-section-title><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>3.1</xocs:item-toc-label><xocs:item-toc-section-title>Interaction with 16<ce:hsp sp=\"0.25\"/>kDa protein</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>3.2</xocs:item-toc-label><xocs:item-toc-section-title>Interaction with HLA-I</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>3.3</xocs:item-toc-label><xocs:item-toc-section-title>Interaction with growth factors EGFR and ErB4</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>3.4</xocs:item-toc-label><xocs:item-toc-section-title>Promoting perinuclear fusion of membrane koilocytosis</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>3.5</xocs:item-toc-label><xocs:item-toc-section-title>ER transport protein, gap junctions and others</xocs:item-toc-section-title></xocs:item-toc-entry></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>4</xocs:item-toc-label><xocs:item-toc-section-title>p7 of hepatitis C virus</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>5</xocs:item-toc-label><xocs:item-toc-section-title>Conclusion</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:acknowledgment\"><xocs:item-toc-section-title>Acknowledgement</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:bibliography\"><xocs:item-toc-section-title>References</xocs:item-toc-section-title></xocs:item-toc-entry></xocs:item-toc><xocs:references><xocs:ref-info refid=\"rf0005\"><xocs:ref-normalized-surname>FISCHER</xocs:ref-normalized-surname><xocs:ref-pub-year>2002</xocs:ref-pub-year><xocs:ref-first-fp>27</xocs:ref-first-fp><xocs:ref-last-lp>45</xocs:ref-last-lp><xocs:ref-normalized-initial>W</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0010\"><xocs:ref-normalized-surname>FISCHER</xocs:ref-normalized-surname><xocs:ref-pub-year>2012</xocs:ref-pub-year><xocs:ref-first-fp>259</xocs:ref-first-fp><xocs:ref-last-lp>321</xocs:ref-last-lp><xocs:ref-normalized-initial>W</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0015\"><xocs:ref-normalized-surname>GONZALES</xocs:ref-normalized-surname><xocs:ref-pub-year>2003</xocs:ref-pub-year><xocs:ref-first-fp>28</xocs:ref-first-fp><xocs:ref-last-lp>34</xocs:ref-last-lp><xocs:ref-normalized-initial>M</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0020\"><xocs:ref-normalized-surname>NIEVA</xocs:ref-normalized-surname><xocs:ref-pub-year>2012</xocs:ref-pub-year><xocs:ref-first-fp>563</xocs:ref-first-fp><xocs:ref-last-lp>574</xocs:ref-last-lp><xocs:ref-normalized-initial>J</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0025\"><xocs:ref-normalized-surname>CARRASCO</xocs:ref-normalized-surname><xocs:ref-pub-year>1995</xocs:ref-pub-year><xocs:ref-first-fp>61</xocs:ref-first-fp><xocs:ref-last-lp>112</xocs:ref-last-lp><xocs:ref-normalized-initial>L</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0030\"><xocs:ref-normalized-surname>WANG</xocs:ref-normalized-surname><xocs:ref-pub-year>2010</xocs:ref-pub-year><xocs:ref-first-fp>510</xocs:ref-first-fp><xocs:ref-last-lp>515</xocs:ref-last-lp><xocs:ref-normalized-initial>K</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0035\"><xocs:ref-normalized-surname>SCHUBERT</xocs:ref-normalized-surname><xocs:ref-pub-year>1996</xocs:ref-pub-year><xocs:ref-first-fp>12</xocs:ref-first-fp><xocs:ref-last-lp>18</xocs:ref-last-lp><xocs:ref-normalized-initial>U</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0040\"><xocs:ref-normalized-surname>COADY</xocs:ref-normalized-surname><xocs:ref-pub-year>1998</xocs:ref-pub-year><xocs:ref-first-fp>39</xocs:ref-first-fp><xocs:ref-last-lp>49</xocs:ref-last-lp><xocs:ref-normalized-initial>M</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0045\"><xocs:ref-normalized-surname>WILLEY</xocs:ref-normalized-surname><xocs:ref-pub-year>1992</xocs:ref-pub-year><xocs:ref-first-fp>7193</xocs:ref-first-fp><xocs:ref-last-lp>7200</xocs:ref-last-lp><xocs:ref-normalized-initial>R</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0050\"><xocs:ref-normalized-surname>SCHUBERT</xocs:ref-normalized-surname><xocs:ref-pub-year>1994</xocs:ref-pub-year><xocs:ref-first-fp>2260</xocs:ref-first-fp><xocs:ref-last-lp>2272</xocs:ref-last-lp><xocs:ref-normalized-initial>U</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0055\"><xocs:ref-normalized-surname>WETHERILL</xocs:ref-normalized-surname><xocs:ref-pub-year>2012</xocs:ref-pub-year><xocs:ref-first-fp>5341</xocs:ref-first-fp><xocs:ref-last-lp>5351</xocs:ref-last-lp><xocs:ref-normalized-initial>L</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0060\"><xocs:ref-normalized-surname>STREBEL</xocs:ref-normalized-surname><xocs:ref-pub-year>1988</xocs:ref-pub-year><xocs:ref-first-fp>1221</xocs:ref-first-fp><xocs:ref-last-lp>1223</xocs:ref-last-lp><xocs:ref-normalized-initial>K</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0065\"><xocs:ref-normalized-surname>COHEN</xocs:ref-normalized-surname><xocs:ref-pub-year>1988</xocs:ref-pub-year><xocs:ref-first-fp>532</xocs:ref-first-fp><xocs:ref-last-lp>534</xocs:ref-last-lp><xocs:ref-normalized-initial>E</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0070\"><xocs:ref-normalized-surname>EWART</xocs:ref-normalized-surname><xocs:ref-pub-year>1996</xocs:ref-pub-year><xocs:ref-first-fp>7108</xocs:ref-first-fp><xocs:ref-last-lp>7115</xocs:ref-last-lp><xocs:ref-normalized-initial>G</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0075\"><xocs:ref-normalized-surname>MEHNERT</xocs:ref-normalized-surname><xocs:ref-pub-year>2007</xocs:ref-pub-year><xocs:ref-first-fp>589</xocs:ref-first-fp><xocs:ref-last-lp>596</xocs:ref-last-lp><xocs:ref-normalized-initial>T</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0080\"><xocs:ref-normalized-surname>MEHNERT</xocs:ref-normalized-surname><xocs:ref-pub-year>2008</xocs:ref-pub-year><xocs:ref-first-fp>1488</xocs:ref-first-fp><xocs:ref-last-lp>1497</xocs:ref-last-lp><xocs:ref-normalized-initial>T</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0085\"><xocs:ref-normalized-surname>GONZALES</xocs:ref-normalized-surname><xocs:ref-pub-year>1998</xocs:ref-pub-year><xocs:ref-first-fp>13710</xocs:ref-first-fp><xocs:ref-last-lp>13719</xocs:ref-last-lp><xocs:ref-normalized-initial>M</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0090\"><xocs:ref-normalized-surname>BOLDUAN</xocs:ref-normalized-surname><xocs:ref-pub-year>2011</xocs:ref-pub-year><xocs:ref-first-fp>75</xocs:ref-first-fp><xocs:ref-last-lp>85</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0095\"><xocs:ref-normalized-surname>GRICE</xocs:ref-normalized-surname><xocs:ref-pub-year>1997</xocs:ref-pub-year><xocs:ref-first-fp>299</xocs:ref-first-fp><xocs:ref-last-lp>304</xocs:ref-last-lp><xocs:ref-normalized-initial>A</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0100\"><xocs:ref-normalized-surname>PATARGIAS</xocs:ref-normalized-surname><xocs:ref-pub-year>2009</xocs:ref-pub-year><xocs:ref-first-fp>1</xocs:ref-first-fp><xocs:ref-last-lp>12</xocs:ref-last-lp><xocs:ref-normalized-initial>G</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0105\"><xocs:ref-normalized-surname>CORDES</xocs:ref-normalized-surname><xocs:ref-pub-year>2002</xocs:ref-pub-year><xocs:ref-first-fp>7359</xocs:ref-first-fp><xocs:ref-last-lp>7365</xocs:ref-last-lp><xocs:ref-normalized-initial>F</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0110\"><xocs:ref-normalized-surname>LOPEZ</xocs:ref-normalized-surname><xocs:ref-pub-year>2002</xocs:ref-pub-year><xocs:ref-first-fp>1259</xocs:ref-first-fp><xocs:ref-last-lp>1267</xocs:ref-last-lp><xocs:ref-normalized-initial>C</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0115\"><xocs:ref-normalized-surname>LI</xocs:ref-normalized-surname><xocs:ref-pub-year>2013</xocs:ref-pub-year><xocs:ref-first-fp>517</xocs:ref-first-fp><xocs:ref-last-lp>529</xocs:ref-last-lp><xocs:ref-normalized-initial>L</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0120\"><xocs:ref-normalized-surname>BOUR</xocs:ref-normalized-surname><xocs:ref-pub-year>1995</xocs:ref-pub-year><xocs:ref-first-fp>1510</xocs:ref-first-fp><xocs:ref-last-lp>1520</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0585\"><xocs:ref-normalized-surname>BLANCHET</xocs:ref-normalized-surname><xocs:ref-pub-year>2012</xocs:ref-pub-year><xocs:ref-first-fp>307</xocs:ref-first-fp><xocs:ref-last-lp>314</xocs:ref-last-lp><xocs:ref-normalized-initial>F</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0125\"><xocs:ref-normalized-surname>MARGOTTIN</xocs:ref-normalized-surname><xocs:ref-pub-year>1998</xocs:ref-pub-year><xocs:ref-first-fp>565</xocs:ref-first-fp><xocs:ref-last-lp>574</xocs:ref-last-lp><xocs:ref-normalized-initial>F</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0130\"><xocs:ref-normalized-surname>SCHUBERT</xocs:ref-normalized-surname><xocs:ref-pub-year>1996</xocs:ref-pub-year><xocs:ref-first-fp>809</xocs:ref-first-fp><xocs:ref-last-lp>819</xocs:ref-last-lp><xocs:ref-normalized-initial>U</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0135\"><xocs:ref-normalized-surname>CHEN</xocs:ref-normalized-surname><xocs:ref-pub-year>1993</xocs:ref-pub-year><xocs:ref-first-fp>3877</xocs:ref-first-fp><xocs:ref-last-lp>3884</xocs:ref-last-lp><xocs:ref-normalized-initial>M</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0140\"><xocs:ref-normalized-surname>SHIN</xocs:ref-normalized-surname><xocs:ref-pub-year>1991</xocs:ref-pub-year><xocs:ref-first-fp>10658</xocs:ref-first-fp><xocs:ref-last-lp>10665</xocs:ref-last-lp><xocs:ref-normalized-initial>J</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0145\"><xocs:ref-normalized-surname>WITTLICH</xocs:ref-normalized-surname><xocs:ref-pub-year>2010</xocs:ref-pub-year><xocs:ref-first-fp>122</xocs:ref-first-fp><xocs:ref-last-lp>127</xocs:ref-last-lp><xocs:ref-normalized-initial>M</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0150\"><xocs:ref-normalized-surname>TIGANOS</xocs:ref-normalized-surname><xocs:ref-pub-year>1997</xocs:ref-pub-year><xocs:ref-first-fp>4452</xocs:ref-first-fp><xocs:ref-last-lp>4460</xocs:ref-last-lp><xocs:ref-normalized-initial>E</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0155\"><xocs:ref-normalized-surname>WRAY</xocs:ref-normalized-surname><xocs:ref-pub-year>1995</xocs:ref-pub-year><xocs:ref-first-fp>35</xocs:ref-first-fp><xocs:ref-last-lp>43</xocs:ref-last-lp><xocs:ref-normalized-initial>V</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0160\"><xocs:ref-normalized-surname>FEDERAU</xocs:ref-normalized-surname><xocs:ref-pub-year>1996</xocs:ref-pub-year><xocs:ref-first-fp>297</xocs:ref-first-fp><xocs:ref-last-lp>310</xocs:ref-last-lp><xocs:ref-normalized-initial>T</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0165\"><xocs:ref-normalized-surname>WILLBOLD</xocs:ref-normalized-surname><xocs:ref-pub-year>1997</xocs:ref-pub-year><xocs:ref-first-fp>581</xocs:ref-first-fp><xocs:ref-last-lp>588</xocs:ref-last-lp><xocs:ref-normalized-initial>D</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0170\"><xocs:ref-normalized-surname>COADOU</xocs:ref-normalized-surname><xocs:ref-pub-year>2002</xocs:ref-pub-year><xocs:ref-first-fp>23</xocs:ref-first-fp><xocs:ref-last-lp>40</xocs:ref-last-lp><xocs:ref-normalized-initial>G</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0175\"><xocs:ref-normalized-surname>MARASSI</xocs:ref-normalized-surname><xocs:ref-pub-year>1999</xocs:ref-pub-year><xocs:ref-first-fp>14336</xocs:ref-first-fp><xocs:ref-last-lp>14341</xocs:ref-last-lp><xocs:ref-normalized-initial>F</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0180\"><xocs:ref-normalized-surname>HENKLEIN</xocs:ref-normalized-surname><xocs:ref-pub-year>2000</xocs:ref-pub-year><xocs:ref-first-fp>220</xocs:ref-first-fp><xocs:ref-last-lp>224</xocs:ref-last-lp><xocs:ref-normalized-initial>P</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0185\"><xocs:ref-normalized-surname>HSU</xocs:ref-normalized-surname><xocs:ref-pub-year>2004</xocs:ref-pub-year><xocs:ref-first-fp>259</xocs:ref-first-fp><xocs:ref-last-lp>267</xocs:ref-last-lp><xocs:ref-normalized-initial>K</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0190\"><xocs:ref-normalized-surname>HSU</xocs:ref-normalized-surname><xocs:ref-pub-year>2010</xocs:ref-pub-year><xocs:ref-first-fp>1718</xocs:ref-first-fp><xocs:ref-last-lp>1725</xocs:ref-last-lp><xocs:ref-normalized-initial>K</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0195\"><xocs:ref-normalized-surname>HERRERO</xocs:ref-normalized-surname><xocs:ref-pub-year>2013</xocs:ref-pub-year><xocs:ref-first-fp>171</xocs:ref-first-fp><xocs:ref-last-lp>177</xocs:ref-last-lp><xocs:ref-normalized-initial>L</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0200\"><xocs:ref-normalized-surname>VANDAMME</xocs:ref-normalized-surname><xocs:ref-pub-year>2008</xocs:ref-pub-year><xocs:ref-first-fp>1</xocs:ref-first-fp><xocs:ref-last-lp>8</xocs:ref-last-lp><xocs:ref-normalized-initial>N</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0205\"><xocs:ref-normalized-surname>NEIL</xocs:ref-normalized-surname><xocs:ref-pub-year>2008</xocs:ref-pub-year><xocs:ref-first-fp>425</xocs:ref-first-fp><xocs:ref-last-lp>431</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0210\"><xocs:ref-normalized-surname>EVANS</xocs:ref-normalized-surname><xocs:ref-pub-year>2010</xocs:ref-pub-year><xocs:ref-first-fp>388</xocs:ref-first-fp><xocs:ref-last-lp>396</xocs:ref-last-lp><xocs:ref-normalized-initial>D</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0215\"><xocs:ref-normalized-surname>DUBE</xocs:ref-normalized-surname><xocs:ref-pub-year>2010</xocs:ref-pub-year><xocs:ref-first-fp>e1000856</xocs:ref-first-fp><xocs:ref-normalized-initial>M</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0220\"><xocs:ref-normalized-surname>MCNATT</xocs:ref-normalized-surname><xocs:ref-pub-year>2013</xocs:ref-pub-year><xocs:ref-first-fp>e1003299</xocs:ref-first-fp><xocs:ref-normalized-initial>M</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0225\"><xocs:ref-normalized-surname>KUPZIG</xocs:ref-normalized-surname><xocs:ref-pub-year>2003</xocs:ref-pub-year><xocs:ref-first-fp>694</xocs:ref-first-fp><xocs:ref-last-lp>709</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0230\"><xocs:ref-normalized-surname>MIYAKAWA</xocs:ref-normalized-surname><xocs:ref-pub-year>2012</xocs:ref-pub-year><xocs:ref-first-fp>ra73</xocs:ref-first-fp><xocs:ref-normalized-initial>K</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0235\"><xocs:ref-normalized-surname>SKASKO</xocs:ref-normalized-surname><xocs:ref-pub-year>2011</xocs:ref-pub-year><xocs:ref-first-fp>65</xocs:ref-first-fp><xocs:ref-last-lp>77</xocs:ref-last-lp><xocs:ref-normalized-initial>M</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0240\"><xocs:ref-normalized-surname>ZHOU</xocs:ref-normalized-surname><xocs:ref-pub-year>2012</xocs:ref-pub-year><xocs:ref-first-fp>1288</xocs:ref-first-fp><xocs:ref-last-lp>1296</xocs:ref-last-lp><xocs:ref-normalized-initial>J</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0245\"><xocs:ref-normalized-surname>SKASKO</xocs:ref-normalized-surname><xocs:ref-pub-year>2012</xocs:ref-pub-year><xocs:ref-first-fp>58</xocs:ref-first-fp><xocs:ref-last-lp>67</xocs:ref-last-lp><xocs:ref-normalized-initial>M</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0250\"><xocs:ref-normalized-surname>LV</xocs:ref-normalized-surname><xocs:ref-pub-year>2011</xocs:ref-pub-year><xocs:ref-first-fp>e20890</xocs:ref-first-fp><xocs:ref-normalized-initial>M</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0255\"><xocs:ref-normalized-surname>SOWRIRAJAN</xocs:ref-normalized-surname><xocs:ref-pub-year>2011</xocs:ref-pub-year><xocs:ref-first-fp>1091</xocs:ref-first-fp><xocs:ref-last-lp>1111</xocs:ref-last-lp><xocs:ref-normalized-initial>B</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0260\"><xocs:ref-normalized-surname>SHAH</xocs:ref-normalized-surname><xocs:ref-pub-year>2010</xocs:ref-pub-year><xocs:ref-first-fp>397</xocs:ref-first-fp><xocs:ref-last-lp>409</xocs:ref-last-lp><xocs:ref-normalized-initial>A</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0265\"><xocs:ref-normalized-surname>KERKAU</xocs:ref-normalized-surname><xocs:ref-pub-year>1997</xocs:ref-pub-year><xocs:ref-first-fp>1295</xocs:ref-first-fp><xocs:ref-last-lp>1305</xocs:ref-last-lp><xocs:ref-normalized-initial>T</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0270\"><xocs:ref-normalized-surname>HUSSAIN</xocs:ref-normalized-surname><xocs:ref-pub-year>2008</xocs:ref-pub-year><xocs:ref-first-fp>893</xocs:ref-first-fp><xocs:ref-last-lp>902</xocs:ref-last-lp><xocs:ref-normalized-initial>A</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0275\"><xocs:ref-normalized-surname>YEWDELL</xocs:ref-normalized-surname><xocs:ref-pub-year>2002</xocs:ref-pub-year><xocs:ref-first-fp>1019</xocs:ref-first-fp><xocs:ref-last-lp>1024</xocs:ref-last-lp><xocs:ref-normalized-initial>J</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0280\"><xocs:ref-normalized-surname>CALLAHAN</xocs:ref-normalized-surname><xocs:ref-pub-year>1998</xocs:ref-pub-year><xocs:ref-first-fp>5189</xocs:ref-first-fp><xocs:ref-last-lp>5197</xocs:ref-last-lp><xocs:ref-normalized-initial>M</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0285\"><xocs:ref-normalized-surname>EVANS</xocs:ref-normalized-surname><xocs:ref-pub-year>2009</xocs:ref-pub-year><xocs:ref-first-fp>27</xocs:ref-first-fp><xocs:ref-normalized-initial>P</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0290\"><xocs:ref-normalized-surname>GISSMANN</xocs:ref-normalized-surname><xocs:ref-pub-year>1984</xocs:ref-pub-year><xocs:ref-first-fp>265</xocs:ref-first-fp><xocs:ref-last-lp>288</xocs:ref-last-lp><xocs:ref-normalized-initial>L</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0590\"><xocs:ref-normalized-surname>ZURHAUSEN</xocs:ref-normalized-surname><xocs:ref-pub-year>1988</xocs:ref-pub-year><xocs:ref-first-fp>147</xocs:ref-first-fp><xocs:ref-last-lp>150</xocs:ref-last-lp><xocs:ref-normalized-initial>H</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0595\"><xocs:ref-normalized-surname>ZURHAUSEN</xocs:ref-normalized-surname><xocs:ref-pub-year>1989</xocs:ref-pub-year><xocs:ref-first-fp>4677</xocs:ref-first-fp><xocs:ref-last-lp>4681</xocs:ref-last-lp><xocs:ref-normalized-initial>H</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0295\"><xocs:ref-normalized-surname>SCHNEIDERGADICKE</xocs:ref-normalized-surname><xocs:ref-pub-year>1986</xocs:ref-pub-year><xocs:ref-first-fp>2285</xocs:ref-first-fp><xocs:ref-last-lp>2292</xocs:ref-last-lp><xocs:ref-normalized-initial>A</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0300\"><xocs:ref-normalized-surname>SMOTKIN</xocs:ref-normalized-surname><xocs:ref-pub-year>1986</xocs:ref-pub-year><xocs:ref-first-fp>4680</xocs:ref-first-fp><xocs:ref-last-lp>4684</xocs:ref-last-lp><xocs:ref-normalized-initial>D</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0305\"><xocs:ref-normalized-surname>LEECHANACHAI</xocs:ref-normalized-surname><xocs:ref-pub-year>1992</xocs:ref-pub-year><xocs:ref-first-fp>19</xocs:ref-first-fp><xocs:ref-last-lp>25</xocs:ref-last-lp><xocs:ref-normalized-initial>P</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0310\"><xocs:ref-normalized-surname>LEPTAK</xocs:ref-normalized-surname><xocs:ref-pub-year>1991</xocs:ref-pub-year><xocs:ref-first-fp>7078</xocs:ref-first-fp><xocs:ref-last-lp>7083</xocs:ref-last-lp><xocs:ref-normalized-initial>C</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0315\"><xocs:ref-normalized-surname>SCHWARZ</xocs:ref-normalized-surname><xocs:ref-pub-year>1985</xocs:ref-pub-year><xocs:ref-first-fp>111</xocs:ref-first-fp><xocs:ref-last-lp>114</xocs:ref-last-lp><xocs:ref-normalized-initial>E</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0600\"><xocs:ref-normalized-surname>ZURHAUSEN</xocs:ref-normalized-surname><xocs:ref-pub-year>1994</xocs:ref-pub-year><xocs:ref-first-fp>427</xocs:ref-first-fp><xocs:ref-last-lp>447</xocs:ref-last-lp><xocs:ref-normalized-initial>H</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0320\"><xocs:ref-normalized-surname>STOLER</xocs:ref-normalized-surname><xocs:ref-pub-year>1992</xocs:ref-pub-year><xocs:ref-first-fp>117</xocs:ref-first-fp><xocs:ref-last-lp>127</xocs:ref-last-lp><xocs:ref-normalized-initial>M</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0325\"><xocs:ref-normalized-surname>KRAWCZYK</xocs:ref-normalized-surname><xocs:ref-pub-year>2008</xocs:ref-pub-year><xocs:ref-first-fp>682</xocs:ref-first-fp><xocs:ref-last-lp>688</xocs:ref-last-lp><xocs:ref-normalized-initial>E</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0330\"><xocs:ref-normalized-surname>CONRAD</xocs:ref-normalized-surname><xocs:ref-pub-year>1993</xocs:ref-pub-year><xocs:ref-first-fp>6170</xocs:ref-first-fp><xocs:ref-last-lp>6178</xocs:ref-last-lp><xocs:ref-normalized-initial>M</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0335\"><xocs:ref-normalized-surname>TSAI</xocs:ref-normalized-surname><xocs:ref-pub-year>2003</xocs:ref-pub-year><xocs:ref-first-fp>1445</xocs:ref-first-fp><xocs:ref-last-lp>1453</xocs:ref-last-lp><xocs:ref-normalized-initial>T</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0340\"><xocs:ref-normalized-surname>KELL</xocs:ref-normalized-surname><xocs:ref-pub-year>1994</xocs:ref-pub-year><xocs:ref-first-fp>2451</xocs:ref-first-fp><xocs:ref-last-lp>2456</xocs:ref-last-lp><xocs:ref-normalized-initial>B</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0345\"><xocs:ref-normalized-surname>GIESWEIN</xocs:ref-normalized-surname><xocs:ref-pub-year>2003</xocs:ref-pub-year><xocs:ref-first-fp>415</xocs:ref-first-fp><xocs:ref-last-lp>426</xocs:ref-last-lp><xocs:ref-normalized-initial>C</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0350\"><xocs:ref-normalized-surname>KRAWCZYK</xocs:ref-normalized-surname><xocs:ref-pub-year>2010</xocs:ref-pub-year><xocs:ref-first-fp>1696</xocs:ref-first-fp><xocs:ref-last-lp>1703</xocs:ref-last-lp><xocs:ref-normalized-initial>E</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0355\"><xocs:ref-normalized-surname>ULLMAN</xocs:ref-normalized-surname><xocs:ref-pub-year>1994</xocs:ref-pub-year><xocs:ref-first-fp>439S</xocs:ref-first-fp><xocs:ref-normalized-initial>C</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0360\"><xocs:ref-normalized-surname>ALONSO</xocs:ref-normalized-surname><xocs:ref-pub-year>2002</xocs:ref-pub-year><xocs:ref-first-fp>9</xocs:ref-first-fp><xocs:ref-last-lp>18</xocs:ref-last-lp><xocs:ref-normalized-initial>A</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0365\"><xocs:ref-normalized-surname>TSAO</xocs:ref-normalized-surname><xocs:ref-pub-year>1996</xocs:ref-pub-year><xocs:ref-first-fp>7535</xocs:ref-first-fp><xocs:ref-last-lp>7539</xocs:ref-last-lp><xocs:ref-normalized-initial>Y</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0370\"><xocs:ref-normalized-surname>CHEN</xocs:ref-normalized-surname><xocs:ref-pub-year>2007</xocs:ref-pub-year><xocs:ref-first-fp>42</xocs:ref-first-fp><xocs:ref-last-lp>53</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0605\"><xocs:ref-normalized-surname>VENUTI</xocs:ref-normalized-surname><xocs:ref-pub-year>2011</xocs:ref-pub-year><xocs:ref-normalized-initial>A</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0375\"><xocs:ref-normalized-surname>GOLDSTEIN</xocs:ref-normalized-surname><xocs:ref-pub-year>1992</xocs:ref-pub-year><xocs:ref-first-fp>405</xocs:ref-first-fp><xocs:ref-last-lp>413</xocs:ref-last-lp><xocs:ref-normalized-initial>D</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0380\"><xocs:ref-normalized-surname>ADAM</xocs:ref-normalized-surname><xocs:ref-pub-year>2000</xocs:ref-pub-year><xocs:ref-first-fp>315</xocs:ref-first-fp><xocs:ref-last-lp>325</xocs:ref-last-lp><xocs:ref-normalized-initial>J</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0385\"><xocs:ref-normalized-surname>RODRIGUEZ</xocs:ref-normalized-surname><xocs:ref-pub-year>2000</xocs:ref-pub-year><xocs:ref-first-fp>3727</xocs:ref-first-fp><xocs:ref-last-lp>3732</xocs:ref-last-lp><xocs:ref-normalized-initial>M</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0390\"><xocs:ref-normalized-surname>ASHRAFI</xocs:ref-normalized-surname><xocs:ref-pub-year>2005</xocs:ref-pub-year><xocs:ref-first-fp>276</xocs:ref-first-fp><xocs:ref-last-lp>283</xocs:ref-last-lp><xocs:ref-normalized-initial>G</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0395\"><xocs:ref-normalized-surname>ARAIBI</xocs:ref-normalized-surname><xocs:ref-pub-year>2004</xocs:ref-pub-year><xocs:ref-first-fp>2809</xocs:ref-first-fp><xocs:ref-last-lp>2814</xocs:ref-last-lp><xocs:ref-normalized-initial>E</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0400\"><xocs:ref-normalized-surname>ASHRAFI</xocs:ref-normalized-surname><xocs:ref-pub-year>2006</xocs:ref-pub-year><xocs:ref-first-fp>2105</xocs:ref-first-fp><xocs:ref-last-lp>2112</xocs:ref-last-lp><xocs:ref-normalized-initial>G</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0610\"><xocs:ref-normalized-surname>GRUENER</xocs:ref-normalized-surname><xocs:ref-pub-year>2007</xocs:ref-pub-year><xocs:ref-first-fp>116</xocs:ref-first-fp><xocs:ref-normalized-initial>M</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0405\"><xocs:ref-normalized-surname>CONRAD</xocs:ref-normalized-surname><xocs:ref-pub-year>1994</xocs:ref-pub-year><xocs:ref-first-fp>796</xocs:ref-first-fp><xocs:ref-last-lp>800</xocs:ref-last-lp><xocs:ref-normalized-initial>M</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0410\"><xocs:ref-normalized-surname>STRAIGHT</xocs:ref-normalized-surname><xocs:ref-pub-year>1993</xocs:ref-pub-year><xocs:ref-first-fp>4521</xocs:ref-first-fp><xocs:ref-last-lp>4532</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0415\"><xocs:ref-normalized-surname>KRAWCZYK</xocs:ref-normalized-surname><xocs:ref-pub-year>2011</xocs:ref-pub-year><xocs:ref-first-fp>10968</xocs:ref-first-fp><xocs:ref-last-lp>10975</xocs:ref-last-lp><xocs:ref-normalized-initial>E</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0615\"><xocs:ref-normalized-surname>WAKANA</xocs:ref-normalized-surname><xocs:ref-pub-year>2008</xocs:ref-pub-year><xocs:ref-first-fp>1825</xocs:ref-first-fp><xocs:ref-last-lp>1836</xocs:ref-last-lp><xocs:ref-normalized-initial>Y</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0425\"><xocs:ref-normalized-surname>REGAN</xocs:ref-normalized-surname><xocs:ref-pub-year>2008</xocs:ref-pub-year><xocs:ref-first-fp>10042</xocs:ref-first-fp><xocs:ref-last-lp>10051</xocs:ref-last-lp><xocs:ref-normalized-initial>J</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0430\"><xocs:ref-normalized-surname>KRAWCZYK</xocs:ref-normalized-surname><xocs:ref-pub-year>2008</xocs:ref-pub-year><xocs:ref-first-fp>684</xocs:ref-first-fp><xocs:ref-last-lp>688</xocs:ref-last-lp><xocs:ref-normalized-initial>E</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0435\"><xocs:ref-normalized-surname>SUDARSHAN</xocs:ref-normalized-surname><xocs:ref-pub-year>2010</xocs:ref-pub-year><xocs:ref-first-fp>617</xocs:ref-first-fp><xocs:ref-last-lp>622</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0440\"><xocs:ref-normalized-surname>TOMAKIDI</xocs:ref-normalized-surname><xocs:ref-pub-year>2000</xocs:ref-pub-year><xocs:ref-first-fp>323</xocs:ref-first-fp><xocs:ref-last-lp>327</xocs:ref-last-lp><xocs:ref-normalized-initial>P</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0445\"><xocs:ref-normalized-surname>SUPRYNOWICZ</xocs:ref-normalized-surname><xocs:ref-pub-year>2008</xocs:ref-pub-year><xocs:ref-first-fp>1071</xocs:ref-first-fp><xocs:ref-last-lp>1078</xocs:ref-last-lp><xocs:ref-normalized-initial>F</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0450\"><xocs:ref-normalized-surname>CUI</xocs:ref-normalized-surname><xocs:ref-pub-year>2012</xocs:ref-pub-year><xocs:ref-first-fp>S5</xocs:ref-first-fp><xocs:ref-normalized-initial>G</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0455\"><xocs:ref-normalized-surname>LIN</xocs:ref-normalized-surname><xocs:ref-pub-year>1994</xocs:ref-pub-year><xocs:ref-first-fp>5063</xocs:ref-first-fp><xocs:ref-last-lp>5073</xocs:ref-last-lp><xocs:ref-normalized-initial>C</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0460\"><xocs:ref-normalized-surname>ELBERS</xocs:ref-normalized-surname><xocs:ref-pub-year>1996</xocs:ref-pub-year><xocs:ref-first-fp>4131</xocs:ref-first-fp><xocs:ref-last-lp>4135</xocs:ref-last-lp><xocs:ref-normalized-initial>K</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0465\"><xocs:ref-normalized-surname>STEINMANN</xocs:ref-normalized-surname><xocs:ref-pub-year>2010</xocs:ref-pub-year><xocs:ref-first-fp>2078</xocs:ref-first-fp><xocs:ref-last-lp>2095</xocs:ref-last-lp><xocs:ref-normalized-initial>E</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0470\"><xocs:ref-normalized-surname>GRIFFIN</xocs:ref-normalized-surname><xocs:ref-pub-year>2009</xocs:ref-pub-year><xocs:ref-first-fp>12567</xocs:ref-first-fp><xocs:ref-last-lp>12568</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0475\"><xocs:ref-normalized-surname>JONES</xocs:ref-normalized-surname><xocs:ref-pub-year>2007</xocs:ref-pub-year><xocs:ref-first-fp>8374</xocs:ref-first-fp><xocs:ref-last-lp>8383</xocs:ref-last-lp><xocs:ref-normalized-initial>C</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0480\"><xocs:ref-normalized-surname>STEINMANN</xocs:ref-normalized-surname><xocs:ref-pub-year>2007</xocs:ref-pub-year><xocs:ref-first-fp>962</xocs:ref-first-fp><xocs:ref-last-lp>971</xocs:ref-last-lp><xocs:ref-normalized-initial>E</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0485\"><xocs:ref-normalized-surname>CARREREKREMER</xocs:ref-normalized-surname><xocs:ref-pub-year>2002</xocs:ref-pub-year><xocs:ref-first-fp>3720</xocs:ref-first-fp><xocs:ref-last-lp>3730</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0490\"><xocs:ref-normalized-surname>PREMKUMAR</xocs:ref-normalized-surname><xocs:ref-pub-year>2004</xocs:ref-pub-year><xocs:ref-first-fp>99</xocs:ref-first-fp><xocs:ref-last-lp>103</xocs:ref-last-lp><xocs:ref-normalized-initial>A</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0495\"><xocs:ref-normalized-surname>MONTSERRET</xocs:ref-normalized-surname><xocs:ref-pub-year>2010</xocs:ref-pub-year><xocs:ref-first-fp>31446</xocs:ref-first-fp><xocs:ref-last-lp>31461</xocs:ref-last-lp><xocs:ref-normalized-initial>R</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0500\"><xocs:ref-normalized-surname>WHITFIELD</xocs:ref-normalized-surname><xocs:ref-pub-year>2011</xocs:ref-pub-year><xocs:ref-first-fp>254</xocs:ref-first-fp><xocs:ref-last-lp>264</xocs:ref-last-lp><xocs:ref-normalized-initial>T</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0505\"><xocs:ref-normalized-surname>CHEW</xocs:ref-normalized-surname><xocs:ref-pub-year>2009</xocs:ref-pub-year><xocs:ref-first-fp>L10</xocs:ref-first-fp><xocs:ref-last-lp>L12</xocs:ref-last-lp><xocs:ref-normalized-initial>C</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0510\"><xocs:ref-normalized-surname>PAVLOVIC</xocs:ref-normalized-surname><xocs:ref-pub-year>2003</xocs:ref-pub-year><xocs:ref-first-fp>6104</xocs:ref-first-fp><xocs:ref-last-lp>6108</xocs:ref-last-lp><xocs:ref-normalized-initial>D</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0515\"><xocs:ref-normalized-surname>GRIFFIN</xocs:ref-normalized-surname><xocs:ref-pub-year>2003</xocs:ref-pub-year><xocs:ref-first-fp>34</xocs:ref-first-fp><xocs:ref-last-lp>38</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0520\"><xocs:ref-normalized-surname>CLARKE</xocs:ref-normalized-surname><xocs:ref-pub-year>2006</xocs:ref-pub-year><xocs:ref-first-fp>37057</xocs:ref-first-fp><xocs:ref-last-lp>37068</xocs:ref-last-lp><xocs:ref-normalized-initial>D</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0525\"><xocs:ref-normalized-surname>LUIK</xocs:ref-normalized-surname><xocs:ref-pub-year>2009</xocs:ref-pub-year><xocs:ref-first-fp>12712</xocs:ref-first-fp><xocs:ref-last-lp>12716</xocs:ref-last-lp><xocs:ref-normalized-initial>P</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0530\"><xocs:ref-normalized-surname>COOK</xocs:ref-normalized-surname><xocs:ref-pub-year>2010</xocs:ref-pub-year><xocs:ref-first-fp>1097</xocs:ref-first-fp><xocs:ref-last-lp>1104</xocs:ref-last-lp><xocs:ref-normalized-initial>G</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0535\"><xocs:ref-normalized-surname>COOK</xocs:ref-normalized-surname><xocs:ref-pub-year>2011</xocs:ref-pub-year><xocs:ref-first-fp>1448</xocs:ref-first-fp><xocs:ref-last-lp>1453</xocs:ref-last-lp><xocs:ref-normalized-initial>G</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0540\"><xocs:ref-normalized-surname>PATARGIAS</xocs:ref-normalized-surname><xocs:ref-pub-year>2006</xocs:ref-pub-year><xocs:ref-first-fp>648</xocs:ref-first-fp><xocs:ref-last-lp>655</xocs:ref-last-lp><xocs:ref-normalized-initial>G</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0545\"><xocs:ref-normalized-surname>CHANDLER</xocs:ref-normalized-surname><xocs:ref-pub-year>2012</xocs:ref-pub-year><xocs:ref-first-fp>e1002702</xocs:ref-first-fp><xocs:ref-normalized-initial>D</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0550\"><xocs:ref-normalized-surname>LI</xocs:ref-normalized-surname><xocs:ref-pub-year>2009</xocs:ref-pub-year><xocs:ref-first-fp>16410</xocs:ref-first-fp><xocs:ref-last-lp>16415</xocs:ref-last-lp><xocs:ref-normalized-initial>Q</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0555\"><xocs:ref-normalized-surname>LIN</xocs:ref-normalized-surname><xocs:ref-pub-year>2003</xocs:ref-pub-year><xocs:ref-first-fp>1270</xocs:ref-first-fp><xocs:ref-last-lp>1276</xocs:ref-last-lp><xocs:ref-normalized-initial>J</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0560\"><xocs:ref-normalized-surname>WANG</xocs:ref-normalized-surname><xocs:ref-pub-year>2010</xocs:ref-pub-year><xocs:ref-first-fp>109</xocs:ref-first-fp><xocs:ref-last-lp>115</xocs:ref-last-lp><xocs:ref-normalized-initial>Y</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0565\"><xocs:ref-normalized-surname>BRAY</xocs:ref-normalized-surname><xocs:ref-pub-year>2006</xocs:ref-pub-year><xocs:ref-first-fp>678</xocs:ref-first-fp><xocs:ref-last-lp>689</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0570\"><xocs:ref-normalized-surname>RANDAL</xocs:ref-normalized-surname><xocs:ref-pub-year>2007</xocs:ref-pub-year><xocs:ref-first-fp>12884</xocs:ref-first-fp><xocs:ref-last-lp>12889</xocs:ref-last-lp><xocs:ref-normalized-initial>G</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0575\"><xocs:ref-normalized-surname>MAGADAN</xocs:ref-normalized-surname><xocs:ref-pub-year>2012</xocs:ref-pub-year><xocs:ref-first-fp>757</xocs:ref-first-fp><xocs:ref-last-lp>772</xocs:ref-last-lp><xocs:ref-normalized-initial>J</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0580\"><xocs:ref-normalized-surname>LAZARCZYK</xocs:ref-normalized-surname><xocs:ref-pub-year>2008</xocs:ref-pub-year><xocs:ref-first-fp>348</xocs:ref-first-fp><xocs:ref-last-lp>370</xocs:ref-last-lp><xocs:ref-normalized-initial>M</xocs:ref-normalized-initial></xocs:ref-info></xocs:references><xocs:refkeys><xocs:refkey3>FISCHERX2014X1113</xocs:refkey3><xocs:refkey4lp>FISCHERX2014X1113X1121</xocs:refkey4lp><xocs:refkey4ai>FISCHERX2014X1113XW</xocs:refkey4ai><xocs:refkey5>FISCHERX2014X1113X1121XW</xocs:refkey5></xocs:refkeys><xocs:open-access><xocs:oa-article-status is-open-access=\"1\" is-open-archive=\"1\">Full</xocs:oa-article-status><xocs:oa-access-effective-date>2015-04-01T00:25:58Z</xocs:oa-access-effective-date><xocs:oa-access-inherited-from winid=\"http://vtw.elsevier.com/content/oaw/BBA_1995_P1Y_ESBranded\" wintype=\"OpenArchive\">OA-Window</xocs:oa-access-inherited-from><xocs:oa-sponsor><xocs:oa-sponsor-type>ElsevierBranded</xocs:oa-sponsor-type></xocs:oa-sponsor><xocs:oa-user-license>http://www.elsevier.com/open-access/userlicense/1.0/</xocs:oa-user-license></xocs:open-access><xocs:attachment-metadata-doc><xocs:attachment-set-type>item</xocs:attachment-set-type><xocs:pii-formatted>S0005-2736(13)00296-4</xocs:pii-formatted><xocs:pii-unformatted>S0005273613002964</xocs:pii-unformatted><xocs:eid>1-s2.0-S0005273613002964</xocs:eid><xocs:doi>10.1016/j.bbamem.2013.08.017</xocs:doi><xocs:cid>271033</xocs:cid><xocs:timestamp>2014-04-11T13:15:56.704589-04:00</xocs:timestamp><xocs:cover-date-start>2014-04-01</xocs:cover-date-start><xocs:cover-date-end>2014-04-30</xocs:cover-date-end><xocs:attachments><xocs:web-pdf><xocs:attachment-eid>1-s2.0-S0005273613002964-main.pdf</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0005273613002964/MAIN/application/pdf/8865e5b06265ebd6efa8b1fadd2416fc/main.pdf</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0005273613002964/MAIN/application/pdf/8865e5b06265ebd6efa8b1fadd2416fc/main.pdf</xocs:ucs-locator><xocs:filename>main.pdf</xocs:filename><xocs:extension>pdf</xocs:extension><xocs:pdf-optimized>true</xocs:pdf-optimized><xocs:filesize>990164</xocs:filesize><xocs:web-pdf-purpose>MAIN</xocs:web-pdf-purpose><xocs:web-pdf-page-count>9</xocs:web-pdf-page-count><xocs:web-pdf-images><xocs:web-pdf-image><xocs:attachment-eid>1-s2.0-S0005273613002964-main_1.png</xocs:attachment-eid><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0005273613002964/PREVIEW/image/png/8a39f3ae70dc4a3e9b2172fa6b642a24/main_1.png</xocs:ucs-locator><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0005273613002964/PREVIEW/image/png/8a39f3ae70dc4a3e9b2172fa6b642a24/main_1.png</xocs:ucs-locator><xocs:filename>main_1.png</xocs:filename><xocs:extension>png</xocs:extension><xocs:filesize>40031</xocs:filesize><xocs:pixel-height>849</xocs:pixel-height><xocs:pixel-width>656</xocs:pixel-width><xocs:attachment-type>IMAGE-WEB-PDF</xocs:attachment-type><xocs:pdf-page-num>1</xocs:pdf-page-num></xocs:web-pdf-image></xocs:web-pdf-images></xocs:web-pdf><xocs:attachment><xocs:attachment-eid>1-s2.0-S0005273613002964-gr2_lrg.jpg</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0005273613002964/gr2/HIGHRES/image/jpeg/d383a13cbda5f356706e15e0cd39d6c7/gr2_lrg.jpg</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0005273613002964/gr2/HIGHRES/image/jpeg/d383a13cbda5f356706e15e0cd39d6c7/gr2_lrg.jpg</xocs:ucs-locator><xocs:file-basename>gr2</xocs:file-basename><xocs:filename>gr2_lrg.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>628542</xocs:filesize><xocs:pixel-height>2872</xocs:pixel-height><xocs:pixel-width>2274</xocs:pixel-width><xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0005273613002964-gr1_lrg.jpg</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0005273613002964/gr1/HIGHRES/image/jpeg/ac35e70d3f8a33a0e0d27c9bbc04b9da/gr1_lrg.jpg</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0005273613002964/gr1/HIGHRES/image/jpeg/ac35e70d3f8a33a0e0d27c9bbc04b9da/gr1_lrg.jpg</xocs:ucs-locator><xocs:file-basename>gr1</xocs:file-basename><xocs:filename>gr1_lrg.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>632761</xocs:filesize><xocs:pixel-height>2459</xocs:pixel-height><xocs:pixel-width>1368</xocs:pixel-width><xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0005273613002964-fx1_lrg.jpg</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0005273613002964/fx1/HIGHRES/image/jpeg/99041298e07ed3812faea1d1320f4c4f/fx1_lrg.jpg</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0005273613002964/fx1/HIGHRES/image/jpeg/99041298e07ed3812faea1d1320f4c4f/fx1_lrg.jpg</xocs:ucs-locator><xocs:file-basename>fx1</xocs:file-basename><xocs:abstract-attachment>true</xocs:abstract-attachment><xocs:filename>fx1_lrg.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>231050</xocs:filesize><xocs:pixel-height>886</xocs:pixel-height><xocs:pixel-width>1400</xocs:pixel-width><xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0005273613002964-gr2.jpg</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0005273613002964/gr2/DOWNSAMPLED/image/jpeg/a278a5e78beeb9826bd11145d07608a3/gr2.jpg</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0005273613002964/gr2/DOWNSAMPLED/image/jpeg/a278a5e78beeb9826bd11145d07608a3/gr2.jpg</xocs:ucs-locator><xocs:file-basename>gr2</xocs:file-basename><xocs:filename>gr2.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>68632</xocs:filesize><xocs:pixel-height>648</xocs:pixel-height><xocs:pixel-width>513</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0005273613002964-gr1.jpg</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0005273613002964/gr1/DOWNSAMPLED/image/jpeg/f578dfa98801a2b9b2964b1ce47ac459/gr1.jpg</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0005273613002964/gr1/DOWNSAMPLED/image/jpeg/f578dfa98801a2b9b2964b1ce47ac459/gr1.jpg</xocs:ucs-locator><xocs:file-basename>gr1</xocs:file-basename><xocs:filename>gr1.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>134541</xocs:filesize><xocs:pixel-height>926</xocs:pixel-height><xocs:pixel-width>515</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0005273613002964-fx1.jpg</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0005273613002964/fx1/DOWNSAMPLED/image/jpeg/4fa8d0059df911b703fdf15e9d97f132/fx1.jpg</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0005273613002964/fx1/DOWNSAMPLED/image/jpeg/4fa8d0059df911b703fdf15e9d97f132/fx1.jpg</xocs:ucs-locator><xocs:file-basename>fx1</xocs:file-basename><xocs:abstract-attachment>true</xocs:abstract-attachment><xocs:filename>fx1.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>28251</xocs:filesize><xocs:pixel-height>200</xocs:pixel-height><xocs:pixel-width>316</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0005273613002964-gr2.sml</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0005273613002964/gr2/THUMBNAIL/image/gif/b52d109498d34c5c4da00775a2c93836/gr2.sml</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0005273613002964/gr2/THUMBNAIL/image/gif/b52d109498d34c5c4da00775a2c93836/gr2.sml</xocs:ucs-locator><xocs:file-basename>gr2</xocs:file-basename><xocs:filename>gr2.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>4614</xocs:filesize><xocs:pixel-height>164</xocs:pixel-height><xocs:pixel-width>130</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0005273613002964-gr1.sml</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0005273613002964/gr1/THUMBNAIL/image/gif/393a0a15311d562e0ce59317ca7839f1/gr1.sml</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0005273613002964/gr1/THUMBNAIL/image/gif/393a0a15311d562e0ce59317ca7839f1/gr1.sml</xocs:ucs-locator><xocs:file-basename>gr1</xocs:file-basename><xocs:filename>gr1.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>5667</xocs:filesize><xocs:pixel-height>164</xocs:pixel-height><xocs:pixel-width>91</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0005273613002964-fx1.sml</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0005273613002964/fx1/THUMBNAIL/image/gif/9c641c881f13b56c5501a929922f22ea/fx1.sml</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0005273613002964/fx1/THUMBNAIL/image/gif/9c641c881f13b56c5501a929922f22ea/fx1.sml</xocs:ucs-locator><xocs:file-basename>fx1</xocs:file-basename><xocs:abstract-attachment>true</xocs:abstract-attachment><xocs:filename>fx1.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>7051</xocs:filesize><xocs:pixel-height>139</xocs:pixel-height><xocs:pixel-width>219</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment></xocs:attachments></xocs:attachment-metadata-doc></xocs:meta><xocs:serial-item><article xmlns=\"http://www.elsevier.com/xml/ja/dtd\" version=\"5.2\" docsubtype=\"rev\" xml:lang=\"en\"><item-info><jid>BBAMEM</jid><aid>81364</aid><ce:pii>S0005-2736(13)00296-4</ce:pii><ce:doi>10.1016/j.bbamem.2013.08.017</ce:doi><ce:copyright type=\"full-transfer\" year=\"2013\">Elsevier B.V.</ce:copyright><ce:copyright-line>© 2013 Elsevier B.V. All rights reserved.</ce:copyright-line></item-info><ce:floats><ce:figure id=\"f0010\"><ce:label>Fig.\\xa01</ce:label><ce:caption id=\"ca0010\"><ce:simple-para id=\"sp0020\" view=\"all\">(A) Computational models of the first 32 amino acids including the transmembrane domain (TMD) of the bitopic Vpu (Vpu<ce:inf loc=\"post\">1–32</ce:inf>) from HIV-1 (Vpu HV1H2) <ce:cross-ref refid=\"bb0115\" id=\"cf0005\">[23]</ce:cross-ref>. The TMD of Vpu<ce:inf loc=\"post\">1–32</ce:inf> is modeled in its interacting form with the TMD of the receptor protein CD4 (blue, left), BST-2 (green, middle) and NTB-A (yellow, right) in the upper panel. The lower panel shows potential pentameric assemblies of Vpu<ce:inf loc=\"post\">1–32</ce:inf> as a hydrophobic pore (left) and a pore with hydrophilic residue serine (yellow) facing the inside of the bundle (right). The putative monomeric form of E5 protein seen from the side of TMD2 (B). Serine residues (yellow) and threonines (blue) are shown in van der Waals spheres. A putative hexameric bundle with TMD2s facing the pore is also shown (right). (C) The polytopic channel protein p7 from HCV is shown as a monomer with its two TMDs aligned antiparallel (left) and in a putative hexameric bundle (right). The models highlight the histidine residues (red), which are thought to face the lumen of the pore. All models are generated with surface mode of MOE software suite coloring hydrophilic residues in green and hydrophilic residues in blue. The backbones of the TMDs are shown in light yellow.</ce:simple-para></ce:caption><ce:link locator=\"gr1\" id=\"lk0005\"/></ce:figure><ce:figure id=\"f0015\"><ce:label>Fig.\\xa02</ce:label><ce:caption id=\"ca0015\"><ce:simple-para id=\"sp0025\" view=\"all\">Putative reaction schemes of the monomeric channel forming proteins (blue, surface mode of MOE suite with highlighted backbone) into homo- or heterooligomers with membrane proteins of the host (orange). It is assumed that there is equilibrium between the monomer and a homooligomeric- or bundle-like form (I). The bundle can consequently interact with the transmembrane domains (TMDs) with the host (II). Another pathway is suggested to allow the monomer to interact with the host protein first (III). In a consequent step the monomer-host assembly either integrats together with other viral monomers into a viral bundle (IV) or forms an oligomeric monomer-host assembly (V).</ce:simple-para></ce:caption><ce:link locator=\"gr2\" id=\"lk0010\"/></ce:figure><ce:table xmlns=\"http://www.elsevier.com/xml/common/cals/dtd\" id=\"t0005\" frame=\"topbot\" colsep=\"0\" rowsep=\"0\"><ce:label>Table\\xa01</ce:label><ce:caption id=\"ca0005\"><ce:simple-para id=\"sp0015\" view=\"all\">Host proteins interacting with the viral proteins Vpu of HIV-1, E5 of HPV-16 and p7 of HCV. Host proteins are identified by experiments or bioinformatics tools <ce:cross-ref refid=\"bb0480\" id=\"cf0010\">[96]</ce:cross-ref>. HPRD ID: human protein reference database identification number; SVM: support vector machine; ELM: eukaryotic linear motif (<ce:inter-ref xlink:href=\"http://elm.eu.org/\" id=\"ir0015\" xlink:type=\"simple\">http://elm.eu.org/</ce:inter-ref>).</ce:simple-para></ce:caption><tgroup cols=\"5\"><colspec colname=\"col1\"/><colspec colname=\"col2\"/><colspec colname=\"col3\"/><colspec colname=\"col4\"/><colspec colname=\"col5\"/><thead><row valign=\"top\" rowsep=\"1\"><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col1\" align=\"left\">Host protein<br/>(HPRD IDs, ELM)</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col2\" align=\"left\">Number of TMDs of host protein</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col3\" align=\"left\">Binding region of viral protein</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col4\" align=\"left\">Experimental and computational methods used</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col5\" align=\"left\">Reference</entry></row></thead><tbody><row valign=\"top\"><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" namest=\"col1\" nameend=\"col5\" align=\"left\"><italic><bold>Vpu</bold></italic></entry></row><row valign=\"top\"><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col1\" align=\"left\">CD4</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col2\" align=\"left\">1</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col3\" align=\"left\">Cytoplasmic region</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col4\" align=\"left\">Immunoprecipitation</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col5\" align=\"left\"><cross-refs refid=\"bb0605 bb0135\" id=\"cf0015\">[121,27]</cross-refs></entry></row><row valign=\"top\"><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col1\" align=\"left\">TASK</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col2\" align=\"left\">4</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col3\" align=\"left\">TMD</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col4\" align=\"left\">Sequence similarity, coimmunoprecipitation</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col5\" align=\"left\"><cross-ref refid=\"bb0190\" id=\"cf0020\">[38]</cross-ref></entry></row><row valign=\"top\"><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col1\" align=\"left\">BST-2</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col2\" align=\"left\">1</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col3\" align=\"left\">TMD</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col4\" align=\"left\">NMR, co-immunoprecipitation, western blot analysis, flow cytometry</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col5\" align=\"left\"><cross-refs refid=\"bb0205 bb0210 bb0220 bb0225 bb0250\" id=\"cf0025\">[41,42,44,45,50]</cross-refs></entry></row><row valign=\"top\"><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col1\" align=\"left\">NTB-A</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col2\" align=\"left\">1</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col3\" align=\"left\">TMD</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col4\" align=\"left\">Immunoprecipitation, western blot analysis</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col5\" align=\"left\"><cross-ref refid=\"bb0265\" id=\"cf0030\">[53]</cross-ref></entry></row><row valign=\"top\"><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col1\" align=\"left\">MHC II/CD74</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col2\" align=\"left\">1</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col3\" align=\"left\">Cytoplasmic region</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col4\" align=\"left\">Yeast two hybrid assay, coimmunoprecipitation</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col5\" align=\"left\"><cross-ref refid=\"bb0275\" id=\"cf0035\">[55]</cross-ref></entry></row><row valign=\"top\"><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" namest=\"col1\" nameend=\"col5\" align=\"left\"><vsp sp=\"0.5\"/></entry></row><row valign=\"top\"><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" namest=\"col1\" nameend=\"col5\" align=\"left\"><italic>From bioinformatics</italic></entry></row><row valign=\"top\"><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col1\" align=\"left\">ELM:<br/>TRG_LysEnd_APsAcLL_1</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col2\" align=\"left\">Found in type I transmembrane proteins</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col3\"/><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col4\" align=\"left\">Comparison of ELMs</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col5\" align=\"left\"><cross-ref refid=\"bb0290\" id=\"cf0040\">[58]</cross-ref></entry></row><row valign=\"top\"><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" namest=\"col1\" nameend=\"col5\" align=\"left\"><vsp sp=\"0.5\"/></entry></row><row valign=\"top\"><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" namest=\"col1\" nameend=\"col5\" align=\"left\"><italic><bold>E5</bold></italic></entry></row><row valign=\"top\"><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col1\" align=\"left\">Karyopherin β3</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col2\" align=\"left\">–</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col3\" align=\"left\">10 amino acids at the C-terminus</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col4\" align=\"left\">Immunoprecipitation and western blot analysis</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col5\" align=\"left\"><cross-ref refid=\"bb0460\" id=\"cf0045\">[92]</cross-ref></entry></row><row valign=\"top\"><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col1\" align=\"left\">COX-2, XBP-1 and IRE1a</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col2\" align=\"left\">IRE1a: 1 TMD</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col3\" align=\"left\">Not defined</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col4\" align=\"left\">RT-PCR and cDNA microarray</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col5\" align=\"left\"><cross-ref refid=\"bb0465\" id=\"cf0050\">[93]</cross-ref></entry></row><row valign=\"top\"><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col1\" align=\"left\">16-kDa protein of vacuolar H<sup loc=\"post\">+</sup>-ATPase</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col2\" align=\"left\">1,<br/>(vacuolar H<sup loc=\"post\">+</sup>-ATPase:<br/>7 TMDs)</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col3\" align=\"left\">Residues 41 to 54</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col4\" align=\"left\">PCR and co-immuniprecipitation</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col5\" align=\"left\"><cross-ref refid=\"bb0405\" id=\"cf0055\">[81]</cross-ref></entry></row><row valign=\"top\"><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col1\" align=\"left\">EVER1, EVER2, ZnT-1</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col2\" align=\"left\">EVER1: 10 TMDs<br/>EVER2: 8 TMDs<br/>ZnT-1: 6 TMDs</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col3\" align=\"left\">Not defined</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col4\" align=\"left\">Yeast two hybrid assay</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col5\" align=\"left\"><cross-ref refid=\"bb0610\" id=\"cf0060\">[122]</cross-ref></entry></row><row valign=\"top\"><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col1\" align=\"left\">Calnexin</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col2\" align=\"left\">1 TMD</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col3\" align=\"left\">1st TMD</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col4\" align=\"left\">Co-immunoprecipitation</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col5\" align=\"left\"><cross-ref refid=\"bb0430\" id=\"cf0065\">[86]</cross-ref></entry></row><row valign=\"top\"><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col1\" align=\"left\">ErbB4</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col2\" align=\"left\">1 TMD</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col3\" align=\"left\">Not defined</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col4\" align=\"left\">Co-immunoprecipitation western blot analysis, RT-PCR, mammalian two hybrid experiment</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col5\" align=\"left\"><cross-ref refid=\"bb0390\" id=\"cf0070\">[78]</cross-ref></entry></row><row valign=\"top\"><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col1\" align=\"left\">Calpactin I</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col2\" align=\"left\">–</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col3\" align=\"left\">20 aa at C-terminus, TMD3</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col4\"/><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col5\" align=\"left\"><cross-ref refid=\"bb0445\" id=\"cf0075\">[89]</cross-ref></entry></row><row valign=\"top\"><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col1\" align=\"left\">Bap31</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col2\" align=\"left\">3 TMDs</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col3\" align=\"left\">Last 10 aa of 3rd TMD</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col4\" align=\"left\">Yeast two hybrid assay</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col5\" align=\"left\"><cross-ref refid=\"bb0455\" id=\"cf0080\">[91]</cross-ref></entry></row><row valign=\"top\"><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col1\" align=\"left\">MHC I, HLA-I<br/>(00826)</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col2\" align=\"left\">1 TMD</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col3\" align=\"left\">With leucine pairs in<br/>1st TMD</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col4\" align=\"left\">RT-PCR, western blot analysis, co-immunoprecipitation, flow cytometry</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col5\" align=\"left\"><cross-refs refid=\"bb0425 bb0480\" id=\"cf0085\">[85,96]</cross-refs></entry></row><row valign=\"top\"><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col1\" align=\"left\">EGFR</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col2\"/><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col3\" align=\"left\">Part of TMD3</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col4\" align=\"left\">Western blot analysis</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col5\" align=\"left\"><cross-ref refid=\"bb0410\" id=\"cf0090\">[82]</cross-ref></entry></row><row valign=\"top\"><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" namest=\"col1\" nameend=\"col5\" align=\"left\"><vsp sp=\"0.5\"/></entry></row><row valign=\"top\"><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" namest=\"col1\" nameend=\"col5\" align=\"left\"><italic>From bioinformatics</italic></entry></row><row valign=\"top\"><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col1\" align=\"left\">MHC I<br/>(00826)</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col2\" align=\"left\">1 TMD</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col3\"/><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col4\" align=\"left\">SVM model</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col5\" align=\"left\"><cross-ref refid=\"bb0480\" id=\"cf0095\">[96]</cross-ref></entry></row><row valign=\"top\"><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col1\" align=\"left\">Integral Membrane proteins<br/>(08387, 15517, 09463)</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col2\" align=\"left\">8 (08387) and 9 TMDs</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col3\"/><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col4\" align=\"left\">SVM model</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col5\" align=\"left\"><cross-ref refid=\"bb0480\" id=\"cf0100\">[96]</cross-ref></entry></row><row valign=\"top\"><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col1\" align=\"left\">Cell adhesion proteins<br/>(06953, 07562, 09392, 06955, 06956)</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col2\" align=\"left\">1 TMD</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col3\"/><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col4\" align=\"left\">SVM model</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col5\" align=\"left\"><cross-ref refid=\"bb0480\" id=\"cf0105\">[96]</cross-ref></entry></row><row valign=\"top\"><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col1\" align=\"left\">Receptor kinase<br/>(02790, 01554, 01266, 02997, 01555)</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col2\" align=\"left\">1 TMD</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col3\"/><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col4\" align=\"left\">SVM model</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col5\" align=\"left\"><cross-ref refid=\"bb0480\" id=\"cf0110\">[96]</cross-ref></entry></row><row valign=\"top\"><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col1\" align=\"left\">G-protein coupled receptors<br/>(00045, 01347, 11809, 00678, 03614, 03576, 01628)</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col2\" align=\"left\">7 TMDs</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col3\"/><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col4\" align=\"left\">SVM model</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col5\" align=\"left\"><cross-ref refid=\"bb0480\" id=\"cf0115\">[96]</cross-ref></entry></row><row valign=\"top\"><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col1\" align=\"left\">Cell surface receptors<br/>(04713)</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col2\" align=\"left\">7 TMDs</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col3\"/><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col4\" align=\"left\">SVM model</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col5\" align=\"left\"><cross-ref refid=\"bb0480\" id=\"cf0120\">[96]</cross-ref></entry></row><row valign=\"top\"><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" namest=\"col1\" nameend=\"col5\" align=\"left\"><vsp sp=\"0.5\"/></entry></row><row valign=\"top\"><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" namest=\"col1\" nameend=\"col5\" align=\"left\"><italic><bold>p7</bold></italic><br/><italic>From bioinformatics</italic></entry></row><row valign=\"top\"><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col1\" align=\"left\">Netrin G1 ligand<br/>(12303)</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col2\" align=\"left\">1 TMD</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col3\"/><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col4\" align=\"left\">SVM model</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col5\" align=\"left\"><cross-ref refid=\"bb0480\" id=\"cf0125\">[96]</cross-ref></entry></row><row valign=\"top\"><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col1\" align=\"left\">Preadipocyte factor 1<br/>(01446)</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col2\" align=\"left\">1 TMD</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col3\"/><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col4\" align=\"left\">SVM model</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col5\" align=\"left\"><cross-ref refid=\"bb0480\" id=\"cf0130\">[96]</cross-ref></entry></row><row valign=\"top\"><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col1\" align=\"left\">Delta like protein<br/>(05957)</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col2\" align=\"left\">1 TMD</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col3\"/><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col4\" align=\"left\">SVM model</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col5\" align=\"left\"><cross-ref refid=\"bb0480\" id=\"cf0135\">[96]</cross-ref></entry></row><row valign=\"top\"><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col1\" align=\"left\">Notch 4<br/>(01290)</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col2\" align=\"left\">1 TMD</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col3\"/><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col4\" align=\"left\">SVM model</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col5\" align=\"left\"><cross-ref refid=\"bb0480\" id=\"cf0140\">[96]</cross-ref></entry></row><row valign=\"top\"><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col1\" align=\"left\">Notch 2<br/>(02606)</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col2\" align=\"left\">1 TMD</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col3\"/><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col4\" align=\"left\">SVM model</entry><entry xmlns=\"http://www.elsevier.com/xml/common/dtd\" colname=\"col5\" align=\"left\"><cross-ref refid=\"bb0480\" id=\"cf0145\">[96]</cross-ref></entry></row></tbody></tgroup></ce:table></ce:floats><head><ce:article-footnote><ce:label>☆</ce:label><ce:note-para id=\"np0005\" view=\"all\">This article is part of a Special Issue entitled: Viral Membrane Proteins — Channels for Cellular Networking.</ce:note-para></ce:article-footnote><ce:dochead id=\"dh0005\"><ce:textfn id=\"tn0005\">Review</ce:textfn></ce:dochead><ce:title id=\"ti0005\">Viral channel proteins in intracellular protein–protein communication: Vpu of HIV-1, E5 of HPV16 and p7 of HCV</ce:title><ce:author-group id=\"ag0005\"><ce:author id=\"au0005\"><ce:given-name>Wolfgang B.</ce:given-name><ce:surname>Fischer</ce:surname><ce:cross-ref refid=\"cr0005\" id=\"cf0150\"><ce:sup loc=\"post\">⁎</ce:sup></ce:cross-ref><ce:e-address id=\"em0005\" type=\"email\">wfischer@ym.edu.tw</ce:e-address></ce:author><ce:author id=\"au0010\"><ce:given-name>Li-Hua</ce:given-name><ce:surname>Li</ce:surname></ce:author><ce:author id=\"au0015\"><ce:given-name>Dhani Ram</ce:given-name><ce:surname>Mahato</ce:surname></ce:author><ce:author id=\"au0020\"><ce:given-name>Yi-Ting</ce:given-name><ce:surname>Wang</ce:surname></ce:author><ce:author id=\"au0025\"><ce:given-name>Chin-Pei</ce:given-name><ce:surname>Chen</ce:surname></ce:author><ce:affiliation id=\"af0005\"><ce:textfn id=\"tn0010\">Institute of Biophotonics, School of Biomedical Science and Engineering, and Biophotonics &amp; Molecular Imaging Research Center (BMIRC), National Yang-Ming University, Taipei 112, Taiwan</ce:textfn><sa:affiliation><sa:organization>Institute of Biophotonics</sa:organization><sa:organization>School of Biomedical Science and Engineering</sa:organization><sa:organization>and Biophotonics &amp; Molecular Imaging Research Center (BMIRC)</sa:organization><sa:organization>National Yang-Ming University</sa:organization><sa:city>Taipei</sa:city><sa:postal-code>112</sa:postal-code><sa:country>Taiwan</sa:country></sa:affiliation></ce:affiliation><ce:correspondence id=\"cr0005\"><ce:label>⁎</ce:label><ce:text id=\"tx0005\">Corresponding author at: Institute of Biophotonics, School of Biomedical Science and Engineering, National Yang-Ming University, 155, Li-Non St., Sec. 2, Taipei 112, Taiwan. Tel.: +<ce:hsp sp=\"0.10\"/>886 2 2826 7394; fax: +<ce:hsp sp=\"0.10\"/>886 2 2823 5460.</ce:text></ce:correspondence></ce:author-group><ce:date-received day=\"5\" month=\"6\" year=\"2013\"/><ce:date-revised day=\"6\" month=\"8\" year=\"2013\"/><ce:date-accepted day=\"9\" month=\"8\" year=\"2013\"/><ce:abstract id=\"ab0005\" view=\"all\" class=\"author\"><ce:section-title id=\"st0005\">Abstract</ce:section-title><ce:abstract-sec id=\"as0005\" view=\"all\"><ce:simple-para id=\"sp0005\" view=\"all\">Viral channel forming proteins are known for their capability to make the lipid membrane of the host cell and its subcellular compartments permeable to ions and small compounds. There is increasing evidence that some of the representatives of this class of proteins are also strongly interacting with host proteins and the effectiveness of this interaction seems to be high. Interaction of viral channel proteins with host factors has been proposed by bioinformatics approaches and has also been identified experimentally. An overview of the interactions with host proteins is given for Vpu from HIV-1, E5 from HPV-16 and p7 from HCV. This article is part of a Special Issue entitled: Viral Membrane Proteins — Channels for Cellular Networking.</ce:simple-para></ce:abstract-sec></ce:abstract><ce:abstract class=\"graphical\" id=\"ab0010\" view=\"all\"><ce:section-title id=\"st0010\">Graphical abstract</ce:section-title><ce:abstract-sec id=\"as0010\" view=\"all\"><ce:simple-para id=\"sp0030\" view=\"all\"><ce:display><ce:figure id=\"f0005\"><ce:link locator=\"fx1\" id=\"lk0015\"/></ce:figure></ce:display></ce:simple-para></ce:abstract-sec></ce:abstract><ce:abstract class=\"author-highlights\" id=\"ab0015\" view=\"all\"><ce:section-title id=\"st0015\">Highlights</ce:section-title><ce:abstract-sec id=\"as0015\" view=\"all\"><ce:simple-para id=\"sp0010\" view=\"all\"><ce:list id=\"l0010\"><ce:list-item id=\"u0020\"><ce:label>•</ce:label><ce:para id=\"p0310\" view=\"all\">Known and predicted interactions of viral channel proteins with host proteins</ce:para></ce:list-item><ce:list-item id=\"u0025\"><ce:label>•</ce:label><ce:para id=\"p0315\" view=\"all\">Interactions of the TMDs of viral proteins with host proteins</ce:para></ce:list-item><ce:list-item id=\"u0030\"><ce:label>•</ce:label><ce:para id=\"p0320\" view=\"all\">Vpu of HIV1, E5 of HPV and p7 of HCV</ce:para></ce:list-item></ce:list></ce:simple-para></ce:abstract-sec></ce:abstract><ce:keywords id=\"ks0005\" view=\"all\" class=\"keyword\"><ce:section-title id=\"st0020\">Keywords</ce:section-title><ce:keyword id=\"kw0030\"><ce:text id=\"tx0010\">Viral-host protein–protein interaction</ce:text></ce:keyword><ce:keyword id=\"kw0035\"><ce:text id=\"tx0015\">Viral channel proteins</ce:text></ce:keyword><ce:keyword id=\"kw0040\"><ce:text id=\"tx0020\">Vpu of HIV-1</ce:text></ce:keyword><ce:keyword id=\"kw0045\"><ce:text id=\"tx0025\">E5 of HPV16</ce:text></ce:keyword><ce:keyword id=\"kw0050\"><ce:text id=\"tx0030\">p7 of HCV</ce:text></ce:keyword></ce:keywords></head><body view=\"all\"><ce:sections><ce:section id=\"s0005\" view=\"all\"><ce:label>1</ce:label><ce:section-title id=\"st0025\">Introduction</ce:section-title><ce:para id=\"p0005\" view=\"all\">Viruses hijack the cell just using their proteins and DNA/RNA. By steering the cell viruses improve their own replication. The improvement could be an alteration of ion and substrate concentrations in cellular sub-compartments, the generation of additional cellular sub-compartments, the suppression of cellular defense system and the stimulation of cell growth factors. The virus does not produce viral hormones to conduct these tasks. The only known mechanism of retroviral proteins is through viral-host protein–protein interactions.</ce:para><ce:para id=\"p0010\" view=\"all\">Viral globular and membrane proteins are used for reproduction and steering of host factors. For the latter, interaction is not only between extramembrane parts of viral and host proteins but also between the transmembrane domains. The membrane allows electrochemical gradients to be generated. With membrane proteins the stored energy can be harvested to drive viral replication. A large number of viruses are identified to harbor short membrane proteins with one to three transmembrane spanning domains able to exploit electrochemical or substrate gradients in the host cell. A major characteristic of these proteins is that they form oligomers similar to their cellular ion channel companions but are very much smaller in size. It is these two issues, cellular steering of host proteins and channel formation, within the lipid membrane which make these proteins a highly attractive topic to investigate. In addition some of these proteins have emerged already as highly important drug targets.</ce:para><ce:para id=\"p0015\" view=\"all\">Investigations of viral membrane proteins have seen the emergence of research focusing on ‘viral channel forming proteins’ <ce:cross-refs refid=\"bb0005 bb0010\" id=\"cf0155\">[1,2]</ce:cross-refs>, also named as ‘viroporins’ <ce:cross-refs refid=\"bb0015 bb0020\" id=\"cf0160\">[3,4]</ce:cross-refs>, which are identified to render lipid membranes permeable to ions and substrates <ce:cross-ref refid=\"bb0025\" id=\"cf0165\">[5]</ce:cross-ref>. One of these proteins, M2 from influenza A, has been a major antiviral drug target. Stimulated by the importance of this protein, a successful search for viral channel proteins has been intensified and lead to an increasing number of potential candidates <ce:cross-refs refid=\"bb0010 bb0030\" id=\"cf0170\">[2,6]</ce:cross-refs>. Viral channels are formed by either bitopic, or polytopic membrane proteins with 2 and 3 TMDs (<ce:cross-ref refid=\"f0010\" id=\"cf9280\">Fig. 1</ce:cross-ref><ce:float-anchor refid=\"f0010\"/>). For most of these viral channel proteins their role within the infectivity cycle is yet to be identified.</ce:para><ce:para id=\"p0020\" view=\"all\">Within the family of viral channel proteins, Vpu from HIV-1 is one of the most controversial channel proteins. Despite the identification of this protein to form channels in artificial bilayers <ce:cross-ref refid=\"bb0035\" id=\"cf0175\">[7]</ce:cross-ref> and to increase conductivity in infected <ce:italic>Xenopus</ce:italic> oocytes <ce:cross-refs refid=\"bb0035 bb0040\" id=\"cf0180\">[7,8]</ce:cross-refs>, its role as a channel has not yet been identified (see K. Strebel, this issue). At the same time of its identification to form ion channels, its role to down-regulate receptor proteins has been found <ce:cross-refs refid=\"bb0045 bb0050\" id=\"cf0185\">[9,10]</ce:cross-refs> (<ce:cross-ref refid=\"f0010\" id=\"cf8280\">Fig. 1</ce:cross-ref>). Within recent years the number of host factors been manipulated by Vpu has risen. With the classification of E5 from HPV to be a viral channel protein in 2012 <ce:cross-ref refid=\"bb0055\" id=\"cf0190\">[11]</ce:cross-ref>, there seems to be a most recent ‘novel’ member of the channel family. Before that time in 2012, E5 has actually been known for a long time for its role as a host factor manipulator interacting with host proteins.</ce:para><ce:para id=\"p0025\" view=\"all\">Thus the question arises, are the virus-encoded channel proteins a single task-unit or can they adopt multiple roles? It is still not clear whether structurally distinct features such as orientation or state of oligomerization of the proteins are necessary to fulfill the tasks or whether there is equilibrium between the different features (<ce:cross-ref refid=\"f0015\" id=\"cf9465\">Fig.\\xa02</ce:cross-ref><ce:float-anchor refid=\"f0015\"/>).</ce:para><ce:para id=\"p0030\" view=\"all\">In this review the focus is on Vpu of HIV-1, E5 of HPV and p7 of HCV for which the interactions with host factors have been experimentally identified or have been proposed by bioinformatics approaches.</ce:para></ce:section><ce:section id=\"s0015\" view=\"all\"><ce:label>2</ce:label><ce:section-title id=\"st0045\">Vpu of human immunodeficiency virus type 1</ce:section-title><ce:para id=\"p0040\" view=\"all\">Vpu is a bitopic 81 amino acid type I membrane protein expressed in the late life cycle of human immunodeficiency virus type 1 <ce:cross-refs refid=\"bb0060 bb0065\" id=\"cf0195\">[12,13]</ce:cross-refs>. Its role in the infectivity cycle is to enhance particle release <ce:italic>via</ce:italic> interaction with host factors and also <ce:italic>via</ce:italic> channel functionality (see recent reviews <ce:cross-refs refid=\"bb0010 bb0020\" id=\"cf0200\">[2,4]</ce:cross-refs>). Its short N terminal extramembrane part of a few amino acids leads into a transmembrane domain (TMD) which is highly hydrophobic, consisting of a single leucine and multiple isoleucines and valines. It harbors a single hydrophilic residue, Ser-24, proceeded by Trp-23. The sequence then enters into the cytoplasmic domain <ce:italic>via</ce:italic> an EYR-motif which probably functions as a hinge between the two domains. Serines at positions 52 and 56 are identified to be phosphorylated <ce:cross-ref refid=\"bb0050\" id=\"cf0205\">[10]</ce:cross-ref>.</ce:para><ce:para id=\"p0045\" view=\"all\">The capability to form channels has been discovered using electrophysiological measurements on artificial lipid bilayers <ce:cross-ref refid=\"bb0035\" id=\"cf0210\">[7]</ce:cross-ref>. Independently channel activity has been confirmed also by other groups using the same techniques <ce:cross-ref refid=\"bb0070\" id=\"cf0215\">[14]</ce:cross-ref>. The protein has been identified to generate a weakly selective pore <ce:cross-refs refid=\"bb0035 bb0070 bb0075 bb0080\" id=\"cf0220\">[7,14–16]</ce:cross-refs>. Mutations within the TMD of the protein are altering channel kinetics <ce:cross-refs refid=\"bb0035 bb0080\" id=\"cf0225\">[7,16]</ce:cross-refs>. In particular, mutating Ser-24 leads to an abrogation of channel activity of a respective peptide corresponding to the TMD of Vpu <ce:cross-ref refid=\"bb0080\" id=\"cf0230\">[16]</ce:cross-ref>. Evidence of Vpu mediated leakage of small molecules from <ce:italic>Escherichia coli</ce:italic> has also been reported <ce:cross-ref refid=\"bb0085\" id=\"cf0235\">[17]</ce:cross-ref>. Physiological measurements on Vpu expressed in <ce:italic>Xenopus</ce:italic> oocytes and 293T cells support the ability of the protein to form channels <ce:cross-refs refid=\"bb0035 bb0090\" id=\"cf0240\">[7,18]</ce:cross-refs>.</ce:para><ce:para id=\"p0050\" view=\"all\">Summarizing the evidences, up to now all channel characteristics are based on peptides and full length proteins reconstituted into artificial lipid membranes or when over expressing a Vpu containing plasmid in cells.</ce:para><ce:para id=\"p0055\" view=\"all\">Identification of channel formation of Vpu has had implications on the computational modeling of the protein. The first computational model of the membrane embedded part of Vpu is a pentameric assembly of the helical TMDs <ce:cross-ref refid=\"bb0095\" id=\"cf0245\">[19]</ce:cross-ref> (<ce:cross-ref refid=\"f0010\" id=\"cf7280\">Fig. 1</ce:cross-ref>A). The helical motif has been chosen in analogy to the M2 channel from influenza A. With the bundle model ion selectivity has been proposed on a structural level by calculating potential energy profiles of Na and Cl ions along the bundle axis. These data have later been confirmed when calculating the potential of mean force for monovalent ions being pulled through a pentameric TMD bundle <ce:cross-ref refid=\"bb0100\" id=\"cf0250\">[20]</ce:cross-ref>. In another study combining bilayer recordings with computational modeling a tetrameric bundle, based on modeling the TMD, has been discarded <ce:cross-ref refid=\"bb0105\" id=\"cf0255\">[21]</ce:cross-ref>. Molecular dynamics simulations have also revealed that hexameric bundles of the TMDs do not remain in a pore like structure when simulated for several nanoseconds <ce:cross-ref refid=\"bb0110\" id=\"cf0260\">[22]</ce:cross-ref>. Also other assemblies, pentameric and tetrameric bundles, do not remain in a bundle structure when simulated for longer time scales <ce:cross-ref refid=\"bb0115\" id=\"cf0265\">[23]</ce:cross-ref>.</ce:para><ce:section id=\"s0020\" view=\"all\"><ce:label>2.1</ce:label><ce:section-title id=\"st0050\">Interaction with CD4</ce:section-title><ce:para id=\"p0065\" view=\"all\">Almost parallel to the emerging evidences that Vpu forms a channel it has been discovered that Vpu down-regulates the receptor protein CD4 (<ce:cross-ref refid=\"f0010\" id=\"cf6280\">Fig. 1</ce:cross-ref>A) from the infected cell <ce:cross-refs refid=\"bb0045 bb0120 bb0125 bb0130\" id=\"cf0275\">[9,24–26]</ce:cross-refs> reviewed in <ce:cross-ref refid=\"bb0125\" id=\"cf0280\">[25]</ce:cross-ref> (<ce:cross-ref refid=\"t0005\" id=\"cf0285\">Table\\xa01</ce:cross-ref><ce:float-anchor refid=\"t0005\"/>). For the down-regulation, the two phosphorylation sites, Ser-52 and Ser-56, have been found to be essential as well as an interaction with the cytoplasmic domain of CD4 <ce:cross-ref refid=\"bb0135\" id=\"cf0290\">[27]</ce:cross-ref>. Without the phosphorous groups, Vpu is still able to contact CD4, but down-regulation is hampered <ce:cross-refs refid=\"bb0050 bb0120 bb0140\" id=\"cf0295\">[10,24,28]</ce:cross-refs>. Mutation studies on both CD4 and Vpu have identified structural and sequence specific motifs on both proteins which seem to be essential for interaction. It has been reported that a stretch in CD4, Arg-396 to Lys-417, is predicted to be helical and essential for phosphorylation-dependent down-regulation of CD4 <ce:cross-ref refid=\"bb0145\" id=\"cf0300\">[29]</ce:cross-ref>. Solution NMR spectroscopic data of a CD4 mutant construct recorded in micelles confirm a helical motif of the membrane-proximal cytoplasmic stretch Ala-404 to Leu-413 of CD4 <ce:cross-ref refid=\"bb0150\" id=\"cf0305\">[30]</ce:cross-ref>. A deletion mutant of CD4 in this region identifies the stretch, KRLLSEKKT, in this cytoplasmic domain to be essential for the Vpu binding <ce:cross-ref refid=\"bb0155\" id=\"cf0310\">[31]</ce:cross-ref>. Substitution mutations in this region have not resulted in abrogation of Vpu binding. Therefore, it has been suggested that the mutations may have not led to a derangement of the helical motif and that this motif is important for proper interaction with Vpu. As far as Vpu is concerned it is reported that both cytoplasmic helices are involved in CD4 down-regulation <ce:cross-ref refid=\"bb0155\" id=\"cf0315\">[31]</ce:cross-ref>. Especially when short specific amino acid sequences within the first cytoplasmic helix of Vpu are mutated, e.g. the short stretches YRK or DRLI, as well as the single mutation L63P, Vpu loses its capability to down-regulate CD4. Since all the mutations are generated to disrupt the helical motif it is concluded that for Vpu-mediated CD4 down-regulation a helix–helix interaction motif is essential.</ce:para><ce:para id=\"p0070\" view=\"all\">The structure of the cytoplasmic domain of Vpu as a whole and also individual parts of this domain have been deciphered by various authors using different techniques such as solution <ce:cross-refs refid=\"bb0160 bb0165 bb0170 bb0175\" id=\"cf0320\">[32–35]</ce:cross-refs> and solid state NMR spectroscopy <ce:cross-refs refid=\"bb0180 bb0185\" id=\"cf0325\">[36,37]</ce:cross-refs>, as well as CD spectroscopy <ce:cross-refs refid=\"bb0160 bb0175\" id=\"cf0330\">[32,35]</ce:cross-refs>. The current structural model of Vpu is comprised of a helical TMD, linked to the cytoplasmic domain consisting of two helices, called 1 and 2. While solid state NMR spectroscopic data give evidence that both helices align parallel to the surface of the lipid membrane <ce:cross-refs refid=\"bb0180 bb0185\" id=\"cf0335\">[36,37]</ce:cross-refs>, solution NMR study also suggests a more globular alignment of these helices <ce:cross-ref refid=\"bb0170\" id=\"cf0340\">[34]</ce:cross-ref>.</ce:para></ce:section><ce:section id=\"s0025\" view=\"all\"><ce:label>2.2</ce:label><ce:section-title id=\"st0090\">Interaction with TASK</ce:section-title><ce:para id=\"p0080\" view=\"all\">Evidence that Vpu interacts not only with itself and CD4 derives from an investigation in which it has been shown that Vpu also interacts with the TWIK-related acid-sensitive K<ce:sup loc=\"post\">+</ce:sup> channel (TASK) and blocks its activity <ce:cross-ref refid=\"bb0190\" id=\"cf0345\">[38]</ce:cross-ref> (TWIK stands for tandem pore weakly inward rectifying K channel). Sequence similarity with the first TMD of TASK suggests that Vpu replaces the TASK–TMD and with this impairs the function of TASK. It is found that the consequence of the interaction is a depolarization of the membrane potential <ce:cross-ref refid=\"bb0195\" id=\"cf0350\">[39]</ce:cross-ref>. Since it could be shown that membrane depolarization <ce:italic>per se</ce:italic> enhances viral release, it is proposed that the effect of Vpu is, to stimulate budding by mediating depolarization of the plasma membrane. In a more recent study based on cell growth assays with yeast and a K<ce:sup loc=\"post\">+</ce:sup>-uptake deficient strain the depolarization effect by modulation of the K-ion concentration is attributed to Vpu to form channels <ce:cross-ref refid=\"bb0200\" id=\"cf0355\">[40]</ce:cross-ref>.</ce:para></ce:section><ce:section id=\"s0030\" view=\"all\"><ce:label>2.3</ce:label><ce:section-title id=\"st0095\">Interaction with BST-2</ce:section-title><ce:para id=\"p0090\" view=\"all\">Another membrane protein with which Vpu interacts <ce:italic>via</ce:italic> its TMDs is the interferon induced CD317/tetherin/BST-2 <ce:cross-refs refid=\"bb0205 bb0210 bb0215 bb0220 bb0225\" id=\"cf0360\">[41–45]</ce:cross-refs> (<ce:cross-ref refid=\"t0005\" id=\"cf0365\">Table\\xa01</ce:cross-ref>). BST-2 dimerizes and is incorporated into lipid rafts <ce:cross-ref refid=\"bb0230\" id=\"cf0370\">[46]</ce:cross-ref>. BST-2 is known to inhibit viral release by tethering virions to the infected cell surface <ce:cross-refs refid=\"bb0205 bb0210\" id=\"cf0375\">[41,42]</ce:cross-refs>. Vpu recruits the β-TrCP ubiquitin ligase complex which leads to ubiquitination and consequent down-regulation of BST-2. The simultaneous phosphorylation of both serines, Ser-52 and Ser-56 of Vpu, are essential for this mechanism <ce:cross-ref refid=\"bb0235\" id=\"cf0380\">[47]</ce:cross-ref>. Important to note is that for the interaction of Vpu with BST-2 the TMDs of both proteins have been found to be relevant (<ce:cross-ref refid=\"f0005\" id=\"cf8460\">Fig. 1</ce:cross-ref>A). It has been shown that with a special Vpu mutant in which the only serine (Ser-23) within the TMD is replaced by a leucine or alanine the down-regulation is not being affected <ce:cross-refs refid=\"bb0090 bb0240\" id=\"cf0385\">[18,48]</ce:cross-refs>. These experiments indicate that the down-regulation is independent of ion channel functionality since this mutation impairs channel activity <ce:cross-ref refid=\"bb0080\" id=\"cf0390\">[16]</ce:cross-ref>. Within the TMD of Vpu alanine residues (Ala-18 and -14) are sensitive to the mode of action <ce:cross-refs refid=\"bb0090 bb0240\" id=\"cf0395\">[18,48]</ce:cross-refs> which has sparked the development of a pharmacophore model <ce:cross-ref refid=\"bb0245\" id=\"cf0400\">[49]</ce:cross-ref>. First NMR spectroscopic data show evidence of the binding of BST-2 TMD with the alanine rim of Vpu <ce:cross-ref refid=\"bb0250\" id=\"cf0405\">[50]</ce:cross-ref>. In another study the triple isoleucine motif, Ile-15, Ile-16, and Ile-17, has been proposed to be an essential site for the interaction with BST-2 <ce:cross-ref refid=\"bb0255\" id=\"cf0410\">[51]</ce:cross-ref>.</ce:para></ce:section><ce:section id=\"s0035\" view=\"all\"><ce:label>2.4</ce:label><ce:section-title id=\"st0100\">Interaction with NTB-A</ce:section-title><ce:para id=\"p0100\" view=\"all\">Most recently it has been verified that Vpu is involved in down- modulation of a membrane protein in infected cells relevant for the activation of natural killer (NK) cells <ce:cross-ref refid=\"bb0260\" id=\"cf0415\">[52]</ce:cross-ref> (<ce:cross-ref refid=\"t0005\" id=\"cf0420\">Table\\xa01</ce:cross-ref>). NK cells are part of the immune system and able to attack infected cells without being exposed to infected cells ever before. In the case of Vpu, infected T-cells activate the members of the signaling lymphocytic activation molecule (SLM) receptor family. One of these members is the type I integral membrane protein NTB-A, natural killer-T-and-B cell antigen, which acts as a co-activating receptor for NK cells to initiate degranulation. It has been shown that Vpu down-modulates this protein <ce:cross-ref refid=\"bb0265\" id=\"cf0425\">[53]</ce:cross-ref>. In contrast to the down modulation of CD4 and BST-2 the phosphorylated cytoplasmic sites (Ser-52 and Ser-56) of Vpu are not essential. The down-modulation is not following the proteasomal pathway. It is therefore speculated that in the presence of Vpu NTB-A is not reaching the cell membrane. Important to note is that the mode of action is similar to BST-2, as much as the TMD of NTB-A is responsible for it (<ce:cross-ref refid=\"f0005\" id=\"cf8960\">Fig. 1</ce:cross-ref>A). Experiments with a scrambled TMD sequence of Vpu, similar to the one used before by others <ce:cross-ref refid=\"bb0035\" id=\"cf0430\">[7]</ce:cross-ref>, down-modulation is not observed.</ce:para></ce:section><ce:section id=\"s0040\" view=\"all\"><ce:label>2.5</ce:label><ce:section-title id=\"st0105\">Interaction with CD74</ce:section-title><ce:para id=\"p0110\" view=\"all\">The two major histocompatibility complexes (MHC) I <ce:cross-ref refid=\"bb0270\" id=\"cf0435\">[54]</ce:cross-ref> and the MHC II invariant chain (Ii), also called CD74, and a precursor of a peptide presenting MHC II (pMCH II) <ce:cross-ref refid=\"bb0275\" id=\"cf0440\">[55]</ce:cross-ref>, are reported to be down-regulated by the involvement of Vpu. MHC proteins, class I proteins, are essential to report the host-own character of the cell and are also essential for presenting peptide antigens to initiate CD8<ce:hsp sp=\"0.10\"/>+ T cells for defense <ce:cross-ref refid=\"bb0280\" id=\"cf0445\">[56]</ce:cross-ref>. Interaction of the cytoplasmic domain of Vpu with both MHC proteins is proposed to be necessary.</ce:para></ce:section><ce:section id=\"s0045\" view=\"all\"><ce:label>2.6</ce:label><ce:section-title id=\"st0110\">Interaction with TPR</ce:section-title><ce:para id=\"p0120\" view=\"all\">A member of the tetratricopeptide repeat (TPR) protein family has also been reported to interact with Vpu <ce:cross-ref refid=\"bb0285\" id=\"cf0450\">[57]</ce:cross-ref>. The 41<ce:hsp sp=\"0.25\"/>kDa protein contains four copies of a 34-amino acid TPR motif which interacts with Vpu. The protein is named as Vpu-binding protein (UBP). Its role is to interfere with the interaction of UBP with HIV-1 Gag protein. A site of Vpu-UBP interaction has not yet been identified.</ce:para></ce:section><ce:section id=\"s0050\" view=\"all\"><ce:label>2.7</ce:label><ce:section-title id=\"st0115\">Motifs for protein–protein interaction in Vpu</ce:section-title><ce:para id=\"p0130\" view=\"all\">In a bioinformatics approach short eukaryotic linear motifs (ELMs) relevant for protein–protein interactions between host proteins are proposed to be present in HIV-1 proteins <ce:cross-ref refid=\"bb0290\" id=\"cf0455\">[58]</ce:cross-ref>. Among the few ELMs suggested for Vpu, one motif, TRG_LysEnd_APsACLL_1 (pattern: [DERQ]…L[LVI], <ce:inter-ref xlink:href=\"http://elm.eu.org/\" id=\"ir0020\" xlink:type=\"simple\">http://elm.eu.org/</ce:inter-ref>), is a common motif in type I integral membrane proteins and found in their membrane–water interfacial regions. It seems to be evident, that Vpu harbors motifs common for protein–protein interaction and thus, a considerable role of Vpu\\'s should comprise indeed the steering of the host cell <ce:italic>via</ce:italic> this type of interaction (<ce:cross-ref refid=\"f0015\" id=\"cf0460\">Fig.\\xa02</ce:cross-ref>).</ce:para><ce:para id=\"p0135\" view=\"all\">At this stage of research the mode of action, as to interact with membrane proteins of the host to steer cellular function and with it the survival of the virus, is well established. In as much ion channel function is essential for the role of viral release enhancement is still under debate.</ce:para></ce:section></ce:section><ce:section id=\"s0055\" view=\"all\"><ce:label>3</ce:label><ce:section-title id=\"st0080\">E5 of human papillomavirus 16</ce:section-title><ce:para id=\"p0145\" view=\"all\">Human papilloma virus (HPV) plays an important role in the pathogenesis of warts, and cancers of the skin, cervical <ce:cross-ref refid=\"bb0295\" id=\"cf0465\">[59]</ce:cross-ref> and anogenital tract <ce:cross-refs refid=\"bb0300 bb0305\" id=\"cf0470\">[60,61]</ce:cross-refs>. In the case of cervical carcinoma subtype HPV-16 belongs to the ‘high risk’ subgroup which is highly associated with the development of cervical cancer induced by infection with the virus. The genome of HPV-16 encodes a number of proteins which are expressed in the early stage of viral infection and found to be oncogenic, E6, E7 <ce:cross-refs refid=\"bb0310 bb0315\" id=\"cf0475\">[62,63]</ce:cross-refs> and E5 <ce:cross-refs refid=\"bb0320 bb0325\" id=\"cf0480\">[64,65]</ce:cross-refs>. In contrast to E6 and E7, expression of E5 is often suppressed later when the genome of HPV-16 is integrated into the host cell genome during progression to malignant disease <ce:cross-refs refid=\"bb0330 bb0335\" id=\"cf0485\">[66,67]</ce:cross-refs>. Therefore E5 is considered to be essential in the early stage of infection <ce:cross-ref refid=\"bb0340\" id=\"cf0490\">[68]</ce:cross-ref>. There is increasing evidence that the three proteins have synergistic effects for some mechanisms within the viral infectivity cycle <ce:cross-ref refid=\"bb0345\" id=\"cf0495\">[69]</ce:cross-ref></ce:para><ce:para id=\"p0150\" view=\"all\">E5 is an 83 amino acid polytopic membrane protein harboring three TMDs and located at the Golgi apparatus, endoplasmic reticulum and nuclear membrane (<ce:cross-ref refid=\"f0005\" id=\"cf9460\">Fig. 1</ce:cross-ref>B, left). A shorter 44 amino acid bitopic E5 protein of bovine papilloma virus (BPV) with its TMD at the N terminal side shares 27% sequence homology with this protein as well as a leucine rich motif at both of their N termini <ce:cross-refs refid=\"bb0350 bb0355\" id=\"cf0500\">[70,71]</ce:cross-refs>. Analysis of the sequence of HPV-16 E5 sequence using the Kyte–Doolittle scale of hydrophobicity identifies the three putative TMDs <ce:cross-ref refid=\"bb0360\" id=\"cf0505\">[72]</ce:cross-ref>. E5 dimerizes on the bases of hydrophobic interactions of its TMDs <ce:cross-ref refid=\"bb0365\" id=\"cf0510\">[73]</ce:cross-ref>, possibly in a concentration dependent manner <ce:cross-ref refid=\"bb0370\" id=\"cf0515\">[74]</ce:cross-ref>. Deletion studies could not single out one TMD responsible for dimerization <ce:cross-ref refid=\"bb0365\" id=\"cf0520\">[73]</ce:cross-ref>. Dimerization is not driven by the cysteines present at the N terminal side and near the C terminus since reducing agents do not affect the capability of E5 to form dimers <ce:cross-ref refid=\"bb0360\" id=\"cf0525\">[72]</ce:cross-ref>. Experiments with epitope tagged E5 at both of its ends reveal that its N-terminal side is located toward the ER while its C-terminus is exposed to the cytoplasm <ce:cross-ref refid=\"bb0370\" id=\"cf0530\">[74]</ce:cross-ref>. FTIR spectroscopic investigations of short peptide constructs, which include the putative TMDs, suggest TMDs to be helical <ce:cross-ref refid=\"bb0375\" id=\"cf0535\">[75]</ce:cross-ref>. The peptides have been derived from solid phase peptide synthesis (SPPS) and dissolved in buffer/trifluoroethanol (TFE) mixture (90<ce:hsp sp=\"0.25\"/>μl/10<ce:hsp sp=\"0.25\"/>μl). In a similar way, CD-spectroscopic analysis has been done with peptide constructs including the putative TMDs derived from SPPS dissolved in various mixtures of buffer/TFE <ce:cross-ref refid=\"bb0380\" id=\"cf0540\">[76]</ce:cross-ref>. Besides spectra recordings in different solvent mixtures, also a series of mixtures of the individual peptides have been measured. The data suggest a large β-sheet content for the first and third TMDs and irregular structure for the second TMD. Due to the large content of leucines in the first and third TMDs the authors relate the structural motif to leucine-rich repeat (LRR) proteins which typically adopt a large content of β-fold. Secondary structure prediction programs for both, helical and β-sheet structure propose a helical motif for the three TMDs (Mahato and Fischer unpublished results). Despite the application of almost membrane like conditions using TFE <ce:cross-ref refid=\"bb0380\" id=\"cf0545\">[76]</ce:cross-ref> it is necessary to include more thorough lipid-membrane like conditions in future experiments to unravel the discrepancy in the experimental results reported above.</ce:para><ce:para id=\"p0155\" view=\"all\">Recently, it has been proposed that E5 exhibits channel activity using fluorescent dye release assays with liposomes <ce:cross-ref refid=\"bb0055\" id=\"cf0550\">[11]</ce:cross-ref>. Channel activity has been shown to be sensitive to pH, which could possibly be related to the histidines present in TMD3. The pore size is proposed to be in a range of 1.2 to 2.8<ce:hsp sp=\"0.25\"/>nm using fluorescein isothiocyanate conjugated dextrans of various molecular masses in the liposome assay. Based on SDS PAGE analysis the oligomeric state of HPV-16 E5 is suggested to be hexameric and modeled accordingly with a monomeric unit consisting of three TMDs (<ce:cross-ref refid=\"f0005\" id=\"cf8490\">Fig. 1</ce:cross-ref>B, right). It could be shown that rimantadine and a series of novel compounds (named MV003 and MV006) block channel activity.</ce:para><ce:para id=\"p0160\" view=\"all\">Similar to Vpu, E5 exerts multiple functions (<ce:cross-refs refid=\"bb0385 bb0390\" id=\"cf0555\">[77,78]</ce:cross-refs> see for review <ce:cross-refs refid=\"bb0355 bb0395\" id=\"cf0560\">[71,79]</ce:cross-refs>).</ce:para><ce:para id=\"p0165\" view=\"all\">The following host proteins are identified to be involved in protein–protein interaction with E5 (<ce:cross-ref refid=\"t0005\" id=\"cf0565\">Table\\xa01</ce:cross-ref>).</ce:para><ce:section id=\"s0060\" view=\"all\"><ce:label>3.1</ce:label><ce:section-title id=\"st0085\">Interaction with 16<ce:hsp sp=\"0.25\"/>kDa protein</ce:section-title><ce:para id=\"p0175\" view=\"all\">Similar to E5 of BPV, HPV-16 E5 interacts with the 16-kDa pore-forming protein component of the vacuolar H<ce:sup loc=\"post\">+</ce:sup>-ATPase <ce:cross-refs refid=\"bb0350 bb0400\" id=\"cf0570\">[70,80]</ce:cross-refs>. Mutant studies with E5 of BPV show that glutamine residue at position 17 is essential for the interaction <ce:cross-ref refid=\"bb0400\" id=\"cf0575\">[80]</ce:cross-ref>. In the case of HPV-16 E5 it seems that the hydrophobicity of TMD2 is important for the interaction <ce:cross-ref refid=\"bb0405\" id=\"cf0580\">[81]</ce:cross-ref> as well as TMD3 <ce:cross-ref refid=\"bb0410\" id=\"cf0585\">[82]</ce:cross-ref>. With a series of E5 mutants (Y63F/Y68F, H75N, H77Q, H75F/H78Q) it could be shown that the tyrosines and histidines are comprising a binding motif of E5 with 16<ce:hsp sp=\"0.25\"/>kDa protein.</ce:para></ce:section><ce:section id=\"s0065\" view=\"all\"><ce:label>3.2</ce:label><ce:section-title id=\"st0120\">Interaction with HLA-I</ce:section-title><ce:para id=\"p0185\" view=\"all\">Down-regulation of the human leukocyte antigens (HLA) class I is observed in HPV-16 E5 expressing cell lines <ce:cross-ref refid=\"bb0415\" id=\"cf0590\">[83]</ce:cross-ref>, which parallels the same activity of E5 BPV <ce:cross-ref refid=\"bb0420\" id=\"cf0595\">[84]</ce:cross-ref>. It is proposed that the first hydrophobic domain of E5 is interacting with the heavy chain of HLA-I <ce:cross-ref refid=\"bb0425\" id=\"cf0600\">[85]</ce:cross-ref>. In another study it is shown that HPV-16 E5 and HLA-I co-precipitates together with calnexin and identifies the first TMD of E5 to be involved in the association <ce:cross-ref refid=\"bb0430\" id=\"cf0605\">[86]</ce:cross-ref>. Mutating three leucine residues to proline, aspartate and arginine (triple mutant L18P/L23D/L28R) within TMD1 abrogates interaction with calnexin and down-regulation of HLA-I.</ce:para><ce:para id=\"p0190\" view=\"all\">In case of interaction of E5 with HLA-I and the 16<ce:hsp sp=\"0.25\"/>kDa protein via the first and the last two TMDs, respectively, a simultaneous binding of a single E5 protein with both proteins is proposed <ce:cross-ref refid=\"bb0425\" id=\"cf0610\">[85]</ce:cross-ref>.</ce:para></ce:section><ce:section id=\"s0070\" view=\"all\"><ce:label>3.3</ce:label><ce:section-title id=\"st0125\">Interaction with growth factors EGFR and ErB4</ce:section-title><ce:para id=\"p0200\" view=\"all\">E5 protein of HPV-6 associates with the epidermal growth factor receptor (EGFR), platelet-derived growth factor (PDGF) and ErbB2, but HPV-16 E5 does not <ce:cross-ref refid=\"bb0435\" id=\"cf0615\">[87]</ce:cross-ref>. However, in the presence of HPV-16 E5 recycling of EGFR to the cell surface is increased <ce:cross-ref refid=\"bb0440\" id=\"cf0620\">[88]</ce:cross-ref>. The C terminal part of E5 including the last 5 amino acids is important for binding and initiating over-activation of EGFR <ce:cross-ref refid=\"bb0410\" id=\"cf0625\">[82]</ce:cross-ref>.</ce:para><ce:para id=\"p0205\" view=\"all\">E5 interacts with ErbB4 a member of the tyrosine kinase growth factor family ErbB <ce:cross-ref refid=\"bb0390\" id=\"cf0630\">[78]</ce:cross-ref>. The TMD of ErbB4 and extracellular domains of ErbB4 are necessary for binding. This implies that possibly the TMDs of E5 are involved in the binding.</ce:para></ce:section><ce:section id=\"s0075\" view=\"all\"><ce:label>3.4</ce:label><ce:section-title id=\"st0130\">Promoting perinuclear fusion of membrane koilocytosis</ce:section-title><ce:para id=\"p0215\" view=\"all\">Membrane fusion regulating complex calpactin I is a target of E5 <ce:cross-refs refid=\"bb0345 bb0445\" id=\"cf0635\">[69,89]</ce:cross-refs>. Calpactin I is a heterodimer of two annexin A2 and p11 subunits. Binding <ce:italic>via</ce:italic> its 20 C-terminal amino acids to both subunits of calpactin I, E5 promotes perinuclear redistribution of calpactin I with the consequence of formation of koilocytotic vacuoles by perinuclear membrane fusion. The 20 amino acids of E5 fully include its TMD3. Deletion of only 10 C-terminal amino acids leaves the protein with half of its activity <ce:cross-ref refid=\"bb0345\" id=\"cf0640\">[69]</ce:cross-ref>.</ce:para></ce:section><ce:section id=\"s0080\" view=\"all\"><ce:label>3.5</ce:label><ce:section-title id=\"st0135\">ER transport protein, gap junctions and others</ce:section-title><ce:para id=\"p0225\" view=\"all\">For regulating Bap31, a polytopic B-cell receptor-associated (Bap) membrane protein involved in the export of transmembrane proteins from the ER <ce:cross-ref refid=\"bb0450\" id=\"cf0645\">[90]</ce:cross-ref>, the last 10 amino acids of the C-terminus of E5 are found to be essential <ce:cross-ref refid=\"bb0455\" id=\"cf0650\">[91]</ce:cross-ref>. Similarly, the last 10 amino acids of E5 are also relevant to associate with karyopherin β3, a member of the nuclear import receptor family <ce:cross-ref refid=\"bb0460\" id=\"cf0655\">[92]</ce:cross-ref>. Interference with the stress response of cells in the presence of E5 indicates that especially residues in TMD3 are highly relevant such as His-77 and Tyr-63 <ce:cross-ref refid=\"bb0465\" id=\"cf0660\">[93]</ce:cross-ref>.</ce:para><ce:para id=\"p0230\" view=\"all\">Furthermore, E5 is also involved in down-regulation of connexin 43 <ce:cross-ref refid=\"bb0470\" id=\"cf0665\">[94]</ce:cross-ref> and alteration of lipid composition in infected cells <ce:cross-ref refid=\"bb0475\" id=\"cf0670\">[95]</ce:cross-ref>.</ce:para><ce:para id=\"p0235\" view=\"all\">It has also been predicted that E5 interacts with a series of host factors using bioinformatics approaches based on support vector machine (SVM) models <ce:cross-ref refid=\"bb0480\" id=\"cf0675\">[96]</ce:cross-ref> (<ce:cross-ref refid=\"t0005\" id=\"cf0680\">Table\\xa01</ce:cross-ref>).</ce:para></ce:section></ce:section><ce:section id=\"s0085\" view=\"all\"><ce:label>4</ce:label><ce:section-title id=\"st0140\">p7 of hepatitis C virus</ce:section-title><ce:para id=\"p0245\" view=\"all\">The p7 HCV is expressed as part of a large polyprotein which is cleaved by cellular and viral proteases into ten cleavage products (<ce:cross-refs refid=\"bb0485 bb0490\" id=\"cf0685\">[97,98]</ce:cross-refs>, for a recent review see <ce:cross-ref refid=\"bb0495\" id=\"cf0690\">[99]</ce:cross-ref>). It is a 63 residue, 6-7<ce:hsp sp=\"0.25\"/>kDa polytopic membrane protein with two TMDs linked via a very short loop (<ce:cross-ref refid=\"f0005\" id=\"cf8469\">Fig. 1</ce:cross-ref>C). Its role is expected to be active during entry into the host cell <ce:cross-ref refid=\"bb0500\" id=\"cf0695\">[100]</ce:cross-ref>. Furthermore it is also essential for particle assembly <ce:cross-refs refid=\"bb0505 bb0510\" id=\"cf0700\">[101,102]</ce:cross-refs>. The two TMDs are connected <ce:italic>via</ce:italic> a short hydrophilic segment; both ends of the TMDs are found to point into the ER lumen <ce:cross-ref refid=\"bb0515\" id=\"cf0705\">[103]</ce:cross-ref>. Channel characteristics identify p7 to be a weak cation selective channel <ce:cross-refs refid=\"bb0520 bb0525 bb0530\" id=\"cf0710\">[104–106]</ce:cross-refs> which is sensitive to the presence of Cu<ce:sup loc=\"post\">2<ce:hsp sp=\"0.10\"/>+</ce:sup> <ce:cross-ref refid=\"bb0535\" id=\"cf0715\">[107]</ce:cross-ref> and small ligands <ce:cross-ref refid=\"bb0540\" id=\"cf0720\">[108]</ce:cross-ref>.</ce:para><ce:para id=\"p0250\" view=\"all\">The oligomerization state of p7 is dependent on the protein:detergent ratio (C<ce:inf loc=\"post\">12</ce:inf>E<ce:inf loc=\"post\">8</ce:inf>) when using sedimentation experiments <ce:cross-ref refid=\"bb0525\" id=\"cf0725\">[105]</ce:cross-ref>. At lower ratio a hexameric assembly is proposed which can shift to slightly higher numbers at higher ratios. These findings are supported by cryo EM pictures of assembled p7 proteins in either hexameric or heptameric form <ce:cross-refs refid=\"bb0545 bb0550 bb0555\" id=\"cf0730\">[109–111]</ce:cross-refs>. Structural information is currently still on the bases of NMR spectroscopic investigations suggesting that the overall two TMDs can each be subdivided into two small helical sections\\xa0<ce:cross-refs refid=\"bb0525 bb0560 bb0565\" id=\"cf0735\">[105,112,113]</ce:cross-refs>. Computational models have been generated supporting the role of histidines as pore lining residues <ce:cross-refs refid=\"bb0570 bb0575\" id=\"cf0740\">[114,115]</ce:cross-refs>.</ce:para><ce:para id=\"p0255\" view=\"all\">Interactions of p7 with host factors are proposed using the same bioinformatics approaches as mentioned above <ce:cross-ref refid=\"bb0480\" id=\"cf0745\">[96]</ce:cross-ref>, as well as a genetic screening approach <ce:cross-ref refid=\"bb0580\" id=\"cf0750\">[116]</ce:cross-ref> (<ce:cross-ref refid=\"t0005\" id=\"cf0755\">Table\\xa01</ce:cross-ref>). Some of the host proteins are identified as globular proteins <ce:cross-ref refid=\"bb0580\" id=\"cf0760\">[116]</ce:cross-ref>. The proposed membrane proteins are as follows <ce:cross-ref refid=\"bb0480\" id=\"cf0765\">[96]</ce:cross-ref>:<ce:list id=\"l0005\"><ce:list-item id=\"u0005\"><ce:label>-</ce:label><ce:para id=\"p0295\" view=\"all\">Netrin-G1 ligand (protein binding), which stimulates the growth of embryonic thalamic axons by binding of netrin-G1 <ce:cross-ref refid=\"bb0585\" id=\"cf0770\">[117]</ce:cross-ref> (single TMD)</ce:para></ce:list-item><ce:list-item id=\"u0010\"><ce:label>-</ce:label><ce:para id=\"p0300\" view=\"all\">Preadipocyte factor 1 (growth factor), involved in cell differentiation of adipocytes (reviewed in <ce:cross-ref refid=\"bb0590\" id=\"cf0775\">[118]</ce:cross-ref> (single TMD)</ce:para></ce:list-item><ce:list-item id=\"u0015\"><ce:label>-</ce:label><ce:para id=\"p0305\" view=\"all\">Notches 4 and 2 (cell surface receptors) involved in cell signaling <ce:cross-ref refid=\"bb0595\" id=\"cf0780\">[119]</ce:cross-ref> (single TMD).</ce:para></ce:list-item></ce:list></ce:para><ce:para id=\"p0275\" view=\"all\">Experimental evidence of interactions has not yet been reported but is proposed to play a major role in future drug therapy <ce:cross-ref refid=\"bb0600\" id=\"cf0785\">[120]</ce:cross-ref>.</ce:para></ce:section><ce:section id=\"s0010\" view=\"all\"><ce:label>5</ce:label><ce:section-title id=\"st0030\">Conclusion</ce:section-title><ce:para id=\"p0280\" view=\"all\">The lipid membrane is a unique location for proteins. Similar to the cytoplasm of the cell, it seems to be used for protein–protein communication. The hydrophobic nature of the membrane restrains the application of amino acids being used. Yet, a complicated communication network in respect of specificity of interactions is established. The proteins presented in this review are found to homo-oligomerize and to form dimers and possibly also hetero-oligomers with host factors (<ce:cross-ref refid=\"f0015\" id=\"cf7460\">Fig.\\xa02</ce:cross-ref>). It is fascinating to learn about the directionality of the interactions between these proteins and specifically the interaction between their TMDs. The consequences will be highly important when it comes to manufacture complex membrane proteins or to develop novel concepts in antiviral therapy.</ce:para></ce:section></ce:sections><ce:acknowledgment id=\"ac0005\" view=\"all\"><ce:section-title id=\"st0035\">Acknowledgement</ce:section-title><ce:para id=\"p0285\" view=\"all\">WBF acknowledges the support from the <ce:grant-sponsor id=\"gts0005\" xlink:type=\"simple\" xlink:role=\"http://www.elsevier.com/xml/linking-roles/grant-sponsor\">National Science Council of Taiwan</ce:grant-sponsor> (<ce:grant-number refid=\"gts0005\">NSC98-2112-M-010-002-MY3</ce:grant-number>). RM thanks the Ministry of Education of Taiwan for a fellowship. Helpful and stimulating discussions with Monoj Mon Kalita, Meng-Han Lin, Roman Schilling and Chao-Lung Wang are acknowledged.</ce:para></ce:acknowledgment></body><tail view=\"all\"><ce:bibliography id=\"bi0005\" view=\"all\"><ce:section-title id=\"st0040\">References</ce:section-title><ce:bibliography-sec id=\"bs0005\" view=\"all\"><ce:bib-reference id=\"bb0005\"><ce:label>[1]</ce:label><sb:reference id=\"rf0005\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>W.B.</ce:given-name><ce:surname>Fischer</ce:surname></sb:author><sb:author><ce:given-name>M.S.P.</ce:given-name><ce:surname>Sansom</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Viral ion channels: structure and function</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Biochim. Biophys. Acta</sb:maintitle></sb:title><sb:volume-nr>1561</sb:volume-nr></sb:series><sb:date>2002</sb:date></sb:issue><sb:pages><sb:first-page>27</sb:first-page><sb:last-page>45</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0010\"><ce:label>[2]</ce:label><sb:reference id=\"rf0010\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>W.B.</ce:given-name><ce:surname>Fischer</ce:surname></sb:author><sb:author><ce:given-name>Y.-T.</ce:given-name><ce:surname>Wang</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Schindler</ce:surname></sb:author><sb:author><ce:given-name>C.-P.</ce:given-name><ce:surname>Chen</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Mechanism of function of viral channel proteins and implications for drug development</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Int. Rev. Cell Mol. Biol.</sb:maintitle></sb:title><sb:volume-nr>294</sb:volume-nr></sb:series><sb:date>2012</sb:date></sb:issue><sb:pages><sb:first-page>259</sb:first-page><sb:last-page>321</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0015\"><ce:label>[3]</ce:label><sb:reference id=\"rf0015\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>M.E.</ce:given-name><ce:surname>Gonzales</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Carrasco</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Viroporins</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>FEBS Lett.</sb:maintitle></sb:title><sb:volume-nr>552</sb:volume-nr></sb:series><sb:date>2003</sb:date></sb:issue><sb:pages><sb:first-page>28</sb:first-page><sb:last-page>34</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0020\"><ce:label>[4]</ce:label><sb:reference id=\"rf0020\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>J.L.</ce:given-name><ce:surname>Nieva</ce:surname></sb:author><sb:author><ce:given-name>V.</ce:given-name><ce:surname>Madan</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Carrasco</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Viroporins: structure and biological functions</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nat. Rev. Microbiol.</sb:maintitle></sb:title><sb:volume-nr>10</sb:volume-nr></sb:series><sb:date>2012</sb:date></sb:issue><sb:pages><sb:first-page>563</sb:first-page><sb:last-page>574</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0025\"><ce:label>[5]</ce:label><sb:reference id=\"rf0025\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Carrasco</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Modification of membrane permeability by animal viruses</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Adv. Virus Res.</sb:maintitle></sb:title><sb:volume-nr>45</sb:volume-nr></sb:series><sb:date>1995</sb:date></sb:issue><sb:pages><sb:first-page>61</sb:first-page><sb:last-page>112</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0030\"><ce:label>[6]</ce:label><sb:reference id=\"rf0030\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Wang</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Xie</ce:surname></sb:author><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Sun</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Viral proteins function as ion channels</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Biochim. Biophys. Acta</sb:maintitle></sb:title><sb:volume-nr>1808</sb:volume-nr></sb:series><sb:date>2010</sb:date></sb:issue><sb:pages><sb:first-page>510</sb:first-page><sb:last-page>515</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0035\"><ce:label>[7]</ce:label><sb:reference id=\"rf0035\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>U.</ce:given-name><ce:surname>Schubert</ce:surname></sb:author><sb:author><ce:given-name>A.V.</ce:given-name><ce:surname>Ferrer-Montiel</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Oblatt-Montal</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Henklein</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Strebel</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Montal</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Identification of an ion channel activity of the Vpu transmembrane domain and its involvement in the regulation of virus release from HIV-1-infected cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>FEBS Lett.</sb:maintitle></sb:title><sb:volume-nr>398</sb:volume-nr></sb:series><sb:date>1996</sb:date></sb:issue><sb:pages><sb:first-page>12</sb:first-page><sb:last-page>18</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0040\"><ce:label>[8]</ce:label><sb:reference id=\"rf0040\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>M.J.</ce:given-name><ce:surname>Coady</ce:surname></sb:author><sb:author><ce:given-name>N.G.</ce:given-name><ce:surname>Daniel</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Tiganos</ce:surname></sb:author><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Allain</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Friborg</ce:surname></sb:author><sb:author><ce:given-name>J.-Y.</ce:given-name><ce:surname>Lapointe</ce:surname></sb:author><sb:author><ce:given-name>E.A.</ce:given-name><ce:surname>Cohen</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Effects of Vpu expression on <ce:italic>Xenopus</ce:italic> oocyte membrane conductance</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Virology</sb:maintitle></sb:title><sb:volume-nr>244</sb:volume-nr></sb:series><sb:date>1998</sb:date></sb:issue><sb:pages><sb:first-page>39</sb:first-page><sb:last-page>49</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0045\"><ce:label>[9]</ce:label><sb:reference id=\"rf0045\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>R.L.</ce:given-name><ce:surname>Willey</ce:surname></sb:author><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Maldarelli</ce:surname></sb:author><sb:author><ce:given-name>M.A.</ce:given-name><ce:surname>Martin</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Strebel</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Virol.</sb:maintitle></sb:title><sb:volume-nr>66</sb:volume-nr></sb:series><sb:date>1992</sb:date></sb:issue><sb:pages><sb:first-page>7193</sb:first-page><sb:last-page>7200</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0050\"><ce:label>[10]</ce:label><sb:reference id=\"rf0050\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>U.</ce:given-name><ce:surname>Schubert</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Strebel</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Differential activities of the human immunodeficiency virus type 1-encoded Vpu protein are regulated by phosphorylation and occur in different cellular compartments</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Virol.</sb:maintitle></sb:title><sb:volume-nr>68</sb:volume-nr></sb:series><sb:date>1994</sb:date></sb:issue><sb:pages><sb:first-page>2260</sb:first-page><sb:last-page>2272</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0055\"><ce:label>[11]</ce:label><sb:reference id=\"rf0055\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>L.F.</ce:given-name><ce:surname>Wetherill</ce:surname></sb:author><sb:author><ce:given-name>K.K.</ce:given-name><ce:surname>Holmes</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Verow</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Müller</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Howell</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Harris</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Fishwick</ce:surname></sb:author><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Stonehouse</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Foster</ce:surname></sb:author><sb:author><ce:given-name>G.E.</ce:given-name><ce:surname>Blair</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Griffin</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Macdonald</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>High-risk human papillomavirus E5 oncoprotein displays channel-forming activity sensitive to small-molecule inhibitors</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Virol.</sb:maintitle></sb:title><sb:volume-nr>86</sb:volume-nr></sb:series><sb:date>2012</sb:date></sb:issue><sb:pages><sb:first-page>5341</sb:first-page><sb:last-page>5351</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0060\"><ce:label>[12]</ce:label><sb:reference id=\"rf0060\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Strebel</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Klimkait</ce:surname></sb:author><sb:author><ce:given-name>M.A.</ce:given-name><ce:surname>Martin</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Novel gene of HIV-1, <ce:italic>vpu</ce:italic>, and its 16-kilodalton product</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Science</sb:maintitle></sb:title><sb:volume-nr>241</sb:volume-nr></sb:series><sb:date>1988</sb:date></sb:issue><sb:pages><sb:first-page>1221</sb:first-page><sb:last-page>1223</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0065\"><ce:label>[13]</ce:label><sb:reference id=\"rf0065\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>E.A.</ce:given-name><ce:surname>Cohen</ce:surname></sb:author><sb:author><ce:given-name>E.F.</ce:given-name><ce:surname>Terwilliger</ce:surname></sb:author><sb:author><ce:given-name>J.G.</ce:given-name><ce:surname>Sodroski</ce:surname></sb:author><sb:author><ce:given-name>W.A.</ce:given-name><ce:surname>Haseltine</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Identification of a protein encoded by the <ce:italic>vpu</ce:italic> gene of HIV-1</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nature</sb:maintitle></sb:title><sb:volume-nr>334</sb:volume-nr></sb:series><sb:date>1988</sb:date></sb:issue><sb:pages><sb:first-page>532</sb:first-page><sb:last-page>534</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0070\"><ce:label>[14]</ce:label><sb:reference id=\"rf0070\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>G.D.</ce:given-name><ce:surname>Ewart</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Sutherland</ce:surname></sb:author><sb:author><ce:given-name>P.W.</ce:given-name><ce:surname>Gage</ce:surname></sb:author><sb:author><ce:given-name>G.B.</ce:given-name><ce:surname>Cox</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The Vpu protein of human immunodeficiency virus type 1 forms cation-selective ion channels</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Virol.</sb:maintitle></sb:title><sb:volume-nr>70</sb:volume-nr></sb:series><sb:date>1996</sb:date></sb:issue><sb:pages><sb:first-page>7108</sb:first-page><sb:last-page>7115</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0075\"><ce:label>[15]</ce:label><sb:reference id=\"rf0075\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Mehnert</ce:surname></sb:author><sb:author><ce:given-name>Y.H.</ce:given-name><ce:surname>Lam</ce:surname></sb:author><sb:author><ce:given-name>P.J.</ce:given-name><ce:surname>Judge</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Routh</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Fischer</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Watts</ce:surname></sb:author><sb:author><ce:given-name>W.B.</ce:given-name><ce:surname>Fischer</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Towards a mechanism of function of the viral ion channel Vpu from HIV-1</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Biomol. Struct. Dyn.</sb:maintitle></sb:title><sb:volume-nr>24</sb:volume-nr></sb:series><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>589</sb:first-page><sb:last-page>596</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0080\"><ce:label>[16]</ce:label><sb:reference id=\"rf0080\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Mehnert</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Routh</ce:surname></sb:author><sb:author><ce:given-name>P.J.</ce:given-name><ce:surname>Judge</ce:surname></sb:author><sb:author><ce:given-name>Y.H.</ce:given-name><ce:surname>Lam</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Fischer</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Watts</ce:surname></sb:author><sb:author><ce:given-name>W.B.</ce:given-name><ce:surname>Fischer</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Biophysical characterisation of Vpu from HIV-1 suggests a channel-pore dualism</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Proteins</sb:maintitle></sb:title><sb:volume-nr>70</sb:volume-nr></sb:series><sb:date>2008</sb:date></sb:issue><sb:pages><sb:first-page>1488</sb:first-page><sb:last-page>1497</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0085\"><ce:label>[17]</ce:label><sb:reference id=\"rf0085\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>M.E.</ce:given-name><ce:surname>Gonzales</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Carrasco</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The human immunodeficiency virus type 1 Vpu protein enhances membrane permeability</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Biochemistry</sb:maintitle></sb:title><sb:volume-nr>37</sb:volume-nr></sb:series><sb:date>1998</sb:date></sb:issue><sb:pages><sb:first-page>13710</sb:first-page><sb:last-page>13719</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0090\"><ce:label>[18]</ce:label><sb:reference id=\"rf0090\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Bolduan</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Votteler</ce:surname></sb:author><sb:author><ce:given-name>V.</ce:given-name><ce:surname>Lodermeyer</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Greiner</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Koppensteiner</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Schindler</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Thiel</ce:surname></sb:author><sb:author><ce:given-name>U.</ce:given-name><ce:surname>Schubert</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Ion channel activity of HIV-1 Vpu is dispensable for counteraction of CD317</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Virology</sb:maintitle></sb:title><sb:volume-nr>416</sb:volume-nr></sb:series><sb:date>2011</sb:date></sb:issue><sb:pages><sb:first-page>75</sb:first-page><sb:last-page>85</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0095\"><ce:label>[19]</ce:label><sb:reference id=\"rf0095\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>A.L.</ce:given-name><ce:surname>Grice</ce:surname></sb:author><sb:author><ce:given-name>I.D.</ce:given-name><ce:surname>Kerr</ce:surname></sb:author><sb:author><ce:given-name>M.S.P.</ce:given-name><ce:surname>Sansom</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Ion channels formed by HIV-1 Vpu: a modelling and simulation study</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>FEBS Lett.</sb:maintitle></sb:title><sb:volume-nr>405</sb:volume-nr></sb:series><sb:date>1997</sb:date></sb:issue><sb:pages><sb:first-page>299</sb:first-page><sb:last-page>304</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0100\"><ce:label>[20]</ce:label><sb:reference id=\"rf0100\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Patargias</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Martay</ce:surname></sb:author><sb:author><ce:given-name>W.B.</ce:given-name><ce:surname>Fischer</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Reconstructing potentials of mean force from short steered molecular dynamics simulations of Vpu from HIV-1</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Biomol. Struct. Dyn.</sb:maintitle></sb:title><sb:volume-nr>26</sb:volume-nr></sb:series><sb:date>2009</sb:date></sb:issue><sb:pages><sb:first-page>1</sb:first-page><sb:last-page>12</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0105\"><ce:label>[21]</ce:label><sb:reference id=\"rf0105\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>F.S.</ce:given-name><ce:surname>Cordes</ce:surname></sb:author><sb:author><ce:given-name>A.D.</ce:given-name><ce:surname>Tustian</ce:surname></sb:author><sb:author><ce:given-name>M.S.</ce:given-name><ce:surname>Sansom</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Watts</ce:surname></sb:author><sb:author><ce:given-name>W.B.</ce:given-name><ce:surname>Fischer</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Bundles consisting of extended transmembrane segments of Vpu from HIV-1: computer simulations and conductance measurements</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Biochemistry</sb:maintitle></sb:title><sb:volume-nr>41</sb:volume-nr></sb:series><sb:date>2002</sb:date></sb:issue><sb:pages><sb:first-page>7359</sb:first-page><sb:last-page>7365</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0110\"><ce:label>[22]</ce:label><sb:reference id=\"rf0110\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>C.F.</ce:given-name><ce:surname>Lopez</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Montal</ce:surname></sb:author><sb:author><ce:given-name>J.K.</ce:given-name><ce:surname>Blasie</ce:surname></sb:author><sb:author><ce:given-name>M.L.</ce:given-name><ce:surname>Klein</ce:surname></sb:author><sb:author><ce:given-name>P.B.</ce:given-name><ce:surname>Moore</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Molecular dynamics investigation of membrane-bound bundles of the channel-forming transmembrane domain of viral protein U from the human immunodeficiency virus HIV-1</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Biophys. J.</sb:maintitle></sb:title><sb:volume-nr>83</sb:volume-nr></sb:series><sb:date>2002</sb:date></sb:issue><sb:pages><sb:first-page>1259</sb:first-page><sb:last-page>1267</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0115\"><ce:label>[23]</ce:label><sb:reference id=\"rf0115\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>L.-H.</ce:given-name><ce:surname>Li</ce:surname></sb:author><sb:author><ce:given-name>H.-J.</ce:given-name><ce:surname>Hsu</ce:surname></sb:author><sb:author><ce:given-name>W.B.</ce:given-name><ce:surname>Fischer</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Assembling viral channel forming proteins: Vpu from HIV-1</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Biopolymers</sb:maintitle></sb:title><sb:volume-nr>99</sb:volume-nr></sb:series><sb:date>2013</sb:date></sb:issue><sb:pages><sb:first-page>517</sb:first-page><sb:last-page>529</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0120\"><ce:label>[24]</ce:label><sb:reference id=\"rf0120\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Bour</ce:surname></sb:author><sb:author><ce:given-name>U.</ce:given-name><ce:surname>Schubert</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Strebel</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The human immunodeficiency virus type 1 Vpu protein specifically binds to the cytoplasmic domain of CD4: implications for the mechanism of degradation</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Virol.</sb:maintitle></sb:title><sb:volume-nr>69</sb:volume-nr></sb:series><sb:date>1995</sb:date></sb:issue><sb:pages><sb:first-page>1510</sb:first-page><sb:last-page>1520</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0125\"><ce:label>[25]</ce:label><sb:reference id=\"rf0585\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>F.P.</ce:given-name><ce:surname>Blanchet</ce:surname></sb:author><sb:author><ce:given-name>J.P.</ce:given-name><ce:surname>Mitchell</ce:surname></sb:author><sb:author><ce:given-name>V.</ce:given-name><ce:surname>Piguet</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>TrCP dependency of HIV-1 Vpu-induced downregulation of CD4 and BST-2/tetherin</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Curr. HIV Res.</sb:maintitle></sb:title><sb:volume-nr>10</sb:volume-nr></sb:series><sb:date>2012</sb:date></sb:issue><sb:pages><sb:first-page>307</sb:first-page><sb:last-page>314</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0130\"><ce:label>[26]</ce:label><sb:reference id=\"rf0125\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Margottin</ce:surname></sb:author><sb:author><ce:given-name>S.P.</ce:given-name><ce:surname>Bour</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Durand</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Selig</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Benichou</ce:surname></sb:author><sb:author><ce:given-name>V.</ce:given-name><ce:surname>Richard</ce:surname></sb:author><sb:author><ce:given-name>D.D.</ce:given-name><ce:surname>Thomas</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Strebel</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Benarous</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>A novel human WD protein, h-βTrCP, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Mol. Cell</sb:maintitle></sb:title><sb:volume-nr>1</sb:volume-nr></sb:series><sb:date>1998</sb:date></sb:issue><sb:pages><sb:first-page>565</sb:first-page><sb:last-page>574</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0135\"><ce:label>[27]</ce:label><sb:reference id=\"rf0130\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>U.</ce:given-name><ce:surname>Schubert</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Bour</ce:surname></sb:author><sb:author><ce:given-name>A.V.</ce:given-name><ce:surname>Ferrer-Montiel</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Montal</ce:surname></sb:author><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Maldarelli</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Strebel</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The two biological activities of human immunodeficiency virus type 1 Vpu protein involve two separable structural domains</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Virol.</sb:maintitle></sb:title><sb:volume-nr>70</sb:volume-nr></sb:series><sb:date>1996</sb:date></sb:issue><sb:pages><sb:first-page>809</sb:first-page><sb:last-page>819</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0140\"><ce:label>[28]</ce:label><sb:reference id=\"rf0135\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>M.-Y.</ce:given-name><ce:surname>Chen</ce:surname></sb:author><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Maldarelli</ce:surname></sb:author><sb:author><ce:given-name>M.A.</ce:given-name><ce:surname>Martin</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Strebel</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Human immunodeficiency virus type 1 Vpu protein induces degradation of CD4 in vitro: the cytoplasmic domain contributes to Vpu sensitivity</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Virol.</sb:maintitle></sb:title><sb:volume-nr>67</sb:volume-nr></sb:series><sb:date>1993</sb:date></sb:issue><sb:pages><sb:first-page>3877</sb:first-page><sb:last-page>3884</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0145\"><ce:label>[29]</ce:label><sb:reference id=\"rf0140\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Shin</ce:surname></sb:author><sb:author><ce:given-name>R.L.</ce:given-name><ce:surname>Dunbrack</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Lee</ce:surname></sb:author><sb:author><ce:given-name>J.L.</ce:given-name><ce:surname>Strominger</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Phosphorylation-dependent down-modulation of CD4 requires a specific structure within the cytoplasmic domain of CD4</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Biol. Chem.</sb:maintitle></sb:title><sb:volume-nr>266</sb:volume-nr></sb:series><sb:date>1991</sb:date></sb:issue><sb:pages><sb:first-page>10658</sb:first-page><sb:last-page>10665</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0150\"><ce:label>[30]</ce:label><sb:reference id=\"rf0145\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Wittlich</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Thiagarajan</ce:surname></sb:author><sb:author><ce:given-name>B.W.</ce:given-name><ce:surname>Koenig</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Hartmann</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Willbold</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>NMR structure of the transmembrane and cytoplasmic domains of human CD4 in micelles</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Biochim. Biophys. Acta</sb:maintitle></sb:title><sb:volume-nr>1798</sb:volume-nr></sb:series><sb:date>2010</sb:date></sb:issue><sb:pages><sb:first-page>122</sb:first-page><sb:last-page>127</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0155\"><ce:label>[31]</ce:label><sb:reference id=\"rf0150\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Tiganos</ce:surname></sb:author><sb:author><ce:given-name>X.-J.</ce:given-name><ce:surname>Yao</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Friborg</ce:surname></sb:author><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Daniel</ce:surname></sb:author><sb:author><ce:given-name>E.A.</ce:given-name><ce:surname>Cohen</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Putative a-helical structures in the human immunodeficiency virus type 1 Vpu protein and CD4 are involved in binding and degradation of the CD4 molecule</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Virol.</sb:maintitle></sb:title><sb:volume-nr>71</sb:volume-nr></sb:series><sb:date>1997</sb:date></sb:issue><sb:pages><sb:first-page>4452</sb:first-page><sb:last-page>4460</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0160\"><ce:label>[32]</ce:label><sb:reference id=\"rf0155\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>V.</ce:given-name><ce:surname>Wray</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Federau</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Henklein</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Klabunde</ce:surname></sb:author><sb:author><ce:given-name>O.</ce:given-name><ce:surname>Kunert</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Schomburg</ce:surname></sb:author><sb:author><ce:given-name>U.</ce:given-name><ce:surname>Schubert</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Solution structure of the hydrophilic region of HIV-1 encoded virus protein U (Vpu) by CD and <ce:sup loc=\"pre\">1</ce:sup>H NMR-spectroscopy</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Int. J. Pept. Protein Res.</sb:maintitle></sb:title><sb:volume-nr>45</sb:volume-nr></sb:series><sb:date>1995</sb:date></sb:issue><sb:pages><sb:first-page>35</sb:first-page><sb:last-page>43</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0165\"><ce:label>[33]</ce:label><sb:reference id=\"rf0160\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Federau</ce:surname></sb:author><sb:author><ce:given-name>U.</ce:given-name><ce:surname>Schubert</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Floßdorf</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Henklein</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Schomburg</ce:surname></sb:author><sb:author><ce:given-name>V.</ce:given-name><ce:surname>Wray</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Solution structure of the cytoplasmic domain of the human immunodeficiency virus type 1 encoded virus protein U (Vpu)</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Int. J. Pept. Protein Res.</sb:maintitle></sb:title><sb:volume-nr>47</sb:volume-nr></sb:series><sb:date>1996</sb:date></sb:issue><sb:pages><sb:first-page>297</sb:first-page><sb:last-page>310</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0170\"><ce:label>[34]</ce:label><sb:reference id=\"rf0165\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Willbold</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Hoffmann</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Rösch</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Secondary structure and tertiary fold of the human immunodeficiency virus protein U (Vpu) cytoplasmatic domain in solution</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Eur. J. Biochem.</sb:maintitle></sb:title><sb:volume-nr>245</sb:volume-nr></sb:series><sb:date>1997</sb:date></sb:issue><sb:pages><sb:first-page>581</sb:first-page><sb:last-page>588</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0175\"><ce:label>[35]</ce:label><sb:reference id=\"rf0170\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Coadou</ce:surname></sb:author><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Evrard-Todeschi</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Gharbi-Benarous</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Benarous</ce:surname></sb:author><sb:author><ce:given-name>J.-P.</ce:given-name><ce:surname>Girault</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>HIV-1 encoded virus protein U (Vpu) solution structure of the 41–62 hydrophilic region containing the phosphorylated sites Ser<ce:sup loc=\"post\">52</ce:sup> and Ser<ce:sup loc=\"post\">56</ce:sup></sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Int. J. Biol. Macromol.</sb:maintitle></sb:title><sb:volume-nr>30</sb:volume-nr></sb:series><sb:date>2002</sb:date></sb:issue><sb:pages><sb:first-page>23</sb:first-page><sb:last-page>40</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0180\"><ce:label>[36]</ce:label><sb:reference id=\"rf0175\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>F.M.</ce:given-name><ce:surname>Marassi</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Ma</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Gratkowski</ce:surname></sb:author><sb:author><ce:given-name>S.K.</ce:given-name><ce:surname>Straus</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Strebel</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Oblatt-Montal</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Montal</ce:surname></sb:author><sb:author><ce:given-name>S.J.</ce:given-name><ce:surname>Opella</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Correlation of the structural and functional domains in the membrane protein Vpu from HIV-1</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Proc. Natl. Acad. Sci. U. S. A.</sb:maintitle></sb:title><sb:volume-nr>96</sb:volume-nr></sb:series><sb:date>1999</sb:date></sb:issue><sb:pages><sb:first-page>14336</sb:first-page><sb:last-page>14341</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0185\"><ce:label>[37]</ce:label><sb:reference id=\"rf0180\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Henklein</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Kinder</ce:surname></sb:author><sb:author><ce:given-name>U.</ce:given-name><ce:surname>Schubert</ce:surname></sb:author><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Bechinger</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Membrane interactions and alignment of structures within the HIV-1 Vpu cytoplasmic domain: effect of phosphorylation of serines 52 and 56</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>FEBS Lett.</sb:maintitle></sb:title><sb:volume-nr>482</sb:volume-nr></sb:series><sb:date>2000</sb:date></sb:issue><sb:pages><sb:first-page>220</sb:first-page><sb:last-page>224</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0190\"><ce:label>[38]</ce:label><sb:reference id=\"rf0185\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Hsu</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Seharaseyon</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Dong</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Bour</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Marbán</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Mutual functional destruction of HIV-1 Vpu and host TASK-1 channel</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Mol. Cell</sb:maintitle></sb:title><sb:volume-nr>14</sb:volume-nr></sb:series><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>259</sb:first-page><sb:last-page>267</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0195\"><ce:label>[39]</ce:label><sb:reference id=\"rf0190\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Hsu</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Han</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Shinlapawittayatorn</ce:surname></sb:author><sb:author><ce:given-name>I.</ce:given-name><ce:surname>Deschenes</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Marbán</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Membrane potential depolarization as a triggering mechanism for Vpu-mediated HIV-1 release</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Biophys. J.</sb:maintitle></sb:title><sb:volume-nr>99</sb:volume-nr></sb:series><sb:date>2010</sb:date></sb:issue><sb:pages><sb:first-page>1718</sb:first-page><sb:last-page>1725</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0200\"><ce:label>[40]</ce:label><sb:reference id=\"rf0195\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Herrero</ce:surname></sb:author><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Monroy</ce:surname></sb:author><sb:author><ce:given-name>M.E.</ce:given-name><ce:surname>Gonzáles</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>HIV-1 Vpu protein mediates the transport of potassium in <ce:italic>Saccharomyces cerevisiae</ce:italic></sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Biochemistry</sb:maintitle></sb:title><sb:volume-nr>52</sb:volume-nr></sb:series><sb:date>2013</sb:date></sb:issue><sb:pages><sb:first-page>171</sb:first-page><sb:last-page>177</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0205\"><ce:label>[41]</ce:label><sb:reference id=\"rf0200\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>N.</ce:given-name><ce:surname>van Damme</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Goff</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Katsura</ce:surname></sb:author><sb:author><ce:given-name>R.L.</ce:given-name><ce:surname>Jorgensen</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Mitchell</ce:surname></sb:author><sb:author><ce:given-name>M.C.</ce:given-name><ce:surname>Johnson</ce:surname></sb:author><sb:author><ce:given-name>E.B.</ce:given-name><ce:surname>Stephens</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Guatelli</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cell Host Microbe</sb:maintitle></sb:title><sb:volume-nr>3</sb:volume-nr></sb:series><sb:date>2008</sb:date></sb:issue><sb:pages><sb:first-page>1</sb:first-page><sb:last-page>8</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0210\"><ce:label>[42]</ce:label><sb:reference id=\"rf0205\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>S.J.D.</ce:given-name><ce:surname>Neil</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Zang</ce:surname></sb:author><sb:author><ce:given-name>P.D.</ce:given-name><ce:surname>Bieniasz</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nature</sb:maintitle></sb:title><sb:volume-nr>451</sb:volume-nr></sb:series><sb:date>2008</sb:date></sb:issue><sb:pages><sb:first-page>425</sb:first-page><sb:last-page>431</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0215\"><ce:label>[43]</ce:label><sb:reference id=\"rf0210\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>D.T.</ce:given-name><ce:surname>Evans</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Serra-Moreno</ce:surname></sb:author><sb:author><ce:given-name>R.K.</ce:given-name><ce:surname>Singh</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Guatelli</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>BST-2/tetherin: a new component of the innate immune response to enveloped viruses</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Trends Microbiol.</sb:maintitle></sb:title><sb:volume-nr>18</sb:volume-nr></sb:series><sb:date>2010</sb:date></sb:issue><sb:pages><sb:first-page>388</sb:first-page><sb:last-page>396</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0220\"><ce:label>[44]</ce:label><sb:reference id=\"rf0215\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Dubé</ce:surname></sb:author><sb:author><ce:given-name>B.B.</ce:given-name><ce:surname>Roy</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Guiot-Guillain</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Binette</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Mercier</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Chiasson</ce:surname></sb:author><sb:author><ce:given-name>É.A.</ce:given-name><ce:surname>Cohen</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Antagonism of tetherin restriction of HIV-1 release by Vpu involves binding and sequestration of the restriction factor in a perinuclear compartment</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>PLoS Pathog.</sb:maintitle></sb:title><sb:volume-nr>6</sb:volume-nr></sb:series><sb:date>2010</sb:date></sb:issue><sb:pages><sb:first-page>e1000856</sb:first-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0225\"><ce:label>[45]</ce:label><sb:reference id=\"rf0220\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>M.W.</ce:given-name><ce:surname>McNatt</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Zang</ce:surname></sb:author><sb:author><ce:given-name>P.D.</ce:given-name><ce:surname>Bieniasz</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Vpu binds directly to tetherin and displaces it from nascent virions</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>PLoS Pathog.</sb:maintitle></sb:title><sb:volume-nr>9</sb:volume-nr></sb:series><sb:date>2013</sb:date></sb:issue><sb:pages><sb:first-page>e1003299</sb:first-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0230\"><ce:label>[46]</ce:label><sb:reference id=\"rf0225\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Kupzig</ce:surname></sb:author><sb:author><ce:given-name>V.</ce:given-name><ce:surname>Korolchuk</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Rollason</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Sugden</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Wilde</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Banting</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Traffic</sb:maintitle></sb:title><sb:volume-nr>4</sb:volume-nr></sb:series><sb:date>2003</sb:date></sb:issue><sb:pages><sb:first-page>694</sb:first-page><sb:last-page>709</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0235\"><ce:label>[47]</ce:label><sb:reference id=\"rf0230\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Miyakawa</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Sawasaki</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Matsunaga</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Tokarev</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Quinn</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Kimura</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Nomaguchi</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Adachi</ce:surname></sb:author><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Yamamoto</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Guatelli</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Ryo</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Interferon-induced SCYL2 limits release of HIV-1 by triggering PP2A-mediated dephosphorylation of the viral protein Vpu</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Sci. Signal.</sb:maintitle></sb:title><sb:volume-nr>5</sb:volume-nr></sb:series><sb:date>2012</sb:date></sb:issue><sb:pages><sb:first-page>ra73</sb:first-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0240\"><ce:label>[48]</ce:label><sb:reference id=\"rf0235\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Skasko</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Tokarev</ce:surname></sb:author><sb:author><ce:given-name>C.-C.</ce:given-name><ce:surname>Chen</ce:surname></sb:author><sb:author><ce:given-name>W.B.</ce:given-name><ce:surname>Fischer</ce:surname></sb:author><sb:author><ce:given-name>S.K.</ce:given-name><ce:surname>Pillai</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Guatelli</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>BST-2 is rapidly down-regulated from the cell surface by the HIV-1 protein Vpu: evidence for a post-ER mechanism of Vpu-action</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Virology</sb:maintitle></sb:title><sb:volume-nr>411</sb:volume-nr></sb:series><sb:date>2011</sb:date></sb:issue><sb:pages><sb:first-page>65</sb:first-page><sb:last-page>77</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0245\"><ce:label>[49]</ce:label><sb:reference id=\"rf0240\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Zhou</ce:surname></sb:author><sb:author><ce:given-name>Z.</ce:given-name><ce:surname>Zhang</ce:surname></sb:author><sb:author><ce:given-name>Z.</ce:given-name><ce:surname>Mi</ce:surname></sb:author><sb:author><ce:given-name>X.</ce:given-name><ce:surname>Wang</ce:surname></sb:author><sb:author><ce:given-name>Q.</ce:given-name><ce:surname>Zhang</ce:surname></sb:author><sb:author><ce:given-name>X.</ce:given-name><ce:surname>Li</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Liang</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Cen</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Characterization of the interface of the bone marrow stromal cell antigen 2-Vpu protein complex via computational chemistry</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Biochemistry</sb:maintitle></sb:title><sb:volume-nr>51</sb:volume-nr></sb:series><sb:date>2012</sb:date></sb:issue><sb:pages><sb:first-page>1288</sb:first-page><sb:last-page>1296</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0250\"><ce:label>[50]</ce:label><sb:reference id=\"rf0245\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Skasko</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Wang</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Tian</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Tokarev</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Munguia</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Ruiz</ce:surname></sb:author><sb:author><ce:given-name>E.B.</ce:given-name><ce:surname>Stephens</ce:surname></sb:author><sb:author><ce:given-name>S.J.</ce:given-name><ce:surname>Opella</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Guatelli</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>HIV-1 Vpu protein antagonizes the innate restriction factor BST-2 via lipid-embedded helix–helix interactions</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Biol. Chem.</sb:maintitle></sb:title><sb:volume-nr>287</sb:volume-nr></sb:series><sb:date>2012</sb:date></sb:issue><sb:pages><sb:first-page>58</sb:first-page><sb:last-page>67</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0255\"><ce:label>[51]</ce:label><sb:reference id=\"rf0250\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Lv</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Wang</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Zuo</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Zhu</ce:surname></sb:author><sb:author><ce:given-name>W.</ce:given-name><ce:surname>Kong</ce:surname></sb:author><sb:author><ce:given-name>X.</ce:given-name><ce:surname>Yu</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Polarity changes in the transmembrane domain core of HIV-1 Vpu inhibits anti-tetherin activity</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>PLoS One</sb:maintitle></sb:title><sb:volume-nr>6</sb:volume-nr></sb:series><sb:date>2011</sb:date></sb:issue><sb:pages><sb:first-page>e20890</sb:first-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0260\"><ce:label>[52]</ce:label><sb:reference id=\"rf0255\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Sowrirajan</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Barker</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The natural killer cell cytotoxic function is modulated by HIV-1 accessory proteins</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Viruses</sb:maintitle></sb:title><sb:volume-nr>3</sb:volume-nr></sb:series><sb:date>2011</sb:date></sb:issue><sb:pages><sb:first-page>1091</sb:first-page><sb:last-page>1111</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0265\"><ce:label>[53]</ce:label><sb:reference id=\"rf0260\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>A.H.</ce:given-name><ce:surname>Shah</ce:surname></sb:author><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Sowrirajan</ce:surname></sb:author><sb:author><ce:given-name>Z.B.</ce:given-name><ce:surname>Davis</ce:surname></sb:author><sb:author><ce:given-name>J.P.</ce:given-name><ce:surname>Ward</ce:surname></sb:author><sb:author><ce:given-name>E.M.</ce:given-name><ce:surname>Campbell</ce:surname></sb:author><sb:author><ce:given-name>V.</ce:given-name><ce:surname>Planelles</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Barker</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Degranulation of natural killer cells following interaction with HIV-1-infected cells is hindered by downmodulation of NTB-A by Vpu</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cell Host Microbe</sb:maintitle></sb:title><sb:volume-nr>8</sb:volume-nr></sb:series><sb:date>2010</sb:date></sb:issue><sb:pages><sb:first-page>397</sb:first-page><sb:last-page>409</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0270\"><ce:label>[54]</ce:label><sb:reference id=\"rf0265\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Kerkau</ce:surname></sb:author><sb:author><ce:given-name>I.</ce:given-name><ce:surname>Bacik</ce:surname></sb:author><sb:author><ce:given-name>J.R.</ce:given-name><ce:surname>Bennink</ce:surname></sb:author><sb:author><ce:given-name>J.W.</ce:given-name><ce:surname>Yewdell</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Hunig</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Schimpl</ce:surname></sb:author><sb:author><ce:given-name>U.</ce:given-name><ce:surname>Schubert</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The human immunodeficiency virus type 1 (HIV-1) vpu protein interferes with an early step in the biosynthesis of major histocompatibility complex (MHC) class I molecules</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Exp. Med.</sb:maintitle></sb:title><sb:volume-nr>185</sb:volume-nr></sb:series><sb:date>1997</sb:date></sb:issue><sb:pages><sb:first-page>1295</sb:first-page><sb:last-page>1305</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0275\"><ce:label>[55]</ce:label><sb:reference id=\"rf0270\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Hussain</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Wesley</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Khalid</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Chaudhry</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Jameel</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Human immunodeficiency virus type 1 Vpu protein interacts with CD74 and modulates major histocompatibility complex class II presentation</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Virol.</sb:maintitle></sb:title><sb:volume-nr>82</sb:volume-nr></sb:series><sb:date>2008</sb:date></sb:issue><sb:pages><sb:first-page>893</sb:first-page><sb:last-page>902</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0280\"><ce:label>[56]</ce:label><sb:reference id=\"rf0275\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>J.W.</ce:given-name><ce:surname>Yewdell</ce:surname></sb:author><sb:author><ce:given-name>A.B.</ce:given-name><ce:surname>Hill</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Viral interference with antigen presentation</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nat. Immunol.</sb:maintitle></sb:title><sb:volume-nr>3</sb:volume-nr></sb:series><sb:date>2002</sb:date></sb:issue><sb:pages><sb:first-page>1019</sb:first-page><sb:last-page>1024</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0285\"><ce:label>[57]</ce:label><sb:reference id=\"rf0280\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>M.A.</ce:given-name><ce:surname>Callahan</ce:surname></sb:author><sb:author><ce:given-name>M.A.</ce:given-name><ce:surname>Handley</ce:surname></sb:author><sb:author><ce:given-name>Y.-H.</ce:given-name><ce:surname>Lee</ce:surname></sb:author><sb:author><ce:given-name>K.J.</ce:given-name><ce:surname>Talbot</ce:surname></sb:author><sb:author><ce:given-name>J.W.</ce:given-name><ce:surname>Harper</ce:surname></sb:author><sb:author><ce:given-name>A.T.</ce:given-name><ce:surname>Panganiban</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Functional interaction of human immunodeficiency virus type 1 Vpu and Gag with a novel membrane of the tetratricopeptide repeat protein family</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Virol.</sb:maintitle></sb:title><sb:volume-nr>72</sb:volume-nr></sb:series><sb:date>1998</sb:date></sb:issue><sb:pages><sb:first-page>5189</sb:first-page><sb:last-page>5197</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0290\"><ce:label>[58]</ce:label><sb:reference id=\"rf0285\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Evans</ce:surname></sb:author><sb:author><ce:given-name>W.</ce:given-name><ce:surname>Dampier</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Ungar</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Tozeren</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Prediction of HIV-1 virus–host protein interactions using virus and host sequence motifs</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>BMC Med. Genomics</sb:maintitle></sb:title><sb:volume-nr>2</sb:volume-nr></sb:series><sb:date>2009</sb:date></sb:issue><sb:pages><sb:first-page>27</sb:first-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0295\"><ce:label>[59]</ce:label><sb:reference id=\"rf0290\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Gissmann</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Boshart</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Dürst</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Ikenberg</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Wagner</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>zur Hausen</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Presence of human papillomavirus (HPV) DNA in genital tumors</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Invest. Dermatol.</sb:maintitle></sb:title><sb:volume-nr>83</sb:volume-nr></sb:series><sb:date>1984</sb:date></sb:issue><sb:pages><sb:first-page>265</sb:first-page><sb:last-page>288</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0300\"><ce:label>[60]</ce:label><sb:reference id=\"rf0590\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>H.</ce:given-name><ce:surname>zur Hausen</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Papillomaviruses in human cancers</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Mol. Carcinog.</sb:maintitle></sb:title><sb:volume-nr>1</sb:volume-nr></sb:series><sb:date>1988</sb:date></sb:issue><sb:pages><sb:first-page>147</sb:first-page><sb:last-page>150</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0305\"><ce:label>[61]</ce:label><sb:reference id=\"rf0595\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>H.</ce:given-name><ce:surname>zur Hausen</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cancer Res.</sb:maintitle></sb:title><sb:volume-nr>49</sb:volume-nr></sb:series><sb:date>1989</sb:date></sb:issue><sb:pages><sb:first-page>4677</sb:first-page><sb:last-page>4681</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0310\"><ce:label>[62]</ce:label><sb:reference id=\"rf0295\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Schneider-Gadicke</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Schwarz</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>EMBO J.</sb:maintitle></sb:title><sb:volume-nr>5</sb:volume-nr></sb:series><sb:date>1986</sb:date></sb:issue><sb:pages><sb:first-page>2285</sb:first-page><sb:last-page>2292</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0315\"><ce:label>[63]</ce:label><sb:reference id=\"rf0300\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Smotkin</ce:surname></sb:author><sb:author><ce:given-name>F.O.</ce:given-name><ce:surname>Wettstein</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Proc. Natl. Acad. Sci. U. S. A.</sb:maintitle></sb:title><sb:volume-nr>83</sb:volume-nr></sb:series><sb:date>1986</sb:date></sb:issue><sb:pages><sb:first-page>4680</sb:first-page><sb:last-page>4684</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0320\"><ce:label>[64]</ce:label><sb:reference id=\"rf0305\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Leechanachai</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Banks</ce:surname></sb:author><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Moreau</ce:surname></sb:author><sb:author><ce:given-name>G.M.</ce:given-name><ce:surname>Matlashewski</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The E5 gene from human papillomavirus type 16 is an oncogene which enhances growth factor-mediated signal transduction to the nucleus</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Oncogene</sb:maintitle></sb:title><sb:volume-nr>7</sb:volume-nr></sb:series><sb:date>1992</sb:date></sb:issue><sb:pages><sb:first-page>19</sb:first-page><sb:last-page>25</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0325\"><ce:label>[65]</ce:label><sb:reference id=\"rf0310\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Leptak</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Ramon</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Cajal</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Kulke</ce:surname></sb:author><sb:author><ce:given-name>B.H.</ce:given-name><ce:surname>Horowitz</ce:surname></sb:author><sb:author><ce:given-name>D.J.</ce:given-name><ce:surname>Riese</ce:surname><ce:suffix>II</ce:suffix></sb:author><sb:author><ce:given-name>G.P.</ce:given-name><ce:surname>Dotto</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>DiMaio</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Tumorigenic transformation of murine keratinocytes by the E5 genes of bovine papillomavirus type 1 and human papillomavirus type 16</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Virol.</sb:maintitle></sb:title><sb:volume-nr>65</sb:volume-nr></sb:series><sb:date>1991</sb:date></sb:issue><sb:pages><sb:first-page>7078</sb:first-page><sb:last-page>7083</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0330\"><ce:label>[66]</ce:label><sb:reference id=\"rf0315\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Schwarz</ce:surname></sb:author><sb:author><ce:given-name>U.K.</ce:given-name><ce:surname>Freese</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Gissmann</ce:surname></sb:author><sb:author><ce:given-name>W.</ce:given-name><ce:surname>Mayer</ce:surname></sb:author><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Roggenbuck</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Stremlau</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>zur Hausen</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Structure and transcription of human papillomavirus sequences in cervical carcinoma cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nature</sb:maintitle></sb:title><sb:volume-nr>314</sb:volume-nr></sb:series><sb:date>1985</sb:date></sb:issue><sb:pages><sb:first-page>111</sb:first-page><sb:last-page>114</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0335\"><ce:label>[67]</ce:label><sb:reference id=\"rf0600\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>H.</ce:given-name><ce:surname>zur Hausen</ce:surname></sb:author><sb:author><ce:given-name>E.M.</ce:given-name><ce:surname>de Villiers</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Human papillomaviruses</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Annu. Rev. Microbiol.</sb:maintitle></sb:title><sb:volume-nr>48</sb:volume-nr></sb:series><sb:date>1994</sb:date></sb:issue><sb:pages><sb:first-page>427</sb:first-page><sb:last-page>447</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0340\"><ce:label>[68]</ce:label><sb:reference id=\"rf0320\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>M.H.</ce:given-name><ce:surname>Stoler</ce:surname></sb:author><sb:author><ce:given-name>C.R.</ce:given-name><ce:surname>Rhodes</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Whitbeck</ce:surname></sb:author><sb:author><ce:given-name>S.M.</ce:given-name><ce:surname>Wolinsky</ce:surname></sb:author><sb:author><ce:given-name>L.T.</ce:given-name><ce:surname>Chow</ce:surname></sb:author><sb:author><ce:given-name>T.R.</ce:given-name><ce:surname>Broker</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Human papillomavirus type 16 and 18 gene expression in cervical neoplasias</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Hum. Pathol.</sb:maintitle></sb:title><sb:volume-nr>23</sb:volume-nr></sb:series><sb:date>1992</sb:date></sb:issue><sb:pages><sb:first-page>117</sb:first-page><sb:last-page>127</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0345\"><ce:label>[69]</ce:label><sb:reference id=\"rf0325\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Krawczyk</ce:surname></sb:author><sb:author><ce:given-name>F.A.</ce:given-name><ce:surname>Suprynowicz</ce:surname></sb:author><sb:author><ce:given-name>X.</ce:given-name><ce:surname>Liu</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Dai</ce:surname></sb:author><sb:author><ce:given-name>D.P.</ce:given-name><ce:surname>Hartmann</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Hanover</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Schlegel</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Koilocytosis. A cooperative interaction between the human papillomavirus E5 and E6 oncoproteins</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Am. J. Pathol.</sb:maintitle></sb:title><sb:volume-nr>173</sb:volume-nr></sb:series><sb:date>2008</sb:date></sb:issue><sb:pages><sb:first-page>682</sb:first-page><sb:last-page>688</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0350\"><ce:label>[70]</ce:label><sb:reference id=\"rf0330\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Conrad</ce:surname></sb:author><sb:author><ce:given-name>V.J.</ce:given-name><ce:surname>Bubb</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Schlegel</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The human papillomavirus type 6 and 16 E5 proteins are membrane-associated proteins which associate with the 16-kilodalton pore-forming protein</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Virol.</sb:maintitle></sb:title><sb:volume-nr>67</sb:volume-nr></sb:series><sb:date>1993</sb:date></sb:issue><sb:pages><sb:first-page>6170</sb:first-page><sb:last-page>6178</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0355\"><ce:label>[71]</ce:label><sb:reference id=\"rf0335\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>T.-C.</ce:given-name><ce:surname>Tsai</ce:surname></sb:author><sb:author><ce:given-name>S.-L.</ce:given-name><ce:surname>Chen</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The biochemical and biological functions of human papillomavirus type 16 E5 protein</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Arch. Virol.</sb:maintitle></sb:title><sb:volume-nr>148</sb:volume-nr></sb:series><sb:date>2003</sb:date></sb:issue><sb:pages><sb:first-page>1445</sb:first-page><sb:last-page>1453</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0360\"><ce:label>[72]</ce:label><sb:reference id=\"rf0340\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Kell</ce:surname></sb:author><sb:author><ce:given-name>R.J.</ce:given-name><ce:surname>Jewers</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Cason</ce:surname></sb:author><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Pakarian</ce:surname></sb:author><sb:author><ce:given-name>J.N.</ce:given-name><ce:surname>Kaye</ce:surname></sb:author><sb:author><ce:given-name>J.M.</ce:given-name><ce:surname>Best</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Detection of E5 oncoprotein in human papillomavirus type 16-positive cervical scrapes using antibodies raised to synthetic peptides</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Gen. Virol.</sb:maintitle></sb:title><sb:volume-nr>75</sb:volume-nr></sb:series><sb:date>1994</sb:date></sb:issue><sb:pages><sb:first-page>2451</sb:first-page><sb:last-page>2456</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0365\"><ce:label>[73]</ce:label><sb:reference id=\"rf0345\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>C.E.</ce:given-name><ce:surname>Gieswein</ce:surname></sb:author><sb:author><ce:given-name>F.J.</ce:given-name><ce:surname>Sharom</ce:surname></sb:author><sb:author><ce:given-name>A.G.</ce:given-name><ce:surname>Wildeman</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Oligomerization of the E5 protein of human papillomavirus type 16 occurs through multiple hydrophobic regions</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Virology</sb:maintitle></sb:title><sb:volume-nr>313</sb:volume-nr></sb:series><sb:date>2003</sb:date></sb:issue><sb:pages><sb:first-page>415</sb:first-page><sb:last-page>426</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0370\"><ce:label>[74]</ce:label><sb:reference id=\"rf0350\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Krawczyk</ce:surname></sb:author><sb:author><ce:given-name>F.A.</ce:given-name><ce:surname>Suprynowicz</ce:surname></sb:author><sb:author><ce:given-name>S.R.</ce:given-name><ce:surname>Sudarshan</ce:surname></sb:author><sb:author><ce:given-name>H.B.</ce:given-name><ce:surname>Schlegel</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Membrane orientation of the human papillomavirus type 16 E5 oncoprotein</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Virol.</sb:maintitle></sb:title><sb:volume-nr>84</sb:volume-nr></sb:series><sb:date>2010</sb:date></sb:issue><sb:pages><sb:first-page>1696</sb:first-page><sb:last-page>1703</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0375\"><ce:label>[75]</ce:label><sb:reference id=\"rf0355\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>C.G.</ce:given-name><ce:surname>Ullman</ce:surname></sb:author><sb:author><ce:given-name>P.I.</ce:given-name><ce:surname>Haris</ce:surname></sb:author><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Kell</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Cason</ce:surname></sb:author><sb:author><ce:given-name>R.J.</ce:given-name><ce:surname>Jewers</ce:surname></sb:author><sb:author><ce:given-name>J.M.</ce:given-name><ce:surname>Best</ce:surname></sb:author><sb:author><ce:given-name>V.C.</ce:given-name><ce:surname>Emery</ce:surname></sb:author><sb:author><ce:given-name>S.J.</ce:given-name><ce:surname>Perkins</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Hypothetical structure of the membrane-associated E5 oncoprotein of human papillomavirus type 16</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Biochem. Soc. Trans.</sb:maintitle></sb:title><sb:volume-nr>22</sb:volume-nr></sb:series><sb:date>1994</sb:date></sb:issue><sb:pages><sb:first-page>439S</sb:first-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0380\"><ce:label>[76]</ce:label><sb:reference id=\"rf0360\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Alonso</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Reed</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Modelling of the human papillomavirus type 16 E5 protein</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Biochim. Biophys. Acta</sb:maintitle></sb:title><sb:volume-nr>1601</sb:volume-nr></sb:series><sb:date>2002</sb:date></sb:issue><sb:pages><sb:first-page>9</sb:first-page><sb:last-page>18</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0385\"><ce:label>[77]</ce:label><sb:reference id=\"rf0365\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>Y.-P.</ce:given-name><ce:surname>Tsao</ce:surname></sb:author><sb:author><ce:given-name>L.-Y.</ce:given-name><ce:surname>Li</ce:surname></sb:author><sb:author><ce:given-name>T.-C.</ce:given-name><ce:surname>Tsai</ce:surname></sb:author><sb:author><ce:given-name>S.-L.</ce:given-name><ce:surname>Chen</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Human papilloma type 11 and 16 E5 represses p21<ce:sup loc=\"post\">WafI/SdiI/CipI</ce:sup> gene expression in fibroblasts and keratinocytes</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Virol.</sb:maintitle></sb:title><sb:volume-nr>70</sb:volume-nr></sb:series><sb:date>1996</sb:date></sb:issue><sb:pages><sb:first-page>7535</sb:first-page><sb:last-page>7539</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0390\"><ce:label>[78]</ce:label><sb:reference id=\"rf0370\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>S.-L.</ce:given-name><ce:surname>Chen</ce:surname></sb:author><sb:author><ce:given-name>S.-T.</ce:given-name><ce:surname>Lin</ce:surname></sb:author><sb:author><ce:given-name>T.-C.</ce:given-name><ce:surname>Tsai</ce:surname></sb:author><sb:author><ce:given-name>W.-C.</ce:given-name><ce:surname>Hsiao</ce:surname></sb:author><sb:author><ce:given-name>Y.-P.</ce:given-name><ce:surname>Tsao</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>ErbB4 (JM-b/CYT-1)-induced expression and phosphorylation of c-Jun is abrogated by human papillomavirus type 16 E5 protein</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Oncogene</sb:maintitle></sb:title><sb:volume-nr>26</sb:volume-nr></sb:series><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>42</sb:first-page><sb:last-page>53</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0395\"><ce:label>[79]</ce:label><sb:reference id=\"rf0605\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Venuti</ce:surname></sb:author><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Paolini</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Nasir</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Corteggio</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Roperto</ce:surname></sb:author><sb:author><ce:given-name>M.S.</ce:given-name><ce:surname>Campo</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Borzacchiello</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Papillomavirus E5: the smallest oncoprotein with many functions</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Mol. Cancer</sb:maintitle></sb:title><sb:volume-nr>10</sb:volume-nr></sb:series><sb:date>2011</sb:date></sb:issue></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0400\"><ce:label>[80]</ce:label><sb:reference id=\"rf0375\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>D.J.</ce:given-name><ce:surname>Goldstein</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Kulke</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Dimaio</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Schlegel</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>A glutamine residue in the membrane-associating domain of the bovine papillomavirus type E5 oncoprotein mediates its binding to a transmembrane component of the vacuolar H(+)-ATPase</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Virol.</sb:maintitle></sb:title><sb:volume-nr>66</sb:volume-nr></sb:series><sb:date>1992</sb:date></sb:issue><sb:pages><sb:first-page>405</sb:first-page><sb:last-page>413</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0405\"><ce:label>[81]</ce:label><sb:reference id=\"rf0380\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>J.L.</ce:given-name><ce:surname>Adam</ce:surname></sb:author><sb:author><ce:given-name>M.W.</ce:given-name><ce:surname>Briggs</ce:surname></sb:author><sb:author><ce:given-name>D.J.</ce:given-name><ce:surname>McCane</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>A mutagenic analysis of the E5 protein of human papillomavirus type 16 reveals that E5 binding to the vacuolar H<ce:sup loc=\"post\">+</ce:sup>-ATPase is not sufficient for biological activity, using mammalian and yeast expression systems</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Virology</sb:maintitle></sb:title><sb:volume-nr>272</sb:volume-nr></sb:series><sb:date>2000</sb:date></sb:issue><sb:pages><sb:first-page>315</sb:first-page><sb:last-page>325</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0410\"><ce:label>[82]</ce:label><sb:reference id=\"rf0385\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>M.I.</ce:given-name><ce:surname>Rodríguez</ce:surname></sb:author><sb:author><ce:given-name>M.E.</ce:given-name><ce:surname>Finbow</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Alonso</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Binding of human papillomavirus 16 E5 to the 16<ce:hsp sp=\"0.25\"/>kDa subunit c (proteolipid) of the vacuolar H<ce:sup loc=\"post\">+</ce:sup>-ATPase can be dissociated from the E5-mediated epidermal growth factor receptor overactivation</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Oncogene</sb:maintitle></sb:title><sb:volume-nr>19</sb:volume-nr></sb:series><sb:date>2000</sb:date></sb:issue><sb:pages><sb:first-page>3727</sb:first-page><sb:last-page>3732</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0415\"><ce:label>[83]</ce:label><sb:reference id=\"rf0390\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>G.H.</ce:given-name><ce:surname>Ashrafi</ce:surname></sb:author><sb:author><ce:given-name>M.R.</ce:given-name><ce:surname>Haghshenas</ce:surname></sb:author><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Marchetti</ce:surname></sb:author><sb:author><ce:given-name>P.M.</ce:given-name><ce:surname>O\\'Brian</ce:surname></sb:author><sb:author><ce:given-name>M.S.</ce:given-name><ce:surname>Campo</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>E5 protein of human papillomavirus type 16 selectively downregulates surface HLA class I</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Int. J. Cancer</sb:maintitle></sb:title><sb:volume-nr>113</sb:volume-nr></sb:series><sb:date>2005</sb:date></sb:issue><sb:pages><sb:first-page>276</sb:first-page><sb:last-page>283</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0420\"><ce:label>[84]</ce:label><sb:reference id=\"rf0395\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>E.H.</ce:given-name><ce:surname>Araibi</ce:surname></sb:author><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Marchetti</ce:surname></sb:author><sb:author><ce:given-name>G.H.</ce:given-name><ce:surname>Ashrafi</ce:surname></sb:author><sb:author><ce:given-name>M.S.</ce:given-name><ce:surname>Campo</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Down regulation of major histocompatibility complex class I in bovine papillomas</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Gen. Virol.</sb:maintitle></sb:title><sb:volume-nr>85</sb:volume-nr></sb:series><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>2809</sb:first-page><sb:last-page>2814</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0425\"><ce:label>[85]</ce:label><sb:reference id=\"rf0400\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>G.H.</ce:given-name><ce:surname>Ashrafi</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Haghshenas</ce:surname></sb:author><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Marchetti</ce:surname></sb:author><sb:author><ce:given-name>M.S.</ce:given-name><ce:surname>Campo</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>E5 protein of human papillomavirus 16 downreguates HLA class I and interacts with the heavy chain <ce:italic>via</ce:italic> its first hydrophobic domain</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Int. J. Cancer</sb:maintitle></sb:title><sb:volume-nr>119</sb:volume-nr></sb:series><sb:date>2006</sb:date></sb:issue><sb:pages><sb:first-page>2105</sb:first-page><sb:last-page>2112</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0430\"><ce:label>[86]</ce:label><sb:reference id=\"rf0610\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Gruener</ce:surname></sb:author><sb:author><ce:given-name>I.G.</ce:given-name><ce:surname>Bravo</ce:surname></sb:author><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Momburg</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Alonso</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Tomakidi</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The E5 protein of the human papillomavirus type 16 down-regulates HLA-1 surface expression in calnexin-expressing but not in calnexin-deficient cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Virol. J.</sb:maintitle></sb:title><sb:volume-nr>4</sb:volume-nr></sb:series><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>116</sb:first-page></sb:pages></sb:host><sb:comment>(111-115)</sb:comment></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0435\"><ce:label>[87]</ce:label><sb:reference id=\"rf0405\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Conrad</ce:surname></sb:author><sb:author><ce:given-name>D.J.</ce:given-name><ce:surname>Goldstein</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Andersson</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Schlegel</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The E5 protein of HPV-6, but not HPV-16, associates efficiently with cellular growth factor receptors</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Virology</sb:maintitle></sb:title><sb:volume-nr>200</sb:volume-nr></sb:series><sb:date>1994</sb:date></sb:issue><sb:pages><sb:first-page>796</sb:first-page><sb:last-page>800</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0440\"><ce:label>[88]</ce:label><sb:reference id=\"rf0410\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>S.W.</ce:given-name><ce:surname>Straight</ce:surname></sb:author><sb:author><ce:given-name>P.M.</ce:given-name><ce:surname>Hinkle</ce:surname></sb:author><sb:author><ce:given-name>R.J.</ce:given-name><ce:surname>Jewers</ce:surname></sb:author><sb:author><ce:given-name>D.J.</ce:given-name><ce:surname>McCance</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Virol.</sb:maintitle></sb:title><sb:volume-nr>67</sb:volume-nr></sb:series><sb:date>1993</sb:date></sb:issue><sb:pages><sb:first-page>4521</sb:first-page><sb:last-page>4532</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0445\"><ce:label>[89]</ce:label><sb:reference id=\"rf0415\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Krawczyk</ce:surname></sb:author><sb:author><ce:given-name>F.A.</ce:given-name><ce:surname>Suprynowicz</ce:surname></sb:author><sb:author><ce:given-name>J.D.</ce:given-name><ce:surname>Hebert</ce:surname></sb:author><sb:author><ce:given-name>C.M.</ce:given-name><ce:surname>Kamonjoh</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Schlegel</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The human papillomavirus type 16 E5 oncoprotein translocates calpactin I to the perinuclear region</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Virol.</sb:maintitle></sb:title><sb:volume-nr>85</sb:volume-nr></sb:series><sb:date>2011</sb:date></sb:issue><sb:pages><sb:first-page>10968</sb:first-page><sb:last-page>10975</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0450\"><ce:label>[90]</ce:label><sb:reference id=\"rf0615\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Wakana</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Takai</ce:surname></sb:author><sb:author><ce:given-name>K.-i.</ce:given-name><ce:surname>Nakajima</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Tani</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Yamamoto</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Watson</ce:surname></sb:author><sb:author><ce:given-name>D.J.</ce:given-name><ce:surname>Stephens</ce:surname></sb:author><sb:author><ce:given-name>H.-P.</ce:given-name><ce:surname>Hauri</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Tagaya</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Bap31 is an itinerant protein that moves between the peripheral endoplasmic reticulum (ER) and a juxtanuclear compartment related to ER-associated degradation</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Mol. Biol. Cell</sb:maintitle></sb:title><sb:volume-nr>19</sb:volume-nr></sb:series><sb:date>2008</sb:date></sb:issue><sb:pages><sb:first-page>1825</sb:first-page><sb:last-page>1836</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0455\"><ce:label>[91]</ce:label><sb:reference id=\"rf0425\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>J.A.</ce:given-name><ce:surname>Regan</ce:surname></sb:author><sb:author><ce:given-name>L.A.</ce:given-name><ce:surname>Laimins</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Bap31 is a novel target of the human papillomavirus E5 protein</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Virol.</sb:maintitle></sb:title><sb:volume-nr>82</sb:volume-nr></sb:series><sb:date>2008</sb:date></sb:issue><sb:pages><sb:first-page>10042</sb:first-page><sb:last-page>10051</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0460\"><ce:label>[92]</ce:label><sb:reference id=\"rf0430\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Krawczyk</ce:surname></sb:author><sb:author><ce:given-name>J.A.</ce:given-name><ce:surname>Hanover</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Schlegel</ce:surname></sb:author><sb:author><ce:given-name>F.A.</ce:given-name><ce:surname>Suprynowicz</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Karyopherin β3: a new cellular target for HOV-16 E5 oncoprotein</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Biochem. Biophys. Res. Commun.</sb:maintitle></sb:title><sb:volume-nr>371</sb:volume-nr></sb:series><sb:date>2008</sb:date></sb:issue><sb:pages><sb:first-page>684</sb:first-page><sb:last-page>688</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0465\"><ce:label>[93]</ce:label><sb:reference id=\"rf0435\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>S.R.</ce:given-name><ce:surname>Sudarshan</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Schlegel</ce:surname></sb:author><sb:author><ce:given-name>X.</ce:given-name><ce:surname>Liu</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The HPV-16 E5 protein represses expression of stress pathway genes XBP-1 and COX-2 in genital keratinocytes</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Biochem. Biophys. Res. Commun.</sb:maintitle></sb:title><sb:volume-nr>399</sb:volume-nr></sb:series><sb:date>2010</sb:date></sb:issue><sb:pages><sb:first-page>617</sb:first-page><sb:last-page>622</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0470\"><ce:label>[94]</ce:label><sb:reference id=\"rf0440\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Tomakidi</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Cheng</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Kohl</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Komposch</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Alonso</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Connexin 43 expression is downregulated in raft cultures of human keratinocytes expressing the human papillomavirus type 16 E5 protein</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cell Tissue Res.</sb:maintitle></sb:title><sb:volume-nr>301</sb:volume-nr></sb:series><sb:date>2000</sb:date></sb:issue><sb:pages><sb:first-page>323</sb:first-page><sb:last-page>327</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0475\"><ce:label>[95]</ce:label><sb:reference id=\"rf0445\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>F.A.</ce:given-name><ce:surname>Suprynowicz</ce:surname></sb:author><sb:author><ce:given-name>G.L.</ce:given-name><ce:surname>Disbrow</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Krawczyk</ce:surname></sb:author><sb:author><ce:given-name>V.</ce:given-name><ce:surname>Simic</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Lantzky</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Schlegel</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>HPV-16 E5 oncoprotein upregulates lipid raft components caveolin-1 and ganglioside GM1 at the plasma membrane of cervical cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Oncogene</sb:maintitle></sb:title><sb:volume-nr>27</sb:volume-nr></sb:series><sb:date>2008</sb:date></sb:issue><sb:pages><sb:first-page>1071</sb:first-page><sb:last-page>1078</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0480\"><ce:label>[96]</ce:label><sb:reference id=\"rf0450\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Cui</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Fang</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Han</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Prediction of protein–protein interactions between viruses and human by an SVM model</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>BMC Bioinformatics</sb:maintitle></sb:title><sb:volume-nr>13</sb:volume-nr></sb:series><sb:date>2012</sb:date></sb:issue><sb:pages><sb:first-page>S5</sb:first-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0485\"><ce:label>[97]</ce:label><sb:reference id=\"rf0455\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Lin</ce:surname></sb:author><sb:author><ce:given-name>B.D.</ce:given-name><ce:surname>Lindenbach</ce:surname></sb:author><sb:author><ce:given-name>B.M.</ce:given-name><ce:surname>Pragai</ce:surname></sb:author><sb:author><ce:given-name>D.W.</ce:given-name><ce:surname>McCourt</ce:surname></sb:author><sb:author><ce:given-name>C.M.</ce:given-name><ce:surname>Rice</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Processing in the hepatitis C virus E2-NS2 region: identification of p7 and two distinct E2-specific products with different C termini</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Virol.</sb:maintitle></sb:title><sb:volume-nr>68</sb:volume-nr></sb:series><sb:date>1994</sb:date></sb:issue><sb:pages><sb:first-page>5063</sb:first-page><sb:last-page>5073</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0490\"><ce:label>[98]</ce:label><sb:reference id=\"rf0460\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Elbers</ce:surname></sb:author><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Tautz</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Becher</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Stoll</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Rumenapf</ce:surname></sb:author><sb:author><ce:given-name>H.J.</ce:given-name><ce:surname>Thiel</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Processing in the pestivirus E2-NS2 region: identification of proteins p7 and E2p7</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Virol.</sb:maintitle></sb:title><sb:volume-nr>70</sb:volume-nr></sb:series><sb:date>1996</sb:date></sb:issue><sb:pages><sb:first-page>4131</sb:first-page><sb:last-page>4135</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0495\"><ce:label>[99]</ce:label><sb:reference id=\"rf0465\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Steinmann</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Pietschmann</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Hepatitis C virus p7 — a viroporin crucial for virus assembly and emerging target for antiviral therapy</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Viruses</sb:maintitle></sb:title><sb:volume-nr>2</sb:volume-nr></sb:series><sb:date>2010</sb:date></sb:issue><sb:pages><sb:first-page>2078</sb:first-page><sb:last-page>2095</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0500\"><ce:label>[100]</ce:label><sb:reference id=\"rf0470\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>S.D.C.</ce:given-name><ce:surname>Griffin</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Plugging the holes in hepatitis C virus antiviral therapy</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Proc. Natl. Acad. Sci. U. S. A.</sb:maintitle></sb:title><sb:volume-nr>106</sb:volume-nr></sb:series><sb:date>2009</sb:date></sb:issue><sb:pages><sb:first-page>12567</sb:first-page><sb:last-page>12568</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0505\"><ce:label>[101]</ce:label><sb:reference id=\"rf0475\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>C.T.</ce:given-name><ce:surname>Jones</ce:surname></sb:author><sb:author><ce:given-name>C.L.</ce:given-name><ce:surname>Murray</ce:surname></sb:author><sb:author><ce:given-name>D.K.</ce:given-name><ce:surname>Eastman</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Tassello</ce:surname></sb:author><sb:author><ce:given-name>C.M.</ce:given-name><ce:surname>Rice</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Hepatitis C virus p7 and NS2 proteins are essential for production of infectious virus</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Virol.</sb:maintitle></sb:title><sb:volume-nr>81</sb:volume-nr></sb:series><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>8374</sb:first-page><sb:last-page>8383</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0510\"><ce:label>[102]</ce:label><sb:reference id=\"rf0480\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Steinmann</ce:surname></sb:author><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Penin</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Kallis</ce:surname></sb:author><sb:author><ce:given-name>A.H.</ce:given-name><ce:surname>Patel</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Bartenschlager</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Pietschmann</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Hepatitis C virus p7 protein is crucial for assembly and release of infectious virions</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>PLoS Pathog.</sb:maintitle></sb:title><sb:volume-nr>3</sb:volume-nr></sb:series><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>962</sb:first-page><sb:last-page>971</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0515\"><ce:label>[103]</ce:label><sb:reference id=\"rf0485\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Carrère-Kremer</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Montpellier-Pala</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Cocquerel</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Wychowski</ce:surname></sb:author><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Penin</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Dubuisson</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Subcellular localization and topology of the p7 polypeptide of hepatitis C virus</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Virol.</sb:maintitle></sb:title><sb:volume-nr>76</sb:volume-nr></sb:series><sb:date>2002</sb:date></sb:issue><sb:pages><sb:first-page>3720</sb:first-page><sb:last-page>3730</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0520\"><ce:label>[104]</ce:label><sb:reference id=\"rf0490\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Premkumar</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Wilson</ce:surname></sb:author><sb:author><ce:given-name>G.D.</ce:given-name><ce:surname>Ewart</ce:surname></sb:author><sb:author><ce:given-name>P.W.</ce:given-name><ce:surname>Gage</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Cation-selective ion channels formed by p7 of hepatitis C virus are blocked by hexamethylene amiloride</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>FEBS Lett.</sb:maintitle></sb:title><sb:volume-nr>557</sb:volume-nr></sb:series><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>99</sb:first-page><sb:last-page>103</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0525\"><ce:label>[105]</ce:label><sb:reference id=\"rf0495\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Montserret</ce:surname></sb:author><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Saint</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Vanbelle</ce:surname></sb:author><sb:author><ce:given-name>A.G.</ce:given-name><ce:surname>Salvay</ce:surname></sb:author><sb:author><ce:given-name>J.P.</ce:given-name><ce:surname>Simorre</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Ebel</ce:surname></sb:author><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Sapay</ce:surname></sb:author><sb:author><ce:given-name>J.-G.</ce:given-name><ce:surname>Renisio</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Böckmann</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Steinmann</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Pietschmann</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Dubuisson</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Chipot</ce:surname></sb:author><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Penin</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>NMR structure and ion channel activity of the p7 protein from hepatitis C virus</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Biol. Chem.</sb:maintitle></sb:title><sb:volume-nr>285</sb:volume-nr></sb:series><sb:date>2010</sb:date></sb:issue><sb:pages><sb:first-page>31446</sb:first-page><sb:last-page>31461</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0530\"><ce:label>[106]</ce:label><sb:reference id=\"rf0500\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Whitfield</ce:surname></sb:author><sb:author><ce:given-name>A.J.</ce:given-name><ce:surname>Miles</ce:surname></sb:author><sb:author><ce:given-name>J.C.</ce:given-name><ce:surname>Scheinost</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Offer</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Wentworth</ce:surname><ce:suffix>Jr.</ce:suffix></sb:author><sb:author><ce:given-name>R.A.</ce:given-name><ce:surname>Dwek</ce:surname></sb:author><sb:author><ce:given-name>B.A.</ce:given-name><ce:surname>Wallace</ce:surname></sb:author><sb:author><ce:given-name>P.C.</ce:given-name><ce:surname>Biggin</ce:surname></sb:author><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Zitzmann</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The influence of different lipid environment on the structure and function of the hepatitis C virus p7 ion channel protein</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Mol. Membr. Biol.</sb:maintitle></sb:title><sb:volume-nr>28</sb:volume-nr></sb:series><sb:date>2011</sb:date></sb:issue><sb:pages><sb:first-page>254</sb:first-page><sb:last-page>264</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0535\"><ce:label>[107]</ce:label><sb:reference id=\"rf0505\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>C.F.</ce:given-name><ce:surname>Chew</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Vijayan</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Chang</ce:surname></sb:author><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Zitzmann</ce:surname></sb:author><sb:author><ce:given-name>P.C.</ce:given-name><ce:surname>Biggin</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Determination of pore-lining residues in the hepatitis C virus p7 protein</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Biophys. J.</sb:maintitle></sb:title><sb:volume-nr>96</sb:volume-nr></sb:series><sb:date>2009</sb:date></sb:issue><sb:pages><sb:first-page>L10</sb:first-page><sb:last-page>L12</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0540\"><ce:label>[108]</ce:label><sb:reference id=\"rf0510\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Pavlovic</ce:surname></sb:author><sb:author><ce:given-name>D.C.A.</ce:given-name><ce:surname>Neville</ce:surname></sb:author><sb:author><ce:given-name>O.</ce:given-name><ce:surname>Argaud</ce:surname></sb:author><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Blumberg</ce:surname></sb:author><sb:author><ce:given-name>R.A.</ce:given-name><ce:surname>Dwek</ce:surname></sb:author><sb:author><ce:given-name>W.B.</ce:given-name><ce:surname>Fischer</ce:surname></sb:author><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Zitzmann</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The hepatitis C virus p7 protein forms an ion channel that is inhibited by long-alkyl-chain iminosugar derivatives</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Proc. Natl. Acad. Sci. U. S. A.</sb:maintitle></sb:title><sb:volume-nr>100</sb:volume-nr></sb:series><sb:date>2003</sb:date></sb:issue><sb:pages><sb:first-page>6104</sb:first-page><sb:last-page>6108</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0545\"><ce:label>[109]</ce:label><sb:reference id=\"rf0515\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>S.D.C.</ce:given-name><ce:surname>Griffin</ce:surname></sb:author><sb:author><ce:given-name>L.P.</ce:given-name><ce:surname>Beales</ce:surname></sb:author><sb:author><ce:given-name>D.S.</ce:given-name><ce:surname>Clarke</ce:surname></sb:author><sb:author><ce:given-name>O.</ce:given-name><ce:surname>Worsfold</ce:surname></sb:author><sb:author><ce:given-name>S.D.</ce:given-name><ce:surname>Evans</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Jäger</ce:surname></sb:author><sb:author><ce:given-name>M.P.G.</ce:given-name><ce:surname>Harris</ce:surname></sb:author><sb:author><ce:given-name>D.J.</ce:given-name><ce:surname>Rowlands</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, amantadine</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>FEBS Lett.</sb:maintitle></sb:title><sb:volume-nr>535</sb:volume-nr></sb:series><sb:date>2003</sb:date></sb:issue><sb:pages><sb:first-page>34</sb:first-page><sb:last-page>38</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0550\"><ce:label>[110]</ce:label><sb:reference id=\"rf0520\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Clarke</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Griffin</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Beales</ce:surname></sb:author><sb:author><ce:given-name>C.S.</ce:given-name><ce:surname>Gelais</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Burgess</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Harris</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Rowlands</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Evidence for the formation of a heptameric ion channel complex by the hepatitis C virus p7 protein in vitro</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Biol. Chem.</sb:maintitle></sb:title><sb:volume-nr>281</sb:volume-nr></sb:series><sb:date>2006</sb:date></sb:issue><sb:pages><sb:first-page>37057</sb:first-page><sb:last-page>37068</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0555\"><ce:label>[111]</ce:label><sb:reference id=\"rf0525\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Luik</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Chew</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Aittoniemi</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Chang</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Wentworth</ce:surname><ce:suffix>Jr.</ce:suffix></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Dwek</ce:surname></sb:author><sb:author><ce:given-name>P.C.</ce:given-name><ce:surname>Biggin</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Vénien-Bryan</ce:surname></sb:author><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Zitzmann</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The 3-dimensional structure of the hepatitis C virus p7 ion channel by electron microscopy</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Proc. Natl. Acad. Sci. U. S. A.</sb:maintitle></sb:title><sb:volume-nr>106</sb:volume-nr></sb:series><sb:date>2009</sb:date></sb:issue><sb:pages><sb:first-page>12712</sb:first-page><sb:last-page>12716</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0560\"><ce:label>[112]</ce:label><sb:reference id=\"rf0530\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>G.A.</ce:given-name><ce:surname>Cook</ce:surname></sb:author><sb:author><ce:given-name>S.J.</ce:given-name><ce:surname>Opella</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>NMR studies of the p7 protein from hepatitis C virus</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Eur. Biophys. J.</sb:maintitle></sb:title><sb:volume-nr>39</sb:volume-nr></sb:series><sb:date>2010</sb:date></sb:issue><sb:pages><sb:first-page>1097</sb:first-page><sb:last-page>1104</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0565\"><ce:label>[113]</ce:label><sb:reference id=\"rf0535\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>G.A.</ce:given-name><ce:surname>Cook</ce:surname></sb:author><sb:author><ce:given-name>S.J.</ce:given-name><ce:surname>Opella</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Secondary structure, dynamics, and architecture of the p7 membrane protein from hepatitis C virus by NMR spectroscopy</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Biochim. Biophys. Acta</sb:maintitle></sb:title><sb:volume-nr>1808</sb:volume-nr></sb:series><sb:date>2011</sb:date></sb:issue><sb:pages><sb:first-page>1448</sb:first-page><sb:last-page>1453</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0570\"><ce:label>[114]</ce:label><sb:reference id=\"rf0540\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Patargias</ce:surname></sb:author><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Zitzmann</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Dwek</ce:surname></sb:author><sb:author><ce:given-name>W.B.</ce:given-name><ce:surname>Fischer</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Protein–protein interactions: modeling the hepatitis C virus ion channel p7</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Med. Chem.</sb:maintitle></sb:title><sb:volume-nr>49</sb:volume-nr></sb:series><sb:date>2006</sb:date></sb:issue><sb:pages><sb:first-page>648</sb:first-page><sb:last-page>655</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0575\"><ce:label>[115]</ce:label><sb:reference id=\"rf0545\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>D.E.</ce:given-name><ce:surname>Chandler</ce:surname></sb:author><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Penin</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Schulten</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Chipot</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The p7 protein of hepatitis C virus forms structurally plastic, minimalist ion channels</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>PLoS Comput. Biol.</sb:maintitle></sb:title><sb:volume-nr>8</sb:volume-nr></sb:series><sb:date>2012</sb:date></sb:issue><sb:pages><sb:first-page>e1002702</sb:first-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0580\"><ce:label>[116]</ce:label><sb:reference id=\"rf0550\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>Q.</ce:given-name><ce:surname>Li</ce:surname></sb:author><sb:author><ce:given-name>A.L.</ce:given-name><ce:surname>Brass</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Ng</ce:surname></sb:author><sb:author><ce:given-name>Z.</ce:given-name><ce:surname>Hu</ce:surname></sb:author><sb:author><ce:given-name>R.J.</ce:given-name><ce:surname>Xavier</ce:surname></sb:author><sb:author><ce:given-name>T.J.</ce:given-name><ce:surname>Liang</ce:surname></sb:author><sb:author><ce:given-name>S.J.</ce:given-name><ce:surname>Elledge</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>A genome-wide genetic screen for host factors required for hepatitis C virus propagation</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Proc. Natl. Acad. Sci. U. S. A.</sb:maintitle></sb:title><sb:volume-nr>106</sb:volume-nr></sb:series><sb:date>2009</sb:date></sb:issue><sb:pages><sb:first-page>16410</sb:first-page><sb:last-page>16415</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0585\"><ce:label>[117]</ce:label><sb:reference id=\"rf0555\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>J.C.</ce:given-name><ce:surname>Lin</ce:surname></sb:author><sb:author><ce:given-name>W.-H.</ce:given-name><ce:surname>Ho</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Gurney</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Rosenthal</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The netrin-G1 ligand NGL-1 promotes the outgrowth of thalamocortical axons</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nat. Neurosci.</sb:maintitle></sb:title><sb:volume-nr>6</sb:volume-nr></sb:series><sb:date>2003</sb:date></sb:issue><sb:pages><sb:first-page>1270</sb:first-page><sb:last-page>1276</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0590\"><ce:label>[118]</ce:label><sb:reference id=\"rf0560\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Wang</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Hudak</ce:surname></sb:author><sb:author><ce:given-name>H.S.</ce:given-name><ce:surname>Sul</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Role of preadipocyte factor 1 in adipocyte differentiation</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Clin. Lipidol.</sb:maintitle></sb:title><sb:volume-nr>5</sb:volume-nr></sb:series><sb:date>2010</sb:date></sb:issue><sb:pages><sb:first-page>109</sb:first-page><sb:last-page>115</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0595\"><ce:label>[119]</ce:label><sb:reference id=\"rf0565\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>S.J.</ce:given-name><ce:surname>Bray</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Notch signalling: a simple pathway becomes complex</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nat. Rev. Mol. Cell Biol.</sb:maintitle></sb:title><sb:volume-nr>7</sb:volume-nr></sb:series><sb:date>2006</sb:date></sb:issue><sb:pages><sb:first-page>678</sb:first-page><sb:last-page>689</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0600\"><ce:label>[120]</ce:label><sb:reference id=\"rf0570\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Randal</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Panis</ce:surname></sb:author><sb:author><ce:given-name>J.D.</ce:given-name><ce:surname>Cooper</ce:surname></sb:author><sb:author><ce:given-name>T.L.</ce:given-name><ce:surname>Tellinghuisen</ce:surname></sb:author><sb:author><ce:given-name>K.E.</ce:given-name><ce:surname>Sukhodolets</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Pfeffer</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Landthaler</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Landgraf</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Kan</ce:surname></sb:author><sb:author><ce:given-name>B.D.</ce:given-name><ce:surname>Lindenbach</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Chien</ce:surname></sb:author><sb:author><ce:given-name>D.B.</ce:given-name><ce:surname>Weir</ce:surname></sb:author><sb:author><ce:given-name>J.J.</ce:given-name><ce:surname>Russo</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Ju</ce:surname></sb:author><sb:author><ce:given-name>M.J.</ce:given-name><ce:surname>Brownstein</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Sheridan</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Sander</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Zavolan</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Tuschl</ce:surname></sb:author><sb:author><ce:given-name>C.M.</ce:given-name><ce:surname>Rice</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Cellular cofactors affecting hepatitis C virus infection and replication</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Proc. Natl. Acad. Sci. U. S. A.</sb:maintitle></sb:title><sb:volume-nr>104</sb:volume-nr></sb:series><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>12884</sb:first-page><sb:last-page>12889</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0605\"><ce:label>[121]</ce:label><sb:reference id=\"rf0575\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>J.G.</ce:given-name><ce:surname>Magadán</ce:surname></sb:author><sb:author><ce:given-name>J.S.</ce:given-name><ce:surname>Bonifacino</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Transmembrane domain determinants of CD4 downregulation by HIV-1 Vpu</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Virol.</sb:maintitle></sb:title><sb:volume-nr>86</sb:volume-nr></sb:series><sb:date>2012</sb:date></sb:issue><sb:pages><sb:first-page>757</sb:first-page><sb:last-page>772</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0610\"><ce:label>[122]</ce:label><sb:reference id=\"rf0580\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Lazarczyk</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Cassonnet</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Pons</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Jacob</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Favre</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The EVER proteins as a natural barrier against papillomavirus: a new insight into the pathogenesis of human papilloma infections</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Microbiol. Mol. Biol. Rev.</sb:maintitle></sb:title><sb:volume-nr>73</sb:volume-nr></sb:series><sb:date>2008</sb:date></sb:issue><sb:pages><sb:first-page>348</sb:first-page><sb:last-page>370</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference></ce:bibliography-sec></ce:bibliography></tail></article></xocs:serial-item></xocs:doc></originalText></full-text-retrieval-response>',\n",
       " 'Two-pore domain K+ channels (K2P), an emerging K+ channel subfamily, contribute to setting membrane potential in both electrically excitable and nonexcitable cells and, as such, influence cellular function. The multinucleate syncytiotrophoblast of human placenta, formed from the fusion of mononucleate cytotrophoblast cells, is a transporting epithelium whose function likely depends on the activity of K+ channels. We have therefore investigated the gene expression of two members of this family, TASK and TREK, in cultured human cytotrophoblast cells, and have also investigated protein expression in cytotrophoblast cells and placenta. We used reverse transcriptase-polymerase chain reaction (RT-PCR), Western blotting, and immunocytochemistry to investigate the gene and protein expression of TASK and TREK isoforms in both isolated cytotrophoblast cells and term placental tissue. In cytotrophoblast cells, mRNAs encoding TASK1, 2, 4, 5, and TREK1 were detected, whereas weak or no signals were observed for TASK3 and TREK2. Western blotting for TASK1 in cytotrophoblast cells gave two bands of approximately 78 and 150 kd; TREK1 gave bands of approximately 90 and 130 kd. TASK1 immunofluorescence in placenta colocalized with cytokeratin-7, a trophoblast-specific marker. TREK1 predominantly stained cells around the villous perimeter and this staining was colocalized with propidium iodide nuclear staining. Human cytotrophoblast cells from term placenta are a site of expression for various K2P genes, two of which, namely, TASK1 and TREK1, are transcribed into protein.',\n",
       " '<!DOCTYPE article PUBLIC \"-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN\" \"JATS-archivearticle1.dtd\">\\n<article xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" article-type=\"research-article\">\\n  <?properties manuscript?>\\n  <front>\\n    <journal-meta>\\n      <journal-id journal-id-type=\"nlm-journal-id\">0217513</journal-id>\\n      <journal-id journal-id-type=\"pubmed-jr-id\">1037</journal-id>\\n      <journal-id journal-id-type=\"nlm-ta\">Biochim Biophys Acta</journal-id>\\n      <journal-id journal-id-type=\"iso-abbrev\">Biochim. Biophys. Acta</journal-id>\\n      <journal-title-group>\\n        <journal-title>Biochimica et biophysica acta</journal-title>\\n      </journal-title-group>\\n      <issn pub-type=\"ppub\">0006-3002</issn>\\n    </journal-meta>\\n    <article-meta>\\n      <article-id pub-id-type=\"pmid\">23831603</article-id>\\n      <article-id pub-id-type=\"pmc\">3859730</article-id>\\n      <article-id pub-id-type=\"doi\">10.1016/j.bbamem.2013.06.029</article-id>\\n      <article-id pub-id-type=\"manuscript\">NIHMS508378</article-id>\\n      <article-categories>\\n        <subj-group subj-group-type=\"heading\">\\n          <subject>Article</subject>\\n        </subj-group>\\n      </article-categories>\\n      <title-group>\\n        <article-title>HIV-1 Vpu – An ion channel in search of a job</article-title>\\n      </title-group>\\n      <contrib-group>\\n        <contrib contrib-type=\"author\">\\n          <name>\\n            <surname>Strebel</surname>\\n            <given-names>Klaus</given-names>\\n          </name>\\n          <aff id=\"A1\">Laboratory of Molecular Microbiology, Viral Biochemistry Section, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, 20892-0460</aff>\\n        </contrib>\\n      </contrib-group>\\n      <author-notes>\\n        <corresp id=\"cor1\"><italic>Correspondent address:</italic> Klaus Strebel, Viral Biochemistry Section, Laboratory of Molecular Microbiology, NIAID, NIH; Bldg. 4, Room 310; 4 Center Drive MSC 0460; Bethesda, MD 20892-0460, Tel: 301 496-3132; Fax: 301 402-0226; <email>kstrebel@nih.gov</email></corresp>\\n      </author-notes>\\n      <pub-date pub-type=\"nihms-submitted\">\\n        <day>22</day>\\n        <month>8</month>\\n        <year>2013</year>\\n      </pub-date>\\n      <pub-date pub-type=\"epub\">\\n        <day>3</day>\\n        <month>7</month>\\n        <year>2013</year>\\n      </pub-date>\\n      <pub-date pub-type=\"ppub\">\\n        <month>4</month>\\n        <year>2014</year>\\n      </pub-date>\\n      <pub-date pub-type=\"pmc-release\">\\n        <day>01</day>\\n        <month>4</month>\\n        <year>2015</year>\\n      </pub-date>\\n      <volume>1838</volume>\\n      <issue>4</issue>\\n      <fpage>1074</fpage>\\n      <lpage>1081</lpage>\\n      <permissions>\\n        <license>\\n          <license-p>This file is available for text mining. It may also be used consistent with the principles of fair use under the copyright law.</license-p>\\n        </license>\\n      </permissions>\\n      <abstract>\\n        <p id=\"P1\">Vpu is a small membrane protein encoded by HIV-1 and some SIV isolates. The protein is best known for its ability to degrade CD4 and to enhance the release of progeny virions from infected cells. However, Vpu also promotes host-cell apoptosis by deregulating the NFκB signaling pathway and it assembles into cation-conducting membrane pores. This review summarizes our current understanding of these various functions of Vpu with particular emphasis on recent progress in the Vpu field.</p>\\n      </abstract>\\n    </article-meta>\\n  </front>\\n  <body>\\n    <sec sec-type=\"intro\" id=\"S1\">\\n      <title>1. Introduction</title>\\n      <p id=\"P2\">Viruses face a variety of obstacles when infecting a new host. Of particular importance is the host innate immune system that can form a potent barrier to viral infections. Viruses have adapted to this challenge in a variety of ways. Primate lentiviruses, including HIV-1, have acquired several genes whose primary if not exclusive function is to neutralize host innate immune defense mechanisms (for review see [<xref rid=\"R1\" ref-type=\"bibr\">1</xref>, <xref rid=\"R2\" ref-type=\"bibr\">2</xref>]). Vpu is an accessory protein unique to HIV-1 and its predecessor SIV strains. The initial functional property attributed to Vpu was to facilitate virus release from infected cells [<xref rid=\"R3\" ref-type=\"bibr\">3</xref>, <xref rid=\"R4\" ref-type=\"bibr\">4</xref>]. It became apparent early on that this function of Vpu was host cell-dependent [<xref rid=\"R5\" ref-type=\"bibr\">5</xref>, <xref rid=\"R6\" ref-type=\"bibr\">6</xref>], suggesting the involvement of host cell factor(s). This observation was further supported by experiments involving heterokaryon analyses [<xref rid=\"R7\" ref-type=\"bibr\">7</xref>]. However, not until 20 years after the initial discovery of Vpu and its effect on virus release was the involvement of BST-2 unraveled [<xref rid=\"R8\" ref-type=\"bibr\">8</xref>, <xref rid=\"R9\" ref-type=\"bibr\">9</xref>]. Prior to the identification of BST-2, different functional models of how Vpu regulates virus release had been proposed. These included a correlation of enhanced virus release with a Vpu ion channel activity or with the inactivation of a cellular background channel, TASK-1 [<xref rid=\"R10\" ref-type=\"bibr\">10</xref>–<xref rid=\"R12\" ref-type=\"bibr\">12</xref>]. However, the identification of BST-2 as an interferon-inducible host factor whose expression induced a severe but Vpu-sensitive restriction of virus release caused a major shift in research focus and made the earlier models fade into the background. It is fair to say that the identification of BST-2 and its effect on virus release has been a major advance in the field and investigating the role of Vpu in the antagonism of BST-2 is currently the most active aspect of Vpu-related research. Nevertheless, one should not ignore the fact that Vpu controls additional functions. These include degradation of the HIV-receptor CD4 or the inhibition of NFκB activation. These functions of Vpu are mechanistically relatively well understood although their functional significance for HIV replication is still under discussion. The purpose of this review is to provide a brief update on our current understanding of the role of Vpu in regulating virus release and to discuss its other known functions and their potential impact on virus replication</p>\\n    </sec>\\n    <sec id=\"S2\">\\n      <title>2. Functional properties of HIV-1 Vpu</title>\\n      <sec id=\"S3\">\\n        <title>2.1. Vpu induces degradation of CD4</title>\\n        <p id=\"P3\">The Vpu open reading frame is located upstream of and overlapping the viral <italic>env</italic> gene. Interestingly, Vpu and the envelope precursor glycoprotein, gpl60, are expressed from a single bicistronic mRNA while all other HIV products are produced from a complex pattern of differentially spliced mRNAs or via the proteolytic processing of the Gag and Gag-Pol polyproteins. This unusual utilization of viral transcripts suggested a requirement for the coordinate action of Vpu and Env. Indeed, it was known at the time that CD4, the receptor for HIV-1 had a propensity to interact with gpl60 in the endoplasmic reticulum (ER), resulting in the accumulation of trafficking-incompetent complexes of CD4 and Env in the ER [<xref rid=\"R13\" ref-type=\"bibr\">13</xref>–<xref rid=\"R15\" ref-type=\"bibr\">15</xref>]. This led to the investigation of a possible role of Vpu in the dissociation of such Env-CD4 complexes and the subsequent identification of Vpu-induced degradation of CD4 [<xref rid=\"R16\" ref-type=\"bibr\">16</xref>, <xref rid=\"R17\" ref-type=\"bibr\">17</xref>]. Indeed, in Vpu-expressing cells, <italic>de novo</italic> synthesized CD4 is rapidly degraded in the ER reducing its normal half-life of about 6 hr to approximately 15 min (for review see [<xref rid=\"R18\" ref-type=\"bibr\">18</xref>]). It is well accepted that ER-associated degradation of CD4 by Vpu requires a physical interaction of the cytoplasmic domains of the two proteins that in CD4 has been mapped to a short membrane-proximal motif [<xref rid=\"R19\" ref-type=\"bibr\">19</xref>–<xref rid=\"R23\" ref-type=\"bibr\">23</xref>] and in Vpu was more recently shown to involve both cytoplasmic α-helices [<xref rid=\"R24\" ref-type=\"bibr\">24</xref>] (<xref ref-type=\"fig\" rid=\"F1\">Figure 1A</xref>). Some groups reported an additional contribution of the transmembrane (TM) domains of CD4 and Vpu as prerequisite for CD4 degradation [<xref rid=\"R25\" ref-type=\"bibr\">25</xref>–<xref rid=\"R27\" ref-type=\"bibr\">27</xref>]. Of particular interest is the observation that a conserved tryptophan residue (W22) in the Vpu TM domain, when mutated to leucine (W22L) did not prevent Vpu-CD4 interaction but almost completely abolished Vpu-induced degradation of CD4 [<xref rid=\"R27\" ref-type=\"bibr\">27</xref>]. This finding is intriguing as it implies a contribution of the Vpu TM domain to CD4 degradation that goes beyond the mere stabilization of Vpu-CD4 complexes. Other reports, however, demonstrated that replacing the TM domain of CD4 by that of CD8 [<xref rid=\"R28\" ref-type=\"bibr\">28</xref>] or scrambling the sequence of the Vpu TM domain, which included a repositioning of W22 [<xref rid=\"R29\" ref-type=\"bibr\">29</xref>] had no impact on the ability of Vpu to induce CD4 degradation. Furthermore, replacing the entire Vpu TM domain by TM domains from heterologous transmembrane proteins did not affect the ability of Vpu to induce CD4 degradation ([<xref rid=\"R30\" ref-type=\"bibr\">30</xref>] and Strebel, unpublished). It is unclear why an individual amino acid change in the Vpu TM domain has a more drastic effect than global replacement of the entire TM domain in either Vpu or CD4. However, structural changes in the membrane helix are a likely cause. It is conceivable that relatively non-specific interactions between the hydrophobic membrane helices of CD4 and Vpu or its chimeras stabilize Vpu-CD4 interactions and contribute to Vpu-induced CD4 degradation.</p>\\n        <p id=\"P4\">Aside from sequences required for the physical interaction of Vpu and CD4, a conserved di-phosphoserine motif located between the two cytoplasmic α-helices in Vpu is critical for the assembly of a β-TrCP-containing SKP1, Cullin, F-box protein(SCF) E3 ubiquitin ligase complex (SCF<sup>TrCP</sup>) [<xref rid=\"R31\" ref-type=\"bibr\">31</xref>] that ultimately leads to the ubiquitination of CD4 followed by proteasomal degradation (reviewed in [<xref rid=\"R18\" ref-type=\"bibr\">18</xref>, <xref rid=\"R32\" ref-type=\"bibr\">32</xref>] (<xref ref-type=\"fig\" rid=\"F1\">Figure 1A</xref>). The role of the Vpu phosphoserine residues in the induction of CD4 degradation became apparent when yeast two-hybrid assays as well as coimmunoprecipitation studies revealed an interaction of Vpu with human β-TrCP [<xref rid=\"R31\" ref-type=\"bibr\">31</xref>]. The interaction of Vpu with β-TrCP leads to the assembly of a ubiquitin ligase complex that targets the cytoplasmic domain of CD4 [<xref rid=\"R31\" ref-type=\"bibr\">31</xref>, <xref rid=\"R33\" ref-type=\"bibr\">33</xref>, <xref rid=\"R34\" ref-type=\"bibr\">34</xref>]. Interestingly, Vpu itself is not ubiquitinated in the process and therefore assumes the role of an inert adapter molecule. This characteristic of Vpu likely accounts for the effect of Vpu on NFκB deregulation described below. The cytoplasmic domain of CD4 contains four lysine residues as potential targets for ubiquitination. Interestingly, mutation of all four lysines neither abolished Vpu-induced CD4 ubiquitination nor did it prevent Vpu-induced degradation [<xref rid=\"R33\" ref-type=\"bibr\">33</xref>]. An explanation for this phenomenon may be provided by the recent observation that degradation of CD4 by Vpu may involve not only ubiquitination of lysines but also serine/threonine residues in its cytoplasmic domain [<xref rid=\"R34\" ref-type=\"bibr\">34</xref>].</p>\\n      </sec>\\n      <sec id=\"S4\">\\n        <title>2.2. Vpu regulates detachment of virions</title>\\n        <sec id=\"S5\">\\n          <title>2.2.1. BST-2 inhibits virus release</title>\\n          <p id=\"P5\">Recent efforts in the Vpu field have almost exclusively focused on understanding its role in regulating virus release. It is now generally accepted that the regulation of virus release by Vpu involves the functional inactivation of BST-2 (also known as CD317, HM1.24, or tetherin). BST-2 was originally identified as a cellular transmembrane protein in terminally differentiated human B cells of patients with multiple myeloma [<xref rid=\"R35\" ref-type=\"bibr\">35</xref>, <xref rid=\"R36\" ref-type=\"bibr\">36</xref>] and was later identified as the host factor responsible for the Vpu-sensitive inhibition of virus particle release [<xref rid=\"R8\" ref-type=\"bibr\">8</xref>, <xref rid=\"R9\" ref-type=\"bibr\">9</xref>]. BST-2 was identified as a target for Vpu already two years earlier in a proteomics study that also identified the Kaposi sarcoma-associated herpesvirus K5 protein as a BST-2 antagonist. In fact, both Vpu and K5 when overexpressed in HeLa cells reduced the levels of endogenous BST-2 [<xref rid=\"R37\" ref-type=\"bibr\">37</xref>].</p>\\n        </sec>\\n        <sec id=\"S6\">\\n          <title>2.2.2. Structural considerations</title>\\n          <p id=\"P6\">BST-2 is a 30–36 kDa type II transmembrane glycoprotein consisting of 180 amino acids [<xref rid=\"R38\" ref-type=\"bibr\">38</xref>]. Rat BST-2 is predicted to have an N-terminal transmembrane (TM) region and a C-terminal glycosyl-phosphatidylinositol (GPI) anchor [<xref rid=\"R39\" ref-type=\"bibr\">39</xref>]. However, recent evidence suggests that the C-terminal membrane anchor, at least in human BST-2, could be a second transmembrane domain rather than a GPI anchor [<xref rid=\"R40\" ref-type=\"bibr\">40</xref>]. The two TM domains are separated by approximately 120 residues that constitute the protein’s ectodomain, which is predicted to form a rod-like α-helical structure of about 16–17 nm [<xref rid=\"R41\" ref-type=\"bibr\">41</xref>–<xref rid=\"R44\" ref-type=\"bibr\">44</xref>]. The BST-2 ectodomain contains two N-linked carbohydrates [<xref rid=\"R35\" ref-type=\"bibr\">35</xref>, <xref rid=\"R39\" ref-type=\"bibr\">39</xref>, <xref rid=\"R45\" ref-type=\"bibr\">45</xref>, <xref rid=\"R46\" ref-type=\"bibr\">46</xref>] whose functional importance is not clear [<xref rid=\"R45\" ref-type=\"bibr\">45</xref>, <xref rid=\"R46\" ref-type=\"bibr\">46</xref>]. Three cysteine residues in the BST-2 ectodomain contribute to the formation of covalently linked dimers [<xref rid=\"R35\" ref-type=\"bibr\">35</xref>, <xref rid=\"R36\" ref-type=\"bibr\">36</xref>, <xref rid=\"R45\" ref-type=\"bibr\">45</xref>, <xref rid=\"R46\" ref-type=\"bibr\">46</xref>]. Interestingly, only one cysteine residue is necessary and any one of the three cysteine residues is sufficient for the assembly of BST-2 into functional covalently linked dimers [<xref rid=\"R45\" ref-type=\"bibr\">45</xref>, <xref rid=\"R46\" ref-type=\"bibr\">46</xref>].</p>\\n          <p id=\"P7\">A current model suggests that BST-2 tethers mature virions to the cell surface by means of its N- and C-terminal TM domains. Interestingly, artificial BST-2 consisting of the N-terminal TM region of transferrin receptor, a coiled-coil ectodomain of the cytoplasmic dimeric protein dystrophia myotonica protein kinase, and a GPI anchor signal derived from urokinase plasminogen activator receptor was capable of inhibiting the release of HIV-1 virions tethered to the cell surface [<xref rid=\"R46\" ref-type=\"bibr\">46</xref>]. This suggests that secondary structure rather than primary amino acid sequence of BST-2 is important for tethering function. This conclusion is supported by the observation that alanine scanning across much of the ectodomain failed to affect BST-2 function [<xref rid=\"R47\" ref-type=\"bibr\">47</xref>] and there is significant flexibility in the size of the BST-2 ectodomain [<xref rid=\"R48\" ref-type=\"bibr\">48</xref>]. Extending or substituting the BST-2 ectodomain using a heterologous coiled-coil motif maintained tethering function [<xref rid=\"R48\" ref-type=\"bibr\">48</xref>]. In fact, adding heterologous coiled-coil sequences to the existing BST-2 coil-coil thereby almost doubling the size of the BST-2 ectodomain had no impact on BST-2 function [<xref rid=\"R48\" ref-type=\"bibr\">48</xref>]. Conversely, approximately half of the ectodomain, including a block of seven heptad motifs believed to be important for coiled-coil formation, could be deleted without losing tethering function. Taken together, these data indicate that the size and primary sequence of the BST-2 ectodomain can be altered to a significant degree without loss of function.</p>\\n          <p id=\"P8\">Electron microscopic images not only revealed <italic>vpu</italic>-defective virions tethered to the cell surface; in many instances, virus particles appear to be tethered to each other [<xref rid=\"R8\" ref-type=\"bibr\">8</xref>, <xref rid=\"R49\" ref-type=\"bibr\">49</xref>, <xref rid=\"R50\" ref-type=\"bibr\">50</xref>]. If BST-2 were responsible for the formation of virus aggregates, it would be expected that BST-2 is present in such virions. Indeed, defective BST-2 variants lacking either N- or C-terminal TM domain were readily detected in cell-free virus preparations [<xref rid=\"R46\" ref-type=\"bibr\">46</xref>] suggesting that BST-2 is not actively excluded from virions. Interestingly, immune-electron microscopy identified the presence of wild type BST-2 in both wild type and Vpu-defective virions [<xref rid=\"R51\" ref-type=\"bibr\">51</xref>, <xref rid=\"R52\" ref-type=\"bibr\">52</xref>] and similar results were obtained using a bead-based virion capture assay [<xref rid=\"R52\" ref-type=\"bibr\">52</xref>]. Furthermore, immunoblot analysis of concentrated virus preparations revealed the presence of BST-2 in both wild type and Vpu-defective virions. Indeed, Vpu-defective virions contained significantly higher levels of BST-2 than wild type virus, when normalized for capsid levels [<xref rid=\"R52\" ref-type=\"bibr\">52</xref>]. This result is surprising if one accepts the popular tethering model of BST-2, which proposes that BST-2 physically tethers virions to the virus-producing cell. If one assumes that the association of BST-2 with nascent virions follows a Gaussian distribution model, one might predict that even in the absence of Vpu, a certain fraction of virions will be spontaneously released due to insufficient levels of BST-2 associated with these virions. Thus, the level of BST-2 in spontaneously released Vpu-defective virions should be lower than or equal to that observed in wild type virions but certainly not higher. Consistent with that we found that preparations of <italic>vpu</italic>-defective virions that had been removed from BST-2 positive HeLa cells by physical force lacked detectable levels of BST-2 [<xref rid=\"R53\" ref-type=\"bibr\">53</xref>]. While the reasons for this apparent discrepancy remain unclear, it is fair to say that endogenous wild type BST-2 is packaged into both wild type and Vpu-defective HIV-1 virions at levels that are not inhibitory.</p>\\n        </sec>\\n        <sec id=\"S7\">\\n          <title>2.2.3. How does Vpu antagonize BST-2?</title>\\n          <p id=\"P9\">While Vpu expression ultimately leads to the cell-surface downmodulation of BST-2 [<xref rid=\"R9\" ref-type=\"bibr\">9</xref>, <xref rid=\"R53\" ref-type=\"bibr\">53</xref>–<xref rid=\"R59\" ref-type=\"bibr\">59</xref>], we found that in productively infected T cell cultures, Vpu can antagonize BST-2 to yield efficient virus release without apparent effect on its cell surface expression [<xref rid=\"R53\" ref-type=\"bibr\">53</xref>]. Similar observations were reported for the antagonism of BST-2 by the Ebola virus glycoprotein [<xref rid=\"R60\" ref-type=\"bibr\">60</xref>]. This raises the question of how it is possible that the tethering activity of BST-2 can be inhibited without removal of the protein from the cell surface. One possible solution is that Vpu and/or Ebola glycoprotein alter the surface distribution of BST-2, which is normally associated with membrane raft structures [<xref rid=\"R39\" ref-type=\"bibr\">39</xref>, <xref rid=\"R40\" ref-type=\"bibr\">40</xref>, <xref rid=\"R60\" ref-type=\"bibr\">60</xref>–<xref rid=\"R64\" ref-type=\"bibr\">64</xref>]. However, Lopez et al failed to see an effect of Vpu or Ebola glycoprotein on BST-2’s distribution within lipid rafts [<xref rid=\"R60\" ref-type=\"bibr\">60</xref>]. BST-2 rapidly cycles between the cell surface and internal membranes [<xref rid=\"R56\" ref-type=\"bibr\">56</xref>, <xref rid=\"R58\" ref-type=\"bibr\">58</xref>, <xref rid=\"R65\" ref-type=\"bibr\">65</xref>] (<xref ref-type=\"fig\" rid=\"F2\">Figure 2</xref>; (1)); however, Vpu does not increase the rate of BST-2 internalization but rather seems to affect the resupply of newly synthesized BST-2 to the cell surface [<xref rid=\"R65\" ref-type=\"bibr\">65</xref>, <xref rid=\"R66\" ref-type=\"bibr\">66</xref>] (<xref ref-type=\"fig\" rid=\"F2\">Figure 2</xref>; (4)). Such a function could be exerted from an intracellular location such as the trans-Golgi compartment. Vpu was also found to reduce total cellular levels of endogenous as well as exogenously expressed BST-2 [<xref rid=\"R37\" ref-type=\"bibr\">37</xref>, <xref rid=\"R53\" ref-type=\"bibr\">53</xref>, <xref rid=\"R56\" ref-type=\"bibr\">56</xref>, <xref rid=\"R57\" ref-type=\"bibr\">57</xref>, <xref rid=\"R67\" ref-type=\"bibr\">67</xref>, <xref rid=\"R68\" ref-type=\"bibr\">68</xref>]. How exactly this is accomplished is still under debate and it is not clear yet whether the reduced BST-2 levels are a cause or consequence of BST-2 surface downmodulation. Several studies reported the involvement of a proteasomal degradation pathway [<xref rid=\"R67\" ref-type=\"bibr\">67</xref>] and suggested β-TrCP dependence [<xref rid=\"R68\" ref-type=\"bibr\">68</xref>]. In contrast, other studies reported a β-TrCP-dependent endo-lysosomal pathway to be important for degradation [<xref rid=\"R56\" ref-type=\"bibr\">56</xref>, <xref rid=\"R57\" ref-type=\"bibr\">57</xref>, <xref rid=\"R59\" ref-type=\"bibr\">59</xref>]. The involvement of β-TrCP in the virus release activity of Vpu necessitates conservation of Vpu’s TrCP binding motif. However, mutation of this motif was previously found to only partially affect Vpu’s virus release activity [<xref rid=\"R9\" ref-type=\"bibr\">9</xref>, <xref rid=\"R69\" ref-type=\"bibr\">69</xref>, <xref rid=\"R70\" ref-type=\"bibr\">70</xref>] and in more recent studies expression of a TrCP-binding mutant of Vpu (Vpu26) supported HIV replication with wild type kinetics in a variety of cell types including PBMC [<xref rid=\"R53\" ref-type=\"bibr\">53</xref>]. Finally, expression of a β-TrCP binding-deficient Vpu26 mutant did not reduce total cellular BST-2 levels but, to the contrary, appeared to stabilize or even increase BST-2 surface expression [<xref rid=\"R53\" ref-type=\"bibr\">53</xref>]. This phenomenon could explain the partial effect of Vpu26 on virus release, which could be the result of increased levels of BST-2 rather than partial antagonism of BST-2 by Vpu26. Importantly, degradation of BST-2 was not essential for Vpu to enhance virus release [<xref rid=\"R53\" ref-type=\"bibr\">53</xref>, <xref rid=\"R71\" ref-type=\"bibr\">71</xref>] suggesting it may be a downstream consequence of the Vpu-induced BST-2 surface downmodulation.</p>\\n        </sec>\\n        <sec id=\"S8\">\\n          <title>2.2.5. BST-2: A host-restricton factor or a modulator of viral dissemination?</title>\\n          <p id=\"P10\">BST-2 can be neutralized by three different lentiviral proteins: HIV-1 employs Vpu, HIV-2 uses its Env glycoprotein, and SIV uses Nef. All three proteins are either integral membrane proteins (Vpu, Env) or are membrane-associated by means of a myristic acid modification (Nef) and are thought to interfere with BST-2 function via direct physical interaction [<xref rid=\"R55\" ref-type=\"bibr\">55</xref>–<xref rid=\"R59\" ref-type=\"bibr\">59</xref>, <xref rid=\"R68\" ref-type=\"bibr\">68</xref>, <xref rid=\"R72\" ref-type=\"bibr\">72</xref>–<xref rid=\"R85\" ref-type=\"bibr\">85</xref>]. While their molecular mechanisms of action may vary, the fact that lentiviruses have evolved three proteins to independently target BST-2 highlights the importance of controlling BST-2 function. It remains a matter of debate however, exactly why control of BST-2 is of such importance to HIV. The expression of BST-2 on human target cells has been credited with the limited transmission of HIV-1 from its predecessor SIV [<xref rid=\"R86\" ref-type=\"bibr\">86</xref>]. This is because Vpu from SIVcpz, while capable of degrading CD4, is unable to target chimpanzee or human BST-2 [<xref rid=\"R75\" ref-type=\"bibr\">75</xref>]. In these viruses, Nef has assumed the role of Vpu to enhance virus release. However, Nef cannot target human BST-2 because its target sequence (G/D)DIWK) located in the cytoplasmic domain of BST-2 has been lost in human BST-2 more than 800,000 years ago [<xref rid=\"R87\" ref-type=\"bibr\">87</xref>]. It is not quite clear how or even why Vpu acquired its anti-BST-2 activity. For instance HIV-2, which lacks a <italic>vpu</italic> gene, has learned to use its Env glycoprotein to antagonize human BST-2 [<xref rid=\"R55\" ref-type=\"bibr\">55</xref>, <xref rid=\"R88\" ref-type=\"bibr\">88</xref>–<xref rid=\"R90\" ref-type=\"bibr\">90</xref>]. Of note, even some HIV-1 isolates, such as the R5-tropic AD8 isolate, can make use of their Env protein to regulate virus release from human cells [<xref rid=\"R91\" ref-type=\"bibr\">91</xref>] raising the interesting question of whether following the initial zoonosis, the Env protein temporarily assumed Vpu-like function. At any rate, the ability to target BST-2 is not a feature of Vpu that arose only as a result of the transmission of SIV into humans. Indeed, Vpus encoded by SIVgsn, SIVmon, SIVmus, and SIVden are active against the BST-2 of their native hosts but not against human BST-2 [<xref rid=\"R75\" ref-type=\"bibr\">75</xref>, <xref rid=\"R92\" ref-type=\"bibr\">92</xref>].</p>\\n          <p id=\"P11\">Inhibition of virus release should not be mistaken for inhibition of virus replication. Even though in short-term analyses, BST-2 seemed to delay the cell-to-cell transmission of <italic>vpu</italic>-defective HIV-1 [<xref rid=\"R93\" ref-type=\"bibr\">93</xref>], and even though BST-2 potently inhibited replication of Mo-MLV in interferon-stimulated NIH 3T3 cells or in mice treated with polyinosinic:polycytidylic acid, no difference in plasma viremia was observed under physiological conditions between untreated normal or BST-2 knockout MoMLV-infected mice [<xref rid=\"R94\" ref-type=\"bibr\">94</xref>]. Also, in long-term multi-round replication analyses, the phenotype of a <italic>vpu</italic> defect in HIV-1 was evident by reduced levels of cell-free virus but not by reduced viral replication kinetics [<xref rid=\"R3\" ref-type=\"bibr\">3</xref>, <xref rid=\"R4\" ref-type=\"bibr\">4</xref>]. This indicates that <italic>vpu</italic>-defective virus can employ a cell-to-cell mode of transmission that, at least in tissue culture, is as effective as cell-free transmission by wild type virus. Thus, we prefer to look at BST-2 as a modulator of the mode of viral transmission (i.e. cell-free versus cell-to-cell) rather than a restriction factor inhibiting virus replication. If virus spread from person to person occurs through transmission of cell-free virus, viruses unable to target BST-2 will certainly have a selective disadvantage. On the other hand, the fact that a number of HIV-1 isolates, including HXB2, MAL, and AD8, carried mutations in the <italic>vpu</italic> translation initiation codon [<xref rid=\"R95\" ref-type=\"bibr\">95</xref>, <xref rid=\"R96\" ref-type=\"bibr\">96</xref>], suggests that Vpu expression may provide selective advantages or disadvantages and may be turned on or off depending on the environmental pressures provided by the host.</p>\\n        </sec>\\n      </sec>\\n    </sec>\\n    <sec id=\"S9\">\\n      <title>3. About ion channels and virus release</title>\\n      <sec id=\"S10\">\\n        <title>3.1. Vpu forms ion conductive membrane pores</title>\\n        <p id=\"P12\">Based on the structural similarity of Vpu with the influenza virus M2 ion channel protein it was speculated that homo-oligomeric complexes of Vpu might possess pore-forming abilities [<xref rid=\"R97\" ref-type=\"bibr\">97</xref>]. Indeed, Vpu ion channel activity was experimentally demonstrated as current fluctuations across an artificial lipid bilayer containing either full-length recombinant Vpu protein or synthetic peptides corresponding to the cytoplasmic domain of Vpu [<xref rid=\"R10\" ref-type=\"bibr\">10</xref>, <xref rid=\"R11\" ref-type=\"bibr\">11</xref>, <xref rid=\"R98\" ref-type=\"bibr\">98</xref>, <xref rid=\"R99\" ref-type=\"bibr\">99</xref>]. The Vpu channel activity is selective for monovalent cations such as sodium and potassium. Of note, the channel activity of the Vpu TM domain was specific as scrambling the sequence abolished channel activity [<xref rid=\"R29\" ref-type=\"bibr\">29</xref>]. This intriguing correlation between the ability of Vpu to form ion conductive channels and to enhance viral particle release <italic>in vivo</italic> led to the proposal that regulation of virus release by Vpu might involve an alteration of the plasma membrane potential. This model was supported by the observation that membrane depolarization could affect the rate of HIV-1 virus release [<xref rid=\"R100\" ref-type=\"bibr\">100</xref>] and that expression of Vpu in yeast caused membrane depolarization resulting in cytotoxicity and impaired cell growth, an effect that could be minimized by increasing extracellular K(+) concentration [<xref rid=\"R101\" ref-type=\"bibr\">101</xref>]. Additional support for the ion channel model of Vpu came from animal studies in which scrambling the Vpu TM domain in the context of a SHIV virus significantly reduced viral load and lowered viral pathogenicity [<xref rid=\"R102\" ref-type=\"bibr\">102</xref>]. Despite all of that, exactly how ion channel activity of Vpu might regulate viral particle production had remained unclear. Indeed, more recent studies argue against an involvement of Vpu ion channel activity in Vpu-enhanced virus release. These new findings are based on the observation that some mutations in the Vpu TM domain affecting channel activity (e.g. S23A or S23L) did not impair the ability to enhance virus release; conversely, some mutations affecting virus release (e.g. A14N, A18N) retained ion channel activity [<xref rid=\"R54\" ref-type=\"bibr\">54</xref>, <xref rid=\"R103\" ref-type=\"bibr\">103</xref>–<xref rid=\"R105\" ref-type=\"bibr\">105</xref>]. Thus, while there is no doubt that Vpu can assemble into ion conducting membrane pores, the functional significance of Vpu ion channel activity for HIV replication remains unclear.</p>\\n      </sec>\\n      <sec id=\"S11\">\\n        <title>3.2. Vpu inhibits the cellular ion channel TASK-1</title>\\n        <p id=\"P13\">A different model for Vpu function was proposed by a study suggesting that Vpu affects the activity of the mammalian background K(+) channel TASK-1 [<xref rid=\"R12\" ref-type=\"bibr\">12</xref>]. The N-terminal domain of TASK-1 exhibits significant structural homology to Vpu. Indeed, Vpu was found to interact with TASK-1 and coexpression of Vpu inhibited the TASK-1 ion channel activity [<xref rid=\"R12\" ref-type=\"bibr\">12</xref>]. Also, coexpression of TASK-1 with the N-terminal fragment exhibiting homology to Vpu (Ttm1) inhibited TASK-1 ion channel function. Interestingly, expression of Ttm1 increased release of Vpu-defective virus from HeLa cells to a similar extend than wt Vpu [<xref rid=\"R12\" ref-type=\"bibr\">12</xref>]. Thus, it was proposed that TASK-1 was a cellular inhibitor of virus release whose activity has to be neutralized by Vpu. If this were true, one would expct that TASK-1 is expressed in non-permissive cell types such as HeLa or Jurkat but is absent in permissive cells, e.g. Cos-7 or 293T. This has not been observed, however. Alternatively, one could argue that TASK-1 itself functions in a cell-type independent manner but indirectly regulates virus release by affecting BST-2 function. At this point, there is, however, no experimental evidence for such a function of TASK-1. Thus, based on current knowledge BST-2 is the sole contender for the role of regulator of viral particle release.</p>\\n      </sec>\\n    </sec>\\n    <sec id=\"S12\">\\n      <title>4. Other functions of Vpu</title>\\n      <sec id=\"S13\">\\n        <title>4.1. Vpu induces apoptosis by deregulating the NFkB pathway</title>\\n        <p id=\"P14\">As noted above (2.1.), Vpu-induced degradation of CD4 involves the recruitment of β-TrCP via a conserved di-phosphserine motif in the Vpu cytoplasmic domain. Interestingly, the recognition motif on all known cellular substrates of β-TrCP consists of a pair of conserved phospho-serine residues similar to those present in Vpu [<xref rid=\"R31\" ref-type=\"bibr\">31</xref>]. Serine-phosphorylation plays the major regulatory role in the stability of SCF target proteins. For example, activation of the IκB kinase complex (IKK) by external stimuli such as TNFα induces the serine-phosphorylation of IκBα followed by rapid TrCP-mediated proteasome degradation [<xref rid=\"R106\" ref-type=\"bibr\">106</xref>]. More relevant to Vpu, BST-2 was recently shown to activate NFκB in a Vpu-sensitive manner [<xref rid=\"R107\" ref-type=\"bibr\">107</xref>, <xref rid=\"R108\" ref-type=\"bibr\">108</xref>]. Intriguingly, Vpu differs from normal cellular substrate of β-TrCP by its resistance to proteasome degradation. Indeed, while the SCF<sup>TrCP</sup> usually degrades the serine-phosphorylated protein directly bound to the β-TrCP WD domains (i.e. Vpu), CD4 - bound to the Vpu cytoplasmic domain - is degraded instead. This phenomenon has serious implications for the regulation and availability of the SCF<sup>TrCP</sup> in cells that express Vpu. Indeed, due to the fact that Vpu is constitutively phosphorylated [<xref rid=\"R109\" ref-type=\"bibr\">109</xref>], binds β-TrCP with high affinity [<xref rid=\"R31\" ref-type=\"bibr\">31</xref>], and is not released from the complex by degradation [<xref rid=\"R110\" ref-type=\"bibr\">110</xref>], Vpu expression in HIV-infected cells was likely to perturb the physiological function of the SCF<sup>TrCP</sup> through competitive trapping of β-TrCP (<xref ref-type=\"fig\" rid=\"F1\">Figure 1B</xref>). Indeed, the deregulation of IκB by Vpu was shown to lead to inhibition of both HIV- and TNF-α-induced activation of NFκB [<xref rid=\"R110\" ref-type=\"bibr\">110</xref>]. The deregulation of NFκB in Vpu expressing cells has far-reaching consequences since NFκB is a central transcription factor that regulates the expression of key cellular genes involved in cell proliferation, cytokine production and the induction of apoptosis [<xref rid=\"R111\" ref-type=\"bibr\">111</xref>, <xref rid=\"R112\" ref-type=\"bibr\">112</xref>]. Inhibition of NFκB activity by Vpu might therefore contribute to the induction of apoptosis in HIV-1 infected cells [<xref rid=\"R113\" ref-type=\"bibr\">113</xref>, <xref rid=\"R114\" ref-type=\"bibr\">114</xref>]. This was confirmed experimentally by showing that in a population of Jurkat cells expressing wild-type HIV-1, twice as many cells underwent apoptosis than in cells infected with a Vpu-defective virus [<xref rid=\"R115\" ref-type=\"bibr\">115</xref>]. Mechanistically, Vpu was shown to inhibit the NFκB-dependent expression of anti-apoptotic genes such as Bcl-2 family proteins, leading to enhanced intracellular levels of the apoptosis-promoting caspase-3 [<xref rid=\"R115\" ref-type=\"bibr\">115</xref>]. Active caspase-3 then triggers a reaction that results in the cleavage of a number of target proteins including Bcl-2 family proteins and leads to cell death [<xref rid=\"R115\" ref-type=\"bibr\">115</xref>].</p>\\n      </sec>\\n    </sec>\\n    <sec sec-type=\"conclusions\" id=\"S14\">\\n      <title>4. Conclusions</title>\\n      <p id=\"P15\">The HIV-1 Vpu protein is a small transmembrane protein with several independent functions that are controlled from different cellular compartment. Degradation of CD4 occurs in the endoplasmic reticulum and involves the ERAD pathway. Vpu’s function is that of a molecular adaptor that connects CD4 to the SCF<sup>TrCP</sup> E3 ubiquitin ligase complex ultimately resulting in the degradation of CD4. Sequences in the Vpu cytoplasmic domain are critical for this process but a specific contribution of the TM domain is being proposed as well. Enhanced virus release is accomplished by down-modulating BST-2 from the cell surface. The precise mechanism of BST-2 antagonism by Vpu is not yet understood. However, the Vpu TM domain is critical for this process to enable the physical association with BST-2. Finally, Vpu deregulates the NFκB pathway due to two unusual characteristics: (i) Vpu is constitutively phosphorylated and thus capable of continuously binding β-TrCP; (ii) unlike normal cellular substrates of β-TrCP, Vpu is not degraded as a result of β-TrCP engagement and is thus capable of depleting the cellular pool of free β-TrCP. Since β-TrCP is a critical regulator of the NFκB inhibitor IκB, depletion of free β-TrCP prevents NFκB activation. Structurally, Vpu assembles into homo-oligomeric complexes with the ability to form ion conductive membrane pores. While regulation of virus release by Vpu was initially attributed to ion channel activity, experimental evidence no longer supports such a model. It is therefore unclear at this point, which –if any- of the described functions of Vpu require oligomerization of Vpu. Thus, while nothing has changed on the fact that Vpu can form ion conducting membrane pores, its job description remains undefined.</p>\\n    </sec>\\n  </body>\\n  <back>\\n    <fn-group>\\n      <fn id=\"FN1\">\\n        <p id=\"P16\" content-type=\"publisher-disclaimer\">This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.</p>\\n      </fn>\\n    </fn-group>\\n    <ack id=\"S15\">\\n      <title>Acknowledgment</title>\\n      <p id=\"P17\">K. Strebel is supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.</p>\\n    </ack>\\n    <ref-list>\\n      <title>References</title>\\n      <ref id=\"R1\">\\n        <label>1</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Andrew</surname>\\n              <given-names>A</given-names>\\n            </name>\\n            <name>\\n              <surname>Strebel</surname>\\n              <given-names>K</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>The interferon-inducible host factor bone marrow stromal antigen 2/tetherin restricts virion release, but is it actually a viral restriction factor?</article-title>\\n          <source>J Interferon Cytokine Res</source>\\n          <year>2011</year>\\n          <volume>31</volume>\\n          <fpage>137</fpage>\\n          <lpage>144</lpage>\\n          <pub-id pub-id-type=\"pmid\">21166593</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R2\">\\n        <label>2</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Strebel</surname>\\n              <given-names>K</given-names>\\n            </name>\\n            <name>\\n              <surname>Luban</surname>\\n              <given-names>J</given-names>\\n            </name>\\n            <name>\\n              <surname>Jeang</surname>\\n              <given-names>KT</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Human cellular restriction factors that target HIV-1 replication</article-title>\\n          <source>BMC Med</source>\\n          <year>2009</year>\\n          <volume>7</volume>\\n          <fpage>48</fpage>\\n          <pub-id pub-id-type=\"pmid\">19758442</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R3\">\\n        <label>3</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Strebel</surname>\\n              <given-names>K</given-names>\\n            </name>\\n            <name>\\n              <surname>Klimkait</surname>\\n              <given-names>T</given-names>\\n            </name>\\n            <name>\\n              <surname>Martin</surname>\\n              <given-names>MA</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>A novel gene of HIV-1, vpu, and its 16-kilodalton product</article-title>\\n          <source>Science</source>\\n          <year>1988</year>\\n          <volume>241</volume>\\n          <fpage>1221</fpage>\\n          <lpage>1223</lpage>\\n          <pub-id pub-id-type=\"pmid\">3261888</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R4\">\\n        <label>4</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Terwilliger</surname>\\n              <given-names>EF</given-names>\\n            </name>\\n            <name>\\n              <surname>Cohen</surname>\\n              <given-names>EA</given-names>\\n            </name>\\n            <name>\\n              <surname>Lu</surname>\\n              <given-names>YC</given-names>\\n            </name>\\n            <name>\\n              <surname>Sodroski</surname>\\n              <given-names>JG</given-names>\\n            </name>\\n            <name>\\n              <surname>Haseltine</surname>\\n              <given-names>WA</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Functional role of human immunodeficiency virus type 1 vpu</article-title>\\n          <source>Proc Natl Acad Sci U S A</source>\\n          <year>1989</year>\\n          <volume>86</volume>\\n          <fpage>5163</fpage>\\n          <lpage>5167</lpage>\\n          <pub-id pub-id-type=\"pmid\">2472639</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R5\">\\n        <label>5</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Sakai</surname>\\n              <given-names>H</given-names>\\n            </name>\\n            <name>\\n              <surname>Tokunaga</surname>\\n              <given-names>K</given-names>\\n            </name>\\n            <name>\\n              <surname>Kawamura</surname>\\n              <given-names>M</given-names>\\n            </name>\\n            <name>\\n              <surname>Adachi</surname>\\n              <given-names>A</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Function of human immunodeficiency virus type 1 Vpu protein in various cell types</article-title>\\n          <source>J Gen Virol</source>\\n          <year>1995</year>\\n          <volume>76</volume>\\n          <issue>Pt 11</issue>\\n          <fpage>2717</fpage>\\n          <lpage>2722</lpage>\\n          <pub-id pub-id-type=\"pmid\">7595378</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R6\">\\n        <label>6</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Geraghty</surname>\\n              <given-names>RJ</given-names>\\n            </name>\\n            <name>\\n              <surname>Talbot</surname>\\n              <given-names>KJ</given-names>\\n            </name>\\n            <name>\\n              <surname>Callahan</surname>\\n              <given-names>M</given-names>\\n            </name>\\n            <name>\\n              <surname>Harper</surname>\\n              <given-names>W</given-names>\\n            </name>\\n            <name>\\n              <surname>Panganiban</surname>\\n              <given-names>AT</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Cell type-dependence for Vpu function</article-title>\\n          <source>J Med Primatol</source>\\n          <year>1994</year>\\n          <volume>23</volume>\\n          <fpage>146</fpage>\\n          <lpage>150</lpage>\\n          <pub-id pub-id-type=\"pmid\">7966229</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R7\">\\n        <label>7</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Varthakavi</surname>\\n              <given-names>V</given-names>\\n            </name>\\n            <name>\\n              <surname>Smith</surname>\\n              <given-names>RM</given-names>\\n            </name>\\n            <name>\\n              <surname>Bour</surname>\\n              <given-names>SP</given-names>\\n            </name>\\n            <name>\\n              <surname>Strebel</surname>\\n              <given-names>K</given-names>\\n            </name>\\n            <name>\\n              <surname>Spearman</surname>\\n              <given-names>P</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Viral protein U counteracts a human host cell restriction that inhibits HIV-1 particle production</article-title>\\n          <source>Proc Natl Acad Sci U S A</source>\\n          <year>2003</year>\\n          <volume>100</volume>\\n          <fpage>15154</fpage>\\n          <lpage>15159</lpage>\\n          <pub-id pub-id-type=\"pmid\">14657387</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R8\">\\n        <label>8</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Neil</surname>\\n              <given-names>SJ</given-names>\\n            </name>\\n            <name>\\n              <surname>Zang</surname>\\n              <given-names>T</given-names>\\n            </name>\\n            <name>\\n              <surname>Bieniasz</surname>\\n              <given-names>PD</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu</article-title>\\n          <source>Nature</source>\\n          <year>2008</year>\\n          <volume>451</volume>\\n          <fpage>425</fpage>\\n          <lpage>430</lpage>\\n          <pub-id pub-id-type=\"pmid\">18200009</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R9\">\\n        <label>9</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Van Damme</surname>\\n              <given-names>N</given-names>\\n            </name>\\n            <name>\\n              <surname>Goff</surname>\\n              <given-names>D</given-names>\\n            </name>\\n            <name>\\n              <surname>Katsura</surname>\\n              <given-names>C</given-names>\\n            </name>\\n            <name>\\n              <surname>Jorgenson</surname>\\n              <given-names>RL</given-names>\\n            </name>\\n            <name>\\n              <surname>Mitchell</surname>\\n              <given-names>R</given-names>\\n            </name>\\n            <name>\\n              <surname>Johnson</surname>\\n              <given-names>MC</given-names>\\n            </name>\\n            <name>\\n              <surname>Stephens</surname>\\n              <given-names>EB</given-names>\\n            </name>\\n            <name>\\n              <surname>Guatelli</surname>\\n              <given-names>J</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein</article-title>\\n          <source>Cell Host Microbe</source>\\n          <year>2008</year>\\n          <volume>3</volume>\\n          <fpage>245</fpage>\\n          <lpage>252</lpage>\\n          <pub-id pub-id-type=\"pmid\">18342597</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R10\">\\n        <label>10</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Schubert</surname>\\n              <given-names>U</given-names>\\n            </name>\\n            <name>\\n              <surname>Ferrer-Montiel</surname>\\n              <given-names>AV</given-names>\\n            </name>\\n            <name>\\n              <surname>Oblatt-Montal</surname>\\n              <given-names>M</given-names>\\n            </name>\\n            <name>\\n              <surname>Henklein</surname>\\n              <given-names>P</given-names>\\n            </name>\\n            <name>\\n              <surname>Strebel</surname>\\n              <given-names>K</given-names>\\n            </name>\\n            <name>\\n              <surname>Montal</surname>\\n              <given-names>M</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Identification of an ion channel activity of the Vpu transmembrane domain and its involvement in the regulation of virus release from HIV-1-infected cells</article-title>\\n          <source>FEBS Lett</source>\\n          <year>1996</year>\\n          <volume>398</volume>\\n          <fpage>12</fpage>\\n          <lpage>18</lpage>\\n          <pub-id pub-id-type=\"pmid\">8946945</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R11\">\\n        <label>11</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Ewart</surname>\\n              <given-names>GD</given-names>\\n            </name>\\n            <name>\\n              <surname>Sutherland</surname>\\n              <given-names>T</given-names>\\n            </name>\\n            <name>\\n              <surname>Gage</surname>\\n              <given-names>PW</given-names>\\n            </name>\\n            <name>\\n              <surname>Cox</surname>\\n              <given-names>GB</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>The Vpu protein of human immunodeficiency virus type 1 forms cation- selective ion channels</article-title>\\n          <source>J Virol</source>\\n          <year>1996</year>\\n          <volume>70</volume>\\n          <fpage>7108</fpage>\\n          <lpage>7115</lpage>\\n          <pub-id pub-id-type=\"pmid\">8794357</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R12\">\\n        <label>12</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Hsu</surname>\\n              <given-names>K</given-names>\\n            </name>\\n            <name>\\n              <surname>Seharaseyon</surname>\\n              <given-names>J</given-names>\\n            </name>\\n            <name>\\n              <surname>Dong</surname>\\n              <given-names>P</given-names>\\n            </name>\\n            <name>\\n              <surname>Bour</surname>\\n              <given-names>S</given-names>\\n            </name>\\n            <name>\\n              <surname>Marban</surname>\\n              <given-names>E</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Mutual Functional Destruction of HIV-1 Vpu and Host TASK-1 Channel</article-title>\\n          <source>Molecular cell</source>\\n          <year>2004</year>\\n          <volume>14</volume>\\n          <fpage>259</fpage>\\n          <lpage>267</lpage>\\n          <pub-id pub-id-type=\"pmid\">15099524</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R13\">\\n        <label>13</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Buonocore</surname>\\n              <given-names>L</given-names>\\n            </name>\\n            <name>\\n              <surname>Rose</surname>\\n              <given-names>JK</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Prevention of HIV-1 glycoprotein transport by soluble CD4 retained in the endoplasmic reticulum</article-title>\\n          <source>Nature</source>\\n          <year>1990</year>\\n          <volume>345</volume>\\n          <fpage>625</fpage>\\n          <lpage>628</lpage>\\n          <pub-id pub-id-type=\"pmid\">2190096</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R14\">\\n        <label>14</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Crise</surname>\\n              <given-names>B</given-names>\\n            </name>\\n            <name>\\n              <surname>Buonocore</surname>\\n              <given-names>L</given-names>\\n            </name>\\n            <name>\\n              <surname>Rose</surname>\\n              <given-names>JK</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>CD4 is retained in the endoplasmic reticulum by the human immunodeficiency virus type 1 glycoprotein precursor</article-title>\\n          <source>J. Virol</source>\\n          <year>1990</year>\\n          <volume>64</volume>\\n          <fpage>5585</fpage>\\n          <lpage>5593</lpage>\\n          <pub-id pub-id-type=\"pmid\">2214026</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R15\">\\n        <label>15</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Bour</surname>\\n              <given-names>S</given-names>\\n            </name>\\n            <name>\\n              <surname>Boulerice</surname>\\n              <given-names>F</given-names>\\n            </name>\\n            <name>\\n              <surname>Wainberg</surname>\\n              <given-names>MA</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Inhibition of gp160 and CD4 maturation in U937 cells after both defective and productive infections by human immunodeficiency virus type 1</article-title>\\n          <source>J. Virol</source>\\n          <year>1991</year>\\n          <volume>65</volume>\\n          <fpage>6387</fpage>\\n          <lpage>6396</lpage>\\n          <pub-id pub-id-type=\"pmid\">1942241</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R16\">\\n        <label>16</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Willey</surname>\\n              <given-names>RL</given-names>\\n            </name>\\n            <name>\\n              <surname>Maldarelli</surname>\\n              <given-names>F</given-names>\\n            </name>\\n            <name>\\n              <surname>Martin</surname>\\n              <given-names>MA</given-names>\\n            </name>\\n            <name>\\n              <surname>Strebel</surname>\\n              <given-names>K</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Human immunodeficiency virus type 1 Vpu protein regulates the formation of intracellular gp160-CD4 complexes</article-title>\\n          <source>J Virol</source>\\n          <year>1992</year>\\n          <volume>66</volume>\\n          <fpage>226</fpage>\\n          <lpage>234</lpage>\\n          <pub-id pub-id-type=\"pmid\">1727486</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R17\">\\n        <label>17</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Willey</surname>\\n              <given-names>RL</given-names>\\n            </name>\\n            <name>\\n              <surname>Maldarelli</surname>\\n              <given-names>F</given-names>\\n            </name>\\n            <name>\\n              <surname>Martin</surname>\\n              <given-names>MA</given-names>\\n            </name>\\n            <name>\\n              <surname>Strebel</surname>\\n              <given-names>K</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4</article-title>\\n          <source>J Virol</source>\\n          <year>1992</year>\\n          <volume>66</volume>\\n          <fpage>7193</fpage>\\n          <lpage>7200</lpage>\\n          <pub-id pub-id-type=\"pmid\">1433512</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R18\">\\n        <label>18</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Bour</surname>\\n              <given-names>S</given-names>\\n            </name>\\n            <name>\\n              <surname>Strebel</surname>\\n              <given-names>K</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>The HIV-1 Vpu protein: a multifunctional enhancer of viral particle release</article-title>\\n          <source>Microbes Infect</source>\\n          <year>2003</year>\\n          <volume>5</volume>\\n          <fpage>1029</fpage>\\n          <lpage>1039</lpage>\\n          <pub-id pub-id-type=\"pmid\">12941395</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R19\">\\n        <label>19</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Bour</surname>\\n              <given-names>S</given-names>\\n            </name>\\n            <name>\\n              <surname>Schubert</surname>\\n              <given-names>U</given-names>\\n            </name>\\n            <name>\\n              <surname>Strebel</surname>\\n              <given-names>K</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>The human immunodeficiency virus type 1 Vpu protein specifically binds to the cytoplasmic domain of CD4: implications for the mechanism of degradation</article-title>\\n          <source>J Virol</source>\\n          <year>1995</year>\\n          <volume>69</volume>\\n          <fpage>1510</fpage>\\n          <lpage>1520</lpage>\\n          <pub-id pub-id-type=\"pmid\">7853484</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R20\">\\n        <label>20</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Yao</surname>\\n              <given-names>XJ</given-names>\\n            </name>\\n            <name>\\n              <surname>Friborg</surname>\\n              <given-names>J</given-names>\\n            </name>\\n            <name>\\n              <surname>Checroune</surname>\\n              <given-names>F</given-names>\\n            </name>\\n            <name>\\n              <surname>Gratton</surname>\\n              <given-names>S</given-names>\\n            </name>\\n            <name>\\n              <surname>Boisvert</surname>\\n              <given-names>F</given-names>\\n            </name>\\n            <name>\\n              <surname>Sekaly</surname>\\n              <given-names>RP</given-names>\\n            </name>\\n            <name>\\n              <surname>Cohen</surname>\\n              <given-names>EA</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Degradation of CD4 induced by human immunodeficiency virus type 1 Vpu protein: a predicted alpha-helix structure in the proximal cytoplasmic region of CD4 contributes to Vpu sensitivity</article-title>\\n          <source>Virology</source>\\n          <year>1995</year>\\n          <volume>209</volume>\\n          <fpage>615</fpage>\\n          <lpage>623</lpage>\\n          <pub-id pub-id-type=\"pmid\">7778293</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R21\">\\n        <label>21</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Vincent</surname>\\n              <given-names>MJ</given-names>\\n            </name>\\n            <name>\\n              <surname>Raja</surname>\\n              <given-names>NU</given-names>\\n            </name>\\n            <name>\\n              <surname>Jabbar</surname>\\n              <given-names>MA</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Human immunodeficiency virus type 1 Vpu protein induces degradation of chimeric envelope glycoproteins bearing the cytoplasmic and anchor domains of CD4: Role of the cytoplasmic domain in Vpu-induced degradation in the endoplasmic reticulum</article-title>\\n          <source>J. Virol</source>\\n          <year>1993</year>\\n          <volume>67</volume>\\n          <fpage>5538</fpage>\\n          <lpage>5549</lpage>\\n          <pub-id pub-id-type=\"pmid\">8350411</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R22\">\\n        <label>22</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Lenburg</surname>\\n              <given-names>ME</given-names>\\n            </name>\\n            <name>\\n              <surname>Landau</surname>\\n              <given-names>NR</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Vpu-induced degradation of CD4: requirement for specific amino acid residues in the cytoplasmic domain of CD4</article-title>\\n          <source>J. Virol</source>\\n          <year>1993</year>\\n          <volume>67</volume>\\n          <fpage>7238</fpage>\\n          <lpage>7245</lpage>\\n          <pub-id pub-id-type=\"pmid\">8230446</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R23\">\\n        <label>23</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Margottin</surname>\\n              <given-names>F</given-names>\\n            </name>\\n            <name>\\n              <surname>Benichou</surname>\\n              <given-names>S</given-names>\\n            </name>\\n            <name>\\n              <surname>Durand</surname>\\n              <given-names>H</given-names>\\n            </name>\\n            <name>\\n              <surname>Richard</surname>\\n              <given-names>V</given-names>\\n            </name>\\n            <name>\\n              <surname>Liu</surname>\\n              <given-names>LX</given-names>\\n            </name>\\n            <name>\\n              <surname>Gomas</surname>\\n              <given-names>E</given-names>\\n            </name>\\n            <name>\\n              <surname>Benarous</surname>\\n              <given-names>R</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Interaction of the cytoplasmic domain of HIV-1 Vpu and CD4: involvement of Vpu amino acid residues required for CD4 degradation</article-title>\\n          <source>Virology</source>\\n          <year>1996</year>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R24\">\\n        <label>24</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Singh</surname>\\n              <given-names>SK</given-names>\\n            </name>\\n            <name>\\n              <surname>Mockel</surname>\\n              <given-names>L</given-names>\\n            </name>\\n            <name>\\n              <surname>Thiagarajan-Rosenkranz</surname>\\n              <given-names>P</given-names>\\n            </name>\\n            <name>\\n              <surname>Wittlich</surname>\\n              <given-names>M</given-names>\\n            </name>\\n            <name>\\n              <surname>Willbold</surname>\\n              <given-names>D</given-names>\\n            </name>\\n            <name>\\n              <surname>Koenig</surname>\\n              <given-names>BW</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Mapping the interaction between the cytoplasmic domains of HIV-1 viral protein U and human CD4 with NMR spectroscopy</article-title>\\n          <source>FEBS J</source>\\n          <year>2012</year>\\n          <volume>279</volume>\\n          <fpage>3705</fpage>\\n          <lpage>3714</lpage>\\n          <pub-id pub-id-type=\"pmid\">22863293</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R25\">\\n        <label>25</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Raja</surname>\\n              <given-names>NU</given-names>\\n            </name>\\n            <name>\\n              <surname>Vincent</surname>\\n              <given-names>MJ</given-names>\\n            </name>\\n            <name>\\n              <surname>Jabbar</surname>\\n              <given-names>MA</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Vpu-mediated proteolysis of gp160/CD4 chimeric envelope glycoproteins in the endoplasmic reticulum: requirement of both the anchor and cytoplasmic domains of CD4</article-title>\\n          <source>Virology</source>\\n          <year>1994</year>\\n          <volume>204</volume>\\n          <fpage>357</fpage>\\n          <lpage>366</lpage>\\n          <pub-id pub-id-type=\"pmid\">8091666</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R26\">\\n        <label>26</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Tiganos</surname>\\n              <given-names>E</given-names>\\n            </name>\\n            <name>\\n              <surname>Friborg</surname>\\n              <given-names>J</given-names>\\n            </name>\\n            <name>\\n              <surname>Allain</surname>\\n              <given-names>B</given-names>\\n            </name>\\n            <name>\\n              <surname>Daniel</surname>\\n              <given-names>NG</given-names>\\n            </name>\\n            <name>\\n              <surname>Yao</surname>\\n              <given-names>XJ</given-names>\\n            </name>\\n            <name>\\n              <surname>Cohen</surname>\\n              <given-names>EA</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Structural and functional analysis of the membrane-spanning domain of the human immunodeficiency virus type 1 Vpu protein</article-title>\\n          <source>Virology</source>\\n          <year>1998</year>\\n          <volume>251</volume>\\n          <fpage>96</fpage>\\n          <lpage>107</lpage>\\n          <pub-id pub-id-type=\"pmid\">9813206</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R27\">\\n        <label>27</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Magadan</surname>\\n              <given-names>JG</given-names>\\n            </name>\\n            <name>\\n              <surname>Bonifacino</surname>\\n              <given-names>JS</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Transmembrane domain determinants of CD4 Downregulation by HIV-1 Vpu</article-title>\\n          <source>J Virol</source>\\n          <year>2012</year>\\n          <volume>86</volume>\\n          <fpage>757</fpage>\\n          <lpage>772</lpage>\\n          <pub-id pub-id-type=\"pmid\">22090097</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R28\">\\n        <label>28</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Willey</surname>\\n              <given-names>RL</given-names>\\n            </name>\\n            <name>\\n              <surname>Buckler-White</surname>\\n              <given-names>A</given-names>\\n            </name>\\n            <name>\\n              <surname>Strebel</surname>\\n              <given-names>K</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Sequences present in the cytoplasmic domain of CD4 are necessary and sufficient to confer sensitivity to the human immunodeficiency virus type 1 Vpu protein</article-title>\\n          <source>J Virol</source>\\n          <year>1994</year>\\n          <volume>68</volume>\\n          <fpage>1207</fpage>\\n          <lpage>1212</lpage>\\n          <pub-id pub-id-type=\"pmid\">8289353</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R29\">\\n        <label>29</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Schubert</surname>\\n              <given-names>U</given-names>\\n            </name>\\n            <name>\\n              <surname>Bour</surname>\\n              <given-names>S</given-names>\\n            </name>\\n            <name>\\n              <surname>Ferrer-Montiel</surname>\\n              <given-names>AV</given-names>\\n            </name>\\n            <name>\\n              <surname>Montal</surname>\\n              <given-names>M</given-names>\\n            </name>\\n            <name>\\n              <surname>Maldarell</surname>\\n              <given-names>F</given-names>\\n            </name>\\n            <name>\\n              <surname>Strebel</surname>\\n              <given-names>K</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>The two biological activities of human immunodeficiency virus type 1 Vpu protein involve two separable structural domains</article-title>\\n          <source>J Virol</source>\\n          <year>1996</year>\\n          <volume>70</volume>\\n          <fpage>809</fpage>\\n          <lpage>819</lpage>\\n          <pub-id pub-id-type=\"pmid\">8551619</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R30\">\\n        <label>30</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Hout</surname>\\n              <given-names>DR</given-names>\\n            </name>\\n            <name>\\n              <surname>Gomez</surname>\\n              <given-names>LM</given-names>\\n            </name>\\n            <name>\\n              <surname>Pacyniak</surname>\\n              <given-names>E</given-names>\\n            </name>\\n            <name>\\n              <surname>Miller</surname>\\n              <given-names>JM</given-names>\\n            </name>\\n            <name>\\n              <surname>Hill</surname>\\n              <given-names>MS</given-names>\\n            </name>\\n            <name>\\n              <surname>Stephens</surname>\\n              <given-names>EB</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>A single amino acid substitution within the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein renders simian-human immunodeficiency virus (SHIV(KU-1bMC33)) susceptible to rimantadine</article-title>\\n          <source>Virology</source>\\n          <year>2006</year>\\n          <volume>348</volume>\\n          <fpage>449</fpage>\\n          <lpage>461</lpage>\\n          <pub-id pub-id-type=\"pmid\">16458946</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R31\">\\n        <label>31</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Margottin</surname>\\n              <given-names>F</given-names>\\n            </name>\\n            <name>\\n              <surname>Bour</surname>\\n              <given-names>SP</given-names>\\n            </name>\\n            <name>\\n              <surname>Durand</surname>\\n              <given-names>H</given-names>\\n            </name>\\n            <name>\\n              <surname>Selig</surname>\\n              <given-names>L</given-names>\\n            </name>\\n            <name>\\n              <surname>Benichou</surname>\\n              <given-names>S</given-names>\\n            </name>\\n            <name>\\n              <surname>Richard</surname>\\n              <given-names>V</given-names>\\n            </name>\\n            <name>\\n              <surname>Thomas</surname>\\n              <given-names>D</given-names>\\n            </name>\\n            <name>\\n              <surname>Strebel</surname>\\n              <given-names>K</given-names>\\n            </name>\\n            <name>\\n              <surname>Benarous</surname>\\n              <given-names>R</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif</article-title>\\n          <source>Molecular cell</source>\\n          <year>1998</year>\\n          <volume>1</volume>\\n          <fpage>565</fpage>\\n          <lpage>574</lpage>\\n          <pub-id pub-id-type=\"pmid\">9660940</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R32\">\\n        <label>32</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Andrew</surname>\\n              <given-names>A</given-names>\\n            </name>\\n            <name>\\n              <surname>Strebel</surname>\\n              <given-names>K</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>HIV-1 Vpu targets cell surface markers CD4 and BST-2 through distinct mechanisms</article-title>\\n          <source>Mol Aspects Med</source>\\n          <year>2010</year>\\n          <volume>31</volume>\\n          <fpage>407</fpage>\\n          <lpage>417</lpage>\\n          <pub-id pub-id-type=\"pmid\">20858517</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R33\">\\n        <label>33</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Binette</surname>\\n              <given-names>J</given-names>\\n            </name>\\n            <name>\\n              <surname>Dube</surname>\\n              <given-names>M</given-names>\\n            </name>\\n            <name>\\n              <surname>Mercier</surname>\\n              <given-names>J</given-names>\\n            </name>\\n            <name>\\n              <surname>Halawani</surname>\\n              <given-names>D</given-names>\\n            </name>\\n            <name>\\n              <surname>Latterich</surname>\\n              <given-names>M</given-names>\\n            </name>\\n            <name>\\n              <surname>Cohen</surname>\\n              <given-names>EA</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Requirements for the selective degradation of CD4 receptor molecules by the human immunodeficiency virus type 1 Vpu protein in the endoplasmic reticulum</article-title>\\n          <source>Retrovirology</source>\\n          <year>2007</year>\\n          <volume>4</volume>\\n          <fpage>75</fpage>\\n          <pub-id pub-id-type=\"pmid\">17937819</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R34\">\\n        <label>34</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Magadan</surname>\\n              <given-names>JG</given-names>\\n            </name>\\n            <name>\\n              <surname>Perez-Victoria</surname>\\n              <given-names>FJ</given-names>\\n            </name>\\n            <name>\\n              <surname>Sougrat</surname>\\n              <given-names>R</given-names>\\n            </name>\\n            <name>\\n              <surname>Ye</surname>\\n              <given-names>Y</given-names>\\n            </name>\\n            <name>\\n              <surname>Strebel</surname>\\n              <given-names>K</given-names>\\n            </name>\\n            <name>\\n              <surname>Bonifacino</surname>\\n              <given-names>JS</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Multilayered mechanism of CD4 downregulation by HIV-1 Vpu involving distinct ER retention and ERAD targeting steps</article-title>\\n          <source>PLoS Pathog</source>\\n          <year>2010</year>\\n          <volume>6</volume>\\n          <fpage>e1000869</fpage>\\n          <pub-id pub-id-type=\"pmid\">20442859</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R35\">\\n        <label>35</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Ohtomo</surname>\\n              <given-names>T</given-names>\\n            </name>\\n            <name>\\n              <surname>Sugamata</surname>\\n              <given-names>Y</given-names>\\n            </name>\\n            <name>\\n              <surname>Ozaki</surname>\\n              <given-names>Y</given-names>\\n            </name>\\n            <name>\\n              <surname>Ono</surname>\\n              <given-names>K</given-names>\\n            </name>\\n            <name>\\n              <surname>Yoshimura</surname>\\n              <given-names>Y</given-names>\\n            </name>\\n            <name>\\n              <surname>Kawai</surname>\\n              <given-names>S</given-names>\\n            </name>\\n            <name>\\n              <surname>Koishihara</surname>\\n              <given-names>Y</given-names>\\n            </name>\\n            <name>\\n              <surname>Ozaki</surname>\\n              <given-names>S</given-names>\\n            </name>\\n            <name>\\n              <surname>Kosaka</surname>\\n              <given-names>M</given-names>\\n            </name>\\n            <name>\\n              <surname>Hirano</surname>\\n              <given-names>T</given-names>\\n            </name>\\n            <name>\\n              <surname>Tsuchiya</surname>\\n              <given-names>M</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Molecular cloning and characterization of a surface antigen preferentially overexpressed on multiple myeloma cells</article-title>\\n          <source>Biochem Biophys Res Commun</source>\\n          <year>1999</year>\\n          <volume>258</volume>\\n          <fpage>583</fpage>\\n          <lpage>591</lpage>\\n          <pub-id pub-id-type=\"pmid\">10329429</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R36\">\\n        <label>36</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Goto</surname>\\n              <given-names>T</given-names>\\n            </name>\\n            <name>\\n              <surname>Kennel</surname>\\n              <given-names>SJ</given-names>\\n            </name>\\n            <name>\\n              <surname>Abe</surname>\\n              <given-names>M</given-names>\\n            </name>\\n            <name>\\n              <surname>Takishita</surname>\\n              <given-names>M</given-names>\\n            </name>\\n            <name>\\n              <surname>Kosaka</surname>\\n              <given-names>M</given-names>\\n            </name>\\n            <name>\\n              <surname>Solomon</surname>\\n              <given-names>A</given-names>\\n            </name>\\n            <name>\\n              <surname>Saito</surname>\\n              <given-names>S</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>A novel membrane antigen selectively expressed on terminally differentiated human B cells</article-title>\\n          <source>Blood</source>\\n          <year>1994</year>\\n          <volume>84</volume>\\n          <fpage>1922</fpage>\\n          <lpage>1930</lpage>\\n          <pub-id pub-id-type=\"pmid\">8080996</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R37\">\\n        <label>37</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Bartee</surname>\\n              <given-names>E</given-names>\\n            </name>\\n            <name>\\n              <surname>McCormack</surname>\\n              <given-names>A</given-names>\\n            </name>\\n            <name>\\n              <surname>Fruh</surname>\\n              <given-names>K</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Quantitative membrane proteomics reveals new cellular targets of viral immune modulators</article-title>\\n          <source>PLoS Pathog</source>\\n          <year>2006</year>\\n          <volume>2</volume>\\n          <fpage>e107</fpage>\\n          <pub-id pub-id-type=\"pmid\">17238276</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R38\">\\n        <label>38</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Ishikawa</surname>\\n              <given-names>J</given-names>\\n            </name>\\n            <name>\\n              <surname>Kaisho</surname>\\n              <given-names>T</given-names>\\n            </name>\\n            <name>\\n              <surname>Tomizawa</surname>\\n              <given-names>H</given-names>\\n            </name>\\n            <name>\\n              <surname>Lee</surname>\\n              <given-names>BO</given-names>\\n            </name>\\n            <name>\\n              <surname>Kobune</surname>\\n              <given-names>Y</given-names>\\n            </name>\\n            <name>\\n              <surname>Inazawa</surname>\\n              <given-names>J</given-names>\\n            </name>\\n            <name>\\n              <surname>Oritani</surname>\\n              <given-names>K</given-names>\\n            </name>\\n            <name>\\n              <surname>Itoh</surname>\\n              <given-names>M</given-names>\\n            </name>\\n            <name>\\n              <surname>Ochi</surname>\\n              <given-names>T</given-names>\\n            </name>\\n            <name>\\n              <surname>Ishihara</surname>\\n              <given-names>K</given-names>\\n            </name>\\n            <name>\\n              <surname>Hirano</surname>\\n              <given-names>T</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Molecular cloning and chromosomal mapping of a bone marrow stromal cell surface gene, BST2, that may be involved in pre-B-cell growth</article-title>\\n          <source>Genomics</source>\\n          <year>1995</year>\\n          <volume>26</volume>\\n          <fpage>527</fpage>\\n          <lpage>534</lpage>\\n          <pub-id pub-id-type=\"pmid\">7607676</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R39\">\\n        <label>39</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Kupzig</surname>\\n              <given-names>S</given-names>\\n            </name>\\n            <name>\\n              <surname>Korolchuk</surname>\\n              <given-names>V</given-names>\\n            </name>\\n            <name>\\n              <surname>Rollason</surname>\\n              <given-names>R</given-names>\\n            </name>\\n            <name>\\n              <surname>Sugden</surname>\\n              <given-names>A</given-names>\\n            </name>\\n            <name>\\n              <surname>Wilde</surname>\\n              <given-names>A</given-names>\\n            </name>\\n            <name>\\n              <surname>Banting</surname>\\n              <given-names>G</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology</article-title>\\n          <source>Traffic</source>\\n          <year>2003</year>\\n          <volume>4</volume>\\n          <fpage>694</fpage>\\n          <lpage>709</lpage>\\n          <pub-id pub-id-type=\"pmid\">12956872</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R40\">\\n        <label>40</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Andrew</surname>\\n              <given-names>AJ</given-names>\\n            </name>\\n            <name>\\n              <surname>Kao</surname>\\n              <given-names>S</given-names>\\n            </name>\\n            <name>\\n              <surname>Strebel</surname>\\n              <given-names>K</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>C-terminal Hydrophobic Region in Human Bone Marrow Stromal Cell Antigen 2 (BST-2)/Tetherin Protein Functions as Second Transmembrane Motif</article-title>\\n          <source>J Biol Chem</source>\\n          <year>2011</year>\\n          <volume>286</volume>\\n          <fpage>39967</fpage>\\n          <lpage>39981</lpage>\\n          <pub-id pub-id-type=\"pmid\">21937450</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R41\">\\n        <label>41</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Hinz</surname>\\n              <given-names>A</given-names>\\n            </name>\\n            <name>\\n              <surname>Miguet</surname>\\n              <given-names>N</given-names>\\n            </name>\\n            <name>\\n              <surname>Natrajan</surname>\\n              <given-names>G</given-names>\\n            </name>\\n            <name>\\n              <surname>Usami</surname>\\n              <given-names>Y</given-names>\\n            </name>\\n            <name>\\n              <surname>Yamanaka</surname>\\n              <given-names>H</given-names>\\n            </name>\\n            <name>\\n              <surname>Renesto</surname>\\n              <given-names>P</given-names>\\n            </name>\\n            <name>\\n              <surname>Hartlieb</surname>\\n              <given-names>B</given-names>\\n            </name>\\n            <name>\\n              <surname>McCarthy</surname>\\n              <given-names>AA</given-names>\\n            </name>\\n            <name>\\n              <surname>Simorre</surname>\\n              <given-names>JP</given-names>\\n            </name>\\n            <name>\\n              <surname>Gottlinger</surname>\\n              <given-names>H</given-names>\\n            </name>\\n            <name>\\n              <surname>Weissenhorn</surname>\\n              <given-names>W</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Structural Basis of HIV-1 Tethering to Membranes by the BST-2/Tetherin Ectodomain</article-title>\\n          <source>Cell Host Microbe</source>\\n          <year>2010</year>\\n          <volume>7</volume>\\n          <fpage>314</fpage>\\n          <lpage>323</lpage>\\n          <pub-id pub-id-type=\"pmid\">20399176</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R42\">\\n        <label>42</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Schubert</surname>\\n              <given-names>HL</given-names>\\n            </name>\\n            <name>\\n              <surname>Zhai</surname>\\n              <given-names>Q</given-names>\\n            </name>\\n            <name>\\n              <surname>Sandrin</surname>\\n              <given-names>V</given-names>\\n            </name>\\n            <name>\\n              <surname>Eckert</surname>\\n              <given-names>DM</given-names>\\n            </name>\\n            <name>\\n              <surname>Garcia-Maya</surname>\\n              <given-names>M</given-names>\\n            </name>\\n            <name>\\n              <surname>Saul</surname>\\n              <given-names>L</given-names>\\n            </name>\\n            <name>\\n              <surname>Sundquist</surname>\\n              <given-names>WI</given-names>\\n            </name>\\n            <name>\\n              <surname>Steiner</surname>\\n              <given-names>RA</given-names>\\n            </name>\\n            <name>\\n              <surname>Hill</surname>\\n              <given-names>CP</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Structural and functional studies on the extracellular domain of BST2/tetherin in reduced and oxidized conformations</article-title>\\n          <source>Proc Natl Acad Sci U S A</source>\\n          <year>2010</year>\\n          <volume>107</volume>\\n          <fpage>17951</fpage>\\n          <lpage>17956</lpage>\\n          <pub-id pub-id-type=\"pmid\">20880831</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R43\">\\n        <label>43</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Yang</surname>\\n              <given-names>H</given-names>\\n            </name>\\n            <name>\\n              <surname>Wang</surname>\\n              <given-names>J</given-names>\\n            </name>\\n            <name>\\n              <surname>Jia</surname>\\n              <given-names>X</given-names>\\n            </name>\\n            <name>\\n              <surname>McNatt</surname>\\n              <given-names>MW</given-names>\\n            </name>\\n            <name>\\n              <surname>Zang</surname>\\n              <given-names>T</given-names>\\n            </name>\\n            <name>\\n              <surname>Pan</surname>\\n              <given-names>B</given-names>\\n            </name>\\n            <name>\\n              <surname>Meng</surname>\\n              <given-names>W</given-names>\\n            </name>\\n            <name>\\n              <surname>Wang</surname>\\n              <given-names>HW</given-names>\\n            </name>\\n            <name>\\n              <surname>Bieniasz</surname>\\n              <given-names>PD</given-names>\\n            </name>\\n            <name>\\n              <surname>Xiong</surname>\\n              <given-names>Y</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Structural insight into the mechanisms of enveloped virus tethering by tetherin</article-title>\\n          <source>Proc Natl Acad Sci U S A</source>\\n          <year>2010</year>\\n          <volume>107</volume>\\n          <fpage>18428</fpage>\\n          <lpage>18432</lpage>\\n          <pub-id pub-id-type=\"pmid\">20940320</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R44\">\\n        <label>44</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Swiecki</surname>\\n              <given-names>M</given-names>\\n            </name>\\n            <name>\\n              <surname>Scheaffer</surname>\\n              <given-names>SM</given-names>\\n            </name>\\n            <name>\\n              <surname>Allaire</surname>\\n              <given-names>M</given-names>\\n            </name>\\n            <name>\\n              <surname>Fremont</surname>\\n              <given-names>DH</given-names>\\n            </name>\\n            <name>\\n              <surname>Colonna</surname>\\n              <given-names>M</given-names>\\n            </name>\\n            <name>\\n              <surname>Brett</surname>\\n              <given-names>TJ</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Structural and biophysical analysis of BST-2/tetherin ectodomains reveals an evolutionary conserved design to inhibit virus release</article-title>\\n          <source>J Biol Chem</source>\\n          <year>2011</year>\\n          <volume>286</volume>\\n          <fpage>2987</fpage>\\n          <lpage>2997</lpage>\\n          <pub-id pub-id-type=\"pmid\">21084286</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R45\">\\n        <label>45</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Andrew</surname>\\n              <given-names>AJ</given-names>\\n            </name>\\n            <name>\\n              <surname>Miyagi</surname>\\n              <given-names>E</given-names>\\n            </name>\\n            <name>\\n              <surname>Kao</surname>\\n              <given-names>S</given-names>\\n            </name>\\n            <name>\\n              <surname>Strebel</surname>\\n              <given-names>K</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>The formation of cysteine-linked dimers of BST-2/tetherin is important for inhibition of HIV-1 virus release but not for sensitivity to Vpu</article-title>\\n          <source>Retrovirology</source>\\n          <year>2009</year>\\n          <volume>6</volume>\\n          <fpage>80</fpage>\\n          <pub-id pub-id-type=\"pmid\">19737401</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R46\">\\n        <label>46</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Perez-Caballero</surname>\\n              <given-names>D</given-names>\\n            </name>\\n            <name>\\n              <surname>Zang</surname>\\n              <given-names>T</given-names>\\n            </name>\\n            <name>\\n              <surname>Ebrahimi</surname>\\n              <given-names>A</given-names>\\n            </name>\\n            <name>\\n              <surname>McNatt</surname>\\n              <given-names>MW</given-names>\\n            </name>\\n            <name>\\n              <surname>Gregory</surname>\\n              <given-names>DA</given-names>\\n            </name>\\n            <name>\\n              <surname>Johnson</surname>\\n              <given-names>MC</given-names>\\n            </name>\\n            <name>\\n              <surname>Bieniasz</surname>\\n              <given-names>PD</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Tetherin inhibits HIV-1 release by directly tethering virions to cells</article-title>\\n          <source>Cell</source>\\n          <year>2009</year>\\n          <volume>139</volume>\\n          <fpage>499</fpage>\\n          <lpage>511</lpage>\\n          <pub-id pub-id-type=\"pmid\">19879838</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R47\">\\n        <label>47</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Hammonds</surname>\\n              <given-names>J</given-names>\\n            </name>\\n            <name>\\n              <surname>Ding</surname>\\n              <given-names>L</given-names>\\n            </name>\\n            <name>\\n              <surname>Chu</surname>\\n              <given-names>H</given-names>\\n            </name>\\n            <name>\\n              <surname>Geller</surname>\\n              <given-names>K</given-names>\\n            </name>\\n            <name>\\n              <surname>Robbins</surname>\\n              <given-names>A</given-names>\\n            </name>\\n            <name>\\n              <surname>Wang</surname>\\n              <given-names>JJ</given-names>\\n            </name>\\n            <name>\\n              <surname>Yi</surname>\\n              <given-names>H</given-names>\\n            </name>\\n            <name>\\n              <surname>Spearman</surname>\\n              <given-names>P</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>The tetherin/BST-2 coiled-coil ectodomain mediates plasma membrane microdomain localization and restriction of particle release</article-title>\\n          <source>J Virol</source>\\n          <year>2012</year>\\n          <volume>86</volume>\\n          <fpage>2259</fpage>\\n          <lpage>2272</lpage>\\n          <pub-id pub-id-type=\"pmid\">22130541</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R48\">\\n        <label>48</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Andrew</surname>\\n              <given-names>AJ</given-names>\\n            </name>\\n            <name>\\n              <surname>Berndsen</surname>\\n              <given-names>CE</given-names>\\n            </name>\\n            <name>\\n              <surname>Kao</surname>\\n              <given-names>S</given-names>\\n            </name>\\n            <name>\\n              <surname>Strebel</surname>\\n              <given-names>K</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>The Size and Conservation of a Coiled-coil Structure in the Ectodomain of Human BST-2/Tetherin Is Dispensable for Inhibition of HIV-1 Virion Release</article-title>\\n          <source>J Biol Chem</source>\\n          <year>2012</year>\\n          <volume>287</volume>\\n          <fpage>44278</fpage>\\n          <lpage>44288</lpage>\\n          <pub-id pub-id-type=\"pmid\">23152502</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R49\">\\n        <label>49</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Klimkait</surname>\\n              <given-names>T</given-names>\\n            </name>\\n            <name>\\n              <surname>Strebel</surname>\\n              <given-names>K</given-names>\\n            </name>\\n            <name>\\n              <surname>Hoggan</surname>\\n              <given-names>MD</given-names>\\n            </name>\\n            <name>\\n              <surname>Martin</surname>\\n              <given-names>MA</given-names>\\n            </name>\\n            <name>\\n              <surname>Orenstein</surname>\\n              <given-names>JM</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release</article-title>\\n          <source>J Virol</source>\\n          <year>1990</year>\\n          <volume>64</volume>\\n          <fpage>621</fpage>\\n          <lpage>629</lpage>\\n          <pub-id pub-id-type=\"pmid\">2404139</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R50\">\\n        <label>50</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Hammonds</surname>\\n              <given-names>J</given-names>\\n            </name>\\n            <name>\\n              <surname>Wang</surname>\\n              <given-names>JJ</given-names>\\n            </name>\\n            <name>\\n              <surname>Yi</surname>\\n              <given-names>H</given-names>\\n            </name>\\n            <name>\\n              <surname>Spearman</surname>\\n              <given-names>P</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Immunoelectron Microscopic Evidence for Tetherin/BST2 as the Physical Bridge between HIV-1 Virions and the Plasma Membrane</article-title>\\n          <source>PLoS Pathog</source>\\n          <year>2010</year>\\n          <volume>6</volume>\\n          <fpage>e1000749</fpage>\\n          <pub-id pub-id-type=\"pmid\">20140192</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R51\">\\n        <label>51</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Habermann</surname>\\n              <given-names>A</given-names>\\n            </name>\\n            <name>\\n              <surname>Krijnse-Locker</surname>\\n              <given-names>J</given-names>\\n            </name>\\n            <name>\\n              <surname>Oberwinkler</surname>\\n              <given-names>H</given-names>\\n            </name>\\n            <name>\\n              <surname>Eckhardt</surname>\\n              <given-names>M</given-names>\\n            </name>\\n            <name>\\n              <surname>Homann</surname>\\n              <given-names>S</given-names>\\n            </name>\\n            <name>\\n              <surname>Andrew</surname>\\n              <given-names>A</given-names>\\n            </name>\\n            <name>\\n              <surname>Strebel</surname>\\n              <given-names>K</given-names>\\n            </name>\\n            <name>\\n              <surname>Krausslich</surname>\\n              <given-names>HG</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>CD317/tetherin is enriched in the HIV-1 envelope and downregulated from the plasma membrane upon virus infection</article-title>\\n          <source>J Virol</source>\\n          <year>2010</year>\\n          <volume>84</volume>\\n          <fpage>4646</fpage>\\n          <lpage>4658</lpage>\\n          <pub-id pub-id-type=\"pmid\">20147389</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R52\">\\n        <label>52</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Fitzpatrick</surname>\\n              <given-names>K</given-names>\\n            </name>\\n            <name>\\n              <surname>Skasko</surname>\\n              <given-names>M</given-names>\\n            </name>\\n            <name>\\n              <surname>Deerinck</surname>\\n              <given-names>TJ</given-names>\\n            </name>\\n            <name>\\n              <surname>Crum</surname>\\n              <given-names>J</given-names>\\n            </name>\\n            <name>\\n              <surname>Ellisman</surname>\\n              <given-names>MH</given-names>\\n            </name>\\n            <name>\\n              <surname>Guatelli</surname>\\n              <given-names>J</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Direct restriction of virus release and incorporation of the interferon-induced protein BST-2 into HIV-1 particles</article-title>\\n          <source>PLoS Pathog</source>\\n          <year>2010</year>\\n          <volume>6</volume>\\n          <fpage>e1000701</fpage>\\n          <pub-id pub-id-type=\"pmid\">20221443</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R53\">\\n        <label>53</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Miyagi</surname>\\n              <given-names>E</given-names>\\n            </name>\\n            <name>\\n              <surname>Andrew</surname>\\n              <given-names>AJ</given-names>\\n            </name>\\n            <name>\\n              <surname>Kao</surname>\\n              <given-names>S</given-names>\\n            </name>\\n            <name>\\n              <surname>Strebel</surname>\\n              <given-names>K</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Vpu enhances HIV-1 virus release in the absence of Bst-2 cell surface down-modulation and intracellular depletion</article-title>\\n          <source>Proc Natl Acad Sci U S A</source>\\n          <year>2009</year>\\n          <volume>106</volume>\\n          <fpage>2868</fpage>\\n          <lpage>2873</lpage>\\n          <pub-id pub-id-type=\"pmid\">19196977</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R54\">\\n        <label>54</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Skasko</surname>\\n              <given-names>M</given-names>\\n            </name>\\n            <name>\\n              <surname>Tokarev</surname>\\n              <given-names>A</given-names>\\n            </name>\\n            <name>\\n              <surname>Chen</surname>\\n              <given-names>CC</given-names>\\n            </name>\\n            <name>\\n              <surname>Fischer</surname>\\n              <given-names>WB</given-names>\\n            </name>\\n            <name>\\n              <surname>Pillai</surname>\\n              <given-names>SK</given-names>\\n            </name>\\n            <name>\\n              <surname>Guatelli</surname>\\n              <given-names>J</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>BST-2 is rapidly down-regulated from the cell surface by the HIV-1 protein Vpu: Evidence for a post-ER mechanism of Vpu-action</article-title>\\n          <source>Virology</source>\\n          <year>2011</year>\\n          <volume>411</volume>\\n          <fpage>65</fpage>\\n          <lpage>77</lpage>\\n          <pub-id pub-id-type=\"pmid\">21237475</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R55\">\\n        <label>55</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Hauser</surname>\\n              <given-names>H</given-names>\\n            </name>\\n            <name>\\n              <surname>Lopez</surname>\\n              <given-names>LA</given-names>\\n            </name>\\n            <name>\\n              <surname>Yang</surname>\\n              <given-names>SJ</given-names>\\n            </name>\\n            <name>\\n              <surname>Oldenburg</surname>\\n              <given-names>JE</given-names>\\n            </name>\\n            <name>\\n              <surname>Exline</surname>\\n              <given-names>CM</given-names>\\n            </name>\\n            <name>\\n              <surname>Guatelli</surname>\\n              <given-names>JC</given-names>\\n            </name>\\n            <name>\\n              <surname>Cannon</surname>\\n              <given-names>PM</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>HIV-1 Vpu and HIV-2 Env counteract BST-2/tetherin by sequestration in a perinuclear compartment</article-title>\\n          <source>Retrovirology</source>\\n          <year>2010</year>\\n          <volume>7</volume>\\n          <fpage>51</fpage>\\n          <pub-id pub-id-type=\"pmid\">20529266</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R56\">\\n        <label>56</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Mitchell</surname>\\n              <given-names>RS</given-names>\\n            </name>\\n            <name>\\n              <surname>Katsura</surname>\\n              <given-names>C</given-names>\\n            </name>\\n            <name>\\n              <surname>Skasko</surname>\\n              <given-names>MA</given-names>\\n            </name>\\n            <name>\\n              <surname>Fitzpatrick</surname>\\n              <given-names>K</given-names>\\n            </name>\\n            <name>\\n              <surname>Lau</surname>\\n              <given-names>D</given-names>\\n            </name>\\n            <name>\\n              <surname>Ruiz</surname>\\n              <given-names>A</given-names>\\n            </name>\\n            <name>\\n              <surname>Stephens</surname>\\n              <given-names>EB</given-names>\\n            </name>\\n            <name>\\n              <surname>Margottin-Goguet</surname>\\n              <given-names>F</given-names>\\n            </name>\\n            <name>\\n              <surname>Benarous</surname>\\n              <given-names>R</given-names>\\n            </name>\\n            <name>\\n              <surname>Guatelli</surname>\\n              <given-names>JC</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Vpu antagonizes BST-2- mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking</article-title>\\n          <source>PLoS Pathog</source>\\n          <year>2009</year>\\n          <volume>5</volume>\\n          <fpage>e1000450</fpage>\\n          <pub-id pub-id-type=\"pmid\">19478868</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R57\">\\n        <label>57</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Douglas</surname>\\n              <given-names>JL</given-names>\\n            </name>\\n            <name>\\n              <surname>Viswanathan</surname>\\n              <given-names>K</given-names>\\n            </name>\\n            <name>\\n              <surname>McCarroll</surname>\\n              <given-names>MN</given-names>\\n            </name>\\n            <name>\\n              <surname>Gustin</surname>\\n              <given-names>JK</given-names>\\n            </name>\\n            <name>\\n              <surname>Fruh</surname>\\n              <given-names>K</given-names>\\n            </name>\\n            <name>\\n              <surname>Moses</surname>\\n              <given-names>AV</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism</article-title>\\n          <source>J Virol</source>\\n          <year>2009</year>\\n          <volume>83</volume>\\n          <fpage>7931</fpage>\\n          <lpage>7947</lpage>\\n          <pub-id pub-id-type=\"pmid\">19515779</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R58\">\\n        <label>58</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Dube</surname>\\n              <given-names>M</given-names>\\n            </name>\\n            <name>\\n              <surname>Roy</surname>\\n              <given-names>BB</given-names>\\n            </name>\\n            <name>\\n              <surname>Guiot-Guillain</surname>\\n              <given-names>P</given-names>\\n            </name>\\n            <name>\\n              <surname>Binette</surname>\\n              <given-names>J</given-names>\\n            </name>\\n            <name>\\n              <surname>Mercier</surname>\\n              <given-names>J</given-names>\\n            </name>\\n            <name>\\n              <surname>Chiasson</surname>\\n              <given-names>A</given-names>\\n            </name>\\n            <name>\\n              <surname>Cohen</surname>\\n              <given-names>EA</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Antagonism of tetherin restriction of HIV-1 release by Vpu involves binding and sequestration of the restriction factor in a perinuclear compartment</article-title>\\n          <source>PLoS Pathog</source>\\n          <year>2010</year>\\n          <volume>6</volume>\\n          <fpage>e1000856</fpage>\\n          <pub-id pub-id-type=\"pmid\">20386718</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R59\">\\n        <label>59</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Iwabu</surname>\\n              <given-names>Y</given-names>\\n            </name>\\n            <name>\\n              <surname>Fujita</surname>\\n              <given-names>H</given-names>\\n            </name>\\n            <name>\\n              <surname>Kinomoto</surname>\\n              <given-names>M</given-names>\\n            </name>\\n            <name>\\n              <surname>Kaneko</surname>\\n              <given-names>K</given-names>\\n            </name>\\n            <name>\\n              <surname>Ishizaka</surname>\\n              <given-names>Y</given-names>\\n            </name>\\n            <name>\\n              <surname>Tanaka</surname>\\n              <given-names>Y</given-names>\\n            </name>\\n            <name>\\n              <surname>Sata</surname>\\n              <given-names>T</given-names>\\n            </name>\\n            <name>\\n              <surname>Tokunaga</surname>\\n              <given-names>K</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>HIV-1 accessory protein Vpu internalizes cell-surface BST-2/tetherin through transmembrane interactions leading to lysosomes</article-title>\\n          <source>J Biol Chem</source>\\n          <year>2009</year>\\n          <volume>284</volume>\\n          <fpage>35060</fpage>\\n          <lpage>35072</lpage>\\n          <pub-id pub-id-type=\"pmid\">19837671</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R60\">\\n        <label>60</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Lopez</surname>\\n              <given-names>LA</given-names>\\n            </name>\\n            <name>\\n              <surname>Yang</surname>\\n              <given-names>SJ</given-names>\\n            </name>\\n            <name>\\n              <surname>Exline</surname>\\n              <given-names>CM</given-names>\\n            </name>\\n            <name>\\n              <surname>Rengarajan</surname>\\n              <given-names>S</given-names>\\n            </name>\\n            <name>\\n              <surname>Haworth</surname>\\n              <given-names>KG</given-names>\\n            </name>\\n            <name>\\n              <surname>Cannon</surname>\\n              <given-names>PM</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Anti-tetherin activities of HIV-1 Vpu and Ebola virus glycoprotein do not involve removal of tetherin from lipid rafts</article-title>\\n          <source>J Virol</source>\\n          <year>2012</year>\\n          <volume>86</volume>\\n          <fpage>5467</fpage>\\n          <lpage>5480</lpage>\\n          <pub-id pub-id-type=\"pmid\">22398279</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R61\">\\n        <label>61</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Masuyama</surname>\\n              <given-names>N</given-names>\\n            </name>\\n            <name>\\n              <surname>Kuronita</surname>\\n              <given-names>T</given-names>\\n            </name>\\n            <name>\\n              <surname>Tanaka</surname>\\n              <given-names>R</given-names>\\n            </name>\\n            <name>\\n              <surname>Muto</surname>\\n              <given-names>T</given-names>\\n            </name>\\n            <name>\\n              <surname>Hirota</surname>\\n              <given-names>Y</given-names>\\n            </name>\\n            <name>\\n              <surname>Takigawa</surname>\\n              <given-names>A</given-names>\\n            </name>\\n            <name>\\n              <surname>Fujita</surname>\\n              <given-names>H</given-names>\\n            </name>\\n            <name>\\n              <surname>Aso</surname>\\n              <given-names>Y</given-names>\\n            </name>\\n            <name>\\n              <surname>Amano</surname>\\n              <given-names>J</given-names>\\n            </name>\\n            <name>\\n              <surname>Tanaka</surname>\\n              <given-names>Y</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>HM1.24 Is Internalized from Lipid Rafts by Clathrin-mediated Endocytosis through Interaction with {alpha}-Adaptin</article-title>\\n          <source>J Biol Chem</source>\\n          <year>2009</year>\\n          <volume>284</volume>\\n          <fpage>15927</fpage>\\n          <lpage>15941</lpage>\\n          <pub-id pub-id-type=\"pmid\">19359243</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R62\">\\n        <label>62</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Rollason</surname>\\n              <given-names>R</given-names>\\n            </name>\\n            <name>\\n              <surname>Korolchuk</surname>\\n              <given-names>V</given-names>\\n            </name>\\n            <name>\\n              <surname>Hamilton</surname>\\n              <given-names>C</given-names>\\n            </name>\\n            <name>\\n              <surname>Schu</surname>\\n              <given-names>P</given-names>\\n            </name>\\n            <name>\\n              <surname>Banting</surname>\\n              <given-names>G</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Clathrin-mediated endocytosis of a lipid-raft-associated protein is mediated through a dual tyrosine motif</article-title>\\n          <source>J Cell Sci</source>\\n          <year>2007</year>\\n          <volume>120</volume>\\n          <fpage>3850</fpage>\\n          <lpage>3858</lpage>\\n          <pub-id pub-id-type=\"pmid\">17940069</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R63\">\\n        <label>63</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Fritz</surname>\\n              <given-names>JV</given-names>\\n            </name>\\n            <name>\\n              <surname>Tibroni</surname>\\n              <given-names>N</given-names>\\n            </name>\\n            <name>\\n              <surname>Keppler</surname>\\n              <given-names>OT</given-names>\\n            </name>\\n            <name>\\n              <surname>Fackler</surname>\\n              <given-names>OT</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>HIV-1 Vpu\\'s lipid raft association is dispensable for counteraction of the particle release restriction imposed by CD317/Tetherin</article-title>\\n          <source>Virology</source>\\n          <year>2012</year>\\n          <volume>424</volume>\\n          <fpage>33</fpage>\\n          <lpage>44</lpage>\\n          <pub-id pub-id-type=\"pmid\">22222210</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R64\">\\n        <label>64</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Miyagi</surname>\\n              <given-names>E</given-names>\\n            </name>\\n            <name>\\n              <surname>Andrew</surname>\\n              <given-names>A</given-names>\\n            </name>\\n            <name>\\n              <surname>Kao</surname>\\n              <given-names>S</given-names>\\n            </name>\\n            <name>\\n              <surname>Yoshida</surname>\\n              <given-names>T</given-names>\\n            </name>\\n            <name>\\n              <surname>Strebel</surname>\\n              <given-names>K</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Antibody-mediated enhancement of HIV-1 and HIV-2 production from BST-2/tetherin+ cells</article-title>\\n          <source>J Virol</source>\\n          <year>2011</year>\\n          <volume>85</volume>\\n          <fpage>11981</fpage>\\n          <lpage>11994</lpage>\\n          <pub-id pub-id-type=\"pmid\">21917971</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R65\">\\n        <label>65</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Andrew</surname>\\n              <given-names>AJ</given-names>\\n            </name>\\n            <name>\\n              <surname>Miyagi</surname>\\n              <given-names>E</given-names>\\n            </name>\\n            <name>\\n              <surname>Strebel</surname>\\n              <given-names>K</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Differential Effects of Human Immunodeficiency Virus Type 1 Vpu on the Stability of BST-2/Tetherin</article-title>\\n          <source>J Virol</source>\\n          <year>2011</year>\\n          <volume>85</volume>\\n          <fpage>2611</fpage>\\n          <lpage>2619</lpage>\\n          <pub-id pub-id-type=\"pmid\">21191020</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R66\">\\n        <label>66</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Dube</surname>\\n              <given-names>M</given-names>\\n            </name>\\n            <name>\\n              <surname>Paquay</surname>\\n              <given-names>C</given-names>\\n            </name>\\n            <name>\\n              <surname>Roy</surname>\\n              <given-names>BB</given-names>\\n            </name>\\n            <name>\\n              <surname>Bego</surname>\\n              <given-names>MG</given-names>\\n            </name>\\n            <name>\\n              <surname>Mercier</surname>\\n              <given-names>J</given-names>\\n            </name>\\n            <name>\\n              <surname>Cohen</surname>\\n              <given-names>EA</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>HIV-1 Vpu Antagonizes BST-2 by Interfering Mainly with the Trafficking of Newly Synthesized BST-2 to the Cell Surface</article-title>\\n          <source>Traffic</source>\\n          <year>2011</year>\\n          <volume>12</volume>\\n          <fpage>1714</fpage>\\n          <lpage>1729</lpage>\\n          <pub-id pub-id-type=\"pmid\">21902775</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R67\">\\n        <label>67</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Goffinet</surname>\\n              <given-names>C</given-names>\\n            </name>\\n            <name>\\n              <surname>Allespach</surname>\\n              <given-names>I</given-names>\\n            </name>\\n            <name>\\n              <surname>Homann</surname>\\n              <given-names>S</given-names>\\n            </name>\\n            <name>\\n              <surname>Tervo</surname>\\n              <given-names>HM</given-names>\\n            </name>\\n            <name>\\n              <surname>Habermann</surname>\\n              <given-names>A</given-names>\\n            </name>\\n            <name>\\n              <surname>Rupp</surname>\\n              <given-names>D</given-names>\\n            </name>\\n            <name>\\n              <surname>Oberbremer</surname>\\n              <given-names>L</given-names>\\n            </name>\\n            <name>\\n              <surname>Kern</surname>\\n              <given-names>C</given-names>\\n            </name>\\n            <name>\\n              <surname>Tibroni</surname>\\n              <given-names>N</given-names>\\n            </name>\\n            <name>\\n              <surname>Welsch</surname>\\n              <given-names>S</given-names>\\n            </name>\\n            <name>\\n              <surname>Krijnse-Locker</surname>\\n              <given-names>J</given-names>\\n            </name>\\n            <name>\\n              <surname>Banting</surname>\\n              <given-names>G</given-names>\\n            </name>\\n            <name>\\n              <surname>Krausslich</surname>\\n              <given-names>HG</given-names>\\n            </name>\\n            <name>\\n              <surname>Fackler</surname>\\n              <given-names>OT</given-names>\\n            </name>\\n            <name>\\n              <surname>Keppler</surname>\\n              <given-names>OT</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>HIV-1 antagonism of CD317 is species specific and involves Vpu-mediated proteasomal degradation of the restriction factor</article-title>\\n          <source>Cell Host Microbe</source>\\n          <year>2009</year>\\n          <volume>5</volume>\\n          <fpage>285</fpage>\\n          <lpage>297</lpage>\\n          <pub-id pub-id-type=\"pmid\">19286137</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R68\">\\n        <label>68</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Mangeat</surname>\\n              <given-names>B</given-names>\\n            </name>\\n            <name>\\n              <surname>Gers-Huber</surname>\\n              <given-names>G</given-names>\\n            </name>\\n            <name>\\n              <surname>Lehmann</surname>\\n              <given-names>M</given-names>\\n            </name>\\n            <name>\\n              <surname>Zufferey</surname>\\n              <given-names>M</given-names>\\n            </name>\\n            <name>\\n              <surname>Luban</surname>\\n              <given-names>J</given-names>\\n            </name>\\n            <name>\\n              <surname>Piguet</surname>\\n              <given-names>V</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation</article-title>\\n          <source>PLoS Pathog</source>\\n          <year>2009</year>\\n          <volume>5</volume>\\n          <fpage>e1000574</fpage>\\n          <pub-id pub-id-type=\"pmid\">19730691</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R69\">\\n        <label>69</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Schubert</surname>\\n              <given-names>U</given-names>\\n            </name>\\n            <name>\\n              <surname>Strebel</surname>\\n              <given-names>K</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Differential activities of the human immunodeficiency virus type 1-encoded Vpu protein are regulated by phosphorylation and occur in different cellular compartments</article-title>\\n          <source>J Virol</source>\\n          <year>1994</year>\\n          <volume>68</volume>\\n          <fpage>2260</fpage>\\n          <lpage>2271</lpage>\\n          <pub-id pub-id-type=\"pmid\">8139011</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R70\">\\n        <label>70</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Schubert</surname>\\n              <given-names>U</given-names>\\n            </name>\\n            <name>\\n              <surname>Clouse</surname>\\n              <given-names>KA</given-names>\\n            </name>\\n            <name>\\n              <surname>Strebel</surname>\\n              <given-names>K</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Augmentation of virus secretion by the human immunodeficiency virus type 1 Vpu protein is cell type independent and occurs in cultured human primary macrophages and lymphocytes</article-title>\\n          <source>J Virol</source>\\n          <year>1995</year>\\n          <volume>69</volume>\\n          <fpage>7699</fpage>\\n          <lpage>7711</lpage>\\n          <pub-id pub-id-type=\"pmid\">7494279</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R71\">\\n        <label>71</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Goffinet</surname>\\n              <given-names>C</given-names>\\n            </name>\\n            <name>\\n              <surname>Homann</surname>\\n              <given-names>S</given-names>\\n            </name>\\n            <name>\\n              <surname>Ambiel</surname>\\n              <given-names>I</given-names>\\n            </name>\\n            <name>\\n              <surname>Tibroni</surname>\\n              <given-names>N</given-names>\\n            </name>\\n            <name>\\n              <surname>Rupp</surname>\\n              <given-names>D</given-names>\\n            </name>\\n            <name>\\n              <surname>Keppler</surname>\\n              <given-names>OT</given-names>\\n            </name>\\n            <name>\\n              <surname>Fackler</surname>\\n              <given-names>OT</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Antagonism of CD317 restriction of HIV-1 particle release and depletion of CD317 are separable activities of HIV-1 Vpu</article-title>\\n          <source>J Virol</source>\\n          <year>2010</year>\\n          <volume>84</volume>\\n          <fpage>4089</fpage>\\n          <lpage>4094</lpage>\\n          <pub-id pub-id-type=\"pmid\">20147395</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R72\">\\n        <label>72</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Gupta</surname>\\n              <given-names>RK</given-names>\\n            </name>\\n            <name>\\n              <surname>Hue</surname>\\n              <given-names>S</given-names>\\n            </name>\\n            <name>\\n              <surname>Schaller</surname>\\n              <given-names>T</given-names>\\n            </name>\\n            <name>\\n              <surname>Verschoor</surname>\\n              <given-names>E</given-names>\\n            </name>\\n            <name>\\n              <surname>Pillay</surname>\\n              <given-names>D</given-names>\\n            </name>\\n            <name>\\n              <surname>Towers</surname>\\n              <given-names>GJ</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Mutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion</article-title>\\n          <source>PLoS Pathog</source>\\n          <year>2009</year>\\n          <volume>5</volume>\\n          <fpage>e1000443</fpage>\\n          <pub-id pub-id-type=\"pmid\">19461879</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R73\">\\n        <label>73</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Jia</surname>\\n              <given-names>B</given-names>\\n            </name>\\n            <name>\\n              <surname>Serra-Moreno</surname>\\n              <given-names>R</given-names>\\n            </name>\\n            <name>\\n              <surname>Neidermyer</surname>\\n              <given-names>W</given-names>\\n            </name>\\n            <name>\\n              <surname>Rahmberg</surname>\\n              <given-names>A</given-names>\\n            </name>\\n            <name>\\n              <surname>Mackey</surname>\\n              <given-names>J</given-names>\\n            </name>\\n            <name>\\n              <surname>Fofana</surname>\\n              <given-names>IB</given-names>\\n            </name>\\n            <name>\\n              <surname>Johnson</surname>\\n              <given-names>WE</given-names>\\n            </name>\\n            <name>\\n              <surname>Westmoreland</surname>\\n              <given-names>S</given-names>\\n            </name>\\n            <name>\\n              <surname>Evans</surname>\\n              <given-names>DT</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2</article-title>\\n          <source>PLoS Pathog</source>\\n          <year>2009</year>\\n          <volume>5</volume>\\n          <fpage>e1000429</fpage>\\n          <pub-id pub-id-type=\"pmid\">19436700</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R74\">\\n        <label>74</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Le Tortorec</surname>\\n              <given-names>A</given-names>\\n            </name>\\n            <name>\\n              <surname>Neil</surname>\\n              <given-names>SJ</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Antagonism to and intracellular sequestration of human tetherin by the human immunodeficiency virus type 2 envelope glycoprotein</article-title>\\n          <source>J Virol</source>\\n          <year>2009</year>\\n          <volume>83</volume>\\n          <fpage>11966</fpage>\\n          <lpage>11978</lpage>\\n          <pub-id pub-id-type=\"pmid\">19740980</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R75\">\\n        <label>75</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Sauter</surname>\\n              <given-names>D</given-names>\\n            </name>\\n            <name>\\n              <surname>Schindler</surname>\\n              <given-names>M</given-names>\\n            </name>\\n            <name>\\n              <surname>Specht</surname>\\n              <given-names>A</given-names>\\n            </name>\\n            <name>\\n              <surname>Landford</surname>\\n              <given-names>WN</given-names>\\n            </name>\\n            <name>\\n              <surname>Munch</surname>\\n              <given-names>J</given-names>\\n            </name>\\n            <name>\\n              <surname>Kim</surname>\\n              <given-names>KA</given-names>\\n            </name>\\n            <name>\\n              <surname>Votteler</surname>\\n              <given-names>J</given-names>\\n            </name>\\n            <name>\\n              <surname>Schubert</surname>\\n              <given-names>U</given-names>\\n            </name>\\n            <name>\\n              <surname>Bibollet-Ruche</surname>\\n              <given-names>F</given-names>\\n            </name>\\n            <name>\\n              <surname>Keele</surname>\\n              <given-names>BF</given-names>\\n            </name>\\n            <name>\\n              <surname>Takehisa</surname>\\n              <given-names>J</given-names>\\n            </name>\\n            <name>\\n              <surname>Ogando</surname>\\n              <given-names>Y</given-names>\\n            </name>\\n            <name>\\n              <surname>Ochsenbauer</surname>\\n              <given-names>C</given-names>\\n            </name>\\n            <name>\\n              <surname>Kappes</surname>\\n              <given-names>JC</given-names>\\n            </name>\\n            <name>\\n              <surname>Ayouba</surname>\\n              <given-names>A</given-names>\\n            </name>\\n            <name>\\n              <surname>Peeters</surname>\\n              <given-names>M</given-names>\\n            </name>\\n            <name>\\n              <surname>Learn</surname>\\n              <given-names>GH</given-names>\\n            </name>\\n            <name>\\n              <surname>Shaw</surname>\\n              <given-names>G</given-names>\\n            </name>\\n            <name>\\n              <surname>Sharp</surname>\\n              <given-names>PM</given-names>\\n            </name>\\n            <name>\\n              <surname>Bieniasz</surname>\\n              <given-names>P</given-names>\\n            </name>\\n            <name>\\n              <surname>Hahn</surname>\\n              <given-names>BH</given-names>\\n            </name>\\n            <name>\\n              <surname>Hatziioannou</surname>\\n              <given-names>T</given-names>\\n            </name>\\n            <name>\\n              <surname>Kirchhoff</surname>\\n              <given-names>F</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains</article-title>\\n          <source>Cell Host Microbe</source>\\n          <year>2009</year>\\n          <volume>6</volume>\\n          <fpage>409</fpage>\\n          <lpage>421</lpage>\\n          <pub-id pub-id-type=\"pmid\">19917496</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R76\">\\n        <label>76</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Yang</surname>\\n              <given-names>SJ</given-names>\\n            </name>\\n            <name>\\n              <surname>Lopez</surname>\\n              <given-names>LA</given-names>\\n            </name>\\n            <name>\\n              <surname>Hauser</surname>\\n              <given-names>H</given-names>\\n            </name>\\n            <name>\\n              <surname>Exline</surname>\\n              <given-names>CM</given-names>\\n            </name>\\n            <name>\\n              <surname>Haworth</surname>\\n              <given-names>KG</given-names>\\n            </name>\\n            <name>\\n              <surname>Cannon</surname>\\n              <given-names>PM</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Anti-tetherin activities in Vpu-expressing primate lentiviruses</article-title>\\n          <source>Retrovirology</source>\\n          <year>2010</year>\\n          <volume>7</volume>\\n          <fpage>13</fpage>\\n          <pub-id pub-id-type=\"pmid\">20167081</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R77\">\\n        <label>77</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Zhang</surname>\\n              <given-names>F</given-names>\\n            </name>\\n            <name>\\n              <surname>Wilson</surname>\\n              <given-names>SJ</given-names>\\n            </name>\\n            <name>\\n              <surname>Landford</surname>\\n              <given-names>WC</given-names>\\n            </name>\\n            <name>\\n              <surname>Virgen</surname>\\n              <given-names>B</given-names>\\n            </name>\\n            <name>\\n              <surname>Gregory</surname>\\n              <given-names>D</given-names>\\n            </name>\\n            <name>\\n              <surname>Johnson</surname>\\n              <given-names>MC</given-names>\\n            </name>\\n            <name>\\n              <surname>Munch</surname>\\n              <given-names>J</given-names>\\n            </name>\\n            <name>\\n              <surname>Kirchhoff</surname>\\n              <given-names>F</given-names>\\n            </name>\\n            <name>\\n              <surname>Bieniasz</surname>\\n              <given-names>PD</given-names>\\n            </name>\\n            <name>\\n              <surname>Hatziioannou</surname>\\n              <given-names>T</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Nef proteins from simian immunodeficiency viruses are tetherin antagonists</article-title>\\n          <source>Cell Host Microbe</source>\\n          <year>2009</year>\\n          <volume>6</volume>\\n          <fpage>54</fpage>\\n          <lpage>67</lpage>\\n          <pub-id pub-id-type=\"pmid\">19501037</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R78\">\\n        <label>78</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Kobayashi</surname>\\n              <given-names>T</given-names>\\n            </name>\\n            <name>\\n              <surname>Ode</surname>\\n              <given-names>H</given-names>\\n            </name>\\n            <name>\\n              <surname>Yoshida</surname>\\n              <given-names>T</given-names>\\n            </name>\\n            <name>\\n              <surname>Sato</surname>\\n              <given-names>K</given-names>\\n            </name>\\n            <name>\\n              <surname>Gee</surname>\\n              <given-names>P</given-names>\\n            </name>\\n            <name>\\n              <surname>Yamamoto</surname>\\n              <given-names>SP</given-names>\\n            </name>\\n            <name>\\n              <surname>Ebina</surname>\\n              <given-names>H</given-names>\\n            </name>\\n            <name>\\n              <surname>Strebel</surname>\\n              <given-names>K</given-names>\\n            </name>\\n            <name>\\n              <surname>Sato</surname>\\n              <given-names>H</given-names>\\n            </name>\\n            <name>\\n              <surname>Koyanagi</surname>\\n              <given-names>Y</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Identification of amino acids in the human tetherin transmembrane domain responsible for HIV-1 Vpu interaction and susceptibility</article-title>\\n          <source>J Virol</source>\\n          <year>2011</year>\\n          <volume>85</volume>\\n          <fpage>932</fpage>\\n          <lpage>945</lpage>\\n          <pub-id pub-id-type=\"pmid\">21068238</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R79\">\\n        <label>79</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Yoshida</surname>\\n              <given-names>T</given-names>\\n            </name>\\n            <name>\\n              <surname>Kao</surname>\\n              <given-names>S</given-names>\\n            </name>\\n            <name>\\n              <surname>Strebel</surname>\\n              <given-names>K</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Identification of residues in the BST-2 TM domain important for antagonism by HIV-1 Vpu using a gain-of-function approach</article-title>\\n          <source>Frontiers in Microbiology</source>\\n          <year>2011</year>\\n          <volume>2</volume>\\n          <fpage>1</fpage>\\n          <pub-id pub-id-type=\"pmid\">21716958</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R80\">\\n        <label>80</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Rong</surname>\\n              <given-names>L</given-names>\\n            </name>\\n            <name>\\n              <surname>Zhang</surname>\\n              <given-names>J</given-names>\\n            </name>\\n            <name>\\n              <surname>Lu</surname>\\n              <given-names>J</given-names>\\n            </name>\\n            <name>\\n              <surname>Pan</surname>\\n              <given-names>Q</given-names>\\n            </name>\\n            <name>\\n              <surname>Lorgeoux</surname>\\n              <given-names>RP</given-names>\\n            </name>\\n            <name>\\n              <surname>Aloysius</surname>\\n              <given-names>C</given-names>\\n            </name>\\n            <name>\\n              <surname>Guo</surname>\\n              <given-names>F</given-names>\\n            </name>\\n            <name>\\n              <surname>Liu</surname>\\n              <given-names>SL</given-names>\\n            </name>\\n            <name>\\n              <surname>Wainberg</surname>\\n              <given-names>MA</given-names>\\n            </name>\\n            <name>\\n              <surname>Liang</surname>\\n              <given-names>C</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>The Transmembrane Domain of BST-2 Determines Its Sensitivity to Down-Modulation by HIV-1 Vpu</article-title>\\n          <source>J Virol</source>\\n          <year>2009</year>\\n          <volume>83</volume>\\n          <fpage>7536</fpage>\\n          <lpage>7546</lpage>\\n          <pub-id pub-id-type=\"pmid\">19474106</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R81\">\\n        <label>81</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Vigan</surname>\\n              <given-names>R</given-names>\\n            </name>\\n            <name>\\n              <surname>Neil</surname>\\n              <given-names>SJ</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Separable determinants of subcellular localization and interaction account for the inability of group O HIV-1 Vpu to counteract tetherin</article-title>\\n          <source>J Virol</source>\\n          <year>2011</year>\\n          <volume>85</volume>\\n          <fpage>9737</fpage>\\n          <lpage>9748</lpage>\\n          <pub-id pub-id-type=\"pmid\">21775465</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R82\">\\n        <label>82</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Skasko</surname>\\n              <given-names>M</given-names>\\n            </name>\\n            <name>\\n              <surname>Wang</surname>\\n              <given-names>Y</given-names>\\n            </name>\\n            <name>\\n              <surname>Tian</surname>\\n              <given-names>Y</given-names>\\n            </name>\\n            <name>\\n              <surname>Tokarev</surname>\\n              <given-names>A</given-names>\\n            </name>\\n            <name>\\n              <surname>Munguia</surname>\\n              <given-names>J</given-names>\\n            </name>\\n            <name>\\n              <surname>Ruiz</surname>\\n              <given-names>A</given-names>\\n            </name>\\n            <name>\\n              <surname>Stephens</surname>\\n              <given-names>EB</given-names>\\n            </name>\\n            <name>\\n              <surname>Opella</surname>\\n              <given-names>SJ</given-names>\\n            </name>\\n            <name>\\n              <surname>Guatelli</surname>\\n              <given-names>J</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>HIV-1 Vpu protein antagonizes innate restriction factor BST-2 via lipid-embedded helix-helix interactions</article-title>\\n          <source>J Biol Chem</source>\\n          <year>2012</year>\\n          <volume>287</volume>\\n          <fpage>58</fpage>\\n          <lpage>67</lpage>\\n          <pub-id pub-id-type=\"pmid\">22072710</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R83\">\\n        <label>83</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Zhou</surname>\\n              <given-names>J</given-names>\\n            </name>\\n            <name>\\n              <surname>Zhang</surname>\\n              <given-names>Z</given-names>\\n            </name>\\n            <name>\\n              <surname>Mi</surname>\\n              <given-names>Z</given-names>\\n            </name>\\n            <name>\\n              <surname>Wang</surname>\\n              <given-names>X</given-names>\\n            </name>\\n            <name>\\n              <surname>Zhang</surname>\\n              <given-names>Q</given-names>\\n            </name>\\n            <name>\\n              <surname>Li</surname>\\n              <given-names>X</given-names>\\n            </name>\\n            <name>\\n              <surname>Liang</surname>\\n              <given-names>C</given-names>\\n            </name>\\n            <name>\\n              <surname>Cen</surname>\\n              <given-names>S</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Characterization of the interface of the bone marrow stromal cell antigen 2-Vpu protein complex via computational chemistry</article-title>\\n          <source>Biochemistry</source>\\n          <year>2012</year>\\n          <volume>51</volume>\\n          <fpage>1288</fpage>\\n          <lpage>1296</lpage>\\n          <pub-id pub-id-type=\"pmid\">22264038</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R84\">\\n        <label>84</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Kueck</surname>\\n              <given-names>T</given-names>\\n            </name>\\n            <name>\\n              <surname>Neil</surname>\\n              <given-names>SJD</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>A Cytoplasmic Tail Determinant in HIV-1 Vpu Mediates Targeting of Tetherin for Endosomal Degradation and Counteracts Interferon-Induced Restriction</article-title>\\n          <source>PLoS Pathog</source>\\n          <year>2012</year>\\n          <volume>8</volume>\\n          <fpage>e1002609</fpage>\\n          <pub-id pub-id-type=\"pmid\">22479182</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R85\">\\n        <label>85</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Banning</surname>\\n              <given-names>C</given-names>\\n            </name>\\n            <name>\\n              <surname>Votteler</surname>\\n              <given-names>J</given-names>\\n            </name>\\n            <name>\\n              <surname>Hoffmann</surname>\\n              <given-names>D</given-names>\\n            </name>\\n            <name>\\n              <surname>Koppensteiner</surname>\\n              <given-names>H</given-names>\\n            </name>\\n            <name>\\n              <surname>Warmer</surname>\\n              <given-names>M</given-names>\\n            </name>\\n            <name>\\n              <surname>Reimer</surname>\\n              <given-names>R</given-names>\\n            </name>\\n            <name>\\n              <surname>Kirchhoff</surname>\\n              <given-names>F</given-names>\\n            </name>\\n            <name>\\n              <surname>Schubert</surname>\\n              <given-names>U</given-names>\\n            </name>\\n            <name>\\n              <surname>Hauber</surname>\\n              <given-names>J</given-names>\\n            </name>\\n            <name>\\n              <surname>Schindler</surname>\\n              <given-names>M</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>A flow cytometry-based FRET assay to identify and analyse protein-protein interactions in living cells</article-title>\\n          <source>PLoS One</source>\\n          <year>2010</year>\\n          <volume>5</volume>\\n          <fpage>e9344</fpage>\\n          <pub-id pub-id-type=\"pmid\">20179761</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R86\">\\n        <label>86</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Sauter</surname>\\n              <given-names>D</given-names>\\n            </name>\\n            <name>\\n              <surname>Unterweger</surname>\\n              <given-names>D</given-names>\\n            </name>\\n            <name>\\n              <surname>Vogl</surname>\\n              <given-names>M</given-names>\\n            </name>\\n            <name>\\n              <surname>Usmani</surname>\\n              <given-names>SM</given-names>\\n            </name>\\n            <name>\\n              <surname>Heigele</surname>\\n              <given-names>A</given-names>\\n            </name>\\n            <name>\\n              <surname>Kluge</surname>\\n              <given-names>SF</given-names>\\n            </name>\\n            <name>\\n              <surname>Hermkes</surname>\\n              <given-names>E</given-names>\\n            </name>\\n            <name>\\n              <surname>Moll</surname>\\n              <given-names>M</given-names>\\n            </name>\\n            <name>\\n              <surname>Barker</surname>\\n              <given-names>E</given-names>\\n            </name>\\n            <name>\\n              <surname>Peeters</surname>\\n              <given-names>M</given-names>\\n            </name>\\n            <name>\\n              <surname>Learn</surname>\\n              <given-names>GH</given-names>\\n            </name>\\n            <name>\\n              <surname>Bibollet-Ruche</surname>\\n              <given-names>F</given-names>\\n            </name>\\n            <name>\\n              <surname>Fritz</surname>\\n              <given-names>JV</given-names>\\n            </name>\\n            <name>\\n              <surname>Fackler</surname>\\n              <given-names>OT</given-names>\\n            </name>\\n            <name>\\n              <surname>Hahn</surname>\\n              <given-names>BH</given-names>\\n            </name>\\n            <name>\\n              <surname>Kirchhoff</surname>\\n              <given-names>F</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Human Tetherin Exerts Strong Selection Pressure on the HIV-1 Group N Vpu Protein</article-title>\\n          <source>PLoS Pathog</source>\\n          <year>2012</year>\\n          <volume>8</volume>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R87\">\\n        <label>87</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Sauter</surname>\\n              <given-names>D</given-names>\\n            </name>\\n            <name>\\n              <surname>Vogl</surname>\\n              <given-names>M</given-names>\\n            </name>\\n            <name>\\n              <surname>Kirchhoff</surname>\\n              <given-names>F</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Ancient origin of a deletion in human BST2/Tetherin that confers protection against viral zoonoses</article-title>\\n          <source>Human mutation</source>\\n          <year>2011</year>\\n          <volume>32</volume>\\n          <fpage>1243</fpage>\\n          <lpage>1245</lpage>\\n          <pub-id pub-id-type=\"pmid\">21796732</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R88\">\\n        <label>88</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Bour</surname>\\n              <given-names>S</given-names>\\n            </name>\\n            <name>\\n              <surname>Schubert</surname>\\n              <given-names>U</given-names>\\n            </name>\\n            <name>\\n              <surname>Peden</surname>\\n              <given-names>K</given-names>\\n            </name>\\n            <name>\\n              <surname>Strebel</surname>\\n              <given-names>K</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>The envelope glycoprotein of human immunodeficiency virus type 2 enhances viral particle release: a Vpu-like factor?</article-title>\\n          <source>J Virol</source>\\n          <year>1996</year>\\n          <volume>70</volume>\\n          <fpage>820</fpage>\\n          <lpage>829</lpage>\\n          <pub-id pub-id-type=\"pmid\">8551620</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R89\">\\n        <label>89</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Bour</surname>\\n              <given-names>S</given-names>\\n            </name>\\n            <name>\\n              <surname>Strebel</surname>\\n              <given-names>K</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>The human immunodeficiency virus (HIV) type 2 envelope protein is a functional complement to HIV type 1 Vpu that enhances particle release of heterologous retroviruses</article-title>\\n          <source>J Virol</source>\\n          <year>1996</year>\\n          <volume>70</volume>\\n          <fpage>8285</fpage>\\n          <lpage>8300</lpage>\\n          <pub-id pub-id-type=\"pmid\">8970948</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R90\">\\n        <label>90</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Noble</surname>\\n              <given-names>B</given-names>\\n            </name>\\n            <name>\\n              <surname>Abada</surname>\\n              <given-names>P</given-names>\\n            </name>\\n            <name>\\n              <surname>Nunez-Iglesias</surname>\\n              <given-names>J</given-names>\\n            </name>\\n            <name>\\n              <surname>Cannon</surname>\\n              <given-names>PM</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Recruitment of the adaptor protein 2 complex by the human immunodeficiency virus type 2 envelope protein is necessary for high levels of virus release</article-title>\\n          <source>J Virol</source>\\n          <year>2006</year>\\n          <volume>80</volume>\\n          <fpage>2924</fpage>\\n          <lpage>2932</lpage>\\n          <pub-id pub-id-type=\"pmid\">16501101</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R91\">\\n        <label>91</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Schubert</surname>\\n              <given-names>U</given-names>\\n            </name>\\n            <name>\\n              <surname>Bour</surname>\\n              <given-names>S</given-names>\\n            </name>\\n            <name>\\n              <surname>Willey</surname>\\n              <given-names>RL</given-names>\\n            </name>\\n            <name>\\n              <surname>Strebel</surname>\\n              <given-names>K</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Regulation of virus release by the macrophage-tropic human immunodeficiency virus type 1 AD8 isolate is redundant and can be controlled by either Vpu or Env</article-title>\\n          <source>J Virol</source>\\n          <year>1999</year>\\n          <volume>73</volume>\\n          <fpage>887</fpage>\\n          <lpage>896</lpage>\\n          <pub-id pub-id-type=\"pmid\">9882289</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R92\">\\n        <label>92</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Nikovics</surname>\\n              <given-names>K</given-names>\\n            </name>\\n            <name>\\n              <surname>Dazza</surname>\\n              <given-names>M-C</given-names>\\n            </name>\\n            <name>\\n              <surname>Ekwalanga</surname>\\n              <given-names>M</given-names>\\n            </name>\\n            <name>\\n              <surname>Mammano</surname>\\n              <given-names>F</given-names>\\n            </name>\\n            <name>\\n              <surname>Clavel</surname>\\n              <given-names>F</given-names>\\n            </name>\\n            <name>\\n              <surname>Saragosti</surname>\\n              <given-names>S</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Counteraction of tetherin antiviral activity by two closely related SIVs differing by the presence of a Vpu gene</article-title>\\n          <source>PLoS One</source>\\n          <year>2012</year>\\n          <volume>7</volume>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R93\">\\n        <label>93</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Casartelli</surname>\\n              <given-names>N</given-names>\\n            </name>\\n            <name>\\n              <surname>Sourisseau</surname>\\n              <given-names>M</given-names>\\n            </name>\\n            <name>\\n              <surname>Feldmann</surname>\\n              <given-names>J</given-names>\\n            </name>\\n            <name>\\n              <surname>Guivel-Benhassine</surname>\\n              <given-names>F</given-names>\\n            </name>\\n            <name>\\n              <surname>Mallet</surname>\\n              <given-names>A</given-names>\\n            </name>\\n            <name>\\n              <surname>Marcelin</surname>\\n              <given-names>AG</given-names>\\n            </name>\\n            <name>\\n              <surname>Guatelli</surname>\\n              <given-names>J</given-names>\\n            </name>\\n            <name>\\n              <surname>Schwartz</surname>\\n              <given-names>O</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Tetherin restricts productive HIV-1 cell-to-cell transmission</article-title>\\n          <source>PLoS Pathog</source>\\n          <year>2010</year>\\n          <volume>6</volume>\\n          <fpage>e1000955</fpage>\\n          <pub-id pub-id-type=\"pmid\">20585562</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R94\">\\n        <label>94</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Liberatore</surname>\\n              <given-names>RA</given-names>\\n            </name>\\n            <name>\\n              <surname>Bieniasz</surname>\\n              <given-names>PD</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Tetherin is a key effector of the antiretroviral activity of type I interferon in vitro and in vivo</article-title>\\n          <source>Proc Natl Acad Sci U S A</source>\\n          <year>2011</year>\\n          <volume>108</volume>\\n          <fpage>18097</fpage>\\n          <lpage>18101</lpage>\\n          <pub-id pub-id-type=\"pmid\">22025715</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R95\">\\n        <label>95</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Cohen</surname>\\n              <given-names>EA</given-names>\\n            </name>\\n            <name>\\n              <surname>Terwilliger</surname>\\n              <given-names>EF</given-names>\\n            </name>\\n            <name>\\n              <surname>Sodroski</surname>\\n              <given-names>JG</given-names>\\n            </name>\\n            <name>\\n              <surname>Haseltine</surname>\\n              <given-names>WA</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Identification of a protein encoded by the vpu gene of HIV-1</article-title>\\n          <source>Nature</source>\\n          <year>1988</year>\\n          <volume>334</volume>\\n          <fpage>532</fpage>\\n          <lpage>534</lpage>\\n          <pub-id pub-id-type=\"pmid\">3043230</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R96\">\\n        <label>96</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Theodore</surname>\\n              <given-names>TS</given-names>\\n            </name>\\n            <name>\\n              <surname>Englund</surname>\\n              <given-names>G</given-names>\\n            </name>\\n            <name>\\n              <surname>Buckler-White</surname>\\n              <given-names>A</given-names>\\n            </name>\\n            <name>\\n              <surname>Buckler</surname>\\n              <given-names>CE</given-names>\\n            </name>\\n            <name>\\n              <surname>Martin</surname>\\n              <given-names>MA</given-names>\\n            </name>\\n            <name>\\n              <surname>Peden</surname>\\n              <given-names>KW</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Construction and characterization of a stable full-length macrophage-tropic HIV type 1 molecular clone that directs the production of high titers of progeny virions</article-title>\\n          <source>AIDS Res Hum Retroviruses</source>\\n          <year>1996</year>\\n          <volume>12</volume>\\n          <fpage>191</fpage>\\n          <lpage>194</lpage>\\n          <pub-id pub-id-type=\"pmid\">8835195</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R97\">\\n        <label>97</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Maldarelli</surname>\\n              <given-names>F</given-names>\\n            </name>\\n            <name>\\n              <surname>Chen</surname>\\n              <given-names>MY</given-names>\\n            </name>\\n            <name>\\n              <surname>Willey</surname>\\n              <given-names>RL</given-names>\\n            </name>\\n            <name>\\n              <surname>Strebel</surname>\\n              <given-names>K</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Human immunodeficiency virus type 1 Vpu protein is an oligomeric type I integral membrane protein</article-title>\\n          <source>J Virol</source>\\n          <year>1993</year>\\n          <volume>67</volume>\\n          <fpage>5056</fpage>\\n          <lpage>5061</lpage>\\n          <pub-id pub-id-type=\"pmid\">8331740</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R98\">\\n        <label>98</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Marassi</surname>\\n              <given-names>FM</given-names>\\n            </name>\\n            <name>\\n              <surname>Ma</surname>\\n              <given-names>C</given-names>\\n            </name>\\n            <name>\\n              <surname>Gratkowski</surname>\\n              <given-names>H</given-names>\\n            </name>\\n            <name>\\n              <surname>Straus</surname>\\n              <given-names>SK</given-names>\\n            </name>\\n            <name>\\n              <surname>Strebel</surname>\\n              <given-names>K</given-names>\\n            </name>\\n            <name>\\n              <surname>Oblatt-Montal</surname>\\n              <given-names>M</given-names>\\n            </name>\\n            <name>\\n              <surname>Montal</surname>\\n              <given-names>M</given-names>\\n            </name>\\n            <name>\\n              <surname>Opella</surname>\\n              <given-names>SJ</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Correlation of the structural and functional domains in the membrane protein Vpu from HIV-1</article-title>\\n          <source>Proc Natl Acad Sci U S A</source>\\n          <year>1999</year>\\n          <volume>96</volume>\\n          <fpage>14336</fpage>\\n          <lpage>14341</lpage>\\n          <pub-id pub-id-type=\"pmid\">10588706</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R99\">\\n        <label>99</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Mehnert</surname>\\n              <given-names>T</given-names>\\n            </name>\\n            <name>\\n              <surname>Lam</surname>\\n              <given-names>YH</given-names>\\n            </name>\\n            <name>\\n              <surname>Judge</surname>\\n              <given-names>PJ</given-names>\\n            </name>\\n            <name>\\n              <surname>Routh</surname>\\n              <given-names>A</given-names>\\n            </name>\\n            <name>\\n              <surname>Fischer</surname>\\n              <given-names>D</given-names>\\n            </name>\\n            <name>\\n              <surname>Watts</surname>\\n              <given-names>A</given-names>\\n            </name>\\n            <name>\\n              <surname>Fischer</surname>\\n              <given-names>WB</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Towards a mechanism of function of the viral ion channel Vpu from HIV-1</article-title>\\n          <source>J Biomol Struct Dyn</source>\\n          <year>2007</year>\\n          <volume>24</volume>\\n          <fpage>589</fpage>\\n          <lpage>596</lpage>\\n          <pub-id pub-id-type=\"pmid\">17508781</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R100\">\\n        <label>100</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Hsu</surname>\\n              <given-names>K</given-names>\\n            </name>\\n            <name>\\n              <surname>Han</surname>\\n              <given-names>J</given-names>\\n            </name>\\n            <name>\\n              <surname>Shinlapawittayatorn</surname>\\n              <given-names>K</given-names>\\n            </name>\\n            <name>\\n              <surname>Deschenes</surname>\\n              <given-names>I</given-names>\\n            </name>\\n            <name>\\n              <surname>Marban</surname>\\n              <given-names>E</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Membrane potential depolarization as a triggering mechanism for Vpu-mediated HIV-1 release</article-title>\\n          <source>Biophys J</source>\\n          <year>2010</year>\\n          <volume>99</volume>\\n          <fpage>1718</fpage>\\n          <lpage>1725</lpage>\\n          <pub-id pub-id-type=\"pmid\">20858415</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R101\">\\n        <label>101</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Herrero</surname>\\n              <given-names>L</given-names>\\n            </name>\\n            <name>\\n              <surname>Monroy</surname>\\n              <given-names>N</given-names>\\n            </name>\\n            <name>\\n              <surname>Gonzalez</surname>\\n              <given-names>ME</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>HIV-1 Vpu protein mediates the transport of potassium in Saccharomyces cerevisiae</article-title>\\n          <source>Biochemistry</source>\\n          <year>2013</year>\\n          <volume>52</volume>\\n          <fpage>171</fpage>\\n          <lpage>177</lpage>\\n          <pub-id pub-id-type=\"pmid\">23240720</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R102\">\\n        <label>102</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Hout</surname>\\n              <given-names>DR</given-names>\\n            </name>\\n            <name>\\n              <surname>Gomez</surname>\\n              <given-names>ML</given-names>\\n            </name>\\n            <name>\\n              <surname>Pacyniak</surname>\\n              <given-names>E</given-names>\\n            </name>\\n            <name>\\n              <surname>Gomez</surname>\\n              <given-names>LM</given-names>\\n            </name>\\n            <name>\\n              <surname>Inbody</surname>\\n              <given-names>SH</given-names>\\n            </name>\\n            <name>\\n              <surname>Mulcahy</surname>\\n              <given-names>ER</given-names>\\n            </name>\\n            <name>\\n              <surname>Culley</surname>\\n              <given-names>N</given-names>\\n            </name>\\n            <name>\\n              <surname>Pinson</surname>\\n              <given-names>DM</given-names>\\n            </name>\\n            <name>\\n              <surname>Powers</surname>\\n              <given-names>MF</given-names>\\n            </name>\\n            <name>\\n              <surname>Wong</surname>\\n              <given-names>SW</given-names>\\n            </name>\\n            <name>\\n              <surname>Stephens</surname>\\n              <given-names>EB</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Scrambling of the amino acids within the transmembrane domain of Vpu results in a simian-human immunodeficiency virus (SHIV(TM)) that is less pathogenic for pig-tailed macaques</article-title>\\n          <source>Virology</source>\\n          <year>2005</year>\\n          <volume>339</volume>\\n          <fpage>56</fpage>\\n          <lpage>69</lpage>\\n          <pub-id pub-id-type=\"pmid\">15975620</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R103\">\\n        <label>103</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Bolduan</surname>\\n              <given-names>S</given-names>\\n            </name>\\n            <name>\\n              <surname>Votteler</surname>\\n              <given-names>J</given-names>\\n            </name>\\n            <name>\\n              <surname>Lodermeyer</surname>\\n              <given-names>V</given-names>\\n            </name>\\n            <name>\\n              <surname>Greiner</surname>\\n              <given-names>T</given-names>\\n            </name>\\n            <name>\\n              <surname>Koppensteiner</surname>\\n              <given-names>H</given-names>\\n            </name>\\n            <name>\\n              <surname>Schindler</surname>\\n              <given-names>M</given-names>\\n            </name>\\n            <name>\\n              <surname>Thiel</surname>\\n              <given-names>G</given-names>\\n            </name>\\n            <name>\\n              <surname>Schubert</surname>\\n              <given-names>U</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Ion channel activity of HIV-1 Vpu is dispensable for counteraction of CD317</article-title>\\n          <source>Virology</source>\\n          <year>2011</year>\\n          <volume>416</volume>\\n          <fpage>75</fpage>\\n          <lpage>85</lpage>\\n          <pub-id pub-id-type=\"pmid\">21601230</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R104\">\\n        <label>104</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Kuhl</surname>\\n              <given-names>BD</given-names>\\n            </name>\\n            <name>\\n              <surname>Cheng</surname>\\n              <given-names>V</given-names>\\n            </name>\\n            <name>\\n              <surname>Donahue</surname>\\n              <given-names>DA</given-names>\\n            </name>\\n            <name>\\n              <surname>Sloan</surname>\\n              <given-names>RD</given-names>\\n            </name>\\n            <name>\\n              <surname>Liang</surname>\\n              <given-names>C</given-names>\\n            </name>\\n            <name>\\n              <surname>Wilkinson</surname>\\n              <given-names>J</given-names>\\n            </name>\\n            <name>\\n              <surname>Wainberg</surname>\\n              <given-names>MA</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>The HIV-1 Vpu viroporin inhibitor BIT225 does not affect Vpu-mediated tetherin antagonism</article-title>\\n          <source>PLoS One</source>\\n          <year>2011</year>\\n          <volume>6</volume>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R105\">\\n        <label>105</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Mehnert</surname>\\n              <given-names>T</given-names>\\n            </name>\\n            <name>\\n              <surname>Routh</surname>\\n              <given-names>A</given-names>\\n            </name>\\n            <name>\\n              <surname>Judge</surname>\\n              <given-names>PJ</given-names>\\n            </name>\\n            <name>\\n              <surname>Lam</surname>\\n              <given-names>YH</given-names>\\n            </name>\\n            <name>\\n              <surname>Fischer</surname>\\n              <given-names>D</given-names>\\n            </name>\\n            <name>\\n              <surname>Watts</surname>\\n              <given-names>A</given-names>\\n            </name>\\n            <name>\\n              <surname>Fischer</surname>\\n              <given-names>WB</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Biophysical characterization of Vpu from HIV-1 suggests a channel-pore dualism</article-title>\\n          <source>Proteins</source>\\n          <year>2008</year>\\n          <volume>70</volume>\\n          <fpage>1488</fpage>\\n          <lpage>1497</lpage>\\n          <pub-id pub-id-type=\"pmid\">17910056</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R106\">\\n        <label>106</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Hochstrasser</surname>\\n              <given-names>M</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Protein degradation or regulation: Ub the judge</article-title>\\n          <source>Cell</source>\\n          <year>1996</year>\\n          <volume>84</volume>\\n          <fpage>813</fpage>\\n          <lpage>815</lpage>\\n          <pub-id pub-id-type=\"pmid\">8601303</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R107\">\\n        <label>107</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Tokarev</surname>\\n              <given-names>A</given-names>\\n            </name>\\n            <name>\\n              <surname>Suarez</surname>\\n              <given-names>M</given-names>\\n            </name>\\n            <name>\\n              <surname>Kwan</surname>\\n              <given-names>W</given-names>\\n            </name>\\n            <name>\\n              <surname>Fitzpatrick</surname>\\n              <given-names>K</given-names>\\n            </name>\\n            <name>\\n              <surname>Singh</surname>\\n              <given-names>R</given-names>\\n            </name>\\n            <name>\\n              <surname>Guatelli</surname>\\n              <given-names>J</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Stimulation of NF-κB Activity by the HIV Restriction Factor BST2</article-title>\\n          <source>J Virol</source>\\n          <year>2013</year>\\n          <volume>87</volume>\\n          <fpage>2046</fpage>\\n          <lpage>2057</lpage>\\n          <pub-id pub-id-type=\"pmid\">23221546</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R108\">\\n        <label>108</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Galao</surname>\\n              <given-names>RP</given-names>\\n            </name>\\n            <name>\\n              <surname>Le Tortorec</surname>\\n              <given-names>A</given-names>\\n            </name>\\n            <name>\\n              <surname>Pickering</surname>\\n              <given-names>S</given-names>\\n            </name>\\n            <name>\\n              <surname>Kueck</surname>\\n              <given-names>T</given-names>\\n            </name>\\n            <name>\\n              <surname>Neil</surname>\\n              <given-names>SJD</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Innate Sensing of HIV-1 Assembly by Tetherin Induces NFκB-Dependent Proinflammatory Responses</article-title>\\n          <source>Cell Host Microbe</source>\\n          <year>2012</year>\\n          <volume>12</volume>\\n          <fpage>633</fpage>\\n          <lpage>644</lpage>\\n          <pub-id pub-id-type=\"pmid\">23159053</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R109\">\\n        <label>109</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Schubert</surname>\\n              <given-names>U</given-names>\\n            </name>\\n            <name>\\n              <surname>Henklein</surname>\\n              <given-names>P</given-names>\\n            </name>\\n            <name>\\n              <surname>Boldyreff</surname>\\n              <given-names>B</given-names>\\n            </name>\\n            <name>\\n              <surname>Wingender</surname>\\n              <given-names>E</given-names>\\n            </name>\\n            <name>\\n              <surname>Strebel</surname>\\n              <given-names>K</given-names>\\n            </name>\\n            <name>\\n              <surname>Porstmann</surname>\\n              <given-names>T</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>The human immunodeficiency virus type 1 encoded Vpu protein is phosphorylated by casein kinase-2 (CK-2) at positions Ser52 and Ser56 within a predicted alpha-helix-turn-alpha-helix-motif</article-title>\\n          <source>J Mol Biol</source>\\n          <year>1994</year>\\n          <volume>236</volume>\\n          <fpage>16</fpage>\\n          <lpage>25</lpage>\\n          <pub-id pub-id-type=\"pmid\">8107101</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R110\">\\n        <label>110</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Bour</surname>\\n              <given-names>S</given-names>\\n            </name>\\n            <name>\\n              <surname>Perrin</surname>\\n              <given-names>C</given-names>\\n            </name>\\n            <name>\\n              <surname>Akari</surname>\\n              <given-names>H</given-names>\\n            </name>\\n            <name>\\n              <surname>Strebel</surname>\\n              <given-names>K</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>The Human Immunodeficiency Virus Type 1 Vpu Protein Inhibits NF-kappa B Activation by Interfering with beta TrCP-mediated Degradation of Ikappa B</article-title>\\n          <source>J Biol Chem</source>\\n          <year>2001</year>\\n          <volume>276</volume>\\n          <fpage>15920</fpage>\\n          <lpage>15928</lpage>\\n          <pub-id pub-id-type=\"pmid\">11278695</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R111\">\\n        <label>111</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Pahl</surname>\\n              <given-names>HL</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Activators and target genes of Rel/NF-kappaB transcription factors</article-title>\\n          <source>Oncogene</source>\\n          <year>1999</year>\\n          <volume>18</volume>\\n          <fpage>6853</fpage>\\n          <lpage>6866</lpage>\\n          <pub-id pub-id-type=\"pmid\">10602461</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R112\">\\n        <label>112</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Barkett</surname>\\n              <given-names>M</given-names>\\n            </name>\\n            <name>\\n              <surname>Gilmore</surname>\\n              <given-names>TD</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Control of apoptosis by Rel/NF-kappaB transcription factors</article-title>\\n          <source>Oncogene</source>\\n          <year>1999</year>\\n          <volume>18</volume>\\n          <fpage>6910</fpage>\\n          <lpage>6924</lpage>\\n          <pub-id pub-id-type=\"pmid\">10602466</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R113\">\\n        <label>113</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Casella</surname>\\n              <given-names>CR</given-names>\\n            </name>\\n            <name>\\n              <surname>Rapaport</surname>\\n              <given-names>EL</given-names>\\n            </name>\\n            <name>\\n              <surname>Finkel</surname>\\n              <given-names>TH</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Vpu increases susceptibility of human immunodeficiency virus type 1-infected cells to fas killing</article-title>\\n          <source>J Virol</source>\\n          <year>1999</year>\\n          <volume>73</volume>\\n          <fpage>92</fpage>\\n          <lpage>100</lpage>\\n          <pub-id pub-id-type=\"pmid\">9847311</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R114\">\\n        <label>114</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Badley</surname>\\n              <given-names>AD</given-names>\\n            </name>\\n            <name>\\n              <surname>Pilon</surname>\\n              <given-names>AA</given-names>\\n            </name>\\n            <name>\\n              <surname>Landay</surname>\\n              <given-names>A</given-names>\\n            </name>\\n            <name>\\n              <surname>Lynch</surname>\\n              <given-names>DH</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Mechanisms of HIV-associated lymphocyte apoptosis</article-title>\\n          <source>Blood</source>\\n          <year>2000</year>\\n          <volume>96</volume>\\n          <fpage>2951</fpage>\\n          <lpage>2964</lpage>\\n          <pub-id pub-id-type=\"pmid\">11049971</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R115\">\\n        <label>115</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Akari</surname>\\n              <given-names>H</given-names>\\n            </name>\\n            <name>\\n              <surname>Bour</surname>\\n              <given-names>S</given-names>\\n            </name>\\n            <name>\\n              <surname>Kao</surname>\\n              <given-names>S</given-names>\\n            </name>\\n            <name>\\n              <surname>Adachi</surname>\\n              <given-names>A</given-names>\\n            </name>\\n            <name>\\n              <surname>Strebel</surname>\\n              <given-names>K</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>The human immunodeficiency virus type 1 accessory protein Vpu induces apoptosis by suppressing the nuclear factor kappaB-dependent expression of antiapoptotic factors</article-title>\\n          <source>J Exp Med</source>\\n          <year>2001</year>\\n          <volume>194</volume>\\n          <fpage>1299</fpage>\\n          <lpage>1311</lpage>\\n          <pub-id pub-id-type=\"pmid\">11696595</pub-id>\\n        </element-citation>\\n      </ref>\\n    </ref-list>\\n  </back>\\n  <floats-group>\\n    <fig id=\"F1\" orientation=\"portrait\" position=\"float\">\\n      <label>Fig. 1</label>\\n      <caption>\\n        <p id=\"P18\">CD4 degradation and deregulation of the NFkB pathway involve Vpu-β-TrCP interactions. <bold>(A)</bold> Vpu can bind newly synthesized CD4 in the endoplasmic reticulum (ER) through interactions mediated by the cytoplasmic helices as well as the transmembrane (TM) helices. The role of W22 in the Vpu TM helix is discussed in the text (2.1.). Vpu is constitutively phosphorylated at serines 52 &amp; 56. This motif constitutes a binding motif for β-TrCP and leads to the assembly of an E3-Ub ligase complex that results in ubiquitination and proteasomal degradation of CD4. <bold>(B)</bold> NFkB resides in the cytoplasm in an inactive form bound to its inhibitor IkB. Upon receptor stimulation, IkB is phosphorylated and degraded following β-TrCP induced ubiquitination. This releases NFkB, which then traffics to the nucleus and activates gene transcription. Deregulation of the NFkB pathway by Vpu is due to the competitive binding of β-TrCP. Unlike IκB, Vpu is not degraded upon binding to β-TrCP. This leads to a depletion of free β-TrCP in the cell and inhibition of NFkB activation following receptor stimulation.</p>\\n      </caption>\\n      <graphic xlink:href=\"nihms508378f1\"/>\\n    </fig>\\n    <fig id=\"F2\" orientation=\"portrait\" position=\"float\">\\n      <label>Fig. 2</label>\\n      <caption>\\n        <p id=\"P19\">Vpu antagonizes BST-2 by inhibiting the resupply of BST-2 from the ER. (1) Existing BST-2 rapidly cycles between the cell surface and endocytic compartments. During each cycle a fraction of the protein is routed to lysosomes for degradation (2). Steady state levels of surface BST-2 are maintained by resupply of degraded BST-2 from the endoplasmic reticulum (ER; (3)). Vpu interferes with the resupply of surface BST-2 presumably by redirecting BST-2 directly to the endocytic/lysosomal compartment (4).</p>\\n      </caption>\\n      <graphic xlink:href=\"nihms508378f2\"/>\\n    </fig>\\n    <boxed-text id=\"BX1\" position=\"float\" orientation=\"portrait\">\\n      <caption>\\n        <title>Highlights</title>\\n      </caption>\\n      <list list-type=\"simple\" id=\"L1\">\\n        <list-item>\\n          <label>-</label>\\n          <p id=\"P20\">Vpu is a transmembrane protein encoded by HIV-1 and some SIV isolates.</p>\\n        </list-item>\\n        <list-item>\\n          <label>-</label>\\n          <p id=\"P21\">Vpu induces CD4 degradation and inactivates BST-2.</p>\\n        </list-item>\\n        <list-item>\\n          <label>-</label>\\n          <p id=\"P22\">Vpu does not have enzymatic activity but acts as an adaptor molecule.</p>\\n        </list-item>\\n        <list-item>\\n          <label>-</label>\\n          <p id=\"P23\">Vpu also induces apoptosis by deregulating the NFkB pathway.</p>\\n        </list-item>\\n        <list-item>\\n          <label>-</label>\\n          <p id=\"P24\">Vpu forms ion channels but the significance for HIV replication remains unclear</p>\\n        </list-item>\\n      </list>\\n    </boxed-text>\\n  </floats-group>\\n</article>\\n',\n",
       " 'The two-pore domain potassium (K2P) channels TASK-1 (KCNK3) and TASK-3 (KCNK9) are important determinants of background K(+) conductance and membrane potential. TASK-1/3 activity is regulated by hormones and transmitters that act through G protein-coupled receptors (GPCR) signalling via G proteins of the Gαq/11 subclass. How the receptors inhibit channel activity has remained unclear. Here, we show that TASK-1 and -3 channels are gated by diacylglycerol (DAG). Receptor-initiated inhibition of TASK required the activity of phospholipase C, but neither depletion of the PLC substrate PI(4,5)P2 nor release of the downstream messengers IP3 and Ca(2+). Attenuation of cellular DAG transients by DAG kinase or lipase suppressed receptor-dependent inhibition, showing that the increase in cellular DAG-but not in downstream lipid metabolites-mediates channel inhibition. The findings identify DAG as the signal regulating TASK channels downstream of GPCRs and define a novel role for DAG that directly links cellular DAG dynamics to excitability. ',\n",
       " \"Familial and twin studies have suggested that anorexia nervosa (AN) is a multifactorial disorder with a substantial genetic contribution. The hSKCa3 potassium channel gene, which contains polymorphic CAG repeats in the coding region and is involved in the regulation of neuronal activity, may be a candidate gene for AN because alleles with longer repeats have been found to be associated with mental disorders. Forty Israeli AN family trios were genotyped for the hSKCa3 CAG repeat polymorphism using the haplotype relative risk (HRR) method. The distribution of alleles transmitted to the patients was found to be significantly different from that of the non-transmitted parental alleles, with the longer alleles being over-represented in the patients (Wilcoxon rank test, P = 0.008). The transmission disequilibrium test (TDT) revealed that longer (>19) repeat alleles were preferentially transmitted to AN patients (McNemar's chi(2) = 10.31, P = 0.0013). These results were corroborated by comparing the distribution of alleles between patients and healthy controls (Mann-Whitney test, P = 0.005). Our study suggests that the longer repeat alleles of the hSKCa3 gene may contribute to the genetic susceptibility to AN.\",\n",
       " 'TASK-1 and TASK-3, members of the two-pore-domain channel family, are widely expressed leak potassium channels responsible for maintenance of cell membrane potential and input resistance. They are sites of action for a variety of modulatory agents, including volatile anesthetics and neurotransmitters/hormones, the latter acting via mechanisms that have remained elusive. To clarify these mechanisms, we generated mutant channels and found that alterations disrupting anesthetic (halothane) activation of these channels also disrupted transmitter (thyrotropin-releasing hormone, TRH) inhibition and did so to a similar degree. For both TASK-1 and TASK-3, mutations (substitutions with corresponding residues from TREK-1) in a six-residue sequence at the beginning of the cytoplasmic C terminus virtually abolished both anesthetic activation and transmitter inhibition. The only sequence motif identified with a classical signaling mechanism in this region is a potential phosphorylation site; however, mutation of this site failed to disrupt modulation. TASK-1 and TASK-3 differed insofar as a large portion of the C terminus was necessary for the full effects of halothane and TRH on TASK-3 but not on TASK-1. Finally, tandem-linked TASK-1/TASK-3 heterodimeric channels were fully modulated by anesthetic and transmitter, and introduction of the identified mutations either into the TASK-1 or the TASK-3 portion of the channel was sufficient to disrupt both effects. Thus, both anesthetic activation and transmitter inhibition of these channels require a region at the interface between the final transmembrane domain and the cytoplasmic C terminus that has not been associated previously with receptor signal transduction. Our results also indicate a close molecular relationship between these two forms of modulation, one endogenous and the other clinically applied.',\n",
       " 'Two major K(+) channels are expressed in T cells, (i) the voltage-dependent K(V)1.3 channel and (ii) the Ca(2+)-activated K(+) channel KCa 3.1 (IKCa channel). Both critically influence T cell effector functions in vitro and animal models in vivo. Here we identify and characterize TWIK-related acid-sensitive potassium channel 1 (TASK1) and TASK3 as an important third K(+) conductance on T lymphocytes. T lymphocytes constitutively express TASK1 and -3 protein. Application of semi-selective TASK blockers resulted in a significant reduction of cytokine production and cell proliferation. Interference with TASK channels on CD3(+) T cells revealed a dose-dependent reduction ( approximately 40%) of an outward current in patch clamp recordings indicative of TASK channels, a finding confirmed by computational modeling. In vivo relevance of our findings was addressed in an experimental model of multiple sclerosis, adoptive transfer experimental autoimmune encephalomyelitis. Pretreatment of myelin basic protein-specific encephalitogenic T lymphocytes with TASK modulators was associated with significant amelioration of the disease course in Lewis rats. These data introduce K(2)P channels as novel potassium conductance on T lymphocytes critically influencing T cell effector function and identify a possible molecular target for immunomodulation in T cell-mediated autoimmune disorders.',\n",
       " '<!DOCTYPE article PUBLIC \"-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN\" \"JATS-archivearticle1.dtd\">\\n<article xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" article-type=\"research-article\"><?properties open_access?><front><journal-meta><journal-id journal-id-type=\"nlm-ta\">J Biol Chem</journal-id><journal-id journal-id-type=\"hwp\">jbc</journal-id><journal-id journal-id-type=\"pmc\">jbc</journal-id><journal-id journal-id-type=\"publisher-id\">JBC</journal-id><journal-title-group><journal-title>The Journal of Biological Chemistry</journal-title></journal-title-group><issn pub-type=\"ppub\">0021-9258</issn><issn pub-type=\"epub\">1083-351X</issn><publisher><publisher-name>American Society for Biochemistry and Molecular Biology</publisher-name><publisher-loc>9650 Rockville Pike, Bethesda, MD 20814, U.S.A.</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type=\"pmid\">21362619</article-id><article-id pub-id-type=\"pmc\">3077598</article-id><article-id pub-id-type=\"publisher-id\">M111.227884</article-id><article-id pub-id-type=\"doi\">10.1074/jbc.M111.227884</article-id><article-categories><subj-group subj-group-type=\"heading\"><subject>Protein Structure and Folding</subject></subj-group></article-categories><title-group><article-title>A Specific Two-pore Domain Potassium Channel Blocker Defines the Structure of the TASK-1 Open Pore<xref ref-type=\"fn\" rid=\"FN1\">*</xref><xref ref-type=\"fn\" rid=\"FN2\"><sup><inline-graphic xlink:href=\"sbox.jpg\"/></sup></xref></article-title><alt-title alt-title-type=\"short\">Structure of the TASK-1 Open Pore</alt-title></title-group><contrib-group><contrib contrib-type=\"author\"><name><surname>Streit</surname><given-names>Anne K.</given-names></name><xref ref-type=\"aff\" rid=\"aff1\"><sup>&#x02021;</sup></xref><xref ref-type=\"author-notes\" rid=\"FN3\"><sup>1</sup></xref></contrib><contrib contrib-type=\"author\"><name><surname>Netter</surname><given-names>Michael F.</given-names></name><xref ref-type=\"aff\" rid=\"aff1\"><sup>&#x02021;</sup></xref><xref ref-type=\"author-notes\" rid=\"FN3\"><sup>1</sup></xref></contrib><contrib contrib-type=\"author\"><name><surname>Kempf</surname><given-names>Franca</given-names></name><xref ref-type=\"aff\" rid=\"aff1\"><sup>&#x02021;</sup></xref><xref ref-type=\"author-notes\" rid=\"FN3\"><sup>1</sup></xref></contrib><contrib contrib-type=\"author\"><name><surname>Walecki</surname><given-names>Magdalena</given-names></name><xref ref-type=\"aff\" rid=\"aff1\"><sup>&#x02021;</sup></xref></contrib><contrib contrib-type=\"author\"><name><surname>Rinn&#x000e9;</surname><given-names>Susanne</given-names></name><xref ref-type=\"aff\" rid=\"aff1\"><sup>&#x02021;</sup></xref></contrib><contrib contrib-type=\"author\"><name><surname>Bollepalli</surname><given-names>Murali K.</given-names></name><xref ref-type=\"aff\" rid=\"aff2\"><sup>&#x000a7;</sup></xref></contrib><contrib contrib-type=\"author\"><name><surname>Preisig-M&#x000fc;ller</surname><given-names>Regina</given-names></name><xref ref-type=\"aff\" rid=\"aff3\"><sup>&#x000b6;</sup></xref></contrib><contrib contrib-type=\"author\"><name><surname>Renigunta</surname><given-names>Vijay</given-names></name><xref ref-type=\"aff\" rid=\"aff3\"><sup>&#x000b6;</sup></xref></contrib><contrib contrib-type=\"author\"><name><surname>Daut</surname><given-names>J&#x000fc;rgen</given-names></name><xref ref-type=\"aff\" rid=\"aff3\"><sup>&#x000b6;</sup></xref></contrib><contrib contrib-type=\"author\"><name><surname>Baukrowitz</surname><given-names>Thomas</given-names></name><xref ref-type=\"aff\" rid=\"aff4\"><sup>&#x02016;</sup></xref></contrib><contrib contrib-type=\"author\"><name><surname>Sansom</surname><given-names>Mark S. P.</given-names></name><xref ref-type=\"aff\" rid=\"aff5\">**</xref><xref ref-type=\"author-notes\" rid=\"FN4\"><sup>2</sup></xref></contrib><contrib contrib-type=\"author\"><name><surname>Stansfeld</surname><given-names>Phillip J.</given-names></name><xref ref-type=\"aff\" rid=\"aff5\">**</xref><xref ref-type=\"author-notes\" rid=\"FN4\"><sup>2</sup></xref></contrib><contrib contrib-type=\"author\"><name><surname>Decher</surname><given-names>Niels</given-names></name><xref ref-type=\"aff\" rid=\"aff1\"><sup>&#x02021;</sup></xref><xref ref-type=\"corresp\" rid=\"cor1\"><sup>3</sup></xref></contrib><aff id=\"aff1\">From the <label>&#x02021;</label>Institute for Physiology and Pathophysiology, Vegetative Physiology Group, University of Marburg, 35037 Marburg, Germany, </aff><aff id=\"aff2\">the <label>&#x000a7;</label>Institute for Physiology II, University of Jena, 07743 Jena, Germany, </aff><aff id=\"aff3\">the <label>&#x000b6;</label>Institute for Physiology and Pathophysiology, Cardiovascular Cell Physiology Group, University of Marburg, 35037 Marburg, Germany, </aff><aff id=\"aff4\">the <label>&#x02016;</label>Physiological Institute, University of Kiel, 24118 Kiel, Germany, and </aff><aff id=\"aff5\">the <label>**</label>Structural Bioinformatics and Computational Biochemistry Unit, Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, United Kingdom</aff></contrib-group><author-notes><corresp id=\"cor1\"><label>3</label> To whom correspondence should be addressed: <addr-line>Deutschhausstrasse 1-2, 35037 Marburg, Germany.</addr-line> Fax: <fax>49-6421-28-66659</fax>; E-mail: <email>decher@staff.uni-marburg.de</email>.</corresp><fn fn-type=\"equal\" id=\"FN3\"><label>1</label><p>These authors contributed equally to this work.</p></fn><fn fn-type=\"supported-by\" id=\"FN4\"><label>2</label><p>Supported by the Wellcome Trust.</p></fn></author-notes><pub-date pub-type=\"ppub\"><day>22</day><month>4</month><year>2011</year></pub-date><pub-date pub-type=\"epub\"><day>1</day><month>3</month><year>2011</year></pub-date><pub-date pub-type=\"pmc-release\"><day>1</day><month>3</month><year>2011</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the\\n\\t\\t\\t\\t\\t\\t\\t<pub-date pub-type=\"epub\"/>. --><volume>286</volume><issue>16</issue><fpage>13977</fpage><lpage>13984</lpage><history><date date-type=\"received\"><day>3</day><month>2</month><year>2011</year></date><date date-type=\"rev-recd\"><day>28</day><month>2</month><year>2011</year></date></history><permissions><copyright-statement>&#x000a9; 2011 by The American Society for Biochemistry and Molecular Biology, Inc.</copyright-statement><license license-type=\"open-access\"><license-p><italic>Author\\'s Choice</italic>&#x02014;Final version full access.</license-p><license-p><ext-link ext-link-type=\"uri\" xlink:href=\"http://creativecommons.org/licenses/by-nc/3.0/\">Creative Commons Attribution Non-Commercial License</ext-link> applies to Author Choice Articles</license-p></license></permissions><self-uri xlink:title=\"pdf\" xlink:type=\"simple\" xlink:href=\"zbc01611013977.pdf\"/><abstract><p>Two-pore domain potassium (K<sub>2P</sub>) channels play a key role in setting the membrane potential of excitable cells. Despite their role as putative targets for drugs and general anesthetics, little is known about the structure and the drug binding site of K<sub>2P</sub> channels. We describe A1899 as a potent and highly selective blocker of the K<sub>2P</sub> channel TASK-1. As A1899 acts as an open-channel blocker and binds to residues forming the wall of the central cavity, the drug was used to further our understanding of the channel pore. Using alanine mutagenesis screens, we have identified residues in both pore loops, the M2 and M4 segments, and the halothane response element to form the drug binding site of TASK-1. Our experimental data were used to validate a K<sub>2P</sub> open-pore homology model of TASK-1, providing structural insights for future rational design of drugs targeting K<sub>2P</sub> channels.</p></abstract><kwd-group><kwd>Drug Design</kwd><kwd>Ion Channels</kwd><kwd>Molecular Dynamics</kwd><kwd>Potassium Channels</kwd><kwd>Protein Conformation</kwd><kwd>ion Channel Blocker</kwd></kwd-group></article-meta></front><body><sec sec-type=\"intro\"><title>Introduction</title><p>The acid-sensitive K<sub>2P</sub><xref ref-type=\"fn\" rid=\"FN5\"><sup>4</sup></xref> channel TASK-1 (<underline>T</underline>WIK-related <underline>a</underline>cid-<underline>s</underline>ensitive <underline>K</underline><sup>+</sup>) gives rise to instantaneous and non-inactivating potassium currents, which can be blocked by extracellular acidification (<xref ref-type=\"bibr\" rid=\"B1\">1</xref>). Five TASK channel family members have been described. The closest relatives of the TASK-1 channel are TASK-3 and TASK-5 (<xref ref-type=\"bibr\" rid=\"B2\">2</xref>, <xref ref-type=\"bibr\" rid=\"B3\">3</xref>). The TASK-4 and TASK-2 channels show less homology and are functionally different as they are primarily blocked by protons in the physiological pH range (<xref ref-type=\"bibr\" rid=\"B4\">4</xref>, <xref ref-type=\"bibr\" rid=\"B5\">5</xref>). Previous studies revealed that TASK channels are key regulators for many physiological processes in cells of the cardiovascular system (<xref ref-type=\"bibr\" rid=\"B6\">6</xref>), the central nervous system (<xref ref-type=\"bibr\" rid=\"B7\">7</xref>), and the adrenal gland (<xref ref-type=\"bibr\" rid=\"B8\">8</xref>). In addition, they are also involved in peripheral chemosensation (<xref ref-type=\"bibr\" rid=\"B9\">9</xref>) and the regulation of the immune system (<xref ref-type=\"bibr\" rid=\"B10\">10</xref>). TASK channels are the molecular targets of volatile and local anesthetics (<xref ref-type=\"bibr\" rid=\"B11\">11</xref>, <xref ref-type=\"bibr\" rid=\"B12\">12</xref>). Although studies of TASK channel knock-out mice have advanced our knowledge about the physiological function of these channels, a selective TASK channel blocker would be very valuable to perform future <italic>in vivo</italic> experiments. In the present study, we describe a highly potent blocker of the TASK-1 channel, A1899, active in the one-digit nanomolar range. As suggested by the high affinity, we found that A1899 is selective for TASK-1 channels. Although anandamide has been reported as a physiological blocker of TASK-1 channels (<xref ref-type=\"bibr\" rid=\"B13\">13</xref>), this lipid does not combine the high affinity and specificity as A1899.</p><p>K<sub>2P</sub> channels have a transmembrane topology that is unique among potassium channels. One subunit contains four transmembrane domains and two pore-forming domains. The functional channel is formed by a dimer. Although other potassium channels are tetramers with a pore formed by four identical transmembrane domains, the domains and symmetry of the K<sub>2P</sub> channel pore have long been a matter of speculation. The different topology of K<sub>2P</sub> channels does not allow a direct transfer of data from the crystal structures of other potassium channels without experimental proof of validity. The pore-forming domains and the rotation of these domains can be validated by an open-channel pore blocker as the amino acids of the binding site should face the water-filled pore cavity. We have identified the binding site of A1899 in the open pore of TASK-1 channels. In good agreement with recently published data (<xref ref-type=\"bibr\" rid=\"B14\">14</xref>), our results suggest that the M2 and M4 segments of two TASK subunits form the walls of the inner pore. Using A1899, we have confirmed the orientation of the M2 and M4 segments and provide a model of the mammalian K<sub>2P</sub> channel TASK-1 in the open state.</p></sec><sec sec-type=\"methods\"><title>EXPERIMENTAL PROCEDURES</title><sec><title/><sec><title/><sec><title>Site-directed Mutagenesis</title><p>Mutations in the human TASK-1 (<italic>KCNK3</italic>, NM_002246) cDNA were introduced with the QuikChange site-directed mutagenesis kit (Stratagene) according to the instructions of the manufacturer.</p></sec><sec><title>Oocyte Preparation, cRNA Synthesis, and cRNA Injection</title><p>Oocytes were obtained from anesthetized <italic>Xenopus laevis</italic> frogs and incubated in OR2 solution containing in m<sc>m</sc>: 82.5 NaCl, 2 KCl, 1 MgCl<sub>2</sub>, 5 HEPES (pH 7.5) substituted with 2 mg/ml collagenase II (Sigma) to remove residual connective tissue. Subsequently, oocytes were stored at 18 &#x000b0;C in ND96 solution supplemented with 50 mg/liter gentamycin, 274 mg/liter sodium pyruvate, and 88 mg/liter theophylline. Human TASK-1 channels were subcloned into a pSGEM or pBF1 vector, and cDNA was linearized with NheI or MluI, respectively. cRNA was synthesized with mMESSAGE mMACHINE kit (Ambion). The quality of cRNA was tested using gel electrophoresis. Oocytes were each injected with 50 nl of cRNA.</p></sec><sec><title>Two-electrode Voltage Clamp Recordings</title><p>All two-electrode voltage clamp recordings were performed at room temperature (20&#x02013;22 &#x000b0;C) with a TurboTEC 10CD (npi) amplifier and a Digidata 1200 Series (Axon Instruments) as analog/digital converter. Micropipettes were made from borosilicate glass capillaries GB 150TF-8P (Science Products) and pulled with a DMZ-Universal Puller (Zeitz). Recording pipettes had a resistance of 0.5&#x02013;1.5 megaohms and were filled with 3 <sc>m</sc> KCl solution. Recording solution ND96 contained in m<sc>m</sc>: 96 NaCl, 2 KCl, 1.8 CaCl<sub>2</sub>, 1 MgCl<sub>2</sub>, 5 HEPES (pH 7.5). Block was analyzed with voltage steps from a holding potential of &#x02212;80 mV. A first test pulse to 0 mV of 1-s duration was followed by a repolarizing step to &#x02212;80 mV for 1 s directly followed by another 1-s test pulse to +40 mV. The sweep time interval was 10 s. For recordings with symmetrical potassium concentrations, the ND96 solution was modified; NaCl was reduced to 2 m<sc>m</sc>, and KCl concentration was increased to 96 m<sc>m</sc>. Data were acquired with Clampex 10 (Molecular Devices) and analyzed with Clampfit 10 (Molecular Devices) and Origin 7 (OriginLab Corp.).</p></sec><sec><title>Molecular Modeling</title><p>Based on the crystal structures of KcsA and KvAP (PDB IDs <ext-link ext-link-type=\"pdb\" xlink:href=\"1K4C\">1K4C</ext-link> and <ext-link ext-link-type=\"pdb\" xlink:href=\"1ORQ\">1ORQ</ext-link>, respectively), homology models of TASK-1 were created using the Modeler 7 version 7 software. For ligand docking predictions, GOLD (version 4.0), AutoDock, and AutoDockTools were used to propose binding conformations for A1899 within the central cavity of TASK-1. Molecular dynamics (MD) simulations were performed with the Gromacs software. Detailed information on molecular modeling is provided in the <ext-link ext-link-type=\"uri\" xlink:href=\"http://www.jbc.org/cgi/content/full/M111.227884/DC1\">supplemental Experimental Procedures</ext-link>, which includes details about the homology modeling, ligand docking experiments, and MD simulations.</p></sec><sec><title>Statistical Analyses</title><p>All values are expressed as means &#x000b1; S.E. For all oocyte and CHO electrophysiological experiments, 3&#x02013;12 cells were studied (<italic>n</italic> = 3&#x02013;12). Error bars in <xref ref-type=\"fig\" rid=\"F1\">Figs. 1</xref> and <xref ref-type=\"fig\" rid=\"F3\">3</xref><xref ref-type=\"fig\" rid=\"F4\"/>&#x02013;<xref ref-type=\"fig\" rid=\"F5\">5</xref> represent S.E. values. Significance was assessed using two-tailed Student\\'s <italic>t</italic> test. Asterisks indicate significance: *, <italic>p</italic> &#x0003c; 0.05; **, <italic>p</italic> &#x0003c; 0.01; ***, <italic>p</italic> &#x0003c; 0.001.</p></sec></sec></sec></sec><sec sec-type=\"results\"><title>RESULTS</title><sec><title/><sec><title/><sec><title>A1899 Is a Selective Blocker of TASK-1 Channels</title><p>We have tested the affinity of A1899 for TASK-1 channels expressed in <italic>Xenopus</italic> oocytes. Application of 40 n<sc>m</sc> A1899 led to a pronounced inhibition of TASK-1 currents (<xref ref-type=\"fig\" rid=\"F1\">Fig. 1</xref><italic>A</italic>). In oocytes, TASK-1 channels were blocked with an IC<sub>50</sub> of 35.1 &#x000b1; 3.8 n<sc>m</sc>, analyzed at +40 mV (<xref ref-type=\"fig\" rid=\"F1\">Fig. 1</xref><italic>B</italic>). The IC<sub>50</sub> of A1899 for TASK-1 channels expressed in CHO cells was only 7 n<sc>m</sc> (<xref ref-type=\"table\" rid=\"T1\">Table 1</xref>), which is consistent with the notion that IC<sub>50</sub> values determined in oocytes are mostly higher than those determined in mammalian cells. The IC<sub>50</sub> for TASK-3 expressed in CHO cells was 70 n<sc>m</sc> (<xref ref-type=\"table\" rid=\"T1\">Table 1</xref>). Thus, TASK-3, the closest relative of TASK-1, binds A1899 with a 10-fold lower affinity. To further probe the selectivity of A1899, we expressed a set of different potassium channels in <italic>Xenopus</italic> oocytes and quantified the extent of current inhibition by 100 n<sc>m</sc> A1899 (<xref ref-type=\"fig\" rid=\"F1\">Fig. 1</xref><italic>C</italic>). Under these conditions, TASK-1 currents were blocked by 74.2 &#x000b1; 3.4%. In contrast, the closest relative, TASK-3, was only blocked by 22.2 &#x000b1; 1.6%. All the other channels tested showed only little (&#x0003c;11%) or no block (<xref ref-type=\"fig\" rid=\"F1\">Fig. 1</xref><italic>C</italic>). The IC<sub>50</sub> values determined for several potassium channels (<xref ref-type=\"table\" rid=\"T1\">Table 1</xref>) indicate that A1899 is a specific TASK-1 blocker.</p><fig id=\"F1\" position=\"float\"><label>FIGURE 1.</label><caption><p><bold>A1899 selectively blocks human TASK-1 channels expressed in <italic>Xenopus</italic> oocytes.</bold> <italic>A</italic>, human TASK-1 channels recorded with a voltage step protocol (200-ms steps from &#x02212;70 mV to +70 mV with an increment of 10 mV; holding potential, &#x02212;80 mV) before (<italic>left</italic>) and after (<italic>right</italic>) application of 40 n<sc>m</sc> A1899 (see <italic>inset</italic> for chemical structure of A1899). <italic>B</italic>, dose-response curve of A1899 on human TASK-1. Block was analyzed at the end of the test pulse to +40 mV. <italic>C</italic>, test for sensitivity of different potassium channels to 100 n<sc>m</sc> A1899 after heterologous expression in <italic>Xenopus</italic> oocytes. <italic>D</italic>, I-V relationships for TASK-1 in bath solution with high potassium concentration before (&#x025a1;) and after (&#x025a0;) application of 400 n<sc>m</sc> A1899. <italic>E</italic>, the percentage of inhibition by 400 n<sc>m</sc> A1899 from <italic>D</italic> plotted against the applied voltage. <italic>F</italic>, application of different concentrations of A1899 to TASK-3 channels recorded in intact whole oocytes (&#x025a1;) and in inside-out macropatches (&#x025cb;). The <italic>inset</italic> shows the recording of inside-out macropatches with a higher temporal resolution. <italic>TEVC</italic>, two-electrode voltage clamp.</p></caption><graphic xlink:href=\"zbc0221159940001\"/></fig><table-wrap id=\"T1\" position=\"float\"><label>TABLE 1</label><caption><p><bold>IC<sub>50</sub> values of A1899 for different human potassium channels</bold></p><p>Values were determined in <italic>Xenopus</italic> oocytes (<italic>n</italic> = 3&#x02013;12) or when indicated in CHO cells (<italic>n</italic> = 3&#x02013;12). TRAAK, TWIK-related arachidonic-acid-stimulated K<sup>+</sup> channel.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead valign=\"bottom\"><tr><th align=\"center\" rowspan=\"1\" colspan=\"1\">Channel</th><th align=\"center\" rowspan=\"1\" colspan=\"1\">IC<sub>50</sub></th></tr></thead><tbody valign=\"top\"><tr><td rowspan=\"1\" colspan=\"1\"/><td align=\"center\" rowspan=\"1\" colspan=\"1\">&#x003bc;<italic><sc>m</sc></italic></td></tr><tr><td align=\"left\" rowspan=\"1\" colspan=\"1\">TASK-1</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">0.035 &#x000b1; 0.003</td></tr><tr><td align=\"left\" rowspan=\"1\" colspan=\"1\">TASK-3</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">0.318 &#x000b1; 0.030</td></tr><tr><td align=\"left\" rowspan=\"1\" colspan=\"1\">TASK-1 CHO</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">0.007 &#x000b1; 0.001</td></tr><tr><td align=\"left\" rowspan=\"1\" colspan=\"1\">TASK-3 CHO</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">0.070 &#x000b1; 0.009</td></tr><tr><td align=\"left\" rowspan=\"1\" colspan=\"1\">TASK-2</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">12.0 &#x000b1; 2.2</td></tr><tr><td align=\"left\" rowspan=\"1\" colspan=\"1\">TASK-4</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">8.1 &#x000b1; 2.3</td></tr><tr><td align=\"left\" rowspan=\"1\" colspan=\"1\">TREK-1</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">23.8 &#x000b1; 1.8</td></tr><tr><td align=\"left\" rowspan=\"1\" colspan=\"1\">TREK-2</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">8.4 &#x000b1; 1.1</td></tr><tr><td align=\"left\" rowspan=\"1\" colspan=\"1\">TRAAK</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">&#x0003e;20</td></tr><tr><td align=\"left\" rowspan=\"1\" colspan=\"1\">THIK-1</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">2.2 &#x000b1; 0.2</td></tr><tr><td align=\"left\" rowspan=\"1\" colspan=\"1\">TRESK</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">0.9 &#x000b1; 0.1</td></tr><tr><td align=\"left\" rowspan=\"1\" colspan=\"1\">Kv1.1</td><td align=\"left\" rowspan=\"1\" colspan=\"1\">2.7 &#x000b1; 0.3</td></tr></tbody></table></table-wrap><p>Subsequently, we recorded TASK-1 currents in the presence of an increased extracellular K<sup>+</sup> concentration ([K<sup>+</sup>]<sub>in</sub> = [K<sup>+</sup>]<sub>out</sub>). Under these conditions, it was possible to test for a potential voltage dependence of block. We found that 400 n<sc>m</sc> A1899 blocked inward and outward currents to the same extent, indicating that the block of A1899 is not voltage-dependent (<xref ref-type=\"fig\" rid=\"F1\">Fig. 1</xref>, <italic>D</italic> and <italic>E</italic>). However, the extent of block at +40 mV elicited by 400 n<sc>m</sc> A1899 in a bath solution with a high concentration of extracellular potassium was only 59.7% in comparison with about 90% in ND96 (<xref ref-type=\"fig\" rid=\"F1\">Fig. 1</xref>, <italic>B</italic> and <italic>D</italic>), reflecting an almost 10-fold increase in IC<sub>50</sub> of A1899. A reduced blocker affinity in bath solutions with elevated extracellular potassium concentrations is typical for an open-channel block mechanism (<xref ref-type=\"bibr\" rid=\"B15\">15</xref>, <xref ref-type=\"bibr\" rid=\"B16\">16</xref>). Most open-channel blockers act from the intracellular side by binding in the water-filled central cavity (<xref ref-type=\"bibr\" rid=\"B15\">15</xref>, <xref ref-type=\"bibr\" rid=\"B17\">17</xref>). To assess whether A1899 blocks TASK channels in the central cavity, we tested the time course of inhibition by A1899 using whole-cell and inside-out macropatch recordings from <italic>Xenopus</italic> oocytes. For these experiments, we tested inhibition of TASK-3 channels as these give rise to large macroscopic currents, necessary for inside-out macropatch recordings. In whole-cell recordings, the block of TASK-3 channels by A1899 developed very slowly. When the blocker was applied from the cytosolic phase during inside-out macropatch experiments, the block was faster by several orders of magnitude (<xref ref-type=\"fig\" rid=\"F1\">Fig. 1</xref><italic>F</italic>). These experiments suggest that A1899 acts as an open-channel blocker of TASK channels, presumably by binding to the inner cavity. If A1899 acts as an open-channel blocker, then the domains and the respective residues that interact with A1899 should form the walls of the central cavity. Hence, we continued to identify the drug binding site of A1899.</p></sec><sec><title>A1899 Interacts with the M2 and M4 Transmembrane Segments of TASK-1 Channels</title><p>As a first step toward identification of the drug binding site and the pore-forming transmembrane domains, we constructed chimeric channels between the drug-sensitive TASK-1 and the drug-insensitive TASK-4. We replaced one of the TASK-1 transmembrane segments at a time by a TASK-4 transmembrane domain (<xref ref-type=\"fig\" rid=\"F2\">Fig. 2</xref>), expressed the chimeric channels in oocytes, and determined the IC<sub>50</sub> values of A1899 (<xref ref-type=\"fig\" rid=\"F2\">Fig. 2</xref>). Replacing the M1 or M3 segment of TASK-1 with TASK-4 did not cause a major reduction in the binding affinity of A1899. The IC<sub>50</sub> values were 0.06 &#x003bc;<sc>m</sc> for the M1 exchange and 0.07 &#x003bc;<sc>m</sc> for the M3 exchange (<xref ref-type=\"fig\" rid=\"F2\">Fig. 2</xref>), whereas the wild-type IC<sub>50</sub> was 0.035 &#x003bc;<sc>m</sc>. In contrast, replacing the M2 or M4 transmembrane segments of TASK-1 increased the IC<sub>50</sub> values of A1899 by several orders of magnitude (IC<sub>50</sub> &#x0003e; 10 &#x003bc;<sc>m</sc>) (<xref ref-type=\"fig\" rid=\"F2\">Fig. 2</xref>). We conclude from these findings that the M2 and M4 segments of TASK-1 are pore-forming domains that are crucial for the binding of A1899 and the subsequent block of the channel.</p><fig id=\"F2\" position=\"float\"><label>FIGURE 2.</label><caption><p><bold>M2 and M4 segments of TASK-1 are part of the binding site for A1899.</bold> Four different chimeras, with TASK-4 transmembrane segments introduced into a TASK-1 background replacing M1, M2, M3, or M4, were analyzed for their IC<sub>50</sub> of block by A1899. <italic>hTASK</italic>, human TASK.</p></caption><graphic xlink:href=\"zbc0221159940002\"/></fig></sec><sec><title>The Halothane Response Element Is Part of the A1899 Binding Site</title><p>Volatile anesthetics activate TASK-1 and TASK-3 channels via the halothane response element (HRE). Therefore, we tested A1899 on wild-type TASK-1 and a mutant TASK-1 channel with a deletion of the HRE sequence, <sup>243</sup>VLRFMT<sup>248</sup> (<xref ref-type=\"fig\" rid=\"F3\">Fig. 3</xref><italic>A</italic>, <italic>left column</italic>). The in-frame deletion of the HRE in TASK-1 led to a drastic reduction of the A1899 affinity, and the IC<sub>50</sub> increased 371-fold from 35 n<sc>m</sc> to 13 &#x003bc;<sc>m</sc>. The decrease in A1899 sensitivity of the &#x00394;HRE channel mutant strongly suggests an involvement of the halothane response element in binding of the drug. A similar in-frame deletion of the HRE in TASK-3 channels also led to a drastic reduction in drug affinity (<xref ref-type=\"fig\" rid=\"F3\">Fig. 3</xref><italic>A</italic>, <italic>right column</italic>). The IC<sub>50</sub> value increased 36-fold from 350 n<sc>m</sc> to 12.7 &#x003bc;<sc>m</sc>.</p><fig id=\"F3\" position=\"float\"><label>FIGURE 3.</label><caption><p><bold>The HRE influences A1899 binding.</bold> <italic>A</italic>, the sequence of the HREs of TASK-1 and TASK-3 differ in one amino acid (VLRF(<bold>M/L</bold>)T) (indicated by a <italic>box</italic>). In both channels, in-frame deletion of the HRE (<italic>bottom</italic>) leads to a massive increase in IC<sub>50</sub> values. <italic>rTASK</italic>, rat TASK. <italic>B</italic>, dose-response curves of A1899 on human TASK-1 WT (&#x025a0;) and an M247L (&#x025b4;) mutant.</p></caption><graphic xlink:href=\"zbc0221159940003\"/></fig><p>The M2 and M4 segments that we have identified as part of the A1899 binding site share about 90% sequence homology between TASK-1 and TASK-3. In each of the two segments, there are only two amino acids that are not identical (<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.jbc.org/cgi/content/full/M111.227884/DC1\">supplemental Fig. S1</ext-link>). One of these four residues is located in the HRE. TASK-1 has a methionine at position 247, whereas TASK-3 has a leucine residue at the same position (<xref ref-type=\"fig\" rid=\"F3\">Fig. 3</xref><italic>A</italic>). We introduced an M247L mutation in the TASK-1 channel, resulting in an HRE with the sequence of TASK-3. The M247L TASK-1 mutant was only blocked by 63.7 &#x000b1; 4.2% by 400 n<sc>m</sc> A1899. The IC<sub>50</sub> of this mutant expressed in oocytes increased from 35 n<sc>m</sc> for wild-type TASK-1 to 117 n<sc>m</sc> (<xref ref-type=\"fig\" rid=\"F3\">Fig. 3</xref><italic>B</italic>), reflecting a 3.3-fold increase in IC<sub>50</sub> by converting the amino acid sequence to that of the TASK-3 HRE. The experiments indicate that the HRE is part of the A1899 drug binding site and that the sequence variations in the TASK-1 and TASK-3 halothane response elements might contribute to the different drug affinities of TASK-1 and TASK-3.</p></sec><sec><title>A1899 Is a Pore Blocker Binding to Threonine Residues of the Signature Sequence</title><p>Our data described above indicate that A1899 blocks TASK-1 channels from the intracellular side and that the M2 and M4 segments including the HRE are involved in A1899 binding. For different Na<sup>+</sup>, Ca<sup>2+</sup>, and K<sup>+</sup> channels, it has been described that threonine residues of the signature sequence directly face into the central cavity and interact with open-channel blockers (<xref ref-type=\"bibr\" rid=\"B18\">18</xref>&#x02013;<xref ref-type=\"bibr\" rid=\"B21\">21</xref>). If A1899 is in fact binding in the central cavity formed by M2 and M4 segments, the drug could interact with the corresponding threonine residues of the signature sequence to plug the channel pore. The positions of the analogous threonine residues (bold) are <sup>92</sup>T<bold>T</bold>IGYG<sup>97</sup> in the P1 loop and <sup>198</sup>T<bold>T</bold>IGFG<sup>203</sup> in the P2 loop. Therefore, we tested the affinity of the Thr<sup>93</sup> and Thr<sup>199</sup> alanine mutations of TASK-1 for 400 n<sc>m</sc> A1899. Although wild-type TASK-1 channels were blocked by 78 &#x000b1; 5%, the T93A and T199A mutants were blocked by only 26.4 &#x000b1; 6.4 and 36.4 &#x000b1; 6.4%, respectively (<xref ref-type=\"fig\" rid=\"F4\">Fig. 4</xref>, <italic>A&#x02013;B</italic> and <italic>D&#x02013;E</italic>). The strong reduction of block resulting from either mutation strongly suggests that A1899 interacts with the two threonine residues of the signature sequence and that A1899 deeply protrudes into the central cavity of the TASK-1 channel to induce a plugging of the pore.</p><fig id=\"F4\" position=\"float\"><label>FIGURE 4.</label><caption><p><bold>The A1899 binding site includes residues of the M2 and M4 segment and the selectivity filter.</bold> <italic>A&#x02013;F</italic>, mutant TASK-1 channels were expressed in <italic>Xenopus</italic> oocytes, and block by 400 n<sc>m</sc> A1899 was analyzed. <italic>A</italic> and <italic>D</italic>, sample current traces for wild-type TASK-1 and mutated channels before (<italic>black</italic>) and after (<italic>gray</italic>) application of 400 n<sc>m</sc> A1899. <italic>B</italic>, <italic>C</italic>, <italic>E</italic>, and <italic>F</italic>, mutant TASK-1 channels with a reduced sensitivity to A1899 indicate residues as part of the binding site for A1899 (illustrated as <italic>striated bars</italic>). Threonine residues of the P1 and P2 pore loops are part of the A1899 binding site. In the M2 and M4 segment, residues of the binding site are located at a distance of 3&#x02013;4 amino acids.</p></caption><graphic xlink:href=\"zbc0221159940004\"/></fig></sec><sec><title>Identification of the A1899 Binding Site by Alanine Mutagenesis Screening</title><p>As our data indicate that A1899 is an open-channel blocker of TASK-1 and that the M2 and M4 segments, the pore loops, and the halothane response elements are involved in the binding of A1899, we performed a systematic alanine mutagenesis screen of these domains to identify the A1899 binding site. TASK-1 channels with single mutations to alanine (or alanine to valine) were expressed in <italic>Xenopus</italic> oocytes, and block by 400 n<sc>m</sc> A1899 was measured (<xref ref-type=\"fig\" rid=\"F4\">Fig. 4</xref>). The rationale was that mutations that remove or strongly reduce block should be part of the A1899 binding site (<xref ref-type=\"fig\" rid=\"F4\">Fig. 4</xref>, <italic>striated columns</italic>). The following residues were identified by the alanine scan: Thr<sup>92</sup> and Thr<sup>93</sup> in the P1 region (<xref ref-type=\"fig\" rid=\"F4\">Fig. 4</xref><italic>B</italic>), Ile<sup>118</sup> and Leu<sup>122</sup> of the M2 segment (<xref ref-type=\"fig\" rid=\"F4\">Fig. 4</xref><italic>C</italic>), Thr<sup>198</sup> and Thr<sup>199</sup> of the P2 region (<xref ref-type=\"fig\" rid=\"F4\">Fig. 4</xref><italic>E</italic>), Ile<sup>235</sup>, Gly<sup>236</sup>, Leu<sup>239</sup>, and Asn<sup>240</sup> of the M4 segment (<xref ref-type=\"fig\" rid=\"F4\">Fig. 4</xref><italic>F</italic>), and Val<sup>243</sup> and Met<sup>247</sup> of the HRE (<xref ref-type=\"fig\" rid=\"F4\">Fig. 4</xref><italic>F</italic>). The alanine scan revealed a helical pattern for the A1889 binding site in the M2 and M4 segment, meaning that substitutions by alanine that disturbed block were located in distances of about 3&#x02013;4 amino acids. Consequently, the amino acids identified as parts of the binding site all point to the same direction of the respective &#x003b1;-helical transmembrane segment. As the identified residues should interact with the drug in the central cavity, our data can be used to validate the rotation of the M2 and M4 segment in a pore homology model.</p><p>To confirm the residues identified by our alanine scan, we introduced multiple mutations of the drug binding site simultaneously in the TASK-1 channels and tested these channels for their A1899 sensitivity (<xref ref-type=\"fig\" rid=\"F5\">Fig. 5</xref>). <xref ref-type=\"fig\" rid=\"F5\">Fig. 5</xref><italic>A</italic> shows currents of the L122A/I235A and L122A/L239A double mutations and the L122A/I235A/M247A triple mutation, which all showed little or almost no block by 400 n<sc>m</sc> A1899. As expected, other TASK-1 constructs harboring multiple mutations at the A1899 binding site also showed a strong reduction in block (<xref ref-type=\"fig\" rid=\"F5\">Fig. 5</xref><italic>B</italic>). Summarizing, we have identified the residues of the A1899 binding site and conclude that the M2 and M4 segments build the pore of TASK-1 channels and that these amino acids forming the binding site of A1899 line the inner face of the pore.</p><fig id=\"F5\" position=\"float\"><label>FIGURE 5.</label><caption><p><bold>TASK-1 channels with multiple mutations at the drug binding site show a strong reduction of A1899 sensitivity.</bold> <italic>A</italic>, sample traces of TASK-1 wild-type, double, and triple mutant channels before (<italic>black</italic>) and after (<italic>gray</italic>) application of 400 n<sc>m</sc> A1899. <italic>B</italic>, inhibition of TASK-1 channels with multiple mutations by 400 n<sc>m</sc> A1899.</p></caption><graphic xlink:href=\"zbc0221159940005\"/></fig></sec><sec><title>Open-state Pore Homology Model of TASK-1 Validated by the A1899 Drug Binding Site</title><p>Based on the crystal structure of KvAP, we created an open-state homology model of TASK-1 using the M2 and M4 segments as the pore-forming helices. The model is in good agreement with our experimental data, expecting that residues of the A1899 binding site are facing into the central cavity (<xref ref-type=\"fig\" rid=\"F6\">Fig. 6</xref>). In the model, the identified residues Thr<sup>93</sup> (<italic>cyan</italic>) and Thr<sup>199</sup> (<italic>black</italic>) of the first and second pore loop, Ile<sup>118</sup> (<italic>magenta</italic>) and Leu<sup>122</sup> (<italic>yellow</italic>) of the M2 segment, Ile<sup>235</sup>/Gly<sup>236</sup> (<italic>green/blue</italic>), Leu<sup>239</sup>/Asn<sup>240</sup> (<italic>orange/white</italic>) of the M4 segment, and Val<sup>243</sup> (<italic>sand</italic>) and Met<sup>247</sup> (<italic>red</italic>) of the HRE element are facing into the central cavity (<xref ref-type=\"fig\" rid=\"F6\">Fig. 6</xref>) or are, in the case of Met<sup>247</sup>, accessible on the way into the pore (<xref ref-type=\"fig\" rid=\"F6\">Fig. 6</xref>). Thus, the A1899 binding site data validate our <italic>in silico</italic> TASK-1 pore homology model.</p><fig id=\"F6\" position=\"float\"><label>FIGURE 6.</label><caption><p><bold>Open-state pore homology model of TASK-1 based on the KvAP structure.</bold> The figure illustrates residues identified as pore-facing using A1899. For better display, the backbone of half a TASK-1 subunit (M1, P1 and M2) is hidden, whereas the identified residues are still depicted. The backbone is shown transparent for a better view on the residues of the drug binding site.</p></caption><graphic xlink:href=\"zbc0221159940006\"/></fig></sec><sec><title>Confirmation of the A1899 Binding Site by Docking of the Drug to the Open Pore</title><p>A proportional ligand molecule was used to perform docking experiments. Dockings of the ligand molecule into the open state of TASK-1 yielded optimal binding scores. When bound, the drug clearly blocks the channel pore and impedes passage of K<sup>+</sup> ions. In this conformation, the difluorobenzene end of the molecule lies closest to the selectivity filter, with the carbonyl oxygen of the amide linkage suggested to accept hydrogen bonds from residues of the signature sequence, Thr<sup>93</sup> and Thr<sup>199</sup> (<xref ref-type=\"fig\" rid=\"F7\">Fig. 7</xref>, <italic>dotted lines</italic>). The majority of the other ligand-protein contacts are hydrophobic in nature, with Ile<sup>118</sup>, Leu<sup>122</sup>, Leu<sup>232</sup> (the latter mutant did not express in oocytes), Ile<sup>235</sup>, and Leu<sup>239</sup> all within 4 &#x0212b; of the first three rings of the molecule. The fourth ring was found to be localized lower in the cavity toward the cytosolic entrance. At this position, the ring forms contacts with Leu<sup>122</sup> and Val<sup>243</sup>, whereas the attached methoxy moiety could potentially form hydrogen bonds with Asn<sup>240</sup>. No interaction of the drug was predicted for Met<sup>247</sup>, which was located too low in the M4 segment. For a table listing the nature of the drug molecule interactions, see <ext-link ext-link-type=\"uri\" xlink:href=\"http://www.jbc.org/cgi/content/full/M111.227884/DC1\">supplemental Fig. S2</ext-link>. It is noteworthy that the majority of the sites predicted by the docking experiments to the open state are in good agreement with our electrophysiological data as the model mostly highlights the same positions as the mutagenic screen (<xref ref-type=\"fig\" rid=\"F4\">Figs. 4</xref> and <xref ref-type=\"fig\" rid=\"F6\">6</xref>). Thus, the docking experiments reconfirmed the validity of the open-pore homology model and the data obtained by the alanine scanning approach.</p><fig id=\"F7\" position=\"float\"><label>FIGURE 7.</label><caption><p><bold>Docking of A1899 to an open-state pore homology model of TASK-1.</bold> The binding mode of A1899 in the pore of TASK-1 as predicted by docking using the software GOLD is shown. All amino acids predicted to interact with the drug molecule are illustrated. For a better display of A1899 binding, the TASK-1 channel is shown in two orientations (rotated by 90&#x000b0;). The <italic>left panel</italic> shows the two M1, P1, and M2 segments, and the <italic>right panel</italic> shows the two M3, P2, and M4 segments. H-bonds are depicted as <italic>dotted lines</italic> between A1899 and the threonine residues of the selectivity filter.</p></caption><graphic xlink:href=\"zbc0221159940007\"/></fig></sec><sec><title>A1899 Docking to a Closed-state Homology Model Supports a Binding to the Open State</title><p>Next, we compared the docking of A1899 to the open state (<xref ref-type=\"fig\" rid=\"F7\">Fig. 7</xref>) with dockings to a closed-state model of TASK-1, which was generated on the basis of the KcsA structure (<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.jbc.org/cgi/content/full/M111.227884/DC1\">supplemental Fig. S3</ext-link>). Using the software GOLD, binding to the closed state was only possible if the M2 side chain and Phe<sup>125</sup> were rotated so that this residue pointed up, toward the selectivity filter. This facilitates a strong binding mode that is in good agreement with the binding observed in the open-state model. In addition, the drug adopts the same orientation as in the open state. However, in this case, Phe<sup>125</sup> would strongly interact with the drug, which is in disagreement with our experimental data (<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.jbc.org/cgi/content/full/M111.227884/DC1\">supplemental Fig. S3</ext-link>). Using the docking software Autodock, the drug does not fit into the binding site, despite the displacement of Phe<sup>125</sup> (as done for GOLD). In addition, using Autodock, enabling a more flexible binding site does not appear to improve the results. The experiments suggest that A1899 does not fit into a closed channel pore and that the channels have to open to allow an optimal binding of A1899.</p></sec><sec><title>MD Simulations of A1899 in the Open Pore of TASK-1 Channels</title><p>To test the binding of the drug molecule in more detail, MD simulations were performed to assess the dynamic interactions of the open-channel complex. Throughout all four of the 30-ns simulations, the complex remained intact, with the protein stabilizing to a typical C&#x003b1; root mean square deviation of between 3 and 3.5 &#x0212b;. The percentage of contacts, for each protein side chain within 4 &#x0212b; of the drug molecule, was calculated at 10-ps intervals for all four simulations. Most contacts were observed for Thr<sup>92</sup> and Thr<sup>93</sup> of P1, Ile<sup>118</sup> and Leu<sup>122</sup> of M2, Thr<sup>198</sup> and Thr<sup>199</sup> of P2, and Ile<sup>235</sup>, Gly<sup>236</sup>, Leu<sup>239</sup>, and Asn<sup>240</sup> of M4 (<xref ref-type=\"fig\" rid=\"F8\">Fig. 8</xref>). Thus, overall, the majority of contacts remained the same as described for the original docking (<xref ref-type=\"fig\" rid=\"F7\">Fig. 7</xref> and <ext-link ext-link-type=\"uri\" xlink:href=\"http://www.jbc.org/cgi/content/full/M111.227884/DC1\">supplemental Fig. S2</ext-link>). As a putative false positive, the MD simulations predicted an interaction with the residue Gln<sup>126</sup>, a residue that was not tested positive by our alanine scan. Similar to the initial docking experiments, the MD simulations did not predict an interaction with Phe<sup>125</sup>. The MD simulations (<xref ref-type=\"fig\" rid=\"F8\">Fig. 8</xref>) and the original docking (<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.jbc.org/cgi/content/full/M111.227884/DC1\">supplemental Fig. S2</ext-link>) predict an interaction with Leu<sup>232</sup>. Unfortunately, introducing mutations at Leu<sup>232</sup> led to non-functional channels. The MD simulations indicate a hydrogen bonding between drug and the side chains of Thr<sup>93</sup> and Thr<sup>199</sup> of the selectivity filter and Asn<sup>240</sup> of the inner transmembrane helices. In addition to the H-bonding with Thr<sup>93</sup> and Thr<sup>199</sup>, the uppermost carbonyl oxygen of the drug also appears to coordinate the S<sub>4</sub> K<sup>+</sup> ion. Moreover, in two simulations tested, the ions starting at the S<sub>3</sub> site move down to S<sub>4</sub> to interact with the ligand (<xref ref-type=\"fig\" rid=\"F8\">Fig. 8</xref>). It is noteworthy that open-channel blockers have been previously reported to interact with the K<sup>+</sup> ion at site 4 of the selectivity filter (<xref ref-type=\"bibr\" rid=\"B20\">20</xref>&#x02013;<xref ref-type=\"bibr\" rid=\"B23\">23</xref>). At depolarized potentials, when TASK-1 is open, the K<sup>+</sup> ion seems to favor the occupancy at site 4 (<xref ref-type=\"bibr\" rid=\"B22\">22</xref>), which in turn appears to favor binding of the open-channel blocker A1899.</p><fig id=\"F8\" position=\"float\"><label>FIGURE 8.</label><caption><p><bold>Molecular dynamics simulations validate the A1899 binding site.</bold> For a better display of A1899 binding, the TASK-1 channel is shown in two orientations (rotated by 90&#x000b0;). The <italic>left panel</italic> shows the two M1, P1, and M2 segments, and the <italic>right panel</italic> shows the two M3, P2, and M4 segments. All amino acids predicted to have multiple contacts with the drug molecule are illustrated. In addition, A1899 interacts with the potassium ion at S<sub>4</sub> of the selectivity filter.</p></caption><graphic xlink:href=\"zbc0221159940008\"/></fig></sec></sec></sec></sec><sec sec-type=\"discussion\"><title>DISCUSSION</title><p>In recent years, K<sub>2P</sub> channels have been considered to represent promising drug targets. However, little is known about the structure of these channels, and in addition, there is a lack of specific blockers. We have identified A1899 as the most potent synthetic K<sub>2P</sub> channel blocker currently known. After showing that A1899 acts from the cytosolic phase as a pore blocker, we used a combined approach of chimeras and alanine scanning to identify the first drug binding site of a K<sub>2P</sub> channel. K<sub>2P</sub> channels have a unique transmembrane topology. Crystal structures of ion channels with different transmembrane topologies, including for example KcsA (<xref ref-type=\"bibr\" rid=\"B24\">24</xref>), rKv1.2 (<xref ref-type=\"bibr\" rid=\"B25\">25</xref>), and KirBac1.1 (<xref ref-type=\"bibr\" rid=\"B26\">26</xref>), suggest that the transmembrane segments following the selectivity filter are pore-forming inner helices. Our data support the idea that the M2 and M4 segments of K<sub>2P</sub> channels form the wall of the inner cavity. In addition, the interaction between the drug located in the central cavity and the amino acids of the M2 and M4 segments was assessed experimentally to provide data analyzing the rotation of the inner helices.</p><p>While we were in the process of finalizing our study, Kollewe <italic>et al.</italic> (<xref ref-type=\"bibr\" rid=\"B14\">14</xref>) proposed a structure for the <italic>Drosophila</italic> K<sub>2P</sub> channel dORK. The group utilized long range electrostatic compensation of positively charged amino acids in the selectivity region by negatively charged residues introduced into the M2 or M4 segment to identify pore-facing amino acids. This approach was used before in Kir2.1 channels by Chatelain <italic>et al.</italic> (<xref ref-type=\"bibr\" rid=\"B27\">27</xref>), who showed that charge and distance between the two mutations are decisive for a rescue effect and that electrostatic rescue does not work for residues that are located in close proximity or in great distance from each other. Because of this limitation, Kollewe <italic>et al.</italic> (<xref ref-type=\"bibr\" rid=\"B14\">14</xref>) could only test amino acids in a restricted region of the lower M2 and M4 segment. They probed residues corresponding to 119&#x02013;127 of the TASK-1 M2 segment and 233&#x02013;241 of the TASK-1 M4 segment (<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.jbc.org/cgi/content/full/M111.227884/DC1\">supplemental Fig. S4</ext-link>), whereas our more comprehensive approach scanned the whole length of those segments: 108&#x02013;128 of the M2 and 227&#x02013;248 of the M4 segment. Strikingly, five of the eight amino acids of dORK (Gly<sup>134</sup>, Leu<sup>257</sup>, Val<sup>258</sup>, Met<sup>261</sup>, and Thr<sup>262</sup>), identified by Kollewe <italic>et al.</italic> (<xref ref-type=\"bibr\" rid=\"B14\">14</xref>) as pore-facing, were also identified by our alanine scan. These residues correspond to the TASK-1 residues Leu<sup>122</sup> in M2 and Ile<sup>235</sup>, Gly<sup>236</sup>, Leu<sup>239</sup>, and Asn<sup>240</sup> in M4 (<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.jbc.org/cgi/content/full/M111.227884/DC1\">supplemental Fig. S4</ext-link>). The data of dORK and TASK-1 can only be partially compared. In addition to the limited region of overlap, the mammalian TASK-1 channel shares only little sequence homology with dORK, and the structures of the two channels might differ as well. For example, we did not identify the M2 residues Thr<sup>121</sup>, Phe<sup>125</sup>, and Gln<sup>126</sup> to be pore-facing as expected from the study with dORK (<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.jbc.org/cgi/content/full/M111.227884/DC1\">supplemental Fig. S4</ext-link>). In contrast, we identified Ile<sup>118</sup>, a residue that was not in the scanning range of the electrostatic interaction approach, as pore-facing (<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.jbc.org/cgi/content/full/M111.227884/DC1\">supplemental Fig. S4</ext-link>). In addition, we identified two residues in the late M4 segment (HRE), namely Val<sup>243</sup> and Met<sup>247</sup>, which were also not within the spatial range for electrostatic interactions (<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.jbc.org/cgi/content/full/M111.227884/DC1\">supplemental Fig. S4</ext-link>).</p><p>The M2 and M4 segments of TASK-1 share low sequence homology (<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.jbc.org/cgi/content/full/M111.227884/DC1\">supplemental Fig. S4</ext-link>). Thus, not as expected from the primary sequence, the TASK-1 drug binding site has a remarkably high symmetry (<xref ref-type=\"fig\" rid=\"F6\">Fig. 6</xref>). The primary binding site in the central cavity is formed by three rings of four identical residues. The first ring, located at the selectivity filter, is formed by four threonine residues, including two Thr<sup>93</sup> residues of the P1 loop and two Thr<sup>199</sup> residues of the P2 loop. The Ile<sup>118</sup> of M2 together with Ile<sup>235</sup> of M4 form a ring of four isoleucines, located underneath the selectivity filter in the central cavity. One helix turn below, there is a ring of four leucine residues formed by Leu<sup>122</sup> of M2 and Leu<sup>239</sup> of M4. In addition to these residues of a four-fold symmetrical binding site, we have identified Gly<sup>236</sup> and Asn<sup>240</sup> in the M4 segment and Val<sup>243</sup> and Met<sup>247</sup> in the HRE, which appear only twice in the binding site.</p><p>Interestingly, the HRE is a molecular prerequisite for the high-affinity block of A1899. This part of the channel is known to be the site of action for volatile anesthetics that activate TASK channels, and it has been described as a domain essential for the inhibition via G<sub>q</sub>-coupled receptors. However, it was not possible to identify single amino acids responsible for the action of anesthetics or the G-protein coupling within this region. In contrast, our alanine scan points out that two residues of the HRE, Val<sup>243</sup> and Met<sup>247</sup>, are responsible for the binding of A1899 to the HRE. Although the docking of A1899 to the pore homology model predicts an interaction of the HRE residue Val<sup>243</sup> with the drug, Met<sup>247</sup> seems to be too remote from the final binding site. Nevertheless, our mutagenesis data suggest that the difference in amino acid sequence at position 247 of the halothane response element contributes to the different drug affinities of TASK-1 and TASK-3. An explanation is that Met<sup>247</sup> is important for a trapping of the drug in the central cavity. Our 30-ns MD simulations, however, showed no evidence for a trapping of the drug through gate closure at Met<sup>247</sup>, although this process likely requires MD simulations on a longer timescale. A more likely explanation lies within the fact that Met<sup>247</sup> is located in the access pathway into the central cavity (<xref ref-type=\"fig\" rid=\"F6\">Fig. 6</xref>). We suggest that position 247 is not part of the binding site but that it influences drug sensitivity because it regulates accessibility of the pore for A1899. The role of the HRE in high-affinity drug binding presented in this study suggests that the mechanism of synthetic modulators and endogenous mechanisms of TASK-1 regulation might be similar. Analogous actions of drug binding and endogenous G protein-coupled receptor modulation of TASK-1 might be the focus of future studies.</p><p>Our alanine scan does not suggest any impact of the F125A mutation on drug binding. The position Phe<sup>125</sup> is analogous to Phe<sup>656</sup> in human ERG channels, which is essential for the binding of most ERG blockers (<xref ref-type=\"bibr\" rid=\"B19\">19</xref>, <xref ref-type=\"bibr\" rid=\"B28\">28</xref>). Former studies propose the corresponding amino acids in dORK (Phe<sup>137</sup>) and TREK-1 (Leu<sup>174</sup>) to line the inner pore (<xref ref-type=\"bibr\" rid=\"B14\">14</xref>, <xref ref-type=\"bibr\" rid=\"B29\">29</xref>). However, in our computer models for the open state, Phe<sup>125</sup> does not line the pore. An interaction of this residue with A1899 is only suggested in the closed-state model (<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.jbc.org/cgi/content/full/M111.227884/DC1\">supplemental Fig. S3</ext-link>). We therefore propose that the M2 segment is slightly rotated in the open state as compared with the closed-state, leading to a displacement of the aromatic residue of Phe<sup>125</sup>. The importance of the exact orientation of the corresponding phenylalanine in human ERG has also been discussed by Chen <italic>et al.</italic> (<xref ref-type=\"bibr\" rid=\"B28\">28</xref>).</p><p>Based on their TREK-1 model, Treptow and Klein (<xref ref-type=\"bibr\" rid=\"B29\">29</xref>) suggest that two leucines, one in the M2 and one in the M4 segment of TREK-1 (Leu<sup>174</sup> and Leu<sup>289</sup>), delimit the narrowest part of the inner pore and form a hydrophobic gate. These leucine residues align to Phe<sup>125</sup> and Leu<sup>239</sup> of TASK-1. Our data indicate that TASK-1 channels do not have the same or conserved hydrophobic gating ring. The hydrophobic gating ring might be the molecular correlate to the difference between the gating mechanisms of TREK-1 and TASK channels.</p><p>The selective TASK-1 blocker A1899 described here is a powerful tool for studying the physiological role of TASK-1 channels in native tissues. We took advantage of the blocker to probe the direct interaction with the amino acids of the inner pore and created the first model for a mammalian K<sub>2P</sub> channel with experimentally validated orientation of the inner helices. Thus, using A1899 as a chemical probe, we validated a model for the mammalian K<sub>2P</sub> channel TASK-1 in the open state and identified the first complete drug binding site in a K<sub>2P</sub> channel. The docking of A1899 into this open-pore homology model and the subsequent molecular dynamics simulations confirmed the amino acids of the drug binding site identified by our alanine scan. Our data provide an excellent starting point for future studies on the molecular pharmacology of other K<sub>2P</sub> channels. In addition, our data should influence the rational drug design of selective blockers of other K<sub>2P</sub> channels. As K<sub>2P</sub> channels have emerged as novel drug targets, the identification of a TASK-1-specific blocker together with the identification of a high-affinity drug binding site in a K<sub>2P</sub> channel is a promising finding for future drug design and for basic research in physiology.</p></sec></body><back><fn-group><fn fn-type=\"supported-by\" id=\"FN1\"><label>*</label><p>This work was supported by Kempkes Stiftung Grant 12/08 (to N. D.) and by Deutsche Forschungsgemeinschaft Grants BA-1793/5-1 (to T. B.), DE-1482/3-1 (to N. D. and J. D.), and DE-1482/2-1 (to N. D.).</p></fn><fn fn-type=\"supplementary-material\" id=\"FN2\"><label><inline-graphic xlink:href=\"sbox.jpg\"/></label><p>The on-line version of this article (available at <ext-link ext-link-type=\"uri\" xlink:href=\"http://www.jbc.org\">http://www.jbc.org</ext-link>) contains <ext-link ext-link-type=\"uri\" xlink:href=\"http://www.jbc.org/cgi/content/full/M111.227884/DC1\">supplemental Experimental Procedures and Figs. S1&#x02013;S4</ext-link>.</p></fn></fn-group><fn-group content-type=\"abbreviations\"><fn id=\"FN5\"><label>4</label><p>The abbreviations used are:\\n<def-list><def-item><term id=\"G1\">K<sub>2P</sub></term><def><p>two-pore domain potassium channel</p></def></def-item><def-item><term id=\"G2\">TASK</term><def><p>TWIK-related acid-sensitive K<sup>+</sup></p></def></def-item><def-item><term id=\"G3\">MD</term><def><p>molecular dynamics</p></def></def-item><def-item><term id=\"G4\">HRE</term><def><p>halothane response element</p></def></def-item><def-item><term id=\"G5\">TWIK</term><def><p>tandem of P domains in a weak inwardly rectifying K<sup>+</sup> channel</p></def></def-item><def-item><term id=\"G6\">ERG</term><def><p>ether-&#x000e0;-go-go-related gene</p></def></def-item><def-item><term id=\"G7\">dORK</term><def><p><italic>Drosophila</italic> open rectifier K<sup>+</sup> channel.</p></def></def-item></def-list></p></fn></fn-group><ack><title>Acknowledgments</title><p>We thank K. Ramlow for excellent technical support and members of the M. S. P. Sansom laboratory for helpful discussions. The compound A1899 was obtained from Sanofi Aventis GmbH Germany.</p></ack><ref-list><title>REFERENCES</title><ref id=\"B1\"><label>1.</label><mixed-citation publication-type=\"journal\">\\n<person-group person-group-type=\"author\"><name><surname>Duprat</surname><given-names>F.</given-names></name><name><surname>Lesage</surname><given-names>F.</given-names></name><name><surname>Fink</surname><given-names>M.</given-names></name><name><surname>Reyes</surname><given-names>R.</given-names></name><name><surname>Heurteaux</surname><given-names>C.</given-names></name><name><surname>Lazdunski</surname><given-names>M.</given-names></name></person-group> (<year>1997</year>) <source>EMBO J.</source> <volume>16</volume>, <fpage>5464</fpage>&#x02013;<lpage>5471</lpage><pub-id pub-id-type=\"pmid\">9312005</pub-id></mixed-citation></ref><ref id=\"B2\"><label>2.</label><mixed-citation publication-type=\"journal\">\\n<person-group person-group-type=\"author\"><name><surname>Rajan</surname><given-names>S.</given-names></name><name><surname>Wischmeyer</surname><given-names>E.</given-names></name><name><surname>Xin Liu</surname><given-names>G.</given-names></name><name><surname>Preisig-M&#x000fc;ller</surname><given-names>R.</given-names></name><name><surname>Daut</surname><given-names>J.</given-names></name><name><surname>Karschin</surname><given-names>A.</given-names></name><name><surname>Derst</surname><given-names>C.</given-names></name></person-group> (<year>2000</year>) <source>J. Biol. Chem.</source> <volume>275</volume>, <fpage>16650</fpage>&#x02013;<lpage>16657</lpage><pub-id pub-id-type=\"pmid\">10747866</pub-id></mixed-citation></ref><ref id=\"B3\"><label>3.</label><mixed-citation publication-type=\"journal\">\\n<person-group person-group-type=\"author\"><name><surname>Ashmole</surname><given-names>I.</given-names></name><name><surname>Goodwin</surname><given-names>P. A.</given-names></name><name><surname>Stanfield</surname><given-names>P. R.</given-names></name></person-group> (<year>2001</year>) <source>Pfl&#x000fc;gers Arch.</source> <volume>442</volume>, <fpage>828</fpage>&#x02013;<lpage>833</lpage></mixed-citation></ref><ref id=\"B4\"><label>4.</label><mixed-citation publication-type=\"journal\">\\n<person-group person-group-type=\"author\"><name><surname>Decher</surname><given-names>N.</given-names></name><name><surname>Maier</surname><given-names>M.</given-names></name><name><surname>Dittrich</surname><given-names>W.</given-names></name><name><surname>Gassenhuber</surname><given-names>J.</given-names></name><name><surname>Br&#x000fc;ggemann</surname><given-names>A.</given-names></name><name><surname>Busch</surname><given-names>A. E.</given-names></name><name><surname>Steinmeyer</surname><given-names>K.</given-names></name></person-group> (<year>2001</year>) <source>FEBS Lett.</source> <volume>492</volume>, <fpage>84</fpage>&#x02013;<lpage>89</lpage><pub-id pub-id-type=\"pmid\">11248242</pub-id></mixed-citation></ref><ref id=\"B5\"><label>5.</label><mixed-citation publication-type=\"journal\">\\n<person-group person-group-type=\"author\"><name><surname>Reyes</surname><given-names>R.</given-names></name><name><surname>Duprat</surname><given-names>F.</given-names></name><name><surname>Lesage</surname><given-names>F.</given-names></name><name><surname>Fink</surname><given-names>M.</given-names></name><name><surname>Salinas</surname><given-names>M.</given-names></name><name><surname>Farman</surname><given-names>N.</given-names></name><name><surname>Lazdunski</surname><given-names>M.</given-names></name></person-group> (<year>1998</year>) <source>J. Biol. Chem.</source> <volume>273</volume>, <fpage>30863</fpage>&#x02013;<lpage>30869</lpage><pub-id pub-id-type=\"pmid\">9812978</pub-id></mixed-citation></ref><ref id=\"B6\"><label>6.</label><mixed-citation publication-type=\"journal\">\\n<person-group person-group-type=\"author\"><name><surname>Putzke</surname><given-names>C.</given-names></name><name><surname>Wemh&#x000f6;ner</surname><given-names>K.</given-names></name><name><surname>Sachse</surname><given-names>F. B.</given-names></name><name><surname>Rinn&#x000e9;</surname><given-names>S.</given-names></name><name><surname>Schlichth&#x000f6;rl</surname><given-names>G.</given-names></name><name><surname>Li</surname><given-names>X. T.</given-names></name><name><surname>Ja&#x000e9;</surname><given-names>L.</given-names></name><name><surname>Eckhardt</surname><given-names>I.</given-names></name><name><surname>Wischmeyer</surname><given-names>E.</given-names></name><name><surname>Wulf</surname><given-names>H.</given-names></name><name><surname>Preisig-M&#x000fc;ller</surname><given-names>R.</given-names></name><name><surname>Daut</surname><given-names>J.</given-names></name><name><surname>Decher</surname><given-names>N.</given-names></name></person-group> (<year>2007</year>) <source>Cardiovasc. Res.</source> <volume>75</volume>, <fpage>59</fpage>&#x02013;<lpage>68</lpage><pub-id pub-id-type=\"pmid\">17389142</pub-id></mixed-citation></ref><ref id=\"B7\"><label>7.</label><mixed-citation publication-type=\"journal\">\\n<person-group person-group-type=\"author\"><name><surname>Budde</surname><given-names>T.</given-names></name><name><surname>Coulon</surname><given-names>P.</given-names></name><name><surname>Pawlowski</surname><given-names>M.</given-names></name><name><surname>Meuth</surname><given-names>P.</given-names></name><name><surname>Kanyshkova</surname><given-names>T.</given-names></name><name><surname>Japes</surname><given-names>A.</given-names></name><name><surname>Meuth</surname><given-names>S. G.</given-names></name><name><surname>Pape</surname><given-names>H. C.</given-names></name></person-group> (<year>2008</year>) <source>Pfl&#x000fc;gers Arch.</source> <volume>456</volume>, <fpage>1061</fpage>&#x02013;<lpage>1073</lpage></mixed-citation></ref><ref id=\"B8\"><label>8.</label><mixed-citation publication-type=\"journal\">\\n<person-group person-group-type=\"author\"><name><surname>Czirj&#x000e1;k</surname><given-names>G.</given-names></name><name><surname>Fischer</surname><given-names>T.</given-names></name><name><surname>Sp&#x000e4;t</surname><given-names>A.</given-names></name><name><surname>Lesage</surname><given-names>F.</given-names></name><name><surname>Enyedi</surname><given-names>P.</given-names></name></person-group> (<year>2000</year>) <source>Mol. Endocrinol.</source> <volume>14</volume>, <fpage>863</fpage>&#x02013;<lpage>874</lpage><pub-id pub-id-type=\"pmid\">10847588</pub-id></mixed-citation></ref><ref id=\"B9\"><label>9.</label><mixed-citation publication-type=\"journal\">\\n<person-group person-group-type=\"author\"><name><surname>Trapp</surname><given-names>S.</given-names></name><name><surname>Aller</surname><given-names>M. I.</given-names></name><name><surname>Wisden</surname><given-names>W.</given-names></name><name><surname>Gourine</surname><given-names>A. V.</given-names></name></person-group> (<year>2008</year>) <source>J. Neurosci.</source> <volume>28</volume>, <fpage>8844</fpage>&#x02013;<lpage>8850</lpage><pub-id pub-id-type=\"pmid\">18753386</pub-id></mixed-citation></ref><ref id=\"B10\"><label>10.</label><mixed-citation publication-type=\"journal\">\\n<person-group person-group-type=\"author\"><name><surname>Meuth</surname><given-names>S. G.</given-names></name><name><surname>Bittner</surname><given-names>S.</given-names></name><name><surname>Meuth</surname><given-names>P.</given-names></name><name><surname>Simon</surname><given-names>O. J.</given-names></name><name><surname>Budde</surname><given-names>T.</given-names></name><name><surname>Wiendl</surname><given-names>H.</given-names></name></person-group> (<year>2008</year>) <source>J. Biol. Chem.</source> <volume>283</volume>, <fpage>14559</fpage>&#x02013;<lpage>14570</lpage><pub-id pub-id-type=\"pmid\">18375952</pub-id></mixed-citation></ref><ref id=\"B11\"><label>11.</label><mixed-citation publication-type=\"journal\">\\n<person-group person-group-type=\"author\"><name><surname>Patel</surname><given-names>A. J.</given-names></name><name><surname>Honor&#x000e9;</surname><given-names>E.</given-names></name><name><surname>Lesage</surname><given-names>F.</given-names></name><name><surname>Fink</surname><given-names>M.</given-names></name><name><surname>Romey</surname><given-names>G.</given-names></name><name><surname>Lazdunski</surname><given-names>M.</given-names></name></person-group> (<year>1999</year>) <source>Nat. Neurosci.</source> <volume>2</volume>, <fpage>422</fpage>&#x02013;<lpage>426</lpage><pub-id pub-id-type=\"pmid\">10321245</pub-id></mixed-citation></ref><ref id=\"B12\"><label>12.</label><mixed-citation publication-type=\"journal\">\\n<person-group person-group-type=\"author\"><name><surname>Meadows</surname><given-names>H. J.</given-names></name><name><surname>Randall</surname><given-names>A. D.</given-names></name></person-group> (<year>2001</year>) <source>Neuropharmacology</source> <volume>40</volume>, <fpage>551</fpage>&#x02013;<lpage>559</lpage><pub-id pub-id-type=\"pmid\">11249964</pub-id></mixed-citation></ref><ref id=\"B13\"><label>13.</label><mixed-citation publication-type=\"journal\">\\n<person-group person-group-type=\"author\"><name><surname>Maingret</surname><given-names>F.</given-names></name><name><surname>Patel</surname><given-names>A. J.</given-names></name><name><surname>Lazdunski</surname><given-names>M.</given-names></name><name><surname>Honor&#x000e9;</surname><given-names>E.</given-names></name></person-group> (<year>2001</year>) <source>EMBO J.</source> <volume>20</volume>, <fpage>47</fpage>&#x02013;<lpage>54</lpage><pub-id pub-id-type=\"pmid\">11226154</pub-id></mixed-citation></ref><ref id=\"B14\"><label>14.</label><mixed-citation publication-type=\"journal\">\\n<person-group person-group-type=\"author\"><name><surname>Kollewe</surname><given-names>A.</given-names></name><name><surname>Lau</surname><given-names>A. Y.</given-names></name><name><surname>Sullivan</surname><given-names>A.</given-names></name><name><surname>Roux</surname><given-names>B.</given-names></name><name><surname>Goldstein</surname><given-names>S. A.</given-names></name></person-group> (<year>2009</year>) <source>J. Gen. Physiol.</source> <volume>134</volume>, <fpage>53</fpage>&#x02013;<lpage>68</lpage><pub-id pub-id-type=\"pmid\">19564427</pub-id></mixed-citation></ref><ref id=\"B15\"><label>15.</label><mixed-citation publication-type=\"journal\">\\n<person-group person-group-type=\"author\"><name><surname>Armstrong</surname><given-names>C. M.</given-names></name></person-group> (<year>1971</year>) <source>J. Gen. Physiol.</source> <volume>58</volume>, <fpage>413</fpage>&#x02013;<lpage>437</lpage><pub-id pub-id-type=\"pmid\">5112659</pub-id></mixed-citation></ref><ref id=\"B16\"><label>16.</label><mixed-citation publication-type=\"journal\">\\n<person-group person-group-type=\"author\"><name><surname>Barrows</surname><given-names>B.</given-names></name><name><surname>Cheung</surname><given-names>K.</given-names></name><name><surname>Bialobrzeski</surname><given-names>T.</given-names></name><name><surname>Foster</surname><given-names>J.</given-names></name><name><surname>Schulze</surname><given-names>J.</given-names></name><name><surname>Miller</surname><given-names>A.</given-names></name></person-group> (<year>2009</year>) <source>Channels</source> <volume>3</volume>, <fpage>239</fpage>&#x02013;<lpage>248</lpage><pub-id pub-id-type=\"pmid\">19617705</pub-id></mixed-citation></ref><ref id=\"B17\"><label>17.</label><mixed-citation publication-type=\"journal\">\\n<person-group person-group-type=\"author\"><name><surname>Decher</surname><given-names>N.</given-names></name><name><surname>Kumar</surname><given-names>P.</given-names></name><name><surname>Gonzalez</surname><given-names>T.</given-names></name><name><surname>Pirard</surname><given-names>B.</given-names></name><name><surname>Sanguinetti</surname><given-names>M. C.</given-names></name></person-group> (<year>2006</year>) <source>Mol. Pharmacol.</source> <volume>70</volume>, <fpage>1204</fpage>&#x02013;<lpage>1211</lpage><pub-id pub-id-type=\"pmid\">16835355</pub-id></mixed-citation></ref><ref id=\"B18\"><label>18.</label><mixed-citation publication-type=\"journal\">\\n<person-group person-group-type=\"author\"><name><surname>Dilmac</surname><given-names>N.</given-names></name><name><surname>Hilliard</surname><given-names>N.</given-names></name><name><surname>Hockerman</surname><given-names>G. H.</given-names></name></person-group> (<year>2004</year>) <source>Mol. Pharmacol.</source> <volume>66</volume>, <fpage>1236</fpage>&#x02013;<lpage>1247</lpage><pub-id pub-id-type=\"pmid\">15286207</pub-id></mixed-citation></ref><ref id=\"B19\"><label>19.</label><mixed-citation publication-type=\"journal\">\\n<person-group person-group-type=\"author\"><name><surname>Mitcheson</surname><given-names>J. S.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Lin</surname><given-names>M.</given-names></name><name><surname>Culberson</surname><given-names>C.</given-names></name><name><surname>Sanguinetti</surname><given-names>M. C.</given-names></name></person-group> (<year>2000</year>) <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>97</volume>, <fpage>12329</fpage>&#x02013;<lpage>12333</lpage><pub-id pub-id-type=\"pmid\">11005845</pub-id></mixed-citation></ref><ref id=\"B20\"><label>20.</label><mixed-citation publication-type=\"journal\">\\n<person-group person-group-type=\"author\"><name><surname>Lerche</surname><given-names>C.</given-names></name><name><surname>Bruhova</surname><given-names>I.</given-names></name><name><surname>Lerche</surname><given-names>H.</given-names></name><name><surname>Steinmeyer</surname><given-names>K.</given-names></name><name><surname>Wei</surname><given-names>A. D.</given-names></name><name><surname>Strutz-Seebohm</surname><given-names>N.</given-names></name><name><surname>Lang</surname><given-names>F.</given-names></name><name><surname>Busch</surname><given-names>A. E.</given-names></name><name><surname>Zhorov</surname><given-names>B. S.</given-names></name><name><surname>Seebohm</surname><given-names>G.</given-names></name></person-group> (<year>2007</year>) <source>Mol. Pharmacol.</source> <volume>71</volume>, <fpage>1503</fpage>&#x02013;<lpage>1511</lpage><pub-id pub-id-type=\"pmid\">17347319</pub-id></mixed-citation></ref><ref id=\"B21\"><label>21.</label><mixed-citation publication-type=\"journal\">\\n<person-group person-group-type=\"author\"><name><surname>Strutz-Seebohm</surname><given-names>N.</given-names></name><name><surname>Gutcher</surname><given-names>I.</given-names></name><name><surname>Decher</surname><given-names>N.</given-names></name><name><surname>Steinmeyer</surname><given-names>K.</given-names></name><name><surname>Lang</surname><given-names>F.</given-names></name><name><surname>Seebohm</surname><given-names>G.</given-names></name></person-group> (<year>2007</year>) <source>Cell Physiol. Biochem.</source> <volume>20</volume>, <fpage>791</fpage>&#x02013;<lpage>800</lpage><pub-id pub-id-type=\"pmid\">17982261</pub-id></mixed-citation></ref><ref id=\"B22\"><label>22.</label><mixed-citation publication-type=\"journal\">\\n<person-group person-group-type=\"author\"><name><surname>Faraldo-G&#x000f3;mez</surname><given-names>J. D.</given-names></name><name><surname>Kutluay</surname><given-names>E.</given-names></name><name><surname>Jogini</surname><given-names>V.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Heginbotham</surname><given-names>L.</given-names></name><name><surname>Roux</surname><given-names>B.</given-names></name></person-group> (<year>2007</year>) <source>J. Mol. Biol.</source> <volume>365</volume>, <fpage>649</fpage>&#x02013;<lpage>662</lpage><pub-id pub-id-type=\"pmid\">17070844</pub-id></mixed-citation></ref><ref id=\"B23\"><label>23.</label><mixed-citation publication-type=\"journal\">\\n<person-group person-group-type=\"author\"><name><surname>Bruhova</surname><given-names>I.</given-names></name><name><surname>Zhorov</surname><given-names>B. S.</given-names></name></person-group> (<year>2007</year>) <source>BMC Struct. Biol.</source> <volume>7</volume>, <fpage>5</fpage><pub-id pub-id-type=\"pmid\">17261195</pub-id></mixed-citation></ref><ref id=\"B24\"><label>24.</label><mixed-citation publication-type=\"journal\">\\n<person-group person-group-type=\"author\"><name><surname>Doyle</surname><given-names>D. A.</given-names></name><name><surname>Morais Cabral</surname><given-names>J.</given-names></name><name><surname>Pfuetzner</surname><given-names>R. A.</given-names></name><name><surname>Kuo</surname><given-names>A.</given-names></name><name><surname>Gulbis</surname><given-names>J. M.</given-names></name><name><surname>Cohen</surname><given-names>S. L.</given-names></name><name><surname>Chait</surname><given-names>B. T.</given-names></name><name><surname>MacKinnon</surname><given-names>R.</given-names></name></person-group> (<year>1998</year>) <source>Science</source> <volume>280</volume>, <fpage>69</fpage>&#x02013;<lpage>77</lpage><pub-id pub-id-type=\"pmid\">9525859</pub-id></mixed-citation></ref><ref id=\"B25\"><label>25.</label><mixed-citation publication-type=\"journal\">\\n<person-group person-group-type=\"author\"><name><surname>Long</surname><given-names>S. B.</given-names></name><name><surname>Tao</surname><given-names>X.</given-names></name><name><surname>Campbell</surname><given-names>E. B.</given-names></name><name><surname>MacKinnon</surname><given-names>R.</given-names></name></person-group> (<year>2007</year>) <source>Nature</source> <volume>450</volume>, <fpage>376</fpage>&#x02013;<lpage>382</lpage><pub-id pub-id-type=\"pmid\">18004376</pub-id></mixed-citation></ref><ref id=\"B26\"><label>26.</label><mixed-citation publication-type=\"journal\">\\n<person-group person-group-type=\"author\"><name><surname>Kuo</surname><given-names>A.</given-names></name><name><surname>Gulbis</surname><given-names>J. M.</given-names></name><name><surname>Antcliff</surname><given-names>J. F.</given-names></name><name><surname>Rahman</surname><given-names>T.</given-names></name><name><surname>Lowe</surname><given-names>E. D.</given-names></name><name><surname>Zimmer</surname><given-names>J.</given-names></name><name><surname>Cuthbertson</surname><given-names>J.</given-names></name><name><surname>Ashcroft</surname><given-names>F. M.</given-names></name><name><surname>Ezaki</surname><given-names>T.</given-names></name><name><surname>Doyle</surname><given-names>D. A.</given-names></name></person-group> (<year>2003</year>) <source>Science</source> <volume>300</volume>, <fpage>1922</fpage>&#x02013;<lpage>1926</lpage><pub-id pub-id-type=\"pmid\">12738871</pub-id></mixed-citation></ref><ref id=\"B27\"><label>27.</label><mixed-citation publication-type=\"journal\">\\n<person-group person-group-type=\"author\"><name><surname>Chatelain</surname><given-names>F. C.</given-names></name><name><surname>Alagem</surname><given-names>N.</given-names></name><name><surname>Xu</surname><given-names>Q.</given-names></name><name><surname>Pancaroglu</surname><given-names>R.</given-names></name><name><surname>Reuveny</surname><given-names>E.</given-names></name><name><surname>Minor</surname><given-names>D. L.</given-names><suffix>Jr.</suffix></name></person-group> (<year>2005</year>) <source>Neuron</source> <volume>47</volume>, <fpage>833</fpage>&#x02013;<lpage>843</lpage><pub-id pub-id-type=\"pmid\">16157278</pub-id></mixed-citation></ref><ref id=\"B28\"><label>28.</label><mixed-citation publication-type=\"journal\">\\n<person-group person-group-type=\"author\"><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Seebohm</surname><given-names>G.</given-names></name><name><surname>Sanguinetti</surname><given-names>M. C.</given-names></name></person-group> (<year>2002</year>) <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>99</volume>, <fpage>12461</fpage>&#x02013;<lpage>12466</lpage><pub-id pub-id-type=\"pmid\">12209010</pub-id></mixed-citation></ref><ref id=\"B29\"><label>29.</label><mixed-citation publication-type=\"journal\">\\n<person-group person-group-type=\"author\"><name><surname>Treptow</surname><given-names>W.</given-names></name><name><surname>Klein</surname><given-names>M. L.</given-names></name></person-group> (<year>2010</year>) <source>J. Am. Chem. Soc.</source> <volume>132</volume>, <fpage>8145</fpage>&#x02013;<lpage>8151</lpage><pub-id pub-id-type=\"pmid\">20491479</pub-id></mixed-citation></ref></ref-list></back></article>',\n",
       " 'Rat organic anion transporter 1 (Oat1), Oat2, and Oat3, members of the organic anion transporter family, transport some organic anions across cellular membranes. Previously, highest Oat1 and Oat3 mRNA expression was reported in kidney and Oat2 in liver. However, gender and developmental differences in Oat expression remain unknown. This study describes gender- and age-specific patterns of rat organic anion transporter expression in various tissues. Oat mRNA expression was evaluated in adult male and female Sprague-Dawley rat tissues, and developmental expression was also determined in kidneys of Sprague-Dawley rats ranging in age from days 0 through 45. Expression was quantified using branched-DNA signal amplification. Oat1 mRNA expression was primarily observed in kidney. Surprisingly, Oat2 mRNA expression was also highest in kidney rather than in liver. Moreover, considerably higher Oat2 levels were seen in female kidney as compared with male. Finally, Oat3 mRNA expression was highest in kidney of both genders, whereas a male-predominant pattern was observed in liver. At birth, all kidney Oat mRNA levels were low. Renal Oat1 expression gradually increased throughout development, approaching adult levels at 30 days of age, where at days 40 and 45 Oat1 levels were greater in males than females. Oat2 expression in kidney was minimal through day 30 but increased dramatically at day 35 in females only. Lastly, Oat3 mRNA expression in kidney matured earliest, rapidly increasing from birth through day 10. These data indicate that Oat mRNA expression is primarily localized to the kidney, and observed expression patterns may explain some previously recognized age- and gender-dependent toxicities associated with chemical exposure.',\n",
       " 'Volatile anesthetics produce safe, reversible unconsciousness, amnesia and analgesia via hyperpolarization of mammalian neurons. In molluscan pacemaker neurons, they activate an inhibitory synaptic K+ current (IKAn), proposed to be important in general anesthesia. Here we show that TASK and TREK-1, two recently cloned mammalian two-P-domain K+ channels similar to IKAn in biophysical properties, are activated by volatile general anesthetics. Chloroform, diethyl ether, halothane and isoflurane activated TREK-1, whereas only halothane and isoflurane activated TASK. Carboxy (C)-terminal regions were critical for anesthetic activation in both channels. Thus both TREK-1 and TASK are possibly important target sites for these agents.',\n",
       " '<full-text-retrieval-response xmlns=\"http://www.elsevier.com/xml/svapi/article/dtd\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\" xmlns:prism=\"http://prismstandard.org/namespaces/basic/2.0/\" xmlns:dcterms=\"http://purl.org/dc/terms/\" xmlns:dc=\"http://purl.org/dc/elements/1.1/\" xmlns:xocs=\"http://www.elsevier.com/xml/xocs/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:tb=\"http://www.elsevier.com/xml/common/table/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" xmlns:ja=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns:cals=\"http://www.elsevier.com/xml/common/cals/dtd\" xmlns:bk=\"http://www.elsevier.com/xml/bk/dtd\"><coredata><prism:url>https://api.elsevier.com/content/article/pii/S0166223607002445</prism:url><dc:identifier>doi:10.1016/j.tins.2007.08.003</dc:identifier><eid>1-s2.0-S0166223607002445</eid><prism:doi>10.1016/j.tins.2007.08.003</prism:doi><pii>S0166-2236(07)00244-5</pii><dc:title>The TASK background K2P channels: chemo- and nutrient sensors </dc:title><prism:publicationName>Trends in Neurosciences</prism:publicationName><prism:aggregationType>Journal</prism:aggregationType><pubType>Review</pubType><prism:issn>01662236</prism:issn><prism:volume>30</prism:volume><prism:issueIdentifier>11</prism:issueIdentifier><prism:startingPage>573</prism:startingPage><prism:endingPage>580</prism:endingPage><prism:pageRange>573-580</prism:pageRange><prism:number>11</prism:number><dc:format>text/xml</dc:format><prism:coverDate>2007-11-30</prism:coverDate><prism:coverDisplayDate>November 2007</prism:coverDisplayDate><prism:copyright>Copyright © 2007 Elsevier Ltd. All rights reserved.</prism:copyright><prism:publisher>Elsevier Ltd.</prism:publisher><dc:creator>Duprat, Fabrice</dc:creator><dc:creator>Lauritzen, Inger</dc:creator><dc:creator>Patel, Amanda</dc:creator><dc:creator>Honoré, Eric</dc:creator><dc:description>Specialized chemo- and nutrient-sensing cells share a common electrophysiological mechanism by transducing low O2, high CO2 and low glucose stimuli into a compensatory cellular response: the closing of background K+ channels encoded by the K2P subunits. Inhibition of the TASK K2P channels by extracellular acidosis leads to an increased excitability of brainstem respiratory neurons. Moreover, hypoxic down-modulation of TASK channels is implicated in the activation of glomus cells in the carotid body. Stimulation of both types of cell leads to an enhanced ventilation and to cardiocirculatory adjustments. Differential modulation of TASK channels by acidosis and high glucose alters excitability of the hypothalamic orexin neurons, which influence arousal, food seeking and breathing. These recent results shed light on the role of TASK channels in sensing physiological stimuli.</dc:description><openaccess>0</openaccess><openaccessArticle>false</openaccessArticle><openaccessType/><openArchiveArticle>false</openArchiveArticle><openaccessSponsorName/><openaccessSponsorType/><openaccessUserLicense/><link rel=\"self\" href=\"https://api.elsevier.com/content/article/pii/S0166223607002445\"/><link rel=\"scidir\" href=\"http://www.sciencedirect.com/science/article/pii/S0166223607002445\"/></coredata><objects><object ref=\"gr1\" category=\"standard\" type=\"IMAGE-DOWNSAMPLED\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"812\" height=\"526\" size=\"82351\">https://api.elsevier.com/content/object/eid/1-s2.0-S0166223607002445-gr1.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr1\" category=\"thumbnail\" type=\"IMAGE-THUMBNAIL\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"219\" height=\"142\" size=\"5696\">https://api.elsevier.com/content/object/eid/1-s2.0-S0166223607002445-gr1.sml?httpAccept=%2A%2F%2A</object><object ref=\"gr2\" category=\"standard\" type=\"IMAGE-DOWNSAMPLED\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"812\" height=\"686\" size=\"84404\">https://api.elsevier.com/content/object/eid/1-s2.0-S0166223607002445-gr2.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr2\" category=\"thumbnail\" type=\"IMAGE-THUMBNAIL\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"194\" height=\"164\" size=\"5744\">https://api.elsevier.com/content/object/eid/1-s2.0-S0166223607002445-gr2.sml?httpAccept=%2A%2F%2A</object><object ref=\"gr3\" category=\"standard\" type=\"IMAGE-DOWNSAMPLED\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"812\" height=\"626\" size=\"85984\">https://api.elsevier.com/content/object/eid/1-s2.0-S0166223607002445-gr3.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr3\" category=\"thumbnail\" type=\"IMAGE-THUMBNAIL\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"213\" height=\"164\" size=\"6729\">https://api.elsevier.com/content/object/eid/1-s2.0-S0166223607002445-gr3.sml?httpAccept=%2A%2F%2A</object></objects><scopus-id>35748957186</scopus-id><scopus-eid>2-s2.0-35748957186</scopus-eid><pubmed-id>17945357</pubmed-id><link rel=\"abstract\" href=\"https://api.elsevier.com/content/abstract/scopus_id/35748957186\"/><originalText><xocs:doc xmlns:xoe=\"http://www.elsevier.com/xml/xoe/dtd\" xsi:schemaLocation=\"http://www.elsevier.com/xml/xocs/dtd http://be-prod3a/schema/dtds/document/fulltext/xcr/xocs-article.xsd\"><xocs:meta><xocs:content-family>serial</xocs:content-family><xocs:content-type>JL</xocs:content-type><xocs:cid>271059</xocs:cid><xocs:ssids><xocs:ssid type=\"alllist\">291210</xocs:ssid><xocs:ssid type=\"subj\">291735</xocs:ssid><xocs:ssid type=\"content\">31</xocs:ssid></xocs:ssids><xocs:srctitle>Trends in Neurosciences</xocs:srctitle><xocs:normalized-srctitle>TRENDSINNEUROSCIENCES</xocs:normalized-srctitle><xocs:orig-load-date yyyymmdd=\"20071022\">2007-10-22</xocs:orig-load-date><xocs:available-online-date yyyymmdd=\"20071022\">2007-10-22</xocs:available-online-date><xocs:ew-transaction-id>2011-05-23T21:06:21</xocs:ew-transaction-id><xocs:eid>1-s2.0-S0166223607002445</xocs:eid><xocs:pii-formatted>S0166-2236(07)00244-5</xocs:pii-formatted><xocs:pii-unformatted>S0166223607002445</xocs:pii-unformatted><xocs:doi>10.1016/j.tins.2007.08.003</xocs:doi><xocs:item-stage>S300</xocs:item-stage><xocs:item-version-number>S300.2</xocs:item-version-number><xocs:item-weight>FULL-TEXT</xocs:item-weight><xocs:hub-eid>1-s2.0-S0166223607X02868</xocs:hub-eid><xocs:timestamp yyyymmdd=\"20150515\">2015-05-15T01:23:23.093869-04:00</xocs:timestamp><xocs:dco>0</xocs:dco><xocs:tomb>0</xocs:tomb><xocs:date-search-begin>20071101</xocs:date-search-begin><xocs:date-search-end>20071130</xocs:date-search-end><xocs:year-nav>2007</xocs:year-nav><xocs:indexeddate epoch=\"1193011200\">2007-10-22T00:00:00Z</xocs:indexeddate><xocs:articleinfo>articleinfo crossmark dco dateupdated tomb dateloaded datesearch indexeddate issuelist volumelist yearnav articletitlenorm authfirstinitialnorm authfirstsurnamenorm cid cids contenttype copyright dateloadedtxt docsubtype doctype doi eid ewtransactionid hubeid issfirst issn issnnorm itemstage itemtransactionid itemweight openaccess openarchive pg pgfirst pglast pii piinorm pubdateend pubdatestart pubdatetxt pubyr sectiontitle sortorder srctitle srctitlenorm srctype subheadings volfirst volissue webpdf webpdfpagecount figure body acknowledge affil articletitle auth authfirstini authfull authlast glossary primabst pubtype ref alllist content subj ssids</xocs:articleinfo><xocs:issns><xocs:issn-primary-formatted>0166-2236</xocs:issn-primary-formatted><xocs:issn-primary-unformatted>01662236</xocs:issn-primary-unformatted></xocs:issns><xocs:crossmark is-crossmark=\"0\"/><xocs:vol-first>30</xocs:vol-first><xocs:volume-list><xocs:volume>30</xocs:volume></xocs:volume-list><xocs:iss-first>11</xocs:iss-first><xocs:issue-list><xocs:issue>11</xocs:issue></xocs:issue-list><xocs:vol-iss-suppl-text>Volume 30, Issue 11</xocs:vol-iss-suppl-text><xocs:sort-order>4</xocs:sort-order><xocs:first-fp>573</xocs:first-fp><xocs:last-lp>580</xocs:last-lp><xocs:pages><xocs:first-page>573</xocs:first-page><xocs:last-page>580</xocs:last-page></xocs:pages><xocs:cover-date-orig><xocs:start-date>200711</xocs:start-date></xocs:cover-date-orig><xocs:cover-date-text>November 2007</xocs:cover-date-text><xocs:cover-date-start>2007-11-01</xocs:cover-date-start><xocs:cover-date-end>2007-11-30</xocs:cover-date-end><xocs:cover-date-year>2007</xocs:cover-date-year><xocs:hub-sec><xocs:hub-sec-title>Review</xocs:hub-sec-title></xocs:hub-sec><xocs:document-type>article</xocs:document-type><xocs:document-subtype>rev</xocs:document-subtype><xocs:copyright-line>Copyright © 2007 Elsevier Ltd. All rights reserved.</xocs:copyright-line><xocs:normalized-article-title>TASKBACKGROUNDK2PCHANNELSCHEMONUTRIENTSENSORS</xocs:normalized-article-title><xocs:normalized-first-auth-surname>DUPRAT</xocs:normalized-first-auth-surname><xocs:normalized-first-auth-initial>F</xocs:normalized-first-auth-initial><xocs:item-toc><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-section-title>Oxygen sensing in the carotid body glomus cells</xocs:item-toc-section-title><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-section-title>The metabolic hypothesis</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-section-title>The NOX4 hypothesis</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-section-title>The CO hypothesis</xocs:item-toc-section-title></xocs:item-toc-entry></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-section-title>Acid sensing in the brainstem</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-section-title>Glucose and CO<ce:inf loc=\"post\">2</ce:inf>/pH sensing in the hypothalamic orexin neurons</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-section-title>Conclusions</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-section-title>Future directions</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:acknowledgment\"><xocs:item-toc-section-title>Acknowledgements</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:bibliography\"><xocs:item-toc-section-title>References</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:glossary\"><xocs:item-toc-section-title>Glossary</xocs:item-toc-section-title></xocs:item-toc-entry></xocs:item-toc><xocs:references><xocs:ref-info refid=\"bib1\"><xocs:ref-normalized-surname>HONORE</xocs:ref-normalized-surname><xocs:ref-pub-year>2007</xocs:ref-pub-year><xocs:ref-first-fp>251</xocs:ref-first-fp><xocs:ref-last-lp>261</xocs:ref-last-lp><xocs:ref-normalized-initial>E</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib2\"><xocs:ref-normalized-surname>LESAGE</xocs:ref-normalized-surname><xocs:ref-pub-year>1996</xocs:ref-pub-year><xocs:ref-first-fp>1004</xocs:ref-first-fp><xocs:ref-last-lp>1011</xocs:ref-last-lp><xocs:ref-normalized-initial>F</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib3\"><xocs:ref-normalized-surname>KETCHUM</xocs:ref-normalized-surname><xocs:ref-pub-year>1995</xocs:ref-pub-year><xocs:ref-first-fp>690</xocs:ref-first-fp><xocs:ref-last-lp>695</xocs:ref-last-lp><xocs:ref-normalized-initial>K</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib4\"><xocs:ref-normalized-surname>GOLDSTEIN</xocs:ref-normalized-surname><xocs:ref-pub-year>1996</xocs:ref-pub-year><xocs:ref-first-fp>13256</xocs:ref-first-fp><xocs:ref-last-lp>13261</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib5\"><xocs:ref-normalized-surname>WARTH</xocs:ref-normalized-surname><xocs:ref-pub-year>2004</xocs:ref-pub-year><xocs:ref-first-fp>8215</xocs:ref-first-fp><xocs:ref-last-lp>8220</xocs:ref-last-lp><xocs:ref-normalized-initial>R</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib6\"><xocs:ref-normalized-surname>BARRIERE</xocs:ref-normalized-surname><xocs:ref-pub-year>2003</xocs:ref-pub-year><xocs:ref-first-fp>177</xocs:ref-first-fp><xocs:ref-last-lp>190</xocs:ref-last-lp><xocs:ref-normalized-initial>H</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib7\"><xocs:ref-normalized-surname>PATEL</xocs:ref-normalized-surname><xocs:ref-pub-year>2001</xocs:ref-pub-year><xocs:ref-first-fp>339</xocs:ref-first-fp><xocs:ref-last-lp>346</xocs:ref-last-lp><xocs:ref-normalized-initial>A</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib8\"><xocs:ref-normalized-surname>LAURITZEN</xocs:ref-normalized-surname><xocs:ref-pub-year>2003</xocs:ref-pub-year><xocs:ref-first-fp>32068</xocs:ref-first-fp><xocs:ref-last-lp>32076</xocs:ref-last-lp><xocs:ref-normalized-initial>I</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib9\"><xocs:ref-normalized-surname>BERG</xocs:ref-normalized-surname><xocs:ref-pub-year>2004</xocs:ref-pub-year><xocs:ref-first-fp>6693</xocs:ref-first-fp><xocs:ref-last-lp>6702</xocs:ref-last-lp><xocs:ref-normalized-initial>A</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib10\"><xocs:ref-normalized-surname>KANG</xocs:ref-normalized-surname><xocs:ref-pub-year>2004</xocs:ref-pub-year><xocs:ref-first-fp>64</xocs:ref-first-fp><xocs:ref-last-lp>77</xocs:ref-last-lp><xocs:ref-normalized-initial>D</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib11\"><xocs:ref-normalized-surname>CZIRJAK</xocs:ref-normalized-surname><xocs:ref-pub-year>2001</xocs:ref-pub-year><xocs:ref-first-fp>5426</xocs:ref-first-fp><xocs:ref-last-lp>5432</xocs:ref-last-lp><xocs:ref-normalized-initial>G</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib12\"><xocs:ref-normalized-surname>DUPRAT</xocs:ref-normalized-surname><xocs:ref-pub-year>1997</xocs:ref-pub-year><xocs:ref-first-fp>5464</xocs:ref-first-fp><xocs:ref-last-lp>5471</xocs:ref-last-lp><xocs:ref-normalized-initial>F</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib13\"><xocs:ref-normalized-surname>HAN</xocs:ref-normalized-surname><xocs:ref-pub-year>2002</xocs:ref-pub-year><xocs:ref-first-fp>431</xocs:ref-first-fp><xocs:ref-last-lp>444</xocs:ref-last-lp><xocs:ref-normalized-initial>J</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib14\"><xocs:ref-normalized-surname>BUCKLER</xocs:ref-normalized-surname><xocs:ref-pub-year>2000</xocs:ref-pub-year><xocs:ref-first-fp>135</xocs:ref-first-fp><xocs:ref-last-lp>142</xocs:ref-last-lp><xocs:ref-normalized-initial>K</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib15\"><xocs:ref-normalized-surname>MULKEY</xocs:ref-normalized-surname><xocs:ref-pub-year>2004</xocs:ref-pub-year><xocs:ref-first-fp>1360</xocs:ref-first-fp><xocs:ref-last-lp>1369</xocs:ref-last-lp><xocs:ref-normalized-initial>D</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib16\"><xocs:ref-normalized-surname>TALLEY</xocs:ref-normalized-surname><xocs:ref-pub-year>2000</xocs:ref-pub-year><xocs:ref-first-fp>399</xocs:ref-first-fp><xocs:ref-last-lp>410</xocs:ref-last-lp><xocs:ref-normalized-initial>E</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib17\"><xocs:ref-normalized-surname>TALLEY</xocs:ref-normalized-surname><xocs:ref-pub-year>2001</xocs:ref-pub-year><xocs:ref-first-fp>7491</xocs:ref-first-fp><xocs:ref-last-lp>7505</xocs:ref-last-lp><xocs:ref-normalized-initial>E</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib18\"><xocs:ref-normalized-surname>WASHBURN</xocs:ref-normalized-surname><xocs:ref-pub-year>2002</xocs:ref-pub-year><xocs:ref-first-fp>1256</xocs:ref-first-fp><xocs:ref-last-lp>1265</xocs:ref-last-lp><xocs:ref-normalized-initial>C</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib19\"><xocs:ref-normalized-surname>HARTNESS</xocs:ref-normalized-surname><xocs:ref-pub-year>2001</xocs:ref-pub-year><xocs:ref-first-fp>26499</xocs:ref-first-fp><xocs:ref-last-lp>26508</xocs:ref-last-lp><xocs:ref-normalized-initial>M</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib20\"><xocs:ref-normalized-surname>GURNEY</xocs:ref-normalized-surname><xocs:ref-pub-year>2003</xocs:ref-pub-year><xocs:ref-first-fp>957</xocs:ref-first-fp><xocs:ref-last-lp>964</xocs:ref-last-lp><xocs:ref-normalized-initial>A</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib21\"><xocs:ref-normalized-surname>OLSCHEWSKI</xocs:ref-normalized-surname><xocs:ref-pub-year>2006</xocs:ref-pub-year><xocs:ref-first-fp>1072</xocs:ref-first-fp><xocs:ref-last-lp>1080</xocs:ref-last-lp><xocs:ref-normalized-initial>A</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib22\"><xocs:ref-normalized-surname>RAU</xocs:ref-normalized-surname><xocs:ref-pub-year>2006</xocs:ref-pub-year><xocs:ref-first-fp>955</xocs:ref-first-fp><xocs:ref-last-lp>963</xocs:ref-last-lp><xocs:ref-normalized-initial>K</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib23\"><xocs:ref-normalized-surname>COOPER</xocs:ref-normalized-surname><xocs:ref-pub-year>2004</xocs:ref-pub-year><xocs:ref-first-fp>209</xocs:ref-first-fp><xocs:ref-last-lp>224</xocs:ref-last-lp><xocs:ref-normalized-initial>B</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib24\"><xocs:ref-normalized-surname>BAUMANN</xocs:ref-normalized-surname><xocs:ref-pub-year>2004</xocs:ref-pub-year><xocs:ref-first-fp>1343</xocs:ref-first-fp><xocs:ref-last-lp>1351</xocs:ref-last-lp><xocs:ref-normalized-initial>T</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib25\"><xocs:ref-normalized-surname>LIN</xocs:ref-normalized-surname><xocs:ref-pub-year>2004</xocs:ref-pub-year><xocs:ref-first-fp>2909</xocs:ref-first-fp><xocs:ref-last-lp>2919</xocs:ref-last-lp><xocs:ref-normalized-initial>W</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib26\"><xocs:ref-normalized-surname>RICHTER</xocs:ref-normalized-surname><xocs:ref-pub-year>2004</xocs:ref-pub-year><xocs:ref-first-fp>1928</xocs:ref-first-fp><xocs:ref-last-lp>1936</xocs:ref-last-lp><xocs:ref-normalized-initial>T</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib27\"><xocs:ref-normalized-surname>BURDAKOV</xocs:ref-normalized-surname><xocs:ref-pub-year>2006</xocs:ref-pub-year><xocs:ref-first-fp>711</xocs:ref-first-fp><xocs:ref-last-lp>722</xocs:ref-last-lp><xocs:ref-normalized-initial>D</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib28\"><xocs:ref-normalized-surname>WILLIAMS</xocs:ref-normalized-surname><xocs:ref-pub-year>2007</xocs:ref-pub-year><xocs:ref-first-fp>10685</xocs:ref-first-fp><xocs:ref-last-lp>10690</xocs:ref-last-lp><xocs:ref-normalized-initial>R</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib29\"><xocs:ref-normalized-surname>BARBE</xocs:ref-normalized-surname><xocs:ref-pub-year>2002</xocs:ref-pub-year><xocs:ref-first-fp>933</xocs:ref-first-fp><xocs:ref-last-lp>945</xocs:ref-last-lp><xocs:ref-normalized-initial>C</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib30\"><xocs:ref-normalized-surname>YAMAMOTO</xocs:ref-normalized-surname><xocs:ref-pub-year>2002</xocs:ref-pub-year><xocs:ref-first-fp>304</xocs:ref-first-fp><xocs:ref-last-lp>307</xocs:ref-last-lp><xocs:ref-normalized-initial>Y</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib31\"><xocs:ref-normalized-surname>KIM</xocs:ref-normalized-surname><xocs:ref-pub-year>2006</xocs:ref-pub-year><xocs:ref-first-fp>43</xocs:ref-first-fp><xocs:ref-last-lp>47</xocs:ref-last-lp><xocs:ref-normalized-initial>I</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib32\"><xocs:ref-normalized-surname>BUCKLER</xocs:ref-normalized-surname><xocs:ref-pub-year>2007</xocs:ref-pub-year><xocs:ref-first-fp>55</xocs:ref-first-fp><xocs:ref-last-lp>64</xocs:ref-last-lp><xocs:ref-normalized-initial>K</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib33\"><xocs:ref-normalized-surname>CLARKE</xocs:ref-normalized-surname><xocs:ref-pub-year>2004</xocs:ref-pub-year><xocs:ref-first-fp>51</xocs:ref-first-fp><xocs:ref-last-lp>62</xocs:ref-last-lp><xocs:ref-normalized-initial>C</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib34\"><xocs:ref-normalized-surname>PLANT</xocs:ref-normalized-surname><xocs:ref-pub-year>2005</xocs:ref-pub-year><xocs:ref-first-fp>326</xocs:ref-first-fp><xocs:ref-last-lp>333</xocs:ref-last-lp><xocs:ref-normalized-initial>L</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib35\"><xocs:ref-normalized-surname>PATEL</xocs:ref-normalized-surname><xocs:ref-pub-year>2001</xocs:ref-pub-year><xocs:ref-first-fp>221</xocs:ref-first-fp><xocs:ref-last-lp>227</xocs:ref-last-lp><xocs:ref-normalized-initial>A</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib36\"><xocs:ref-normalized-surname>JOHNSON</xocs:ref-normalized-surname><xocs:ref-pub-year>2004</xocs:ref-pub-year><xocs:ref-first-fp>C391</xocs:ref-first-fp><xocs:ref-last-lp>C397</xocs:ref-last-lp><xocs:ref-normalized-initial>R</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib37\"><xocs:ref-normalized-surname>LEWIS</xocs:ref-normalized-surname><xocs:ref-pub-year>2001</xocs:ref-pub-year><xocs:ref-first-fp>1290</xocs:ref-first-fp><xocs:ref-last-lp>1294</xocs:ref-last-lp><xocs:ref-normalized-initial>A</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib38\"><xocs:ref-normalized-surname>DUCHEN</xocs:ref-normalized-surname><xocs:ref-pub-year>1992</xocs:ref-pub-year><xocs:ref-first-fp>13</xocs:ref-first-fp><xocs:ref-last-lp>31</xocs:ref-last-lp><xocs:ref-normalized-initial>M</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib39\"><xocs:ref-normalized-surname>WYATT</xocs:ref-normalized-surname><xocs:ref-pub-year>2004</xocs:ref-pub-year><xocs:ref-first-fp>175</xocs:ref-first-fp><xocs:ref-last-lp>191</xocs:ref-last-lp><xocs:ref-normalized-initial>C</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib40\"><xocs:ref-normalized-surname>MAINGRET</xocs:ref-normalized-surname><xocs:ref-pub-year>2001</xocs:ref-pub-year><xocs:ref-first-fp>47</xocs:ref-first-fp><xocs:ref-last-lp>54</xocs:ref-last-lp><xocs:ref-normalized-initial>F</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib41\"><xocs:ref-normalized-surname>WILLIAMS</xocs:ref-normalized-surname><xocs:ref-pub-year>2004</xocs:ref-pub-year><xocs:ref-first-fp>L221</xocs:ref-first-fp><xocs:ref-last-lp>L230</xocs:ref-last-lp><xocs:ref-normalized-initial>B</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib42\"><xocs:ref-normalized-surname>CHEMIN</xocs:ref-normalized-surname><xocs:ref-pub-year>2003</xocs:ref-pub-year><xocs:ref-first-fp>5403</xocs:ref-first-fp><xocs:ref-last-lp>5411</xocs:ref-last-lp><xocs:ref-normalized-initial>J</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib43\"><xocs:ref-normalized-surname>WYATT</xocs:ref-normalized-surname><xocs:ref-pub-year>2007</xocs:ref-pub-year><xocs:ref-first-fp>8092</xocs:ref-first-fp><xocs:ref-last-lp>8098</xocs:ref-last-lp><xocs:ref-normalized-initial>C</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib44\"><xocs:ref-normalized-surname>LEE</xocs:ref-normalized-surname><xocs:ref-pub-year>2006</xocs:ref-pub-year><xocs:ref-first-fp>499</xocs:ref-first-fp><xocs:ref-last-lp>507</xocs:ref-last-lp><xocs:ref-normalized-initial>Y</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib45\"><xocs:ref-normalized-surname>GONZALEZ</xocs:ref-normalized-surname><xocs:ref-pub-year>2007</xocs:ref-pub-year><xocs:ref-first-fp>30</xocs:ref-first-fp><xocs:ref-last-lp>44</xocs:ref-last-lp><xocs:ref-normalized-initial>C</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib46\"><xocs:ref-normalized-surname>DUPRAT</xocs:ref-normalized-surname><xocs:ref-pub-year>2004</xocs:ref-pub-year><xocs:ref-first-fp>235</xocs:ref-first-fp><xocs:ref-last-lp>244</xocs:ref-last-lp><xocs:ref-normalized-initial>F</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib47\"><xocs:ref-normalized-surname>WILLIAMS</xocs:ref-normalized-surname><xocs:ref-pub-year>2004</xocs:ref-pub-year><xocs:ref-first-fp>2093</xocs:ref-first-fp><xocs:ref-last-lp>2097</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib48\"><xocs:ref-normalized-surname>ORTEGASAENZ</xocs:ref-normalized-surname><xocs:ref-pub-year>2006</xocs:ref-pub-year><xocs:ref-first-fp>405</xocs:ref-first-fp><xocs:ref-last-lp>411</xocs:ref-last-lp><xocs:ref-normalized-initial>P</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib49\"><xocs:ref-normalized-surname>WASHBURN</xocs:ref-normalized-surname><xocs:ref-pub-year>2003</xocs:ref-pub-year><xocs:ref-first-fp>19</xocs:ref-first-fp><xocs:ref-last-lp>35</xocs:ref-last-lp><xocs:ref-normalized-initial>C</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib50\"><xocs:ref-normalized-surname>BRICKLEY</xocs:ref-normalized-surname><xocs:ref-pub-year>2007</xocs:ref-pub-year><xocs:ref-first-fp>9329</xocs:ref-first-fp><xocs:ref-last-lp>9340</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib51\"><xocs:ref-normalized-surname>VARAS</xocs:ref-normalized-surname><xocs:ref-pub-year>2007</xocs:ref-pub-year><xocs:ref-first-fp>521</xocs:ref-first-fp><xocs:ref-last-lp>536</xocs:ref-last-lp><xocs:ref-normalized-initial>R</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib52\"><xocs:ref-normalized-surname>RAJAN</xocs:ref-normalized-surname><xocs:ref-pub-year>2000</xocs:ref-pub-year><xocs:ref-first-fp>16650</xocs:ref-first-fp><xocs:ref-last-lp>16657</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib53\"><xocs:ref-normalized-surname>LOPES</xocs:ref-normalized-surname><xocs:ref-pub-year>2001</xocs:ref-pub-year><xocs:ref-first-fp>24449</xocs:ref-first-fp><xocs:ref-last-lp>24452</xocs:ref-last-lp><xocs:ref-normalized-initial>C</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib54\"><xocs:ref-normalized-surname>YUILL</xocs:ref-normalized-surname><xocs:ref-pub-year>2004</xocs:ref-pub-year><xocs:ref-first-fp>63</xocs:ref-first-fp><xocs:ref-last-lp>69</xocs:ref-last-lp><xocs:ref-normalized-initial>K</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib55\"><xocs:ref-normalized-surname>MORTON</xocs:ref-normalized-surname><xocs:ref-pub-year>2003</xocs:ref-pub-year><xocs:ref-first-fp>577</xocs:ref-first-fp><xocs:ref-last-lp>583</xocs:ref-last-lp><xocs:ref-normalized-initial>M</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib56\"><xocs:ref-normalized-surname>KIM</xocs:ref-normalized-surname><xocs:ref-pub-year>2000</xocs:ref-pub-year><xocs:ref-first-fp>9340</xocs:ref-first-fp><xocs:ref-last-lp>9347</xocs:ref-last-lp><xocs:ref-normalized-initial>Y</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib57\"><xocs:ref-normalized-surname>PATEL</xocs:ref-normalized-surname><xocs:ref-pub-year>1999</xocs:ref-pub-year><xocs:ref-first-fp>422</xocs:ref-first-fp><xocs:ref-last-lp>426</xocs:ref-last-lp><xocs:ref-normalized-initial>A</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib58\"><xocs:ref-normalized-surname>SIROIS</xocs:ref-normalized-surname><xocs:ref-pub-year>2000</xocs:ref-pub-year><xocs:ref-first-fp>6347</xocs:ref-first-fp><xocs:ref-last-lp>6354</xocs:ref-last-lp><xocs:ref-normalized-initial>J</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib59\"><xocs:ref-normalized-surname>GRUSS</xocs:ref-normalized-surname><xocs:ref-pub-year>2004</xocs:ref-pub-year><xocs:ref-first-fp>443</xocs:ref-first-fp><xocs:ref-last-lp>452</xocs:ref-last-lp><xocs:ref-normalized-initial>M</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib60\"><xocs:ref-normalized-surname>ANDRESENGUIX</xocs:ref-normalized-surname><xocs:ref-pub-year>2007</xocs:ref-pub-year><xocs:ref-first-fp>20977</xocs:ref-first-fp><xocs:ref-last-lp>20990</xocs:ref-last-lp><xocs:ref-normalized-initial>I</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib61\"><xocs:ref-normalized-surname>TALLEY</xocs:ref-normalized-surname><xocs:ref-pub-year>2002</xocs:ref-pub-year><xocs:ref-first-fp>17733</xocs:ref-first-fp><xocs:ref-last-lp>17742</xocs:ref-last-lp><xocs:ref-normalized-initial>E</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib62\"><xocs:ref-normalized-surname>LEONOUDAKIS</xocs:ref-normalized-surname><xocs:ref-pub-year>1998</xocs:ref-pub-year><xocs:ref-first-fp>868</xocs:ref-first-fp><xocs:ref-last-lp>877</xocs:ref-last-lp><xocs:ref-normalized-initial>D</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib63\"><xocs:ref-normalized-surname>KINDLER</xocs:ref-normalized-surname><xocs:ref-pub-year>1999</xocs:ref-pub-year><xocs:ref-first-fp>1092</xocs:ref-first-fp><xocs:ref-last-lp>1102</xocs:ref-last-lp><xocs:ref-normalized-initial>C</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib64\"><xocs:ref-normalized-surname>CZIRJAK</xocs:ref-normalized-surname><xocs:ref-pub-year>2003</xocs:ref-pub-year><xocs:ref-first-fp>646</xocs:ref-first-fp><xocs:ref-last-lp>652</xocs:ref-last-lp><xocs:ref-normalized-initial>G</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib65\"><xocs:ref-normalized-surname>MUSSET</xocs:ref-normalized-surname><xocs:ref-pub-year>2006</xocs:ref-pub-year><xocs:ref-first-fp>639</xocs:ref-first-fp><xocs:ref-last-lp>657</xocs:ref-last-lp><xocs:ref-normalized-initial>B</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib66\"><xocs:ref-normalized-surname>MILLAR</xocs:ref-normalized-surname><xocs:ref-pub-year>2000</xocs:ref-pub-year><xocs:ref-first-fp>3614</xocs:ref-first-fp><xocs:ref-last-lp>3618</xocs:ref-last-lp><xocs:ref-normalized-initial>J</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib67\"><xocs:ref-normalized-surname>CZIRJAK</xocs:ref-normalized-surname><xocs:ref-pub-year>2001</xocs:ref-pub-year><xocs:ref-first-fp>C700</xocs:ref-first-fp><xocs:ref-last-lp>C708</xocs:ref-last-lp><xocs:ref-normalized-initial>G</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib68\"><xocs:ref-normalized-surname>CHEN</xocs:ref-normalized-surname><xocs:ref-pub-year>2006</xocs:ref-pub-year><xocs:ref-first-fp>3422</xocs:ref-first-fp><xocs:ref-last-lp>3427</xocs:ref-last-lp><xocs:ref-normalized-initial>X</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib69\"><xocs:ref-normalized-surname>VEALE</xocs:ref-normalized-surname><xocs:ref-pub-year>2007</xocs:ref-pub-year><xocs:ref-first-fp>1666</xocs:ref-first-fp><xocs:ref-last-lp>1675</xocs:ref-last-lp><xocs:ref-normalized-initial>E</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib70\"><xocs:ref-normalized-surname>BESANA</xocs:ref-normalized-surname><xocs:ref-pub-year>2004</xocs:ref-pub-year><xocs:ref-first-fp>33154</xocs:ref-first-fp><xocs:ref-last-lp>33160</xocs:ref-last-lp><xocs:ref-normalized-initial>A</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib71\"><xocs:ref-normalized-surname>OCONNELL</xocs:ref-normalized-surname><xocs:ref-pub-year>2002</xocs:ref-pub-year><xocs:ref-first-fp>152</xocs:ref-first-fp><xocs:ref-last-lp>161</xocs:ref-last-lp><xocs:ref-normalized-initial>A</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib72\"><xocs:ref-normalized-surname>BUCKLER</xocs:ref-normalized-surname><xocs:ref-pub-year>1999</xocs:ref-pub-year><xocs:ref-first-fp>179</xocs:ref-first-fp><xocs:ref-last-lp>187</xocs:ref-last-lp><xocs:ref-normalized-initial>K</xocs:ref-normalized-initial></xocs:ref-info></xocs:references><xocs:refkeys><xocs:refkey3>DUPRATX2007X573</xocs:refkey3><xocs:refkey4lp>DUPRATX2007X573X580</xocs:refkey4lp><xocs:refkey4ai>DUPRATX2007X573XF</xocs:refkey4ai><xocs:refkey5>DUPRATX2007X573X580XF</xocs:refkey5></xocs:refkeys><xocs:open-access><xocs:oa-article-status is-open-access=\"0\" is-open-archive=\"0\"/></xocs:open-access><xocs:attachment-metadata-doc><xocs:attachment-set-type>item</xocs:attachment-set-type><xocs:pii-formatted>S0166-2236(07)00244-5</xocs:pii-formatted><xocs:pii-unformatted>S0166223607002445</xocs:pii-unformatted><xocs:eid>1-s2.0-S0166223607002445</xocs:eid><xocs:doi>10.1016/j.tins.2007.08.003</xocs:doi><xocs:cid>271059</xocs:cid><xocs:timestamp>2011-05-24T03:11:13.822255-04:00</xocs:timestamp><xocs:cover-date-start>2007-11-01</xocs:cover-date-start><xocs:cover-date-end>2007-11-30</xocs:cover-date-end><xocs:attachments><xocs:web-pdf><xocs:attachment-eid>1-s2.0-S0166223607002445-main.pdf</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0166223607002445/MAIN/application/pdf/0bde10dfe3c31908fe50f8ee33e9bc1d/main.pdf</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0166223607002445/MAIN/application/pdf/0bde10dfe3c31908fe50f8ee33e9bc1d/main.pdf</xocs:ucs-locator><xocs:filename>main.pdf</xocs:filename><xocs:extension>pdf</xocs:extension><xocs:pdf-optimized>true</xocs:pdf-optimized><xocs:filesize>1048119</xocs:filesize><xocs:web-pdf-purpose>MAIN</xocs:web-pdf-purpose><xocs:web-pdf-page-count>8</xocs:web-pdf-page-count><xocs:web-pdf-images><xocs:web-pdf-image><xocs:attachment-eid>1-s2.0-S0166223607002445-main_1.png</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0166223607002445/PREVIEW/image/png/3ec33ae4a17bd655e8019df427f2de4d/main_1.png</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0166223607002445/PREVIEW/image/png/3ec33ae4a17bd655e8019df427f2de4d/main_1.png</xocs:ucs-locator><xocs:filename>main_1.png</xocs:filename><xocs:extension>png</xocs:extension><xocs:filesize>118999</xocs:filesize><xocs:pixel-height>849</xocs:pixel-height><xocs:pixel-width>656</xocs:pixel-width><xocs:attachment-type>IMAGE-WEB-PDF</xocs:attachment-type><xocs:pdf-page-num>1</xocs:pdf-page-num></xocs:web-pdf-image></xocs:web-pdf-images></xocs:web-pdf><xocs:attachment><xocs:attachment-eid>1-s2.0-S0166223607002445-gr1.jpg</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0166223607002445/gr1/DOWNSAMPLED/image/jpeg/6e3b6296e6bc0d0d5a2d0beef922a22b/gr1.jpg</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0166223607002445/gr1/DOWNSAMPLED/image/jpeg/6e3b6296e6bc0d0d5a2d0beef922a22b/gr1.jpg</xocs:ucs-locator><xocs:file-basename>gr1</xocs:file-basename><xocs:filename>gr1.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>82351</xocs:filesize><xocs:pixel-height>526</xocs:pixel-height><xocs:pixel-width>812</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0166223607002445-gr1.sml</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0166223607002445/gr1/THUMBNAIL/image/gif/1dc3e8bed9e15761490e5fd89652e205/gr1.sml</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0166223607002445/gr1/THUMBNAIL/image/gif/1dc3e8bed9e15761490e5fd89652e205/gr1.sml</xocs:ucs-locator><xocs:file-basename>gr1</xocs:file-basename><xocs:filename>gr1.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>5696</xocs:filesize><xocs:pixel-height>142</xocs:pixel-height><xocs:pixel-width>219</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0166223607002445-gr2.jpg</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0166223607002445/gr2/DOWNSAMPLED/image/jpeg/8cc033aa1dec8d866b5cdbf198a900b6/gr2.jpg</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0166223607002445/gr2/DOWNSAMPLED/image/jpeg/8cc033aa1dec8d866b5cdbf198a900b6/gr2.jpg</xocs:ucs-locator><xocs:file-basename>gr2</xocs:file-basename><xocs:filename>gr2.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>84404</xocs:filesize><xocs:pixel-height>686</xocs:pixel-height><xocs:pixel-width>812</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0166223607002445-gr2.sml</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0166223607002445/gr2/THUMBNAIL/image/gif/a155ef660dcf7fb14fe664d241c645e3/gr2.sml</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0166223607002445/gr2/THUMBNAIL/image/gif/a155ef660dcf7fb14fe664d241c645e3/gr2.sml</xocs:ucs-locator><xocs:file-basename>gr2</xocs:file-basename><xocs:filename>gr2.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>5744</xocs:filesize><xocs:pixel-height>164</xocs:pixel-height><xocs:pixel-width>194</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0166223607002445-gr3.jpg</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0166223607002445/gr3/DOWNSAMPLED/image/jpeg/e7fea64b55016be83e5d868a6ed76afc/gr3.jpg</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0166223607002445/gr3/DOWNSAMPLED/image/jpeg/e7fea64b55016be83e5d868a6ed76afc/gr3.jpg</xocs:ucs-locator><xocs:file-basename>gr3</xocs:file-basename><xocs:filename>gr3.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>85984</xocs:filesize><xocs:pixel-height>626</xocs:pixel-height><xocs:pixel-width>812</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0166223607002445-gr3.sml</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0166223607002445/gr3/THUMBNAIL/image/gif/2be6b918d29aa9acd78f42b79529f13e/gr3.sml</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0166223607002445/gr3/THUMBNAIL/image/gif/2be6b918d29aa9acd78f42b79529f13e/gr3.sml</xocs:ucs-locator><xocs:file-basename>gr3</xocs:file-basename><xocs:filename>gr3.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>6729</xocs:filesize><xocs:pixel-height>164</xocs:pixel-height><xocs:pixel-width>213</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment></xocs:attachments></xocs:attachment-metadata-doc></xocs:meta><xocs:serial-item><article xmlns=\"http://www.elsevier.com/xml/ja/dtd\" version=\"5.0\" xml:lang=\"en\" docsubtype=\"rev\"><item-info><jid>TINS</jid><aid>558</aid><ce:pii>S0166-2236(07)00244-5</ce:pii><ce:doi>10.1016/j.tins.2007.08.003</ce:doi><ce:copyright type=\"full-transfer\" year=\"2007\">Elsevier Ltd</ce:copyright></item-info><ce:floats><ce:figure id=\"fig1\"><ce:label>Figure 1</ce:label><ce:caption><ce:simple-para id=\"simple-para0005\" view=\"all\">The TASK K<ce:inf loc=\"post\">2P</ce:inf> channels. <ce:bold>(a)</ce:bold> The subunits of dimeric K<ce:sup loc=\"post\">+</ce:sup> channels each contain four transmembrane segments (4TMs) and two conserved motifs called the P (pore-forming) domain that forms part of the wall of the channel through which K<ce:sup loc=\"post\">+</ce:sup> ions are conducted; these are known as K<ce:inf loc=\"post\">2P</ce:inf> channels. His98 in the P1 domain is involved in sensing pH. <ce:bold>(b)</ce:bold> Fifteen human K<ce:inf loc=\"post\">2P</ce:inf> channel subunits have been identified and are classified into six different structural and functional subgroups. The TASK-1 and TASK-3 subunits share a background K<ce:sup loc=\"post\">+</ce:sup> channel activity that is inhibited at extracellular acidic pH. Heteromultimerization, which contributes to the increase in the functional diversity of these channels, has been demonstrated for TASK-1 and TASK-3. TASK-5 is structurally related to TASK-1 and TASK-3 but is electrically silent. <ce:bold>(c)</ce:bold> Effect of extracellular pH on TASK-1 recorded in a transfected COS cell. TASK channel activity monitored between −120<ce:hsp sp=\"0.25\"/>mV and 100<ce:hsp sp=\"0.25\"/>mV using a voltage ramp is increased by alkaline extracellular pH (pH 8.4) but inhibited by extracellular acidosis (pH 6.4). This curve represents the whole cell current amplitude (in nA) as a function of the membrane voltage (in mV). The pH sensitivity of the TASK-1 and TASK-3 channels is dependent on the protonation of His98 in the first pore domain (P1) as shown in (a). <ce:bold>(d)</ce:bold> TASK-1 and TASK-3 show different pH sensitivities with a pK of ∼7.3 and 6.7 for TASK-1 and TASK-3, respectively. Adapted, with permission, from Refs <ce:cross-refs refid=\"bib40 bib71\">[40,71]</ce:cross-refs>.</ce:simple-para></ce:caption><ce:link locator=\"gr1\"/></ce:figure><ce:figure id=\"fig2\"><ce:label>Figure 2</ce:label><ce:caption><ce:simple-para id=\"simple-para0010\" view=\"all\">The TASK channels in type I carotid body cells. <ce:bold>(a)</ce:bold> The carotid bodies located at the carotid artery bifurcation are in close apposition to the afferent sensory fibers of the sinus nerve. Type I glomus cells containing tyrosine hydroxylase (TH) (visualized in red lower panels) express TASK-1 (visualized in blue lower panels). Type II cells are supporting cells that do not express tryrosine hydroxylase and lack chemosensitivity, but also express TASK-1. Hypoxic stimulation of type I carotid body cells provokes neurotransmitter release (presynaptic elements), stimulation of sinus nerve activity and a reflex increase in respiration. <ce:bold>(b)</ce:bold> Hypoxia produces the closing of tetraethylammonium (TEA) and 4-aminopyridine (4-AP)-resistant K<ce:sup loc=\"post\">+</ce:sup> channels provoking cell depolarization and a consequent increase in intracellular calcium. <ce:bold>(c)</ce:bold> The O<ce:inf loc=\"post\">2</ce:inf>-sensitive background K<ce:sup loc=\"post\">+</ce:sup> current (IKO<ce:inf loc=\"post\">2</ce:inf>) in type I carotid body cells (i.e. the current inhibited by hypoxia) shares the functional properties of TASK channels with inhibition by extracellular acidosis (pH 6.4 shown in red). This current is recorded during a voltage range from −100<ce:hsp sp=\"0.25\"/>mV to −40<ce:hsp sp=\"0.25\"/>mV. The current amplitude is shown as a function of membrane voltage (I–V curve). <ce:bold>(d)</ce:bold> The carotid body O<ce:inf loc=\"post\">2</ce:inf>-sensitive TASK current is stimulated by halothane (shown in red). The experimental conditions were the same as in (c). Adapted, with permission, from Refs <ce:cross-refs refid=\"bib14 bib72\">[14,72]</ce:cross-refs>.</ce:simple-para></ce:caption><ce:link locator=\"gr2\"/></ce:figure><ce:figure id=\"fig3\"><ce:label>Figure 3</ce:label><ce:caption><ce:simple-para id=\"simple-para0015\" view=\"all\">The TASK channels in respiratory brainstem motoneurons and in hypothalamic orexin neurons. <ce:bold>(a)</ce:bold> <ce:italic>In situ</ce:italic> hybridization showing that TASK-1 is abundantly expressed in brainstem respiratory motoneurons, including the hypoglossal (XII), vagal (X) and ambigual (Aml) motor nuclei. <ce:bold>(b)</ce:bold> Halothane (1.25<ce:hsp sp=\"0.25\"/>mM) hyperpolarizes hypoglossal motoneurons and inhibits firing of the respiratory motoneurons. This inhibition is reversed when extracellular pH is lowered to 6.5. <ce:bold>(c)</ce:bold> The pH-sensitive K<ce:sup loc=\"post\">+</ce:sup> current (IpH7.3 - IpH6.5) of hypoglossal motoneurons follows the Goldman Hodgkin Katz (GHK) formulation (open rectification). The current amplitude is shown as a function of membrane voltage (I-V curve). Adapted with permission from Refs <ce:cross-refs refid=\"bib16 bib58\">[16,58]</ce:cross-refs>. <ce:bold>(d)</ce:bold> Staining of hypothalamic orexin neurons (expressing eGFP) with an antibody against TASK-1 (blue) and overlay of TASK-3 staining (in red) in the same cell (colocalization shown in pink). <ce:bold>(e)</ce:bold> Effects of increasing extracellular glucose from 0.2 to 4.5<ce:hsp sp=\"0.25\"/>mM on membrane potential of an orexin neuron. Glucose induces hyperpolarization and silences orexin neurons. <ce:bold>(f)</ce:bold> Current–voltage (I–V) plot of the net glucose-activated K<ce:sup loc=\"post\">+</ce:sup> current. The current reverses at the predicted equilibrium potential for potassium and follows the GHK equation. The current amplitude is shown as a function of membrane voltage (I–V curve). Adapted, with permission, from Ref. <ce:cross-ref refid=\"bib27\">[27]</ce:cross-ref>.</ce:simple-para></ce:caption><ce:link locator=\"gr3\"/></ce:figure><ce:textbox id=\"tb1\"><ce:label>Box 1</ce:label><ce:caption><ce:simple-para id=\"simple-para0020\" view=\"all\">Acidic inhibition, pharmacology and regulation of the TASK channels</ce:simple-para></ce:caption><ce:textbox-body><ce:sections><ce:para id=\"para0005\" view=\"all\">TASK-1 and TASK-3 are sensitive to variations in extracellular pH, but not to intracellular pH (<ce:cross-ref refid=\"fig1\">Figure 1</ce:cross-ref>c,d) <ce:cross-refs refid=\"bib12 bib52\">[12,52]</ce:cross-refs>. The pK values for TASK-1 and TASK-3 are 7.3–7.5 and 6.5–6.7, respectively (<ce:cross-ref refid=\"fig1\">Figure 1</ce:cross-ref>d). Protonation of His98 in the first pore domain (P1) is at least partly responsible for TASK-1 and TASK-3 inhibition, although additional residues, including D204, K73 and K210 have also been implicated <ce:cross-refs refid=\"bib53 bib54 bib55 bib56\">[53–56]</ce:cross-refs> (<ce:cross-ref refid=\"fig1\">Figure 1</ce:cross-ref>c inset). Tandem-linked heterodimeric TASK-1–TASK-3 channels display a pH sensitivity (pK value 7.3) in the physiological range, closer to that of TASK-1 than of TASK-3 <ce:cross-ref refid=\"bib9\">[9]</ce:cross-ref>.</ce:para><ce:para id=\"para0010\" view=\"all\">TASK-1, TASK-3 and the heteromer TASK-1–TASK-3 are inhibited by the endocannabinoid anandamide <ce:cross-refs refid=\"bib9 bib40\">[9,40]</ce:cross-refs>. This inhibition is not mimicked by the active compound of marijuana Δ9-THC. Moreover, anandamide hydrolysis is not required and the effect is independent of the cannabinoid CB receptors <ce:cross-ref refid=\"bib40\">[40]</ce:cross-ref>.</ce:para><ce:para id=\"para0015\" view=\"all\">TASK-1 is stimulated by halothane and is partially inhibited by chloroform, diethylether and isoflurane <ce:cross-refs refid=\"bib9 bib57 bib58\">[9,57,58]</ce:cross-refs>. TASK-3 channel activity is stimulated by the volatile general anesthetics halothane, isoflurane and chloroform, but is resistant to the anesthetic gas xenon <ce:cross-refs refid=\"bib59 bib60\">[59,60]</ce:cross-refs>. The heteromer TASK-1–TASK-3 is similarly stimulated by isoflurane <ce:cross-ref refid=\"bib9\">[9]</ce:cross-ref>. A halothane-responsive sequence, VLRFM(L)T, has been mapped in the cytosolic C-terminal domain of TASK-1 and TASK-3 <ce:cross-refs refid=\"bib57 bib58 bib61\">[57,58,61]</ce:cross-refs>. Furthermore, Lys159 in the <ce:italic>Lymnea stagnalis</ce:italic> TASK channel (47% identical to hTASK-1) is responsible for stereoselective stimulation by isoflurane, suggesting that this crucial amino acid could form part of an anesthetic binding site <ce:cross-ref refid=\"bib60\">[60]</ce:cross-ref>. By contrast, TASK-1 and TASK-3 are both inhibited by local anesthetics including bupivacaine <ce:cross-refs refid=\"bib56 bib62 bib63\">[56,62,63]</ce:cross-refs>.</ce:para><ce:para id=\"para0020\" view=\"all\">TASK-3, unlike TASK-1 and the heteromer TASK-1–TASK-3, is blocked by ruthenium red, spermine and zinc <ce:cross-refs refid=\"bib33 bib64 bib65\">[33,64,65]</ce:cross-refs>. The negatively charged residue E70 in P1, absent in TASK-1, is responsible for ruthenium red and extracellular divalent cation inhibition of TASK-3 <ce:cross-ref refid=\"bib64\">[64]</ce:cross-ref>.</ce:para><ce:para id=\"para0025\" view=\"all\">TASK-1, TASK-3 and the heteromer TASK-1–TASK-3 are down-modulated by stimulation of Gq-coupled receptors, including the metabotropic glutamatergic receptors mGluR1/5 <ce:cross-refs refid=\"bib11 bib16 bib61 bib66\">[11,16,61,66]</ce:cross-refs>. Inhibition has been attributed to depletion of phosphoinositol bisphosphate (PtdIns(4,5)<ce:italic>P</ce:italic><ce:inf loc=\"post\">2</ce:inf>) by phospholipase C <ce:cross-refs refid=\"bib42 bib67\">[42,67]</ce:cross-refs>. Moreover, a direct inhibitory action of the Gqα subunit on TASK-1 and TASK-3 channels has also been recently implicated <ce:cross-refs refid=\"bib68 bib69\">[68,69]</ce:cross-refs>. Finally, activation of PKCɛ might further contribute to TASK-1 inhibition, although the role of PKCα has been ruled out in the down-modulation of TASK-3 <ce:cross-refs refid=\"bib69 bib70\">[69,70]</ce:cross-refs>.</ce:para></ce:sections></ce:textbox-body></ce:textbox></ce:floats><head><ce:dochead><ce:textfn>Review</ce:textfn></ce:dochead><ce:title>The TASK background K<ce:inf loc=\"post\">2P</ce:inf> channels: chemo- and nutrient sensors</ce:title><ce:author-group><ce:author><ce:given-name>Fabrice</ce:given-name><ce:surname>Duprat</ce:surname></ce:author><ce:author><ce:given-name>Inger</ce:given-name><ce:surname>Lauritzen</ce:surname></ce:author><ce:author><ce:given-name>Amanda</ce:given-name><ce:surname>Patel</ce:surname></ce:author><ce:author><ce:given-name>Eric</ce:given-name><ce:surname>Honoré</ce:surname><ce:e-address type=\"email\">honore@ipmc.cnrs.fr</ce:e-address></ce:author><ce:affiliation><ce:textfn>Institut de Pharmacologie Moléculaire et Cellulaire, Université de Nice-Sophia Antipolis, UMR CNRS 6097, 06660 Valbonne, France</ce:textfn></ce:affiliation></ce:author-group><ce:abstract class=\"author\"><ce:abstract-sec><ce:simple-para id=\"simple-para0025\" view=\"all\">Specialized chemo- and nutrient-sensing cells share a common electrophysiological mechanism by transducing low O<ce:inf loc=\"post\">2</ce:inf>, high CO<ce:inf loc=\"post\">2</ce:inf> and low glucose stimuli into a compensatory cellular response: the closing of background K<ce:sup loc=\"post\">+</ce:sup> channels encoded by the K<ce:inf loc=\"post\">2P</ce:inf> subunits. Inhibition of the TASK K<ce:inf loc=\"post\">2P</ce:inf> channels by extracellular acidosis leads to an increased excitability of brainstem respiratory neurons. Moreover, hypoxic down-modulation of TASK channels is implicated in the activation of glomus cells in the carotid body. Stimulation of both types of cell leads to an enhanced ventilation and to cardiocirculatory adjustments. Differential modulation of TASK channels by acidosis and high glucose alters excitability of the hypothalamic orexin neurons, which influence arousal, food seeking and breathing. These recent results shed light on the role of TASK channels in sensing physiological stimuli.</ce:simple-para></ce:abstract-sec></ce:abstract></head><body view=\"all\"><ce:sections><ce:para id=\"para0030\" view=\"all\">Background K<ce:sup loc=\"post\"><ce:bold>+</ce:bold></ce:sup> channels characterized by a leak, baseline or resting activity play a key role in setting the resting membrane potential, tuning the action potential duration and modulating the responsiveness to synaptic inputs <ce:cross-ref refid=\"bib1\">[1]</ce:cross-ref>. At the mechanistic level, the background K<ce:sup loc=\"post\">+</ce:sup> channels offer the advantage of being active over the whole voltage range compared with other K<ce:sup loc=\"post\">+</ce:sup> channels, such as the inward rectifiers (K<ce:inf loc=\"post\">ir</ce:inf>), which are mainly opened at negative membrane potentials or the voltage-gated K<ce:sup loc=\"post\">+</ce:sup> channels (K<ce:inf loc=\"post\">v</ce:inf>) that activate only upon depolarization.</ce:para><ce:para id=\"para0035\" view=\"all\">Although the function of background K<ce:sup loc=\"post\">+</ce:sup> channels had long been recognized – as early as 1943 by Goldman, Hodgkin, Katz and Huxley – their molecular identity in yeast, the nematode <ce:italic>Caenorhabditis elegans</ce:italic>, the fruit fly <ce:italic>Drosophila</ce:italic> and mammals was discovered only in 1995–1996 <ce:cross-refs refid=\"bib2 bib3 bib4\">[2–4]</ce:cross-refs>. Background K<ce:sup loc=\"post\">+</ce:sup> channels are formed by the K<ce:inf loc=\"post\">2P</ce:inf> channel subunits (also called KCNK or TWIK-related subunits), constituting a novel structural class of K<ce:sup loc=\"post\">+</ce:sup> channels <ce:cross-ref refid=\"bib1\">[1]</ce:cross-ref> (<ce:cross-ref refid=\"fig1\">Figure 1</ce:cross-ref>a,b<ce:float-anchor refid=\"fig1\"/>). K<ce:inf loc=\"post\">2P</ce:inf> channel subunits contain four transmembrane segments and two pore domains in tandem. A functional channel is a dimer of subunits which are either identical (homomer) or different (heteromer).</ce:para><ce:para id=\"para0040\" view=\"all\">The leak behavior ties the K<ce:inf loc=\"post\">2P</ce:inf> channels together, but their sensitivity to a multitude of physiological and pharmacological modulators makes this a remarkably varied class of polymodal ion channels, each with unique physiological functions. For instance, recent studies concerning the K<ce:inf loc=\"post\">2P</ce:inf> channel TREK-1 have demonstrated that this ‘unconventional’ K<ce:sup loc=\"post\">+</ce:sup> channel, sensitive to membrane stretch and cellular lipids, plays a major role in mediating ischemic and epileptic neuroprotection by polyunsaturated fatty acids, general anesthesia by volatile agents, pain sensing, endothelial-dependent vasodilation and mood regulation (for review see Ref. <ce:cross-ref refid=\"bib1\">[1]</ce:cross-ref>). Another K<ce:inf loc=\"post\">2P</ce:inf> channel with a recognized physiological function is the alkaline-activated K<ce:inf loc=\"post\">2P</ce:inf> channel TASK-2 <ce:cross-refs refid=\"bib5 bib6\">[5,6]</ce:cross-refs>. It is involved in cell volume regulation and in bicarbonate reabsorption through external alkalinization at the renal proximal tubules and papillary collecting ducts <ce:cross-refs refid=\"bib5 bib6\">[5,6]</ce:cross-refs>.</ce:para><ce:para id=\"para0045\" view=\"all\">Although the K<ce:inf loc=\"post\">2P</ce:inf> channel subunits display the same structural motif with four transmembrane segments (except those in yeast which have eight transmembrane segments), an extended extracellular loop located between the first segment and the first pore region (P1) which forms the K<ce:sup loc=\"post\">+</ce:sup> selectivity filter, and intracellularly located amino- and carboxy- termini, they share only moderate sequence similarity (<ce:cross-ref refid=\"fig1\">Figure 1</ce:cross-ref>a,b). Among the 15 human K<ce:inf loc=\"post\">2P</ce:inf> channel subunits that have been identified, TASK-1 and TASK-3, along with the silent subunit TASK-5, form a distinct structural and functional subgroup (<ce:cross-ref refid=\"fig1\">Figure 1</ce:cross-ref>b–d) (for review see Ref. <ce:cross-ref refid=\"bib7\">[7]</ce:cross-ref>). The TASK-3 amino acid sequence shares 54% identity with TASK-1 and heteromultimerization between both subunits has been demonstrated <ce:cross-refs refid=\"bib8 bib9 bib10 bib11\">[8–11]</ce:cross-refs>.</ce:para><ce:para id=\"para0050\" view=\"all\">The TASK currents are characterized by an outward rectification in a physiological K<ce:sup loc=\"post\">+</ce:sup> gradient (reversing at the predicted equilibrium potential for K<ce:sup loc=\"post\">+</ce:sup> ions of about −80<ce:hsp sp=\"0.25\"/>mV) (<ce:cross-ref refid=\"fig1\">Figure 1</ce:cross-ref>c). The current to voltage relationship of TASK channels becomes linear in a symmetrical K<ce:sup loc=\"post\">+</ce:sup> gradient (reversing at 0<ce:hsp sp=\"0.25\"/>mV) <ce:cross-ref refid=\"bib12\">[12]</ce:cross-ref>. This typical channel behavior is expected for a K<ce:sup loc=\"post\">+</ce:sup>-selective leak channel, as predicted by the Goldman Hodgkin Katz formulation (open rectifier) (<ce:cross-ref refid=\"fig1\">Figure 1</ce:cross-ref>c) (for review see Refs <ce:cross-refs refid=\"bib1 bib7\">[1,7]</ce:cross-refs>). The homomultimers TASK-1, TASK-3 and the heteromultimer TASK-1–TASK-3 have single-channel conductances (determined in a symmetrical K<ce:sup loc=\"post\">+</ce:sup> gradient) of 14 pS, 37 pS and 38 pS, respectively and are characterized by a typical flickery gating <ce:cross-refs refid=\"bib10 bib13\">[10,13]</ce:cross-refs>.</ce:para><ce:para id=\"para0055\" view=\"all\">Background K<ce:sup loc=\"post\">+</ce:sup> channels have been implicated in O<ce:inf loc=\"post\">2</ce:inf>, and pH and/or glucose sensing in a variety of cell types, including carotid body type I cells <ce:cross-ref refid=\"bib14\">[14]</ce:cross-ref>, brainstem respiratory neurons <ce:cross-refs refid=\"bib15 bib16 bib17 bib18\">[15–18]</ce:cross-refs>, neuroepithelial body cells <ce:cross-ref refid=\"bib19\">[19]</ce:cross-ref>, pulmonary artery myocytes <ce:cross-refs refid=\"bib20 bib21\">[20,21]</ce:cross-refs>, dorsal root ganglion neurons <ce:cross-refs refid=\"bib22 bib23 bib24\">[22–24]</ce:cross-refs>, taste bud cells <ce:cross-refs refid=\"bib25 bib26\">[25,26]</ce:cross-refs> and hypothalamic orexin neurons <ce:cross-refs refid=\"bib27 bib28\">[27,28]</ce:cross-refs>. Until recently, the molecular basis of these responses was obscure. Several studies, based on pharmacological and knock-down strategies, now demonstrate that heteromultimeric TASK channels are indeed involved in chemo- and nutrient sensing. It should be noted that attributing the effects of various chemostimuli to a particular ion channel family is quite challenging, because multiple conductances and other molecular pathways are simultaneously involved in such important integrated physiological responses. However, recent studies taking advantage of the unique biophysical properties of the TASK channels, their stimulation by volatile general anesthetics and their differential sensitivity to various inhibitors, including ruthenium red, have recently provided strong evidence for a functional role of the TASK heteromultimeric K<ce:inf loc=\"post\">2P</ce:inf> channels in both chemo- and nutrient sensing.</ce:para><ce:para id=\"para0060\" view=\"all\">First, we will focus on the role of TASK channels in oxygen sensing in the carotid body. Second, we will discuss the evidence that this background K<ce:sup loc=\"post\">+</ce:sup> conductance is also implicated in brainstem CO<ce:inf loc=\"post\">2</ce:inf>/acid sensing. Third, we will comment on the function of TASK-3 in hypothalamic glucose and pH sensing. In conclusion, we will envisage possible future directions in this field.</ce:para><ce:section id=\"section0005\" view=\"all\"><ce:section-title>Oxygen sensing in the carotid body glomus cells</ce:section-title><ce:para id=\"para0065\" view=\"all\">In response to environmental hypoxia, there is a rapid, reflex increase in the respiration rate <ce:cross-refs refid=\"bib14 bib29\">[14,29]</ce:cross-refs>. The primary sensory glomus cells (type I) of the carotid body respond to hypoxia and acidosis with depolarization that initiates electrical activity, Ca<ce:sup loc=\"post\">2+</ce:sup> entry and neurosecretion (<ce:cross-ref refid=\"fig2\">Figure 2</ce:cross-ref>a,b<ce:float-anchor refid=\"fig2\"/>). The type I cells activate afferent sensory fibers of the sinus nerve, which in turn stimulate brainstem respiratory centers, culminating in enhanced ventilation (<ce:cross-ref refid=\"fig2\">Figure 2</ce:cross-ref>a). A key ionic current involved in mediating these responses in rat type I cells is an O<ce:inf loc=\"post\">2</ce:inf>- and acid-sensitive background K<ce:sup loc=\"post\">+</ce:sup> current <ce:cross-refs refid=\"bib14 bib29\">[14,29]</ce:cross-refs> (<ce:cross-ref refid=\"fig2\">Figure 2</ce:cross-ref>c). This current displays a baseline activity with no voltage- or time-dependency, a single channel conductance of 14–16<ce:hsp sp=\"0.25\"/>pS (measured in a symmetrical K<ce:sup loc=\"post\">+</ce:sup> gradient) and shares many of the biophysical and pharmacological properties of the TASK channels, including resistance to tetraethylammonium and 4-aminopyridine, inhibition by anandamide, and stimulation by halothane <ce:cross-ref refid=\"bib14\">[14]</ce:cross-ref> (<ce:cross-ref refid=\"fig2\">Figure 2</ce:cross-ref>d, <ce:cross-ref refid=\"tb1\">Box 1</ce:cross-ref><ce:float-anchor refid=\"tb1\"/>). Stimulation of the O<ce:inf loc=\"post\">2</ce:inf>-sensitive K<ce:sup loc=\"post\">+</ce:sup> current in glomus cells by halothane is of pharmacological interest because this widely used clinical agent is known to depress the hypoxic ventilatory drive under anesthesia <ce:cross-ref refid=\"bib14\">[14]</ce:cross-ref>.</ce:para><ce:para id=\"para0070\" view=\"all\">The effect of hypoxia on the carotid body background K<ce:sup loc=\"post\">+</ce:sup> channel is to stabilize the closed state of the channel with no effect on the single channel conductance. In patch clamp experiments, loss of the hypoxic inhibition of this channel is observed when the patch is excised in the inside-out configuration, thus suggesting that the oxygen sensor is independent of the channel complex <ce:cross-ref refid=\"bib14\">[14]</ce:cross-ref>.</ce:para><ce:para id=\"para0075\" view=\"all\"><ce:italic>In situ</ce:italic> hybridization, RT–PCR analysis and immunostaining have demonstrated that TASK-1 and TASK-3 are indeed both expressed in type I carotid body cells <ce:cross-refs refid=\"bib14 bib30 bib31\">[14,30,31]</ce:cross-refs> (<ce:cross-ref refid=\"fig2\">Figure 2</ce:cross-ref>a). However, the observed kinetics, single channel conductance and sensitivity to external divalent cations at negative membrane potentials do not precisely match those of either TASK-1 or TASK-3 homomers <ce:cross-ref refid=\"bib32\">[32]</ce:cross-ref>. For instance, the O<ce:inf loc=\"post\">2</ce:inf>-sensitive background K<ce:sup loc=\"post\">+</ce:sup> current in carotid body cells is inhibited by zinc (<ce:cross-ref refid=\"tb1\">Box 1</ce:cross-ref>). Moreover, the single channel conductance of the channel increases when external Mg<ce:sup loc=\"post\">2+</ce:sup> is removed. Although these properties are suggestive of the TASK-3 homomer <ce:cross-ref refid=\"bib33\">[33]</ce:cross-ref>, the single channel conductance of the native channel is consistent with a TASK-1 homomer (14<ce:hsp sp=\"0.25\"/>pS). Thus, heteromultimeric assembly of TASK-1 or TASK-3 with other K<ce:inf loc=\"post\">2P</ce:inf> channel subunits, possibly TASK-5 <ce:cross-refs refid=\"bib30 bib31\">[30,31]</ce:cross-refs>, or other interacting components <ce:cross-ref refid=\"bib34\">[34]</ce:cross-ref> is likely to occur in glomus cells <ce:cross-ref refid=\"bib32\">[32]</ce:cross-ref>. Although the TASK channels are now considered to be functionally important in the carotid body, the hypoxic modulation of other K<ce:sup loc=\"post\">+</ce:sup> channels, including the voltage-gated Kv channels, as well as the Ca<ce:sup loc=\"post\">2+</ce:sup>-dependent large conductance BK channels is also clearly involved (for reviews see Ref. <ce:cross-ref refid=\"bib35\">[35]</ce:cross-ref>).</ce:para><ce:para id=\"para0080\" view=\"all\">When expressed in immortalized adrenomedullary chromaffin cells, TASK-1 currents are not significantly altered by hypoxia <ce:cross-ref refid=\"bib36\">[36]</ce:cross-ref>. However, a stable HEK293 cell line expressing TASK-1 displays O<ce:inf loc=\"post\">2</ce:inf> sensitivity, further suggesting that the O<ce:inf loc=\"post\">2</ce:inf> sensor is independent of the channel and might be expressed only in a subset of cells, including the glomus cells of the carotid body <ce:cross-ref refid=\"bib37\">[37]</ce:cross-ref>. Several molecular candidates have been implicated in the hypoxic down-modulation of the TASK channels in type I carotid body cells and these candidates are discussed below.</ce:para><ce:section id=\"section0010\" view=\"all\"><ce:section-title>The metabolic hypothesis</ce:section-title><ce:para id=\"para0085\" view=\"all\">Mitochondrial oxidative phosphorylation is impaired at a relatively modest hypoxia in glomus cells, compared with other nonspecialized cells <ce:cross-ref refid=\"bib38\">[38]</ce:cross-ref>. Various metabolic inhibitors acting on oxidative phosphorylation, electron transport or ATP synthase inhibit carotid body TASK currents and are potent stimulators of respiration <ce:cross-ref refid=\"bib39\">[39]</ce:cross-ref>. These mitochondrial effects are nonadditive with hypoxia and it was suggested that the effect of low oxygen might be mediated, at least in part, by a decrease in ATP production <ce:cross-ref refid=\"bib39\">[39]</ce:cross-ref>. Moreover, the activity of the native TASK channels shows a rapid rundown after patch excision <ce:cross-refs refid=\"bib40 bib41\">[40,41]</ce:cross-refs>. However, addition of intracellular ATP refreshes channel activity <ce:cross-ref refid=\"bib41\">[41]</ce:cross-ref>. The effect of intracellular ATP might be mediated by a phosphorylation mechanism. For instance, phosphatidylinositol (4,5)-bisphosphate (PtdIns(4,5)<ce:italic>P</ce:italic><ce:inf loc=\"post\">2</ce:inf>) formation by a kinase closely associated with the channel could be involved in the up-modulation of the TASK channels in normoxia <ce:cross-ref refid=\"bib42\">[42]</ce:cross-ref>.</ce:para><ce:para id=\"para0090\" view=\"all\">Alternatively, hypoxia increases the AMP:ATP ratio and activates AMP-activated protein kinase (AMPK), a sensor of metabolic stress <ce:cross-ref refid=\"bib43\">[43]</ce:cross-ref>. AMPK activation mimics the effect of hypoxia in glomus cells by inhibiting a TASK-like and a large conductance calcium-dependent K<ce:sup loc=\"post\">+</ce:sup> channel (BK) conductance <ce:cross-ref refid=\"bib43\">[43]</ce:cross-ref>. Conversely, inhibition of AMPK reduces the effect of hypoxia on type I cells and carotid body activation <ce:cross-ref refid=\"bib43\">[43]</ce:cross-ref>. These results suggest that activation of AMPK could be involved in carotid body activation by hypoxia, possibly via phosphorylation of K<ce:sup loc=\"post\">+</ce:sup> channels, possibly including TASK channels <ce:cross-ref refid=\"bib43\">[43]</ce:cross-ref>.</ce:para></ce:section><ce:section id=\"section0015\" view=\"all\"><ce:section-title>The NOX4 hypothesis</ce:section-title><ce:para id=\"para0095\" view=\"all\">The role of an oxygen sensor located at the plasma membrane has also been suggested <ce:cross-ref refid=\"bib44\">[44]</ce:cross-ref>. Transmembrane NADPH oxidase 4 (NOX4), which is constitutively active, was shown to be required for the oxygen-dependent regulation of TASK-1 <ce:cross-ref refid=\"bib44\">[44]</ce:cross-ref>. NOX4 is expressed in type I carotid body cells in which its mRNA is induced under conditions of chronic hypoxia <ce:cross-ref refid=\"bib45\">[45]</ce:cross-ref>. Both TASK-1 and NOX4 are co-localized at the plasma membrane <ce:cross-ref refid=\"bib44\">[44]</ce:cross-ref>. Overexpression of NOX4, unlike NOX2, in HEK cells significantly increases hypoxic inhibition of TASK-1 <ce:cross-ref refid=\"bib44\">[44]</ce:cross-ref>. On the contrary, the oxygen sensitivity of TASK-1 is abolished by NOX4 small interfering RNA (siRNA) as well as by NADPH oxidase inhibitors <ce:cross-ref refid=\"bib44\">[44]</ce:cross-ref>.</ce:para><ce:para id=\"para0100\" view=\"all\">A possible form of oxygen sensing is the conversion of O<ce:inf loc=\"post\">2</ce:inf> into reactive oxygen species produced by NOX (or originating from the mitochondria), which would in turn regulate the activity of specific ion channels, including TASK. It is of interest that several K<ce:inf loc=\"post\">2P</ce:inf> channels, including TASK-2, are modulated by reactive oxygen species <ce:cross-ref refid=\"bib46\">[46]</ce:cross-ref>. Future studies are needed to determine whether TASK-1 and TASK-3 channels are modulated in a similar manner by reactive oxygen species.</ce:para></ce:section><ce:section id=\"section0020\" view=\"all\"><ce:section-title>The CO hypothesis</ce:section-title><ce:para id=\"para0105\" view=\"all\">An O<ce:inf loc=\"post\">2</ce:inf>-dependent production of carbon monoxide (CO) from the heme oxygenase 2 enzyme (HO-2), which stimulates the activity of BK channels in carotid body type I cells, has recently been proposed as an additional possible O<ce:inf loc=\"post\">2</ce:inf>-sensing mechanism <ce:cross-ref refid=\"bib47\">[47]</ce:cross-ref>. However, at high doses, CO decreases the TASK-like current in glomus cells (probably via an intracellular messenger) <ce:cross-ref refid=\"bib29\">[29]</ce:cross-ref>. Moreover, this hypothesis has recently been challenged as genetic inactivation of HO-2 has no significant effect on hypoxic responses <ce:cross-ref refid=\"bib48\">[48]</ce:cross-ref>.</ce:para><ce:para id=\"para0110\" view=\"all\">Although these possible candidate oxygen sensors have been proposed recently, the exact molecular mechanisms responsible for the hypoxic down-modulation of the TASK channels, probably heteromeric, in chemosensitive glomus cells in the carotid body still remains obscure and thus deserves additional study.</ce:para></ce:section></ce:section><ce:section id=\"section0025\" view=\"all\"><ce:section-title>Acid sensing in the brainstem</ce:section-title><ce:para id=\"para0115\" view=\"all\">Central chemoreception is the homeostatic process by which pH variations in the brainstem, caused by increased levels of CO<ce:inf loc=\"post\">2</ce:inf>, contribute to changes in the depth and frequency of breathing, and thereby elimination of CO<ce:inf loc=\"post\">2</ce:inf>. Many neurons within the respiratory control system in the brainstem might contribute to this pH sensitivity (<ce:cross-ref refid=\"fig3\">Figure 3</ce:cross-ref>a<ce:float-anchor refid=\"fig3\"/>).</ce:para><ce:para id=\"para0120\" view=\"all\">Specialized neurons located at the ventral surface of the medulla oblongata, in the retrotrapezoid nucleus, serve as sensors for CO<ce:inf loc=\"post\">2</ce:inf>/pH <ce:cross-ref refid=\"bib15\">[15]</ce:cross-ref>. These neurons are exquisitely sensitive to CO<ce:inf loc=\"post\">2</ce:inf>-mediated acidosis, apparently by virtue of a pH-sensitive background K<ce:sup loc=\"post\">+</ce:sup> current. It remains to be determined whether TASK channels account for this current in RTN neurons.</ce:para><ce:para id=\"para0125\" view=\"all\">Both TASK-1 and TASK-3 subunits are present in neurons of the rostral ventral respiratory group (rVRG), pre-Botzinger complex (preBotC) and the Botzinger region (groups of brainstem neurons involved in the control of respiration), including the glutamatergic neurokinin-1 receptor immunoreactive (NK1R-ir) neurons that are implicated in respiratory rhythmogenesis <ce:cross-refs refid=\"bib17 bib49\">[17,49]</ce:cross-refs>. The excitability of the preBotC neurons is thought to result from a balance between a persistent depolarizing Na<ce:sup loc=\"post\">+</ce:sup> current and a background TASK-like repolarizing K<ce:sup loc=\"post\">+</ce:sup> current. Inhibition of the resting TASK-like K<ce:sup loc=\"post\">+</ce:sup> conductance by acidosis or Gq-coupled receptor stimulation results in neuronal depolarization and intrinsic bursting behavior <ce:cross-ref refid=\"bib49\">[49]</ce:cross-ref>.</ce:para><ce:para id=\"para0130\" view=\"all\">TASK-1 and TASK-3 subunits are also co-localized within most serotonergic dorsal and caudal raphe neurons as well as within the noradrenergic cell bodies of the locus coeruleus <ce:cross-refs refid=\"bib17 bib18\">[17,18]</ce:cross-refs>. Inhibition of TASK currents and activation of these neurons at acidic pH also contribute to stimulate behavioral arousal and enhance respiratory output (<ce:cross-ref refid=\"fig1\">Figure 1</ce:cross-ref>c,d). Conversely, opening of the TASK channels has been linked to the immobilizing and sedative–hypnotic effects of volatile general anesthetics <ce:cross-ref refid=\"bib18\">[18]</ce:cross-ref>.</ce:para><ce:para id=\"para0135\" view=\"all\">Respiratory motoneurons, including facial (VII), hypoglossal (XII), ambigual (Amb), motor trigeminal (MoV) and vagal (X), are similarly sensitive to extracellular pH, and this involves an anesthetic-sensitive TASK-like background K<ce:sup loc=\"post\">+</ce:sup> current <ce:cross-refs refid=\"bib9 bib15 bib16\">[9,15,16]</ce:cross-refs> (<ce:cross-ref refid=\"fig3\">Figure 3</ce:cross-ref>a–c).</ce:para><ce:para id=\"para0140\" view=\"all\">Thus, the different neurons regulating respiration express high levels of both the acid-sensitive TASK-1 and TASK-3 K<ce:inf loc=\"post\">2P</ce:inf> subunits <ce:cross-refs refid=\"bib9 bib17 bib49\">[9,17,49]</ce:cross-refs>. This finding together with their observed pH sensitivity (pK: 7.3, similar to that of TASK-1), stimulation by isoflurane (like TASK-3) and resistance to ruthenium red (like TASK-3), indicate that they contain functional TASK-1–TASK-3 heteromers <ce:cross-ref refid=\"bib9\">[9]</ce:cross-ref> (<ce:cross-ref refid=\"tb1\">Box 1</ce:cross-ref>). Heteromultimeric association of TASK-1 and TASK-3 is further supported by other studies, including those performed with cerebellar granule neurons, in which sensitivities to pH and ruthenium red were also measured <ce:cross-refs refid=\"bib8 bib9 bib10 bib11\">[8–11]</ce:cross-refs>.</ce:para><ce:para id=\"para0145\" view=\"all\">Although compelling evidence has been provided recently for a role of heteromeric TASK-1–TASK-3 channels in respiratory brainstem neurons, it should be remembered that other pH sensors, which remain to be identified, are also probably simultaneously involved in sensing both intra- and extracellular pH at a variety of sites within the medulla oblongata. Further studies will clearly be needed to demonstrate whether the TASK channels represent the main sensors in these neurons or whether they act in parallel with other pH-sensitive pathways.</ce:para></ce:section><ce:section id=\"section0030\" view=\"all\"><ce:section-title>Glucose and CO<ce:inf loc=\"post\">2</ce:inf>/pH sensing in the hypothalamic orexin neurons</ce:section-title><ce:para id=\"para0150\" view=\"all\">Glucose homeostasis is essential for brain function, as glucose is the primary fuel for neurons. Specific neurons, including the hypothalamic orexin neurons, are able to sense glucose and trigger adaptive behavioral responses. Orexin neurons have been identified <ce:italic>in situ</ce:italic> in a transgenic mouse expressing enhanced green fluorescent protein (eGFP) driven by the human pre-pro-orexin promoter. These neurons express both TASK-1 and TASK-3 subunits <ce:cross-ref refid=\"bib27\">[27]</ce:cross-ref> (<ce:cross-ref refid=\"fig3\">Figure 3</ce:cross-ref>d). The activity of these hypothalamic neurons, which project to almost all brain areas, supports wakefulness, whereas the loss of these neurons results in narcolepsy and compromises vital ventilatory adaptation. The activity of orexin neurons is directly controlled by glucose levels <ce:cross-ref refid=\"bib27\">[27]</ce:cross-ref>. When body energy is high, hypothalamic orexin neurons are inhibited by high glucose, leading to increased sleepiness and decreased metabolism (<ce:cross-ref refid=\"fig3\">Figure 3</ce:cross-ref>e). By contrast, when glucose levels fall during fasting, the excitability of orexin neurons is increased, thus potentiating wakefulness and food-seeking behavior <ce:cross-ref refid=\"bib27\">[27]</ce:cross-ref>.</ce:para><ce:para id=\"para0155\" view=\"all\">One possible mechanism responsible for glucose sensing in orexin neurons has recently been identified <ce:cross-ref refid=\"bib27\">[27]</ce:cross-ref>. Glucose increases the amplitude of a TASK-like hyperpolarizing K<ce:sup loc=\"post\">+</ce:sup> current and reduces the spontaneous electrical activity (<ce:cross-ref refid=\"fig3\">Figure 3</ce:cross-ref>f). This glucose-activated K<ce:sup loc=\"post\">+</ce:sup> current shares the biophysical and pharmacological properties of a TASK-3 heteromer with a single channel conductance of 40<ce:hsp sp=\"0.25\"/>pS (similar to TASK-3 homomer), a stimulation by halothane (similar to TASK-1 and TASK-3), inhibition by external acidosis (pK: pH 6.9)(intermediate between TASK-1 and TASK-3), but resistance to ruthenium red (similar to TASK-1) <ce:cross-ref refid=\"bib27\">[27]</ce:cross-ref> (<ce:cross-ref refid=\"tb1\">Box 1</ce:cross-ref>).</ce:para><ce:para id=\"para0160\" view=\"all\">Small variations in glucose concentration similar to those occurring between normal meals during the day (in the range of 1–2.5<ce:hsp sp=\"0.25\"/>mM) modulate this background K<ce:sup loc=\"post\">+</ce:sup> current <ce:cross-ref refid=\"bib27\">[27]</ce:cross-ref>. Glucose acts at an extracellular site, although a direct interaction with the TASK channel has been ruled out <ce:cross-ref refid=\"bib27\">[27]</ce:cross-ref>. This effect is independent of a change in intracellular ATP or calcium and the mechanism of this regulation remains to be identified.</ce:para><ce:para id=\"para0165\" view=\"all\">Hypothalamic orexin neurons are also crucial for normal stimulation of breathing. Recent findings demonstrate a modulation of these neurons by acid and CO<ce:inf loc=\"post\">2</ce:inf>, as described above for respiratory brainstem motoneurons <ce:cross-ref refid=\"bib28\">[28]</ce:cross-ref>. Excitability is enhanced when external pH decreases, whereas alkalinization reduces the firing rate. These effects are mediated by the pH modulation of background TASK-like channels <ce:cross-ref refid=\"bib28\">[28]</ce:cross-ref>.</ce:para><ce:para id=\"para0170\" view=\"all\">Therefore, these findings reveal an unexpected role for a TASK channel, most probably a heteromeric assembly including TASK-3, in an energy-sensing neuronal pathway that is central to the regulation of states of consciousness and energy balance.</ce:para></ce:section><ce:section id=\"section0035\" view=\"all\"><ce:section-title>Conclusions</ce:section-title><ce:para id=\"para0175\" view=\"all\">Taken together, these recent studies suggest that both TASK-1 and TASK-3 subunits play an important functional role in chemo- and nutrient-sensing integrating multiple physiological stimuli, including hypoxia, acidosis and glucose levels. For instance, the inhibition of TASK channels in brainstem respiratory neurons and glomus cells in the carotid body by acidic and/or hypoxic stimuli plays a central role in initiating the reflex increase in ventilation. By contrast, stimulation of TASK channels by extracellular glucose turns off the activity of the hypothalamic orexin neurons that regulate feeding and neuroendocrine and autonomic function, and thereby energy expenditure and storage. Pharmacological properties and sensitivity to extracellular pH indicate that TASK heteromeric channels are likely to play a role. Although the effect of extracelluar pH on the TASK channels is now well understood, the modulation by hypoxia and glucose still remains enigmatic.</ce:para><ce:para id=\"para0180\" view=\"all\">As additional TASK K<ce:inf loc=\"post\">2P</ce:inf> channel transgenic animals become available, including knock-in mutants, the role of this intriguing class of ion channels in physiology, pharmacology and pathology should soon be understood better.</ce:para></ce:section><ce:section id=\"section0040\" view=\"all\"><ce:section-title>Future directions</ce:section-title><ce:para id=\"para0185\" view=\"all\">Although major progress has been made recently in the biophysical and pharmacological characterization of the TASK K<ce:inf loc=\"post\">2P</ce:inf> channels in chemosensitive cells, several important issues remain to be addressed including: (i) Which subunits constitute the heteromeric TASK complex in chemosensitive cells? (ii) Is the chemo- and glucose sensitivity altered in the TASK-1, TASK-3 and TASK-1–TASK-3 double knockout mice? (iii) What is the identity of the oxygen sensor(s) regulating TASK channels? (iv) What is the mechanism of TASK regulation by extracellular glucose? (v) Are human genetic diseases associated with mutations in TASK channels? (vi) What is the role of TASK channels in vascular physiopathology? (vii) What is the function of the silent subunit TASK-5? (viii) How is the expression of TASK channels regulated?</ce:para><ce:para id=\"para0190\" view=\"all\">A recent report <ce:cross-ref refid=\"bib50\">[50]</ce:cross-ref> shows that cerebellar granule neurons lacking TASK-3 exhibit marked accommodation of action potential firing, thus demonstrating that this K<ce:inf loc=\"post\">2P</ce:inf> channel not only increases the resting potassium conductance but also stimulates excitability by supporting high-frequency firing once action potential threshold is reached. Finally, it was recently shown <ce:cross-ref refid=\"bib51\">[51]</ce:cross-ref> that the carotid body oxygen-sensitive background K<ce:sup loc=\"post\">+</ce:sup> channel is stimulated by a variety of Mg<ce:sup loc=\"post\">2+</ce:sup> nucleotides, including GTP, UTP, AMP-PCP and ATP-γ-s, which suggests a stimulatory mechanism that may involve some form of Mg<ce:sup loc=\"post\">2+</ce:sup>-nucleotide sensor rather than an enzymatic process.</ce:para></ce:section></ce:sections><ce:acknowledgment><ce:section-title>Acknowledgements</ce:section-title><ce:para id=\"para0195\" view=\"all\">We are grateful to the ANR 2005 Cardiovasculaire-obésité-diabète, to the Association for Information and Research on Genetic Kidney Disease France, to the Fondation del Duca, to the Fondation de France, to the Fondation de la Recherche Médicale, to EEC Marie-Curie fellowships, to the Fondation de Recherche sur l’Hypertension Artérielle, to AFM, to HFSP to INSERM and to CNRS for support. We thank Douglas Bayliss and Keith Buckler for their constructive input and personal communications.</ce:para></ce:acknowledgment></body><tail view=\"all\"><ce:bibliography id=\"bibliography0005\" view=\"all\"><ce:section-title>References</ce:section-title><ce:bibliography-sec id=\"bibliography-sec0005\"><ce:bib-reference id=\"bib1\"><ce:label>1</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Honoré</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The neuronal background K<ce:inf loc=\"post\">2P</ce:inf> channels: focus on TREK-1</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nat. Rev. Neurosci.</sb:maintitle></sb:title><sb:volume-nr>8</sb:volume-nr></sb:series><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>251</sb:first-page><sb:last-page>261</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib2\"><ce:label>2</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Lesage</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>TWIK-1, a ubiquitous human weakly inward rectifying K<ce:sup loc=\"post\">+</ce:sup> channel with a novel structure</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>EMBO J.</sb:maintitle></sb:title><sb:volume-nr>15</sb:volume-nr></sb:series><sb:date>1996</sb:date></sb:issue><sb:pages><sb:first-page>1004</sb:first-page><sb:last-page>1011</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib3\"><ce:label>3</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>K.A.</ce:given-name><ce:surname>Ketchum</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>A new family of outwardly rectifying potassium channel proteins with two pore domains in tandem</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nature</sb:maintitle></sb:title><sb:volume-nr>376</sb:volume-nr></sb:series><sb:date>1995</sb:date></sb:issue><sb:pages><sb:first-page>690</sb:first-page><sb:last-page>695</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib4\"><ce:label>4</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>S.A.</ce:given-name><ce:surname>Goldstein</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>ORK1, a potassium-selective leak channel with two pore domains cloned from <ce:italic>Drosophila melanogaster</ce:italic> by expression in <ce:italic>Saccharomyces cerevisiae</ce:italic></sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Proc. Natl. Acad. Sci. U. S. A.</sb:maintitle></sb:title><sb:volume-nr>93</sb:volume-nr></sb:series><sb:date>1996</sb:date></sb:issue><sb:pages><sb:first-page>13256</sb:first-page><sb:last-page>13261</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib5\"><ce:label>5</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Warth</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Proximal renal tubular acidosis in TASK2 K<ce:sup loc=\"post\">+</ce:sup> channel-deficient mice reveals a mechanism for stabilizing bicarbonate transport</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Proc. Natl. Acad. Sci. U. S. A.</sb:maintitle></sb:title><sb:volume-nr>101</sb:volume-nr></sb:series><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>8215</sb:first-page><sb:last-page>8220</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib6\"><ce:label>6</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Barriere</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Role of TASK2 potassium channels regarding volume regulation in primary cultures of mouse proximal tubules</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Gen. Physiol.</sb:maintitle></sb:title><sb:volume-nr>122</sb:volume-nr></sb:series><sb:date>2003</sb:date></sb:issue><sb:pages><sb:first-page>177</sb:first-page><sb:last-page>190</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib7\"><ce:label>7</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>A.J.</ce:given-name><ce:surname>Patel</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Honoré</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Properties and modulation of mammalian 2P domain K<ce:sup loc=\"post\">+</ce:sup> channels</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Trends Neurosci.</sb:maintitle></sb:title><sb:volume-nr>24</sb:volume-nr></sb:series><sb:date>2001</sb:date></sb:issue><sb:pages><sb:first-page>339</sb:first-page><sb:last-page>346</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib8\"><ce:label>8</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>I.</ce:given-name><ce:surname>Lauritzen</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>K<ce:sup loc=\"post\">+</ce:sup>-dependent cerebellar granule neuron apoptosis: role of TASK leak K<ce:sup loc=\"post\">+</ce:sup> channels</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Biol. Chem.</sb:maintitle></sb:title><sb:volume-nr>278</sb:volume-nr></sb:series><sb:date>2003</sb:date></sb:issue><sb:pages><sb:first-page>32068</sb:first-page><sb:last-page>32076</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib9\"><ce:label>9</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>A.P.</ce:given-name><ce:surname>Berg</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Motoneurons express heteromeric TWIK-related acid-sensitive K<ce:sup loc=\"post\">+</ce:sup> (TASK) channels containing TASK-1 (KCNK3) and TASK-3 (KCNK9) subunits</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Neurosci.</sb:maintitle></sb:title><sb:volume-nr>24</sb:volume-nr></sb:series><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>6693</sb:first-page><sb:last-page>6702</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib10\"><ce:label>10</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Kang</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Functional expression of TASK-1/TASK-3 heteromers in cerebellar granule cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Physiol.</sb:maintitle></sb:title><sb:volume-nr>554</sb:volume-nr></sb:series><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>64</sb:first-page><sb:last-page>77</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib11\"><ce:label>11</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Czirjak</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Enyedi</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Formation of functional heterodimers between the TASK-1 and TASK-3 two pore domain potassium channel subunits</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Biol. Chem.</sb:maintitle></sb:title><sb:volume-nr>277</sb:volume-nr></sb:series><sb:date>2001</sb:date></sb:issue><sb:pages><sb:first-page>5426</sb:first-page><sb:last-page>5432</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib12\"><ce:label>12</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Duprat</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>TASK, a human background K<ce:sup loc=\"post\">+</ce:sup> channel to sense external pH variations near physiological pH</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>EMBO J.</sb:maintitle></sb:title><sb:volume-nr>16</sb:volume-nr></sb:series><sb:date>1997</sb:date></sb:issue><sb:pages><sb:first-page>5464</sb:first-page><sb:last-page>5471</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib13\"><ce:label>13</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Han</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Characterization of four types of background potassium channels in rat cerebellar granule neurons</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Physiol.</sb:maintitle></sb:title><sb:volume-nr>542</sb:volume-nr></sb:series><sb:date>2002</sb:date></sb:issue><sb:pages><sb:first-page>431</sb:first-page><sb:last-page>444</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib14\"><ce:label>14</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>K.J.</ce:given-name><ce:surname>Buckler</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>An oxygen-, acid- and anaesthetic-sensitive TASK-like background potassium channel in rat arterial chemoreceptor cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Physiol.</sb:maintitle></sb:title><sb:volume-nr>525</sb:volume-nr></sb:series><sb:date>2000</sb:date></sb:issue><sb:pages><sb:first-page>135</sb:first-page><sb:last-page>142</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib15\"><ce:label>15</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>D.K.</ce:given-name><ce:surname>Mulkey</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Respiratory control by ventral surface chemoreceptor neurons in rats</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nat. Neurosci.</sb:maintitle></sb:title><sb:volume-nr>7</sb:volume-nr></sb:series><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>1360</sb:first-page><sb:last-page>1369</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib16\"><ce:label>16</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>E.M.</ce:given-name><ce:surname>Talley</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>TASK-1, a two-pore domain K<ce:sup loc=\"post\">+</ce:sup> channel, is modulated by multiple neurotransmitters in motoneurons</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Neuron</sb:maintitle></sb:title><sb:volume-nr>25</sb:volume-nr></sb:series><sb:date>2000</sb:date></sb:issue><sb:pages><sb:first-page>399</sb:first-page><sb:last-page>410</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib17\"><ce:label>17</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>E.M.</ce:given-name><ce:surname>Talley</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Cns distribution of members of the two-pore-domain (KCNK) potassium channel family</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Neurosci.</sb:maintitle></sb:title><sb:volume-nr>21</sb:volume-nr></sb:series><sb:date>2001</sb:date></sb:issue><sb:pages><sb:first-page>7491</sb:first-page><sb:last-page>7505</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib18\"><ce:label>18</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>C.P.</ce:given-name><ce:surname>Washburn</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Serotonergic raphe neurons express TASK channel transcripts and a TASK- like pH- and halothane-sensitive K<ce:sup loc=\"post\">+</ce:sup> conductance</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Neurosci.</sb:maintitle></sb:title><sb:volume-nr>22</sb:volume-nr></sb:series><sb:date>2002</sb:date></sb:issue><sb:pages><sb:first-page>1256</sb:first-page><sb:last-page>1265</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib19\"><ce:label>19</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>M.E.</ce:given-name><ce:surname>Hartness</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Combined antisense and pharmacological approaches implicate hTASK as an airway O<ce:inf loc=\"post\">2</ce:inf> sensing K<ce:sup loc=\"post\">+</ce:sup> channel</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Biol. Chem.</sb:maintitle></sb:title><sb:volume-nr>276</sb:volume-nr></sb:series><sb:date>2001</sb:date></sb:issue><sb:pages><sb:first-page>26499</sb:first-page><sb:last-page>26508</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib20\"><ce:label>20</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>A.M.</ce:given-name><ce:surname>Gurney</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Two-pore domain K<ce:sup loc=\"post\">+</ce:sup> channel, TASK-1, in pulmonary artery smooth muscle cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Circ. Res.</sb:maintitle></sb:title><sb:volume-nr>93</sb:volume-nr></sb:series><sb:date>2003</sb:date></sb:issue><sb:pages><sb:first-page>957</sb:first-page><sb:last-page>964</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib21\"><ce:label>21</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Olschewski</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Impact of TASK-1 in human pulmonary artery smooth muscle cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Circ. Res.</sb:maintitle></sb:title><sb:volume-nr>98</sb:volume-nr></sb:series><sb:date>2006</sb:date></sb:issue><sb:pages><sb:first-page>1072</sb:first-page><sb:last-page>1080</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib22\"><ce:label>22</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>K.K.</ce:given-name><ce:surname>Rau</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Expression of TWIK-related acid sensitive K<ce:sup loc=\"post\">+</ce:sup> channels in capsaicin sensitive and insensitive cells of rat dorsal root ganglia</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Neuroscience</sb:maintitle></sb:title><sb:volume-nr>141</sb:volume-nr></sb:series><sb:date>2006</sb:date></sb:issue><sb:pages><sb:first-page>955</sb:first-page><sb:last-page>963</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib23\"><ce:label>23</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>B.Y.</ce:given-name><ce:surname>Cooper</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Characterization and function of TWIK-related acid sensing K<ce:sup loc=\"post\">+</ce:sup> channels in a rat nociceptive cell</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Neuroscience</sb:maintitle></sb:title><sb:volume-nr>129</sb:volume-nr></sb:series><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>209</sb:first-page><sb:last-page>224</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib24\"><ce:label>24</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>T.K.</ce:given-name><ce:surname>Baumann</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Background potassium channel block and TRPV1 activation contribute to proton depolarization of sensory neurons from humans with neuropathic pain</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Eur. J. Neurosci.</sb:maintitle></sb:title><sb:volume-nr>19</sb:volume-nr></sb:series><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>1343</sb:first-page><sb:last-page>1351</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib25\"><ce:label>25</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>W.</ce:given-name><ce:surname>Lin</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Taste receptor cells express pH-sensitive leak K<ce:sup loc=\"post\">+</ce:sup> channels</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Neurophysiol.</sb:maintitle></sb:title><sb:volume-nr>92</sb:volume-nr></sb:series><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>2909</sb:first-page><sb:last-page>2919</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib26\"><ce:label>26</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>T.A.</ce:given-name><ce:surname>Richter</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Acid-sensitive two-pore domain potassium (K<ce:inf loc=\"post\">2P</ce:inf>) channels in mouse taste buds</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Neurophysiol.</sb:maintitle></sb:title><sb:volume-nr>92</sb:volume-nr></sb:series><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>1928</sb:first-page><sb:last-page>1936</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib27\"><ce:label>27</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Burdakov</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Tandem-pore K<ce:sup loc=\"post\">+</ce:sup> channels mediate inhibition of orexin neurons by glucose</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Neuron</sb:maintitle></sb:title><sb:volume-nr>50</sb:volume-nr></sb:series><sb:date>2006</sb:date></sb:issue><sb:pages><sb:first-page>711</sb:first-page><sb:last-page>722</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib28\"><ce:label>28</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>R.H.</ce:given-name><ce:surname>Williams</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Control of hypothalamic orexin neurons by acid and CO<ce:inf loc=\"post\">2</ce:inf></sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Proc. Natl. Acad. Sci. U. S. A.</sb:maintitle></sb:title><sb:volume-nr>104</sb:volume-nr></sb:series><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>10685</sb:first-page><sb:last-page>10690</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib29\"><ce:label>29</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Barbe</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>A possible dual site of action for carbon monoxide-mediated chemoexcitation in the rat carotid body</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Physiol.</sb:maintitle></sb:title><sb:volume-nr>543</sb:volume-nr></sb:series><sb:date>2002</sb:date></sb:issue><sb:pages><sb:first-page>933</sb:first-page><sb:last-page>945</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib30\"><ce:label>30</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Yamamoto</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>TASK-1, TASK-2, TASK-3 and TRAAK immunoreactivities in the rat carotid body</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Brain Res.</sb:maintitle></sb:title><sb:volume-nr>950</sb:volume-nr></sb:series><sb:date>2002</sb:date></sb:issue><sb:pages><sb:first-page>304</sb:first-page><sb:last-page>307</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib31\"><ce:label>31</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>I.</ce:given-name><ce:surname>Kim</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Postnatal changes in gene expression of subfamilies of TASK K<ce:sup loc=\"post\">+</ce:sup> channels in rat carotid body</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Adv. Exp. Med. Biol.</sb:maintitle></sb:title><sb:volume-nr>580</sb:volume-nr></sb:series><sb:date>2006</sb:date></sb:issue><sb:pages><sb:first-page>43</sb:first-page><sb:last-page>47</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib32\"><ce:label>32</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>K.J.</ce:given-name><ce:surname>Buckler</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>TASK-like potassium channels and oxygen sensing in the carotid body</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Respir. Physiol. Neurobiol.</sb:maintitle></sb:title><sb:volume-nr>157</sb:volume-nr></sb:series><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>55</sb:first-page><sb:last-page>64</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib33\"><ce:label>33</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>C.E.</ce:given-name><ce:surname>Clarke</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Selective block of the human 2-P domain potassium channel, TASK-3, and the native leak potassium current, IKSO, by zinc</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Physiol.</sb:maintitle></sb:title><sb:volume-nr>560</sb:volume-nr></sb:series><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>51</sb:first-page><sb:last-page>62</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib34\"><ce:label>34</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>L.D.</ce:given-name><ce:surname>Plant</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>K<ce:inf loc=\"post\">2P</ce:inf> channels and their protein partners</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Curr. Opin. Neurobiol.</sb:maintitle></sb:title><sb:volume-nr>15</sb:volume-nr></sb:series><sb:date>2005</sb:date></sb:issue><sb:pages><sb:first-page>326</sb:first-page><sb:last-page>333</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib35\"><ce:label>35</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>A.J.</ce:given-name><ce:surname>Patel</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Honoré</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Molecular physiology of oxygen-sensitive potassium channels</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Eur. Resp. J.</sb:maintitle></sb:title><sb:volume-nr>18</sb:volume-nr></sb:series><sb:date>2001</sb:date></sb:issue><sb:pages><sb:first-page>221</sb:first-page><sb:last-page>227</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib36\"><ce:label>36</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>R.P.</ce:given-name><ce:surname>Johnson</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>System-specific O<ce:inf loc=\"post\">2</ce:inf> sensitivity of the tandem pore domain K<ce:sup loc=\"post\">+</ce:sup> channel TASK-1</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Am. J. Physiol. Cell Physiol</sb:maintitle></sb:title><sb:volume-nr>286</sb:volume-nr></sb:series><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>C391</sb:first-page><sb:last-page>C397</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib37\"><ce:label>37</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Lewis</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Recombinant hTASK1 is an O<ce:inf loc=\"post\">2</ce:inf>-sensitive K<ce:sup loc=\"post\">+</ce:sup> channel</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Biochem. Biophys. Res. Commun.</sb:maintitle></sb:title><sb:volume-nr>285</sb:volume-nr></sb:series><sb:date>2001</sb:date></sb:issue><sb:pages><sb:first-page>1290</sb:first-page><sb:last-page>1294</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib38\"><ce:label>38</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>M.R.</ce:given-name><ce:surname>Duchen</ce:surname></sb:author><sb:author><ce:given-name>T.J.</ce:given-name><ce:surname>Biscoe</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Mitochondrial function in type I cells isolated from rabbit arterial chemoreceptors</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Physiol.</sb:maintitle></sb:title><sb:volume-nr>450</sb:volume-nr></sb:series><sb:date>1992</sb:date></sb:issue><sb:pages><sb:first-page>13</sb:first-page><sb:last-page>31</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib39\"><ce:label>39</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>C.N.</ce:given-name><ce:surname>Wyatt</ce:surname></sb:author><sb:author><ce:given-name>K.J.</ce:given-name><ce:surname>Buckler</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The effect of mitochondrial inhibitors on membrane currents in isolated neonatal rat carotid body type I cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Physiol.</sb:maintitle></sb:title><sb:volume-nr>556</sb:volume-nr></sb:series><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>175</sb:first-page><sb:last-page>191</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib40\"><ce:label>40</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Maingret</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>The endocannabinoid anandamide is a direct and selective blocker of the background K<ce:sup loc=\"post\">+</ce:sup> channel TASK-1</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>EMBO J.</sb:maintitle></sb:title><sb:volume-nr>20</sb:volume-nr></sb:series><sb:date>2001</sb:date></sb:issue><sb:pages><sb:first-page>47</sb:first-page><sb:last-page>54</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib41\"><ce:label>41</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>B.A.</ce:given-name><ce:surname>Williams</ce:surname></sb:author><sb:author><ce:given-name>K.J.</ce:given-name><ce:surname>Buckler</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Biophysical properties and metabolic regulation of a TASK-like potassium channel in rat carotid body type 1 cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Am. J. Physiol. Lung Cell. Mol. Physiol.</sb:maintitle></sb:title><sb:volume-nr>286</sb:volume-nr></sb:series><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>L221</sb:first-page><sb:last-page>L230</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib42\"><ce:label>42</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Chemin</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Mechanisms underlying excitatory effects of group I metabotropic glutamate receptors via inhibition of 2P domain K<ce:sup loc=\"post\">+</ce:sup> channels</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>EMBO J.</sb:maintitle></sb:title><sb:volume-nr>22</sb:volume-nr></sb:series><sb:date>2003</sb:date></sb:issue><sb:pages><sb:first-page>5403</sb:first-page><sb:last-page>5411</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib43\"><ce:label>43</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>C.N.</ce:given-name><ce:surname>Wyatt</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>AMP-activated protein kinase mediates carotid body excitation by hypoxia</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Biol. Chem.</sb:maintitle></sb:title><sb:volume-nr>282</sb:volume-nr></sb:series><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>8092</sb:first-page><sb:last-page>8098</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib44\"><ce:label>44</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>Y.M.</ce:given-name><ce:surname>Lee</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>NOX4 as an oxygen sensor to regulate TASK-1 activity</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cell. Signal.</sb:maintitle></sb:title><sb:volume-nr>18</sb:volume-nr></sb:series><sb:date>2006</sb:date></sb:issue><sb:pages><sb:first-page>499</sb:first-page><sb:last-page>507</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib45\"><ce:label>45</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Gonzalez</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Chemoreception in the context of the general biology of ROS</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Respir. Physiol. Neurobiol.</sb:maintitle></sb:title><sb:volume-nr>157</sb:volume-nr></sb:series><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>30</sb:first-page><sb:last-page>44</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib46\"><ce:label>46</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Duprat</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Pancreatic two P domain K<ce:sup loc=\"post\">+</ce:sup> channels TALK-1 and TALK-2 are activated by nitric oxide and reactive oxygen species</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Physiol.</sb:maintitle></sb:title><sb:volume-nr>562</sb:volume-nr></sb:series><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>235</sb:first-page><sb:last-page>244</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib47\"><ce:label>47</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>S.E.</ce:given-name><ce:surname>Williams</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Hemoxygenase-2 is an oxygen sensor for a calcium-sensitive potassium channel</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Science</sb:maintitle></sb:title><sb:volume-nr>306</sb:volume-nr></sb:series><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>2093</sb:first-page><sb:last-page>2097</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib48\"><ce:label>48</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Ortega-Saenz</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Acute oxygen sensing in heme oxygenase-2 null mice</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Gen. Physiol.</sb:maintitle></sb:title><sb:volume-nr>128</sb:volume-nr></sb:series><sb:date>2006</sb:date></sb:issue><sb:pages><sb:first-page>405</sb:first-page><sb:last-page>411</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib49\"><ce:label>49</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>C.P.</ce:given-name><ce:surname>Washburn</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Cardiorespiratory neurons of the rat ventrolateral medulla contain TASK-1 and TASK-3 channel mRNA</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Respir. Physiol. Neurobiol.</sb:maintitle></sb:title><sb:volume-nr>138</sb:volume-nr></sb:series><sb:date>2003</sb:date></sb:issue><sb:pages><sb:first-page>19</sb:first-page><sb:last-page>35</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib50\"><ce:label>50</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>S.G.</ce:given-name><ce:surname>Brickley</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>TASK-3 two-pore domain potassium channels enable sustained high-frequency firing in cerebellar granule neurons</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Neurosci.</sb:maintitle></sb:title><sb:volume-nr>27</sb:volume-nr></sb:series><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>9329</sb:first-page><sb:last-page>9340</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib51\"><ce:label>51</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Varas</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Modulation of TASK-like background potassium channels in rat arterial chemoreceptor cells by intracellular ATP and other nucleotides</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Physiol.</sb:maintitle></sb:title><sb:volume-nr>583</sb:volume-nr></sb:series><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>521</sb:first-page><sb:last-page>536</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib52\"><ce:label>52</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Rajan</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>TASK-3, a novel tandem pore-domain acid-sensitive K<ce:sup loc=\"post\">+</ce:sup> channel: an extracellular histidine as pH sensor</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Biol. Chem.</sb:maintitle></sb:title><sb:volume-nr>275</sb:volume-nr></sb:series><sb:date>2000</sb:date></sb:issue><sb:pages><sb:first-page>16650</sb:first-page><sb:last-page>16657</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib53\"><ce:label>53</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>C.M.</ce:given-name><ce:surname>Lopes</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Block of Kcnk3 by protons. Evidence that 2-P-domain potassium channel subunits function as homodimers</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Biol. Chem.</sb:maintitle></sb:title><sb:volume-nr>276</sb:volume-nr></sb:series><sb:date>2001</sb:date></sb:issue><sb:pages><sb:first-page>24449</sb:first-page><sb:last-page>24452</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib54\"><ce:label>54</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Yuill</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>The selectivity filter of the tandem pore potassium channel TASK-1 and its pH-sensitivity and ionic selectivity</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Pflugers Arch.</sb:maintitle></sb:title><sb:volume-nr>448</sb:volume-nr></sb:series><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>63</sb:first-page><sb:last-page>69</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib55\"><ce:label>55</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>M.J.</ce:given-name><ce:surname>Morton</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Determinants of pH sensing in the two-pore domain K<ce:sup loc=\"post\">+</ce:sup> channels TASK-1 and -2</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Pflugers Arch.</sb:maintitle></sb:title><sb:volume-nr>445</sb:volume-nr></sb:series><sb:date>2003</sb:date></sb:issue><sb:pages><sb:first-page>577</sb:first-page><sb:last-page>583</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib56\"><ce:label>56</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Kim</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>TASK-3, a new member of the tandem pore K<ce:sup loc=\"post\">+</ce:sup> channel family</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Biol. Chem.</sb:maintitle></sb:title><sb:volume-nr>275</sb:volume-nr></sb:series><sb:date>2000</sb:date></sb:issue><sb:pages><sb:first-page>9340</sb:first-page><sb:last-page>9347</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib57\"><ce:label>57</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>A.J.</ce:given-name><ce:surname>Patel</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Inhalational anaesthetics activate two-pore-domain background K<ce:sup loc=\"post\">+</ce:sup> channels</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nat. Neurosci.</sb:maintitle></sb:title><sb:volume-nr>2</sb:volume-nr></sb:series><sb:date>1999</sb:date></sb:issue><sb:pages><sb:first-page>422</sb:first-page><sb:last-page>426</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib58\"><ce:label>58</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>J.E.</ce:given-name><ce:surname>Sirois</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>The TASK-1 two-pore domain K<ce:sup loc=\"post\">+</ce:sup> channel is a molecular substrate for neuronal effects of inhalational anesthetics</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Neurosci</sb:maintitle></sb:title><sb:volume-nr>20</sb:volume-nr></sb:series><sb:date>2000</sb:date></sb:issue><sb:pages><sb:first-page>6347</sb:first-page><sb:last-page>6354</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib59\"><ce:label>59</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Gruss</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Two-pore-domain K<ce:sup loc=\"post\">+</ce:sup> channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Mol. Pharmacol</sb:maintitle></sb:title><sb:volume-nr>65</sb:volume-nr></sb:series><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>443</sb:first-page><sb:last-page>452</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib60\"><ce:label>60</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>I.</ce:given-name><ce:surname>Andres-Enguix</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Determinants of the anesthetic sensitivity of TASK channels: molecular cloning of an anesthetic-activated potassium channel from <ce:italic>Lymnaea stagnalis</ce:italic></sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Biol. Chem.</sb:maintitle></sb:title><sb:volume-nr>282</sb:volume-nr></sb:series><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>20977</sb:first-page><sb:last-page>20990</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib61\"><ce:label>61</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>E.M.</ce:given-name><ce:surname>Talley</ce:surname></sb:author><sb:author><ce:given-name>D.A.</ce:given-name><ce:surname>Bayliss</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Modulation of TASK-1 (Kcnk3) and TASK-3 (Kcnk9) potassium channels: volatile anesthetics and neurotransmitters share a molecular site of action</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Biol. Chem.</sb:maintitle></sb:title><sb:volume-nr>277</sb:volume-nr></sb:series><sb:date>2002</sb:date></sb:issue><sb:pages><sb:first-page>17733</sb:first-page><sb:last-page>17742</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib62\"><ce:label>62</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Leonoudakis</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>An open rectifier potassium channel with two pore domains in tandem cloned from rat cerebellum</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Neurosci.</sb:maintitle></sb:title><sb:volume-nr>18</sb:volume-nr></sb:series><sb:date>1998</sb:date></sb:issue><sb:pages><sb:first-page>868</sb:first-page><sb:last-page>877</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib63\"><ce:label>63</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>C.H.</ce:given-name><ce:surname>Kindler</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Local anaesthetic inhibition of baseline potassium channels with two pore domains in tandem</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Anesthesiology</sb:maintitle></sb:title><sb:volume-nr>90</sb:volume-nr></sb:series><sb:date>1999</sb:date></sb:issue><sb:pages><sb:first-page>1092</sb:first-page><sb:last-page>1102</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib64\"><ce:label>64</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Czirjak</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Enyedi</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Ruthenium red inhibits TASK-3 potassium channel by interconnecting glutamate 70 of the two subnits</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Mol. Pharmacol.</sb:maintitle></sb:title><sb:volume-nr>63</sb:volume-nr></sb:series><sb:date>2003</sb:date></sb:issue><sb:pages><sb:first-page>646</sb:first-page><sb:last-page>652</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib65\"><ce:label>65</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Musset</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Effects of divalent cations and spermine on the K<ce:sup loc=\"post\">+</ce:sup> channel TASK-3 and on the outward current in thalamic neurons</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Physiol.</sb:maintitle></sb:title><sb:volume-nr>572</sb:volume-nr></sb:series><sb:date>2006</sb:date></sb:issue><sb:pages><sb:first-page>639</sb:first-page><sb:last-page>657</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib66\"><ce:label>66</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>J.A.</ce:given-name><ce:surname>Millar</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>A functional role for the two-pore domain potassium channel TASK-1 in cerebellar granule neurons</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Proc. Natl. Acad. Sci. U. S. A.</sb:maintitle></sb:title><sb:volume-nr>97</sb:volume-nr></sb:series><sb:date>2000</sb:date></sb:issue><sb:pages><sb:first-page>3614</sb:first-page><sb:last-page>3618</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib67\"><ce:label>67</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Czirjak</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Inhibition of TASK-1 potassium channel by phospholipase C</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Am. J. Physiol. Cell Physiol.</sb:maintitle></sb:title><sb:volume-nr>281</sb:volume-nr></sb:series><sb:date>2001</sb:date></sb:issue><sb:pages><sb:first-page>C700</sb:first-page><sb:last-page>C708</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib68\"><ce:label>68</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>X.</ce:given-name><ce:surname>Chen</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Inhibition of a background potassium channel by Gq protein {alpha}-subunits</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Proc. Natl. Acad. Sci. U. S. A.</sb:maintitle></sb:title><sb:volume-nr>103</sb:volume-nr></sb:series><sb:date>2006</sb:date></sb:issue><sb:pages><sb:first-page>3422</sb:first-page><sb:last-page>3427</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib69\"><ce:label>69</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>E.L.</ce:given-name><ce:surname>Veale</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>G(alpha)q-mediated regulation of TASK3 two-pore domain potassium channels: the role of protein kinase C</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Mol. Pharmacol.</sb:maintitle></sb:title><sb:volume-nr>71</sb:volume-nr></sb:series><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>1666</sb:first-page><sb:last-page>1675</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib70\"><ce:label>70</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Besana</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Activation of protein kinase C epsilon inhibits the two-pore domain K<ce:sup loc=\"post\">+</ce:sup> channel, TASK-1, inducing repolarization abnormalities in cardiac ventricular myocytes</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Biol. Chem.</sb:maintitle></sb:title><sb:volume-nr>279</sb:volume-nr></sb:series><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>33154</sb:first-page><sb:last-page>33160</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib71\"><ce:label>71</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>A.D.</ce:given-name><ce:surname>O’Connell</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Two-pore domain K<ce:sup loc=\"post\">+</ce:sup> channels-molecular sensors</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Biochim. Biophys. Acta</sb:maintitle></sb:title><sb:volume-nr>1566</sb:volume-nr></sb:series><sb:date>2002</sb:date></sb:issue><sb:pages><sb:first-page>152</sb:first-page><sb:last-page>161</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib72\"><ce:label>72</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>K.J.</ce:given-name><ce:surname>Buckler</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Background leak K<ce:sup loc=\"post\">+</ce:sup>-currents and oxygen sensing in carotid body type 1 cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Respir. Physiol.</sb:maintitle></sb:title><sb:volume-nr>115</sb:volume-nr></sb:series><sb:date>1999</sb:date></sb:issue><sb:pages><sb:first-page>179</sb:first-page><sb:last-page>187</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference></ce:bibliography-sec></ce:bibliography><ce:glossary id=\"glossary0005\" view=\"all\"><ce:section-title>Glossary</ce:section-title><ce:glossary-sec id=\"glossary-sec0005\"><ce:glossary-entry id=\"glossary-entry0005\"><ce:glossary-heading>4-aminopryridine (4-AP)</ce:glossary-heading><ce:glossary-def>a blocker of K<ce:inf loc=\"post\">v</ce:inf> channels.</ce:glossary-def></ce:glossary-entry><ce:glossary-entry id=\"glossary-entry0010\"><ce:glossary-heading>AMP-activated protein kinase (AMPK)</ce:glossary-heading><ce:glossary-def>this enzyme induces a cascade of events in response to an increase in AMP concentration, reflecting the energy status of the cell. AMPK-mediated phosphorylation switches cells from ATP consumption to ATP production. AMPK also regulates insulin synthesis and secretion in pancreatic islet β-cells as well as modulation of hypothalamic functions. AMPK is expressed in glomus cells in the carotid body.</ce:glossary-def></ce:glossary-entry><ce:glossary-entry id=\"glossary-entry0015\"><ce:glossary-heading>Cell-attached patch configuration</ce:glossary-heading><ce:glossary-def>recording configuration in which the patch of membrane at the tip of the recording electrode is not excised but remains attached to the cell. This configuration allows the measurement of the current flowing through the ion channels embedded in the electrically isolated membrane patch on the cell.</ce:glossary-def></ce:glossary-entry><ce:glossary-entry id=\"glossary-entry0020\"><ce:glossary-heading>Guanine-nucleotide-binding protein Gq</ce:glossary-heading><ce:glossary-def>activates phospholipase C and triggers PIP<ce:inf loc=\"post\">2</ce:inf> hydrolysis generating InsP<ce:inf loc=\"post\">3</ce:inf> and diacylglycerol (DG). InsP<ce:inf loc=\"post\">3</ce:inf> releases calcium from the intracellular stores and DG stimulates protein kinase C (PKC) activity phosphorylating multiple substrates, including ion channels.</ce:glossary-def></ce:glossary-entry><ce:glossary-entry id=\"glossary-entry0025\"><ce:glossary-heading>Heme oxygenase-2 (HO-2)</ce:glossary-heading><ce:glossary-def>this enzyme catalyzes the conversion of heme (Fe-protoporphyrin IX) to biliverdin and CO and releases Fe in a reaction that utilizes oxygen and NADPH. All products of HO activity are suspected to be physiologically active. HO-2 is expressed in glomus cells in the carotid body.</ce:glossary-def></ce:glossary-entry><ce:glossary-entry id=\"glossary-entry0030\"><ce:glossary-heading>Inside-out patch configuration</ce:glossary-heading><ce:glossary-def>recording configuration in which the patch of membrane at the tip of the patch clamp electrode is excised from the cell and when the intracellular side of the channel is facing the bath.</ce:glossary-def></ce:glossary-entry><ce:glossary-entry id=\"glossary-entry0035\"><ce:glossary-heading>Inward rectifiers (K<ce:inf loc=\"post\">ir</ce:inf>)</ce:glossary-heading><ce:glossary-def>these K<ce:sup loc=\"post\">+</ce:sup> channels allow long depolarizing responses, as they close during depolarizing pulses and open with steep voltage dependence upon hyperpolarization. They are called inward rectifiers because current flows through them more easily into than out of the cell. K<ce:inf loc=\"post\">ir</ce:inf> channels are blocked by intracellular Mg<ce:sup loc=\"post\">2+</ce:sup> and polyamines at depolarized membrane potentials.</ce:glossary-def></ce:glossary-entry><ce:glossary-entry id=\"glossary-entry0040\"><ce:glossary-heading>NADPH oxidase (NOX)</ce:glossary-heading><ce:glossary-def>this enzymatic complex is normally latent in neutrophils and is activated to assemble in the membranes during a respiratory burst. It generates superoxide by transferring electrons from NADPH inside the cell across the membrane and coupling these to molecular oxygen to produce the superoxide, a highly reactive free radical. NOX4 is expressed in glomus cells in the carotid body.</ce:glossary-def></ce:glossary-entry><ce:glossary-entry id=\"glossary-entry0045\"><ce:glossary-heading>P domain</ce:glossary-heading><ce:glossary-def>a short amino acid segment, also called the selectivity filter, between two transmembrane helices that dips into the membrane without fully crossing it. The P domain determines ionic permeability and selectivity of K<ce:sup loc=\"post\">+</ce:sup> channels.</ce:glossary-def></ce:glossary-entry><ce:glossary-entry id=\"glossary-entry0050\"><ce:glossary-heading>Permeability</ce:glossary-heading><ce:glossary-def>a given ion channel can allow the passage of related ionic species, although not all with the same ease.</ce:glossary-def></ce:glossary-entry><ce:glossary-entry id=\"glossary-entry0055\"><ce:glossary-heading>Phosphoinositol bisphosphate (PIP<ce:inf loc=\"post\">2</ce:inf>)</ce:glossary-heading><ce:glossary-def>a minor phospholipid component of the plasma membrane regulating the activity of multiple ion channels and transporters. Intracellular polylysine, a polycationic agent that interacts with PIP<ce:inf loc=\"post\">2</ce:inf>, inhibits the TREK and TASK K<ce:inf loc=\"post\">2P</ce:inf> channels, whereas exogenous PIP<ce:inf loc=\"post\">2</ce:inf> promotes their opening.</ce:glossary-def></ce:glossary-entry><ce:glossary-entry id=\"glossary-entry0060\"><ce:glossary-heading>pK</ce:glossary-heading><ce:glossary-def>value of pH inhibiting the TASK channels by 50%.</ce:glossary-def></ce:glossary-entry><ce:glossary-entry id=\"glossary-entry0065\"><ce:glossary-heading>Rectification</ce:glossary-heading><ce:glossary-def>the property whereby current through a channel does not flow with the same ease from the inside as from the outside.</ce:glossary-def></ce:glossary-entry><ce:glossary-entry id=\"glossary-entry0070\"><ce:glossary-heading>Tandem of P domains in a weak inward rectifying K<ce:sup loc=\"post\">+</ce:sup> channel (TWIK-1)</ce:glossary-heading><ce:glossary-def>the first cloned mammalian K<ce:inf loc=\"post\">2P</ce:inf> channel, also called KCNK1 or K<ce:inf loc=\"post\">2P</ce:inf>1.1. This current shows a mild decrease in amplitude at depolarized potentials.</ce:glossary-def></ce:glossary-entry><ce:glossary-entry id=\"glossary-entry0075\"><ce:glossary-heading>TASK-1, KCNK3 or K<ce:inf loc=\"post\">2P</ce:inf>3.1</ce:glossary-heading><ce:glossary-def>initially called TWIK-1-related acid-sensitive K<ce:sup loc=\"post\">+</ce:sup> channel because of its inhibition by acidic extracellular pH.</ce:glossary-def></ce:glossary-entry><ce:glossary-entry id=\"glossary-entry0080\"><ce:glossary-heading>Tetraethylammonium (TEA)</ce:glossary-heading><ce:glossary-def>a blocker of K<ce:inf loc=\"post\">v</ce:inf> and BK channels.</ce:glossary-def></ce:glossary-entry><ce:glossary-entry id=\"glossary-entry0085\"><ce:glossary-heading>The Goldman Hodgkin Katz (GHK) formulation</ce:glossary-heading><ce:glossary-def>the constant field equation predicts an increase in conductance when ions flow across the membrane from the more concentrated side. The current to voltage relationship of a leak channel is anticipated to be linear in a symmetrical ionic gradient, while rectifying in a nonsymmetrical ionic gradient.</ce:glossary-def></ce:glossary-entry><ce:glossary-entry id=\"glossary-entry0090\"><ce:glossary-heading>TREK-1, KCNK-2 or K<ce:inf loc=\"post\">2P</ce:inf>2.1</ce:glossary-heading><ce:glossary-def>initially called TWIK-1-related K<ce:sup loc=\"post\">+</ce:sup> channel, is opened by membrane stretch, heat stimulation, intracellular acidosis and cellular lipids, including polyunsaturated fatty acids and lysophospholipids.</ce:glossary-def></ce:glossary-entry><ce:glossary-entry id=\"glossary-entry0095\"><ce:glossary-heading>Voltage-gated K<ce:sup loc=\"post\">+</ce:sup> channels (K<ce:inf loc=\"post\">v</ce:inf>)</ce:glossary-heading><ce:glossary-def>these K<ce:sup loc=\"post\">+</ce:sup> channels open when the membrane is depolarized. A movement of the positively charged fourth transmembrane segment, also called the voltage sensor S4, triggers channel opening. K<ce:inf loc=\"post\">v</ce:inf> channels are outward rectifiers allowing current to flow more easily out of the cell. Kv channels shape the action potential duration.</ce:glossary-def></ce:glossary-entry></ce:glossary-sec></ce:glossary></tail></article></xocs:serial-item></xocs:doc></originalText></full-text-retrieval-response>',\n",
       " '<full-text-retrieval-response xmlns=\"http://www.elsevier.com/xml/svapi/article/dtd\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\" xmlns:prism=\"http://prismstandard.org/namespaces/basic/2.0/\" xmlns:dcterms=\"http://purl.org/dc/terms/\" xmlns:dc=\"http://purl.org/dc/elements/1.1/\" xmlns:xocs=\"http://www.elsevier.com/xml/xocs/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:tb=\"http://www.elsevier.com/xml/common/table/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" xmlns:ja=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns:cals=\"http://www.elsevier.com/xml/common/cals/dtd\" xmlns:bk=\"http://www.elsevier.com/xml/bk/dtd\"><coredata><prism:url>https://api.elsevier.com/content/article/pii/S0022282815000309</prism:url><dc:identifier>doi:10.1016/j.yjmcc.2015.01.017</dc:identifier><eid>1-s2.0-S0022282815000309</eid><prism:doi>10.1016/j.yjmcc.2015.01.017</prism:doi><pii>S0022-2828(15)00030-9</pii><dc:title>TASK-1 and TASK-3 may form heterodimers in human atrial cardiomyocytes </dc:title><prism:publicationName>Journal of Molecular and Cellular Cardiology</prism:publicationName><prism:aggregationType>Journal</prism:aggregationType><pubType>Original article</pubType><prism:issn>00222828</prism:issn><prism:volume>81</prism:volume><prism:startingPage>71</prism:startingPage><prism:endingPage>80</prism:endingPage><prism:pageRange>71-80</prism:pageRange><dc:format>text/xml</dc:format><prism:coverDate>2015-04-30</prism:coverDate><prism:coverDisplayDate>April 2015</prism:coverDisplayDate><prism:copyright>Copyright © 2015 Elsevier Ltd. All rights reserved.</prism:copyright><prism:publisher>Elsevier Ltd.</prism:publisher><dc:creator>Rinné, Susanne</dc:creator><dc:creator>Kiper, Aytug K.</dc:creator><dc:creator>Schlichthörl, Günter</dc:creator><dc:creator>Dittmann, Sven</dc:creator><dc:creator>Netter, Michael F.</dc:creator><dc:creator>Limberg, Sven H.</dc:creator><dc:creator>Silbernagel, Nicole</dc:creator><dc:creator>Zuzarte, Marylou</dc:creator><dc:creator>Moosdorf, Rainer</dc:creator><dc:creator>Wulf, Hinnerk</dc:creator><dc:creator>Schulze-Bahr, Eric</dc:creator><dc:creator>Rolfes, Caroline</dc:creator><dc:creator>Decher, Niels</dc:creator><dc:description>AbstractTASK-1 channels have emerged as promising drug targets against atrial fibrillation, the most common arrhythmia in the elderly. While TASK-3, the closest relative of TASK-1, was previously not described in cardiac tissue, we found a very prominent expression of TASK-3 in right human auricles. Immunocytochemistry experiments of human right auricular cardiomyocytes showed that TASK-3 is primarily localized at the plasma membrane. Single-channel recordings of right human auricles in the cell-attached mode, using divalent-cation-free solutions, revealed a TASK-1-like channel with a single-channel conductance of about 30pS. While homomeric TASK-3 channels were not found, we observed an intermediate single-channel conductance of about 55pS, possibly reflecting the heteromeric channel formed by TASK-1 and TASK-3. Subsequent experiments with TASK-1/TASK-3 tandem channels or with co-expressed TASK-1 and TASK-3 channels in HEK293 cells or Xenopus oocytes, supported that the 55pS channels observed in right auricles have electrophysiological characteristics of TASK-1/TASK-3 heteromers. In addition, co-expression experiments and single-channel recordings suggest that heteromeric TASK-1/TASK-3 channels have a predominant surface expression and a reduced affinity for TASK-1 blockers. In summary, the evidence for heteromeric TASK-1/TASK-3 channel complexes together with an altered pharmacologic response to TASK-1 blockers in vitro is likely to have further impact for studies isolating ITASK-1 from cardiomyocytes and for the development of drugs specifically targeting TASK-1 in atrial fibrillation treatment.</dc:description><openaccess>0</openaccess><openaccessArticle>false</openaccessArticle><openaccessType/><openArchiveArticle>false</openArchiveArticle><openaccessSponsorName/><openaccessSponsorType/><openaccessUserLicense/><dcterms:subject>K2P channel</dcterms:subject><dcterms:subject>TASK</dcterms:subject><dcterms:subject>Atrial fibrillation</dcterms:subject><dcterms:subject>Right human auricles</dcterms:subject><dcterms:subject>Cardiomyocytes</dcterms:subject><dcterms:subject>Heteromers</dcterms:subject><link rel=\"self\" href=\"https://api.elsevier.com/content/article/pii/S0022282815000309\"/><link rel=\"scidir\" href=\"http://www.sciencedirect.com/science/article/pii/S0022282815000309\"/></coredata><objects><object ref=\"gr8\" category=\"high\" type=\"IMAGE-HIGH-RES\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"3347\" height=\"1769\" size=\"504128\">https://api.elsevier.com/content/object/eid/1-s2.0-S0022282815000309-gr8_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr7\" category=\"high\" type=\"IMAGE-HIGH-RES\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"2378\" height=\"867\" size=\"184096\">https://api.elsevier.com/content/object/eid/1-s2.0-S0022282815000309-gr7_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr6\" category=\"high\" type=\"IMAGE-HIGH-RES\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"2769\" height=\"1015\" size=\"233097\">https://api.elsevier.com/content/object/eid/1-s2.0-S0022282815000309-gr6_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr5\" category=\"high\" type=\"IMAGE-HIGH-RES\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"2779\" height=\"1630\" size=\"393330\">https://api.elsevier.com/content/object/eid/1-s2.0-S0022282815000309-gr5_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr4\" category=\"high\" type=\"IMAGE-HIGH-RES\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"3347\" height=\"1611\" size=\"453320\">https://api.elsevier.com/content/object/eid/1-s2.0-S0022282815000309-gr4_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr3\" category=\"high\" type=\"IMAGE-HIGH-RES\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"1631\" height=\"2250\" size=\"343052\">https://api.elsevier.com/content/object/eid/1-s2.0-S0022282815000309-gr3_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr2\" category=\"high\" type=\"IMAGE-HIGH-RES\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"1733\" height=\"1520\" size=\"286052\">https://api.elsevier.com/content/object/eid/1-s2.0-S0022282815000309-gr2_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr1\" category=\"high\" type=\"IMAGE-HIGH-RES\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"1575\" height=\"1097\" size=\"148668\">https://api.elsevier.com/content/object/eid/1-s2.0-S0022282815000309-gr1_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr8\" category=\"standard\" type=\"IMAGE-DOWNSAMPLED\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"756\" height=\"400\" size=\"59324\">https://api.elsevier.com/content/object/eid/1-s2.0-S0022282815000309-gr8.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr7\" category=\"standard\" type=\"IMAGE-DOWNSAMPLED\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"537\" height=\"196\" size=\"23720\">https://api.elsevier.com/content/object/eid/1-s2.0-S0022282815000309-gr7.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr6\" category=\"standard\" type=\"IMAGE-DOWNSAMPLED\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"625\" height=\"229\" size=\"29663\">https://api.elsevier.com/content/object/eid/1-s2.0-S0022282815000309-gr6.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr5\" category=\"standard\" type=\"IMAGE-DOWNSAMPLED\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"628\" height=\"368\" size=\"48780\">https://api.elsevier.com/content/object/eid/1-s2.0-S0022282815000309-gr5.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr4\" category=\"standard\" type=\"IMAGE-DOWNSAMPLED\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"756\" height=\"364\" size=\"51975\">https://api.elsevier.com/content/object/eid/1-s2.0-S0022282815000309-gr4.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr3\" category=\"standard\" type=\"IMAGE-DOWNSAMPLED\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"368\" height=\"508\" size=\"46428\">https://api.elsevier.com/content/object/eid/1-s2.0-S0022282815000309-gr3.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr2\" category=\"standard\" type=\"IMAGE-DOWNSAMPLED\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"391\" height=\"343\" size=\"30287\">https://api.elsevier.com/content/object/eid/1-s2.0-S0022282815000309-gr2.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr1\" category=\"standard\" type=\"IMAGE-DOWNSAMPLED\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"355\" height=\"247\" size=\"17225\">https://api.elsevier.com/content/object/eid/1-s2.0-S0022282815000309-gr1.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr8\" category=\"thumbnail\" type=\"IMAGE-THUMBNAIL\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"219\" height=\"116\" size=\"3990\">https://api.elsevier.com/content/object/eid/1-s2.0-S0022282815000309-gr8.sml?httpAccept=%2A%2F%2A</object><object ref=\"gr7\" category=\"thumbnail\" type=\"IMAGE-THUMBNAIL\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"219\" height=\"80\" size=\"2922\">https://api.elsevier.com/content/object/eid/1-s2.0-S0022282815000309-gr7.sml?httpAccept=%2A%2F%2A</object><object ref=\"gr6\" category=\"thumbnail\" type=\"IMAGE-THUMBNAIL\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"219\" height=\"80\" size=\"3190\">https://api.elsevier.com/content/object/eid/1-s2.0-S0022282815000309-gr6.sml?httpAccept=%2A%2F%2A</object><object ref=\"gr5\" category=\"thumbnail\" type=\"IMAGE-THUMBNAIL\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"219\" height=\"128\" size=\"5005\">https://api.elsevier.com/content/object/eid/1-s2.0-S0022282815000309-gr5.sml?httpAccept=%2A%2F%2A</object><object ref=\"gr4\" category=\"thumbnail\" type=\"IMAGE-THUMBNAIL\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"219\" height=\"105\" size=\"3385\">https://api.elsevier.com/content/object/eid/1-s2.0-S0022282815000309-gr4.sml?httpAccept=%2A%2F%2A</object><object ref=\"gr3\" category=\"thumbnail\" type=\"IMAGE-THUMBNAIL\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"119\" height=\"164\" size=\"3545\">https://api.elsevier.com/content/object/eid/1-s2.0-S0022282815000309-gr3.sml?httpAccept=%2A%2F%2A</object><object ref=\"gr2\" category=\"thumbnail\" type=\"IMAGE-THUMBNAIL\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"187\" height=\"164\" size=\"4250\">https://api.elsevier.com/content/object/eid/1-s2.0-S0022282815000309-gr2.sml?httpAccept=%2A%2F%2A</object><object ref=\"gr1\" category=\"thumbnail\" type=\"IMAGE-THUMBNAIL\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"219\" height=\"153\" size=\"5894\">https://api.elsevier.com/content/object/eid/1-s2.0-S0022282815000309-gr1.sml?httpAccept=%2A%2F%2A</object><object ref=\"mmc1\" category=\"standard\" type=\"APPLICATION\" multimediatype=\"Acrobat PDF file\" mimetype=\"application/pdf\" size=\"589657\">https://api.elsevier.com/content/object/eid/1-s2.0-S0022282815000309-mmc1.pdf?httpAccept=%2A%2F%2A</object></objects><scopus-id>84922570219</scopus-id><scopus-eid>2-s2.0-84922570219</scopus-eid><pubmed-id>25655935</pubmed-id><link rel=\"abstract\" href=\"https://api.elsevier.com/content/abstract/scopus_id/84922570219\"/><originalText><xocs:doc xmlns:xoe=\"http://www.elsevier.com/xml/xoe/dtd\" xsi:schemaLocation=\"http://www.elsevier.com/xml/xocs/dtd http://be-prod3a/schema/dtds/document/fulltext/xcr/xocs-article.xsd\"><xocs:meta><xocs:content-family>serial</xocs:content-family><xocs:content-type>JL</xocs:content-type><xocs:cid>272480</xocs:cid><xocs:ssids><xocs:ssid type=\"alllist\">291210</xocs:ssid><xocs:ssid type=\"subj\">291852</xocs:ssid><xocs:ssid type=\"subj\">291857</xocs:ssid><xocs:ssid type=\"subj\">291896</xocs:ssid><xocs:ssid type=\"content\">31</xocs:ssid></xocs:ssids><xocs:srctitle>Journal of Molecular and Cellular Cardiology</xocs:srctitle><xocs:normalized-srctitle>JOURNALMOLECULARCELLULARCARDIOLOGY</xocs:normalized-srctitle><xocs:orig-load-date yyyymmdd=\"20150202\">2015-02-02</xocs:orig-load-date><xocs:available-online-date yyyymmdd=\"20150202\">2015-02-02</xocs:available-online-date><xocs:ew-transaction-id>2015-03-25T03:35:14</xocs:ew-transaction-id><xocs:eid>1-s2.0-S0022282815000309</xocs:eid><xocs:pii-formatted>S0022-2828(15)00030-9</xocs:pii-formatted><xocs:pii-unformatted>S0022282815000309</xocs:pii-unformatted><xocs:doi>10.1016/j.yjmcc.2015.01.017</xocs:doi><xocs:item-stage>S300</xocs:item-stage><xocs:item-version-number>S300.1</xocs:item-version-number><xocs:item-weight>FULL-TEXT</xocs:item-weight><xocs:hub-eid>1-s2.0-S0022282815X00022</xocs:hub-eid><xocs:timestamp yyyymmdd=\"20150514\">2015-05-14T01:20:21.503208-04:00</xocs:timestamp><xocs:dco>0</xocs:dco><xocs:tomb>0</xocs:tomb><xocs:date-search-begin>20150401</xocs:date-search-begin><xocs:date-search-end>20150430</xocs:date-search-end><xocs:year-nav>2015</xocs:year-nav><xocs:indexeddate epoch=\"1422896803\">2015-02-02T17:06:43.390108Z</xocs:indexeddate><xocs:articleinfo>articleinfo articletitlenorm authfirstinitialnorm authfirstsurnamenorm cid cids contenttype copyright crossmark dateloaded dateloadedtxt datesearch datesort dateupdated dco docsubtype doctype doi eid ewtransactionid hubeid indexeddate issn issnnorm itemstage itemtransactionid itemweight openaccess openarchive pg pgfirst pglast pii piinorm pubdateend pubdatestart pubdatetxt pubyr sectiontitle sortorder srctitle srctitlenorm srctype ssids alllist content subj subheadings suppl tomb volfirst volissue volumelist webpdf webpdfpagecount yearnav figure e-component body acknowledge affil appendices articletitle auth authfirstini authfull authkeywords authlast footnotes grantnumber grantsponsor grantsponsorid highlightsabst primabst pubtype ref</xocs:articleinfo><xocs:issns><xocs:issn-primary-formatted>0022-2828</xocs:issn-primary-formatted><xocs:issn-primary-unformatted>00222828</xocs:issn-primary-unformatted></xocs:issns><xocs:crossmark is-crossmark=\"1\">true</xocs:crossmark><xocs:vol-first>81</xocs:vol-first><xocs:volume-list><xocs:volume>81</xocs:volume></xocs:volume-list><xocs:suppl>C</xocs:suppl><xocs:vol-iss-suppl-text>Volume 81</xocs:vol-iss-suppl-text><xocs:sort-order>16</xocs:sort-order><xocs:first-fp>71</xocs:first-fp><xocs:last-lp>80</xocs:last-lp><xocs:pages><xocs:first-page>71</xocs:first-page><xocs:last-page>80</xocs:last-page></xocs:pages><xocs:cover-date-orig><xocs:start-date>201504</xocs:start-date></xocs:cover-date-orig><xocs:cover-date-text>April 2015</xocs:cover-date-text><xocs:cover-date-start>2015-04-01</xocs:cover-date-start><xocs:cover-date-end>2015-04-30</xocs:cover-date-end><xocs:cover-date-year>2015</xocs:cover-date-year><xocs:hub-sec><xocs:hub-sec-title>Original Articles</xocs:hub-sec-title></xocs:hub-sec><xocs:document-type>article</xocs:document-type><xocs:document-subtype>fla</xocs:document-subtype><xocs:copyright-line>Copyright © 2015 Elsevier Ltd. All rights reserved.</xocs:copyright-line><xocs:normalized-article-title>TASK1TASK3MAYFORMHETERODIMERSINHUMANATRIALCARDIOMYOCYTES</xocs:normalized-article-title><xocs:normalized-first-auth-surname>RINNE</xocs:normalized-first-auth-surname><xocs:normalized-first-auth-initial>S</xocs:normalized-first-auth-initial><xocs:item-toc><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>1</xocs:item-toc-label><xocs:item-toc-section-title>Introduction</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>2</xocs:item-toc-label><xocs:item-toc-section-title>Material and methods</xocs:item-toc-section-title><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>2.1</xocs:item-toc-label><xocs:item-toc-section-title>Expression analysis</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>2.2</xocs:item-toc-label><xocs:item-toc-section-title>Isolation of human atrial cardiomyocytes</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>2.3</xocs:item-toc-label><xocs:item-toc-section-title>Fluorescence imaging</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>2.4</xocs:item-toc-label><xocs:item-toc-section-title>Single-channel recordings in human atrial myocytes and in transfected HEK293 cells</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>2.5</xocs:item-toc-label><xocs:item-toc-section-title>Isolation of <ce:italic>Xenopus</ce:italic> oocytes and TEVC recordings</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>2.6</xocs:item-toc-label><xocs:item-toc-section-title>Single-channel recordings from <ce:italic>Xenopus</ce:italic> oocytes</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>2.7</xocs:item-toc-label><xocs:item-toc-section-title>Chemiluminescence assay in <ce:italic>Xenopus</ce:italic> oocytes</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>2.8</xocs:item-toc-label><xocs:item-toc-section-title>Drugs</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>2.9</xocs:item-toc-label><xocs:item-toc-section-title>Data analyses</xocs:item-toc-section-title></xocs:item-toc-entry></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>3</xocs:item-toc-label><xocs:item-toc-section-title>Results</xocs:item-toc-section-title><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>3.1</xocs:item-toc-label><xocs:item-toc-section-title>TASK-3 expression in the human heart</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>3.2</xocs:item-toc-label><xocs:item-toc-section-title>Electrophysiological characterization of TASK currents from human atrial cells</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>3.3</xocs:item-toc-label><xocs:item-toc-section-title>Electrophysiological characterization of TASK-1, TASK-3 and TASK-1/TASK-3 heteromers in HEK293 cells</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>3.4</xocs:item-toc-label><xocs:item-toc-section-title>Electrophysiological characterization of TASK-1–TASK-3 and TASK-3–TASK-1 concatemers in HEK293 cells</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>3.5</xocs:item-toc-label><xocs:item-toc-section-title>Pharmacology of TASK-1–TASK-3 (T1–T3) and TASK-3–TASK-1 (T3–T1) concatemers</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>3.6</xocs:item-toc-label><xocs:item-toc-section-title>Pharmacology of TASK-1/TASK-3 heteromers after co-expression in <ce:italic>Xenopus</ce:italic> oocytes</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>3.7</xocs:item-toc-label><xocs:item-toc-section-title>Preferential surface expression of heteromeric TASK-1/TASK-3 channels after co-expression of TASK-1 and TASK-3</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>3.8</xocs:item-toc-label><xocs:item-toc-section-title>Single channel recordings show a reduced drug affinity for heteromeric TASK-1/TASK-3 channels</xocs:item-toc-section-title></xocs:item-toc-entry></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>4</xocs:item-toc-label><xocs:item-toc-section-title>Discussion</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-section-title>Disclosures</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:acknowledgment\"><xocs:item-toc-section-title>Acknowledgments</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:appendices\"><xocs:item-toc-label>Appendix A</xocs:item-toc-label><xocs:item-toc-section-title>Supplementary data</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:bibliography\"><xocs:item-toc-section-title>References</xocs:item-toc-section-title></xocs:item-toc-entry></xocs:item-toc><xocs:references><xocs:ref-info refid=\"rf0005\"><xocs:ref-normalized-surname>XU</xocs:ref-normalized-surname><xocs:ref-pub-year>1999</xocs:ref-pub-year><xocs:ref-first-fp>661</xocs:ref-first-fp><xocs:ref-last-lp>678</xocs:ref-last-lp><xocs:ref-normalized-initial>H</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0010\"><xocs:ref-normalized-surname>BACKX</xocs:ref-normalized-surname><xocs:ref-pub-year>1993</xocs:ref-pub-year><xocs:ref-first-fp>890</xocs:ref-first-fp><xocs:ref-last-lp>900</xocs:ref-last-lp><xocs:ref-normalized-initial>P</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0015\"><xocs:ref-normalized-surname>YUE</xocs:ref-normalized-surname><xocs:ref-pub-year>1988</xocs:ref-pub-year><xocs:ref-first-fp>127</xocs:ref-first-fp><xocs:ref-last-lp>133</xocs:ref-last-lp><xocs:ref-normalized-initial>D</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0020\"><xocs:ref-normalized-surname>DECHER</xocs:ref-normalized-surname><xocs:ref-pub-year>2011</xocs:ref-pub-year><xocs:ref-first-fp>77</xocs:ref-first-fp><xocs:ref-last-lp>86</xocs:ref-last-lp><xocs:ref-normalized-initial>N</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0025\"><xocs:ref-normalized-surname>LIMBERG</xocs:ref-normalized-surname><xocs:ref-pub-year>2011</xocs:ref-pub-year><xocs:ref-first-fp>613</xocs:ref-first-fp><xocs:ref-last-lp>624</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0030\"><xocs:ref-normalized-surname>PUTZKE</xocs:ref-normalized-surname><xocs:ref-pub-year>2007</xocs:ref-pub-year><xocs:ref-first-fp>59</xocs:ref-first-fp><xocs:ref-last-lp>68</xocs:ref-last-lp><xocs:ref-normalized-initial>C</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0035\"><xocs:ref-normalized-surname>SCHIEKEL</xocs:ref-normalized-surname><xocs:ref-pub-year>2013</xocs:ref-pub-year><xocs:ref-first-fp>97</xocs:ref-first-fp><xocs:ref-last-lp>105</xocs:ref-last-lp><xocs:ref-normalized-initial>J</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0040\"><xocs:ref-normalized-surname>XIANTAO</xocs:ref-normalized-surname><xocs:ref-pub-year>2006</xocs:ref-pub-year><xocs:ref-first-fp>86</xocs:ref-first-fp><xocs:ref-last-lp>97</xocs:ref-last-lp><xocs:ref-normalized-initial>L</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0045\"><xocs:ref-normalized-surname>FRIEDRICH</xocs:ref-normalized-surname><xocs:ref-pub-year>2014</xocs:ref-pub-year><xocs:ref-first-fp>937</xocs:ref-first-fp><xocs:ref-last-lp>951</xocs:ref-last-lp><xocs:ref-normalized-initial>C</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0050\"><xocs:ref-normalized-surname>LIANG</xocs:ref-normalized-surname><xocs:ref-pub-year>2014</xocs:ref-pub-year><xocs:ref-first-fp>69</xocs:ref-first-fp><xocs:ref-last-lp>76</xocs:ref-last-lp><xocs:ref-normalized-initial>B</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0055\"><xocs:ref-normalized-surname>GRAHAM</xocs:ref-normalized-surname><xocs:ref-pub-year>2006</xocs:ref-pub-year><xocs:ref-first-fp>143</xocs:ref-first-fp><xocs:ref-last-lp>151</xocs:ref-last-lp><xocs:ref-normalized-initial>V</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0060\"><xocs:ref-normalized-surname>BARTH</xocs:ref-normalized-surname><xocs:ref-pub-year>2005</xocs:ref-pub-year><xocs:ref-first-fp>1022</xocs:ref-first-fp><xocs:ref-last-lp>1029</xocs:ref-last-lp><xocs:ref-normalized-initial>A</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0065\"><xocs:ref-normalized-surname>KIM</xocs:ref-normalized-surname><xocs:ref-pub-year>2000</xocs:ref-pub-year><xocs:ref-first-fp>9340</xocs:ref-first-fp><xocs:ref-last-lp>9347</xocs:ref-last-lp><xocs:ref-normalized-initial>Y</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0070\"><xocs:ref-normalized-surname>CHAPMAN</xocs:ref-normalized-surname><xocs:ref-pub-year>2000</xocs:ref-pub-year><xocs:ref-first-fp>74</xocs:ref-first-fp><xocs:ref-last-lp>83</xocs:ref-last-lp><xocs:ref-normalized-initial>C</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0075\"><xocs:ref-normalized-surname>MEDHURST</xocs:ref-normalized-surname><xocs:ref-pub-year>2001</xocs:ref-pub-year><xocs:ref-first-fp>101</xocs:ref-first-fp><xocs:ref-last-lp>114</xocs:ref-last-lp><xocs:ref-normalized-initial>A</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0080\"><xocs:ref-normalized-surname>RAJAN</xocs:ref-normalized-surname><xocs:ref-pub-year>2000</xocs:ref-pub-year><xocs:ref-first-fp>16650</xocs:ref-first-fp><xocs:ref-last-lp>16657</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0085\"><xocs:ref-normalized-surname>CZIRJAK</xocs:ref-normalized-surname><xocs:ref-pub-year>2002</xocs:ref-pub-year><xocs:ref-first-fp>5426</xocs:ref-first-fp><xocs:ref-last-lp>5432</xocs:ref-last-lp><xocs:ref-normalized-initial>G</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0090\"><xocs:ref-normalized-surname>BAREL</xocs:ref-normalized-surname><xocs:ref-pub-year>2008</xocs:ref-pub-year><xocs:ref-first-fp>193</xocs:ref-first-fp><xocs:ref-last-lp>199</xocs:ref-last-lp><xocs:ref-normalized-initial>O</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0095\"><xocs:ref-normalized-surname>KANG</xocs:ref-normalized-surname><xocs:ref-pub-year>2004</xocs:ref-pub-year><xocs:ref-first-fp>64</xocs:ref-first-fp><xocs:ref-last-lp>77</xocs:ref-last-lp><xocs:ref-normalized-initial>D</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0100\"><xocs:ref-normalized-surname>BERG</xocs:ref-normalized-surname><xocs:ref-pub-year>2004</xocs:ref-pub-year><xocs:ref-first-fp>6693</xocs:ref-first-fp><xocs:ref-last-lp>6702</xocs:ref-last-lp><xocs:ref-normalized-initial>A</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0105\"><xocs:ref-normalized-surname>KIM</xocs:ref-normalized-surname><xocs:ref-pub-year>2009</xocs:ref-pub-year><xocs:ref-first-fp>2963</xocs:ref-first-fp><xocs:ref-last-lp>2975</xocs:ref-last-lp><xocs:ref-normalized-initial>D</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0110\"><xocs:ref-normalized-surname>TURNER</xocs:ref-normalized-surname><xocs:ref-pub-year>2013</xocs:ref-pub-year><xocs:ref-first-fp>5977</xocs:ref-first-fp><xocs:ref-last-lp>5998</xocs:ref-last-lp><xocs:ref-normalized-initial>P</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0115\"><xocs:ref-normalized-surname>BUSTAMANTE</xocs:ref-normalized-surname><xocs:ref-pub-year>1982</xocs:ref-pub-year><xocs:ref-first-fp>791</xocs:ref-first-fp><xocs:ref-last-lp>793</xocs:ref-last-lp><xocs:ref-normalized-initial>J</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0120\"><xocs:ref-normalized-surname>MAIER</xocs:ref-normalized-surname><xocs:ref-pub-year>1999</xocs:ref-pub-year><xocs:ref-first-fp>390</xocs:ref-first-fp><xocs:ref-last-lp>397</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0125\"><xocs:ref-normalized-surname>GU</xocs:ref-normalized-surname><xocs:ref-pub-year>2002</xocs:ref-pub-year><xocs:ref-first-fp>657</xocs:ref-first-fp><xocs:ref-last-lp>668</xocs:ref-last-lp><xocs:ref-normalized-initial>W</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0130\"><xocs:ref-normalized-surname>RENIGUNTA</xocs:ref-normalized-surname><xocs:ref-pub-year>2006</xocs:ref-pub-year><xocs:ref-first-fp>168</xocs:ref-first-fp><xocs:ref-last-lp>181</xocs:ref-last-lp><xocs:ref-normalized-initial>V</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0135\"><xocs:ref-normalized-surname>RENIGUNTA</xocs:ref-normalized-surname><xocs:ref-pub-year>2014</xocs:ref-pub-year><xocs:ref-first-fp>1877</xocs:ref-first-fp><xocs:ref-last-lp>1891</xocs:ref-last-lp><xocs:ref-normalized-initial>V</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0140\"><xocs:ref-normalized-surname>MUSSET</xocs:ref-normalized-surname><xocs:ref-pub-year>2006</xocs:ref-pub-year><xocs:ref-first-fp>639</xocs:ref-first-fp><xocs:ref-last-lp>657</xocs:ref-last-lp><xocs:ref-normalized-initial>B</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0145\"><xocs:ref-normalized-surname>STREIT</xocs:ref-normalized-surname><xocs:ref-pub-year>2011</xocs:ref-pub-year><xocs:ref-first-fp>13977</xocs:ref-first-fp><xocs:ref-last-lp>13984</xocs:ref-last-lp><xocs:ref-normalized-initial>A</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0150\"><xocs:ref-normalized-surname>DONNER</xocs:ref-normalized-surname><xocs:ref-pub-year>2011</xocs:ref-pub-year><xocs:ref-first-fp>75</xocs:ref-first-fp><xocs:ref-last-lp>87</xocs:ref-last-lp><xocs:ref-normalized-initial>B</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0155\"><xocs:ref-normalized-surname>PETRIC</xocs:ref-normalized-surname><xocs:ref-pub-year>2012</xocs:ref-pub-year><xocs:ref-first-fp>523</xocs:ref-first-fp><xocs:ref-last-lp>537</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0160\"><xocs:ref-normalized-surname>BROHAWN</xocs:ref-normalized-surname><xocs:ref-pub-year>2013</xocs:ref-pub-year><xocs:ref-first-fp>2129</xocs:ref-first-fp><xocs:ref-last-lp>2134</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0165\"><xocs:ref-normalized-surname>BROHAWN</xocs:ref-normalized-surname><xocs:ref-pub-year>2012</xocs:ref-pub-year><xocs:ref-first-fp>436</xocs:ref-first-fp><xocs:ref-last-lp>441</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info></xocs:references><xocs:refkeys><xocs:refkey3>RINNEX2015X71</xocs:refkey3><xocs:refkey4lp>RINNEX2015X71X80</xocs:refkey4lp><xocs:refkey4ai>RINNEX2015X71XS</xocs:refkey4ai><xocs:refkey5>RINNEX2015X71X80XS</xocs:refkey5></xocs:refkeys><xocs:open-access><xocs:oa-article-status is-open-access=\"0\" is-open-archive=\"0\"/></xocs:open-access><xocs:attachment-metadata-doc><xocs:attachment-set-type>item</xocs:attachment-set-type><xocs:pii-formatted>S0022-2828(15)00030-9</xocs:pii-formatted><xocs:pii-unformatted>S0022282815000309</xocs:pii-unformatted><xocs:eid>1-s2.0-S0022282815000309</xocs:eid><xocs:doi>10.1016/j.yjmcc.2015.01.017</xocs:doi><xocs:cid>272480</xocs:cid><xocs:timestamp>2015-03-25T01:46:52.33895-04:00</xocs:timestamp><xocs:cover-date-start>2015-04-01</xocs:cover-date-start><xocs:cover-date-end>2015-04-30</xocs:cover-date-end><xocs:attachments><xocs:web-pdf><xocs:attachment-eid>1-s2.0-S0022282815000309-main.pdf</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282815000309/MAIN/application/pdf/8f423e24b297911795b2e343ce8746c4/main.pdf</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282815000309/MAIN/application/pdf/8f423e24b297911795b2e343ce8746c4/main.pdf</xocs:ucs-locator><xocs:filename>main.pdf</xocs:filename><xocs:extension>pdf</xocs:extension><xocs:pdf-optimized>true</xocs:pdf-optimized><xocs:filesize>1224503</xocs:filesize><xocs:web-pdf-purpose>MAIN</xocs:web-pdf-purpose><xocs:web-pdf-page-count>10</xocs:web-pdf-page-count><xocs:web-pdf-images><xocs:web-pdf-image><xocs:attachment-eid>1-s2.0-S0022282815000309-main_1.png</xocs:attachment-eid><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282815000309/PREVIEW/image/png/361e91d6fc2299044974f063723be87d/main_1.png</xocs:ucs-locator><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282815000309/PREVIEW/image/png/361e91d6fc2299044974f063723be87d/main_1.png</xocs:ucs-locator><xocs:filename>main_1.png</xocs:filename><xocs:extension>png</xocs:extension><xocs:filesize>61459</xocs:filesize><xocs:pixel-height>849</xocs:pixel-height><xocs:pixel-width>656</xocs:pixel-width><xocs:attachment-type>IMAGE-WEB-PDF</xocs:attachment-type><xocs:pdf-page-num>1</xocs:pdf-page-num></xocs:web-pdf-image></xocs:web-pdf-images></xocs:web-pdf><xocs:attachment><xocs:attachment-eid>1-s2.0-S0022282815000309-gr8_lrg.jpg</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282815000309/gr8/HIGHRES/image/jpeg/ce98b7921e88746970251632b43f6d1d/gr8_lrg.jpg</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282815000309/gr8/HIGHRES/image/jpeg/ce98b7921e88746970251632b43f6d1d/gr8_lrg.jpg</xocs:ucs-locator><xocs:file-basename>gr8</xocs:file-basename><xocs:filename>gr8_lrg.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>504128</xocs:filesize><xocs:pixel-height>1769</xocs:pixel-height><xocs:pixel-width>3347</xocs:pixel-width><xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0022282815000309-gr7_lrg.jpg</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282815000309/gr7/HIGHRES/image/jpeg/afb7713967fe25d0f1346bd85e06b723/gr7_lrg.jpg</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282815000309/gr7/HIGHRES/image/jpeg/afb7713967fe25d0f1346bd85e06b723/gr7_lrg.jpg</xocs:ucs-locator><xocs:file-basename>gr7</xocs:file-basename><xocs:filename>gr7_lrg.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>184096</xocs:filesize><xocs:pixel-height>867</xocs:pixel-height><xocs:pixel-width>2378</xocs:pixel-width><xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0022282815000309-gr6_lrg.jpg</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282815000309/gr6/HIGHRES/image/jpeg/58c0c127f82f457f907796120c1f0679/gr6_lrg.jpg</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282815000309/gr6/HIGHRES/image/jpeg/58c0c127f82f457f907796120c1f0679/gr6_lrg.jpg</xocs:ucs-locator><xocs:file-basename>gr6</xocs:file-basename><xocs:filename>gr6_lrg.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>233097</xocs:filesize><xocs:pixel-height>1015</xocs:pixel-height><xocs:pixel-width>2769</xocs:pixel-width><xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0022282815000309-gr5_lrg.jpg</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282815000309/gr5/HIGHRES/image/jpeg/5f67e99c8d13fce71cc504c090ba19f4/gr5_lrg.jpg</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282815000309/gr5/HIGHRES/image/jpeg/5f67e99c8d13fce71cc504c090ba19f4/gr5_lrg.jpg</xocs:ucs-locator><xocs:file-basename>gr5</xocs:file-basename><xocs:filename>gr5_lrg.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>393330</xocs:filesize><xocs:pixel-height>1630</xocs:pixel-height><xocs:pixel-width>2779</xocs:pixel-width><xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0022282815000309-gr4_lrg.jpg</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282815000309/gr4/HIGHRES/image/jpeg/c5a913b655499da88e4888c4b9b96f82/gr4_lrg.jpg</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282815000309/gr4/HIGHRES/image/jpeg/c5a913b655499da88e4888c4b9b96f82/gr4_lrg.jpg</xocs:ucs-locator><xocs:file-basename>gr4</xocs:file-basename><xocs:filename>gr4_lrg.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>453320</xocs:filesize><xocs:pixel-height>1611</xocs:pixel-height><xocs:pixel-width>3347</xocs:pixel-width><xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0022282815000309-gr3_lrg.jpg</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282815000309/gr3/HIGHRES/image/jpeg/7134c3db1bbf10b53559bb9d244b4d7a/gr3_lrg.jpg</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282815000309/gr3/HIGHRES/image/jpeg/7134c3db1bbf10b53559bb9d244b4d7a/gr3_lrg.jpg</xocs:ucs-locator><xocs:file-basename>gr3</xocs:file-basename><xocs:filename>gr3_lrg.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>343052</xocs:filesize><xocs:pixel-height>2250</xocs:pixel-height><xocs:pixel-width>1631</xocs:pixel-width><xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0022282815000309-gr2_lrg.jpg</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282815000309/gr2/HIGHRES/image/jpeg/c04f1a326bf175f43a57fc11b20bf770/gr2_lrg.jpg</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282815000309/gr2/HIGHRES/image/jpeg/c04f1a326bf175f43a57fc11b20bf770/gr2_lrg.jpg</xocs:ucs-locator><xocs:file-basename>gr2</xocs:file-basename><xocs:filename>gr2_lrg.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>286052</xocs:filesize><xocs:pixel-height>1520</xocs:pixel-height><xocs:pixel-width>1733</xocs:pixel-width><xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0022282815000309-gr1_lrg.jpg</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282815000309/gr1/HIGHRES/image/jpeg/26da59d106fbe80dd8c0f1628fc75942/gr1_lrg.jpg</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282815000309/gr1/HIGHRES/image/jpeg/26da59d106fbe80dd8c0f1628fc75942/gr1_lrg.jpg</xocs:ucs-locator><xocs:file-basename>gr1</xocs:file-basename><xocs:filename>gr1_lrg.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>148668</xocs:filesize><xocs:pixel-height>1097</xocs:pixel-height><xocs:pixel-width>1575</xocs:pixel-width><xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0022282815000309-gr8.jpg</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282815000309/gr8/DOWNSAMPLED/image/jpeg/669af96b88ef46147aef6e74f42199f3/gr8.jpg</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282815000309/gr8/DOWNSAMPLED/image/jpeg/669af96b88ef46147aef6e74f42199f3/gr8.jpg</xocs:ucs-locator><xocs:file-basename>gr8</xocs:file-basename><xocs:filename>gr8.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>59324</xocs:filesize><xocs:pixel-height>400</xocs:pixel-height><xocs:pixel-width>756</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0022282815000309-gr7.jpg</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282815000309/gr7/DOWNSAMPLED/image/jpeg/4ceee7282fdca45bad23542bc6767439/gr7.jpg</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282815000309/gr7/DOWNSAMPLED/image/jpeg/4ceee7282fdca45bad23542bc6767439/gr7.jpg</xocs:ucs-locator><xocs:file-basename>gr7</xocs:file-basename><xocs:filename>gr7.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>23720</xocs:filesize><xocs:pixel-height>196</xocs:pixel-height><xocs:pixel-width>537</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0022282815000309-gr6.jpg</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282815000309/gr6/DOWNSAMPLED/image/jpeg/412ed64f1e7786a949914a2eb2cc91d7/gr6.jpg</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282815000309/gr6/DOWNSAMPLED/image/jpeg/412ed64f1e7786a949914a2eb2cc91d7/gr6.jpg</xocs:ucs-locator><xocs:file-basename>gr6</xocs:file-basename><xocs:filename>gr6.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>29663</xocs:filesize><xocs:pixel-height>229</xocs:pixel-height><xocs:pixel-width>625</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0022282815000309-gr5.jpg</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282815000309/gr5/DOWNSAMPLED/image/jpeg/b035b6fcfd3b64ccb3559cff93438d12/gr5.jpg</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282815000309/gr5/DOWNSAMPLED/image/jpeg/b035b6fcfd3b64ccb3559cff93438d12/gr5.jpg</xocs:ucs-locator><xocs:file-basename>gr5</xocs:file-basename><xocs:filename>gr5.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>48780</xocs:filesize><xocs:pixel-height>368</xocs:pixel-height><xocs:pixel-width>628</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0022282815000309-gr4.jpg</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282815000309/gr4/DOWNSAMPLED/image/jpeg/a16e6160070e79eac22a287b7033e659/gr4.jpg</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282815000309/gr4/DOWNSAMPLED/image/jpeg/a16e6160070e79eac22a287b7033e659/gr4.jpg</xocs:ucs-locator><xocs:file-basename>gr4</xocs:file-basename><xocs:filename>gr4.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>51975</xocs:filesize><xocs:pixel-height>364</xocs:pixel-height><xocs:pixel-width>756</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0022282815000309-gr3.jpg</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282815000309/gr3/DOWNSAMPLED/image/jpeg/6498bcf0974f6c74b7d1a06a6105bfc4/gr3.jpg</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282815000309/gr3/DOWNSAMPLED/image/jpeg/6498bcf0974f6c74b7d1a06a6105bfc4/gr3.jpg</xocs:ucs-locator><xocs:file-basename>gr3</xocs:file-basename><xocs:filename>gr3.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>46428</xocs:filesize><xocs:pixel-height>508</xocs:pixel-height><xocs:pixel-width>368</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0022282815000309-gr2.jpg</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282815000309/gr2/DOWNSAMPLED/image/jpeg/b09a8a65c49260e48dc52a2a4044b436/gr2.jpg</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282815000309/gr2/DOWNSAMPLED/image/jpeg/b09a8a65c49260e48dc52a2a4044b436/gr2.jpg</xocs:ucs-locator><xocs:file-basename>gr2</xocs:file-basename><xocs:filename>gr2.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>30287</xocs:filesize><xocs:pixel-height>343</xocs:pixel-height><xocs:pixel-width>391</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0022282815000309-gr1.jpg</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282815000309/gr1/DOWNSAMPLED/image/jpeg/151d87b0cc9a9a4f2ac07cf0c639cc0c/gr1.jpg</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282815000309/gr1/DOWNSAMPLED/image/jpeg/151d87b0cc9a9a4f2ac07cf0c639cc0c/gr1.jpg</xocs:ucs-locator><xocs:file-basename>gr1</xocs:file-basename><xocs:filename>gr1.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>17225</xocs:filesize><xocs:pixel-height>247</xocs:pixel-height><xocs:pixel-width>355</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0022282815000309-gr8.sml</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282815000309/gr8/THUMBNAIL/image/gif/9772d540f6336bea10dc18da737f2e47/gr8.sml</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282815000309/gr8/THUMBNAIL/image/gif/9772d540f6336bea10dc18da737f2e47/gr8.sml</xocs:ucs-locator><xocs:file-basename>gr8</xocs:file-basename><xocs:filename>gr8.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>3990</xocs:filesize><xocs:pixel-height>116</xocs:pixel-height><xocs:pixel-width>219</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0022282815000309-gr7.sml</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282815000309/gr7/THUMBNAIL/image/gif/a05726f1ddae273add66487a7febf4e7/gr7.sml</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282815000309/gr7/THUMBNAIL/image/gif/a05726f1ddae273add66487a7febf4e7/gr7.sml</xocs:ucs-locator><xocs:file-basename>gr7</xocs:file-basename><xocs:filename>gr7.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>2922</xocs:filesize><xocs:pixel-height>80</xocs:pixel-height><xocs:pixel-width>219</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0022282815000309-gr6.sml</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282815000309/gr6/THUMBNAIL/image/gif/7f97fa69e94608acd9192146d88a49fc/gr6.sml</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282815000309/gr6/THUMBNAIL/image/gif/7f97fa69e94608acd9192146d88a49fc/gr6.sml</xocs:ucs-locator><xocs:file-basename>gr6</xocs:file-basename><xocs:filename>gr6.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>3190</xocs:filesize><xocs:pixel-height>80</xocs:pixel-height><xocs:pixel-width>219</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0022282815000309-gr5.sml</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282815000309/gr5/THUMBNAIL/image/gif/8f51e6ff04756199b24283ae322d7c86/gr5.sml</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282815000309/gr5/THUMBNAIL/image/gif/8f51e6ff04756199b24283ae322d7c86/gr5.sml</xocs:ucs-locator><xocs:file-basename>gr5</xocs:file-basename><xocs:filename>gr5.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>5005</xocs:filesize><xocs:pixel-height>128</xocs:pixel-height><xocs:pixel-width>219</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0022282815000309-gr4.sml</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282815000309/gr4/THUMBNAIL/image/gif/e366941d3740f88e1005e4f50fab9018/gr4.sml</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282815000309/gr4/THUMBNAIL/image/gif/e366941d3740f88e1005e4f50fab9018/gr4.sml</xocs:ucs-locator><xocs:file-basename>gr4</xocs:file-basename><xocs:filename>gr4.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>3385</xocs:filesize><xocs:pixel-height>105</xocs:pixel-height><xocs:pixel-width>219</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0022282815000309-gr3.sml</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282815000309/gr3/THUMBNAIL/image/gif/ec13f4c0bd6692580fcbc105b456eeaf/gr3.sml</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282815000309/gr3/THUMBNAIL/image/gif/ec13f4c0bd6692580fcbc105b456eeaf/gr3.sml</xocs:ucs-locator><xocs:file-basename>gr3</xocs:file-basename><xocs:filename>gr3.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>3545</xocs:filesize><xocs:pixel-height>164</xocs:pixel-height><xocs:pixel-width>119</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0022282815000309-gr2.sml</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282815000309/gr2/THUMBNAIL/image/gif/f535e41afb1442766eb9aa969fd22deb/gr2.sml</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282815000309/gr2/THUMBNAIL/image/gif/f535e41afb1442766eb9aa969fd22deb/gr2.sml</xocs:ucs-locator><xocs:file-basename>gr2</xocs:file-basename><xocs:filename>gr2.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>4250</xocs:filesize><xocs:pixel-height>164</xocs:pixel-height><xocs:pixel-width>187</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0022282815000309-gr1.sml</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282815000309/gr1/THUMBNAIL/image/gif/5385bcba283807c3725bb3dd60cecf6e/gr1.sml</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282815000309/gr1/THUMBNAIL/image/gif/5385bcba283807c3725bb3dd60cecf6e/gr1.sml</xocs:ucs-locator><xocs:file-basename>gr1</xocs:file-basename><xocs:filename>gr1.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>5894</xocs:filesize><xocs:pixel-height>153</xocs:pixel-height><xocs:pixel-width>219</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0022282815000309-mmc1.pdf</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282815000309/mmc1/MAIN/application/pdf/0b90df070f338c783ea48e8bcea56a70/mmc1.pdf</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282815000309/mmc1/MAIN/application/pdf/0b90df070f338c783ea48e8bcea56a70/mmc1.pdf</xocs:ucs-locator><xocs:file-basename>mmc1</xocs:file-basename><xocs:filename>mmc1.pdf</xocs:filename><xocs:extension>pdf</xocs:extension><xocs:filesize>589657</xocs:filesize><xocs:attachment-type>APPLICATION</xocs:attachment-type></xocs:attachment></xocs:attachments></xocs:attachment-metadata-doc></xocs:meta><xocs:serial-item><article xmlns=\"http://www.elsevier.com/xml/ja/dtd\" version=\"5.2\" docsubtype=\"fla\" xml:lang=\"en\"><item-info><jid>YJMCC</jid><aid>8003</aid><ce:pii>S0022-2828(15)00030-9</ce:pii><ce:doi>10.1016/j.yjmcc.2015.01.017</ce:doi><ce:copyright type=\"full-transfer\" year=\"2015\">Elsevier Ltd</ce:copyright></item-info><ce:floats><ce:figure id=\"f0005\"><ce:label>Fig.\\xa01</ce:label><ce:caption id=\"ca0005\"><ce:simple-para id=\"sp0010\" view=\"all\">Cardiac expression pattern of TASK-3 in the human heart. (A) Quantitative mRNA expression analysis (n<ce:hsp sp=\"0.25\"/>=<ce:hsp sp=\"0.25\"/>8) of human potassium channels in right auricle tissue. Relative expression was quantified as 1/2<ce:sup loc=\"post\">ΔCt</ce:sup>, where ΔCt is Ct (GAPDH)<ce:hsp sp=\"0.25\"/>−<ce:hsp sp=\"0.25\"/>Ct (channel) and normalized to TASK-1. (B) Immunofluorescence of TASK-3 channels in human atrial myocytes using TASK-3 specific antibodies.</ce:simple-para></ce:caption><ce:link locator=\"gr1\" id=\"lk0005\"/></ce:figure><ce:figure id=\"f0010\"><ce:label>Fig.\\xa02</ce:label><ce:caption id=\"ca0010\"><ce:simple-para id=\"sp0015\" view=\"all\">Single-channel recordings of TASK-like channels in human atrial myocytes using divalent-cation-free solutions. (A) Cell-attached recording of the TASK-1-like channel with a slope conductance of 30.8<ce:hsp sp=\"0.25\"/>±<ce:hsp sp=\"0.25\"/>1.6<ce:hsp sp=\"0.25\"/>pS between −<ce:hsp sp=\"0.10\"/>60 and −<ce:hsp sp=\"0.10\"/>120<ce:hsp sp=\"0.25\"/>mV. (B) Partial enlargement of the recording depicted in (A). (C) Cell-attached recording of a TASK-1/TASK-3 heteromeric-like channel with a slope conductance of 55.3<ce:hsp sp=\"0.25\"/>±<ce:hsp sp=\"0.25\"/>4.3<ce:hsp sp=\"0.25\"/>pS between −<ce:hsp sp=\"0.10\"/>60 and −<ce:hsp sp=\"0.10\"/>120<ce:hsp sp=\"0.25\"/>mV. (D) Partial enlargement of the recording depicted in (C).</ce:simple-para></ce:caption><ce:link locator=\"gr2\" id=\"lk0010\"/></ce:figure><ce:figure id=\"f0015\"><ce:label>Fig.\\xa03</ce:label><ce:caption id=\"ca0015\"><ce:simple-para id=\"sp0020\" view=\"all\">Electrophysiological characteristics of the TASK-like channels recorded in human atrial myocytes using divalent-cation-free solutions. (A) Amplitude histogram of the TASK-1-like channel showing the single-channel amplitude of 3.3<ce:hsp sp=\"0.25\"/>pA at −<ce:hsp sp=\"0.10\"/>120<ce:hsp sp=\"0.25\"/>mV (gray) and 1.37<ce:hsp sp=\"0.25\"/>pA at −<ce:hsp sp=\"0.10\"/>60<ce:hsp sp=\"0.25\"/>mV (black), respectively. (B) Amplitude histogram of the TASK-1/TASK-3 heteromeric-like channel with a single-channel amplitude of 6.46<ce:hsp sp=\"0.25\"/>pA at −<ce:hsp sp=\"0.10\"/>120<ce:hsp sp=\"0.25\"/>mV (gray) and 3.19<ce:hsp sp=\"0.25\"/>pA at −<ce:hsp sp=\"0.10\"/>60<ce:hsp sp=\"0.25\"/>mV (black), respectively. (C) Example for the calculation of the single-channel (SC) conductance of the TASK-1-like channel and the (D) TASK-1/TASK-3 heteromer-like channel calculated between −<ce:hsp sp=\"0.10\"/>120 and −<ce:hsp sp=\"0.10\"/>40<ce:hsp sp=\"0.25\"/>mV. (E) Example for the calculation of the open time (τ<ce:inf loc=\"post\">o</ce:inf>) of the TASK-1-like channel and the (F) TASK-1/TASK-3 heteromer-like channel. The average τ<ce:inf loc=\"post\">o</ce:inf> determined by these correlation blots is indicated.</ce:simple-para></ce:caption><ce:link locator=\"gr3\" id=\"lk0015\"/></ce:figure><ce:figure id=\"f0020\"><ce:label>Fig.\\xa04</ce:label><ce:caption id=\"ca0020\"><ce:simple-para id=\"sp0025\" view=\"all\">Single-channel recordings of TASK-1 and TASK-3 channels co-transfected in HEK293 cells. (A–B) Examples of cell-attached recordings in divalent-cation-free solution at −<ce:hsp sp=\"0.10\"/>80<ce:hsp sp=\"0.25\"/>mV containing (A) a TASK-3 channel and (B) a heteromeric TASK-1/TASK-3 channel. (C) Example of a cell-attached recording in divalent-cation-free solution at −<ce:hsp sp=\"0.10\"/>160<ce:hsp sp=\"0.25\"/>mV containing in the same patch: a TASK-1-like channel with a small conductance (T1), a TASK-1/TASK-3 heteromer-like channel with an intermediate conductance (T1/T3) and a TASK-3-like channel with a high conductance (T3). (D) Illustrated is an example of the calculation of the open time (τ<ce:inf loc=\"post\">o</ce:inf>) for the TASK-1/TASK-3 heteromer-like channel recorded in HEK293 cells after co-expression of TASK-1 and TASK-3. The average τ<ce:inf loc=\"post\">o</ce:inf> determined by these correlation blots is 0.30<ce:hsp sp=\"0.25\"/>±<ce:hsp sp=\"0.25\"/>0.02<ce:hsp sp=\"0.25\"/>ms. (E) Summary of the single-channel (SC) conductances measured in human atrial cells (‘Atrium’) or after co-transfection of TASK-1 and TASK-3 in HEK293 cells (‘HEK293’).</ce:simple-para></ce:caption><ce:link locator=\"gr4\" id=\"lk0020\"/></ce:figure><ce:figure id=\"f0025\"><ce:label>Fig.\\xa05</ce:label><ce:caption id=\"ca0025\"><ce:simple-para id=\"sp0030\" view=\"all\">Single-channel recordings and pharmacology of TASK-1–TASK-3 (T1–T3) and TASK-3–TASK-1 (T3–T1) concatemers. (A) Example of a cell-attached recording in divalent-cation-free solution at −<ce:hsp sp=\"0.10\"/>80<ce:hsp sp=\"0.25\"/>mV from HEK293 cells transfected with a T3–T1 concatemer. (B) Amplitude histogram of the T3–T1 concatemer, illustrated in (A) with a single-channel amplitude of 5.2<ce:hsp sp=\"0.25\"/>pA at −<ce:hsp sp=\"0.10\"/>80<ce:hsp sp=\"0.25\"/>mV. (C) Schematic drawing illustrating that the single-channel conductance recorded in divalent-cation-free solution depends on the orientation of the concatemer. (D) Representative TEVC measurements from <ce:italic>Xenopus</ce:italic> oocytes using voltage steps to +<ce:hsp sp=\"0.10\"/>40<ce:hsp sp=\"0.25\"/>mV before and after application of 200<ce:hsp sp=\"0.25\"/>nM A293. (E) Average inhibition of TASK-1, TASK-3 and the two concatemeric constructs, T1–T3 and T3–T1, by 200<ce:hsp sp=\"0.25\"/>nM A293 (n<ce:hsp sp=\"0.25\"/>=<ce:hsp sp=\"0.25\"/>4–6) analyzed at the end of the step to +<ce:hsp sp=\"0.10\"/>40<ce:hsp sp=\"0.25\"/>mV. (F) Example of TEVC recordings as in (D) but using 40<ce:hsp sp=\"0.25\"/>nM A1899. (G) Mean block of the different channels or constructs by 40<ce:hsp sp=\"0.25\"/>nM A1899 (n<ce:hsp sp=\"0.25\"/>=<ce:hsp sp=\"0.25\"/>3–5) analyzed as in (E).</ce:simple-para></ce:caption><ce:link locator=\"gr5\" id=\"lk0025\"/></ce:figure><ce:figure id=\"f0030\"><ce:label>Fig.\\xa06</ce:label><ce:caption id=\"ca0030\"><ce:simple-para id=\"sp0035\" view=\"all\">Pharmacology of co-expressed TASK-1 and TASK-3 channels. (A) Representative TEVC measurements from <ce:italic>Xenopus</ce:italic> oocytes using voltage steps to +<ce:hsp sp=\"0.10\"/>40<ce:hsp sp=\"0.25\"/>mV before and after application of 200<ce:hsp sp=\"0.25\"/>nM A293 or (B) 40<ce:hsp sp=\"0.25\"/>nM A1899. (C) Average inhibition of TASK-1, TASK-3 and of TASK-1 and TASK-3 co-injected in different cRNA ratios by 200<ce:hsp sp=\"0.25\"/>nM A293 (n<ce:hsp sp=\"0.25\"/>=<ce:hsp sp=\"0.25\"/>3–7), analyzed at the end of the test pulse to +<ce:hsp sp=\"0.10\"/>40<ce:hsp sp=\"0.25\"/>mV. For the co-expressions the following cRNA amounts were injected: 4<ce:hsp sp=\"0.25\"/>+<ce:hsp sp=\"0.25\"/>1, 0.3<ce:hsp sp=\"0.25\"/>ng TASK-1 plus 0.075<ce:hsp sp=\"0.25\"/>ng TASK-3 per oocyte; 1<ce:hsp sp=\"0.25\"/>+<ce:hsp sp=\"0.25\"/>1, 0.075<ce:hsp sp=\"0.25\"/>ng TASK-1 plus 0.075<ce:hsp sp=\"0.25\"/>ng TASK-3 per oocyte; 1<ce:hsp sp=\"0.25\"/>+<ce:hsp sp=\"0.25\"/>4, 0.075<ce:hsp sp=\"0.25\"/>ng TASK-1 plus 0.3<ce:hsp sp=\"0.25\"/>ng TASK-3 per oocyte. (D) Average inhibition, analyzed as in (C), but using 40<ce:hsp sp=\"0.25\"/>nM A1899 (n<ce:hsp sp=\"0.25\"/>=<ce:hsp sp=\"0.25\"/>3–5). (E) Current amplitudes after injection of either TASK-1 or TASK-3 using the same amount of cRNA (1<ce:hsp sp=\"0.25\"/>ng/oocyte), analyzed at 0<ce:hsp sp=\"0.25\"/>mV.</ce:simple-para></ce:caption><ce:link locator=\"gr6\" id=\"lk0030\"/></ce:figure><ce:figure id=\"f0035\"><ce:label>Fig.\\xa07</ce:label><ce:caption id=\"ca0035\"><ce:simple-para id=\"sp0040\" view=\"all\">Preferential surface expression of heteromeric TASK-1/TASK-3 channels after co-expression of TASK-1 and TASK-3. (A) Representative voltage ramps recorded for TASK-1 expressed alone (1<ce:hsp sp=\"0.25\"/>ng/oocyte) in <ce:italic>Xenopus</ce:italic> oocytes or after co-expression with only half the amount of TASK-3 (0.5<ce:hsp sp=\"0.25\"/>ng/oocyte). (B) Quantification of the current amplitudes analyzed at 0<ce:hsp sp=\"0.25\"/>mV after co-expression of TASK-1 with half the amount of TASK-3. (C) Count of inside-out patches recorded from <ce:italic>Xenopus</ce:italic> oocytes after co-injection of TASK-1 with half the amount of TASK-3. Indicated are the number of patches that contained single-channel activities (SC activity), as well as the number of patches that contained heteromeric TASK-1/TASK-3 (T1/T3) channels or TASK-3 (T3). (D) Chemiluminescence-assay using single <ce:italic>Xenopus</ce:italic> oocytes after injection of TASK-1 with an extracellular HA-epitope (TASK-1-HA) alone (2.5<ce:hsp sp=\"0.25\"/>ng/oocyte) or after co-expression with half the amount (1.25<ce:hsp sp=\"0.25\"/>ng/oocyte) of TASK-3 (T1-HA<ce:hsp sp=\"0.25\"/>+<ce:hsp sp=\"0.25\"/>T3 (1<ce:hsp sp=\"0.25\"/>+<ce:hsp sp=\"0.25\"/>0.5)).</ce:simple-para></ce:caption><ce:link locator=\"gr7\" id=\"lk0035\"/></ce:figure><ce:figure id=\"f0040\"><ce:label>Fig.\\xa08</ce:label><ce:caption id=\"ca0040\"><ce:simple-para id=\"sp0045\" view=\"all\">Inside-out patch clamp recordings of single heteromeric TASK-1/TASK-3 channels after co-expression of TASK-1 and TASK-3 in <ce:italic>Xenopus</ce:italic> oocytes reveal a reduced drug affinity for TASK-1 blockers. (A) Examples of an inside-out single-channel recording of a heteromeric TASK-1/TASK-3 channel in divalent-cation-free solution at −<ce:hsp sp=\"0.10\"/>120<ce:hsp sp=\"0.25\"/>mV. (B) Single-channel amplitudes of TASK-1, heteromeric TASK-1/TASK-3 and TASK-3 recorded in inside-out patches at −<ce:hsp sp=\"0.10\"/>120<ce:hsp sp=\"0.25\"/>mV. (C) Single-channel amplitudes of a heteromeric TASK-1/TASK-3 channel recorded in an inside-out patch plotted against the membrane voltage to determine the slope conductance. (D) Illustrated is the calculation of the open time (τ<ce:inf loc=\"post\">o</ce:inf>) for TASK-1/TASK-3 heteromeric channels (n<ce:hsp sp=\"0.25\"/>=<ce:hsp sp=\"0.25\"/>9), recorded in oocytes after co-expression of TASK-1 and TASK-3. (E) Data from inside-out single-channel recordings of heteromeric TASK-1/TASK-3 channels, analyzing the single-channel parameters 15<ce:hsp sp=\"0.25\"/>s before and 15<ce:hsp sp=\"0.25\"/>s after the drug was directly applied with a micropipette to the cytoplasmatic phase of the patch. Illustrated are the change in the single-channel amplitude, the reduction in the open time (τ<ce:inf loc=\"post\">o</ce:inf>), the reduction in the burst duration (τ<ce:inf loc=\"post\">burst</ce:inf>) and (F) the reduction in the open probability.</ce:simple-para></ce:caption><ce:link locator=\"gr8\" id=\"lk0040\"/></ce:figure></ce:floats><head><ce:dochead id=\"dh0005\"><ce:textfn id=\"tn0005\">Original article</ce:textfn></ce:dochead><ce:title id=\"ti0005\">TASK-1 and TASK-3 may form heterodimers in human atrial cardiomyocytes</ce:title><ce:author-group id=\"ag0005\"><ce:author id=\"au0005\"><ce:indexed-name>Rinne</ce:indexed-name><ce:given-name>Susanne</ce:given-name><ce:surname>Rinné</ce:surname><ce:cross-ref refid=\"af0005\" id=\"cf0005\"><ce:sup loc=\"post\">a</ce:sup></ce:cross-ref></ce:author><ce:author id=\"au0010\"><ce:given-name>Aytug K.</ce:given-name><ce:surname>Kiper</ce:surname><ce:cross-ref refid=\"af0005\" id=\"cf0010\"><ce:sup loc=\"post\">a</ce:sup></ce:cross-ref></ce:author><ce:author id=\"au0015\"><ce:indexed-name>Schlichthorl</ce:indexed-name><ce:given-name>Günter</ce:given-name><ce:surname>Schlichthörl</ce:surname><ce:cross-ref refid=\"af0010\" id=\"cf0015\"><ce:sup loc=\"post\">b</ce:sup></ce:cross-ref></ce:author><ce:author id=\"au0020\"><ce:given-name>Sven</ce:given-name><ce:surname>Dittmann</ce:surname><ce:cross-ref refid=\"af0015\" id=\"cf0020\"><ce:sup loc=\"post\">c</ce:sup></ce:cross-ref></ce:author><ce:author id=\"au0025\"><ce:given-name>Michael F.</ce:given-name><ce:surname>Netter</ce:surname><ce:cross-ref refid=\"af0005\" id=\"cf0025\"><ce:sup loc=\"post\">a</ce:sup></ce:cross-ref></ce:author><ce:author id=\"au0030\"><ce:given-name>Sven H.</ce:given-name><ce:surname>Limberg</ce:surname><ce:cross-ref refid=\"af0020\" id=\"cf0030\"><ce:sup loc=\"post\">d</ce:sup></ce:cross-ref></ce:author><ce:author id=\"au0035\"><ce:given-name>Nicole</ce:given-name><ce:surname>Silbernagel</ce:surname><ce:cross-ref refid=\"af0005\" id=\"cf0035\"><ce:sup loc=\"post\">a</ce:sup></ce:cross-ref></ce:author><ce:author id=\"au0040\"><ce:given-name>Marylou</ce:given-name><ce:surname>Zuzarte</ce:surname><ce:cross-ref refid=\"af0010\" id=\"cf0040\"><ce:sup loc=\"post\">b</ce:sup></ce:cross-ref></ce:author><ce:author id=\"au0045\"><ce:given-name>Rainer</ce:given-name><ce:surname>Moosdorf</ce:surname><ce:cross-ref refid=\"af0025\" id=\"cf0045\"><ce:sup loc=\"post\">e</ce:sup></ce:cross-ref></ce:author><ce:author id=\"au0050\"><ce:given-name>Hinnerk</ce:given-name><ce:surname>Wulf</ce:surname><ce:cross-ref refid=\"af0020\" id=\"cf0050\"><ce:sup loc=\"post\">d</ce:sup></ce:cross-ref></ce:author><ce:author id=\"au0055\"><ce:given-name>Eric</ce:given-name><ce:surname>Schulze-Bahr</ce:surname><ce:cross-ref refid=\"af0015\" id=\"cf0055\"><ce:sup loc=\"post\">c</ce:sup></ce:cross-ref></ce:author><ce:author id=\"au0060\"><ce:given-name>Caroline</ce:given-name><ce:surname>Rolfes</ce:surname><ce:cross-ref refid=\"af0020\" id=\"cf0060\"><ce:sup loc=\"post\">d</ce:sup></ce:cross-ref><ce:cross-ref refid=\"fn0005\" id=\"cf0065\"><ce:sup loc=\"post\">1</ce:sup></ce:cross-ref></ce:author><ce:author id=\"au0065\"><ce:given-name>Niels</ce:given-name><ce:surname>Decher</ce:surname><ce:cross-ref refid=\"af0005\" id=\"cf0070\"><ce:sup loc=\"post\">a</ce:sup></ce:cross-ref><ce:cross-ref refid=\"fn0005\" id=\"cf0075\"><ce:sup loc=\"post\">1</ce:sup></ce:cross-ref><ce:cross-ref refid=\"cr0005\" id=\"cf0080\"><ce:sup loc=\"post\">⁎</ce:sup></ce:cross-ref><ce:e-address id=\"em0005\" type=\"email\">decher@staff.uni-marburg.de</ce:e-address></ce:author><ce:affiliation id=\"af0005\"><ce:label>a</ce:label><ce:textfn id=\"tn0010\">Institut für Physiologie und Pathophysiologie, Abteilung vegetative Physiologie, Universität Marburg, 35037 Marburg, Germany</ce:textfn><sa:affiliation><sa:organization>Institut für Physiologie und Pathophysiologie</sa:organization><sa:organization>Abteilung vegetative Physiologie</sa:organization><sa:organization>Universität Marburg</sa:organization><sa:city>Marburg</sa:city><sa:postal-code>35037</sa:postal-code><sa:country>Germany</sa:country></sa:affiliation></ce:affiliation><ce:affiliation id=\"af0010\"><ce:label>b</ce:label><ce:textfn id=\"tn0015\">Institut für Physiologie und Pathophysiologie, Abteilung kardiovaskuläre Zellphysiologie, Universität Marburg, 35037 Marburg, Germany</ce:textfn><sa:affiliation><sa:organization>Institut für Physiologie und Pathophysiologie</sa:organization><sa:organization>Abteilung kardiovaskuläre Zellphysiologie</sa:organization><sa:organization>Universität Marburg</sa:organization><sa:city>Marburg</sa:city><sa:postal-code>35037</sa:postal-code><sa:country>Germany</sa:country></sa:affiliation></ce:affiliation><ce:affiliation id=\"af0015\"><ce:label>c</ce:label><ce:textfn id=\"tn0020\">Institut für Genetik von Herzerkrankungen (IfGH), Department für Kardiologie und Angiologie, Universitätsklinikum Münster, Münster, Germany</ce:textfn><sa:affiliation><sa:organization>Institut für Genetik von Herzerkrankungen (IfGH)</sa:organization><sa:organization>Department für Kardiologie und Angiologie</sa:organization><sa:organization>Universitätsklinikum Münster</sa:organization><sa:city>Münster</sa:city><sa:country>Germany</sa:country></sa:affiliation></ce:affiliation><ce:affiliation id=\"af0020\"><ce:label>d</ce:label><ce:textfn id=\"tn0025\">Klinik für Anästhesie und Intensivtherapie, Philipps-Universität Marburg, 35033 Marburg, Germany</ce:textfn><sa:affiliation><sa:organization>Klinik für Anästhesie und Intensivtherapie, Philipps-Universität Marburg</sa:organization><sa:city>Marburg</sa:city><sa:postal-code>35033</sa:postal-code><sa:country>Germany</sa:country></sa:affiliation></ce:affiliation><ce:affiliation id=\"af0025\"><ce:label>e</ce:label><ce:textfn id=\"tn0030\">Klinik für Herz- und thorakale Gefäßchirurgie, Universitätsklinikum Giessen und Marburg, Standort Marburg, 35033 Marburg, Germany</ce:textfn><sa:affiliation><sa:organization>Klinik für Herz- und thorakale Gefäßchirurgie</sa:organization><sa:organization>Universitätsklinikum Giessen und Marburg</sa:organization><sa:organization>Standort Marburg</sa:organization><sa:city>Marburg</sa:city><sa:postal-code>35033</sa:postal-code><sa:country>Germany</sa:country></sa:affiliation></ce:affiliation><ce:correspondence id=\"cr0005\"><ce:label>⁎</ce:label><ce:text id=\"tx0005\">Corresponding author at: Institut für Physiologie, Vegetative Physiologie, Philipps-Universität Marburg, Deutschhausstraße 1-2, 35037 Marburg, Germany. Tel.: +<ce:hsp sp=\"0.10\"/>49 6421 28 62148; fax: +<ce:hsp sp=\"0.10\"/>49 6421 28 66659.</ce:text></ce:correspondence><ce:footnote id=\"fn0005\"><ce:label>1</ce:label><ce:note-para id=\"np0005\" view=\"all\">Shared senior authors.</ce:note-para></ce:footnote></ce:author-group><ce:date-received day=\"11\" month=\"7\" year=\"2014\"/><ce:date-revised day=\"30\" month=\"12\" year=\"2014\"/><ce:date-accepted day=\"27\" month=\"1\" year=\"2015\"/><ce:abstract id=\"ab0005\" view=\"all\" class=\"author\"><ce:section-title id=\"st0005\">Abstract</ce:section-title><ce:abstract-sec id=\"as0005\" view=\"all\"><ce:simple-para id=\"sp0005\" view=\"all\">TASK-1 channels have emerged as promising drug targets against atrial fibrillation, the most common arrhythmia in the elderly. While TASK-3, the closest relative of TASK-1, was previously not described in cardiac tissue, we found a very prominent expression of TASK-3 in right human auricles. Immunocytochemistry experiments of human right auricular cardiomyocytes showed that TASK-3 is primarily localized at the plasma membrane. Single-channel recordings of right human auricles in the cell-attached mode, using divalent-cation-free solutions, revealed a TASK-1-like channel with a single-channel conductance of about 30<ce:hsp sp=\"0.25\"/>pS. While homomeric TASK-3 channels were not found, we observed an intermediate single-channel conductance of about 55<ce:hsp sp=\"0.25\"/>pS, possibly reflecting the heteromeric channel formed by TASK-1 and TASK-3. Subsequent experiments with TASK-1/TASK-3 tandem channels or with co-expressed TASK-1 and TASK-3 channels in HEK293 cells or <ce:italic>Xenopus</ce:italic> oocytes, supported that the 55<ce:hsp sp=\"0.25\"/>pS channels observed in right auricles have electrophysiological characteristics of TASK-1/TASK-3 heteromers. In addition, co-expression experiments and single-channel recordings suggest that heteromeric TASK-1/TASK-3 channels have a predominant surface expression and a reduced affinity for TASK-1 blockers. In summary, the evidence for heteromeric TASK-1/TASK-3 channel complexes together with an altered pharmacologic response to TASK-1 blockers <ce:italic>in vitro</ce:italic> is likely to have further impact for studies isolating <ce:italic>I</ce:italic><ce:inf loc=\"post\">TASK-1</ce:inf> from cardiomyocytes and for the development of drugs specifically targeting TASK-1 in atrial fibrillation treatment.</ce:simple-para></ce:abstract-sec></ce:abstract><ce:abstract class=\"author-highlights\" id=\"ab0010\" view=\"all\"><ce:section-title id=\"st0010\">Highlights</ce:section-title><ce:abstract-sec id=\"as0010\" view=\"all\"><ce:simple-para id=\"sp0055\" view=\"all\"><ce:list id=\"l0005\"><ce:list-item id=\"u0005\"><ce:label>•</ce:label><ce:para id=\"p0155\" view=\"all\">In contrast to previous studies we found a strong TASK-3 expression in human auricles.</ce:para></ce:list-item><ce:list-item id=\"u0010\"><ce:label>•</ce:label><ce:para id=\"p0160\" view=\"all\">TASK-3 is localized at the plasma membrane of isolated cardiomyocytes.</ce:para></ce:list-item><ce:list-item id=\"u0015\"><ce:label>•</ce:label><ce:para id=\"p0165\" view=\"all\">Single-channel recordings identified heteromeric channels formed by TASK-1 and TASK-3.</ce:para></ce:list-item><ce:list-item id=\"u0020\"><ce:label>•</ce:label><ce:para id=\"p0170\" view=\"all\">Heteromeric TASK-1 and TASK-3 channels have a reduced affinity for TASK-1 blockers.</ce:para></ce:list-item><ce:list-item id=\"u0025\"><ce:label>•</ce:label><ce:para id=\"p0175\" view=\"all\">Drug design against atrial fibrillation should consider potential TASK-3 heteromers.</ce:para></ce:list-item></ce:list></ce:simple-para></ce:abstract-sec></ce:abstract><ce:keywords id=\"ks0005\" view=\"all\" class=\"keyword\"><ce:section-title id=\"st0015\">Keywords</ce:section-title><ce:keyword id=\"kw0035\"><ce:text id=\"tx0010\">K<ce:inf loc=\"post\">2P</ce:inf> channel</ce:text></ce:keyword><ce:keyword id=\"kw0040\"><ce:text id=\"tx0015\">TASK</ce:text></ce:keyword><ce:keyword id=\"kw0045\"><ce:text id=\"tx0020\">Atrial fibrillation</ce:text></ce:keyword><ce:keyword id=\"kw0050\"><ce:text id=\"tx0025\">Right human auricles</ce:text></ce:keyword><ce:keyword id=\"kw0055\"><ce:text id=\"tx0030\">Cardiomyocytes</ce:text></ce:keyword><ce:keyword id=\"kw0060\"><ce:text id=\"tx0035\">Heteromers</ce:text></ce:keyword></ce:keywords></head><body view=\"all\"><ce:sections><ce:section id=\"s0005\" view=\"all\"><ce:label>1</ce:label><ce:section-title id=\"st0020\">Introduction</ce:section-title><ce:para id=\"p0005\" view=\"all\">TASK-1 (<ce:italic>KCNK3</ce:italic>) and TASK-3 (<ce:italic>KCNK9</ce:italic>) belong to the acid-sensitive subfamily of two pore domain potassium (K<ce:inf loc=\"post\">2P</ce:inf>) channels. The current kinetics of K<ce:inf loc=\"post\">2P</ce:inf> channels resemble those of the native steady-state K<ce:sup loc=\"post\">+</ce:sup> current (<ce:italic>I</ce:italic><ce:inf loc=\"post\">K,SS</ce:inf>) observed in mouse cardiomyocytes <ce:cross-ref refid=\"bb0005\" id=\"cf0085\">[1]</ce:cross-ref> or the so-called “plateau current” (<ce:italic>I</ce:italic><ce:inf loc=\"post\">K,P</ce:inf>) described in cardiomyocytes from guinea-pig <ce:cross-refs refid=\"bb0010 bb0015\" id=\"cf0090\">[2,3]</ce:cross-refs>. In cardiomyocytes, expression of several K<ce:inf loc=\"post\">2P</ce:inf> channels was described, with TREK-1 (<ce:italic>KCNK2</ce:italic>) and TASK-1 as the most detailed studied cardiac leak channels <ce:cross-refs refid=\"bb0015 bb0020 bb0025 bb0030 bb0035 bb0040\" id=\"cf0095\">[3–8]</ce:cross-refs>. Nevertheless, the distinct role of the different K<ce:inf loc=\"post\">2P</ce:inf> channels in human cardiac pathophysiology and arrhythmogenesis is known only in part so far <ce:cross-refs refid=\"bb0045 bb0050\" id=\"cf0100\">[9,10]</ce:cross-refs>. Recently, we have identified the first K<ce:inf loc=\"post\">2P</ce:inf> channel mutation that is associated with a cardiac arrhythmia. We found that the G88R mutation in TASK-4 (gene: <ce:italic>KCNK17</ce:italic>) causes a gain-of-function which is contributing to the phenotype of a severe form of progressive cardiac conduction disorder combined with idiopathic ventricular fibrillation <ce:cross-ref refid=\"bb0045\" id=\"cf0105\">[9]</ce:cross-ref>. TASK-4 G88R expression in HL-1 cells slowed the upstroke velocity of the action potential and caused an increased after hyperpolarization, suggesting that the TASK-4 mutation might act by hyperpolarizing the resting membrane potential of cells in the conduction system <ce:cross-ref refid=\"bb0045\" id=\"cf0110\">[9]</ce:cross-ref>. Like TASK-4, TASK-1 is preferentially expressed in the cardiac conduction system and less abundant in the ventricle <ce:cross-ref refid=\"bb0020\" id=\"cf0115\">[4]</ce:cross-ref>. We have previously described the contribution of the cardiac <ce:italic>I</ce:italic><ce:inf loc=\"post\">TASK-1</ce:inf> to the repolarization of rat and mouse ventricular cardiomyocytes <ce:cross-refs refid=\"bb0020 bb0030\" id=\"cf0120\">[4,6]</ce:cross-refs>. In rat, application of low concentrations of the TASK-1 blocker A293 led to a prolongation of the action potential duration <ce:cross-ref refid=\"bb0030\" id=\"cf0125\">[6]</ce:cross-ref>. ECG recordings of the TASK-1 knock-out mouse showed a QT time prolongation suggesting a role of TASK-1 in cardiac repolarization <ce:cross-ref refid=\"bb0020\" id=\"cf0130\">[4]</ce:cross-ref>. In mice, TASK-1 is, however, preferentially expressed in the conduction system, indicating a dominant role of the channel in this tissue. Consistently, a QRS complex disturbance was observed in the TASK-1 knock-out mouse <ce:cross-refs refid=\"bb0020 bb0055\" id=\"cf0135\">[4,11]</ce:cross-refs>. In contrast to what has been observed in rodents, in humans TASK-1 is preferentially expressed in the atria. In these cells <ce:italic>I</ce:italic><ce:inf loc=\"post\">TASK-1</ce:inf> was functionally characterized and described to modulate atrial action potential duration <ce:cross-ref refid=\"bb0025\" id=\"cf0140\">[5]</ce:cross-ref>. Due to the lack of ventricular expression and the observation that blockade of TASK-1 channels prolonged human atrial action potentials <ce:cross-ref refid=\"bb0025\" id=\"cf0145\">[5]</ce:cross-ref>, TASK-1 might be a potentially relevant drug target for the treatment or prevention of atrial fibrillation <ce:cross-ref refid=\"bb0025\" id=\"cf0150\">[5]</ce:cross-ref>. This conclusion is strengthened by the observation, that during atrial fibrillation, TASK-1 is transcriptionally up-regulated <ce:cross-ref refid=\"bb0060\" id=\"cf0155\">[12]</ce:cross-ref> and thus, the channel is also present under pathophysiological conditions.</ce:para><ce:para id=\"p0010\" view=\"all\">Until now, TASK-3 was thought to be a ‘non-cardiac channel’, as most of the studies, using different species, detected only a minor <ce:italic>KCNK9</ce:italic> expression in whole heart tissue <ce:cross-refs refid=\"bb0030 bb0065 bb0070 bb0075 bb0080\" id=\"cf0160\">[6,13–16]</ce:cross-refs>. However, in cardiomyocytes of right human auricles, our quantitative PCR analysis showed a high mRNA transcription level for TASK-3. It is well established that TASK-1 and TASK-3 channels form functional heterodimers after co-expression in heterologous expression systems <ce:cross-ref refid=\"bb0085\" id=\"cf0165\">[17]</ce:cross-ref>. Another evidence for heterodimer formation is that the TASK-3 mutation causing Birk Barel mental retardation dysmorphism syndrome does not only fully abolish the activity of TASK-3, but also acts in a dominant-negative manner on TASK-1 channels <ce:cross-ref refid=\"bb0090\" id=\"cf0170\">[18]</ce:cross-ref>. Most importantly, physiological formation of TASK-1/TASK-3 heterodimers was described in cerebellar granule cells <ce:cross-ref refid=\"bb0095\" id=\"cf0175\">[19]</ce:cross-ref>, motoneurons <ce:cross-ref refid=\"bb0100\" id=\"cf0180\">[20]</ce:cross-ref> or in mouse and rat carotid body glomus cells <ce:cross-refs refid=\"bb0105 bb0110\" id=\"cf0185\">[21,22]</ce:cross-refs>. Here, it is noteworthy that in native tissue TASK-1 and TASK-3 seem to predominantly assemble as heterodimers <ce:cross-refs refid=\"bb0100 bb0105 bb0110\" id=\"cf0190\">[20–22]</ce:cross-refs>. The expression of TASK-3 in the human atrium and the appearance of TASK-1/TASK-3 heterodimers in cardiomyocytes were previously not described and were subject of this study. Our results now suggest that TASK-1 in right human auricles is, similar as in other tissue with concurrent TASK-3 expression, expressed as heteromeric channel complex with TASK-3. Most importantly, we now describe by co-expression studies, chemiluminescence-assays and by single-channel recordings that the heteromeric channel complexes of TASK-1/TASK-3 have a predominant surface expression and an altered sensitivity to classic TASK-1 channel blockers. This altered drug-sensitivity of the heteromeric channels containing TASK-3 has to be further considered when developing drugs targeting TASK-1.</ce:para></ce:section><ce:section id=\"s0010\" view=\"all\"><ce:label>2</ce:label><ce:section-title id=\"st0025\">Material and methods</ce:section-title><ce:para id=\"p0015\" view=\"all\">The investigation conforms to the principles outlined in the Declaration of Helsinki and to the guide for the Care and Use of Laboratory Animals (NIH Publication 85–23).</ce:para><ce:section id=\"s0015\" view=\"all\"><ce:label>2.1</ce:label><ce:section-title id=\"st0030\">Expression analysis</ce:section-title><ce:para id=\"p0020\" view=\"all\">The study was approved by the local ethics committee of the University of Marburg (medical faculty) (No. 53/07). Each patient gave written informed consent. To study the expression of different potassium channels in the human atrium, right atrial auricle specimens were obtained from previously described 12 patients with sinus rhythm undergoing cardiac surgery in extracorporeal circulation <ce:cross-ref refid=\"bb0025\" id=\"cf0195\">[5]</ce:cross-ref>. The characteristics of the patients are listed in Table 1 of the study by Limberg et al. <ce:cross-ref refid=\"bb0025\" id=\"cf0200\">[5]</ce:cross-ref>. Total RNA was isolated using a RNA/DNA/Protein Purification Kit (Norgen). After reverse transcription (RT) with random hexamers (Applied Biosystems) and Superscript II reverse transcriptase (Invitrogen) according to the instructions of the manufacturer, cDNA was pooled. Quantitative PCRs (qPCR) were performed using the Platinum SYBR Green qPCR SuperMix-UDG (Invitrogen) according to the instructions of the manufacturer. Reaction mixtures were preheated at 50<ce:hsp sp=\"0.25\"/>°C for 2<ce:hsp sp=\"0.25\"/>min and at 95<ce:hsp sp=\"0.25\"/>°C for 2<ce:hsp sp=\"0.25\"/>min, followed by 40<ce:hsp sp=\"0.25\"/>cycles at 95<ce:hsp sp=\"0.25\"/>°C for 15<ce:hsp sp=\"0.25\"/>s, 60<ce:hsp sp=\"0.25\"/>°C for 30<ce:hsp sp=\"0.25\"/>s, and 72<ce:hsp sp=\"0.25\"/>°C for 30<ce:hsp sp=\"0.25\"/>s. Emitted fluorescence was detected online using a Mx3000P real-time PCR system (Stratagene). For all primer pairs the amplification products were confirmed by sequencing, no template control (NTC) and dissociation curve analysis. In addition, amplification efficiency was determined by analyzing the slope of a Ct/log (template concentration) plot. For normalization, primers for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were used (rE<ce:hsp sp=\"0.25\"/>=<ce:hsp sp=\"0.25\"/>1/2<ce:sup loc=\"post\">ΔCt</ce:sup>). Primers used in qPCR expression analysis: GAPDH for 5′-AGTCAACGGATTTGGTCGTAT-3′, rev 5′-ACCATGTAGTTGAGGTCAATGAAG-3′; Kir2.1 for 5′-CAGTTCATCAATGTGGGTGAGAAG-3′, rev 5′-ACGAAAGCCAGGCAGAAGATAAC-3′; Kv1.5 for 5′-CCCTGGAGAATGCAGACAGT-3′, rev 5′-TCCAGGCAGAGGGCATAAAG-3′; TREK-1b for 5′-GAATGCTGCATGCCTCATGCTT-3′, rev 5′-AATGAGAGCCTCGGTTTGGAGTTC-3′; TASK-1 for 5′-TTCGCCGGCTCCTTCTACTTC-3′, rev 5′-CGTAGAACATGCAGAACACCTTG-3′, TASK-2 for 5′-GCCTCTTCTGTGTTTTCTATGGTC-3′, rev 5′-GTAAGGAACTGCCCTAGTCTCTTG-3′; TASK-3 for 5′-TACTACTGCTTCATCACGTTGACTAC-3′, rev 5′-TACATAAAGCTAAAGGCCACGTAGA-3′; TASK-4 for 5′-CTACACAGAGGGCTTCTACTTCG-3′, rev 5′-GACACCATGTTCTTGTACCACAG-3′.</ce:para></ce:section><ce:section id=\"s0020\" view=\"all\"><ce:label>2.2</ce:label><ce:section-title id=\"st0035\">Isolation of human atrial cardiomyocytes</ce:section-title><ce:para id=\"p0025\" view=\"all\">Right atrial auricle specimens were obtained from 12 patients described previously <ce:cross-ref refid=\"bb0025\" id=\"cf0205\">[5]</ce:cross-ref> with sinus rhythm undergoing cardiac surgery in extracorporeal circulation. The preparation of human auricle cardiomyocytes was previously described <ce:cross-refs refid=\"bb0115 bb0120\" id=\"cf0210\">[23,24]</ce:cross-refs> and modified only marginally <ce:cross-ref refid=\"bb0025\" id=\"cf0215\">[5]</ce:cross-ref>. Briefly, after biopsy specimens were stored for 60<ce:hsp sp=\"0.25\"/>min at 4<ce:hsp sp=\"0.25\"/>°C in calcium-free solution containing in mM: NaCl 27, KCl 20, MgCl<ce:inf loc=\"post\">2</ce:inf> 1.5, HEPES 5, glucose 274; pH<ce:hsp sp=\"0.25\"/>7.0. Then, specimens were cut into pieces of 1–2<ce:hsp sp=\"0.25\"/>mm<ce:sup loc=\"post\">3</ce:sup> and oxygenized (tension: 100–150<ce:hsp sp=\"0.25\"/>mm<ce:hsp sp=\"0.25\"/>Hg) at 37<ce:hsp sp=\"0.25\"/>°C in 10<ce:hsp sp=\"0.25\"/>ml of calcium-free solution containing in mM: NaCl 140, KCl 5.4, MgCl<ce:inf loc=\"post\">2</ce:inf> 1.2, HEPES 5, glucose 5; pH<ce:hsp sp=\"0.25\"/>7.0. Using a miniature magnetic stirring bar rotating with 3<ce:hsp sp=\"0.25\"/>Hz, blood and calcium were washed out of the specimens three times for 7<ce:hsp sp=\"0.25\"/>min each. Specimens were then transferred into calcium-free solution containing 720<ce:hsp sp=\"0.25\"/>U/ml collagenase Type 2 (Worthington), 0.52<ce:hsp sp=\"0.25\"/>U/ml protease Type XXIV (Sigma) and 0.1% bovine albumin. After 30<ce:hsp sp=\"0.25\"/>min of digestion, cells in suspension were separated from debris by centrifuging at 2000<ce:hsp sp=\"0.25\"/>rpm for 2<ce:hsp sp=\"0.25\"/>min. Rod-shaped striated cells were then placed on 35<ce:hsp sp=\"0.25\"/>mm dishes for measurements.</ce:para></ce:section><ce:section id=\"s0025\" view=\"all\"><ce:label>2.3</ce:label><ce:section-title id=\"st0040\">Fluorescence imaging</ce:section-title><ce:para id=\"p0030\" view=\"all\">Isolated cells were set on 35<ce:hsp sp=\"0.25\"/>mm glass bottom Petri dishes (WillCo). Cells were fixed with 4% paraformaldehyde in PBS, washed and labeled with TASK-1 antibodies (Alomone) diluted 1:200 as previously described <ce:cross-ref refid=\"bb0030\" id=\"cf0220\">[6]</ce:cross-ref>. Anti rabbit Alexa 488 (Invitrogen) diluted 1:100 served as secondary antibody. For TASK-3 staining, TASK-3 antibodies (Santa Cruz) and Alexa antibodies (anti goat Alexa 594; Invitrogen) were used. Microscopy and imaging were performed with an Olympus IX71 microscope equipped with a 60<ce:hsp sp=\"0.10\"/>× N.A. 1.3 PL APO objective or a 100<ce:hsp sp=\"0.10\"/>× N.A. 1.4 PL APO objective (Olympus), standard EGFP filter and Texas red filter sets and a cooled 12-bit CCD camera (SensiCam QE). Digital images were processed using Image-Pro Plus 4.5 (MediaCybernetics).</ce:para></ce:section><ce:section id=\"s0030\" view=\"all\"><ce:label>2.4</ce:label><ce:section-title id=\"st0045\">Single-channel recordings in human atrial myocytes and in transfected HEK293 cells</ce:section-title><ce:para id=\"p0035\" view=\"all\">Isolated cardiomyocytes were placed on 35<ce:hsp sp=\"0.25\"/>mm dishes (Corning). After 15<ce:hsp sp=\"0.25\"/>min of settling, patch clamp recordings were performed. Tandem heterodimeric TASK-1/TASK-3 and TASK-3/TASK-1 constructs were generated by PCR to generate a final product bearing a three-residue (glycine-serine-alanine) linker region between the C-terminal amino acid of the first subunit and the start methionine of the second subunit <ce:cross-ref refid=\"bb0100\" id=\"cf0225\">[20]</ce:cross-ref>. HEK293 cells were transfected with the indicated cDNA constructs using Lipofectamine 2000 (Life Technologies) and measured 24–48<ce:hsp sp=\"0.25\"/>h after transfection using the patch clamp technique. Concatemeric TASK-1–TASK-3 or TASK-3–TASK-1 constructs in pCDNA3-HE were transfected with 0.5<ce:hsp sp=\"0.25\"/>μg per dish. For co-expression studies HEK293 cells were transfected with pCDNA3.1 constructs of rat TASK-1 and human TASK-3, using 0.5<ce:hsp sp=\"0.25\"/>μg per dish for each construct. Patch clamp recordings were performed with an Axopatch 200B amplifier at room temperature (21–24<ce:hsp sp=\"0.25\"/>°C) and pipettes had a tip resistance of 3.0–5.0<ce:hsp sp=\"0.25\"/>MΩ when filled with the pipette solution containing in mM: 140 KCl, 5 HEPES; pH<ce:hsp sp=\"0.25\"/>7.2 with KOH. Cells were superfused with a bath solution containing in mM: NaCl 140, KCl 5.4, CaCl<ce:inf loc=\"post\">2</ce:inf> 1, MgCl<ce:inf loc=\"post\">2</ce:inf> 1, NaH<ce:inf loc=\"post\">2</ce:inf>PO<ce:inf loc=\"post\">4</ce:inf> 0.33, glucose 10 and HEPES 5; pH<ce:hsp sp=\"0.25\"/>7.4 with NaOH. For data recording a 16-bit data acquisition card (National Instruments) and an in-house software written with LabView (National Instruments) was used, as previously described <ce:cross-ref refid=\"bb0125\" id=\"cf0230\">[25]</ce:cross-ref>. For all measurements the sampling rate was 15<ce:hsp sp=\"0.25\"/>kHz and the filter cut-off frequency was 5<ce:hsp sp=\"0.25\"/>kHz. Single-channel currents were evaluated from raw data histograms. Bursts were defined as bursts, when the openings were separated by at least 2<ce:hsp sp=\"0.25\"/>ms. Open and closed times were evaluated either from histograms yielded by an event based evaluation using in-house written software (LabView, National Instruments) or by manually averaging the length of openings.</ce:para></ce:section><ce:section id=\"s0035\" view=\"all\"><ce:label>2.5</ce:label><ce:section-title id=\"st0050\">Isolation of <ce:italic>Xenopus</ce:italic> oocytes and TEVC recordings</ce:section-title><ce:para id=\"p0040\" view=\"all\"><ce:italic>Xenopus laevis</ce:italic> oocytes were prepared as previously described <ce:cross-ref refid=\"bb0025\" id=\"cf0235\">[5]</ce:cross-ref>. Briefly, ovarian lobes were obtained from anesthetized <ce:italic>Xenopus</ce:italic> toads, mechanically separated with forceps and then incubated for 60–120<ce:hsp sp=\"0.25\"/>min in an OR2 solution (in mM: NaCl 82.5, KCl 2, MgCl<ce:inf loc=\"post\">2</ce:inf> 1, HEPES 5) containing 2<ce:hsp sp=\"0.25\"/>mg/ml collagenase. Thus separated oocytes were washed in ND96 solution (in mM: NaCl 96, KCl 2, CaCl<ce:inf loc=\"post\">2</ce:inf> 1.8, MgCl<ce:inf loc=\"post\">2</ce:inf> 1, HEPES 5; pH<ce:hsp sp=\"0.25\"/>7.4 with NaOH) and stored in the same solution at 18<ce:hsp sp=\"0.25\"/>°C supplemented with Na-pyruvate (275<ce:hsp sp=\"0.25\"/>mg/l), theophylline (90<ce:hsp sp=\"0.25\"/>mg/l) and gentamicin (50<ce:hsp sp=\"0.25\"/>mg/l) before and after injection of cRNA. Stage IV and V oocytes were injected with a volume of 50<ce:hsp sp=\"0.25\"/>nl cRNA solution per oocyte with a NanojectII microinjector (Drummond Scientific). cRNA was synthesized using the mMESSAGE mMACHINE Kit (Ambion). Standard two-electrode voltage-clamp (TEVC) experiments were performed at room temperature (21–24<ce:hsp sp=\"0.25\"/>°C) in ND96 recording solution 1–2<ce:hsp sp=\"0.25\"/>days after injection. Microelectrodes were fabricated from glass capillary tubes and filled with 3<ce:hsp sp=\"0.25\"/>M KCl. Tip resistance was in the range of 0.2–1.0<ce:hsp sp=\"0.25\"/>MΩ. TEVC recordings were performed using a TurboTEC-10CD Amplifier (npi) with a Digidata 1200 A/D-converter (Axon Instruments). For data acquisition the software pCLAMP7 (Axon Instruments) was used and data were analyzed with ClampFit10 (Axon Instruments).</ce:para></ce:section><ce:section id=\"s0040\" view=\"all\"><ce:label>2.6</ce:label><ce:section-title id=\"st0055\">Single-channel recordings from <ce:italic>Xenopus</ce:italic> oocytes</ce:section-title><ce:para id=\"p0045\" view=\"all\">Vitelline membranes of ooctyes were manually removed with tweezers under stereo binocular control, after shrinkage in a hyperosmolaric solution. As shrinkage solution glucose was added to the bath solution. Inside-out patches were excised from oocytes and currents were measured at room temperature one to two days after cRNA injection. Patch clamp recordings were performed with an Axopatch 200B amplifier at room temperature (21–24<ce:hsp sp=\"0.25\"/>°C) and pipettes had a tip resistance of 5.0–10.0<ce:hsp sp=\"0.25\"/>MΩ when filled with the pipette solution containing in mM: KCl 140, HEPES 5, EGTA 1; pH<ce:hsp sp=\"0.25\"/>7.4 with KOH. The bath solution which was applied from the cytosolic side of the batch was identical to the pipette solution. Single-channel currents were recorded with a sampling rate of 15<ce:hsp sp=\"0.25\"/>kHz with analog filter set to 5<ce:hsp sp=\"0.25\"/>kHz. To characterize the single-channel conductance, voltage steps of 1<ce:hsp sp=\"0.25\"/>s duration were applied ranging from potentials of −<ce:hsp sp=\"0.10\"/>80 to −<ce:hsp sp=\"0.10\"/>140<ce:hsp sp=\"0.25\"/>mV, to determine the slope conductance. Voltage steps were applied with a sweep time interval of 8<ce:hsp sp=\"0.25\"/>s, from a holding potential of 0<ce:hsp sp=\"0.25\"/>mV. To apply TASK-1 blockers single channels were recorded in gap free mode at −<ce:hsp sp=\"0.10\"/>120<ce:hsp sp=\"0.25\"/>mV. Blocker solutions were directly applied to the cytoplasmatic side of excised patches through a multi-barrel pipette. Single-channel amplitudes were evaluated from raw data histograms and kinetics were analyzed using the ClampFit10 software (Molecular Devices). For illustration the data were subsequently filtered with a −<ce:hsp sp=\"0.10\"/>3<ce:hsp sp=\"0.25\"/>dB, 8-pole Bessel filter at 2<ce:hsp sp=\"0.25\"/>kHz using the ClampFit10 software (Molecular Devices).</ce:para></ce:section><ce:section id=\"s0045\" view=\"all\"><ce:label>2.7</ce:label><ce:section-title id=\"st0060\">Chemiluminescence assay in <ce:italic>Xenopus</ce:italic> oocytes</ce:section-title><ce:para id=\"p0050\" view=\"all\">Surface expression of TASK-1 channels was studied using a chemiluminescence based assay. Therefore, we introduced into the extracellular P2-M4 loop of the channel after the residue 213 a hemagglutinin (HA) epitope including Pro-Gly-Gly spacers, with the amino acid sequence “PGGYPYDVPDYAGGP”. cRNA of HA-tagged TASK-1 channels, without or mixed with TASK-3 cRNA, was injected into <ce:italic>Xenopus</ce:italic> oocytes and surface expression was analyzed after 48<ce:hsp sp=\"0.25\"/>h. First, oocytes were incubated in ND96 plus 1% BSA on ice for 30<ce:hsp sp=\"0.25\"/>min to reduce unspecific antibody binding, followed by incubation with primary antibody (rat anti-HA (Roche), 1:100) for 1<ce:hsp sp=\"0.25\"/>h, extensive washing and incubation with secondary antibody (goat anti-rat-IgG, HRP-coupled (Dianova), 1:500) for 1<ce:hsp sp=\"0.25\"/>h. Oocytes were again extensively washed, before they were individually placed into a vial with 20<ce:hsp sp=\"0.25\"/>μl of luminescence substrate (SuperSignal Femto (Thermo Scientific)). Light emission was detected with a GloMax luminometer (Promega).</ce:para></ce:section><ce:section id=\"s0050\" view=\"all\"><ce:label>2.8</ce:label><ce:section-title id=\"st0065\">Drugs</ce:section-title><ce:para id=\"p0055\" view=\"all\">A293 (2-(Butane-1-sulfonylamino)-N-[1-(R)-(6-methoxy-pyridin-3-yl)-propyl]-benzamide) and A1899 were obtained from Sanofi Aventis GmbH Germany. Drugs were stored as DMSO stocks and final DMSO concentration did not exceed 0.1%.</ce:para></ce:section><ce:section id=\"s0055\" view=\"all\"><ce:label>2.9</ce:label><ce:section-title id=\"st0070\">Data analyses</ce:section-title><ce:para id=\"p0060\" view=\"all\">Data are reported as means<ce:hsp sp=\"0.25\"/>±<ce:hsp sp=\"0.25\"/>S.E.M. Statistical significance was calculated using unpaired Student\\'s t-test. All experiments were performed at room temperature (21–24<ce:hsp sp=\"0.25\"/>°C). * indicates <ce:italic>P</ce:italic><ce:hsp sp=\"0.25\"/>&lt;<ce:hsp sp=\"0.25\"/>0.05; ** <ce:italic>P</ce:italic><ce:hsp sp=\"0.25\"/>&lt;<ce:hsp sp=\"0.25\"/>0.01; *** <ce:italic>P</ce:italic><ce:hsp sp=\"0.25\"/>&lt;<ce:hsp sp=\"0.25\"/>0.001.</ce:para></ce:section></ce:section><ce:section id=\"s0060\" view=\"all\"><ce:label>3</ce:label><ce:section-title id=\"st0075\">Results</ce:section-title><ce:section id=\"s0065\" view=\"all\"><ce:label>3.1</ce:label><ce:section-title id=\"st0080\">TASK-3 expression in the human heart</ce:section-title><ce:para id=\"p0065\" view=\"all\">We aimed at investigating the role of TASK channels in the human atrium and thus first analyzed the mRNA expression levels of different TASK channels in comparison to other cardiac potassium channels (<ce:cross-ref refid=\"f0005\" id=\"cf0240\">Fig.\\xa01</ce:cross-ref>A<ce:float-anchor refid=\"f0005\"/>). A cDNA pool of human atrial auricles was prepared as previously described <ce:cross-ref refid=\"bb0025\" id=\"cf0245\">[5]</ce:cross-ref> and analyzed by quantitative PCR experiments. A major TASK-3 expression was previously not reported in cardiac tissue and thus to our surprise, our experiments showed that TASK-3 had a strong mRNA expression level which was much higher than that of the atrium-specific K<ce:inf loc=\"post\">2P</ce:inf> channel TASK-1 (3.8-fold). In addition, the relative expression of TASK-3 was much higher as for the other TASK channels, with TASK-2 (8.7-fold), TASK-4 (3.7-fold) or the K<ce:inf loc=\"post\">2P</ce:inf> channel TREK-1b. The mRNA expression level was almost as high as for Kv1.5 and was 2.6-fold higher as for the inward rectifier potassium channel Kir2.1 (<ce:cross-ref refid=\"f0005\" id=\"cf0250\">Fig.\\xa01</ce:cross-ref>A). Preliminary data indicate that TASK-3 expression in the human heart is not restricted to the atria (data not shown), as being described for TASK-1. Immunocytochemical studies demonstrated that TASK-3 in right human auricle cardiomyocytes is predominantly localized at the plasma membrane (<ce:cross-ref refid=\"f0005\" id=\"cf0255\">Fig.\\xa01</ce:cross-ref>B and Supplemental Fig. S1). Human atrial cells lack a classic T-tubular system and accordingly the TASK-3 immunostaining does not give the typical cross striation pattern, as described for TASK-1 in rat ventricular cardiomyocytes <ce:cross-ref refid=\"bb0030\" id=\"cf0260\">[6]</ce:cross-ref>. TASK-1 channels were also detected in intracellular compartments, which is in accordance with the previously described retention and/or endocytosis of these channels <ce:cross-refs refid=\"bb0130 bb0135\" id=\"cf0265\">[26,27]</ce:cross-refs>. In contrast, TASK-3 seems to be primarily localized at the plasma membrane (<ce:cross-ref refid=\"f0005\" id=\"cf0270\">Fig.\\xa01</ce:cross-ref>B and Supplemental Fig. S1) and TASK-3 co-localization with TASK-1 is almost exclusively observed at the cell surface of human atrial cells (Supplemental Fig. S1C). This observation is in line with the previously proposed idea that in native tissue TASK-1/TASK-3 heteromers may be more readily assembled and/or trafficked to the plasma membrane than homomers <ce:cross-ref refid=\"bb0110\" id=\"cf0275\">[22]</ce:cross-ref>. However, as we have noticed that the TASK-1 antibody, which was for instance also previously used to show TASK-1 expression in the mouse cardiac conduction system <ce:cross-refs refid=\"bb0020 bb0055\" id=\"cf0280\">[4,11]</ce:cross-refs>, most likely also recognizes other proteins (Supplemental Figs. S1 and S2), the conclusion of a spatial co-expression of TASK-3 with TASK-1 by immunocytochemistry needs to be interpreted with caution.</ce:para></ce:section><ce:section id=\"s0070\" view=\"all\"><ce:label>3.2</ce:label><ce:section-title id=\"st0085\">Electrophysiological characterization of TASK currents from human atrial cells</ce:section-title><ce:para id=\"p0070\" view=\"all\">After showing TASK-3 in the human heart on mRNA and protein level, we next aimed at recording TASK-3 single-channel currents in right auricular myocytes, to prove the functional expression in human atria. Therefore, we performed single-channel recordings of right human auricles in the cell-attached mode using divalent-cation-free solutions, to distinguish between TASK-1 and TASK-3, as under these conditions the single-channel conductance of TASK-3 is much higher than that of TASK-1. For instance in divalent-cation-free solution, the slope conductance for TASK-1 and for TASK-3 at −<ce:hsp sp=\"0.10\"/>100<ce:hsp sp=\"0.25\"/>mV was reported with 20<ce:hsp sp=\"0.25\"/>pS and 122<ce:hsp sp=\"0.25\"/>pS, respectively <ce:cross-ref refid=\"bb0140\" id=\"cf0285\">[28]</ce:cross-ref>. Interestingly, we found two types of channels (<ce:cross-ref refid=\"f0010\" id=\"cf0290\">Fig.\\xa02</ce:cross-ref><ce:float-anchor refid=\"f0010\"/>): An example of a cell-attached recording with a TASK-1-like channel is depicted in <ce:cross-ref refid=\"f0010\" id=\"cf0295\">Figs.\\xa02</ce:cross-ref>A and B. One type resembled a TASK-1-like channel with the typical low open probability and short open-times characteristic for TASK-1 (<ce:cross-ref refid=\"f0010\" id=\"cf0300\">Figs.\\xa02</ce:cross-ref>A and B). The other type of channel, presumably reflecting heteromeric TASK-1/TASK-3 channels, had a larger single-channel conductance which was intermediate to TASK-1 and TASK-3 and had in comparison to the TASK-1-like channel an increased open probability (<ce:cross-ref refid=\"f0010\" id=\"cf0305\">Figs.\\xa02</ce:cross-ref>C and D).</ce:para><ce:para id=\"p0075\" view=\"all\">The TASK-1-like channel had a single-channel amplitude of about 1.37<ce:hsp sp=\"0.25\"/>pA and 3.3<ce:hsp sp=\"0.25\"/>pA at −<ce:hsp sp=\"0.10\"/>60 and -120<ce:hsp sp=\"0.25\"/>mV, respectively (<ce:cross-ref refid=\"f0015\" id=\"cf0310\">Fig.\\xa03</ce:cross-ref>A<ce:float-anchor refid=\"f0015\"/>). The slope conductance, recorded between −<ce:hsp sp=\"0.10\"/>60 and −<ce:hsp sp=\"0.10\"/>120<ce:hsp sp=\"0.25\"/>mV, was 30.8<ce:hsp sp=\"0.25\"/>±<ce:hsp sp=\"0.25\"/>1.6<ce:hsp sp=\"0.25\"/>pS (n<ce:hsp sp=\"0.25\"/>=<ce:hsp sp=\"0.25\"/>4) (<ce:cross-ref refid=\"f0015\" id=\"cf0315\">Figs.\\xa03</ce:cross-ref>A and C). The open probability was low (p<ce:hsp sp=\"0.25\"/>&lt;<ce:hsp sp=\"0.25\"/>0.1%), the mean burst duration was 1.04<ce:hsp sp=\"0.25\"/>±<ce:hsp sp=\"0.25\"/>0.15<ce:hsp sp=\"0.25\"/>ms (n<ce:hsp sp=\"0.25\"/>=<ce:hsp sp=\"0.25\"/>65 bursts) and the open time was τ<ce:inf loc=\"post\">o</ce:inf> 0.81<ce:hsp sp=\"0.25\"/>±<ce:hsp sp=\"0.25\"/>0.08<ce:hsp sp=\"0.25\"/>ms (<ce:cross-ref refid=\"f0015\" id=\"cf0320\">Fig.\\xa03</ce:cross-ref>E). The TASK-1/TASK-3 heteromer-like channels had a single-channel amplitude of about 3.2<ce:hsp sp=\"0.25\"/>pA and 6.5<ce:hsp sp=\"0.25\"/>pA at −<ce:hsp sp=\"0.10\"/>60 and −<ce:hsp sp=\"0.10\"/>120<ce:hsp sp=\"0.25\"/>mV, respectively (<ce:cross-ref refid=\"f0015\" id=\"cf0325\">Fig.\\xa03</ce:cross-ref>B). The slope conductance, recorded between −<ce:hsp sp=\"0.10\"/>60 and −<ce:hsp sp=\"0.10\"/>120<ce:hsp sp=\"0.25\"/>mV, was 55.3<ce:hsp sp=\"0.25\"/>±<ce:hsp sp=\"0.25\"/>4.3<ce:hsp sp=\"0.25\"/>pS (n<ce:hsp sp=\"0.25\"/>=<ce:hsp sp=\"0.25\"/>4) (<ce:cross-ref refid=\"f0015\" id=\"cf0330\">Figs.\\xa03</ce:cross-ref>B and D). For this type of channel the open probability was 0.35<ce:hsp sp=\"0.25\"/>±<ce:hsp sp=\"0.25\"/>0.09 (n<ce:hsp sp=\"0.25\"/>=<ce:hsp sp=\"0.25\"/>4), the mean burst duration was 1.74<ce:hsp sp=\"0.25\"/>±<ce:hsp sp=\"0.25\"/>0.25 (n<ce:hsp sp=\"0.25\"/>=<ce:hsp sp=\"0.25\"/>55 bursts) and the open time τ<ce:inf loc=\"post\">o</ce:inf> was 0.47<ce:hsp sp=\"0.25\"/>±<ce:hsp sp=\"0.25\"/>0.05<ce:hsp sp=\"0.25\"/>ms (<ce:cross-ref refid=\"f0015\" id=\"cf0335\">Fig.\\xa03</ce:cross-ref>F). Interestingly, no TASK-3-like channels which would have a high slope conductance of about 120<ce:hsp sp=\"0.25\"/>pS <ce:cross-ref refid=\"bb0140\" id=\"cf0340\">[28]</ce:cross-ref>, were observed in human atrial cells. The lack of native TASK-3 single-channel recordings is in good agreement with a predominant formation and trafficking of heteromeric channels to the plasma membrane <ce:cross-ref refid=\"bb0110\" id=\"cf0345\">[22]</ce:cross-ref>.</ce:para></ce:section><ce:section id=\"s0075\" view=\"all\"><ce:label>3.3</ce:label><ce:section-title id=\"st0090\">Electrophysiological characterization of TASK-1, TASK-3 and TASK-1/TASK-3 heteromers in HEK293 cells</ce:section-title><ce:para id=\"p0080\" view=\"all\">To further support that the 55<ce:hsp sp=\"0.25\"/>pS channels which we have recorded in human auricular cardiomyocytes are in fact TASK-1/TASK-3 heterodimeric channels, TASK-1 and TASK-3 were co-transfected in HEK293 cells and cell-attached patch clamp recordings were performed, using the methods and solutions as described above. After co-transfection we recorded three distinct types of single TASK channels. <ce:cross-ref refid=\"f0020\" id=\"cf0350\">Fig.\\xa04</ce:cross-ref><ce:float-anchor refid=\"f0020\"/> illustrates examples of cell-attached recordings containing only a TASK-3 channel (<ce:cross-ref refid=\"f0020\" id=\"cf0355\">Fig.\\xa04</ce:cross-ref>A) or a heteromeric TASK-1/TASK-3 channel with the TASK-1/TASK-3 heteromer-like characteristics that we have observed in right human auricles (<ce:cross-ref refid=\"f0020\" id=\"cf0360\">Fig.\\xa04</ce:cross-ref>B). <ce:cross-ref refid=\"f0020\" id=\"cf0365\">Fig.\\xa04</ce:cross-ref>C illustrates a patch which contained all three types of single-channel events typical for TASK-1, TASK-3 and heteromeric TASK-1/TASK-3 channels. The high conductance TASK-like single-channel recordings of about 124.7<ce:hsp sp=\"0.25\"/>±<ce:hsp sp=\"0.25\"/>14.5<ce:hsp sp=\"0.25\"/>pS (n<ce:hsp sp=\"0.25\"/>=<ce:hsp sp=\"0.25\"/>7) (<ce:cross-ref refid=\"f0020\" id=\"cf0370\">Fig.\\xa04</ce:cross-ref>A and Supplemental Figs. S3A and C) represent most probably TASK-3 channels. In addition, these channels showed typical TASK-3 gating behavior and the mean single-channel conductance was close to what has been previously described for TASK-3 transfected in HEK293 cells (122 pS) <ce:cross-ref refid=\"bb0140\" id=\"cf0375\">[28]</ce:cross-ref>. The channels with an intermediate single-channel conductance of 69.0<ce:hsp sp=\"0.25\"/>±<ce:hsp sp=\"0.25\"/>2.9<ce:hsp sp=\"0.25\"/>pS (n<ce:hsp sp=\"0.25\"/>=<ce:hsp sp=\"0.25\"/>4) had an open probability of about 2.57%, a mean burst duration of 1.07<ce:hsp sp=\"0.25\"/>±<ce:hsp sp=\"0.25\"/>0.14<ce:hsp sp=\"0.25\"/>ms (n<ce:hsp sp=\"0.25\"/>=<ce:hsp sp=\"0.25\"/>112 bursts) and an open time of 0.30<ce:hsp sp=\"0.25\"/>±<ce:hsp sp=\"0.25\"/>0.02<ce:hsp sp=\"0.25\"/>ms (<ce:cross-ref refid=\"f0020\" id=\"cf0380\">Fig.\\xa04</ce:cross-ref>D). However, only one TASK single-channel recording showed a small conductance channel of 25<ce:hsp sp=\"0.25\"/>pS (Supplemental Figs. S3B and C), presumably resembling TASK-1, which has been previously described with a single-channel conductance of 20<ce:hsp sp=\"0.25\"/>pS in divalent-cation-free solution after heterologous expression in HEK293 cells <ce:cross-ref refid=\"bb0140\" id=\"cf0385\">[28]</ce:cross-ref> or with 28<ce:hsp sp=\"0.25\"/>pS in auricular cardiomyocytes <ce:cross-ref refid=\"bb0025\" id=\"cf0390\">[5]</ce:cross-ref>. The single-channel conductances recorded in cardiomyocytes and in co-transfected HEK293 cells (<ce:cross-ref refid=\"f0020\" id=\"cf0395\">Fig.\\xa04</ce:cross-ref>E) suggest that human atrial myocytes are most likely expressing a TASK-1-like channel and a TASK-1/TASK-3 heterodimer with an intermediate conductance and rarely homomeric TASK-3 channels.</ce:para></ce:section><ce:section id=\"s0080\" view=\"all\"><ce:label>3.4</ce:label><ce:section-title id=\"st0095\">Electrophysiological characterization of TASK-1–TASK-3 and TASK-3–TASK-1 concatemers in HEK293 cells</ce:section-title><ce:para id=\"p0085\" view=\"all\">To further support the molecular background of the atrial channel with the intermediate conductance of about 55<ce:hsp sp=\"0.25\"/>pS, we performed cell-attached single-channel measurements of a TASK-3–TASK-1 concatemer (T3–T1) transfected in HEK293 cells (<ce:cross-ref refid=\"f0025\" id=\"cf0400\">Figs.\\xa05</ce:cross-ref>A–C<ce:float-anchor refid=\"f0025\"/>). Heterologous expression of the T3–T1 concatemer resulted in a 65.7<ce:hsp sp=\"0.25\"/>±<ce:hsp sp=\"0.25\"/>15.3<ce:hsp sp=\"0.25\"/>pS (n<ce:hsp sp=\"0.25\"/>=<ce:hsp sp=\"0.25\"/>6) channel (<ce:cross-ref refid=\"f0025\" id=\"cf0405\">Figs.\\xa05</ce:cross-ref>A and C). An example of a cell-attached recording of the T3–T1 concatemer at −<ce:hsp sp=\"0.10\"/>80<ce:hsp sp=\"0.25\"/>mV is illustrated in <ce:cross-ref refid=\"f0025\" id=\"cf0410\">Fig.\\xa05</ce:cross-ref>A. The single-channel amplitude of this example at −<ce:hsp sp=\"0.10\"/>80<ce:hsp sp=\"0.25\"/>mV was about 5.2<ce:hsp sp=\"0.25\"/>pA (<ce:cross-ref refid=\"f0025\" id=\"cf0415\">Fig.\\xa05</ce:cross-ref>B). We also recorded the single-channel activity of the concatemer with the opposite orientation (TASK-1–TASK-3, T1–T3). However, it was difficult to gain cell-attached recordings of the T1–T3 concatemer and its single-channel conductance of 38.0<ce:hsp sp=\"0.25\"/>±<ce:hsp sp=\"0.25\"/>6.0<ce:hsp sp=\"0.25\"/>pS (n<ce:hsp sp=\"0.25\"/>=<ce:hsp sp=\"0.25\"/>4) was different from that of the T3–T1 concatemer (<ce:cross-ref refid=\"f0025\" id=\"cf0420\">Fig.\\xa05</ce:cross-ref>C). It is noteworthy, that also native heteromeric channels of TASK-3 and TASK-1 might exist in two orientations which might not have been resolved by our patch clamp recordings from cardiomyocytes. In this context it should be mentioned that the average single-channel conductance combining all T1–T3 and T3–T1 concatemer recordings was 54.6<ce:hsp sp=\"0.25\"/>±<ce:hsp sp=\"0.25\"/>6.1<ce:hsp sp=\"0.25\"/>pS (n<ce:hsp sp=\"0.25\"/>=<ce:hsp sp=\"0.25\"/>10) and close to the value recorded in the human atrium. However, the observed differences in single-channel behavior between the two orientations of the concatemer, albeit not statistically significant, suggest that the utilization of the concatemers is ambiguous. Nevertheless, the sum of the data observed with the concatemers and with the co-expression experiments of TASK-1 and TASK-3 in HEK293 cells led us to the conclusion that human atrial myocytes most likely express a TASK-1-like channel with a low conductance and a TASK-1–TASK-3 heterodimer-like channel with an intermediate conductance.</ce:para></ce:section><ce:section id=\"s0085\" view=\"all\"><ce:label>3.5</ce:label><ce:section-title id=\"st0100\">Pharmacology of TASK-1–TASK-3 (T1–T3) and TASK-3–TASK-1 (T3–T1) concatemers</ce:section-title><ce:para id=\"p0090\" view=\"all\">We have previously used A293 to isolate <ce:italic>I</ce:italic><ce:inf loc=\"post\">TASK-1</ce:inf> from right human auricular cardiomyocytes <ce:cross-ref refid=\"bb0025\" id=\"cf0425\">[5]</ce:cross-ref>. Since our present experiments indicate that human atrial myocytes express heteromeric TASK-1/TASK-3 channels, we were interested in assessing whether heteromeric channels with TASK-3 have a pharmacology similar to homomeric TASK-1 channels. For this purpose we tested the TASK-1 blocker A293 <ce:cross-ref refid=\"bb0030\" id=\"cf0430\">[6]</ce:cross-ref> on the concatemeric TASK-1/TASK-3 channels. We found that application of 200<ce:hsp sp=\"0.25\"/>nM A293 on TASK-1 channels expressed in oocytes led to a current reduction of 49.3<ce:hsp sp=\"0.25\"/>±<ce:hsp sp=\"0.25\"/>0.6% (<ce:cross-ref refid=\"f0025\" id=\"cf0435\">Figs.\\xa05</ce:cross-ref>D and E). In contrast, using the same concentration of A293, TASK-3 was blocked only by 16.1<ce:hsp sp=\"0.25\"/>±<ce:hsp sp=\"0.25\"/>0.4% (<ce:cross-ref refid=\"f0025\" id=\"cf0440\">Figs.\\xa05</ce:cross-ref>D and E). Surprisingly, while the T3–T1 concatemers were blocked by 43.7<ce:hsp sp=\"0.25\"/>±<ce:hsp sp=\"0.25\"/>3.7% and thus behaved like TASK-1 channels (<ce:cross-ref refid=\"f0025\" id=\"cf0445\">Figs.\\xa05</ce:cross-ref>D and E), the T1–T3 concatemers showed a reduced A293-sensitivity with 7.0<ce:hsp sp=\"0.25\"/>±<ce:hsp sp=\"0.25\"/>1.5% inhibition which more resembled the pharmacology of TASK-3 (<ce:cross-ref refid=\"f0025\" id=\"cf0450\">Figs.\\xa05</ce:cross-ref>D and E). To probe whether the orientation of the concatemer also influences the inhibition by other TASK-1 blockers, we additionally tested A1899 which was shown to be a specific TASK-1 blocker <ce:cross-ref refid=\"bb0145\" id=\"cf0455\">[29]</ce:cross-ref>. Applying 40<ce:hsp sp=\"0.25\"/>nM of A1899, TASK-1 channels were blocked by 45.8<ce:hsp sp=\"0.25\"/>±<ce:hsp sp=\"0.25\"/>1.0% (<ce:cross-ref refid=\"f0025\" id=\"cf0460\">Figs.\\xa05</ce:cross-ref>F and G). In contrast, using the same concentration of A1899, TASK-3 was blocked only by 9.13<ce:hsp sp=\"0.25\"/>±<ce:hsp sp=\"0.25\"/>0.9% (<ce:cross-ref refid=\"f0025\" id=\"cf0465\">Figs.\\xa05</ce:cross-ref>F and G). Similar as for A293, while the T3–T1 concatemers were blocked by 34.5<ce:hsp sp=\"0.25\"/>±<ce:hsp sp=\"0.25\"/>1.9% and thus behaved like TASK-1 channels (<ce:cross-ref refid=\"f0025\" id=\"cf0470\">Figs.\\xa05</ce:cross-ref>F and G), the T1–T3 concatemer showed a reduced A1899-sensitivity with 8.6<ce:hsp sp=\"0.25\"/>±<ce:hsp sp=\"0.25\"/>1.0% inhibition which is more resembling the pharmacology of TASK-3 (<ce:cross-ref refid=\"f0025\" id=\"cf0475\">Figs.\\xa05</ce:cross-ref>F and G).</ce:para><ce:para id=\"p0095\" view=\"all\">Thus, one orientation (T1–T3) of the concatemeric constructs of TASK-1 and TASK-3 had a reduced TASK-1 blocker affinity. Similar to the single-channel conductance, the pharmacology of the concatemers seems to depend on the orientation of the constructs, an effect which was previously not described in detail. Therefore, to finally conclude about changes in pharmacology of native heteromeric TASK-1/TASK-3 channels compared to TASK-1 alone, it is more suitable to ‘freely’ co-express TASK-1 and TASK-3.</ce:para></ce:section><ce:section id=\"s0090\" view=\"all\"><ce:label>3.6</ce:label><ce:section-title id=\"st0105\">Pharmacology of TASK-1/TASK-3 heteromers after co-expression in <ce:italic>Xenopus</ce:italic> oocytes</ce:section-title><ce:para id=\"p0100\" view=\"all\">Thus, for an estimation of the pharmacology of heteromeric TASK-1 and TASK-3 channels, we co-expressed TASK-1 and TASK-3 using increasing cRNA ratios ranging from four plus one (4<ce:hsp sp=\"0.25\"/>+<ce:hsp sp=\"0.25\"/>1) up to one plus four (1<ce:hsp sp=\"0.25\"/>+<ce:hsp sp=\"0.25\"/>4). Note that the 1<ce:hsp sp=\"0.25\"/>+<ce:hsp sp=\"0.25\"/>4 ratio approximates the relative mRNA expression levels, we have found in right human auricles (<ce:cross-ref refid=\"f0005\" id=\"cf0480\">Fig.\\xa01</ce:cross-ref>A). As already shown above, TASK-1 is sensitive to 200<ce:hsp sp=\"0.25\"/>nM A293 and 40<ce:hsp sp=\"0.25\"/>nM A1899 (approximately 50% inhibition), whereas TASK-3 is less efficiently blocked by the drugs (<ce:cross-ref refid=\"f0030\" id=\"cf0485\">Figs.\\xa06</ce:cross-ref>A and B<ce:float-anchor refid=\"f0030\"/>). Gradually increasing the relative amount of TASK-3 in the co-expression experiments strongly reduced block by A293 and A1899 in a ‘dose dependent manner’ (<ce:cross-ref refid=\"f0030\" id=\"cf0490\">Figs.\\xa06</ce:cross-ref>C and D). Co-expressing TASK-1 and TASK-3 in a one plus four ratio strongly reduced the block by 200<ce:hsp sp=\"0.25\"/>nM A293, with an average inhibition of 18.3<ce:hsp sp=\"0.25\"/>±<ce:hsp sp=\"0.25\"/>2.4% (<ce:cross-ref refid=\"f0030\" id=\"cf0495\">Figs.\\xa06</ce:cross-ref>A and C). The same effect was observed for inhibition by 40<ce:hsp sp=\"0.25\"/>nM of A1899. Co-expressing TASK-1 and TASK-3 in a one plus four ratio strongly reduced the block by 40<ce:hsp sp=\"0.25\"/>nM A1899, with an average inhibition of only 14.1<ce:hsp sp=\"0.25\"/>±<ce:hsp sp=\"0.25\"/>1.0% (<ce:cross-ref refid=\"f0030\" id=\"cf0500\">Figs.\\xa06</ce:cross-ref>B and D). These effects are in agreement with the concatemer in the T1–T3 orientation and show that when TASK-1 and TASK-3 assemble ‘freely’, in a non-covalently fused manner, they might gain a TASK-3-like pharmacology, meaning a reduced affinity for TASK-1 blockers. Most importantly, as we injected TASK-1 and TASK-3 in a cRNA ratio similar to that observed in right human auricles, we expect a reduced affinity of the native whole-cell currents for the TASK-1 blockers A293 and A1899.</ce:para><ce:para id=\"p0105\" view=\"all\">However, TASK-3 is known to have a much more efficient surface expression than TASK-1 in heterologous expression systems, which we also confirmed, injecting the same amount of TASK-1 or TASK-3 alone (<ce:cross-ref refid=\"f0030\" id=\"cf0505\">Fig.\\xa06</ce:cross-ref>E). As TASK-3 in the <ce:italic>Xenopus</ce:italic> expression system generates much more current than TASK-1 (<ce:cross-ref refid=\"f0030\" id=\"cf0510\">Fig.\\xa06</ce:cross-ref>E), the reduced drug affinity in the expression system is rather artificial and might not reflect the situation in native cardiomyocytes, where we primarily detected TASK-1 and heteromeric TASK-1/TASK-3 at the plasma membrane. Therefore, the observed effects can result either from more TASK-3 channels contributing to the whole-cell currents or by an increased number of heteromeric channels at the plasma membrane with a reduced drug affinity.</ce:para></ce:section><ce:section id=\"s0095\" view=\"all\"><ce:label>3.7</ce:label><ce:section-title id=\"st0110\">Preferential surface expression of heteromeric TASK-1/TASK-3 channels after co-expression of TASK-1 and TASK-3</ce:section-title><ce:para id=\"p0110\" view=\"all\">To further address the two possibilities discussed above, we performed co-expression experiments of TASK-1 and TASK-3 in <ce:italic>Xenopus</ce:italic> oocytes, quantified the whole-cell current amplitudes and in parallel we analyzed with inside-out single-channel recordings from these oocytes how many patches contained heteromeric TASK-1/TASK-3 or TASK-3 channels. Co-expression of TASK-1 with half the amount of TASK-3 already massively increased whole-cell current amplitudes recorded in two-electrode voltage-clamp recordings (<ce:cross-ref refid=\"f0035\" id=\"cf0515\">Figs.\\xa07</ce:cross-ref>A and B<ce:float-anchor refid=\"f0035\"/>). However, despite this strong increase in macroscopic currents (<ce:cross-ref refid=\"f0035\" id=\"cf0520\">Fig.\\xa07</ce:cross-ref>B), from 53 patches that yielded accurate single-channel recordings, we found only 4 patches with TASK-3 channels, while 42 patches (80%) contained heteromeric TASK-1/TASK-3 channels (<ce:cross-ref refid=\"f0035\" id=\"cf0525\">Fig.\\xa07</ce:cross-ref>C). Of note, also assessing other co-expression ratios, including the 1<ce:hsp sp=\"0.25\"/>+<ce:hsp sp=\"0.25\"/>4 ratio with the strong reduction in pharmacology, we could only rarely detect TASK-3 single channels (data not shown). These data are in agreement with previous reports that TASK-1/TASK-3 heteromers may be more readily assembled and/or trafficked to the plasma membrane than homomers <ce:cross-ref refid=\"bb0110\" id=\"cf0530\">[22]</ce:cross-ref> and that it is in right human auricles relatively unlikely to patch homomeric TASK-3 channels. To further support our conclusion that the reduced drug block, we have observed in our co-expression experiments, results from a more efficient surface expression of less drug affine heteromeric TASK-1/TASK-3 channels, we performed surface expression assays in these oocytes. To this end, the surface expression of TASK-1 channels with an extracellular HA-epitope (T1-HA) was quantified with a chemiluminescence assay (<ce:cross-ref refid=\"f0035\" id=\"cf0535\">Fig.\\xa07</ce:cross-ref>D). When TASK-1-HA was injected with only half the amount of TASK-3 the surface expression of TASK-1-HA was strongly increased (<ce:cross-ref refid=\"f0035\" id=\"cf0540\">Fig.\\xa07</ce:cross-ref>D). The most straightforward interpretation of the surface expression data, combined with the predominant prevalence of heteromeric TASK-1/TASK-3 channels in patches (<ce:cross-ref refid=\"f0035\" id=\"cf0545\">Fig.\\xa07</ce:cross-ref>C), is that TASK-3 channels efficiently heteromerize with TASK-1 and traffic to the surface membrane. Accordingly, the co-expression of TASK-1 with TASK-3 will increase the number of less drug sensitive heteromeric channels at the surface membrane.</ce:para></ce:section><ce:section id=\"s0100\" view=\"all\"><ce:label>3.8</ce:label><ce:section-title id=\"st0115\">Single channel recordings show a reduced drug affinity for heteromeric TASK-1/TASK-3 channels</ce:section-title><ce:para id=\"p0115\" view=\"all\">As discussed above concatemeric constructs and co-expression experiments have their limitations, i.e., for the concatemers the orientation influences pharmacology and for co-expressions it is difficult to isolate pools of pure heteromeric channels. Thus, we performed single-channel recordings from TASK-1 and TASK-3 co-expressed in <ce:italic>Xenopus</ce:italic> oocytes in the inside-out configuration to directly probe the drug sensitivity of the heteromeric channels. At −<ce:hsp sp=\"0.10\"/>120<ce:hsp sp=\"0.25\"/>mV TASK-1 channels had an amplitude of 3.4<ce:hsp sp=\"0.25\"/>±<ce:hsp sp=\"0.25\"/>0.2<ce:hsp sp=\"0.25\"/>pA (n<ce:hsp sp=\"0.25\"/>=<ce:hsp sp=\"0.25\"/>7), TASK-1/TASK-3 heteromers of 6.8<ce:hsp sp=\"0.25\"/>±<ce:hsp sp=\"0.25\"/>0.2<ce:hsp sp=\"0.25\"/>pA (n<ce:hsp sp=\"0.25\"/>=<ce:hsp sp=\"0.25\"/>4) and TASK-3 of 10.1<ce:hsp sp=\"0.25\"/>pA<ce:hsp sp=\"0.25\"/>±<ce:hsp sp=\"0.25\"/>0.5 (n<ce:hsp sp=\"0.25\"/>=<ce:hsp sp=\"0.25\"/>4) (<ce:cross-ref refid=\"f0040\" id=\"cf0550\">Fig.\\xa08</ce:cross-ref>B<ce:float-anchor refid=\"f0040\"/> and Supplemental Fig. S4), indicating single-channel conductances (about 28<ce:hsp sp=\"0.25\"/>pS for TASK-1 and 85<ce:hsp sp=\"0.25\"/>pS for TASK-3) similar to those after co-transfection of TASK-1 and TASK-3 in HEK293 cells. Heteromeric TASK-1/TASK-3 channels had similar single-channel characteristics as in HEK293 cells (<ce:cross-ref refid=\"f0040\" id=\"cf0555\">Fig.\\xa08</ce:cross-ref>A and Supplemental Fig. S4). In our detailed analyses the single-channel conductance was 54.0<ce:hsp sp=\"0.25\"/>±<ce:hsp sp=\"0.25\"/>2.0<ce:hsp sp=\"0.25\"/>pS (n<ce:hsp sp=\"0.25\"/>=<ce:hsp sp=\"0.25\"/>4) (<ce:cross-ref refid=\"f0040\" id=\"cf0560\">Figs.\\xa08</ce:cross-ref>B–C), with an open probability of about 1.4<ce:hsp sp=\"0.25\"/>±<ce:hsp sp=\"0.25\"/>0.4% (n<ce:hsp sp=\"0.25\"/>=<ce:hsp sp=\"0.25\"/>9), a mean burst duration of 1.57<ce:hsp sp=\"0.25\"/>±<ce:hsp sp=\"0.25\"/>0.28<ce:hsp sp=\"0.25\"/>ms (n<ce:hsp sp=\"0.25\"/>=<ce:hsp sp=\"0.25\"/>805 bursts) and a mean open time τ<ce:inf loc=\"post\">o</ce:inf> of 1.22<ce:hsp sp=\"0.25\"/>±<ce:hsp sp=\"0.25\"/>0.23<ce:hsp sp=\"0.25\"/>ms (n<ce:hsp sp=\"0.25\"/>=<ce:hsp sp=\"0.25\"/>9) (<ce:cross-ref refid=\"f0040\" id=\"cf0565\">Fig.\\xa08</ce:cross-ref>D). In inside-out patches held at −<ce:hsp sp=\"0.10\"/>120<ce:hsp sp=\"0.25\"/>mV in a gap-free mode, we directly applied 200<ce:hsp sp=\"0.25\"/>nM A293 to the cytoplasmatic phase of the patch and analyzed the current kinetics over a time period of 15<ce:hsp sp=\"0.25\"/>s before and after drug application. While the single-channel conductance of the heteromeric channels was not reduced by 200<ce:hsp sp=\"0.25\"/>nM A293 (<ce:cross-ref refid=\"f0040\" id=\"cf0570\">Fig.\\xa08</ce:cross-ref>E), we have observed a reduction in the open time τ<ce:inf loc=\"post\">o</ce:inf> and mean burst duration (<ce:cross-ref refid=\"f0040\" id=\"cf0575\">Fig.\\xa08</ce:cross-ref>E) which is in agreement with an open-channel block mechanism. Analyzing the open probability of single heteromeric TASK-1/TASK-3 channels as a measure of block, we only observed a 22.4<ce:hsp sp=\"0.25\"/>±<ce:hsp sp=\"0.25\"/>6.6% (n<ce:hsp sp=\"0.25\"/>=<ce:hsp sp=\"0.25\"/>6) reduction in P<ce:inf loc=\"post\">o</ce:inf>, although the drug was applied at a concentration which should cause a 50% reduction of TASK-1 channels (IC<ce:inf loc=\"post\">50</ce:inf><ce:hsp sp=\"0.25\"/>=<ce:hsp sp=\"0.25\"/>200<ce:hsp sp=\"0.25\"/>nM in <ce:italic>Xenopus</ce:italic> oocytes). A similar reduction in drug block was also observed in inside-out patches applying 40<ce:hsp sp=\"0.25\"/>nM of A1899 (also reflecting the IC<ce:inf loc=\"post\">50</ce:inf>). Here we also observed only a 14.5% (n<ce:hsp sp=\"0.25\"/>=<ce:hsp sp=\"0.25\"/>3) reduction in open probability. Therefore, the reduced block by A293 and A1899 caused by co-expression of TASK-1 with TASK-3 (<ce:cross-ref refid=\"f0030\" id=\"cf0580\">Figs.\\xa06</ce:cross-ref>C and D) is most likely caused by a reduced drug affinity or drug efficacy of the heteromeric channels.</ce:para></ce:section></ce:section><ce:section id=\"s0105\" view=\"all\"><ce:label>4</ce:label><ce:section-title id=\"st0120\">Discussion</ce:section-title><ce:para id=\"p0120\" view=\"all\">TASK-1 channels have been carefully studied in ventricular myocytes of the rat <ce:cross-refs refid=\"bb0030 bb0035\" id=\"cf0585\">[6,7]</ce:cross-refs> and mouse heart <ce:cross-refs refid=\"bb0020 bb0150 bb0155\" id=\"cf0590\">[4,30,31]</ce:cross-refs>, but also in the human atrium <ce:cross-ref refid=\"bb0025\" id=\"cf0595\">[5]</ce:cross-ref>. The TASK-1 knock-out mouse <ce:cross-refs refid=\"bb0020 bb0150\" id=\"cf0600\">[4,30]</ce:cross-refs> and patch clamp studies of human right auricular cardiomyocytes <ce:cross-ref refid=\"bb0025\" id=\"cf0605\">[5]</ce:cross-ref> revealed the physiological relevance of these cardiac ‘leak channels’. In our current study we aimed at investigating the role of other TASK channel family members in the human atrium. TASK-3 was assumed to be a ‘non-cardiac channel’, presumably as it is not or only very poorly expressed in cardiomyocytes of rodents <ce:cross-refs refid=\"bb0020 bb0030\" id=\"cf0610\">[4,6]</ce:cross-refs>. Thus, it was surprising that we found very pronounced TASK-3 mRNA expression levels in right human auricles. In native tissue it is possible to distinguish between TASK-1 and TASK-3 channels, by using single-channel recordings in divalent-cation-free solutions, since under these conditions the single-channel conductance of TASK-3 is much higher than that of TASK-1 <ce:cross-refs refid=\"bb0105 bb0140\" id=\"cf0615\">[21,28]</ce:cross-refs>. In divalent-cation-free solution, the slope conductance at −<ce:hsp sp=\"0.10\"/>100<ce:hsp sp=\"0.25\"/>mV of human TASK-3 and mouse TASK-1, heterologously expressed in HEK293 cells, is about 122<ce:hsp sp=\"0.25\"/>pS and 20<ce:hsp sp=\"0.25\"/>pS, respectively <ce:cross-ref refid=\"bb0140\" id=\"cf0620\">[28]</ce:cross-ref>. While our electrophysiological measurements in atrial myocytes using these conditions, revealed no TASK-3-like currents, we found a small conducting TASK-1-like channel with a single-channel conductance of about 31<ce:hsp sp=\"0.25\"/>pS and an intermediate conducting channel with a single-channel conductance of about 55<ce:hsp sp=\"0.25\"/>pS, presumably reflecting heterodimeric channels consisting of TASK-1 and TASK-3 subunits. The fact that we did not find homomeric TASK-3 channels, but a TASK-1/TASK-3-like channel with an intermediate conductance is in good agreement with the recent studies describing that in native tissue TASK-1 and TASK-3 seem to assemble primarily as heterodimers. For example, in motoneurons the heterodimer portion was about 52% <ce:cross-ref refid=\"bb0100\" id=\"cf0625\">[20]</ce:cross-ref> or in rat carotid body glomus cells TASK-1/3 heteromer provides the major part (about 75%) of the oxygen-sensitive TASK-like background K<ce:sup loc=\"post\">+</ce:sup> conductance <ce:cross-ref refid=\"bb0105\" id=\"cf0630\">[21]</ce:cross-ref>. The data from our co-expression experiments in <ce:italic>Xenopus</ce:italic> oocytes, combining analyses of current amplitudes, single-channel recordings and surface expression assays are in agreement with previous reports that TASK-1/TASK-3 heteromers may be more readily assembled and/or trafficked to the plasma membrane than homomers <ce:cross-ref refid=\"bb0110\" id=\"cf0635\">[22]</ce:cross-ref>. In addition, these data also explain why TASK-3 channels in human auricular cardiomyocytes will rarely be detected despite the relatively high mRNA expression level.</ce:para><ce:para id=\"p0125\" view=\"all\">To further support that the 55<ce:hsp sp=\"0.25\"/>pS channel observed in atrial myocytes is a TASK-1/TASK-3-like channel, we co-expressed TASK-1 and TASK-3 in HEK293 cells or <ce:italic>Xenopus</ce:italic> oocytes. In HEK293 cells we found a 125<ce:hsp sp=\"0.25\"/>pS channel resembling TASK-3 homomeric channels, a TASK-1-like channel with a single-channel conductance of 25<ce:hsp sp=\"0.25\"/>pS (similar to TASK-1 in atrial myocytes with 31<ce:hsp sp=\"0.25\"/>pS), and a channel with an intermediate conductance of about 69<ce:hsp sp=\"0.25\"/>pS, presumably formed by heterodimers consisting of TASK-1 and TASK-3 subunits. The single-channel conductance of this heteromeric channel, recorded for rat TASK-1 and human TASK-3 co-transfected in HEK293 cells, was however higher than in the native cardiomyocytes (69.0<ce:hsp sp=\"0.25\"/>±<ce:hsp sp=\"0.25\"/>2.9<ce:hsp sp=\"0.25\"/>pS versus 55.3<ce:hsp sp=\"0.25\"/>±<ce:hsp sp=\"0.25\"/>4.3<ce:hsp sp=\"0.25\"/>pS), albeit not significantly. Moreover, in <ce:italic>Xenopus</ce:italic> oocytes the co-expression of human TASK-1 and TASK-3 resulted in heteromeric channels with a single-channel conductance of 54.0<ce:hsp sp=\"0.25\"/>±<ce:hsp sp=\"0.25\"/>2.0<ce:hsp sp=\"0.25\"/>pS. The single-channel characteristics, of heteromeric TASK-1/TASK-3 channels recorded in HEK293 cells and <ce:italic>Xenopus</ce:italic> oocytes, especially the mean burst duration and the open times, are comparable with those obtained in human auricular cardiomyocytes and support our conclusion that the 55<ce:hsp sp=\"0.25\"/>pS channels are generated by heteromeric TASK-1/TASK-3 channels. In addition, we used T1–T3 and T3–T1 concatemers and found that both concatemers had an intermediate conductance compared to TASK-1 and TASK-3, but while the T1–T3 concatemer showed a single-channel conductance about 38<ce:hsp sp=\"0.25\"/>pS, the T3-T1 concatemer had a single-channel conductance of about 65<ce:hsp sp=\"0.25\"/>pS. Consistent with our data, a T1–T3 concatemeric construct was also studied by Kim et al. and the construct showed a similar intermediate single-channel conductance of 42<ce:hsp sp=\"0.25\"/>pS, using divalent-cation-free bath solution <ce:cross-ref refid=\"bb0105\" id=\"cf0640\">[21]</ce:cross-ref>. However, the concatemer with the other direction (T3–T1) was not used in this study. Interestingly, almost identical effects were previously observed using chimeras of TASK-1 and TASK-3 channels. Also here both types of chimeras were reported to have an intermediate conductance in divalent-cation-free external solution and dependent on the orientation the single-channel conductance was 40<ce:hsp sp=\"0.25\"/>pS (T1–T3-chimera) or 66<ce:hsp sp=\"0.25\"/>pS (T3–1-chimera), respectively <ce:cross-ref refid=\"bb0140\" id=\"cf0645\">[28]</ce:cross-ref>. The main difference for the concatemers is which C-termini and N-termini are linked together, however recent crystal structures of the TRAAK (<ce:italic>KCNK4</ce:italic>) channel described two different conformations <ce:cross-refs refid=\"bb0160 bb0165\" id=\"cf0650\">[32,33]</ce:cross-refs>. This domain swapping does not only affect the extracellular CAP structure but also causes differences in the structural organization of the transmembrane spanning domains. Accordingly, in the domain swapped conformation M1 of TASK-3 could interact with M2 of the TASK-1 subunit, while in the non-swapped variant it would be an intrasubunit-interaction within TASK-3. Currently it is still discussed whether K<ce:inf loc=\"post\">2P</ce:inf> channels assemble in the domain swapped or non-swapped variant and whether they can be functionally distinguished. Most importantly the covalent fusion of the concatemeric channels introduces physical constraints which could change the assembly in the swapped or non-swapped variant and the physical constraints could also influence the gating properties. Thus, the correlation of the data, using concatemeric but also chimeric constructs, with the native heteromeric channels should be interpreted with caution. However, the sum of our data strongly suggests that the 55<ce:hsp sp=\"0.25\"/>pS channel in right human auricles is in fact a heteromeric channel formed by TASK-1 and TASK-3: (1) We have observed a strong surface expression of TASK-3 and (2) a co-localization of TASK-3 and TASK-1 in immunocytochemistry experiments and (3) TASK-3 is known to preferentially form heteromers with TASK-1. (4) Chimeric and concatemeric channels of TASK-1 and TASK-3 are known to form channels with an intermediate single-channel conductance in divalent-cation-free solution. (5) The single-channel characteristics, especially the mean burst duration and the open times of co-expressed TASK-1 and TASK-3 channels are in agreement with those obtained in human auricular cardiomyocytes.</ce:para><ce:para id=\"p0130\" view=\"all\">Since our data indicate that TASK-1 and TASK-3 channels may primarily form heterodimers in atrial myocytes, we aimed to analyze the pharmacology of the heterodimers as this has not been the subject of previous studies. The pharmacology of the heteromeric channels is of particular interest, since TASK-1 is a putative drug target against atrial fibrillation <ce:cross-ref refid=\"bb0025\" id=\"cf0655\">[5]</ce:cross-ref>. A293 and A1899 were described to specifically block TASK-1 channels. In oocytes the IC<ce:inf loc=\"post\">50</ce:inf> values for A293 and A1899 are 200<ce:hsp sp=\"0.25\"/>nM and 40<ce:hsp sp=\"0.25\"/>nM, respectively <ce:cross-refs refid=\"bb0030 bb0145\" id=\"cf0660\">[6,29]</ce:cross-refs>. Concatemeric channels could not answer the questions about the pharmacology of the heteromeric channels, as depending on the orientation the concatemers had a TASK-1-like pharmacology (T3–T1) or a TASK-3-like pharmacology (T1–T3). Therefore, the pharmacological data obtained by using the concatemeric constructs should be interpreted with caution. Unfortunately, many previous studies trying to address questions about the pharmacology of heteromeric TASK channels used the above mentioned concatemers, but only probing it in one orientation. To get an idea of the A293- and A1899-sensitivity of heteromeric TASK-1 and TASK-3 channels in right human auricles, we co-expressed TASK-1 and TASK-3 in a cRNA ratio of one plus four, resembling the expression levels of both subunit types. Co-expressing TASK-1 and TASK-3 in this ratio strongly reduced the drug-sensitivity and the observed pharmacology was TASK-3-like, similar as for the T1–T3 orientation of the concatemer. The oocyte expression experiments which show a predominant trafficking of heteromeric channels to the plasma membrane, together with the single-channel recordings directly assessing the drug affinity of heteromeric channels, led us to the final conclusion that the co-expression of TASK-1 with TASK-3 will increase the number of less drug sensitive heteromeric channels at the surface membrane. These data suggest that our previous studies, isolating native TASK-1 whole-cell currents in the human atrium using low concentrations of A293 <ce:cross-ref refid=\"bb0025\" id=\"cf0665\">[5]</ce:cross-ref>, primarily isolated <ce:italic>I</ce:italic><ce:inf loc=\"post\">TASK-1</ce:inf> but not the fraction of TASK-3 present in heteromeric TASK-1/TASK-3 channels, as these have a TASK-3-like pharmacology. In addition, it would be valuable to conduct future clinical studies to obtain in vivo pharmacological data or get insights into the regulation of TASK-3 expression under pathophysiological conditions. The latter point would be of particular interest as it might provide answers why previous studies did not identify TASK-3 channels in the human heart.</ce:para><ce:para id=\"p0135\" view=\"all\">Thus, taken together our data indicate that TASK-3 may be expressed in the human atrium and preferentially incorporated into heteromeric complexes with TASK-1. In addition, the pharmacology of heteromeric channels containing TASK-1 and TASK-3 subunits has to be taken into account in designing drugs against atrial fibrillation.</ce:para></ce:section><ce:section id=\"s0110\" view=\"all\"><ce:section-title id=\"st0135\">Disclosures</ce:section-title><ce:para id=\"p0150\" view=\"all\">None.</ce:para></ce:section></ce:sections><ce:acknowledgment id=\"ac0005\" view=\"all\"><ce:section-title id=\"st0125\">Acknowledgments</ce:section-title><ce:para id=\"p0140\" view=\"all\">This work was supported by grants from the <ce:grant-sponsor id=\"gts0005\" sponsor-id=\"http://dx.doi.org/10.13039/501100001659\" xlink:type=\"simple\" xlink:role=\"http://www.elsevier.com/xml/linking-roles/grant-sponsor\">Deutsche Forschungsgemeinschaft</ce:grant-sponsor> DE <ce:grant-number refid=\"gts0005\">1482-3/1</ce:grant-number> and DE <ce:grant-number refid=\"gts0005\">1482-3/2</ce:grant-number> to N.D., the <ce:grant-sponsor id=\"gts0010\" xlink:type=\"simple\" xlink:role=\"http://www.elsevier.com/xml/linking-roles/grant-sponsor\">Universitätsklinikum Gießen and Marburg (UKGM)</ce:grant-sponsor> to S.R. and the <ce:grant-sponsor id=\"gts0015\" xlink:type=\"simple\" xlink:role=\"http://www.elsevier.com/xml/linking-roles/grant-sponsor\">Anneliese Pohl Stiftung</ce:grant-sponsor> to S.R. We thank Douglas A. Bayliss for providing concatemeric TASK-1/TASK-3 constructs. We are grateful to Oxana Nowak for excellent technical support.</ce:para></ce:acknowledgment><ce:appendices view=\"all\"><ce:section id=\"s0115\" view=\"extended\"><ce:label>Appendix A</ce:label><ce:section-title id=\"st0140\">Supplementary data</ce:section-title><ce:para id=\"p0180\" view=\"all\"><ce:display><ce:e-component id=\"ec0005\"><ce:caption id=\"ca0045\"><ce:simple-para id=\"sp0050\" view=\"all\">Supplementary Figures 1 to 4.</ce:simple-para></ce:caption><ce:link locator=\"mmc1\"/></ce:e-component></ce:display></ce:para></ce:section><ce:section view=\"compact-standard\" id=\"s0120\"><ce:label>Appendix A</ce:label><ce:section-title id=\"st0145\">Supplementary data</ce:section-title><ce:para id=\"p0185\" view=\"all\">Supplementary data to this article can be found online at <ce:inter-ref xlink:href=\"doi:10.1016/j.yjmcc.2015.01.017\" id=\"ir0005\" xlink:type=\"simple\">http://dx.doi.org/10.1016/j.yjmcc.2015.01.017</ce:inter-ref>.</ce:para></ce:section></ce:appendices></body><tail view=\"all\"><ce:bibliography id=\"bi0005\" view=\"all\"><ce:section-title id=\"st0130\">References</ce:section-title><ce:bibliography-sec id=\"bs0005\" view=\"all\"><ce:bib-reference id=\"bb0005\"><ce:label>[1]</ce:label><sb:reference id=\"rf0005\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Xu</ce:surname></sb:author><sb:author><ce:given-name>W.</ce:given-name><ce:surname>Guo</ce:surname></sb:author><sb:author><ce:given-name>J.M.</ce:given-name><ce:surname>Nerbonne</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Four kinetically distinct depolarization-activated K<ce:sup loc=\"post\">+</ce:sup> currents in adult mouse ventricular myocytes</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J Gen Physiol</sb:maintitle></sb:title><sb:volume-nr>113</sb:volume-nr></sb:series><sb:date>1999</sb:date></sb:issue><sb:pages><sb:first-page>661</sb:first-page><sb:last-page>678</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0010\"><ce:label>[2]</ce:label><sb:reference id=\"rf0010\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>P.H.</ce:given-name><ce:surname>Backx</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Marban</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Background potassium current active during the plateau of the action potential in guinea pig ventricular myocytes</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Circ Res</sb:maintitle></sb:title><sb:volume-nr>72</sb:volume-nr></sb:series><sb:date>1993</sb:date></sb:issue><sb:pages><sb:first-page>890</sb:first-page><sb:last-page>900</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0015\"><ce:label>[3]</ce:label><sb:reference id=\"rf0015\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>D.T.</ce:given-name><ce:surname>Yue</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Marban</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>A novel cardiac potassium channel that is active and conductive at depolarized potentials</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Pflügers Arch</sb:maintitle></sb:title><sb:volume-nr>413</sb:volume-nr></sb:series><sb:date>1988</sb:date></sb:issue><sb:pages><sb:first-page>127</sb:first-page><sb:last-page>133</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0020\"><ce:label>[4]</ce:label><sb:reference id=\"rf0020\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Decher</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Wemhöner</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Rinné</ce:surname></sb:author><sb:author><ce:given-name>M.F.</ce:given-name><ce:surname>Netter</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Zuzarte</ce:surname></sb:author><sb:author><ce:given-name>M.I.</ce:given-name><ce:surname>Aller</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Knock-out of the potassium channel TASK-1 leads to a prolonged QT interval and a disturbed QRS complex</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cell Physiol Biochem</sb:maintitle></sb:title><sb:volume-nr>28</sb:volume-nr></sb:series><sb:date>2011</sb:date></sb:issue><sb:pages><sb:first-page>77</sb:first-page><sb:last-page>86</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0025\"><ce:label>[5]</ce:label><sb:reference id=\"rf0025\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>S.H.</ce:given-name><ce:surname>Limberg</ce:surname></sb:author><sb:author><ce:given-name>M.F.</ce:given-name><ce:surname>Netter</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Rolfes</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Rinné</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Schlichthörl</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Zuzarte</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>TASK-1 channels may modulate action potential duration of human atrial cardiomyocytes</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cell Physiol Biochem</sb:maintitle></sb:title><sb:volume-nr>28</sb:volume-nr></sb:series><sb:date>2011</sb:date></sb:issue><sb:pages><sb:first-page>613</sb:first-page><sb:last-page>624</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0030\"><ce:label>[6]</ce:label><sb:reference id=\"rf0030\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Putzke</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Wemhöner</ce:surname></sb:author><sb:author><ce:given-name>F.B.</ce:given-name><ce:surname>Sachse</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Rinné</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Schlichthörl</ce:surname></sb:author><sb:author><ce:given-name>X.T.</ce:given-name><ce:surname>Li</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>The acid-sensitive potassium channel TASK-1 in rat cardiac muscle</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cardiovasc Res</sb:maintitle></sb:title><sb:volume-nr>75</sb:volume-nr></sb:series><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>59</sb:first-page><sb:last-page>68</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0035\"><ce:label>[7]</ce:label><sb:reference id=\"rf0035\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Schiekel</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Lindner</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Hetzel</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Wemhöner</ce:surname></sb:author><sb:author><ce:given-name>V.</ce:given-name><ce:surname>Renigunta</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Schlichthörl</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>The inhibition of the potassium channel TASK-1 in rat cardiac muscle by endothelin-1 is mediated by phospholipase C</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cardiovasc Res</sb:maintitle></sb:title><sb:volume-nr>97</sb:volume-nr></sb:series><sb:date>2013</sb:date></sb:issue><sb:pages><sb:first-page>97</sb:first-page><sb:last-page>105</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0040\"><ce:label>[8]</ce:label><sb:reference id=\"rf0040\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Xian Tao</ce:surname></sb:author><sb:author><ce:given-name>V.</ce:given-name><ce:surname>Dyachenko</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Zuzarte</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Putzke</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Preisig-Müller</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Isenberg</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>The stretch-activated potassium channel TREK-1 in rat cardiac ventricular muscle</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cardiovasc Res</sb:maintitle></sb:title><sb:volume-nr>69</sb:volume-nr></sb:series><sb:date>2006</sb:date></sb:issue><sb:pages><sb:first-page>86</sb:first-page><sb:last-page>97</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0045\"><ce:label>[9]</ce:label><sb:reference id=\"rf0045\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Friedrich</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Rinné</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Zumhagen</ce:surname></sb:author><sb:author><ce:given-name>A.K.</ce:given-name><ce:surname>Kiper</ce:surname></sb:author><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Silbernagel</ce:surname></sb:author><sb:author><ce:given-name>M.F.</ce:given-name><ce:surname>Netter</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Gain-of-function mutation in TASK-4 channels and severe cardiac conduction disorder</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>EMBO Mol Med</sb:maintitle></sb:title><sb:volume-nr>6</sb:volume-nr></sb:series><sb:date>2014</sb:date></sb:issue><sb:pages><sb:first-page>937</sb:first-page><sb:last-page>951</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0050\"><ce:label>[10]</ce:label><sb:reference id=\"rf0050\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Liang</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Soka</ce:surname></sb:author><sb:author><ce:given-name>A.H.</ce:given-name><ce:surname>Christensen</ce:surname></sb:author><sb:author><ce:given-name>M.S.</ce:given-name><ce:surname>Olesen</ce:surname></sb:author><sb:author><ce:given-name>A.P.</ce:given-name><ce:surname>Larsen</ce:surname></sb:author><sb:author><ce:given-name>F.K.</ce:given-name><ce:surname>Knop</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Genetic variation in the two-pore domain potassium channel, TASK-1, may contribute to an atrial substrate for arrhythmogenesis</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J Mol Cell Cardiol</sb:maintitle></sb:title><sb:volume-nr>67</sb:volume-nr></sb:series><sb:date>2014</sb:date></sb:issue><sb:pages><sb:first-page>69</sb:first-page><sb:last-page>76</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0055\"><ce:label>[11]</ce:label><sb:reference id=\"rf0055\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>V.</ce:given-name><ce:surname>Graham</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Zhang</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Willis</ce:surname></sb:author><sb:author><ce:given-name>T.L.</ce:given-name><ce:surname>Creazzo</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Expression of a two-pore domain K<ce:sup loc=\"post\">+</ce:sup> channel (TASK-1) in developing avian and mouse ventricular conduction systems</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Dev Dyn</sb:maintitle></sb:title><sb:volume-nr>235</sb:volume-nr></sb:series><sb:date>2006</sb:date></sb:issue><sb:pages><sb:first-page>143</sb:first-page><sb:last-page>151</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0060\"><ce:label>[12]</ce:label><sb:reference id=\"rf0060\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>A.S.</ce:given-name><ce:surname>Barth</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Merk</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Arnoldi</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Zwermann</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Kloos</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Gebauer</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Reprogramming of the human atrial transcriptome in permanent atrial fibrillation: expression of a ventricular-like genomic signature</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Circ Res</sb:maintitle></sb:title><sb:volume-nr>96</sb:volume-nr></sb:series><sb:date>2005</sb:date></sb:issue><sb:pages><sb:first-page>1022</sb:first-page><sb:last-page>1029</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0065\"><ce:label>[13]</ce:label><sb:reference id=\"rf0065\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Kim</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Bang</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Kim</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>TASK-3, a new member of the tandem pore K<ce:sup loc=\"post\">+</ce:sup> channel family</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J Biol Chem</sb:maintitle></sb:title><sb:volume-nr>275</sb:volume-nr></sb:series><sb:date>2000</sb:date></sb:issue><sb:pages><sb:first-page>9340</sb:first-page><sb:last-page>9347</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0070\"><ce:label>[14]</ce:label><sb:reference id=\"rf0070\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>C.G.</ce:given-name><ce:surname>Chapman</ce:surname></sb:author><sb:author><ce:given-name>H.J.</ce:given-name><ce:surname>Meadows</ce:surname></sb:author><sb:author><ce:given-name>R.J.</ce:given-name><ce:surname>Godden</ce:surname></sb:author><sb:author><ce:given-name>D.A.</ce:given-name><ce:surname>Campbell</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Duckworth</ce:surname></sb:author><sb:author><ce:given-name>R.E.</ce:given-name><ce:surname>Kelsell</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Cloning, localisation and functional expression of a novel human, cerebellum specific, two pore domain potassium channel</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Brain Res Mol Brain Res</sb:maintitle></sb:title><sb:volume-nr>82</sb:volume-nr></sb:series><sb:date>2000</sb:date></sb:issue><sb:pages><sb:first-page>74</sb:first-page><sb:last-page>83</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0075\"><ce:label>[15]</ce:label><sb:reference id=\"rf0075\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>A.D.</ce:given-name><ce:surname>Medhurst</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Rennie</ce:surname></sb:author><sb:author><ce:given-name>C.G.</ce:given-name><ce:surname>Chapman</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Meadows</ce:surname></sb:author><sb:author><ce:given-name>M.D.</ce:given-name><ce:surname>Duckworth</ce:surname></sb:author><sb:author><ce:given-name>R.E.</ce:given-name><ce:surname>Kelsell</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Distribution analysis of human two pore domain potassium channels in tissues of the central nervous system and periphery</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Brain Res Mol Brain Res</sb:maintitle></sb:title><sb:volume-nr>86</sb:volume-nr></sb:series><sb:date>2001</sb:date></sb:issue><sb:pages><sb:first-page>101</sb:first-page><sb:last-page>114</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0080\"><ce:label>[16]</ce:label><sb:reference id=\"rf0080\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Rajan</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Wischmeyer</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Xin Liu</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Preisig-Müller</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Daut</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Karschin</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>TASK-3, a novel tandem pore domain acid-sensitive K<ce:sup loc=\"post\">+</ce:sup> channel. An extracellular histiding as pH sensor</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J Biol Chem</sb:maintitle></sb:title><sb:volume-nr>275</sb:volume-nr></sb:series><sb:date>2000</sb:date></sb:issue><sb:pages><sb:first-page>16650</sb:first-page><sb:last-page>16657</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0085\"><ce:label>[17]</ce:label><sb:reference id=\"rf0085\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Czirjak</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Enyedi</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Formation of functional heterodimers between the TASK-1 and TASK-3 two-pore domain potassium channel subunits</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J Biol Chem</sb:maintitle></sb:title><sb:volume-nr>277</sb:volume-nr></sb:series><sb:date>2002</sb:date></sb:issue><sb:pages><sb:first-page>5426</sb:first-page><sb:last-page>5432</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0090\"><ce:label>[18]</ce:label><sb:reference id=\"rf0090\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>O.</ce:given-name><ce:surname>Barel</ce:surname></sb:author><sb:author><ce:given-name>S.A.</ce:given-name><ce:surname>Shalev</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Ofir</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Cohen</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Zlotogora</ce:surname></sb:author><sb:author><ce:given-name>Z.</ce:given-name><ce:surname>Shorer</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Maternally inherited Birk Barel mental retardation dysmorphism syndrome caused by a mutation in the genomically imprinted potassium channel <ce:italic>KCNK9</ce:italic></sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Am J Hum Genet</sb:maintitle></sb:title><sb:volume-nr>83</sb:volume-nr></sb:series><sb:date>2008</sb:date></sb:issue><sb:pages><sb:first-page>193</sb:first-page><sb:last-page>199</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0095\"><ce:label>[19]</ce:label><sb:reference id=\"rf0095\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Kang</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Han</ce:surname></sb:author><sb:author><ce:given-name>E.M.</ce:given-name><ce:surname>Talley</ce:surname></sb:author><sb:author><ce:given-name>D.A.</ce:given-name><ce:surname>Bayliss</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Kim</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Functional expression of TASK-1/TASK-3 heteromers in cerebellar granule cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J Physiol</sb:maintitle></sb:title><sb:volume-nr>554</sb:volume-nr></sb:series><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>64</sb:first-page><sb:last-page>77</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0100\"><ce:label>[20]</ce:label><sb:reference id=\"rf0100\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>A.P.</ce:given-name><ce:surname>Berg</ce:surname></sb:author><sb:author><ce:given-name>E.M.</ce:given-name><ce:surname>Talley</ce:surname></sb:author><sb:author><ce:given-name>J.P.</ce:given-name><ce:surname>Manger</ce:surname></sb:author><sb:author><ce:given-name>D.A.</ce:given-name><ce:surname>Bayliss</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Motoneurons express heteromeric TWIK-related acid-sensitive K<ce:sup loc=\"post\">+</ce:sup> (TASK) channels containing TASK-1 (<ce:italic>KCNK3</ce:italic>) and TASK-3 (<ce:italic>KCNK9</ce:italic>) subunits</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J Neurosci</sb:maintitle></sb:title><sb:volume-nr>24</sb:volume-nr></sb:series><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>6693</sb:first-page><sb:last-page>6702</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0105\"><ce:label>[21]</ce:label><sb:reference id=\"rf0105\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Kim</ce:surname></sb:author><sb:author><ce:given-name>E.J.</ce:given-name><ce:surname>Cavanaugh</ce:surname></sb:author><sb:author><ce:given-name>I.</ce:given-name><ce:surname>Kim</ce:surname></sb:author><sb:author><ce:given-name>J.L.</ce:given-name><ce:surname>Carroll</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Heteromeric TASK-1/TASK-3 is the major oxygen-sensitive background K<ce:sup loc=\"post\">+</ce:sup> channel in rat carotid body glomus cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J Physiol</sb:maintitle></sb:title><sb:volume-nr>587</sb:volume-nr></sb:series><sb:date>2009</sb:date></sb:issue><sb:pages><sb:first-page>2963</sb:first-page><sb:last-page>2975</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0110\"><ce:label>[22]</ce:label><sb:reference id=\"rf0110\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>P.J.</ce:given-name><ce:surname>Turner</ce:surname></sb:author><sb:author><ce:given-name>K.J.</ce:given-name><ce:surname>Buckler</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Oxygen and mitochondrial inhibitors modulate both monomeric and heteromeric TASK-1 and TASK-3 channels in mouse carotid body type-1 cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J Physiol</sb:maintitle></sb:title><sb:volume-nr>591</sb:volume-nr></sb:series><sb:date>2013</sb:date></sb:issue><sb:pages><sb:first-page>5977</sb:first-page><sb:last-page>5998</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0115\"><ce:label>[23]</ce:label><sb:reference id=\"rf0115\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>J.O.</ce:given-name><ce:surname>Bustamante</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Watanabe</ce:surname></sb:author><sb:author><ce:given-name>D.A.</ce:given-name><ce:surname>Murphy</ce:surname></sb:author><sb:author><ce:given-name>T.F.</ce:given-name><ce:surname>McDonald</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Isolation of single atrial and ventricular cells from the human heart</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Can Med Assoc J</sb:maintitle></sb:title><sb:volume-nr>126</sb:volume-nr></sb:series><sb:date>1982</sb:date></sb:issue><sb:pages><sb:first-page>791</sb:first-page><sb:last-page>793</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0120\"><ce:label>[24]</ce:label><sb:reference id=\"rf0120\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Maier</ce:surname></sb:author><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Aulbach</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Simm</ce:surname></sb:author><sb:author><ce:given-name>V.</ce:given-name><ce:surname>Lange</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Langenfeld</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Behre</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Stimulation of L-type Ca<ce:sup loc=\"post\">2<ce:hsp sp=\"0.10\"/>+</ce:sup> current in human atrial myocytes by insulin</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cardiovasc Res</sb:maintitle></sb:title><sb:volume-nr>44</sb:volume-nr></sb:series><sb:date>1999</sb:date></sb:issue><sb:pages><sb:first-page>390</sb:first-page><sb:last-page>397</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0125\"><ce:label>[25]</ce:label><sb:reference id=\"rf0125\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>W.</ce:given-name><ce:surname>Gu</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Schlichthörl</ce:surname></sb:author><sb:author><ce:given-name>J.R.</ce:given-name><ce:surname>Hirsch</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Engels</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Karschin</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Karschin</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Expression pattern and functional characteristics of two novel splice variants of the two-pore-domain potassium channel TREK-2</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J Physiol</sb:maintitle></sb:title><sb:volume-nr>539</sb:volume-nr></sb:series><sb:date>2002</sb:date></sb:issue><sb:pages><sb:first-page>657</sb:first-page><sb:last-page>668</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0130\"><ce:label>[26]</ce:label><sb:reference id=\"rf0130\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>V.</ce:given-name><ce:surname>Renigunta</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Yuan</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Zuzarte</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Rinné</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Koch</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Wischmeyer</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>The retention factor p11 confers an endoplasmic reticulum-localization signal to the potassium channel TASK-1</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Traffic</sb:maintitle></sb:title><sb:volume-nr>7</sb:volume-nr></sb:series><sb:date>2006</sb:date></sb:issue><sb:pages><sb:first-page>168</sb:first-page><sb:last-page>181</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0135\"><ce:label>[27]</ce:label><sb:reference id=\"rf0135\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>V.</ce:given-name><ce:surname>Renigunta</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Fischer</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Zuzarte</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Kling</ce:surname></sb:author><sb:author><ce:given-name>X.</ce:given-name><ce:surname>Zou</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Siebert</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Cooperative endocytosis of the endosomal SNARE protein syntaxin-8 and the potassium channel TASK-1</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Mol Biol Cell</sb:maintitle></sb:title><sb:volume-nr>25</sb:volume-nr></sb:series><sb:date>2014</sb:date></sb:issue><sb:pages><sb:first-page>1877</sb:first-page><sb:last-page>1891</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0140\"><ce:label>[28]</ce:label><sb:reference id=\"rf0140\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Musset</ce:surname></sb:author><sb:author><ce:given-name>S.G.</ce:given-name><ce:surname>Meuth</ce:surname></sb:author><sb:author><ce:given-name>G.X.</ce:given-name><ce:surname>Liu</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Derst</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Wegner</ce:surname></sb:author><sb:author><ce:given-name>H.C.</ce:given-name><ce:surname>Pape</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Effects of divalent cations and spermine on the K<ce:sup loc=\"post\">+</ce:sup> channel TASK-3 and on the outward current in thalamic neurons</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J Physiol</sb:maintitle></sb:title><sb:volume-nr>572</sb:volume-nr></sb:series><sb:date>2006</sb:date></sb:issue><sb:pages><sb:first-page>639</sb:first-page><sb:last-page>657</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0145\"><ce:label>[29]</ce:label><sb:reference id=\"rf0145\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>A.K.</ce:given-name><ce:surname>Streit</ce:surname></sb:author><sb:author><ce:given-name>M.F.</ce:given-name><ce:surname>Netter</ce:surname></sb:author><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Kempf</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Walecki</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Rinné</ce:surname></sb:author><sb:author><ce:given-name>M.K.</ce:given-name><ce:surname>Bollepalli</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>A specific two-pore domain potassium channel blocker defines the structure of the TASK-1 open pore</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J Biol Chem</sb:maintitle></sb:title><sb:volume-nr>286</sb:volume-nr></sb:series><sb:date>2011</sb:date></sb:issue><sb:pages><sb:first-page>13977</sb:first-page><sb:last-page>13984</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0150\"><ce:label>[30]</ce:label><sb:reference id=\"rf0150\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>B.C.</ce:given-name><ce:surname>Donner</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Schullenberg</ce:surname></sb:author><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Geduldig</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Huning</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Mersmann</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Zacharowski</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Functional role of TASK-1 in the heart: studies in TASK-1-deficient mice show prolonged cardiac repolarization and reduced heart rate variability</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Basic Res Cardiol</sb:maintitle></sb:title><sb:volume-nr>106</sb:volume-nr></sb:series><sb:date>2011</sb:date></sb:issue><sb:pages><sb:first-page>75</sb:first-page><sb:last-page>87</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0155\"><ce:label>[31]</ce:label><sb:reference id=\"rf0155\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Petric</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Clasen</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>van Wessel</ce:surname></sb:author><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Geduldig</ce:surname></sb:author><sb:author><ce:given-name>Z.</ce:given-name><ce:surname>Ding</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Schullenberg</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>In vivo electrophysiological characterization of TASK-1 deficient mice</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cell Physiol Biochem</sb:maintitle></sb:title><sb:volume-nr>30</sb:volume-nr></sb:series><sb:date>2012</sb:date></sb:issue><sb:pages><sb:first-page>523</sb:first-page><sb:last-page>537</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0160\"><ce:label>[32]</ce:label><sb:reference id=\"rf0160\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>S.G.</ce:given-name><ce:surname>Brohawn</ce:surname></sb:author><sb:author><ce:given-name>E.B.</ce:given-name><ce:surname>Campbell</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>MacKinnon</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Domain-swapped chain connectivity and gated membrane access in a Fab-mediated crystal of the human TRAAK K<ce:sup loc=\"post\">+</ce:sup> channel</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Proc Natl Acad Sci U S A</sb:maintitle></sb:title><sb:volume-nr>110</sb:volume-nr></sb:series><sb:date>2013</sb:date></sb:issue><sb:pages><sb:first-page>2129</sb:first-page><sb:last-page>2134</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0165\"><ce:label>[33]</ce:label><sb:reference id=\"rf0165\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>S.G.</ce:given-name><ce:surname>Brohawn</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>del Marmol</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>MacKinnon</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Crystal structure of the human K<ce:inf loc=\"post\">2P</ce:inf> TRAAK, a lipid- and mechano-sensitive K<ce:sup loc=\"post\">+</ce:sup> ion channel</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Science</sb:maintitle></sb:title><sb:volume-nr>335</sb:volume-nr></sb:series><sb:date>2012</sb:date></sb:issue><sb:pages><sb:first-page>436</sb:first-page><sb:last-page>441</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference></ce:bibliography-sec></ce:bibliography></tail></article></xocs:serial-item></xocs:doc></originalText></full-text-retrieval-response>',\n",
       " '<!DOCTYPE article PUBLIC \"-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN\" \"JATS-archivearticle1.dtd\">\\n<article xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" article-type=\"research-article\"><?properties open_access?><front><journal-meta><journal-id journal-id-type=\"nlm-ta\">Biochem J</journal-id><journal-id journal-id-type=\"iso-abbrev\">Biochem. J</journal-id><journal-id journal-id-type=\"pmc\">bic</journal-id><journal-id journal-id-type=\"publisher-id\">BJ</journal-id><journal-title-group><journal-title>Biochemical Journal</journal-title></journal-title-group><issn pub-type=\"ppub\">0264-6021</issn><issn pub-type=\"epub\">1470-8728</issn><publisher><publisher-name>Portland Press Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type=\"pmid\">24015703</article-id><article-id pub-id-type=\"pmc\">3898203</article-id><article-id pub-id-type=\"publisher-id\">BJ20130100</article-id><article-id pub-id-type=\"doi\">10.1042/BJ20130100</article-id><article-categories><subj-group subj-group-type=\"heading\"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Reorientation of the first signal-anchor sequence during potassium channel biogenesis at the Sec61 complex</article-title><alt-title alt-title-type=\"right-running-head\">Signal-anchor reorientation at the Sec61 complex</alt-title><alt-title alt-title-type=\"left-running-head\">H. R. Watson and others</alt-title></title-group><contrib-group><contrib contrib-type=\"author\"><name><surname>Watson</surname><given-names>Helen&#x000a0;R.</given-names></name><xref ref-type=\"aff\" rid=\"A1\">*</xref><xref ref-type=\"author-notes\" rid=\"fn1\"><sup>1</sup></xref></contrib><contrib contrib-type=\"author\"><name><surname>Wunderley</surname><given-names>Lydia</given-names></name><xref ref-type=\"aff\" rid=\"A1\">*</xref></contrib><contrib contrib-type=\"author\"><name><surname>Andreou</surname><given-names>Tereza</given-names></name><xref ref-type=\"aff\" rid=\"A1\">*</xref></contrib><contrib contrib-type=\"author\"><name><surname>Warwicker</surname><given-names>Jim</given-names></name><xref ref-type=\"aff\" rid=\"A1\">*</xref></contrib><contrib contrib-type=\"author\"><name><surname>High</surname><given-names>Stephen</given-names></name><xref ref-type=\"aff\" rid=\"A1\">*</xref><xref ref-type=\"corresp\" rid=\"COR2\"><sup>2</sup></xref></contrib><aff id=\"A1\">*Faculty of Life Sciences, University of Manchester, Michael Smith Building, Oxford Road, Manchester M13 9PT, U.K.</aff></contrib-group><author-notes><fn id=\"fn1\" fn-type=\"present-address\"><p><sup>1</sup>Present address: University of Exeter Medical School, St. Lukes Campus, Magdalen Road, Exeter, Devon EX1 2LU, U.K.</p></fn><corresp id=\"COR2\"><sup>2</sup>To whom correspondence should be addressed (email <email>stephen.high@manchester.ac.uk</email>).</corresp></author-notes><pub-date pub-type=\"epreprint\"><day>10</day><month>9</month><year>2013</year></pub-date><pub-date pub-type=\"epub\"><day>8</day><month>11</month><year>2013</year></pub-date><pub-date pub-type=\"ppub\"><day>1</day><month>12</month><year>2013</year></pub-date><volume>456</volume><issue>Pt 2</issue><fpage>297</fpage><lpage>309</lpage><history><date date-type=\"received\"><day>17</day><month>1</month><year>2013</year></date><date date-type=\"rev-recd\"><day>9</day><month>8</month><year>2013</year></date><date date-type=\"accepted\"><day>10</day><month>9</month><year>2013</year></date></history><permissions><copyright-statement>&#x000a9; 2013 The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Licence (CC-BY)(http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.</copyright-statement><copyright-year>2013</copyright-year><license license-type=\"open-access\" xlink:href=\"http://creativecommons.org/licenses/by/3.0/\"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>The majority of the polytopic proteins that are synthesized at the ER (endoplasmic reticulum) are integrated co-translationally via the Sec61 translocon, which provides lateral access for their hydrophobic TMs (transmembrane regions) to the phospholipid bilayer. A prolonged association between TMs of the potassium channel subunit, TASK-1 [TWIK (tandem-pore weak inwardly rectifying potassium channel)-related acid-sensitive potassium channel 1], and the Sec61 complex suggests that the ER translocon co-ordinates the folding/assembly of the TMs present in the nascent chain. The N-terminus of both TASK-1 and Kcv (potassium channel protein of chlorella virus), another potassium channel subunit of viral origin, has access to the N-glycosylation machinery located in the ER lumen, indicating that the Sec61 complex can accommodate multiple arrangements/orientations of TMs within the nascent chain, both <italic>in&#x000a0;vitro</italic> and <italic>in&#x000a0;vivo</italic>. Hence the ER translocon can provide the ribosome-bound nascent chain with a dynamic environment in which it can explore a range of different conformations en route to its correct transmembrane topology and final native structure.</p></abstract><abstract abstract-type=\"short\"><p>The Sec61 translocon provides an unexpectedly flexible and dynamic environment within which transmembrane regions of nascent polypeptides can be completely reoriented during the biosynthesis of multiple-spanning membrane proteins.</p></abstract><kwd-group kwd-group-type=\"kwd\"><kwd>endoplasmic reticulum</kwd><kwd>membrane protein folding</kwd><kwd>potassium channel protein of chlorella virus (Kcv channel)</kwd><kwd>site-specific cross-linking</kwd><kwd>TWIK (tandem-pore weak inwardly rectifying potassium channel)-related acid-sensitive potassium channel 1 (TASK-1)</kwd></kwd-group><kwd-group kwd-group-type=\"abbr\"><kwd>BMH, bismaleimidohexane</kwd><kwd>Cys-null, cysteine-null</kwd><kwd>EndoH, endoglycosidase H</kwd><kwd>ER, endoplasmic reticulum</kwd><kwd>Kcv, potassium channel protein of chlorella virus</kwd><kwd>OPG, opsin N-glycosylation tag</kwd><kwd>TASK-1, TWIK (tandem-pore weak inwardly rectifying potassium channel)-related acid-sensitive potassium channel 1</kwd><kwd>TM, transmembrane region</kwd><kwd>TRAM, translocating chain-associated membrane protein</kwd></kwd-group><counts><fig-count count=\"6\"/><table-count count=\"1\"/><ref-count count=\"41\"/><page-count count=\"13\"/></counts></article-meta></front><body><sec><title>INTRODUCTION</title><p>The majority of membrane proteins synthesized at the ER (endoplasmic reticulum) are delivered as ribosome-bound nascent chains via the SRP (signal recognition particle)-dependent pathway [<xref ref-type=\"bibr\" rid=\"B1\">1</xref>], and subsequently engage the Sec61 translocon responsible for the co-translational translocation of polypeptides into and across the ER membrane [<xref ref-type=\"bibr\" rid=\"B1\">1</xref>&#x02013;<xref ref-type=\"bibr\" rid=\"B3\">3</xref>]. The Sec61 translocon discriminates between hydrophobic TMs (transmembrane regions) destined for membrane integration and hydrophilic stretches destined for complete translocation [<xref ref-type=\"bibr\" rid=\"B4\">4</xref>]; with TM integration requiring their lateral exit from the translocon into the surrounding phospholipid bilayer [<xref ref-type=\"bibr\" rid=\"B2\">2</xref>,<xref ref-type=\"bibr\" rid=\"B5\">5</xref>]. In the case of polytopic, or multi-spanning, membrane proteins, several TMs must be membrane-integrated and assembled, and both the ribosome and the Sec61 complex play key roles in this process [<xref ref-type=\"bibr\" rid=\"B6\">6</xref>]. It is generally accepted that ER translocon-associated components, such as TRAM (translocating chain-associated membrane protein) and the TRAP (translocon-associated protein) complex, may facilitate membrane insertion [<xref ref-type=\"bibr\" rid=\"B3\">3</xref>,<xref ref-type=\"bibr\" rid=\"B7\">7</xref>,<xref ref-type=\"bibr\" rid=\"B8\">8</xref>].</p><p>The ER translocon is not simply a passive conduit providing access for TMs to the bilayer, but rather it actively contributes to polytopic membrane protein biogenesis by facilitating the assembly of TMs before their complete integration [<xref ref-type=\"bibr\" rid=\"B8\">8</xref>&#x02013;<xref ref-type=\"bibr\" rid=\"B14\">14</xref>]. Hence the association of TMs into pairs and bundles is a well-defined stage during theoretical and experimental studies of polytopic membrane protein folding [<xref ref-type=\"bibr\" rid=\"B15\">15</xref>,<xref ref-type=\"bibr\" rid=\"B16\">16</xref>], and current models suggest that this process can occur within the context of the ER translocon, where cohorts of TMs may assemble before integration [<xref ref-type=\"bibr\" rid=\"B17\">17</xref>&#x02013;<xref ref-type=\"bibr\" rid=\"B19\">19</xref>].</p><p>Early models for polytopic membrane protein biogenesis suggested that they could be viewed as a series of individual signal sequences that were dealt with sequentially, and in essence individually, by the ER translocon [<xref ref-type=\"bibr\" rid=\"B17\">17</xref>,<xref ref-type=\"bibr\" rid=\"B20\">20</xref>]. It is now apparent that such early models are over-simplistic [<xref ref-type=\"bibr\" rid=\"B14\">14</xref>], and they are also unable to account for the complete translocon-mediated reorientation of TMs [<xref ref-type=\"bibr\" rid=\"B21\">21</xref>,<xref ref-type=\"bibr\" rid=\"B22\">22</xref>] that occurs via a carefully orchestrated series of events at the Sec61 complex [<xref ref-type=\"bibr\" rid=\"B6\">6</xref>]. The influence of one TM on the fate of its neighbour [<xref ref-type=\"bibr\" rid=\"B23\">23</xref>] further underlines the potential for a &#x02018;non-linear&#x02019; treatment of TMs by the ER translocon, and there is even evidence for the positional editing of fully integrated TMs during the assembly of membrane protein complexes [<xref ref-type=\"bibr\" rid=\"B24\">24</xref>].</p><p>The acid-sensitive, two-pore, potassium channel protein TASK-1 [TWIK (tandem-pore weak inwardly rectifying potassium channel)-related acid-sensitive potassium channel 1], or K<sub>2P</sub>3.1, has four TMs separated by hydrophilic loops, two of which include the pore helix and selectivity filter domains that contribute to transport selectivity in the functional dimer [<xref ref-type=\"bibr\" rid=\"B25\">25</xref>]. Regions in TMs 2 and 4, and both pore loops, have been shown to contribute to a drug-binding site in TASK-1, providing structural insights into the open form of the channel [<xref ref-type=\"bibr\" rid=\"B26\">26</xref>], whereas N-glycosylation of TASK-1 regulates the delivery of functional channels to the cell surface [<xref ref-type=\"bibr\" rid=\"B27\">27</xref>]. In the present study, we have employed TASK-1 as a model for studying polytopic membrane protein biogenesis at the ER. Site-specific cross-linking indicated that an N-terminal region of TASK-1 incorporating the first TM (TM1), a type&#x000a0;II signal-anchor, displays a prolonged association with the Sec61 complex during its biogenesis and integration. Adduct formation with Sec61&#x003b2; suggested that a proportion of nascent chains acquire an inverted or &#x02018;head-first&#x02019; orientation at the ER translocon, a hypothesis that was validated using an N-glycosylation tag as a membrane topology reporter and reproduced with Kcv (potassium channel protein of chlorella virus), a &#x02018;minimal&#x02019; potassium channel subunit of viral origin [<xref ref-type=\"bibr\" rid=\"B28\">28</xref>,<xref ref-type=\"bibr\" rid=\"B29\">29</xref>]. In the case of the shortest TASK-1 chain analysed, we can even detect some polypeptides that are N-glycosylated on each side of TM1, suggesting that a fraction of these molecules can reorient TM1 even after the modification of a flanking region (cf. [<xref ref-type=\"bibr\" rid=\"B21\">21</xref>]). The unusual behaviour of this very short TASK-1 chain underlines the flexibility of the environment provided by the ER translocon [<xref ref-type=\"bibr\" rid=\"B6\">6</xref>]. By analysing specific TASK-1 fragments in cultured mammalian cells, we identified a cohort of polypeptides that assume an inverted topology <italic>in&#x000a0;vivo</italic>, and found that this phenotype is &#x02018;corrected&#x02019; upon synthesis of the full-length protein. These findings provide further evidence for the dynamic nature of Sec61-mediated TM integration and underline the complexity of the molecular events leading to the acquisition of a native membrane topology.</p></sec><sec><title>EXPERIMENTAL</title><sec><title>Materials</title><p>Where possible, amino acid changes were designed to preserve the biophysical properties of the resulting mutants by maintaining the &#x00394;<italic>G</italic><sup>pred</sup> values for residues located in TMs [<xref ref-type=\"bibr\" rid=\"B5\">5</xref>] or provide a side chain of comparable size in hydrophilic loops. Cys-null (cysteine-null) versions of human TASK-1 (UniProt ID O14649) and <italic>Paramecium bursaria</italic> chlorella virus 1 Kcv (UniProt ID Q84568) genes were made to order (GenScript), and used valine to replace cysteine residues in TMs and serine to substitute for cysteine residues in hydrophilic regions. When synthesized <italic>in&#x000a0;vitro</italic>, the wild-type and Cys-null versions of TASK-1 appear to be of identical size and N-glycosylation status upon SDS/PAGE, confirming that the alterations had not grossly perturbed membrane insertion (results not shown). The locations of novel cysteine probes were also chosen to minimize any perturbation of &#x00394;<italic>G</italic><sup>pred</sup> values for membrane insertion [<xref ref-type=\"bibr\" rid=\"B5\">5</xref>]. Single cysteine residues were introduced into the constructs with QuikChange&#x02122; site-directed mutagenesis (Stratagene), and N-glycosylation sites were removed and inserted using the same approach. OPG (opsin N-glycosylation tag) derivatives of both proteins were produced from cDNAs containing an in-frame fusion of the coding region for residues 1&#x02013;26 of bovine opsin (UniProt ID P02699) in place of the original start codon (TASK-1) or before it (Kcv), and all mutagenesis was confirmed by DNA sequencing. All <italic>in&#x000a0;vitro</italic> studies used the pTNT vector (Promega), whereas for expression in HeLaM cells, OPG&#x02013;TASK-1 derivatives were cloned into pCDNA3.1+ (Invitrogen). TorsinA Myc&#x02013;His<sub>6</sub> [<xref ref-type=\"bibr\" rid=\"B30\">30</xref>] was used as a positive control for EndoH (endoglycosidase H) treatment of cell lysates (see <xref ref-type=\"fig\" rid=\"F5\">Figure 5</xref>).</p></sec><sec><title><italic>In&#x000a0;vitro</italic> transcription and translation</title><p>Transcription templates were generated by PCR, in most cases incorporating a C-terminal V5 tag via the reverse primer, and RNA produced as described previously [<xref ref-type=\"bibr\" rid=\"B11\">11</xref>]. Ribosome-bound integration intermediates were generated by translating the resulting transcripts in rabbit reticulocyte lysate at 30&#x000b0;C for 40&#x000a0;min in the presence of canine pancreatic microsomes and [<sup>35</sup>S]methionine/[<sup>35</sup>S]cysteine followed by treatment with 0.1&#x000a0;mM aurintricarboxylic acid for 10&#x000a0;min at 30&#x000b0;C, then 2.5&#x000a0;mM cycloheximide (cf. [<xref ref-type=\"bibr\" rid=\"B10\">10</xref>,<xref ref-type=\"bibr\" rid=\"B11\">11</xref>,<xref ref-type=\"bibr\" rid=\"B13\">13</xref>]). Alternatively, ribosome/nascent chain complexes were dissociated using 1&#x000a0;mM puromycin and 20&#x000a0;mM EDTA at 37&#x000b0;C for 10&#x000a0;min. Membrane-associated components were isolated by centrifugation through a 750&#x000a0;mM sucrose cushion (120000&#x000a0;<bold><italic>g</italic></bold> for 10&#x000a0;min at 4&#x000b0;C) and membrane pellets were resuspended in 110&#x000a0;mM potassium acetate, 20&#x000a0;mM Hepes and 2&#x000a0;mM magnesium acetate (pH&#x000a0;7.2).</p></sec><sec><title>Cross-linking, immunoprecipitation and deglycoslation</title><p>Resuspended membrane fractions were treated with 1&#x000a0;mM BMH (bismaleimidohexane) cross-linker for 10&#x000a0;min at 30&#x000b0;C, quenched with 5&#x000a0;mM 2-mercaptoethanol for 5&#x000a0;min and treated with 250&#x000a0;&#x003bc;g/ml RNase A for 5&#x000a0;min at 37&#x000b0;C [<xref ref-type=\"bibr\" rid=\"B13\">13</xref>,<xref ref-type=\"bibr\" rid=\"B31\">31</xref>]. SDS was added to 1% (v/v), samples were heated to 70&#x000b0;C for 10&#x000a0;min and then processed further as described previously [<xref ref-type=\"bibr\" rid=\"B31\">31</xref>]. Antibodies used for immunoprecipitation were: mouse anti-V5 (Serotec), rabbit anti-Sec61&#x003b1; (Richard Zimmerman, Saarland University, Saarbr&#x000fc;cken, Germany), rabbit anti-Sec61&#x003b2; and rabbit anti-TRAM (Bernhard Dobberstein, ZMBH, Heidelberg, Germany). Samples were deglycosylated using EndoH (New England Biolabs) according to the manufacturer\\'s instructions or by adding recombinant enzyme to samples in SDS/PAGE sample buffer and incubated at 37&#x000b0;C overnight.</p></sec><sec><title>Cell culture and DNA transfection</title><p>HeLaM cells were maintained in DMEM (Dulbecco\\'s modified Eagle\\'s medium) containing 10% (v/v) FBS and 2&#x000a0;mM <sc>L</sc>-glutamine, 0.1&#x000a0;mM non-essential amino acids at 37&#x000b0;C, 5% CO<sub>2</sub>. Lipofectamine&#x02122; 2000 (Invitrogen) was used for transient transfection in accordance with the manufacturer\\'s instructions, and cells were harvested after ~18&#x000a0;h.</p></sec><sec><title>SDS/PAGE and sample analysis</title><p>Samples were heated in SDS/PAGE sample buffer at 37&#x000b0;C for 30&#x000a0;min before electrophoresis on 12% Tris/glycine or 15% Tris/bicine gels (in <xref ref-type=\"fig\" rid=\"F4\">Figure 4</xref>E only; cf. [<xref ref-type=\"bibr\" rid=\"B32\">32</xref>]). Gels were fixed, dried and exposed to a phosphorimaging plate, and products visualized using a FLA-3000 (Fuji). Adducts were considered authentic (cf. <xref ref-type=\"table\" rid=\"T1\">Table 1</xref>), where products of the same apparent size were immunoprecipitated with both the anti-V5 antibody and a serum recognizing a component of the ER translocon, i.e. Sec61&#x003b1;, Sec61&#x003b2; and TRAM (cf. [<xref ref-type=\"bibr\" rid=\"B13\">13</xref>]). The quantification of radiolabelled products was performed using AIDA version 3.44 software (see <xref ref-type=\"fig\" rid=\"F3\">Figure 3</xref>C). To analyse OPG&#x02013;TASK-1 products expressed in HeLaM cells, lysates were prepared directly in sample buffer and, following SDS/PAGE and Western blotting, proteins detected using antibodies against the OPG (OPG&#x02013;TASK-1) or Myc (control) tag respectively with donkey anti-mouse 800 IR dye-conjugated secondary (LI-COR Biosciences) antibody. Proteins were visualized and quantified using an Odyssey LC scanner and Image Studio software (LI-COR Biosciences).</p><table-wrap id=\"T1\" position=\"float\"><label>Table 1</label><caption><title>Summary of TASK-1 cross-linking analysis</title><p>Schematic representations of the truncation lengths are shown for each column, together with the number of residues in the chain (including the 14-residue C-terminal V5 tag). These fragments are named after the last residue before the chain was truncated. Each row summarizes data from one or more cysteine residues located within either the TM indicated, or the first P-loop (P1). Cysteine mutants that generated specific adducts with subunits of the Sec61 complex (as specified in the Experimental section) are indicated with &#x003b1;, &#x003b2; or &#x003b1;&#x003b2; where a single adduct of the nascent with both components was detected. Some cysteine probes could not be tested with short integration intermediates (NA), some combinations were not tested (NT), and a number of combinations of probe location and longer chain lengths resulted in no discrete cross-linking products being observed (NDC).</p></caption><table frame=\"hsides\" rules=\"groups\"><tbody><tr><td rowspan=\"1\" colspan=\"1\"><graphic id=\"m07\" xlink:href=\"bj2013-0100i007\"/></td></tr></tbody></table></table-wrap></sec></sec><sec sec-type=\"results\"><title>RESULTS</title><p>Our aim was to investigate two aspects of TASK-1 biogenesis at the ER membrane: (i) the proximity of distinct TMs to the Sec61 translocon at different nascent chain lengths; and (ii) the orientation of the first TM, a type&#x000a0;II signal-anchor, during membrane integration. To this end, we employed <italic>in&#x000a0;vitro</italic> translation and site-specific cross-linking, combined with non-native N-glycosylation sites as a topology reporter, to study integration intermediates. Notwithstanding technical limitations [<xref ref-type=\"bibr\" rid=\"B33\">33</xref>], both photo- and maleimide-mediated site-specific cross-linking have provided useful insights into the components and mechanisms underlying polytopic membrane protein biogenesis at the ER (e.g. [<xref ref-type=\"bibr\" rid=\"B6\">6</xref>,<xref ref-type=\"bibr\" rid=\"B8\">8</xref>&#x02013;<xref ref-type=\"bibr\" rid=\"B14\">14</xref>]). The TMs of TASK-1 each contain hydrophilic amino acids that might potentially compromise membrane insertion (Supplementary Figure S1 at <ext-link ext-link-type=\"uri\" xlink:href=\"http://www.biochemj.org/bj/456/bj4560297add.htm\">http://www.biochemj.org/bj/456/bj4560297add.htm</ext-link>), and we have used single cysteine residues to probe their proximity to specific components of the ER translocon.</p><sec><title>TMs remain in close proximity to the ER translocon during TASK-1 biosynthesis</title><p>To estimate a &#x02018;window of proximity&#x02019; to the Sec61 complex for different TMs of TASK-1, we built a series of single-cysteine mutants and generated ribosome-bound integration intermediates for each one of increasing chain length (<xref ref-type=\"fig\" rid=\"F1\">Figure 1</xref>A). All intermediates included a C-terminal V5 tag to identify authentically truncated polypeptides and encoding mRNAs lacked stop codons to favour the formation of ribosome-bound ER translocon-associated integration intermediates [<xref ref-type=\"bibr\" rid=\"B10\">10</xref>,<xref ref-type=\"bibr\" rid=\"B13\">13</xref>]. The treatment of 74-residue-long TASK-1 integration intermediates, containing single cysteine probes at different locations, with BMH resulted in discrete cross-linking products (<xref ref-type=\"fig\" rid=\"F1\">Figure 1</xref>B). Among these products, adducts with subunits of the Sec61 complex could be identified by immunoprecipitation using validated antibodies known to recognize specific components of the ER translocon [<xref ref-type=\"bibr\" rid=\"B10\">10</xref>,<xref ref-type=\"bibr\" rid=\"B11\">11</xref>,<xref ref-type=\"bibr\" rid=\"B13\">13</xref>,<xref ref-type=\"bibr\" rid=\"B31\">31</xref>,<xref ref-type=\"bibr\" rid=\"B34\">34</xref>]. The most prominent cross-linking partner that could be identified in this fashion was the Sec61&#x003b1; subunit (<xref ref-type=\"fig\" rid=\"F1\">Figure 1</xref>B), although we also observed a trimeric adduct of TASK-1&#x02013;Sec61&#x003b1;&#x02013;Sec61&#x003b2; when the cysteine probe was located at residue 28 (<xref ref-type=\"fig\" rid=\"F1\">Figure 1</xref>B, A28C panel). A TASK-1 Cys-null variant generated no such products (<xref ref-type=\"fig\" rid=\"F1\">Figure 1</xref>B, Cys null panel), confirming the site-specific nature of these adducts. Furthermore, adduct formation depended on a stable ribosome-bound nascent chain, hence puromycin treatment before BMH addition abolished cross-linking to components of the ER translocon (Supplementary Figure S2 at <ext-link ext-link-type=\"uri\" xlink:href=\"http://www.biochemj.org/bj/456/bj4560297add.htm\">http://www.biochemj.org/bj/456/bj4560297add.htm</ext-link>). Taken together, these data suggest that TM1 of a 74-residue-long TASK-1 integration intermediate engages the Sec61 complex upon its delivery to the ER membrane.</p><fig id=\"F1\" position=\"float\"><label>Figure 1</label><caption><title>Site-specific cross-linking of TASK-1-integration intermediates</title><p>(<bold>A</bold>) Representation of human TASK-1 showing four TMs (TM1&#x02013;TM4) and two pore loops (P1 and P2) [<xref ref-type=\"bibr\" rid=\"B25\">25</xref>] (see also Supplementary Figure S1 at <ext-link ext-link-type=\"uri\" xlink:href=\"http://www.biochemj.org/bj/456/bj4560297add.htm\">http://www.biochemj.org/bj/456/bj4560297add.htm</ext-link>). Truncated chains used to generate integration intermediates are indicated (see E60, V108, F125, N158, V221, D283 and S392, in each case a C-terminal 14-residue V5 tag was appended; see <xref ref-type=\"table\" rid=\"T1\">Table 1</xref>), together with locations of single cysteine targets for BMH-dependent cross-linking. The endogenous site for N-glycosylation is indicated (Asn<sup>53</sup>). Representative cross-linking experiments with integration intermediates of 74 (<bold>B</bold>), 172 (<bold>C</bold> and <bold>E</bold>) and 139 (<bold>D</bold>) residues (&#x02018;aa&#x02019;) are shown for cysteine probes located in or near TM1 (<bold>B</bold> and <bold>C</bold>), P1 (<bold>D</bold>) and TM2 (<bold>E</bold>). Total membrane-associated products after BMH treatment (&#x02212;), or products recovered via immunoprecipitation with anti-V5 (V5), anti-Sec61&#x003b1; (&#x003b1;), anti-Sec61&#x003b2; (&#x003b2;) or anti-TRAM (T) antibodies are shown. A Cys-null version of TASK-1 was used to control for the authenticity of BMH mediated cross-linking products (<bold>B</bold> and <bold>C</bold>). Adducts with Sec61&#x003b1;, Sec61&#x003b2; and Sec61&#x003b1;+&#x003b2; are labelled (&#x003b1;, &#x003b2; and &#x003b1;&#x003b2; respectively). No discrete TRAM adducts were observed. Molecular masses are indicated in kDa.</p></caption><graphic xlink:href=\"bj2013-0100i001\"/></fig><p>Interestingly, at this shortest chain length, we also observed rather weak cross-linking products formed between a single cysteine probe located at both the N- and C-terminal side of TM1 and the single cytoplasmically located cysteine residue of Sec61&#x003b2; (<xref ref-type=\"fig\" rid=\"F1\">Figure 1</xref>B, A10C and L35C panels, and Supplementary Figure S2, lane 3). The adduct with L35C was unexpected, and suggested that either TM1 is in a loop conformation at an early stage of biogenesis, or at least a proportion of nascent TASK-1 chains might assume an inverted topology during membrane integration. When the cross-linking partners of a longer integration intermediate were analysed, in addition to adducts with Sec61&#x003b1;, the L35C-mediated adduct with Sec61&#x003b2; was still present and, if anything, became more apparent (<xref ref-type=\"fig\" rid=\"F1\">Figure 1</xref>C, L35C panel, and Supplementary Figure S2, lane 6). We extended these studies to look at probes at or near the first pore loop, P1, and TMs 2, 3 and 4 (<xref ref-type=\"fig\" rid=\"F1\">Figure 1</xref>A, and Supplementary Figure S1) and could identify further adducts with Sec61&#x003b1; and Sec61&#x003b2; (<xref ref-type=\"fig\" rid=\"F1\">Figures 1</xref>C&#x02013;<xref ref-type=\"fig\" rid=\"F1\">1</xref>E, <xref ref-type=\"table\" rid=\"T1\">Table 1</xref> and Supplementary Figure S2). Although these cross-linking products became more diffuse with longer integration intermediates, as observed previously [<xref ref-type=\"bibr\" rid=\"B11\">11</xref>], a clear pattern emerged (<xref ref-type=\"fig\" rid=\"F1\">Figure 1</xref>, <xref ref-type=\"table\" rid=\"T1\">Table 1</xref> and results not shown). In short, these data indicate that: (i) TM1 remains in close proximity to the Sec61 complex after the P1 loop and TM2 are synthesized; (ii) P1 remains adjacent to Sec61 after TM2 synthesis; (iii) TM2 remains close to Sec61 when the nascent chain is extended to include TM3 and P2; and (iv) TM3 is adjacent Sec61&#x003b1; after TM4 synthesis. Taken together, these data are consistent with models suggesting that the ER translocon may provide an environment that facilitates the folding of polytopic membrane proteins by orchestrating the assembly of their TMs [<xref ref-type=\"bibr\" rid=\"B11\">11</xref>,<xref ref-type=\"bibr\" rid=\"B12\">12</xref>]. Furthermore, since Sec61&#x003b2; has only a single cysteine residue located in its cytoplasmic domain, its capacity to cross-link probe L35C from integration intermediates of 74 and 172 residues (<xref ref-type=\"fig\" rid=\"F1\">Figures 1</xref>B and <xref ref-type=\"fig\" rid=\"F1\">1</xref>C, and Supplementary Figure S2) suggests that TASK-1 biogenesis may not simply involve the sequential threading of TMs in their native orientation into the ER translocon.</p></sec><sec><title>Truncated TASK-1 chains assume a mixed topology in the ER membrane</title><p>The ability of L35C to cross-link Sec61&#x003b2; in the context of two different integration intermediates suggests that the C-terminal end of TASK-TM1 may have access to the cytosolic side of the ER translocon during membrane insertion, at least in a proportion of nascent chains. To better clarify this issue, we analysed adduct formation between probes L35C and T103C and Sec61&#x003b2; using a stalled TASK-1 integration intermediate of 172 residues in length. Importantly, at this nascent chain length, TM1, the first pore loop (P1) and TM2 of TASK-1 should have fully exited the ribosome and hence be capable of engaging the Sec61 complex [<xref ref-type=\"bibr\" rid=\"B34\">34</xref>] (cf. <xref ref-type=\"fig\" rid=\"F1\">Figure 1</xref>A and Supplementary Figure S1). In this case, we combined cross-linking with EndoH digestion to establish whether adducts with Sec61&#x003b2; were formed by nascent chains that had also been N-glycosylated at Asn<sup>53</sup>, and hence whether this region of the polypeptide had reached the ER lumen. In the case of the TASK-1:L35C intermediate, the Sec61&#x003b2; adducts were insensitive to EndoH treatment (<xref ref-type=\"fig\" rid=\"F2\">Figure 2</xref>A, compare lanes 5 and 6) consistent with this probe cross-linking the cytosolic domain of Sec61&#x003b2;, and hence Asn<sup>53</sup> being unable to access the oligosaccharyltransferase. Interestingly, a proportion of nascent TASK-1 chains were N-glycosylated, suggesting that, for these integration intermediates, Asn<sup>53</sup> has access to the ER lumen (<xref ref-type=\"fig\" rid=\"F2\">Figure 2</xref>A, lanes 3 and 4, compare 1g with 0g products). For comparison, the Sec61&#x003b2; adducts formed from a second probe location were analysed using the TASK-1:T103C mutant with a single cysteine residue located just after the P1 loop (cf. <xref ref-type=\"fig\" rid=\"F1\">Figure 1</xref>A and Supplementary Figure S1). In this case, Sec61&#x003b2; adducts are EndoH-sensitive (<xref ref-type=\"fig\" rid=\"F2\">Figure 2</xref>A, compare lanes 11 and 12, see products labelled &#x003b2;0g and &#x003b2;1g), indicating that, for this cohort of cross-linking products, Asn<sup>53</sup> has access to the ER lumen whereas residue 103 can cross-link the cytosolic domain of Sec61&#x003b2;. Taken together, these data suggest that in at least a proportion of TASK-1 integration intermediates, TM1 has not adopted its correct topology even at a stage where P1 and TM2 have probably exited the ribosome and engaged the Sec61 complex (cf. <xref ref-type=\"table\" rid=\"T1\">Table 1</xref>).</p><fig id=\"F2\" position=\"float\"><label>Figure 2</label><caption><title>Analysis of TM1 topology by cross-linking and EndoH treatment</title><p>(<bold>A</bold>) Integration intermediates of 172 residues (158 residues of TASK-1 plus 14-residue V5 tag) containing a single cysteine probe at either residue 35 or 103 were treated with BMH and immunoprecipitated (IP) with anti-V5 (V5) or anti-Sec61&#x003b2; (&#x003b2;) antibodies. Total products or immunoprecipitated material were then treated with EndoH (+) or were mock-treated (&#x02212;). Molecular masses are indicated in kDa. (<bold>B</bold>) Possible conformations of TM1 as deduced from (<bold>A</bold>), showing the native conformation (i) and four alternatives (ii&#x02013;v), together with an indication of predicted N-glycosylation status.</p></caption><graphic xlink:href=\"bj2013-0100i002\"/></fig></sec><sec><title>A greater proportion of TASK-1 achieves the correct topology at longer chain lengths</title><p>Although our studies indicated that TM1 of at least a proportion of nascent TASK-1 chains does not adopt its final topology in a strictly sequential manner, i.e. before or even during TM2 biogenesis, the exact disposition of the N-terminus of these chains could not be clearly delineated by cross-linking alone. To this end, we incorporated an N-terminal tag comprising the first 26 residues of bovine opsin, a region of polypeptide known to be efficiently translocated when appended to either the N- or C-terminus of heterologous TMs [<xref ref-type=\"bibr\" rid=\"B11\">11</xref>,<xref ref-type=\"bibr\" rid=\"B35\">35</xref>], thus creating OPG&#x02013;TASK-1. Crucially, the OPG tag includes two N-glycosylation sites that can be used as a reporter for ER translocation [<xref ref-type=\"bibr\" rid=\"B31\">31</xref>], in this case signalling TASK-1 chains where TM1 assumes an inverted type&#x000a0;I topology (i.e. N-terminus ER-luminal; cf. <xref ref-type=\"fig\" rid=\"F3\">Figure 3</xref>A). Our cross-linking experiments exploited truncated TASK-1 chains encoded by mRNAs lacking a stop codon, and, in order to exclude any effect from the artificial trapping of the C-terminus of the polypeptide as a ribosome-associated peptidyl-tRNA, the N-terminal glycosylation analysis was performed using truncated chains encoded by mRNAs that include a premature stop codon, thereby allowing the authentic termination of translation.</p><fig id=\"F3\" position=\"float\"><label>Figure 3</label><caption><title>Topology analysis of OPG&#x02013;TASK-1 <italic>in&#x000a0;vitro</italic></title><p>(<bold>A</bold>) Predicted orientation of OPG&#x02013;TASK-1 N-terminal region assuming the fragment assumes a native topology where the two N-glycosylation sites of OPG would not be used, but the endogenous Asn<sup>53</sup> site would be modified. (<bold>B</bold>) A 26-residue OPG tag together with residues 2 to 60, 78, 108 or 158 of the TASK-1 coding region as indicated were synthesized in the presence of ER-derived microsomes using mRNAs with a premature stop codon at the relevant location. Resulting products were treated with EndoH (+), or were mock-treated (&#x02212;), with singly (filled circle), doubly (asterisk) and triply (filled diamond) N-glycosylated species indicated. (<bold>C</bold>) The N-glycosylated products shown in (<bold>B</bold>) were quantified by phosphorimaging, and the proportion of total N-glycosylated products that had two-N-linked glycans was used to estimate the percentage of molecules where TM1 had assumed an inverted topology during the membrane integration of each OPG&#x02013;TASK-1 fragment. Results are means&#x000b1;S.E.M. (<italic>n</italic>=3). (<bold>D</bold>) The origin of a triply N-glycosylated TASK-1 species (filled diamond) was determined by comparing the EndoH-sensitive products obtained when OPG&#x02013;TASK-1 E60, and its variant OPG&#x02013;TASK-1 E60<sub>N53Q</sub>, were synthesized in the presence and absence of ER-derived microsomes. (<bold>E</bold>) Ribosome-bound integration intermediates of OPG&#x02013;TASK-1:L35C truncated at Glu<sup>60</sup>, Val<sup>108</sup> or Asn<sup>158</sup> of the TASK-1 coding sequence were subjected to BMH-mediated cross-linking followed by immunoprecipitation (IP) with anti-V5 (V5) or anti-Sec61&#x003b2; (&#x003b2;) antibodies. The resulting material together with a fraction of the total products were treated with EndoH where indicated (+). Adducts between doubly glycosylated TASK-1 chains and Sec61&#x003b2; are indicated (*&#x003b2;). Molecular masses are indicated in kDa in (<bold>B</bold>), (<bold>D</bold>) and (<bold>E</bold>).</p></caption><graphic xlink:href=\"bj2013-0100i003\"/></fig><p>On the basis of nascent chain cross-linking to Sec61&#x003b2; (<xref ref-type=\"fig\" rid=\"F1\">Figure 1</xref> and <xref ref-type=\"table\" rid=\"T1\">Table 1</xref>), we focused our N-glycosylation analysis of OPG&#x02013;TASK-1 on truncations that contain: TM1; TM1 and P1; and TM1, P1 and TM2. It was striking that, in every case, both singly and doubly N-glycosylated OPG&#x02013;TASK-1-derived species were apparent, although their relative abundance appeared to alter with the chain length of the fragment analysed (<xref ref-type=\"fig\" rid=\"F3\">Figure 3</xref>B, lanes 1&#x02013;8, filled circles and asterisks). In the simplest scenario, OPG&#x02013;TASK-1 fragments with two glycans have assumed an inverted orientation with the N-terminus in the ER lumen, whereas those with one N-linked glycan will reflect a combination of polypeptides with the correct type&#x000a0;II topology that have been N-glycosylated on Asn<sup>53</sup> (cf. <xref ref-type=\"fig\" rid=\"F2\">Figure 2</xref>) and those with an inverted topology where only one of the two potential acceptor sites in the OPG tag is used. When the proportion of glycosylated TASK-1 species bearing two N-linked glycans was determined for each fragment analysed, we observed a measurable change with the general trend of less doubly glycosylated species at longer chain lengths (<xref ref-type=\"fig\" rid=\"F3\">Figure 3</xref>C). In fact, following an initial decrease in the proportion of polypeptides with an inverted form of TM1, we then observed an increase with the 183-residue fragment (<xref ref-type=\"fig\" rid=\"F3\">Figure 3</xref>C). This longest fragment incorporates the entire TM2 region of OPG&#x02013;TASK-1, and this effect supports the view that TMs may act in concert during membrane integration [<xref ref-type=\"bibr\" rid=\"B17\">17</xref>&#x02013;<xref ref-type=\"bibr\" rid=\"B19\">19</xref>] (and see the Discussion).</p><p>When analysing the products resulting from the <italic>in&#x000a0;vitro</italic> synthesis of the shortest OPG&#x02013;TASK-1 fragment, the 85-residue-long E60 truncation, we noted an additional EndoH-sensitive product migrating even more slowly than the doubly N-glycosylated species (<xref ref-type=\"fig\" rid=\"F3\">Figure 3</xref>B, lane 2, filled diamonds). We speculated that this was most likely to be a triply N-glycosylated form of the OPG&#x02013;TASK-1-E60 fragment that had been modified at both its N- and C-terminal extensions during membrane insertion (cf. <xref ref-type=\"fig\" rid=\"F3\">Figure 3</xref>A). We confirmed this hypothesis by showing that this species disappeared when the C-terminal N-glycosylation site at Asn<sup>53</sup> was mutated to glutamine (<xref ref-type=\"fig\" rid=\"F3\">Figure 3</xref>D, compare lanes 2 and 4). Quantification showed that this triply glycosylated form of TASK-1 represented ~15&#x000b1;1% of the total N-glycosylated products obtained. Hence at least this fraction of molecules appears to undergo a complete inversion of TM1 at some stage during biogenesis. No evidence for triply N-glycosylated chains was apparent with the longer OPG&#x02013;TASK-1 chains studied (<xref ref-type=\"fig\" rid=\"F3\">Figure 3</xref>B). Taken as a whole, the N-glycosylation profile of these OPG&#x02013;TASK-1 derivatives suggest a model where TM1 can assume at least two quite distinct topologies within the ER membrane, and suggests that the topology of TM1 may be influenced by the synthesis of additional regions of polypeptide to its C-terminus. It should be noted that this approach provides no information regarding the topology of any membrane integrated TASK-1 fragments that are not N-glycosylated (see <xref ref-type=\"fig\" rid=\"F5\">Figure 5</xref>).</p><p>To confirm that the BMH-mediated cross-linking to Sec61&#x003b2; from TASK-1:L35C, where the probe is located C-terminal to TM1, and N-glycosylation of an OPG tag placed N-terminal to TM1 both reflect the same population of nascent chains, OPG&#x02013;TASK-1:L35C was created and its cross-linking to components of the Sec61 translocon was analysed, paying particular attention to whether Sec61&#x003b2; adducts were EndoH-sensitive (<xref ref-type=\"fig\" rid=\"F3\">Figure 3</xref>E). For the three chain lengths analysed, a substantial proportion of the Sec61&#x003b2; adducts are formed with doubly N-glycosylated TASK-1 nascent chains (<xref ref-type=\"fig\" rid=\"F3\">Figure 3</xref>E, compare lanes 5, 6, 11, 12, 17 and 18). Together, these data suggest that a proportion of nascent TASK-1 polypeptides, with chain lengths up to and including 172 residues, are oriented with their N-terminus in the ER lumen and residue 35 at or close to the cytoplasmic side of the ER translocon, and hence able to cross-link Sec61&#x003b2;.</p></sec><sec><title>TM1 of the small potassium channel Kcv displays a mixed topology</title><p>Although previous studies have shown an initial &#x02018;head-first&#x02019;, and hence inverted, insertion of signal-anchor sequences [<xref ref-type=\"bibr\" rid=\"B6\">6</xref>,<xref ref-type=\"bibr\" rid=\"B22\">22</xref>], the suggestion that TM1 of TASK-1 can assume a completely inverted topology was nevertheless unanticipated. To establish whether this process reflected a specialized pathway or a more general feature of membrane protein biogenesis, we analysed an even simpler potassium channel subunit with only two TMs separated by a putative pore loop, the viral Kcv protein [<xref ref-type=\"bibr\" rid=\"B28\">28</xref>] (<xref ref-type=\"fig\" rid=\"F4\">Figure 4</xref>A, and Supplementary Figure S3 at <ext-link ext-link-type=\"uri\" xlink:href=\"http://www.biochemj.org/bj/456/bj4560297add.htm\">http://www.biochemj.org/bj/456/bj4560297add.htm</ext-link>). Preliminary studies revealed that a number of BMH-dependent adducts could be detected using a ribosome-bound integration intermediate of Kcv that contained a single cysteine probe, but not with the equivalent Cys-null version of Kcv (Supplementary Figure S4 at <ext-link ext-link-type=\"uri\" xlink:href=\"http://www.biochemj.org/bj/456/bj4560297add.htm\">http://www.biochemj.org/bj/456/bj4560297add.htm</ext-link>). This 89-amino-acid-long integration intermediate, denoted Kcv:N37C, lacks TM2, and consists of the first 75 residues of the coding region followed by a V5 epitope tag (cf. <xref ref-type=\"fig\" rid=\"F4\">Figure 4</xref>A). When these BMH-dependent adducts were analysed further by immunoprecipitation using antibodies recognizing well-defined components of the ER translocon, Sec61&#x003b1; and Sec61&#x003b2; were found to be two of the most prominent cross-linking partners that could be identified (<xref ref-type=\"fig\" rid=\"F4\">Figure 4</xref>B, lanes 9 and 10, and Supplementary Figure S4). Although this is consistent with the insertion of the Kcv monomer via an ER translocon-mediated process, the cross-linking of this nascent chain to Sec61&#x003b2; is especially relevant, since if TM1 attains its native topology, Asn<sup>37</sup> would be on the ER-luminal side of the membrane and hence incapable of forming such a product when replaced with a cysteine residue [<xref ref-type=\"bibr\" rid=\"B13\">13</xref>] (cf. <xref ref-type=\"fig\" rid=\"F4\">Figure 4</xref>A).</p><fig id=\"F4\" position=\"float\"><label>Figure 4</label><caption><title>Cross-linking and topology analysis of Kcv</title><p>(<bold>A</bold>) Schematic representation of Kcv indicating the N37C probe, the engineered N-glycosylation site K47N and the last amino acid of the Kcv coding region (Gly<sup>75</sup>) present in the 89-residue-long V5-tagged integration intermediate used for cross-linking. (<bold>B</bold>) Integration intermediates of Kcv:N37C truncated at Gly<sup>75</sup> and with a V5 tag appended were treated with solvent only (DMSO) or BMH as indicated, and products were recovered by immunoprecipitation using antibodies recognizing the V5 tag (V5), Sec61&#x003b1; (&#x003b1;), Sec61&#x003b2; (&#x003b2;), Sec61&#x003b3; (&#x003b3;), TRAM (T), RAMP4 (ribosome-associated membrane protein 4) (R4) or FLAG as a non-related control (NR). Rabbit anti-Sec61&#x003b3; and anti-RAMP4 antibodies are as described previously [<xref ref-type=\"bibr\" rid=\"B40\">40</xref>,<xref ref-type=\"bibr\" rid=\"B41\">41</xref>]. Adducts are labelled as described in the legend for <xref ref-type=\"fig\" rid=\"F1\">Figure 1</xref>, except that T indicates an adduct with TRAM. (<bold>C</bold> and <bold>D</bold>) Schematic diagrams of the OPG&#x02013;Kcv and Kcv:K47N derivatives respectively, used to study membrane topology. (<bold>E</bold>) OPG&#x02013;Kcv or Kcv:K47N was synthesized as a 75-residue N-terminal fragment created by introducing an artificial stop codon (1&#x02013;75), or the full-length protein (FL), reaction mixtures were incubated with puromycin, and the resulting products treated with EndoH (+) or left untreated (&#x02212;). Doubly (white asterisk) and singly (filled white circle) N-glycosylated polypeptides are indicated. The filled white diamond indicates SDS-resistant Kcv-derived complexes that are most likely to be tetramers [<xref ref-type=\"bibr\" rid=\"B29\">29</xref>]. Whereas the samples shown in (<bold>E</bold>) were all resolved on the same gel, intervening lanes have been removed between lanes 4 and 5 of the final image. Molecular masses are indicated in (<bold>B</bold>) and (<bold>E</bold>).</p></caption><graphic xlink:href=\"bj2013-0100i004\"/></fig><p>The strength of the Sec61&#x003b2; adduct obtained with the Kcv integration intermediate suggested that a substantial proportion of these nascent chains may have an &#x02018;inverted&#x02019; topology, and therefore we used N-glycosylation reporters to further explore Kcv biogenesis (cf. <xref ref-type=\"fig\" rid=\"F3\">Figure 3</xref>A). To this end, OPG&#x02013;Kcv, an N-terminally tagged Kcv derivative, and Kcv:K47N, a variant with a single novel site for N-glycosylation in the loop region joining TM1 and TM2, were created (see <xref ref-type=\"fig\" rid=\"F4\">Figures 4</xref>C and <xref ref-type=\"fig\" rid=\"F4\">4</xref>D respectively). OPG&#x02013;Kcv was synthesized in the presence of ER-derived microsomes, either in its full-length form or as a truncated chain that lacked TM2, in both cases using an mRNA containing a stop codon to terminate translation (cf. <xref ref-type=\"fig\" rid=\"F3\">Figure 3</xref>B). For each of these OPG&#x02013;Kcv polypeptides, both singly and, especially, doubly N-glycosylated species were observed at a level comparable with the non-glycosylated Kcv chains observed (<xref ref-type=\"fig\" rid=\"F4\">Figure 4</xref>E, compare lanes 1&#x02013;4). This pattern of N-glycosylation is consistent with a substantial proportion of nascent Kcv chains assuming an inverted topology at the ER translocon and maintaining this topology upon termination of translation. With full-length OPG&#x02013;Kcv, some of the protein forms an SDS-resistant complex, probably a tetramer [<xref ref-type=\"bibr\" rid=\"B29\">29</xref>]. However, even this complex is sensitive to EndoH, suggesting that N-glycosylation of the OPG tag and an inverted TM1 topology does not preclude subunit assembly/oligomerization.</p><p>To establish whether any Kcv chains adopted a transmembrane orientation where TM1 assumed the expected type&#x000a0;II topology, equivalent forms of Kcv:K47N were analysed, and a substantial proportion of chains were also N-glycosylated at this single site (<xref ref-type=\"fig\" rid=\"F4\">Figures 4</xref>D and <xref ref-type=\"fig\" rid=\"F4\">4</xref>E, lanes 5&#x02013;8). These data suggest that two populations of Kcv chains exist having either the N- or the C-terminal end of TM1 located in the ER lumen (cf. <xref ref-type=\"fig\" rid=\"F4\">Figure 4</xref>A). Although Kcv:K47N is effectively N-glycosylated, the modified form of the full-length protein appears to be refractive to the formation of SDS-resistant tetramers when compared with the OPG&#x02013;Kcv mutant (<xref ref-type=\"fig\" rid=\"F4\">Figure 4</xref>E, compare lanes 3, 4, 7 and 8). Alternatively, the bulk of these SDS-resistant oligomers maybe made up of Kcv channels where TM1 spans the membrane with an &#x02018;inverted&#x02019; topology, in which case the lack of N-linked glycans is consistent with the levels of N-glycosylated tetramer observed with full-length OPG-Kcv (cf. <xref ref-type=\"fig\" rid=\"F4\">Figure 4</xref>E, lanes 4 and 8).</p></sec><sec><title>TM1 of TASK-1 assumes mixed topologies when expressed in cultured mammalian cells</title><p>Our <italic>in&#x000a0;vitro</italic> data suggested that TASK-1-TM1 had an increased tendency to assume an incorrect transmembrane topology when short fragments of the polypeptide were synthesized, whereas the native topology of TM1 was generally favoured as longer fragments of the protein were made (<xref ref-type=\"fig\" rid=\"F3\">Figures 3</xref>B and <xref ref-type=\"fig\" rid=\"F3\">3</xref>C). To establish whether this inverted topology was simply a consequence of the <italic>in&#x000a0;vitro</italic> system we had exploited, we investigated whether TASK-1 chains can assume a non-native topology when expressed in cultured mammalian cells. When full-length or truncated forms of OPG&#x02013;TASK-1:N53Q were expressed in HeLaM cells, an ER-localized pool was observed in each case, consistent with their efficient targeting and membrane integration (Supplementary Figure S5 at <ext-link ext-link-type=\"uri\" xlink:href=\"http://www.biochemj.org/bj/456/bj4560297add.htm\">http://www.biochemj.org/bj/456/bj4560297add.htm</ext-link>). We found detectable levels of N-glycosylated TASK-1 polypeptides modified on their N-terminal OPG tags, using fragments incorporating TM1 alone, and TM1-P1-TM2, but not with the full-length protein (<xref ref-type=\"fig\" rid=\"F5\">Figure 5</xref>A, compare lanes 2&#x02013;7). As for OPG&#x02013;Kcv (cf. <xref ref-type=\"fig\" rid=\"F4\">Figure 4</xref>D), the proportion of singly glycosylated OPG&#x02013;TASK-1:N53Q at the shortest chain length analysed appeared higher than that typically observed with the OPG tag [<xref ref-type=\"bibr\" rid=\"B11\">11</xref>]. Nevertheless, since the only potential N-glycosylation sites present in these chains are N-terminal to TASK-1-TM1, both the singly and doubly glycosylated species reflect an inverted topology. Using the proportion of N-glycosylated precursors to quantify the percentage of truncated polypeptides with an inverted topology, we estimate that up to one-third of the proteins detectable at steady state are mis-inserted (<xref ref-type=\"fig\" rid=\"F5\">Figure 5</xref>A,% inverted topology).</p><fig id=\"F5\" position=\"float\"><label>Figure 5</label><caption><title>Topology analysis of OPG&#x02013;TASK-1&#x000a0;in cultured mammalian cells</title><p>(<bold>A</bold>) Full-length OPG-tagged TASK-1:N53Q, or N-terminal fragments thereof, were transiently transfected into HeLaM cells and products were analysed before (&#x02212;) and after (+) treatment with EndoH. Untransfected cells (UTF) were included as a control. The percentage of inverted TASK-1 was determined by quantitative Western blotting of glycosylated and non-glycosylated products. (<bold>B</bold>) Opsin-tagged fragments or full-length (FL) TASK-1 containing the endogenous glycosylation site at Asn<sup>53</sup> were analysed as described for (<bold>A</bold>). Both high and low exposures are shown to accommodate low steady-state levels of the smallest OPG&#x02013;TASK-1-derived fragment (TM1). Open circles indicate non-glycosylated material, closed circles indicate singly glycosylated TASK-1 species, and asterisks indicate doubly glycosylated TASK-1 species. The samples shown in (<bold>B</bold>) were resolved on the same gel, but intervening lanes between lanes 3 and 4 have been removed from the final image. Molecular masses are indicated in kDa.</p></caption><graphic xlink:href=\"bj2013-0100i005\"/></fig><p>When equivalent fragments of OPG&#x02013;TASK-1 that maintain Asn<sup>53</sup> were expressed, higher levels of the singly N-glycosylated proteins were observed for the truncated fragments, consistent with a substantial proportion of these chains having the expected type&#x000a0;II transmembrane topology (<xref ref-type=\"fig\" rid=\"F5\">Figures 5</xref>B, lanes 3 and 5, filled circles). For full-length OPG&#x02013;TASK-1, the bulk of the protein is N-glycosylated (<xref ref-type=\"fig\" rid=\"F5\">Figure 5</xref>B, low exposure, lanes 6 and 7), in contrast with OPG&#x02013;TASK-1:N53Q where no modification of the full-length precursor was detectable (cf. <xref ref-type=\"fig\" rid=\"F5\">Figure 5</xref>A, lanes 6 and 7). On this basis, most of the full-length TASK-1 detectable at steady state has TM1 oriented with a native topology. In summary, even under circumstances where aberrant and misfolded precursors are potential targets for ER-associated degradation, we observe patterns of N-glycosylation that strongly support a model where TM1 can assume an inverted topology during TASK-1 biogenesis at the ER, and we conclude that this phenomenon is physiologically relevant to <italic>bona fide</italic> membrane protein synthesis <italic>in&#x000a0;vivo</italic>.</p></sec></sec><sec sec-type=\"discussion\"><title>DISCUSSION</title><p>We have used <italic>in&#x000a0;vitro</italic> translation, cross-linking and N-glycosylation to investigate the biogenesis of two distinct potassium channels at the ER membrane. Our key findings are: (i) the TMs of TASK-1 remain in close proximity to the Sec61 complex for a substantial period during its biogenesis, consistent with their co-ordinated assembly; (ii) TM1 of TASK-1 and Kcv can assume an inverted topology in a cohort of nascent chains during protein biogenesis at the ER; and (iii) the Sec61 translocon can accommodate at least two distinct transmembrane orientations of TASK-TM1 and Kcv-TM1. Taken together, our data are consistent with a model where the first TMs of nascent TASK-1 and Kcv chains do not adopt a stable transmembrane topology immediately upon engaging the ER translocon, but are retained in a Sec61-dependent environment that enables their subsequent reorientation in order to achieve a native topology.</p><p>Our data strongly support previous studies [<xref ref-type=\"bibr\" rid=\"B6\">6</xref>,<xref ref-type=\"bibr\" rid=\"B22\">22</xref>], both of which provide compelling evidence for a pathway involving the &#x02018;head-first&#x02019; insertion of model signal-anchor sequences followed by their subsequent inversion to achieve their native type&#x000a0;II topology (N-terminus cytosolic). Our work underlines the generality of a &#x02018;head-first&#x02019; membrane insertion pathway at the ER, and shows it operates both <italic>in&#x000a0;vitro</italic> and in cultured mammalian cells. Studies with a synthetic signal-anchor found both its intrinsic hydrophobicity and the &#x02018;positive-inside rule&#x02019; influence its rate of inversion [<xref ref-type=\"bibr\" rid=\"B22\">22</xref>], and there is compelling evidence that signal-anchor reorientation is carefully orchestrated event that occurs within an environment created by both the ribosome and the ER translocon [<xref ref-type=\"bibr\" rid=\"B6\">6</xref>].</p><p>Our cross-linking studies suggest that, for nascent chains of both TASK-1 and Kcv, their TM1 remains associated with the Sec61 complex for a comparatively extensive period of biogenesis, a conclusion that is supported by a delay in TM exit from the ER translocon that was recently observed using an elegant FRET-based approach [<xref ref-type=\"bibr\" rid=\"B14\">14</xref>]. Furthermore, for TASK-1, we confirmed TM1 cross-linking to Sec61&#x003b2; from two different conformations/orientations of nascent chain, whereas nascent Kcv chains displayed unusually strong adducts with Sec61&#x003b2;, indicating that a substantial proportion of integration intermediates adopt an inverted topology. N-glycosylation reporters confirmed mixed topologies for both TASK-1 fragments and full-length Kcv. In the case of the shortest TASK-1 fragment studied, we could even detect a fraction of molecules that were triply N-glycosylated. This strongly suggests that at least a subset of TASK-1 chains can assume both a type&#x000a0;I and type&#x000a0;II transmembrane orientation during their integration into the ER membrane. Overall, the <italic>in&#x000a0;vitro</italic> synthesis of longer TASK-1 fragments typically favoured a native type&#x000a0;II topology of TM1 at the expense of the inverted form (cf. <xref ref-type=\"fig\" rid=\"F6\">Figure 6</xref>). Importantly, this effect did not rely on the use of ribosome-tethered precursors that might favour N-terminal translocation (the present study, and [<xref ref-type=\"bibr\" rid=\"B6\">6</xref>]), and was also observed following the <italic>in&#x000a0;vivo</italic> expression of TASK-1 derivatives in mammalian cells.</p><fig id=\"F6\" position=\"float\"><label>Figure 6</label><caption><title>Membrane integration of TASK-1-TM1 at the ER translocon</title><p>When the ribosome-bound nascent TASK-1 chain is comparatively short (exemplified here by E60), a substantial proportion of the first transmembrane domain (labelled 1) is detected with an inverted topology, consistent with these integration intermediates providing a flexible environment that is compatible with both mixed topologies and/or TM reorientation (thick double-headed arrow). On the basis of our cross-linking studies, we conclude that this environment is provided at least in part by the Sec61 translocon (dark grey box). Recent work suggests that the ribosome (not shown for simplicity) is also likely to make an important contribution [<xref ref-type=\"bibr\" rid=\"B6\">6</xref>]. As more of the nascent TASK-1 chain is synthesized (cf. V108&#x02013;S392), an increasing proportion of TM1 is found to adopt a native transmembrane topology.</p></caption><graphic xlink:href=\"bj2013-0100i006\"/></fig><p>What is the significance of the increasing fidelity of TM1 topology as more of the TASK-1 polypeptide is synthesized? We favour a model where TM1 of the nascent TASK-1 chain transiently resides in a Sec61-enabled dynamic equilibrium such that the synthesis of additional polypeptide promotes the acquisition of its native orientation (<xref ref-type=\"fig\" rid=\"F6\">Figure 6</xref>). In this scenario, there is a short window of opportunity during which a signal sequence can reorient within the ER translocon [<xref ref-type=\"bibr\" rid=\"B21\">21</xref>], a process that requires an appropriately assembled ribosome/translocon complex [<xref ref-type=\"bibr\" rid=\"B6\">6</xref>]. The introduction of artificial stop codons, as used in the present study, will result in the premature release of N-terminal fragments of TASK-1 from both the ribosome and the translocon, presumably resulting in a cohort of precursors where TM1 is locked in an inverted topology. Furthermore, the addition of N-linked glycans can inhibit reorientation within the ER [<xref ref-type=\"bibr\" rid=\"B21\">21</xref>], and hence the doubly N-glycosylated OPG tag we used as a reporter for exposure to the ER lumen may have acted as a &#x02018;kinetic trap&#x02019; that stabilizes otherwise transient or reversible topological intermediates (cf. [<xref ref-type=\"bibr\" rid=\"B21\">21</xref>]). Although the cell-free system employed in the present study generates Kcv subunits that form functional potassium channels [<xref ref-type=\"bibr\" rid=\"B29\">29</xref>], we find that a substantial proportion of full-length OPG&#x02013;Kcv assumes an inverted topology. Even if modification of the OPG tag accentuates this effect, our findings raise the intriguing possibility that Kcv subunits may normally acquire two different topologies, as established previously for both Ductin [<xref ref-type=\"bibr\" rid=\"B36\">36</xref>] and the Newcastle disease virus fusion protein [<xref ref-type=\"bibr\" rid=\"B37\">37</xref>].</p><p>A &#x02018;prolonged&#x02019; association between individual signal-anchor sequences present in polytopic membrane proteins and the Sec61 complex is often assumed to reflect a role for the ER translocon in co-ordinating the assembly of TMs into pairs and/or bundles that facilitate membrane integration [<xref ref-type=\"bibr\" rid=\"B10\">10</xref>&#x02013;<xref ref-type=\"bibr\" rid=\"B13\">13</xref>]. Given the complexity underlying the acquisition of a native topology by multiple different type&#x000a0;II signal anchors (the present study, and [<xref ref-type=\"bibr\" rid=\"B6\">6</xref>,<xref ref-type=\"bibr\" rid=\"B21\">21</xref>]), it seems likely that ribosome/translocon-mediated folding events and TM inversion (cf. [<xref ref-type=\"bibr\" rid=\"B6\">6</xref>]) also contribute to these perceived &#x02018;delays&#x02019; in the lateral exit of such TMs from the Sec61 complex. In addition to simply tethering the nascent chain in an environment where TM1 reorientation is facilitated, in the case of TASK-1 and Kcv, ongoing protein synthesis may also provide additional topological information, for example other TMs that might influence the fate of TM1 (see also [<xref ref-type=\"bibr\" rid=\"B14\">14</xref>]). Hence, in prokaryotes, the topology acquired by TM1 can be determined by later, more C-terminal, TMs [<xref ref-type=\"bibr\" rid=\"B38\">38</xref>] and in one case even a single C-terminal residue can control the membrane topology of an entire polytopic protein [<xref ref-type=\"bibr\" rid=\"B39\">39</xref>]. In summary, the once widely held view that the TMs of a polytopic protein are &#x02018;stitched&#x02019; into the ER membrane one by one as they leave the ribosome and enter the ER translocon (cf. [<xref ref-type=\"bibr\" rid=\"B17\">17</xref>]), is giving way to compelling evidence that this event is often a much more complex and co-ordinated process [<xref ref-type=\"bibr\" rid=\"B3\">3</xref>,<xref ref-type=\"bibr\" rid=\"B6\">6</xref>,<xref ref-type=\"bibr\" rid=\"B14\">14</xref>,<xref ref-type=\"bibr\" rid=\"B18\">18</xref>,<xref ref-type=\"bibr\" rid=\"B23\">23</xref>].</p></sec><sec sec-type=\"supplementary-material\"><title>Online data</title><supplementary-material id=\"SD1\" content-type=\"local-data\" position=\"float\" xlink:type=\"simple\"><caption><title>Supplementary data</title></caption><media mimetype=\"application\" mime-subtype=\"pdf\" xlink:href=\"bj4560297add.pdf\" position=\"float\" xlink:type=\"simple\"/></supplementary-material></sec></body><back><ack><title>ACKNOWLEDGEMENTS</title><p>We thank Professor Mike Blatt (University of Glasgow, Glasgow, U.K.) for bringing the Kcv channel protein to our attention, and colleagues who provided antibodies against ER translocon components.</p></ack><sec><title>AUTHOR CONTRIBUTION</title><p>Stephen High and Jim Warwicker developed the original concept. Helen Watson, Lydia Wunderley, Tereza Andreou, Jim Warwicker and Stephen High conceived and designed the experiments. Helen Watson, Lydia Wunderley and Tereza Andreou performed the experiments. Helen Watson, Lydia Wunderley, Tereza Andreou and Stephen High analysed the data. Helen Watson, Lydia Wunderley and Stephen High wrote the paper. Tereza Andreou and Jim Warwicker proofread drafts of the paper before submission.</p></sec><sec><title>FUNDING</title><p>This work was supported by <funding-source id=\"gs1\">project grant funding</funding-source> [grant number <award-id rid=\"gs1\">088163/Z/09/Z</award-id>] and a Ph.D. studentship [grant number <award-id rid=\"gs1\">093176/Z/10/A</award-id>] from the <funding-source id=\"gs2\">Wellcome Trust</funding-source>.</p></sec><ref-list><ref id=\"B1\"><label>1</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Cross</surname><given-names>B. C. S.</given-names></name><name><surname>Sinning</surname><given-names>I.</given-names></name><name><surname>Luirink</surname><given-names>J.</given-names></name><name><surname>High</surname><given-names>S.</given-names></name></person-group><article-title>Delivering proteins for export from the cytosol</article-title><source>Nat. Rev. Mol. Cell Biol.</source><year>2009</year><volume>10</volume><fpage>255</fpage><lpage>264</lpage><pub-id pub-id-type=\"pmid\">19305415</pub-id></element-citation></ref><ref id=\"B2\"><label>2</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Zimmermann</surname><given-names>R.</given-names></name><name><surname>Eyrisch</surname><given-names>S.</given-names></name><name><surname>Ahmad</surname><given-names>M.</given-names></name><name><surname>Helms</surname><given-names>V.</given-names></name></person-group><article-title>Protein translocation across the ER membrane</article-title><source>Biochim. Biophys. Acta</source><year>2011</year><volume>1808</volume><fpage>912</fpage><lpage>924</lpage><pub-id pub-id-type=\"pmid\">20599535</pub-id></element-citation></ref><ref id=\"B3\"><label>3</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Mart&#x000ed;nez-Gil</surname><given-names>L.</given-names></name><name><surname>Saur&#x000ed;</surname><given-names>A.</given-names></name><name><surname>Marti-Renom</surname><given-names>M. A.</given-names></name><name><surname>Mingarro</surname><given-names>I.</given-names></name></person-group><article-title>Membrane protein integration into the endoplasmic reticulum</article-title><source>FEBS J.</source><year>2011</year><volume>278</volume><fpage>3846</fpage><lpage>3858</lpage><pub-id pub-id-type=\"pmid\">21592307</pub-id></element-citation></ref><ref id=\"B4\"><label>4</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Hessa</surname><given-names>T.</given-names></name><name><surname>Kim</surname><given-names>H.</given-names></name><name><surname>Bihlmaier</surname><given-names>K.</given-names></name><name><surname>Lundin</surname><given-names>C.</given-names></name><name><surname>Boekel</surname><given-names>J.</given-names></name><name><surname>Andersson</surname><given-names>H.</given-names></name><name><surname>Nilsson</surname><given-names>I.</given-names></name><name><surname>White</surname><given-names>S. H.</given-names></name><name><surname>von Heijne</surname><given-names>G.</given-names></name></person-group><article-title>Recognition of transmembrane helices by the endoplasmic reticulum translocon</article-title><source>Nature</source><year>2005</year><volume>433</volume><fpage>377</fpage><lpage>381</lpage><pub-id pub-id-type=\"pmid\">15674282</pub-id></element-citation></ref><ref id=\"B5\"><label>5</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Hessa</surname><given-names>T.</given-names></name><name><surname>Meindl-Beinker</surname><given-names>N. M.</given-names></name><name><surname>Bernsel</surname><given-names>A.</given-names></name><name><surname>Kim</surname><given-names>H.</given-names></name><name><surname>Sato</surname><given-names>Y.</given-names></name><name><surname>Lerch-Bader</surname><given-names>M.</given-names></name><name><surname>Nilsson</surname><given-names>I.</given-names></name><name><surname>White</surname><given-names>S. H.</given-names></name><name><surname>von Heijne</surname><given-names>G.</given-names></name></person-group><article-title>Molecular code for transmembrane-helix recognition by the Sec61 translocon</article-title><source>Nature</source><year>2007</year><volume>450</volume><fpage>1026</fpage><lpage>1030</lpage><pub-id pub-id-type=\"pmid\">18075582</pub-id></element-citation></ref><ref id=\"B6\"><label>6</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Devaraneni</surname><given-names>P. K.</given-names></name><name><surname>Conti</surname><given-names>B.</given-names></name><name><surname>Matsumura</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>Z.</given-names></name><name><surname>Johnson</surname><given-names>A. E.</given-names></name><name><surname>Skach</surname><given-names>W. R.</given-names></name></person-group><article-title>Stepwise insertion and inversion of a type&#x000a0;II signal anchor sequence in the ribosome&#x02013;Sec61 translocon complex</article-title><source>Cell</source><year>2011</year><volume>146</volume><fpage>134</fpage><lpage>147</lpage><pub-id pub-id-type=\"pmid\">21729785</pub-id></element-citation></ref><ref id=\"B7\"><label>7</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Hegde</surname><given-names>R. S.</given-names></name><name><surname>Kang</surname><given-names>S. W.</given-names></name></person-group><article-title>The concept of translocational regulation</article-title><source>J. Cell Biol.</source><year>2008</year><volume>182</volume><fpage>225</fpage><lpage>232</lpage><pub-id pub-id-type=\"pmid\">18644895</pub-id></element-citation></ref><ref id=\"B8\"><label>8</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Sauri</surname><given-names>A.</given-names></name><name><surname>McCormick</surname><given-names>P. J.</given-names></name><name><surname>Johnson</surname><given-names>A. E.</given-names></name><name><surname>Mingarro</surname><given-names>I.</given-names></name></person-group><article-title>Sec61&#x003b1; and TRAM are sequentially adjacent to a nascent viral membrane protein during its ER integration</article-title><source>J. Mol. Biol.</source><year>2007</year><volume>366</volume><fpage>366</fpage><lpage>374</lpage><pub-id pub-id-type=\"pmid\">17169373</pub-id></element-citation></ref><ref id=\"B9\"><label>9</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Sauri</surname><given-names>A.</given-names></name><name><surname>Saksena</surname><given-names>S.</given-names></name><name><surname>Salgado</surname><given-names>J.</given-names></name><name><surname>Johnson</surname><given-names>A. E.</given-names></name><name><surname>Mingarro</surname><given-names>I.</given-names></name></person-group><article-title>Double-spanning plant viral movement protein integration into the ER membrane is SRP-dependent, translocon-mediated, and concerted</article-title><source>J. Biol. Chem.</source><year>2005</year><volume>280</volume><fpage>25907</fpage><lpage>25912</lpage><pub-id pub-id-type=\"pmid\">15888454</pub-id></element-citation></ref><ref id=\"B10\"><label>10</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Ismail</surname><given-names>N.</given-names></name><name><surname>Crawshaw</surname><given-names>S. G.</given-names></name><name><surname>High</surname><given-names>S.</given-names></name></person-group><article-title>Active and passive displacement of transmembrane domains both occur during opsin biogenesis at the Sec61 translocon</article-title><source>J. Cell. Sci.</source><year>2006</year><volume>119</volume><fpage>2826</fpage><lpage>2836</lpage><pub-id pub-id-type=\"pmid\">16787949</pub-id></element-citation></ref><ref id=\"B11\"><label>11</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Ismail</surname><given-names>N.</given-names></name><name><surname>Crawshaw</surname><given-names>S. G.</given-names></name><name><surname>Cross</surname><given-names>B. C. S.</given-names></name><name><surname>Haagsma</surname><given-names>A. C.</given-names></name><name><surname>High</surname><given-names>S.</given-names></name></person-group><article-title>Specific transmembrane segments are selectively delayed at the ER translocon during opsin biogenesis</article-title><source>Biochem. J.</source><year>2008</year><volume>411</volume><fpage>495</fpage><lpage>506</lpage><pub-id pub-id-type=\"pmid\">18248332</pub-id></element-citation></ref><ref id=\"B12\"><label>12</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Sadlish</surname><given-names>H.</given-names></name><name><surname>Pitonzo</surname><given-names>D.</given-names></name><name><surname>Johnson</surname><given-names>A. E.</given-names></name><name><surname>Skach</surname><given-names>W. R.</given-names></name></person-group><article-title>Sequential triage of transmembrane segments by Sec61&#x003b1; during biogenesis of a native multispanning membrane protein</article-title><source>Nat. Struct. Mol. Biol.</source><year>2005</year><volume>12</volume><fpage>870</fpage><lpage>878</lpage><pub-id pub-id-type=\"pmid\">16186821</pub-id></element-citation></ref><ref id=\"B13\"><label>13</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Cross</surname><given-names>B. C. S.</given-names></name><name><surname>High</surname><given-names>S.</given-names></name></person-group><article-title>Dissecting the physiological role of selective transmembrane-segment retention at the ER translocon</article-title><source>J. Cell. Sci.</source><year>2009</year><volume>122</volume><fpage>1768</fpage><lpage>1777</lpage><pub-id pub-id-type=\"pmid\">19417003</pub-id></element-citation></ref><ref id=\"B14\"><label>14</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Hou</surname><given-names>B.</given-names></name><name><surname>Lin</surname><given-names>P.-J.</given-names></name><name><surname>Johnson</surname><given-names>A. E.</given-names></name></person-group><article-title>Membrane protein TM segments are retained at the translocon during integration until the nascent chain cues FRET-detected release into bulk lipid</article-title><source>Mol. Cell</source><year>2012</year><volume>48</volume><fpage>398</fpage><lpage>408</lpage><pub-id pub-id-type=\"pmid\">23022384</pub-id></element-citation></ref><ref id=\"B15\"><label>15</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Popot</surname><given-names>J.-L.</given-names></name><name><surname>Engelman</surname><given-names>D. M.</given-names></name></person-group><article-title>Helical membrane protein folding, stability, and evolution</article-title><source>Annu. Rev. Biochem.</source><year>2000</year><volume>69</volume><fpage>881</fpage><lpage>922</lpage><pub-id pub-id-type=\"pmid\">10966478</pub-id></element-citation></ref><ref id=\"B16\"><label>16</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Booth</surname><given-names>P. J.</given-names></name><name><surname>High</surname><given-names>S.</given-names></name></person-group><article-title>Polytopic membrane protein folding and assembly <italic>in&#x000a0;vitro</italic> and <italic>in&#x000a0;vivo</italic></article-title><source>Mol. Membr. Biol.</source><year>2004</year><volume>21</volume><fpage>163</fpage><lpage>170</lpage><pub-id pub-id-type=\"pmid\">15204624</pub-id></element-citation></ref><ref id=\"B17\"><label>17</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>High</surname><given-names>S.</given-names></name><name><surname>Laird</surname><given-names>V.</given-names></name></person-group><article-title>Membrane protein biosynthesis: all sewn up?</article-title><source>Trends Cell Biol.</source><year>1997</year><volume>7</volume><fpage>206</fpage><lpage>210</lpage><pub-id pub-id-type=\"pmid\">17708946</pub-id></element-citation></ref><ref id=\"B18\"><label>18</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Skach</surname><given-names>W. R.</given-names></name></person-group><article-title>Cellular mechanisms of membrane protein folding</article-title><source>Nat. Struct. Mol. Biol.</source><year>2009</year><volume>16</volume><fpage>606</fpage><lpage>612</lpage><pub-id pub-id-type=\"pmid\">19491932</pub-id></element-citation></ref><ref id=\"B19\"><label>19</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Mart&#x000ed;nez-Gil</surname><given-names>L.</given-names></name><name><surname>Ba&#x000f1;&#x000f3;-Polo</surname><given-names>M.</given-names></name><name><surname>Redondo</surname><given-names>N.</given-names></name><name><surname>S&#x000e1;nchez-Mart&#x000ed;nez</surname><given-names>S.</given-names></name><name><surname>Nieva</surname><given-names>J. L.</given-names></name><name><surname>Carrasco</surname><given-names>L.</given-names></name><name><surname>Mingarro</surname><given-names>I.</given-names></name></person-group><article-title>Membrane integration of poliovirus 2B viroporin</article-title><source>J. Virol.</source><year>2011</year><volume>85</volume><fpage>11315</fpage><lpage>11324</lpage><pub-id pub-id-type=\"pmid\">21835803</pub-id></element-citation></ref><ref id=\"B20\"><label>20</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Blobel</surname><given-names>G.</given-names></name></person-group><article-title>Intracellular protein topogenesis</article-title><source>Proc. Natl. Acad. Sci. U.S.A.</source><year>1980</year><volume>77</volume><fpage>1496</fpage><lpage>1500</lpage><pub-id pub-id-type=\"pmid\">6929499</pub-id></element-citation></ref><ref id=\"B21\"><label>21</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Goder</surname><given-names>V.</given-names></name><name><surname>Bieri</surname><given-names>C.</given-names></name><name><surname>Spiess</surname><given-names>M.</given-names></name></person-group><article-title>Glycosylation can influence topogenesis of membrane proteins and reveals dynamic reorientation of nascent polypeptides within the translocon</article-title><source>J. Cell Biol.</source><year>1999</year><volume>147</volume><fpage>257</fpage><lpage>266</lpage><pub-id pub-id-type=\"pmid\">10525533</pub-id></element-citation></ref><ref id=\"B22\"><label>22</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Goder</surname><given-names>V.</given-names></name><name><surname>Spiess</surname><given-names>M.</given-names></name></person-group><article-title>Molecular mechanism of signal sequence orientation in the endoplasmic reticulum</article-title><source>EMBO J.</source><year>2003</year><volume>22</volume><fpage>3645</fpage><lpage>3653</lpage><pub-id pub-id-type=\"pmid\">12853479</pub-id></element-citation></ref><ref id=\"B23\"><label>23</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Ojemalm</surname><given-names>K.</given-names></name><name><surname>Halling</surname><given-names>K. K.</given-names></name><name><surname>Nilsson</surname><given-names>I.</given-names></name><name><surname>von Heijne</surname><given-names>G.</given-names></name></person-group><article-title>Orientational preferences of neighboring helices can drive ER insertion of a marginally hydrophobic transmembrane helix</article-title><source>Mol. Cell</source><year>2012</year><volume>45</volume><fpage>529</fpage><lpage>540</lpage><pub-id pub-id-type=\"pmid\">22281052</pub-id></element-citation></ref><ref id=\"B24\"><label>24</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Ojemalm</surname><given-names>K.</given-names></name><name><surname>Watson</surname><given-names>H. R.</given-names></name><name><surname>Roboti</surname><given-names>P.</given-names></name><name><surname>Cross</surname><given-names>B. C. S.</given-names></name><name><surname>Warwicker</surname><given-names>J.</given-names></name><name><surname>von Heijne</surname><given-names>G.</given-names></name><name><surname>High</surname><given-names>S.</given-names></name></person-group><article-title>Positional editing of transmembrane domains during ion channel assembly</article-title><source>J. Cell Sci.</source><year>2012</year><volume>126</volume><fpage>464</fpage><lpage>472</lpage><pub-id pub-id-type=\"pmid\">23230148</pub-id></element-citation></ref><ref id=\"B25\"><label>25</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Buckingham</surname><given-names>S. D.</given-names></name><name><surname>Kidd</surname><given-names>J. F.</given-names></name><name><surname>Law</surname><given-names>R. J.</given-names></name><name><surname>Franks</surname><given-names>C. J.</given-names></name><name><surname>Sattelle</surname><given-names>D. B.</given-names></name></person-group><article-title>Structure and function of two-pore-domain K<sup>+</sup> channels: contributions from genetic model organisms</article-title><source>Trends Pharm. Sci.</source><year>2005</year><volume>26</volume><fpage>361</fpage><lpage>367</lpage><pub-id pub-id-type=\"pmid\">15939489</pub-id></element-citation></ref><ref id=\"B26\"><label>26</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Streit</surname><given-names>A. K.</given-names></name><name><surname>Netter</surname><given-names>M. F.</given-names></name><name><surname>Kempf</surname><given-names>F.</given-names></name><name><surname>Walecki</surname><given-names>M.</given-names></name><name><surname>Rinn&#x000e9;</surname><given-names>S.</given-names></name><name><surname>Bollepalli</surname><given-names>M. K.</given-names></name><name><surname>Preisig-M&#x000fc;ller</surname><given-names>R.</given-names></name><name><surname>Renigunta</surname><given-names>V.</given-names></name><name><surname>Daut</surname><given-names>J.</given-names></name><name><surname>Baukrowitz</surname><given-names>T.</given-names></name><etal/></person-group><article-title>A specific two-pore domain potassium channel blocker defines the structure of the TASK-1 open pore</article-title><source>J. Biol. Chem.</source><year>2011</year><volume>286</volume><fpage>13977</fpage><lpage>13984</lpage><pub-id pub-id-type=\"pmid\">21362619</pub-id></element-citation></ref><ref id=\"B27\"><label>27</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Mant</surname><given-names>A.</given-names></name><name><surname>Williams</surname><given-names>S.</given-names></name><name><surname>Roncoroni</surname><given-names>L.</given-names></name><name><surname>Lowry</surname><given-names>E.</given-names></name><name><surname>Johnson</surname><given-names>D.</given-names></name><name><surname>O&#x02019;Kelly</surname><given-names>I.</given-names></name></person-group><article-title>N-glycosylation-dependent control of functional expression of background potassium channels K<sub>2P</sub>3.1 and K<sub>2P</sub>9.1</article-title><source>J. Biol. Chem.</source><year>2012</year><volume>288</volume><fpage>3251</fpage><lpage>3264</lpage><pub-id pub-id-type=\"pmid\">23250752</pub-id></element-citation></ref><ref id=\"B28\"><label>28</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Gazzarrini</surname><given-names>S.</given-names></name><name><surname>Severino</surname><given-names>M.</given-names></name><name><surname>Lombardi</surname><given-names>M.</given-names></name><name><surname>Morandi</surname><given-names>M.</given-names></name><name><surname>DiFrancesco</surname><given-names>D.</given-names></name><name><surname>Van Etten</surname><given-names>J. L.</given-names></name><name><surname>Thiel</surname><given-names>G.</given-names></name><name><surname>Moroni</surname><given-names>A.</given-names></name></person-group><article-title>The viral potassium channel Kcv: structural and functional features</article-title><source>FEBS Lett.</source><year>2003</year><volume>552</volume><fpage>12</fpage><lpage>16</lpage><pub-id pub-id-type=\"pmid\">12972145</pub-id></element-citation></ref><ref id=\"B29\"><label>29</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Shim</surname><given-names>J. W.</given-names></name><name><surname>Yang</surname><given-names>M.</given-names></name><name><surname>Gu</surname><given-names>L.-Q.</given-names></name></person-group><article-title><italic>In&#x000a0;vitro</italic> synthesis, tetramerization and single channel characterization of virus-encoded potassium channel Kcv</article-title><source>FEBS Lett.</source><year>2007</year><volume>581</volume><fpage>1027</fpage><lpage>1034</lpage><pub-id pub-id-type=\"pmid\">17316630</pub-id></element-citation></ref><ref id=\"B30\"><label>30</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Callan</surname><given-names>A. C.</given-names></name><name><surname>Bunning</surname><given-names>S.</given-names></name><name><surname>Jones</surname><given-names>O. T.</given-names></name><name><surname>High</surname><given-names>S.</given-names></name><name><surname>Swanton</surname><given-names>E.</given-names></name></person-group><article-title>Biosynthesis of the dystonia-associated AAA<sup>+</sup> ATPase torsinA at the endoplasmic reticulum</article-title><source>Biochem. J.</source><year>2007</year><volume>401</volume><fpage>607</fpage><lpage>612</lpage><pub-id pub-id-type=\"pmid\">17037984</pub-id></element-citation></ref><ref id=\"B31\"><label>31</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Meacock</surname><given-names>S. L.</given-names></name><name><surname>Lecomte</surname><given-names>F. J. L.</given-names></name><name><surname>Crawshaw</surname><given-names>S. G.</given-names></name><name><surname>High</surname><given-names>S.</given-names></name></person-group><article-title>Different transmembrane domains associate with distinct endoplasmic reticulum components during membrane integration of a polytopic protein</article-title><source>Mol. Biol. Cell</source><year>2002</year><volume>13</volume><fpage>4114</fpage><lpage>4129</lpage><pub-id pub-id-type=\"pmid\">12475939</pub-id></element-citation></ref><ref id=\"B32\"><label>32</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Wiltfang</surname><given-names>J.</given-names></name><name><surname>Smirnov</surname><given-names>A.</given-names></name><name><surname>Schnierstein</surname><given-names>B.</given-names></name><name><surname>Kelemen</surname><given-names>G.</given-names></name><name><surname>Matthies</surname><given-names>U.</given-names></name><name><surname>Klafki</surname><given-names>H. W.</given-names></name><name><surname>Staufenbiel</surname><given-names>M.</given-names></name><name><surname>H&#x000fc;ther</surname><given-names>G.</given-names></name><name><surname>R&#x000fc;ther</surname><given-names>E.</given-names></name><name><surname>Kornhuber</surname><given-names>J.</given-names></name></person-group><article-title>Improved electrophoretic separation and immunoblotting of &#x003b2;-amyloid (A&#x003b2;) peptides 1&#x02013;40, 1&#x02013;42, and 1&#x02013;43</article-title><source>Electrophoresis</source><year>1997</year><volume>18</volume><fpage>527</fpage><lpage>532</lpage><pub-id pub-id-type=\"pmid\">9150936</pub-id></element-citation></ref><ref id=\"B33\"><label>33</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Martoglio</surname><given-names>B.</given-names></name><name><surname>Dobberstein</surname><given-names>B.</given-names></name></person-group><article-title>Snapshots of membrane-translocating proteins</article-title><source>Trends Cell Biol.</source><year>1996</year><volume>6</volume><fpage>142</fpage><lpage>147</lpage><pub-id pub-id-type=\"pmid\">15157477</pub-id></element-citation></ref><ref id=\"B34\"><label>34</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Laird</surname><given-names>V.</given-names></name><name><surname>High</surname><given-names>S.</given-names></name></person-group><article-title>Discrete cross-linking products identified during membrane protein biosynthesis</article-title><source>J. Biol. Chem.</source><year>1997</year><volume>272</volume><fpage>1983</fpage><lpage>1989</lpage><pub-id pub-id-type=\"pmid\">8999890</pub-id></element-citation></ref><ref id=\"B35\"><label>35</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Leznicki</surname><given-names>P.</given-names></name><name><surname>Clancy</surname><given-names>A.</given-names></name><name><surname>Schwappach</surname><given-names>B.</given-names></name><name><surname>High</surname><given-names>S.</given-names></name></person-group><article-title>Bat3 promotes the membrane integration of tail-anchored proteins</article-title><source>J. Cell Sci.</source><year>2010</year><volume>123</volume><fpage>2170</fpage><lpage>2178</lpage><pub-id pub-id-type=\"pmid\">20516149</pub-id></element-citation></ref><ref id=\"B36\"><label>36</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Dunlop</surname><given-names>J.</given-names></name><name><surname>Jones</surname><given-names>P. C.</given-names></name><name><surname>Finbow</surname><given-names>M. E.</given-names></name></person-group><article-title>Membrane insertion and assembly of ductin: a polytopic channel with dual orientations</article-title><source>EMBO J.</source><year>1995</year><volume>14</volume><fpage>3609</fpage><lpage>3616</lpage><pub-id pub-id-type=\"pmid\">7641680</pub-id></element-citation></ref><ref id=\"B37\"><label>37</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>McGinnes</surname><given-names>L. W.</given-names></name><name><surname>Reitter</surname><given-names>J. N.</given-names></name><name><surname>Gravel</surname><given-names>K.</given-names></name><name><surname>Morrison</surname><given-names>T. G.</given-names></name></person-group><article-title>Evidence for mixed membrane topology of the newcastle disease virus fusion protein</article-title><source>J. Virol.</source><year>2003</year><volume>77</volume><fpage>1951</fpage><lpage>1963</lpage><pub-id pub-id-type=\"pmid\">12525629</pub-id></element-citation></ref><ref id=\"B38\"><label>38</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Nilsson</surname><given-names>I.</given-names></name><name><surname>Witt</surname><given-names>S.</given-names></name><name><surname>Kiefer</surname><given-names>H.</given-names></name><name><surname>Mingarro</surname><given-names>I.</given-names></name><name><surname>von Heijne</surname><given-names>G.</given-names></name></person-group><article-title>Distant downstream sequence determinants can control N-tail translocation during protein insertion into the endoplasmic reticulum membrane</article-title><source>J. Biol. Chem.</source><year>2000</year><volume>275</volume><fpage>6207</fpage><lpage>6213</lpage><pub-id pub-id-type=\"pmid\">10692414</pub-id></element-citation></ref><ref id=\"B39\"><label>39</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Sepp&#x000e4;l&#x000e4;</surname><given-names>S.</given-names></name><name><surname>Slusky</surname><given-names>J. S.</given-names></name><name><surname>Lloris-Garcer&#x000e1;</surname><given-names>P.</given-names></name><name><surname>Rapp</surname><given-names>M.</given-names></name><name><surname>von Heijne</surname><given-names>G.</given-names></name></person-group><article-title>Control of membrane protein topology by a single C-terminal residue</article-title><source>Science</source><year>2010</year><volume>328</volume><fpage>1698</fpage><lpage>1700</lpage><pub-id pub-id-type=\"pmid\">20508091</pub-id></element-citation></ref><ref id=\"B40\"><label>40</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Knight</surname><given-names>B. C.</given-names></name><name><surname>High</surname><given-names>S.</given-names></name></person-group><article-title>Membrane integration of Sec61&#x003b1;: a core component of the endoplasmic reticulum translocation complex</article-title><source>Biochem. J.</source><year>1998</year><volume>331</volume><fpage>161</fpage><lpage>167</lpage><pub-id pub-id-type=\"pmid\">9512475</pub-id></element-citation></ref><ref id=\"B41\"><label>41</label><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Dobberstein</surname><given-names>B.</given-names></name></person-group><article-title>Oligomeric complexes involved in translocation of proteins across the membrane of the endoplasmic reticulum</article-title><source>FEBS Lett.</source><year>1999</year><volume>457</volume><fpage>316</fpage><lpage>22</lpage><pub-id pub-id-type=\"pmid\">10471800</pub-id></element-citation></ref></ref-list></back></article>',\n",
       " 'TASK is a new member of the recently recognized TWIK K+ channel family. This 395 amino acid polypeptide has four transmembrane segments and two P domains. In adult human, TASK transcripts are found in pancreas<placenta<brain<lung, prostate<heart, kidney<uterus, small intestine and colon. Electrophysiological properties of TASK were determined after expression in Xenopus oocytes and COS cells. TASK currents are K+-selective, instantaneous and non-inactivating. They show an outward rectification when external [K+] is low ([K+]out = 2 mM) which is not observed for high [K+]out (98 mM). The rectification can be approximated by the Goldman-Hodgkin-Katz current equation that predicts a curvature of the current-voltage plot in asymmetric K+ conditions. This strongly suggests that TASK lacks intrinsic voltage sensitivity. The absence of activation and inactivation kinetics as well as voltage independence are characteristic of conductances referred to as leak or background conductances. For this reason, TASK is designated as a background K+ channel. TASK is very sensitive to variations of extracellular pH in a narrow physiological range; as much as 90% of the maximum current is recorded at pH 7.7 and only 10% at pH 6.7. This property is probably essential for its physiological function, and suggests that small pH variations may serve a communication role in the nervous system.',\n",
       " 'The excitability of pulmonary artery smooth muscle cells (PASMC) is regulated by potassium (K+) conductances. Although studies suggest that background K+ currents carried by 2-pore domain K+ channels are important regulators of resting membrane potential in PASMC, their role in human PASMC is unknown. Our study tested the hypothesis that TASK-1 leak K+ channels contribute to the K+ current and resting membrane potential in human PASMC. We used the whole-cell patch-clamp technique and TASK-1 small interfering RNA (siRNA). Noninactivating K+ current performed by TASK-1 K+ channels were identified by current characteristics and inhibition by anandamide and acidosis (pH 6.3), each resulting in significant membrane depolarization. Moreover, we showed that TASK-1 is blocked by moderate hypoxia and activated by treprostinil at clinically relevant concentrations. This is mediated via protein kinase A (PKA)-dependent phosphorylation of TASK-1. To further confirm the role of TASK-1 channels in regulation of resting membrane potential, we knocked down TASK-1 expression using TASK-1 siRNA. The knockdown of TASK-1 was reflected by a significant depolarization of resting membrane potential. Treatment of human PASMC with TASK-1 siRNA resulted in loss of sensitivity to anandamide, acidosis, alkalosis, hypoxia, and treprostinil. These results suggest that (1) TASK-1 is expressed in human PASMC; (2) TASK-1 is hypoxia-sensitive and controls the resting membrane potential, thus implicating an important role for TASK-1 K+ channels in the regulation of pulmonary vascular tone; and (3) treprostinil activates TASK-1 at clinically relevant concentrations via PKA, which might represent an important mechanism underlying the vasorelaxing properties of prostanoids and their beneficial effect in vivo.',\n",
       " 'Hypoxic inhibition of K+ current is a critical O2-sensing mechanism. Previously, it was demonstrated that the cooperative action of TASK-1 and NADPH oxidase-4 (NOX4) mediated the O2-sensitive K+ current response. Here we addressed the O2-sensing mechanism of NOX4 in terms of TASK-1 regulation. In TASK-1 and NOX4-coexpressing human embryonic kidney 293 cells, hypoxia (5% O2) decreased the amplitude of TASK-1 current (hypoxia-DeltaI(TASK-1)). To examine whether reactive oxygen species (ROS) mediate the hypoxia-DeltaI(TASK-1), we treated the cells with carbon monoxide (CO) which is known to reduce ROS generation from the heme-containing NOX4. Unexpectedly, CO failed to mimic hypoxia in TASK-1 regulation, rather blocked the hypoxia-DeltaI(TASK-1). Moreover, the hypoxia-DeltaI(TASK-1) was neither recovered by H2O2 treatment nor prevented by antioxidant such as ascorbic acid. However, the hypoxia-DeltaI(TASK-1) was noticeably attenuated by succinyl acetone, a heme synthase inhibitor. To further evaluate the role of heme, we constructed and expressed various NOX4 mutants, such as HBD(-) lacking the heme binding domain, NBD(-) lacking the NADPH binding domain, FBD(-) lacking the FAD binding domain, and HFBD(-) lacking both heme and FAD domains. The hypoxia-DeltaI(TASK-1) was significantly reduced in HBD(-)-, FBD(-)-, or HFBD(-)-expressing cells, versus wild-type NOX4-expressing cells. However, NBD(-) did not affect the TASK-1 response to hypoxia. We also found that p22 is required for the NOX4-dependent TASK-1 regulation. These results suggest that O2 binding with NOX4 per se controls TASK-1 activity. In this process, the heme moiety and FBD seem to be responsible for the NOX4 regulation of TASK-1, and p22 might support the NOX4-TASK-1 interaction.',\n",
       " '<!DOCTYPE article PUBLIC \"-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN\" \"JATS-archivearticle1.dtd\">\\n<article xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" article-type=\"research-article\"><?properties open_access?><front><journal-meta><journal-id journal-id-type=\"nlm-ta\">FEBS Open Bio</journal-id><journal-id journal-id-type=\"iso-abbrev\">FEBS Open Bio</journal-id><journal-title-group><journal-title>FEBS Open Bio</journal-title></journal-title-group><issn pub-type=\"epub\">2211-5463</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type=\"pmid\">23772394</article-id><article-id pub-id-type=\"pmc\">3668539</article-id><article-id pub-id-type=\"publisher-id\">FOB90</article-id><article-id pub-id-type=\"doi\">10.1016/j.fob.2013.04.002</article-id><article-categories><subj-group subj-group-type=\"heading\"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Potential use of potassium efflux-deficient yeast for studying trafficking signals and potassium channel functions<sup><xref ref-type=\"fn\" rid=\"d32e69\">&#x02606;</xref></sup></article-title></title-group><contrib-group><contrib contrib-type=\"author\"><name><surname>Bernstein</surname><given-names>Joshua D.</given-names></name></contrib><contrib contrib-type=\"author\"><name><surname>Okamoto</surname><given-names>Yukari</given-names></name></contrib><contrib contrib-type=\"author\"><name><surname>Kim</surname><given-names>Minjee</given-names></name></contrib><contrib contrib-type=\"author\"><name><surname>Shikano</surname><given-names>Sojin</given-names></name><email>sshikano@uic.edu</email><xref rid=\"cor0001\" ref-type=\"corresp\">*</xref></contrib></contrib-group><aff id=\"aff0001\">Department of Biochemistry and Molecular Genetics, University of Illinois at Chicago, Chicago, IL 60607, USA</aff><author-notes><corresp id=\"cor0001\"><label>*</label>Corresponding author. Address: 900 S. Ashland Ave, MBRB2006, Chicago, IL 60607, USA. Tel.: +1 312 413 2029; fax: +1 312 413 0353. <email>sshikano@uic.edu</email></corresp></author-notes><pub-date pub-type=\"pmc-release\"><day>16</day><month>4</month><year>2013</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date pub-type=\"epub\">.--><pub-date pub-type=\"epub\"><day>16</day><month>4</month><year>2013</year></pub-date><pub-date pub-type=\"collection\"><year>2013</year></pub-date><volume>3</volume><fpage>196</fpage><lpage>203</lpage><history><date date-type=\"received\"><day>18</day><month>2</month><year>2013</year></date><date date-type=\"rev-recd\"><day>2</day><month>4</month><year>2013</year></date><date date-type=\"accepted\"><day>11</day><month>4</month><year>2013</year></date></history><permissions><copyright-statement>&#x000a9; 2013 The Authors</copyright-statement><copyright-year>2013</copyright-year><license license-type=\"open-access\" xlink:href=\"http://creativecommons.org/licenses/BY-license/3.0/\"><license-p>This is an open-access article distributed under the terms of the Creative CommonsAttribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><abstract><p>The activity of potassium (K<sup>+</sup>) channels critically depends on their density on the cell surface membrane, which is regulated by dynamic protein&#x02013;protein interactions that often involve distinct trafficking signals on the cargo proteins. In this paper we explored the possibility of utilizing the <italic>Saccharomyces cerevisiae</italic> strain B31 for identification of the signal motifs that regulate surface expression of membrane proteins and for studying structure&#x02013;function relationships of K<sup>+</sup> channels. B31 cells lack the K<sup>+</sup> efflux system and were reported to show overloaded K<sup>+</sup>-mediated growth inhibition in high K<sup>+</sup> media upon heterologous expression of a mammalian inwardly rectifying K<sup>+</sup> channel (Kir2.1). We show that while the expression of wild-type Kir2.1 channel inhibits the growth of B31 cells in high K<sup>+</sup> media, the human disease-causing mutations of Kir2.1 that abolish K<sup>+</sup> conduction (V302M) or surface trafficking (&#x00394;314/315) fully restores the growth. The expression of two-pore-domain K<sup>+</sup> channel KCNK3 or KCNK9 also inhibited the growth of B31 in high K<sup>+</sup> media while C-terminal mutations that reduce their 14-3-3 protein-dependent cell surface trafficking restored the growth of B31. Finally, the expression of Kir2.1 channels that were C-terminally fused with known sequence motifs including ER retention/retrieval signals and an endocytosis signal allowed the growth of B31 in high K<sup>+</sup> media. These results demonstrate the potential of B31 yeast strain as a unique biological tool to screen the random peptide libraries for novel sequence signals that down-regulate surface expression of membrane proteins, as well as to systematically identify the structural determinants for cell surface trafficking and/or ion conductance of K<sup>+</sup> channels.</p></abstract><abstract abstract-type=\"author-highlights\"><title>Highlights</title><p><list list-type=\"simple\"><list-item id=\"celistitem0001\"><label>&#x02022;</label><p><italic>Saccharomyces cerevisiae</italic> strain B31 lacks a K<sup>+</sup> efflux system.</p></list-item><list-item id=\"celistitem0002\"><label>&#x02022;</label><p>B31 tolerance to high K<sup>+</sup> reflects loss of cell surface density or activity of Kir2.1.</p></list-item><list-item id=\"celistitem0003\"><label>&#x02022;</label><p>B31 tolerance to high K<sup>+</sup> reflects loss of cell surface density of KCNK3 or KCNK9.</p></list-item><list-item id=\"celistitem0004\"><label>&#x02022;</label><p>Peptide motifs regulating surface trafficking can be screened by B31 growth assay.</p></list-item></list></p></abstract><kwd-group><title>Keywords</title><kwd>Potassium channel</kwd><kwd>Yeast</kwd><kwd>Trafficking</kwd><kwd>Surface membrane</kwd><kwd>Screening</kwd></kwd-group><kwd-group><title>Abbreviations</title><kwd>ER, endoplasmic reticulum</kwd><kwd>FCM, flow cytometry</kwd><kwd>COP, coatomer protein</kwd><kwd>IP, immunoprecipitation</kwd><kwd>Ab, antibody</kwd><kwd>HA, hemagglutinine</kwd><kwd>SD, standard deviation</kwd><kwd>aa, amino acids</kwd><kwd>O/N, overnight</kwd></kwd-group></article-meta></front><body><sec id=\"sec0001\"><label>1</label><title>Introduction</title><p>Ion channels play crucial roles in the cellular response to signals and changes in the extracellular environment by controlling ion homeostasis and membrane excitability. Their proper functioning critically depends on the fine tuning of their localization at cell surface. This process is dictated by the secretory and endocytic vesicular trafficking pathways that often involve dynamic interactions between distinct sequence signals on the cargos and cellular transport machineries. Many important discoveries on trafficking signals have come from the studies on ion channels including K<sup>+</sup> channels. For instance, the Arg-based (&#x02018;RXR&#x02019;) endoplasmic reticulum (ER) retention/retrieval signal was first discovered in the ATP-sensitive inwardly rectifying K<sup>+</sup> channel (Kir) subunit, Kir6.2 [<xref rid=\"bib1\" ref-type=\"bibr\">1</xref>]. This finding has lead to a proposed mechanism by which the incompletely assembled channel proteins can be screened for a distinct peptide signal by the quality control system and returned to the ER. The RXR motif is recognized by a coatomer protein (COP)I complex that forms the Golgi-to-ER retrograde transport vesicles [<xref rid=\"bib1 bib2 bib3\" ref-type=\"bibr\">1&#x02013;3</xref>], and now numerous surface membrane proteins including ion channels and receptors are known to carry this signal [<xref rid=\"bib4 bib5 bib6 bib7\" ref-type=\"bibr\">4&#x02013;7</xref>]. Moreover, multiple different peptide signals necessary for promoting cell surface trafficking have been also found in K<sup>+</sup> channels [<xref rid=\"bib8 bib9 bib10 bib11\" ref-type=\"bibr\">8&#x02013;11</xref>]. These findings have supported a concept that the surface trafficking of membrane proteins is not a default process but is highly regulated by different sequence motifs that are displayed on the cargo proteins.</p><p>Yeast offers a good model for studying mammalian protein trafficking mechanisms, since basic molecular machinery for protein trafficking is well conserved between yeast and mammals. More importantly, clonal expression of library transgenes in a cell enables a systematic screening and analysis, which is not achievable in mammalian cells that will inevitably take up multiple gene clones within a cell upon transfection of libraries. The ability of animal K<sup>+</sup> channels such as Kir family channels to complement the growth of K<sup>+</sup> uptake-deficient Saccharomyces cerevisiae strain, e.g., SGY1528 that lacks K<sup>+</sup> uptake transporters Trk1 and Trk2 [<xref rid=\"bib12\" ref-type=\"bibr\">12</xref>], in low K<sup>+</sup> media has proven particularly useful for identification of novel trafficking pathways of membrane proteins. For instance, Shikano et al. used SGY1528 cells to screen library of Kir2.1 channels that are fused with C-terminal random 8-mer peptide sequences and identified a group of <italic>cis</italic>-acting sequences that specifically interact with 14-3-3 proteins and promote surface expression of membrane proteins [<xref rid=\"bib13\" ref-type=\"bibr\">13</xref>]. Moreover, the screening of a cDNA library transduced into the Kir2.1 channel-expressing SGY1528 cells resulted in a discovery of a <italic>trans</italic>-acting protein that enhances the cell surface expression of Kir2.1 [<xref rid=\"bib14\" ref-type=\"bibr\">14</xref>]. The SGY1528 has been also successfully used to identify the structural determinants for the K<sup>+</sup> selectivity of G-protein gated inwardly-rectifying K<sup>+</sup> channel (GIRK) [<xref rid=\"bib15\" ref-type=\"bibr\">15</xref>].</p><p>On the other hand, Kolacna and colleagues have developed K<sup>+</sup> efflux-deficient <italic>S. cerevisiae</italic> strain, B31. This strain lacks a Na<sup>+</sup>-ATPase and a Na<sup>+</sup><italic>/</italic>H<sup>+</sup> antiporter and therefore shows growth inhibition in high K<sup>+</sup> media due to the excessive accumulation of intracellular K<sup>+</sup> upon heterologous expression of a mammalian Kir2.1 channel [<xref rid=\"bib16\" ref-type=\"bibr\">16</xref>]. Having the fact that Kir2.1 activity inversely correlates with the B31 growth in high K<sup>+</sup>, we explored the possibility that B31 growth assay can be conveniently utilized to systematically screen for the structural determinants of K<sup>+</sup> channel functions and for the novel signal motifs that down-regulate cell surface expression of membrane proteins by a gain-of-function (i.e., cell survival) assay. As a proof of concept, we examined (1) if specific mutations that disrupt functions of Kir2.1 can be represented by B31 tolerance to high K<sup>+</sup>, (2) if other K<sup>+</sup> channel family members can also function in B31 growth assay, and (3) if the activities of Kir2.1-fused trafficking signals that down-regulate surface expression can be represented by B31 tolerance to high K<sup>+</sup>.</p></sec><sec sec-type=\"materials|methods\" id=\"sec0002\"><label>2</label><title>Materials and methods</title><sec id=\"sec0003\"><label>2.1</label><title>Plasmids</title><p>For B31 growth assay, mouse Kir2.1 was cloned at BamHI and NotI in pYES2 vector in which GAL1 promoter was replaced with MET25 promoter (kindly supplied by Dr. Lily Jan). The EcoRI site was added before the termination codon (this was referred to as a wild-type Kir2.1) for fusion of the exogenous trafficking motifs. The C-terminal sequences were cloned from mouse Kir6.2 (aa 355&#x02013;399), human GPR15 (aa 351&#x02013;360), or human sodium-dependent dopamine transporter [<xref rid=\"bib17\" ref-type=\"bibr\">17</xref>] (aa 587&#x02013;596) and fused to Kir2.1 at EcoRI-NotI. For GPR15 sequence, Ser residue at 359 was mutated to Ala. Human KCNK3 and KCNK9 were also cloned in pYES2met vector. Site-directed mutagenesis was performed by overlap extension PCR. For detection of cell surface expression in HEK293 cells, Kir2.1 was tagged with hemagglutinin (HA) epitope at between aa 117 and 118, rat KCNK3 was tagged with HA at between aa 213 and 214, and human KCNK9 was tagged with Myc between aa 40 and 41. These tagged constructs were cloned in pCDNA3.1(+) vector (Invitrogen, Carlsbad, CA).</p></sec><sec id=\"sec0004\"><label>2.2</label><title>Yeast strains and growth conditions</title><p>The <italic>S. cerevisiae</italic> strain B31 (<italic>MAT&#x003b1; ena1-4_::HIS3 nha1_::LEU2</italic>) is a derivative of W303-1A (<italic>MAT</italic><bold>a</bold>\\n<italic>ade 2-1 can1-100 his3-11/15 leu2-3/112 mal10 trp1-1 ura3-1</italic>) [<xref rid=\"bib16\" ref-type=\"bibr\">16</xref>] and was kindly provided by Dr. Hana Sychrova. Cells were grown aerobically at 30 &#x000b0;C on YPD (1% yeast extract, 2% bactopeptone, 2% glucose, 120 mg/L adenine hemisulfate, 1.7% agar for solid media) or YNB media (6.7 g/L yeast nitrogen base without amino acids, 2% glucose, 10 mg/L adenine hemisulfate, 0.73 g/L methionine- and uracil-dropout amino acid mixture, 1% agar for solid media). The YNB media were supplemented with the indicated amount of potassium chloride and adjusted to pH 6.5 or 7.0 by Tris&#x02013;HCl.</p></sec><sec id=\"sec0005\"><label>2.3</label><title>Plasmids and yeast transformation</title><p>Yeast cells grown to early logarithmic phase in YPD media were transformed by a lithium acetate method [<xref rid=\"bib18\" ref-type=\"bibr\">18</xref>] and plated on YNB plates with no additional KCl (referred to as 0 mM K<sup>+</sup> plate).</p></sec><sec id=\"sec0006\"><label>2.4</label><title>Growth assay of B31</title><p>For the growth assay of the K<sup>+</sup> channel-transformed B31 cells, the cells were taken from the isolated colonies of freshly-transformed B31 cells and adjusted to 2&#x02009;&#x000d7;&#x02009;10<sup>6</sup> cells/ml in water by using a hemocytometer. This was followed by two 10-fold serial dilutions and 5&#x02009;&#x003bc;l aliquots of each dilution were spotted on the YNB plates with indicated concentrations of KCl. Plates were incubated at 30&#x02009;&#x000b0;C and the digital images of the cells were taken at the indicated times (usually Days 5&#x02013;7).</p></sec><sec id=\"sec0007\"><label>2.5</label><title>Growth assay of KCNK9-expressing B31 in liquid media</title><p>For testing the effect of pH on B31 growth, the cells freshly transformed with pYes2met vector or Wt KCNK9 were adjusted to 2&#x02009;&#x000d7;&#x02009;10<sup>6</sup> cells/ml in YNB media (400&#x02009;mM KCl) with pH adjusted to 5.0, 5.5, 6.0, 6.5, or 7.0 using Tris&#x02013;HCl. For testing the effect of zinc ion, the cells were adjusted as above in YNB media (400&#x02009;mM KCl, pH 6.5) containing 0, 10, and 100&#x02009;&#x003bc;M zinc chloride. Zinc chloride at higher than 100&#x02009;&#x003bc;M caused salt precipitation and reduction of the medium pH, so was not tested. The turbidity (OD 600&#x02009;nm) was measured before and after 15&#x02009;h of culture at 30&#x02009;&#x000b0;C. Cultures were performed in triplicate for each construct.</p></sec><sec id=\"sec0008\"><label>2.6</label><title>Antibodies (Abs)</title><p>The following Abs were used: mouse HA, rabbit Kir2.1, and rabbit 14-3-3&#x003b2; from Santa Cruz Biotechnologies (Dallas, TX), rabbit HA from Cell Signaling Technology (Danvers, MA), mouse Myc (both non-conjugated and Alexa Fluor (AF) 488-conjugated) from Millipore (Billerica, MA), rabbit &#x003b2;-COP from Affinity BioReagent (Golden, CO), mouse GST from NeuroMab (Davis, CA), AF488-conjugated goat anti-mouse IgG from Invitrogen, horse radish peroxidase (HRP)-conjugated goat anti-mouse and goat anti-rabbit IgG from Vector laboratory (Berlingame, CA).</p></sec><sec id=\"sec0009\"><label>2.7</label><title>Cell culture and transfection</title><p>HEK293 cells were maintained in 50% DMEM/50% Ham\\'s F-12 medium containing 10% FBS, 2 mM <sc>l</sc>-glutamine, 100 U/ml penicillin, and 100 &#x003bc;g/ml streptomycin. Transient transfection of plasmids was performed using Mirus TransIT-LT1 (Mirus Bio, Madison, WI) according to the manufacturer\\'s instructions.</p></sec><sec id=\"sec0010\"><label>2.8</label><title>Flow cytometry (FCM)</title><p>Transfected HEK293 cells were collected by gentle flushing and washed with Hanks&#x02019; Balanced Salt Solution supplemented with 1% BSA (staining buffer). All the Ab staining and washing thereafter were performed in the staining buffer on ice. For surface staining of HA-tagged Kir2.1 and KCNK3, the transfected cells were incubated with mouse HA Ab followed by AF488-conjugated secondary Ab for 20&#x02009;min on ice. For Myc-tagged KCNK9, the transfected cells were stained with AF488-conjugated mouse Myc Ab. The stained cells were fixed with 1% paraformaldehyde and analyzed by Cell Lab Quanta SC (Beckman Coulter, Brea, CA). For measurement of surface fluorescence intensity, the Median values were determined for the entire cell populations (Kir2.1 and KCNK3) or for the myc-positive population (KCNK9) by using FlowJo software (Tree Star Inc., Ashland, OR). The surface expression of the channels was shown in the histograms except that KCNK9 expression was shown in a density plot because the percentage of KCNK9 signal-positive cells were too small (&#x0003c;10%) to clearly show in histograms. This may be due to the inefficient accessibility of the Myc Ab to the epitope.</p></sec><sec id=\"sec0011\"><label>2.9</label><title>Protein extraction from B31 yeast cells</title><p>Proteins were extracted from B31 cells to examine the expression of Kir2.1 channels. B31 cells transformed with pYES2met vector or Kir2.1 constructs were inoculated in the methionine- and uracil-deficient YNB media with no added KCl and cultured O/N at 30&#x02009;&#x000b0;C. The next morning the cell density was adjusted to a density of 0.3 OD600 in 3&#x02009;ml of the same medium and cultured for 4&#x02009;h. The proteins were extracted as described previously [<xref rid=\"bib19\" ref-type=\"bibr\">19</xref>] and the samples were subjected to the western blot for Kir2.1 and KCNK channels.</p></sec><sec id=\"sec0012\"><label>2.10</label><title>Immunoprecipitation (IP)</title><p>The transfected HEK293 cells were washed with PBS once and lysed with lysis buffer (0.5% Igepal, 25&#x02009;mM Tris, 150&#x02009;mM NaCl, pH 7.5) containing protease inhibitors for 20&#x02009;min at 4&#x02009;&#x000b0;C. After centrifugation for 20&#x02009;min at 11,000x<italic>g,</italic> the supernatant was mixed with mouse HA or mouse Myc and Protein A- or Protein G-conjugated agarose beads (Invitrogen). After O/N incubation at 4&#x02009;&#x000b0;C, the beads were washed 4 times with lysis buffer and then the immunoprecipitated proteins were eluted by incubating the beads with 2X sample buffer.</p></sec><sec id=\"sec0013\"><label>2.11</label><title>SDS&#x02013;PAGE and western blots</title><p>The protein samples resolved by 10 or 12% SDS&#x02013;PAGE were transferred to nitrocellulose membranes. Transfer was confirmed by staining of the membranes with Ponceau S. The membranes were blocked with skim milk and then incubated with primary Abs for 1 h at room temperature (RT) or O/N at 4 &#x000b0;C and then with corresponding secondary Abs conjugated with HRP. Blot signals were obtained using ECL substrates (Thermo Scientific) and collected by exposure to X-ray films.</p></sec></sec><sec id=\"sec0014\"><label>3</label><title>Results and discussion</title><sec id=\"sec0015\"><label>3.1</label><title>B31 tolerance to high K<sup>+</sup> media represents the loss of Kir2.1 activity on cell surface</title><p>A previous study by Kolacna et al. reported that B31 strain (<italic>ena1-4&#x00394; nha1&#x00394;</italic>) lacking the K<sup>+</sup> and Na<sup>+</sup> efflux system shows sensitivity to higher external concentrations of alkali&#x02013;metal&#x02013;cation salts when transformed with a mammalian Kir2.1 channel [<xref rid=\"bib16\" ref-type=\"bibr\">16</xref>]. We explored the potential of B31 cells as a tool for identifying the structural determinants of Kir2.1 channel functions by testing the mutants of Kir2.1. We selected V302M and &#x00394;314/315 mutants, which are both responsible for human Andersen&#x02013;Tawil syndrome that causes periodic paralysis and ventricular arrhythmias [<xref rid=\"bib20\" ref-type=\"bibr\">20</xref>]. The V302M mutation is reported to disrupt K<sup>+</sup> ion conduction through G-loop without reducing the cell surface expression of the channel [<xref rid=\"bib21\" ref-type=\"bibr\">21</xref>], while &#x00394;314/315 (deletion of aa 314 and 315) is known to retain the channel in the Golgi [<xref rid=\"bib20\" ref-type=\"bibr\">20</xref>,<xref rid=\"bib22\" ref-type=\"bibr\">22</xref>]. Our flow cytometry (FCM) and western blot analyses of the transfected HEK293 cells confirmed the cell surface phenotypes of these mutant Kir2.1 channels (<xref rid=\"fig0001\" ref-type=\"fig\">Fig. 1</xref>A). Slightly elevated surface expression of V302M mutant compared with the wild-type (Wt) Kir2.1 was consistent with the observations from other studies [<xref rid=\"bib21\" ref-type=\"bibr\">21</xref>]. On this basis, we tested the growth of B31 cells transformed with these Kir2.1 constructs. Consistent with the previous report [<xref rid=\"bib16\" ref-type=\"bibr\">16</xref>], the expression of Wt Kir2.1 showed a marked growth inhibition of B31 cells in high external KCl conditions such as 200&#x02009;mM and higher (<xref rid=\"fig0001\" ref-type=\"fig\">Fig. 1</xref>B, 2nd row). In contrast, both of the mutants V302M and &#x00394;314/315 allowed growth of B31 at comparable level to that of vector-transformed cells (<xref rid=\"fig0001\" ref-type=\"fig\">Fig. 1</xref>B, 1st, 3rd, and 4th rows). In B31 yeast cells, the &#x00394;314/315 mutant channel showed somewhat lower expression than Wt and V302M channels did (<xref rid=\"fig0001\" ref-type=\"fig\">Fig. 1</xref>C). This may represent possibly higher susceptibility of the intracellularly retained Kir2.1 channels to the proteolytic pathways in yeast, relative to the surface trafficking-competent channels.</p><p>It is conceivable that other inwardly rectifying channel family members also work in a similar manner to that of Kir2.1. Thus, combined with random mutagenesis techniques such as an error-prone PCR, the B31 growth assay will enable a systematic screening to identify the functional determinants of Kir channels, in which the loss of channel activity at cell surface can be conveniently visualized as yeast cell survival. The recently reported improvement in yeast transformation efficiency [<xref rid=\"bib23\" ref-type=\"bibr\">23</xref>] may further promise success of such assays.</p></sec><sec id=\"sec0016\"><label>3.2</label><title>B31 growth inhibition in high K<sup>+</sup> media represents KCNK channel activities on cell surface</title><p>We were curious if other K<sup>+</sup> channel family members can also be studied in B31 yeast. It has been reported that a voltage-gated mammalian neuronal K<sup>+</sup> channel <italic>ether &#x000e0; go-go</italic> 1 (EAG1), when lacking its intracellular N-terminus, can be functionally expressed in B31 and increase the growth sensitivity to high K<sup>+</sup> [<xref rid=\"bib24\" ref-type=\"bibr\">24</xref>]. It is conceivable that a K<sup>+</sup> channel with high open probability at the resting membrane potential has a good chance to function in B31 cells. We tested two members of a two-pore-domain K<sup>+</sup> channel (KCNK) family, KCNK3 and KCNK9. Many of the KCNK family members are open channels and responsible for generating the background &#x02018;leak&#x02019; K<sup>+</sup> current at the resting membrane potential [<xref rid=\"bib25\" ref-type=\"bibr\">25</xref>]. Increasing studies show critical involvement of KCNK channels in a wide range of human diseases. For instance, human genetic studies indicate an involvement of KCNK3 gene in the pathogenesis of primary hyperaldosteronism [<xref rid=\"bib26\" ref-type=\"bibr\">26</xref>]. KCNK9 was found to be overexpressed in various human cancers and its overexpression was experimentally shown to be sufficient to confer a tumorigenic phenotype such as tolerance to low oxygen and low serum [<xref rid=\"bib27\" ref-type=\"bibr\">27</xref>]. In addition, a genetic point mutation of KCNK9 is associated with abnormal development that causes a mental retardation [<xref rid=\"bib28\" ref-type=\"bibr\">28</xref>]. Nevertheless, compared with other voltage-gated K<sup>+</sup> channel families, KCNKs are still relatively new and their biochemical properties are not fully understood.</p><p>Previous studies including ours reported that KCNK3 and KCNK9 channels carry a 14-3-3 protein binding motif at the extreme C-terminus (RXXSX-COOH, see <xref rid=\"fig0002\" ref-type=\"fig\">Fig. 2</xref>A) [<xref rid=\"bib6\" ref-type=\"bibr\">6</xref>,<xref rid=\"bib13\" ref-type=\"bibr\">13</xref>]. The phosphorylation-dependent 14-3-3 binding appears to occlude the overlapping di-basic ER retention/retrieval signal that would be otherwise recognized by the COPI complex, and thus allows optimal surface trafficking of the channels. The presence and the exact penultimate position of the Ser residue (<xref rid=\"fig0002\" ref-type=\"fig\">Fig. 2</xref>A underlined) in the C-terminus is critical for the 14-3-3 binding [<xref rid=\"bib6\" ref-type=\"bibr\">6</xref>,<xref rid=\"bib13\" ref-type=\"bibr\">13</xref>]. So, we created the 14-3-3 binding-deficient KCNK channels by shifting the position of a penultimate Ser (KCNK3 &#x00394;410) or by mutating Ser to Ala (KCNK9 S373A). These mutants and Wt channels were expressed in HEK293 cells and examined for the association with 14-3-3 and COPI proteins (<xref rid=\"fig0002\" ref-type=\"fig\">Fig. 2</xref>B). As expected, both KCNK3 and KCNK9 mutants lacked 14-3-3 binding but associated with more &#x003b2;-COP, a major binding subunit of COPI complex, than the Wt channels did. The FCM analysis showed that the surface expression of these mutants were substantially lower when compared with that of Wt channels (<xref rid=\"fig0002\" ref-type=\"fig\">Fig. 2</xref>C). Having this, we expressed these KCNK channels in B31 for the growth test (<xref rid=\"fig0002\" ref-type=\"fig\">Fig. 2</xref>D). The expression of Wt KCNK3 and Wt KCNK9 resulted in a marked growth inhibition of B31 cells on the high external K<sup>+</sup> plates, i.e., 500&#x02009;mM for KCNK3 (left panels) and 600&#x02009;mM for KCNK9 (right panels). In contrast, the 14-3-3-binding mutants allowed similar level of growth to that of vector-transformed cells. The expression of KCNK proteins in these B31 transformants was below detectable level by the antibodies we used (data not shown). Wt KCNK9 also caused substantial inhibition of B31 growth in the liquid media with high K<sup>+</sup>, and this inhibition was sensitive to the acidic pH lower than 6.0 (<xref rid=\"fig0002\" ref-type=\"fig\">Fig. 2</xref>E). This was consistent with the reported acid sensitivity of several KCNK members including KCNK9 [<xref rid=\"bib25\" ref-type=\"bibr\">25</xref>]. Moreover, the growth inhibition of KCNK9-transformed B31 was attenuated by zinc ion (<xref rid=\"fig0002\" ref-type=\"fig\">Fig. 2</xref>F), which has been reported to inhibit this channel in mammalian cell [<xref rid=\"bib29\" ref-type=\"bibr\">29</xref>]. These results indicate that KCNK3 and KCNK9, and possibly more KCNK members, function in B31 yeast similarly to Kir2.1 to confer sensitivity to high external K<sup>+</sup>. Thus, B31 growth assay offers a valuable tool for identifying the structural determinants for the activities and cell surface expression of KCNK channels. Moreover, the restored growth of KCNK9-transformed B31 in liquid culture with zinc (<xref rid=\"fig0002\" ref-type=\"fig\">Fig. 2</xref>F) provides a basis for potential high-throughput screening for small molecule inhibitors of KCNK channels. Indeed, such work has been reported with SGY1528 strain to successfully identify the inhibitors of Kir2.1 channel [<xref rid=\"bib30\" ref-type=\"bibr\">30</xref>].</p></sec><sec id=\"sec0017\"><label>3.3</label><title>B31 tolerance to high K<sup>+</sup> represents the activity of trafficking signals that down-regulate surface expression of membrane proteins</title><p>The utility of K<sup>+</sup> transport-defective yeast is not limited to the study of K<sup>+</sup> channel biology itself. We previously used the K<sup>+</sup> uptake-deficient strain SGY1528 to screen a random peptide library for the novel signal motifs that would promote cell surface trafficking of membrane proteins [<xref rid=\"bib13\" ref-type=\"bibr\">13</xref>]. The Kir2.1 channels fused with 8-mer random peptide library sequences at the C-terminus were transformed in SGY1528 and screened for the clones that promoted cell growth in low external K<sup>+</sup> media. This screen identified the C-terminal 14-3-3 binding motifs that were eventually found to promote surface expression of various membrane proteins including a G-protein coupled receptor GPR15 as well as KCNK3 and KCNK9 channels [<xref rid=\"bib4\" ref-type=\"bibr\">4</xref>,<xref rid=\"bib13\" ref-type=\"bibr\">13</xref>]. Since the loss of cell surface Kir2.1 or KCNK channels results in B31 survival in high K<sup>+</sup> media (<xref rid=\"fig0001\" ref-type=\"fig\">Figs. 1</xref> and <xref rid=\"fig0002\" ref-type=\"fig\">2</xref>), we thought that B31 strain would be potentially applicable to such screening of the random peptide library that would allow identification of novel sequence motifs that down-regulate surface expression of membrane proteins. To explore this possibility we tested the signal motifs that have been reported to target intracellular compartments. These include the RXR-type ER retention/retrieval motifs from the C-terminus of Kir6.2 channel [<xref rid=\"bib1\" ref-type=\"bibr\">1</xref>] and a G-protein coupled receptor GPR15 [<xref rid=\"bib4\" ref-type=\"bibr\">4</xref>], and also the endocytosis motif from a dopamine transporter DAT [<xref rid=\"bib17\" ref-type=\"bibr\">17</xref>] (<xref rid=\"fig0003\" ref-type=\"fig\">Fig. 3</xref>A). For the RXR motif from GPR15, the penultimate Ser was mutated to Ala (S359A) in order to prevent occlusion of the RXR motif (Arg<sup>352</sup>/Arg<sup>354</sup>) by 14-3-3 binding [<xref rid=\"bib4\" ref-type=\"bibr\">4</xref>]. The expression levels of these Kir2.1 fusions were similar in the transiently transfected HEK293 cells (<xref rid=\"fig0003\" ref-type=\"fig\">Fig. 3</xref>B). As expected, the Kir2.1 fused with the RXR motifs from Kir6.2 and GPR15<sub>S359A</sub> were associated with more &#x003b2;-COP when compared with Wt Kir2.1 (<xref rid=\"fig0003\" ref-type=\"fig\">Fig. 3</xref>C). The FCM analysis showed that the surface expression of all of the tested Kir2.1 fusions were significantly lower than that of Wt channel (<xref rid=\"fig0003\" ref-type=\"fig\">Fig. 3</xref>D). Then we addressed if these cell surface phenotypes of Kir2.1 channels are represented by the B31 growth. All of the Kir2.1 fusions allowed better growth of B31 in high K<sup>+</sup> media when compared with Wt Kir2.1 (<xref rid=\"fig0003\" ref-type=\"fig\">Fig. 3</xref>E). In B31 cells, the Kir2.1 channels fused with the RXR motif from Kir6.2 and the endocytic motif from DAT showed somewhat lower expression than the Wt channel did (<xref rid=\"fig0003\" ref-type=\"fig\">Fig. 3</xref>F). As mentioned for the Kir2.1 &#x00394;314/315 mutant (<xref rid=\"fig0001\" ref-type=\"fig\">Fig. 1</xref>C), we believe that this represents the enhanced susceptibility of those channels to the yeast degradation pathways due to their intracellular retention. It is of note that the RXR motif from GPR15<sub>S359A</sub> did not support B31 growth as efficiently as the RXR motif from Kir6.2 did (<xref rid=\"fig0003\" ref-type=\"fig\">Fig. 3</xref>E), while both of these motifs seemed equally effective in retaining the Kir2.1 channel in HEK293 cells (<xref rid=\"fig0003\" ref-type=\"fig\">Fig. 3</xref>D). In addition, the endocytic motif from DAT was less effective in reducing the surface expression of Kir2.1 in HEK293 cells while it allowed more B31 growth when compared with the GPR15<sub>S359A</sub> sequence. These observations might reflect the difference between yeast and mammalian cells in the recognition of these trafficking motifs by the cellular transport machineries. Nevertheless, our results indicate that the C-terminally transplanted signal motifs attenuated the Kir2.1 channel activity by reducing its cell surface density in B31 yeast. This demonstrate the potential of B31 strain for identifying the <italic>cis</italic>-acting peptide sequences that down-regulate surface trafficking of the K<sup>+</sup> channels and other membrane proteins in mammalian cells.</p><p>Although the RXR motifs have been found in increasing number of surface membrane proteins [<xref rid=\"bib4 bib5 bib6 bib7\" ref-type=\"bibr\">4&#x02013;7</xref>], their physiological roles and biochemical characteristics are still not fully understood. Moreover, certain proteins are known to use COPI-independent retrograde transport [<xref rid=\"bib31\" ref-type=\"bibr\">31</xref>,<xref rid=\"bib32\" ref-type=\"bibr\">32</xref>], which implies the presence of unidentified pathways that regulate cell surface expression. In addition, in spite of extensive studies on the endocytic motifs such as those interact with clathrin adapters [<xref rid=\"bib33\" ref-type=\"bibr\">33</xref>], novel motifs that mediate internalization of surface membrane proteins continue to be discovered [<xref rid=\"bib34\" ref-type=\"bibr\">34</xref>,<xref rid=\"bib35\" ref-type=\"bibr\">35</xref>]. Hence, the functional screening of the random peptide libraries in B31 will be a promising approach to elucidate novel trafficking mechanisms of membrane proteins. Since the activity of trafficking motifs would depend on the structural attributes of the protein in which they are placed, identification of more K<sup>+</sup> channels that function in B31 cells will increase the chance of success in such screens.</p></sec></sec></body><back><ref-list><title>References</title><ref id=\"bib1\"><label>1</label><element-citation publication-type=\"journal\" id=\"sbref0001\"><person-group person-group-type=\"author\"><name><surname>Zerangue</surname><given-names>N.</given-names></name><name><surname>Schwappach</surname><given-names>B.</given-names></name><name><surname>Jan</surname><given-names>Y.N.</given-names></name><name><surname>Jan</surname><given-names>L.Y.</given-names></name></person-group><article-title>A new ER trafficking signal regulates the subunit stoichiometry of plasma membrane K(ATP) channels.</article-title><source>Neuron</source><volume>22</volume><year>1999</year><fpage>537</fpage><lpage>548</lpage><pub-id pub-id-type=\"pmid\">10197533</pub-id></element-citation></ref><ref id=\"bib2\"><label>2</label><element-citation publication-type=\"journal\" id=\"sbref0002\"><person-group person-group-type=\"author\"><name><surname>Michelsen</surname><given-names>K.</given-names></name><name><surname>Schmid</surname><given-names>V.</given-names></name><name><surname>Metz</surname><given-names>J.</given-names></name><name><surname>Heusser</surname><given-names>K.</given-names></name><name><surname>Liebel</surname><given-names>U.</given-names></name><name><surname>Schwede</surname><given-names>T.</given-names></name><name><surname>Spang</surname><given-names>A.</given-names></name><name><surname>Schwappach</surname><given-names>B.</given-names></name></person-group><article-title>Novel cargo-binding site in the beta and delta subunits of coatomer.</article-title><source>J. Cell Biol.</source><volume>179</volume><year>2007</year><fpage>209</fpage><lpage>217</lpage><pub-id pub-id-type=\"pmid\">17954604</pub-id></element-citation></ref><ref id=\"bib3\"><label>3</label><element-citation publication-type=\"journal\" id=\"sbref0003\"><person-group person-group-type=\"author\"><name><surname>Popoff</surname><given-names>V.</given-names></name><name><surname>Adolf</surname><given-names>F.</given-names></name><name><surname>Brugger</surname><given-names>B.</given-names></name><name><surname>Wieland</surname><given-names>F.</given-names></name></person-group><article-title>COPI budding within the Golgi stack.</article-title><source>Cold Spring Harb. Perspect. Biol.</source><volume>3</volume><year>2011</year><fpage>a005231</fpage><pub-id pub-id-type=\"pmid\">21844168</pub-id></element-citation></ref><ref id=\"bib4\"><label>4</label><element-citation publication-type=\"journal\" id=\"sbref0004\"><person-group person-group-type=\"author\"><name><surname>Okamoto</surname><given-names>Y.</given-names></name><name><surname>Shikano</surname><given-names>S.</given-names></name></person-group><article-title>Phosphorylation-dependent C-terminal binding of 14-3-3 proteins promotes cell surface expression of HIV co-receptor GPR15.</article-title><source>J. Biol. Chem.</source><volume>286</volume><year>2011</year><fpage>7171</fpage><lpage>7181</lpage><pub-id pub-id-type=\"pmid\">21189250</pub-id></element-citation></ref><ref id=\"bib5\"><label>5</label><element-citation publication-type=\"journal\" id=\"sbref0005\"><person-group person-group-type=\"author\"><name><surname>Hegedus</surname><given-names>T.</given-names></name><name><surname>Aleksandrov</surname><given-names>A.</given-names></name><name><surname>Cui</surname><given-names>L.</given-names></name><name><surname>Gentzsch</surname><given-names>M.</given-names></name><name><surname>Chang</surname><given-names>X.B.</given-names></name><name><surname>Riordan</surname><given-names>J.R.</given-names></name></person-group><article-title>F508del CFTR with two altered RXR motifs escapes from ER quality control but its channel activity is thermally sensitive.</article-title><source>Biochim. Biophys. Acta</source><volume>1758</volume><year>2006</year><fpage>565</fpage><lpage>572</lpage><pub-id pub-id-type=\"pmid\">16624253</pub-id></element-citation></ref><ref id=\"bib6\"><label>6</label><element-citation publication-type=\"journal\" id=\"sbref0006\"><person-group person-group-type=\"author\"><name><surname>O&#x02019;Kelly</surname><given-names>I.</given-names></name><name><surname>Butler</surname><given-names>M.H.</given-names></name><name><surname>Zilberberg</surname><given-names>N.</given-names></name><name><surname>Goldstein</surname><given-names>S.A.</given-names></name></person-group><article-title>Forward transport. binding overcomes retention in endoplasmic reticulum by dibasic signals.</article-title><source>Cell</source><volume>111</volume><year>2002</year><fpage>577</fpage><lpage>588</lpage><pub-id pub-id-type=\"pmid\">12437930</pub-id></element-citation></ref><ref id=\"bib7\"><label>7</label><element-citation publication-type=\"journal\" id=\"sbref0007\"><person-group person-group-type=\"author\"><name><surname>Zhang</surname><given-names>Z.N.</given-names></name><name><surname>Li</surname><given-names>Q.</given-names></name><name><surname>Liu</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>H.B.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Bao</surname><given-names>L.</given-names></name></person-group><article-title>The voltage-gated Na+ channel Nav1.8 contains an ER-retention/retrieval signal antagonized by the beta3 subunit.</article-title><source>J. Cell Sci.</source><volume>121</volume><year>2008</year><fpage>3243</fpage><lpage>3252</lpage><pub-id pub-id-type=\"pmid\">18782866</pub-id></element-citation></ref><ref id=\"bib8\"><label>8</label><element-citation publication-type=\"journal\" id=\"sbref0008\"><person-group person-group-type=\"author\"><name><surname>Yoo</surname><given-names>D.</given-names></name><name><surname>Fang</surname><given-names>L.</given-names></name><name><surname>Mason</surname><given-names>A.</given-names></name><name><surname>Kim</surname><given-names>B.Y.</given-names></name><name><surname>Welling</surname><given-names>P.A.</given-names></name></person-group><article-title>A phosphorylation-dependent export structure in ROMK (Kir 1.1) channel overrides an endoplasmic reticulum localization signal.</article-title><source>J. Biol. Chem.</source><volume>280</volume><year>2005</year><fpage>35281</fpage><lpage>35289</lpage><pub-id pub-id-type=\"pmid\">16118216</pub-id></element-citation></ref><ref id=\"bib9\"><label>9</label><element-citation publication-type=\"journal\" id=\"sbref0009\"><person-group person-group-type=\"author\"><name><surname>Ma</surname><given-names>D.</given-names></name><name><surname>Zerangue</surname><given-names>N.</given-names></name><name><surname>Lin</surname><given-names>Y.F.</given-names></name><name><surname>Collins</surname><given-names>A.</given-names></name><name><surname>Yu</surname><given-names>M.</given-names></name><name><surname>Jan</surname><given-names>Y.N.</given-names></name><name><surname>Jan</surname><given-names>L.Y.</given-names></name></person-group><article-title>Role of ER export signals in controlling surface potassium channel numbers.</article-title><source>Science</source><volume>291</volume><year>2001</year><fpage>316</fpage><lpage>319</lpage><pub-id pub-id-type=\"pmid\">11209084</pub-id></element-citation></ref><ref id=\"bib10\"><label>10</label><element-citation publication-type=\"journal\" id=\"sbref0010\"><person-group person-group-type=\"author\"><name><surname>Zuzarte</surname><given-names>M.</given-names></name><name><surname>Rinne</surname><given-names>S.</given-names></name><name><surname>Schlichthorl</surname><given-names>G.</given-names></name><name><surname>Schubert</surname><given-names>A.</given-names></name><name><surname>Daut</surname><given-names>J.</given-names></name><name><surname>Preisig-Muller</surname><given-names>R.</given-names></name></person-group><article-title>A di-acidic sequence motif enhances the surface expression of the potassium channel TASK-3.</article-title><source>Traffic</source><volume>8</volume><year>2007</year><fpage>1093</fpage><lpage>1100</lpage><pub-id pub-id-type=\"pmid\">17547699</pub-id></element-citation></ref><ref id=\"bib11\"><label>11</label><element-citation publication-type=\"journal\" id=\"sbref0011\"><person-group person-group-type=\"author\"><name><surname>Barlowe</surname><given-names>C.</given-names></name></person-group><article-title>Signals for COPII-dependent export from the ER: what\\'s the ticket out?</article-title><source>Trends Cell Biol.</source><volume>13</volume><year>2003</year><fpage>295</fpage><lpage>300</lpage><pub-id pub-id-type=\"pmid\">12791295</pub-id></element-citation></ref><ref id=\"bib12\"><label>12</label><element-citation publication-type=\"journal\" id=\"sbref0012\"><person-group person-group-type=\"author\"><name><surname>Tang</surname><given-names>W.</given-names></name><name><surname>Ruknudin</surname><given-names>A.</given-names></name><name><surname>Yang</surname><given-names>W.P.</given-names></name><name><surname>Shaw</surname><given-names>S.Y.</given-names></name><name><surname>Knickerbocker</surname><given-names>A.</given-names></name><name><surname>Kurtz</surname><given-names>S.</given-names></name></person-group><article-title>Functional expression of a vertebrate inwardly rectifying K+ channel in yeast.</article-title><source>Mol. Biol. Cell</source><volume>6</volume><year>1995</year><fpage>1231</fpage><lpage>1240</lpage><pub-id pub-id-type=\"pmid\">8534918</pub-id></element-citation></ref><ref id=\"bib13\"><label>13</label><element-citation publication-type=\"journal\" id=\"sbref0013\"><person-group person-group-type=\"author\"><name><surname>Shikano</surname><given-names>S.</given-names></name><name><surname>Coblitz</surname><given-names>B.</given-names></name><name><surname>Sun</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name></person-group><article-title>Genetic isolation of transport signals directing cell surface expression.</article-title><source>Nat. Cell Biol.</source><volume>7</volume><year>2005</year><fpage>985</fpage><lpage>992</lpage><pub-id pub-id-type=\"pmid\">16155591</pub-id></element-citation></ref><ref id=\"bib14\"><label>14</label><element-citation publication-type=\"journal\" id=\"sbref0014\"><person-group person-group-type=\"author\"><name><surname>Grishin</surname><given-names>A.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Levitan</surname><given-names>E.S.</given-names></name><name><surname>Zaks-Makhina</surname><given-names>E.</given-names></name></person-group><article-title>Identification of gamma-aminobutyric acid receptor-interacting factor 1 (TRAK2) as a trafficking factor for the K+ channel Kir2.1.</article-title><source>J. Biol. Chem.</source><volume>281</volume><year>2006</year><fpage>30104</fpage><lpage>30111</lpage><pub-id pub-id-type=\"pmid\">16895905</pub-id></element-citation></ref><ref id=\"bib15\"><label>15</label><element-citation publication-type=\"journal\" id=\"sbref0015\"><person-group person-group-type=\"author\"><name><surname>Yi</surname><given-names>B.A.</given-names></name><name><surname>Lin</surname><given-names>Y.F.</given-names></name><name><surname>Jan</surname><given-names>Y.N.</given-names></name><name><surname>Jan</surname><given-names>L.Y.</given-names></name></person-group><article-title>Yeast screen for constitutively active mutant G protein-activated potassium channels.</article-title><source>Neuron</source><volume>29</volume><year>2001</year><fpage>657</fpage><lpage>667</lpage><pub-id pub-id-type=\"pmid\">11301025</pub-id></element-citation></ref><ref id=\"bib16\"><label>16</label><element-citation publication-type=\"journal\" id=\"sbref0016\"><person-group person-group-type=\"author\"><name><surname>Kolacna</surname><given-names>L.</given-names></name><name><surname>Zimmermannova</surname><given-names>O.</given-names></name><name><surname>Hasenbrink</surname><given-names>G.</given-names></name><name><surname>Schwarzer</surname><given-names>S.</given-names></name><name><surname>Ludwig</surname><given-names>J.</given-names></name><name><surname>Lichtenberg-Frate</surname><given-names>H.</given-names></name><name><surname>Sychrova</surname><given-names>H.</given-names></name></person-group><article-title>New phenotypes of functional expression of the mKir2.1 channel in potassium efflux-deficient <italic>Saccharomyces cerevisiae</italic> strains.</article-title><source>Yeast</source><volume>22</volume><year>2005</year><fpage>1315</fpage><lpage>1323</lpage><pub-id pub-id-type=\"pmid\">16358319</pub-id></element-citation></ref><ref id=\"bib17\"><label>17</label><element-citation publication-type=\"journal\" id=\"sbref0017\"><person-group person-group-type=\"author\"><name><surname>Holton</surname><given-names>K.L.</given-names></name><name><surname>Loder</surname><given-names>M.K.</given-names></name><name><surname>Melikian</surname><given-names>H.E.</given-names></name></person-group><article-title>Nonclassical, distinct endocytic signals dictate constitutive and PKC-regulated neurotransmitter transporter internalization.</article-title><source>Nat. Neurosci.</source><volume>8</volume><year>2005</year><fpage>881</fpage><lpage>888</lpage><pub-id pub-id-type=\"pmid\">15924135</pub-id></element-citation></ref><ref id=\"bib18\"><label>18</label><element-citation publication-type=\"journal\" id=\"sbref0018\"><person-group person-group-type=\"author\"><name><surname>Gietz</surname><given-names>R.D.</given-names></name><name><surname>Schiestl</surname><given-names>R.H.</given-names></name></person-group><article-title>High-efficiency yeast transformation using the LiAc/SS carrier DNA/PEG method.</article-title><source>Nat. Protoc.</source><volume>2</volume><year>2007</year><fpage>31</fpage><lpage>34</lpage><pub-id pub-id-type=\"pmid\">17401334</pub-id></element-citation></ref><ref id=\"bib19\"><label>19</label><element-citation publication-type=\"journal\" id=\"sbref0019\"><person-group person-group-type=\"author\"><name><surname>Kushnirov</surname><given-names>V.V.</given-names></name></person-group><article-title>Rapid and reliable protein extraction from yeast.</article-title><source>Yeast</source><volume>16</volume><year>2000</year><fpage>857</fpage><lpage>860</lpage><pub-id pub-id-type=\"pmid\">10861908</pub-id></element-citation></ref><ref id=\"bib20\"><label>20</label><element-citation publication-type=\"journal\" id=\"sbref0020\"><person-group person-group-type=\"author\"><name><surname>Bendahhou</surname><given-names>S.</given-names></name><name><surname>Donaldson</surname><given-names>M.R.</given-names></name><name><surname>Plaster</surname><given-names>N.M.</given-names></name><name><surname>Tristani-Firouzi</surname><given-names>M.</given-names></name><name><surname>Fu</surname><given-names>Y.H.</given-names></name><name><surname>Ptacek</surname><given-names>L.J.</given-names></name></person-group><article-title>Defective potassium channel Kir2.1 trafficking underlies Andersen&#x02013;Tawil syndrome.</article-title><source>J. Biol. Chem.</source><volume>278</volume><year>2003</year><fpage>51779</fpage><lpage>51785</lpage><pub-id pub-id-type=\"pmid\">14522976</pub-id></element-citation></ref><ref id=\"bib21\"><label>21</label><element-citation publication-type=\"journal\" id=\"sbref0021\"><person-group person-group-type=\"author\"><name><surname>Ma</surname><given-names>D.</given-names></name><name><surname>Tang</surname><given-names>X.D.</given-names></name><name><surname>Rogers</surname><given-names>T.B.</given-names></name><name><surname>Welling</surname><given-names>P.A.</given-names></name></person-group><article-title>An Andersen&#x02013;Tawil syndrome mutation in Kir2.1 (V302M) alters the G-loop cytoplasmic K+ conduction pathway.</article-title><source>J. Biol. Chem.</source><volume>282</volume><year>2007</year><fpage>5781</fpage><lpage>5789</lpage><pub-id pub-id-type=\"pmid\">17166852</pub-id></element-citation></ref><ref id=\"bib22\"><label>22</label><element-citation publication-type=\"journal\" id=\"sbref0022\"><person-group person-group-type=\"author\"><name><surname>Ma</surname><given-names>D.</given-names></name><name><surname>Taneja</surname><given-names>T.K.</given-names></name><name><surname>Hagen</surname><given-names>B.M.</given-names></name><name><surname>Kim</surname><given-names>B.Y.</given-names></name><name><surname>Ortega</surname><given-names>B.</given-names></name><name><surname>Lederer</surname><given-names>W.J.</given-names></name><name><surname>Welling</surname><given-names>P.A.</given-names></name></person-group><article-title>Golgi export of the Kir2.1 channel is driven by a trafficking signal located within its tertiary structure.</article-title><source>Cell</source><volume>145</volume><year>2011</year><fpage>1102</fpage><lpage>1115</lpage><pub-id pub-id-type=\"pmid\">21703452</pub-id></element-citation></ref><ref id=\"bib23\"><label>23</label><element-citation publication-type=\"journal\" id=\"sbref0023\"><person-group person-group-type=\"author\"><name><surname>Benatuil</surname><given-names>L.</given-names></name><name><surname>Perez</surname><given-names>J.M.</given-names></name><name><surname>Belk</surname><given-names>J.</given-names></name><name><surname>Hsieh</surname><given-names>C.M.</given-names></name></person-group><article-title>An improved yeast transformation method for the generation of very large human antibody libraries.</article-title><source>Protein Eng. Des. Sel.</source><volume>23</volume><year>2010</year><fpage>155</fpage><lpage>159</lpage><pub-id pub-id-type=\"pmid\">20130105</pub-id></element-citation></ref><ref id=\"bib24\"><label>24</label><element-citation publication-type=\"journal\" id=\"sbref0024\"><person-group person-group-type=\"author\"><name><surname>Schwarzer</surname><given-names>S.</given-names></name><name><surname>Kolacna</surname><given-names>L.</given-names></name><name><surname>Lichtenberg-Frate</surname><given-names>H.</given-names></name><name><surname>Sychrova</surname><given-names>H.</given-names></name><name><surname>Ludwig</surname><given-names>J.</given-names></name></person-group><article-title>Functional expression of the voltage-gated neuronal mammalian potassium channel rat ether a go-go1 in yeast.</article-title><source>FEMS Yeast Res.</source><volume>8</volume><year>2008</year><fpage>405</fpage><lpage>413</lpage><pub-id pub-id-type=\"pmid\">18248412</pub-id></element-citation></ref><ref id=\"bib25\"><label>25</label><element-citation publication-type=\"journal\" id=\"sbref0025\"><person-group person-group-type=\"author\"><name><surname>Goldstein</surname><given-names>S.A.</given-names></name><name><surname>Bockenhauer</surname><given-names>D.</given-names></name><name><surname>O&#x02019;Kelly</surname><given-names>I.</given-names></name><name><surname>Zilberberg</surname><given-names>N.</given-names></name></person-group><article-title>Potassium leak channels and the KCNK family of two-P-domain subunits.</article-title><source>Nat. Rev. Neurosci.</source><volume>2</volume><year>2001</year><fpage>175</fpage><lpage>184</lpage><pub-id pub-id-type=\"pmid\">11256078</pub-id></element-citation></ref><ref id=\"bib26\"><label>26</label><element-citation publication-type=\"journal\" id=\"sbref0026\"><person-group person-group-type=\"author\"><name><surname>Boulkroun</surname><given-names>S.</given-names></name><name><surname>Samson-Couterie</surname><given-names>B.</given-names></name><name><surname>Golib-Dzib</surname><given-names>J.F.</given-names></name><name><surname>Amar</surname><given-names>L.</given-names></name><name><surname>Plouin</surname><given-names>P.F.</given-names></name><name><surname>Sibony</surname><given-names>M.</given-names></name><name><surname>Lefebvre</surname><given-names>H.</given-names></name><name><surname>Louiset</surname><given-names>E.</given-names></name><name><surname>Jeunemaitre</surname><given-names>X.</given-names></name><name><surname>Meatchi</surname><given-names>T.</given-names></name><name><surname>Benecke</surname><given-names>A.</given-names></name><name><surname>Lalli</surname><given-names>E.</given-names></name><name><surname>Zennaro</surname><given-names>M.C.</given-names></name></person-group><article-title>Aldosterone-producing adenoma formation in the adrenal cortex involves expression of stem/progenitor cell markers.</article-title><source>Endocrinology</source><volume>152</volume><year>2011</year><fpage>4753</fpage><lpage>4763</lpage><pub-id pub-id-type=\"pmid\">21971159</pub-id></element-citation></ref><ref id=\"bib27\"><label>27</label><element-citation publication-type=\"journal\" id=\"sbref0027\"><person-group person-group-type=\"author\"><name><surname>Pei</surname><given-names>L.</given-names></name><name><surname>Wiser</surname><given-names>O.</given-names></name><name><surname>Slavin</surname><given-names>A.</given-names></name><name><surname>Mu</surname><given-names>D.</given-names></name><name><surname>Powers</surname><given-names>S.</given-names></name><name><surname>Jan</surname><given-names>L.Y.</given-names></name><name><surname>Hoey</surname><given-names>T.</given-names></name></person-group><article-title>Oncogenic potential of TASK3 (Kcnk9) depends on K+ channel function.</article-title><source>Proc. Natl. Acad. Sci. U.S.A.</source><volume>100</volume><year>2003</year><fpage>7803</fpage><lpage>7807</lpage><pub-id pub-id-type=\"pmid\">12782791</pub-id></element-citation></ref><ref id=\"bib28\"><label>28</label><element-citation publication-type=\"journal\" id=\"sbref0028\"><person-group person-group-type=\"author\"><name><surname>Barel</surname><given-names>O.</given-names></name><name><surname>Shalev</surname><given-names>S.A.</given-names></name><name><surname>Ofir</surname><given-names>R.</given-names></name><name><surname>Cohen</surname><given-names>A.</given-names></name><name><surname>Zlotogora</surname><given-names>J.</given-names></name><name><surname>Shorer</surname><given-names>Z.</given-names></name><name><surname>Mazor</surname><given-names>G.</given-names></name><name><surname>Finer</surname><given-names>G.</given-names></name><name><surname>Khateeb</surname><given-names>S.</given-names></name><name><surname>Zilberberg</surname><given-names>N.</given-names></name><name><surname>Birk</surname><given-names>O.S.</given-names></name></person-group><article-title>Maternally inherited Birk Barel mental retardation dysmorphism syndrome caused by a mutation in the genomically imprinted potassium channel KCNK9.</article-title><source>Am. J. Hum. Genet.</source><volume>83</volume><year>2008</year><fpage>193</fpage><lpage>199</lpage><pub-id pub-id-type=\"pmid\">18678320</pub-id></element-citation></ref><ref id=\"bib29\"><label>29</label><element-citation publication-type=\"journal\" id=\"sbref0029\"><person-group person-group-type=\"author\"><name><surname>Clarke</surname><given-names>C.E.</given-names></name><name><surname>Veale</surname><given-names>E.L.</given-names></name><name><surname>Green</surname><given-names>P.J.</given-names></name><name><surname>Meadows</surname><given-names>H.J.</given-names></name><name><surname>Mathie</surname><given-names>A.</given-names></name></person-group><article-title>Selective block of the human 2-P domain potassium channel, TASK-3, and the native leak potassium current, IKSO, by zinc.</article-title><source>J. Physiol.</source><volume>560</volume><year>2004</year><fpage>51</fpage><lpage>62</lpage><pub-id pub-id-type=\"pmid\">15284350</pub-id></element-citation></ref><ref id=\"bib30\"><label>30</label><element-citation publication-type=\"journal\" id=\"sbref0030\"><person-group person-group-type=\"author\"><name><surname>Zaks-Makhina</surname><given-names>E.</given-names></name><name><surname>Kim</surname><given-names>Y.</given-names></name><name><surname>Aizenman</surname><given-names>E.</given-names></name><name><surname>Levitan</surname><given-names>E.S.</given-names></name></person-group><article-title>Novel neuroprotective K+ channel inhibitor identified by high-throughput screening in yeast.</article-title><source>Mol. Pharmacol.</source><volume>65</volume><year>2004</year><fpage>214</fpage><lpage>219</lpage><pub-id pub-id-type=\"pmid\">14722253</pub-id></element-citation></ref><ref id=\"bib31\"><label>31</label><element-citation publication-type=\"journal\" id=\"sbref0031\"><person-group person-group-type=\"author\"><name><surname>Sannerud</surname><given-names>R.</given-names></name><name><surname>Marie</surname><given-names>M.</given-names></name><name><surname>Nizak</surname><given-names>C.</given-names></name><name><surname>Dale</surname><given-names>H.A.</given-names></name><name><surname>Pernet-Gallay</surname><given-names>K.</given-names></name><name><surname>Perez</surname><given-names>F.</given-names></name><name><surname>Goud</surname><given-names>B.</given-names></name><name><surname>Saraste</surname><given-names>J.</given-names></name></person-group><article-title>Rab1 defines a novel pathway connecting the pre-Golgi intermediate compartment with the cell periphery.</article-title><source>Mol. Biol. Cell</source><volume>17</volume><year>2006</year><fpage>1514</fpage><lpage>1526</lpage><pub-id pub-id-type=\"pmid\">16421253</pub-id></element-citation></ref><ref id=\"bib32\"><label>32</label><element-citation publication-type=\"journal\" id=\"sbref0032\"><person-group person-group-type=\"author\"><name><surname>Kano</surname><given-names>F.</given-names></name><name><surname>Yamauchi</surname><given-names>S.</given-names></name><name><surname>Yoshida</surname><given-names>Y.</given-names></name><name><surname>Watanabe-Takahashi</surname><given-names>M.</given-names></name><name><surname>Nishikawa</surname><given-names>K.</given-names></name><name><surname>Nakamura</surname><given-names>N.</given-names></name><name><surname>Murata</surname><given-names>M.</given-names></name></person-group><article-title>Yip1A regulates the COPI-independent retrograde transport from the Golgi complex to the ER.</article-title><source>J. Cell Sci.</source><volume>122</volume><year>2009</year><fpage>2218</fpage><lpage>2227</lpage><pub-id pub-id-type=\"pmid\">19509059</pub-id></element-citation></ref><ref id=\"bib33\"><label>33</label><element-citation publication-type=\"journal\" id=\"sbref0033\"><person-group person-group-type=\"author\"><name><surname>Rao</surname><given-names>Y.</given-names></name><name><surname>Ruckert</surname><given-names>C.</given-names></name><name><surname>Saenger</surname><given-names>W.</given-names></name><name><surname>Haucke</surname><given-names>V.</given-names></name></person-group><article-title>The early steps of endocytosis: from cargo selection to membrane deformation.</article-title><source>Eur. J. Cell Biol.</source><volume>91</volume><year>2012</year><fpage>226</fpage><lpage>233</lpage><pub-id pub-id-type=\"pmid\">21458101</pub-id></element-citation></ref><ref id=\"bib34\"><label>34</label><element-citation publication-type=\"journal\" id=\"sbref0034\"><person-group person-group-type=\"author\"><name><surname>Declercq</surname><given-names>J.</given-names></name><name><surname>Meulemans</surname><given-names>S.</given-names></name><name><surname>Plets</surname><given-names>E.</given-names></name><name><surname>Creemers</surname><given-names>J.W.</given-names></name></person-group><article-title>Internalization of proprotein convertase PC7 from plasma membrane is mediated by a novel motif.</article-title><source>J. Biol. Chem.</source><volume>287</volume><year>2012</year><fpage>9052</fpage><lpage>9060</lpage><pub-id pub-id-type=\"pmid\">22294700</pub-id></element-citation></ref><ref id=\"bib35\"><label>35</label><element-citation publication-type=\"journal\" id=\"sbref0035\"><person-group person-group-type=\"author\"><name><surname>Yancoski</surname><given-names>J.</given-names></name><name><surname>Sadat</surname><given-names>M.A.</given-names></name><name><surname>Aksentijevich</surname><given-names>N.</given-names></name><name><surname>Bernasconi</surname><given-names>A.</given-names></name><name><surname>Holland</surname><given-names>S.M.</given-names></name><name><surname>Rosenzweig</surname><given-names>S.D.</given-names></name></person-group><article-title>A novel internalization motif regulates human IFN-gamma R1 endocytosis.</article-title><source>J. Leukoc. Biol.</source><volume>92</volume><year>2012</year><fpage>301</fpage><lpage>308</lpage><pub-id pub-id-type=\"pmid\">22595141</pub-id></element-citation></ref></ref-list><ack id=\"acknowledgment001\"><title>Acknowledgements</title><p>We are thankful to Dr. Hana Sychrova of Academy of Sciences of the Czech Republic for providing B31 strain. This study was supported by <funding-source id=\"GS1\">National Institutes of Health</funding-source> Grant 1R01GM099974&#x02013;01 (to S.S.) and <funding-source id=\"GS2\">LUNGevity Foundation/American Cancer Society Lung Cancer Research</funding-source> Grant 2009&#x02013;07001&#x02013;00&#x02013;00 (to S.S.).</p></ack><fn-group><fn id=\"d32e69\"><label>&#x02606;</label><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p></fn></fn-group></back><floats-group><fig id=\"fig0001\"><label>Fig. 1</label><caption><p>B31 tolerance to high K<sup>+</sup> media represents the loss of Kir2.1 activity on cell surface. (A) Surface expression of Kir2.1 channels. HEK293 cells were transiently transfected with HA-tagged Kir2.1 constructs or pCDNA3.1(+) vector alone. Cells stained with the HA Ab followed by Alexa Fluor 488-conjugated secondary Ab were analyzed by flow cytometry (FCM). Histograms from the representative samples are shown (left panels). The <italic>x</italic>-axis indicates the fluorescence intensity in a logarithmic scale and <italic>y</italic>-axis indicates the cell number. The histograms of Kir2.1-transfected cells (filled) were overlaid with that of vector-transfected cells (unfilled). The bar graph (right panel) shows the Median values for the total cell populations determined by FlowJo software to compare the relative surface intensity of Wt and mutant Kir2.1 channels. The values indicate average&#x02009;&#x000b1;&#x02009;s.d. of triplicate samples from the representative of three experiments. The lower panel shows the total expression levels of Kir2.1 proteins. Total lysates from HEK293 cells transfected with HA-Kir2.1 constructs were resolved by SDS&#x02013;PAGE and immunoblotted for HA. (B) Growth assay of Kir2.1-expressing B31. The Kir2.1- or pYES2met vector-transformed B31 cells were plated on YNB media (pH 6.50) with the indicated concentrations of KCl and cultured at 30&#x02009;&#x000b0;C. The images were photographed at Day 5. (C) Expression of Kir2.1 channels in B31 cells. The proteins were extracted from B31 cells transformed with pYES2met vector or the indicated Kir2.1 constructs. The samples were resolved by SDS&#x02013;PAGE and immunoblotted for Kir2.1 (upper panel). The lower panel shows the Ponceau S staining of the transfer membrane, indicating similar loading of the proteins for each sample.</p></caption><graphic xlink:href=\"gr1\"/></fig><fig id=\"fig0002\"><label>Fig. 2</label><caption><p>B31 growth inhibition in high K<sup>+</sup> media represents KCNK channel activities on cell surface. (A) Alignment of C-terminal sequences from KCNK3 and KCNK9 channels. (B) Association of COPI and 14-3-3 proteins with KCNK3 (upper panels) and KCNK9 (lower panels). HEK293 cells transfected with HA-KCNK3 or Myc-KCNK9 were lysed and immunoprecipitated with HA or Myc Abs. The eluants were resolved by SDS&#x02013;PAGE and immunoblotted for the associating &#x003b2;-COP and 14-3-3 as well as HA (KCNK3) or Myc (KCNK9). (C) Surface expression of KCNK3 and KCNK9. HEK293 cells were transfected with HA-tagged rat KCNK3 or Myc-tagged human KCNK9 and analyzed for cell surface expression by FCM. For KCNK3 (upper panels), the expression is shown in histograms and the Median values were determined for the total cell populations as described for <xref rid=\"fig0001\" ref-type=\"fig\">Fig. 1</xref>. The histograms of KCNK3-transfected cells (filled) were overlaid with that of vector-transfected cells (unfilled). For KCNK9 (lower panels), the expression is shown in density plots (see <xref rid=\"sec0002\" ref-type=\"sec\">Section 2</xref>) where <italic>x</italic>-axis indicates the fluorescence intensity in a logarithmic scale and <italic>y</italic>-axis indicates the side scatter (SSC) of the cell. The Median values were determined for the cells that were positive for the KCNK9 signal (shown in squares within the density plots). The bar graphs indicate the Median values in average&#x02009;&#x000b1;&#x02009;s.d. of triplicate samples from the representative of three different experiments. (D) Growth assay of KCNK-expressing B31. The KCNK- or pYES2met vector-transformed B31 cells were plated on YNB media (pH 7.0 for KCNK3 and pH 6.50 for KCNK9) with indicated concentrations of KCl and cultured at 30&#x02009;&#x000b0;C. The images were photographed at Day 7. (E) The effect of pH on the growth of KCNK9-expressing B31. The B31 cells transformed with vector or KCNK9 Wt were grown in the liquid YNB media with indicated pH and 400 mM KCl. (F) The effect of zinc on the growth of KCNK9-expressing B31.The B31 cells transformed with vector or KCNK9 Wt were grown in the liquid YNB media with indicated concentrations of ZnCl<sub>2</sub> and 400 mM KCl at pH 6.50. In both of the pH and zinc tests, the OD at 600 nm was measured at the start of and after 15&#x02009;h of culture. The values after the culture was subtracted with those at the start and shown in average&#x02009;&#x000b1;&#x02009;s.d. of triplicate samples from the representative of three experiments.</p></caption><graphic xlink:href=\"gr2\"/></fig><fig id=\"fig0003\"><label>Fig. 3</label><caption><p>B31 tolerance to high K<sup>+</sup> represents the activity of trafficking signals that down-regulate surface expression of membrane proteins. (A) Sequences that were fused to the C-terminus of Kir2.1 channels. (B) Total expression levels of Kir2.1 fusions. Total lysates from HEK293 cells transfected with HA-Kir2.1 constructs were resolved by SDS&#x02013;PAGE and immunoblotted for HA. (C) Association of COPI with Kir2.1 fusions. The Kir2.1 fusions immunoprecipitated with HA Ab were resolved by SDS&#x02013;PAGE and immunoblotted for HA (lower panel) and the associating &#x003b2;-COP (upper panel). (D) Surface expression of Kir2.1 fusions. HEK293 cells were transfected with HA-Kir2.1 constructs and analyzed for cell surface expression by FCM. The histograms (left panels) of Kir2.1-transfected cells (filled) were overlaid with that of vector-transfected cells (unfilled). The Median values were determined for the total cell populations and shown in average&#x000b1;s.d. of triplicate samples from the representative of three experiments (right panel). (E) Growth assay of B31 expressing Kir2.1 fusions. The Kir2.1- or pYES2met vector-transformed B31 cells were plated on YNB media (pH 6.50) with indicated concentrations of KCl and cultured at 30&#x02009;&#x000b0;C. The images were photographed at Day 7. (F) Expression of Kir2.1 channels in B31 cells. The proteins were extracted from the B31 cells transformed with pYES2met vector or the indicated Kir2.1 constructs. The samples were resolved by SDS&#x02013;PAGE and immunoblotted for Kir2.1 (upper panel). The lower panel shows the Ponceau S staining of the transfer membrane, indicating similar loading of the proteins for each sample.</p></caption><graphic xlink:href=\"gr3\"/></fig></floats-group></article>',\n",
       " '<!DOCTYPE article PUBLIC \"-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN\" \"JATS-archivearticle1.dtd\">\\n<article xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" article-type=\"research-article\"><?properties open_access?><front><journal-meta><journal-id journal-id-type=\"nlm-ta\">Mol Biol Cell</journal-id><journal-id journal-id-type=\"iso-abbrev\">Mol. Biol. Cell</journal-id><journal-id journal-id-type=\"hwp\">molbiolcell</journal-id><journal-id journal-id-type=\"pmc\">mbc</journal-id><journal-id journal-id-type=\"publisher-id\">Mol. Bio. Cell</journal-id><journal-title-group><journal-title>Molecular Biology of the Cell</journal-title></journal-title-group><issn pub-type=\"ppub\">1059-1524</issn><issn pub-type=\"epub\">1939-4586</issn><publisher><publisher-name>The American Society for Cell Biology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type=\"pmid\">24743596</article-id><article-id pub-id-type=\"pmc\">4055267</article-id><article-id pub-id-type=\"publisher-id\">E13-10-0592</article-id><article-id pub-id-type=\"doi\">10.1091/mbc.E13-10-0592</article-id><article-categories><subj-group subj-group-type=\"heading\"><subject>Articles</subject><subj-group><subject>Membrane Trafficking</subject></subj-group></subj-group></article-categories><title-group><article-title>Cooperative endocytosis of the endosomal SNARE protein syntaxin-8 and the potassium channel TASK-1</article-title></title-group><contrib-group><contrib contrib-type=\"author\"><name><surname>Renigunta</surname><given-names>Vijay</given-names></name><xref ref-type=\"corresp\" rid=\"cor1\"><sup>1</sup></xref></contrib><contrib contrib-type=\"author\"><name><surname>Fischer</surname><given-names>Thomas</given-names></name></contrib><contrib contrib-type=\"author\"><name><surname>Zuzarte</surname><given-names>Marylou</given-names></name></contrib><contrib contrib-type=\"author\"><name><surname>Kling</surname><given-names>Stefan</given-names></name></contrib><contrib contrib-type=\"author\"><name><surname>Zou</surname><given-names>Xinle</given-names></name></contrib><contrib contrib-type=\"author\"><name><surname>Siebert</surname><given-names>Kai</given-names></name></contrib><contrib contrib-type=\"author\"><name><surname>Limberg</surname><given-names>Maren M.</given-names></name></contrib><contrib contrib-type=\"author\"><name><surname>Rinn&#x000e9;</surname><given-names>Susanne</given-names></name></contrib><contrib contrib-type=\"author\"><name><surname>Decher</surname><given-names>Niels</given-names></name></contrib><contrib contrib-type=\"author\"><name><surname>Schlichth&#x000f6;rl</surname><given-names>G&#x000fc;nter</given-names></name></contrib><contrib contrib-type=\"author\"><name><surname>Daut</surname><given-names>J&#x000fc;rgen</given-names></name><xref ref-type=\"corresp\" rid=\"cor1\"><sup>1</sup></xref></contrib><aff>Institute of Physiology and Pathophysiology, Marburg University, 35037 Marburg, Germany</aff></contrib-group><contrib-group><contrib contrib-type=\"editor\"><name><surname>Spang</surname><given-names>Anne</given-names></name><role>Monitoring Editor</role></contrib><aff>University of Basel</aff></contrib-group><author-notes><corresp id=\"cor1\"><sup>1</sup>Address correspondence to: J&#x000fc;rgen Daut (<email>jdaut@staff.uni-marburg.de</email>), Vijay Renigunta (<email>vijay@staff.uni-marburg.de</email>).</corresp></author-notes><pub-date pub-type=\"ppub\"><day>15</day><month>6</month><year>2014</year></pub-date><volume>25</volume><issue>12</issue><fpage>1877</fpage><lpage>1891</lpage><history><date date-type=\"received\"><day>15</day><month>10</month><year>2013</year></date><date date-type=\"rev-recd\"><day>07</day><month>4</month><year>2014</year></date><date date-type=\"accepted\"><day>10</day><month>4</month><year>2014</year></date></history><permissions><copyright-statement>&#x000a9; 2014 Renigunta <italic>et&#x000a0;al.</italic> This article is distributed by The American Society for Cell Biology under license from the author(s). Two months after publication it is available to the public under an Attribution&#x02013;Noncommercial&#x02013;Share Alike 3.0 Unported Creative Commons License (<ext-link ext-link-type=\"uri\" xlink:href=\"http://creativecommons.org/licenses/by-nc-sa/3.0\">http://creativecommons.org/licenses/by-nc-sa/3.0</ext-link>).</copyright-statement><copyright-year>2014</copyright-year><license license-type=\"creative-commons\"><license-p>&#x0201c;ASCB&#x000ae;,&#x0201d; &#x0201c;The American Society for Cell Biology&#x000ae;,&#x0201d; and &#x0201c;Molecular Biology of the Cell&#x000ae;&#x0201d; are registered trademarks of The American Society of Cell Biology.</license-p></license></permissions><self-uri xlink:title=\"pdf\" xlink:type=\"simple\" xlink:href=\"1877.pdf\"/><abstract abstract-type=\"precis\"><p>SNARE proteins can have functions unrelated to membrane fusion. The unassembled form of the SNARE protein syntaxin-8 interacts with the K<sup>+</sup> channel TASK-1; both proteins are internalized via clathrin-mediated endocytosis in a cooperative manner. This is a novel mechanism for the control of endocytosis by cargo proteins.</p></abstract><abstract><p>The endosomal SNARE protein syntaxin-8 interacts with the acid-sensitive potassium channel TASK-1. The functional relevance of this interaction was studied by heterologous expression of these proteins (and mutants thereof) in <italic>Xenopus</italic> oocytes and in mammalian cell lines. Coexpression of syntaxin-8 caused a fourfold reduction in TASK-1 current, a corresponding reduction in the expression of TASK-1 at the cell surface, and a marked increase in the rate of endocytosis of the channel. TASK-1 and syntaxin-8 colocalized in the early endosomal compartment, as indicated by the endosomal markers 2xFYVE and rab5. The stimulatory effect of the SNARE protein on the endocytosis of the channel was abolished when both an endocytosis signal in TASK-1 and an endocytosis signal in syntaxin-8 were mutated. A syntaxin-8 mutant that cannot assemble with other SNARE proteins had virtually the same effect as wild-type syntaxin-8. Total internal reflection fluorescence microscopy showed formation and endocytosis of vesicles containing fluorescence-tagged clathrin, TASK-1, and/or syntaxin-8. Our results suggest that the unassembled form of syntaxin-8 and the potassium channel TASK-1 are internalized via clathrin-mediated endocytosis in a cooperative manner. This implies that syntaxin-8 regulates the endocytosis of TASK-1. Our study supports the idea that endosomal SNARE proteins can have functions unrelated to membrane fusion.</p></abstract></article-meta></front><body><sec sec-type=\"intro\"><title>INTRODUCTION</title><p>Membrane proteins are shuttled between subcellular compartments by carrier vesicles that bud from donor membranes and fuse with acceptor membranes. The &#x0201c;identity&#x0201d; of these vesicles is mainly determined by 1) specific phosphoinositides (<xref rid=\"B5\" ref-type=\"bibr\">Behnia and Munro, 2005</xref>; <xref rid=\"B21\" ref-type=\"bibr\">Di Paolo and De Camilli, 2006</xref>; <xref rid=\"B39\" ref-type=\"bibr\">Lemmon, 2008</xref>), 2) specific small GTPases and their associated regulatory factors (<xref rid=\"B18\" ref-type=\"bibr\">Conner and Schmid, 2003</xref>; <xref rid=\"B38\" ref-type=\"bibr\">Lee <italic>et&#x000a0;al.</italic>, 2009</xref>; <xref rid=\"B55\" ref-type=\"bibr\">Pucadyil and Schmid, 2009</xref>), and 3) specific soluble <italic>N</italic>-ethylmaleimide&#x02013;factor attachment protein receptor (SNARE) proteins (<xref rid=\"B52\" ref-type=\"bibr\">McNew <italic>et&#x000a0;al.</italic>, 2000</xref>; <xref rid=\"B45\" ref-type=\"bibr\">Malsam <italic>et&#x000a0;al.</italic>, 2008</xref>). All of these components are capable of interacting with membrane proteins transported by the vesicles (the cargo; <xref rid=\"B21\" ref-type=\"bibr\">Di Paolo and De Camilli, 2006</xref>; <xref rid=\"B25\" ref-type=\"bibr\">Falkenburger <italic>et&#x000a0;al.</italic>, 2010</xref>). There has been growing support for the idea that there is a large variety of vesicle subtypes and that the identity and the itinerary of the carrier vesicles is at least partially determined by the cargo molecules (<xref rid=\"B36\" ref-type=\"bibr\">Lakadamyali <italic>et&#x000a0;al.</italic>, 2006</xref>; <xref rid=\"B22\" ref-type=\"bibr\">Doherty and McMahon, 2009</xref>; <xref rid=\"B44\" ref-type=\"bibr\">Loerke <italic>et&#x000a0;al.</italic>, 2009</xref>; <xref rid=\"B53\" ref-type=\"bibr\">Mettlen <italic>et&#x000a0;al.</italic>, 2010</xref>). One mechanism by which membrane proteins control their intracellular transport is the exposure of cytosolic sorting signals: short peptide motifs that interact with cytosolic proteins involved in the formation and budding of transport vesicles (<xref rid=\"B11\" ref-type=\"bibr\">Bonifacino and Glick, 2004</xref>; <xref rid=\"B66\" ref-type=\"bibr\">Traub, 2009</xref>). However, on their route between different compartments, cargo proteins also interact with many other proteins that influence their sorting decisions and trafficking kinetics (<xref rid=\"B12\" ref-type=\"bibr\">Bonifacino and Hurley, 2008</xref>; <xref rid=\"B48\" ref-type=\"bibr\">Mathie <italic>et&#x000a0;al.</italic>, 2010</xref>; <xref rid=\"B50\" ref-type=\"bibr\">McMahon and Boucrot, 2011</xref>; <xref rid=\"B61\" ref-type=\"bibr\">Smith <italic>et&#x000a0;al.</italic>, 2011</xref>). Thus the binding sites of such interacting proteins may also be regarded as trafficking signals in the wider sense, and they may provide for distinct itineraries for distinct cargoes.</p><p>The TREK-related acid-sensitive K<sup>+</sup> channel 1 (TASK-1) is a two-pore-domain potassium channel (K<sub>2P</sub> channel) that is strongly inhibited by a decrease in extracellular pH (<xref rid=\"B23\" ref-type=\"bibr\">Duprat <italic>et&#x000a0;al.</italic>, 1997</xref>). It plays an important role in the regulation of the electrical activity of neurons (<xref rid=\"B54\" ref-type=\"bibr\">Meuth <italic>et&#x000a0;al.</italic>, 2003</xref>; <xref rid=\"B4\" ref-type=\"bibr\">Bayliss and Barrett, 2008</xref>) and cardiac muscle cells (<xref rid=\"B56\" ref-type=\"bibr\">Putzke <italic>et&#x000a0;al.</italic>, 2007</xref>; <xref rid=\"B20\" ref-type=\"bibr\">Decher <italic>et&#x000a0;al.</italic>, 2011</xref>; <xref rid=\"B43\" ref-type=\"bibr\">Limberg <italic>et&#x000a0;al.</italic>, 2011</xref>), in the release of steroid hormones by the adrenal gland (<xref rid=\"B32\" ref-type=\"bibr\">Heitzmann <italic>et&#x000a0;al.</italic>, 2008</xref>; <xref rid=\"B3\" ref-type=\"bibr\">Bandulik <italic>et&#x000a0;al.</italic>, 2010</xref>), and in the immune system (<xref rid=\"B10\" ref-type=\"bibr\">Bittner <italic>et&#x000a0;al.</italic>, 2009</xref>). In the present study we obtained evidence that the K<sup>+</sup> channel TASK-1 can interact with the endosomal SNARE protein syntaxin-8, and we analyzed the mechanisms by which this SNARE protein influences the intracellular traffic of the channel.</p><p>In the human genome there are 36 different SNARE proteins, which are localized to distinct subcellular compartments. SNARE proteins are essential for the fusion of transport vesicles with their acceptor compartments (<xref rid=\"B45\" ref-type=\"bibr\">Malsam <italic>et&#x000a0;al.</italic>, 2008</xref>; <xref rid=\"B64\" ref-type=\"bibr\">S&#x000fc;dhof and Rothman, 2009</xref>). There are four subclasses of SNARE proteins, Qa-, Qb-, Qc-, and R-SNAREs, which all possess a characteristic 16-turn SNARE helix (<xref rid=\"B26\" ref-type=\"bibr\">Fasshauer <italic>et&#x000a0;al.</italic>, 1998</xref>). Four SNARE helices, one from each subclass, assemble as a tetrameric coiled-coil complex that brings two membranes into close apposition and provides the energy for membrane fusion. The neuronal SNARE complex, consisting of syntaxin-1A (stx1A), synaptosome-associated protein 25 (SNAP-25), and vesicle-associated membrane protein 2 (VAMP2), is essential for fusion of synaptic vesicles with the presynaptic membrane and subsequent release of neurotransmitters into the synaptic cleft. After disassembly of the <italic>neuronal</italic> SNARE complex in the presynaptic membrane, R-SNAREs are retrieved by clathrin-mediated endocytosis using cargo-specific sorting adaptors such as adaptor protein 180 (AP180; <xref rid=\"B47\" ref-type=\"bibr\">Maritzen <italic>et&#x000a0;al.</italic>, 2012</xref>). The Qa-SNARE stx1A interacts with voltage-activated Ca<sup>2+</sup> channels, and this interaction appears to be involved in the coupling between the electrical activity of nerve terminals and release of neurotransmitters (<xref rid=\"B30\" ref-type=\"bibr\">Hagalili <italic>et&#x000a0;al.</italic>, 2008</xref>; <xref rid=\"B1\" ref-type=\"bibr\">Atlas, 2013</xref>; <xref rid=\"B2\" ref-type=\"bibr\">Bachnoff <italic>et&#x000a0;al.</italic>, 2013</xref>). In addition, the <italic>neuronal</italic> SNARE proteins stx1A and VAMP2 were reported to interact with K<sup>+</sup> channels present in neurons, insulin-secreting cells, and cardiomyocytes (<xref rid=\"B15\" ref-type=\"bibr\">Chao <italic>et&#x000a0;al.</italic>, 2011a</xref>, <xref rid=\"B16\" ref-type=\"bibr\">b</xref>; <xref rid=\"B19\" ref-type=\"bibr\">Dai <italic>et&#x000a0;al.</italic>, 2012</xref>) and to modulate their open probability.</p><p>The <italic>endosomal</italic> SNARE complex, consisting of the R-SNARE VAMP8 and the Q-SNAREs stx7, vesicle transport through interaction with target-SNARE analogue 1b (vti1b), and stx8, plays a role in fusion of early endosomes with later endosomal compartments. The entire endosomal SNARE complex has been reported to interact with the CFTR chloride channel and to reduce its surface expression (<xref rid=\"B9\" ref-type=\"bibr\">Bilan <italic>et&#x000a0;al.</italic>, 2004</xref>, <xref rid=\"B8\" ref-type=\"bibr\">2008</xref>; <xref rid=\"B65\" ref-type=\"bibr\">Tang <italic>et&#x000a0;al.</italic>, 2011</xref>), but the underlying molecular mechanisms have not been studied. No information is available on the interaction of <italic>endosomal</italic> SNARE proteins with potassium or calcium channels, and very little is known about molecular mechanisms by which <italic>endosomal</italic> SNARE proteins are sorted to their cognate compartments.</p><p>In the present study we address the following questions: 1) Which part of the endosomal SNARE protein stx8 interacts with which part of the potassium channel TASK&#x02011;1? 2) Does the interaction with stx8 affect the gating or the intracellular traffic of TASK-1? 3) Which step of the intracellular transport of TASK-1 is modulated by stx8, and which sorting signals are involved? 4) Is it the unassembled SNARE protein stx8 or the endosomal SNARE complex that interacts with the channels? 5) How does stx8 reach its intracellular destination? 6) What is the functional role of the interaction between stx8 and TASK-1?</p></sec><sec sec-type=\"results\"><title>RESULTS</title><sec><title>Syntaxin-8 interacts with the K<sup>+</sup> channel TASK-1 and changes its surface expression</title><p>TASK-1 is a two-pore-domain potassium channel (K<sub>2P</sub> channel) with four transmembrane domains (M1&#x02013;M4), two pore domains (P1 and P1), and a long cytosolic C-terminus (amino acids 243&#x02013;394; <xref ref-type=\"fig\" rid=\"F1\">Figure 1A</xref>). To identify proteins interacting with TASK&#x02011;1, we performed a yeast two-hybrid screen with a human brain cDNA library. We used the split-ubiquitin variant of the yeast two-hybrid system since it enables the use of full-length integral membrane proteins as baits and screens for interactions with integral membrane proteins and membrane-associated proteins. The C-terminal half of ubiquitin, along with an artificial transcription factor, was fused to the C-terminus of TASK-1. Screening with a brain cDNA library coding for proteins fused to the N-terminal half of ubiquitin (NubG-x; Molecular Biotechnology) yielded 63 putative interacting proteins. One of these proteins was the endosomal SNARE syntaxin-8 (stx8). The topology of stx8 is illustrated in <xref ref-type=\"fig\" rid=\"F1\">Figure 1A</xref>. The protein has three N-terminal helices (Ha, Hb, and Hc), a SNARE domain (amino acids 145&#x02013;207), and a C-terminal transmembrane domain (amino acids 216&#x02013;233). In a specific yeast-two-hybrid assay using TASK-1 as bait and stx8 as prey, the robust interaction of TASK-1 with stx8 was confirmed (<xref ref-type=\"fig\" rid=\"F1\">Figure 1B</xref>). With the closely related channel TASK-3 (<xref rid=\"B57\" ref-type=\"bibr\">Rajan <italic>et&#x000a0;al.</italic>, 2000</xref>) as bait, no interaction with stx8 was found. A stx8 mutant that cannot form SNARE complexes (stx8<sup>Q179A</sup>; because it lacks the critical glutamine residue in the &#x0201c;0&#x0201d; layer; <xref rid=\"B26\" ref-type=\"bibr\">Fasshauer <italic>et&#x000a0;al.</italic>, 1998</xref>) also showed robust interaction with TASK-1 (<xref ref-type=\"fig\" rid=\"F1\">Figure 1B</xref>). In contrast, a mutant of stx8 in which the linker between the Hc helix and the SNARE domain was removed (stx8<sup>&#x00394;100-140</sup>) showed no interaction (<xref ref-type=\"fig\" rid=\"F1\">Figure 1B</xref>).</p><fig id=\"F1\" position=\"float\"><label>FIGURE 1:</label><caption><p>The K<sub>2P</sub> channel TASK-1 interacts with the SNARE protein syntaxin-8. (A) The topology of TASK-1 and stx8. (B) Membrane yeast two-hybrid screen with TASK-1 or TASK-3 as bait and stx8 or mutants thereof as prey. The Q179A mutant of stx8 cannot assemble with other SNARE proteins; in the &#x00394;100&#x02013;140 mutant the linker between the Hc domain and the SNARE domain was excised. (C) RT-PCR analysis of TASK-1 and endosomal SNARE proteins in human brain and in A549 cells. Asterisks represent nonspecific PCR products. (D) Coimmunoprecipitation of stx8 and TASK-1 endogenously expressed in A549 cells. The complex containing TASK-1 was precipitated from cell lysate with a TASK-1&#x02013;specific antibody from Alomone (APC-024), and a Western blot of the precipitate was probed with TASK-1, stx8, and stx7 antibodies (left); the cell lysate (input) was used as positive control. Coimmunoprecipitation with an unrelated immunoglobulin G antibody (Santa Cruz Biotechnology) was used as a negative control (right).</p></caption><graphic xlink:href=\"1877fig1\"/></fig><p>In all of our membrane yeast-two hybrid experiments we used the positive and negative controls provided by the manufacturer (Supplemental Figure S1A). The positive controls clearly indicate that the <italic>bait</italic> proteins are expressed in the yeast strain. However, the negative result obtained with the <italic>prey</italic> protein stx8<sup>&#x00394;100-140</sup> (<xref ref-type=\"fig\" rid=\"F1\">Figure 1B</xref>) might also be attributable to the lack of expression of this protein in yeast. Therefore we tested the expression of stx8 and its mutants in the yeast strain using Western blot analysis. We found that stx8, stx8<sup>Q179A</sup>, and stx8<sup>&#x00394;100-140</sup> were robustly expressed (Supplemental Figure S1B).</p><p>The interaction between TASK-1 and stx8 was confirmed by coimmunoprecipitation experiments. Myelocytomatosis oncogene&#x02013;derived dekapeptide (myc)&#x02013;tagged stx8 (<sub>myc</sub>stx8) or stx7 (<sub>myc</sub>stx7) was coexpressed with green fluorescent protein (GFP)&#x02013;tagged human TASK&#x02011;1 (<sub>GFP</sub>TASK-1). Stx8 and stx7 were precipitated with anti-myc antibodies, and the precipitate was probed with anti-myc and anti-GFP antibodies. We found that <sub>GFP</sub>TASK-1 was coimmunoprecipitated with <sub>myc</sub>stx8 but not with <sub>myc</sub>stx7 (Supplemental Figure S2). We then performed coimmunoprecipitation experiments with cells that endogenously express TASK-1 and stx8. We analyzed the expression of the channel and all four endosomal SNARE proteins by reverse transcriptase (RT) PCR in several cell lines; the functionality of the primers was tested with human brain cDNA (<xref ref-type=\"fig\" rid=\"F1\">Figure 1C</xref>). We found that A549 cells (a human alveolar adenocarcinoma cell line) express TASK-1, stx8, stx7, vti1b (weakly), and VAMP8 (<xref ref-type=\"fig\" rid=\"F1\">Figure 1C</xref>). We precipitated the protein complex containing TASK-1 from the lysate of these cells using an anti&#x02013;TASK-1 antibody from Alomone (APC-024). The Western blot of the precipitate showed a band of the predicted size of stx8 (red arrow, <xref ref-type=\"fig\" rid=\"F1\">Figure 1D</xref>), which was also found in the lysate. No band corresponding to stx7 was detected in the precipitate (<xref ref-type=\"fig\" rid=\"F1\">Figure 1D</xref>). Thus TASK&#x02011;1 and stx8 could be coprecipitated from nontransfected mammalian cells, which supports the idea that this interaction may be functionally relevant.</p><p>To study the functional consequences of the interaction between TASK-1 and stx8, we expressed the two proteins in another mammalian cell line (CHO cells, which do not express TASK&#x02011;1), and measured the acid-sensitive TASK-1 current (<xref rid=\"B23\" ref-type=\"bibr\">Duprat <italic>et&#x000a0;al.</italic>, 1997</xref>) using the patch-clamp technique. When the cells were transfected with rat TASK-1, a typical outwardly rectifying potassium current was recorded that could be blocked by extracellular acidification (<xref ref-type=\"fig\" rid=\"F2\">Figure 2A</xref>). When the cells were cotransfected with rat TASK-1 and <sub>myc</sub>stx8, the shape of the current&#x02013;voltage relation was unchanged, but the amplitude of the currents was reduced to &#x0223c;50% of control (<xref ref-type=\"fig\" rid=\"F2\">Figure 2, B and C</xref>). Coexpression of <sub>myc</sub>stx7 had no effect on TASK-1 currents (<xref ref-type=\"fig\" rid=\"F2\">Figure 2C</xref>). Cotransfection of <italic>human</italic> TASK-1 with <sub>myc</sub>stx8 or <sub>myc</sub>stx7 gave similar results as <italic>rat</italic> TASK-1 (Supplemental Figure S3). Western blot and immunohistochemistry showed that the expression of <sub>myc</sub>stx8 and <sub>myc</sub>stx7 was approximately equal (Supplemental Figure S4).</p><fig id=\"F2\" position=\"float\"><label>FIGURE 2:</label><caption><p>Coexpression of TASK-1 with stx8 or stx7 in CHO cells and <italic>Xenopus</italic> oocytes. (A) Current&#x02013;voltage relation of rTASK-1 expressed in CHO cells. The currents were measured using voltage ramps from &#x02212;120 to +40 mV at pH 7.4 (black curve) and 6.0 (red curve). (B) TASK-1 current&#x02013;voltage relation measured in the same batches of CHO cells 48 h after transfection of TASK-1 alone (black curve) and after cotransfection of TASK-1 with stx8 (green curve); mean values &#x000b1; SEM of <italic>n</italic> = 28 cells. (C) Mean outward currents &#x000b1; SEM measured in CHO cells at 0 mV after transfection with rat TASK&#x02011;1 alone (black) and after cotransfection of TASK-1 with stx8 (green) or stx7 (orange). (D) Typical current&#x02013;voltage relation measured 48 h after injection of human TASK-1 cRNA (black curve) and after coinjection of TASK-1 and stx8 cRNA. For experiments with human TASK-1 we used the <sup>NQ</sup>TASK-1 mutant, which displays a higher current amplitude (<xref rid=\"B68\" ref-type=\"bibr\">Zuzarte <italic>et&#x000a0;al.</italic>, 2009</xref>; <italic>Materials and Methods</italic>). (E) Mean outward currents &#x000b1; SEM measured in <italic>Xenopus</italic> oocytes at 0 mV after injection of hTASK&#x02011;1 or hTASK-3 cRNA alone (black) or together with 1.5, 3, or 6 ng stx8 cRNA per oocyte as indicated. (F) Mean outward currents &#x000b1; SEM measured in <italic>Xenopus</italic> oocytes at 0 mV measured after injection of hTASK&#x02011;1 cRNA alone (black) or together with 6 ng cRNA encoding stx8, VAMP8, vti1b, or stx7. (G) Mean surface expression of HA-tagged hTASK-1 channels (measured in relative light units [RLUs]) in <italic>Xenopus</italic> oocytes after injection of TASK-1 cRNA alone or together with 6 ng of stx8 or stx8<sup>Q179A</sup>. (H) Mean hTASK-1 current measured in <italic>Xenopus</italic> oocytes after injection of hTASK-1 cRNA alone or together with stx8 or stx8<sup>Q179A</sup>. In all bar graphs the number of oocytes or CHO cells from which the data were obtained is indicated in brackets. Note that in the series of experiments shown in E, F, and H, coinjection of 6 ng of stx8 cRNA caused a reduction of TASK-1 current to values between 13 and 23% of control, illustrating that there was a certain degree of variability among different batches of oocytes. For this reason, TASK-1 (and other) currents with and without coinjection of a second cRNA were always compared in the same batch of oocytes (measured on the same day); normalized current amplitudes of at least three different batches are combined in the bar graphs.</p></caption><graphic xlink:href=\"1877fig2\"/></fig><p>We then studied the effects of stx8 on hTASK-1 currents expressed in <italic>Xenopus</italic> oocytes. Coexpression of stx8 reduced current amplitude but did not change the shape of the current&#x02013;voltage relation (<xref ref-type=\"fig\" rid=\"F2\">Figure 2D</xref>). The extent of the reduction of TASK&#x02011;1 current depended on the amount of complementary RNA (cRNA) injected into the oocytes (<xref ref-type=\"fig\" rid=\"F2\">Figure 2E</xref>). In contrast, the amplitude of TASK&#x02011;3 currents was not reduced by coexpression of stx8 (<xref ref-type=\"fig\" rid=\"F2\">Figure 2E</xref>). We then asked whether the three other components of the endosomal SNARE complex can also interact with TASK-1. We found that coexpression of vti1b, VAMP8, or stx7 had no effect on the amplitude of TASK-1 currents (<xref ref-type=\"fig\" rid=\"F2\">Figure 2F</xref>).</p><p>The current (<italic>I</italic>) produced by ion channels is given by <italic>I</italic> = &#x003b3;<italic>NP</italic><sub>o</sub>, where &#x003b3; is the single-channel conductance, <italic>N</italic> is the number of ion channels at the surface membrane, and <italic>P</italic><sub>o</sub> is the open-state probability. To find out which of these parameters was changed by coexpression of stx8, we attached an extracellular hemagglutinin (HA) tag to TASK-1 and measured its surface expression with an enzyme-linked luminometric assay (<xref rid=\"B68\" ref-type=\"bibr\">Zuzarte <italic>et&#x000a0;al.</italic>, 2009</xref>). Coexpression of stx8 reduced the surface expression of TASK-1 in <italic>Xenopus</italic> oocytes to &#x0223c;24% (<xref ref-type=\"fig\" rid=\"F2\">Figure 2G</xref>), which is similar to the relative reduction in current amplitude produced by stx8 in <italic>Xenopus</italic> oocytes (<xref ref-type=\"fig\" rid=\"F2\">Figure 2, E and F</xref>). This finding suggests that the reduction in TASK-1 current observed in the presence of stx8 was due to a reduction of the copy number (<italic>N</italic>) of TASK&#x02011;1 channels at the surface membrane.</p></sec><sec><title>Dissection of the interacting regions of stx8 and TASK-1</title><p>We then asked whether the formation of a SNARE complex was necessary for the interaction between TASK-1 and stx8. To clarify this, we used a mutant of syntaxin-8, stx8<sup>Q179A</sup>, that is unable to form SNARE complexes (<xref rid=\"B26\" ref-type=\"bibr\">Fasshauer <italic>et&#x000a0;al.</italic>, 1998</xref>; <xref rid=\"B34\" ref-type=\"bibr\">Jahn and Scheller, 2006</xref>). We found that stx8<sup>Q197A</sup> caused a similar reduction of TASK-1 surface expression and TASK-1 current as wild-type stx8 (<xref ref-type=\"fig\" rid=\"F2\">Figure 2, G and H</xref>). These findings suggest that it is the unassembled form of stx8 that interacts with TASK-1.</p><p>To identify the region of stx8 that interacts with TASK-1 channels, we constructed chimeras between stx8 and stx7 (which does not interact with the channel) and coexpressed them with TASK-1. We found that chimera 1 (<xref ref-type=\"fig\" rid=\"F3\">Figure 3A</xref>), in which the SNARE motif of stx8 was replaced by that of stx7, had the same effect on current amplitude as wild-type stx8 (<xref ref-type=\"fig\" rid=\"F3\">Figure 3B</xref>), which suggests that this construct was fully capable of interacting with TASK-1. Similar results were obtained with chimera 2, in which both the SNARE motif and the C-terminus of stx8 were replaced by the corresponding domains of stx7 (<xref ref-type=\"fig\" rid=\"F3\">Figure 3, A and B</xref>). However, chimera 3, in which, in addition, the linker between the Hc helix and the SNARE domain of stx8 was replaced, had no significant effect on current amplitude (<xref ref-type=\"fig\" rid=\"F3\">Figure 3, A and B</xref>). We then repeated these experiments with myc-tagged chimeras and obtained very similar results (Supplemental Figure S5, A and B). Western blotting with anti-myc antibodies showed that wild-type stx8 and the three stx8/stx7 chimeras were all strongly (and about equally) expressed in <italic>Xenopus</italic> oocytes (Supplemental Figure S5C). These results are consistent with the idea that the linker region (amino acids 100&#x02013;140) proximal to the SNARE motif of stx8 interacts with the channel.</p><fig id=\"F3\" position=\"float\"><label>FIGURE 3:</label><caption><p>Dissection of the interacting regions of stx8 and TASK-1. (A) Topology of stx8, stx7, and the stx8/stx7 chimeras. (B) TASK-1 currents measured in <italic>Xenopus</italic> oocytes expressing TASK-1 and stx8 or stx8/stx7 chimeras. (C) Normalized hTASK-1 currents measured in <italic>Xenopus</italic> oocytes expressing hTASK-1 and stx8 or deletion mutants of stx8. (D) Normalized currents measured in <italic>Xenopus</italic> oocytes expressing TASK-3/TASK-1 or TASK-1/TASK-3 chimeras alone or together with stx8 or stx8Q179A. (E) Schematic drawing of TASK-3/TASK-1 and TASK-1/TASK-3 chimeras.</p></caption><graphic xlink:href=\"1877fig3\"/></fig><p>To confirm the data obtained with the chimeras, we excised amino acids 100&#x02013;140 of stx8 and measured the effect of this deletion mutant on TASK-1 current in <italic>Xenopus</italic> oocytes. Coexpression of stx8<sup>&#x00394;100-140</sup> had no effect on TASK-1 current (<xref ref-type=\"fig\" rid=\"F3\">Figure 3C</xref>). This result is in agreement with our yeast two-hybrid analysis, which also showed no interaction with the stx8<sup>&#x00394;100-140</sup> mutant (<xref ref-type=\"fig\" rid=\"F1\">Figure 1B</xref>). By attaching a myc tag to the deletion mutant, we verified that the protein expression of stx8<sup>&#x00394;100-140</sup> in <italic>Xenopus</italic> oocytes was comparable to that of wild-type stx8 (Supplemental Figure S5, B and C). Coexpression of stx8<sup>&#x00394;100-119</sup> or stx8<sup>&#x00394;120-139</sup> had a smaller effect on TASK-1 current than wild-type stx8 (<xref ref-type=\"fig\" rid=\"F3\">Figure 3C</xref>). Interestingly, a mutant of stx8 in which the transmembrane region was removed (stx<sup>&#x00394;216&#x02011;233</sup>) had no significant effect in TASK-1 current (<xref ref-type=\"fig\" rid=\"F3\">Figure 3C</xref>, right), which suggests that stx8 needs to be anchored in the membrane for the interaction with TASK&#x02011;1 to occur. Taken together, the results of our yeast two-hybrid analysis (<xref ref-type=\"fig\" rid=\"F1\">Figure 1B</xref>), our stx8/stx7 chimera experiments (<xref ref-type=\"fig\" rid=\"F3\">Figure 3, A and B</xref>), and our deletion mutants (<xref ref-type=\"fig\" rid=\"F3\">Figure 3C</xref>) suggest that the linker region between the Hc helix and the SNARE domain of stx8 is necessary for the interaction with TASK-1 channels.</p><p>To learn which part of TASK-1 may be responsible for the interaction with stx8, we used another set of chimeras (<xref ref-type=\"fig\" rid=\"F3\">Figure 3, D and E</xref>) in which the C-terminus of TASK-3 was attached to TASK-1 (T1/T3 chimeras) or vice versa (T3/T1 chimeras; <xref rid=\"B58\" ref-type=\"bibr\">Renigunta <italic>et&#x000a0;al.</italic>, 2006</xref>). In the T1/T3 chimeras, stx8 had only a relatively small effect; in the T3/T1 chimeras, the reduction in current amplitude produced by coexpression of stx8 was as large as in wild-type TASK-1 channels (<xref ref-type=\"fig\" rid=\"F3\">Figure 3D</xref>). These experiments suggest that it is (mainly) the C-terminus of TASK-1 that interacts with stx8. The current produced by the T3/T1 chimera was reduced by stx8 and by stx8<sup>Q179A</sup> to a similar extent (<xref ref-type=\"fig\" rid=\"F3\">Figure 3D</xref>), in agreement with the results obtained with TASK-1 (<xref ref-type=\"fig\" rid=\"F2\">Figure 2, G and H</xref>).</p></sec><sec><title>Cooperative endocytosis of TASK-1 and syntaxin-8</title><p>In searching for the possible mechanisms underlying the decrease in the surface expression of TASK-1 caused by stx8, we noted that both proteins harbor putative endocytosis signals (<xref rid=\"B13\" ref-type=\"bibr\">Bonifacino and Traub, 2003</xref>): TASK-1 has the sequence motif <bold>Y</bold>AE<bold>V</bold><sup>300-303</sup>, and stx8 has the sequence motif <bold>D</bold>RRQN<bold>LL</bold><sup>77-83</sup> (<xref ref-type=\"fig\" rid=\"F1\">Figure 1A</xref>). We tested the hypothesis that stx8 may stimulate clathrin-mediated endocytosis of TASK-1 by coexpressing the channel and the SNARE protein with the C-terminus of the clathrin adaptor AP180 (AP180C), a construct that blocks clathrin-mediated endocytosis (<xref rid=\"B22\" ref-type=\"bibr\">Doherty and McMahon, 2009</xref>). Coexpression of TASK-1 with AP180C in oocytes caused a significant increase in TASK-1 current (<xref ref-type=\"fig\" rid=\"F4\">Figure 4A</xref>), consistent with the idea that there may be constitutive endocytosis of TASK-1 channels (<xref rid=\"B46\" ref-type=\"bibr\">Mant <italic>et&#x000a0;al.</italic>, 2013</xref>). Furthermore, the effect of stx8 on TASK-1 current was substantially reduced by coexpression of AP180C (<xref ref-type=\"fig\" rid=\"F4\">Figure 4A</xref>). These findings support the idea that the effects of stx8 on TASK-1 surface expression were at least partially due to stimulation of clathrin-mediated endocytosis. When we mutated the dileucine motif of stx8 to two alanines (stx8<sup>LL82,83AA</sup>), the effect of stx8 on wild-type TASK-1 current amplitude was diminished (<xref ref-type=\"fig\" rid=\"F4\">Figure 4B</xref>). Similarly, when we replaced the tyrosine residue at position 300 in TASK-1 by alanine (TASK&#x02011;1<sup>Y300A</sup>), the effect of wild-type stx8 on TASK-1 current amplitude was diminished (<xref ref-type=\"fig\" rid=\"F4\">Figure 4B</xref>). When we mutated both motifs, the effect of stx8 on TASK-1 currents was completely abolished (<xref ref-type=\"fig\" rid=\"F4\">Figure 4B</xref>).</p><fig id=\"F4\" position=\"float\"><label>FIGURE 4:</label><caption><p>Clathrin-mediated endocytosis of TASK-1. (A) The effects of stx8 on TASK-1 currents in <italic>Xenopus</italic> oocytes with and without coexpression of AP180C, a suppressor of clathrin-mediated endocytosis. (B) The effects of mutating the dileucine-based endocytosis signal in stx8, the tyrosine-based endocytosis signal in TASK-1, or both on the amplitude of TASK-1 currents. For each batch of oocytes the currents were normalized to the currents measured with TASK-1 (or the mutant TASK-1<sup>Y300A</sup>) alone. (C) The effect of mutating the two endocytosis signals on the surface expression of HA-tagged TASK&#x02011;1 in <italic>Xenopus</italic> oocytes. The surface expression was measured using an antibody-based luminometric assay (<italic>Materials and Methods</italic>).</p></caption><graphic xlink:href=\"1877fig4\"/></fig><p>Very similar results were obtained in a surface expression assay in <italic>Xenopus</italic> oocytes (<xref ref-type=\"fig\" rid=\"F4\">Figure 4C</xref>). Wild-type stx8 reduced the surface expression of wild-type TASK-1, but no significant effect of the SNARE protein on the surface expression of the channel was observed when the endocytosis signals of TASK-1 and stx8 were mutated. Because both the tyrosine-based and the leucine-based endocytosis signals interact with the AP&#x02011;2 adapter proteins of the clathrin coat (<xref rid=\"B66\" ref-type=\"bibr\">Traub, 2009</xref>; <xref rid=\"B49\" ref-type=\"bibr\">Mattera <italic>et&#x000a0;al.</italic>, 2011</xref>), our results raise the possibility that the endocytosis signals on TASK&#x02011;1 and stx8 may act in a cooperative manner to promote endocytosis of both proteins (see <italic>Discussion</italic>).</p><p>This idea was tested using an antibody uptake assay (<xref ref-type=\"fig\" rid=\"F5\">Figure 5</xref>). The HA-tagged TASK-1 channels at the cell surface were decorated with a primary antibody at 4&#x000b0;C for 60 min. To initiate endocytosis, the cells were rewarmed to 37&#x000b0;C for 0, 15, and 30 min. At the end of the rewarming period, the cells were fixed with paraformaldehyde, and the channels at the cell surface were labeled with an Alexa Fluor 594&#x02013;conjugated secondary antibody (red). Then the cells were permeabilized, and the internalized TASK-1 channels were labeled with an Alexa Fluor 488&#x02013;conjugated secondary antibody (green). The green fluorescence signal in our assay represents the <italic>net</italic> uptake of the channels into the cells; channels recycled during the rewarming period would be included in the red fluorescence signal. Coexpression of stx8 led to a dramatic increase in the net uptake of HA-tagged TASK-1 channels, that is, a greater green/red ratio (<xref ref-type=\"fig\" rid=\"F5\">Figure 5, A and B</xref>). In the presence of stx8, the increase in green fluorescence (indicating endocytosis) was detectable 15 min after rewarming; after 30 min, green fluorescence was increased about ninefold compared with control cells (not cotransfected with stx8). In contrast, coexpression of stx7 did not induce internalization of TASK-1 channels (<xref ref-type=\"fig\" rid=\"F5\">Figure 5, A and B</xref>). Subsequently we mutated the endocytosis motifs of both TASK-1 and stx8 and repeated the antibody uptake assay. Consistent with our current measurements, coexpression of rTASK-1<sup>Y317A</sup> with stx8<sup>LL82,83AA</sup> was associated with a negligibly small antibody uptake (<xref ref-type=\"fig\" rid=\"F5\">Figure 5, A and B</xref>). These data are consistent with the hypothesis that TASK-1 and stx8 are endocytosed in a cooperative manner.</p><fig id=\"F5\" position=\"float\"><label>FIGURE 5:</label><caption><p>Analysis of endocytosis of TASK-1 using an antibody uptake assay. (A) COS-7 cells expressing HA epitope&#x02013;tagged TASK-1 (or TASK-1 mutants) and stx8 (or stx8 mutants) were incubated with an anti-HA antibody at 4&#x000b0;C to label the channels at the cell surface and then warmed to 37&#x000b0;C to initiate internalization. After incubation at 37&#x000b0;C for 30 min, the anti-HA&#x02013;labeled channels that remained on the surface were detected with a secondary antibody labeled with Alexa Fluor 594 (red). Then the cells were permeabilized, and the internalized channels were detected with a different secondary antibody, labeled with Alexa Fluor 488 (green). The measurements were carried out 48 h after transfection of TASK-1, TASK-1 mutants, stx8, stx8 mutants, or stx7. Note that rTASK&#x02011;1<sup>Y317A</sup> corresponds to hTASK-1<sup>Y300A</sup>. (B) Statistical evaluation of the antibody uptake assay under different conditions. The ratio between the fluorescence of internalized channels (green) and channels at the cell surface (red) was calculated at 0 and 30 min after heating to 37&#x000b0;C; number of cells is indicated in brackets. Scale bars, 50 &#x003bc;m.</p></caption><graphic xlink:href=\"1877fig5\"/></fig></sec><sec><title>TASK-1 and syntaxin-8 colocalize in an endosomal compartment</title><p>To visualize the subcellular compartment in which TASK-1 and stx8 are localized, we cotransfected constructs tagged with enhanced GFP (EGFP) and mCherry, respectively, in HeLa cells. Live-cell images showed that the channel and the SNARE protein mainly localized to vesicular structures throughout the cytoplasm (<xref ref-type=\"fig\" rid=\"F6\">Figure 6, A&#x02013;G</xref>). A relatively high number of these vesicles showed perinuclear localization, but some vesicles were also found in the periphery of the cells. A large fraction of the vesicles were labeled with both TASK-1 (green) and stx8 (red). The vesicles were highly mobile, as can be seen in Supplemental Video S1. Previous studies also reported localization of stx8 to early endosomes (<xref rid=\"B63\" ref-type=\"bibr\">Subramaniam <italic>et&#x000a0;al.</italic>, 2000</xref>; <xref rid=\"B35\" ref-type=\"bibr\">Kasai and Akagawa, 2001</xref>).</p><fig id=\"F6\" position=\"float\"><label>FIGURE 6:</label><caption><p>Live-cell imaging of HeLa cells cotransfected with mCherry-tagged stx8 and EGFP-tagged hTASK-1. (A&#x02013;G) Cotransfection of TASK-1 and stx8; the Pearson coefficient was 0.89 &#x000b1; 0.02 (<italic>n</italic> = 7 cotransfection experiments, 37 cells). Plain arrows indicate colocalization; crossed arrows indicate lack of colocalization. (D&#x02013;F) Higher magnifications of the region indicated by the square in C. (H&#x02013;N) Cotransfection of TASK-1 and stx8<sup>Q179A</sup>; the Pearson coefficient was 0.86 &#x000b1; 0.02 (<italic>n</italic> = 4 cotransfection experiments, 33 cells). (O&#x02013;Q) Cotransfection of TASK-1 with stx8<sup>&#x00394;216-233</sup>; the Pearson coefficient was 0.41 &#x000b1; 0.03 (<italic>n</italic> = 4 transfection experiments, 33 cells). (K&#x02013;M) Higher magnifications of the regions indicated by the square in J. All images were taken 48 h after transfection. Scale bars, 5 &#x003bc;m (A&#x02013;C, G&#x02013;I), 1 &#x003bc;m (D&#x02013;F, K&#x02013;M). (G, N) Intensity profiles of F and M (green line, EGFP; red line, mCherry). For calculating the Pearson coefficient, the entire cell was selected as region of interest.</p></caption><graphic xlink:href=\"1877fig6\"/></fig><p>The mutant stx8<sup>Q179A</sup>, which cannot be incorporated in the SNARE complex, was localized to apparently the same very mobile vesicular compartment (Supplemental Videos S2 and S3) and showed virtually the same colocalization with TASK-1 as wild-type stx8 (<xref ref-type=\"fig\" rid=\"F6\">Figure 6, H&#x02013;N</xref>); the Pearson coefficient was 0.86 &#x000b1; 0.02. These findings are consistent with the idea that it is the unassembled SNARE protein that interacts with the channel. It should be noted that not all of the stx8 protein localized to intracellular vesicles; a fraction of stx8 and stx8<sup>Q179A</sup> localized to the surface membrane, as indicated by distinct labeling of the surface membrane in HeLa cells (Supplemental Figure S6). The stx8 mutant in which the transmembrane domain was removed (stx8<sup>&#x00394;216-233</sup>) showed diffuse localization in the cytoplasm (<xref ref-type=\"fig\" rid=\"F6\">Figure 6, O&#x02013;Q</xref>) and had no significant effect on TASK-1 currents (<xref ref-type=\"fig\" rid=\"F3\">Figure 3C</xref>).</p><p>To identify the intracellular compartment in which TASK-1 channels reside, we used the endosomal marker 2&#x000d7;FYVE (<xref rid=\"B28\" ref-type=\"bibr\">Gillooly <italic>et&#x000a0;al.</italic>, 2000</xref>, <xref rid=\"B29\" ref-type=\"bibr\">2001</xref>; <xref rid=\"B63\" ref-type=\"bibr\">Subramaniam <italic>et&#x000a0;al.</italic>, 2000</xref>). We found that TASK-1 and 2&#x000d7;FYVE colocalized in a large fraction of the vesicular structures observed (<xref ref-type=\"fig\" rid=\"F7\">Figure 7, A&#x02013;G</xref>). In addition, we found partial colocalization TASK-1 with the marker of the early endosome, Rab5 (<xref ref-type=\"fig\" rid=\"F7\">Figure 7, H&#x02013;N</xref>). These findings suggest that the bulk of the heterologously expressed TASK-1 and stx8 proteins colocalized in an endosomal compartment.</p><fig id=\"F7\" position=\"float\"><label>FIGURE 7:</label><caption><p>Live-cell imaging of HeLa cells cotransfected with fluorescence-labeled TASK-1 and the endosomal marker 2xFYVE or rab5. (A&#x02013;G) Cotransfection of mCherry-tagged TASK-1 and EGFP-tagged 2xFYVE. Similar results were obtained in <italic>n</italic> = 3 transfections. Plain arrows indicate colocalization; crossed arrows indicate lack of colocalization. (H&#x02013;N) Cotransfection of mCherry-tagged rab5 and EGFP-tagged TASK-1. (D&#x02013;F, K&#x02013;M) Higher magnifications of the regions indicated by the squares in C and J. (G, N) Intensity profiles of F and M (green line, EGFP; red line, mCherry/DsRed). All images were taken 48 h after transfection. Similar results were obtained in <italic>n</italic> = 3 transfections. Scale bars, 5 &#x003bc;m (A&#x02013;C, H&#x02013;J), 1 &#x003bc;m (D&#x02013;F, K&#x02013;M).</p></caption><graphic xlink:href=\"1877fig7\"/></fig></sec><sec><title>Analysis of the endocytosis of TASK-1 and stx8 by total internal reflection fluorescence microscopy</title><p>Finally, we used total internal reflection fluorescence (TIRF) microscopy at 30&#x000b0;C to test our hypothesis that TASK-1 channels and stx8 may be taken up cooperatively into an endosomal compartment. After transfection of EGFP-tagged clathrin light chain into HeLa cells, we observed relatively large static patches and rapidly appearing and disappearing small spots of 200&#x02013;400 nm diameter (Supplemental Video S4), indicative of constitutive clathrin-mediated endocytosis. Transfection of mCherry-tagged stx8 showed some diffuse fluorescence and numerous small spots appearing and disappearing (Supplemental Video S5), which most likely represent the formation and budding of clathrin-coated pits and the fission of clathrin-coated vesicles. Transfection of TASK-1 showed similar dynamic spots (Supplemental Video S6).</p><p>Dynamic TIRF microscopy measurements after transfection with two labeled proteins required a change of filter sets and laser wavelength after each frame and therefore could only be carried out at a relatively low frame rate (0.2 Hz). Thus many of the short-lasting endocytic events were probably missed. Nevertheless, we succeeded in recording simultaneous endocytosis of TASK-1 channels and syntaxin-8 (<xref ref-type=\"fig\" rid=\"F8\">Figure 8</xref>). <xref ref-type=\"fig\" rid=\"F8\">Figure 8</xref>, A and C, shows TASK-1 and stx8 spots of &#x0223c;200 nm diameter appearing in consecutive frames taken at an interval of &#x0223c;5 s; colocalization of the two proteins was observed in two neighboring spots for at least 30 s. <xref ref-type=\"fig\" rid=\"F8\">Figure 8</xref>, B and D, shows one spot with a shorter-lived colocalization of TASK-1 and stx8 (&#x0003c;5s). These data suggest that the channel and the SNARE protein were indeed endocytosed in the same vesicles.</p><fig id=\"F8\" position=\"float\"><label>FIGURE 8:</label><caption><p>TIRF microscopy of TASK-1 and stx8. (A, B) HeLa cells transfected with EGFP-tagged hTASK-1 and mCherry-tagged stx8; scale bars, 5 &#x003bc;m. (C) Sequence of TIRF images taken from the cell shown in A; scale bars, 0.5 &#x003bc;m. The two bottom rows show the red and green channels (<italic>Materials and Methods</italic>). TASK-1 and stx8 are colocalized in diffraction-limited spots for at least 37 s. (D) Sequence of TIRF images taken from the cell shown in B; scale bars, 0.5 &#x003bc;m. The two bottom rows show the red and green channels (<italic>Materials and Methods</italic>). TASK-1 and stx8 are colocalized in diffraction-limited spots for at least 4.6 s.</p></caption><graphic xlink:href=\"1877fig8\"/></fig></sec></sec><sec sec-type=\"discussion\"><title>DISCUSSION</title><p>We found that the acid-sensitive potassium channel TASK-1 interacts with the endosomal SNARE protein syntaxin-8 and tried to elucidate the functional consequences of this interaction. Potassium channels regulate many cellular functions. Activation or inhibition of potassium channels can change the membrane potential of electrically inexcitable cells or regulate the time course of the repolarization of action potentials in excitable cells; these changes in turn modulate Ca<sup>2+</sup> influx into the cells and thus influence gene expression and the activity of various enzymes. The functional connection between potassium channels and SNARE proteins is not immediately obvious. In the exocytic and in the endocytic pathway, membrane proteins are shuttled between different intracellular compartments via transport vesicles. Membrane fusion of donor vesicles with the acceptor compartment, mediated by SNARE proteins, is the final and irreversible event in each step of intracellular traffic. Many SNARE proteins reside predominantly in specific compartments and may thus contribute the specificity and directionality of transport along different trafficking routes (<xref rid=\"B45\" ref-type=\"bibr\">Malsam <italic>et&#x000a0;al.</italic>, 2008</xref>; <xref rid=\"B64\" ref-type=\"bibr\">S&#x000fc;dhof and Rothman, 2009</xref>). Recently, the concept has emerged that SNARE proteins may have physiological roles other than membrane fusion (<xref rid=\"B6\" ref-type=\"bibr\">Bezprozvanny <italic>et&#x000a0;al.</italic>, 1995</xref>; <xref rid=\"B42\" ref-type=\"bibr\">Leung <italic>et&#x000a0;al.</italic>, 2007</xref>; <xref rid=\"B30\" ref-type=\"bibr\">Hagalili <italic>et&#x000a0;al.</italic>, 2008</xref>; <xref rid=\"B60\" ref-type=\"bibr\">Singer-Lahat <italic>et&#x000a0;al.</italic>, 2008</xref>; <xref rid=\"B1\" ref-type=\"bibr\">Atlas, 2013</xref>; <xref rid=\"B2\" ref-type=\"bibr\">Bachnoff <italic>et&#x000a0;al.</italic>, 2013</xref>).</p><p>The evidence that TASK-1 robustly and specifically interacts with stx8 is based on the following observations: 1) The interaction between TASK-1 and stx8 was found under stringent conditions in membrane yeast-two-hybrid analysis. 2) The interaction was confirmed by coimmunoprecipitation of TASK-1 and stx8 in a cell line that endogenously expresses the two proteins. 3) Coexpression of stx8 with TASK-1 in oocytes and cultured mammalian cells caused a marked reduction of TASK-1 current amplitude, indicating functional interaction. 4) Coexpression of TASK-1 with stx7 and coexpression of TASK-3 with stx8 had no significant effect on current amplitude. 5) The surface expression of TASK-1 channels in <italic>Xenopus</italic> oocytes was markedly reduced by coexpression of stx8. 6) An antibody uptake assay in a mammalian cell line showed that the rate of endocytosis of TASK-1 channels was increased about ninefold after coexpression of stx8. 7) Analysis of chimeric TASK&#x02011;1/TASK-3 constructs showed that the C-terminus of TASK-1 was required (and sufficient) for functional interaction with stx8. 8) Yeast-two hybrid analysis and coexpression experiments in oocytes showed that the linker between the Hc helix and the SNARE helix of stx8 (amino acids 100&#x02013;140) was essential for the interaction with TASK-1.</p><p>The linker region of stx8 is necessary but probably not sufficient for functional interaction of the SNARE protein with the channel, given that coexpression of stx8<sup>&#x00394;216-233</sup> (the mutant in which the transmembrane domain of stx8 was removed) had no significant effect on TASK-1 current. This finding suggests that the linker region needs to be localized near the membrane and perhaps at a defined distance from the surface membrane for the interaction with TASK-1 to take place.</p><p>We consider it very likely that TASK-1 interacts with the <italic>unassembled</italic> SNARE protein stx8, for the following reasons: 1) Overexpression of stx8 necessarily leads to an imbalance of the four SNARE proteins forming the endosomal SNARE complex and may cause the formation of isolated stx8 proteins; 2) overexpression of the other SNARE proteins of the endosomal SNARE complex, stx7, VAMP8, and vti1b, had no effect on TASK-1 currents; and 3) the stx8 mutant Q179A, which cannot form a SNARE complex, had the same effect on TASK-1 current amplitude and surface expression as wild-type stx8 and showed the same colocalization with TASK-1 in endosomes.</p><p>Several lines of evidence suggest that TASK-1 and stx8 are endocytosed together to the early endosomal compartment: 1) We observed a relatively weak but unequivocal expression of syntaxin-8 in the surface membrane of a mammalian cell line (Supplemental Figure S6), in agreement with previous work (<xref rid=\"B35\" ref-type=\"bibr\">Kasai and Akagawa, 2001</xref>). 2) Live-cell imaging showed extensive colocalization of TASK-1 and stx8 in an intracellular compartment, most likely corresponding to the early endosome, as indicated by colocalization with the endosomal markers 2&#x000d7;FYVE and rab5. The vesicles in which TASK-1 and stx8 were colocalized were highly mobile (Supplemental Videos S1&#x02013;S3). 3) Using TIRF microscopy, we observed the formation of endocytic vesicles containing both TASK-1 and stx8. 4) In <italic>Xenopus</italic> oocytes, coexpression of stx8 had a smaller effect on the current carried by TASK&#x02011;1<sup>Y300A</sup> (in which the tyrosine-based endocytosis signal was removed) than on the current carried by wild-type TASK-1 channels. 5) Conversely, the current carried by wild-type TASK-1 channels was less reduced by coexpression of stx8<sup>LL82,83AA</sup> (in which the leucine-based endocytosis signal was removed) than by coexpression of wild-type stx8. 6) When TASK-1<sup>Y300A</sup> was coexpressed with stx8<sup>LL82,83AA</sup>, the effect of the SNARE protein on TASK-1 current and surface expression of TASK-1 was abolished. 7) The antibody uptake assay showed that endocytosis of the channels was almost completely abolished when both endocytic motifs were mutated (coexpression of TASK&#x02011;1<sup>Y300A</sup> and stx8<sup>LL82,83AA</sup> in COS-7 cells). The latter finding suggests that the two endocytic motifs, which both interact with the adaptor protein complex AP-2, may promote endocytosis in a cooperative manner.</p><p>There are some precedent cases in which cooperative binding of two membrane proteins to a coat protein complex has been observed. <xref rid=\"B62\" ref-type=\"bibr\">Springer and Schekman (1998)</xref> found that the yeast SNARE proteins Bet1p and Bos1p interact with the monomeric G-protein Sar1p and that both Sar1p and one of the SNARE proteins are required for COPII coat formation from isolated endoplasmic reticulum membranes (<xref rid=\"B62\" ref-type=\"bibr\">Springer and Schekman, 1998</xref>). <xref rid=\"B31\" ref-type=\"bibr\">Haucke and De Camilli (1999)</xref> found that the adaptor protein complex AP-2 interacts with both synaptotagmin (a Ca<sup>2+</sup>-dependent SNARE regulator carrying dilysine-based endocytosis signals) and SV2a (a transmembrane protein of synaptic vesicles carrying Yxx&#x003a6; endocytosis signals); the binding of synaptotagmin to AP-2 was enhanced in the presence of peptides containing the Yxx&#x003a6; signals of SV2a (<xref rid=\"B31\" ref-type=\"bibr\">Haucke and De Camilli, 1999</xref>). Kornfeld and coworkers found that dileucine-based and tyrosine-based sorting signals interact with the AP-1 adaptor complex in such a way that binding of one sorting signal facilitates the binding of the other sorting signal (<xref rid=\"B37\" ref-type=\"bibr\">Lee <italic>et&#x000a0;al.</italic>, 2008</xref>). Owen and coworkers showed that AP&#x02011;2 exhibits tighter binding to a membrane harboring both dileucine- and tyrosine-based sorting signals (<xref rid=\"B33\" ref-type=\"bibr\">Jackson <italic>et&#x000a0;al.</italic>, 2010</xref>). All of these results were obtained in vitro using sophisticated biochemical assays. The present study shows that <italic>in intact cells</italic> the potassium channel TASK-1 (with its <bold>Y</bold>AE<bold>V</bold> motif) and the SNARE protein stx8 (with its <bold>D</bold>RRQN<bold>LL</bold> motif) are internalized via clathrin-mediated endocytosis in a cooperative manner. Although there is emerging evidence that different subtypes of clathrin-coated vesicles may control the internalization of distinct cargoes (<xref rid=\"B36\" ref-type=\"bibr\">Lakadamyali <italic>et&#x000a0;al.</italic>, 2006</xref>; <xref rid=\"B22\" ref-type=\"bibr\">Doherty and McMahon, 2009</xref>; <xref rid=\"B44\" ref-type=\"bibr\">Loerke <italic>et&#x000a0;al.</italic>, 2009</xref>; <xref rid=\"B53\" ref-type=\"bibr\">Mettlen <italic>et&#x000a0;al.</italic>, 2010</xref>), it is not clear to what extent cargo molecules determine the fate of a transport vesicle. It is tempting to speculate that in vivo the joint endocytosis of TASK-1 and unassembled stx8 may provide the basis for the subsequent steps in the intracellular transport of the channel. SNARE molecules are important determinants of vesicular identity (<xref rid=\"B34\" ref-type=\"bibr\">Jahn and Scheller, 2006</xref>; <xref rid=\"B51\" ref-type=\"bibr\">McNew, 2008</xref>), and the endowment of a transport vesicle with components of the endosomal SNARE complex may influence its itinerary. After dissociation from TASK-1, the Qc-SNARE protein stx8 may participate in the formation of endosomal SNARE complexes, and in this way stx8 may contribute to the sorting of the channel to specific intracellular compartments.</p><p>Previous studies of the interaction between SNARE proteins and channels mainly focused on the effects of the <italic>neuronal</italic> Qa-SNARE protein stx1A on the <italic>gating</italic> of calcium channels and potassium channels in neurons (<xref rid=\"B6\" ref-type=\"bibr\">Bezprozvanny <italic>et&#x000a0;al.</italic>, 1995</xref>, <xref rid=\"B7\" ref-type=\"bibr\">2000</xref>; <xref rid=\"B41\" ref-type=\"bibr\">Leung <italic>et&#x000a0;al.</italic>, 2005</xref>; <xref rid=\"B14\" ref-type=\"bibr\">Chang <italic>et&#x000a0;al.</italic>, 2011</xref>; <xref rid=\"B24\" ref-type=\"bibr\">Etzioni <italic>et&#x000a0;al.</italic>, 2011</xref>; <xref rid=\"B67\" ref-type=\"bibr\">Weiss and Zamponi, 2012</xref>). In a few studies, the effects of stx1A on the <italic>trafficking</italic> of potassium channels were also investigated. For example, the rate of endocytosis of ATP-sensitive potassium channels was found to be increased after coexpression of stx1A (<xref rid=\"B17\" ref-type=\"bibr\">Chen <italic>et&#x000a0;al.</italic>, 2011</xref>). Furthermore, it was reported that coexpression of stx1A <italic>reduced</italic> the surface expression of the voltage-activated potassium channel Kv2.1 (<xref rid=\"B40\" ref-type=\"bibr\">Leung <italic>et&#x000a0;al.</italic>, 2003</xref>) but <italic>increased</italic> the surface expression of Kv1.1 (<xref rid=\"B27\" ref-type=\"bibr\">Feinshreiber <italic>et&#x000a0;al.</italic>, 2009</xref>). However, the mechanisms underlying these changes in surface expression have not been investigated, and no putative sorting signals have been identified. As far as we know, there are no previous studies on the effects of <italic>endosomal</italic> SNARE proteins on the intracellular traffic of potassium channels.</p><p>In conclusion, our results suggest that the SNARE protein stx8 reaches its destination (the endosomal compartment) via the surface membrane. We propose that TASK-1 and the endosomal SNARE protein stx8 interact at the surface membrane and are transported to the early endosome in a cooperative manner via clathrin-mediated endocytosis. Thus, stx8 has functions other than mediating membrane fusion; these functions are most likely mediated by the unassembled form of stx8 and are independent of other endosomal SNARE proteins. Our results provide some evidence for the idea that the endocytosis of SNARE proteins may be modulated by the presence of specific cargo proteins like TASK-1, and that, conversely, the endocytosis of membrane proteins may be modulated by unassembled SNARE proteins.</p></sec><sec sec-type=\"materials|methods\"><title>MATERIALS AND METHODS</title><sec><title>Animal studies</title><p>For experiments involving <italic>Xenopus</italic> oocytes, adult female African clawed frogs (<italic>Xenopus laevis</italic>) were used. The frogs were anesthetized by putting them in water containing 1 g/l tricaine. Stage V oocytes were obtained from the ovarian lobes. Anesthesia and operation were carried out in accordance with the principles of German legislation with approval of the animal welfare officer of the Medical Faculty of Marburg University under the governance of the Regierungspr&#x000e4;sidium Giessen (the regional veterinary heath authority).</p></sec><sec><title>Molecular cloning and mutagenesis</title><p>Supplemental Table S1 summarizes the constructs used in this study. In most experiments with human TASK-1, we used a mutant in which the amino acids at positions 2 and 3, KR, were replaced by NQ (<xref rid=\"B68\" ref-type=\"bibr\">Zuzarte <italic>et&#x000a0;al.</italic>, 2009</xref>; <sup>NQ</sup>TASK-1). This mutant shows higher surface expression and higher current amplitude than wild type (<xref rid=\"B68\" ref-type=\"bibr\">Zuzarte <italic>et&#x000a0;al.</italic>, 2009</xref>), resulting in better signal-to-noise ratio. Otherwise, the results obtained with <sup>NQ</sup>TASK-1 were identical to those obtained with wild-type TASK-1 (<xref rid=\"B59\" ref-type=\"bibr\">Schiekel <italic>et&#x000a0;al.</italic>, 2013</xref>). We also used chimeras of TASK-1 and TASK&#x02011;3 (<xref rid=\"B58\" ref-type=\"bibr\">Renigunta <italic>et&#x000a0;al.</italic>, 2006</xref>) in which the C-terminus of TASK-1 was replaced by the C-terminus of TASK&#x02011;3 (T1/T3 mutant) or vice versa (T3/T1 mutant). Chimeras were generated using an overlap extension PCR method. QuikChange (Agilent Technologies, Santa Clara, CA) was used to introduce point mutations. For surface luminescence and antibody uptake measurements, TASK&#x02011;1 containing an external HA epitope tag was used (<xref rid=\"B68\" ref-type=\"bibr\">Zuzarte <italic>et&#x000a0;al.</italic>, 2009</xref>). All DNA constructs were verified by sequencing.</p></sec><sec><title>Split-ubiquitin membrane yeast two-hybrid assay</title><p>We used the split-ubiquitin variant (Molecular Biotechnology, G&#x000f6;ttingen, Germany) of the yeast-two-hybrid system to identify proteins that interact with hTASK-1. This assay allows the use of full-length integral membrane proteins as baits; it screens for interactions with integral membrane proteins and membrane-associated proteins. Identification of positive clones, recovery of library plasmids, and identification of prey sequences were carried out following the manufacturer\\'s guidelines. Protein&#x02013;protein interaction was determined by growth on plates lacking the amino acids leucine, tryptophan, histidine, and adenine (&#x02013;LWHA). Positive colonies were further verified using the second marker &#x003b2;-galactosidase. The yeast strains expressing the baits were transformed with a human brain cDNA library (Molecular Biotechnology) for screening or with prey vectors for specific interaction studies. The nucleotide sequence of the screened positive clones was determined by sequencing, and the identity of the encoded putative interacting proteins was determined by a database search (BLASTX).</p></sec><sec><title>Cell culture</title><p>HeLa, COS-7, and A549 cells were cultured in high-glucose DMEM, 10% fetal calf serum (FCS; Life Technologies, Paisley, United Kingdom), and 1% penicillin/streptomycin (PAA Laboratories, Pasching, Austria). CHO cells were cultured in MEM alpha with glutamine (Thermo Fisher Scientific, Waltham, MA), 10% FCS, and 1% penicillin/streptomycin (PAA Laboratories). For live-cell imaging and TIRF microscopy, the cells were seeded in 35-mm glass-bottom dishes (ibidi, Martinsried, Germany) and transfected 24 h later with the indicated constructs using jetPRIME reagent (Polyplus, Illkirch, France) or Fugene6 (Invitrogen, Darmstadt, Germany) according to the manufacturers&#x02019; protocols and further maintained in the same cell culture medium without phenol red. For each method we used the cell line that appeared most suitable. CHO cells were preferred for patch-clamp experiments with transfected channels because they express very few endogenous channels that might contaminate the measurements. HeLa cells were preferred for imaging because they are optimal for detecting membrane localization and the early endosome; they show a &#x0201c;ring&#x0201d; of surface membrane (unlike COS cells, which are very flat) and have numerous clearly visible endosomal vesicles. The antibody uptake assay (empirically) worked best with COS-7 cells.</p></sec><sec><title>RT-PCR</title><p>The total RNA of A549 cells was isolated by using the HighPure RNA kit (Roche, Mannheim, Germany). The RNA was reverse transcribed into cDNA by using Superscript II reverse transcriptase (Invitrogen). RT-PCR was performed with AmpliTaq Gold DNA polymerase (Applied Biosystems, Darmstadt, Germany) using the following intron-spanning primers. Glyceraldehyde-3-phosphate dehydrogenase: sense, 5&#x02032;&#x02011;CATCACCATCTTCCAGGAGCGA-3&#x02032;, and antisense, 5&#x02032;&#x02011;GTCTTCTGGGTGGCAGTGATGG-3&#x02032;. TASK-1: sense, 5&#x02032;-GCTCCTTCTACTTCGCCATC&#x02011;3&#x02032;, and antisense, 5&#x02032;&#x02011;CAGGTACCTCACCAAGGTGT&#x02011;3&#x02032;. Stx8: sense, 5&#x02032;-TCGCCCTTTTGAAGGACTTA-3&#x02032;, and antisense, 5&#x02032;- CCATTTGTTTTTGGCGACTT-3&#x02032;. Stx7: sense, 5&#x02032;-CAGCAGATTATCAGCGCAAA-3&#x02032;, and antisense, 5&#x02032;-CATATGCAAT&#x000ad;GTGGGCAA&#x000ad;AA-3&#x02032;. VAMP8: sense, 5&#x02032;&#x02011;GGAGCAAGCAGGAAGTGAAC-3&#x02032;, and antisense, 5&#x02032;&#x02011;TGGCAAAGAGCACAATGAAG-3&#x02032;. Vti1b: sense, 5&#x02032;&#x02011;ATCACTGGCTGGAGAAGGTG&#x02011;3&#x02032;, and antisense, 5&#x02032;-ATCTCT&#x000ad;GCCAGCGTTT&#x000ad;CATT-3&#x02032;. PCRs were performed with the following program: (95&#x000b0;C, 10 min) &#x000d7; 1 cycle, (95&#x000b0;C, 40 s; 55&#x000b0;C, 40 s; 72&#x000b0;C, 1 min) &#x000d7; 30 cycles, and (72&#x000b0;C, 5 min) &#x000d7; 1 cycle. The identity of all PCR products was confirmed by sequencing.</p></sec><sec><title>Coimmunoprecipitation</title><p>Immunoprecipitations were carried out using the Dynabeads Protein G Immunoprecipitation Kit (Invitrogen) according to the manufacturer\\'s instructions. In one set of experiments, we used HeLa cells expressing myc-tagged stx8 and GFP-tagged TASK-1; the cells were lysed with Triton X-100, and the lysate was probed with a mouse anti-myc antibody (Santa Cruz Biotechnology, Dallas, TX) coupled to Protein G Dynabeads using the cross-linking agent BS3 (Invitrogen). In another set of experiments, we used A549 cells endogenously expressing TASK-1 and stx8; the cells were lysed using a buffer containing 50 mM Tris&#x02013;HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% NP-40, 0.25% Na deoxycholate, and 10 &#x003bc;l/ml protease-inhibitor cocktail (Sigma, Taufkirchen, Germany), and the lysate was probed with an anti&#x02013;TASK-1 antibody (APC-024; Alomone, Jerusalem, Israel) coupled to protein G Dynabeads using the cross-linking agent BS3 (Invitrogen). Antibody-coated beads were then incubated with the cell lysates under rotation for 6 h at 4&#x000b0;C. Dynabeads coated with antigen&#x02013;antibody complex were washed extensively (4&#x000d7;) with the wash buffer supplied by the manufacturer. The proteins on Dynabeads were eluted by boiling at 95&#x000b0;C for 10 min in SDS sample loading buffer and separated on a 10&#x02013;12% SDS&#x02013;PAGE under reducing conditions. Proteins were transferred to nitrocellulose membrane and probed with either mouse anti-myc antibody (1:1000; Santa Cruz Biotechnology), rabbit anti-GFP antibody (1:1000; Abcam, Cambridge, United Kingdom), anti&#x02013;TASK-1 (1:1000; Alomone), anti-stx8 (1:1000; BD Biosciences, Heidelberg, Germany), or anti-stx7 (1:1000; Acris Antibodies, Herford, Germany). The membrane was washed and visualized with IRDye LICOR-secondary antibodies (1:5000; LI-COR Biosciences, Bad Homburg, Germany). Immunoreactivity was detected using an infrared imaging system (Odyssey Sa; LI-COR Biosciences).</p></sec><sec><title>Measurements of TASK-1 currents in transfected CHO cells</title><p>Electrophysiological measurements were performed with CHO cells 24 h after transfection with rat TASK-1 or human <sup>NQ</sup>TASK-1, either alone or together with human stx7 or stx8. The cells were superfused at room temperature with a bath solution containing (mM): 135 NaCl, 5 KCl, 1 CaCl<sub>2</sub>, 1 MgCl<sub>2</sub>, 0.33 NaH<sub>2</sub>PO<sub>4</sub>, 10 glucose, and 10 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES); the pH was adjusted to 7.4 with NaOH. Patch-clamp experiments were performed in the whole-cell configuration using pipettes pulled from borosilicate glass capillaries. The patch pipettes (resistance, 3&#x02013;6 M&#x003a9;) were filled with an &#x0201c;intracellular&#x0201d; solution containing (mM): 60 KCl, 65 K glutamate, 5 ethylene glycol tetraacetic acid, 3.5 MgCl<sub>2</sub>, 2 CaCl<sub>2</sub>, 3 K<sub>2</sub>ATP, 0.2 Na<sub>2</sub>GTP, and 5 HEPES; the pH was adjusted to 7.2 with KOH. Steady-state current&#x02013;voltage relations were obtained by applying slow voltage ramps (40 mV/s) between &#x02212;120 and +40 mV. The liquid junction potential between the patch electrode and the bath solution (&#x0223c;&#x02212;8 mV) was not compensated.</p></sec><sec><title>Voltage-clamp measurements with <italic>Xenopus</italic> oocytes</title><p>For heterologous expression in <italic>Xenopus</italic> oocytes, cRNA was transcribed in vitro from <italic>Nhe</italic>1-linearized plasmids containing the cDNA of interest using T7 RNA polymerase (mMessage mMachine T7 Kit; Ambion, Austin, TX). cRNA quality was determined by gel electrophoresis and ultraviolet spectroscopy. Defolliculated <italic>Xenopus</italic> oocytes were injected with nuclease-free water containing cRNA coding for TASK-1 (0.76 ng/oocyte), T1/T3 chimeras (0.76 ng/oocyte), or TASK-3 (0.05 ng/oocyte) alone or together with stx8, stx7, and stx8/stx7 chimeras, VAMP8, vti1B, or AP180C (all 6 ng/oocyte). Oocytes were incubated at 19&#x000b0;C for 24&#x02013;48 h in ND96 solution containing (mM) 96 NaCl, 2 KCl, 1 MgCl<sub>2</sub>, 1.8 CaCl<sub>2</sub>, and 5 HEPES (pH 7.4&#x02013;7.5), supplemented with 100 &#x003bc;g/ml gentamicin and 2.5 mM sodium pyruvate. Two-microelectrode voltage-clamp measurements with ramp-shaped voltage commands were performed with a TurboTec&#x02011;10 C amplifier (npi electronic, Tamm, Germany), and data were recorded at a sampling rate of 120 Hz. The oocytes were placed in a small-volume perfusion chamber and superfused with ND96 solution. For quantification of current amplitude under different experimental conditions, the currents were measured at 0 mV. The experiments were carried out at room temperature (20&#x02013;23&#x000b0;C).</p></sec><sec><title>Surface expression analysis in <italic>Xenopus</italic> oocytes</title><p>Surface expression of HA-tagged TASK-1 channels in <italic>Xenopus</italic> oocytes was analyzed 2 d after injection with the cRNA for TASK-1 (0.76 ng/oocyte) alone or together with stx8 (6 ng/oocyte) as described previously (<xref rid=\"B68\" ref-type=\"bibr\">Zuzarte <italic>et&#x000a0;al.</italic>, 2009</xref>). Oocytes were incubated for 30 min in ND96 solution containing 1% bovine serum albumin (BSA) at 4&#x000b0;C to block nonspecific binding of antibodies. Subsequently, oocytes were incubated for 60 min at 4&#x000b0;C with rat monoclonal anti-HA antibody (clone 3F10, 0.1 mg/ml; Roche) in 1% BSA/ND96, washed six times at 4&#x000b0;C with 1% BSA/ND96, and incubated with peroxidase-conjugated, affinity-purified F(ab)2 fragment goat anti-rat immunoglobulin G antibody (0.8 mg/ml; Jackson Immuno&#x000ad;Research, Newmarket, UK) in 1% BSA/ND96 for 60 min. Oocytes were washed thoroughly, initially in 1% BSA/ND96 (at 4&#x000b0;C for 60 min) and then in ND96 without BSA (at 4&#x000b0;C for 15 min). Individual oocytes were placed in 20 &#x003bc;l of SuperSignal Elisa Femto solution (Pierce Protein Biology Products, Rockford, IL), and chemiluminescence was quantified in a luminometer (Lumat LB9507; Berthold Technologies, Bad Wildbad, Germany). The luminescence produced by uninjected oocytes was used as reference signal (negative control).</p></sec><sec><title>Antibody uptake assay</title><p>COS-7 cells were seeded in glass-bottom Petri dishes (35-mm diameter) and transfected with HA-tagged TASK-1 alone or together with stx8 or stx7. Fluorescence imaging experiments with COS-7 cells were performed 24 h after transfection. Cells were blocked with 1&#x000d7; phosphate-buffered saline (PBS) containing 5% FCS (Life Technologies) for 30 min at room temperature. Channels at the cell surface were labeled with mouse anti-HA antibody (1:1000; Sigma-Aldrich) at 4&#x000b0;C for 60 min. The cells were then washed three times with PBS at 4&#x000b0;C to remove unbound antibody. Subsequently, the labeled channels were allowed to internalize for 0, 15, or 30 min at 37&#x000b0;C. The cells were then fixed for 10 min at 4&#x000b0;C in PBS containing 4% paraformaldehyde. The channels remaining at the surface were labeled with a saturating concentration of Alexa Fluor 594&#x02013;conjugated goat anti-mouse secondary antibody (1:1000; Molecular Probes, Darmstadt, Germany). After cell permeabilization with 0.1% Triton X-100 for 5 min at room temperature, internalized channels were labeled with Alexa Fluor 488&#x02013;conjugated goat anti-mouse secondary antibody (1:5000; Molecular Probes). Then the cells were washed extensively with PBS buffer and covered with the antifade agent Mowiol 4-88 (Carl Roth, Karlsruhe, Germany; containing 25 &#x003bc;g/&#x003bc;l DABCO). The cells were visualized using an Olympus IX71 microscope equipped with a 60&#x000d7; objective (PlanApo 60&#x000d7;/1.40 Oil; Olympus, Hamburg, Germany), a cooled 12-bit charge-coupled device (CCD) camera (SensiCam QE, PCO, Kelheim, Germany), and the corresponding filters for the fluorescent dyes. Images were acquired with Image-Pro Plus 4.5 (Media Cybernetics, Rockville, MD) and analyzed with NIS Elements AR 4 software (Nikon, D&#x000fc;sseldorf, Germany). Channel endocytosis was quantified by taking the ratio between the fluorescence of the Alexa Fluor 488&#x02013;coupled secondary antibody (green, internalized channels) and the fluorescence of the Alexa Fluor 594&#x02013;coupled secondary antibody (red, channels at the cell surface). The background green fluorescence measured after application of Mowiol 4-88 was very low (between 0.1 and 1% of the red fluorescence; see <xref ref-type=\"fig\" rid=\"F5\">Figure 5B</xref>); it varied between different Petri dishes, probably due to the presence of a very small fraction of damaged cells.</p></sec><sec><title>Live-cell imaging</title><p>HeLa cells were analyzed 24&#x02013;48 h after transfection using an inverted Nikon Eclipse Ti microscope equipped with a 100&#x000d7; objective (Plan Apo VC 100&#x000d7; Oil DIC N2; Nikon). EGFP and mCherry/DsRed channels were acquired simultaneously using a dual camera port system composed of custom-made excitation/emission filters, a dual-band beam splitter, and two cooled 14-bit electron-multiplying CCD cameras (DU-885; Andor Technology, Belfast, UK). For recording live-cell image sequences, cells were maintained at 37&#x000b0;C by means of a stage heater (ibidi, Martinsried, Germany) with a temperature control system (TC 20; npi, Tamm, Germany) and an objective heater (PeCon, Erbach, Germany). Images and sequences were acquired and analyzed with NIS Elements AR 4 software (Nikon).</p></sec><sec><title>Total internal reflection microscopy</title><p>HeLa cells were analyzed 48 h after transfection using an inverted Leica AF 6000 LX TIRF microscope equipped with a 100&#x000d7; objective (HCX PL APO 100&#x000d7; 1.47 Oil; Leica) and a 12-bit CCD camera (DFC350FXR2; Leica); the temperature was 28&#x02013;30&#x000b0;C. The penetration depth of the evanescent wave was 70 and 90 nm, respectively, for the lasers exciting EGFP and mCherry. The exposure time was set individually for each cell and channel to obtain the best signal-to-noise ratio. Image sequences were acquired every 0.5&#x02013;5 s for &#x0223c;10 min with LAS AF software (Leica Microsystems, Wetzlar, Germany), and data were postprocessed using NIS Elements AR 4 software.</p></sec><sec><title>Statistics</title><p>Data are reported as means &#x000b1; SEM. Statistical significance was determined using Student\\'s <italic>t</italic> test. In the figures, statistically significant differences from control values are marked by asterisks: *<italic>p</italic> &#x0003c; 0.05; **<italic>p</italic> &#x0003c; 0.01; ***<italic>p</italic> &#x0003c; 0.001.</p></sec></sec>\\n<sec sec-type=\"supplementary-material\">\\n<title>Supplementary Material</title>\\n<supplementary-material id=\"PMC_1\" content-type=\"local-data\">\\n<caption>\\n<title>Supplemental Materials</title>\\n</caption>\\n<media mimetype=\"text\" mime-subtype=\"html\" xlink:href=\"supp_25_12_1877__index.html\"/>\\n<media xlink:role=\"associated-file\" mimetype=\"application\" mime-subtype=\"pdf\"\\nxlink:href=\"supp_E13-10-0592v1_CombinedSupMats.pdf\"/>\\n<media xlink:role=\"associated-file\" mimetype=\"video\" mime-subtype=\"quicktime\"\\nxlink:href=\"supp_E13-10-0592v1_mc-E13-10-0592-s02.mov\"/>\\n<media xlink:role=\"associated-file\" mimetype=\"video\" mime-subtype=\"quicktime\"\\nxlink:href=\"supp_E13-10-0592v1_mc-E13-10-0592-s03.mov\"/>\\n<media xlink:role=\"associated-file\" mimetype=\"video\" mime-subtype=\"quicktime\"\\nxlink:href=\"supp_E13-10-0592v1_mc-E13-10-0592-s04.mov\"/>\\n<media xlink:role=\"associated-file\" mimetype=\"video\" mime-subtype=\"quicktime\"\\nxlink:href=\"supp_E13-10-0592v1_mc-E13-10-0592-s05.mov\"/>\\n<media xlink:role=\"associated-file\" mimetype=\"video\" mime-subtype=\"quicktime\"\\nxlink:href=\"supp_E13-10-0592v1_mc-E13-10-0592-s06.mov\"/>\\n<media xlink:role=\"associated-file\" mimetype=\"video\" mime-subtype=\"quicktime\"\\nxlink:href=\"supp_E13-10-0592v1_mc-E13-10-0592-s07.mov\"/>\\n</supplementary-material>\\n</sec>\\n</body><back><fn-group><fn fn-type=\"other\"><p>This article was published online ahead of print in MBoC in Press (<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.molbiolcell.org/cgi/doi/10.1091/mbc.E13-10-0592\">http://www.molbiolcell.org/cgi/doi/10.1091/mbc.E13-10-0592</ext-link>) on April 17, 2014.</p></fn></fn-group><ack><p>We thank Doris Wagner and Kirsten Ramlow for excellent technical support. Some of the constructs used were generously supplied by Harald Stenmark (Oslo University Hospital, Oslo, Norway; 2&#x000d7;FYVE-EGFP, syntaxin-7), Wanjin Hong (Institute of Molecular and Cell Biology, Singapore; VAMP8), Harvey McMahon (MRC Laboratory of Molecular Biology, Cambridge, United Kingdom; AP180C), and Ralf Jacob (Institute of Cytobiology, Marburg, Germany; clathrin light chain). This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB593-TP4 and FOR1086-TP7 to J.D.) and the P. E. Kempkes Foundation (to V.R.).</p></ack><glossary><title>Abbreviations used:</title><def-list><def-item><term id=\"G1\">AP180C</term><def><p>C&#x02011;terminus of adaptor protein 180</p></def></def-item><def-item><term id=\"G2\">GFP</term><def><p>green fluorescent protein</p></def></def-item><def-item><term id=\"G3\">HA</term><def><p>hemagglutinin</p></def></def-item><def-item><term id=\"G4\">myc</term><def><p>myelocytomatosis oncogene&#x02013;derived dekapeptide</p></def></def-item><def-item><term id=\"G5\">SNARE</term><def><p>soluble <italic>N</italic>-ethylmaleimide&#x02013;factor attachment protein receptor</p></def></def-item><def-item><term id=\"G6\">stx</term><def><p>syntaxin</p></def></def-item><def-item><term id=\"G7\">TASK-1</term><def><p>TREK-related acid-sensitive K<sup>+</sup> channel</p></def></def-item><def-item><term id=\"G8\">VAMP2</term><def><p>vesicle-associated membrane protein 2</p></def></def-item><def-item><term id=\"G9\">vti1b</term><def><p>vesicle transport through interaction with target-SNARE analogue 1b</p></def></def-item></def-list></glossary><ref-list><title>REFERENCES</title><ref id=\"B1\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Atlas</surname><given-names>D</given-names></name></person-group><article-title>The voltage-gated calcium channel functions as the molecular switch of synaptic transmission</article-title><source>Annu Rev Biochem</source><year>2013</year><volume>82</volume><fpage>607</fpage><lpage>635</lpage><pub-id pub-id-type=\"pmid\">23331239</pub-id></element-citation></ref><ref id=\"B2\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Bachnoff</surname><given-names>N</given-names></name><name><surname>Cohen-Kutner</surname><given-names>M</given-names></name><name><surname>Trus</surname><given-names>M</given-names></name><name><surname>Atlas</surname><given-names>D</given-names></name></person-group><article-title>Intra-membrane signaling between the voltage-gated Ca<sup>2+</sup>-channel and cysteine residues of syntaxin 1A coordinates synchronous release</article-title><source>Sci Rep</source><year>2013</year><volume>3</volume><fpage>1620</fpage><pub-id pub-id-type=\"pmid\">23567899</pub-id></element-citation></ref><ref id=\"B3\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Bandulik</surname><given-names>S</given-names></name><name><surname>Penton</surname><given-names>D</given-names></name><name><surname>Barhanin</surname><given-names>J</given-names></name><name><surname>Warth</surname><given-names>R</given-names></name></person-group><article-title>TASK1 and TASK3 potassium channels: determinants of aldosterone secretion and adrenocortical zonation</article-title><source>Horm Metab Res</source><year>2010</year><volume>42</volume><fpage>450</fpage><lpage>457</lpage><pub-id pub-id-type=\"pmid\">20049674</pub-id></element-citation></ref><ref id=\"B4\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Bayliss</surname><given-names>DA</given-names></name><name><surname>Barrett</surname><given-names>PQ</given-names></name></person-group><article-title>Emerging roles for two-pore-domain potassium channels and their potential therapeutic impact</article-title><source>Trends Pharmacol Sci</source><year>2008</year><volume>29</volume><fpage>566</fpage><lpage>575</lpage><pub-id pub-id-type=\"pmid\">18823665</pub-id></element-citation></ref><ref id=\"B5\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Behnia</surname><given-names>R</given-names></name><name><surname>Munro</surname><given-names>S</given-names></name></person-group><article-title>Organelle identity and the signposts for membrane traffic</article-title><source>Nature</source><year>2005</year><volume>438</volume><fpage>597</fpage><lpage>604</lpage><pub-id pub-id-type=\"pmid\">16319879</pub-id></element-citation></ref><ref id=\"B6\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Bezprozvanny</surname><given-names>I</given-names></name><name><surname>Scheller</surname><given-names>RH</given-names></name><name><surname>Tsien</surname><given-names>RW</given-names></name></person-group><article-title>Functional impact of syntaxin on gating of N-type and Q-type calcium channels</article-title><source>Nature</source><year>1995</year><volume>378</volume><fpage>623</fpage><lpage>626</lpage><pub-id pub-id-type=\"pmid\">8524397</pub-id></element-citation></ref><ref id=\"B7\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Bezprozvanny</surname><given-names>I</given-names></name><name><surname>Zhong</surname><given-names>P</given-names></name><name><surname>Scheller</surname><given-names>RH</given-names></name><name><surname>Tsien</surname><given-names>RW</given-names></name></person-group><article-title>Molecular determinants of the functional interaction between syntaxin and N-type Ca<sup>2+</sup> channel gating</article-title><source>Proc Natl Acad Sci USA</source><year>2000</year><volume>97</volume><fpage>13943</fpage><lpage>13948</lpage><pub-id pub-id-type=\"pmid\">11087812</pub-id></element-citation></ref><ref id=\"B8\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Bilan</surname><given-names>F</given-names></name><name><surname>Nacfer</surname><given-names>M</given-names></name><name><surname>Fresquet</surname><given-names>F</given-names></name><name><surname>Norez</surname><given-names>C</given-names></name><name><surname>Melin</surname><given-names>P</given-names></name><name><surname>Martin-Berge</surname><given-names>A</given-names></name><name><surname>Costa de Beauregard</surname><given-names>MA</given-names></name><name><surname>Becq</surname><given-names>F</given-names></name><name><surname>Kitzis</surname><given-names>A</given-names></name><name><surname>Thoreau</surname><given-names>V</given-names></name></person-group><article-title>Endosomal SNARE proteins regulate CFTR activity and trafficking in epithelial cells</article-title><source>Exp Cell Res</source><year>2008</year><volume>314</volume><fpage>2199</fpage><lpage>2211</lpage><pub-id pub-id-type=\"pmid\">18570918</pub-id></element-citation></ref><ref id=\"B9\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Bilan</surname><given-names>F</given-names></name><name><surname>Thoreau</surname><given-names>V</given-names></name><name><surname>Nacfer</surname><given-names>M</given-names></name><name><surname>Derand</surname><given-names>R</given-names></name><name><surname>Norez</surname><given-names>C</given-names></name><name><surname>Cantereau</surname><given-names>A</given-names></name><name><surname>Garcia</surname><given-names>M</given-names></name><name><surname>Becq</surname><given-names>F</given-names></name><name><surname>Kitzis</surname><given-names>A</given-names></name></person-group><article-title>Syntaxin 8 impairs trafficking of cystic fibrosis transmembrane conductance regulator (CFTR) and inhibits its channel activity</article-title><source>J Cell Sci</source><year>2004</year><volume>117</volume><fpage>1923</fpage><lpage>1935</lpage><pub-id pub-id-type=\"pmid\">15039462</pub-id></element-citation></ref><ref id=\"B10\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Bittner</surname><given-names>S</given-names></name><etal/></person-group><article-title>TASK1 modulates inflammation and neurodegeneration in autoimmune inflammation of the central nervous system</article-title><source>Brain</source><year>2009</year><volume>132</volume><fpage>2501</fpage><lpage>2516</lpage><pub-id pub-id-type=\"pmid\">19570851</pub-id></element-citation></ref><ref id=\"B11\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Bonifacino</surname><given-names>JS</given-names></name><name><surname>Glick</surname><given-names>BS</given-names></name></person-group><article-title>The mechanisms of vesicle budding and fusion</article-title><source>Cell</source><year>2004</year><volume>116</volume><fpage>153</fpage><lpage>166</lpage><pub-id pub-id-type=\"pmid\">14744428</pub-id></element-citation></ref><ref id=\"B12\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Bonifacino</surname><given-names>JS</given-names></name><name><surname>Hurley</surname><given-names>JH</given-names></name></person-group><article-title>Retromer</article-title><source>Curr Opin Cell Biol</source><year>2008</year><volume>20</volume><fpage>427</fpage><lpage>436</lpage><pub-id pub-id-type=\"pmid\">18472259</pub-id></element-citation></ref><ref id=\"B13\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Bonifacino</surname><given-names>JS</given-names></name><name><surname>Traub</surname><given-names>LM</given-names></name></person-group><article-title>Signals for sorting of transmembrane proteins to endosomes and lysosomes</article-title><source>Annu Rev Biochem</source><year>2003</year><volume>72</volume><fpage>395</fpage><lpage>447</lpage><pub-id pub-id-type=\"pmid\">12651740</pub-id></element-citation></ref><ref id=\"B14\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Chang</surname><given-names>N</given-names></name><name><surname>Liang</surname><given-names>T</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name><name><surname>Kang</surname><given-names>Y</given-names></name><name><surname>Xie</surname><given-names>H</given-names></name><name><surname>Feng</surname><given-names>ZP</given-names></name><name><surname>Gaisano</surname><given-names>HY</given-names></name></person-group><article-title>Syntaxin-1A interacts with distinct domains within nucleotide-binding folds of sulfonylurea receptor 1 to inhibit beta-cell ATP-sensitive potassium channels</article-title><source>J Biol Chem</source><year>2011</year><volume>286</volume><fpage>23308</fpage><lpage>23318</lpage><pub-id pub-id-type=\"pmid\">21540180</pub-id></element-citation></ref><ref id=\"B15\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Chao</surname><given-names>C</given-names></name><name><surname>Liang</surname><given-names>T</given-names></name><name><surname>Kang</surname><given-names>Y</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name><name><surname>Xie</surname><given-names>H</given-names></name><name><surname>Feng</surname><given-names>ZP</given-names></name><name><surname>Gaisano</surname><given-names>HY</given-names></name></person-group><article-title>Syntaxin-1A inhibits K<sub>ATP</sub> channels by interacting with specific conserved motifs within sulfonylurea receptor 2A</article-title><source>J Mol Cell Cardiol</source><year>2011a</year><volume>51</volume><fpage>790</fpage><lpage>802</lpage><pub-id pub-id-type=\"pmid\">21884702</pub-id></element-citation></ref><ref id=\"B16\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Chao</surname><given-names>CC</given-names></name><name><surname>Mihic</surname><given-names>A</given-names></name><name><surname>Tsushima</surname><given-names>RG</given-names></name><name><surname>Gaisano</surname><given-names>HY</given-names></name></person-group><article-title>SNARE protein regulation of cardiac potassium channels and atrial natriuretic factor secretion</article-title><source>J Mol Cell Cardiol</source><year>2011b</year><volume>50</volume><fpage>401</fpage><lpage>407</lpage><pub-id pub-id-type=\"pmid\">21129378</pub-id></element-citation></ref><ref id=\"B17\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Chen</surname><given-names>PC</given-names></name><name><surname>Bruederle</surname><given-names>CE</given-names></name><name><surname>Gaisano</surname><given-names>HY</given-names></name><name><surname>Shyng</surname><given-names>SL</given-names></name></person-group><article-title>Syntaxin 1A regulates surface expression of beta-cell ATP-sensitive potassium channels</article-title><source>Am J Physiol Cell Physiol</source><year>2011</year><volume>300</volume><fpage>C506</fpage><lpage>C516</lpage><pub-id pub-id-type=\"pmid\">21209369</pub-id></element-citation></ref><ref id=\"B18\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Conner</surname><given-names>SD</given-names></name><name><surname>Schmid</surname><given-names>SL</given-names></name></person-group><article-title>Regulated portals of entry into the cell</article-title><source>Nature</source><year>2003</year><volume>422</volume><fpage>37</fpage><lpage>44</lpage><pub-id pub-id-type=\"pmid\">12621426</pub-id></element-citation></ref><ref id=\"B19\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Dai</surname><given-names>XQ</given-names></name><etal/></person-group><article-title>The voltage-dependent potassium channel subunit Kv2.1 regulates insulin secretion from rodent and human islets independently of its electrical function</article-title><source>Diabetologia</source><year>2012</year><volume>55</volume><fpage>1709</fpage><lpage>1720</lpage><pub-id pub-id-type=\"pmid\">22411134</pub-id></element-citation></ref><ref id=\"B20\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Decher</surname><given-names>N</given-names></name><etal/></person-group><article-title>Knock-out of the potassium channel TASK-1 leads to a prolonged QT interval and a disturbed QRS complex</article-title><source>Cell Physiol Biochem</source><year>2011</year><volume>28</volume><fpage>77</fpage><lpage>86</lpage><pub-id pub-id-type=\"pmid\">21865850</pub-id></element-citation></ref><ref id=\"B21\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Di Paolo</surname><given-names>G</given-names></name><name><surname>De Camilli</surname><given-names>P</given-names></name></person-group><article-title>Phosphoinositides in cell regulation and membrane dynamics</article-title><source>Nature</source><year>2006</year><volume>443</volume><fpage>651</fpage><lpage>657</lpage><pub-id pub-id-type=\"pmid\">17035995</pub-id></element-citation></ref><ref id=\"B22\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Doherty</surname><given-names>GJ</given-names></name><name><surname>McMahon</surname><given-names>HT</given-names></name></person-group><article-title>Mechanisms of endocytosis</article-title><source>Annu Rev Biochem</source><year>2009</year><volume>78</volume><fpage>857</fpage><lpage>902</lpage><pub-id pub-id-type=\"pmid\">19317650</pub-id></element-citation></ref><ref id=\"B23\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Duprat</surname><given-names>F</given-names></name><name><surname>Lesage</surname><given-names>F</given-names></name><name><surname>Fink</surname><given-names>M</given-names></name><name><surname>Reyes</surname><given-names>R</given-names></name><name><surname>Heurteaux</surname><given-names>C</given-names></name><name><surname>Lazdunski</surname><given-names>M</given-names></name></person-group><article-title>TASK, a human background K<sup>+</sup> channel to sense external pH variations near physiological pH</article-title><source>EMBO J</source><year>1997</year><volume>16</volume><fpage>5464</fpage><lpage>5471</lpage><pub-id pub-id-type=\"pmid\">9312005</pub-id></element-citation></ref><ref id=\"B24\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Etzioni</surname><given-names>A</given-names></name><name><surname>Siloni</surname><given-names>S</given-names></name><name><surname>Chikvashvilli</surname><given-names>D</given-names></name><name><surname>Strulovich</surname><given-names>R</given-names></name><name><surname>Sachyani</surname><given-names>D</given-names></name><name><surname>Regev</surname><given-names>N</given-names></name><name><surname>Greitzer-Antes</surname><given-names>D</given-names></name><name><surname>Hirsch</surname><given-names>JA</given-names></name><name><surname>Lotan</surname><given-names>I</given-names></name></person-group><article-title>Regulation of neuronal M-channel gating in an isoform-specific manner: functional interplay between calmodulin and syntaxin 1A</article-title><source>J Neurosci</source><year>2011</year><volume>31</volume><fpage>14158</fpage><lpage>14171</lpage><pub-id pub-id-type=\"pmid\">21976501</pub-id></element-citation></ref><ref id=\"B25\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Falkenburger</surname><given-names>BH</given-names></name><name><surname>Jensen</surname><given-names>JB</given-names></name><name><surname>Dickson</surname><given-names>EJ</given-names></name><name><surname>Suh</surname><given-names>BC</given-names></name><name><surname>Hille</surname><given-names>B</given-names></name></person-group><article-title>Phosphoinositides: lipid regulators of membrane proteins</article-title><source>J Physiol</source><year>2010</year><volume>588</volume><fpage>3179</fpage><lpage>3185</lpage><pub-id pub-id-type=\"pmid\">20519312</pub-id></element-citation></ref><ref id=\"B26\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Fasshauer</surname><given-names>D</given-names></name><name><surname>Sutton</surname><given-names>RB</given-names></name><name><surname>Brunger</surname><given-names>AT</given-names></name><name><surname>Jahn</surname><given-names>R</given-names></name></person-group><article-title>Conserved structural features of the synaptic fusion complex: SNARE proteins reclassified as Q- and R-SNAREs</article-title><source>Proc Natl Acad Sci USA</source><year>1998</year><volume>95</volume><fpage>15781</fpage><lpage>15786</lpage><pub-id pub-id-type=\"pmid\">9861047</pub-id></element-citation></ref><ref id=\"B27\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Feinshreiber</surname><given-names>L</given-names></name><name><surname>Chikvashvili</surname><given-names>D</given-names></name><name><surname>Michaelevski</surname><given-names>I</given-names></name><name><surname>Lotan</surname><given-names>I</given-names></name></person-group><article-title>Syntaxin modulates Kv1.1 through dual action on channel surface expression and conductance</article-title><source>Biochem</source><year>2009</year><volume>48</volume><fpage>4109</fpage><lpage>4114</lpage><pub-id pub-id-type=\"pmid\">19331362</pub-id></element-citation></ref><ref id=\"B28\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Gillooly</surname><given-names>DJ</given-names></name><name><surname>Morrow</surname><given-names>IC</given-names></name><name><surname>Lindsay</surname><given-names>M</given-names></name><name><surname>Gould</surname><given-names>R</given-names></name><name><surname>Bryant</surname><given-names>NJ</given-names></name><name><surname>Gaullier</surname><given-names>JM</given-names></name><name><surname>Parton</surname><given-names>RG</given-names></name><name><surname>Stenmark</surname><given-names>H</given-names></name></person-group><article-title>Localization of phosphatidylinositol 3-phosphate in yeast and mammalian cells</article-title><source>EMBO J</source><year>2000</year><volume>19</volume><fpage>4577</fpage><lpage>4588</lpage><pub-id pub-id-type=\"pmid\">10970851</pub-id></element-citation></ref><ref id=\"B29\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Gillooly</surname><given-names>DJ</given-names></name><name><surname>Simonsen</surname><given-names>A</given-names></name><name><surname>Stenmark</surname><given-names>H</given-names></name></person-group><article-title>Cellular functions of phosphatidylinositol 3-phosphate and FYVE domain proteins</article-title><source>Biochem J</source><year>2001</year><volume>355</volume><fpage>249</fpage><lpage>258</lpage><pub-id pub-id-type=\"pmid\">11284710</pub-id></element-citation></ref><ref id=\"B30\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Hagalili</surname><given-names>Y</given-names></name><name><surname>Bachnoff</surname><given-names>N</given-names></name><name><surname>Atlas</surname><given-names>D</given-names></name></person-group><article-title>The voltage-gated Ca<sup>2+</sup> channel is the Ca<sup>2+</sup> sensor protein of secretion</article-title><source>Biochem</source><year>2008</year><volume>47</volume><fpage>13822</fpage><lpage>13830</lpage><pub-id pub-id-type=\"pmid\">19061337</pub-id></element-citation></ref><ref id=\"B31\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Haucke</surname><given-names>V</given-names></name><name><surname>De Camilli</surname><given-names>P</given-names></name></person-group><article-title>AP-2 recruitment to synaptotagmin stimulated by tyrosine-based endocytic motifs</article-title><source>Science</source><year>1999</year><volume>285</volume><fpage>1268</fpage><lpage>1271</lpage><pub-id pub-id-type=\"pmid\">10455054</pub-id></element-citation></ref><ref id=\"B32\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Heitzmann</surname><given-names>D</given-names></name><etal/></person-group><article-title>Invalidation of TASK1 potassium channels disrupts adrenal gland zonation and mineralocorticoid homeostasis</article-title><source>EMBO J</source><year>2008</year><volume>27</volume><fpage>179</fpage><lpage>187</lpage><pub-id pub-id-type=\"pmid\">18034154</pub-id></element-citation></ref><ref id=\"B33\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Jackson</surname><given-names>LP</given-names></name><name><surname>Kelly</surname><given-names>BT</given-names></name><name><surname>McCoy</surname><given-names>AJ</given-names></name><name><surname>Gaffry</surname><given-names>T</given-names></name><name><surname>James</surname><given-names>LC</given-names></name><name><surname>Collins</surname><given-names>BM</given-names></name><name><surname>Honing</surname><given-names>S</given-names></name><name><surname>Evans</surname><given-names>PR</given-names></name><name><surname>Owen</surname><given-names>DJ</given-names></name></person-group><article-title>A large-scale conformational change couples membrane recruitment to cargo binding in the AP2 clathrin adaptor complex</article-title><source>Cell</source><year>2010</year><volume>141</volume><fpage>1220</fpage><lpage>1229</lpage><pub-id pub-id-type=\"pmid\">20603002</pub-id></element-citation></ref><ref id=\"B34\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Jahn</surname><given-names>R</given-names></name><name><surname>Scheller</surname><given-names>RH</given-names></name></person-group><article-title>SNAREs&#x02014;engines for membrane fusion</article-title><source>Nat Rev Mol Cell Biol</source><year>2006</year><volume>7</volume><fpage>631</fpage><lpage>643</lpage><pub-id pub-id-type=\"pmid\">16912714</pub-id></element-citation></ref><ref id=\"B35\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Kasai</surname><given-names>K</given-names></name><name><surname>Akagawa</surname><given-names>K</given-names></name></person-group><article-title>Roles of the cytoplasmic and transmembrane domains of syntaxins in intracellular localization and trafficking</article-title><source>J Cell Sci</source><year>2001</year><volume>114</volume><fpage>3115</fpage><lpage>3124</lpage><pub-id pub-id-type=\"pmid\">11590238</pub-id></element-citation></ref><ref id=\"B36\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Lakadamyali</surname><given-names>M</given-names></name><name><surname>Rust</surname><given-names>MJ</given-names></name><name><surname>Zhuang</surname><given-names>X</given-names></name></person-group><article-title>Ligands for clathrin-mediated endocytosis are differentially sorted into distinct populations of early endosomes</article-title><source>Cell</source><year>2006</year><volume>124</volume><fpage>997</fpage><lpage>1009</lpage><pub-id pub-id-type=\"pmid\">16530046</pub-id></element-citation></ref><ref id=\"B37\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Lee</surname><given-names>I</given-names></name><name><surname>Doray</surname><given-names>B</given-names></name><name><surname>Govero</surname><given-names>J</given-names></name><name><surname>Kornfeld</surname><given-names>S</given-names></name></person-group><article-title>Binding of cargo sorting signals to AP-1 enhances its association with ADP ribosylation factor 1-GTP</article-title><source>J Cell Biol</source><year>2008</year><volume>180</volume><fpage>467</fpage><lpage>472</lpage><pub-id pub-id-type=\"pmid\">18250197</pub-id></element-citation></ref><ref id=\"B38\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Lee</surname><given-names>MT</given-names></name><name><surname>Mishra</surname><given-names>A</given-names></name><name><surname>Lambright</surname><given-names>DG</given-names></name></person-group><article-title>Structural mechanisms for regulation of membrane traffic by rab GTPases</article-title><source>Traffic</source><year>2009</year><volume>10</volume><fpage>1377</fpage><lpage>1389</lpage><pub-id pub-id-type=\"pmid\">19522756</pub-id></element-citation></ref><ref id=\"B39\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Lemmon</surname><given-names>MA</given-names></name></person-group><article-title>Membrane recognition by phospholipid-binding domains</article-title><source>Nat Rev Mol Cell Biol</source><year>2008</year><volume>9</volume><fpage>99</fpage><lpage>111</lpage><pub-id pub-id-type=\"pmid\">18216767</pub-id></element-citation></ref><ref id=\"B40\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Leung</surname><given-names>YM</given-names></name><name><surname>Kang</surname><given-names>Y</given-names></name><name><surname>Gao</surname><given-names>X</given-names></name><name><surname>Xia</surname><given-names>F</given-names></name><name><surname>Xie</surname><given-names>H</given-names></name><name><surname>Sheu</surname><given-names>L</given-names></name><name><surname>Tsuk</surname><given-names>S</given-names></name><name><surname>Lotan</surname><given-names>I</given-names></name><name><surname>Tsushima</surname><given-names>RG</given-names></name><name><surname>Gaisano</surname><given-names>HY</given-names></name></person-group><article-title>Syntaxin 1A binds to the cytoplasmic C terminus of Kv2.1 to regulate channel gating and trafficking</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><fpage>17532</fpage><lpage>17538</lpage><pub-id pub-id-type=\"pmid\">12621036</pub-id></element-citation></ref><ref id=\"B41\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Leung</surname><given-names>YM</given-names></name><name><surname>Kang</surname><given-names>Y</given-names></name><name><surname>Xia</surname><given-names>F</given-names></name><name><surname>Sheu</surname><given-names>L</given-names></name><name><surname>Gao</surname><given-names>X</given-names></name><name><surname>Xie</surname><given-names>H</given-names></name><name><surname>Tsushima</surname><given-names>RG</given-names></name><name><surname>Gaisano</surname><given-names>HY</given-names></name></person-group><article-title>Open form of syntaxin-1A is a more potent inhibitor than wild-type syntaxin-1A of Kv2.1 channels</article-title><source>Biochem J</source><year>2005</year><volume>387</volume><fpage>195</fpage><lpage>202</lpage><pub-id pub-id-type=\"pmid\">15518587</pub-id></element-citation></ref><ref id=\"B42\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Leung</surname><given-names>YM</given-names></name><name><surname>Kwan</surname><given-names>EP</given-names></name><name><surname>Ng</surname><given-names>B</given-names></name><name><surname>Kang</surname><given-names>Y</given-names></name><name><surname>Gaisano</surname><given-names>HY</given-names></name></person-group><article-title>SNAREing voltage-gated K<sup>+</sup> and ATP-sensitive K<sup>+</sup> channels: tuning beta-cell excitability with syntaxin-1A and other exocytotic proteins</article-title><source>Endocr Rev</source><year>2007</year><volume>28</volume><fpage>653</fpage><lpage>663</lpage><pub-id pub-id-type=\"pmid\">17878408</pub-id></element-citation></ref><ref id=\"B43\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Limberg</surname><given-names>SH</given-names></name><etal/></person-group><article-title>TASK-1 channels may modulate action potential duration of human atrial cardiomyocytes</article-title><source>Cell Physiol Biochem</source><year>2011</year><volume>28</volume><fpage>613</fpage><lpage>624</lpage><pub-id pub-id-type=\"pmid\">22178873</pub-id></element-citation></ref><ref id=\"B44\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Loerke</surname><given-names>D</given-names></name><name><surname>Mettlen</surname><given-names>M</given-names></name><name><surname>Yarar</surname><given-names>D</given-names></name><name><surname>Jaqaman</surname><given-names>K</given-names></name><name><surname>Jaqaman</surname><given-names>H</given-names></name><name><surname>Danuser</surname><given-names>G</given-names></name><name><surname>Schmid</surname><given-names>SL</given-names></name></person-group><article-title>Cargo and dynamin regulate clathrin-coated pit maturation</article-title><source>PLoS Biol</source><year>2009</year><volume>7</volume><fpage>e57</fpage><pub-id pub-id-type=\"pmid\">19296720</pub-id></element-citation></ref><ref id=\"B45\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Malsam</surname><given-names>J</given-names></name><name><surname>Kreye</surname><given-names>S</given-names></name><name><surname>S&#x000f6;llner</surname><given-names>TH</given-names></name></person-group><article-title>Membrane fusion: SNAREs and regulation</article-title><source>Cell Mol Life Sci</source><year>2008</year><volume>65</volume><fpage>2814</fpage><lpage>2832</lpage><pub-id pub-id-type=\"pmid\">18726177</pub-id></element-citation></ref><ref id=\"B46\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Mant</surname><given-names>A</given-names></name><name><surname>Williams</surname><given-names>S</given-names></name><name><surname>O\\'Kelly</surname><given-names>I</given-names></name></person-group><article-title>Acid sensitive background potassium channels K<sub>2P</sub>3.1 and K<sub>2P</sub>9.1 undergo rapid dynamin-dependent endocytosis</article-title><source>Channels (Austin)</source><year>2013</year><volume>7</volume><fpage>288</fpage><lpage>292</lpage></element-citation></ref><ref id=\"B47\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Maritzen</surname><given-names>T</given-names></name><name><surname>Koo</surname><given-names>SJ</given-names></name><name><surname>Haucke</surname><given-names>V</given-names></name></person-group><article-title>Turning CALM into excitement: AP180 and CALM in endocytosis and disease</article-title><source>Biol Cell</source><year>2012</year><volume>104</volume><fpage>588</fpage><lpage>602</lpage><pub-id pub-id-type=\"pmid\">22639918</pub-id></element-citation></ref><ref id=\"B48\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Mathie</surname><given-names>A</given-names></name><name><surname>Rees</surname><given-names>KA</given-names></name><name><surname>El Hachmane</surname><given-names>MF</given-names></name><name><surname>Veale</surname><given-names>EL</given-names></name></person-group><article-title>Trafficking of neuronal two pore domain potassium channels</article-title><source>Curr Neuropharmacol</source><year>2010</year><volume>8</volume><fpage>276</fpage><lpage>286</lpage><pub-id pub-id-type=\"pmid\">21358977</pub-id></element-citation></ref><ref id=\"B49\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Mattera</surname><given-names>R</given-names></name><name><surname>Boehm</surname><given-names>M</given-names></name><name><surname>Chaudhuri</surname><given-names>R</given-names></name><name><surname>Prabhu</surname><given-names>Y</given-names></name><name><surname>Bonifacino</surname><given-names>JS</given-names></name></person-group><article-title>Conservation and diversification of dileucine signal recognition by adaptor protein (AP) complex variants</article-title><source>J Biol Chem</source><year>2011</year><volume>286</volume><fpage>2022</fpage><lpage>2030</lpage><pub-id pub-id-type=\"pmid\">21097499</pub-id></element-citation></ref><ref id=\"B50\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>McMahon</surname><given-names>HT</given-names></name><name><surname>Boucrot</surname><given-names>E</given-names></name></person-group><article-title>Molecular mechanism and physiological functions of clathrin-mediated endocytosis</article-title><source>Nat Rev Mol Cell Biol</source><year>2011</year><volume>12</volume><fpage>517</fpage><lpage>533</lpage><pub-id pub-id-type=\"pmid\">21779028</pub-id></element-citation></ref><ref id=\"B51\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>McNew</surname><given-names>JA</given-names></name></person-group><article-title>Regulation of SNARE-mediated membrane fusion during exocytosis</article-title><source>Chem Rev</source><year>2008</year><volume>108</volume><fpage>1669</fpage><lpage>1686</lpage><pub-id pub-id-type=\"pmid\">18419164</pub-id></element-citation></ref><ref id=\"B52\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>McNew</surname><given-names>JA</given-names></name><name><surname>Parlati</surname><given-names>F</given-names></name><name><surname>Fukuda</surname><given-names>R</given-names></name><name><surname>Johnston</surname><given-names>RJ</given-names></name><name><surname>Paz</surname><given-names>K</given-names></name><name><surname>Paumet</surname><given-names>F</given-names></name><name><surname>Sollner</surname><given-names>TH</given-names></name><name><surname>Rothman</surname><given-names>JE</given-names></name></person-group><article-title>Compartmental specificity of cellular membrane fusion encoded in SNARE proteins</article-title><source>Nature</source><year>2000</year><volume>407</volume><fpage>153</fpage><lpage>159</lpage><pub-id pub-id-type=\"pmid\">11001046</pub-id></element-citation></ref><ref id=\"B53\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Mettlen</surname><given-names>M</given-names></name><name><surname>Loerke</surname><given-names>D</given-names></name><name><surname>Yarar</surname><given-names>D</given-names></name><name><surname>Danuser</surname><given-names>G</given-names></name><name><surname>Schmid</surname><given-names>SL</given-names></name></person-group><article-title>Cargo- and adaptor-specific mechanisms regulate clathrin-mediated endocytosis</article-title><source>J Cell Biol</source><year>2010</year><volume>188</volume><fpage>919</fpage><lpage>933</lpage><pub-id pub-id-type=\"pmid\">20231386</pub-id></element-citation></ref><ref id=\"B54\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Meuth</surname><given-names>SG</given-names></name><name><surname>Budde</surname><given-names>T</given-names></name><name><surname>Kanyshkova</surname><given-names>T</given-names></name><name><surname>Broicher</surname><given-names>T</given-names></name><name><surname>Munsch</surname><given-names>T</given-names></name><name><surname>Pape</surname><given-names>HC</given-names></name></person-group><article-title>Contribution of TWIK-related acid-sensitive K<sup>+</sup> channel 1 (TASK1) and TASK3 channels to the control of activity modes in thalamocortical neurons</article-title><source>J Neurosci</source><year>2003</year><volume>23</volume><fpage>6460</fpage><lpage>6469</lpage><pub-id pub-id-type=\"pmid\">12878686</pub-id></element-citation></ref><ref id=\"B55\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Pucadyil</surname><given-names>TJ</given-names></name><name><surname>Schmid</surname><given-names>SL</given-names></name></person-group><article-title>Conserved functions of membrane active GTPases in coated vesicle formation</article-title><source>Science</source><year>2009</year><volume>325</volume><fpage>1217</fpage><lpage>1220</lpage><pub-id pub-id-type=\"pmid\">19729648</pub-id></element-citation></ref><ref id=\"B56\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Putzke</surname><given-names>C</given-names></name><etal/></person-group><article-title>The acid-sensitive potassium channel TASK-1 in rat cardiac muscle</article-title><source>Cardiovasc Res</source><year>2007</year><volume>75</volume><fpage>59</fpage><lpage>68</lpage><pub-id pub-id-type=\"pmid\">17389142</pub-id></element-citation></ref><ref id=\"B57\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Rajan</surname><given-names>S</given-names></name><name><surname>Wischmeyer</surname><given-names>E</given-names></name><name><surname>Liu</surname><given-names>GX</given-names></name><name><surname>Preisig-M&#x000fc;ller</surname><given-names>R</given-names></name><name><surname>Daut</surname><given-names>J</given-names></name><name><surname>Karschin</surname><given-names>A</given-names></name><name><surname>Derst</surname><given-names>C</given-names></name></person-group><article-title>TASK-3, a novel tandem pore domain acid-sensitive K<sup>+</sup> channel. An extracellular histidine as pH sensor</article-title><source>J Biol Chem</source><year>2000</year><volume>275</volume><fpage>16650</fpage><lpage>16657</lpage><pub-id pub-id-type=\"pmid\">10747866</pub-id></element-citation></ref><ref id=\"B58\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Renigunta</surname><given-names>V</given-names></name><etal/></person-group><article-title>The retention factor p11 confers an endoplasmic reticulum-localization signal to the potassium channel TASK-1</article-title><source>Traffic</source><year>2006</year><volume>7</volume><fpage>168</fpage><lpage>181</lpage><pub-id pub-id-type=\"pmid\">16420525</pub-id></element-citation></ref><ref id=\"B59\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Schiekel</surname><given-names>J</given-names></name><name><surname>Lindner</surname><given-names>M</given-names></name><name><surname>Hetzel</surname><given-names>A</given-names></name><name><surname>Wemh&#x000f6;ner</surname><given-names>K</given-names></name><name><surname>Renigunta</surname><given-names>V</given-names></name><name><surname>Schlichth&#x000f6;rl</surname><given-names>G</given-names></name><name><surname>Decher</surname><given-names>N</given-names></name><name><surname>Oliver</surname><given-names>D</given-names></name><name><surname>Daut</surname><given-names>J</given-names></name></person-group><article-title>The inhibition of the potassium channel TASK-1 in rat cardiac muscle by endothelin-1 is mediated by phospholipase C</article-title><source>Cardiovasc Res</source><year>2013</year><volume>97</volume><fpage>97</fpage><lpage>105</lpage><pub-id pub-id-type=\"pmid\">22977011</pub-id></element-citation></ref><ref id=\"B60\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Singer-Lahat</surname><given-names>D</given-names></name><name><surname>Chikvashvili</surname><given-names>D</given-names></name><name><surname>Lotan</surname><given-names>I</given-names></name></person-group><article-title>Direct interaction of endogenous Kv channels with syntaxin enhances exocytosis by neuroendocrine cells</article-title><source>PLoS One</source><year>2008</year><volume>3</volume><fpage>e1381</fpage><pub-id pub-id-type=\"pmid\">18167541</pub-id></element-citation></ref><ref id=\"B61\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Smith</surname><given-names>AJ</given-names></name><name><surname>Daut</surname><given-names>J</given-names></name><name><surname>Schwappach</surname><given-names>B</given-names></name></person-group><article-title>Membrane proteins as 14-3-3 clients in functional regulation and intracellular transport</article-title><source>Physiology (Bethesda)</source><year>2011</year><volume>26</volume><fpage>181</fpage><lpage>191</lpage><pub-id pub-id-type=\"pmid\">21670164</pub-id></element-citation></ref><ref id=\"B62\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Springer</surname><given-names>S</given-names></name><name><surname>Schekman</surname><given-names>R</given-names></name></person-group><article-title>Nucleation of COPII vesicular coat complex by endoplasmic reticulum to Golgi vesicle SNAREs</article-title><source>Science</source><year>1998</year><volume>281</volume><fpage>698</fpage><lpage>700</lpage><pub-id pub-id-type=\"pmid\">9685263</pub-id></element-citation></ref><ref id=\"B63\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Subramaniam</surname><given-names>VN</given-names></name><name><surname>Loh</surname><given-names>E</given-names></name><name><surname>Horstmann</surname><given-names>H</given-names></name><name><surname>Habermann</surname><given-names>A</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Coe</surname><given-names>J</given-names></name><name><surname>Griffiths</surname><given-names>G</given-names></name><name><surname>Hong</surname><given-names>W</given-names></name></person-group><article-title>Preferential association of syntaxin 8 with the early endosome</article-title><source>J Cell Sci</source><year>2000</year><volume>113</volume><fpage>997</fpage><lpage>1008</lpage><pub-id pub-id-type=\"pmid\">10683148</pub-id></element-citation></ref><ref id=\"B64\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>S&#x000fc;dhof</surname><given-names>TC</given-names></name><name><surname>Rothman</surname><given-names>JE</given-names></name></person-group><article-title>Membrane fusion: grappling with SNARE and SM proteins</article-title><source>Science</source><year>2009</year><volume>323</volume><fpage>474</fpage><lpage>477</lpage><pub-id pub-id-type=\"pmid\">19164740</pub-id></element-citation></ref><ref id=\"B65\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Tang</surname><given-names>BL</given-names></name><name><surname>Gee</surname><given-names>HY</given-names></name><name><surname>Lee</surname><given-names>MG</given-names></name></person-group><article-title>The cystic fibrosis transmembrane conductance regulator\\'s expanding SNARE interactome</article-title><source>Traffic</source><year>2011</year><volume>12</volume><fpage>364</fpage><lpage>371</lpage><pub-id pub-id-type=\"pmid\">21223469</pub-id></element-citation></ref><ref id=\"B66\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Traub</surname><given-names>LM</given-names></name></person-group><article-title>Tickets to ride: selecting cargo for clathrin-regulated internalization</article-title><source>Nat Rev Mol Cell Biol</source><year>2009</year><volume>10</volume><fpage>583</fpage><lpage>596</lpage><pub-id pub-id-type=\"pmid\">19696796</pub-id></element-citation></ref><ref id=\"B67\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Weiss</surname><given-names>N</given-names></name><name><surname>Zamponi</surname><given-names>GW</given-names></name></person-group><article-title>Regulation of voltage-gated calcium channels by synaptic proteins</article-title><source>Adv Exp Med Biol</source><year>2012</year><volume>740</volume><fpage>759</fpage><lpage>775</lpage><pub-id pub-id-type=\"pmid\">22453968</pub-id></element-citation></ref><ref id=\"B68\"><element-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name><surname>Zuzarte</surname><given-names>M</given-names></name><name><surname>Heusser</surname><given-names>K</given-names></name><name><surname>Renigunta</surname><given-names>V</given-names></name><name><surname>Schlichth&#x000f6;rl</surname><given-names>G</given-names></name><name><surname>Rinn&#x000e9;</surname><given-names>S</given-names></name><name><surname>Wischmeyer</surname><given-names>E</given-names></name><name><surname>Daut</surname><given-names>J</given-names></name><name><surname>Schwappach</surname><given-names>B</given-names></name><name><surname>Preisig-M&#x000fc;ller</surname><given-names>R</given-names></name></person-group><article-title>Intracellular traffic of the K<sup>+</sup> channels TASK-1 and TASK-3: role of N- and C-terminal sorting signals and interaction with 14-3-3 proteins</article-title><source>J Physiol</source><year>2009</year><volume>587</volume><fpage>929</fpage><lpage>952</lpage><pub-id pub-id-type=\"pmid\">19139046</pub-id></element-citation></ref></ref-list></back></article>',\n",
       " 'The National Institutes of Health Mammalian Gene Collection (MGC) Program is a multiinstitutional effort to identify and sequence a cDNA clone containing a complete ORF for each human and mouse gene. ESTs were generated from libraries enriched for full-length cDNAs and analyzed to identify candidate full-ORF clones, which then were sequenced to high accuracy. The MGC has currently sequenced and verified the full ORF for a nonredundant set of >9,000 human and >6,000 mouse genes. Candidate full-ORF clones for an additional 7,800 human and 3,500 mouse genes also have been identified. All MGC sequences and clones are available without restriction through public databases and clone distribution networks (see http:mgc.nci.nih.gov).',\n",
       " 'TASK-1 belongs to the 2P domain K+ channel family and is the prototype of background K+ channels that set the resting membrane potential and tune action potential duration. Its activity is highly regulated by hormones and neurotransmitters. Although numerous auxiliary proteins have been described to modify biophysical, pharmacological and expression properties of different voltage- and Ca2+-sensitive K+ channels, none of them is known to modulate 2P domain K+ channel activity. We show here that p11 interacts specifically with the TASK-1 K+ channel. p11 is a subunit of annexin II, a cytoplasmic protein thought to bind and organize specialized membrane cytoskeleton compartments. This association with p11 requires the integrity of the last three C-terminal amino acids, Ser-Ser-Val, in TASK-1. Using series of C-terminal TASK-1 deletion mutants and several TASK-1-GFP chimeras, we demonstrate that association with p11 is essential for trafficking of TASK-1 to the plasma membrane. p11 association with the TASK-1 channel masks an endoplasmic reticulum retention signal identified as Lys-Arg-Arg that precedes the Ser-Ser-Val sequence.',\n",
       " '<full-text-retrieval-response xmlns=\"http://www.elsevier.com/xml/svapi/article/dtd\" xmlns:bk=\"http://www.elsevier.com/xml/bk/dtd\" xmlns:cals=\"http://www.elsevier.com/xml/common/cals/dtd\" xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns:ja=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" xmlns:tb=\"http://www.elsevier.com/xml/common/table/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:xocs=\"http://www.elsevier.com/xml/xocs/dtd\" xmlns:dc=\"http://purl.org/dc/elements/1.1/\" xmlns:dcterms=\"http://purl.org/dc/terms/\" xmlns:prism=\"http://prismstandard.org/namespaces/basic/2.0/\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\"><coredata><prism:url>https://api.elsevier.com/content/article/pii/S1097276504002059</prism:url><dc:identifier>doi:10.1016/S1097-2765(04)00205-9</dc:identifier><eid>1-s2.0-S1097276504002059</eid><prism:doi>10.1016/S1097-2765(04)00205-9</prism:doi><pii>S1097-2765(04)00205-9</pii><dc:title>HIV-1 Vpu Putting a Channel to the TASK</dc:title><prism:publicationName>Molecular Cell</prism:publicationName><prism:aggregationType>Journal</prism:aggregationType><pubType>\\n               Preview\\n            </pubType><prism:issn>10972765</prism:issn><prism:volume>14</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:startingPage>150</prism:startingPage><prism:endingPage>152</prism:endingPage><prism:pageRange>150-152</prism:pageRange><prism:number>2</prism:number><dc:format>text/xml</dc:format><prism:coverDate>2004-04-23</prism:coverDate><prism:coverDisplayDate>23 April 2004</prism:coverDisplayDate><prism:copyright>Copyright © 2004 Cell Press.  All rights reserved.</prism:copyright><prism:publisher>Cell Press.</prism:publisher><dc:creator>Strebel, Klaus</dc:creator><dc:description>\\n               Abstract\\n               \\n                  Vpu is an HIV-encoded protein that enhances virus release. Previously, this activity was correlated with an intrinsic ion channel activity of Vpu. In this issue of Molecular Cell, Hsu et al. (2004) propose an alternative mechanism: they suggest that Vpu functions by inhibiting another ion channel, TASK-1.\\n               \\n            </dc:description><openaccess>1</openaccess><openaccessArticle>true</openaccessArticle><openaccessType>Full</openaccessType><openArchiveArticle>true</openArchiveArticle><openaccessSponsorName/><openaccessSponsorType>ElsevierBranded</openaccessSponsorType><openaccessUserLicense>http://www.elsevier.com/open-access/userlicense/1.0/</openaccessUserLicense><link href=\"https://api.elsevier.com/content/article/pii/S1097276504002059\" rel=\"self\"/><link href=\"https://www.sciencedirect.com/science/article/pii/S1097276504002059\" rel=\"scidir\"/></coredata><scopus-id>1942470600</scopus-id><scopus-eid>2-s2.0-1942470600</scopus-eid><pubmed-id>15099514</pubmed-id><link href=\"https://api.elsevier.com/content/abstract/scopus_id/1942470600\" rel=\"abstract\"/><originalText><xocs:doc><xocs:meta><xocs:open-access xmlns:xocs=\"http://www.elsevier.com/xml/xocs/dtd\"\\n                  xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\"\\n                  xmlns:xoe=\"http://www.elsevier.com/xml/xoe/dtd\">\\n   <xocs:oa-access-effective-date>2013-07-17T11:43:29Z</xocs:oa-access-effective-date>\\n   <xocs:oa-access-inherited-from winid=\"http://vtw.elsevier.com/content/oaw/GEN_1995_P1Y_ESBranded\"\\n                                  wintype=\"OpenArchive\">OA-Window</xocs:oa-access-inherited-from>\\n   <xocs:oa-article-status is-open-access=\"1\" is-open-archive=\"1\">Full</xocs:oa-article-status>\\n   <xocs:oa-sponsor>\\n      <xocs:oa-sponsor-type>ElsevierBranded</xocs:oa-sponsor-type>\\n   </xocs:oa-sponsor>\\n   <xocs:oa-user-license>http://www.elsevier.com/open-access/userlicense/1.0/</xocs:oa-user-license>\\n</xocs:open-access><xocs:available-online-date xmlns:xoe=\"http://www.elsevier.com/xml/xoe/dtd\" yyyymmdd=\"20040422\">2004-04-22</xocs:available-online-date></xocs:meta></xocs:doc></originalText></full-text-retrieval-response>',\n",
       " 'Multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE) are characterized by T cell-mediated autoimmune inflammation of the central nervous system (CNS) leading to oligodendrocyte loss and demyelination accompanied by neuronal cell death. Neuronal TWIK-related acid-sensitive potassium (TASK) channels allow the regulated efflux of potassium ions. These channels might either protect neurons in the inflamed CNS by modulating electrical excitability or even contribute to inflammatory neurodegeneration mediating intracellular potassium depletion. Using a combination of in-situ-hybridisation and immunofluorescence staining, we found increased neuronal expression of TASK1 and TASK3 channels in the optic nerve and decreased expression in the spinal cord and thalamus of rats undergoing MOG-induced EAE. Inflammatory plaques of human MS patients displayed profoundly lowered expression of both TASK isoforms. Thus, regulated expression of TASK channels might contribute to a molecular switch between death and survival of neurons in autoimmune CNS inflammation.',\n",
       " \"TASK channels are background K+ channels that contribute to the resting conductance in many neurons. A key feature of TASK channels is the reversible inhibition by Gq-coupled receptors, thereby mediating the dynamic regulation of neuronal activity by modulatory transmitters. The mechanism that mediates channel inhibition is not fully understood. While it is clear that activation of Gαq is required, the immediate signal for channel closure remains controversial. Experimental evidence pointed to either phospholipase C (PLC)-mediated depletion of phosphatidylinositol-4,5-bisphosphate (PI(4,5)P2) as the cause for channel closure or to a direct inhibitory interaction of active Gαq with the channel. Here, we address the role of PI(4,5)P2 for G-protein-coupled receptor (GPCR)-mediated TASK inhibition by using recently developed genetically encoded tools to alter phosphoinositide (PI) concentrations in the living cell.When expressed in CHO cells, TASK-1- and TASK-3-mediated currents were not affected by depletion of plasma membrane PI(4,5)P2 either via the voltage-activated phosphatase Ci-VSP or via chemically triggered recruitment of a PI(4,5)P2-5'-phosphatase. Depletion of both PI(4,5)P2 and PI(4)P via membrane recruitment of a novel engineered dual-specificity phosphatase also did not inhibit TASK currents. In contrast, each of these methods produced robust inhibition of the bona fide PI(4,5)P2-dependent channel KCNQ4. Efficient depletion of PI(4,5)P2 and PI(4)P was further confirmed with a fluorescent phosphoinositide sensor. Moreover, TASK channels recovered normally from inhibition by co-expressed muscarinic M1 receptors when resynthesis of PI(4,5)P2 was prevented by depletion of cellular ATP. These results demonstrate that TASK channel activity is independent of phosphoinositide concentrations within the physiological range. Consequently, Gq-mediated inhibition of TASK channels is not mediated by depletion of PI(4,5)P2.\",\n",
       " 'We have cloned a novel member of the tandem pore K+ channel family from human brain cDNA. The novel cDNA encodes a 330-residue polypeptide of predicted molecular mass 36 kDa. We have named the channel TASK-5 owing to its sequence homology with TASK-1 and TASK-3. TASK-5 mRNA is expressed in pancreas, liver, kidney, lung, ovary, testis and heart. However, expression of TASK-5 in heterologous systems failed to elicit ionic currents. Removal of a putative endoplasmic reticulum retention sequence did not alter this finding and the distribution of channel proteins in HEK293 cells was similar for both TASK-1 and TASK-5. We tested whether TASK-5 could form heteromers with TASK-1. We show a mutant form of TASK-1 (H98N) to have a radically reduced sensitivity to acidification. Proton sensitivity could be rescued by injecting equimolar amounts of wild-type and mutant TASK-1 cRNA into Xenopus oocytes; the effect was that expected if half the channels formed are heteromers. Co-expression of TASK-5 with TASK-1 H98N does not affect the proton sensitivity of mutant TASK-1; thus TASK-5 appears not to form heteromers with TASK-1. Nonetheless, TASK-5 may require some other, unidentified partner subunit to form functional channels in the plasma membrane or it may form a channel in an intracellular organelle.',\n",
       " 'Viral protein U (Vpu) is encoded by one of several accessory genes of HIV-1. Like the accessory gene products Vif and Vpr, Vpu targets host proteins such as CD4 for degradation via the recruitment of cellular multi-subunit ubiquitin ligases. Vpu also forms ion channels in cellular membranes. Through one or both of these attributes, Vpu antagonizes host cell factors that restrict the release of progeny virions from infected cells. A key target of Vpu has recently been identified as the interferon-induced transmembrane protein BST-2/CD317 (tetherin), which restricts viral replication by retaining nascent virions on the cell surface. The counteraction of this host defense allows Vpu to be considered an antagonist of the innate immune response to viral infection.',\n",
       " 'Medulloblastoma is a pediatric high-grade cerebellar malignancy derived from neuronal precursors. Although electrophysiologic characteristics of cerebellar granule neurons at all stages of cell development have been well described, such characterization has not been reported for medulloblastoma. In this study we attempt to characterize important electrophysiologic features of medulloblastoma that may distinguish it from the surrounding cerebellum. Using patient-derived cell lines and tumor tissues, we show that medulloblastoma cells have no inward Na+ current or transient K+ current involved in action potential generation and propagation, typically seen in granule neurons. Expression and function of calcium-activated, large-conductance K+ channels are diminished in medulloblastoma, judged by electrophysiology and Western analysis. The resting membrane potential of medulloblastoma cells in culture is quite depolarized compared to granule neurons. Interestingly, medulloblastoma cells express small, fast-inactivating calcium currents consistent with T-type calcium channels, but these channels are activated only from hyperpolarized potentials, which are unlikely to occur. Additionally, a background acid-sensitive K+ current is present with features characteristic of TASK1 or TASK3 channels, such as inhibition by ruthenium red. Western analysis confirms expression of TASK1 and TASK3. In describing the electrophysiologic characteristics of medulloblastoma, one can see features that resemble other high-grade malignancies as opposed to normal cerebellar granule neurons. This supports the notion that the malignant phenotype of medulloblastoma is characterized by unique changes in ion channel expression.',\n",
       " '<full-text-retrieval-response xmlns=\"http://www.elsevier.com/xml/svapi/article/dtd\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\" xmlns:prism=\"http://prismstandard.org/namespaces/basic/2.0/\" xmlns:dcterms=\"http://purl.org/dc/terms/\" xmlns:dc=\"http://purl.org/dc/elements/1.1/\" xmlns:xocs=\"http://www.elsevier.com/xml/xocs/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:tb=\"http://www.elsevier.com/xml/common/table/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" xmlns:ja=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns:cals=\"http://www.elsevier.com/xml/common/cals/dtd\" xmlns:bk=\"http://www.elsevier.com/xml/bk/dtd\"><coredata><prism:url>https://api.elsevier.com/content/article/pii/S0022282813003635</prism:url><dc:identifier>doi:10.1016/j.yjmcc.2013.12.014</dc:identifier><eid>1-s2.0-S0022282813003635</eid><prism:doi>10.1016/j.yjmcc.2013.12.014</prism:doi><pii>S0022-2828(13)00363-5</pii><dc:title>Genetic variation in the two-pore domain potassium channel, TASK-1, may contribute to an atrial substrate for arrhythmogenesis </dc:title><prism:publicationName>Journal of Molecular and Cellular Cardiology</prism:publicationName><prism:aggregationType>Journal</prism:aggregationType><pubType>Original article</pubType><prism:issn>00222828</prism:issn><prism:volume>67</prism:volume><prism:startingPage>69</prism:startingPage><prism:endingPage>76</prism:endingPage><prism:pageRange>69-76</prism:pageRange><dc:format>text/xml</dc:format><prism:coverDate>2014-02-28</prism:coverDate><prism:coverDisplayDate>February 2014</prism:coverDisplayDate><prism:copyright>Copyright © 2013 Elsevier Ltd. All rights reserved.</prism:copyright><prism:publisher>Elsevier Ltd.</prism:publisher><dc:creator>Liang, Bo</dc:creator><dc:creator>Soka, Magdalena</dc:creator><dc:creator>Christensen, Alex Horby</dc:creator><dc:creator>Olesen, Morten S.</dc:creator><dc:creator>Larsen, Anders P.</dc:creator><dc:creator>Knop, Filip K.</dc:creator><dc:creator>Wang, Fan</dc:creator><dc:creator>Nielsen, Jonas B.</dc:creator><dc:creator>Andersen, Martin N.</dc:creator><dc:creator>Humphreys, David</dc:creator><dc:creator>Mann, Stefan A.</dc:creator><dc:creator>Huttner, Inken G.</dc:creator><dc:creator>Vandenberg, Jamie I.</dc:creator><dc:creator>Svendsen, Jesper H.</dc:creator><dc:creator>Haunsø, Stig</dc:creator><dc:creator>Preiss, Thomas</dc:creator><dc:creator>Seebohm, Guiscard</dc:creator><dc:creator>Olesen, Søren-Peter</dc:creator><dc:creator>Schmitt, Nicole</dc:creator><dc:creator>Fatkin, Diane</dc:creator><dc:description>AbstractThe two-pore domain potassium channel, K2P3.1 (TASK-1) modulates background conductance in isolated human atrial cardiomyocytes and has been proposed as a potential drug target for atrial fibrillation (AF). TASK-1 knockout mice have a predominantly ventricular phenotype however, and effects of TASK-1 inactivation on atrial structure and function have yet to be demonstrated in vivo. The extent to which genetic variation in KCNK3, that encodes TASK-1, might be a determinant of susceptibility to AF is also unknown. To address these questions, we first evaluated the effects of transient knockdown of the zebrafish kcnk3a and kcnk3b genes and cardiac phenotypes were evaluated using videomicroscopy. Combined kcnk3a and kcnk3b knockdown in 72 hour post fertilization embryos resulted in lower heart rate (p&lt;0.001), marked increase in atrial diameter (p&lt;0.001), and mild increase in end-diastolic ventricular diameter (p=0.01) when compared with control-injected embryos. We next performed genetic screening of KCNK3 in two independent AF cohorts (373 subjects) and identified three novel KCNK3 variants. Two of these variants, present in one proband with familial AF, were located at adjacent nucleotides in the Kozak sequence and reduced expression of an engineered reporter. A third missense variant, V123L, in a patient with lone AF, reduced resting membrane potential and altered pH sensitivity in patch-clamp experiments, with structural modeling predicting instability in the vicinity of the TASK-1 pore. These in vitro data suggest that the double Kozak variants and V123L will have loss-of-function effects on ITASK. Cardiac action potential modeling predicted that reduced ITASK prolongs atrial action potential duration, and that this is potentiated by reciprocal changes in activity of other ion channel currents. Our findings demonstrate the functional importance of ITASK in the atrium and suggest that inactivation of TASK-1 may have diverse effects on atrial size and electrophysiological properties that can contribute to an arrhythmogenic substrate.</dc:description><openaccess>0</openaccess><openaccessArticle>false</openaccessArticle><openaccessType/><openArchiveArticle>false</openArchiveArticle><openaccessSponsorName/><openaccessSponsorType/><openaccessUserLicense/><dcterms:subject>Two-pore domain potassium channels</dcterms:subject><dcterms:subject>TASK-1</dcterms:subject><dcterms:subject>Atrial action potential duration</dcterms:subject><dcterms:subject>Atrial fibrillation</dcterms:subject><link rel=\"self\" href=\"https://api.elsevier.com/content/article/pii/S0022282813003635\"/><link rel=\"scidir\" href=\"http://www.sciencedirect.com/science/article/pii/S0022282813003635\"/></coredata><objects><object ref=\"mmc3\" category=\"thumbnail\" type=\"IMAGE-MMC-THUMBNAIL\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"218\" height=\"164\" size=\"7101\">https://api.elsevier.com/content/object/eid/1-s2.0-S0022282813003635-mmc3.sml?httpAccept=%2A%2F%2A</object><object ref=\"mmc2\" category=\"thumbnail\" type=\"IMAGE-MMC-THUMBNAIL\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"218\" height=\"164\" size=\"6618\">https://api.elsevier.com/content/object/eid/1-s2.0-S0022282813003635-mmc2.sml?httpAccept=%2A%2F%2A</object><object ref=\"mmc3\" category=\"standard\" type=\"VIDEO\" multimediatype=\"MPEG-4 movie\" mimetype=\"video/mp4\" size=\"204637\">https://api.elsevier.com/content/object/eid/1-s2.0-S0022282813003635-mmc3.mp4?httpAccept=%2A%2F%2A</object><object ref=\"mmc2\" category=\"standard\" type=\"VIDEO\" multimediatype=\"MPEG-4 movie\" mimetype=\"video/mp4\" size=\"110326\">https://api.elsevier.com/content/object/eid/1-s2.0-S0022282813003635-mmc2.mp4?httpAccept=%2A%2F%2A</object><object ref=\"gr6\" category=\"high\" type=\"IMAGE-HIGH-RES\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"2962\" height=\"1882\" size=\"512873\">https://api.elsevier.com/content/object/eid/1-s2.0-S0022282813003635-gr6_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr5\" category=\"high\" type=\"IMAGE-HIGH-RES\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"1719\" height=\"2091\" size=\"731046\">https://api.elsevier.com/content/object/eid/1-s2.0-S0022282813003635-gr5_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr4\" category=\"high\" type=\"IMAGE-HIGH-RES\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"2956\" height=\"2200\" size=\"480298\">https://api.elsevier.com/content/object/eid/1-s2.0-S0022282813003635-gr4_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr3\" category=\"high\" type=\"IMAGE-HIGH-RES\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"2433\" height=\"1521\" size=\"274450\">https://api.elsevier.com/content/object/eid/1-s2.0-S0022282813003635-gr3_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr2\" category=\"high\" type=\"IMAGE-HIGH-RES\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"2197\" height=\"1234\" size=\"145435\">https://api.elsevier.com/content/object/eid/1-s2.0-S0022282813003635-gr2_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr1\" category=\"high\" type=\"IMAGE-HIGH-RES\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"1719\" height=\"1577\" size=\"349922\">https://api.elsevier.com/content/object/eid/1-s2.0-S0022282813003635-gr1_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref=\"mmc3\" category=\"standard\" type=\"VIDEO-FLASH\" multimediatype=\"Flash Video file\" mimetype=\"video/x-flv\" width=\"\" height=\"\" size=\"530137\">https://api.elsevier.com/content/object/eid/1-s2.0-S0022282813003635-mmc3.flv?httpAccept=%2A%2F%2A</object><object ref=\"mmc2\" category=\"standard\" type=\"VIDEO-FLASH\" multimediatype=\"Flash Video file\" mimetype=\"video/x-flv\" width=\"\" height=\"\" size=\"342878\">https://api.elsevier.com/content/object/eid/1-s2.0-S0022282813003635-mmc2.flv?httpAccept=%2A%2F%2A</object><object ref=\"gr6\" category=\"standard\" type=\"IMAGE-DOWNSAMPLED\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"669\" height=\"425\" size=\"68996\">https://api.elsevier.com/content/object/eid/1-s2.0-S0022282813003635-gr6.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr5\" category=\"standard\" type=\"IMAGE-DOWNSAMPLED\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"388\" height=\"472\" size=\"77137\">https://api.elsevier.com/content/object/eid/1-s2.0-S0022282813003635-gr5.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr4\" category=\"standard\" type=\"IMAGE-DOWNSAMPLED\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"668\" height=\"497\" size=\"59763\">https://api.elsevier.com/content/object/eid/1-s2.0-S0022282813003635-gr4.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr3\" category=\"standard\" type=\"IMAGE-DOWNSAMPLED\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"549\" height=\"343\" size=\"40758\">https://api.elsevier.com/content/object/eid/1-s2.0-S0022282813003635-gr3.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr2\" category=\"standard\" type=\"IMAGE-DOWNSAMPLED\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"496\" height=\"279\" size=\"25483\">https://api.elsevier.com/content/object/eid/1-s2.0-S0022282813003635-gr2.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr1\" category=\"standard\" type=\"IMAGE-DOWNSAMPLED\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"647\" height=\"594\" size=\"95672\">https://api.elsevier.com/content/object/eid/1-s2.0-S0022282813003635-gr1.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr6\" category=\"thumbnail\" type=\"IMAGE-THUMBNAIL\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"219\" height=\"139\" size=\"6327\">https://api.elsevier.com/content/object/eid/1-s2.0-S0022282813003635-gr6.sml?httpAccept=%2A%2F%2A</object><object ref=\"gr5\" category=\"thumbnail\" type=\"IMAGE-THUMBNAIL\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"135\" height=\"164\" size=\"10441\">https://api.elsevier.com/content/object/eid/1-s2.0-S0022282813003635-gr5.sml?httpAccept=%2A%2F%2A</object><object ref=\"gr4\" category=\"thumbnail\" type=\"IMAGE-THUMBNAIL\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"219\" height=\"163\" size=\"4967\">https://api.elsevier.com/content/object/eid/1-s2.0-S0022282813003635-gr4.sml?httpAccept=%2A%2F%2A</object><object ref=\"gr3\" category=\"thumbnail\" type=\"IMAGE-THUMBNAIL\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"219\" height=\"137\" size=\"5467\">https://api.elsevier.com/content/object/eid/1-s2.0-S0022282813003635-gr3.sml?httpAccept=%2A%2F%2A</object><object ref=\"gr2\" category=\"thumbnail\" type=\"IMAGE-THUMBNAIL\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"219\" height=\"123\" size=\"3819\">https://api.elsevier.com/content/object/eid/1-s2.0-S0022282813003635-gr2.sml?httpAccept=%2A%2F%2A</object><object ref=\"gr1\" category=\"thumbnail\" type=\"IMAGE-THUMBNAIL\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"179\" height=\"164\" size=\"9962\">https://api.elsevier.com/content/object/eid/1-s2.0-S0022282813003635-gr1.sml?httpAccept=%2A%2F%2A</object><object ref=\"mmc1\" category=\"standard\" type=\"APPLICATION\" multimediatype=\"Acrobat PDF file\" mimetype=\"application/pdf\" size=\"1254023\">https://api.elsevier.com/content/object/eid/1-s2.0-S0022282813003635-mmc1.pdf?httpAccept=%2A%2F%2A</object></objects><scopus-id>84892884303</scopus-id><scopus-eid>2-s2.0-84892884303</scopus-eid><pubmed-id>24374141</pubmed-id><link rel=\"abstract\" href=\"https://api.elsevier.com/content/abstract/scopus_id/84892884303\"/><originalText><xocs:doc xmlns:xoe=\"http://www.elsevier.com/xml/xoe/dtd\" xsi:schemaLocation=\"http://www.elsevier.com/xml/xocs/dtd http://be-prod3a/schema/dtds/document/fulltext/xcr/xocs-article.xsd\"><xocs:meta><xocs:content-family>serial</xocs:content-family><xocs:content-type>JL</xocs:content-type><xocs:cid>272480</xocs:cid><xocs:ssids><xocs:ssid type=\"alllist\">291210</xocs:ssid><xocs:ssid type=\"subj\">291852</xocs:ssid><xocs:ssid type=\"subj\">291857</xocs:ssid><xocs:ssid type=\"subj\">291896</xocs:ssid><xocs:ssid type=\"content\">31</xocs:ssid></xocs:ssids><xocs:srctitle>Journal of Molecular and Cellular Cardiology</xocs:srctitle><xocs:normalized-srctitle>JOURNALMOLECULARCELLULARCARDIOLOGY</xocs:normalized-srctitle><xocs:orig-load-date yyyymmdd=\"20131226\">2013-12-26</xocs:orig-load-date><xocs:available-online-date yyyymmdd=\"20131226\">2013-12-26</xocs:available-online-date><xocs:ew-transaction-id>2014-06-05T20:48:47</xocs:ew-transaction-id><xocs:eid>1-s2.0-S0022282813003635</xocs:eid><xocs:pii-formatted>S0022-2828(13)00363-5</xocs:pii-formatted><xocs:pii-unformatted>S0022282813003635</xocs:pii-unformatted><xocs:doi>10.1016/j.yjmcc.2013.12.014</xocs:doi><xocs:item-stage>S300</xocs:item-stage><xocs:item-version-number>S300.2</xocs:item-version-number><xocs:item-weight>FULL-TEXT</xocs:item-weight><xocs:hub-eid>1-s2.0-S0022282814X00027</xocs:hub-eid><xocs:timestamp yyyymmdd=\"20150514\">2015-05-14T01:20:21.503208-04:00</xocs:timestamp><xocs:dco>0</xocs:dco><xocs:tomb>0</xocs:tomb><xocs:date-search-begin>20140201</xocs:date-search-begin><xocs:date-search-end>20140228</xocs:date-search-end><xocs:year-nav>2014</xocs:year-nav><xocs:indexeddate epoch=\"1388016000\">2013-12-26T00:00:00Z</xocs:indexeddate><xocs:articleinfo>articleinfo articletitlenorm authfirstinitialnorm authfirstsurnamenorm cid cids contenttype copyright crossmark dateloaded dateloadedtxt datesearch datesort dateupdated dco docsubtype doctype doi eid ewtransactionid hubeid indexeddate issn issnnorm itemstage itemtransactionid itemweight openaccess openarchive pg pgfirst pglast pii piinorm pubdateend pubdatestart pubdatetxt pubyr sectiontitle sortorder srctitle srctitlenorm srctype subheadings suppl tomb volfirst volissue volumelist webpdf webpdfpagecount yearnav figure e-component body acknowledge affil appendices articletitle auth authfirstini authfull authkeywords authlast footnotes highlightsabst otherkwds primabst pubtype ref alllist content subj ssids</xocs:articleinfo><xocs:issns><xocs:issn-primary-formatted>0022-2828</xocs:issn-primary-formatted><xocs:issn-primary-unformatted>00222828</xocs:issn-primary-unformatted></xocs:issns><xocs:crossmark is-crossmark=\"1\">true</xocs:crossmark><xocs:vol-first>67</xocs:vol-first><xocs:volume-list><xocs:volume>67</xocs:volume></xocs:volume-list><xocs:suppl>C</xocs:suppl><xocs:vol-iss-suppl-text>Volume 67</xocs:vol-iss-suppl-text><xocs:sort-order>8</xocs:sort-order><xocs:first-fp>69</xocs:first-fp><xocs:last-lp>76</xocs:last-lp><xocs:pages><xocs:first-page>69</xocs:first-page><xocs:last-page>76</xocs:last-page></xocs:pages><xocs:cover-date-orig><xocs:start-date>201402</xocs:start-date></xocs:cover-date-orig><xocs:cover-date-text>February 2014</xocs:cover-date-text><xocs:cover-date-start>2014-02-01</xocs:cover-date-start><xocs:cover-date-end>2014-02-28</xocs:cover-date-end><xocs:cover-date-year>2014</xocs:cover-date-year><xocs:hub-sec><xocs:hub-sec-title>Original Articles</xocs:hub-sec-title></xocs:hub-sec><xocs:document-type>article</xocs:document-type><xocs:document-subtype>fla</xocs:document-subtype><xocs:copyright-line>Copyright © 2013 Elsevier Ltd. All rights reserved.</xocs:copyright-line><xocs:normalized-article-title>GENETICVARIATIONINTWOPOREDOMAINPOTASSIUMCHANNELTASK1MAYCONTRIBUTEATRIALSUBSTRATEFORARRHYTHMOGENESIS</xocs:normalized-article-title><xocs:normalized-first-auth-surname>LIANG</xocs:normalized-first-auth-surname><xocs:normalized-first-auth-initial>B</xocs:normalized-first-auth-initial><xocs:item-toc><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>1</xocs:item-toc-label><xocs:item-toc-section-title>Introduction</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>2</xocs:item-toc-label><xocs:item-toc-section-title>Materials and methods</xocs:item-toc-section-title><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>2.1</xocs:item-toc-label><xocs:item-toc-section-title>Zebrafish studies</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>2.2</xocs:item-toc-label><xocs:item-toc-section-title>Study populations and clinical evaluation</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>2.3</xocs:item-toc-label><xocs:item-toc-section-title>Genetic screening</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>2.4</xocs:item-toc-label><xocs:item-toc-section-title>Luciferase reporter assays</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>2.5</xocs:item-toc-label><xocs:item-toc-section-title>Cellular electrophysiology</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>2.6</xocs:item-toc-label><xocs:item-toc-section-title>In silico modeling</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>2.7</xocs:item-toc-label><xocs:item-toc-section-title>Statistical analyses</xocs:item-toc-section-title></xocs:item-toc-entry></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>3</xocs:item-toc-label><xocs:item-toc-section-title>Results</xocs:item-toc-section-title><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>3.1</xocs:item-toc-label><xocs:item-toc-section-title>Task-1 knockdown in zebrafish</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>3.2</xocs:item-toc-label><xocs:item-toc-section-title>KCNK3 sequencing</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>3.3</xocs:item-toc-label><xocs:item-toc-section-title>Additional variants</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>3.4</xocs:item-toc-label><xocs:item-toc-section-title>KCNK3 Kozak variants reduce translation efficiency</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>3.5</xocs:item-toc-label><xocs:item-toc-section-title>V123L_TASK-1 reduces I<ce:inf loc=\"post\">TASK</ce:inf></xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>3.6</xocs:item-toc-label><xocs:item-toc-section-title>Modulation of V123L_TASK-1 by extracellular pH</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>3.7</xocs:item-toc-label><xocs:item-toc-section-title>Cardiac action potential modeling</xocs:item-toc-section-title></xocs:item-toc-entry></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>4</xocs:item-toc-label><xocs:item-toc-section-title>Discussion</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-label>5</xocs:item-toc-label><xocs:item-toc-section-title>Conclusions</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-section-title>Conflict of interest statement</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:acknowledgment\"><xocs:item-toc-section-title>Acknowledgments</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:appendices\"><xocs:item-toc-label>Appendix A</xocs:item-toc-label><xocs:item-toc-section-title>Supplementary data</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:bibliography\"><xocs:item-toc-section-title>References</xocs:item-toc-section-title></xocs:item-toc-entry></xocs:item-toc><xocs:references><xocs:ref-info refid=\"rf0005\"><xocs:ref-normalized-surname>GURNEY</xocs:ref-normalized-surname><xocs:ref-pub-year>2009</xocs:ref-pub-year><xocs:ref-first-fp>305</xocs:ref-first-fp><xocs:ref-last-lp>318</xocs:ref-last-lp><xocs:ref-normalized-initial>A</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0010\"><xocs:ref-normalized-surname>KIM</xocs:ref-normalized-surname><xocs:ref-pub-year>1999</xocs:ref-pub-year><xocs:ref-first-fp>H1669</xocs:ref-first-fp><xocs:ref-last-lp>H1678</xocs:ref-last-lp><xocs:ref-normalized-initial>Y</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0015\"><xocs:ref-normalized-surname>DONNER</xocs:ref-normalized-surname><xocs:ref-pub-year>2011</xocs:ref-pub-year><xocs:ref-first-fp>75</xocs:ref-first-fp><xocs:ref-last-lp>87</xocs:ref-last-lp><xocs:ref-normalized-initial>B</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0020\"><xocs:ref-normalized-surname>JONES</xocs:ref-normalized-surname><xocs:ref-pub-year>2002</xocs:ref-pub-year><xocs:ref-first-fp>H181</xocs:ref-first-fp><xocs:ref-last-lp>H185</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0025\"><xocs:ref-normalized-surname>DECHER</xocs:ref-normalized-surname><xocs:ref-pub-year>2011</xocs:ref-pub-year><xocs:ref-first-fp>77</xocs:ref-first-fp><xocs:ref-last-lp>86</xocs:ref-last-lp><xocs:ref-normalized-initial>N</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0030\"><xocs:ref-normalized-surname>ELLINGHAUS</xocs:ref-normalized-surname><xocs:ref-pub-year>2005</xocs:ref-pub-year><xocs:ref-first-fp>1383</xocs:ref-first-fp><xocs:ref-last-lp>1390</xocs:ref-last-lp><xocs:ref-normalized-initial>P</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0035\"><xocs:ref-normalized-surname>GABORIT</xocs:ref-normalized-surname><xocs:ref-pub-year>2007</xocs:ref-pub-year><xocs:ref-first-fp>675</xocs:ref-first-fp><xocs:ref-last-lp>693</xocs:ref-last-lp><xocs:ref-normalized-initial>N</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0040\"><xocs:ref-normalized-surname>CHANDLER</xocs:ref-normalized-surname><xocs:ref-pub-year>2009</xocs:ref-pub-year><xocs:ref-first-fp>1562</xocs:ref-first-fp><xocs:ref-last-lp>1575</xocs:ref-last-lp><xocs:ref-normalized-initial>N</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0045\"><xocs:ref-normalized-surname>LIMBERG</xocs:ref-normalized-surname><xocs:ref-pub-year>2011</xocs:ref-pub-year><xocs:ref-first-fp>613</xocs:ref-first-fp><xocs:ref-last-lp>624</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0050\"><xocs:ref-normalized-surname>BARTH</xocs:ref-normalized-surname><xocs:ref-pub-year>2005</xocs:ref-pub-year><xocs:ref-first-fp>1022</xocs:ref-first-fp><xocs:ref-last-lp>1029</xocs:ref-last-lp><xocs:ref-normalized-initial>A</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0055\"><xocs:ref-normalized-surname>GIERTEN</xocs:ref-normalized-surname><xocs:ref-pub-year>2010</xocs:ref-pub-year><xocs:ref-first-fp>261</xocs:ref-first-fp><xocs:ref-last-lp>270</xocs:ref-last-lp><xocs:ref-normalized-initial>J</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0060\"><xocs:ref-normalized-surname>HARLETON</xocs:ref-normalized-surname><xocs:ref-pub-year>2013</xocs:ref-pub-year><xocs:ref-first-fp>2829</xocs:ref-first-fp><xocs:ref-last-lp>2838</xocs:ref-last-lp><xocs:ref-normalized-initial>E</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0065\"><xocs:ref-normalized-surname>OLESEN</xocs:ref-normalized-surname><xocs:ref-pub-year>2012</xocs:ref-pub-year><xocs:ref-first-fp>450</xocs:ref-first-fp><xocs:ref-last-lp>459</xocs:ref-last-lp><xocs:ref-normalized-initial>M</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0070\"><xocs:ref-normalized-surname>MANN</xocs:ref-normalized-surname><xocs:ref-pub-year>2012</xocs:ref-pub-year><xocs:ref-first-fp>1017</xocs:ref-first-fp><xocs:ref-last-lp>1025</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0160\"><xocs:ref-normalized-surname>ELLINOR</xocs:ref-normalized-surname><xocs:ref-pub-year>2012</xocs:ref-pub-year><xocs:ref-first-fp>670</xocs:ref-first-fp><xocs:ref-last-lp>675</xocs:ref-last-lp><xocs:ref-normalized-initial>P</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0080\"><xocs:ref-normalized-surname>HUMPHREYS</xocs:ref-normalized-surname><xocs:ref-pub-year>2012</xocs:ref-pub-year><xocs:ref-first-fp>e30933</xocs:ref-first-fp><xocs:ref-normalized-initial>D</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0085\"><xocs:ref-normalized-surname>KRIEGER</xocs:ref-normalized-surname><xocs:ref-pub-year>2009</xocs:ref-pub-year><xocs:ref-first-fp>114</xocs:ref-first-fp><xocs:ref-last-lp>122</xocs:ref-last-lp><xocs:ref-normalized-initial>E</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0090\"><xocs:ref-normalized-surname>COURTEMANCHE</xocs:ref-normalized-surname><xocs:ref-pub-year>1998</xocs:ref-pub-year><xocs:ref-first-fp>H301</xocs:ref-first-fp><xocs:ref-last-lp>H321</xocs:ref-last-lp><xocs:ref-normalized-initial>M</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0095\"><xocs:ref-normalized-surname>RAMAEKERS</xocs:ref-normalized-surname><xocs:ref-pub-year>1998</xocs:ref-pub-year><xocs:ref-first-fp>1546</xocs:ref-first-fp><xocs:ref-last-lp>1552</xocs:ref-last-lp><xocs:ref-normalized-initial>D</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0100\"><xocs:ref-normalized-surname>KOZAK</xocs:ref-normalized-surname><xocs:ref-pub-year>1986</xocs:ref-pub-year><xocs:ref-first-fp>283</xocs:ref-first-fp><xocs:ref-last-lp>292</xocs:ref-last-lp><xocs:ref-normalized-initial>M</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0105\"><xocs:ref-normalized-surname>SIGNORI</xocs:ref-normalized-surname><xocs:ref-pub-year>2001</xocs:ref-pub-year><xocs:ref-first-fp>4596</xocs:ref-first-fp><xocs:ref-last-lp>4600</xocs:ref-last-lp><xocs:ref-normalized-initial>E</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0110\"><xocs:ref-normalized-surname>MILLER</xocs:ref-normalized-surname><xocs:ref-pub-year>2012</xocs:ref-pub-year><xocs:ref-first-fp>432</xocs:ref-first-fp><xocs:ref-last-lp>436</xocs:ref-last-lp><xocs:ref-normalized-initial>A</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0115\"><xocs:ref-normalized-surname>DUPRAT</xocs:ref-normalized-surname><xocs:ref-pub-year>1997</xocs:ref-pub-year><xocs:ref-first-fp>5464</xocs:ref-first-fp><xocs:ref-last-lp>5471</xocs:ref-last-lp><xocs:ref-normalized-initial>F</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0120\"><xocs:ref-normalized-surname>MA</xocs:ref-normalized-surname><xocs:ref-pub-year>2013</xocs:ref-pub-year><xocs:ref-first-fp>351</xocs:ref-first-fp><xocs:ref-last-lp>361</xocs:ref-last-lp><xocs:ref-normalized-initial>L</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0125\"><xocs:ref-normalized-surname>KOZAK</xocs:ref-normalized-surname><xocs:ref-pub-year>2002</xocs:ref-pub-year><xocs:ref-first-fp>401</xocs:ref-first-fp><xocs:ref-last-lp>410</xocs:ref-last-lp><xocs:ref-normalized-initial>M</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0130\"><xocs:ref-normalized-surname>BAKKERS</xocs:ref-normalized-surname><xocs:ref-pub-year>2011</xocs:ref-pub-year><xocs:ref-first-fp>279</xocs:ref-first-fp><xocs:ref-last-lp>288</xocs:ref-last-lp><xocs:ref-normalized-initial>J</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0135\"><xocs:ref-normalized-surname>BAMSHAD</xocs:ref-normalized-surname><xocs:ref-pub-year>2011</xocs:ref-pub-year><xocs:ref-first-fp>745</xocs:ref-first-fp><xocs:ref-last-lp>755</xocs:ref-last-lp><xocs:ref-normalized-initial>M</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0140\"><xocs:ref-normalized-surname>OLSON</xocs:ref-normalized-surname><xocs:ref-pub-year>2006</xocs:ref-pub-year><xocs:ref-first-fp>2185</xocs:ref-first-fp><xocs:ref-last-lp>2191</xocs:ref-last-lp><xocs:ref-normalized-initial>T</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0145\"><xocs:ref-normalized-surname>ANTZELEVITCH</xocs:ref-normalized-surname><xocs:ref-pub-year>2009</xocs:ref-pub-year><xocs:ref-first-fp>543</xocs:ref-first-fp><xocs:ref-last-lp>548</xocs:ref-last-lp><xocs:ref-normalized-initial>C</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0150\"><xocs:ref-normalized-surname>SHEETS</xocs:ref-normalized-surname><xocs:ref-pub-year>1988</xocs:ref-pub-year><xocs:ref-first-fp>386</xocs:ref-first-fp><xocs:ref-last-lp>398</xocs:ref-last-lp><xocs:ref-normalized-initial>M</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"rf0155\"><xocs:ref-normalized-surname>BETTONI</xocs:ref-normalized-surname><xocs:ref-pub-year>2002</xocs:ref-pub-year><xocs:ref-first-fp>2753</xocs:ref-first-fp><xocs:ref-last-lp>2759</xocs:ref-last-lp><xocs:ref-normalized-initial>M</xocs:ref-normalized-initial></xocs:ref-info></xocs:references><xocs:refkeys><xocs:refkey3>LIANGX2014X69</xocs:refkey3><xocs:refkey4lp>LIANGX2014X69X76</xocs:refkey4lp><xocs:refkey4ai>LIANGX2014X69XB</xocs:refkey4ai><xocs:refkey5>LIANGX2014X69X76XB</xocs:refkey5></xocs:refkeys><xocs:open-access><xocs:oa-article-status is-open-access=\"0\" is-open-archive=\"0\"/></xocs:open-access><xocs:attachment-metadata-doc><xocs:attachment-set-type>item</xocs:attachment-set-type><xocs:pii-formatted>S0022-2828(13)00363-5</xocs:pii-formatted><xocs:pii-unformatted>S0022282813003635</xocs:pii-unformatted><xocs:eid>1-s2.0-S0022282813003635</xocs:eid><xocs:doi>10.1016/j.yjmcc.2013.12.014</xocs:doi><xocs:cid>272480</xocs:cid><xocs:timestamp>2014-06-06T02:09:35.412358-04:00</xocs:timestamp><xocs:cover-date-start>2014-02-01</xocs:cover-date-start><xocs:cover-date-end>2014-02-28</xocs:cover-date-end><xocs:attachments><xocs:web-pdf><xocs:attachment-eid>1-s2.0-S0022282813003635-main.pdf</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282813003635/MAIN/application/pdf/ebe693c9507a83e07781ee6ab99746e2/main.pdf</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282813003635/MAIN/application/pdf/ebe693c9507a83e07781ee6ab99746e2/main.pdf</xocs:ucs-locator><xocs:filename>main.pdf</xocs:filename><xocs:extension>pdf</xocs:extension><xocs:pdf-optimized>true</xocs:pdf-optimized><xocs:filesize>1171222</xocs:filesize><xocs:web-pdf-purpose>MAIN</xocs:web-pdf-purpose><xocs:web-pdf-page-count>8</xocs:web-pdf-page-count><xocs:web-pdf-images><xocs:web-pdf-image><xocs:attachment-eid>1-s2.0-S0022282813003635-main_1.png</xocs:attachment-eid><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282813003635/PREVIEW/image/png/31ed77c7b6e7eb06fb8182a1e126912d/main_1.png</xocs:ucs-locator><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282813003635/PREVIEW/image/png/31ed77c7b6e7eb06fb8182a1e126912d/main_1.png</xocs:ucs-locator><xocs:filename>main_1.png</xocs:filename><xocs:extension>png</xocs:extension><xocs:filesize>61751</xocs:filesize><xocs:pixel-height>849</xocs:pixel-height><xocs:pixel-width>656</xocs:pixel-width><xocs:attachment-type>IMAGE-WEB-PDF</xocs:attachment-type><xocs:pdf-page-num>1</xocs:pdf-page-num></xocs:web-pdf-image></xocs:web-pdf-images></xocs:web-pdf><xocs:attachment><xocs:attachment-eid>1-s2.0-S0022282813003635-mmc3.sml</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282813003635/mmc3/THUMBNAIL/image/gif/3fa77e607e10cf54ef4a94e86d85a96a/mmc3.sml</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282813003635/mmc3/THUMBNAIL/image/gif/3fa77e607e10cf54ef4a94e86d85a96a/mmc3.sml</xocs:ucs-locator><xocs:file-basename>mmc3</xocs:file-basename><xocs:filename>mmc3.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>7101</xocs:filesize><xocs:pixel-height>164</xocs:pixel-height><xocs:pixel-width>218</xocs:pixel-width><xocs:attachment-type>IMAGE-MMC-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0022282813003635-mmc2.sml</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282813003635/mmc2/THUMBNAIL/image/gif/5152a551f15e7ca62b21aba12f39894c/mmc2.sml</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282813003635/mmc2/THUMBNAIL/image/gif/5152a551f15e7ca62b21aba12f39894c/mmc2.sml</xocs:ucs-locator><xocs:file-basename>mmc2</xocs:file-basename><xocs:filename>mmc2.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>6618</xocs:filesize><xocs:pixel-height>164</xocs:pixel-height><xocs:pixel-width>218</xocs:pixel-width><xocs:attachment-type>IMAGE-MMC-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0022282813003635-mmc3.mp4</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282813003635/mmc3/MAIN/video/mp4/07b835180dae0461dc2c0f6d37b5da36/mmc3.mp4</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282813003635/mmc3/MAIN/video/mp4/07b835180dae0461dc2c0f6d37b5da36/mmc3.mp4</xocs:ucs-locator><xocs:file-basename>mmc3</xocs:file-basename><xocs:filename>mmc3.mp4</xocs:filename><xocs:extension>mp4</xocs:extension><xocs:filesize>204637</xocs:filesize><xocs:attachment-type>VIDEO</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0022282813003635-mmc2.mp4</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282813003635/mmc2/MAIN/video/mp4/ac821accf3df85e9d7c545a6f5436b74/mmc2.mp4</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282813003635/mmc2/MAIN/video/mp4/ac821accf3df85e9d7c545a6f5436b74/mmc2.mp4</xocs:ucs-locator><xocs:file-basename>mmc2</xocs:file-basename><xocs:filename>mmc2.mp4</xocs:filename><xocs:extension>mp4</xocs:extension><xocs:filesize>110326</xocs:filesize><xocs:attachment-type>VIDEO</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0022282813003635-gr6_lrg.jpg</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282813003635/gr6/HIGHRES/image/jpeg/fb61a60d22164667b42069ec7f474537/gr6_lrg.jpg</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282813003635/gr6/HIGHRES/image/jpeg/fb61a60d22164667b42069ec7f474537/gr6_lrg.jpg</xocs:ucs-locator><xocs:file-basename>gr6</xocs:file-basename><xocs:filename>gr6_lrg.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>512873</xocs:filesize><xocs:pixel-height>1882</xocs:pixel-height><xocs:pixel-width>2962</xocs:pixel-width><xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0022282813003635-gr5_lrg.jpg</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282813003635/gr5/HIGHRES/image/jpeg/44079d31b725584b54181e04271691e1/gr5_lrg.jpg</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282813003635/gr5/HIGHRES/image/jpeg/44079d31b725584b54181e04271691e1/gr5_lrg.jpg</xocs:ucs-locator><xocs:file-basename>gr5</xocs:file-basename><xocs:filename>gr5_lrg.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>731046</xocs:filesize><xocs:pixel-height>2091</xocs:pixel-height><xocs:pixel-width>1719</xocs:pixel-width><xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0022282813003635-gr4_lrg.jpg</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282813003635/gr4/HIGHRES/image/jpeg/c8170bdc7171ddccdf91ca659ff1671c/gr4_lrg.jpg</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282813003635/gr4/HIGHRES/image/jpeg/c8170bdc7171ddccdf91ca659ff1671c/gr4_lrg.jpg</xocs:ucs-locator><xocs:file-basename>gr4</xocs:file-basename><xocs:filename>gr4_lrg.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>480298</xocs:filesize><xocs:pixel-height>2200</xocs:pixel-height><xocs:pixel-width>2956</xocs:pixel-width><xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0022282813003635-gr3_lrg.jpg</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282813003635/gr3/HIGHRES/image/jpeg/94d307e83f46ee980a2fc854c8a86e39/gr3_lrg.jpg</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282813003635/gr3/HIGHRES/image/jpeg/94d307e83f46ee980a2fc854c8a86e39/gr3_lrg.jpg</xocs:ucs-locator><xocs:file-basename>gr3</xocs:file-basename><xocs:filename>gr3_lrg.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>274450</xocs:filesize><xocs:pixel-height>1521</xocs:pixel-height><xocs:pixel-width>2433</xocs:pixel-width><xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0022282813003635-gr2_lrg.jpg</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282813003635/gr2/HIGHRES/image/jpeg/7e9c24d845969fc9d193a6505cdcf34f/gr2_lrg.jpg</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282813003635/gr2/HIGHRES/image/jpeg/7e9c24d845969fc9d193a6505cdcf34f/gr2_lrg.jpg</xocs:ucs-locator><xocs:file-basename>gr2</xocs:file-basename><xocs:filename>gr2_lrg.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>145435</xocs:filesize><xocs:pixel-height>1234</xocs:pixel-height><xocs:pixel-width>2197</xocs:pixel-width><xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0022282813003635-gr1_lrg.jpg</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282813003635/gr1/HIGHRES/image/jpeg/5121524823f4ea378700ec97de3da1a7/gr1_lrg.jpg</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282813003635/gr1/HIGHRES/image/jpeg/5121524823f4ea378700ec97de3da1a7/gr1_lrg.jpg</xocs:ucs-locator><xocs:file-basename>gr1</xocs:file-basename><xocs:filename>gr1_lrg.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>349922</xocs:filesize><xocs:pixel-height>1577</xocs:pixel-height><xocs:pixel-width>1719</xocs:pixel-width><xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0022282813003635-mmc3.flv</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282813003635/mmc3/OPT-STREAM/video/x-flv/ff52bd5ced6a0e7651fa1ca56fe3c10f/mmc3.flv</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282813003635/mmc3/OPT-STREAM/video/x-flv/ff52bd5ced6a0e7651fa1ca56fe3c10f/mmc3.flv</xocs:ucs-locator><xocs:file-basename>mmc3</xocs:file-basename><xocs:filename>mmc3.flv</xocs:filename><xocs:extension>flv</xocs:extension><xocs:filesize>530137</xocs:filesize><xocs:pixel-height/><xocs:pixel-width/><xocs:attachment-type>VIDEO-FLASH</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0022282813003635-mmc2.flv</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282813003635/mmc2/OPT-STREAM/video/x-flv/33386a18dab93ff1a512464291b4d14c/mmc2.flv</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282813003635/mmc2/OPT-STREAM/video/x-flv/33386a18dab93ff1a512464291b4d14c/mmc2.flv</xocs:ucs-locator><xocs:file-basename>mmc2</xocs:file-basename><xocs:filename>mmc2.flv</xocs:filename><xocs:extension>flv</xocs:extension><xocs:filesize>342878</xocs:filesize><xocs:pixel-height/><xocs:pixel-width/><xocs:attachment-type>VIDEO-FLASH</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0022282813003635-gr6.jpg</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282813003635/gr6/DOWNSAMPLED/image/jpeg/090a489226fbb4ee134d2b4e35d0de87/gr6.jpg</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282813003635/gr6/DOWNSAMPLED/image/jpeg/090a489226fbb4ee134d2b4e35d0de87/gr6.jpg</xocs:ucs-locator><xocs:file-basename>gr6</xocs:file-basename><xocs:filename>gr6.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>68996</xocs:filesize><xocs:pixel-height>425</xocs:pixel-height><xocs:pixel-width>669</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0022282813003635-gr5.jpg</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282813003635/gr5/DOWNSAMPLED/image/jpeg/2136b4d3487056b49fccf984ed75e770/gr5.jpg</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282813003635/gr5/DOWNSAMPLED/image/jpeg/2136b4d3487056b49fccf984ed75e770/gr5.jpg</xocs:ucs-locator><xocs:file-basename>gr5</xocs:file-basename><xocs:filename>gr5.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>77137</xocs:filesize><xocs:pixel-height>472</xocs:pixel-height><xocs:pixel-width>388</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0022282813003635-gr4.jpg</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282813003635/gr4/DOWNSAMPLED/image/jpeg/5fcf61f6005a6d44919f4b36d248e59b/gr4.jpg</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282813003635/gr4/DOWNSAMPLED/image/jpeg/5fcf61f6005a6d44919f4b36d248e59b/gr4.jpg</xocs:ucs-locator><xocs:file-basename>gr4</xocs:file-basename><xocs:filename>gr4.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>59763</xocs:filesize><xocs:pixel-height>497</xocs:pixel-height><xocs:pixel-width>668</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0022282813003635-gr3.jpg</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282813003635/gr3/DOWNSAMPLED/image/jpeg/bebf8108a6fea52f6558c86dd385cee7/gr3.jpg</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282813003635/gr3/DOWNSAMPLED/image/jpeg/bebf8108a6fea52f6558c86dd385cee7/gr3.jpg</xocs:ucs-locator><xocs:file-basename>gr3</xocs:file-basename><xocs:filename>gr3.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>40758</xocs:filesize><xocs:pixel-height>343</xocs:pixel-height><xocs:pixel-width>549</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0022282813003635-gr2.jpg</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282813003635/gr2/DOWNSAMPLED/image/jpeg/4a6020346124e81b6d23182ba43b5314/gr2.jpg</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282813003635/gr2/DOWNSAMPLED/image/jpeg/4a6020346124e81b6d23182ba43b5314/gr2.jpg</xocs:ucs-locator><xocs:file-basename>gr2</xocs:file-basename><xocs:filename>gr2.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>25483</xocs:filesize><xocs:pixel-height>279</xocs:pixel-height><xocs:pixel-width>496</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0022282813003635-gr1.jpg</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282813003635/gr1/DOWNSAMPLED/image/jpeg/12092200a223868625ce81387a1b73ac/gr1.jpg</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282813003635/gr1/DOWNSAMPLED/image/jpeg/12092200a223868625ce81387a1b73ac/gr1.jpg</xocs:ucs-locator><xocs:file-basename>gr1</xocs:file-basename><xocs:filename>gr1.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>95672</xocs:filesize><xocs:pixel-height>594</xocs:pixel-height><xocs:pixel-width>647</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0022282813003635-gr6.sml</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282813003635/gr6/THUMBNAIL/image/gif/2b12cf2cb9c22ad932d492bdd339d868/gr6.sml</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282813003635/gr6/THUMBNAIL/image/gif/2b12cf2cb9c22ad932d492bdd339d868/gr6.sml</xocs:ucs-locator><xocs:file-basename>gr6</xocs:file-basename><xocs:filename>gr6.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>6327</xocs:filesize><xocs:pixel-height>139</xocs:pixel-height><xocs:pixel-width>219</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0022282813003635-gr5.sml</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282813003635/gr5/THUMBNAIL/image/gif/f5825908e438d280869e1ec37ba4ffcf/gr5.sml</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282813003635/gr5/THUMBNAIL/image/gif/f5825908e438d280869e1ec37ba4ffcf/gr5.sml</xocs:ucs-locator><xocs:file-basename>gr5</xocs:file-basename><xocs:filename>gr5.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>10441</xocs:filesize><xocs:pixel-height>164</xocs:pixel-height><xocs:pixel-width>135</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0022282813003635-gr4.sml</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282813003635/gr4/THUMBNAIL/image/gif/149ae952d68d8f37b9c67359672caa01/gr4.sml</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282813003635/gr4/THUMBNAIL/image/gif/149ae952d68d8f37b9c67359672caa01/gr4.sml</xocs:ucs-locator><xocs:file-basename>gr4</xocs:file-basename><xocs:filename>gr4.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>4967</xocs:filesize><xocs:pixel-height>163</xocs:pixel-height><xocs:pixel-width>219</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0022282813003635-gr3.sml</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282813003635/gr3/THUMBNAIL/image/gif/5c01b5f657001e1398e9cda17c2d9f77/gr3.sml</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282813003635/gr3/THUMBNAIL/image/gif/5c01b5f657001e1398e9cda17c2d9f77/gr3.sml</xocs:ucs-locator><xocs:file-basename>gr3</xocs:file-basename><xocs:filename>gr3.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>5467</xocs:filesize><xocs:pixel-height>137</xocs:pixel-height><xocs:pixel-width>219</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0022282813003635-gr2.sml</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282813003635/gr2/THUMBNAIL/image/gif/fff290b5a9c2fa063a53747b3c7ce4da/gr2.sml</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282813003635/gr2/THUMBNAIL/image/gif/fff290b5a9c2fa063a53747b3c7ce4da/gr2.sml</xocs:ucs-locator><xocs:file-basename>gr2</xocs:file-basename><xocs:filename>gr2.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>3819</xocs:filesize><xocs:pixel-height>123</xocs:pixel-height><xocs:pixel-width>219</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0022282813003635-gr1.sml</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282813003635/gr1/THUMBNAIL/image/gif/4016b153ebcb6fd3dfcd2fb68f27231c/gr1.sml</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282813003635/gr1/THUMBNAIL/image/gif/4016b153ebcb6fd3dfcd2fb68f27231c/gr1.sml</xocs:ucs-locator><xocs:file-basename>gr1</xocs:file-basename><xocs:filename>gr1.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>9962</xocs:filesize><xocs:pixel-height>164</xocs:pixel-height><xocs:pixel-width>179</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0022282813003635-mmc1.pdf</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0022282813003635/mmc1/MAIN/application/pdf/2ea4500f1f1fdb616f50bd7cfcd87531/mmc1.pdf</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0022282813003635/mmc1/MAIN/application/pdf/2ea4500f1f1fdb616f50bd7cfcd87531/mmc1.pdf</xocs:ucs-locator><xocs:file-basename>mmc1</xocs:file-basename><xocs:filename>mmc1.pdf</xocs:filename><xocs:extension>pdf</xocs:extension><xocs:filesize>1254023</xocs:filesize><xocs:attachment-type>APPLICATION</xocs:attachment-type></xocs:attachment></xocs:attachments></xocs:attachment-metadata-doc></xocs:meta><xocs:serial-item><article xmlns=\"http://www.elsevier.com/xml/ja/dtd\" version=\"5.2\" docsubtype=\"fla\" xml:lang=\"en\"><item-info><jid>YJMCC</jid><aid>7699</aid><ce:pii>S0022-2828(13)00363-5</ce:pii><ce:doi>10.1016/j.yjmcc.2013.12.014</ce:doi><ce:copyright type=\"full-transfer\" year=\"2013\">Elsevier Ltd</ce:copyright></item-info><ce:floats><ce:figure id=\"f0005\"><ce:label>Fig.\\xa01</ce:label><ce:caption id=\"ca0005\"><ce:simple-para id=\"sp0015\" view=\"all\">Expression and knockdown of <ce:italic>kcnk3a</ce:italic> and <ce:italic>kcnk3b</ce:italic> in 72<ce:hsp sp=\"0.25\"/>hpf zebrafish. Whole-mount <ce:italic>in situ</ce:italic> hybridization using orthologue-specific antisense riboprobes against <ce:italic>kcnk3a</ce:italic> (A) and <ce:italic>kcnk3b</ce:italic> (B). Moderate expression is seen in the central nervous system with relatively weaker expression in the heart (arrowhead). (C) RT-PCR showing cardiac expression of <ce:italic>kcnk3a</ce:italic> and <ce:italic>kcnk3b</ce:italic> in isolated wild-type zebrafish hearts. (D) RT-PCR from splice-site morpholino-injected (MO) and control-injected (control) embryos showing reduced amounts of endogenous <ce:italic>knck3</ce:italic> transcript in MO (lane 1) <ce:italic>vs.</ce:italic> control (lane 3), as well as intron retention due to abnormal splicing in MO (lane 2) but not control (lane 4) embryos. Gross phenotype in 72<ce:hsp sp=\"0.25\"/>hpf embryos co-injected with <ce:italic>kcnk3a</ce:italic> and <ce:italic>kcnk3b</ce:italic> (<ce:italic>kcn3a</ce:italic><ce:hsp sp=\"0.25\"/>+<ce:hsp sp=\"0.25\"/><ce:italic>b</ce:italic>) (E) or control morpholinos (F). Representative images of the (G) ventricle, V, and (I) and atrium, A, in 72<ce:hsp sp=\"0.25\"/>hpf Tg(myl7:eGFP) zebrafish injected with <ce:italic>kcn3a</ce:italic><ce:hsp sp=\"0.25\"/>+<ce:hsp sp=\"0.25\"/><ce:italic>b</ce:italic> (G,I) or control morpholinos. (H,J). Cardiac expression of GFP is indicated by green fluorescence and all images are taken in ventricular diastole. Scale bar<ce:hsp sp=\"0.25\"/>=<ce:hsp sp=\"0.25\"/>100<ce:hsp sp=\"0.25\"/>μm. (K–N) Phenotypic evaluation in <ce:italic>kcn3a</ce:italic><ce:hsp sp=\"0.25\"/>+<ce:hsp sp=\"0.25\"/><ce:italic>b</ce:italic> injected (solid bars) and control-injected (C, open bars) embryos. Mean heart rate (K), short-axis atrial end-diastolic and end-systolic diameters (L), short-axis ventricular end-diastolic (EDD) and end-systolic diameters (ESD) (M), and ventricular fractional shortening (N) are shown. <ce:sup loc=\"post\">⁎</ce:sup>p<ce:hsp sp=\"0.25\"/>≤<ce:hsp sp=\"0.25\"/>0.01; <ce:sup loc=\"post\">⁎⁎</ce:sup>p<ce:hsp sp=\"0.25\"/>&lt;<ce:hsp sp=\"0.25\"/>0.001; NS<ce:hsp sp=\"0.25\"/>=<ce:hsp sp=\"0.25\"/>non-significant.</ce:simple-para></ce:caption><ce:link locator=\"gr1\" id=\"lk0005\"/></ce:figure><ce:figure id=\"f0010\"><ce:label>Fig.\\xa02</ce:label><ce:caption id=\"ca0010\"><ce:simple-para id=\"sp0020\" view=\"all\">Genetic information. (A) Pedigree of proband (arrow) with c.367G<ce:hsp sp=\"0.25\"/>&gt;<ce:hsp sp=\"0.25\"/>C (V123L) <ce:italic>KCNK3</ce:italic> variant. (B) Pedigree of proband (arrow) with −<ce:hsp sp=\"0.10\"/>4G<ce:hsp sp=\"0.25\"/>&gt;<ce:hsp sp=\"0.25\"/>A and −<ce:hsp sp=\"0.10\"/>3A<ce:hsp sp=\"0.25\"/>&gt;<ce:hsp sp=\"0.25\"/>U variants (Family HF). Phenotypes are denoted as: documented AF (dark blue symbol), symptomatic but not documented AF (light blue symbol), no history of AF (open symbols). Squares: male, circles: female family members, respectively.</ce:simple-para></ce:caption><ce:link locator=\"gr2\" id=\"lk0010\"/></ce:figure><ce:figure id=\"f0015\"><ce:label>Fig.\\xa03</ce:label><ce:caption id=\"ca0015\"><ce:simple-para id=\"sp0025\" view=\"all\">Translation efficiency of the −<ce:hsp sp=\"0.10\"/>4G<ce:hsp sp=\"0.25\"/>&gt;<ce:hsp sp=\"0.25\"/>A and −<ce:hsp sp=\"0.10\"/>3A<ce:hsp sp=\"0.25\"/>&gt;<ce:hsp sp=\"0.25\"/>U <ce:italic>KCNK3</ce:italic> variants. (A) Sequence logo plot of Kozak consensus sequence around AUG start codons in human mRNA. Relative abundance and extent of conservation are indicated by the height of each nucleotide (note the boxed AUG start codon has been scaled down from a value of 2<ce:hsp sp=\"0.25\"/>bits). Shown below is the corresponding region of TASK-1 mRNA and identified sequence variants. (B) Renilla luciferase constructs showing the inserted TASK-1 sequence flanking the start codon. Underlined bases in MUT highlight the base changes identified in the Kozak consensus sequence (C) Luciferase activity from HeLa cells transfected with double mutant Kozak TASK-1 (red) or wild-type TASK-1 (blue) Renilla luciferase plasmids. Data were normalized to a co-transfected Firefly Luciferase construct, with wild-type activity set to 100%; n<ce:hsp sp=\"0.25\"/>=<ce:hsp sp=\"0.25\"/>3–5 runs for each group.</ce:simple-para></ce:caption><ce:link locator=\"gr3\" id=\"lk0015\"/></ce:figure><ce:figure id=\"f0020\"><ce:label>Fig.\\xa04</ce:label><ce:caption id=\"ca0020\"><ce:simple-para id=\"sp0030\" view=\"all\">Electrophysiological characterization of V123L_TASK-1. (A) Representative recordings of CHO-K1 cells expressing WT, V123L, WT/V123L, or mock-transfected cells (control). Current was recorded during 500<ce:hsp sp=\"0.25\"/>ms voltage-clamp pulses from −<ce:hsp sp=\"0.10\"/>120 to 100<ce:hsp sp=\"0.25\"/>mV in 20<ce:hsp sp=\"0.25\"/>mV steps from a holding potential of −<ce:hsp sp=\"0.10\"/>80<ce:hsp sp=\"0.25\"/>mV. (B) Steady-state current–voltage relationships showing significant differences between WT, V123L, WT/V123L and control. (C) E<ce:inf loc=\"post\">m</ce:inf> of CHO-K1 cells expressing WT, V123L, WT/V123L, or control. Measurements were performed under current-clamp mode before step protocol was applied. <ce:sup loc=\"post\">⁎⁎</ce:sup>p<ce:hsp sp=\"0.25\"/>&lt;<ce:hsp sp=\"0.25\"/>0.01, <ce:sup loc=\"post\">⁎⁎⁎</ce:sup>p<ce:hsp sp=\"0.25\"/>&lt;<ce:hsp sp=\"0.25\"/>0.001.</ce:simple-para></ce:caption><ce:link locator=\"gr4\" id=\"lk0020\"/></ce:figure><ce:figure id=\"f0025\"><ce:label>Fig.\\xa05</ce:label><ce:caption id=\"ca0025\"><ce:simple-para id=\"sp0035\" view=\"all\">Open-state pore homology model of TASK-1 based on the TWIK-1 structure. (A) The backbone of one TASK-1 subunit is shown in red and the other in blue, with the channel surface shown in light gray. Val123 residues (cyan or yellow) are fatty acid alkyl chain-facing. The magnified region depicts lateral fenestrae that allow binding of a fatty acid alkyl chain. (B) Side chains of Val123 and Leu11 form stable interactions. The residues are shown in CPK color code.</ce:simple-para></ce:caption><ce:link locator=\"gr5\" id=\"lk0025\"/></ce:figure><ce:figure id=\"f0030\"><ce:label>Fig.\\xa06</ce:label><ce:caption id=\"ca0030\"><ce:simple-para id=\"sp0040\" view=\"all\">Modeling of reduced TASK-1 current density in an atrial cell model. (A) Simulated action potentials are shown for BCL of 1000<ce:hsp sp=\"0.25\"/>ms and 400<ce:hsp sp=\"0.25\"/>ms under control conditions (Ctrl, black) and 40% (red), 50% (blue), and 60% (green) reduced TASK-1 current; red.<ce:hsp sp=\"0.25\"/>=<ce:hsp sp=\"0.25\"/>reduction. The first derivatives (dV/dt) of the action potential upstrokes at BCL 400<ce:hsp sp=\"0.25\"/>ms are shown in the insert. (B, C, D) Rate dependence of APD<ce:inf loc=\"post\">90</ce:inf>, E<ce:inf loc=\"post\">m,</ce:inf> and V<ce:inf loc=\"post\">max</ce:inf>. Legends as in A. (E) Simulation of combined effects of reduced <ce:italic>I</ce:italic><ce:inf loc=\"post\">TASK</ce:inf> together with S38G_KCNE1 (<ce:italic>I</ce:italic><ce:inf loc=\"post\">Ks</ce:inf>) and E444K_K<ce:inf loc=\"post\">V</ce:inf>11.1 (<ce:italic>I</ce:italic><ce:inf loc=\"post\">Kr</ce:inf>) variations present in the −<ce:hsp sp=\"0.10\"/>4G<ce:hsp sp=\"0.25\"/>&gt;<ce:hsp sp=\"0.25\"/>A/−<ce:hsp sp=\"0.10\"/>3A<ce:hsp sp=\"0.25\"/>&gt;<ce:hsp sp=\"0.25\"/>U carrier, Action potential waveforms at baseline (black) and with incremental effects of 50% reduction of <ce:italic>I</ce:italic><ce:inf loc=\"post\">TASK</ce:inf> (blue)<ce:hsp sp=\"0.25\"/>+<ce:hsp sp=\"0.25\"/>50% reduction of <ce:italic>I</ce:italic><ce:inf loc=\"post\">Ks</ce:inf> (red)<ce:hsp sp=\"0.25\"/>+<ce:hsp sp=\"0.25\"/>10% reduction of <ce:italic>I</ce:italic><ce:inf loc=\"post\">Kr</ce:inf> (green). (F) APD<ce:inf loc=\"post\">90</ce:inf> sensitivity coefficients for major cardiac ion channels under baseline conditions (black) and after 50% reduction of <ce:italic>I</ce:italic><ce:inf loc=\"post\">TASK</ce:inf> (blue)<ce:hsp sp=\"0.25\"/>+<ce:hsp sp=\"0.25\"/>50% reduction of <ce:italic>I</ce:italic><ce:inf loc=\"post\">Ks</ce:inf> (red).</ce:simple-para></ce:caption><ce:link locator=\"gr6\" id=\"lk0030\"/></ce:figure></ce:floats><head><ce:dochead id=\"dh0005\"><ce:textfn id=\"tn0005\">Original article</ce:textfn></ce:dochead><ce:title id=\"ti0005\">Genetic variation in the two-pore domain potassium channel, TASK-1, may contribute to an atrial substrate for arrhythmogenesis</ce:title><ce:author-group id=\"ag0005\"><ce:author id=\"au0005\"><ce:given-name>Bo</ce:given-name><ce:surname>Liang</ce:surname><ce:cross-ref refid=\"af0005\" id=\"cf0005\"><ce:sup loc=\"post\">a</ce:sup></ce:cross-ref><ce:cross-ref refid=\"fn0005\" id=\"cf0010\"><ce:sup loc=\"post\">1</ce:sup></ce:cross-ref></ce:author><ce:author id=\"au0010\"><ce:given-name>Magdalena</ce:given-name><ce:surname>Soka</ce:surname><ce:cross-ref refid=\"af0010\" id=\"cf0015\"><ce:sup loc=\"post\">b</ce:sup></ce:cross-ref><ce:cross-ref refid=\"fn0005\" id=\"cf0020\"><ce:sup loc=\"post\">1</ce:sup></ce:cross-ref></ce:author><ce:author id=\"au0015\"><ce:given-name>Alex Horby</ce:given-name><ce:surname>Christensen</ce:surname><ce:cross-ref refid=\"af0010\" id=\"cf0025\"><ce:sup loc=\"post\">b</ce:sup></ce:cross-ref></ce:author><ce:author id=\"au0020\"><ce:given-name>Morten S.</ce:given-name><ce:surname>Olesen</ce:surname><ce:cross-ref refid=\"af0005\" id=\"cf0030\"><ce:sup loc=\"post\">a</ce:sup></ce:cross-ref></ce:author><ce:author id=\"au0025\"><ce:given-name>Anders P.</ce:given-name><ce:surname>Larsen</ce:surname><ce:cross-ref refid=\"af0005\" id=\"cf0035\"><ce:sup loc=\"post\">a</ce:sup></ce:cross-ref><ce:cross-ref refid=\"af0015\" id=\"cf0040\"><ce:sup loc=\"post\">c</ce:sup></ce:cross-ref></ce:author><ce:author id=\"au0030\"><ce:given-name>Filip K.</ce:given-name><ce:surname>Knop</ce:surname><ce:cross-ref refid=\"af0010\" id=\"cf0045\"><ce:sup loc=\"post\">b</ce:sup></ce:cross-ref><ce:cross-ref refid=\"fn0010\" id=\"cf0050\"><ce:sup loc=\"post\">2</ce:sup></ce:cross-ref></ce:author><ce:author id=\"au0035\"><ce:given-name>Fan</ce:given-name><ce:surname>Wang</ce:surname><ce:cross-ref refid=\"af0005\" id=\"cf0055\"><ce:sup loc=\"post\">a</ce:sup></ce:cross-ref></ce:author><ce:author id=\"au0040\"><ce:given-name>Jonas B.</ce:given-name><ce:surname>Nielsen</ce:surname><ce:cross-ref refid=\"af0005\" id=\"cf0060\"><ce:sup loc=\"post\">a</ce:sup></ce:cross-ref></ce:author><ce:author id=\"au0045\"><ce:given-name>Martin N.</ce:given-name><ce:surname>Andersen</ce:surname><ce:cross-ref refid=\"af0005\" id=\"cf0065\"><ce:sup loc=\"post\">a</ce:sup></ce:cross-ref></ce:author><ce:author id=\"au0050\"><ce:given-name>David</ce:given-name><ce:surname>Humphreys</ce:surname><ce:cross-ref refid=\"af0020\" id=\"cf0070\"><ce:sup loc=\"post\">d</ce:sup></ce:cross-ref></ce:author><ce:author id=\"au0055\"><ce:given-name>Stefan A.</ce:given-name><ce:surname>Mann</ce:surname><ce:cross-ref refid=\"af0010\" id=\"cf0075\"><ce:sup loc=\"post\">b</ce:sup></ce:cross-ref></ce:author><ce:author id=\"au0060\"><ce:given-name>Inken G.</ce:given-name><ce:surname>Huttner</ce:surname><ce:cross-ref refid=\"af0010\" id=\"cf0080\"><ce:sup loc=\"post\">b</ce:sup></ce:cross-ref></ce:author><ce:author id=\"au0065\"><ce:given-name>Jamie I.</ce:given-name><ce:surname>Vandenberg</ce:surname><ce:cross-ref refid=\"af0010\" id=\"cf0085\"><ce:sup loc=\"post\">b</ce:sup></ce:cross-ref><ce:cross-ref refid=\"af0025\" id=\"cf0090\"><ce:sup loc=\"post\">e</ce:sup></ce:cross-ref></ce:author><ce:author id=\"au0070\"><ce:given-name>Jesper H.</ce:given-name><ce:surname>Svendsen</ce:surname><ce:cross-ref refid=\"af0005\" id=\"cf0095\"><ce:sup loc=\"post\">a</ce:sup></ce:cross-ref></ce:author><ce:author id=\"au0075\"><ce:given-name>Stig</ce:given-name><ce:surname>Haunsø</ce:surname><ce:cross-ref refid=\"af0005\" id=\"cf0100\"><ce:sup loc=\"post\">a</ce:sup></ce:cross-ref></ce:author><ce:author id=\"au0080\"><ce:given-name>Thomas</ce:given-name><ce:surname>Preiss</ce:surname><ce:cross-ref refid=\"af0030\" id=\"cf0105\"><ce:sup loc=\"post\">f</ce:sup></ce:cross-ref></ce:author><ce:author id=\"au0085\"><ce:given-name>Guiscard</ce:given-name><ce:surname>Seebohm</ce:surname><ce:cross-ref refid=\"af0035\" id=\"cf0110\"><ce:sup loc=\"post\">g</ce:sup></ce:cross-ref></ce:author><ce:author id=\"au0090\"><ce:given-name>Søren-Peter</ce:given-name><ce:surname>Olesen</ce:surname><ce:cross-ref refid=\"af0005\" id=\"cf0115\"><ce:sup loc=\"post\">a</ce:sup></ce:cross-ref></ce:author><ce:author id=\"au0095\"><ce:given-name>Nicole</ce:given-name><ce:surname>Schmitt</ce:surname><ce:cross-ref refid=\"af0005\" id=\"cf0120\"><ce:sup loc=\"post\">a</ce:sup></ce:cross-ref><ce:cross-ref refid=\"cr0005\" id=\"cf0125\"><ce:sup loc=\"post\">⁎</ce:sup></ce:cross-ref><ce:e-address id=\"em0005\" type=\"email\">nschmitt@sund.ku.dk</ce:e-address></ce:author><ce:author id=\"au0100\"><ce:given-name>Diane</ce:given-name><ce:surname>Fatkin</ce:surname><ce:cross-ref refid=\"af0010\" id=\"cf0130\"><ce:sup loc=\"post\">b</ce:sup></ce:cross-ref><ce:cross-ref refid=\"af0025\" id=\"cf0135\"><ce:sup loc=\"post\">e</ce:sup></ce:cross-ref><ce:cross-ref refid=\"af0040\" id=\"cf0140\"><ce:sup loc=\"post\">h</ce:sup></ce:cross-ref></ce:author><ce:affiliation id=\"af0005\"><ce:label>a</ce:label><ce:textfn id=\"tn0010\">Danish National Research Foundation Centre for Cardiac Arrhythmia, University of Copenhagen, Copenhagen, Denmark</ce:textfn><sa:affiliation><sa:organization>Danish National Research Foundation Centre for Cardiac Arrhythmia</sa:organization><sa:organization>University of Copenhagen</sa:organization><sa:city>Copenhagen</sa:city><sa:country>Denmark</sa:country></sa:affiliation></ce:affiliation><ce:affiliation id=\"af0010\"><ce:label>b</ce:label><ce:textfn id=\"tn0015\">Molecular Cardiology Division, Victor Chang Cardiac Research Institute, Darlinghurst, New South Wales, Australia</ce:textfn><sa:affiliation><sa:organization>Molecular Cardiology Division</sa:organization><sa:organization>Victor Chang Cardiac Research Institute</sa:organization><sa:city>Darlinghurst</sa:city><sa:state>New South Wales</sa:state><sa:country>Australia</sa:country></sa:affiliation></ce:affiliation><ce:affiliation id=\"af0015\"><ce:label>c</ce:label><ce:textfn id=\"tn0020\">Nora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City, UT, USA</ce:textfn><sa:affiliation><sa:organization>Nora Eccles Harrison Cardiovascular Research and Training Institute</sa:organization><sa:organization>University of Utah</sa:organization><sa:city>Salt Lake City</sa:city><sa:state>UT</sa:state><sa:country>USA</sa:country></sa:affiliation></ce:affiliation><ce:affiliation id=\"af0020\"><ce:label>d</ce:label><ce:textfn id=\"tn0025\">Molecular Genetics Division, Victor Chang Cardiac Research Institute, Darlinghurst, New South Wales, Australia</ce:textfn><sa:affiliation><sa:organization>Molecular Genetics Division</sa:organization><sa:organization>Victor Chang Cardiac Research Institute</sa:organization><sa:city>Darlinghurst</sa:city><sa:state>New South Wales</sa:state><sa:country>Australia</sa:country></sa:affiliation></ce:affiliation><ce:affiliation id=\"af0025\"><ce:label>e</ce:label><ce:textfn id=\"tn0030\">Faculty of Medicine, University of New South Wales, Kensington, New South Wales, Australia</ce:textfn><sa:affiliation><sa:organization>Faculty of Medicine</sa:organization><sa:organization>University of New South Wales</sa:organization><sa:city>Kensington</sa:city><sa:state>New South Wales</sa:state><sa:country>Australia</sa:country></sa:affiliation></ce:affiliation><ce:affiliation id=\"af0030\"><ce:label>f</ce:label><ce:textfn id=\"tn0035\">John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia</ce:textfn><sa:affiliation><sa:organization>John Curtin School of Medical Research</sa:organization><sa:organization>Australian National University</sa:organization><sa:city>Canberra</sa:city><sa:state>Australian Capital Territory</sa:state><sa:country>Australia</sa:country></sa:affiliation></ce:affiliation><ce:affiliation id=\"af0035\"><ce:label>g</ce:label><ce:textfn id=\"tn0040\">Institute for Genetics of Heart Diseases (IfGH), Department of Cardiovascular Medicine, University Hospital Münster, Germany</ce:textfn><sa:affiliation><sa:organization>Institute for Genetics of Heart Diseases (IfGH)</sa:organization><sa:organization>Department of Cardiovascular Medicine</sa:organization><sa:organization>University Hospital Münster</sa:organization><sa:country>Germany</sa:country></sa:affiliation></ce:affiliation><ce:affiliation id=\"af0040\"><ce:label>h</ce:label><ce:textfn id=\"tn0045\">Cardiology Department, St Vincent\\'s Hospital, Darlinghurst, New South Wales, Australia</ce:textfn><sa:affiliation><sa:organization>Cardiology Department</sa:organization><sa:organization>St Vincent\\'s Hospital</sa:organization><sa:city>Darlinghurst</sa:city><sa:state>New South Wales</sa:state><sa:country>Australia</sa:country></sa:affiliation></ce:affiliation><ce:correspondence id=\"cr0005\"><ce:label>⁎</ce:label><ce:text id=\"tx0005\">Corresponding author at: Danish National Research Foundation Centre for Cardiac Arrhythmia and Dept. of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3, 12.5.14, 2200 Copenhagen N, Denmark. Tel.: +<ce:hsp sp=\"0.10\"/>45 35327448; fax: +<ce:hsp sp=\"0.10\"/>45 35327555.</ce:text></ce:correspondence><ce:footnote id=\"fn0005\"><ce:label>1</ce:label><ce:note-para id=\"np0005\" view=\"all\">Equal contribution.</ce:note-para></ce:footnote><ce:footnote id=\"fn0010\"><ce:label>2</ce:label><ce:note-para id=\"np0010\" view=\"all\">Present address: Diabetes Research Division, Department of Internal Medicine, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.</ce:note-para></ce:footnote></ce:author-group><ce:date-received day=\"22\" month=\"5\" year=\"2013\"/><ce:date-revised day=\"9\" month=\"12\" year=\"2013\"/><ce:date-accepted day=\"17\" month=\"12\" year=\"2013\"/><ce:abstract id=\"ab0005\" view=\"all\" class=\"author\"><ce:section-title id=\"st0005\">Abstract</ce:section-title><ce:abstract-sec id=\"as0005\" view=\"all\"><ce:simple-para id=\"sp0005\" view=\"all\">The two-pore domain potassium channel, K<ce:inf loc=\"post\">2</ce:inf><ce:inf loc=\"post\">P</ce:inf>3.1 (TASK-1) modulates background conductance in isolated human atrial cardiomyocytes and has been proposed as a potential drug target for atrial fibrillation (AF). TASK-1 knockout mice have a predominantly ventricular phenotype however, and effects of TASK-1 inactivation on atrial structure and function have yet to be demonstrated <ce:italic>in vivo</ce:italic>. The extent to which genetic variation in <ce:italic>KCNK3</ce:italic>, that encodes TASK-1, might be a determinant of susceptibility to AF is also unknown. To address these questions, we first evaluated the effects of transient knockdown of the zebrafish <ce:italic>kcnk3a</ce:italic> and <ce:italic>kcnk3b</ce:italic> genes and cardiac phenotypes were evaluated using videomicroscopy. Combined <ce:italic>kcnk3a</ce:italic> and <ce:italic>kcnk3b</ce:italic> knockdown in 72 hour post fertilization embryos resulted in lower heart rate (p<ce:hsp sp=\"0.25\"/>&lt;<ce:hsp sp=\"0.25\"/>0.001), marked increase in atrial diameter (p<ce:hsp sp=\"0.25\"/>&lt;<ce:hsp sp=\"0.25\"/>0.001), and mild increase in end-diastolic ventricular diameter (p<ce:hsp sp=\"0.25\"/>=<ce:hsp sp=\"0.25\"/>0.01) when compared with control-injected embryos. We next performed genetic screening of <ce:italic>KCNK3</ce:italic> in two independent AF cohorts (373 subjects) and identified three novel <ce:italic>KCNK3</ce:italic> variants. Two of these variants, present in one proband with familial AF, were located at adjacent nucleotides in the Kozak sequence and reduced expression of an engineered reporter. A third missense variant, V123L, in a patient with lone AF, reduced resting membrane potential and altered pH sensitivity in patch-clamp experiments, with structural modeling predicting instability in the vicinity of the TASK-1 pore. These <ce:italic>in vitro</ce:italic> data suggest that the double Kozak variants and V123L will have loss-of-function effects on <ce:italic>I</ce:italic><ce:inf loc=\"post\">TASK</ce:inf>. Cardiac action potential modeling predicted that reduced <ce:italic>I</ce:italic><ce:inf loc=\"post\">TASK</ce:inf> prolongs atrial action potential duration, and that this is potentiated by reciprocal changes in activity of other ion channel currents. Our findings demonstrate the functional importance of <ce:italic>I</ce:italic><ce:inf loc=\"post\">TASK</ce:inf> in the atrium and suggest that inactivation of TASK-1 may have diverse effects on atrial size and electrophysiological properties that can contribute to an arrhythmogenic substrate.</ce:simple-para></ce:abstract-sec></ce:abstract><ce:abstract class=\"author-highlights\" id=\"ab0010\" view=\"all\"><ce:section-title id=\"st0010\">Highlights</ce:section-title><ce:abstract-sec id=\"as0010\" view=\"all\"><ce:simple-para id=\"sp0010\" view=\"all\"><ce:list id=\"l0005\"><ce:list-item id=\"u0005\"><ce:label>•</ce:label><ce:para id=\"p0155\" view=\"all\">This study underlines the functional importance of <ce:italic>I</ce:italic><ce:inf loc=\"post\">TASK</ce:inf> in the atrium.</ce:para></ce:list-item><ce:list-item id=\"u0010\"><ce:label>•</ce:label><ce:para id=\"p0160\" view=\"all\">Transient TASK-1 knockdown in zebrafish results in bradycardia and atrial dilation.</ce:para></ce:list-item><ce:list-item id=\"u0015\"><ce:label>•</ce:label><ce:para id=\"p0165\" view=\"all\">Genetic variation in <ce:italic>KCNK3</ce:italic> is associated with atrial fibrillation.</ce:para></ce:list-item><ce:list-item id=\"u0020\"><ce:label>•</ce:label><ce:para id=\"p0170\" view=\"all\">Characterization of these novel <ce:italic>KCNK3</ce:italic> variants shows loss-of-function effects.</ce:para></ce:list-item><ce:list-item id=\"u0025\"><ce:label>•</ce:label><ce:para id=\"p0175\" view=\"all\">Inactivation of TASK-1 may contribute to an arrhythmogenic substrate.</ce:para></ce:list-item></ce:list></ce:simple-para></ce:abstract-sec></ce:abstract><ce:keywords id=\"ks0005\" class=\"abr\" view=\"all\"><ce:section-title id=\"st0015\">Abbreviations</ce:section-title><ce:keyword id=\"kw0125\"><ce:text id=\"tx0010\">AF</ce:text><ce:keyword id=\"kw0130\"><ce:text id=\"tx0015\">atrial fibrillation</ce:text></ce:keyword></ce:keyword><ce:keyword id=\"kw0135\"><ce:text id=\"tx0020\">APD</ce:text><ce:keyword id=\"kw0140\"><ce:text id=\"tx0025\">action potential duration</ce:text></ce:keyword></ce:keyword><ce:keyword id=\"kw0145\"><ce:text id=\"tx0030\">BCL</ce:text><ce:keyword id=\"kw0150\"><ce:text id=\"tx0035\">basic cycle length</ce:text></ce:keyword></ce:keyword><ce:keyword id=\"kw0155\"><ce:text id=\"tx0040\">CHO</ce:text><ce:keyword id=\"kw0160\"><ce:text id=\"tx0045\">Chinese hamster ovary</ce:text></ce:keyword></ce:keyword><ce:keyword id=\"kw0165\"><ce:text id=\"tx0050\">ERP</ce:text><ce:keyword id=\"kw0170\"><ce:text id=\"tx0055\">effective refractory period</ce:text></ce:keyword></ce:keyword><ce:keyword id=\"kw0175\"><ce:text id=\"tx0060\">hpf</ce:text><ce:keyword id=\"kw0180\"><ce:text id=\"tx0065\">hours post fertilization</ce:text></ce:keyword></ce:keyword><ce:keyword id=\"kw0185\"><ce:text id=\"tx0070\">HRV</ce:text><ce:keyword id=\"kw0190\"><ce:text id=\"tx0075\">heart rate variability</ce:text></ce:keyword></ce:keyword><ce:keyword id=\"kw0195\"><ce:text id=\"tx0080\">K<ce:inf loc=\"post\">2</ce:inf><ce:inf loc=\"post\">P</ce:inf></ce:text><ce:keyword id=\"kw0200\"><ce:text id=\"tx0085\">two-pore domain K<ce:sup loc=\"post\">+</ce:sup> channels</ce:text></ce:keyword></ce:keyword><ce:keyword id=\"kw0205\"><ce:text id=\"tx0090\">SNP</ce:text><ce:keyword id=\"kw0210\"><ce:text id=\"tx0095\">single nucleotide polymorphisms</ce:text></ce:keyword></ce:keyword><ce:keyword id=\"kw0215\"><ce:text id=\"tx0100\">WT</ce:text><ce:keyword id=\"kw0220\"><ce:text id=\"tx0105\">wild-type</ce:text></ce:keyword></ce:keyword></ce:keywords><ce:keywords id=\"ks0010\" view=\"all\" class=\"keyword\"><ce:section-title id=\"st0020\">Keywords</ce:section-title><ce:keyword id=\"kw0225\"><ce:text id=\"tx0110\">Two-pore domain potassium channels</ce:text></ce:keyword><ce:keyword id=\"kw0230\"><ce:text id=\"tx0115\">TASK-1</ce:text></ce:keyword><ce:keyword id=\"kw0235\"><ce:text id=\"tx0120\">Atrial action potential duration</ce:text></ce:keyword><ce:keyword id=\"kw0240\"><ce:text id=\"tx0125\">Atrial fibrillation</ce:text></ce:keyword></ce:keywords></head><body view=\"all\"><ce:sections><ce:section id=\"s0005\" view=\"all\"><ce:label>1</ce:label><ce:section-title id=\"st0025\">Introduction</ce:section-title><ce:para id=\"p0005\" view=\"all\">Two-pore domain K<ce:sup loc=\"post\">+</ce:sup> (K<ce:inf loc=\"post\">2</ce:inf><ce:inf loc=\"post\">P</ce:inf>) channels are increasingly being recognized to be key determinants of background K<ce:sup loc=\"post\">+</ce:sup> conductance in cardiomyocytes. These channels, which are comprised of four transmembrane segments and two pore-forming domains, act as sensors of numerous physical, chemical and pharmacological stimuli, and provide dynamic regulation of cellular membrane potential under normal conditions and in disease states <ce:cross-ref refid=\"bb0005\" id=\"cf0145\">[1]</ce:cross-ref>.</ce:para><ce:para id=\"p0010\" view=\"all\">Recently, there has been considerable interest in the K<ce:inf loc=\"post\">2</ce:inf><ce:inf loc=\"post\">P</ce:inf> channel, TASK-1 (<ce:italic>T</ce:italic>WIK-related <ce:italic>A</ce:italic>cid-<ce:italic>S</ce:italic>ensitive <ce:italic>K</ce:italic><ce:sup loc=\"post\">+</ce:sup> channel) that is expressed in a variety of tissues including the heart. TASK-1 activity is modified by numerous factors including hypoxia, extracellular acidosis, inhalational anesthetics such as halothane and isoflurane, and signaling molecules such as phospholipase C, protein kinase C, and protein kinase A <ce:cross-ref refid=\"bb0005\" id=\"cf0150\">[1]</ce:cross-ref>. Studies in rodents have shown that TASK-1 is present in the ventricles and atria, with a ventricular predominance found in mice <ce:cross-refs refid=\"bb0010 bb0015 bb0020 bb0025\" id=\"cf0155\">[2–5]</ce:cross-refs>. Concordant with this, homozygous TASK-1 knockout mice have been demonstrated by two groups to have a ventricular phenotype with prolonged QT interval, wide QRS, and increased ventricular action potential duration (APD) <ce:cross-refs refid=\"bb0015 bb0025\" id=\"cf0160\">[3,5]</ce:cross-refs>. Reduced heart rate variability (HRV) has also been noted <ce:cross-ref refid=\"bb0015\" id=\"cf0165\">[3]</ce:cross-ref>. In human hearts however, TASK-1 is expressed mainly in the atria, especially the paranodal region, and in the atrioventricular node <ce:cross-refs refid=\"bb0030 bb0035 bb0040 bb0045\" id=\"cf0170\">[6–9]</ce:cross-refs>, and TASK-1 current, <ce:italic>I</ce:italic><ce:inf loc=\"post\">TASK</ce:inf>, is estimated to account for 40% of resting current in atrial myocytes <ce:cross-ref refid=\"bb0045\" id=\"cf0175\">[9]</ce:cross-ref>. Because of this, it has been proposed that TASK-1 might have a role in the pathogenesis of atrial fibrillation (AF) and TASK-1 modifying drugs as a potential novel therapeutic intervention. It remains unclear, however, whether TASK-1 deficiency has any phenotypic manifestations that are specifically relevant to the development of AF. Pharmacological inhibition of <ce:italic>I</ce:italic><ce:inf loc=\"post\">TASK</ce:inf> using the compound A293 was found to prolong APD in isolated atrial cardiomyocytes <ce:cross-ref refid=\"bb0045\" id=\"cf0180\">[9]</ce:cross-ref>, but the effects of TASK-1 deficiency on atrial structure and function have not been evaluated <ce:italic>in vivo</ce:italic>. In patients with chronic AF, increased levels of TASK-1 expression in the atrium have been observed in some studies but not others <ce:cross-refs refid=\"bb0030 bb0040 bb0050\" id=\"cf0185\">[6,8,10]</ce:cross-refs>. Reduced <ce:italic>I</ce:italic><ce:inf loc=\"post\">TASK</ce:inf> has been proposed to contribute not only to the anti-arrhythmic effects of amiodarone <ce:cross-ref refid=\"bb0055\" id=\"cf0190\">[11]</ce:cross-ref>, but also to pro-arrhythmic effects in a canine post-operative AF model <ce:cross-ref refid=\"bb0060\" id=\"cf0195\">[12]</ce:cross-ref>. Determining the direction of association between TASK-1 and AF is of paramount importance for the potential usefulness of TASK-1 blockers or activators as AF therapy.</ce:para><ce:para id=\"p0015\" view=\"all\">In this study, we sought to characterize the atrial phenotype associated with TASK-1 deficiency using the zebrafish model and found that transient TASK-1 knockdown in zebrafish results in bradycardia and atrial dilation. Further, to determine whether genetic variation in TASK-1 might have a role in AF, we screened the <ce:italic>KCNK3</ce:italic> gene, that encodes TASK-1, in two independent populations with familial AF and early-onset lone AF, respectively. We identified three novel <ce:italic>KCNK3</ce:italic> variants that were functionally characterized and found to have loss-of-function effects. Our data collectively show that <ce:italic>I</ce:italic><ce:inf loc=\"post\">TASK</ce:inf> has an underappreciated and important role in the atrium and that TASK-1 deficiency can contribute to a substrate for arrhythmogenesis.</ce:para></ce:section><ce:section id=\"s0010\" view=\"all\"><ce:label>2</ce:label><ce:section-title id=\"st0030\">Materials and methods</ce:section-title><ce:section id=\"s0015\" view=\"all\"><ce:label>2.1</ce:label><ce:section-title id=\"st0035\">Zebrafish studies</ce:section-title><ce:para id=\"p0020\" view=\"all\">Expression of the two zebrafish orthologues of <ce:italic>KCNK3</ce:italic> was evaluated by whole-mount <ce:italic>in situ</ce:italic> hybridization and RT-PCR. Knockdown was performed with morpholino oligonucleotides injected into fertilized zebrafish eggs at the one-cell stage. End phenotypic evaluation was performed 72<ce:hsp sp=\"0.25\"/>hour post fertilization (hpf) (see Supplemental Methods).</ce:para></ce:section><ce:section id=\"s0020\" view=\"all\"><ce:label>2.2</ce:label><ce:section-title id=\"st0040\">Study populations and clinical evaluation</ce:section-title><ce:para id=\"p0025\" view=\"all\">The <ce:italic>Danish study population</ce:italic> comprised 208 Caucasian patients described previously <ce:cross-ref refid=\"bb0065\" id=\"cf0200\">[13]</ce:cross-ref> with early-onset lone AF (Supplemental Table 1). The control group comprised 216 unrelated Danish healthy blood donors (52% males), aged 30 to 48 (median 39) years with no cardiac symptoms and normal ECGs. The <ce:italic>Australian study population</ce:italic> comprised 165 Caucasian individuals described in part previously <ce:cross-ref refid=\"bb0070\" id=\"cf0205\">[14]</ce:cross-ref> with familial AF (61% males), aged 17 to 90 (median 59) years. The control group comprised 244 healthy volunteers (36% males), aged 16 to 88 (median 44) years with no history of cardiovascular disease. All subjects gave written informed consent for study participation. Subjects with AF were evaluated by history and physical examination, ECG, and transthoracic echocardiography. Three-channel 24-hour Holter recording was performed in selected Danish subjects (see Supplemental Methods). Protocols were approved by the Scientific Ethics Committee of Copenhagen and Frederiksberg (KF 01313322) or St Vincent\\'s Hospital Human Research Ethics Committee (H00/038).</ce:para></ce:section><ce:section id=\"s0025\" view=\"all\"><ce:label>2.3</ce:label><ce:section-title id=\"st0045\">Genetic screening</ce:section-title><ce:para id=\"p0030\" view=\"all\">Protein-coding sequences of the <ce:italic>KCNK3</ce:italic> gene [NM_002246.2] were PCR-amplified from genomic DNA and sequenced. In subjects with <ce:italic>KCNK3</ce:italic> variants, genetic screening of other cardiac ion channel genes and three common single nucleotide polymorphisms (SNPs) identified by GWAS to be associated with AF <ce:cross-ref refid=\"bb0075\" id=\"cf0210\">[15]</ce:cross-ref> was also performed (Supplemental Methods).</ce:para></ce:section><ce:section id=\"s0030\" view=\"all\"><ce:label>2.4</ce:label><ce:section-title id=\"st0050\">Luciferase reporter assays</ce:section-title><ce:para id=\"p0035\" view=\"all\">Constructs carrying wild-type (WT) or mutant Kozak TASK-1 sequences were generated and luciferase assays were performed <ce:cross-ref refid=\"bb0080\" id=\"cf0215\">[16]</ce:cross-ref> (see Supplemental Methods).</ce:para></ce:section><ce:section id=\"s0035\" view=\"all\"><ce:label>2.5</ce:label><ce:section-title id=\"st0055\">Cellular electrophysiology</ce:section-title><ce:para id=\"p0040\" view=\"all\">Chinese hamster ovary (CHO-K1) cells were transfected with WT or mutant cDNA constructs and currents were recorded using conventional patch-clamp techniques (see Supplemental Methods).</ce:para></ce:section><ce:section id=\"s0040\" view=\"all\"><ce:label>2.6</ce:label><ce:section-title id=\"st0060\">In silico modeling</ce:section-title><ce:para id=\"p0045\" view=\"all\">A consensus TASK-1 homology model was generated using YASARA (YASARA Biosciences, Vienna, Austria). This model is based on TASK-1 amino acids 1–268 and refinement of a high-resolution model using a CASP approved protocol <ce:cross-ref refid=\"bb0085\" id=\"cf0220\">[17]</ce:cross-ref> (Supplemental Methods). To model the effect of reduced TASK-1 current density on the atrial action potential we used the atrial cardiomyocyte model developed by Courtemanche et al. <ce:cross-ref refid=\"bb0090\" id=\"cf0225\">[18]</ce:cross-ref> (see Supplemental Methods).</ce:para></ce:section><ce:section id=\"s0045\" view=\"all\"><ce:label>2.7</ce:label><ce:section-title id=\"st0065\">Statistical analyses</ce:section-title><ce:para id=\"p0050\" view=\"all\">Data are presented as mean<ce:hsp sp=\"0.25\"/>±<ce:hsp sp=\"0.25\"/>SEM. For statistical analyses, unpaired <ce:italic>t</ce:italic>-tests and one way ANOVA combined with a Bonferroni post hoc test were used. <ce:italic>P</ce:italic><ce:hsp sp=\"0.25\"/>&lt;<ce:hsp sp=\"0.25\"/>0.05 was considered statistically significant.</ce:para></ce:section></ce:section><ce:section id=\"s0050\" view=\"all\"><ce:label>3</ce:label><ce:section-title id=\"st0070\">Results</ce:section-title><ce:section id=\"s0055\" view=\"all\"><ce:label>3.1</ce:label><ce:section-title id=\"st0075\">Task-1 knockdown in zebrafish</ce:section-title><ce:para id=\"p0055\" view=\"all\">The zebrafish orthologues of <ce:italic>KCNK3</ce:italic>, <ce:italic>kcnk3a</ce:italic> and <ce:italic>kcnk3b</ce:italic>, share 72% and 66% amino acid identity with human TASK-1, respectively. Expression patterns of <ce:italic>kcnk3a</ce:italic> and <ce:italic>kcnk3b</ce:italic> were evaluated in 72<ce:hsp sp=\"0.25\"/>hpf fish. Whole-mount <ce:italic>in situ</ce:italic> hybridization using orthologue-specific probes showed that both genes were expressed in the central nervous system and in the heart (<ce:cross-ref refid=\"f0005\" id=\"cf0230\">Figs.\\xa01</ce:cross-ref>A–B<ce:float-anchor refid=\"f0005\"/>), with cardiac expression confirmed by RT-PCR (<ce:cross-ref refid=\"f0005\" id=\"cf0235\">Fig.\\xa01</ce:cross-ref>C). TASK-1 inactivation was achieved using both splice site (<ce:cross-ref refid=\"f0005\" id=\"cf0240\">Fig.\\xa01</ce:cross-ref>D) and translation-blocking morpholinos and resulted in macroscopically normal fish (<ce:cross-ref refid=\"f0005\" id=\"cf0245\">Figs.\\xa01</ce:cross-ref>E–F). Knockdown of either <ce:italic>kcnk3a</ce:italic> or <ce:italic>kcnk3b</ce:italic> alone did not produce any consistent heart phenotype indicating redundant roles of the two zebrafish orthologues, however, when both genes were targeted, cardiac abnormalities were present in 71% (&gt;<ce:hsp sp=\"0.10\"/>250) of embryos. The phenotype was reproducible irrespective of whether start- or splice site morpholinos were used. Similar to TASK-1 knockout mice <ce:cross-refs refid=\"bb0015 bb0025\" id=\"cf0250\">[3,5]</ce:cross-refs>, no spontaneous atrial or ventricular arrhythmias were observed in <ce:italic>kcnk3a</ce:italic><ce:hsp sp=\"0.25\"/>+<ce:hsp sp=\"0.25\"/><ce:italic>b</ce:italic>-injected embryos (morphant) zebrafish embryos. The morphants had significant bradycardia (123 <ce:italic>vs.</ce:italic> 147<ce:hsp sp=\"0.25\"/>beats<ce:hsp sp=\"0.25\"/>per<ce:hsp sp=\"0.25\"/>minute, p<ce:hsp sp=\"0.25\"/>≤<ce:hsp sp=\"0.25\"/>0.001) compared with controls, with marked increases in atrial end-diastolic (105.4 <ce:italic>vs.</ce:italic> 81.2<ce:hsp sp=\"0.25\"/>μm, p<ce:hsp sp=\"0.25\"/>=<ce:hsp sp=\"0.25\"/>≤<ce:hsp sp=\"0.10\"/>0.001) and end-systolic diameters (72.3 <ce:italic>vs.</ce:italic> 63.1<ce:hsp sp=\"0.25\"/>μm, p<ce:hsp sp=\"0.25\"/>≤<ce:hsp sp=\"0.25\"/>0.001). Morphant embryos also showed modest increases in ventricular end-diastolic (88.9 <ce:italic>vs.</ce:italic> 84.9<ce:hsp sp=\"0.25\"/>μm, p<ce:hsp sp=\"0.25\"/>=<ce:hsp sp=\"0.25\"/>0.01) and end-systolic diameters (67.7 <ce:italic>vs.</ce:italic> 64.1<ce:hsp sp=\"0.25\"/>μm, p<ce:hsp sp=\"0.25\"/>=<ce:hsp sp=\"0.25\"/>0.006) with no changes in ventricular systolic function (fractional shortening 24 <ce:italic>vs.</ce:italic> 24%, p<ce:hsp sp=\"0.25\"/>=<ce:hsp sp=\"0.25\"/>0.45) (<ce:cross-ref refid=\"f0005\" id=\"cf0255\">Figs.\\xa01</ce:cross-ref>G–N). Representative video recordings are available in the online Supplemental Data. Taken together, these findings indicate that TASK-1 inactivation in zebrafish has a predominant atrial phenotype and might contribute to an atrial substrate for arrhythmogenesis.</ce:para></ce:section><ce:section id=\"s0060\" view=\"all\"><ce:label>3.2</ce:label><ce:section-title id=\"st0080\">KCNK3 sequencing</ce:section-title><ce:para id=\"p0060\" view=\"all\">We performed genetic screening of <ce:italic>KCNK3</ce:italic> in a Danish cohort of 208 patients with early-onset lone AF and identified three novel heterozygous <ce:italic>KCNK3</ce:italic> variants in three patients. All three variants were absent in 216 ethnically-matched controls and in the dbSNP, 1000 Genomes, or Exome Sequencing Project databases. Two <ce:italic>KCNK3</ce:italic> variants were synonymous (c654g<ce:hsp sp=\"0.25\"/>&gt;<ce:hsp sp=\"0.25\"/>t (p.218P<ce:hsp sp=\"0.25\"/>&gt;<ce:hsp sp=\"0.25\"/>P); c1056c<ce:hsp sp=\"0.25\"/>&gt;<ce:hsp sp=\"0.25\"/>g (p.353R<ce:hsp sp=\"0.25\"/>&gt;<ce:hsp sp=\"0.25\"/>R)), and did not affect splice sites. The third variant was a non-synonymous change c.367<ce:hsp sp=\"0.25\"/>g<ce:hsp sp=\"0.25\"/>&gt;<ce:hsp sp=\"0.25\"/>c that resulted in a valine to leucine amino acid substitution p.123<ce:hsp sp=\"0.25\"/>V<ce:hsp sp=\"0.25\"/>&gt;<ce:hsp sp=\"0.25\"/>L (V123L). This variant was identified in a male subject with persistent AF that was first diagnosed at 35 years of age following a presentation with dyspnea. He had no family history of AF and there were no additional relatives available for genetic analysis (<ce:cross-ref refid=\"f0010\" id=\"cf0260\">Fig.\\xa02</ce:cross-ref>A<ce:float-anchor refid=\"f0010\"/>). Echocardiography showed upper normal left atrial diameter (38<ce:hsp sp=\"0.25\"/>mm) and normal left ventricular function (ejection fraction 60%). An ECG showed AF with a controlled ventricular rate (96<ce:hsp sp=\"0.25\"/>bpm), normal QRS duration (94<ce:hsp sp=\"0.25\"/>ms), and QTc (457<ce:hsp sp=\"0.25\"/>ms), on metoprolol 50<ce:hsp sp=\"0.25\"/>mg and amlodipine 10<ce:hsp sp=\"0.25\"/>mg daily. A 24-h Holter was performed to assess heart rate variability (HRV). When compared to an age- and gender-matched healthy population <ce:cross-ref refid=\"bb0095\" id=\"cf0265\">[19]</ce:cross-ref>, there was a shift in the frequency bands indicating reduced HRV (Supplemental Table 2).</ce:para><ce:para id=\"p0065\" view=\"all\"><ce:italic>KCNK3</ce:italic> screening in 165 Australian probands with familial AF identified seven heterozygous <ce:italic>KCNK3</ce:italic> variants, including six variants in the 5′UTR and one synonymous amino acid change (Supplemental Table 3). Two 5′UTR variants, −<ce:hsp sp=\"0.10\"/>4G<ce:hsp sp=\"0.25\"/>&gt;<ce:hsp sp=\"0.25\"/>A and −<ce:hsp sp=\"0.10\"/>3A<ce:hsp sp=\"0.25\"/>&gt;<ce:hsp sp=\"0.25\"/>U, were novel and present in a single proband (HF-II-1, <ce:cross-ref refid=\"f0010\" id=\"cf0270\">Fig.\\xa02</ce:cross-ref>B). Neither the −<ce:hsp sp=\"0.10\"/>4G<ce:hsp sp=\"0.25\"/>&gt;<ce:hsp sp=\"0.25\"/>A nor the −<ce:hsp sp=\"0.10\"/>3A<ce:hsp sp=\"0.25\"/>&gt;<ce:hsp sp=\"0.25\"/>U variant was present in the proband\\'s unaffected sibling (II-2) but in the absence of parental DNA, we were unable to determine whether these variants were inherited or arose <ce:italic>de novo</ce:italic>. The proband had paroxysmal episodes of AF since her late 40s. Echocardiography showed mild left ventricular dilation (61<ce:hsp sp=\"0.25\"/>mm) and reduced contraction (ejection fraction 50%) with moderate atrial dilation (46<ce:hsp sp=\"0.25\"/>mm). An ECG during sinus rhythm showed sinus bradycardia (51<ce:hsp sp=\"0.25\"/>bpm,), with first degree atrioventricular block (PR 216<ce:hsp sp=\"0.25\"/>ms), normal QRS duration (102<ce:hsp sp=\"0.25\"/>ms), and normal QTc (422<ce:hsp sp=\"0.25\"/>ms), on atenolol 25<ce:hsp sp=\"0.25\"/>mg and flecainide 75<ce:hsp sp=\"0.25\"/>mg daily.</ce:para></ce:section><ce:section id=\"s0065\" view=\"all\"><ce:label>3.3</ce:label><ce:section-title id=\"st0085\">Additional variants</ce:section-title><ce:para id=\"p0070\" view=\"all\">Carriers of the V123L_ TASK-1 and novel 5′UTR variants were evaluated for the presence of variants in other ion channel genes and chromosomal loci associated previously with AF (see Supplemental Methods) <ce:cross-ref refid=\"bb0075\" id=\"cf0275\">[15]</ce:cross-ref>. The V123L_ TASK-1 carrier was also heterozygous for two SNPs, rs2200733 (4q25) and rs13376333 (1q21), while the −<ce:hsp sp=\"0.10\"/>4G<ce:hsp sp=\"0.25\"/>&gt;<ce:hsp sp=\"0.25\"/>A/−<ce:hsp sp=\"0.10\"/>3A<ce:hsp sp=\"0.25\"/>&gt;<ce:hsp sp=\"0.25\"/>U carrier was heterozygous for rs2200733 and three non-synonymous function-altering variants in K<ce:sup loc=\"post\">+</ce:sup> channel genes, E444K_K<ce:inf loc=\"post\">V</ce:inf>11.1, S38G_KCNE1, and E145D_KCNE4 <ce:cross-ref refid=\"bb0070\" id=\"cf0280\">[14]</ce:cross-ref>.</ce:para></ce:section><ce:section id=\"s0070\" view=\"all\"><ce:label>3.4</ce:label><ce:section-title id=\"st0090\">KCNK3 Kozak variants reduce translation efficiency</ce:section-title><ce:para id=\"p0075\" view=\"all\">The −<ce:hsp sp=\"0.10\"/>4 and −<ce:hsp sp=\"0.10\"/>3 residues of TASK-1 are located within the Kozak sequence that surrounds the AUG start codon and that is known to be important for translation initiation by ribosomes <ce:cross-ref refid=\"bb0100\" id=\"cf0285\">[20]</ce:cross-ref> (<ce:cross-ref refid=\"f0015\" id=\"cf0290\">Fig.\\xa03</ce:cross-ref>A<ce:float-anchor refid=\"f0015\"/>). The −<ce:hsp sp=\"0.10\"/>3 position has a particularly important role and loss of an A or G at this site has been shown to impair translation efficiency <ce:cross-refs refid=\"bb0100 bb0105\" id=\"cf0295\">[20,21]</ce:cross-refs>. To evaluate the effects of the −<ce:hsp sp=\"0.10\"/>4G<ce:hsp sp=\"0.25\"/>&gt;<ce:hsp sp=\"0.25\"/>A and −<ce:hsp sp=\"0.10\"/>3A<ce:hsp sp=\"0.25\"/>&gt;<ce:hsp sp=\"0.25\"/>U variants, we performed transfection assays with luciferase reporters engineered to contain an AUG within either the WT or variant TASK-1 Kozak context (<ce:cross-ref refid=\"f0015\" id=\"cf0300\">Fig.\\xa03</ce:cross-ref>B). When compared to WT_TASK-1, the double variant reduced luciferase activity by approximately 40% (<ce:cross-ref refid=\"f0015\" id=\"cf0305\">Fig.\\xa03</ce:cross-ref>C). This is indicative of reduced translation initiation efficiency and thus these TASK-1 sequence variants are expected to reduce TASK-1 expression.</ce:para></ce:section><ce:section id=\"s0075\" view=\"all\"><ce:label>3.5</ce:label><ce:section-title id=\"st0095\">V123L_TASK-1 reduces I<ce:inf loc=\"post\">TASK</ce:inf></ce:section-title><ce:para id=\"p0080\" view=\"all\">Residue V123 is located in the M2 transmembrane segment and is highly conserved across species (Supplemental Fig. S1). The functional impact of the V123L substitution was assessed using whole-cell patch-clamp experiments (<ce:cross-ref refid=\"f0020\" id=\"cf0310\">Fig.\\xa04</ce:cross-ref><ce:float-anchor refid=\"f0020\"/>). Currents elicited by V123L_TASK-1 were markedly reduced compared to WT_TASK-1, and co-expression of WT and mutant constructs to mimic the heterozygous carrier state indicates that V123L_TASK-1 has a dominant-negative effect. Peak current densities (pA/pF) at 20<ce:hsp sp=\"0.25\"/>mV for WT, V123L, WT/V123L and control were 9<ce:hsp sp=\"0.25\"/>±<ce:hsp sp=\"0.25\"/>1.1, 3.6<ce:hsp sp=\"0.25\"/>±<ce:hsp sp=\"0.25\"/>0.7, 4.7<ce:hsp sp=\"0.25\"/>±<ce:hsp sp=\"0.25\"/>1.1 and 1.5<ce:hsp sp=\"0.25\"/>±<ce:hsp sp=\"0.25\"/>0.2, respectively (WT/V123L <ce:italic>vs.</ce:italic> WT p<ce:hsp sp=\"0.25\"/>&lt;<ce:hsp sp=\"0.25\"/>0.01; V123L <ce:italic>vs.</ce:italic> WT p<ce:hsp sp=\"0.25\"/>&lt;<ce:hsp sp=\"0.25\"/>0.001; WT <ce:italic>vs.</ce:italic> control, p<ce:hsp sp=\"0.25\"/>&lt;<ce:hsp sp=\"0.25\"/>0.001). Expression of V123L_TASK-1 also resulted in a depolarized resting membrane potential (E<ce:inf loc=\"post\">m</ce:inf>) compared to WT. The E<ce:inf loc=\"post\">m</ce:inf> for CHO-K1 cells expressing WT, V123L, WT/V123L, and control was (mV) −<ce:hsp sp=\"0.10\"/>57.4<ce:hsp sp=\"0.25\"/>±<ce:hsp sp=\"0.25\"/>4.4, −<ce:hsp sp=\"0.10\"/>37.3<ce:hsp sp=\"0.25\"/>±<ce:hsp sp=\"0.25\"/>3.3, −<ce:hsp sp=\"0.10\"/>40.1<ce:hsp sp=\"0.25\"/>±<ce:hsp sp=\"0.25\"/>4.4, and −<ce:hsp sp=\"0.10\"/>15.7<ce:hsp sp=\"0.25\"/>±<ce:hsp sp=\"0.25\"/>1.8, respectively (WT/V123L <ce:italic>vs.</ce:italic> WT, p<ce:hsp sp=\"0.25\"/>&lt;<ce:hsp sp=\"0.25\"/>0.01; V123L <ce:italic>vs.</ce:italic> WT, p<ce:hsp sp=\"0.25\"/>&lt;<ce:hsp sp=\"0.25\"/>0.01; WT <ce:italic>vs.</ce:italic> control, p<ce:hsp sp=\"0.25\"/>&lt;<ce:hsp sp=\"0.25\"/>0.001). Similar results were obtained in <ce:italic>Xenopus laevis</ce:italic> oocytes (Supplemental Fig. S2).</ce:para><ce:para id=\"p0085\" view=\"all\">To determine whether reduction of <ce:italic>I</ce:italic><ce:inf loc=\"post\">TASK</ce:inf> might be due to a trafficking defect, confocal microscopy of CHO-K1 cells transiently transfected with WT or V123L channels was performed. WT_TASK-1 and V123L_TASK-1 were primarily seen in the endoplasmic reticulum in this system; however, the extent of cell surface expression of these proteins was similar (Supplemental Fig. S3).</ce:para><ce:para id=\"p0090\" view=\"all\">Molecular-dynamic simulations were performed employing the recently published crystal structure of the human K<ce:inf loc=\"post\">2</ce:inf>P1.1 <ce:cross-ref refid=\"bb0110\" id=\"cf0315\">[22]</ce:cross-ref>. TASK-1 open-pore-based complexes containing two alkyl chains in both subunits at conserved sites were calculated and simulations were performed in a membranous environment (Supplemental Fig. S4). In these structural simulations, residue 123 is localized at the lateral fenestrae, potentially allowing for interactions with alkyl molecules (<ce:cross-ref refid=\"f0025\" id=\"cf0320\">Fig.\\xa05</ce:cross-ref>A<ce:float-anchor refid=\"f0025\"/>). Further, a stable attractive van-der-Waals interaction of Val123 is present with residue Leu11 in the transmembrane helix 1 (<ce:cross-ref refid=\"f0025\" id=\"cf0325\">Fig.\\xa05</ce:cross-ref>B). These findings suggest that loss of the valine at this residue may affect the local structural stability of the TASK-1 pore.</ce:para></ce:section><ce:section id=\"s0080\" view=\"all\"><ce:label>3.6</ce:label><ce:section-title id=\"st0100\">Modulation of V123L_TASK-1 by extracellular pH</ce:section-title><ce:para id=\"p0095\" view=\"all\">Since TASK-1 channels are modulated by extracellular pH <ce:cross-ref refid=\"bb0115\" id=\"cf0330\">[23]</ce:cross-ref>, we investigated whether the V123L mutation altered pH sensitivity of channels expressed in <ce:italic>X. laevis</ce:italic> oocytes. Using two-electrode voltage-clamp, we measured steady-state currents with pH ranging from 5.4 to 8.6. The inhibitory effect of acidic pH levels was characterized by half-inhibitory pH value (<ce:italic>pH<ce:inf loc=\"post\">i</ce:inf></ce:italic>). Both WT_TASK-1 and V123L_TASK-1 were extremely sensitive to extracellular pH (Supplemental Fig. S5). At 20<ce:hsp sp=\"0.25\"/>mV, the <ce:italic>pH<ce:inf loc=\"post\">i</ce:inf></ce:italic> for WT and V123L were 7.35<ce:hsp sp=\"0.25\"/>±<ce:hsp sp=\"0.25\"/>0.02 and 7.45<ce:hsp sp=\"0.25\"/>±<ce:hsp sp=\"0.25\"/>0.01, respectively, indicating small but significant differences in pH sensitivity (<ce:italic>p</ce:italic><ce:hsp sp=\"0.25\"/>&lt;<ce:hsp sp=\"0.25\"/>0.001). In agreement with a previous report <ce:cross-ref refid=\"bb0115\" id=\"cf0335\">[23]</ce:cross-ref>, we found that the kinetics of both WT and V123L currents were unchanged by pH values, and that the inhibitory effect of external protons was not voltage-dependent (data not shown).</ce:para></ce:section><ce:section id=\"s0085\" view=\"all\"><ce:label>3.7</ce:label><ce:section-title id=\"st0105\">Cardiac action potential modeling</ce:section-title><ce:para id=\"p0100\" view=\"all\">We performed computer simulations to investigate the effect of reduced <ce:italic>I</ce:italic><ce:inf loc=\"post\">TASK</ce:inf> on the rate dependency of APD and maximum diastolic potential (E<ce:inf loc=\"post\">m</ce:inf>) (<ce:cross-ref refid=\"f0030\" id=\"cf0340\">Fig.\\xa06</ce:cross-ref><ce:float-anchor refid=\"f0030\"/>). Reduced <ce:italic>I</ce:italic><ce:inf loc=\"post\">TASK</ce:inf> prolonged APD and depolarized E<ce:inf loc=\"post\">m</ce:inf>, with more pronounced effects at shorter basic cycle lengths (BCL). Also, the simulations show that <ce:italic>I</ce:italic><ce:inf loc=\"post\">TASK</ce:inf> reduction reduced maximal upstroke velocity <ce:italic>V<ce:inf loc=\"post\">max</ce:inf></ce:italic> (<ce:cross-ref refid=\"f0030\" id=\"cf0345\">Figs.\\xa06</ce:cross-ref>D and A insert).</ce:para><ce:para id=\"p0105\" view=\"all\">To explore how variations in <ce:italic>I</ce:italic><ce:inf loc=\"post\">TASK</ce:inf> might interact with other genetic and atrial environmental effects, we simulated the combined effects of K<ce:sup loc=\"post\">+</ce:sup> channel variants identified in the −<ce:hsp sp=\"0.10\"/>4G<ce:hsp sp=\"0.25\"/>&gt;<ce:hsp sp=\"0.25\"/>A/−<ce:hsp sp=\"0.10\"/>3A<ce:hsp sp=\"0.25\"/>&gt;<ce:hsp sp=\"0.25\"/>U family proband <ce:cross-ref refid=\"bb0070\" id=\"cf0350\">[14]</ce:cross-ref>. Subtraction of <ce:italic>I</ce:italic><ce:inf loc=\"post\">TASK</ce:inf> alone prolonged the APD<ce:inf loc=\"post\">90</ce:inf> from 296<ce:hsp sp=\"0.25\"/>ms in the unmodified model to 317<ce:hsp sp=\"0.25\"/>ms (<ce:cross-ref refid=\"f0030\" id=\"cf0355\">Fig.\\xa06</ce:cross-ref>E). Reductions of <ce:italic>I</ce:italic><ce:inf loc=\"post\">Ks</ce:inf> by 50% (estimated effects of S38G_KCNE1) and <ce:italic>I</ce:italic><ce:inf loc=\"post\">Kr</ce:inf> by 10% (E444K_K<ce:inf loc=\"post\">V</ce:inf>11.1) exacerbated this effect and increased the APD<ce:inf loc=\"post\">90</ce:inf> to 348<ce:hsp sp=\"0.25\"/>ms. In this genetic background, additional modulation of <ce:italic>I</ce:italic><ce:inf loc=\"post\">TASK</ce:inf> that might occur with physiological stimuli such as changes in pH or pO<ce:inf loc=\"post\">2</ce:inf>, shifted the APD<ce:inf loc=\"post\">90</ce:inf> from 348<ce:hsp sp=\"0.25\"/>ms to 341 (+<ce:hsp sp=\"0.10\"/>10% <ce:italic>I</ce:italic><ce:inf loc=\"post\">TASK</ce:inf>) or 356<ce:hsp sp=\"0.25\"/>ms (−<ce:hsp sp=\"0.10\"/>10% <ce:italic>I</ce:italic><ce:inf loc=\"post\">TASK</ce:inf>), respectively. Simultaneous changes in <ce:italic>I<ce:inf loc=\"post\">TASK</ce:inf></ce:italic>, <ce:italic>I<ce:inf loc=\"post\">Ks</ce:inf></ce:italic>, and <ce:italic>I<ce:inf loc=\"post\">Kr</ce:inf></ce:italic> also altered how changes in other ion channels in the atrial cell model influenced AP duration as reflected in APD<ce:inf loc=\"post\">90</ce:inf> sensitivity coefficients of other ion currents (<ce:cross-ref refid=\"f0030\" id=\"cf0360\">Fig.\\xa06</ce:cross-ref>F). The currents most affected were <ce:italic>I</ce:italic><ce:inf loc=\"post\">Kur</ce:inf>, <ce:italic>I</ce:italic><ce:inf loc=\"post\">to</ce:inf> and <ce:italic>I</ce:italic><ce:inf loc=\"post\">Kr</ce:inf>. After <ce:italic>I</ce:italic><ce:inf loc=\"post\">TASK</ce:inf> subtraction, the sensitivity coefficient for <ce:italic>I</ce:italic><ce:inf loc=\"post\">Kur</ce:inf>, increased approximately three-fold from 0.06 at baseline to 0.18, while the coefficient for <ce:italic>I</ce:italic><ce:inf loc=\"post\">to</ce:inf> decreased from 0.26 to 0.17. There were no additional changes in either <ce:italic>I</ce:italic><ce:inf loc=\"post\">Kur</ce:inf> or <ce:italic>I</ce:italic><ce:inf loc=\"post\">to</ce:inf> when <ce:italic>I</ce:italic><ce:inf loc=\"post\">Ks</ce:inf> and/or <ce:italic>I</ce:italic><ce:inf loc=\"post\">Kr</ce:inf> conductance variations were included. In contrast, the sensitivity coefficient for <ce:italic>I</ce:italic><ce:inf loc=\"post\">Kr</ce:inf> increased from −<ce:hsp sp=\"0.10\"/>0.37 to −<ce:hsp sp=\"0.10\"/>0.45 with <ce:italic>I</ce:italic><ce:inf loc=\"post\">TASK</ce:inf> subtraction and rose to −<ce:hsp sp=\"0.10\"/>0.49 with a 50% reduction of <ce:italic>I</ce:italic><ce:inf loc=\"post\">Ks</ce:inf>. These data suggest that reductions of <ce:italic>I</ce:italic><ce:inf loc=\"post\">TASK</ce:inf> due to the −<ce:hsp sp=\"0.10\"/>4G<ce:hsp sp=\"0.25\"/>&gt;<ce:hsp sp=\"0.25\"/>A and −<ce:hsp sp=\"0.10\"/>3A<ce:hsp sp=\"0.25\"/>&gt;<ce:hsp sp=\"0.25\"/>U <ce:italic>KCNK3</ce:italic> variants are potentiated by the presence of additional K<ce:sup loc=\"post\">+</ce:sup> channel genetic variants resulting in further prolongation of atrial APD.</ce:para></ce:section></ce:section><ce:section id=\"s0090\" view=\"all\"><ce:label>4</ce:label><ce:section-title id=\"st0110\">Discussion</ce:section-title><ce:para id=\"p0110\" view=\"all\">Here we report the discovery of three novel <ce:italic>KCNK3</ce:italic> variants in two patients with AF. In both cases, functional characterization of the <ce:italic>KCNK3</ce:italic> variants predicted reduced atrial <ce:italic>I</ce:italic><ce:inf loc=\"post\">TASK</ce:inf>. Recently, <ce:italic>KCNK3</ce:italic> loss-of-function mutations have been identified in patients with pulmonary arterial hypertension <ce:cross-ref refid=\"bb0120\" id=\"cf0365\">[24]</ce:cross-ref>. Our findings now provide the first report of K<ce:inf loc=\"post\">2</ce:inf><ce:inf loc=\"post\">P</ce:inf> mutations in a setting of cardiac disease. Interesting questions arise about the impact of TASK-1 deficiency on atrial electrophysiological properties and how these changes might predispose to AF.</ce:para><ce:para id=\"p0115\" view=\"all\">The V123L_TASK-1 variant reduced <ce:italic>I</ce:italic><ce:inf loc=\"post\">TASK</ce:inf> and depolarized resting membrane potential in transfected CHO-K1 cells and had a dominant negative effect on WT_TASK-1. <ce:italic>In silico</ce:italic> modeling suggested that V123L_TASK-1 reduces the structural stability of the TASK-1 pore and prolongs the atrial APD. The two Kozak variants −<ce:hsp sp=\"0.10\"/>4G<ce:hsp sp=\"0.25\"/>&gt;<ce:hsp sp=\"0.25\"/>A and −<ce:hsp sp=\"0.10\"/>3A<ce:hsp sp=\"0.25\"/>&gt;<ce:hsp sp=\"0.25\"/>U, in combination, reduced luciferase reporter activity. Although we were unable to evaluate TASK-1 expression directly due to a lack of patient heart tissue, it can be expected that these variants would reduce translation initiation efficiency and TASK-1 levels <ce:cross-refs refid=\"bb0100 bb0105\" id=\"cf0370\">[20,21]</ce:cross-refs>. Similar Kozak sequence variants have been shown to be functionally deleterious and associated with a variety of human diseases <ce:cross-ref refid=\"bb0125\" id=\"cf0375\">[25]</ce:cross-ref>.</ce:para><ce:para id=\"p0120\" view=\"all\">The consequences of TASK-1 deficiency in the heart have been evaluated mainly in murine models that have strong ventricular expression of TASK-1, with homozygous knockout mice consistently showing prolonged QTc and wide QRS <ce:cross-refs refid=\"bb0015 bb0025\" id=\"cf0380\">[3,5]</ce:cross-refs>. Notably, both QTc interval and QRS duration were normal in the two patients with <ce:italic>KCNK3</ce:italic> variants. Given the predominant atrial expression of TASK-1 in humans <ce:cross-refs refid=\"bb0030 bb0035 bb0040 bb0045\" id=\"cf0385\">[6–9]</ce:cross-refs>, murine models may thus not be ideal to study mechanisms underpinning AF. Zebrafish have numerous advantages as a cardiac disease model <ce:cross-ref refid=\"bb0130\" id=\"cf0390\">[26]</ce:cross-ref> and appear to be a highly relevant model to study TASK-1. Due to the small size of 3 day-old zebrafish hearts, chamber-specific expression of TASK-1 could not be readily evaluated. Nevertheless, we found that transient knockdown of the two <ce:italic>KCNK3</ce:italic> homologues, <ce:italic>kcnk3a</ce:italic> and <ce:italic>kcnk3b</ce:italic>, resulted in a predominant atrial phenotype with sinus bradycardia and atrial dilation and only minimal ventricular dilation and normal ventricular contraction. In the human subjects with <ce:italic>KCNK3</ce:italic> variants, the V123L_TASK-1 carrier had upper normal atrial diameter, while the −<ce:hsp sp=\"0.10\"/>4G<ce:hsp sp=\"0.25\"/>&gt;<ce:hsp sp=\"0.25\"/>A/−<ce:hsp sp=\"0.10\"/>3A<ce:hsp sp=\"0.25\"/>&gt;<ce:hsp sp=\"0.25\"/>U carrier also had bradycardia, moderately enlarged atria and mild ventricular dilation. Direct extrapolation of the zebrafish findings to humans is limited by differences in the relative extent of TASK-1 depletion and the numerous additional factors that affect heart rate and atrial size, including age, the presence and duration of AF, and concomitant anti-arrhythmic drug therapy. Despite these caveats, the zebrafish data confirm the functional importance of TASK-1 in the atrium and indicate two potential factors that could predispose to AF, namely, slow heart rate and increased atrial size.</ce:para><ce:para id=\"p0125\" view=\"all\">Atrial membrane potential and APD are not fixed parameters but are dynamically altered by a variety of factors. We hypothesize that changes in atrial membrane potential and APD associated with loss-of-function <ce:italic>KCNK3</ce:italic> variants might sensitize the cardiomyocyte to effects of other genetic and atrial “environmental” perturbations. A complete profile of the genetic make-up of our two <ce:italic>KCNK3</ce:italic> variant carriers is beyond the scope of this study, however it can be expected that each individual would harbor at least 20,000 exonic variants, many of which may alter protein function <ce:cross-ref refid=\"bb0135\" id=\"cf0395\">[27]</ce:cross-ref>. Evaluation of other ion channel genes associated with AF and the top GWAS SNPs indicates that additional potential disease-modifying genetic variants are present in both cases. We predict that TASK-1-mediated changes in resting membrane potential may modify the extent of normal adaptive changes of other ion channels as well as the threshold levels for manifestations of other ion channel genetic variants. Computer simulation of the cumulative effects of reduced <ce:italic>I</ce:italic><ce:inf loc=\"post\">TASK</ce:inf> and three additional function-altering K<ce:sup loc=\"post\">+</ce:sup> channel variants, E444K_K<ce:inf loc=\"post\">V</ce:inf>11.1, S38G_KCNE1, and E145D_KCNE4 identified in the −<ce:hsp sp=\"0.10\"/>4G<ce:hsp sp=\"0.25\"/>&gt;<ce:hsp sp=\"0.25\"/>A/−<ce:hsp sp=\"0.10\"/>3A<ce:hsp sp=\"0.25\"/>&gt;<ce:hsp sp=\"0.25\"/>U carrier, predicted reciprocal alterations of <ce:italic>I</ce:italic><ce:inf loc=\"post\">Kur</ce:inf>, <ce:italic>I</ce:italic><ce:inf loc=\"post\">to</ce:inf> and <ce:italic>I</ce:italic><ce:inf loc=\"post\">Kr</ce:inf> and potentiated effects on atrial APD. <ce:italic>KCNK3</ce:italic> variant-mediated changes may be exacerbated by the presence of AF. For example, data from a post-operative canine AF model and from atrial tissues of patients with chronic AF, suggest that disease-related changes can independently depress <ce:italic>I</ce:italic><ce:inf loc=\"post\">TASK</ce:inf> activity and alter TASK-1 expression\\xa0<ce:cross-refs refid=\"bb0030 bb0035 bb0050 bb0060\" id=\"cf0400\">[6,7,10,12]</ce:cross-refs>. <ce:italic>KCNK3</ce:italic> variant-mediated changes in resting membrane potential of cardiomyocytes may affect the susceptibility to adverse effects of other acquired stimuli that inhibit TASK-1 function, such as hypoxia or acidosis that may occur in pathophysiological conditions, such as myocardial ischemia <ce:cross-refs refid=\"bb0005 bb0115\" id=\"cf0405\">[1,23]</ce:cross-refs>. Noteworthy, we find that the V123L mutation results in altered pH sensitivity. Taken together, these observations suggest that <ce:italic>KCNK3</ce:italic> genetic variation is one of a number of factors that are determinants of <ce:italic>I</ce:italic><ce:inf loc=\"post\">TASK</ce:inf> and atrial electrophysiological properties.</ce:para><ce:para id=\"p0130\" view=\"all\">Although the V123L_TASK-1 and −<ce:hsp sp=\"0.10\"/>4G<ce:hsp sp=\"0.25\"/>&gt;<ce:hsp sp=\"0.25\"/>A/−<ce:hsp sp=\"0.10\"/>3A<ce:hsp sp=\"0.25\"/>&gt;<ce:hsp sp=\"0.25\"/>U variants appear to have functional effects, we are unable to definitively establish these as causative of AF, since these were each demonstrated to be present in single individuals. The absence of arrhythmias in homozygous TASK-1 knockout mice suggests that TASK-1 deficiency <ce:italic>per se</ce:italic> may not be sufficient to induce arrhythmia. However, the electrophysiological defects in these mice and in our analyses of human <ce:italic>KCNK3</ce:italic> mutations are consistent with TASK-1 contributing to a myocardial arrhythmogenic substrate and increased susceptibility to develop AF in the presence of arrhythmic stimuli. Prolongation of the atrial APD has been observed with other K<ce:sup loc=\"post\">+</ce:sup> channel gene mutations identified in families with AF and may increase the risk for reactivation of L-type Ca<ce:sup loc=\"post\">2+</ce:sup> channels and predispose to early after-depolarizations that can trigger AF <ce:cross-refs refid=\"bb0045 bb0140\" id=\"cf0410\">[9,28]</ce:cross-refs>. The changes in membrane potential seen with V123L_TASK-1 occur close to half-maximal steady-state inactivation voltages of atrial Na<ce:sup loc=\"post\">+</ce:sup> channels, and hence, a slight depolarization of the cardiomyocytes could significantly alter Na<ce:inf loc=\"post\">V</ce:inf> channel availability <ce:cross-ref refid=\"bb0145\" id=\"cf0415\">[29]</ce:cross-ref>. Our simulation data suggest that a 40–60% reduction in <ce:italic>I</ce:italic><ce:inf loc=\"post\">TASK</ce:inf> depolarizes E<ce:inf loc=\"post\">m</ce:inf> and decreases V<ce:italic><ce:inf loc=\"post\">max</ce:inf></ce:italic>. Although V<ce:italic><ce:inf loc=\"post\">max</ce:inf></ce:italic> is a non-linear index of Na<ce:inf loc=\"post\">V</ce:inf> availability <ce:cross-ref refid=\"bb0150\" id=\"cf0420\">[30]</ce:cross-ref>, these changes may result in slower impulse propagation in atrial tissue. Importantly, the effects on both E<ce:inf loc=\"post\">m</ce:inf> and V<ce:italic><ce:inf loc=\"post\">max</ce:inf></ce:italic> were more pronounced at short cycle lengths that would favor the development of AF. Paroxysmal episodes of AF can also be initiated by fluctuations in the autonomic nervous system, with sympathetic and vagal triggers in subsets of patients <ce:cross-ref refid=\"bb0155\" id=\"cf0425\">[31]</ce:cross-ref>. The sympathovagal balance can be assessed by HRV, and abnormal HRV with a sympathetic preponderance has been demonstrated in TASK-1 knockout mice <ce:cross-ref refid=\"bb0015\" id=\"cf0430\">[3]</ce:cross-ref>. Interestingly, the V123L_TASK-1 carrier showed abnormal time- and frequency domain indices that are suggestive of altered HRV with a parasympathetic predominance.</ce:para><ce:para id=\"p0135\" view=\"all\">There are a number of limitations of this study, including the small family size and lack of power to demonstrate robust genetic associations with disease. For the V123L variant, we used heterologous expression systems to assess TASK-1 function and these can only approximate the situation in native cardiac tissue. Heterologous systems are unable to adequately assess the magnitude of change in TASK-1 expression that might result from the −<ce:hsp sp=\"0.10\"/>4G<ce:hsp sp=\"0.25\"/>&gt;<ce:hsp sp=\"0.25\"/>A/−<ce:hsp sp=\"0.10\"/>3A<ce:hsp sp=\"0.25\"/>&gt;<ce:hsp sp=\"0.25\"/>U variants and the lack of readily-available patient heart tissue precludes definitive information to be obtained. Although we modeled the effects of TASK-1 variants at the single cell level, the effects of reduced <ce:italic>I</ce:italic><ce:inf loc=\"post\">TASK</ce:inf> may differ in coupled atrial tissue.</ce:para></ce:section><ce:section id=\"s0095\" view=\"all\"><ce:label>5</ce:label><ce:section-title id=\"st0115\">Conclusions</ce:section-title><ce:para id=\"p0140\" view=\"all\">We have identified three <ce:italic>KCNK3</ce:italic> variants in two subjects with AF. The V123L_TASK-1 variant alters <ce:italic>I</ce:italic><ce:inf loc=\"post\">TASK</ce:inf>, and membrane potential in CHO-K1 cells and is predicted to alter atrial APD, while two contiguous Kozak sequence variants, −<ce:hsp sp=\"0.10\"/>4G<ce:hsp sp=\"0.25\"/>&gt;<ce:hsp sp=\"0.25\"/>A and −<ce:hsp sp=\"0.10\"/>3A<ce:hsp sp=\"0.25\"/>&gt;<ce:hsp sp=\"0.25\"/>U reduce luciferase reporter activity with likely effects on translation initiation efficiency and myocardial TASK-1 expression. Transient TASK-1 knockdown in zebrafish results in bradycardia and atrial dilatation. Our data highlight the key role of TASK-1 as a determinant of structure and function of atrial cardiomyocytes and suggest that TASK-1 loss-of-function contributes to an arrhythmogenic substrate.</ce:para></ce:section><ce:section id=\"s0100\" view=\"all\"><ce:section-title id=\"st0120\">Conflict of interest statement</ce:section-title><ce:para id=\"p0145\" view=\"all\">None declared.</ce:para></ce:section></ce:sections><ce:acknowledgment id=\"ac0005\" view=\"all\"><ce:section-title id=\"st0135\">Acknowledgments</ce:section-title><ce:para id=\"p0150\" view=\"all\">We thank Florian Lésage for TASK-1 cDNA. We thank Jonathan Silberberg and collaborating physicians for family referrals; Ingrid E. Christophersen, Anders G. Holst, Monique Ohanian, Arie Jacoby, Kathryn Stockhammer, and Gunjan Trivedi for assistance with clinical, genetics and zebrafish studies. This work was supported by the <ce:grant-sponsor id=\"gts0005\" xlink:type=\"simple\" xlink:role=\"http://www.elsevier.com/xml/linking-roles/grant-sponsor\">Danish National Research Foundation</ce:grant-sponsor>, <ce:grant-sponsor id=\"gts0010\" xlink:type=\"simple\" xlink:role=\"http://www.elsevier.com/xml/linking-roles/grant-sponsor\">John and Birthe Meyer Foundation</ce:grant-sponsor>, <ce:grant-sponsor id=\"gts0015\" xlink:type=\"simple\" xlink:role=\"http://www.elsevier.com/xml/linking-roles/grant-sponsor\">Danish Heart Foundation</ce:grant-sponsor> (No. <ce:grant-number refid=\"gts0015\">11-04-R84-A3333-22660</ce:grant-number> and <ce:grant-number refid=\"gts0015\">12-04-R90-A3935-22739</ce:grant-number> to B.L.), <ce:grant-sponsor id=\"gts0020\" xlink:type=\"simple\" xlink:role=\"http://www.elsevier.com/xml/linking-roles/grant-sponsor\">A.P. Møller Foundation</ce:grant-sponsor> (to F.K.K.), <ce:grant-sponsor id=\"gts0025\" xlink:type=\"simple\" xlink:role=\"http://www.elsevier.com/xml/linking-roles/grant-sponsor\">Direktør Ib Henriksen Foundation</ce:grant-sponsor>, <ce:grant-sponsor id=\"gts0030\" xlink:type=\"simple\" xlink:role=\"http://www.elsevier.com/xml/linking-roles/grant-sponsor\">Arvid Nilsson Foundation</ce:grant-sponsor>, <ce:grant-sponsor id=\"gts0035\" xlink:type=\"simple\" xlink:role=\"http://www.elsevier.com/xml/linking-roles/grant-sponsor\">Deutsche Forschungsgemeinschaft</ce:grant-sponsor> (No. <ce:grant-number refid=\"gts0035\">DFG-SE1077</ce:grant-number> to G.S.), <ce:grant-sponsor id=\"gts0040\" xlink:type=\"simple\" xlink:role=\"http://www.elsevier.com/xml/linking-roles/grant-sponsor\">National Health and Medical Research Council of Australia</ce:grant-sponsor>, the <ce:grant-sponsor id=\"gts0045\" xlink:type=\"simple\" xlink:role=\"http://www.elsevier.com/xml/linking-roles/grant-sponsor\">National Heart Foundation of Australia</ce:grant-sponsor>, <ce:grant-sponsor id=\"gts0050\" xlink:type=\"simple\" xlink:role=\"http://www.elsevier.com/xml/linking-roles/grant-sponsor\">Estate of the Late RT Hall</ce:grant-sponsor>, <ce:grant-sponsor id=\"gts0055\" xlink:type=\"simple\" xlink:role=\"http://www.elsevier.com/xml/linking-roles/grant-sponsor\">Roth Foundation</ce:grant-sponsor> and <ce:grant-sponsor id=\"gts0060\" xlink:type=\"simple\" xlink:role=\"http://www.elsevier.com/xml/linking-roles/grant-sponsor\">St Vincent\\'s Clinic Foundation</ce:grant-sponsor>.</ce:para></ce:acknowledgment><ce:appendices view=\"all\"><ce:section id=\"s0105\" view=\"extended\"><ce:label>Appendix A</ce:label><ce:section-title id=\"st0140\">Supplementary data</ce:section-title><ce:para id=\"p0180\" view=\"all\"><ce:display><ce:e-component id=\"ec0005\"><ce:caption id=\"ca0035\"><ce:simple-para id=\"sp0045\" view=\"all\">Supplementary Methods and Data.</ce:simple-para></ce:caption><ce:link locator=\"mmc1\"/></ce:e-component></ce:display><ce:display><ce:e-component id=\"ec0010\"><ce:label>Supplementary video\\xa01</ce:label><ce:caption id=\"ca0040\"><ce:simple-para id=\"sp0050\" view=\"all\">Cardiac phenotype in control-injected zebrafish embryo.</ce:simple-para><ce:simple-para id=\"sp0055\" view=\"all\">Control-injected 72<ce:hsp sp=\"0.25\"/>hpf zebrafish embryo showing normal heart rhythm and normal atrium.</ce:simple-para></ce:caption><ce:link locator=\"mmc2\"/></ce:e-component></ce:display><ce:display><ce:e-component id=\"ec0015\"><ce:label>Supplementary video\\xa02</ce:label><ce:caption id=\"ca0045\"><ce:simple-para id=\"sp0060\" view=\"all\">Cardiac phenotype in <ce:italic>kcnk3a</ce:italic><ce:hsp sp=\"0.25\"/>+<ce:hsp sp=\"0.25\"/><ce:italic>b</ce:italic>-injected zebrafish embryo.</ce:simple-para><ce:simple-para id=\"sp0065\" view=\"all\">72<ce:hsp sp=\"0.25\"/>hpf zebrafish embryo co-injected with <ce:italic>kcnk3a</ce:italic><ce:hsp sp=\"0.25\"/>+<ce:hsp sp=\"0.25\"/><ce:italic>b</ce:italic> morpholinos shows bradycardia and atrial dilatation.</ce:simple-para></ce:caption><ce:link locator=\"mmc3\"/></ce:e-component></ce:display></ce:para></ce:section><ce:section view=\"compact-standard\" id=\"s0110\"><ce:label>Appendix A</ce:label><ce:section-title id=\"st0145\">Supplementary data</ce:section-title><ce:para id=\"p0185\" view=\"all\">Supplementary data to this article can be found online at <ce:inter-ref xlink:href=\"doi:10.1016/j.yjmcc.2013.12.014\" id=\"ir0005\" xlink:type=\"simple\">http://dx.doi.org/10.1016/j.yjmcc.2013.12.014</ce:inter-ref>.</ce:para></ce:section></ce:appendices></body><tail view=\"all\"><ce:bibliography id=\"bi0005\" view=\"all\"><ce:section-title id=\"st0130\">References</ce:section-title><ce:bibliography-sec id=\"bs0005\" view=\"all\"><ce:bib-reference id=\"bb0005\"><ce:label>[1]</ce:label><sb:reference id=\"rf0005\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Gurney</ce:surname></sb:author><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Manoury</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Two-pore potassium channels in the cardiovascular system</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Eur Biophys J</sb:maintitle></sb:title><sb:volume-nr>38</sb:volume-nr></sb:series><sb:date>2009</sb:date></sb:issue><sb:pages><sb:first-page>305</sb:first-page><sb:last-page>318</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0010\"><ce:label>[2]</ce:label><sb:reference id=\"rf0010\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Kim</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Bang</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Kim</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>TBAK-1 and TASK-1, two-pore K(+) channel subunits: kinetic properties and expression in rat heart</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Am J Physiol</sb:maintitle></sb:title><sb:volume-nr>277</sb:volume-nr></sb:series><sb:date>1999</sb:date></sb:issue><sb:pages><sb:first-page>H1669</sb:first-page><sb:last-page>H1678</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0015\"><ce:label>[3]</ce:label><sb:reference id=\"rf0015\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>B.C.</ce:given-name><ce:surname>Donner</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Schullenberg</ce:surname></sb:author><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Geduldig</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Huning</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Mersmann</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Zacharowski</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Functional role of TASK-1 in the heart: studies in TASK-1-deficient mice show prolonged cardiac repolarization and reduced heart rate variability</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Basic Res Cardiol</sb:maintitle></sb:title><sb:volume-nr>106</sb:volume-nr></sb:series><sb:date>2011</sb:date></sb:issue><sb:pages><sb:first-page>75</sb:first-page><sb:last-page>87</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0020\"><ce:label>[4]</ce:label><sb:reference id=\"rf0020\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>S.A.</ce:given-name><ce:surname>Jones</ce:surname></sb:author><sb:author><ce:given-name>M.J.</ce:given-name><ce:surname>Morton</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Hunter</ce:surname></sb:author><sb:author><ce:given-name>M.R.</ce:given-name><ce:surname>Boyett</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Expression of TASK-1, a pH-sensitive twin-pore domain K(+) channel, in rat myocytes</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Am J Physiol Heart Circ Physiol</sb:maintitle></sb:title><sb:volume-nr>283</sb:volume-nr></sb:series><sb:date>2002</sb:date></sb:issue><sb:pages><sb:first-page>H181</sb:first-page><sb:last-page>H185</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0025\"><ce:label>[5]</ce:label><sb:reference id=\"rf0025\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Decher</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Wemhöner</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Rinné</ce:surname></sb:author><sb:author><ce:given-name>M.F.</ce:given-name><ce:surname>Netter</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Zuzarte</ce:surname></sb:author><sb:author><ce:given-name>M.I.</ce:given-name><ce:surname>Aller</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Knock-out of the potassium channel TASK-1 leads to a prolonged QT interval and a disturbed QRS complex</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cell Physiol Biochem</sb:maintitle></sb:title><sb:volume-nr>28</sb:volume-nr></sb:series><sb:date>2011</sb:date></sb:issue><sb:pages><sb:first-page>77</sb:first-page><sb:last-page>86</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0030\"><ce:label>[6]</ce:label><sb:reference id=\"rf0030\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Ellinghaus</ce:surname></sb:author><sb:author><ce:given-name>R.J.</ce:given-name><ce:surname>Scheubel</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Dobrev</ce:surname></sb:author><sb:author><ce:given-name>U.</ce:given-name><ce:surname>Ravens</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Holtz</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Huetter</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Comparing the global mRNA expression profile of human atrial and ventricular myocardium with high-density oligonucleotide arrays</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J Thorac Cardiovasc Surg</sb:maintitle></sb:title><sb:volume-nr>129</sb:volume-nr></sb:series><sb:date>2005</sb:date></sb:issue><sb:pages><sb:first-page>1383</sb:first-page><sb:last-page>1390</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0035\"><ce:label>[7]</ce:label><sb:reference id=\"rf0035\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Gaborit</ce:surname></sb:author><sb:author><ce:given-name>B.S.</ce:given-name><ce:surname>Le</ce:surname></sb:author><sb:author><ce:given-name>V.</ce:given-name><ce:surname>Szuts</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Varro</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Escande</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Nattel</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Regional and tissue specific transcript signatures of ion channel genes in the non-diseased human heart</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J Physiol</sb:maintitle></sb:title><sb:volume-nr>582</sb:volume-nr></sb:series><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>675</sb:first-page><sb:last-page>693</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0040\"><ce:label>[8]</ce:label><sb:reference id=\"rf0040\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>N.J.</ce:given-name><ce:surname>Chandler</ce:surname></sb:author><sb:author><ce:given-name>I.D.</ce:given-name><ce:surname>Greener</ce:surname></sb:author><sb:author><ce:given-name>J.O.</ce:given-name><ce:surname>Tellez</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Inada</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Musa</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Molenaar</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Molecular architecture of the human sinus node: insights into the function of the cardiac pacemaker</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Circulation</sb:maintitle></sb:title><sb:volume-nr>119</sb:volume-nr></sb:series><sb:date>2009</sb:date></sb:issue><sb:pages><sb:first-page>1562</sb:first-page><sb:last-page>1575</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0045\"><ce:label>[9]</ce:label><sb:reference id=\"rf0045\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>S.H.</ce:given-name><ce:surname>Limberg</ce:surname></sb:author><sb:author><ce:given-name>M.F.</ce:given-name><ce:surname>Netter</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Rolfes</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Rinne</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Schlichthorl</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Zuzarte</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>TASK-1 channels may modulate action potential duration of human atrial cardiomyocytes</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cell Physiol Biochem</sb:maintitle></sb:title><sb:volume-nr>28</sb:volume-nr></sb:series><sb:date>2011</sb:date></sb:issue><sb:pages><sb:first-page>613</sb:first-page><sb:last-page>624</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0050\"><ce:label>[10]</ce:label><sb:reference id=\"rf0050\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>A.S.</ce:given-name><ce:surname>Barth</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Merk</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Arnoldi</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Zwermann</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Kloos</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Gebauer</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Reprogramming of the human atrial transcriptome in permanent atrial fibrillation: expression of a ventricular-like genomic signature</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Circ Res</sb:maintitle></sb:title><sb:volume-nr>96</sb:volume-nr></sb:series><sb:date>2005</sb:date></sb:issue><sb:pages><sb:first-page>1022</sb:first-page><sb:last-page>1029</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0055\"><ce:label>[11]</ce:label><sb:reference id=\"rf0055\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Gierten</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Ficker</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Bloehs</ce:surname></sb:author><sb:author><ce:given-name>P.A.</ce:given-name><ce:surname>Schweizer</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Zitron</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Scholz</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>The human cardiac K2P3.1 (TASK-1) potassium leak channel is a molecular target for the class III antiarrhythmic drug amiodarone</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Naunyn Schmiedebergs Arch Pharmacol</sb:maintitle></sb:title><sb:volume-nr>381</sb:volume-nr></sb:series><sb:date>2010</sb:date></sb:issue><sb:pages><sb:first-page>261</sb:first-page><sb:last-page>270</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0060\"><ce:label>[12]</ce:label><sb:reference id=\"rf0060\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Harleton</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Besana</ce:surname></sb:author><sb:author><ce:given-name>G.M.</ce:given-name><ce:surname>Comas</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Danilo</ce:surname><ce:suffix>Jr.</ce:suffix></sb:author><sb:author><ce:given-name>T.S.</ce:given-name><ce:surname>Rosen</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Argenziano</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Ability to induce atrial fibrillation in the peri-operative period is associated with phosphorylation-dependent inhibition of TWIK protein-related acid-sensitive potassium channel 1 (TASK-1)</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J Biol Chem</sb:maintitle></sb:title><sb:volume-nr>288</sb:volume-nr></sb:series><sb:date>2013</sb:date></sb:issue><sb:pages><sb:first-page>2829</sb:first-page><sb:last-page>2838</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0065\"><ce:label>[13]</ce:label><sb:reference id=\"rf0065\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>M.S.</ce:given-name><ce:surname>Olesen</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Yuan</ce:surname></sb:author><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Liang</ce:surname></sb:author><sb:author><ce:given-name>A.G.</ce:given-name><ce:surname>Holst</ce:surname></sb:author><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Nielsen</ce:surname></sb:author><sb:author><ce:given-name>J.B.</ce:given-name><ce:surname>Nielsen</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>High prevalence of long QT syndrome-associated SCN5A variants in patients with early-onset lone atrial fibrillation</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Circ Cardiovasc Genet</sb:maintitle></sb:title><sb:volume-nr>5</sb:volume-nr></sb:series><sb:date>2012</sb:date></sb:issue><sb:pages><sb:first-page>450</sb:first-page><sb:last-page>459</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0070\"><ce:label>[14]</ce:label><sb:reference id=\"rf0070\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>S.A.</ce:given-name><ce:surname>Mann</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Otway</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Guo</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Soka</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Karlsdotter</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Trivedi</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Epistatic effects of potassium channel variation on cardiac repolarization and atrial fibrillation risk</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J Am Coll Cardiol</sb:maintitle></sb:title><sb:volume-nr>59</sb:volume-nr></sb:series><sb:date>2012</sb:date></sb:issue><sb:pages><sb:first-page>1017</sb:first-page><sb:last-page>1025</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0075\"><ce:label>[15]</ce:label><sb:reference id=\"rf0160\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>P.T.</ce:given-name><ce:surname>Ellinor</ce:surname></sb:author><sb:author><ce:given-name>K.L.</ce:given-name><ce:surname>Lunetta</ce:surname></sb:author><sb:author><ce:given-name>C.M.</ce:given-name><ce:surname>Albert</ce:surname></sb:author><sb:author><ce:given-name>N.L.</ce:given-name><ce:surname>Glazer</ce:surname></sb:author><sb:author><ce:given-name>M.D.</ce:given-name><ce:surname>Ritchie</ce:surname></sb:author><sb:author><ce:given-name>A.V.</ce:given-name><ce:surname>Smith</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Meta-analysis identifies six new susceptibility loci for atrial fibrillation</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nat Genet</sb:maintitle></sb:title><sb:volume-nr>44</sb:volume-nr></sb:series><sb:issue-nr>6</sb:issue-nr><sb:date>2012</sb:date></sb:issue><sb:pages><sb:first-page>670</sb:first-page><sb:last-page>675</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0080\"><ce:label>[16]</ce:label><sb:reference id=\"rf0080\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>D.T.</ce:given-name><ce:surname>Humphreys</ce:surname></sb:author><sb:author><ce:given-name>C.J.</ce:given-name><ce:surname>Hynes</ce:surname></sb:author><sb:author><ce:given-name>H.R.</ce:given-name><ce:surname>Patel</ce:surname></sb:author><sb:author><ce:given-name>G.H.</ce:given-name><ce:surname>Wei</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Cannon</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Fatkin</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Complexity of murine cardiomyocyte miRNA biogenesis, sequence variant expression and function</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>PLoS One</sb:maintitle></sb:title><sb:volume-nr>7</sb:volume-nr></sb:series><sb:date>2012</sb:date></sb:issue><sb:pages><sb:first-page>e30933</sb:first-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0085\"><ce:label>[17]</ce:label><sb:reference id=\"rf0085\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Krieger</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Joo</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Lee</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Lee</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Raman</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Thompson</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Improving physical realism, stereochemistry, and side-chain accuracy in homology modeling: four approaches that performed well in CASP8</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Proteins</sb:maintitle></sb:title><sb:volume-nr>77</sb:volume-nr></sb:series><sb:issue-nr>Suppl. 9</sb:issue-nr><sb:date>2009</sb:date></sb:issue><sb:pages><sb:first-page>114</sb:first-page><sb:last-page>122</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0090\"><ce:label>[18]</ce:label><sb:reference id=\"rf0090\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Courtemanche</ce:surname></sb:author><sb:author><ce:given-name>R.J.</ce:given-name><ce:surname>Ramirez</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Nattel</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Ionic mechanisms underlying human atrial action potential properties: insights from a mathematical model</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Am J Physiol</sb:maintitle></sb:title><sb:volume-nr>275</sb:volume-nr></sb:series><sb:date>1998</sb:date></sb:issue><sb:pages><sb:first-page>H301</sb:first-page><sb:last-page>H321</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0095\"><ce:label>[19]</ce:label><sb:reference id=\"rf0095\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Ramaekers</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Ector</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Demyttenaere</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Rubens</ce:surname></sb:author><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Van de Werf</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Association between cardiac autonomic function and coping style in healthy subjects</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Pacing Clin Electrophysiol</sb:maintitle></sb:title><sb:volume-nr>21</sb:volume-nr></sb:series><sb:date>1998</sb:date></sb:issue><sb:pages><sb:first-page>1546</sb:first-page><sb:last-page>1552</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0100\"><ce:label>[20]</ce:label><sb:reference id=\"rf0100\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Kozak</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cell</sb:maintitle></sb:title><sb:volume-nr>44</sb:volume-nr></sb:series><sb:date>1986</sb:date></sb:issue><sb:pages><sb:first-page>283</sb:first-page><sb:last-page>292</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0105\"><ce:label>[21]</ce:label><sb:reference id=\"rf0105\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Signori</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Bagni</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Papa</ce:surname></sb:author><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Primerano</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Rinaldi</ce:surname></sb:author><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Amaldi</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>A somatic mutation in the 5′UTR of BRCA1 gene in sporadic breast cancer causes down-modulation of translation efficiency</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Oncogene</sb:maintitle></sb:title><sb:volume-nr>20</sb:volume-nr></sb:series><sb:date>2001</sb:date></sb:issue><sb:pages><sb:first-page>4596</sb:first-page><sb:last-page>4600</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0110\"><ce:label>[22]</ce:label><sb:reference id=\"rf0110\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>A.N.</ce:given-name><ce:surname>Miller</ce:surname></sb:author><sb:author><ce:given-name>S.B.</ce:given-name><ce:surname>Long</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Crystal structure of the human two-pore domain potassium channel K2P1</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Science</sb:maintitle></sb:title><sb:volume-nr>335</sb:volume-nr></sb:series><sb:date>2012</sb:date></sb:issue><sb:pages><sb:first-page>432</sb:first-page><sb:last-page>436</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0115\"><ce:label>[23]</ce:label><sb:reference id=\"rf0115\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Duprat</ce:surname></sb:author><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Lesage</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Fink</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Reyes</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Heurteaux</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Lazdunski</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>TASK, a human background K<ce:hsp sp=\"0.25\"/>+<ce:hsp sp=\"0.25\"/>channel to sense external pH variations near physiological pH</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>EMBO J</sb:maintitle></sb:title><sb:volume-nr>16</sb:volume-nr></sb:series><sb:date>1997</sb:date></sb:issue><sb:pages><sb:first-page>5464</sb:first-page><sb:last-page>5471</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0120\"><ce:label>[24]</ce:label><sb:reference id=\"rf0120\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Ma</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Roman-Campos</ce:surname></sb:author><sb:author><ce:given-name>E.D.</ce:given-name><ce:surname>Austin</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Eyries</ce:surname></sb:author><sb:author><ce:given-name>K.S.</ce:given-name><ce:surname>Sampson</ce:surname></sb:author><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Soubrier</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>A novel channelopathy in pulmonary arterial hypertension</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>N Engl J Med</sb:maintitle></sb:title><sb:volume-nr>369</sb:volume-nr></sb:series><sb:date>2013</sb:date></sb:issue><sb:pages><sb:first-page>351</sb:first-page><sb:last-page>361</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0125\"><ce:label>[25]</ce:label><sb:reference id=\"rf0125\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Kozak</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Emerging links between initiation of translation and human diseases</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Mamm Genome</sb:maintitle></sb:title><sb:volume-nr>13</sb:volume-nr></sb:series><sb:date>2002</sb:date></sb:issue><sb:pages><sb:first-page>401</sb:first-page><sb:last-page>410</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0130\"><ce:label>[26]</ce:label><sb:reference id=\"rf0130\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Bakkers</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Zebrafish as a model to study cardiac development and human cardiac disease</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cardiovasc Res</sb:maintitle></sb:title><sb:volume-nr>91</sb:volume-nr></sb:series><sb:date>2011</sb:date></sb:issue><sb:pages><sb:first-page>279</sb:first-page><sb:last-page>288</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0135\"><ce:label>[27]</ce:label><sb:reference id=\"rf0135\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>M.J.</ce:given-name><ce:surname>Bamshad</ce:surname></sb:author><sb:author><ce:given-name>S.B.</ce:given-name><ce:surname>Ng</ce:surname></sb:author><sb:author><ce:given-name>A.W.</ce:given-name><ce:surname>Bigham</ce:surname></sb:author><sb:author><ce:given-name>H.K.</ce:given-name><ce:surname>Tabor</ce:surname></sb:author><sb:author><ce:given-name>M.J.</ce:given-name><ce:surname>Emond</ce:surname></sb:author><sb:author><ce:given-name>D.A.</ce:given-name><ce:surname>Nickerson</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Exome sequencing as a tool for Mendelian disease gene discovery</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nat Rev Genet</sb:maintitle></sb:title><sb:volume-nr>12</sb:volume-nr></sb:series><sb:date>2011</sb:date></sb:issue><sb:pages><sb:first-page>745</sb:first-page><sb:last-page>755</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0140\"><ce:label>[28]</ce:label><sb:reference id=\"rf0140\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>T.M.</ce:given-name><ce:surname>Olson</ce:surname></sb:author><sb:author><ce:given-name>A.E.</ce:given-name><ce:surname>Alekseev</ce:surname></sb:author><sb:author><ce:given-name>X.K.</ce:given-name><ce:surname>Liu</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Park</ce:surname></sb:author><sb:author><ce:given-name>L.V.</ce:given-name><ce:surname>Zingman</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Bienengraeber</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Hum Mol Genet</sb:maintitle></sb:title><sb:volume-nr>15</sb:volume-nr></sb:series><sb:date>2006</sb:date></sb:issue><sb:pages><sb:first-page>2185</sb:first-page><sb:last-page>2191</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0145\"><ce:label>[29]</ce:label><sb:reference id=\"rf0145\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Antzelevitch</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Burashnikov</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Atrial-selective sodium channel block as a novel strategy for the management of atrial fibrillation</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J Electrocardiol</sb:maintitle></sb:title><sb:volume-nr>42</sb:volume-nr></sb:series><sb:date>2009</sb:date></sb:issue><sb:pages><sb:first-page>543</sb:first-page><sb:last-page>548</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0150\"><ce:label>[30]</ce:label><sb:reference id=\"rf0150\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>M.F.</ce:given-name><ce:surname>Sheets</ce:surname></sb:author><sb:author><ce:given-name>D.A.</ce:given-name><ce:surname>Hanck</ce:surname></sb:author><sb:author><ce:given-name>H.A.</ce:given-name><ce:surname>Fozzard</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Nonlinear relation between Vmax and INa in canine cardiac Purkinje cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Circ Res</sb:maintitle></sb:title><sb:volume-nr>63</sb:volume-nr></sb:series><sb:date>1988</sb:date></sb:issue><sb:pages><sb:first-page>386</sb:first-page><sb:last-page>398</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bb0155\"><ce:label>[31]</ce:label><sb:reference id=\"rf0155\"><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Bettoni</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Zimmermann</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Autonomic tone variations before the onset of paroxysmal atrial fibrillation</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Circulation</sb:maintitle></sb:title><sb:volume-nr>105</sb:volume-nr></sb:series><sb:date>2002</sb:date></sb:issue><sb:pages><sb:first-page>2753</sb:first-page><sb:last-page>2759</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference></ce:bibliography-sec></ce:bibliography></tail></article></xocs:serial-item></xocs:doc></originalText></full-text-retrieval-response>',\n",
       " 'Calcium entry through voltage-dependent Ca(2+) channels (VDCCs) is required for pancreatic β-cell insulin secretion. The 2-pore-domain acid-sensitive potassium channel (TASK-1) regulates neuronal excitability and VDCC activation by hyperpolarizing the plasma membrane potential (Δψp); however, a role for pancreatic β-cell TASK-1 channels is unknown. Here we examined the influence of TASK-1 channel activity on the β-cell Δψp and insulin secretion during secretagogue stimulation. TASK-1 channels were found to be highly expressed in human and rodent islets and localized to the plasma membrane of β-cells. TASK-1-like currents of mouse and human β-cells were blocked by the potent TASK-1 channel inhibitor, A1899 (250nM). Although inhibition of TASK-1 currents did not influence the β-cell Δψp in the presence of low (2mM) glucose, A1899 significantly enhanced glucose-stimulated (14mM) Δψp depolarization of human and mouse β-cells. TASK-1 inhibition also resulted in greater secretagogue-stimulated Ca(2+) influx in both human and mouse islets. Moreover, conditional ablation of mouse β-cell TASK-1 channels reduced K2P currents, increased glucose-stimulated Δψp depolarization, and augmented secretagogue-stimulated Ca(2+) influx. The Δψp depolarization caused by TASK-1 inhibition resulted in a transient increase in glucose-stimulated mouse β-cell action potential (AP) firing frequency. However, secretagogue-stimulated β-cell AP duration eventually increased in the presence of A1899 as well as in β-cells without TASK-1, causing a decrease in AP firing frequency. Ablation or inhibition of mouse β-cell TASK-1 channels also significantly enhanced glucose-stimulated insulin secretion, which improved glucose tolerance. Conversely, TASK-1 ablation did not perturb β-cell Δψp, Ca(2+) influx, or insulin secretion under low-glucose conditions (2mM). These results reveal a glucose-dependent role for β-cell TASK-1 channels of limiting glucose-stimulated Δψp depolarization and insulin secretion, which modulates glucose homeostasis.',\n",
       " 'International Union of Pharmacology. LV. Nomenclature and molecular relationships of two-P potassium channels.',\n",
       " 'Endothelin (ET)-1 causes long-lasting vasoconstriction and vascular remodeling by interacting with specific G-protein-coupled receptors in pulmonary artery smooth muscle cells (PASMCs), and thus plays an important role in the pathophysiology of pulmonary arterial hypertension. The two-pore domain K(+) channel, TASK-1, controls the resting membrane potential in human PASMCs (hPASMCs), and renders these cells sensitive to a variety of vasoactive factors, as previously shown. ET-1 may exert its vasoconstrictive effects in part by targeting TASK-1. To clarify this, we analyzed the ET-1 signaling pathway related to TASK-1 in primary hPASMCs. We employed the whole-cell patch-clamp technique combined with TASK-1 small interfering RNA (siRNA) in hPASMC and the isolated, perfused, and ventilated mouse lung model. We found that ET-1 depolarized primary hPASMCs by phosphorylating TASK-1 at clinically relevant concentrations. The ET sensitivity of TASK-1 required ET(A) receptors, phospholipase C, phosphatidylinositol 4,5-biphosphate, diacylglycerol, and protein kinase C in primary hPASMCs. The ET-1 effect on membrane potential and TASK-1 was abrogated using TASK-1 siRNA. This is the first time that the background K(+) channel, TASK-1, has been identified in the ET-1-mediated depolarization in native hPASMC, and might represent a novel pathologic mechanism related to pulmonary arterial hypertension.',\n",
       " 'Mapping of human potassium channel genes TREK-1 (KCNK2) and TASK (KCNK3) to chromosomes 1q41 and 2p23.',\n",
       " '<full-text-retrieval-response xmlns=\"http://www.elsevier.com/xml/svapi/article/dtd\" xmlns:bk=\"http://www.elsevier.com/xml/bk/dtd\" xmlns:cals=\"http://www.elsevier.com/xml/common/cals/dtd\" xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns:ja=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" xmlns:tb=\"http://www.elsevier.com/xml/common/table/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:xocs=\"http://www.elsevier.com/xml/xocs/dtd\" xmlns:dc=\"http://purl.org/dc/elements/1.1/\" xmlns:dcterms=\"http://purl.org/dc/terms/\" xmlns:prism=\"http://prismstandard.org/namespaces/basic/2.0/\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\"><coredata><prism:url>https://api.elsevier.com/content/article/pii/S1097276504001832</prism:url><dc:identifier>doi:10.1016/S1097-2765(04)00183-2</dc:identifier><eid>1-s2.0-S1097276504001832</eid><prism:doi>10.1016/S1097-2765(04)00183-2</prism:doi><pii>S1097-2765(04)00183-2</pii><dc:title>Mutual Functional Destruction of HIV-1 Vpu and Host TASK-1 Channel </dc:title><prism:publicationName>Molecular Cell</prism:publicationName><prism:aggregationType>Journal</prism:aggregationType><pubType>\\n               Article\\n            </pubType><prism:issn>10972765</prism:issn><prism:volume>14</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:startingPage>259</prism:startingPage><prism:endingPage>267</prism:endingPage><prism:pageRange>259-267</prism:pageRange><prism:number>2</prism:number><dc:format>text/xml</dc:format><prism:coverDate>2004-04-23</prism:coverDate><prism:coverDisplayDate>23 April 2004</prism:coverDisplayDate><prism:copyright>Copyright © 2004 Cell Press.  All rights reserved.</prism:copyright><prism:publisher>Cell Press.</prism:publisher><dc:creator>Hsu, Kate</dc:creator><dc:creator>Seharaseyon, Jegatheesan</dc:creator><dc:creator>Dong, Peihong</dc:creator><dc:creator>Bour, Stephan</dc:creator><dc:creator>Marbán, Eduardo</dc:creator><dc:description>\\n               Abstract\\n               \\n                  Sequence analysis predicted significant structural homology between the HIV-1 accessory protein Vpu and the N-terminal region of TASK-1, a mammalian background K+ channel. If the homology resulted from molecular piracy during HIV-1 evolution, these two proteins may have important functional interactions. Here we demonstrate that TASK and Vpu physically interact in cultured cells and in AIDS lymphoid tissues. The functional consequences were potentially destructive for both components: Vpu abolished TASK-1 current, while overexpressing TASK led to a marked impairment of Vpu\\'s ability to enhance viral particle release. Further, the first 40 amino acids of TASK-1 (part of the homology to Vpu) were capable of enhancing HIV-1 particle release. This virus-host interaction may influence HIV-1/AIDS progression, as well as electrical signaling in infected host tissues.\\n               \\n            </dc:description><openaccess>1</openaccess><openaccessArticle>true</openaccessArticle><openaccessType>Full</openaccessType><openArchiveArticle>true</openArchiveArticle><openaccessSponsorName/><openaccessSponsorType>ElsevierBranded</openaccessSponsorType><openaccessUserLicense>http://www.elsevier.com/open-access/userlicense/1.0/</openaccessUserLicense><link href=\"https://api.elsevier.com/content/article/pii/S1097276504001832\" rel=\"self\"/><link href=\"https://www.sciencedirect.com/science/article/pii/S1097276504001832\" rel=\"scidir\"/></coredata><objects><object ref=\"si4\" category=\"thumbnail\" type=\"ALTIMG\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"11\" height=\"14\" size=\"135\">https://api.elsevier.com/content/object/eid/1-s2.0-S1097276504001832-si4.gif?httpAccept=%2A%2F%2A</object><object ref=\"si3\" category=\"thumbnail\" type=\"ALTIMG\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"11\" height=\"9\" size=\"122\">https://api.elsevier.com/content/object/eid/1-s2.0-S1097276504001832-si3.gif?httpAccept=%2A%2F%2A</object><object ref=\"si2\" category=\"thumbnail\" type=\"ALTIMG\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"11\" height=\"14\" size=\"135\">https://api.elsevier.com/content/object/eid/1-s2.0-S1097276504001832-si2.gif?httpAccept=%2A%2F%2A</object><object ref=\"si1\" category=\"thumbnail\" type=\"ALTIMG\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"11\" height=\"9\" size=\"122\">https://api.elsevier.com/content/object/eid/1-s2.0-S1097276504001832-si1.gif?httpAccept=%2A%2F%2A</object><object ref=\"gr1\" category=\"standard\" type=\"IMAGE-DOWNSAMPLED\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"715\" height=\"472\" size=\"86230\">https://api.elsevier.com/content/object/eid/1-s2.0-S1097276504001832-gr1.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr1\" category=\"thumbnail\" type=\"IMAGE-THUMBNAIL\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"125\" height=\"83\" size=\"4116\">https://api.elsevier.com/content/object/eid/1-s2.0-S1097276504001832-gr1.sml?httpAccept=%2A%2F%2A</object><object ref=\"gr1\" category=\"high\" type=\"IMAGE-HIGH-RES\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"1900\" height=\"1255\" size=\"444268\">https://api.elsevier.com/content/object/eid/1-s2.0-S1097276504001832-gr1_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr2\" category=\"standard\" type=\"IMAGE-DOWNSAMPLED\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"339\" height=\"550\" size=\"30419\">https://api.elsevier.com/content/object/eid/1-s2.0-S1097276504001832-gr2.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr2\" category=\"thumbnail\" type=\"IMAGE-THUMBNAIL\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"57\" height=\"92\" size=\"1368\">https://api.elsevier.com/content/object/eid/1-s2.0-S1097276504001832-gr2.sml?httpAccept=%2A%2F%2A</object><object ref=\"gr2\" category=\"high\" type=\"IMAGE-HIGH-RES\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"1500\" height=\"2434\" size=\"314461\">https://api.elsevier.com/content/object/eid/1-s2.0-S1097276504001832-gr2_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr6\" category=\"standard\" type=\"IMAGE-DOWNSAMPLED\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"452\" height=\"316\" size=\"21387\">https://api.elsevier.com/content/object/eid/1-s2.0-S1097276504001832-gr6.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr6\" category=\"thumbnail\" type=\"IMAGE-THUMBNAIL\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"125\" height=\"87\" size=\"2153\">https://api.elsevier.com/content/object/eid/1-s2.0-S1097276504001832-gr6.sml?httpAccept=%2A%2F%2A</object><object ref=\"gr6\" category=\"high\" type=\"IMAGE-HIGH-RES\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"2000\" height=\"1398\" size=\"207401\">https://api.elsevier.com/content/object/eid/1-s2.0-S1097276504001832-gr6_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr7\" category=\"standard\" type=\"IMAGE-DOWNSAMPLED\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"339\" height=\"250\" size=\"20049\">https://api.elsevier.com/content/object/eid/1-s2.0-S1097276504001832-gr7.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr7\" category=\"thumbnail\" type=\"IMAGE-THUMBNAIL\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"125\" height=\"92\" size=\"2137\">https://api.elsevier.com/content/object/eid/1-s2.0-S1097276504001832-gr7.sml?httpAccept=%2A%2F%2A</object><object ref=\"gr7\" category=\"high\" type=\"IMAGE-HIGH-RES\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"3000\" height=\"2209\" size=\"364672\">https://api.elsevier.com/content/object/eid/1-s2.0-S1097276504001832-gr7_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref=\"mmc1\" category=\"standard\" type=\"APPLICATION\" multimediatype=\"Acrobat PDF file\" mimetype=\"application/pdf\" size=\"53541\">https://api.elsevier.com/content/object/eid/1-s2.0-S1097276504001832-mmc1.pdf?httpAccept=%2A%2F%2A</object><object ref=\"gr3\" category=\"standard\" type=\"IMAGE-DOWNSAMPLED\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"452\" height=\"180\" size=\"10356\">https://api.elsevier.com/content/object/eid/1-s2.0-S1097276504001832-gr3.gif?httpAccept=%2A%2F%2A</object><object ref=\"gr3\" category=\"thumbnail\" type=\"IMAGE-THUMBNAIL\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"219\" height=\"87\" size=\"3503\">https://api.elsevier.com/content/object/eid/1-s2.0-S1097276504001832-gr3.sml?httpAccept=%2A%2F%2A</object><object ref=\"gr3\" category=\"high\" type=\"IMAGE-HIGH-RES\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"4000\" height=\"1592\" size=\"81271\">https://api.elsevier.com/content/object/eid/1-s2.0-S1097276504001832-gr3_lrg.gif?httpAccept=%2A%2F%2A</object><object ref=\"gr4\" category=\"standard\" type=\"IMAGE-DOWNSAMPLED\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"452\" height=\"188\" size=\"8479\">https://api.elsevier.com/content/object/eid/1-s2.0-S1097276504001832-gr4.gif?httpAccept=%2A%2F%2A</object><object ref=\"gr4\" category=\"thumbnail\" type=\"IMAGE-THUMBNAIL\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"219\" height=\"91\" size=\"2825\">https://api.elsevier.com/content/object/eid/1-s2.0-S1097276504001832-gr4.sml?httpAccept=%2A%2F%2A</object><object ref=\"gr4\" category=\"high\" type=\"IMAGE-HIGH-RES\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"4000\" height=\"1667\" size=\"69746\">https://api.elsevier.com/content/object/eid/1-s2.0-S1097276504001832-gr4_lrg.gif?httpAccept=%2A%2F%2A</object><object ref=\"gr5\" category=\"standard\" type=\"IMAGE-DOWNSAMPLED\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"339\" height=\"286\" size=\"9910\">https://api.elsevier.com/content/object/eid/1-s2.0-S1097276504001832-gr5.gif?httpAccept=%2A%2F%2A</object><object ref=\"gr5\" category=\"thumbnail\" type=\"IMAGE-THUMBNAIL\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"194\" height=\"164\" size=\"4661\">https://api.elsevier.com/content/object/eid/1-s2.0-S1097276504001832-gr5.sml?httpAccept=%2A%2F%2A</object><object ref=\"gr5\" category=\"high\" type=\"IMAGE-HIGH-RES\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"3000\" height=\"2533\" size=\"74191\">https://api.elsevier.com/content/object/eid/1-s2.0-S1097276504001832-gr5_lrg.gif?httpAccept=%2A%2F%2A</object></objects><scopus-id>1942502838</scopus-id><scopus-eid>2-s2.0-1942502838</scopus-eid><pubmed-id>15099524</pubmed-id><link href=\"https://api.elsevier.com/content/abstract/scopus_id/1942502838\" rel=\"abstract\"/><originalText><xocs:doc xmlns:xoe=\"http://www.elsevier.com/xml/xoe/dtd\" xsi:schemaLocation=\"http://www.elsevier.com/xml/xocs/dtd http://null/schema/dtds/document/fulltext/xcr/xocs-article.xsd\">\\n   <xocs:meta>\\n      <xocs:content-family>serial</xocs:content-family>\\n      <xocs:content-type>JL</xocs:content-type>\\n      <xocs:cid>272198</xocs:cid>\\n      <xocs:ssids>\\n         <xocs:ssid type=\"alllist\">291210</xocs:ssid>\\n         <xocs:ssid type=\"subj\">291847</xocs:ssid>\\n         <xocs:ssid type=\"subj\">291852</xocs:ssid>\\n         <xocs:ssid type=\"subj\">291857</xocs:ssid>\\n         <xocs:ssid type=\"subj\">291859</xocs:ssid>\\n         <xocs:ssid type=\"content\">31</xocs:ssid>\\n         <xocs:ssid type=\"oa\">80</xocs:ssid>\\n      </xocs:ssids>\\n      <xocs:srctitle>Molecular Cell</xocs:srctitle>\\n      <xocs:normalized-srctitle>MOLECULARCELL</xocs:normalized-srctitle>\\n      <xocs:orig-load-date yyyymmdd=\"20040422\">2004-04-22</xocs:orig-load-date>\\n      <xocs:available-online-date yyyymmdd=\"20040422\">2004-04-22</xocs:available-online-date>\\n      <xocs:ew-transaction-id>2010-11-14T04:19:40</xocs:ew-transaction-id>\\n      <xocs:eid>1-s2.0-S1097276504001832</xocs:eid>\\n      <xocs:pii-formatted>S1097-2765(04)00183-2</xocs:pii-formatted>\\n      <xocs:pii-unformatted>S1097276504001832</xocs:pii-unformatted>\\n      <xocs:doi>10.1016/S1097-2765(04)00183-2</xocs:doi>\\n      <xocs:item-stage>S300</xocs:item-stage>\\n      <xocs:item-version-number>S300.3</xocs:item-version-number>\\n      <xocs:item-weight>FULL-TEXT</xocs:item-weight>\\n      <xocs:hub-eid>1-s2.0-S1097276500X00810</xocs:hub-eid>\\n      <xocs:timestamp yyyymmdd=\"20150515\">2015-05-15T05:15:48.763397-04:00</xocs:timestamp>\\n      <xocs:dco>0</xocs:dco>\\n      <xocs:tomb>0</xocs:tomb>\\n      <xocs:date-search-begin>20040423</xocs:date-search-begin>\\n      <xocs:year-nav>2004</xocs:year-nav>\\n      <xocs:indexeddate epoch=\"1082592000\">2004-04-22T00:00:00Z</xocs:indexeddate>\\n      <xocs:articleinfo>articleinfo crossmark dco dateupdated tomb dateloaded datesearch indexeddate issuelist volumelist yearnav articletitlenorm authfirstinitialnorm authfirstsurnamenorm cid cids contenttype copyright dateloadedtxt docsubtype doctype doi eid ewtransactionid hubeid issfirst issn issnnorm itemstage itemtransactionid itemweight oauserlicense openaccess openarchive pg pgfirst pglast pii piinorm pubdatestart pubdatetxt pubyr sortorder srctitle srctitlenorm srctype subheadings volfirst volissue webpdf webpdfpagecount figure e-component body acknowledge affil appendices articletitle auth authfirstini authfull authlast footnotes misctext primabst pubtype ref alllist content oa subj ssids</xocs:articleinfo>\\n      <xocs:issns>\\n         <xocs:issn-primary-formatted>1097-2765</xocs:issn-primary-formatted>\\n         <xocs:issn-primary-unformatted>10972765</xocs:issn-primary-unformatted>\\n      </xocs:issns>\\n      <xocs:crossmark is-crossmark=\"0\"/>\\n      <xocs:vol-first>14</xocs:vol-first>\\n      <xocs:volume-list>\\n         <xocs:volume>14</xocs:volume>\\n      </xocs:volume-list>\\n      <xocs:iss-first>2</xocs:iss-first>\\n      <xocs:issue-list>\\n         <xocs:issue>2</xocs:issue>\\n      </xocs:issue-list>\\n      <xocs:vol-iss-suppl-text>Volume 14, Issue 2</xocs:vol-iss-suppl-text>\\n      <xocs:sort-order>13</xocs:sort-order>\\n      <xocs:first-fp>259</xocs:first-fp>\\n      <xocs:last-lp>267</xocs:last-lp>\\n      <xocs:pages>\\n         <xocs:first-page>259</xocs:first-page>\\n         <xocs:last-page>267</xocs:last-page>\\n      </xocs:pages>\\n      <xocs:cover-date-orig>\\n         <xocs:start-date>20040423</xocs:start-date>\\n      </xocs:cover-date-orig>\\n      <xocs:cover-date-text>23 April 2004</xocs:cover-date-text>\\n      <xocs:cover-date-start>2004-04-23</xocs:cover-date-start>\\n      <xocs:cover-date-year>2004</xocs:cover-date-year>\\n      <xocs:document-type>converted-article</xocs:document-type>\\n      <xocs:document-subtype>fla</xocs:document-subtype>\\n      <xocs:copyright-line>Copyright © 2004 Cell Press.  All rights reserved.</xocs:copyright-line>\\n      <xocs:normalized-article-title>MUTUALFUNCTIONALDESTRUCTIONHIV1VPUHOSTTASK1CHANNEL</xocs:normalized-article-title>\\n      <xocs:normalized-first-auth-surname>HSU</xocs:normalized-first-auth-surname>\\n      <xocs:normalized-first-auth-initial>K</xocs:normalized-first-auth-initial>\\n      <xocs:item-toc>\\n         <xocs:item-toc-entry ref-elem=\"ce:sections\">\\n            <xocs:item-toc-section-title>Introduction</xocs:item-toc-section-title>\\n         </xocs:item-toc-entry>\\n         <xocs:item-toc-entry ref-elem=\"ce:sections\">\\n            <xocs:item-toc-section-title>Results</xocs:item-toc-section-title>\\n            <xocs:item-toc-entry ref-elem=\"ce:sections\">\\n               <xocs:item-toc-section-title>Proposal for Molecular Piracy of Cellular TASK-1 Channels</xocs:item-toc-section-title>\\n            </xocs:item-toc-entry>\\n            <xocs:item-toc-entry ref-elem=\"ce:sections\">\\n               <xocs:item-toc-section-title>TASK-Vpu Protein-Protein Interaction</xocs:item-toc-section-title>\\n            </xocs:item-toc-entry>\\n            <xocs:item-toc-entry ref-elem=\"ce:sections\">\\n               <xocs:item-toc-section-title>Suppression of TASK-1 Current by Vpu Coexpression</xocs:item-toc-section-title>\\n            </xocs:item-toc-entry>\\n            <xocs:item-toc-entry ref-elem=\"ce:sections\">\\n               <xocs:item-toc-section-title>Inhibition of Vpu-Mediated Virus Release by TASK</xocs:item-toc-section-title>\\n            </xocs:item-toc-entry>\\n            <xocs:item-toc-entry ref-elem=\"ce:sections\">\\n               <xocs:item-toc-section-title>Vpu as a Mimic of the First Transmembrane Segment of TASK</xocs:item-toc-section-title>\\n            </xocs:item-toc-entry>\\n            <xocs:item-toc-entry ref-elem=\"ce:sections\">\\n               <xocs:item-toc-section-title>TASK Degradation during HIV-1 Infection</xocs:item-toc-section-title>\\n            </xocs:item-toc-entry>\\n            <xocs:item-toc-entry ref-elem=\"ce:sections\">\\n               <xocs:item-toc-section-title>Ttm1 as Functionally Equivalent to Vpu in HIV-1 Release</xocs:item-toc-section-title>\\n            </xocs:item-toc-entry>\\n         </xocs:item-toc-entry>\\n         <xocs:item-toc-entry ref-elem=\"ce:sections\">\\n            <xocs:item-toc-section-title>Discussion</xocs:item-toc-section-title>\\n         </xocs:item-toc-entry>\\n         <xocs:item-toc-entry ref-elem=\"ce:sections\">\\n            <xocs:item-toc-section-title>Experimental Procedures</xocs:item-toc-section-title>\\n            <xocs:item-toc-entry ref-elem=\"ce:sections\">\\n               <xocs:item-toc-section-title>Plasmids</xocs:item-toc-section-title>\\n            </xocs:item-toc-entry>\\n            <xocs:item-toc-entry ref-elem=\"ce:sections\">\\n               <xocs:item-toc-section-title>Antibodies</xocs:item-toc-section-title>\\n            </xocs:item-toc-entry>\\n            <xocs:item-toc-entry ref-elem=\"ce:sections\">\\n               <xocs:item-toc-section-title>Cells, Specimens, and Infection</xocs:item-toc-section-title>\\n            </xocs:item-toc-entry>\\n            <xocs:item-toc-entry ref-elem=\"ce:sections\">\\n               <xocs:item-toc-section-title>Immunohistochemistry and Confocal Microscopy</xocs:item-toc-section-title>\\n            </xocs:item-toc-entry>\\n            <xocs:item-toc-entry ref-elem=\"ce:sections\">\\n               <xocs:item-toc-section-title>Coimmunoprecipitation and Western Blot</xocs:item-toc-section-title>\\n            </xocs:item-toc-entry>\\n            <xocs:item-toc-entry ref-elem=\"ce:sections\">\\n               <xocs:item-toc-section-title>Electrophysiology</xocs:item-toc-section-title>\\n            </xocs:item-toc-entry>\\n            <xocs:item-toc-entry ref-elem=\"ce:sections\">\\n               <xocs:item-toc-section-title>Virus Release Assay</xocs:item-toc-section-title>\\n            </xocs:item-toc-entry>\\n         </xocs:item-toc-entry>\\n         <xocs:item-toc-entry ref-elem=\"ce:acknowledgment\">\\n            <xocs:item-toc-section-title>Acknowledgements</xocs:item-toc-section-title>\\n         </xocs:item-toc-entry>\\n         <xocs:item-toc-entry ref-elem=\"ce:appendices\">\\n            <xocs:item-toc-section-title>Supplementary Material</xocs:item-toc-section-title>\\n         </xocs:item-toc-entry>\\n         <xocs:item-toc-entry ref-elem=\"ce:bibliography\">\\n            <xocs:item-toc-section-title>References</xocs:item-toc-section-title>\\n         </xocs:item-toc-entry>\\n      </xocs:item-toc>\\n      <xocs:references>\\n         <xocs:ref-info refid=\"BIB1\">\\n            <xocs:ref-normalized-surname>ABBOTT</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1998</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>357</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>398</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>G</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB2\">\\n            <xocs:ref-normalized-surname>ABBOTT</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1999</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>175</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>187</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>G</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB3\">\\n            <xocs:ref-normalized-surname>AKARI</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>2001</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>1299</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>1311</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>H</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB4\">\\n            <xocs:ref-normalized-surname>BABILA</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1994</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>615</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>626</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>T</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB5\">\\n            <xocs:ref-normalized-surname>BACKX</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1993</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>890</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>900</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>P</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB6\">\\n            <xocs:ref-normalized-surname>BAGASRA</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1996</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>573</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>585</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>O</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB7\">\\n            <xocs:ref-normalized-surname>BOUR</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>2003</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>1029</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>1039</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>S</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB8\">\\n            <xocs:ref-normalized-surname>BOUR</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1991</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>6387</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>6396</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>S</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB9\">\\n            <xocs:ref-normalized-surname>BOUR</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1999</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>33800</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>33806</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>S</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB10\">\\n            <xocs:ref-normalized-surname>BOUR</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>2001</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>15920</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>15928</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>S</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB11\">\\n            <xocs:ref-normalized-surname>BUONOCORE</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1990</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>625</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>628</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>L</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB12\">\\n            <xocs:ref-normalized-surname>COADY</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1998</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>39</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>49</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB13\">\\n            <xocs:ref-normalized-surname>CZIRJAK</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>2002</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>5426</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>5432</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>G</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB14\">\\n            <xocs:ref-normalized-surname>DEUTSCH</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>2002</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>19</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>46</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>C</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB15\">\\n            <xocs:ref-normalized-surname>DUPRAT</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1997</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>5464</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>5471</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>F</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB16\">\\n            <xocs:ref-normalized-surname>FOLCO</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1997</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>26505</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>26510</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>E</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB17\">\\n            <xocs:ref-normalized-surname>GONZALEZ</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1998</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>13710</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>13719</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB18\">\\n            <xocs:ref-normalized-surname>GREENE</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>2002</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>673</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>680</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>W</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB19\">\\n            <xocs:ref-normalized-surname>HOPPE</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1999</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>964</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>972</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>U</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB20\">\\n            <xocs:ref-normalized-surname>JOHNS</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1997</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>31598</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>31603</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>D</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB21\">\\n            <xocs:ref-normalized-surname>KIM</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1998</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>513</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>518</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>D</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB22\">\\n            <xocs:ref-normalized-surname>KIM</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1999</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>H1669</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>H1678</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>Y</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB23\">\\n            <xocs:ref-normalized-surname>KLIMKAIT</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1990</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>621</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>629</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>T</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB24\">\\n            <xocs:ref-normalized-surname>LAKOS</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1990</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>41</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>46</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>Z</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB25\">\\n            <xocs:ref-normalized-surname>LAMB</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1997</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>1</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>11</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>R</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB26\">\\n            <xocs:ref-normalized-surname>LELKES</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1979</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>656</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>662</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>P</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB27\">\\n            <xocs:ref-normalized-surname>LEONOUDAKIS</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1998</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>868</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>877</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>D</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB28\">\\n            <xocs:ref-normalized-surname>LONDON</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1998</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>2926</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>2931</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>B</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB29\">\\n            <xocs:ref-normalized-surname>MALDARELLI</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1993</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>5056</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>5061</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>F</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB30\">\\n            <xocs:ref-normalized-surname>MARGOTTIN</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1998</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>565</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>574</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>F</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB31\">\\n            <xocs:ref-normalized-surname>MARIN</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>2003</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>1398</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>1403</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB32\">\\n            <xocs:ref-normalized-surname>MCDONALD</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1997</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>289</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>292</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>T</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB33\">\\n            <xocs:ref-normalized-surname>OTTSCHYTSCH</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>2002</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>7986</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>7991</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>N</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB34\">\\n            <xocs:ref-normalized-surname>PAUL</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1998</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>1270</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>1279</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB35\">\\n            <xocs:ref-normalized-surname>PIERSON</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>2002</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>8518</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>8531</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>T</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB36\">\\n            <xocs:ref-normalized-surname>SCHUBERT</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1996</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>12</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>18</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>U</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB37\">\\n            <xocs:ref-normalized-surname>SESTI</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>2000</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>1369</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>1378</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>F</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB38\">\\n            <xocs:ref-normalized-surname>SHEEHY</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>2003</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>1404</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>1407</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>A</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB39\">\\n            <xocs:ref-normalized-surname>SHIMBO</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1995</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>1819</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>1829</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>K</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB40\">\\n            <xocs:ref-normalized-surname>SINKOVICS</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1998</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>349</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>390</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB41\">\\n            <xocs:ref-normalized-surname>STOPAK</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>2003</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>591</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>601</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>K</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB42\">\\n            <xocs:ref-normalized-surname>STREBEL</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1988</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>1221</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>1223</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>K</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB43\">\\n            <xocs:ref-normalized-surname>STREBEL</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1989</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>3784</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>3791</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>K</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB44\">\\n            <xocs:ref-normalized-surname>TALLEY</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>2001</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>7491</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>7505</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>E</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB45\">\\n            <xocs:ref-normalized-surname>VINK</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1999</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>342</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>349</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>C</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB46\">\\n            <xocs:ref-normalized-surname>WILLEY</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1992</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>7193</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>7200</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>R</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB47\">\\n            <xocs:ref-normalized-surname>WINSTON</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>2001</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>1979</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>1984</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n         <xocs:ref-info refid=\"BIB48\">\\n            <xocs:ref-normalized-surname>WRAY</xocs:ref-normalized-surname>\\n            <xocs:ref-pub-year>1995</xocs:ref-pub-year>\\n            <xocs:ref-first-fp>35</xocs:ref-first-fp>\\n            <xocs:ref-last-lp>43</xocs:ref-last-lp>\\n            <xocs:ref-normalized-initial>V</xocs:ref-normalized-initial>\\n         </xocs:ref-info>\\n      </xocs:references>\\n      <xocs:refkeys>\\n         <xocs:refkey3>HSUX2004X259</xocs:refkey3>\\n         <xocs:refkey4lp>HSUX2004X259X267</xocs:refkey4lp>\\n         <xocs:refkey4ai>HSUX2004X259XK</xocs:refkey4ai>\\n         <xocs:refkey5>HSUX2004X259X267XK</xocs:refkey5>\\n      </xocs:refkeys>\\n      <xocs:open-access>\\n         <xocs:oa-access-effective-date>2013-07-17T11:43:29Z</xocs:oa-access-effective-date>\\n         <xocs:oa-access-inherited-from winid=\"http://vtw.elsevier.com/content/oaw/GEN_1995_P1Y_ESBranded\" wintype=\"OpenArchive\">OA-Window</xocs:oa-access-inherited-from>\\n         <xocs:oa-article-status is-open-access=\"1\" is-open-archive=\"1\">Full</xocs:oa-article-status>\\n         <xocs:oa-sponsor>\\n            <xocs:oa-sponsor-type>ElsevierBranded</xocs:oa-sponsor-type>\\n         </xocs:oa-sponsor>\\n         <xocs:oa-user-license>http://www.elsevier.com/open-access/userlicense/1.0/</xocs:oa-user-license>\\n      </xocs:open-access>\\n      <xocs:attachment-metadata-doc>\\n         <xocs:attachment-set-type>item</xocs:attachment-set-type>\\n         <xocs:pii-formatted>S1097-2765(04)00183-2</xocs:pii-formatted>\\n         <xocs:pii-unformatted>S1097276504001832</xocs:pii-unformatted>\\n         <xocs:eid>1-s2.0-S1097276504001832</xocs:eid>\\n         <xocs:doi>10.1016/S1097-2765(04)00183-2</xocs:doi>\\n         <xocs:cid>272198</xocs:cid>\\n         <xocs:timestamp>2010-12-23T05:09:15.359905-05:00</xocs:timestamp>\\n         <xocs:cover-date-start>2004-04-23</xocs:cover-date-start>\\n         <xocs:attachments>\\n            <xocs:web-pdf>\\n               <xocs:attachment-eid>1-s2.0-S1097276504001832-main.pdf</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S1097276504001832/MAIN/application/pdf/f81a611b1625af553aec881b7c9dff0f/main.pdf</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S1097276504001832/MAIN/application/pdf/f81a611b1625af553aec881b7c9dff0f/main.pdf</xocs:ucs-locator>\\n               <xocs:filename>main.pdf</xocs:filename>\\n               <xocs:extension>pdf</xocs:extension>\\n               <xocs:pdf-optimized>true</xocs:pdf-optimized>\\n               <xocs:filesize>337590</xocs:filesize>\\n               <xocs:web-pdf-purpose>MAIN</xocs:web-pdf-purpose>\\n               <xocs:web-pdf-page-count>9</xocs:web-pdf-page-count>\\n               <xocs:web-pdf-images>\\n                  <xocs:web-pdf-image>\\n                     <xocs:attachment-eid>1-s2.0-S1097276504001832-main_1.png</xocs:attachment-eid>\\n                     <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S1097276504001832/PREVIEW/image/png/c925898adbe2557aeef8f9df7f9008e8/main_1.png</xocs:ucs-locator>\\n                     <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S1097276504001832/PREVIEW/image/png/c925898adbe2557aeef8f9df7f9008e8/main_1.png</xocs:ucs-locator>\\n                     <xocs:filename>main_1.png</xocs:filename>\\n                     <xocs:extension>png</xocs:extension>\\n                     <xocs:filesize>93887</xocs:filesize>\\n                     <xocs:pixel-height>849</xocs:pixel-height>\\n                     <xocs:pixel-width>656</xocs:pixel-width>\\n                     <xocs:attachment-type>IMAGE-WEB-PDF</xocs:attachment-type>\\n                     <xocs:pdf-page-num>1</xocs:pdf-page-num>\\n                  </xocs:web-pdf-image>\\n               </xocs:web-pdf-images>\\n            </xocs:web-pdf>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S1097276504001832-si4.gif</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S1097276504001832/STRIPIN/image/gif/2e063092e2c306e19b51b0687d62f4be/si4.gif</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S1097276504001832/STRIPIN/image/gif/2e063092e2c306e19b51b0687d62f4be/si4.gif</xocs:ucs-locator>\\n               <xocs:file-basename>si4</xocs:file-basename>\\n               <xocs:filename>si4.gif</xocs:filename>\\n               <xocs:extension>gif</xocs:extension>\\n               <xocs:filesize>135</xocs:filesize>\\n               <xocs:pixel-height>14</xocs:pixel-height>\\n               <xocs:pixel-width>11</xocs:pixel-width>\\n               <xocs:attachment-type>ALTIMG</xocs:attachment-type>\\n            </xocs:attachment>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S1097276504001832-si3.gif</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S1097276504001832/STRIPIN/image/gif/826e5dbf03f594a97dfc2b49634b3840/si3.gif</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S1097276504001832/STRIPIN/image/gif/826e5dbf03f594a97dfc2b49634b3840/si3.gif</xocs:ucs-locator>\\n               <xocs:file-basename>si3</xocs:file-basename>\\n               <xocs:filename>si3.gif</xocs:filename>\\n               <xocs:extension>gif</xocs:extension>\\n               <xocs:filesize>122</xocs:filesize>\\n               <xocs:pixel-height>9</xocs:pixel-height>\\n               <xocs:pixel-width>11</xocs:pixel-width>\\n               <xocs:attachment-type>ALTIMG</xocs:attachment-type>\\n            </xocs:attachment>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S1097276504001832-si2.gif</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S1097276504001832/STRIPIN/image/gif/2e063092e2c306e19b51b0687d62f4be/si4.gif</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S1097276504001832/STRIPIN/image/gif/2e063092e2c306e19b51b0687d62f4be/si4.gif</xocs:ucs-locator>\\n               <xocs:file-basename>si2</xocs:file-basename>\\n               <xocs:filename>si2.gif</xocs:filename>\\n               <xocs:extension>gif</xocs:extension>\\n               <xocs:filesize>135</xocs:filesize>\\n               <xocs:pixel-height>14</xocs:pixel-height>\\n               <xocs:pixel-width>11</xocs:pixel-width>\\n               <xocs:attachment-type>ALTIMG</xocs:attachment-type>\\n            </xocs:attachment>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S1097276504001832-si1.gif</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S1097276504001832/STRIPIN/image/gif/826e5dbf03f594a97dfc2b49634b3840/si3.gif</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S1097276504001832/STRIPIN/image/gif/826e5dbf03f594a97dfc2b49634b3840/si3.gif</xocs:ucs-locator>\\n               <xocs:file-basename>si1</xocs:file-basename>\\n               <xocs:filename>si1.gif</xocs:filename>\\n               <xocs:extension>gif</xocs:extension>\\n               <xocs:filesize>122</xocs:filesize>\\n               <xocs:pixel-height>9</xocs:pixel-height>\\n               <xocs:pixel-width>11</xocs:pixel-width>\\n               <xocs:attachment-type>ALTIMG</xocs:attachment-type>\\n            </xocs:attachment>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S1097276504001832-gr1.jpg</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S1097276504001832/gr1/DOWNSAMPLED/image/jpeg/3dcdd349a8bc547b92c3c7788aa30c4f/gr1.jpg</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S1097276504001832/gr1/DOWNSAMPLED/image/jpeg/3dcdd349a8bc547b92c3c7788aa30c4f/gr1.jpg</xocs:ucs-locator>\\n               <xocs:file-basename>gr1</xocs:file-basename>\\n               <xocs:filename>gr1.jpg</xocs:filename>\\n               <xocs:extension>jpg</xocs:extension>\\n               <xocs:filesize>86230</xocs:filesize>\\n               <xocs:pixel-height>472</xocs:pixel-height>\\n               <xocs:pixel-width>715</xocs:pixel-width>\\n               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>\\n            </xocs:attachment>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S1097276504001832-gr1.sml</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S1097276504001832/gr1/THUMBNAIL/image/gif/e20feebb056b08ec10a6978e118d0f73/gr1.sml</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S1097276504001832/gr1/THUMBNAIL/image/gif/e20feebb056b08ec10a6978e118d0f73/gr1.sml</xocs:ucs-locator>\\n               <xocs:file-basename>gr1</xocs:file-basename>\\n               <xocs:filename>gr1.sml</xocs:filename>\\n               <xocs:extension>sml</xocs:extension>\\n               <xocs:filesize>4116</xocs:filesize>\\n               <xocs:pixel-height>83</xocs:pixel-height>\\n               <xocs:pixel-width>125</xocs:pixel-width>\\n               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>\\n            </xocs:attachment>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S1097276504001832-gr1_lrg.jpg</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S1097276504001832/gr1/HIGHRES/image/jpeg/623f89c6baddb77497b1662935228dd9/gr1_lrg.jpg</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S1097276504001832/gr1/HIGHRES/image/jpeg/623f89c6baddb77497b1662935228dd9/gr1_lrg.jpg</xocs:ucs-locator>\\n               <xocs:file-basename>gr1</xocs:file-basename>\\n               <xocs:filename>gr1_lrg.jpg</xocs:filename>\\n               <xocs:extension>jpg</xocs:extension>\\n               <xocs:filesize>444268</xocs:filesize>\\n               <xocs:pixel-height>1255</xocs:pixel-height>\\n               <xocs:pixel-width>1900</xocs:pixel-width>\\n               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>\\n            </xocs:attachment>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S1097276504001832-gr2.jpg</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S1097276504001832/gr2/DOWNSAMPLED/image/jpeg/08a384aa159c4474b7569efdc1120cce/gr2.jpg</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S1097276504001832/gr2/DOWNSAMPLED/image/jpeg/08a384aa159c4474b7569efdc1120cce/gr2.jpg</xocs:ucs-locator>\\n               <xocs:file-basename>gr2</xocs:file-basename>\\n               <xocs:filename>gr2.jpg</xocs:filename>\\n               <xocs:extension>jpg</xocs:extension>\\n               <xocs:filesize>30419</xocs:filesize>\\n               <xocs:pixel-height>550</xocs:pixel-height>\\n               <xocs:pixel-width>339</xocs:pixel-width>\\n               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>\\n            </xocs:attachment>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S1097276504001832-gr2.sml</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S1097276504001832/gr2/THUMBNAIL/image/gif/ebc88dc3839d22a8868c48f540646964/gr2.sml</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S1097276504001832/gr2/THUMBNAIL/image/gif/ebc88dc3839d22a8868c48f540646964/gr2.sml</xocs:ucs-locator>\\n               <xocs:file-basename>gr2</xocs:file-basename>\\n               <xocs:filename>gr2.sml</xocs:filename>\\n               <xocs:extension>sml</xocs:extension>\\n               <xocs:filesize>1368</xocs:filesize>\\n               <xocs:pixel-height>92</xocs:pixel-height>\\n               <xocs:pixel-width>57</xocs:pixel-width>\\n               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>\\n            </xocs:attachment>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S1097276504001832-gr2_lrg.jpg</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S1097276504001832/gr2/HIGHRES/image/jpeg/a0d2548fb5438067b98b7cf0dc710ea7/gr2_lrg.jpg</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S1097276504001832/gr2/HIGHRES/image/jpeg/a0d2548fb5438067b98b7cf0dc710ea7/gr2_lrg.jpg</xocs:ucs-locator>\\n               <xocs:file-basename>gr2</xocs:file-basename>\\n               <xocs:filename>gr2_lrg.jpg</xocs:filename>\\n               <xocs:extension>jpg</xocs:extension>\\n               <xocs:filesize>314461</xocs:filesize>\\n               <xocs:pixel-height>2434</xocs:pixel-height>\\n               <xocs:pixel-width>1500</xocs:pixel-width>\\n               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>\\n            </xocs:attachment>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S1097276504001832-gr6.jpg</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S1097276504001832/gr6/DOWNSAMPLED/image/jpeg/9938a32519d204a977c0e95b0c75f000/gr6.jpg</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S1097276504001832/gr6/DOWNSAMPLED/image/jpeg/9938a32519d204a977c0e95b0c75f000/gr6.jpg</xocs:ucs-locator>\\n               <xocs:file-basename>gr6</xocs:file-basename>\\n               <xocs:filename>gr6.jpg</xocs:filename>\\n               <xocs:extension>jpg</xocs:extension>\\n               <xocs:filesize>21387</xocs:filesize>\\n               <xocs:pixel-height>316</xocs:pixel-height>\\n               <xocs:pixel-width>452</xocs:pixel-width>\\n               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>\\n            </xocs:attachment>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S1097276504001832-gr6.sml</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S1097276504001832/gr6/THUMBNAIL/image/gif/5cffa23dd4772539566dbf1e1e222fa0/gr6.sml</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S1097276504001832/gr6/THUMBNAIL/image/gif/5cffa23dd4772539566dbf1e1e222fa0/gr6.sml</xocs:ucs-locator>\\n               <xocs:file-basename>gr6</xocs:file-basename>\\n               <xocs:filename>gr6.sml</xocs:filename>\\n               <xocs:extension>sml</xocs:extension>\\n               <xocs:filesize>2153</xocs:filesize>\\n               <xocs:pixel-height>87</xocs:pixel-height>\\n               <xocs:pixel-width>125</xocs:pixel-width>\\n               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>\\n            </xocs:attachment>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S1097276504001832-gr6_lrg.jpg</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S1097276504001832/gr6/HIGHRES/image/jpeg/6489d0ccdc12cd3d446ebfdec2208014/gr6_lrg.jpg</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S1097276504001832/gr6/HIGHRES/image/jpeg/6489d0ccdc12cd3d446ebfdec2208014/gr6_lrg.jpg</xocs:ucs-locator>\\n               <xocs:file-basename>gr6</xocs:file-basename>\\n               <xocs:filename>gr6_lrg.jpg</xocs:filename>\\n               <xocs:extension>jpg</xocs:extension>\\n               <xocs:filesize>207401</xocs:filesize>\\n               <xocs:pixel-height>1398</xocs:pixel-height>\\n               <xocs:pixel-width>2000</xocs:pixel-width>\\n               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>\\n            </xocs:attachment>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S1097276504001832-gr7.jpg</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S1097276504001832/gr7/DOWNSAMPLED/image/jpeg/2e05ad3133df5b9b1355a063aaf02ead/gr7.jpg</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S1097276504001832/gr7/DOWNSAMPLED/image/jpeg/2e05ad3133df5b9b1355a063aaf02ead/gr7.jpg</xocs:ucs-locator>\\n               <xocs:file-basename>gr7</xocs:file-basename>\\n               <xocs:filename>gr7.jpg</xocs:filename>\\n               <xocs:extension>jpg</xocs:extension>\\n               <xocs:filesize>20049</xocs:filesize>\\n               <xocs:pixel-height>250</xocs:pixel-height>\\n               <xocs:pixel-width>339</xocs:pixel-width>\\n               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>\\n            </xocs:attachment>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S1097276504001832-gr7.sml</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S1097276504001832/gr7/THUMBNAIL/image/gif/c17d13995f89a24c0706c150413b2bbb/gr7.sml</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S1097276504001832/gr7/THUMBNAIL/image/gif/c17d13995f89a24c0706c150413b2bbb/gr7.sml</xocs:ucs-locator>\\n               <xocs:file-basename>gr7</xocs:file-basename>\\n               <xocs:filename>gr7.sml</xocs:filename>\\n               <xocs:extension>sml</xocs:extension>\\n               <xocs:filesize>2137</xocs:filesize>\\n               <xocs:pixel-height>92</xocs:pixel-height>\\n               <xocs:pixel-width>125</xocs:pixel-width>\\n               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>\\n            </xocs:attachment>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S1097276504001832-gr7_lrg.jpg</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S1097276504001832/gr7/HIGHRES/image/jpeg/47323a2614afa2acd7e144607c762cbd/gr7_lrg.jpg</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S1097276504001832/gr7/HIGHRES/image/jpeg/47323a2614afa2acd7e144607c762cbd/gr7_lrg.jpg</xocs:ucs-locator>\\n               <xocs:file-basename>gr7</xocs:file-basename>\\n               <xocs:filename>gr7_lrg.jpg</xocs:filename>\\n               <xocs:extension>jpg</xocs:extension>\\n               <xocs:filesize>364672</xocs:filesize>\\n               <xocs:pixel-height>2209</xocs:pixel-height>\\n               <xocs:pixel-width>3000</xocs:pixel-width>\\n               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>\\n            </xocs:attachment>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S1097276504001832-mmc1.pdf</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S1097276504001832/mmc1/MAIN/application/pdf/c310c4c4357fcdb73706c1c5a1146f5c/mmc1.pdf</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S1097276504001832/mmc1/MAIN/application/pdf/c310c4c4357fcdb73706c1c5a1146f5c/mmc1.pdf</xocs:ucs-locator>\\n               <xocs:file-basename>mmc1</xocs:file-basename>\\n               <xocs:filename>mmc1.pdf</xocs:filename>\\n               <xocs:extension>pdf</xocs:extension>\\n               <xocs:pdf-optimized>true</xocs:pdf-optimized>\\n               <xocs:filesize>53541</xocs:filesize>\\n               <xocs:attachment-type>APPLICATION</xocs:attachment-type>\\n            </xocs:attachment>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S1097276504001832-gr3.gif</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S1097276504001832/gr3/DOWNSAMPLED/image/gif/a5c77be352ed7fb804700e7f36b8a26c/gr3.gif</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S1097276504001832/gr3/DOWNSAMPLED/image/gif/a5c77be352ed7fb804700e7f36b8a26c/gr3.gif</xocs:ucs-locator>\\n               <xocs:file-basename>gr3</xocs:file-basename>\\n               <xocs:filename>gr3.gif</xocs:filename>\\n               <xocs:extension>gif</xocs:extension>\\n               <xocs:filesize>10356</xocs:filesize>\\n               <xocs:pixel-height>180</xocs:pixel-height>\\n               <xocs:pixel-width>452</xocs:pixel-width>\\n               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>\\n            </xocs:attachment>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S1097276504001832-gr3.sml</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S1097276504001832/gr3/THUMBNAIL/image/gif/d87339a2537cdac1115a95a135446dd8/gr3.sml</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S1097276504001832/gr3/THUMBNAIL/image/gif/d87339a2537cdac1115a95a135446dd8/gr3.sml</xocs:ucs-locator>\\n               <xocs:file-basename>gr3</xocs:file-basename>\\n               <xocs:filename>gr3.sml</xocs:filename>\\n               <xocs:extension>sml</xocs:extension>\\n               <xocs:filesize>3503</xocs:filesize>\\n               <xocs:pixel-height>87</xocs:pixel-height>\\n               <xocs:pixel-width>219</xocs:pixel-width>\\n               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>\\n            </xocs:attachment>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S1097276504001832-gr3_lrg.gif</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S1097276504001832/gr3/HIGHRES/image/gif/08d7bd7ee0a583d19379d97a9ddad538/gr3_lrg.gif</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S1097276504001832/gr3/HIGHRES/image/gif/08d7bd7ee0a583d19379d97a9ddad538/gr3_lrg.gif</xocs:ucs-locator>\\n               <xocs:file-basename>gr3</xocs:file-basename>\\n               <xocs:filename>gr3_lrg.gif</xocs:filename>\\n               <xocs:extension>gif</xocs:extension>\\n               <xocs:filesize>81271</xocs:filesize>\\n               <xocs:pixel-height>1592</xocs:pixel-height>\\n               <xocs:pixel-width>4000</xocs:pixel-width>\\n               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>\\n            </xocs:attachment>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S1097276504001832-gr4.gif</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S1097276504001832/gr4/DOWNSAMPLED/image/gif/59462f91beb52cba2ae8b69c5781799f/gr4.gif</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S1097276504001832/gr4/DOWNSAMPLED/image/gif/59462f91beb52cba2ae8b69c5781799f/gr4.gif</xocs:ucs-locator>\\n               <xocs:file-basename>gr4</xocs:file-basename>\\n               <xocs:filename>gr4.gif</xocs:filename>\\n               <xocs:extension>gif</xocs:extension>\\n               <xocs:filesize>8479</xocs:filesize>\\n               <xocs:pixel-height>188</xocs:pixel-height>\\n               <xocs:pixel-width>452</xocs:pixel-width>\\n               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>\\n            </xocs:attachment>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S1097276504001832-gr4.sml</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S1097276504001832/gr4/THUMBNAIL/image/gif/40d6efb0b3bc879c711547a17d691271/gr4.sml</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S1097276504001832/gr4/THUMBNAIL/image/gif/40d6efb0b3bc879c711547a17d691271/gr4.sml</xocs:ucs-locator>\\n               <xocs:file-basename>gr4</xocs:file-basename>\\n               <xocs:filename>gr4.sml</xocs:filename>\\n               <xocs:extension>sml</xocs:extension>\\n               <xocs:filesize>2825</xocs:filesize>\\n               <xocs:pixel-height>91</xocs:pixel-height>\\n               <xocs:pixel-width>219</xocs:pixel-width>\\n               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>\\n            </xocs:attachment>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S1097276504001832-gr4_lrg.gif</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S1097276504001832/gr4/HIGHRES/image/gif/05c8caf3f0f5f217ce3287ba574772c6/gr4_lrg.gif</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S1097276504001832/gr4/HIGHRES/image/gif/05c8caf3f0f5f217ce3287ba574772c6/gr4_lrg.gif</xocs:ucs-locator>\\n               <xocs:file-basename>gr4</xocs:file-basename>\\n               <xocs:filename>gr4_lrg.gif</xocs:filename>\\n               <xocs:extension>gif</xocs:extension>\\n               <xocs:filesize>69746</xocs:filesize>\\n               <xocs:pixel-height>1667</xocs:pixel-height>\\n               <xocs:pixel-width>4000</xocs:pixel-width>\\n               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>\\n            </xocs:attachment>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S1097276504001832-gr5.gif</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S1097276504001832/gr5/DOWNSAMPLED/image/gif/fd87d56567fdaef8e7f521182136711f/gr5.gif</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S1097276504001832/gr5/DOWNSAMPLED/image/gif/fd87d56567fdaef8e7f521182136711f/gr5.gif</xocs:ucs-locator>\\n               <xocs:file-basename>gr5</xocs:file-basename>\\n               <xocs:filename>gr5.gif</xocs:filename>\\n               <xocs:extension>gif</xocs:extension>\\n               <xocs:filesize>9910</xocs:filesize>\\n               <xocs:pixel-height>286</xocs:pixel-height>\\n               <xocs:pixel-width>339</xocs:pixel-width>\\n               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>\\n            </xocs:attachment>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S1097276504001832-gr5.sml</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S1097276504001832/gr5/THUMBNAIL/image/gif/0b4bb083b95778fb3f9e7f7b30b5d6a0/gr5.sml</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S1097276504001832/gr5/THUMBNAIL/image/gif/0b4bb083b95778fb3f9e7f7b30b5d6a0/gr5.sml</xocs:ucs-locator>\\n               <xocs:file-basename>gr5</xocs:file-basename>\\n               <xocs:filename>gr5.sml</xocs:filename>\\n               <xocs:extension>sml</xocs:extension>\\n               <xocs:filesize>4661</xocs:filesize>\\n               <xocs:pixel-height>164</xocs:pixel-height>\\n               <xocs:pixel-width>194</xocs:pixel-width>\\n               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>\\n            </xocs:attachment>\\n            <xocs:attachment>\\n               <xocs:attachment-eid>1-s2.0-S1097276504001832-gr5_lrg.gif</xocs:attachment-eid>\\n               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S1097276504001832/gr5/HIGHRES/image/gif/87397c6efd96f3d280b949bbd5a6216c/gr5_lrg.gif</xocs:ucs-locator>\\n               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S1097276504001832/gr5/HIGHRES/image/gif/87397c6efd96f3d280b949bbd5a6216c/gr5_lrg.gif</xocs:ucs-locator>\\n               <xocs:file-basename>gr5</xocs:file-basename>\\n               <xocs:filename>gr5_lrg.gif</xocs:filename>\\n               <xocs:extension>gif</xocs:extension>\\n               <xocs:filesize>74191</xocs:filesize>\\n               <xocs:pixel-height>2533</xocs:pixel-height>\\n               <xocs:pixel-width>3000</xocs:pixel-width>\\n               <xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type>\\n            </xocs:attachment>\\n         </xocs:attachments>\\n      </xocs:attachment-metadata-doc>\\n   </xocs:meta>\\n   <xocs:serial-item>\\n      <converted-article xmlns=\"http://www.elsevier.com/xml/ja/dtd\" version=\"4.5.2\" docsubtype=\"fla\" xml:lang=\"en\">\\n         <item-info>\\n            <jid>MOLCEL</jid>\\n            <aid>1180</aid>\\n            <ce:pii>S1097-2765(04)00183-2</ce:pii>\\n            <ce:doi>10.1016/S1097-2765(04)00183-2</ce:doi>\\n            <ce:copyright type=\"society\" year=\"2004\">Cell Press</ce:copyright>\\n         </item-info>\\n         <ce:floats>\\n            <ce:figure id=\"FIG1\">\\n               <ce:label>Figure 1</ce:label>\\n               <ce:caption>\\n                  <ce:simple-para view=\"all\">TASK-Vpu Homology Leads to Their Physical Association</ce:simple-para>\\n                  <ce:simple-para view=\"all\">(A and B) Protein sequence alignment between Vpu and the first quarter of TASK. PHD-predicted helices (including TMH) are indicated by gray symbols. The Vpu alignment includes the consensus sequence from NCBI Conserved Domain Database (CD: pfam00558), the sequence from pLAI plasmid, and another consensus from the rare SIVcpz strains compiled by the HIV Database. PD013020: the TASK-1 consensus sequence from ProDom database. In Vpu, the hinge region linking the 2 non-TM helices (blue underline and boxes) contains two phosphoserines (red asterisks) that are important for CD4 degradation. A potential N-linked glycosylation site is conserved in TASK (branch). Aligned amino acids are color coded by MView 1.41 (positive charge, bright red; negative charge, bright blue; polar, purple; small alcohol, dull blue; hydrophobic, bright green; large hydrophobic, dull green).</ce:simple-para>\\n                  <ce:simple-para view=\"all\">(C) Colocalization of GT (green) and CD4U (red): shown both individual scans and the overlay.</ce:simple-para>\\n               </ce:caption>\\n               <ce:link locator=\"gr1\"/>\\n            </ce:figure>\\n            <ce:figure id=\"FIG2\">\\n               <ce:label>Figure 2</ce:label>\\n               <ce:caption>\\n                  <ce:simple-para view=\"all\">Coimmunoprecipitation of TASK-1 and Vpu</ce:simple-para>\\n                  <ce:simple-para view=\"all\">(A) Vpu was identified as part of the TASK complexes in HEK-293 cells expressing both TASK and Vpu (VT). Negative controls include expression of the control GFP alone (C), TASK-1 alone (T), and Vpu alone (V).</ce:simple-para>\\n                  <ce:simple-para view=\"all\">(B) TASK expression (55 kDa) in PHA-activated normal primary CD4<ce:sup loc=\"post\">+</ce:sup> T lymphocytes.</ce:simple-para>\\n                  <ce:simple-para view=\"all\">(C) TASK-Vpu interaction detected in an AIDS peripheral blood sample (AIDS), and not in the peripheral blood from a treated HIV-1-positive patient with an <math altimg=\"si1.gif\">\\n                        <unl type=\"bar\" style=\"s\">\\n                           <rm>u</rm>\\n                        </unl>\\n                     </math>n<math altimg=\"si2.gif\">\\n                        <unl type=\"bar\" style=\"s\">\\n                           <rm>d</rm>\\n                        </unl>\\n                     </math>etectable viral load (UD).</ce:simple-para>\\n                  <ce:simple-para view=\"all\">(D) T-V interaction found in AIDS autopsied lymph node tissues. “Bead” (negative control): not chemically coupled to anti-TASK.</ce:simple-para>\\n               </ce:caption>\\n               <ce:link locator=\"gr2\"/>\\n            </ce:figure>\\n            <ce:figure id=\"FIG3\">\\n               <ce:label>Figure 3</ce:label>\\n               <ce:caption>\\n                  <ce:simple-para view=\"all\">Vpu Coexpression Inhibits TASK-1-Specific Current</ce:simple-para>\\n                  <ce:simple-para view=\"all\">(A) Coexpression of TASK and Vpu abolished the Ba<ce:sup loc=\"post\">2+</ce:sup>-sensitive, TEA<ce:sup loc=\"post\">+</ce:sup>-insensitive component of TASK-1 current. HEK-293 cells transfected with TASK-1 alone (T) or with both TASK-1 and Vpu (VT) were voltage-clamped under whole cell configuration. The cells were perfused from K<ce:sup loc=\"post\">+</ce:sup>-containing bath solution to the same solution eliminating K<ce:sup loc=\"post\">+</ce:sup>, then with an addition of 10 mM TEA<ce:sup loc=\"post\">+</ce:sup> (solid symbols). Continued perfusion with additional 2 mM Ba<ce:sup loc=\"post\">2+</ce:sup> (hollow symbols) reveals the Ba<ce:sup loc=\"post\">2+</ce:sup>-sensitive and TEA<ce:sup loc=\"post\">+</ce:sup>-insensitive K<ce:sup loc=\"post\">+</ce:sup> conductance, specific of TASK-1 (square; mean ± SEM). This conductance component was absent with Vpu coexpression (circle; mean ± SEM). Inlet: Subtraction for the Ba<ce:sup loc=\"post\">2+</ce:sup>-sensitive, TEA<ce:sup loc=\"post\">+</ce:sup>-insensitive conductance.</ce:simple-para>\\n                  <ce:simple-para view=\"all\">(B) TASK-Vpu coexpression also suppressed the pH-sensitive component of TASK current, activated by pH increase from 7.5 to 8.5. Shown dose dependence of Vpu-imposed inhibition of TASK-1 current.</ce:simple-para>\\n               </ce:caption>\\n               <ce:link locator=\"gr3\"/>\\n            </ce:figure>\\n            <ce:figure id=\"FIG4\">\\n               <ce:label>Figure 4</ce:label>\\n               <ce:caption>\\n                  <ce:simple-para view=\"all\">TASK-Vpu Interactions Interfere with HIV-1 Release</ce:simple-para>\\n                  <ce:simple-para view=\"all\">(A) TASK-1 coexpression with pNL4-3 suppressed virus release, as compared with the control HERG channel. Asterisk designating <ce:italic>p</ce:italic> &lt; 0.05 in a Student\\'s <ce:italic>t</ce:italic>-Test is the significance of a comparison of virus release affected by TASK-1 (pooled data) to that by HERG, from seven independent experiments. Deletion of Vpu (pNL4-3*Udel) resulted in inhibition of virus release (mean ± SEM, n = 3).</ce:simple-para>\\n                  <ce:simple-para view=\"all\">(B) Dose dependence of TASK-1 inhibition on Vpu-mediated virus release.</ce:simple-para>\\n               </ce:caption>\\n               <ce:link locator=\"gr4\"/>\\n            </ce:figure>\\n            <ce:figure id=\"FIG5\">\\n               <ce:label>Figure 5</ce:label>\\n               <ce:caption>\\n                  <ce:simple-para view=\"all\">Ttm1 Coexpression Suppressed the pH-Sensitive Current of TASK-1</ce:simple-para>\\n                  <ce:simple-para view=\"all\">Dose dependence of Ttm1-imposed inhibition of TASK-1 current. The molar ratio of TASK (0.4 μg): Ttm1 (0.4 μg) is roughly 1:1.</ce:simple-para>\\n               </ce:caption>\\n               <ce:link locator=\"gr5\"/>\\n            </ce:figure>\\n            <ce:figure id=\"FIG6\">\\n               <ce:label>Figure 6</ce:label>\\n               <ce:caption>\\n                  <ce:simple-para view=\"all\">TASK-1 Degradation during HIV-1 Infection</ce:simple-para>\\n                  <ce:simple-para view=\"all\">(A) Endogenous TASK expression is diminished in HIV-1 infection. PHA-activated primary CD4<ce:sup loc=\"post\">+</ce:sup> T cells were infected with HIV-1 in vitro. The protein level of TASK-1 was assessed on day 0 and day 2 postinfection. Immunoprecipitation followed by Western blot revealed decreasing TASK expressions in infected cells, compared to the controls. TASK-Vpu association was also detected in in vitro infected primary cells.</ce:simple-para>\\n                  <ce:simple-para view=\"all\">(B) Coimmunoprecipitation of TASK-1, Vpu, and βTrCP in an AIDS peripheral blood sample.</ce:simple-para>\\n               </ce:caption>\\n               <ce:link locator=\"gr6\"/>\\n            </ce:figure>\\n            <ce:figure id=\"FIG7\">\\n               <ce:label>Figure 7</ce:label>\\n               <ce:caption>\\n                  <ce:simple-para view=\"all\">Ttm1 Is Functionally Equivalent to Vpu in Assisting HIV-1 Release</ce:simple-para>\\n                  <ce:simple-para view=\"all\">Ttm1 coexpression with pNL4-3/Udel supported viral particle release in HeLa cells, as did Vpu. Folds of increase of virus release were determined by comparison to the coexpression of pNL4-3/Udel and pCGI (fold = 1). Data summarized from two to five independent experiments.</ce:simple-para>\\n               </ce:caption>\\n               <ce:link locator=\"gr7\"/>\\n            </ce:figure>\\n         </ce:floats>\\n         <head>\\n            <ce:dochead>\\n               <ce:textfn>Article</ce:textfn>\\n            </ce:dochead>\\n            <ce:title>Mutual Functional Destruction of HIV-1 Vpu and Host TASK-1 Channel</ce:title>\\n            <ce:author-group>\\n               <ce:author>\\n                  <ce:given-name>Kate</ce:given-name>\\n                  <ce:surname>Hsu</ce:surname>\\n                  <ce:cross-ref refid=\"AFF1\">\\n                     <ce:sup loc=\"post\">1</ce:sup>\\n                  </ce:cross-ref>\\n                  <ce:cross-ref refid=\"AFF2\">\\n                     <ce:sup loc=\"post\">2</ce:sup>\\n                  </ce:cross-ref>\\n               </ce:author>\\n               <ce:author>\\n                  <ce:given-name>Jegatheesan</ce:given-name>\\n                  <ce:surname>Seharaseyon</ce:surname>\\n                  <ce:cross-ref refid=\"AFF2\">\\n                     <ce:sup loc=\"post\">2</ce:sup>\\n                  </ce:cross-ref>\\n                  <ce:cross-ref refid=\"FN1\">\\n                     <ce:sup loc=\"post\">4</ce:sup>\\n                  </ce:cross-ref>\\n               </ce:author>\\n               <ce:author>\\n                  <ce:given-name>Peihong</ce:given-name>\\n                  <ce:surname>Dong</ce:surname>\\n                  <ce:cross-ref refid=\"AFF2\">\\n                     <ce:sup loc=\"post\">2</ce:sup>\\n                  </ce:cross-ref>\\n               </ce:author>\\n               <ce:author>\\n                  <ce:given-name>Stephan</ce:given-name>\\n                  <ce:surname>Bour</ce:surname>\\n                  <ce:cross-ref refid=\"AFF3\">\\n                     <ce:sup loc=\"post\">3</ce:sup>\\n                  </ce:cross-ref>\\n               </ce:author>\\n               <ce:author>\\n                  <ce:given-name>Eduardo</ce:given-name>\\n                  <ce:surname>Marbán</ce:surname>\\n                  <ce:cross-ref refid=\"COR1\">*</ce:cross-ref>\\n                  <ce:cross-ref refid=\"AFF2\">\\n                     <ce:sup loc=\"post\">2</ce:sup>\\n                  </ce:cross-ref>\\n                  <ce:e-address type=\"email\">marban@jhmi.edu</ce:e-address>\\n               </ce:author>\\n               <ce:affiliation id=\"AFF1\">\\n                  <ce:label>1</ce:label>\\n                  <ce:textfn>Program in Molecular Biophysics, Johns Hopkins University, Baltimore, MD 21205 USA</ce:textfn>\\n               </ce:affiliation>\\n               <ce:affiliation id=\"AFF2\">\\n                  <ce:label>2</ce:label>\\n                  <ce:textfn>Institute of Molecular Cardiobiology, Johns Hopkins University School of Medicine, Baltimore, MD 21205 USA</ce:textfn>\\n               </ce:affiliation>\\n               <ce:affiliation id=\"AFF3\">\\n                  <ce:label>3</ce:label>\\n                  <ce:textfn>Bioinformatics Core Facility, Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892 USA</ce:textfn>\\n               </ce:affiliation>\\n               <ce:correspondence id=\"COR1\">\\n                  <ce:label>*</ce:label>\\n                  <ce:text>Correspondence: Eduardo Marbán, 410 955 2776 (phone), 410 955 7953 (fax)</ce:text>\\n               </ce:correspondence>\\n               <ce:footnote id=\"FN1\">\\n                  <ce:label>4</ce:label>\\n                  <ce:note-para>Present address: United States Patent and Trademark Office, Arlington, Virginia 22202.</ce:note-para>\\n               </ce:footnote>\\n            </ce:author-group>\\n            <ce:date-received day=\"1\" month=\"10\" year=\"2003\"/>\\n            <ce:date-revised day=\"1\" month=\"3\" year=\"2004\"/>\\n            <ce:date-accepted day=\"3\" month=\"3\" year=\"2004\"/>\\n            <ce:miscellaneous>Published: April 22, 2004</ce:miscellaneous>\\n            <ce:abstract class=\"author\">\\n               <ce:section-title>Abstract</ce:section-title>\\n               <ce:abstract-sec>\\n                  <ce:simple-para view=\"all\">Sequence analysis predicted significant structural homology between the HIV-1 accessory protein Vpu and the N-terminal region of TASK-1, a mammalian background K<ce:sup loc=\"post\">+</ce:sup> channel. If the homology resulted from molecular piracy during HIV-1 evolution, these two proteins may have important functional interactions. Here we demonstrate that TASK and Vpu physically interact in cultured cells and in AIDS lymphoid tissues. The functional consequences were potentially destructive for both components: Vpu abolished TASK-1 current, while overexpressing TASK led to a marked impairment of Vpu\\'s ability to enhance viral particle release. Further, the first 40 amino acids of TASK-1 (part of the homology to Vpu) were capable of enhancing HIV-1 particle release. This virus-host interaction may influence HIV-1/AIDS progression, as well as electrical signaling in infected host tissues.</ce:simple-para>\\n               </ce:abstract-sec>\\n            </ce:abstract>\\n         </head>\\n         <body>\\n            <ce:sections>\\n               <ce:section view=\"all\">\\n                  <ce:section-title>Introduction</ce:section-title>\\n                  <ce:para view=\"all\">HIV-1 proteins constantly interact with host components in infected cells <ce:cross-ref refid=\"BIB18\">(Greene and Peterlin, 2002)</ce:cross-ref>. How such interactions emerged during the course of virus evolution is not clear. One common theme in virology is that of “molecular piracy”—viral components may evolve from replication of related host genes, thus being capable of interacting with native proteins <ce:cross-ref refid=\"BIB40\">(Sinkovics et al., 1998)</ce:cross-ref>. For molecular piracy, cellular immunomodulatory genes are popular targets; this is well illustrated in cytomegaloviruses (CMVs), which incorporate homologs to host MHC class I, chemokines, and G protein-coupled receptors <ce:cross-ref refid=\"BIB45\">(Vink et al., 1999)</ce:cross-ref>. Here we report an unusual example of virus mimicry using an ancient K<ce:sup loc=\"post\">+</ce:sup> channel as a template. Significant sequence homologies were found between the HIV-1 Vpu protein and the N-terminal 70 residues of the two-pore K<ce:sup loc=\"post\">+</ce:sup> (K<ce:inf loc=\"post\">2P</ce:inf>) channel TASK-1.</ce:para>\\n                  <ce:para view=\"all\">TASK-1 is a widely expressed, acid-sensitive K<ce:sup loc=\"post\">+</ce:sup> channel that exhibits background conductance <ce:cross-refs refid=\"BIB15 BIB21 BIB27\">(Duprat et al., 1997; Kim et al., 1998; Leonoudakis et al., 1998)</ce:cross-refs>. Vpu plays multiple roles during HIV-1 infection: support of virus release <ce:cross-refs refid=\"BIB23 BIB43\">(Klimkait et al., 1990; Strebel et al., 1989)</ce:cross-refs> and promotion of CD4 degradation <ce:cross-ref refid=\"BIB46\">(Willey et al., 1992)</ce:cross-ref>. This small integral membrane protein of HIV-1 also influences cationic currents in planar lipid bilayers and in <ce:italic>Xenopus</ce:italic> oocytes <ce:cross-refs refid=\"BIB12 BIB17 BIB36\">(Coady et al., 1998; Gonzalez and Carrasco, 1998; Schubert et al., 1996)</ce:cross-refs>. This electrophysiological property of Vpu requires conservation of the transmembrane (TM) sequence. Since Vpu is multimeric in native states <ce:cross-ref refid=\"BIB29\">(Maldarelli et al., 1993)</ce:cross-ref>, it has been proposed to form ion channels <ce:cross-ref refid=\"BIB36\">(Schubert et al., 1996)</ce:cross-ref>, but it is also possible that Vpu affects membrane conductance through modulation of endogenous ion channels <ce:cross-ref refid=\"BIB25\">(Lamb and Pinto, 1997)</ce:cross-ref>, as do other small integral membrane proteins <ce:cross-refs refid=\"BIB1 BIB32 BIB37 BIB39\">(Abbott and Goldstein, 1998; McDonald et al., 1997; Sesti et al., 2000; Shimbo et al., 1995)</ce:cross-refs>. In this report, we provide the first evidence that HIV-1 Vpu alters the normal function of cellular channel subunits by direct interaction with those subunits.</ce:para>\\n                  <ce:para view=\"all\">Using a number of biochemical and biophysical approaches, we first demonstrated that TASK and Vpu interact in heterologous expression systems and in HIV-1-infected specimens. The functional consequences of such interaction are mutually destructive: Vpu abolishes the background conductance of TASK-1, while TASK expression also suppresses Vpu-mediated virus release. Since K<ce:sup loc=\"post\">+</ce:sup> channel subunits have the propensity to oligomerize with homologous subunits to form a functional pore (e.g., hetero-dimerization of TASK-1 and TASK-3 <ce:cross-ref refid=\"BIB13\">[Czirjak and Enyedi, 2002]</ce:cross-ref>; hetero-tetramerization of “silent subunits” to Kv 2.1 subunits <ce:cross-ref refid=\"BIB33\">[Ottschytsch et al., 2002]</ce:cross-ref>), TASK, and Vpu may interact through the same mechanism as channel assembly. By intercalating into TASK complexes, Vpu inhibits the background current generated by TASK channels. Conversely, it is conceivable that, if HIV-1 infection takes place in cells with substantial TASK expression, the amount of Vpu trapped by TASK could become significant enough to affect viral particle release.</ce:para>\\n                  <ce:para view=\"all\">The first transmembrane segment is essential for assembly of voltage-dependent K<ce:sup loc=\"post\">+</ce:sup> (Kv) channel subunits <ce:cross-ref refid=\"BIB4\">(Babila et al., 1994)</ce:cross-ref>. A truncated Kv channel with only the first transmembrane segment (TM1) remains capable of homo- or hetero-multimerization. Coexpression of these TM1 fragments with wild-type Kv channel subunits exerts a negative <ce:italic>trans</ce:italic>-dominant effect on the currents encoded by wild-type channels. Since these TM1 fragments can spontaneously assemble with native homologous Kv subunits (likely during cotranslation <ce:cross-ref refid=\"BIB14\">[Deutsch, 2002]</ce:cross-ref>), their oligomerization results in nonfunctional channel complexes on the cell surface or retention in the ER <ce:cross-ref refid=\"BIB16\">(Folco et al., 1997)</ce:cross-ref>. If we envision Vpu as a mimic of the TM1-containing TASK fragment, its inhibition of TASK function may be mechanistically similar to inhibition of Kv channels by their TM1 fragments.</ce:para>\\n                  <ce:para view=\"all\">We therefore tested whether the first TM region of TASK (termed “Ttm1”) could functionally mimic Vpu. Not only did Ttm1 suppress TASK conductance, but it also enhanced HIV-1 release. Hence, the minimal structural requirement for Vpu-mediated virus release is equivalent to a segment of the host K<ce:sup loc=\"post\">+</ce:sup> channel that is essential for channel assembly. Consequently, Vpu expression in HIV-1-infected cells disrupts the cellular pathway for K<ce:sup loc=\"post\">+</ce:sup> channel biogenesis. The resultant changes in the transmembrane electric field induced by the TASK-Vpu interaction are expected to alter conformations of membrane proteins, membrane fluidity and structure <ce:cross-refs refid=\"BIB24 BIB26\">(Lakos et al., 1990; Lelkes, 1979)</ce:cross-refs>, as well as intracellular ion homeostasis, undermining efficient virus packaging and release.</ce:para>\\n               </ce:section>\\n               <ce:section view=\"all\">\\n                  <ce:section-title>Results</ce:section-title>\\n                  <ce:section view=\"all\">\\n                     <ce:section-title>Proposal for Molecular Piracy of Cellular TASK-1 Channels</ce:section-title>\\n                     <ce:para view=\"all\">Significant sequence homologies were identified between HIV-1 Vpu and the first quarter of mammalian TASK-1 with overall identities of 24% (16/68) and sequence conservation of 56% (38/68) <ce:cross-ref refid=\"FIG1\">(Figures 1A and 1B)</ce:cross-ref>\\n                        <ce:float-anchor refid=\"FIG1\"/>. This degree of sequence similarity is comparable to that among different subfamilies of K<ce:inf loc=\"post\">2P</ce:inf> channels. As the evolution of K<ce:inf loc=\"post\">2P</ce:inf> channels probably spanned a much longer time frame than that of Vpu, it is anticipated that the rates of their sequence divergence were different, and that a virus-specific evolutionary mechanism such as molecular piracy was involved.</ce:para>\\n                     <ce:para view=\"all\">In addition to pairwise comparison, the neural-net-based PHD program also predicts a similar folding pattern in the aligned regions (transmembrane helix-helix-loop-helix) for both proteins. While the secondary structure of TASK-1 is unknown, the PHD prediction for Vpu matches its post-TM structure resolved by NMR <ce:cross-ref refid=\"BIB48\">(Wray et al., 1995)</ce:cross-ref> \\n                        <ce:cross-ref refid=\"FIG1\">(Figure 1A)</ce:cross-ref>.</ce:para>\\n                     <ce:para view=\"all\">The high degree of Vpu-TASK homology, and the fact that both proteins have the ability to oligomerize, suggested that these two proteins might interact to form hetero-oligomers. We used confocal imaging as a means to verify TASK-Vpu association. A GFP-TASK fusion (GT) and the CD4U chimera (CD4 ectodomain tagged to Vpu) were used <ce:cross-ref refid=\"BIB10\">(Bour et al., 2001)</ce:cross-ref>. Both CD4U and GT are functionally equivalent to the untagged Vpu and TASK-1, respectively: CD4U maintains full Vpu functionality—enhancement of virus release and modulation of CD4 degradation <ce:cross-refs refid=\"BIB10 BIB34\">(Bour et al., 2001; Paul et al., 1998)</ce:cross-refs>, while GT exhibits K<ce:sup loc=\"post\">+</ce:sup> conductance equivalent to that of TASK-1 (data not shown). Coexpression of CD4U and GT in A549 cells revealed that these two proteins were colocalized intracellularly and on the plasma membrane <ce:cross-ref refid=\"FIG1\">(Figure 1C)</ce:cross-ref>. Despite the inability to achieve molecular resolution by confocal imaging, the spatial correlation of TASK and Vpu provides a basis for interpretation of their functional interactions as described below.</ce:para>\\n                  </ce:section>\\n                  <ce:section view=\"all\">\\n                     <ce:section-title>TASK-Vpu Protein-Protein Interaction</ce:section-title>\\n                     <ce:para view=\"all\">We characterized the TASK-Vpu protein-protein interaction by coimmunoprecipitation. Anti-TASK-1 antibody, which recognizes a C-terminal peptide far from the region homologous to Vpu, was used to immunoprecipitate TASK-1 complexes under conditions of mild detergent dissociation. For HEK-293 cells expressing TASK (T, TASK-alone; VT, TASK + Vpu), Western blot revealed monomeric and dimeric TASK bands in their immunoprecipitates (<ce:cross-ref refid=\"FIG2\">Figure 2A</ce:cross-ref>\\n                        <ce:float-anchor refid=\"FIG2\"/>, left panel). Vpu expression was not affected by cotransfection of TASK (<ce:cross-ref refid=\"FIG2\">Figure 2A</ce:cross-ref>, right panel). Indeed, Vpu was only identified in the TASK precipitates from the VT sample (<ce:cross-ref refid=\"FIG2\">Figure 2A</ce:cross-ref>, middle panel), indicating that these two proteins form stable oligomers through heterologous expression. Interestingly, the U2-3 anti-Vpu antiserum was unable to coimmunoprecipitate TASK, suggesting that, under our experimental conditions, the U2-3 epitope in the Vpu cytoplasmic tail was masked. Therefore, both the transmembrane segment and cytoplasmic tail of Vpu may be involved in TASK interaction.</ce:para>\\n                     <ce:para view=\"all\">To determine whether this interaction is meaningful in the context of HIV-1 infection, we first characterized the expression level of TASK-1 in phytohemagglutinin (PHA)-activated primary CD4<ce:sup loc=\"post\">+</ce:sup> T lymphocytes <ce:cross-ref refid=\"FIG2\">(Figure 2B)</ce:cross-ref>. Further tests on AIDS lymphoid tissues (peripheral blood and autopsied lymph nodes) revealed the existence of the TASK-Vpu interaction in vivo <ce:cross-ref refid=\"FIG2\">(Figures 2C and 2D)</ce:cross-ref>. The interaction was examined in blood samples from an AIDS patient and from a treated HIV<ce:sup loc=\"post\">+</ce:sup> patient with <math altimg=\"si3.gif\">\\n                           <unl type=\"bar\" style=\"s\">\\n                              <rm>u</rm>\\n                           </unl>\\n                        </math>n<math altimg=\"si4.gif\">\\n                           <unl type=\"bar\" style=\"s\">\\n                              <rm>d</rm>\\n                           </unl>\\n                        </math>etectable viral load (UD). The expression levels of monomeric and dimeric TASK (55 kDa, 110 kDa) in both samples were comparable. Only in AIDS blood was Vpu identified in the TASK oligomers. Western blots against Vpu also frequently identified TASK-sized bands on native samples; this crossreactivity may be explained by the overall homology of Vpu to the first quarter of TASK-1, and further implies a structural resemblance between the two proteins in vivo.</ce:para>\\n                  </ce:section>\\n                  <ce:section view=\"all\">\\n                     <ce:section-title>Suppression of TASK-1 Current by Vpu Coexpression</ce:section-title>\\n                     <ce:para view=\"all\">To identify the functional consequences of TASK-Vpu oligomerization, we first dissected the background conductance of TASK in the presence or absence of Vpu in heterologous expression systems (HEK-293, A549). Since TASK-1 neither displays detectable kinetics nor has a specific channel blocker, two methods of measurement were employed to differentiate its current from endogenous currents in a cell. The first method measured TASK conductance by differential blockade using two K<ce:sup loc=\"post\">+</ce:sup> channel blockers, Ba<ce:sup loc=\"post\">2+</ce:sup> and TEA<ce:sup loc=\"post\">+</ce:sup>. Because TASK-1 can be completely blocked by Ba<ce:sup loc=\"post\">2+</ce:sup>, but not TEA<ce:sup loc=\"post\">+</ce:sup> \\n                        <ce:cross-refs refid=\"BIB15 BIB22\">(Duprat et al., 1997; Kim et al., 1999)</ce:cross-refs>, we employed stepwise blockade in a K<ce:sup loc=\"post\">+</ce:sup>-free bath condition at 0 mV to suppress any endogenous currents <ce:cross-ref refid=\"BIB5\">(Backx and Marbán, 1993)</ce:cross-ref>. A 1:1 molar ratio of TASK and Vpu DNA was applied in transfection. HEK-293 cells expressing TASK-1 alone exhibited a sizable Ba<ce:sup loc=\"post\">2+</ce:sup>-sensitive, TEA<ce:sup loc=\"post\">+</ce:sup>-insensitive outward current (<ce:cross-ref refid=\"FIG3\">Figure 3A</ce:cross-ref>\\n                        <ce:float-anchor refid=\"FIG3\"/>, inset: T). However, coexpression of TASK and Vpu completely suppressed this characteristic TASK-1 current component (<ce:cross-ref refid=\"FIG3\">Figure 3A</ce:cross-ref>, inset: VT). Combined with the coimmunoprecipitation results, the findings indicate that the TASK-1 channel becomes functionally impaired following oligomerization with Vpu.</ce:para>\\n                     <ce:para view=\"all\">The second method measured TASK-1 by activating its pH-sensitive current. TASK-1 is sensitive to extracellular pH changes in the physiological range; the current can augment 50% from pH 7.5 to pH 8.5, at which point it saturates <ce:cross-refs refid=\"BIB15 BIB27\">(Duprat et al., 1997; Leonoudakis et al., 1998)</ce:cross-refs>. We therefore examined whether the pH-sensitive component of TASK (subtracting the value at pH 7.5 from that at pH 8.5) was affected by Vpu. To differentiate between specific channel inhibition by Vpu and cytotoxic effects, a dose-response experiment was performed in which TASK current was measured in the presence of increasing amounts of transfected Vpu. The results correlate well with the previous measurements by differential blockade: Vpu coexpression significantly suppressed the TASK-specific current <ce:cross-ref refid=\"FIG3\">(Figure 3B)</ce:cross-ref>. Although further increase of Vpu DNA completely inhibited the pH-sensitive TASK current, it also made the cells difficult to patch, presumably due to cytotoxic effects of Vpu overexpression <ce:cross-ref refid=\"FIG3\">(Figure 3B)</ce:cross-ref>.</ce:para>\\n                     <ce:para view=\"all\">To exclude the possibility that the observed suppression of TASK-1 currents by Vpu results from Vpu-induced toxicity and not from hetero-oligomerization, in the second patch-clamp experiment <ce:cross-ref refid=\"FIG3\">(Figure 3B)</ce:cross-ref>, we identified apoptotic cells with two markers: Alexa Fluor-conjugated anti-annexin V and propidium iodide. Despite the fact that immunostaining prior to electrophysiological recording revealed some Vpu-expressing, apoptotic cells, the majority of such cells did not attach to coverslips well and were quickly washed away during perfusion of the recording chamber. We also compared the surface areas of all patched cells for signs of cell shrinkage or apoptotic volume decrease, a prerequisite for the onset of apoptosis. Vpu coexpression did not affect the surface area of HEK (data not shown). Additionally, suppression of TASK conductance by Vpu appeared consistent throughout the whole time course of transient expression (data not shown). The results suggest that coassembly and functional interference begin before TASK is functionally mature, and do not result from Vpu-induced apoptotic effects.</ce:para>\\n                  </ce:section>\\n                  <ce:section view=\"all\">\\n                     <ce:section-title>Inhibition of Vpu-Mediated Virus Release by TASK</ce:section-title>\\n                     <ce:para view=\"all\">The TASK-Vpu protein-protein interaction may also affect Vpu functionality. Of the two functions of Vpu, promotion of CD4 degradation and enhancement of virus release, we chose to focus on the latter for two reasons. First, <ce:cross-ref refid=\"BIB36\">Schubert et al. (1996)</ce:cross-ref> have correlated the putative channel-like activity of Vpu to its regulation of HIV-1 release. Second, our confocal imaging and whole-cell electrophysiological studies both point to a functional interaction of TASK-1 and Vpu at the level of the plasma membrane, the reported site of Vpu-mediated particle release enhancement <ce:cross-ref refid=\"BIB9\">(Bour et al., 1999)</ce:cross-ref>. Therefore, if Vpu inactivates TASK by disrupting oligomeric structures necessary for the formation of a functional channel, the reciprocal effect might be observed in circumstances where TASK is in excess over Vpu.</ce:para>\\n                     <ce:para view=\"all\">To determine the effect of TASK-1 on virus release, HeLa cells were cotransfected with wild-type and Vpu-defective HIV-1 proviral constructs (pNL4-3 and pNL4-3/Udel, respectively). Viral contents in culture media were determined at 25 hr posttransfection. The particle release efficiency of NL4-3 alone was set to 100%. As previously reported <ce:cross-ref refid=\"BIB42\">(Strebel et al., 1988)</ce:cross-ref>, inactivation of the <ce:italic>vpu</ce:italic> gene in the NL4-3 proviral clone of HIV-1 dramatically reduced the efficiency of particle release (<ce:cross-ref refid=\"FIG4\">Figure 4A</ce:cross-ref>\\n                        <ce:float-anchor refid=\"FIG4\"/>, pNL4-3/Udel). TASK-1 coexpression with wild-type pNL4-3 reduced virus release by 2- to 3-fold (<ce:cross-ref refid=\"FIG4\">Figure 4A</ce:cross-ref>, pNL4-3 + TASK). The suppressive effects of TASK-1 on viral particle release did not result from a general overexpression of K<ce:sup loc=\"post\">+</ce:sup> channels, as demonstrated in the negative control using another K<ce:sup loc=\"post\">+</ce:sup> channel of comparable current density, HERG (<ce:cross-ref refid=\"FIG4\">Figure 4A</ce:cross-ref>, pNL4-3 + HERG). 2-fold suppression of HIV-1 release was observed when applying 0.7 μg of TASK DNA (equivalent to the usage in electrophysiological studies <ce:cross-ref refid=\"FIG3\">[Figure 3]</ce:cross-ref>). A dose-response study of TASK-mediated inhibition of particle release showed up to 3-fold inhibition of particle release, with a minimal effect on total viral protein production <ce:cross-ref refid=\"FIG4\">(Figure 4B)</ce:cross-ref>. On the other hand, TASK-1 coexpression with pNL4-3/Udel lacking Vpu did not affect virus release (<ce:cross-ref refid=\"FIG4\">Figure 4A</ce:cross-ref>, pNL4-3/Udel + TASK). Therefore, the suppressive effect of TASK-1 on HIV-1 is Vpu specific. These data further reinforce the notion that Vpu and TASK engage in hetero-oligomer formation, disrupting their individual multimeric structures. While it is likely that, in actively HIV-1-infected cells, the Vpu/TASK ratio is in favor of Vpu and that most of the inhibitory effect would be directed against TASK, overexpressing TASK has allowed us to further characterize the mechanism of TASK-Vpu interaction.</ce:para>\\n                  </ce:section>\\n                  <ce:section view=\"all\">\\n                     <ce:section-title>Vpu as a Mimic of the First Transmembrane Segment of TASK</ce:section-title>\\n                     <ce:para view=\"all\">There is much resemblance between the TASK-Vpu interaction and the effect of a truncated Kv channel polypeptide on native Kv channels <ce:cross-ref refid=\"BIB4\">(Babila et al., 1994)</ce:cross-ref>. An N-terminal TM1-containing fragment of Kv1.1 was shown to spontaneously oligomerize with native Kv1 subunits in vitro <ce:cross-ref refid=\"BIB16\">(Folco et al., 1997)</ce:cross-ref> and in transgenic mice <ce:cross-ref refid=\"BIB28\">(London et al., 1998)</ce:cross-ref>. Such coassembly resulted in inhibition of endogenous Kv conductance, presumably due to the formation of misfolded and nonfunctional hetero-oligomers.</ce:para>\\n                     <ce:para view=\"all\">If the homology between HIV-1 Vpu and TASK is indeed evolutionarily meaningful, the inhibitory mechanism of Vpu on TASK may resemble that whereby a truncated Kv polypeptide suppresses native voltage-gated K<ce:sup loc=\"post\">+</ce:sup> channels. First, to establish that TASK can also be inhibited by its N-terminal TM-containing fragment, we constructed a TASK-1 truncation that comprises the NH<ce:inf loc=\"post\">2</ce:inf> terminus and the first TM segment (“Ttm1”). Coexpression of Ttm1 with TASK suppressed TASK current, in analogy with previous observations for voltage-gated K<ce:sup loc=\"post\">+</ce:sup> channels <ce:cross-ref refid=\"BIB4\">(Babila et al., 1994)</ce:cross-ref>. More importantly, the suppression of TASK current by Ttm1 closely resembled that by HIV-1 Vpu <ce:cross-refs refid=\"FIG5 FIG3\">(Figures 5 and 3B)</ce:cross-refs>\\n                        <ce:float-anchor refid=\"FIG5\"/>.</ce:para>\\n                     <ce:para view=\"all\">The dose-response analysis, however, reveals that the mechanism of TASK inhibition by Ttm1 is not identical to that by Vpu. Ttm1 overexpression did not completely eliminate the TASK-1-specific current. The maximal Ttm1-imposed inhibition was reached with 0.2 μg of Ttm1 DNA in cotransfection (DNA molar ratio of TASK: Ttm1 ≅ 2: 1). Further increase of Ttm1 doses did not enhance suppression of TASK, and there was always some residual TASK-1-specific current <ce:cross-ref refid=\"FIG5\">(Figure 5)</ce:cross-ref>. On the other hand, Vpu-imposed inhibition of TASK appears to be directly proportional to the quantity of Vpu DNA applied in transfection. Unlike Ttm1-imposed inhibition, increasing Vpu quantities in transfection could completely suppress TASK current (TASK: Vpu ≅ 1: 2) <ce:cross-ref refid=\"FIG3\">(Figure 3B)</ce:cross-ref>.</ce:para>\\n                  </ce:section>\\n                  <ce:section view=\"all\">\\n                     <ce:section-title>TASK Degradation during HIV-1 Infection</ce:section-title>\\n                     <ce:para view=\"all\">Although the mechanism previously invoked to account for TASK inhibition by Vpu could only involve disruption of the TASK complexes, Vpu is also known to function as a connector between target proteins and the ubiquitin-proteasome degradation pathway. It is therefore conceivable that Vpu-TASK interactions lead to the recruitment of the SCF<ce:sup loc=\"post\">TrCP</ce:sup> E3 ligase and degradation of TASK, as observed in the case of CD4 <ce:cross-ref refid=\"BIB30\">(Margottin et al., 1998)</ce:cross-ref>. To address this possibility, we monitored TASK-1 expression in primary lymphocytes during HIV-1 infection. CD4<ce:sup loc=\"post\">+</ce:sup> T lymphocytes on the third day of PHA activation were infected with HIV-1 by spin inoculation <ce:cross-ref refid=\"BIB35\">(Pierson et al., 2002)</ce:cross-ref>. On day 2 or 3 postinfection, endogenous TASK-1 was extracted and compared among the three groups: infected cells, plus uninfected (control) cells at t = 0 and at t = 48–72 hr postinfection. TASK expression was significantly reduced in HIV-1 infected cells. The two groups of uninfected cells exhibited similar TASK levels, indicating that PHA activation after day 3 did not affect endogenous TASK expression <ce:cross-ref refid=\"FIG6\">(Figure 6A)</ce:cross-ref>\\n                        <ce:float-anchor refid=\"FIG6\"/>. Despite the decreasing expression of TASK in the infected sample, Vpu was still identified in the TASK complexes from immunoprecipitation.</ce:para>\\n                     <ce:para view=\"all\">We have also identified βTrCP, a component of the ubiquitin-proteasome degradation pathway that binds to Vpu <ce:cross-ref refid=\"BIB30\">(Margottin et al., 1998)</ce:cross-ref>, in the TASK precipitates from AIDS samples <ce:cross-ref refid=\"FIG6\">(Figure 6B)</ce:cross-ref>. Taken together, the physical associations among TASK, Vpu, and βTrCP during HIV-1 infection may lead to acceleration of TASK degradation in primary cells. The data also suggest that Vpu-imposed inhibition of TASK conductance <ce:cross-ref refid=\"FIG3\">(Figure 3)</ce:cross-ref> occurs at least partly through acceleration of TASK degradation.</ce:para>\\n                  </ce:section>\\n                  <ce:section view=\"all\">\\n                     <ce:section-title>Ttm1 as Functionally Equivalent to Vpu in HIV-1 Release</ce:section-title>\\n                     <ce:para view=\"all\">Our findings that Vpu inhibits TASK activity might conceivably be used to further define the mechanism by which Vpu enhances viral particle release and to gain a better understanding of the evolutionary origin of this HIV-1-specific protein. If Vpu was indeed pirated from TASK, its major function—support of particle release—may have a structural root in host TASK. As Vpu-mediated viral release requires conservation of the Vpu TM region, the structural root of this function could be the first transmembrane region of TASK. Therefore, we extended our investigation of Ttm1 to viral particle release.</ce:para>\\n                     <ce:para view=\"all\">To determine whether Ttm1 could mimic the effects of Vpu on viral particle release, Ttm1 was coexpressed with the Vpu-defective pNL4-3/Udel. Virus release efficiency of NL4-3/Udel was set as the baseline (<ce:cross-ref refid=\"FIG7\">Figure 7</ce:cross-ref>\\n                        <ce:float-anchor refid=\"FIG7\"/>: fold = 1). Transfection of as little as 0.18 μg Ttm1 DNA significantly enhanced HIV-1 release. This enhancer effect of Ttm1 was comparable to that of Vpu applied <ce:italic>in trans</ce:italic> to pNL4-3/Udel <ce:cross-ref refid=\"FIG7\">(Figure 7)</ce:cross-ref>. Although Ttm1 seems to be more effective than Vpu in suppressing viral release at 40 hr posttransfection, differences persist throughout the entire time course, with an eventual reversal of the apparent efficacy; this suggests that the kinetics of protein synthesis and lifetime may differ between Vpu and Ttm1. We also observed a gradual diminution of the Ttm1 enhancer effect with increasing Ttm1 doses (data not shown). This is possibly contributed by a cytotoxic effect of Ttm1 overexpression, as overexpression of Vpu also imposes considerable cytotoxicity <ce:cross-ref refid=\"BIB3\">(Akari et al., 2001)</ce:cross-ref>.</ce:para>\\n                  </ce:section>\\n               </ce:section>\\n               <ce:section view=\"all\">\\n                  <ce:section-title>Discussion</ce:section-title>\\n                  <ce:para view=\"all\">This work began with the hypothesis that the mammalian K<ce:sup loc=\"post\">+</ce:sup> channel TASK-1 could oligomerize with HIV-1 Vpu given their structural homology <ce:cross-ref refid=\"FIG1\">(Figure 1)</ce:cross-ref>. We indeed found the TASK-Vpu interaction in vitro, and in lymphoid tissues from AIDS donors <ce:cross-refs refid=\"FIG2 FIG6\">(Figures 2 and 6)</ce:cross-refs>. Functional studies point to bidirectional destruction as a consequence of oligomerization: HIV-1 Vpu could inhibit host TASK current <ce:cross-ref refid=\"FIG3\">(Figure 3)</ce:cross-ref>, while TASK expression could also restrain Vpu-mediated virus release <ce:cross-ref refid=\"FIG4\">(Figure 4)</ce:cross-ref>. Due to the ubiquitous expression of TASK in tissues (heart, brain/neurons, lung, kidney/glomerulosa, placenta, peripheral blood, and CD4<ce:sup loc=\"post\">+</ce:sup> T lymphocytes), the consequences of the TASK-Vpu interactions are likely multifold and clinically relevant.</ce:para>\\n                  <ce:para view=\"all\">Their disproportionate protein sizes suggest that Vpu likely acts as a “viral auxiliary subunit” to TASK. Many K<ce:sup loc=\"post\">+</ce:sup> channel complexes have been shown to incorporate small integral membrane proteins that contain a single transmembrane span. Coassembly of the main channel α-subunits with such auxiliary subunits often modify the original channel properties <ce:cross-refs refid=\"BIB1 BIB32 BIB37 BIB39\">(Abbott and Goldstein, 1998; McDonald et al., 1997; Sesti et al., 2000; Shimbo et al., 1995)</ce:cross-refs>. This is well illustrated by the interaction between the cardiac K<ce:sup loc=\"post\">+</ce:sup> channel HERG and a single TM protein, MiRP1 <ce:cross-ref refid=\"BIB2\">(Abbott et al., 1999)</ce:cross-ref>. Besides functional modulation, auxiliary subunits may also influence the biogenesis/trafficking of channel α-subunits.</ce:para>\\n                  <ce:para view=\"all\">On the other hand, the global homology of Vpu to the first quarter of TASK implies that the basis of their coassembly is similar to the basis of oligomerization of homologous channel subunits, provided that the TM1-containing fragment is essential for K<ce:sup loc=\"post\">+</ce:sup> channel assembly <ce:cross-ref refid=\"BIB4\">(Babila et al., 1994)</ce:cross-ref>. We have indeed observed functional mimicry between Vpu and the first TM segment of TASK-1 (Ttm1): both are capable of inhibiting TASK-1 current and promoting viral particle release <ce:cross-refs refid=\"FIG5 FIG7\">(Figures 5 and 7)</ce:cross-refs>. These similarities support our initial conjecture that Vpu was pirated from host TASK during the evolution of HIV-1. Upon viral infection, the cellular machinery for TASK or K<ce:sup loc=\"post\">+</ce:sup> channel ontogeny is co-opted and redirected by Vpu. We indeed observed substantial TASK degradation in primary CD4<ce:sup loc=\"post\">+</ce:sup> T cells infected with HIV-1 in vitro <ce:cross-ref refid=\"FIG6\">(Figure 6)</ce:cross-ref>.</ce:para>\\n                  <ce:para view=\"all\">The mechanisms that Vpu can employ to impair TASK currents were deduced by comparing the dose-response relationships of Ttm1- and Vpu-imposed inhibitions <ce:cross-refs refid=\"FIG3 FIG5\">(Figures 3B and 5)</ce:cross-refs>. While overexpression of Vpu could completely eliminate TASK current, application of Ttm1 at any dose could not. The differences are likely attributable to the non-TM sequence of Vpu that Ttm1 lacks. Ttm1 overexpression at most results in intracellular accumulation of full-length channel subunits and reduction of functional TASK. On the other hand, the Vpu cytoplasmic tail interacts with βTrCP in the ubiquitin-proteasome degradation pathway, and it is this interaction that promotes the degradation of CD4 in infected T lymphocytes. Endogenous TASK-1 probably is targeted for degradation in the same way during HIV-1 infection <ce:cross-ref refid=\"FIG6\">(Figure 6)</ce:cross-ref>. Thus, Vpu is capable of (1) limiting TASK function through transmembrane interactions, and (2) accelerating TASK degradation through its cytoplasmic association with the ubiquitin-degradation pathway. The latter is analogous to HIV-1 Vif-induced proteasome degradation of the host antiviral enzyme APOBEC3G <ce:cross-refs refid=\"BIB31 BIB38 BIB41\">(Marin et al., 2003; Sheehy et al., 2003; Stopak et al., 2003)</ce:cross-refs>. Future studies using the proteasome inhibitors, <ce:italic>trans</ce:italic>-dominant TrCPΔF, and Vpu26 will determine whether SCF-TrCP assists Vpu in degradation of TASK <ce:cross-refs refid=\"BIB10 BIB30\">(Bour et al., 2001; Margottin et al., 1998)</ce:cross-refs>.</ce:para>\\n                  <ce:para view=\"all\">It seems paradoxical that Ttm1 appears more effective than Vpu in suppressing viral release (at 40 hr posttransfection, <ce:cross-ref refid=\"FIG7\">Figure 7</ce:cross-ref>), but Ttm1 inhibits TASK channel activity to the same extent as does Vpu <ce:cross-refs refid=\"FIG5 FIG3\">(Figures 5 and 3B)</ce:cross-refs>. While Ttm1 is specifically designed to interact with TASK, Vpu has a number of cellular targets other than TASK; thus, TASK may be competing with other proteins for interaction with Vpu. Alternatively, the discrepancy may simply reflect different synthesis and/or turnover rates between Vpu and Ttm1.</ce:para>\\n                  <ce:para view=\"all\">TASK-Vpu oligomerization potentially destroys the individual normal functions of the two proteins. The functional implications are multiple, and are determined by two factors: (1) the divergency of the TM sequences of Vpu; and (2) their relative steady state levels. First, as suggested in the Ttm1 experiments <ce:cross-refs refid=\"FIG5 FIG7\">(Figures 5 and 7)</ce:cross-refs>, the transmembrane association between TASK and Vpu is the key to the bidirectional functional interference. We indeed found that some degree of randomization of the Vpu TM sequence could weaken its physical and functional interaction with TASK (see Supplemental Figure S1 at <ce:inter-ref xlink:href=\"http://www.molecule.org/cgi/content/full/14/2/259/dc1\" xlink:type=\"simple\">http://www.molecule.org/cgi/content/full/14/2/259/DC1</ce:inter-ref>), compounding the pathological complexity that may result from TASK-Vpu interactions.</ce:para>\\n                  <ce:para view=\"all\">The second factor determining TASK-Vpu association is their relative steady state protein expressions. Previous studies of HIV-mediated inhibition of cellular protein function have shown a tight dependence on the ratio between the viral effector and the cellular target. For example, the gp160 viral envelope protein precursor could form intracellular complexes with the CD4 receptor, leading to trapping of CD4 in the endoplasmic reticulum and complete downregulation from the cell surface <ce:cross-ref refid=\"BIB8\">(Bour et al., 1991)</ce:cross-ref>. However, this mechanism relies on the fact that levels of gp160 in HIV-infected cells were several-fold higher than that of CD4. Artificially reversing this ratio restored CD4 at the cell surface and led to quantitative trapping of gp160 in the ER instead <ce:cross-ref refid=\"BIB11\">(Buonocore and Rose, 1990)</ce:cross-ref>. As TASK expression varies in different specialized cells, and Vpu expression also varies depending on infection conditions, the outcomes of their interaction would not be expected to be the same in various HIV-1 accessible cell types. At a low level of TASK expression, such as in primary T lymphocytes, TASK-1 may be rapidly degraded when wrestling with Vpu during infection. In other HIV-1 reservoirs, such as neurons <ce:cross-ref refid=\"BIB6\">(Bagasra et al., 1996)</ce:cross-ref> and kidney <ce:cross-ref refid=\"BIB47\">(Winston et al., 2001)</ce:cross-ref>, the high expression of TASK-1 <ce:cross-ref refid=\"BIB44\">(Talley et al., 2001)</ce:cross-ref> may pose an inhibitory effect on the spread of viruses, at the expense of having TASK channels degraded at an abnormal rate. The counteracting effects of TASK-1 on Vpu seemingly negate any selective advantage attributable to molecular piracy. In any case, this molecular pas de deux may ultimately serve to stabilize the virus-host relationship, facilitating the cellular and anatomical reservoirs of HIV-1 in infected patients <ce:cross-refs refid=\"BIB6 BIB7 BIB18 BIB47\">(Bagasra et al., 1996; Bour and Strebel, 2003; Greene and Peterlin, 2002; Winston et al., 2001)</ce:cross-refs>.</ce:para>\\n               </ce:section>\\n               <ce:section view=\"all\">\\n                  <ce:section-title>Experimental Procedures</ce:section-title>\\n                  <ce:section view=\"all\">\\n                     <ce:section-title>Plasmids</ce:section-title>\\n                     <ce:para view=\"all\">The coding sequence of rat TASK1 (AF031384) was subcloned into the expression vector pCGI (pGFPIRS <ce:cross-ref refid=\"BIB20\">[Johns et al., 1997]</ce:cross-ref>) to generate pCGI-TASK1. The GFP-TASK1 fusion construct (pGT) was made by subcloning rat TASK1 into pEGFP-C2 (CLONTECH). The coding sequence of Vpu from the HIV-1 PLAI plasmid was subcloned into two similar bicistronic vectors: pCCI (CFP instead of GFP) and pAdC8I, which has CD8 as the reporter gene <ce:cross-ref refid=\"BIB19\">(Hoppe et al., 1999)</ce:cross-ref>. Ttm1, a naturally occurring TASK-1 mutant comprising the first 40 residues with point mutation E37A, was subcloned into pCGI (pCGI-Ttm1).</ce:para>\\n                  </ce:section>\\n                  <ce:section view=\"all\">\\n                     <ce:section-title>Antibodies</ce:section-title>\\n                     <ce:para view=\"all\">The polyclonal rat anti-TASK1 antibody was custom produced against a synthetic C-terminal peptide of human TASK1 (EDEKRDAEHRALLTRNGQ) by BIOSYNTHESIS, INC., and further purified through a peptide-specific column (AminoLink Plus Immobilization kit, Pierce). The rabbit anti-Vpu antibody (U2-3) was made as described previously <ce:cross-ref refid=\"BIB29\">(Maldarelli et al., 1993)</ce:cross-ref>.</ce:para>\\n                  </ce:section>\\n                  <ce:section view=\"all\">\\n                     <ce:section-title>Cells, Specimens, and Infection</ce:section-title>\\n                     <ce:para view=\"all\">HEK-293 and A549 cells were maintained in Dulbecco\\'s modified Eagle\\'s medium (DMEM) containing 10% fetal bovine serum (FBS) and 5 μg/mL plasmocin (ant-mpp, InvivoGen, San Diego, CA). HeLa cells were maintained in Eagle\\'s minimum essential medium (EMEM) supplementing with 1× nonessential amino acids, same FBS and antibiotics. The autopsied lymph nodes retrieved by National Disease Research Interchange were from an AIDS donor who refused any antiretroviral treatments. PBMC obtained from HIV-negative donors were maintained in STCM (RPMI, 10% fetal calf serum, interleukin-2 [100 U/ml], T cell growth factor), followed by 3 days of phytohemagglutinin activation and depletion of CD8<ce:sup loc=\"post\">+</ce:sup> cells. Primary CD4<ce:sup loc=\"post\">+</ce:sup> T lymphocytes were HIV-1 infected on the third day of PHA activation by 2 hr of spin inoculation, as previously described <ce:cross-ref refid=\"BIB35\">(Pierson et al., 2002)</ce:cross-ref>, followed by 2 to 3 days of incubation.</ce:para>\\n                  </ce:section>\\n                  <ce:section view=\"all\">\\n                     <ce:section-title>Immunohistochemistry and Confocal Microscopy</ce:section-title>\\n                     <ce:para view=\"all\">A549 cells were cotransfected with pCD4U and pGT using LipofectAMINE Plus (Invitrogen). Within 36–48 hr, CD4U was immunolabeled with T4-4 antibody followed by Alexa Fluor 568-conjugated anti-rabbit antibody (Molecular Probes); the green Fluorescence of GT was enhanced by labeling with Alexa Fluor 488-conjugated anti-GFP antibody. Confocal images were taken on a Zeiss LSM 410 confocal microscope.</ce:para>\\n                  </ce:section>\\n                  <ce:section view=\"all\">\\n                     <ce:section-title>Coimmunoprecipitation and Western Blot</ce:section-title>\\n                     <ce:para view=\"all\">Heterologous expressions in HEK-293 cells were introduced by transient transfection. Within 36–48 hr posttransduction, these cells were lysed in digitonin lysis buffer (0.8–1% digitonin, Dnase, and complete protease inhibitor cocktail in PBS) at 4°C for 40 min. The rat anti-TASK1 antibody was preincubated with anti-rat coated magnetic beads (Dynal) prior to DMP crosslinking. Alternatively, the rabbit anti-TASK1 antibody (Alomone) crosslinked with protein-A coated Dynal beads was used. Both the rat and the rabbit anti-TASK antibodies were equally potent for IP. Cell lysates were immunoprecipitated with antibody-crosslinked beads overnight. After immunoprecipitation, beads were washed 10 times beginning and ending with low-salt wash buffer (0.1% digitonin, 50 mM Tris-HCl [pH 8.0], and 150 mM KCl). During middle washes the salt content was increased to 500 mM KCl. TASK1 complexes were eluted and dissociated in 2% LDS sample buffer (Invitrogen) supplemented with 20 mM DTT at 37°C for 30 min, and analyzed by Western blot.</ce:para>\\n                  </ce:section>\\n                  <ce:section view=\"all\">\\n                     <ce:section-title>Electrophysiology</ce:section-title>\\n                     <ce:para view=\"all\">HEK-293 cells on a 6-well plate were transiently transfected with 0.4 μg of pCGI-TASK alone, or with both 0.4 μg of TASK and 0.4 μg of pAdC8I-Vpu. Whole-cell current recording was performed during day 1 to day 3 posttransfection, at room temperature (21–23°C). Due to the use of the bicistronic construct pCGI-TASK1, cells expressing TASK1 exhibited green fluorescence. Similarly, cells transfected with pAdC8I-Vpu expressed both Vpu and CD8. CD8-positive cells were identified by immunostaining with anti-CD8 Quantum Red conjugate antibody (clone UCHT-4, Sigma). Coexpression was determined by both green and red Fluorescence. Whole-cell currents of the transfected cells were recorded using an Axonpatch 200B patch-clamp amplifier and filtered at 5 kHz. The membrane potential was held at 0 mV, before applying a voltage step of 100 msec, starting from –100 to 80 mV with an increment of 20 mV every 2 s. The bath solution contained (in mM) NaCl, 140; KCl, 5; Ca(OH)<ce:inf loc=\"post\">2</ce:inf>, 2; Mg(OH)<ce:inf loc=\"post\">2</ce:inf>, 1; glucose, 10; and HEPES, 10 (pH 7.4). The internal pipette solution contained (in mM) NaCl, 5; KCl, 120; MgCl<ce:inf loc=\"post\">2</ce:inf>, 1; EGTA, 2; HEPES, 10; and Mg-ATP, 2.5 (pH 7.2). In differential blockade experiments, continuous perfusion began with (1) the bath solution, (2) the bath solution without K<ce:sup loc=\"post\">+</ce:sup>, (3) removal of K<ce:sup loc=\"post\">+</ce:sup> and addition of 10 mM TEA<ce:sup loc=\"post\">+</ce:sup>, and last (4) removal of K<ce:sup loc=\"post\">+</ce:sup> and addition of both 10 mM TEA<ce:sup loc=\"post\">+</ce:sup> and 2 mM Ba<ce:sup loc=\"post\">2+</ce:sup>. Before each change of solution, the step protocol was applied for recording. Leak current was not subtracted throughout. The currents recorded at each voltage step were averaged among the mid-40 msec and divided by individual cell capacitance to express current densities (pA/pF). The Ba<ce:sup loc=\"post\">2+</ce:sup>-sensitive, TEA<ce:sup loc=\"post\">+</ce:sup>-insensitive TASK1 current component was determined by subtraction of the current-voltage relationships taken at the third and the fourth perfusion <ce:cross-ref refid=\"BIB5\">(Backx and Marbán, 1993)</ce:cross-ref>. For measurements of pH-sensitive currents, continuous perfusion was switched between the bath solution (pH 7.5) and the same solution adjusted to pH 8.5. The pH-sensitive TASK-1 current was defined as the difference in currents at pH 7.5 and pH 8.5. Vpu-expressing, apoptotic cells were identified using annexin V markers and propidium iodide (Molecular Probes).</ce:para>\\n                  </ce:section>\\n                  <ce:section view=\"all\">\\n                     <ce:section-title>Virus Release Assay</ce:section-title>\\n                     <ce:para view=\"all\">HeLa cells plated in P25 flasks were transiently transfected at 50% confluency with 2–3 μg of a HIV-1 proviral construct (pNL4-3, pNL4-3/Udel), and with of one of the constructs: pCGI (0.7 μg), pCGI-HERG (0.7 μg), pCGI-TASK1 (0.7 μg), or pCGI-Ttm1 (0.18 μg) using LipofectAMINE 2000 (Invitrogen). Various quantities of pCGI-TASK1 and pCGI-Ttm1 (0.18 μg, 0.35 μg, 0.70 μg, and 1.4 μg) have been assessed for optimization in virus release assays. At specific time-points posttransfection, one-tenth of the culture medium was retrieved from each sample and filtered through a 0.22 mm syringe filter. The viral content in culture medium was determined by Coulter HIV-1 p24 Antigen Assay kit. Data from individual experiments were averaged and expressed in mean ± SEM. The K<ce:sup loc=\"post\">+</ce:sup> channel effects on virus release were compared with respect to the control (cotransfection of pNL4-3 and pCGI). The comparisons were made using a Student\\'s <ce:italic>t</ce:italic>-Test. <ce:italic>P</ce:italic> &lt; 0.05 were deemed significant.</ce:para>\\n                  </ce:section>\\n               </ce:section>\\n            </ce:sections>\\n            <ce:acknowledgment>\\n               <ce:section-title>Acknowledgements</ce:section-title>\\n               <ce:para view=\"all\">We thank the National Disease Research Interchange for providing autopsied tissues from AIDS donors without antiretroviral treatments, O. Laeyendecker and T.C. Quinn for providing HIV/AIDS PBMC samples, J. Kajdas and R.F. Siliciano for providing the PBMC of HIV-negative donors, C.S. Yost (U.C.S.F.) for providing the rat TASK-1 gene, D. Disilvestre and G. Tomaselli for providing pCGI-HERG, H. Zhang and Y. Zhou for assistance in HIV experiments, and B. O\\'Rourke and J. Hildreth for critical reading of the manuscript. The work was supported by an NIH grant to E.M (R37 HL 36957).</ce:para>\\n            </ce:acknowledgment>\\n            <ce:appendices view=\"all\">\\n               <ce:section view=\"extended\">\\n                  <ce:section-title>Supplementary Material</ce:section-title>\\n                  <ce:para view=\"all\">\\n                     <display>\\n                        <ce:e-component>\\n                           <ce:link locator=\"mmc1\"/>\\n                        </ce:e-component>\\n                     </display>\\n                  </ce:para>\\n               </ce:section>\\n            </ce:appendices>\\n         </body>\\n         <tail>\\n            <ce:bibliography view=\"all\">\\n               <ce:section-title>References</ce:section-title>\\n               <ce:bibliography-sec>\\n                  <ce:bib-reference id=\"BIB1\">\\n                     <ce:label>Abbott and Goldstein 1998</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>G.W.</ce:given-name>\\n                                 <ce:surname>Abbott</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>S.A.</ce:given-name>\\n                                 <ce:surname>Goldstein</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>A superfamily of small potassium channel subunits</sb:maintitle>\\n                              <sb:subtitle>form and function of the MinK-related peptides (MiRPs)</sb:subtitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Q. Rev. Biophys.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>31</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1998</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>357</sb:first-page>\\n                              <sb:last-page>398</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB2\">\\n                     <ce:label>Abbott et al. 1999</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>G.W.</ce:given-name>\\n                                 <ce:surname>Abbott</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>F.</ce:given-name>\\n                                 <ce:surname>Sesti</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>I.</ce:given-name>\\n                                 <ce:surname>Splawski</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>M.E.</ce:given-name>\\n                                 <ce:surname>Buck</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>M.H.</ce:given-name>\\n                                 <ce:surname>Lehmann</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>K.W.</ce:given-name>\\n                                 <ce:surname>Timothy</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>M.T.</ce:given-name>\\n                                 <ce:surname>Keating</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>S.A.</ce:given-name>\\n                                 <ce:surname>Goldstein</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Cell</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>97</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1999</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>175</sb:first-page>\\n                              <sb:last-page>187</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB3\">\\n                     <ce:label>Akari et al. 2001</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>H.</ce:given-name>\\n                                 <ce:surname>Akari</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>S.</ce:given-name>\\n                                 <ce:surname>Bour</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>S.</ce:given-name>\\n                                 <ce:surname>Kao</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>A.</ce:given-name>\\n                                 <ce:surname>Adachi</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>K.</ce:given-name>\\n                                 <ce:surname>Strebel</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>The human immunodeficiency virus type 1 accessory protein Vpu induces apoptosis by suppressing the nuclear factor kappaB-dependent expression of antiapoptotic factors</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>J. Exp. Med.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>194</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>2001</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>1299</sb:first-page>\\n                              <sb:last-page>1311</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB4\">\\n                     <ce:label>Babila et al. 1994</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>T.</ce:given-name>\\n                                 <ce:surname>Babila</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>A.</ce:given-name>\\n                                 <ce:surname>Moscucci</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>H.</ce:given-name>\\n                                 <ce:surname>Wang</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>F.E.</ce:given-name>\\n                                 <ce:surname>Weaver</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>G.</ce:given-name>\\n                                 <ce:surname>Koren</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Assembly of mammalian voltage-gated potassium channels</sb:maintitle>\\n                              <sb:subtitle>evidence for an important role of the first transmembrane segment</sb:subtitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Neuron</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>12</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1994</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>615</sb:first-page>\\n                              <sb:last-page>626</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB5\">\\n                     <ce:label>Backx and Marbán 1993</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>P.H.</ce:given-name>\\n                                 <ce:surname>Backx</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>E.</ce:given-name>\\n                                 <ce:surname>Marbán</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Background potassium current active during the plateau of the action potential in guinea pig ventricular myocytes</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Circ. Res.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>72</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1993</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>890</sb:first-page>\\n                              <sb:last-page>900</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB6\">\\n                     <ce:label>Bagasra et al. 1996</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>O.</ce:given-name>\\n                                 <ce:surname>Bagasra</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>E.</ce:given-name>\\n                                 <ce:surname>Lavi</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>L.</ce:given-name>\\n                                 <ce:surname>Bobroski</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>K.</ce:given-name>\\n                                 <ce:surname>Khalili</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>J.P.</ce:given-name>\\n                                 <ce:surname>Pestaner</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>R.</ce:given-name>\\n                                 <ce:surname>Tawadros</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>R.J.</ce:given-name>\\n                                 <ce:surname>Pomerantz</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Cellular reservoirs of HIV-1 in the central nervous system of infected individuals</sb:maintitle>\\n                              <sb:subtitle>identification by the combination of in situ polymerase chain reaction and immunohistochemistry</sb:subtitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>AIDS</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>10</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1996</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>573</sb:first-page>\\n                              <sb:last-page>585</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB7\">\\n                     <ce:label>Bour and Strebel 2003</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>S.</ce:given-name>\\n                                 <ce:surname>Bour</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>K.</ce:given-name>\\n                                 <ce:surname>Strebel</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>The HIV-1 Vpu protein</sb:maintitle>\\n                              <sb:subtitle>a multifunctional enhancer of viral particle release</sb:subtitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Microbes Infect.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>5</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>2003</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>1029</sb:first-page>\\n                              <sb:last-page>1039</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB8\">\\n                     <ce:label>Bour et al. 1991</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>S.</ce:given-name>\\n                                 <ce:surname>Bour</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>F.</ce:given-name>\\n                                 <ce:surname>Boulerice</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>M.A.</ce:given-name>\\n                                 <ce:surname>Wainberg</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Inhibition of gp160 and CD4 maturation in U937 cells after both defective and productive infections by human immunodeficiency virus type 1</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>J. Virol.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>65</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1991</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>6387</sb:first-page>\\n                              <sb:last-page>6396</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB9\">\\n                     <ce:label>Bour et al. 1999</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>S.</ce:given-name>\\n                                 <ce:surname>Bour</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>C.</ce:given-name>\\n                                 <ce:surname>Perrin</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>K.</ce:given-name>\\n                                 <ce:surname>Strebel</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Cell surface CD4 inhibits HIV-1 particle release by interfering with Vpu activity</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>J. Biol. Chem.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>274</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1999</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>33800</sb:first-page>\\n                              <sb:last-page>33806</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB10\">\\n                     <ce:label>Bour et al. 2001</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>S.</ce:given-name>\\n                                 <ce:surname>Bour</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>C.</ce:given-name>\\n                                 <ce:surname>Perrin</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>H.</ce:given-name>\\n                                 <ce:surname>Akari</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>K.</ce:given-name>\\n                                 <ce:surname>Strebel</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>The human immunodeficiency virus type 1 Vpu protein inhibits NF-kappa B activation by interfering with beta TrCP-mediated degradation of Ikappa B</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>J. Biol. Chem.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>276</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>2001</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>15920</sb:first-page>\\n                              <sb:last-page>15928</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB11\">\\n                     <ce:label>Buonocore and Rose 1990</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>L.</ce:given-name>\\n                                 <ce:surname>Buonocore</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>J.K.</ce:given-name>\\n                                 <ce:surname>Rose</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Prevention of HIV-1 glycoprotein transport by soluble CD4 retained in the endoplasmic reticulum</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Nature</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>345</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1990</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>625</sb:first-page>\\n                              <sb:last-page>628</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB12\">\\n                     <ce:label>Coady et al. 1998</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>M.J.</ce:given-name>\\n                                 <ce:surname>Coady</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>N.G.</ce:given-name>\\n                                 <ce:surname>Daniel</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>E.</ce:given-name>\\n                                 <ce:surname>Tiganos</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>B.</ce:given-name>\\n                                 <ce:surname>Allain</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>J.</ce:given-name>\\n                                 <ce:surname>Friborg</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>J.Y.</ce:given-name>\\n                                 <ce:surname>Lapointe</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>E.A.</ce:given-name>\\n                                 <ce:surname>Cohen</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Effects of Vpu expression on Xenopus oocyte membrane conductance</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Virology</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>244</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1998</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>39</sb:first-page>\\n                              <sb:last-page>49</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB13\">\\n                     <ce:label>Czirjak and Enyedi 2002</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>G.</ce:given-name>\\n                                 <ce:surname>Czirjak</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>P.</ce:given-name>\\n                                 <ce:surname>Enyedi</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Formation of functional heterodimers between the TASK-1 and TASK-3 two-pore domain potassium channel subunits</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>J. Biol. Chem.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>277</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>2002</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>5426</sb:first-page>\\n                              <sb:last-page>5432</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB14\">\\n                     <ce:label>Deutsch 2002</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>C.</ce:given-name>\\n                                 <ce:surname>Deutsch</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Potassium channel ontogeny</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Annu. Rev. Physiol.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>64</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>2002</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>19</sb:first-page>\\n                              <sb:last-page>46</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB15\">\\n                     <ce:label>Duprat et al. 1997</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>F.</ce:given-name>\\n                                 <ce:surname>Duprat</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>F.</ce:given-name>\\n                                 <ce:surname>Lesage</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>M.</ce:given-name>\\n                                 <ce:surname>Fink</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>R.</ce:given-name>\\n                                 <ce:surname>Reyes</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>C.</ce:given-name>\\n                                 <ce:surname>Heurteaux</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>M.</ce:given-name>\\n                                 <ce:surname>Lazdunski</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>TASK, a human background K+ channel to sense external pH variations near physiological pH</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>EMBO J.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>16</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1997</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>5464</sb:first-page>\\n                              <sb:last-page>5471</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB16\">\\n                     <ce:label>Folco et al. 1997</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>E.</ce:given-name>\\n                                 <ce:surname>Folco</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>R.</ce:given-name>\\n                                 <ce:surname>Mathur</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>Y.</ce:given-name>\\n                                 <ce:surname>Mori</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>P.</ce:given-name>\\n                                 <ce:surname>Buckett</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>G.</ce:given-name>\\n                                 <ce:surname>Koren</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>A cellular model for long QT syndrome. Trapping of heteromultimeric complexes consisting of truncated Kv1.1 potassium channel polypeptides and native Kv1.4 and Kv1.5 channels in the endoplasmic reticulum</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>J. Biol. Chem.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>272</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1997</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>26505</sb:first-page>\\n                              <sb:last-page>26510</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB17\">\\n                     <ce:label>Gonzalez and Carrasco 1998</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>M.E.</ce:given-name>\\n                                 <ce:surname>Gonzalez</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>L.</ce:given-name>\\n                                 <ce:surname>Carrasco</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>The human immunodeficiency virus type 1 Vpu protein enhances membrane permeability</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Biochemistry</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>37</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1998</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>13710</sb:first-page>\\n                              <sb:last-page>13719</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB18\">\\n                     <ce:label>Greene and Peterlin 2002</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>W.C.</ce:given-name>\\n                                 <ce:surname>Greene</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>B.M.</ce:given-name>\\n                                 <ce:surname>Peterlin</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Charting HIV\\'s remarkable voyage through the cell</sb:maintitle>\\n                              <sb:subtitle>basic science as a passport to future therapy</sb:subtitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Nat. Med.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>8</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>2002</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>673</sb:first-page>\\n                              <sb:last-page>680</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB19\">\\n                     <ce:label>Hoppe et al. 1999</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>U.C.</ce:given-name>\\n                                 <ce:surname>Hoppe</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>D.C.</ce:given-name>\\n                                 <ce:surname>Johns</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>E.</ce:given-name>\\n                                 <ce:surname>Marbán</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>B.</ce:given-name>\\n                                 <ce:surname>O\\'Rourke</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Manipulation of cellular excitability by cell fusion</sb:maintitle>\\n                              <sb:subtitle>effects of rapid introduction of transient outward K+ current on the guinea pig action potential</sb:subtitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Circ. Res.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>84</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1999</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>964</sb:first-page>\\n                              <sb:last-page>972</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB20\">\\n                     <ce:label>Johns et al. 1997</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>D.C.</ce:given-name>\\n                                 <ce:surname>Johns</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>H.B.</ce:given-name>\\n                                 <ce:surname>Nuss</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>E.</ce:given-name>\\n                                 <ce:surname>Marbán</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Suppression of neuronal and cardiac transient outward currents by viral gene transfer of dominant-negative Kv4.2 constructs</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>J. Biol. Chem.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>272</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1997</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>31598</sb:first-page>\\n                              <sb:last-page>31603</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB21\">\\n                     <ce:label>Kim et al. 1998</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>D.</ce:given-name>\\n                                 <ce:surname>Kim</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>A.</ce:given-name>\\n                                 <ce:surname>Fujita</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>Y.</ce:given-name>\\n                                 <ce:surname>Horio</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>Y.</ce:given-name>\\n                                 <ce:surname>Kurachi</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Cloning and functional expression of a novel cardiac two-pore background K+ channel (cTBAK-1)</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Circ. Res.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>82</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1998</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>513</sb:first-page>\\n                              <sb:last-page>518</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB22\">\\n                     <ce:label>Kim et al. 1999</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>Y.</ce:given-name>\\n                                 <ce:surname>Kim</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>H.</ce:given-name>\\n                                 <ce:surname>Bang</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>D.</ce:given-name>\\n                                 <ce:surname>Kim</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>TBAK-1 and TASK-1, two-pore K(+) channel subunits</sb:maintitle>\\n                              <sb:subtitle>kinetic properties and expression in rat heart</sb:subtitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Am. J. Physiol.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>277</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1999</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>H1669</sb:first-page>\\n                              <sb:last-page>H1678</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB23\">\\n                     <ce:label>Klimkait et al. 1990</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>T.</ce:given-name>\\n                                 <ce:surname>Klimkait</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>K.</ce:given-name>\\n                                 <ce:surname>Strebel</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>M.D.</ce:given-name>\\n                                 <ce:surname>Hoggan</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>M.A.</ce:given-name>\\n                                 <ce:surname>Martin</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>J.M.</ce:given-name>\\n                                 <ce:surname>Orenstein</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>J. Virol.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>64</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1990</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>621</sb:first-page>\\n                              <sb:last-page>629</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB24\">\\n                     <ce:label>Lakos et al. 1990</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>Z.</ce:given-name>\\n                                 <ce:surname>Lakos</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>B.</ce:given-name>\\n                                 <ce:surname>Somogyi</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>M.</ce:given-name>\\n                                 <ce:surname>Balazs</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>J.</ce:given-name>\\n                                 <ce:surname>Matko</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>S.</ce:given-name>\\n                                 <ce:surname>Damjanovich</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>The effect of transmembrane potential on the dynamic behavior of cell membranes</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Biochim. Biophys. Acta</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>1023</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1990</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>41</sb:first-page>\\n                              <sb:last-page>46</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB25\">\\n                     <ce:label>Lamb and Pinto 1997</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>R.A.</ce:given-name>\\n                                 <ce:surname>Lamb</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>L.H.</ce:given-name>\\n                                 <ce:surname>Pinto</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Do Vpu and Vpr of human immunodeficiency virus type 1 and NB of influenza B virus have ion channel activities in the viral life cycles?</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Virology</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>229</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1997</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>1</sb:first-page>\\n                              <sb:last-page>11</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB26\">\\n                     <ce:label>Lelkes 1979</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>P.I.</ce:given-name>\\n                                 <ce:surname>Lelkes</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Potential dependent riigidity changes in lipid membrane vesicles</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Biochem. Biophys. Res. Commun.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>90</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1979</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>656</sb:first-page>\\n                              <sb:last-page>662</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB27\">\\n                     <ce:label>Leonoudakis et al. 1998</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>D.</ce:given-name>\\n                                 <ce:surname>Leonoudakis</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>A.T.</ce:given-name>\\n                                 <ce:surname>Gray</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>B.D.</ce:given-name>\\n                                 <ce:surname>Winegar</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>C.H.</ce:given-name>\\n                                 <ce:surname>Kindler</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>M.</ce:given-name>\\n                                 <ce:surname>Harada</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>D.M.</ce:given-name>\\n                                 <ce:surname>Taylor</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>R.A.</ce:given-name>\\n                                 <ce:surname>Chavez</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>J.R.</ce:given-name>\\n                                 <ce:surname>Forsayeth</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>C.S.</ce:given-name>\\n                                 <ce:surname>Yost</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>An open rectifier potassium channel with two pore domains in tandem cloned from rat cerebellum</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>J. Neurosci.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>18</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1998</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>868</sb:first-page>\\n                              <sb:last-page>877</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB28\">\\n                     <ce:label>London et al. 1998</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>B.</ce:given-name>\\n                                 <ce:surname>London</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>A.</ce:given-name>\\n                                 <ce:surname>Jeron</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>J.</ce:given-name>\\n                                 <ce:surname>Zhou</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>P.</ce:given-name>\\n                                 <ce:surname>Buckett</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>X.</ce:given-name>\\n                                 <ce:surname>Han</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>G.F.</ce:given-name>\\n                                 <ce:surname>Mitchell</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>G.</ce:given-name>\\n                                 <ce:surname>Koren</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Long QT and ventricular arrhythmias in transgenic mice expressing the N terminus and first transmembrane segment of a voltage-gated potassium channel</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Proc. Natl. Acad. Sci. USA</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>95</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1998</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>2926</sb:first-page>\\n                              <sb:last-page>2931</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB29\">\\n                     <ce:label>Maldarelli et al. 1993</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>F.</ce:given-name>\\n                                 <ce:surname>Maldarelli</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>M.Y.</ce:given-name>\\n                                 <ce:surname>Chen</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>R.L.</ce:given-name>\\n                                 <ce:surname>Willey</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>K.</ce:given-name>\\n                                 <ce:surname>Strebel</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Human immunodeficiency virus type 1 Vpu protein is an oligomeric type I integral membrane protein</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>J. Virol.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>67</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1993</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>5056</sb:first-page>\\n                              <sb:last-page>5061</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB30\">\\n                     <ce:label>Margottin et al. 1998</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>F.</ce:given-name>\\n                                 <ce:surname>Margottin</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>S.P.</ce:given-name>\\n                                 <ce:surname>Bour</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>H.</ce:given-name>\\n                                 <ce:surname>Durand</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>L.</ce:given-name>\\n                                 <ce:surname>Selig</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>S.</ce:given-name>\\n                                 <ce:surname>Benichou</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>V.</ce:given-name>\\n                                 <ce:surname>Richard</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>D.</ce:given-name>\\n                                 <ce:surname>Thomas</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>K.</ce:given-name>\\n                                 <ce:surname>Strebel</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>R.</ce:given-name>\\n                                 <ce:surname>Benarous</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Mol. Cell</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>1</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1998</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>565</sb:first-page>\\n                              <sb:last-page>574</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB31\">\\n                     <ce:label>Marin et al. 2003</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>M.</ce:given-name>\\n                                 <ce:surname>Marin</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>K.M.</ce:given-name>\\n                                 <ce:surname>Rose</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>S.L.</ce:given-name>\\n                                 <ce:surname>Kozak</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>D.</ce:given-name>\\n                                 <ce:surname>Kabat</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Nat. Med.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>9</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>2003</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>1398</sb:first-page>\\n                              <sb:last-page>1403</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB32\">\\n                     <ce:label>McDonald et al. 1997</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>T.V.</ce:given-name>\\n                                 <ce:surname>McDonald</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>Z.</ce:given-name>\\n                                 <ce:surname>Yu</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>Z.</ce:given-name>\\n                                 <ce:surname>Ming</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>E.</ce:given-name>\\n                                 <ce:surname>Palma</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>M.B.</ce:given-name>\\n                                 <ce:surname>Meyers</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>K.W.</ce:given-name>\\n                                 <ce:surname>Wang</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>S.A.</ce:given-name>\\n                                 <ce:surname>Goldstein</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>G.I.</ce:given-name>\\n                                 <ce:surname>Fishman</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>A minK-HERG complex regulates the cardiac potassium current I(Kr)</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Nature</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>388</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1997</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>289</sb:first-page>\\n                              <sb:last-page>292</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB33\">\\n                     <ce:label>Ottschytsch et al. 2002</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>N.</ce:given-name>\\n                                 <ce:surname>Ottschytsch</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>A.</ce:given-name>\\n                                 <ce:surname>Raes</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>D.</ce:given-name>\\n                                 <ce:surname>Van Hoorick</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>D.J.</ce:given-name>\\n                                 <ce:surname>Snyders</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Obligatory heterotetramerization of three previously uncharacterized Kv channel alpha-subunits identified in the human genome</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Proc. Natl. Acad. Sci. USA</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>99</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>2002</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>7986</sb:first-page>\\n                              <sb:last-page>7991</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB34\">\\n                     <ce:label>Paul et al. 1998</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>M.</ce:given-name>\\n                                 <ce:surname>Paul</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>S.</ce:given-name>\\n                                 <ce:surname>Mazumder</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>N.</ce:given-name>\\n                                 <ce:surname>Raja</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>M.A.</ce:given-name>\\n                                 <ce:surname>Jabbar</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Mutational analysis of the human immunodeficiency virus type 1 Vpu transmembrane domain that promotes the enhanced release of virus-like particles from the plasma membrane of mammalian cells</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>J. Virol.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>72</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1998</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>1270</sb:first-page>\\n                              <sb:last-page>1279</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB35\">\\n                     <ce:label>Pierson et al. 2002</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>T.C.</ce:given-name>\\n                                 <ce:surname>Pierson</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>Y.</ce:given-name>\\n                                 <ce:surname>Zhou</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>T.L.</ce:given-name>\\n                                 <ce:surname>Kieffer</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>C.T.</ce:given-name>\\n                                 <ce:surname>Ruff</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>C.</ce:given-name>\\n                                 <ce:surname>Buck</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>R.F.</ce:given-name>\\n                                 <ce:surname>Siliciano</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Molecular characterization of preintegration latency in human immunodeficiency virus type 1 infection</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>J. Virol.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>76</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>2002</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>8518</sb:first-page>\\n                              <sb:last-page>8531</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB36\">\\n                     <ce:label>Schubert et al. 1996</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>U.</ce:given-name>\\n                                 <ce:surname>Schubert</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>A.V.</ce:given-name>\\n                                 <ce:surname>Ferrer-Montiel</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>M.</ce:given-name>\\n                                 <ce:surname>Oblatt-Montal</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>P.</ce:given-name>\\n                                 <ce:surname>Henklein</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>K.</ce:given-name>\\n                                 <ce:surname>Strebel</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>M.</ce:given-name>\\n                                 <ce:surname>Montal</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Identification of an ion channel activity of the Vpu transmembrane domain and its involvement in the regulation of virus release from HIV-1-infected cells</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>FEBS Lett.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>398</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1996</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>12</sb:first-page>\\n                              <sb:last-page>18</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB37\">\\n                     <ce:label>Sesti et al. 2000</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>F.</ce:given-name>\\n                                 <ce:surname>Sesti</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>K.K.</ce:given-name>\\n                                 <ce:surname>Tai</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>S.A.</ce:given-name>\\n                                 <ce:surname>Goldstein</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>MinK endows the I(Ks) potassium channel pore with sensitivity to internal tetraethylammonium</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Biophys. J.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>79</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>2000</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>1369</sb:first-page>\\n                              <sb:last-page>1378</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB38\">\\n                     <ce:label>Sheehy et al. 2003</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>A.M.</ce:given-name>\\n                                 <ce:surname>Sheehy</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>N.C.</ce:given-name>\\n                                 <ce:surname>Gaddis</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>M.H.</ce:given-name>\\n                                 <ce:surname>Malim</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Nat. Med.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>9</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>2003</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>1404</sb:first-page>\\n                              <sb:last-page>1407</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB39\">\\n                     <ce:label>Shimbo et al. 1995</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>K.</ce:given-name>\\n                                 <ce:surname>Shimbo</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>D.L.</ce:given-name>\\n                                 <ce:surname>Brassard</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>R.A.</ce:given-name>\\n                                 <ce:surname>Lamb</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>L.H.</ce:given-name>\\n                                 <ce:surname>Pinto</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Viral and cellular small integral membrane proteins can modify ion channels endogenous to Xenopus oocytes</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Biophys. J.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>69</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1995</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>1819</sb:first-page>\\n                              <sb:last-page>1829</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB40\">\\n                     <ce:label>Sinkovics et al. 1998</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>J.</ce:given-name>\\n                                 <ce:surname>Sinkovics</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>J.</ce:given-name>\\n                                 <ce:surname>Horvath</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>A.</ce:given-name>\\n                                 <ce:surname>Horak</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>The origin and evolution of viruses (a review)</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Acta Microbiol. Immunol. Hung.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>45</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1998</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>349</sb:first-page>\\n                              <sb:last-page>390</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB41\">\\n                     <ce:label>Stopak et al. 2003</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>K.</ce:given-name>\\n                                 <ce:surname>Stopak</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>C.</ce:given-name>\\n                                 <ce:surname>de Noronha</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>W.</ce:given-name>\\n                                 <ce:surname>Yonemoto</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>W.C.</ce:given-name>\\n                                 <ce:surname>Greene</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Mol. Cell</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>12</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>2003</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>591</sb:first-page>\\n                              <sb:last-page>601</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB42\">\\n                     <ce:label>Strebel et al. 1988</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>K.</ce:given-name>\\n                                 <ce:surname>Strebel</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>T.</ce:given-name>\\n                                 <ce:surname>Klimkait</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>M.A.</ce:given-name>\\n                                 <ce:surname>Martin</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>A novel gene of HIV-1, vpu, and its 16-kilodalton product</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Science</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>241</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1988</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>1221</sb:first-page>\\n                              <sb:last-page>1223</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB43\">\\n                     <ce:label>Strebel et al. 1989</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>K.</ce:given-name>\\n                                 <ce:surname>Strebel</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>T.</ce:given-name>\\n                                 <ce:surname>Klimkait</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>F.</ce:given-name>\\n                                 <ce:surname>Maldarelli</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>M.A.</ce:given-name>\\n                                 <ce:surname>Martin</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Molecular and biochemical analyses of human immunodeficiency virus type 1 vpu protein</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>J. Virol.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>63</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1989</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>3784</sb:first-page>\\n                              <sb:last-page>3791</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB44\">\\n                     <ce:label>Talley et al. 2001</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>E.M.</ce:given-name>\\n                                 <ce:surname>Talley</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>G.</ce:given-name>\\n                                 <ce:surname>Solorzano</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>Q.</ce:given-name>\\n                                 <ce:surname>Lei</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>D.</ce:given-name>\\n                                 <ce:surname>Kim</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>D.A.</ce:given-name>\\n                                 <ce:surname>Bayliss</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Cns distribution of members of the two-pore-domain (KCNK) potassium channel family</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>J. Neurosci.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>21</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>2001</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>7491</sb:first-page>\\n                              <sb:last-page>7505</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB45\">\\n                     <ce:label>Vink et al. 1999</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>C.</ce:given-name>\\n                                 <ce:surname>Vink</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>P.S.</ce:given-name>\\n                                 <ce:surname>Beisser</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>C.A.</ce:given-name>\\n                                 <ce:surname>Bruggeman</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Molecular mimicry by cytomegaloviruses. Function of cytomegalovirus-encoded homologues of G protein-coupled receptors, MHC class I heavy chains and chemokines</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Intervirology</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>42</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1999</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>342</sb:first-page>\\n                              <sb:last-page>349</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB46\">\\n                     <ce:label>Willey et al. 1992</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>R.L.</ce:given-name>\\n                                 <ce:surname>Willey</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>F.</ce:given-name>\\n                                 <ce:surname>Maldarelli</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>M.A.</ce:given-name>\\n                                 <ce:surname>Martin</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>K.</ce:given-name>\\n                                 <ce:surname>Strebel</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>J. Virol.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>66</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1992</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>7193</sb:first-page>\\n                              <sb:last-page>7200</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB47\">\\n                     <ce:label>Winston et al. 2001</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>J.A.</ce:given-name>\\n                                 <ce:surname>Winston</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>L.A.</ce:given-name>\\n                                 <ce:surname>Bruggeman</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>M.D.</ce:given-name>\\n                                 <ce:surname>Ross</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>J.</ce:given-name>\\n                                 <ce:surname>Jacobson</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>L.</ce:given-name>\\n                                 <ce:surname>Ross</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>V.D.</ce:given-name>\\n                                 <ce:surname>D\\'Agati</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>P.E.</ce:given-name>\\n                                 <ce:surname>Klotman</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>M.E.</ce:given-name>\\n                                 <ce:surname>Klotman</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>N. Engl. J. Med.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>344</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>2001</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>1979</sb:first-page>\\n                              <sb:last-page>1984</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n                  <ce:bib-reference id=\"BIB48\">\\n                     <ce:label>Wray et al. 1995</ce:label>\\n                     <sb:reference>\\n                        <sb:contribution langtype=\"en\">\\n                           <sb:authors>\\n                              <sb:author>\\n                                 <ce:given-name>V.</ce:given-name>\\n                                 <ce:surname>Wray</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>T.</ce:given-name>\\n                                 <ce:surname>Federau</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>P.</ce:given-name>\\n                                 <ce:surname>Henklein</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>S.</ce:given-name>\\n                                 <ce:surname>Klabunde</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>O.</ce:given-name>\\n                                 <ce:surname>Kunert</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>D.</ce:given-name>\\n                                 <ce:surname>Schomburg</ce:surname>\\n                              </sb:author>\\n                              <sb:author>\\n                                 <ce:given-name>U.</ce:given-name>\\n                                 <ce:surname>Schubert</ce:surname>\\n                              </sb:author>\\n                           </sb:authors>\\n                           <sb:title>\\n                              <sb:maintitle>Solution structure of the hydrophilic region of HIV-1 encoded virus protein U (Vpu) by CD and 1H NMR spectroscopy</sb:maintitle>\\n                           </sb:title>\\n                        </sb:contribution>\\n                        <sb:host>\\n                           <sb:issue>\\n                              <sb:series>\\n                                 <sb:title>\\n                                    <sb:maintitle>Int. J. Pept. Protein Res.</sb:maintitle>\\n                                 </sb:title>\\n                                 <sb:volume-nr>45</sb:volume-nr>\\n                              </sb:series>\\n                              <sb:date>1995</sb:date>\\n                           </sb:issue>\\n                           <sb:pages>\\n                              <sb:first-page>35</sb:first-page>\\n                              <sb:last-page>43</sb:last-page>\\n                           </sb:pages>\\n                        </sb:host>\\n                     </sb:reference>\\n                  </ce:bib-reference>\\n               </ce:bibliography-sec>\\n            </ce:bibliography>\\n         </tail>\\n      </converted-article>\\n   </xocs:serial-item>\\n</xocs:doc></originalText></full-text-retrieval-response>',\n",
       " 'Acid-sensitive, two-pore domain potassium channels, K(2P)3.1 and K(2P)9.1, are implicated in cardiac and nervous tissue responses to hormones, neurotransmitters and drugs. K(2P)3.1 and K(2P)9.1 leak potassium from the cell at rest and directly impact membrane potential. Hence altering channel number on the cell surface drives changes in cellular electrical properties. The rate of K(2P)3.1 and K(2P)9.1 delivery to and recovery from the plasma membrane determines both channel number at the cell surface and potassium leak from cells. This study examines the endocytosis of K(2P)3.1 and K(2P)9.1. Plasma membrane biotinylation was used to follow the fate of internalized GFP-tagged rat K(2P)3.1 and K(2P)9.1 transiently expressed in HeLa cells. Confocal fluorescence images were analyzed using Imaris software, which revealed that both channels are endocytosed by a dynamin-dependent mechanism and over the course of 60 min, move progressively toward the nucleus. Endogenous endocytosis of human K(2P)3.1 and K(2P)9.1 was examined in the lung carcinoma cell line, A549. Endogenous channels are endocytosed over a similar time-scale to the channels expressed transiently in HeLa cells. These findings both validate the use of recombinant systems and identify an endogenous model system in which K(2P)3.1 and K(2P)9.1 trafficking can be further studied.',\n",
       " 'Mutations in the KCNK3 gene have been identified in some patients suffering from heritable pulmonary arterial hypertension (PAH). KCNK3 encodes an outward rectifier K(+) channel, and each identified mutation leads to a loss of function. However, the pathophysiological role of potassium channel subfamily K member 3 (KCNK3) in PAH is unclear. We hypothesized that loss of function of KCNK3 is a hallmark of idiopathic and heritable PAH and contributes to dysfunction of pulmonary artery smooth muscle cells and pulmonary artery endothelial cells, leading to pulmonary artery remodeling: consequently, restoring KCNK3 function could alleviate experimental pulmonary hypertension (PH). We demonstrated that KCNK3 expression and function were reduced in human PAH and in monocrotaline-induced PH in rats. Using a patch-clamp technique in freshly isolated (not cultured) pulmonary artery smooth muscle cells and pulmonary artery endothelial cells, we found that KCNK3 current decreased progressively during the development of monocrotaline-induced PH and correlated with plasma-membrane depolarization. We demonstrated that KCNK3 modulated pulmonary arterial tone. Long-term inhibition of KCNK3 in rats induced distal neomuscularization and early hemodynamic signs of PH, which were related to exaggerated proliferation of pulmonary artery endothelial cells, pulmonary artery smooth muscle cell, adventitial fibroblasts, and pulmonary and systemic inflammation. Lastly, in vivo pharmacological activation of KCNK3 significantly reversed monocrotaline-induced PH in rats. In PAH and experimental PH, KCNK3 expression and activity are strongly reduced in pulmonary artery smooth muscle cells and endothelial cells. KCNK3 inhibition promoted increased proliferation, vasoconstriction, and inflammation. In vivo pharmacological activation of KCNK3 alleviated monocrotaline-induced PH, thus demonstrating that loss of KCNK3 is a key event in PAH pathogenesis and thus could be therapeutically targeted.',\n",
       " 'Potassium channels control the membrane voltage of aldosterone-producing zona glomerulosa cells. They are responsible for the unique K(+) sensitivity of these cells and are important molecular targets of angiotensin II signaling. Among the 78 pore-forming K(+) channels in human genome only a few are found in adrenal glands. The 2-P-domain K(+) channels TASK1 and TASK3 are strongly expressed in the adrenal cortex and produce a background K(+) conductance, which is pivotal for the regulation of the aldosterone secretion in zona glomerulosa cells. Disruption of the TASK1 gene in mice resulted in an autonomous aldosterone production and caused a remarkable aberrant expression of aldosterone synthase in zona fasciculata cells that normally produce glucocorticoids. After puberty, only in male mice aldosterone production was switched off in the zona fasciculata and regular zonation of aldosterone synthase occurred. In double mutant TASK1(-/-)/TASK3(-/-) mice, also adult male mice displayed primary hyperaldosteronism. Therefore, these knockout mice are interesting models to study mechanisms of autonomous aldosterone production and adrenocortical zonation. These data suggest that modifications of the adrenocortical K(+) conductances could also contribute to autonomic aldosterone production and primary hyperaldosteronism in humans.',\n",
       " 'Atrial fibrillation is the most common arrhythmia in the elderly, and potassium channels with atrium-specific expression have been discussed as targets to treat atrial fibrillation. Our aim was to characterize TASK-1 channels in human heart and to functionally describe the role of the atrial whole cell current I(TASK-1). Using quantitative PCR, we show that TASK-1 is predominantly expressed in the atria, auricles and atrio-ventricular node of the human heart. Single channel recordings show the functional expression of TASK-1 in right human auricles. In addition, we describe for the first time the whole cell current carried by TASK-1 channels (I(TASK-1)) in human atrial tissue. We show that I(TASK-1) contributes to the sustained outward current I(Ksus) and that I(TASK-1) is a major component of the background conductance in human atrial cardiomyocytes. Using patch clamp recordings and mathematical modeling of action potentials, we demonstrate that modulation of I(TASK-1) can alter human atrial action potential duration. Due to the lack of ventricular expression and the ability to alter human atrial action potential duration, TASK-1 might be a drug target for the treatment of atrial fibrillation.',\n",
       " 'Two potassium (K) channel genes, Kcnk3 and Kcnk9, when deleted in mice, produced a model of hyperaldosteronism and hypertension. Our objective was to explore genetic variation [single-nucleotide polymorphisms (SNP)] in KCNK3 and KCNK9 in relation to blood pressure (BP) and aldosterone production in humans. Two groups of healthy European Americans (EA) and African Americans (AA) were studied: 1) a longitudinal study group (age ∼14 yr when enrolled, 444 EA and 351 AA) and 2) an inpatient cross-sectional study group (age ∼23 yr, 85 EA and 109 AA). Plasma renin activity, plasma aldosterone concentration, and level of serum K were measured cross-sectionally; BP was measured semiannually in the longitudinal study. SNP were selected to provide coverage of the genes for both EA and AA (15 in KCNK3 and 74 in KCNK9). No associations with KCNK3 were observed. In the longitudinal study, multiple SNP in KCNK9 associated with systolic BP in AA, whereas associations were primarily with aldosterone production in EA. The direction of the changes was the same for aldosterone production and BP, whereas serum K changed in the opposite direction. In the cross-sectional study, associations were observed only in AA. Combining the two studies, one SNP in particular, rs888345, was strongly associated with BP in AA and with indices of aldosterone production in AA and EA. Results of an exploratory study suggest that BP and aldosterone production may be affected by variations in KCNK9. The findings could have relevance to risk for hypertension.',\n",
       " 'Potassium leak conductances were recently revealed to exist as independent molecular entities. Here, the genomic structure, cardiac localization, and biophysical properties of a murine example are considered. Kcnk3 subunits have two pore-forming P domains and unique functional attributes. At steady state, Kcnk3 channels behave like open, potassium-selective, transmembrane holes that are inhibited by physiological levels of proton. With voltage steps, Kcnk3 channels open and close in two phases, one appears to be immediate and one is time-dependent (tau = approximately 5 ms). Both proton block and gating are potassium-sensitive; this produces an anomalous increase in outward flux as external potassium levels rise because of decreased proton block. Single Kcnk3 channels open across the physiological voltage range; hence they are \"leak\" conductances; however, they open only briefly and rarely even after exposure to agents that activate other potassium channels.',\n",
       " 'With a bang, a new family of potassium channels has exploded into view. Although KCNK channels were discovered only five years ago, they already outnumber other channel types. KCNK channels are easy to identify because of their unique structure--they possess two preforming domains in each subunit. The new channels function in a most remarkable fashion: they are highly regulated, potassium-selective leak channels. Although leak currents are fundamental to the function of nerves and muscles, the molecular basis for this type of conductance had been a mystery. Here we review the discovery of KCNK channels, what has been learned about them and what lies ahead. Even though two-P-domain channels are widespread and essential, they were hidden from sight in plain view--our most basic questions remain to be answered.',\n",
       " 'Although membrane vesicle studies have established the driving forces that mediate renal organic anion secretion and the organic anion transporter Oat1 has now been cloned in several species, its stoichiometry has remained uncertain. In this study, we used electrophysiology, kinetic measurements, and static head experiments to determine the coupling ratio for Oat1-mediated organic anion/dicarboxylate exchange. Initial experiments demonstrated that uptake of PAH by voltage-clamped Xenopus laevis oocytes expressing rOat1 led to net entry of positive charge, suggesting that coupling was one-to-one. This conclusion was confirmed by kinetic analysis of PAH and glutarate fluxes in native basolateral membrane vesicles from the rat renal cortex, which showed a Hill coefficient of 1. Similarly, static head experiments on the rat vesicles also showed a 1:1 coupling ratio. To confirm these conclusions in a system expressing a single cloned transporter, Madin-Darby canine kidney cells were stably transfected with the human exchanger hOAT1. The hOAT1-expressing cell line showed extensive PAH transport, which was very similar in all respects to transport expressed by hOAT1 in Xenopus oocytes. Its Km for PAH was 8 microM and glutarate effectively trans-stimulated PAH transport. When stoichiometry was assessed using plasma membranes isolated from the hOAT1-expressing cells, both kinetic and static head data indicated that hOAT1 also demonstrated a 1:1 coupling between organic anion and dicarboxylate.',\n",
       " '<!DOCTYPE article PUBLIC \"-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN\" \"JATS-archivearticle1.dtd\">\\n<article xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" article-type=\"research-article\">\\n  <?properties manuscript?>\\n  <front>\\n    <journal-meta>\\n      <journal-id journal-id-type=\"nlm-journal-id\">0255562</journal-id>\\n      <journal-id journal-id-type=\"pubmed-jr-id\">5985</journal-id>\\n      <journal-id journal-id-type=\"nlm-ta\">N Engl J Med</journal-id>\\n      <journal-id journal-id-type=\"iso-abbrev\">N. Engl. J. Med.</journal-id>\\n      <journal-title-group>\\n        <journal-title>The New England journal of medicine</journal-title>\\n      </journal-title-group>\\n      <issn pub-type=\"ppub\">0028-4793</issn>\\n      <issn pub-type=\"epub\">1533-4406</issn>\\n    </journal-meta>\\n    <article-meta>\\n      <article-id pub-id-type=\"pmid\">23883380</article-id>\\n      <article-id pub-id-type=\"pmc\">3792227</article-id>\\n      <article-id pub-id-type=\"doi\">10.1056/NEJMoa1211097</article-id>\\n      <article-id pub-id-type=\"manuscript\">NIHMS515515</article-id>\\n      <article-categories>\\n        <subj-group subj-group-type=\"heading\">\\n          <subject>Article</subject>\\n        </subj-group>\\n      </article-categories>\\n      <title-group>\\n        <article-title>A Novel Channelopathy in Pulmonary Arterial Hypertension</article-title>\\n      </title-group>\\n      <contrib-group>\\n        <contrib contrib-type=\"author\" equal-contrib=\"yes\">\\n          <name>\\n            <surname>Ma</surname>\\n            <given-names>Lijiang</given-names>\\n          </name>\\n          <degrees>M.D., Ph.D.</degrees>\\n        </contrib>\\n        <contrib contrib-type=\"author\" equal-contrib=\"yes\">\\n          <name>\\n            <surname>Roman-Campos</surname>\\n            <given-names>Danilo</given-names>\\n          </name>\\n          <degrees>Ph.D.</degrees>\\n        </contrib>\\n        <contrib contrib-type=\"author\">\\n          <name>\\n            <surname>Austin</surname>\\n            <given-names>Eric D.</given-names>\\n          </name>\\n          <degrees>M.D.</degrees>\\n        </contrib>\\n        <contrib contrib-type=\"author\">\\n          <name>\\n            <surname>Eyries</surname>\\n            <given-names>Mélanie</given-names>\\n          </name>\\n          <degrees>Ph.D.</degrees>\\n        </contrib>\\n        <contrib contrib-type=\"author\">\\n          <name>\\n            <surname>Sampson</surname>\\n            <given-names>Kevin S.</given-names>\\n          </name>\\n          <degrees>Ph.D.</degrees>\\n        </contrib>\\n        <contrib contrib-type=\"author\">\\n          <name>\\n            <surname>Soubrier</surname>\\n            <given-names>Florent</given-names>\\n          </name>\\n          <degrees>M.D., Ph.D.</degrees>\\n        </contrib>\\n        <contrib contrib-type=\"author\">\\n          <name>\\n            <surname>Germain</surname>\\n            <given-names>Marine</given-names>\\n          </name>\\n          <degrees>M.Sc.</degrees>\\n        </contrib>\\n        <contrib contrib-type=\"author\">\\n          <name>\\n            <surname>Trégouët</surname>\\n            <given-names>David-Alexandre</given-names>\\n          </name>\\n          <degrees>Ph.D.</degrees>\\n        </contrib>\\n        <contrib contrib-type=\"author\">\\n          <name>\\n            <surname>Borczuk</surname>\\n            <given-names>Alain</given-names>\\n          </name>\\n          <degrees>M.D.</degrees>\\n        </contrib>\\n        <contrib contrib-type=\"author\">\\n          <name>\\n            <surname>Rosenzweig</surname>\\n            <given-names>Erika Berman</given-names>\\n          </name>\\n          <degrees>M.D.</degrees>\\n        </contrib>\\n        <contrib contrib-type=\"author\">\\n          <name>\\n            <surname>Girerd</surname>\\n            <given-names>Barbara</given-names>\\n          </name>\\n          <degrees>Ph.D.</degrees>\\n        </contrib>\\n        <contrib contrib-type=\"author\">\\n          <name>\\n            <surname>Montani</surname>\\n            <given-names>David</given-names>\\n          </name>\\n          <degrees>M.D., Ph.D.</degrees>\\n        </contrib>\\n        <contrib contrib-type=\"author\">\\n          <name>\\n            <surname>Humbert</surname>\\n            <given-names>Marc</given-names>\\n          </name>\\n          <degrees>M.D., Ph.D.</degrees>\\n        </contrib>\\n        <contrib contrib-type=\"author\">\\n          <name>\\n            <surname>Loyd</surname>\\n            <given-names>James E.</given-names>\\n          </name>\\n          <degrees>M.D.</degrees>\\n        </contrib>\\n        <contrib contrib-type=\"author\">\\n          <name>\\n            <surname>Kass</surname>\\n            <given-names>Robert S.</given-names>\\n          </name>\\n          <degrees>Ph.D.</degrees>\\n        </contrib>\\n        <contrib contrib-type=\"author\">\\n          <name>\\n            <surname>Chung</surname>\\n            <given-names>Wendy K.</given-names>\\n          </name>\\n          <degrees>M.D., Ph.D.</degrees>\\n        </contrib>\\n        <aff id=\"A1\">Departments of Pediatrics (L.M., E.B.R., W.K.C.), Pharmacology (D.R.-C., K.S.S., R.S.K.), and Pathology (A.B.), Columbia University Medical Center, New York; the Departments of Pediatrics (E.D.A.) and Medicine (J.E.L.), Vanderbilt University Medical Center, Nashville; the Genetics Department, Hospital Pitié-Salpêtrière, Assistance Publique–Hôpitaux de Paris (APHP), Institut National de la Santé et de la Recherche Médicale (INSERM), and Université Pierre et Marie Curie (UPMC) Unité Mixte de Recherche en Santé (UMRS) 956, Institute of Cardiometabolism and Nutrition (ICAN) (M.E., F.S.); and INSERM–UPMC UMRS 937, ICAN (M.G., D.-A.T.) — all in Paris; and APHP, Département Hospitalo–Universitaire Thorax Innovation (DHU TORINO), Service de Pneumologie, Hôpital Bicêtre; Université Paris-Sud, Laboratoire d’Excellence en Recherche sur le Médicament et Innovation Thérapeutique (LERMIT); and INSERM UMRS 999 — all in Le Kremlin-Bicêtre, France (B.G., D.M., M.H.).</aff>\\n      </contrib-group>\\n      <author-notes>\\n        <corresp id=\"CR1\">Address reprint requests to Dr. Chung at the Department of Pediatrics, Columbia University Medical Center, 1150 St. Nicholas Ave., New York, NY 10032, or at <email>wkc15@columbia.edu.</email></corresp>\\n      </author-notes>\\n      <pub-date pub-type=\"nihms-submitted\">\\n        <day>27</day>\\n        <month>9</month>\\n        <year>2013</year>\\n      </pub-date>\\n      <pub-date pub-type=\"ppub\">\\n        <day>25</day>\\n        <month>7</month>\\n        <year>2013</year>\\n      </pub-date>\\n      <pub-date pub-type=\"pmc-release\">\\n        <day>25</day>\\n        <month>1</month>\\n        <year>2014</year>\\n      </pub-date>\\n      <volume>369</volume>\\n      <issue>4</issue>\\n      <fpage>351</fpage>\\n      <lpage>361</lpage>\\n      <permissions>\\n        <license>\\n          <license-p>This file is available for text mining. It may also be used consistent with the principles of fair use under the copyright law.</license-p>\\n        </license>\\n      </permissions>\\n      <abstract>\\n        <sec id=\"S1\">\\n          <title>BACKGROUND</title>\\n          <p id=\"P1\">Pulmonary arterial hypertension is a devastating disease with high mortality. Familial cases of pulmonary arterial hypertension are usually characterized by autosomal dominant transmission with reduced penetrance, and some familial cases have unknown genetic causes.</p>\\n        </sec>\\n        <sec id=\"S2\">\\n          <title>METHODS</title>\\n          <p id=\"P2\">We studied a family in which multiple members had pulmonary arterial hypertension without identifiable mutations in any of the genes known to be associated with the disease, including <italic>BMPR2, ALK1, ENG, SMAD9</italic>, and <italic>CAV1</italic>. Three family members were studied with whole-exome sequencing. Additional patients with familial or idiopathic pulmonary arterial hypertension were screened for the mutations in the gene that was identified on whole-exome sequencing. All variants were expressed in COS-7 cells, and channel function was studied by means of patch-clamp analysis.</p>\\n        </sec>\\n        <sec id=\"S3\">\\n          <title>RESULTS</title>\\n          <p id=\"P3\">We identified a novel heterozygous missense variant c.608 G→A (G203D) in <italic>KCNK3</italic> (the gene encoding potassium channel subfamily K, member 3) as a disease-causing candidate gene in the family. Five additional heterozygous missense variants in <italic>KCNK3</italic> were independently identified in 92 unrelated patients with familial pulmonary arterial hypertension and 230 patients with idiopathic pulmonary arterial hypertension. We used in silico bioinformatic tools to predict that all six novel variants would be damaging. Electrophysiological studies of the channel indicated that all these missense mutations resulted in loss of function, and the reduction in the potassium-channel current was remedied by the application of the phospholipase inhibitor ONO-RS-082.</p>\\n        </sec>\\n        <sec id=\"S4\">\\n          <title>CONCLUSIONS</title>\\n          <p id=\"P4\">Our study identified the association of a novel gene, <italic>KCNK3,</italic> with familial and idiopathic pulmonary arterial hypertension. Mutations in this gene produced reduced potassium-channel current, which was successfully remedied by pharmacologic manipulation. (Funded by the National Institutes of Health.)</p>\\n        </sec>\\n      </abstract>\\n      <funding-group>\\n        <award-group>\\n          <funding-source country=\"United States\">National Center for Research Resources : NCRR</funding-source>\\n          <award-id>UL1 RR024975 || RR</award-id>\\n        </award-group>\\n        <award-group>\\n          <funding-source country=\"United States\">National Heart, Lung, and Blood Institute : NHLBI</funding-source>\\n          <award-id>R01 HL060056 || HL</award-id>\\n        </award-group>\\n        <award-group>\\n          <funding-source country=\"United States\">National Heart, Lung, and Blood Institute : NHLBI</funding-source>\\n          <award-id>R01 HL056810 || HL</award-id>\\n        </award-group>\\n        <award-group>\\n          <funding-source country=\"United States\">National Heart, Lung, and Blood Institute : NHLBI</funding-source>\\n          <award-id>R01 HL048164 || HL</award-id>\\n        </award-group>\\n        <award-group>\\n          <funding-source country=\"United States\">National Heart, Lung, and Blood Institute : NHLBI</funding-source>\\n          <award-id>P01 HL072058 || HL</award-id>\\n        </award-group>\\n        <award-group>\\n          <funding-source country=\"United States\">National Heart, Lung, and Blood Institute : NHLBI</funding-source>\\n          <award-id>K23 HL098743 || HL</award-id>\\n        </award-group>\\n      </funding-group>\\n    </article-meta>\\n  </front>\\n  <body>\\n    <p id=\"P5\">Pulmonary Arterial Hypertension Is a rare disease that is characterized by increased pulmonary-artery pressure in the absence of common causes of pulmonary hypertension, such as chronic heart, lung, or thromboembolic disease.<sup><xref ref-type=\"bibr\" rid=\"R1\">1</xref></sup> Before the advent of novel therapies, patients with idiopathic or familial pulmonary arterial hypertension had an estimated median survival of 2.8 years, with 1-year, 3-year, and 5-year survival rates of 68%, 48%, and 34%, respectively.<sup><xref ref-type=\"bibr\" rid=\"R2\">2</xref></sup> However, despite progress in treatment, pulmonary arterial hypertension remains a progressive, fatal disease. The clinical presentation can be nonspecific, and patients often receive a diagnosis late in their clinical course.</p>\\n    <p id=\"P6\">The cause of pulmonary arterial hypertension is heterogeneous, and some cases are familial. Molecular genetic studies have shown that mutations in the gene encoding bone morphogenetic protein receptor type II (<italic>BMPR2</italic>) are present in approximately 70% of patients with familial pulmonary arterial hypertension, as well as in 10 to 25% of those with idiopathic pulmonary arterial hypertension.<sup><xref ref-type=\"bibr\" rid=\"R3\">3</xref>-<xref ref-type=\"bibr\" rid=\"R5\">5</xref></sup> Pulmonary arterial hypertension may also occur in patients carrying mutations in the gene encoding activin receptor–like kinase 1 (<italic>ALK1</italic>) and more rarely in patients carrying mutations in the gene encoding endoglin (<italic>ENG</italic>); mutations in both genes are known to cause hereditary hemorrhagic telangiectasia.<sup><xref ref-type=\"bibr\" rid=\"R3\">3</xref>,<xref ref-type=\"bibr\" rid=\"R6\">6</xref>-<xref ref-type=\"bibr\" rid=\"R9\">9</xref></sup> In rare cases, mutations in the gene encoding mothers against decapentaplegic homologue 9 (<italic>SMAD</italic>9) have been identified in patients with idiopathic pulmonary arterial hypertension.<sup><xref ref-type=\"bibr\" rid=\"R10\">10</xref>,<xref ref-type=\"bibr\" rid=\"R11\">11</xref></sup> We previously identified novel mutations in the gene encoding caveolin 1 (<italic>CAV1</italic>) in patients with either familial or idiopathic pulmonary arterial hypertension.<sup><xref ref-type=\"bibr\" rid=\"R12\">12</xref></sup> In approximately 25% of patients with familial pulmonary arterial hypertension, there is no identifiable genetic cause.</p>\\n    <p id=\"P7\">In this study, we used whole-exome sequencing to identify a novel cause of pulmonary arterial hypertension in a family with this disorder, replicated our findings in patients with either familial or idiopathic pulmonary arterial hypertension, and characterized the loss of channel function for each mutation.</p>\\n    <sec sec-type=\"methods\" id=\"S5\">\\n      <title>Methods</title>\\n      <sec sec-type=\"subjects\" id=\"S6\">\\n        <title>STUDY PARTICIPANTS AND GENETIC STUDIES</title>\\n        <p id=\"P8\">We studied a family in which pulmonary arterial hypertension had been diagnosed in five members (two living and three deceased at the time of the analysis) (<xref ref-type=\"fig\" rid=\"F1\">Fig. 1A</xref>). The diagnosis of pulmonary arterial hypertension was confirmed by means of medical-record review and rightheart catheterization. Written informed consent for genetic studies was obtained from all the participants. The study was funded by the National Institutes of Health, and the protocol was approved by the appropriate human-subjects committees. Details of the methods are provided in the <xref ref-type=\"supplementary-material\" rid=\"SD1\">Supplementary Appendix</xref>, available with the full text of this article at <email>NEJM.org</email>. DNA from the family members had been sequenced previously to establish that they did not carry <italic>BMPR2, ALK1, ENG, SMAD9</italic>, or <italic>CAV1</italic> mutations.</p>\\n        <p id=\"P9\">We used whole-exome sequencing to compare the three affected family members, assuming an autosomal dominant mode of inheritance, and variants were filtered on the basis of allele frequency in controls and predicted pathogenicity. A novel variant was identified in <italic>KCNK3</italic> (the gene encoding potassium channel subfamily K, member 3), and Sanger sequencing of <italic>KCNK3</italic> was performed on samples obtained from all available members of the study family to assess for cosegregation with disease. To identify additional mutations and mutation carriers, DNA samples from 82 unrelated patients with familial pulmonary arterial hypertension and 230 patients with idiopathic pulmonary arterial hypertension were sequenced, and whole-exome sequencing data from 10 additional patients with familial pulmonary arterial hypertension were reviewed, to replicate the findings in the initial family and determine the frequency of mutations in <italic>KCNK3</italic> in patients with familial and idiopathic pulmonary arterial hypertension. For patients with familial pulmonary arterial hypertension who were found to have <italic>KCNK3</italic> mutations, other available family members were tested to evaluate segregation within the family.</p>\\n      </sec>\\n      <sec id=\"S7\">\\n        <title>LUNG-TISSUE SAMPLING</title>\\n        <p id=\"P10\">Lung tissue was obtained from explanted lungs of two patients with idiopathic pulmonary arterial hypertension. The specimens were fixed in 10% formalin, processed, embedded in paraffin, sectioned, and stained with hematoxylin and eosin, CD31, alpha–smooth-muscle actin, or von Willebrand factor, along with Verhoeff–van Gieson elastic stain.</p>\\n      </sec>\\n      <sec id=\"S8\">\\n        <title>EXPRESSION AND FUNCTIONAL ANALYSIS OF HUMAN KCNK3 CHANNEL</title>\\n        <p id=\"P11\">We performed functional analysis of the human KCNK3 (hKCNK3) channel to evaluate the genetic variants that had been identified. Mutations were engineered into hKCNK3 complementary DNA (cDNA) and expressed with the use of transient transfection in COS-7 cells. Whole-cell patch-clamp procedures were used to measure expressed currents and their response to pH and pharmacologic agents. Detailed methods for the molecular biologic and electrophysiological studies are provided in the <xref ref-type=\"supplementary-material\" rid=\"SD1\">Supplementary Appendix</xref>.</p>\\n      </sec>\\n    </sec>\\n    <sec sec-type=\"results\" id=\"S9\">\\n      <title>Results</title>\\n      <sec id=\"S10\">\\n        <title>WHOLE-EXOME SEQUENCING</title>\\n        <p id=\"P12\">The average depth of sequence coverage of the whole-exome sequencing data was 78.7×, with 87.5% of the target region for exome capture having coverage of more than 20×. We removed variants that had an allele frequency of more than 1% in established databases, including dbSNP, the 1000 Genomes Project, and the National Heart, Lung, and Blood Institute Exome Variant Server. This left 4719 rare or novel variants that were present in at least one of the three affected family members. We filtered these variants to identify heterozygous variants shared by the three affected family members and were left with 377 novel single-nucleotide variants (SNVs) and 6 insertions or deletions (indels). Because the pedigree suggested an autosomal dominant mode of inheritance, homozygous variants were excluded.</p>\\n        <p id=\"P13\">Variants were then filtered for predicted pathogenic effects with the use of a series of in silico bioinformatic tools (see the <xref ref-type=\"supplementary-material\" rid=\"SD1\">Supplementary Appendix</xref>). A total of 19 SNVs and 5 indels were predicted to be deleterious. Of these, a novel missense variant, c.608 G→A (G203D), in <italic>KCNK3</italic> was identified as the strongest candidate because <italic>KCNK3</italic> is reported to be important in the regulation of pulmonary vascular tone in humans.<sup><xref ref-type=\"bibr\" rid=\"R13\">13</xref></sup> The function of this channel is to conduct potassium current, maintain resting membrane potential, and regulate the vascular tone of the pulmonary artery.<sup><xref ref-type=\"bibr\" rid=\"R14\">14</xref>-<xref ref-type=\"bibr\" rid=\"R16\">16</xref></sup> On the basis of homologic modeling of hKCNK3, amino acid G203 is located in the highly conserved second pore region of the protein, which is critical for the gating function of the potassium channel. Examination of dbSNP indicated that there are no common missense variants (allele frequency, &gt;1%) in <italic>KCNK3</italic>.</p>\\n      </sec>\\n      <sec id=\"S11\">\\n        <title>CONFIRMATION OF THE MUTATION</title>\\n        <p id=\"P14\">Segregation analysis of the c.608 G→A variant in <italic>KCNK3</italic> was performed on all available members of the index family (<xref ref-type=\"fig\" rid=\"F1\">Fig. 1A</xref>). Affected Family Member II-1 was found to carry the variant, but her unaffected brother-in-law (Family Member II-3) was not. Her affected sister (Family Member II-2) was deceased at the time of our study and had no DNA available for testing, but it was assumed that she had also carried the variant, since four of her children (Family Members III-1, III-2, III-4, and III-5) were all carriers. Although Family Member III-5 was initially unaffected at the time of recruitment, he subsequently received a diagnosis of pulmonary arterial hypertension. Family Member III-2 remains unaffected. The c.608 G→A KCNK3 variant was not present in DNA samples from 100 ethnically matched, unrelated, unaffected white controls.</p>\\n      </sec>\\n      <sec sec-type=\"cases\" id=\"S12\">\\n        <title>CASE SERIES OF PATIENTS</title>\\n        <p id=\"P15\">We also used whole-exome sequencing to study samples obtained from 10 additional probands from families with familial pulmonary arterial hypertension. Two novel heterozygous <italic>KCNK3</italic> variants, G97R and V221L, were identified in two of these families. These variants were confirmed on Sanger sequencing and tested in available family members and were found to segregate with disease (<xref ref-type=\"fig\" rid=\"F1\">Fig. 1B and 1C</xref>). We screened an additional 82 unrelated probands from families with familial pulmonary arterial hypertension and 230 patients with idiopathic pulmonary arterial hypertension for mutations in <italic>KCNK3</italic>. Among the latter group of patients, we identified three novel heterozygous amino acid substitutions: T8K, E182K, and Y192C. The five additional variants were all predicted to be damaging. <italic>KCNK3</italic> mutations were found in 3 of 230 participants (1.3%) in the cohort of patients with idiopathic pulmonary arterial hypertension and in 3 of 93 participants (3.2%) in the cohort of probands with familial disease.</p>\\n      </sec>\\n      <sec id=\"S13\">\\n        <title>CLINICAL PHENOTYPES OF MUTATION CARRIERS</title>\\n        <p id=\"P16\">In the three families with familial pulmonary arterial hypertension, two of nine family members who inherited a <italic>KCNK3</italic> mutation did not have evidence of disease, suggesting incomplete penetrance. Among all the patients with clinical evidence of pulmonary arterial hypertension (familial or idiopathic), the age at diagnosis ranged from 8 to 44 years (<xref ref-type=\"table\" rid=\"T1\">Table 1</xref>). Both male and female patients were affected. No patient had a response to acute vasodilator challenge. Three patients ultimately required lung transplantation. The histopathological analysis for one patient who underwent lung transplantation is shown in <xref ref-type=\"fig\" rid=\"F1\">Figure 1</xref> in the <xref ref-type=\"supplementary-material\" rid=\"SD1\">Supplementary Appendix</xref>. Findings included hypertrophy of the media of muscular pulmonary arteries and progressive, generalized arterial dilatation with formation of complex plexiform lesions.</p>\\n      </sec>\\n      <sec id=\"S14\">\\n        <title>FUNCTIONAL STUDIES OF HUMAN KCNK3 CHANNEL</title>\\n        <p id=\"P17\"><italic>KCNK3</italic> encodes a pH-sensitive potassium channel in the two-pore domain superfamily.<sup><xref ref-type=\"bibr\" rid=\"R17\">17</xref></sup> The primary role of KCNK3 channels is to control the resting membrane potential in many cell types, including human pulmonary-artery smoothmuscle cells,<sup><xref ref-type=\"bibr\" rid=\"R17\">17</xref></sup> and to contribute to arterial relaxation through the action of smooth-muscle cells. KCNK3 channels lack voltage dependence. Alignment of the KCNK3 channel with other two-pore domain potassium channels reveals that most of the mutations found in this study occurred at conserved residues that were likely to be critical for function (<xref ref-type=\"fig\" rid=\"F2\">Fig. 2</xref>).</p>\\n        <p id=\"P18\">To investigate the consequences of <italic>KCNK3</italic> variants, we studied the effect of the six mutations that were discovered in our genetic studies of the hKCNK3 channel. Nonmutant channels and all mutant channels were tested for pH sensitivity to confirm their identity as hKCNK3 channels. The pH dependence of nonmutant hKCNK3 channels is shown in <xref ref-type=\"fig\" rid=\"F3\">Figure 3A</xref>. All mutants that were tested resulted in loss of function at physiologic pH (7.4) when expressed alone, a condition that simulates homozygous expression in humans (<xref ref-type=\"fig\" rid=\"F3\">Fig. 3B and 3C</xref>). However, because two-pore–domain potassium channels assemble as dimers<sup><xref ref-type=\"bibr\" rid=\"R16\">16</xref></sup> and patients carrying mutations are heterozygotes, we also coexpressed nonmutant and mutant hKCNK3 channel cDNA to simulate expression in heterozygous patients. For these experiments, we chose three mutations located in distinct regions of the channel and found that the mutations studied (Y192C, G203D, and V221L) reduced current density when coexpressed with nonmutant channels, as compared with expression of nonmutant hKCNK3 channels alone (<xref ref-type=\"fig\" rid=\"F3\">Fig. 3D</xref>).</p>\\n        <p id=\"P19\">A number of compounds, including the phospholipase A2 inhibitor ONO-RS-082, have been shown to activate nonmutant hKCNK3 channels.<sup><xref ref-type=\"bibr\" rid=\"R18\">18</xref></sup> Thus, we sought to determine whether this drug was capable of rescuing channel activity in the hKCNK3 mutant channels in this study. We found recovery of current for some, but not all, disease-associated mutants. Shown in <xref ref-type=\"fig\" rid=\"F4\">Figure 4</xref> are examples of current recordings with ONO-RS-082 (10 <italic>μ</italic>M) and without ONO-RS-082 for nonmutant and mutant hKCNK3 channels (<xref ref-type=\"fig\" rid=\"F4\">Fig. 4A</xref>) as well as current density (at +60 mV) before, during, and after application of the drug (<xref ref-type=\"fig\" rid=\"F4\">Fig. 4B</xref>). Steady-state effects of the drug are summarized in <xref ref-type=\"fig\" rid=\"F4\">Figure 4C</xref>. The results indicate a robust increase in nonmutant hKCNK3 current after application of ONO-RS-082 and an increase in current density to levels similar to those seen in the nonmutant channel for two mutant channels (T8K and E182K) but not a third mutant channel (G203D).</p>\\n      </sec>\\n    </sec>\\n    <sec sec-type=\"discussion\" id=\"S15\">\\n      <title>Discussion</title>\\n      <p id=\"P20\">We used whole-exome sequencing to identify the association of a novel gene, <italic>KCNK3,</italic> with pulmonary arterial hypertension in a family that had multiple affected members. We also identified mutations in <italic>KCNK3</italic> in other families with familial pulmonary arterial hypertension and in patients with idiopathic pulmonary arterial hypertension and showed that all such mutations resulted in a loss of ion-channel function. These findings suggest that KCNK3 is involved in the pathogenesis of pulmonary arterial hypertension.</p>\\n      <p id=\"P21\">KCNK3, also called TASK-1, belongs to a family of mammalian potassium channels that is characterized by the presence of four transmembrane domains and two pore domains per subunit.<sup><xref ref-type=\"bibr\" rid=\"R19\">19</xref></sup> It has been reported that this potassium channel is sensitive to hypoxia and plays a role in the regulation of resting membrane potential and pulmonary vascular tone.<sup><xref ref-type=\"bibr\" rid=\"R13\">13</xref>-<xref ref-type=\"bibr\" rid=\"R15\">15</xref>,<xref ref-type=\"bibr\" rid=\"R20\">20</xref></sup> Ion channels also play a critical role in vascular remodeling, and it has been postulated that <italic>KCNK3</italic> is involved in the regulation of vascular remodeling and abnormal vascular proliferation in patients with pulmonary arterial hypertension by preventing apoptosis.<sup><xref ref-type=\"bibr\" rid=\"R21\">21</xref></sup><italic>KCNK3</italic> knockout mice have a blunted (although not abolished) ventilatory response to hypoxia.<sup><xref ref-type=\"bibr\" rid=\"R22\">22</xref></sup> Quantitative analysis of oxygen-sensing and pulmonary-artery pressures has not, to our knowledge, been reported in these mutant mice. <italic>KCNK3</italic> is expressed in human pulmonary-artery smooth-muscle cells, and knockdown of <italic>KCNK3</italic> has been shown to cause membrane depolarization and reduced potassium current.<sup><xref ref-type=\"bibr\" rid=\"R13\">13</xref></sup> Taken together, these results strongly suggest that <italic>KCNK3</italic> is important in the regulation of pulmonary vascular tone.</p>\\n      <p id=\"P22\">As indicated by our electrophysiological studies, the variants that were identified in this study are all loss-of-function mutations. Because KCNK3 channels are not voltage-dependent and are open at negative potentials, these mutations probably cause depolarization of the resting membrane potential, which could lead to pulmonary-artery vasoconstriction.<sup><xref ref-type=\"bibr\" rid=\"R23\">23</xref></sup> The molecular mechanisms for loss of function probably vary according to the location of the mutation in the channel. One mutation, T8K, is in the N-terminal, a part of the channel that is important to membrane transport out of the endoplasmic reticulum through interaction with 14-3-3 proteins.<sup><xref ref-type=\"bibr\" rid=\"R24\">24</xref></sup> Four of the mutations fall in the pore domains in KCNK3 that are critical for the pH sensitivity and potassium selectivity of this potassium-channel family.<sup><xref ref-type=\"bibr\" rid=\"R25\">25</xref>,<xref ref-type=\"bibr\" rid=\"R26\">26</xref></sup> Two of the mutations, G97R and G203D, are in the pore-domain GXG triplet selectivity filters (in which X is any amino acid) of KCNK3 (<xref ref-type=\"fig\" rid=\"F2\">Fig. 2A</xref>) and may have their deleterious effects as a result of alterations in potassium selectivity. The last mutation falls in one of the transmembrane domains that have been implicated by structural models as important for dimerization.<sup><xref ref-type=\"bibr\" rid=\"R16\">16</xref>,<xref ref-type=\"bibr\" rid=\"R26\">26</xref></sup> Each mutation we identified (possibly excepting T8K) falls in a highly conserved region of <italic>KCNK3</italic> (<xref ref-type=\"fig\" rid=\"F2\">Fig. 2B</xref>), indicating that these residues are important for the normal biophysical properties of the KCNK3 channel. There are parallels to our findings in studies of voltage-gated potassium (Kv) channels in human pulmonary-artery smooth-muscle cells in that down-regulation of Kv channels has been implicated in altered contraction and proliferation in smooth-muscle cells in patients with primary pulmonary hypertension.<sup><xref ref-type=\"bibr\" rid=\"R27\">27</xref></sup></p>\\n      <p id=\"P23\">Although <italic>KCNK3</italic> is expressed in multiple tissues, including heart, brain, and pancreas, the mutations in <italic>KCNK3</italic> that we identified were associated only with pulmonary arterial hypertension in the patients we studied. This finding may be due to redundancy within the two-pore–domain potassium channels. KCNK9 is expressed in the brain,<sup><xref ref-type=\"bibr\" rid=\"R13\">13</xref></sup> KCNK5 and KCNK6 are abundant in the pancreas,<sup><xref ref-type=\"bibr\" rid=\"R28\">28</xref></sup> and KCNK1 is expressed in the heart.<sup><xref ref-type=\"bibr\" rid=\"R29\">29</xref></sup> This redundancy may explain why the phenotype of mutations in <italic>KCNK3</italic> is specific to pulmonary hypertension.</p>\\n      <p id=\"P24\">We found that the function of channels incorporating mutant KCNK3 can be rescued (to a variable degree, depending on the mutation) with the use of the phospholipase inhibitor ONO-RS-082. Other pharmacologic interventions may activate KCNK3 as well. In human pulmonaryartery smooth-muscle cells, KCNK3 can be activated by treprostinil (a stable prostacyclin analogue) through cyclic AMP (cAMP)–dependent phosphorylation of the channel induced by protein kinase A (PKA).<sup><xref ref-type=\"bibr\" rid=\"R30\">30</xref>,<xref ref-type=\"bibr\" rid=\"R31\">31</xref></sup> Application of the cAMP analogue 8-bromo-cAMP, an endogenous PKA activator, also results in KCNK3 activation.<sup><xref ref-type=\"bibr\" rid=\"R13\">13</xref></sup> In addition, KCNK3 has been shown to mediate vasoconstriction induced by endothelin 1,<sup><xref ref-type=\"bibr\" rid=\"R32\">32</xref></sup> and application of the specific Rho kinase inhibitor Y-27632 can attenuate endothelin-1–induced KCNK3 inhibition.<sup><xref ref-type=\"bibr\" rid=\"R33\">33</xref></sup> Thus, our study suggests a potential novel mechanism for therapeutic intervention by pharmacologically increasing currents through KCNK3 in patients with pulmonary arterial hypertension.</p>\\n      <p id=\"P25\">It is also possible that in patients with pulmonary arterial hypertension, variation in KCNK3 function may be a more broadly applicable risk factor (or a secondary disease modifier) that is not caused by mutations in <italic>KCNK3</italic>. There is precedent for this concept, since BMPR2 expression is reduced in the lungs of patients with idiopathic pulmonary arterial hypertension who do not have <italic>BMPR2</italic> mutations.<sup><xref ref-type=\"bibr\" rid=\"R34\">34</xref></sup> In addition, previous studies of Kv channels support the concept that the expression or function of Kv channels is altered in patients with idiopathic pulmonary arterial hypertension, and dysfunctional Kv-channel activity may contribute to the development or persistence of pulmonary arterial hypertension.<sup><xref ref-type=\"bibr\" rid=\"R35\">35</xref></sup> In a study of mice with wild-type Kv channels, therapeutic Kv-channel activation was useful in the treatment of established pulmonary arterial hypertension in the absence of known genetic variations in Kv channels.<sup><xref ref-type=\"bibr\" rid=\"R36\">36</xref></sup> Thus, the therapeutic targeting of KCNK3 may be beneficial for patients with pulmonary arterial hypertension who have increased vascular tone independent of their KCNK3 genetic status.</p>\\n      <p id=\"P26\">In our study, two members of families with familial pulmonary arterial hypertension who had inherited <italic>KCNK3</italic> mutations had no evidence of disease. These family members may be examples of incomplete penetrance or of late-onset disease that has not yet developed. Other genetic forms of pulmonary arterial hypertension have incomplete penetrance, and the disease develops at a wide range of ages. Presumably, there are other genetic, environmental, or developmental modifiers that in concert with KCNK3 dysfunction determine whether or when pulmonary arterial hypertension will develop. Identifying asymptomatic persons who are genetically at risk provides a potential opportunity for early intervention and treatment if an effective therapy is available.</p>\\n      <p id=\"P27\">In conclusion, in patients with either familial or idiopathic pulmonary arterial hypertension, we have identified mutations in the potassium channel KCNK3 that represent a mechanistically novel cause of pulmonary arterial hypertension.</p>\\n    </sec>\\n    <sec sec-type=\"supplementary-material\" id=\"SM\">\\n      <title>Supplementary Material</title>\\n      <supplementary-material content-type=\"loca-data\" id=\"SD1\">\\n        <label>Supplement1</label>\\n        <media xlink:href=\"NIHMS515515-supplement-Supplement1.pdf\" mimetype=\"application\" mime-subtype=\"pdf\" orientation=\"portrait\" xlink:type=\"simple\" id=\"d36e657\" position=\"anchor\"/>\\n      </supplementary-material>\\n    </sec>\\n  </body>\\n  <back>\\n    <ack id=\"S16\">\\n      <p>Supported by grants (R01 HL060056, P01 HL072058, K23 HL098743, and R01 HL 56810) from the National Institutes of Health and a Vanderbilt Clinical and Translational Science Awards grant (UL1 RR024975) from the National Center for Research Resources. Funding for the Grand Opportunity Exome Sequencing Project (GO-ESP) was provided by grants (RC2 HL-103010, RC2 HL-102923, and RC2 HL-102924) from the National Heart, Lung, and Blood Institute (NHLBI). Exome sequencing was performed through grants (RC2 HL-102925 and RC2 HL-102926) from the NHLBI.</p>\\n      <p>We thank the families for their contributions to this study; Lisa Wheeler of Vanderbilt University, Nashville, for coordinating the study enrollment and sample acquisition for patients and families; Nicole Mallory, Laura Brenner, Patricia Lanzano, Julia Wynn, Robyn Barst, and Jane Morse for coordinating the patient studies and referring patients to the study at Columbia University, New York; and David Montani, Xavier Jaïs, Olivier Sitbon, and Gérald Simonneau for coordinating the patient studies at the French Referral Centre for Severe Pulmonary Hypertension, Assistance Publique–Hôpitaux de Paris, Université Paris-Sud, Inserm U999, Le Kremlin-Bicêtre, France.</p>\\n    </ack>\\n    <fn-group>\\n      <fn id=\"FN1\">\\n        <p id=\"P28\">Disclosure forms provided by the authors are available with the full text of this article at <email>NEJM.org</email>.</p>\\n      </fn>\\n    </fn-group>\\n    <ref-list>\\n      <title>References</title>\\n      <ref id=\"R1\">\\n        <label>1</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <collab>The Task Force for Diagnosis and Treatment of Pulmonary Hypertension of European Society of Cardiology (ESC) and the European Respiratory Society (ERS) endorsed by the International Society of Heart and Lung Transplantation (ISHLT)</collab>\\n          </person-group>\\n          <article-title>Guidelines for the diagnosis and treatment of pulmonary hypertension</article-title>\\n          <source>Eur Respir J</source>\\n          <year>2009</year>\\n          <volume>34</volume>\\n          <fpage>1219</fpage>\\n          <lpage>63</lpage>\\n          <pub-id pub-id-type=\"pmid\">19749199</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R2\">\\n        <label>2</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>D’Alonzo</surname>\\n              <given-names>GE</given-names>\\n            </name>\\n            <name>\\n              <surname>Barst</surname>\\n              <given-names>RJ</given-names>\\n            </name>\\n            <name>\\n              <surname>Ayres</surname>\\n              <given-names>SM</given-names>\\n            </name>\\n            <etal/>\\n          </person-group>\\n          <article-title>Survival in patients with primary pulmonary hypertension: results from a national prospective registry</article-title>\\n          <source>Ann Intern Med</source>\\n          <year>1991</year>\\n          <volume>115</volume>\\n          <fpage>343</fpage>\\n          <lpage>9</lpage>\\n          <pub-id pub-id-type=\"pmid\">1863023</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R3\">\\n        <label>3</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Girerd</surname>\\n              <given-names>B</given-names>\\n            </name>\\n            <name>\\n              <surname>Montani</surname>\\n              <given-names>D</given-names>\\n            </name>\\n            <name>\\n              <surname>Coulet</surname>\\n              <given-names>F</given-names>\\n            </name>\\n            <etal/>\\n          </person-group>\\n          <article-title>Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation</article-title>\\n          <source>Am J Respir Crit Care Med</source>\\n          <year>2010</year>\\n          <volume>181</volume>\\n          <fpage>851</fpage>\\n          <lpage>61</lpage>\\n          <pub-id pub-id-type=\"pmid\">20056902</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R4\">\\n        <label>4</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Deng</surname>\\n              <given-names>Z</given-names>\\n            </name>\\n            <name>\\n              <surname>Morse</surname>\\n              <given-names>JH</given-names>\\n            </name>\\n            <name>\\n              <surname>Slager</surname>\\n              <given-names>SL</given-names>\\n            </name>\\n            <etal/>\\n          </person-group>\\n          <article-title>Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene</article-title>\\n          <source>Am J Hum Genet</source>\\n          <year>2000</year>\\n          <volume>67</volume>\\n          <fpage>737</fpage>\\n          <lpage>44</lpage>\\n          <pub-id pub-id-type=\"pmid\">10903931</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R5\">\\n        <label>5</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Machado</surname>\\n              <given-names>RD</given-names>\\n            </name>\\n            <name>\\n              <surname>Eickelberg</surname>\\n              <given-names>O</given-names>\\n            </name>\\n            <name>\\n              <surname>Elliott</surname>\\n              <given-names>CG</given-names>\\n            </name>\\n            <etal/>\\n          </person-group>\\n          <article-title>Genetics and genomics of pulmonary arterial hypertension</article-title>\\n          <source>J Am Coll Cardiol</source>\\n          <year>2009</year>\\n          <volume>54</volume>\\n          <issue>Suppl</issue>\\n          <fpage>S32</fpage>\\n          <lpage>S42</lpage>\\n          <pub-id pub-id-type=\"pmid\">19555857</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R6\">\\n        <label>6</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>McAllister</surname>\\n              <given-names>KA</given-names>\\n            </name>\\n            <name>\\n              <surname>Grogg</surname>\\n              <given-names>KM</given-names>\\n            </name>\\n            <name>\\n              <surname>Johnson</surname>\\n              <given-names>DW</given-names>\\n            </name>\\n            <etal/>\\n          </person-group>\\n          <article-title>Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1</article-title>\\n          <source>Nat Genet</source>\\n          <year>1994</year>\\n          <volume>8</volume>\\n          <fpage>345</fpage>\\n          <lpage>51</lpage>\\n          <pub-id pub-id-type=\"pmid\">7894484</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R7\">\\n        <label>7</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Johnson</surname>\\n              <given-names>DW</given-names>\\n            </name>\\n            <name>\\n              <surname>Berg</surname>\\n              <given-names>JN</given-names>\\n            </name>\\n            <name>\\n              <surname>Baldwin</surname>\\n              <given-names>MA</given-names>\\n            </name>\\n            <etal/>\\n          </person-group>\\n          <article-title>Mutations in the activin receptorlike kinase 1 gene in hereditary haemorrhagic telangiectasia type 2</article-title>\\n          <source>Nat Genet</source>\\n          <year>1996</year>\\n          <volume>13</volume>\\n          <fpage>189</fpage>\\n          <lpage>95</lpage>\\n          <pub-id pub-id-type=\"pmid\">8640225</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R8\">\\n        <label>8</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Abdalla</surname>\\n              <given-names>SA</given-names>\\n            </name>\\n            <name>\\n              <surname>Pece-Barbara</surname>\\n              <given-names>N</given-names>\\n            </name>\\n            <name>\\n              <surname>Vera</surname>\\n              <given-names>S</given-names>\\n            </name>\\n            <etal/>\\n          </person-group>\\n          <article-title>Analysis of ALK-1 and endoglin in newborns from families with hereditary hemorrhagic telangiectasia type 2</article-title>\\n          <source>Hum Mol Genet</source>\\n          <year>2000</year>\\n          <volume>9</volume>\\n          <fpage>1227</fpage>\\n          <lpage>37</lpage>\\n          <pub-id pub-id-type=\"pmid\">10767348</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R9\">\\n        <label>9</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Harrison</surname>\\n              <given-names>RE</given-names>\\n            </name>\\n            <name>\\n              <surname>Flanagan</surname>\\n              <given-names>JA</given-names>\\n            </name>\\n            <name>\\n              <surname>Sankelo</surname>\\n              <given-names>M</given-names>\\n            </name>\\n            <etal/>\\n          </person-group>\\n          <article-title>Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia</article-title>\\n          <source>J Med Genet</source>\\n          <year>2003</year>\\n          <volume>40</volume>\\n          <fpage>865</fpage>\\n          <lpage>71</lpage>\\n          <comment>[Erratum, J Med Genet 2004;41:576.]</comment>\\n          <pub-id pub-id-type=\"pmid\">14684682</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R10\">\\n        <label>10</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Shintani</surname>\\n              <given-names>M</given-names>\\n            </name>\\n            <name>\\n              <surname>Yagi</surname>\\n              <given-names>H</given-names>\\n            </name>\\n            <name>\\n              <surname>Nakayama</surname>\\n              <given-names>T</given-names>\\n            </name>\\n            <name>\\n              <surname>Saji</surname>\\n              <given-names>T</given-names>\\n            </name>\\n            <name>\\n              <surname>Matsuoka</surname>\\n              <given-names>R</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension</article-title>\\n          <source>J Med Genet</source>\\n          <year>2009</year>\\n          <volume>46</volume>\\n          <fpage>331</fpage>\\n          <lpage>7</lpage>\\n          <pub-id pub-id-type=\"pmid\">19211612</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R11\">\\n        <label>11</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Nasim</surname>\\n              <given-names>MT</given-names>\\n            </name>\\n            <name>\\n              <surname>Ogo</surname>\\n              <given-names>T</given-names>\\n            </name>\\n            <name>\\n              <surname>Ahmed</surname>\\n              <given-names>M</given-names>\\n            </name>\\n            <etal/>\\n          </person-group>\\n          <article-title>Molecular genetic characterization of SMAD signaling molecules in pulmonary arterial hypertension</article-title>\\n          <source>Hum Mutat</source>\\n          <year>2011</year>\\n          <volume>32</volume>\\n          <fpage>1385</fpage>\\n          <lpage>9</lpage>\\n          <pub-id pub-id-type=\"pmid\">21898662</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R12\">\\n        <label>12</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Austin</surname>\\n              <given-names>ED</given-names>\\n            </name>\\n            <name>\\n              <surname>Ma</surname>\\n              <given-names>L</given-names>\\n            </name>\\n            <name>\\n              <surname>LeDuc</surname>\\n              <given-names>C</given-names>\\n            </name>\\n            <etal/>\\n          </person-group>\\n          <article-title>Whole exome sequencing to identify a novel gene (Caveolin-1) associated with human pulmonary arterial hypertension</article-title>\\n          <source>Circ Cardiovasc Genet</source>\\n          <year>2012</year>\\n          <volume>5</volume>\\n          <fpage>336</fpage>\\n          <lpage>43</lpage>\\n          <pub-id pub-id-type=\"pmid\">22474227</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R13\">\\n        <label>13</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Olschewski</surname>\\n              <given-names>A</given-names>\\n            </name>\\n            <name>\\n              <surname>Li</surname>\\n              <given-names>Y</given-names>\\n            </name>\\n            <name>\\n              <surname>Tang</surname>\\n              <given-names>B</given-names>\\n            </name>\\n            <etal/>\\n          </person-group>\\n          <article-title>Impact of TASK-1 in human pulmonary artery smooth muscle cells</article-title>\\n          <source>Circ Res</source>\\n          <year>2006</year>\\n          <volume>98</volume>\\n          <fpage>1072</fpage>\\n          <lpage>80</lpage>\\n          <pub-id pub-id-type=\"pmid\">16574908</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R14\">\\n        <label>14</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Hartness</surname>\\n              <given-names>ME</given-names>\\n            </name>\\n            <name>\\n              <surname>Lewis</surname>\\n              <given-names>A</given-names>\\n            </name>\\n            <name>\\n              <surname>Searle</surname>\\n              <given-names>GJ</given-names>\\n            </name>\\n            <name>\\n              <surname>O’Kelly</surname>\\n              <given-names>I</given-names>\\n            </name>\\n            <name>\\n              <surname>Peers</surname>\\n              <given-names>C</given-names>\\n            </name>\\n            <name>\\n              <surname>Kemp</surname>\\n              <given-names>PJ</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Combined antisense and pharmacological approaches implicate hTASK as an airway O(2) sensing K(+) channel</article-title>\\n          <source>J Biol Chem</source>\\n          <year>2001</year>\\n          <volume>276</volume>\\n          <fpage>26499</fpage>\\n          <lpage>508</lpage>\\n          <pub-id pub-id-type=\"pmid\">11344164</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R15\">\\n        <label>15</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Osipenko</surname>\\n              <given-names>ON</given-names>\\n            </name>\\n            <name>\\n              <surname>Evans</surname>\\n              <given-names>AM</given-names>\\n            </name>\\n            <name>\\n              <surname>Gurney</surname>\\n              <given-names>AM</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Regulation of the resting potential of rabbit pulmonary artery myocytes by a low threshold, O2-sensing potassium current</article-title>\\n          <source>Br J Pharmacol</source>\\n          <year>1997</year>\\n          <volume>120</volume>\\n          <fpage>1461</fpage>\\n          <lpage>70</lpage>\\n          <pub-id pub-id-type=\"pmid\">9113366</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R16\">\\n        <label>16</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Czirják</surname>\\n              <given-names>G</given-names>\\n            </name>\\n            <name>\\n              <surname>Enyedi</surname>\\n              <given-names>P</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Formation of functional heterodimers between the TASK-1 and TASK-3 two-pore domain potassium channel subunits</article-title>\\n          <source>J Biol Chem</source>\\n          <year>2002</year>\\n          <volume>277</volume>\\n          <fpage>5426</fpage>\\n          <lpage>32</lpage>\\n          <pub-id pub-id-type=\"pmid\">11733509</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R17\">\\n        <label>17</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Patel</surname>\\n              <given-names>AJ</given-names>\\n            </name>\\n            <name>\\n              <surname>Honoré</surname>\\n              <given-names>E</given-names>\\n            </name>\\n            <name>\\n              <surname>Lesage</surname>\\n              <given-names>F</given-names>\\n            </name>\\n            <name>\\n              <surname>Fink</surname>\\n              <given-names>M</given-names>\\n            </name>\\n            <name>\\n              <surname>Romey</surname>\\n              <given-names>G</given-names>\\n            </name>\\n            <name>\\n              <surname>Lazdunski</surname>\\n              <given-names>M</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Inhalational anesthetics activate two-pore-domain background K+ channels</article-title>\\n          <source>Nat Neurosci</source>\\n          <year>1999</year>\\n          <volume>2</volume>\\n          <fpage>422</fpage>\\n          <lpage>6</lpage>\\n          <pub-id pub-id-type=\"pmid\">10321245</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R18\">\\n        <label>18</label>\\n        <element-citation publication-type=\"web\">\\n          <source>Method of treating a condition associated with phosphorylation of TASK-1: patent no. 8097650</source>\\n          <comment>(<ext-link ext-link-type=\"uri\" xlink:href=\"http://www.google.com/patents/US8097650\">http://www.google.com/patents/US8097650</ext-link>)</comment>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R19\">\\n        <label>19</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Reyes</surname>\\n              <given-names>R</given-names>\\n            </name>\\n            <name>\\n              <surname>Duprat</surname>\\n              <given-names>F</given-names>\\n            </name>\\n            <name>\\n              <surname>Lesage</surname>\\n              <given-names>F</given-names>\\n            </name>\\n            <etal/>\\n          </person-group>\\n          <article-title>Cloning and expression of a novel pH-sensitive two pore domain K+ channel from human kidney</article-title>\\n          <source>J Biol Chem</source>\\n          <year>1998</year>\\n          <volume>273</volume>\\n          <fpage>30863</fpage>\\n          <lpage>9</lpage>\\n          <pub-id pub-id-type=\"pmid\">9812978</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R20\">\\n        <label>20</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Gurney</surname>\\n              <given-names>AM</given-names>\\n            </name>\\n            <name>\\n              <surname>Osipenko</surname>\\n              <given-names>ON</given-names>\\n            </name>\\n            <name>\\n              <surname>MacMillan</surname>\\n              <given-names>D</given-names>\\n            </name>\\n            <name>\\n              <surname>McFarlane</surname>\\n              <given-names>KM</given-names>\\n            </name>\\n            <name>\\n              <surname>Tate</surname>\\n              <given-names>RJ</given-names>\\n            </name>\\n            <name>\\n              <surname>Kempsill</surname>\\n              <given-names>FE</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Two-pore domain K channel, TASK-1, in pulmonary artery smooth muscle cells</article-title>\\n          <source>Circ Res</source>\\n          <year>2003</year>\\n          <volume>93</volume>\\n          <fpage>957</fpage>\\n          <lpage>64</lpage>\\n          <pub-id pub-id-type=\"pmid\">14551239</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R21\">\\n        <label>21</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Yu</surname>\\n              <given-names>SP</given-names>\\n            </name>\\n            <name>\\n              <surname>Choi</surname>\\n              <given-names>DW</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Ions, cell volume, and apoptosis</article-title>\\n          <source>Proc Natl Acad Sci U S A</source>\\n          <year>2000</year>\\n          <volume>97</volume>\\n          <fpage>9360</fpage>\\n          <lpage>2</lpage>\\n          <pub-id pub-id-type=\"pmid\">10944207</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R22\">\\n        <label>22</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Trapp</surname>\\n              <given-names>S</given-names>\\n            </name>\\n            <name>\\n              <surname>Aller</surname>\\n              <given-names>MI</given-names>\\n            </name>\\n            <name>\\n              <surname>Wisden</surname>\\n              <given-names>W</given-names>\\n            </name>\\n            <name>\\n              <surname>Gourine</surname>\\n              <given-names>AV</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>A role for TASK-1 (KCNK3) channels in the chemosensory control of breathing</article-title>\\n          <source>J Neurosci</source>\\n          <year>2008</year>\\n          <volume>28</volume>\\n          <fpage>8844</fpage>\\n          <lpage>50</lpage>\\n          <pub-id pub-id-type=\"pmid\">18753386</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R23\">\\n        <label>23</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Gardener</surname>\\n              <given-names>MJ</given-names>\\n            </name>\\n            <name>\\n              <surname>Johnson</surname>\\n              <given-names>IT</given-names>\\n            </name>\\n            <name>\\n              <surname>Burnham</surname>\\n              <given-names>MP</given-names>\\n            </name>\\n            <name>\\n              <surname>Edwards</surname>\\n              <given-names>G</given-names>\\n            </name>\\n            <name>\\n              <surname>Heagerty</surname>\\n              <given-names>AM</given-names>\\n            </name>\\n            <name>\\n              <surname>Weston</surname>\\n              <given-names>AH</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Functional evidence of a role for two-pore domain potassium channels in rat mesenteric and pulmonary arteries</article-title>\\n          <source>Br J Pharmacol</source>\\n          <year>2004</year>\\n          <volume>142</volume>\\n          <fpage>192</fpage>\\n          <lpage>202</lpage>\\n          <pub-id pub-id-type=\"pmid\">15066906</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R24\">\\n        <label>24</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Zuzarte</surname>\\n              <given-names>M</given-names>\\n            </name>\\n            <name>\\n              <surname>Heusser</surname>\\n              <given-names>K</given-names>\\n            </name>\\n            <name>\\n              <surname>Renigunta</surname>\\n              <given-names>V</given-names>\\n            </name>\\n            <etal/>\\n          </person-group>\\n          <article-title>Intracellular traffic of the K+ channels TASK-1 and TASK-3: role of N- and C-terminal sorting signals and interaction with 14-3-3 proteins</article-title>\\n          <source>J Physiol</source>\\n          <year>2009</year>\\n          <volume>587</volume>\\n          <fpage>929</fpage>\\n          <lpage>52</lpage>\\n          <pub-id pub-id-type=\"pmid\">19139046</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R25\">\\n        <label>25</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Yuill</surname>\\n              <given-names>KH</given-names>\\n            </name>\\n            <name>\\n              <surname>Stansfeld</surname>\\n              <given-names>PJ</given-names>\\n            </name>\\n            <name>\\n              <surname>Ashmole</surname>\\n              <given-names>I</given-names>\\n            </name>\\n            <name>\\n              <surname>Sutcliffe</surname>\\n              <given-names>MJ</given-names>\\n            </name>\\n            <name>\\n              <surname>Stanfield</surname>\\n              <given-names>PR</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>The selectivity, voltage-dependence and acid sensitivity of the tandem pore potassium channel TASK-1: contributions of the pore domains</article-title>\\n          <source>Pflugers Arch</source>\\n          <year>2007</year>\\n          <volume>455</volume>\\n          <fpage>333</fpage>\\n          <lpage>48</lpage>\\n          <pub-id pub-id-type=\"pmid\">17541788</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R26\">\\n        <label>26</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Streit</surname>\\n              <given-names>AK</given-names>\\n            </name>\\n            <name>\\n              <surname>Netter</surname>\\n              <given-names>MF</given-names>\\n            </name>\\n            <name>\\n              <surname>Kempf</surname>\\n              <given-names>F</given-names>\\n            </name>\\n            <etal/>\\n          </person-group>\\n          <article-title>A specific two-pore domain potassium channel blocker defines the structure of the TASK-1 open pore</article-title>\\n          <source>J Biol Chem</source>\\n          <year>2011</year>\\n          <volume>286</volume>\\n          <fpage>13977</fpage>\\n          <lpage>84</lpage>\\n          <pub-id pub-id-type=\"pmid\">21362619</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R27\">\\n        <label>27</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Yuan</surname>\\n              <given-names>XJ</given-names>\\n            </name>\\n            <name>\\n              <surname>Wang</surname>\\n              <given-names>J</given-names>\\n            </name>\\n            <name>\\n              <surname>Juhaszova</surname>\\n              <given-names>M</given-names>\\n            </name>\\n            <name>\\n              <surname>Gaine</surname>\\n              <given-names>SP</given-names>\\n            </name>\\n            <name>\\n              <surname>Rubin</surname>\\n              <given-names>LJ</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Attenuated K channel gene transcription in primary pulmonary hypertension</article-title>\\n          <source>Lancet</source>\\n          <year>1998</year>\\n          <volume>351</volume>\\n          <fpage>726</fpage>\\n          <lpage>7</lpage>\\n          <pub-id pub-id-type=\"pmid\">9504523</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R28\">\\n        <label>28</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Medhurst</surname>\\n              <given-names>AD</given-names>\\n            </name>\\n            <name>\\n              <surname>Rennie</surname>\\n              <given-names>G</given-names>\\n            </name>\\n            <name>\\n              <surname>Chapman</surname>\\n              <given-names>CG</given-names>\\n            </name>\\n            <etal/>\\n          </person-group>\\n          <article-title>Distribution analysis of human two pore domain potassium channels in tissues of the central nervous system and periphery</article-title>\\n          <source>Brain Res Mol Brain Res</source>\\n          <year>2001</year>\\n          <volume>86</volume>\\n          <fpage>101</fpage>\\n          <lpage>14</lpage>\\n          <pub-id pub-id-type=\"pmid\">11165377</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R29\">\\n        <label>29</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Gaborit</surname>\\n              <given-names>N</given-names>\\n            </name>\\n            <name>\\n              <surname>Le Bouter</surname>\\n              <given-names>S</given-names>\\n            </name>\\n            <name>\\n              <surname>Szuts</surname>\\n              <given-names>V</given-names>\\n            </name>\\n            <etal/>\\n          </person-group>\\n          <article-title>Regional and tissue specific transcript signatures of ion channel genes in the non-diseased human heart</article-title>\\n          <source>J Physiol</source>\\n          <year>2007</year>\\n          <volume>582</volume>\\n          <fpage>675</fpage>\\n          <lpage>93</lpage>\\n          <pub-id pub-id-type=\"pmid\">17478540</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R30\">\\n        <label>30</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Moncada</surname>\\n              <given-names>S</given-names>\\n            </name>\\n            <name>\\n              <surname>Gryglewsli</surname>\\n              <given-names>R</given-names>\\n            </name>\\n            <name>\\n              <surname>Bunting</surname>\\n              <given-names>S</given-names>\\n            </name>\\n            <name>\\n              <surname>Vane</surname>\\n              <given-names>JR</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation</article-title>\\n          <source>Nature</source>\\n          <year>1976</year>\\n          <volume>263</volume>\\n          <fpage>663</fpage>\\n          <lpage>5</lpage>\\n          <pub-id pub-id-type=\"pmid\">802670</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R31\">\\n        <label>31</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Higenbottam</surname>\\n              <given-names>T</given-names>\\n            </name>\\n            <name>\\n              <surname>Wheeldon</surname>\\n              <given-names>D</given-names>\\n            </name>\\n            <name>\\n              <surname>Wells</surname>\\n              <given-names>F</given-names>\\n            </name>\\n            <name>\\n              <surname>Wallwork</surname>\\n              <given-names>J</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Long-term treatment of primary pulmonary hypertension with continuous intravenous epoprostenol (prostacyclin)</article-title>\\n          <source>Lancet</source>\\n          <year>1984</year>\\n          <volume>1</volume>\\n          <fpage>1046</fpage>\\n          <lpage>7</lpage>\\n          <pub-id pub-id-type=\"pmid\">6143976</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R32\">\\n        <label>32</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Tang</surname>\\n              <given-names>B</given-names>\\n            </name>\\n            <name>\\n              <surname>Li</surname>\\n              <given-names>Y</given-names>\\n            </name>\\n            <name>\\n              <surname>Nagaraj</surname>\\n              <given-names>C</given-names>\\n            </name>\\n            <etal/>\\n          </person-group>\\n          <article-title>Endothelin-1 inhibits background two-pore domain channel TASK-1 in primary human pulmonary artery smooth muscle cells</article-title>\\n          <source>Am J Respir Cell Mol Biol</source>\\n          <year>2009</year>\\n          <volume>41</volume>\\n          <fpage>476</fpage>\\n          <lpage>83</lpage>\\n          <pub-id pub-id-type=\"pmid\">19188660</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R33\">\\n        <label>33</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Seyler</surname>\\n              <given-names>C</given-names>\\n            </name>\\n            <name>\\n              <surname>Duthil-Straub</surname>\\n              <given-names>E</given-names>\\n            </name>\\n            <name>\\n              <surname>Zitron</surname>\\n              <given-names>E</given-names>\\n            </name>\\n            <etal/>\\n          </person-group>\\n          <article-title>TASK1 (K(2P)3.1) K(+) channel inhibition by endothelin-1 is mediated through Rho kinase-dependent phosphorylation</article-title>\\n          <source>Br J Pharmacol</source>\\n          <year>2012</year>\\n          <volume>165</volume>\\n          <fpage>1467</fpage>\\n          <lpage>75</lpage>\\n          <pub-id pub-id-type=\"pmid\">21838752</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R34\">\\n        <label>34</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Atkinson</surname>\\n              <given-names>C</given-names>\\n            </name>\\n            <name>\\n              <surname>Stewart</surname>\\n              <given-names>S</given-names>\\n            </name>\\n            <name>\\n              <surname>Upton</surname>\\n              <given-names>PD</given-names>\\n            </name>\\n            <etal/>\\n          </person-group>\\n          <article-title>Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor</article-title>\\n          <source>Circulation</source>\\n          <year>2002</year>\\n          <volume>105</volume>\\n          <fpage>1672</fpage>\\n          <lpage>8</lpage>\\n          <pub-id pub-id-type=\"pmid\">11940546</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R35\">\\n        <label>35</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Remillard</surname>\\n              <given-names>CV</given-names>\\n            </name>\\n            <name>\\n              <surname>Tigno</surname>\\n              <given-names>DD</given-names>\\n            </name>\\n            <name>\\n              <surname>Platoshyn</surname>\\n              <given-names>O</given-names>\\n            </name>\\n            <etal/>\\n          </person-group>\\n          <article-title>Function of Kv1.5 channels and genetic variations of KCNA5 in patients with idiopathic pulmonary arterial hypertension</article-title>\\n          <source>Am J Physiol Cell Physiol</source>\\n          <year>2007</year>\\n          <volume>292</volume>\\n          <fpage>C1837</fpage>\\n          <lpage>C1853</lpage>\\n          <pub-id pub-id-type=\"pmid\">17267549</pub-id>\\n        </element-citation>\\n      </ref>\\n      <ref id=\"R36\">\\n        <label>36</label>\\n        <element-citation publication-type=\"journal\">\\n          <person-group person-group-type=\"author\">\\n            <name>\\n              <surname>Morecroft</surname>\\n              <given-names>I</given-names>\\n            </name>\\n            <name>\\n              <surname>Murray</surname>\\n              <given-names>A</given-names>\\n            </name>\\n            <name>\\n              <surname>Nilsen</surname>\\n              <given-names>M</given-names>\\n            </name>\\n            <name>\\n              <surname>Gurney</surname>\\n              <given-names>AM</given-names>\\n            </name>\\n            <name>\\n              <surname>MacLean</surname>\\n              <given-names>MR</given-names>\\n            </name>\\n          </person-group>\\n          <article-title>Treatment with the Kv7 potassium channel activator flupirtine is beneficial in two independent mouse models of pulmonary hypertension</article-title>\\n          <source>Br J Pharmacol</source>\\n          <year>2009</year>\\n          <volume>157</volume>\\n          <fpage>1241</fpage>\\n          <lpage>9</lpage>\\n          <pub-id pub-id-type=\"pmid\">19508393</pub-id>\\n        </element-citation>\\n      </ref>\\n    </ref-list>\\n  </back>\\n  <floats-group>\\n    <fig id=\"F1\" orientation=\"portrait\" position=\"float\">\\n      <label>Figure 1</label>\\n      <caption>\\n        <title>Pedigrees of Families with Familial Pulmonary Arterial Hypertension</title>\\n        <p>Segregation of <italic>KCNK3</italic> mutations c.608 G→A (G203D) in the index family (Family 1) (Panel A), c.289G→A (G97R) in Family 2 (Panel B), and c.661G→C (V221L) in Family 3 (Panel C) is indicated. The sequence shown in Panel C is the sequence of the complementary strand. Arrows show the family members whose DNA was analyzed with the use of whole-exome sequencing. Genotypes of family members are shown under each symbol. NM/NM denotes nonmutated homozygote, and NM/M heterozygote with one copy of the <italic>KCNK3</italic> mutation. The current age or the age at death, as well as the age at diagnosis (Dx), where applicable, is provided for each family member. Black squares denote affected males, black circles affected females, white squares unaffected males, and white circles unaffected females; slashes indicate deceased family members.</p>\\n      </caption>\\n      <graphic xlink:href=\"nihms-515515-f0001\"/>\\n    </fig>\\n    <fig id=\"F2\" orientation=\"portrait\" position=\"float\">\\n      <label>Figure 2</label>\\n      <caption>\\n        <title>Topologic Analysis of the Human KCNK3 (hKCNK3) Channel and Sequence Alignment with Other Members of the KCNK Channel Family</title>\\n        <p>Panel A shows a topologic analysis of the hKCNK3 channel, indicating the positions of the mutations that were identified in this study. Panel B shows the alignment of the amino acid sequences of KCNK3 with three other acid-sensitive members of the KCNK channel family and KCNK1. The positions of the mutations are indicated by the various colors. COOH denotes C-terminal.</p>\\n      </caption>\\n      <graphic xlink:href=\"nihms-515515-f0002\"/>\\n    </fig>\\n    <fig id=\"F3\" orientation=\"portrait\" position=\"float\">\\n      <label>Figure 3(facing page)</label>\\n      <caption>\\n        <title>Functional Consequences of hKCNK3 Mutations</title>\\n        <p>Whole-cell patch-clamp procedures were used to measure expressed currents and their response to pH and pharmacologic agents. Panel A shows the representative pH dependence of the current in the nonmutant (NM) hKCNK3 channel. Dashed lines indicate current density at a pH of 7.4. For each point, 4 to 14 cells were studied. The solid curve shows the best fit for the dose–response values. Currents were measured at +60 mV and normalized to current measured at a pH of 10.4. Panel B shows current traces at a pH of 7.4 for the nonmutant hKCNK3 channel and the T8K, G97R, E182K, Y192C, G203D, and V221 mutants. Current density is measured as picoamperes per picofarad (pA/pF). For all current traces, the vertical scale is 10 pA/pF and the horizontal scale is 20 mV. The inset shows the ramp protocol (i.e., voltage steps or ramps). The vertical dashed lines represent the current at 60 mV. Panel C shows a summary of results illustrated in Panel B, according to mutation. Panel D shows a comparison between the homozygous nonmutant hKCNK3 channel and heterozygous channels incorporating the Y192C, G203D, or V221L mutant at a pH of 7.4. For every point, 7 to 25 cells were studied. In Panels C and D, data are shown as means; T bars indicate standard errors. Asterisks denote P&lt;0.05 for the comparison between the nonmutant hKCNK3 channel and each mutant.</p>\\n      </caption>\\n      <graphic xlink:href=\"nihms-515515-f0003\"/>\\n    </fig>\\n    <fig id=\"F4\" orientation=\"portrait\" position=\"float\">\\n      <label>Figure 4(facing page)</label>\\n      <caption>\\n        <title>Pharmacologic Recovery of Mutant hKCNK3 Channels</title>\\n        <p>The phospholipase A2 inhibitor ONO-RS-082 has been shown to activate nonmutant (NM) hKCNK3 channels. Panel A shows the representative recordings before the application of ONO-RS-082 (gray lines) and after the application (black lines) in nonmutant and mutant hKCNK3 channels. For all current traces, the vertical scale is 8 pA/pF. Panel B shows the time course of drug application before (gray squares), during (black circles), and after (gray triangles) application. Arrows indicate the current-density level before drug application. Panel C shows a summary of results of drug effects on nonmutant and mutant hKCNK3 channels. Light blue bars represent the current before drug application; dark blue bars represent the maximal drug response. Data are shown as means; T bars indicate standard errors. Asterisks indicate P&lt;0.05 for the comparison between the current before drug application and the maximal drug response, as calculated by means of the paired Student’s t-test.</p>\\n      </caption>\\n      <graphic xlink:href=\"nihms-515515-f0004\"/>\\n    </fig>\\n    <table-wrap id=\"T1\" position=\"float\" orientation=\"landscape\">\\n      <label>Table 1</label>\\n      <caption>\\n        <title>Clinical Characteristics of Seven Patients with Pulmonary Arterial Hypertension with <italic>KCNK3</italic> Mutations<xref ref-type=\"table-fn\" rid=\"TFN1\">*</xref></title>\\n      </caption>\\n      <table frame=\"box\" rules=\"rows\">\\n        <thead>\\n          <tr>\\n            <th align=\"left\" valign=\"bottom\" rowspan=\"1\" colspan=\"1\">Characteristic</th>\\n            <th align=\"center\" valign=\"bottom\" rowspan=\"1\" colspan=\"1\">Family 1<break/>Member<break/>11-2</th>\\n            <th align=\"center\" valign=\"bottom\" rowspan=\"1\" colspan=\"1\">Family 1<break/>Member<break/>lll-l</th>\\n            <th align=\"center\" valign=\"bottom\" rowspan=\"1\" colspan=\"1\">Family 2<break/>Member<break/>lll-l</th>\\n            <th align=\"center\" valign=\"bottom\" rowspan=\"1\" colspan=\"1\">Family 3<break/>Member<break/>11-2</th>\\n            <th align=\"center\" valign=\"bottom\" rowspan=\"1\" colspan=\"1\">Patient 1</th>\\n            <th align=\"center\" valign=\"bottom\" rowspan=\"1\" colspan=\"1\">Patient 2</th>\\n            <th align=\"center\" valign=\"bottom\" rowspan=\"1\" colspan=\"1\">Patient 3</th>\\n          </tr>\\n        </thead>\\n        <tbody>\\n          <tr>\\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Sex</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Female</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Female</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Male</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Female</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Male</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Female</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Male</td>\\n          </tr>\\n          <tr>\\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Age at diagnosis (yr)</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">44</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">37</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">19</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">29</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">25</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">38</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">8</td>\\n          </tr>\\n          <tr>\\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Current age (yr)</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Deceased at 46</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Deceased at 49</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">20</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Deceased at 40</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">40</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">43</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">20</td>\\n          </tr>\\n          <tr>\\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Lung transplantation</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">No</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">No</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">No</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">At age 33</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">At age 29</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">No</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">At age 15</td>\\n          </tr>\\n          <tr>\\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\"><italic>KCNK3</italic> variant</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">G203D</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">G203D</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">G97R</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">V221L</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">E182K</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">T8K</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Y192C</td>\\n          </tr>\\n          <tr>\\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Type of pulmonary arterial hypertension</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Familial</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Familial</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Familial</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Familial</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Idiopathic</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Idiopathic</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Idiopathic</td>\\n          </tr>\\n          <tr>\\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Mean pulmonary-artery pressure at diagnosis<break/>\\u2003\\u2003(mm Hg)</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">76</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">62</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">86</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">67</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">101</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">54</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">107</td>\\n          </tr>\\n          <tr>\\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Right atrial pressure at diagnosis (mm Hg)</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">18</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">7</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">11</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">7</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">16</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">24</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">3</td>\\n          </tr>\\n          <tr>\\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Pulmonary capillary wedge pressure at diagnosis<break/>\\u2003\\u2003(mm Hg)</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">13</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">10</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">13</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">7</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">15</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">6</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">10</td>\\n          </tr>\\n          <tr>\\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Cardiac index at diagnosis (liters/min/m<sup>2</sup>)</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">2.74</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">3.16</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">3.22</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">2.72</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">1.73</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">1.21</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">2.70</td>\\n          </tr>\\n          <tr>\\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Pulmonary vascular resistance index at diagnosis<break/>\\u2003\\u2003(dyn·sec·cm<sup>−5</sup>)</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">1839</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">1316</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">1813</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">1764</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">3977</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">3174</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">2874</td>\\n          </tr>\\n          <tr>\\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">NYHA functional class at diagnosis</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">NA</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">NA</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">III</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">III</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">III</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">III</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">III</td>\\n          </tr>\\n          <tr>\\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Response to acute vasodilator challenge</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">NA</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">NA</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">No</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">No</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">No</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">No</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">No</td>\\n          </tr>\\n          <tr>\\n            <td align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Arrhythmias</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Partial right<break/>bundle-branch<break/>block</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\"/>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\"/>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\"/>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Atrial flutter</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">First-degree<break/>atrioventricular<break/>block; right bundle-<break/>branch block</td>\\n            <td align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\"/>\\n          </tr>\\n        </tbody>\\n      </table>\\n      <table-wrap-foot>\\n        <fn id=\"TFN1\">\\n          <label>*</label>\\n          <p id=\"P29\">Family 1 members 11-2 and lll-l, Family 2 member lll-l, and Family 3 member 11-2 all received the diagnosis of familial pulmonary arterial hypertension. Patients 1, 2, and 3 received the diagnosis of idiopathic pulmonary arterial hypertension. NA denotes not available, and NYHA New York Heart Association.</p>\\n        </fn>\\n      </table-wrap-foot>\\n    </table-wrap>\\n  </floats-group>\\n</article>\\n',\n",
       " '<full-text-retrieval-response xmlns=\"http://www.elsevier.com/xml/svapi/article/dtd\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\" xmlns:prism=\"http://prismstandard.org/namespaces/basic/2.0/\" xmlns:dcterms=\"http://purl.org/dc/terms/\" xmlns:dc=\"http://purl.org/dc/elements/1.1/\" xmlns:xocs=\"http://www.elsevier.com/xml/xocs/dtd\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:tb=\"http://www.elsevier.com/xml/common/table/dtd\" xmlns:sb=\"http://www.elsevier.com/xml/common/struct-bib/dtd\" xmlns:sa=\"http://www.elsevier.com/xml/common/struct-aff/dtd\" xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" xmlns:ja=\"http://www.elsevier.com/xml/ja/dtd\" xmlns:ce=\"http://www.elsevier.com/xml/common/dtd\" xmlns:cals=\"http://www.elsevier.com/xml/common/cals/dtd\" xmlns:bk=\"http://www.elsevier.com/xml/bk/dtd\"><coredata><prism:url>https://api.elsevier.com/content/article/pii/S0002929708004102</prism:url><dc:identifier>doi:10.1016/j.ajhg.2008.07.010</dc:identifier><eid>1-s2.0-S0002929708004102</eid><prism:doi>10.1016/j.ajhg.2008.07.010</prism:doi><pii>S0002-9297(08)00410-2</pii><dc:title>Maternally Inherited Birk Barel Mental Retardation Dysmorphism Syndrome Caused by a Mutation in the Genomically Imprinted Potassium Channel KCNK9 </dc:title><prism:publicationName>The American Journal of Human Genetics</prism:publicationName><prism:aggregationType>Journal</prism:aggregationType><pubType>Article</pubType><prism:issn>00029297</prism:issn><prism:volume>83</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:startingPage>193</prism:startingPage><prism:endingPage>199</prism:endingPage><prism:pageRange>193-199</prism:pageRange><prism:number>2</prism:number><dc:format>text/xml</dc:format><prism:coverDate>2008-08-08</prism:coverDate><prism:coverDisplayDate>8 August 2008</prism:coverDisplayDate><prism:copyright>Copyright © 2008 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.</prism:copyright><prism:publisher>The American Society of Human Genetics. Published by Elsevier Inc.</prism:publisher><dc:creator>Barel, Ortal</dc:creator><dc:creator>Shalev, Stavit A.</dc:creator><dc:creator>Ofir, Rivka</dc:creator><dc:creator>Cohen, Asi</dc:creator><dc:creator>Zlotogora, Joel</dc:creator><dc:creator>Shorer, Zamir</dc:creator><dc:creator>Mazor, Galia</dc:creator><dc:creator>Finer, Gal</dc:creator><dc:creator>Khateeb, Shareef</dc:creator><dc:creator>Zilberberg, Noam</dc:creator><dc:creator>Birk, Ohad S.</dc:creator><dc:description>We describe a maternally transmitted genomic-imprinting syndrome of mental retardation, hypotonia, and unique dysmorphism with elongated face. We mapped the disease-associated locus to ∼7.27 Mb on chromosome 8q24 and demonstrated that the disease is caused by a missense mutation in the maternal copy of KCNK9 within this locus. KCNK9 is maternally transmitted (imprinted with paternal silencing) and encodes K2P9.1, a member of the two pore-domain potassium channel (K2P) subfamily. The mutation fully abolishes the channel\\'s currents—both when functioning as a homodimer or as a heterodimer with K2P3.1.</dc:description><openaccess>1</openaccess><openaccessArticle>true</openaccessArticle><openaccessType>Full</openaccessType><openArchiveArticle>true</openArchiveArticle><openaccessSponsorName/><openaccessSponsorType>ElsevierBranded</openaccessSponsorType><openaccessUserLicense>http://www.elsevier.com/open-access/userlicense/1.0/</openaccessUserLicense><link rel=\"self\" href=\"https://api.elsevier.com/content/article/pii/S0002929708004102\"/><link rel=\"scidir\" href=\"http://www.sciencedirect.com/science/article/pii/S0002929708004102\"/></coredata><objects><object ref=\"gr2\" category=\"high\" type=\"IMAGE-HIGH-RES\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"3404\" height=\"3619\" size=\"902685\">https://api.elsevier.com/content/object/eid/1-s2.0-S0002929708004102-gr2_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr1\" category=\"high\" type=\"IMAGE-HIGH-RES\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"1660\" height=\"3531\" size=\"322507\">https://api.elsevier.com/content/object/eid/1-s2.0-S0002929708004102-gr1_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr4\" category=\"high\" type=\"IMAGE-HIGH-RES\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"3403\" height=\"2458\" size=\"547647\">https://api.elsevier.com/content/object/eid/1-s2.0-S0002929708004102-gr4_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr3\" category=\"high\" type=\"IMAGE-HIGH-RES\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"3404\" height=\"866\" size=\"299643\">https://api.elsevier.com/content/object/eid/1-s2.0-S0002929708004102-gr3_lrg.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr2\" category=\"standard\" type=\"IMAGE-DOWNSAMPLED\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"769\" height=\"818\" size=\"141366\">https://api.elsevier.com/content/object/eid/1-s2.0-S0002929708004102-gr2.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr1\" category=\"standard\" type=\"IMAGE-DOWNSAMPLED\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"375\" height=\"798\" size=\"39179\">https://api.elsevier.com/content/object/eid/1-s2.0-S0002929708004102-gr1.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr4\" category=\"standard\" type=\"IMAGE-DOWNSAMPLED\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"769\" height=\"555\" size=\"73669\">https://api.elsevier.com/content/object/eid/1-s2.0-S0002929708004102-gr4.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr3\" category=\"standard\" type=\"IMAGE-DOWNSAMPLED\" multimediatype=\"JPEG image file\" mimetype=\"image/jpeg\" width=\"769\" height=\"196\" size=\"50298\">https://api.elsevier.com/content/object/eid/1-s2.0-S0002929708004102-gr3.jpg?httpAccept=%2A%2F%2A</object><object ref=\"gr2\" category=\"thumbnail\" type=\"IMAGE-THUMBNAIL\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"154\" height=\"164\" size=\"4735\">https://api.elsevier.com/content/object/eid/1-s2.0-S0002929708004102-gr2.sml?httpAccept=%2A%2F%2A</object><object ref=\"gr1\" category=\"thumbnail\" type=\"IMAGE-THUMBNAIL\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"77\" height=\"164\" size=\"2055\">https://api.elsevier.com/content/object/eid/1-s2.0-S0002929708004102-gr1.sml?httpAccept=%2A%2F%2A</object><object ref=\"gr4\" category=\"thumbnail\" type=\"IMAGE-THUMBNAIL\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"219\" height=\"158\" size=\"6796\">https://api.elsevier.com/content/object/eid/1-s2.0-S0002929708004102-gr4.sml?httpAccept=%2A%2F%2A</object><object ref=\"gr3\" category=\"thumbnail\" type=\"IMAGE-THUMBNAIL\" multimediatype=\"GIF image file\" mimetype=\"image/gif\" width=\"219\" height=\"56\" size=\"4281\">https://api.elsevier.com/content/object/eid/1-s2.0-S0002929708004102-gr3.sml?httpAccept=%2A%2F%2A</object><object ref=\"mmc1\" category=\"standard\" type=\"APPLICATION\" multimediatype=\"Acrobat PDF file\" mimetype=\"application/pdf\" size=\"266454\">https://api.elsevier.com/content/object/eid/1-s2.0-S0002929708004102-mmc1.pdf?httpAccept=%2A%2F%2A</object></objects><scopus-id>48449105481</scopus-id><scopus-eid>2-s2.0-48449105481</scopus-eid><pubmed-id>18678320</pubmed-id><link rel=\"abstract\" href=\"https://api.elsevier.com/content/abstract/scopus_id/48449105481\"/><originalText><xocs:doc xmlns:xoe=\"http://www.elsevier.com/xml/xoe/dtd\" xsi:schemaLocation=\"http://www.elsevier.com/xml/xocs/dtd http://be-prod3a/schema/dtds/document/fulltext/xcr/xocs-article.xsd\"><xocs:meta><xocs:content-family>serial</xocs:content-family><xocs:content-type>JL</xocs:content-type><xocs:cid>276895</xocs:cid><xocs:ssids><xocs:ssid type=\"alllist\">291210</xocs:ssid><xocs:ssid type=\"subj\">291856</xocs:ssid><xocs:ssid type=\"subj\">291857</xocs:ssid><xocs:ssid type=\"content\">31</xocs:ssid><xocs:ssid type=\"oa\">80</xocs:ssid></xocs:ssids><xocs:srctitle>The American Journal of Human Genetics</xocs:srctitle><xocs:normalized-srctitle>AMERICANJOURNALHUMANGENETICS</xocs:normalized-srctitle><xocs:orig-load-date yyyymmdd=\"20080807\">2008-08-07</xocs:orig-load-date><xocs:available-online-date yyyymmdd=\"20080807\">2008-08-07</xocs:available-online-date><xocs:ew-transaction-id>2014-12-06T05:06:12</xocs:ew-transaction-id><xocs:eid>1-s2.0-S0002929708004102</xocs:eid><xocs:pii-formatted>S0002-9297(08)00410-2</xocs:pii-formatted><xocs:pii-unformatted>S0002929708004102</xocs:pii-unformatted><xocs:doi>10.1016/j.ajhg.2008.07.010</xocs:doi><xocs:item-stage>S300</xocs:item-stage><xocs:item-version-number>S300.4</xocs:item-version-number><xocs:item-weight>FULL-TEXT</xocs:item-weight><xocs:hub-eid>1-s2.0-S0002929708X00096</xocs:hub-eid><xocs:timestamp yyyymmdd=\"20150513\">2015-05-13T23:15:57.723918-04:00</xocs:timestamp><xocs:dco>0</xocs:dco><xocs:tomb>0</xocs:tomb><xocs:date-search-begin>20080808</xocs:date-search-begin><xocs:year-nav>2008</xocs:year-nav><xocs:indexeddate epoch=\"1218067200\">2008-08-07T00:00:00Z</xocs:indexeddate><xocs:articleinfo>articleinfo articletitlenorm authfirstinitialnorm authfirstsurnamenorm cid cids contenttype copyright crossmark dateloaded dateloadedtxt datesearch datesort dateupdated dco docsubtype doctype doi eid ewtransactionid hubeid indexeddate issfirst issn issnnorm issuelist itemstage itemtransactionid itemweight oauserlicense openaccess openarchive pg pgfirst pglast pii piinorm pubdatestart pubdatetxt pubyr sectiontitle sortorder srctitle srctitlenorm srctype ssids alllist content oa subj subheadings tomb volfirst volissue volumelist webpdf webpdfpagecount yearnav figure e-component body acknowledge affil appendices articletitle auth authfirstini authfull authlast footnotes misctext primabst pubtype ref</xocs:articleinfo><xocs:issns><xocs:issn-primary-formatted>0002-9297</xocs:issn-primary-formatted><xocs:issn-primary-unformatted>00029297</xocs:issn-primary-unformatted></xocs:issns><xocs:crossmark is-crossmark=\"0\">false</xocs:crossmark><xocs:vol-first>83</xocs:vol-first><xocs:volume-list><xocs:volume>83</xocs:volume></xocs:volume-list><xocs:iss-first>2</xocs:iss-first><xocs:issue-list><xocs:issue>2</xocs:issue></xocs:issue-list><xocs:vol-iss-suppl-text>Volume 83, Issue 2</xocs:vol-iss-suppl-text><xocs:sort-order>6</xocs:sort-order><xocs:first-fp>193</xocs:first-fp><xocs:last-lp>199</xocs:last-lp><xocs:pages><xocs:first-page>193</xocs:first-page><xocs:last-page>199</xocs:last-page></xocs:pages><xocs:cover-date-orig><xocs:start-date>20080808</xocs:start-date></xocs:cover-date-orig><xocs:cover-date-text>8 August 2008</xocs:cover-date-text><xocs:cover-date-start>2008-08-08</xocs:cover-date-start><xocs:cover-date-year>2008</xocs:cover-date-year><xocs:hub-sec><xocs:hub-sec-title>Articles</xocs:hub-sec-title></xocs:hub-sec><xocs:document-type>article</xocs:document-type><xocs:document-subtype>fla</xocs:document-subtype><xocs:copyright-line>Copyright © 2008 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.</xocs:copyright-line><xocs:normalized-article-title>MATERNALLYINHERITEDBIRKBARELMENTALRETARDATIONDYSMORPHISMSYNDROMECAUSEDBYAMUTATIONINGENOMICALLYIMPRINTEDPOTASSIUMCHANNELKCNK9</xocs:normalized-article-title><xocs:normalized-first-auth-surname>BAREL</xocs:normalized-first-auth-surname><xocs:normalized-first-auth-initial>O</xocs:normalized-first-auth-initial><xocs:item-toc><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-section-title>Introduction</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-section-title>Material and Methods</xocs:item-toc-section-title><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-section-title>Electrophysiology</xocs:item-toc-section-title></xocs:item-toc-entry></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-section-title>Results</xocs:item-toc-section-title><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-section-title>Clinical Phenotype of the Syndrome</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-section-title>Linkage-Analysis Studies</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-section-title>Determination of the Specific Gene Mutation</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-section-title>Determination of the Physiological Effect of the K<ce:inf loc=\"post\">2P</ce:inf>9.1 Mutation</xocs:item-toc-section-title></xocs:item-toc-entry></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:sections\"><xocs:item-toc-section-title>Discussion</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:acknowledgment\"><xocs:item-toc-section-title>Acknowledgments</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:appendices\"><xocs:item-toc-section-title>Supplemental Data</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:appendices\"><xocs:item-toc-section-title>Web Resources</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem=\"ce:bibliography\"><xocs:item-toc-section-title>References</xocs:item-toc-section-title></xocs:item-toc-entry></xocs:item-toc><xocs:references><xocs:ref-info refid=\"bib1\"><xocs:ref-normalized-surname>TEMPLE</xocs:ref-normalized-surname><xocs:ref-pub-year>2007</xocs:ref-pub-year><xocs:ref-first-fp>113</xocs:ref-first-fp><xocs:ref-last-lp>123</xocs:ref-last-lp><xocs:ref-normalized-initial>I</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib2\"><xocs:ref-normalized-surname>HAREL</xocs:ref-normalized-surname><xocs:ref-pub-year>2004</xocs:ref-pub-year><xocs:ref-first-fp>38</xocs:ref-first-fp><xocs:ref-last-lp>43</xocs:ref-last-lp><xocs:ref-normalized-initial>T</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib3\"><xocs:ref-normalized-surname>FISHELSON</xocs:ref-normalized-surname><xocs:ref-pub-year>2002</xocs:ref-pub-year><xocs:ref-first-fp>S189</xocs:ref-first-fp><xocs:ref-last-lp>S198</xocs:ref-last-lp><xocs:ref-normalized-initial>M</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib4\"><xocs:ref-normalized-surname>BENSON</xocs:ref-normalized-surname><xocs:ref-pub-year>1999</xocs:ref-pub-year><xocs:ref-first-fp>573</xocs:ref-first-fp><xocs:ref-last-lp>580</xocs:ref-last-lp><xocs:ref-normalized-initial>G</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib5\"><xocs:ref-normalized-surname>LUEDI</xocs:ref-normalized-surname><xocs:ref-pub-year>2007</xocs:ref-pub-year><xocs:ref-first-fp>1723</xocs:ref-first-fp><xocs:ref-last-lp>1730</xocs:ref-last-lp><xocs:ref-normalized-initial>P</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib6\"><xocs:ref-normalized-surname>RUF</xocs:ref-normalized-surname><xocs:ref-pub-year>2007</xocs:ref-pub-year><xocs:ref-first-fp>2591</xocs:ref-first-fp><xocs:ref-last-lp>2599</xocs:ref-last-lp><xocs:ref-normalized-initial>N</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib7\"><xocs:ref-normalized-surname>DOYLE</xocs:ref-normalized-surname><xocs:ref-pub-year>1998</xocs:ref-pub-year><xocs:ref-first-fp>69</xocs:ref-first-fp><xocs:ref-last-lp>77</xocs:ref-last-lp><xocs:ref-normalized-initial>D</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib8\"><xocs:ref-normalized-surname>GOLDSTEIN</xocs:ref-normalized-surname><xocs:ref-pub-year>2001</xocs:ref-pub-year><xocs:ref-first-fp>175</xocs:ref-first-fp><xocs:ref-last-lp>184</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib9\"><xocs:ref-normalized-surname>KIM</xocs:ref-normalized-surname><xocs:ref-pub-year>2000</xocs:ref-pub-year><xocs:ref-first-fp>9340</xocs:ref-first-fp><xocs:ref-last-lp>9347</xocs:ref-last-lp><xocs:ref-normalized-initial>Y</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib10\"><xocs:ref-normalized-surname>ALLER</xocs:ref-normalized-surname><xocs:ref-pub-year>2005</xocs:ref-pub-year><xocs:ref-first-fp>11455</xocs:ref-first-fp><xocs:ref-last-lp>11467</xocs:ref-last-lp><xocs:ref-normalized-initial>M</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib11\"><xocs:ref-normalized-surname>KANG</xocs:ref-normalized-surname><xocs:ref-pub-year>2004</xocs:ref-pub-year><xocs:ref-first-fp>64</xocs:ref-first-fp><xocs:ref-last-lp>77</xocs:ref-last-lp><xocs:ref-normalized-initial>D</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib12\"><xocs:ref-normalized-surname>BERG</xocs:ref-normalized-surname><xocs:ref-pub-year>2004</xocs:ref-pub-year><xocs:ref-first-fp>6693</xocs:ref-first-fp><xocs:ref-last-lp>6702</xocs:ref-last-lp><xocs:ref-normalized-initial>A</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib13\"><xocs:ref-normalized-surname>MEUTH</xocs:ref-normalized-surname><xocs:ref-pub-year>2003</xocs:ref-pub-year><xocs:ref-first-fp>6460</xocs:ref-first-fp><xocs:ref-last-lp>6469</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib14\"><xocs:ref-normalized-surname>CZIRJAK</xocs:ref-normalized-surname><xocs:ref-pub-year>2002</xocs:ref-pub-year><xocs:ref-first-fp>621</xocs:ref-first-fp><xocs:ref-last-lp>629</xocs:ref-last-lp><xocs:ref-normalized-initial>G</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib15\"><xocs:ref-normalized-surname>RUSZNAK</xocs:ref-normalized-surname><xocs:ref-pub-year>2004</xocs:ref-pub-year><xocs:ref-first-fp>1532</xocs:ref-first-fp><xocs:ref-last-lp>1542</xocs:ref-last-lp><xocs:ref-normalized-initial>Z</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib16\"><xocs:ref-normalized-surname>MCINNIS</xocs:ref-normalized-surname><xocs:ref-pub-year>2003</xocs:ref-pub-year><xocs:ref-first-fp>288</xocs:ref-first-fp><xocs:ref-last-lp>298</xocs:ref-last-lp><xocs:ref-normalized-initial>M</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib17\"><xocs:ref-normalized-surname>ZARA</xocs:ref-normalized-surname><xocs:ref-pub-year>1995</xocs:ref-pub-year><xocs:ref-first-fp>1201</xocs:ref-first-fp><xocs:ref-last-lp>1207</xocs:ref-last-lp><xocs:ref-normalized-initial>F</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib18\"><xocs:ref-normalized-surname>LAURITZEN</xocs:ref-normalized-surname><xocs:ref-pub-year>2003</xocs:ref-pub-year><xocs:ref-first-fp>32068</xocs:ref-first-fp><xocs:ref-last-lp>32076</xocs:ref-last-lp><xocs:ref-normalized-initial>I</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib19\"><xocs:ref-normalized-surname>ZANZOURI</xocs:ref-normalized-surname><xocs:ref-pub-year>2006</xocs:ref-pub-year><xocs:ref-first-fp>28910</xocs:ref-first-fp><xocs:ref-last-lp>28918</xocs:ref-last-lp><xocs:ref-normalized-initial>M</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib20\"><xocs:ref-normalized-surname>BRICKLEY</xocs:ref-normalized-surname><xocs:ref-pub-year>2007</xocs:ref-pub-year><xocs:ref-first-fp>9329</xocs:ref-first-fp><xocs:ref-last-lp>9340</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib21\"><xocs:ref-normalized-surname>LINDEN</xocs:ref-normalized-surname><xocs:ref-pub-year>2007</xocs:ref-pub-year><xocs:ref-first-fp>924</xocs:ref-first-fp><xocs:ref-last-lp>934</xocs:ref-last-lp><xocs:ref-normalized-initial>A</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib22\"><xocs:ref-normalized-surname>MEUTH</xocs:ref-normalized-surname><xocs:ref-pub-year>2006</xocs:ref-pub-year><xocs:ref-first-fp>1517</xocs:ref-first-fp><xocs:ref-last-lp>1529</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib23\"><xocs:ref-normalized-surname>DUBE</xocs:ref-normalized-surname><xocs:ref-pub-year>2007</xocs:ref-pub-year><xocs:ref-first-fp>490</xocs:ref-first-fp><xocs:ref-last-lp>496</xocs:ref-last-lp><xocs:ref-normalized-initial>C</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib24\"><xocs:ref-normalized-surname>SMITH</xocs:ref-normalized-surname><xocs:ref-pub-year>2003</xocs:ref-pub-year><xocs:ref-first-fp>558</xocs:ref-first-fp><xocs:ref-last-lp>569</xocs:ref-last-lp><xocs:ref-normalized-initial>R</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib25\"><xocs:ref-normalized-surname>DAVIES</xocs:ref-normalized-surname><xocs:ref-pub-year>2004</xocs:ref-pub-year><xocs:ref-first-fp>741</xocs:ref-first-fp><xocs:ref-last-lp>747</xocs:ref-last-lp><xocs:ref-normalized-initial>W</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib26\"><xocs:ref-normalized-surname>KARANJAWALA</xocs:ref-normalized-surname><xocs:ref-pub-year>2000</xocs:ref-pub-year><xocs:ref-first-fp>207</xocs:ref-first-fp><xocs:ref-last-lp>210</xocs:ref-last-lp><xocs:ref-normalized-initial>Z</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid=\"bib27\"><xocs:ref-normalized-surname>BENLIAN</xocs:ref-normalized-surname><xocs:ref-pub-year>1996</xocs:ref-pub-year><xocs:ref-first-fp>431</xocs:ref-first-fp><xocs:ref-last-lp>436</xocs:ref-last-lp><xocs:ref-normalized-initial>P</xocs:ref-normalized-initial></xocs:ref-info></xocs:references><xocs:refkeys><xocs:refkey3>BARELX2008X193</xocs:refkey3><xocs:refkey4lp>BARELX2008X193X199</xocs:refkey4lp><xocs:refkey4ai>BARELX2008X193XO</xocs:refkey4ai><xocs:refkey5>BARELX2008X193X199XO</xocs:refkey5></xocs:refkeys><xocs:open-access><xocs:oa-article-status is-open-access=\"1\" is-open-archive=\"1\">Full</xocs:oa-article-status><xocs:oa-access-effective-date>2013-07-19T09:19:52Z</xocs:oa-access-effective-date><xocs:oa-sponsor><xocs:oa-sponsor-type>ElsevierBranded</xocs:oa-sponsor-type></xocs:oa-sponsor><xocs:oa-user-license>http://www.elsevier.com/open-access/userlicense/1.0/</xocs:oa-user-license><xocs:oa-access-inherited-from winid=\"http://vtw.elsevier.com/content/oaw/00029297_P6M_ESBranded\" wintype=\"OpenArchive\">OA-Window</xocs:oa-access-inherited-from></xocs:open-access><xocs:attachment-metadata-doc><xocs:attachment-set-type>item</xocs:attachment-set-type><xocs:pii-formatted>S0002-9297(08)00410-2</xocs:pii-formatted><xocs:pii-unformatted>S0002929708004102</xocs:pii-unformatted><xocs:eid>1-s2.0-S0002929708004102</xocs:eid><xocs:doi>10.1016/j.ajhg.2008.07.010</xocs:doi><xocs:cid>276895</xocs:cid><xocs:timestamp>2014-12-06T10:38:17.540288-05:00</xocs:timestamp><xocs:cover-date-start>2008-08-08</xocs:cover-date-start><xocs:attachments><xocs:web-pdf><xocs:attachment-eid>1-s2.0-S0002929708004102-main.pdf</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0002929708004102/MAIN/application/pdf/1694fb25e36324858b6ffee6bfc287ea/main.pdf</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0002929708004102/MAIN/application/pdf/1694fb25e36324858b6ffee6bfc287ea/main.pdf</xocs:ucs-locator><xocs:filename>main.pdf</xocs:filename><xocs:extension>pdf</xocs:extension><xocs:pdf-optimized>true</xocs:pdf-optimized><xocs:filesize>878431</xocs:filesize><xocs:web-pdf-purpose>MAIN</xocs:web-pdf-purpose><xocs:web-pdf-page-count>7</xocs:web-pdf-page-count><xocs:web-pdf-images><xocs:web-pdf-image><xocs:attachment-eid>1-s2.0-S0002929708004102-main_1.png</xocs:attachment-eid><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0002929708004102/PREVIEW/image/png/f7aba56b159b0eb276f5e2a0758dffce/main_1.png</xocs:ucs-locator><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0002929708004102/PREVIEW/image/png/f7aba56b159b0eb276f5e2a0758dffce/main_1.png</xocs:ucs-locator><xocs:filename>main_1.png</xocs:filename><xocs:extension>png</xocs:extension><xocs:filesize>85761</xocs:filesize><xocs:pixel-height>849</xocs:pixel-height><xocs:pixel-width>656</xocs:pixel-width><xocs:attachment-type>IMAGE-WEB-PDF</xocs:attachment-type><xocs:pdf-page-num>1</xocs:pdf-page-num></xocs:web-pdf-image></xocs:web-pdf-images></xocs:web-pdf><xocs:attachment><xocs:attachment-eid>1-s2.0-S0002929708004102-gr2_lrg.jpg</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0002929708004102/gr2/HIGHRES/image/jpeg/647a2db43d6daf71fbaab5086bfb6e00/gr2_lrg.jpg</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0002929708004102/gr2/HIGHRES/image/jpeg/647a2db43d6daf71fbaab5086bfb6e00/gr2_lrg.jpg</xocs:ucs-locator><xocs:file-basename>gr2</xocs:file-basename><xocs:filename>gr2_lrg.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>902685</xocs:filesize><xocs:pixel-height>3619</xocs:pixel-height><xocs:pixel-width>3404</xocs:pixel-width><xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0002929708004102-gr1_lrg.jpg</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0002929708004102/gr1/HIGHRES/image/jpeg/ac70b685141bd121e443cffad349fb0a/gr1_lrg.jpg</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0002929708004102/gr1/HIGHRES/image/jpeg/ac70b685141bd121e443cffad349fb0a/gr1_lrg.jpg</xocs:ucs-locator><xocs:file-basename>gr1</xocs:file-basename><xocs:filename>gr1_lrg.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>322507</xocs:filesize><xocs:pixel-height>3531</xocs:pixel-height><xocs:pixel-width>1660</xocs:pixel-width><xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0002929708004102-gr4_lrg.jpg</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0002929708004102/gr4/HIGHRES/image/jpeg/25727ce78490739c581639e6c068a709/gr4_lrg.jpg</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0002929708004102/gr4/HIGHRES/image/jpeg/25727ce78490739c581639e6c068a709/gr4_lrg.jpg</xocs:ucs-locator><xocs:file-basename>gr4</xocs:file-basename><xocs:filename>gr4_lrg.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>547647</xocs:filesize><xocs:pixel-height>2458</xocs:pixel-height><xocs:pixel-width>3403</xocs:pixel-width><xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0002929708004102-gr3_lrg.jpg</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0002929708004102/gr3/HIGHRES/image/jpeg/e147c5398bdc4fb2c203f4980599eae2/gr3_lrg.jpg</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0002929708004102/gr3/HIGHRES/image/jpeg/e147c5398bdc4fb2c203f4980599eae2/gr3_lrg.jpg</xocs:ucs-locator><xocs:file-basename>gr3</xocs:file-basename><xocs:filename>gr3_lrg.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>299643</xocs:filesize><xocs:pixel-height>866</xocs:pixel-height><xocs:pixel-width>3404</xocs:pixel-width><xocs:attachment-type>IMAGE-HIGH-RES</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0002929708004102-gr2.jpg</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0002929708004102/gr2/DOWNSAMPLED/image/jpeg/96fffebb0e8a7a2b1208503b0aaeed5a/gr2.jpg</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0002929708004102/gr2/DOWNSAMPLED/image/jpeg/96fffebb0e8a7a2b1208503b0aaeed5a/gr2.jpg</xocs:ucs-locator><xocs:file-basename>gr2</xocs:file-basename><xocs:filename>gr2.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>141366</xocs:filesize><xocs:pixel-height>818</xocs:pixel-height><xocs:pixel-width>769</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0002929708004102-gr1.jpg</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0002929708004102/gr1/DOWNSAMPLED/image/jpeg/0c195205a830e9180736f2b03dc54dfd/gr1.jpg</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0002929708004102/gr1/DOWNSAMPLED/image/jpeg/0c195205a830e9180736f2b03dc54dfd/gr1.jpg</xocs:ucs-locator><xocs:file-basename>gr1</xocs:file-basename><xocs:filename>gr1.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>39179</xocs:filesize><xocs:pixel-height>798</xocs:pixel-height><xocs:pixel-width>375</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0002929708004102-gr4.jpg</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0002929708004102/gr4/DOWNSAMPLED/image/jpeg/54be4b6efe0d330770882a179f496dc3/gr4.jpg</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0002929708004102/gr4/DOWNSAMPLED/image/jpeg/54be4b6efe0d330770882a179f496dc3/gr4.jpg</xocs:ucs-locator><xocs:file-basename>gr4</xocs:file-basename><xocs:filename>gr4.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>73669</xocs:filesize><xocs:pixel-height>555</xocs:pixel-height><xocs:pixel-width>769</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0002929708004102-gr3.jpg</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0002929708004102/gr3/DOWNSAMPLED/image/jpeg/f21fb581aa2985b79f8213f183b220b3/gr3.jpg</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0002929708004102/gr3/DOWNSAMPLED/image/jpeg/f21fb581aa2985b79f8213f183b220b3/gr3.jpg</xocs:ucs-locator><xocs:file-basename>gr3</xocs:file-basename><xocs:filename>gr3.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>50298</xocs:filesize><xocs:pixel-height>196</xocs:pixel-height><xocs:pixel-width>769</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0002929708004102-gr2.sml</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0002929708004102/gr2/THUMBNAIL/image/gif/980f0d7ccc3acd3b5b4ac76580b8657a/gr2.sml</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0002929708004102/gr2/THUMBNAIL/image/gif/980f0d7ccc3acd3b5b4ac76580b8657a/gr2.sml</xocs:ucs-locator><xocs:file-basename>gr2</xocs:file-basename><xocs:filename>gr2.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>4735</xocs:filesize><xocs:pixel-height>164</xocs:pixel-height><xocs:pixel-width>154</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0002929708004102-gr1.sml</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0002929708004102/gr1/THUMBNAIL/image/gif/e8608eb026a8f70ef36bb14d3578c85e/gr1.sml</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0002929708004102/gr1/THUMBNAIL/image/gif/e8608eb026a8f70ef36bb14d3578c85e/gr1.sml</xocs:ucs-locator><xocs:file-basename>gr1</xocs:file-basename><xocs:filename>gr1.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>2055</xocs:filesize><xocs:pixel-height>164</xocs:pixel-height><xocs:pixel-width>77</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0002929708004102-gr4.sml</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0002929708004102/gr4/THUMBNAIL/image/gif/3fe2db2ba1292dfdfbae4aefe08d928c/gr4.sml</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0002929708004102/gr4/THUMBNAIL/image/gif/3fe2db2ba1292dfdfbae4aefe08d928c/gr4.sml</xocs:ucs-locator><xocs:file-basename>gr4</xocs:file-basename><xocs:filename>gr4.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>6796</xocs:filesize><xocs:pixel-height>158</xocs:pixel-height><xocs:pixel-width>219</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0002929708004102-gr3.sml</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0002929708004102/gr3/THUMBNAIL/image/gif/f982e694dedb394c2ae0d2539f94071b/gr3.sml</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0002929708004102/gr3/THUMBNAIL/image/gif/f982e694dedb394c2ae0d2539f94071b/gr3.sml</xocs:ucs-locator><xocs:file-basename>gr3</xocs:file-basename><xocs:filename>gr3.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>4281</xocs:filesize><xocs:pixel-height>56</xocs:pixel-height><xocs:pixel-width>219</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S0002929708004102-mmc1.pdf</xocs:attachment-eid><xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0002929708004102/mmc1/MAIN/application/pdf/1e0b581e1f6cb3eb62c16dd0ecb6d147/mmc1.pdf</xocs:ucs-locator><xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0002929708004102/mmc1/MAIN/application/pdf/1e0b581e1f6cb3eb62c16dd0ecb6d147/mmc1.pdf</xocs:ucs-locator><xocs:file-basename>mmc1</xocs:file-basename><xocs:filename>mmc1.pdf</xocs:filename><xocs:extension>pdf</xocs:extension><xocs:filesize>266454</xocs:filesize><xocs:attachment-type>APPLICATION</xocs:attachment-type></xocs:attachment></xocs:attachments></xocs:attachment-metadata-doc></xocs:meta><xocs:serial-item><article xmlns=\"http://www.elsevier.com/xml/ja/dtd\" docsubtype=\"fla\" version=\"5.0\" xml:lang=\"en\"><item-info><jid>AJHG</jid><aid>220</aid><ce:pii>S0002-9297(08)00410-2</ce:pii><ce:doi>10.1016/j.ajhg.2008.07.010</ce:doi><ce:copyright type=\"society\" year=\"2008\">The American Society of Human Genetics</ce:copyright></item-info><ce:floats><ce:figure id=\"fig1\"><ce:label>Figure\\xa01</ce:label><ce:caption><ce:simple-para id=\"simple-para0005\" view=\"all\">Clinical Features</ce:simple-para><ce:simple-para id=\"simple-para0010\" view=\"all\">(A) Pedigree of the affected Israeli Arab family. The numbers denote individuals whose DNA samples were analyzed. It can be seen that the disease is maternally transmitted (paternally imprinted).</ce:simple-para><ce:simple-para id=\"simple-para0015\" view=\"all\">(B and C) Dysmorphic features of affected siblings.</ce:simple-para><ce:simple-para id=\"simple-para0020\" view=\"all\">(D) Prominent incisor teeth of young affected individual.</ce:simple-para></ce:caption><ce:link locator=\"gr1\"/></ce:figure><ce:figure id=\"fig2\"><ce:label>Figure\\xa02</ce:label><ce:caption><ce:simple-para id=\"simple-para0025\" view=\"all\">Mapping the KCNK9 Locus</ce:simple-para><ce:simple-para id=\"simple-para0030\" view=\"all\">(A) Partial pedigree and segregation analysis of the affected family. The numbers denote individuals whose DNA samples were analyzed. Haplotypes are represented as columns of numbers; the disease-associated haplotype is shaded. Physical distances between the markers are shown.</ce:simple-para><ce:simple-para id=\"simple-para0035\" view=\"all\">(B) Two-point LOD-score analysis for the polymorphic markers at the <ce:italic>KCNK9</ce:italic> locus. The arrow indicates the gene location.</ce:simple-para></ce:caption><ce:link locator=\"gr2\"/></ce:figure><ce:figure id=\"fig3\"><ce:label>Figure\\xa03</ce:label><ce:caption><ce:simple-para id=\"simple-para0040\" view=\"all\">Analysis of the 770G→A Mutation in Exon 2 of <ce:italic>KCNK9</ce:italic></ce:simple-para><ce:simple-para id=\"simple-para0045\" view=\"all\">Sequence analysis of a healthy obligatory-carrier mother and her affected and healthy offspring.</ce:simple-para></ce:caption><ce:link locator=\"gr3\"/></ce:figure><ce:figure id=\"fig4\"><ce:label>Figure\\xa04</ce:label><ce:caption><ce:simple-para id=\"simple-para0050\" view=\"all\">The K<ce:inf loc=\"post\">2P</ce:inf>9.1-G236R Mutant Does Not Produce Functional Channels</ce:simple-para><ce:simple-para id=\"simple-para0055\" view=\"all\">Macroscopic currents measured by two-electrode voltage clamp.</ce:simple-para><ce:simple-para id=\"simple-para0060\" view=\"all\">(A) Raw current traces for representative oocytes expressing WT-K<ce:inf loc=\"post\">2P</ce:inf>9.1 and K<ce:inf loc=\"post\">2P</ce:inf>9.1-G236R channels and bathed in 5 mM potassium solution. Oocyte membrane potential was held at −80 mV and pulsed from −155 to +40 mV in 15 mV voltage steps for 70 ms with 1\\xa0s interpulse intervals.</ce:simple-para><ce:simple-para id=\"simple-para0065\" view=\"all\">(B) K<ce:inf loc=\"post\">2P</ce:inf>9.1 steady-state current-voltage relationships for WT-K<ce:inf loc=\"post\">2P</ce:inf>9.1 (full circles), K<ce:inf loc=\"post\">2P</ce:inf>9.1-G236R mutated channels (open circles), and coexpression of WT-K<ce:inf loc=\"post\">2P</ce:inf>9.1 + K<ce:inf loc=\"post\">2P</ce:inf>9.1-G236R (triangles) (mean ± SEM, n = 6-9 cells).</ce:simple-para><ce:simple-para id=\"simple-para0070\" view=\"all\">(C) Currents at +40 mV of oocytes injected with equal cRNA amounts of the different channels, as indicated (mean ± standard error of the mean, n = 6–9 cells).</ce:simple-para><ce:simple-para id=\"simple-para0075\" view=\"all\">(D) Predicted membrane topology of a K<ce:inf loc=\"post\">2P</ce:inf>9.1 subunit indicating the two P domains and four transmembrane segments (M1–4). The predicted position of G236 is highlighted in red.</ce:simple-para><ce:simple-para id=\"simple-para0080\" view=\"all\">(E) Surface representation of two opposing KcsA subunits.<ce:cross-ref refid=\"bib7\"><ce:sup loc=\"post\">7</ce:sup></ce:cross-ref> G104 was replaced by an arginine residue (highlighted in red), as in the K<ce:inf loc=\"post\">2P</ce:inf>9.1-G236 mutant. Ribbon representation of the carbon backbone is in dark green, and potassium ions are in light green. Molecular graphics images were produced with the UCSF Chimera (an extensible molecular-modeling system) package from the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco.</ce:simple-para></ce:caption><ce:link locator=\"gr4\"/></ce:figure></ce:floats><head><ce:dochead><ce:textfn>Article</ce:textfn></ce:dochead><ce:title>Maternally Inherited Birk Barel Mental Retardation Dysmorphism Syndrome Caused by a Mutation in the Genomically Imprinted Potassium Channel <ce:italic>KCNK9</ce:italic></ce:title><ce:author-group><ce:author><ce:given-name>Ortal</ce:given-name><ce:surname>Barel</ce:surname><ce:cross-ref refid=\"aff1\"><ce:sup loc=\"post\">1</ce:sup></ce:cross-ref><ce:cross-ref refid=\"fn1\"><ce:sup loc=\"post\">6</ce:sup></ce:cross-ref></ce:author><ce:author><ce:given-name>Stavit A.</ce:given-name><ce:surname>Shalev</ce:surname><ce:cross-ref refid=\"aff2\"><ce:sup loc=\"post\">2</ce:sup></ce:cross-ref><ce:cross-ref refid=\"fn1\"><ce:sup loc=\"post\">6</ce:sup></ce:cross-ref></ce:author><ce:author><ce:given-name>Rivka</ce:given-name><ce:surname>Ofir</ce:surname><ce:cross-ref refid=\"aff1\"><ce:sup loc=\"post\">1</ce:sup></ce:cross-ref></ce:author><ce:author><ce:given-name>Asi</ce:given-name><ce:surname>Cohen</ce:surname><ce:cross-ref refid=\"aff3\"><ce:sup loc=\"post\">3</ce:sup></ce:cross-ref></ce:author><ce:author><ce:given-name>Joel</ce:given-name><ce:surname>Zlotogora</ce:surname><ce:cross-ref refid=\"aff4\"><ce:sup loc=\"post\">4</ce:sup></ce:cross-ref></ce:author><ce:author><ce:given-name>Zamir</ce:given-name><ce:surname>Shorer</ce:surname><ce:cross-ref refid=\"aff5\"><ce:sup loc=\"post\">5</ce:sup></ce:cross-ref></ce:author><ce:author><ce:given-name>Galia</ce:given-name><ce:surname>Mazor</ce:surname><ce:cross-ref refid=\"aff2\"><ce:sup loc=\"post\">2</ce:sup></ce:cross-ref></ce:author><ce:author><ce:given-name>Gal</ce:given-name><ce:surname>Finer</ce:surname><ce:cross-ref refid=\"aff1\"><ce:sup loc=\"post\">1</ce:sup></ce:cross-ref></ce:author><ce:author><ce:given-name>Shareef</ce:given-name><ce:surname>Khateeb</ce:surname><ce:cross-ref refid=\"aff1\"><ce:sup loc=\"post\">1</ce:sup></ce:cross-ref></ce:author><ce:author><ce:given-name>Noam</ce:given-name><ce:surname>Zilberberg</ce:surname><ce:cross-ref refid=\"aff3\"><ce:sup loc=\"post\">3</ce:sup></ce:cross-ref></ce:author><ce:author><ce:given-name>Ohad S.</ce:given-name><ce:surname>Birk</ce:surname><ce:cross-ref refid=\"aff1\"><ce:sup loc=\"post\">1</ce:sup></ce:cross-ref><ce:cross-ref refid=\"aff5\"><ce:sup loc=\"post\">5</ce:sup></ce:cross-ref><ce:cross-ref refid=\"cor1\"><ce:sup loc=\"post\">∗</ce:sup></ce:cross-ref><ce:e-address type=\"email\">obirk@bgu.ac.il</ce:e-address></ce:author><ce:affiliation id=\"aff1\"><ce:label>1</ce:label><ce:textfn>The Morris Kahn Laboratory of Human Genetics, National Institute for Biotechnology in the Negev, Ben Gurion University, Beer-Sheva 84105, Israel</ce:textfn></ce:affiliation><ce:affiliation id=\"aff2\"><ce:label>2</ce:label><ce:textfn>Genetics Institute and Child Development Center, Ha\\'Emek Medical Center, Afula, and the Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa 18101, Israel</ce:textfn></ce:affiliation><ce:affiliation id=\"aff3\"><ce:label>3</ce:label><ce:textfn>Department of Life Sciences and the Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel</ce:textfn></ce:affiliation><ce:affiliation id=\"aff4\"><ce:label>4</ce:label><ce:textfn>Department of Community Genetics, Public Health Services, Ministry of Health, Ramat Gan 52662, Israel</ce:textfn></ce:affiliation><ce:affiliation id=\"aff5\"><ce:label>5</ce:label><ce:textfn>Genetics Institute, Soroka Medical Center, Beer-Sheva 84101, Israel</ce:textfn></ce:affiliation><ce:correspondence id=\"cor1\"><ce:label>∗</ce:label><ce:text>Corresponding author</ce:text></ce:correspondence><ce:footnote id=\"fn1\"><ce:label>6</ce:label><ce:note-para>These authors contributed equally to this manuscript</ce:note-para></ce:footnote></ce:author-group><ce:date-received day=\"12\" month=\"5\" year=\"2008\"/><ce:date-revised day=\"18\" month=\"6\" year=\"2008\"/><ce:date-accepted day=\"2\" month=\"7\" year=\"2008\"/><ce:miscellaneous>Published online: July 31, 2008</ce:miscellaneous><ce:abstract class=\"author\"><ce:abstract-sec><ce:simple-para id=\"simple-para0085\" view=\"all\">We describe a maternally transmitted genomic-imprinting syndrome of mental retardation, hypotonia, and unique dysmorphism with elongated face. We mapped the disease-associated locus to ∼7.27 Mb on chromosome 8q24 and demonstrated that the disease is caused by a missense mutation in the maternal copy of <ce:italic>KCNK9</ce:italic> within this locus. <ce:italic>KCNK9</ce:italic> is maternally transmitted (imprinted with paternal silencing) and encodes K<ce:inf loc=\"post\">2P</ce:inf>9.1, a member of the two pore-domain potassium channel (K<ce:inf loc=\"post\">2P</ce:inf>) subfamily. The mutation fully abolishes the channel\\'s currents—both when functioning as a homodimer or as a heterodimer with K<ce:inf loc=\"post\">2P</ce:inf>3.1.</ce:simple-para></ce:abstract-sec></ce:abstract></head><body view=\"all\"><ce:sections><ce:section id=\"sec1\" view=\"all\"><ce:section-title>Introduction</ce:section-title><ce:para id=\"para0005\" view=\"all\">In contrast with Mendel\\'s theory, for some autosomal human genes, only the paternal or the maternal copy of the gene is expressed. Thus, for a gene that is normally imprinted with paternal silencing, a mutation in the maternal copy of the gene will result in disease, whereas a mutation in the paternal copy will have no effect. Thus far, more than 80\\xa0genes have been demonstrated to be imprinted in humans and mice, yet only a few have been associated with\\xa0a human disease.<ce:cross-ref refid=\"bib1\"><ce:sup loc=\"post\">1</ce:sup></ce:cross-ref> To date, several recognizable developmental syndromes due to abnormalities within specific domains have been described. The most studied genomic-imprinting defects in humans are Prader-Willi (PWS [MIM <ce:inter-ref xlink:href=\"omim:176270\" xlink:type=\"simple\">176270</ce:inter-ref>]) and Angelman (AS [MIM <ce:inter-ref xlink:href=\"omim:105830\" xlink:type=\"simple\">105830</ce:inter-ref>]) syndromes, which are due to paternal and maternal imprinting disorders of genes on chromosome 15q11-q13, and Beckwith-Wiedemann (BWS [MIM <ce:inter-ref xlink:href=\"omim:130650\" xlink:type=\"simple\">130650</ce:inter-ref>]) and Russell-Silver (SRS [MIM <ce:inter-ref xlink:href=\"omim:180860\" xlink:type=\"simple\">180860</ce:inter-ref>]) syndromes, which are associated with genomic imprinting of genes in two adjacent domains on chromosome 11p15.5. Other human imprinting disorders include transient neonatal diabetes (at 6q24) (MIM <ce:inter-ref xlink:href=\"omim:601410\" xlink:type=\"simple\">601410</ce:inter-ref>), maternal and paternal chromosome 14 uniparental-disomy syndromes (at 14q32), and pseudohypoparathyroidism type\\xa01b (PHP1B [MIM <ce:inter-ref xlink:href=\"omim:603233\" xlink:type=\"simple\">603233</ce:inter-ref>]) (at 20q13.2).<ce:cross-ref refid=\"bib1\"><ce:sup loc=\"post\">1</ce:sup></ce:cross-ref> We now describe a\\xa0human syndrome of mental retardation, hypotonia, and characteristic dysmorphism caused by\\xa0a mutation in\\xa0a genomically imprinted gene on chromosome 8.</ce:para></ce:section><ce:section id=\"sec2\" role=\"materials-methods\" view=\"all\"><ce:section-title>Material and Methods</ce:section-title><ce:para id=\"para0010\" view=\"all\">The study was approved by the Institutional Review Board of Soroka Medical Center.</ce:para><ce:para id=\"para0015\" view=\"all\">Genome-wide linkage analysis with the 400 microsatellite markers (ABI PRISM Linkage Mapping Set MD10, Applied Biosystems) and fine mapping were done as previously described.<ce:cross-ref refid=\"bib2\"><ce:sup loc=\"post\">2</ce:sup></ce:cross-ref> Statistical analysis was done with an autosomal-dominant disease model assuming imprinting with paternal silencing. Extended two-point LOD scores were calculated on the entire kindred with SUPERLINK.<ce:cross-ref refid=\"bib3\"><ce:sup loc=\"post\">3</ce:sup></ce:cross-ref></ce:para><ce:para id=\"para0020\" view=\"all\">Fine mapping of the disease-associated genomic locus was performed with 18 markers designed with Tandem Repeats Finder.<ce:cross-ref refid=\"bib4\"><ce:sup loc=\"post\">4</ce:sup></ce:cross-ref> Coding sequences of potassium channel, subfamily K, member 9 (KCNK9 [MIM <ce:inter-ref xlink:href=\"omim:605874\" xlink:type=\"simple\">605874</ce:inter-ref>]) were PCR amplified from genomic DNA and sequenced. Analysis of the mutation in the entire family and controls was performed by restriction analysis of <ce:italic>KCNK9</ce:italic> exon 2 with the restriction enzyme NlaIV on PCR products (the 770G→A mutation abolishes a recognition site). PCR primers used are available upon request.</ce:para><ce:section id=\"sec2.1\" view=\"all\"><ce:section-title>Electrophysiology</ce:section-title><ce:para id=\"para0025\" view=\"all\">Full-length cDNAs of human KCNK9 (TASK3; K<ce:inf loc=\"post\">2P</ce:inf>9.1; <ce:inter-ref xlink:href=\"genbank:NT_008046\" xlink:type=\"simple\">NT_008046</ce:inter-ref>; NP_057685.1) and human KCNK3 (TASK1; K<ce:inf loc=\"post\">2P</ce:inf>3.1; <ce:inter-ref xlink:href=\"genbank:NP_002237\" xlink:type=\"simple\">NP_002237</ce:inter-ref>; MIM <ce:inter-ref xlink:href=\"omim:603220\" xlink:type=\"simple\">603220</ce:inter-ref>) channels were cloned into pMAX and pRAT plasmids, respectively; both plasmids include a T7 RNA polymerase promoter to enable cRNA synthesis, as well as 3′-UTR and 5′-UTR sequences of the <ce:italic>Xenopus laevis</ce:italic> β-actin gene to ensure efficient expression in <ce:italic>Xenopus</ce:italic> oocytes. The mutant was generated with the Quickchange site-directed mutagenesis technique (Stratagene, La Jolla, CA). The mutation was confirmed by DNA sequencing. cRNA was transcribed in\\xa0vitro with T7 polymerase and the AmpliCap High Yield Message Maker (Epicenter, Madison, WI) kit.</ce:para><ce:para id=\"para0030\" view=\"all\"><ce:italic>Xenopus laevis</ce:italic> oocytes were isolated and injected 7 ng of cRNA in 20 nl of RNase-free water. Whole-cell currents were measured 3–4 days after injection by the two-electrode voltage-clamp technique (GeneClamp 500B, Axon Instruments, Union City, CA). Data were sampled at 2 kHz and filtered at 0.5 kHz with Clampex 9.0 software (Axon Instruments, Union City, CA). The pipettes contained 3 M KCl, and the bath solution contained 4 mM KCl, 96 mM NaCl, 1 mM MgCl<ce:inf loc=\"post\">2</ce:inf>, 0.3 mM CaCl<ce:inf loc=\"post\">2</ce:inf>, and 5 mM HEPES (pH 7.4 [adjusted with NaOH]).</ce:para></ce:section></ce:section><ce:section id=\"sec3\" view=\"all\"><ce:section-title>Results</ce:section-title><ce:section id=\"sec3.1\" view=\"all\"><ce:section-title>Clinical Phenotype of the Syndrome</ce:section-title><ce:para id=\"para0035\" view=\"all\">An Israeli Arab kindred presented with an apparently maternally transmitted (imprinted with paternal silencing) syndrome (<ce:float-anchor refid=\"fig1\"/><ce:cross-ref refid=\"fig1\">Figure\\xa01</ce:cross-ref>A). All affected individuals had moderate to severe mental retardation and were hyperactive. Severe feeding difficulties at infancy (requiring tube feeding in most) were followed in all patients by dysphagia of solid foods until near puberty. Generalized hypotonia at an early age was followed by weakness of proximal muscles and of the supra- and infrascapular and trapezius muscles later on. Coordination, tendon reflexes, deep and superficial sensation, and vibration were all within normal limits. Babinski sign was negative. Hearing, vision, and ophthalmologic examination were normal. As depicted in <ce:cross-ref refid=\"fig1\">Figures 1</ce:cross-ref>B–1D, similar dysmorphic features were found in affected individuals, with most elements being more prominent at younger ages: The face was elongated with narrow bitemporal diameter, mild atrophy of temporalis and masseter muscles, and reduced facial movements. The eyebrows were flared, bushy, and arched upward, with downturned eyelids and sparse eyelashes in the inner third of the lower eyelids, and with congested conjunctivae in most patients. Ears were mildly protruding with a very prominent fold of the crux of the helix and a prominent antihelical fold. The nasal bridge was high and narrow with a broad nasal tip. The colummella was normal, but the philtrum was extremely short, broad, and thick in all patients. The maxillary and premaxillary regions were prominent, with hypotonia of the mandible and micrognathia—leading (in combination with the short philtrum) to an open mouth. The lips were thick, with downturned upper lips (“fish mouth”) and a lower lip that was shorter than the upper lip. Most patients had a narrow, high-arched palate with full or submucous cleft and dysphonic speech. Large and protruding incisors were seen in younger patients (<ce:cross-ref refid=\"fig1\">Figure\\xa01</ce:cross-ref>D). All patients had narrow, elongated necks, trunks, and feet. In some infants, mild joint contractures of the hips, elbows, phalanx, and feet were present and became prominent with age. A pilonidal dimple or sinus was evident in most patients. Extensive skeletal X-ray studies were normal. Thorough metabolic work-up, karyotypes, blood levels of muscle-associated enzymes, and EEG and brain CT studies were normal (mild periventricular leukomalacia was present in a single child). Muscle biopsies in two patients were compatible with spinal muscular atrophy (SMA [MIM <ce:inter-ref xlink:href=\"omim:253300\" xlink:type=\"simple\">253300</ce:inter-ref>]), with normal molecular SMA tests. Mitochondria appeared normal on EM examination, and normal activity of the mitochondrial respiratory-chain enzymes was demonstrated in muscle.</ce:para></ce:section><ce:section id=\"sec3.2\" view=\"all\"><ce:section-title>Linkage-Analysis Studies</ce:section-title><ce:para id=\"para0040\" view=\"all\">Genome-wide linkage analysis of seven affected individuals, one healthy individual, and four obligatory-transmitting mothers was done with 400 fluorescent end-labeled polymorphic markers as previously described.<ce:cross-ref refid=\"bib4\"><ce:sup loc=\"post\">4</ce:sup></ce:cross-ref> Assuming the disease is caused by a mutation in a paternally imprinted gene, we looked for a genomic locus with a haplotype shared by the (obligatory transmitting) healthy mothers and their affected children, but not their healthy children. Studies using polymorphic markers excluded noninformative regions as well as six of seven genomic loci identified (data not shown). The remaining single locus spanned ∼37.91 cM (corresponding to 26.34 Mb) on chromosome 8q24, between marker D8S514 and the telomeric end of 8q. Fine mapping of the locus was done, testing DNA samples of the 27 available family members (11 affected and 16 nonaffected) with additional polymorphic markers in the identified interval (details in <ce:cross-ref refid=\"sec2\">Material and Methods</ce:cross-ref>). One affected child (26) in the family presented with a crossing-over event at ATCT-1389, setting the centromeric border of the common interval at ATCT-1389, delineating a ∼7.27 Mb locus (harboring ∼153 known or predicted genes) common to all affected individuals and their mothers in the family (<ce:float-anchor refid=\"fig2\"/><ce:cross-ref refid=\"fig2\">Figure\\xa02</ce:cross-ref>A). Two-point analysis with <ce:italic>SUPERLINK</ce:italic><ce:cross-ref refid=\"bib3\"><ce:sup loc=\"post\">3</ce:sup></ce:cross-ref> demonstrated a LOD score above 5 at θ = 0 for two separate markers within the haplotype (<ce:cross-ref refid=\"fig2\">Figure\\xa02</ce:cross-ref>B).</ce:para></ce:section><ce:section id=\"sec3.3\" view=\"all\"><ce:section-title>Determination of the Specific Gene Mutation</ce:section-title><ce:para id=\"para0045\" view=\"all\">The next step was to identify and sequence candidate genes within the locus that are known to be imprinted in humans or mice. Using specific DNA sequences characteristic of known imprinted genes to screen for previously unreported potentially imprinted genes, Luedi et\\xa0al. recently identified two human imprinted genes on chromosome 8,<ce:cross-ref refid=\"bib5\"><ce:sup loc=\"post\">5</ce:sup></ce:cross-ref> one of which lies within our identified locus: <ce:italic>KCNK9</ce:italic> (also known as K<ce:inf loc=\"post\">2P</ce:inf>9.1 and TASK-3). <ce:italic>KCNK9</ce:italic> has been shown to be imprinted with paternal silencing in humans and mice and to be exclusively expressed from the maternal allele in the brain.<ce:cross-ref refid=\"bib6\"><ce:sup loc=\"post\">6</ce:sup></ce:cross-ref> As shown in <ce:float-anchor refid=\"fig3\"/><ce:cross-ref refid=\"fig3\">Figure\\xa03</ce:cross-ref>, sequence analysis of <ce:italic>KCNK9</ce:italic> (GenBank accession number <ce:inter-ref xlink:href=\"genbank:NM_016601\" xlink:type=\"simple\">NM_016601</ce:inter-ref>) in affected individuals revealed a 770G→A mutation in exon 2, replacing glycine at position 236 by arginine (G236R). The mutation abolishes a recognition site of the restriction enzyme NlaIV, allowing easy analysis of the entire family and controls. Analysis of all 27 DNA samples of the kindred was compatible with the mutation being associated with the disease phenotype, implying dominant inheritance with paternal imprinting. The mutation was not found in any of 548 chromosomes from ethnically matched controls.</ce:para></ce:section><ce:section id=\"sec3.4\" view=\"all\"><ce:section-title>Determination of the Physiological Effect of the K<ce:inf loc=\"post\">2P</ce:inf>9.1 Mutation</ce:section-title><ce:para id=\"para0050\" view=\"all\">The biophysical implications of the K<ce:inf loc=\"post\">2P</ce:inf>9.1-G236R mutation were studied with the two-electrode voltage-clamp technique (<ce:float-anchor refid=\"fig4\"/><ce:cross-ref refid=\"fig4\">Figure\\xa04</ce:cross-ref>). On the basis of the published structure of the KcsA potassium channel,<ce:cross-ref refid=\"bib7\"><ce:sup loc=\"post\">7</ce:sup></ce:cross-ref> the small G236 residue (homologous to KcsA-G104) is expected to lie within the ion-conduction pathway of the channel (<ce:cross-ref refid=\"fig4\">Figure\\xa04</ce:cross-ref>E). Hence, the introduction of the positively charged arginine residue at this position is expected to interfere with potassium conductance by forming both physical and electrostatic barriers. Wild-type and mutant channel cRNAs were transcribed in\\xa0vitro and injected to <ce:italic>Xenopus laevis</ce:italic> oocytes, and whole-cell currents were measured 3–4 days subsequent to injection. Unlike wild-type channels, K<ce:inf loc=\"post\">2P</ce:inf>9.1-G236R channels produced no measurable currents (<ce:cross-ref refid=\"fig4\">Figure\\xa04</ce:cross-ref>). Moreover, coexpression of mutant and wild-type channels resulted in a ∼4-fold decrease in wild-type currents (<ce:cross-ref refid=\"fig4\">Figures 4</ce:cross-ref>B and 4C). Furthermore, a similar dominant-negative effect was observed when the K<ce:inf loc=\"post\">2P</ce:inf>9.1-G236R mutant was coexpressed with human K<ce:inf loc=\"post\">2P</ce:inf>3.1 (also known as TASK-1, KCNK3) (<ce:cross-ref refid=\"fig4\">Figure\\xa04</ce:cross-ref>C), a closely related K<ce:inf loc=\"post\">2P</ce:inf> channel, known to form heterodimers with K<ce:inf loc=\"post\">2P</ce:inf>9.1 in expression systems as well as in native tissues.<ce:cross-ref refid=\"bib8\"><ce:sup loc=\"post\">8</ce:sup></ce:cross-ref> Thus, the loss of current seen in the heterologous system is likely to occur also in\\xa0vivo and cause the disease. The loss of current could be either due to expression of nonfunctional channels or due to failure to traffic to the membrane.</ce:para></ce:section></ce:section><ce:section id=\"sec4\" view=\"all\"><ce:section-title>Discussion</ce:section-title><ce:para id=\"para0055\" view=\"all\">Genomic imprinting has been associated with very few human phenotypes, caused by defects in specific imprinting domains on human autosomes. Each domain is under the regulatory control of an “imprinting center” that harbors a differentially methylated region. A number of molecular mechanisms result in differential silencing of some genes within these domains, making them vulnerable to naturally occurring genetic and epigenetic aberrations.<ce:cross-ref refid=\"bib1\"><ce:sup loc=\"post\">1</ce:sup></ce:cross-ref></ce:para><ce:para id=\"para0060\" view=\"all\">We clearly demonstrate that the disease is caused by a mutation in the maternal copy of <ce:italic>KCNK9</ce:italic> and that the mutation fully abolishes the activity of this potassium channel both when acting as a homodimer and when functioning as a heterodimer. <ce:italic>KCNK9</ce:italic> was recently shown to be imprinted with paternal silencing, well in line with the form of heredity demonstrated in the kindred presented here. <ce:italic>KCNK9</ce:italic> encodes K<ce:inf loc=\"post\">2P</ce:inf>9.1 potassium channel, a member of the two-pore domain (K<ce:inf loc=\"post\">2P</ce:inf>) family.<ce:cross-ref refid=\"bib9\"><ce:sup loc=\"post\">9</ce:sup></ce:cross-ref> K<ce:inf loc=\"post\">2P</ce:inf> potassium channels comprise the newest branch of the potassium-channel superfamily serving to carry leak or “background” currents that are mostly time- and voltage-independent. K<ce:inf loc=\"post\">2P</ce:inf> channels operate as dimers with four transmembrane segments and two pore-forming domains in each subunit (<ce:cross-ref refid=\"fig4\">Figure\\xa04</ce:cross-ref>D). Leak currents shape the duration, frequency, and amplitude of action potentials and regulate cell responsiveness and excitability<ce:cross-ref refid=\"bib8\"><ce:sup loc=\"post\">8</ce:sup></ce:cross-ref> by modulating membrane resting potential and resistance. The 15 human members of the K<ce:inf loc=\"post\">2P</ce:inf> channel family have a wide and diverse anatomical distribution pattern and are involved in numerous physiological processes. To our knowledge, this is the first report of a disease-causing mutation in a member of this gene family. Mammalian K<ce:inf loc=\"post\">2P</ce:inf>9.1 channels are involved in various physiological functions, including adjustment of neuronal excitability<ce:cross-refs refid=\"bib10 bib11 bib12 bib13\"><ce:sup loc=\"post\">10–13</ce:sup></ce:cross-refs> and regulation of aldosterone secretion.<ce:cross-ref refid=\"bib14\"><ce:sup loc=\"post\">14</ce:sup></ce:cross-ref> Human K<ce:inf loc=\"post\">2P</ce:inf>9.1 channels are expressed primarily in the central nervous system and particularly in the cerebellum.<ce:cross-ref refid=\"bib15\"><ce:sup loc=\"post\">15</ce:sup></ce:cross-ref> K<ce:inf loc=\"post\">2P</ce:inf>9.1 activity is modulated by extracellular pH, neurotransmitters, volatile anesthetics, and more.<ce:cross-ref refid=\"bib9\"><ce:sup loc=\"post\">9</ce:sup></ce:cross-ref></ce:para><ce:para id=\"para0065\" view=\"all\"><ce:italic>KCNK9</ce:italic> resides within 6.2 Mb of the marker D8S256, linked with bipolar disorder,<ce:cross-ref refid=\"bib16\"><ce:sup loc=\"post\">16</ce:sup></ce:cross-ref> and has been suggested to be a candidate for idiopathic-absence epilepsies.<ce:cross-ref refid=\"bib17\"><ce:sup loc=\"post\">17</ce:sup></ce:cross-ref> K<ce:inf loc=\"post\">2P</ce:inf>9.1 channels were suggested to play an important role in K<ce:sup loc=\"post\">+</ce:sup>-dependent apoptosis of cerebellar granule neurons in culture<ce:cross-ref refid=\"bib18\"><ce:sup loc=\"post\">18</ce:sup></ce:cross-ref> and in maturation of neurons in the cerebellum during neuronal development.<ce:cross-ref refid=\"bib19\"><ce:sup loc=\"post\">19</ce:sup></ce:cross-ref> Indeed, through the use of knockout mice, K<ce:inf loc=\"post\">2P</ce:inf>9.1 was shown to modulate action-potential firing in cerebellar granule neurons,<ce:cross-ref refid=\"bib20\"><ce:sup loc=\"post\">20</ce:sup></ce:cross-ref> circadian rhythms, cognitive functions, and specific pharmacological effects.<ce:cross-refs refid=\"bib20 bib21\"><ce:sup loc=\"post\">20,21</ce:sup></ce:cross-refs> Moreover, we expect that the physiological impact of a dominant loss-of-function mutation might exceed that of a complete null mutation, because nonfunctional K<ce:inf loc=\"post\">2P</ce:inf>9.1 protein might affect the function of\\xa0associated proteins such as K<ce:inf loc=\"post\">2P</ce:inf>3.1 (<ce:cross-ref refid=\"fig4\">Figure\\xa04</ce:cross-ref>C) and hyperpolarization-activated cyclic-nucleotide-gated (HCN2) channels.<ce:cross-ref refid=\"bib22\"><ce:sup loc=\"post\">22</ce:sup></ce:cross-ref> In cerebellar granule neurons, the standing outward K<ce:sup loc=\"post\">+</ce:sup> current (IKso) corresponds to either K<ce:inf loc=\"post\">2P</ce:inf>9.1 homomeric or K<ce:inf loc=\"post\">2P</ce:inf>9.1/K<ce:inf loc=\"post\">2P</ce:inf>3.1 heteromeric channels. Because K<ce:inf loc=\"post\">2P</ce:inf>3.1 knockout mice exhibited compromised motor performance consistent with altered cerebellar function,<ce:cross-ref refid=\"bib10\"><ce:sup loc=\"post\">10</ce:sup></ce:cross-ref> a mutated K<ce:inf loc=\"post\">2P</ce:inf>9.1 channel is expected to further diminish IKso and perturb neuronal activity. In addition, membrane resting potential of thalamocortical relay neurons is shaped\\xa0by the interaction of K<ce:inf loc=\"post\">2P</ce:inf>9.1 and HCN2 channels.<ce:cross-ref refid=\"bib22\"><ce:sup loc=\"post\">22</ce:sup></ce:cross-ref> HCN channels that conduct I<ce:inf loc=\"post\">h</ce:inf>, a hyperpolarization-triggered cationic current that contributes to the maintenance of neuronal membrane potential, were recently proposed to take part in febrile seizures and epilepsy.<ce:cross-ref refid=\"bib23\"><ce:sup loc=\"post\">23</ce:sup></ce:cross-ref> We thus hypothesize that damaging the possible K<ce:inf loc=\"post\">2P</ce:inf>9.1-HCN2 association might also alter the I<ce:inf loc=\"post\">h</ce:inf> current and potentially contribute to the phenotype described here. Moreover, we expect K<ce:inf loc=\"post\">2P</ce:inf>9.1 to have a more pivotal role in human cerebellum than in mice because of its high relative expression levels.<ce:cross-ref refid=\"bib15\"><ce:sup loc=\"post\">15</ce:sup></ce:cross-ref> Taken together, the K<ce:inf loc=\"post\">2P</ce:inf>9.1 loss of function during brain development specifically disrupts the efficiency of the cerebro-cerebellar pathways, resulting in cognitive deficits and deterioration in muscle strength and function.</ce:para><ce:para id=\"para0070\" view=\"all\">Imprinting of both the human and mouse orthologs of this gene does not seem to be regulated by short-range <ce:italic>cis</ce:italic>-acting differential methylation at their CpG-island promoter.<ce:cross-ref refid=\"bib6\"><ce:sup loc=\"post\">6</ce:sup></ce:cross-ref> In the mouse, <ce:italic>Kcnk9</ce:italic> is located on chromosome 15, 260 kb downstream of the imprinted <ce:italic>Peg13</ce:italic> gene, a non-protein-coding RNA gene of unknown function. Similar to <ce:italic>Kcnk9</ce:italic>, <ce:italic>Peg13</ce:italic> is expressed predominantly in brain, but, in contrast, the maternal allele is silenced and marked by DNA methylation in somatic tissues.<ce:cross-ref refid=\"bib24\"><ce:sup loc=\"post\">24</ce:sup></ce:cross-ref> Nearly full methylation of the <ce:italic>Peg13</ce:italic> differentially methylated region (DMR) was shown in mature oocytes with near complete absence of methylation in sperm DNA. It was thus hypothesized that the nearby murine <ce:italic>Peg13</ce:italic>-DMR acts as a long-range acting imprinting control element controlling the imprinting of the distal murine <ce:italic>Kcnk9</ce:italic> gene. To date, there is no known <ce:italic>Peg13</ce:italic> or <ce:italic>Peg13</ce:italic>-DMR human homolog,<ce:cross-refs refid=\"bib6 bib24 bib25\"><ce:sup loc=\"post\">6,24,25</ce:sup></ce:cross-refs> and the mechanism of imprinting of human <ce:italic>KCNK9</ce:italic> remains to be elucidated.</ce:para><ce:para id=\"para0075\" view=\"all\">To our knowledge, the syndrome we describe is the first human syndrome caused by a defect in a specific imprinted gene on chromosome 8. Imprinting syndromes can evolve from a mutation or deletion of the “active” copy of an imprinted gene, but they can also be caused by defects in an adjacent imprinting center or by uniparental disomy of the “inactive” copy of the gene. A single previous report suggested possible association of maternal uniprental disomy of chromosome 8 with early-onset ileal carcinoid tumor.<ce:cross-ref refid=\"bib26\"><ce:sup loc=\"post\">26</ce:sup></ce:cross-ref> This finding does not conflict with our data, and it remains to be seen whether this single case is an incidental finding or whether it reflects a true phenotypic effect of unimaternal disomy of chromosome 8. Of more relevance to our findings is a single case report<ce:cross-ref refid=\"bib27\"><ce:sup loc=\"post\">27</ce:sup></ce:cross-ref> demonstrating that paternal uniparental disomy of chromosome 8 found in lymphocytes is not associated with a human clinical phenotype. This latter report in conjunction with our data can be explained in several ways. One option is that the previously reported case of unipaternal disomy of chromosome 8 was a mosaic. Thus, for instance, it might reflect a trisomy rescue that occurred differently in various tissues, resulting in unipaternal disomy in blood cells, yet in one maternal and one parental copy of chromosome 8 in all or most cells of neuronal tissues. However, because there is no evidence of any moasicism in the blood of the individual reported, the above suggestion is possible yet not very likely. Alternatively and perhaps more likely, the previously reported case of paternal uniparental disomy is indeed such in all tissues. In such a case, it might well be that complete null mutation and loss of function of human K<ce:inf loc=\"post\">2P</ce:inf>9.1 is compensated for by other molecules and has no phenotypic effect. This would then suggest that the missense mutation we describe might exert a dominant-negative effect on other molecules, as suggested by the dominant-negative effect that was observed when the K<ce:inf loc=\"post\">2P</ce:inf>9.1-G236R mutant was coexpressed with human K<ce:inf loc=\"post\">2P</ce:inf>3.1 (<ce:cross-ref refid=\"fig4\">Figure\\xa04</ce:cross-ref>C). If this is the case, this would be to the best of our knowledge the first report of a mutation in a genomically imprinted gene causing a human phenotype through a dominant-negative effect on other (nonimprinted) molecules. If this interpretation is true, null mutations (or deletions) of <ce:italic>KCNK9</ce:italic> would have no phenotypic effect in humans. Future identification and characterization of more cases of human unipaternal disomy of chromosome 8 will allow better understanding of the mechanism through which the phenotype we describe evolves and will determine whether unipaternal disomy of human chromsome 8 (or null mutations or deletions of <ce:italic>KCNK9</ce:italic>) are of clinical significance.</ce:para></ce:section></ce:sections><ce:acknowledgment><ce:section-title>Acknowledgments</ce:section-title><ce:para id=\"para0080\" view=\"all\">We deeply thank the Morris Kahn Family Foundation for making this study possible. This work was also supported by grants from the Israel Science Foundation (431/03) and the Zlotowski Center for Neuroscience to N.Z. We thank Professor Hanna Mandel for the metabolic work-up; Professor Shapira for the analysis of muscle biopsies; Dr. Dan Reich and the team at the Department of Neonatology, Tal Shoshani, for technical assistance; Professor Juan (Moshe) Chemke, Professor Dvora Abeliovich, Dr. Morkos Siman, and Dr. Ahmed Haj-Daud for clinical insights; the families and patients; and the devoted family physicians and pediatricians responsible for the routine medical care of the family members in their communities.</ce:para></ce:acknowledgment><ce:appendices view=\"all\"><ce:section view=\"compact-standard\" id=\"app1\"><ce:section-title>Supplemental Data</ce:section-title><ce:para id=\"para0085\" view=\"all\">Supplemental Data include a genome scan and can be found with this article online at <ce:inter-ref xlink:href=\"http://www.ajhg.org/\" xlink:type=\"simple\">http://www.ajhg.org/</ce:inter-ref>.</ce:para></ce:section><ce:section view=\"extended\" id=\"app2\"><ce:section-title>Supplemental Data</ce:section-title><ce:para id=\"para0090\" view=\"all\"><ce:display><ce:e-component id=\"mmc1\"><ce:label>Document S1. Genome Scan</ce:label><ce:link locator=\"mmc1\"/></ce:e-component></ce:display></ce:para></ce:section><ce:section id=\"app3\" view=\"all\"><ce:section-title>Web Resources</ce:section-title><ce:para id=\"para0095\" view=\"all\">The URLs for data presented herein are as follows:<ce:list id=\"list0005\"><ce:list-item id=\"list-item0005\"><ce:para id=\"para0100\" view=\"all\">Online Mendelian Inheritance in Man (OMIM), <ce:inter-ref xlink:href=\"http://www.ncbi.nlm.nih.gov/Omim/\" xlink:type=\"simple\">http://www.ncbi.nlm.nih.gov/Omim/</ce:inter-ref></ce:para></ce:list-item><ce:list-item id=\"list-item0010\"><ce:para id=\"para0105\" view=\"all\">UCSF Chimera, <ce:inter-ref xlink:href=\"http://www.cgl.ucsf.edu/chimera\" xlink:type=\"simple\">http://www.cgl.ucsf.edu/chimera</ce:inter-ref></ce:para></ce:list-item></ce:list></ce:para></ce:section></ce:appendices></body><tail view=\"all\"><ce:bibliography id=\"bibliography0005\" view=\"all\"><ce:section-title>References</ce:section-title><ce:bibliography-sec id=\"bibliography-sec0005\"><ce:bib-reference id=\"bib1\"><ce:label>1</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>I.K.</ce:given-name><ce:surname>Temple</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Imprinting in human disease with special reference to transient neonatal diabetes and Beckwith-Wiedemann syndrome</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Endocr. Dev.</sb:maintitle></sb:title><sb:volume-nr>12</sb:volume-nr></sb:series><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>113</sb:first-page><sb:last-page>123</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib2\"><ce:label>2</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Harel</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Goldberg</ce:surname></sb:author><sb:author><ce:given-name>S.A.</ce:given-name><ce:surname>Shalev</ce:surname></sb:author><sb:author><ce:given-name>I.</ce:given-name><ce:surname>Chervinski</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Ofir</ce:surname></sb:author><sb:author><ce:given-name>O.S.</ce:given-name><ce:surname>Birk</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Limb-girdle muscular dystrophy 2I: Phenotypic variability within a large consanguineous Bedouin family associated with a novel FKRP mutation</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Eur. J. Hum. Genet.</sb:maintitle></sb:title><sb:volume-nr>12</sb:volume-nr></sb:series><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>38</sb:first-page><sb:last-page>43</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib3\"><ce:label>3</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Fishelson</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Geiger</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Exact genetic linkage computations for general pedigrees</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Bioinformatics</sb:maintitle></sb:title><sb:volume-nr>18</sb:volume-nr></sb:series><sb:date>2002</sb:date></sb:issue><sb:pages><sb:first-page>S189</sb:first-page><sb:last-page>S198</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib4\"><ce:label>4</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Benson</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Tandem repeats finder: A program to analyze DNA sequences</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nucleic Acids Res.</sb:maintitle></sb:title><sb:volume-nr>27</sb:volume-nr></sb:series><sb:date>1999</sb:date></sb:issue><sb:pages><sb:first-page>573</sb:first-page><sb:last-page>580</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib5\"><ce:label>5</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>P.P.</ce:given-name><ce:surname>Luedi</ce:surname></sb:author><sb:author><ce:given-name>F.S.</ce:given-name><ce:surname>Dietrich</ce:surname></sb:author><sb:author><ce:given-name>J.R.</ce:given-name><ce:surname>Weidman</ce:surname></sb:author><sb:author><ce:given-name>J.M.</ce:given-name><ce:surname>Bosko</ce:surname></sb:author><sb:author><ce:given-name>R.L.</ce:given-name><ce:surname>Jirtle</ce:surname></sb:author><sb:author><ce:given-name>A.J.</ce:given-name><ce:surname>Hartemink</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Computational and experimental identification of novel human imprinted genes</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Genome Res.</sb:maintitle></sb:title><sb:volume-nr>17</sb:volume-nr></sb:series><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>1723</sb:first-page><sb:last-page>1730</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib6\"><ce:label>6</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Ruf</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Bähring</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Galetzka</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Pliushch</ce:surname></sb:author><sb:author><ce:given-name>F.C.</ce:given-name><ce:surname>Luft</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Nürnberg</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Haaf</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Kelsey</ce:surname></sb:author><sb:author><ce:given-name>U.</ce:given-name><ce:surname>Zechner</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Sequence-based bioinformatic prediction and QUASEP identify genomic imprinting of the KCNK9 potassium channel gene in mouse and human</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Hum. Mol. Genet.</sb:maintitle></sb:title><sb:volume-nr>16</sb:volume-nr></sb:series><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>2591</sb:first-page><sb:last-page>2599</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib7\"><ce:label>7</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>D.A.</ce:given-name><ce:surname>Doyle</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Morais Cabral</ce:surname></sb:author><sb:author><ce:given-name>R.A.</ce:given-name><ce:surname>Pfuetzner</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Kuo</ce:surname></sb:author><sb:author><ce:given-name>J.M.</ce:given-name><ce:surname>Gulbis</ce:surname></sb:author><sb:author><ce:given-name>S.L.</ce:given-name><ce:surname>Cohen</ce:surname></sb:author><sb:author><ce:given-name>B.T.</ce:given-name><ce:surname>Chait</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>MacKinnon</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The structure of the potassium channel: Molecular basis of K<ce:sup loc=\"post\">+</ce:sup> conduction and selectivity</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Science</sb:maintitle></sb:title><sb:volume-nr>280</sb:volume-nr></sb:series><sb:date>1998</sb:date></sb:issue><sb:pages><sb:first-page>69</sb:first-page><sb:last-page>77</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib8\"><ce:label>8</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>S.A.</ce:given-name><ce:surname>Goldstein</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Bockenhauer</ce:surname></sb:author><sb:author><ce:given-name>I.</ce:given-name><ce:surname>O\\'Kelly</ce:surname></sb:author><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Zilberberg</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Potassium leak channels and the KCNK family of two-P-domain subunits</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nat. Rev. Neurosci.</sb:maintitle></sb:title><sb:volume-nr>2</sb:volume-nr></sb:series><sb:date>2001</sb:date></sb:issue><sb:pages><sb:first-page>175</sb:first-page><sb:last-page>184</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib9\"><ce:label>9</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Kim</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Bang</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Kim</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>TASK-3, a new member of the tandem pore K<ce:sup loc=\"post\">+</ce:sup> channel family</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Biol. Chem.</sb:maintitle></sb:title><sb:volume-nr>275</sb:volume-nr></sb:series><sb:date>2000</sb:date></sb:issue><sb:pages><sb:first-page>9340</sb:first-page><sb:last-page>9347</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib10\"><ce:label>10</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>M.I.</ce:given-name><ce:surname>Aller</ce:surname></sb:author><sb:author><ce:given-name>E.L.</ce:given-name><ce:surname>Veale</ce:surname></sb:author><sb:author><ce:given-name>A.M.</ce:given-name><ce:surname>Linden</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Sandu</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Schwaninger</ce:surname></sb:author><sb:author><ce:given-name>L.J.</ce:given-name><ce:surname>Evans</ce:surname></sb:author><sb:author><ce:given-name>E.R.</ce:given-name><ce:surname>Korpi</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Mathie</ce:surname></sb:author><sb:author><ce:given-name>W.</ce:given-name><ce:surname>Wisden</ce:surname></sb:author><sb:author><ce:given-name>S.G.</ce:given-name><ce:surname>Brickley</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Modifying the subunit composition of TASK channels alters the modulation of a leak conductance in cerebellar granule neurons</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Neurosci.</sb:maintitle></sb:title><sb:volume-nr>25</sb:volume-nr></sb:series><sb:date>2005</sb:date></sb:issue><sb:pages><sb:first-page>11455</sb:first-page><sb:last-page>11467</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib11\"><ce:label>11</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Kang</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Han</ce:surname></sb:author><sb:author><ce:given-name>E.M.</ce:given-name><ce:surname>Talley</ce:surname></sb:author><sb:author><ce:given-name>D.A.</ce:given-name><ce:surname>Bayliss</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Kim</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Functional expression of TASK-1/TASK-3 heteromers in cerebellar granule cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Physiol.</sb:maintitle></sb:title><sb:volume-nr>554</sb:volume-nr></sb:series><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>64</sb:first-page><sb:last-page>77</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib12\"><ce:label>12</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>A.P.</ce:given-name><ce:surname>Berg</ce:surname></sb:author><sb:author><ce:given-name>E.M.</ce:given-name><ce:surname>Talley</ce:surname></sb:author><sb:author><ce:given-name>J.P.</ce:given-name><ce:surname>Manger</ce:surname></sb:author><sb:author><ce:given-name>D.A.</ce:given-name><ce:surname>Bayliss</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Motoneurons express heteromeric TWIK-related acid-sensitive K<ce:sup loc=\"post\">+</ce:sup> (TASK) channels containing TASK-1 (KCNK3) and TASK-3 (KCNK9) subunits</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Neurosci.</sb:maintitle></sb:title><sb:volume-nr>24</sb:volume-nr></sb:series><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>6693</sb:first-page><sb:last-page>6702</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib13\"><ce:label>13</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>S.G.</ce:given-name><ce:surname>Meuth</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Budde</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Kanyshkova</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Broicher</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Munsch</ce:surname></sb:author><sb:author><ce:given-name>H.C.</ce:given-name><ce:surname>Pape</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Contribution of TWIK-related acid-sensitive K<ce:sup loc=\"post\">+</ce:sup> channel 1 (TASK1) and TASK3 channels to the control of activity modes in thalamocortical neurons</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Neurosci.</sb:maintitle></sb:title><sb:volume-nr>23</sb:volume-nr></sb:series><sb:date>2003</sb:date></sb:issue><sb:pages><sb:first-page>6460</sb:first-page><sb:last-page>6469</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib14\"><ce:label>14</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Czirják</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Enyedi</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>TASK-3 dominates the background potassium conductance in rat adrenal glomerulosa cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Mol. Endocrinol.</sb:maintitle></sb:title><sb:volume-nr>16</sb:volume-nr></sb:series><sb:date>2002</sb:date></sb:issue><sb:pages><sb:first-page>621</sb:first-page><sb:last-page>629</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib15\"><ce:label>15</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>Z.</ce:given-name><ce:surname>Rusznák</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Pocsai</ce:surname></sb:author><sb:author><ce:given-name>I.</ce:given-name><ce:surname>Kovács</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Pór</ce:surname></sb:author><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Pál</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Bíró</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Szücs</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Differential distribution of TASK-1, TASK-2 and TASK-3 immunoreactivities in the rat and human cerebellum</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cell. Mol. Life Sci.</sb:maintitle></sb:title><sb:volume-nr>61</sb:volume-nr></sb:series><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>1532</sb:first-page><sb:last-page>1542</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib16\"><ce:label>16</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>M.G.</ce:given-name><ce:surname>McInnis</ce:surname></sb:author><sb:author><ce:given-name>T.H.</ce:given-name><ce:surname>Lan</ce:surname></sb:author><sb:author><ce:given-name>V.L.</ce:given-name><ce:surname>Willour</ce:surname></sb:author><sb:author><ce:given-name>F.J.</ce:given-name><ce:surname>McMahon</ce:surname></sb:author><sb:author><ce:given-name>S.G.</ce:given-name><ce:surname>Simpson</ce:surname></sb:author><sb:author><ce:given-name>A.M.</ce:given-name><ce:surname>Addington</ce:surname></sb:author><sb:author><ce:given-name>D.F.</ce:given-name><ce:surname>MacKinnon</ce:surname></sb:author><sb:author><ce:given-name>J.B.</ce:given-name><ce:surname>Potash</ce:surname></sb:author><sb:author><ce:given-name>A.T.</ce:given-name><ce:surname>Mahoney</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Chellis</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Genome-wide scan of bipolar disorder in 65 pedigrees: Supportive evidence for linkage at 8q24, 18q22, 4q32, 2p12, and 13q12</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Mol. Psychiatry</sb:maintitle></sb:title><sb:volume-nr>8</sb:volume-nr></sb:series><sb:date>2003</sb:date></sb:issue><sb:pages><sb:first-page>288</sb:first-page><sb:last-page>298</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib17\"><ce:label>17</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Zara</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Bianchi</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Avanzini</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Di Donato</ce:surname></sb:author><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Castellotti</ce:surname></sb:author><sb:author><ce:given-name>P.I.</ce:given-name><ce:surname>Patel</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Pandolfo</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Mapping of genes predisposing to idiopathic generalized epilepsy</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Hum. Mol. Genet.</sb:maintitle></sb:title><sb:volume-nr>4</sb:volume-nr></sb:series><sb:date>1995</sb:date></sb:issue><sb:pages><sb:first-page>1201</sb:first-page><sb:last-page>1207</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib18\"><ce:label>18</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>I.</ce:given-name><ce:surname>Lauritzen</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Zanzouri</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Honoré</ce:surname></sb:author><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Duprat</ce:surname></sb:author><sb:author><ce:given-name>M.U.</ce:given-name><ce:surname>Ehrengruber</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Lazdunski</ce:surname></sb:author><sb:author><ce:given-name>A.J.</ce:given-name><ce:surname>Patel</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>K<ce:sup loc=\"post\">+</ce:sup>-dependent cerebellar granule neuron apoptosis. Role of TASK leak K<ce:sup loc=\"post\">+</ce:sup> channels</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Biol. Chem.</sb:maintitle></sb:title><sb:volume-nr>278</sb:volume-nr></sb:series><sb:date>2003</sb:date></sb:issue><sb:pages><sb:first-page>32068</sb:first-page><sb:last-page>32076</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib19\"><ce:label>19</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Zanzouri</ce:surname></sb:author><sb:author><ce:given-name>I.</ce:given-name><ce:surname>Lauritzen</ce:surname></sb:author><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Duprat</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Mazzuca</ce:surname></sb:author><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Lesage</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Lazdunski</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Patel</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Membrane potential-regulated transcription of the resting K<ce:sup loc=\"post\">+</ce:sup> conductance TASK-3 via the calcineurin pathway</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Biol. Chem.</sb:maintitle></sb:title><sb:volume-nr>281</sb:volume-nr></sb:series><sb:date>2006</sb:date></sb:issue><sb:pages><sb:first-page>28910</sb:first-page><sb:last-page>28918</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib20\"><ce:label>20</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>S.G.</ce:given-name><ce:surname>Brickley</ce:surname></sb:author><sb:author><ce:given-name>M.I.</ce:given-name><ce:surname>Aller</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Sandu</ce:surname></sb:author><sb:author><ce:given-name>E.L.</ce:given-name><ce:surname>Veale</ce:surname></sb:author><sb:author><ce:given-name>F.G.</ce:given-name><ce:surname>Alder</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Sambi</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Mathie</ce:surname></sb:author><sb:author><ce:given-name>W.</ce:given-name><ce:surname>Wisden</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>TASK-3 two-pore domain potassium channels enable sustained high-frequency firing in cerebellar granule neurons</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Neurosci.</sb:maintitle></sb:title><sb:volume-nr>27</sb:volume-nr></sb:series><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>9329</sb:first-page><sb:last-page>9340</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib21\"><ce:label>21</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>A.M.</ce:given-name><ce:surname>Linden</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Sandu</ce:surname></sb:author><sb:author><ce:given-name>M.I.</ce:given-name><ce:surname>Aller</ce:surname></sb:author><sb:author><ce:given-name>O.Y.</ce:given-name><ce:surname>Vekovischeva</ce:surname></sb:author><sb:author><ce:given-name>P.H.</ce:given-name><ce:surname>Rosenberg</ce:surname></sb:author><sb:author><ce:given-name>W.</ce:given-name><ce:surname>Wisden</ce:surname></sb:author><sb:author><ce:given-name>E.R.</ce:given-name><ce:surname>Korpi</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>TASK-3 knockout mice exhibit exaggerated nocturnal activity, impairments in cognitive functions, and reduced sensitivity to inhalation anesthetics</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Pharmacol. Exp. Ther.</sb:maintitle></sb:title><sb:volume-nr>323</sb:volume-nr></sb:series><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>924</sb:first-page><sb:last-page>934</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib22\"><ce:label>22</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>S.G.</ce:given-name><ce:surname>Meuth</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Kanyshkova</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Meuth</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Landgraf</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Munsch</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Ludwig</ce:surname></sb:author><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Hofmann</ce:surname></sb:author><sb:author><ce:given-name>H.C.</ce:given-name><ce:surname>Pape</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Budde</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Membrane resting potential of thalamocortical relay neurons is shaped by the interaction among TASK3 and HCN2 channels</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Neurophysiol.</sb:maintitle></sb:title><sb:volume-nr>96</sb:volume-nr></sb:series><sb:date>2006</sb:date></sb:issue><sb:pages><sb:first-page>1517</sb:first-page><sb:last-page>1529</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib23\"><ce:label>23</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>C.M.</ce:given-name><ce:surname>Dubé</ce:surname></sb:author><sb:author><ce:given-name>A.L.</ce:given-name><ce:surname>Brewster</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Richichi</ce:surname></sb:author><sb:author><ce:given-name>Q.</ce:given-name><ce:surname>Zha</ce:surname></sb:author><sb:author><ce:given-name>T.Z.</ce:given-name><ce:surname>Baram</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Fever, febrile seizures and epilepsy</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Trends Neurosci.</sb:maintitle></sb:title><sb:volume-nr>30</sb:volume-nr></sb:series><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>490</sb:first-page><sb:last-page>496</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib24\"><ce:label>24</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>R.J.</ce:given-name><ce:surname>Smith</ce:surname></sb:author><sb:author><ce:given-name>W.</ce:given-name><ce:surname>Dean</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Konfortova</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Kelsey</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Identification of novel imprinted genes in a genome-wide screen for maternal methylation</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Genome Res.</sb:maintitle></sb:title><sb:volume-nr>13</sb:volume-nr></sb:series><sb:date>2003</sb:date></sb:issue><sb:pages><sb:first-page>558</sb:first-page><sb:last-page>569</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib25\"><ce:label>25</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>W.</ce:given-name><ce:surname>Davies</ce:surname></sb:author><sb:author><ce:given-name>R.J.</ce:given-name><ce:surname>Smith</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Kelsey</ce:surname></sb:author><sb:author><ce:given-name>L.S.</ce:given-name><ce:surname>Wilkinson</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Expression patterns of the novel imprinted genes Nap1l5 and Peg13 and their non-imprinted host genes in the adult mouse brain</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Gene Expr. Patterns</sb:maintitle></sb:title><sb:volume-nr>4</sb:volume-nr></sb:series><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>741</sb:first-page><sb:last-page>747</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib26\"><ce:label>26</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>Z.E.</ce:given-name><ce:surname>Karanjawala</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Kääriäinen</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Ghosh</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Tannenbaum</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Martin</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Ally</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Tuomilehto</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Valle</ce:surname></sb:author><sb:author><ce:given-name>F.S.</ce:given-name><ce:surname>Collins</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Complete maternal isodisomy of chromosome 8 in an individual with an early-onset ileal carcinoid tumor</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Am. J. Med. Genet.</sb:maintitle></sb:title><sb:volume-nr>93</sb:volume-nr></sb:series><sb:date>2000</sb:date></sb:issue><sb:pages><sb:first-page>207</sb:first-page><sb:last-page>210</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id=\"bib27\"><ce:label>27</ce:label><sb:reference><sb:contribution langtype=\"en\"><sb:authors><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Benlian</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Foubert</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Gagné</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Bernard</ce:surname></sb:author><sb:author><ce:given-name>J.L.</ce:given-name><ce:surname>De Gennes</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Langlois</ce:surname></sb:author><sb:author><ce:given-name>W.</ce:given-name><ce:surname>Robinson</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Hayden</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Complete paternal isodisomy for chromosome 8 unmasked by lipoprotein lipase deficiency</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Am. J. Hum. Genet.</sb:maintitle></sb:title><sb:volume-nr>59</sb:volume-nr></sb:series><sb:date>1996</sb:date></sb:issue><sb:pages><sb:first-page>431</sb:first-page><sb:last-page>436</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference></ce:bibliography-sec></ce:bibliography></tail></article></xocs:serial-item></xocs:doc></originalText></full-text-retrieval-response>',\n",
       " 'TASK1 (K(2P)3.1) two-pore-domain K(+) channels contribute substantially to the resting membrane potential in human pulmonary artery smooth muscle cells (hPASMC), modulating vascular tone and diameter. The endothelin-1 (ET-1) pathway mediates vasoconstriction and is an established target of pulmonary arterial hypertension (PAH) therapy. ET-1-mediated inhibition of TASK1 currents in hPASMC is implicated in the pathophysiology of PAH. This study was designed to elucidate molecular mechanisms underlying inhibition of TASK1 channels by ET-1. Two-electrode voltage clamp and whole-cell patch clamp electrophysiology was used to record TASK1 currents from hPASMC and Xenopus oocytes. ET-1 inhibited TASK1-mediated I(KN) currents in hPASMC, an effect attenuated by Rho kinase inhibition with Y-27632. In Xenopus oocytes, TASK1 current reduction by ET-1 was mediated by endothelin receptors ET(A) (IC(50) = 0.08 nM) and ET(B) (IC(50) = 0.23 nM) via Rho kinase signalling. TASK1 channels contain two putative Rho kinase phosphorylation sites, Ser(336) and Ser(393) . Mutation of Ser(393) rendered TASK1 channels insensitive to ET(A) - or ET(B)-mediated current inhibition. In contrast, removal of Ser(336) selectively attenuated ET(A) -dependent TASK1 regulation without affecting the ET(B) pathway. ET-1 regulated vascular TASK1 currents through ET(A) and ET(B) receptors mediated by downstream activation of Rho kinase and direct channel phosphorylation. The Rho kinase pathway in PASMC may provide a more specific therapeutic target in pulmonary arterial hypertension treatment.']"
      ]
     },
     "execution_count": 32,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "list(kcnk3_content.values())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "INFO: [2019-12-10 14:54:16] /Users/albertsteppi/adeft/adeft/modeling/find_anomalies.py - Best score of -0.37575757575757573 found for parameter values:\n",
      "{'nu': 0.2, 'max_features': 100, 'ngram_range': (1, 1)}\n"
     ]
    }
   ],
   "source": [
    "anomaly_detector.cv(list(kcnk3_content.values()), [], param_grid, cv=5, n_jobs=8)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.6242424242424243"
      ]
     },
     "execution_count": 35,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "anomaly_detector.specificity"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {},
   "outputs": [],
   "source": [
    "preds = anomaly_detector.predict(task_content.values())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.7244318181818182"
      ]
     },
     "execution_count": 48,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sum(preds)/len(preds)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(0.8751381423792146, 0.9345610535987627)"
      ]
     },
     "execution_count": 39,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "anomaly_detector.confidence_interval(task_content.values(), sensitivity=0.75)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "metadata": {},
   "outputs": [],
   "source": [
    "task1_stmts = list(channel_texts.values())[2]['task1']\n",
    "task1_stmts = [x[0] for x in task1_stmts]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0"
      ]
     },
     "execution_count": 52,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(task1_stmts)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "from adeft.modeling.find_anomalies import _sensitivity_score, _specificity_score"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "y = [0, 0, 0, 0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "preds = [0, 0, 1, 1]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "No positive examples in sample. Returning 0.0\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "0.0"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "_sensitivity_score(y, preds)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "2 2\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "0.5"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "_specificity_score(y, preds)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 58,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.5"
      ]
     },
     "execution_count": 58,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "_sensitivity_score(y, preds)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "1.0"
      ]
     },
     "execution_count": 59,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "_specificity_score(y, preds)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 60,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.0"
      ]
     },
     "execution_count": 60,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "_specificity_score(preds, y)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 61,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "1.0"
      ]
     },
     "execution_count": 61,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "_sensitivity_score(preds, y)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "metadata": {},
   "outputs": [],
   "source": [
    "t = [[1, 2, 3], [1, 2, 3], [3, 2, 1]]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 53,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>a</th>\n",
       "      <th>b</th>\n",
       "      <th>c</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>3</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   a  b  c\n",
       "0  1  2  3\n",
       "1  1  2  3\n",
       "2  3  2  1"
      ]
     },
     "execution_count": 53,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pd.DataFrame(t, columns=['a', 'b', 'c'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.5"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
